PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Kubli, LR; Pinto, RL; Burrows, HL; Littlefield, PD; Brungart, DS				Kubli, Lina R.; Pinto, Robin L.; Burrows, Holly L.; Littlefield, Philip D.; Brungart, Douglas S.			The Effects of Repeated Low-Level Blast Exposure on Hearing in Marines	NOISE & HEALTH			English	Article						Head trauma; military injury; peripheral nerve injury; traumatic brain injury	IN-NOISE TEST; PERFORMANCE; INJURY; SPEECH	Background: The study evaluates a group of Military Service Members specialized in blast explosive training called "Breachers" who are routinely exposed to multiple low-level blasts while teaching breaching at the U.S. Marine Corps in Quantico Virginia. The objective of this study was to determine if there are any acute or long-term auditory changes due to repeated low-level blast exposures used in training. The performance of the instructor group "Breachers" was compared to a control group, "Engineers". Methods: A total of 11 Breachers and four engineers were evaluated in the study. The participants received comprehensive auditory tests, including pure-tone testing, speech-in-noise (SIN) measures, and central auditory behavioral and objective tests using early and late (P300) auditory evoked potentials over a period of 17 months. They also received shorter assessments immediately following the blast-exposure onsite at Quantico. Results: No acute or longitudinal effects were identified. However, there were some interesting baseline effects found in both groups. Contrary to the expected, the onsite hearing thresholds and distortion product otoacoustic emissions were slightly better at a few frequencies immediately after blast-exposure than measurements obtained with the same equipment weeks to months after each blast-exposure. Conclusions: To date, the current study is the most comprehensive study that evaluates the long-term effects of blast-exposure on hearing. Despite extensive testing to assess changes, the findings of this study suggest that the levels of current exposures used in this military training environment do not seem to have an obvious deleterious effect on hearing.	[Kubli, Lina R.] US Army Publ Hlth Ctr Provis, Edgewood, MD USA; [Kubli, Lina R.; Pinto, Robin L.; Burrows, Holly L.; Brungart, Douglas S.] Walter Reed Natl Mil Med Ctr, Audiol & Speech Pathol Ctr, 801 Vermont Ave NW, Washington, DC 20005 USA; [Littlefield, Philip D.] Walter Reed Natl Mil Med Ctr, Dept Otolaryngol, Bethesda, MD USA; [Littlefield, Philip D.] Tripler Army Med Ctr, Dept Otolaryngol, Honolulu, HI 96859 USA		Kubli, LR (corresponding author), US Army Publ Hlth Ctr Provis, Edgewood, MD USA.; Kubli, LR (corresponding author), Walter Reed Natl Mil Med Ctr, Audiol & Speech Pathol Ctr, 801 Vermont Ave NW, Washington, DC 20005 USA.	lina.kubli@va.gov			Department of Defense Intramural War Supplemental Grant [W81XWH-09-2-0192]; US Army Medical Research and Materiel Command, Intramural War Supplementation Program [W81XWH-09-2-0192]	The research was supported by a Department of Defense Intramural War Supplemental Grant (award number W81XWH-09-2-0192) awarded to William Ahroon. The grant was provided by The US Army Medical Research and Materiel Command, Intramural War Supplementation Program, award number W81XWH-09-2-0192.	Amsc N, 1999, MILSTD1474 IAW; Brungart D, J ACOUST SOC AM, V136, P777; Brungart D, 2014, 37 ANN MIDW M FEBR 2; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gatehouse S, 2004, INT J AUDIOL, V43, P85, DOI 10.1080/14992020400050014; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; JERGER J, 1984, ARCH OTOLARYNGOL, V110, P290; Katz J., 1998, THE SSW TEST MANUAL; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; Musiek F.E., 2006, AUDITORY SYSTEM ANAT; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; St Onge Paul, 2011, US Army Med Dep J, P97; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Wilson Richard H, 2003, J Am Acad Audiol, V14, P1, DOI 10.3766/jaaa.14.1.2	21	10	10	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1463-1741	1998-4030		NOISE HEALTH	Noise Health	SEP-OCT	2017	19	90					227	238		10.4103/nah.NAH_58_16			12	Audiology & Speech-Language Pathology; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Public, Environmental & Occupational Health	FI2BX	WOS:000411742800004	28937017	Green Published, gold			2022-02-06	
J	Liu, HQ; Dong, XL; Yin, Y; Chen, ZX; Zhang, JN				Liu, Huiquan; Dong, Xinlong; Yin, Yue; Chen, Zixiang; Zhang, Jianning			Reduction of Surgical Site Infections After Cranioplasty With Perioperative Bundle	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Antimicrobial prophylaxis; care bundles; cranioplasty; hand hygiene; skin preparation; surgical site infection	TRAUMATIC BRAIN-INJURY; CLINICAL ARTICLE; TITANIUM MESH; CRANIECTOMY; SURGERY; COMPLICATIONS; NEUROSURGERY	Background: Surgical site infections (SSI) are the most common complication after cranioplasty and it is associated with poor prognosis. The aim of this study was to identify the risk factors that triggered the development of SSI after cranioplasty and establish a new perioperative bundle and monitoring system to reduce SSI. Methods: A retrospective review of a database that included all cranioplasty patients from 2001 to 2007 was carried out to determine the prevalence of infection. A surveillance team was set up, which assessed the clinical practice and led to the development of a new perioperative bundle and supervision system. A prospective study between 2008 and 2014 was carried out to observe whether infection rates had changed and whether an active surveillance program can change clinical practice. Results: Retrospective period included 86 adult patients. The overall rate of infection was 10.5% (9 SSI in 86 patients). Age >= 60 years (OR 1.05; 95% CI: 1.00-1.10; P = 0.04), smoking (OR 9.13; 95% CI: 1.65-50.60; P = 0.01), and duration of operation >= 180 minutes (OR1.19; 95% CI: 1.06-1.34; P < 0.01) as significant predictors of postcranioplasty SSI development. Length of preoperative stay and length of hospitalization was significantly longer among infected patients compared with uninfected patients (P < 0.01, respectively). In prospective period, the general SSI rate was reduced to 1.8% (2 SSI in 113 patients). The difference was statistically significant (P < 0.01). Conclusions: A perioperative bundle and monitoring system may help to reduce SSI rates after cranioplasty. This work also indicates how an active surveillance program can successfully change clinical practice.	[Liu, Huiquan; Dong, Xinlong; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Tianjin Inst Neurol, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Liu, Huiquan; Chen, Zixiang] Tianjin Haihe Hosp, Dept Neurol Sci, Tianjin, Peoples R China; [Yin, Yue] Tianjin Med Univ, Int Med Sch, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Inst Neurol, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzh@hotmail.com					Akins PT, 2010, J NEUROSURG, V112, P354, DOI 10.3171/2009.5.JNS081589; Broughton E, 2014, BRIT J NEUROSURG, V28, P34, DOI 10.3109/02688697.2013.815319; Buffet-Bataillon S, 2011, J HOSP INFECT, V77, P352, DOI 10.1016/j.jhin.2010.10.011; Chen ST, 2015, INJURY, V46, P80, DOI 10.1016/j.injury.2014.09.019; Hardy SJ, 2010, J NEUROSURG, V113, P161, DOI 10.3171/2010.2.JNS09950; Holloway KL, 1996, CLIN THER, V18, P84, DOI 10.1016/S0149-2918(96)80181-0; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Horgan MA, 1997, PEDIATR NEUROSURG, V26, P180, DOI 10.1159/000121187; Kimchi G, 2016, J CLIN NEUROSCI, V34, P182, DOI 10.1016/j.jocn.2016.06.007; Kung WM, 2012, J NEUROTRAUM, V29, P2030, DOI 10.1089/neu.2011.2220; Le C, 2014, CLIN NEUROL NEUROSUR, V120, P41, DOI 10.1016/j.clineuro.2014.02.009; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; MISHRIKI SF, 1990, J HOSP INFECT, V16, P223, DOI 10.1016/0195-6701(90)90110-A; Oliveira AC, 2004, AM J INFECT CONTROL, V32, P358, DOI 10.1016/j.ajic.2004.02.009; Petrosillo N, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-34; Ratanalert S, 1999, SURG NEUROL, V51, P458, DOI 10.1016/S0090-3019(98)00132-3; Riordan MA, 2016, WORLD NEUROSURG, V87, P207, DOI 10.1016/j.wneu.2015.11.070; Shen NJ, 2015, J MICROBIOL IMMUNOL, V48, P322, DOI 10.1016/j.jmii.2013.08.005; Thu LTA, 2007, INFECT CONT HOSP EP, V28, P583, DOI 10.1086/516661; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470	23	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2017	28	6					1408	1412		10.1097/SCS.0000000000003650			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FO7IW	WOS:000417048300035	28692506				2022-02-06	
J	Naylor, JC; Wagner, HR; Brancu, M; Shepherd-Banigan, M; Elbogen, E; Kelley, M; Fecteau, T; Goldstein, K; Kimbrel, NA; Marx, CE; Strauss, JL				Naylor, Jennifer C.; Wagner, H. Ryan; Brancu, Mira; Shepherd-Banigan, Megan; Elbogen, Eric; Kelley, Michelle; Fecteau, Teresa; Goldstein, Karen; Kimbrel, Nathan A.; Marx, Christine E.; Strauss, Jennifer L.		VA Mid-Atlantic MIRECC Work Grp; VA Mid-Atlantic MIRECC Women Veter	Self-Reported Pain in Male and Female Iraq/Afghanistan-Era Veterans: Associations with Psychiatric Symptoms and Functioning	PAIN MEDICINE			English	Article						Pain Disorder; Veteran; Function; Mental Health; Gender; Female; Male	POSTTRAUMATIC-STRESS-DISORDER; POLYTRAUMA CLINICAL TRIAD; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; AFGHANISTAN VETERANS; GENERAL-POPULATION; PERSISTENT PAIN; SEX-DIFFERENCES; IRAQI FREEDOM; WAR VETERANS	Objective. To examine pain symptoms and co-occurring psychiatric and functional indices in male and female Iraq/Afghanistan-era veterans. Design. Self-reported data collection and interviews of Iraq/Afghanistan-era veterans who participated in a multisite study of postdeployment mental health. Setting. Veterans were enrolled at one of four participating VA sites. Subjects. Two thousand five hundred eighty-seven male and 662 female Iraq/Afghanistan-era veterans. Methods. Nonparametric Wilcoxon rank tests examined differences in pain scores between male and female veterans. Chi-square tests assessed differences between male and female veterans in the proportion of respondents endorsing moderate to high levels of pain vs no pain. Multilevel regression analyses evaluated the effect of pain on a variety of psychiatric and functional measures. Results. Compared with males, female veterans reported significantly higher mean levels of headache (P < 0.0001), muscle soreness (P < 0.008), and total pain (P < 0.0001), and were more likely to report the highest levels of headache (P < 0.0001) and muscle soreness (P < 0.0039). The presence of pain symptoms in Iraq/Afghanistan-era veterans was positively associated with psychiatric comorbidity and negatively associated with psychosocial functioning. There were no observed gender differences in psychiatric and functional indices when levels of pain were equated. Conclusions. Although female Iraq/Afghanistan-era veterans reported higher levels of pain than male veterans overall, male and female veterans experienced similar levels of psychiatric and functional problems at equivalent levels of reported pain. These findings suggest that pain-associated psychological and functional impacts are comparable and consequential for both male and female veterans.	[Naylor, Jennifer C.; Kimbrel, Nathan A.; Marx, Christine E.] Durham Vet Affairs Med Ctr, Res & Dev, Durham, NC USA; [Naylor, Jennifer C.; Elbogen, Eric; Fecteau, Teresa; Marx, Christine E.] Durham Vet Affairs Med Ctr, Mental Hlth Serv Line, Durham, NC USA; [Shepherd-Banigan, Megan] Durham Vet Affairs Med Ctr, Hlth Serv Res & Dev, Durham, NC USA; [Naylor, Jennifer C.; Wagner, H. Ryan; Brancu, Mira; Elbogen, Eric; Kimbrel, Nathan A.; Marx, Christine E.; Strauss, Jennifer L.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Goldstein, Karen] Duke Univ, Med Ctr, Div Gen Internal Med, Durham, NC 27705 USA; [Naylor, Jennifer C.; Wagner, H. Ryan; Brancu, Mira; Elbogen, Eric; Kimbrel, Nathan A.; Marx, Christine E.; VA Mid-Atlantic MIRECC Work Grp; VA Mid-Atlantic MIRECC Women Veter] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Kelley, Michelle; Goldstein, Karen] Old Dominion Univ, Dept Psychol, Norfolk, VA USA; [Strauss, Jennifer L.] Mental Hlth Serv, Dept Vet Affairs, Washington, DC USA		Naylor, JC (corresponding author), Duke Univ, Med Ctr, Durham VA Med Ctr, Durham, NC 27705 USA.	Jennifer.naylor2@va.gov	Shepherd-Banigan, Megan/Q-6687-2019	Shepherd-Banigan, Megan/0000-0002-4020-8936; Goldstein, Karen/0000-0003-4419-5869	VA Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC) of the Department of Veterans Affairs Office of Mental Health Services; VA Mid-Atlantic Healthcare Network [VISN 6]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardsUS Department of Veterans Affairs [1lK2RX000908, 1K2RX001298]; Department of Veterans Affairs Clinical Science Research and Development Career Development Award [IK2CX000525, IK2CX000718]; VA Health Services Research and Development Career Development AwardUS Department of Veterans Affairs [1IK2HX001540, CDA 13-263]; VA OAA HSR&D PhD Fellowship from the US Department of Veterans Affairs, Health Services Research and Development Service [TPP 21-027]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000908] Funding Source: NIH RePORTER	This work was supported by the VA Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC) of the Department of Veterans Affairs Office of Mental Health Services and the VA Mid-Atlantic Healthcare Network (VISN 6). Dr. Naylor (1lK2RX000908) and Dr. Van Voorhees (1K2RX001298) are funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Awards. Dr. Kimbrel (IK2CX000525) and Dr. Dedert (IK2CX000718) are funded by Department of Veterans Affairs Clinical Science Research and Development Career Development Award. Dr. Goldstein is funded by a VA Health Services Research and Development Career Development Award (1IK2HX001540, CDA 13-263). Dr. Shepherd-Banigan is supported by a VA OAA HSR&D PhD Fellowship (TPP 21-027) from the US Department of Veterans Affairs, Health Services Research and Development Service.	BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beehler GP., 2015, ROLE FUNCTIONS EMBED; Booth-Kewley S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-130; Bryan CJ, 2009, J CLIN PSYCHOL, V65, P281, DOI 10.1002/jclp.20539; Butler M, 2008, EVIDENCE REPORTS TEC; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caldeiro RM, 2008, ADDICTION, V103, P1996, DOI 10.1111/j.1360-0443.2008.02358.x; Cepeda MS, 2003, ANESTH ANALG, V97, P1464, DOI 10.1213/01.ANE.0000080153.36643.83; Chen EH, 2008, ACAD EMERG MED, V15, P414, DOI 10.1111/j.1553-2712.2008.00100.x; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2015, AN VA HLTH CAR UT OP; Fillingim R B, 2000, Curr Rev Pain, V4, P24; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Funderburk JS, 2013, FAM SYST HEALTH, V31, P341, DOI 10.1037/a0032770; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Haskell SG, 2011, WOMEN HEALTH ISS, V21, P92, DOI 10.1016/j.whi.2010.08.001; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Ilgen MA, 2010, SUICIDE LIFE-THREAT, V40, P597, DOI 10.1521/suli.2010.40.6.597; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lipton RB, 2005, NEUROLOGY, V65, pS50, DOI 10.1212/WNL.65.12_suppl_4.S50; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; National Center for Veterans Analysis and Statistics, 2011, AM WOM VET MIL SERV; Oliva EM, 2015, PAIN MED, V16, P112, DOI 10.1111/pme.12501; Outcalt SD, 2014, J REHABIL RES DEV, V51, P559, DOI 10.1682/JRRD.2013.06.0134; Paller CJ, 2009, PAIN MED, V10, P289, DOI 10.1111/j.1526-4637.2008.00558.x; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P720, DOI 10.1016/j.jpsychires.2010.11.015; Rauhala K, 2000, CRANIO, V18, P40, DOI 10.1080/08869634.2000.11746112; Ruau D, 2012, J PAIN, V13, P228, DOI 10.1016/j.jpain.2011.11.002; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Stavropoulos Franci, 2007, Oral Maxillofac Surg Clin North Am, V19, P245, DOI 10.1016/j.coms.2007.01.010; Szymanski BR, 2013, J GEN INTERN MED, V28, P346, DOI 10.1007/s11606-012-2218-y; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tsan JY, 2012, PSYCHOL SERV, V9, P336, DOI 10.1037/a0028308; VHA Epidemiology Program. Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2013, AN VA HLTH CAR UT OP; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104	47	10	10	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	SEP	2017	18	9					1658	1667		10.1093/pm/pnw308			10	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	FG7NK	WOS:000410604600007	28122941	hybrid, Green Submitted			2022-02-06	
J	Pei, D; Liu, N; Li, D; Yan, HJ; Wang, QB; Fang, Y; Xie, L; Li, HP				Pei, Dan; Liu, Nan; Li, Dan; Yan, Hongjing; Wang, Qiu-bo; Fang, Yan; Xie, Ling; Li, Hong-Peng			Inhibition of platelet-derived growth factor receptor beta reduces reactive glia and scar formation after traumatic brain injury in mice	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Scar formation; Regeneration; PDGFR beta, p-PDGFR beta; AG1296; Astrocyte	SPINAL-CORD; PDGFR-BETA; REGENERATION; REPAIR; PERICYTES; INFLAMMATION; ASTROCYTES; MECHANISMS; TISSUE; CELLS	Brain injury leads to complex cellular and molecular interactions within the central nervous system. As the glial scar was a mechanical barrier to regeneration, inhibitory molecules in the forming scar and methods to overcome them have suggested molecular modification strategies to allow neuronal growth and functional regeneration. Here we investigated the roles of PDGFR beta signaling in regulating astrocyte reactivity and scar formation in mice following traumatic brain injury (TBI). The expression and distribution of phosphorylated PDGFR beta was analyzed, and its cell type-specific expression was verified with double labeling of astrocytes (GFAP), microglia (IBA1), oligodendrocyte precursor cells (OPC) (NG2) and leukocytes (CD45). We found PDGFR beta was activated around the injury site after TBI, and primarily expressed in astrocytes, microglia, OPC and leukocytes in the boundary of the lesion site, suggesting PDGFR beta was involved in glial scar formation. Then the PDGFR inhibitor (AG1296) was administered following TBI. Reactive astrocytes were significantly inhibited in AG1296-treated mice. Furthermore, AG1296-treatment attenuated reactive leukocytes, OPC and astrocytes and pronouncedly disrupted of glial scar formation after TBI. These findings prove that PDGFR beta signaling inhibited reactive glia-mediated scar formation after TBI in mice.	[Pei, Dan; Liu, Nan; Li, Dan; Yan, Hongjing; Wang, Qiu-bo; Li, Hong-Peng] China Med Univ, Dept Human Anat, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China; [Pei, Dan; Fang, Yan; Xie, Ling] Jinzhou Med Univ, Dept Anat, Jinzhou, Peoples R China; [Wang, Qiu-bo] Jinzhou Cent Hosp, Dept Clin Lab, Jinzhou, Peoples R China		Li, HP (corresponding author), China Med Univ, Dept Human Anat, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China.	lihongpeng1966@126.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [NSFC - 81171248]	This work was supported by the National Natural Science Foundation of China (NSFC), Grant no: NSFC - 81171248.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Ishitsuka K, 2012, MICROVASC RES, V83, P352, DOI 10.1016/j.mvr.2012.02.009; Kawano H, 2005, J NEUROSCI RES, V80, P191, DOI 10.1002/jnr.20441; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Kumagai S, 2001, TOHOKU J EXP MED, V195, P21, DOI 10.1620/tjem.195.21; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; MARX M, 1994, J CLIN INVEST, V93, P131, DOI 10.1172/JCI116936; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Milesi S, 2014, NEUROBIOL DIS, V71, P151, DOI 10.1016/j.nbd.2014.07.010; Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Warburton E., 2011, BMJ CLIN EVID; Yoshioka N, 2010, J COMP NEUROL, V518, P3867, DOI 10.1002/cne.22431; Zhang HQ, 2006, ANN NY ACAD SCI, V1086, P81, DOI 10.1196/annals.1377.014	24	10	10	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2017	134						121	127		10.1016/j.brainresbull.2017.06.020			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI3HA	WOS:000411847400016	28684344				2022-02-06	
J	Reams, N; Hayward, RA; Kutcher, JS; Burke, JF				Reams, Nicole; Hayward, Rodney A.; Kutcher, Jeffrey S.; Burke, James F.			Effect of Concussion on Performance of National Football League Players	INTERNATIONAL JOURNAL OF SPORTS PHYSIOLOGY AND PERFORMANCE			English	Article						NFL; American football; head injury	TRAUMATIC BRAIN-INJURY; STABILITY; STATEMENT; RETURN; SPORT; TASK	Purpose: Lingering neurologic injury after concussion may expose athletes to increased risk if return to play is premature. The authors explored whether on-field performance after concussion is a marker of lingering neurologic injury. Design: Retrospective cohort study on 1882 skill-position players who played in the National Football League (NFL) during 2007-2010. Methods: Players with concussion based on the weekly injury report were compared with players with other head and neck injuries (controls) on measures of on-field performance using Football Outsiders' calculation of defense-adjusted yards above replacement (DYAR), a measure of a player's contribution controlling for game context. Changes in performance, relative to a player's baseline level of performance, were estimated before and after injury using fixed-effects models. Results: The study included 140 concussed players and 57 controls. Players with concussion performed no better or worse than their baseline on return to play. However, a decline in DYAR relative to their prior performance was noted 2 wk and 1 wk before appearing on the injury report. Concussed players performed slightly better than controls in situations where they returned to play the same week as appearing on the injury report. Conclusions: On return, concussed NFL players performed at their baseline level of performance, suggesting that players have recovered from concussion. Decline in performance noted 2 wk and 1 wk before appearing on the injury report may suggest that concussion diagnosis was delayed or that concussion can be a multihit phenomenon. Athletic performance may be a novel tool for assessing concussion injury and recovery.	[Reams, Nicole] NorthShore Univ HealthSyst, NorthShore Neurol Inst, Evanston, IL 60076 USA; [Hayward, Rodney A.] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA; [Hayward, Rodney A.] Univ Michigan Hlth Syst, Dept Hlth Management & Policy, Ann Arbor, MI USA; [Burke, James F.] Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI USA; [Kutcher, Jeffrey S.] CORE Inst, Sports Neurol Clin, Brighton, MI USA		Reams, N (corresponding author), NorthShore Univ HealthSyst, NorthShore Neurol Inst, Evanston, IL 60076 USA.	nreams@northshore.org					[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Associated Press, 2011, ASS PRESS; Boeck S, 2007, US TODAY; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Football Outsiders Information, METH OUR MADN EXPL D; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130	28	10	10	1	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1555-0265	1555-0273		INT J SPORT PHYSIOL	Int. J. Sport Physiol. Perform.	SEP	2017	12	8					1100	1104		10.1123/ijspp.2016-0508			5	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	FM9TS	WOS:000415614900015	28095082				2022-02-06	
J	Roden-Foreman, K; Solis, J; Jones, A; Bennett, M; Roden-Foreman, JW; Rainey, EE; Foreman, ML; Warren, AM				Roden-Foreman, Kenleigh; Solis, Jaicus; Jones, Alan; Bennett, Monica; Roden-Foreman, Jacob W.; Rainey, Evan E.; Foreman, Michael L.; Warren, Ann Marie			Prospective Evaluation of Posttraumatic Stress Disorder and Depression in Orthopaedic Injury Patients With and Without Concomitant Traumatic Brain Injury	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						posttraumatic stress; depression; PTSD; traumatic brain injury; TBI; orthopaedic trauma; injury; outcomes	QUALITY-OF-LIFE; OUTCOMES; SURVIVORS; DISTRESS; US	Objectives: Psychological morbidities after injury [eg, posttraumatic stress disorder (PTSD) and depression] are increasingly recognized as a significant determinant of overall outcome. Traumatic brain injury (TBI) negatively impacts outcomes of patients with orthopaedic injury, but the association of concurrent TBI, orthopaedic injury, and symptoms of PTSD and depression has not been examined. This study's objective was to examine symptoms of PTSD and depression in patients with orthopaedic trauma with and without TBI. Design: Longitudinal prospective cohort study. Setting: Urban Level I Trauma Center in the Southwest United States. Patients/Participants: Orthopaedic trauma patients older than 18 years admitted for >= 24 hours. Main Outcome Measurements: Questionnaires examining demographics, injury-related variables, PTSD, and depression were administered during hospitalization and 3, 6, and 12 months later. Orthopaedic injury and TBI were determined based on ICD-9 codes. Generalized linear models determined whether PTSD and depression at follow-up were associated with TBI. Results: Of the total sample (N = 214), 44 (21%) sustained a TBI. Those with TBI had higher rates of PTSD symptoms, 12 months postinjury (P = 0.04). The TBI group also had higher rates of depressive symptoms, 6 months postinjury (P = 0.038). Conclusions: Having a TBI in addition to orthopaedic injury was associated with significantly higher rates of PTSD at 12 months and depression at 6 months postinjury. This suggests that sustaining a TBI in addition to orthopaedic injury places patients at a higher risk for negative psychological outcomes. The findings of this study may help clinicians to identify patients who are in need for psychological screening and could potentially benefit from intervention.	[Roden-Foreman, Kenleigh] UT Southwestern Med Ctr, Div Psychol, 200 Treadway Plaza, Dallas, TX 75235 USA; [Solis, Jaicus; Jones, Alan; Bennett, Monica; Roden-Foreman, Jacob W.; Rainey, Evan E.; Foreman, Michael L.; Warren, Ann Marie] Baylor Univ, Med Ctr, Dept Surg, Dallas, TX 75246 USA		Roden-Foreman, K (corresponding author), UT Southwestern Med Ctr, Div Psychol, 200 Treadway Plaza, Dallas, TX 75235 USA.	kenleigh.roden-foreman@utsouthwestern.edu		Roden-Foreman, Jacob/0000-0002-8338-397X; Warren, Ann Marie/0000-0002-3753-5573; McMinn, PhD, Kenleigh/0000-0002-4623-8634; McShan, Evan Elizabeth/0000-0002-9250-3240	Stanley Seeger Surgical Fund of the Baylor Healthcare System Foundation	Support for this study was graciously provided by the Stanley Seeger Surgical Fund of the Baylor Healthcare System Foundation.	American College of Surgeons, 2014, RES OPT CAR INJ PAT; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bhandari M, 2008, CAN J SURG, V51, P15; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant R., 2001, DIALOGUES CLIN NEURO, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Center for Disease Control and Prevention (CDC), 2014, INJ PREV CONTR DAT S; Centers for Disease Control and Prevention, 2010, NAT AMB MED CAR SURV; Clement RC, 2013, J TRAUMA ACUTE CARE, V75, P687, DOI 10.1097/TA.0b013e31829a0ac7; De Sousa A, 2010, INDIAN J PLAST SURG, V43, P200, DOI 10.4103/0970-0358.73452; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Gravetter J., 2013, STAT BEHAV SCI; Hanley J, 2013, J TRAUMA ACUTE CARE, V75, P722, DOI 10.1097/TA.0b013e3182a53a5f; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Li JCH, 2016, BEHAV RES METHODS, V48, P1560, DOI 10.3758/s13428-015-0667-z; Osenbach JE, 2014, PSYCHIATRY, V77, P386, DOI 10.1521/psyc.2014.77.4.386; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Rea L.M., 1992, DESIGNING CONDUCTING; Reese C, 2012, J TRAUMA ACUTE CARE, V73, P462, DOI 10.1097/TA.0b013e31825ff713; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Steel JL, 2011, INJURY, V42, P288, DOI 10.1016/j.injury.2010.11.045; The National Institute of Mental Health, 2014, MAJ DEPR AD; Uhl RL, 2013, J AM ACAD ORTHOP SUR, V21, P624, DOI 10.5435/JAAOS-21-10-624; Warren AM, 2015, J TRAUMA ACUTE CARE, V79, P1062, DOI 10.1097/TA.0000000000000875; Warren AM, 2014, J TRAUMA ACUTE CARE, V76, P517, DOI 10.1097/TA.0000000000000110; Weathers FW, 1996, MEASUREMENT STRESS T, P250; Zatzick D, 2004, J TRAUMA, V57, P360, DOI 10.1097/01.TA.0000141332.43183.7F; Zatzick DF, 2003, PSYCHOSOMATICS, V44, P479, DOI 10.1176/appi.psy.44.6.479; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8	36	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	SEP	2017	31	9					E275	E280		10.1097/BOT.0000000000000884			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	FI7FV	WOS:000412163200002	28832389				2022-02-06	
J	Roquilly, A; Lasocki, S; Moyer, JD; Huet, O; Perrigault, PF; Dahyot-Fizelier, C; Seguin, P; Sharshar, T; Geeraerts, T; Remerand, F; Feuillet, F; Asehnoune, K				Roquilly, Antoine; Lasocki, Sigismond; Moyer, Jean Denis; Huet, Olivier; Perrigault, Pierre Francois; Dahyot-Fizelier, Claire; Seguin, Philippe; Sharshar, Tarek; Geeraerts, Thomas; Remerand, Francis; Feuillet, Fanny; Asehnoune, Karim		COBI Grp	COBI (COntinuous hyperosmolar therapy for traumatic Brain-Injured patients) trial protocol: a multicentre randomised open-label trial with blinded adjudication of primary outcome	BMJ OPEN			English	Article							QUALITY IMPROVEMENT PROJECT; STRUCTURED INTERVIEWS; CLINICAL-TRIALS; MODERATE; INFUSION; DISEASE; SCALES	Introduction Traumatic brain injury (TBI) is a major cause of death and severe prolonged disability. Intracranial hypertension (ICH) is a critical risk factor of bad outcomes after TBI. Continuous infusion of hyperosmolar therapy has been proposed for the prevention and the treatment of ICH. Whether an early administration of continuous hyperosmolar therapy improves long-term outcomes of patients with TBI is uncertain. The aim of the COBI study (number clinicaltrial. gov 03143751, pre-results stage) is to assess the efficiency and the safety of continuous hyperosmolar therapy in patients with TBI. Methods and analysis The COBI (COntinuous hyperosmolar therapy in traumatic Brain-Injured patients) trial is a multicentre, randomised, controlled, open-label, two-arms study with blinded adjudication of primary outcome. Three hundred and seventy patients hospitalised in intensive care unit with a TBI (Glasgow Coma Scale <= 12 and abnormal brain CT scan) are randomised in the first 24 hours following trauma to standard care or continuous hyperosmolar therapy (20% NaCl) plus standard care. Continuous hyperosmolar therapy is maintained for at least 48 hours in the treatment group and continued for as long as is necessary to prevent ICH. The primary outcome is the score on the Extended Glasgow Outcome Scale at 6 months. The treatment effect is estimated with ordinal logistic regression adjusted for prespecified prognostic factors and expressed as a common OR. Ethics and dissemination The COBI trial protocol has been approved by the ethics committee of Paris Ile de France VIII and will be carried out according to the principles of the Declaration of Helsinki and the Good Clinical Practice guidelines. The results of this study will be disseminated through presentation at scientific conferences and publication in peer-reviewed journals. The COBI trial is the first randomised controlled trial powered to investigate whether continuous hyperosmolar therapy in patients with TBI improve long-term recovery.	[Roquilly, Antoine; Asehnoune, Karim] CHU Nantes, Anaesthesia Intens Care Unit, Nantes, France; [Lasocki, Sigismond] CHU Angers, Anaesthesia Intens Care Unit, Angers, France; [Moyer, Jean Denis] CHU Beaujon, AP HP, Anaesthesia Intens Care Unit, Beaujon, France; [Huet, Olivier] CHU Brest, Intens Care Unit, Anaesthesia, Brest, France; [Perrigault, Pierre Francois] CHU Montpellier, Anaesthesia Intens Care Unit, Montpellier, France; [Dahyot-Fizelier, Claire] CHU Poitiers, Anaesthesia & Intens Care Unit, Poitiers, France; [Seguin, Philippe] CHU Rennes, Anaesthesia & Intens Care Unit, Rennes, France; [Sharshar, Tarek] Hop St Anne, AP HP, Anaesthesia & Intens Care Unit, Paris, France; [Geeraerts, Thomas] Univ Toulouse 3 Paul Sabatier, Toulouse NeuroImaging Ctr, INSERM,TONIC, Univ Hosp Toulouse,Dept Anesthesiol & Critical Ca, Toulouse, France; [Remerand, Francis] Univ F Rabelais, CHRU Tours, Serv Anesthesie Reanimat 2, Tours, France; [Feuillet, Fanny] CHU Nantes, Dept Promot, Plateforme Methodol & Biostat, Direct Rech, Nantes, France; [Feuillet, Fanny] Univ Tours, Univ Nantes, INSERM, SPHERE U1246, Nantes, France		Roquilly, A (corresponding author), CHU Nantes, Anaesthesia Intens Care Unit, Nantes, France.	antoine.roquilly@chu-nantes.Fr	Roquilly, Antoine/P-9826-2017; lasocki, sigismond/G-9443-2016; Sharshar, Tarek/ABF-4117-2021	Seguin, Philippe/0000-0002-7774-4257	French Ministry of Health (PHRCI) [RC16_0474]	This study is an investigator-initiated trial, funded by a grant from the French Ministry of Health (PHRCI 2016, RC16_0474).	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Asehnoune K, 2017, INTENS CARE MED, V43, P957, DOI 10.1007/s00134-017-4764-6; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Assessing disability after head injury, 2009, J NEUROSURG, V89, P939; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Carney N, 2016, GUIDELINES MANAGEMEN, P1; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Geeraets T, MANAGEMENT SEVERE TR; Hauer EM, 2011, CRIT CARE MED, V39, P1766, DOI 10.1097/CCM.0b013e318218a390; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Roquilly A, 2013, AM J RESP CRIT CARE, V188, P958, DOI 10.1164/rccm.201301-0116OC; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Tan SKR, 2016, CAN J ANESTH, V63, P664, DOI 10.1007/s12630-016-0633-y; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2017	7	9							e018035	10.1136/bmjopen-2017-018035			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ3RY	WOS:000412650700278	28947465	Green Published, gold			2022-02-06	
J	Scheller, A; Bai, XS; Kirchhoff, F				Scheller, Anja; Bai, Xianshu; Kirchhoff, Frank			The Role of the Oligodendrocyte Lineage in Acute Brain Trauma	NEUROCHEMICAL RESEARCH			English	Article						Oligodendrocytes; Oligodendrocyte precursor; NG2 glia; Traumatic brain injury; Myelination; Astrocytes	CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER; NG2 PROTEOGLYCAN; WALLERIAN DEGENERATION; NEURITE OUTGROWTH; PROGENITOR CELLS; PRECURSOR CELL; RAT-BRAIN; IN-VITRO; MYELIN	An acute brain injury is commonly characterized by an extended cellular damage. The post-injury process of scar formation is largely determined by responses of various local glial cells and blood-derived immune cells. The role of astrocytes and microglia have been frequently reviewed in the traumatic sequelae. Here, we summarize the diverse contributions of oligodendrocytes (OLs) and their precursor cells (OPCs) in acute injuries. OLs at the lesion site are highly sensitive to a damaging insult, provoked by Ca2+ overload after hyperexcitation originating from increased levels of transmitters. At the lesion site, differentiating OPCs can replace injured oligodendrocytes to guarantee proper myelination that is instrumental for healthy brain function. In contrast to finally differentiated and non-dividing OLs, OPCs are the most proliferative cells of the brain and their proliferation rate even increases after injury. There exist even evidence that OPCs might also generate some type of astrocyte beside OLs. Thereby, OPCs can contribute to the generation and maintenance of the glial scar. In the future, detailed knowledge of the molecular cues that help to prevent injury-evoked glial cell death and that control differentiation and myelination of the oligodendroglial lineage will be pivotal in developing novel therapeutic approaches.	[Scheller, Anja; Bai, Xianshu; Kirchhoff, Frank] Univ Saarland, CIPMM, Mol Physiol, D-66421 Homburg, Germany		Kirchhoff, F (corresponding author), Univ Saarland, CIPMM, Mol Physiol, D-66421 Homburg, Germany.	frank.kirchhoff@uks.eu	Bai, Xianshu/AAN-8029-2021; Kirchhoff, Frank/B-9335-2008; Scheller, Anja/B-8577-2018	Bai, Xianshu/0000-0002-4758-1645; Kirchhoff, Frank/0000-0002-2324-2761; Scheller, Anja/0000-0001-8955-2634	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG SPP 1757, SFB 894, FOR2289]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7-202167 NeuroGLIA, H2020-732344 Neurofibres]; Fondation pour l'Aide a la Recherche sur la Sclerose En PlaquesFondation pour la Recherche Medicale; Association Francaise contre les Myopathies (ARSEP-AFM) Brain, Inflammation and Epilepsy (BrIE); University of Saarland Medical School	The authors are grateful to Frank Rhode for excellent technical assistance and to Daniel Rhode for animal husbandry and tamoxifen treatment. We thank Hongkui Zeng (Allen Institute for Brain Science, Seattle, Washington, USA) for providing R26tdTomato reporter mice, Ueli Suter (Institute for Molecular Health Sciences, ETH Zurich, Switzerland) for PLP-CreERT2 mice, Dwight Bergles (Johns Hopkins University School of Medicine, Baltimore, USA) for GCaMP3 reporter mice, Bernard Zalc (Universite Pierre et Marie Curie, Paris, France) for PLP-EGFP<INF>mem</INF> mice and Jacqueline Trotter (Johannes Gutenberg University, Mainz, Germany) for TgH(NG2-EYFP) mice. Authors thank Dr. Jens Grosche (Effigos AG) for help with Fig. 2A. This work was supported by grants from Deutsche Forschungsgemeinschaft DFG SPP 1757, SFB 894, FOR2289, European Commission FP7-202167 NeuroGLIA, H2020-732344 Neurofibres, Fondation pour l'Aide a la Recherche sur la Sclerose En Plaques and Association Francaise contre les Myopathies (ARSEP-AFM) Brain, Inflammation and Epilepsy (BrIE); and the HOMFOR programme of the University of Saarland Medical School (AS, XB).	Abe Y, 1999, J NEUROTRAUM, V16, P945, DOI 10.1089/neu.1999.16.945; Alberdi E, 2005, CELL CALCIUM, V38, P417, DOI 10.1016/j.ceca.2005.06.020; Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Baxi EG, 2014, GLIA, V62, P1513, DOI 10.1002/glia.22697; Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Bribian A, 2016, NEUROSCIENCE, V323, P10, DOI 10.1016/j.neuroscience.2015.04.036; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Chung SH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.74; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dehn D, 2006, GLIA, V53, P491, DOI 10.1002/glia.20307; Del Rio-Hortega P, 1928, MEM REAL SOC ESP HIS, P5; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fern RF, 2014, GLIA, V62, P1780, DOI 10.1002/glia.22722; Fernandez-Castaneda A, 2016, BRAIN BEHAV IMMUN, V57, P1, DOI 10.1016/j.bbi.2016.01.005; Filous AR, 2014, J NEUROSCI, V34, P16369, DOI 10.1523/JNEUROSCI.1309-14.2014; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Geoffroy CG, 2014, CURR OPIN NEUROBIOL, V27, P31, DOI 10.1016/j.conb.2014.02.012; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; JESERICH G, 1990, GLIA, V3, P65, DOI 10.1002/glia.440030109; Jeserich G, 2008, J MOL NEUROSCI, V35, P117, DOI 10.1007/s12031-008-9035-0; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kassis H, 2014, NEUROCHEM INT, V77, P17, DOI 10.1016/j.neuint.2014.03.006; Kelland EE, 2001, EUR J PHARMACOL, V424, pR3, DOI 10.1016/S0014-2999(01)01157-8; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kramer-Albers EM, 2016, CURR OPIN NEUROBIOL, V39, P101, DOI 10.1016/j.conb.2016.04.016; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Leoni G, 2009, MOL CELL NEUROSCI, V42, P208, DOI 10.1016/j.mcn.2009.07.007; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LEVINE JM, 1987, J NEUROSCI, V7, P2721; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lipsky Robert H, 2015, Handb Clin Neurol, V127, P23, DOI 10.1016/B978-0-444-52892-6.00003-9; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Love S., 2008, GREENFIELDS NEUROPAT; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandai K, 1997, NEUROSCIENCE, V77, P849, DOI 10.1016/S0306-4522(97)00517-4; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Masel B, 2009, CONCEPTUALIZING BRAI; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ornelas IM, 2016, J NEUROSCI RES, V94, P1421, DOI 10.1002/jnr.23900; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez-Cerda F, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00092; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Saab AS, 2016, NEURON, V91, P119, DOI 10.1016/j.neuron.2016.05.016; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Snaidero N, 2017, GLIA, V65, P1021, DOI 10.1002/glia.23116; Sobottka B, 2011, GLIA, V59, P1841, DOI 10.1002/glia.21228; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tamura Y, 2012, J CEREBR BLOOD F MET, V32, P1879, DOI 10.1038/jcbfm.2012.98; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; Tegla CA, 2011, EXP MOL PATHOL, V91, P335, DOI 10.1016/j.yexmp.2011.04.006; Tomassy GS, 2016, TRENDS CELL BIOL, V26, P135, DOI 10.1016/j.tcb.2015.09.002; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	112	10	11	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2017	42	9			SI		2479	2489		10.1007/s11064-017-2343-4			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FH5AA	WOS:000411172700005	28702713				2022-02-06	
J	Skrifvars, MB; Bailey, M; French, C; Presneill, J; Nichol, A; Little, L; Duranteau, J; Huet, O; Haddad, S; Arabi, Y; McArthur, C; Cooper, DJ; Bellomo, R				Skrifvars, Markus B.; Bailey, Michael; French, Craig; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine; Duranteau, Jacques; Huet, Olivier; Haddad, Samir; Arabi, Yaseen; McArthur, Colin; Cooper, D. James; Bellomo, Rinaldo		EPO-TBI Investigators; ANZICS Clinical Trials Grp	Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Erythropoietin; traumatic brain injury; multiple trauma	RECOMBINANT-HUMAN-ERYTHROPOIETIN; HYPOTENSION; INFLAMMATION; DYSFUNCTION; DEFINITION; EFFICACY; OUTCOMES; MODEL	BACKGROUND: Erythropoietin (EPO) may reduce mortality after traumatic brain injury (TBI). Secondary brain injury is exacerbated by multiple trauma, and possibly modifiable by EPO. We hypothesized that EPO decreases mortality more in TBI patients with multiple trauma, than in patients with TBI alone. METHODS: A post hoc analysis of the EPO-TBI randomized controlled trial conducted in 2009 to 2014. To evaluate the impact of injuries outside the brain, we calculated an extracranial Injury Severity Score (ISS) that included the same components of the ISS, excluding head and face components. We defined multiple trauma as two injured body regions with an Abbreviated Injury Scale (AIS) score of 3 or higher. Cox regression analyses, allowing for potential differential responses per the presence or absence of extracranial injury defined by these injury scores, were used to assess the effect of EPO on time to mortality. RESULTS: Of 603 included patients, the median extracranial ISS was 6 (interquartile range, 1-13) and 258 (43%) had an AIS score of 3 or higher in at least two body regions. On Cox regression, EPO was associated with decreased mortality in patients with greater extracranial ISS (interaction p = 0.048) and weakly associated with differential mortality with multiple trauma (AIS score > 3 or in two regions, interaction p = 0.17). At 6 months in patients with extracranial ISS higher than 6, 10 (6.8%) of 147 EPO-treated patients compared with 26 (17%) of 154 placebo-treated patients died (risk reduction, 10%; 95% confidence interval, 2.9-17%; p = 0.007). CONCLUSION: In this post hoc analysis, EPO administration was associated with a potential differential improvement in 6-month mortality in TBI patients with more severe extracranial injury. These findings need confirmation in future clinical and experimental studies. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.)	[Skrifvars, Markus B.; Bailey, Michael; French, Craig; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine; Cooper, D. James; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Skrifvars, Markus B.] Univ Helsinki, Div Intens Care, Dept Anaesthesiol Intens Care & Pain Med, Helsinki, Finland; Helsinki Univ Hosp, Helsinki, Finland; Dept Intens Care Helsinki, Helsinki, Finland; [French, Craig] Western Health, Dept Intens Care, St Albans, Vic, Australia; [French, Craig] Univ Melbourne, Melbourne, Vic, Australia; [Presneill, Jeffrey] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Nichol, Alistair; Cooper, D. James] The Alfred, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Duranteau, Jacques] Univ Paris Sud, Hop Univ Paris Sud, Hop Bicetre, Assistance Publ Hop Paris,Dept Anesthesie Reanima, Paris, France; [Huet, Olivier] CHU La Cavale Blanche, Dept Anaesthesiol & Intens Care Med, Brest, France; [Haddad, Samir; Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Haddad, Samir; Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [McArthur, Colin] Auckland City Hosp, Auckland, New Zealand; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia		Skrifvars, MB (corresponding author), Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	markus.skrifvars@hus.fi	French, Craig/ABF-5087-2020; Cooper, D. James/G-7961-2013; Bailey, Michael J/A-4499-2012; Arabi, Yaseen/ABF-3316-2020	French, Craig/0000-0003-1363-9711; Cooper, D. James/0000-0002-5872-9051; Bailey, Michael J/0000-0002-5551-1401; Arabi, Yaseen/0000-0001-5735-6241; Nichol, Alistair/0000-0002-4689-1238	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [545902]; Transport Accident Commission of Victoria [D162]; Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Svenska Kulturfonden; Health Research Board of Ireland	EPO-TBI was supported by grants from the National Health and Medical Research Council of Australia (grant 545902) and the Transport Accident Commission of Victoria (grant D162). M.S. has received personal research funding from Medicinska Understodsforeningen Liv och Halsa, Finska Lakaresallskapet and Svenska Kulturfonden. A.N. has received support from the Health Research Board of Ireland.	Akkose S, 2007, ADV THER, V24, P955, DOI 10.1007/BF02877699; Borovnik-Lesjak V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110908; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Caucio L, 2008, J TRAUMA, V65, P297; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chu HL, 2014, LAB INVEST, V94, P1042, DOI 10.1038/labinvest.2014.84; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; French CJ, 2017, ANN SURG, V265, P54, DOI 10.1097/SLA.0000000000001746; Gantner DC, 2017, ANN SURG; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Matejkova S, 2013, INTENS CARE MED, V39, P497, DOI 10.1007/s00134-012-2766-y; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Nandra KK, 2013, DIS MODEL MECH, V6, P701, DOI 10.1242/dmm.011353; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Selvin S, 2004, STAT ANAL EPIDEMIOLO; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Simon F, 2011, INTENS CARE MED, V37, P1525, DOI 10.1007/s00134-011-2303-4; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang C, 2013, EXP BIOL MED, V238, P111, DOI 10.1258/ebm.2012.012185	35	10	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2017	83	3					449	456		10.1097/TA.0000000000001594			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FF0ET	WOS:000408575700015	28590358				2022-02-06	
J	Thiessen, A; Brown, J; Beukelman, D; Hux, K				Thiessen, Amber; Brown, Jessica; Beukelman, David; Hux, Karen			The effect of human engagement depicted in contextual photographs on the visual attention patterns of adults with traumatic brain injury	JOURNAL OF COMMUNICATION DISORDERS			English	Article						Traumatic brain injury; Eye-tracking; Contextual photographs; Engagement	EYE-MOVEMENTS; SCENE DISPLAYS; OBJECT IDENTIFICATION; TRACKING; COMMUNICATION; INFORMATION; FIXATION; APHASIA; DESIGN; PEOPLE	Photographs are a frequently employed tool for the rehabilitation of adults with traumatic brain injury (TBI). Speech-language pathologists (SLPs) working with these individuals must select photos that are easily identifiable and meaningful to their clients. In this investigation, we examined the visual attention response to camera- (i.e., depicted human figure looking toward camera) and task-engaged (i.e., depicted human figure looking at and touching an object) contextual photographs for a group of adults with TBI and a group of adults without neurological conditions. Eye-tracking technology served to accurately and objectively measure visual fixations. Although differences were hypothesized given the cognitive deficits associated with TBI, study results revealed little difference in the visual fixation patterns of adults with and without TBI. Specifically, both groups of participants tended to fixate rapidly on the depicted human figure and fixate more on objects in which a human figure was task-engaged than when a human figure was camera-engaged. These results indicate that strategic placement of human figures in a contextual photograph may modify the way in which individuals with TBI visually attend to and interpret photographs. In addition, task-engagement appears to have a guiding effect on visual attention that may be of benefit to SLPs hoping to select more effective contextual photographs for their clients with TBI. Finally, the limited differences in visual attention patterns between individuals with TBI and their age and gender matched peers without neurological impairments indicates that these two groups find similar photograph regions to be worthy of visual fixation. Learning outcomes: Readers will gain knowledge regarding the photograph selection process for individuals with TBI. In addition, readers will be able to identify camera- and task-engaged photographs and to explain why task-engagement may be a beneficial component of contextual photographs.	[Thiessen, Amber] Univ Houston, Dept Commun Sci & Disorders, Clin Res Serv 114, Houston, TX 77004 USA; [Brown, Jessica] Univ Minnesota, Dept Speech Language Hearing Sci, 164 Pillsbury Dr SE,115 Shevlin Hall, Minneapolis, MN 55455 USA; [Beukelman, David; Hux, Karen] Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Barkley Mem Ctr 301, Lincoln, NE 68583 USA		Thiessen, A (corresponding author), Univ Houston, Dept Commun Sci & Disorders, Clin Res Serv 114, Houston, TX 77004 USA.	althiess@central.uh.edu	Hux, Karen/AAQ-2078-2020		National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90RE5017-02-01]; Tobii Technologies	The contents of this paper were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant # 90RE5017-02-01). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this paper do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government. The authors wish to thank the residents and the staff at QLI in Omaha, Nebraska for their participation in the research activities and Tobii Technologies for their support. The authors report no conflicts of interest and are solely responsible for the content and writing of the article.	[Anonymous], 2011, TOBII TECHNOLOGY ACC; ANTES JR, 1974, J EXP PSYCHOL, V103, P62, DOI 10.1037/h0036799; Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; BIEDERMAN I, 1981, PERCEPTION, V10, P573, DOI 10.1068/p100573; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Brown J, 2015, AUGMENT ALTERN COMM, V31, P15, DOI 10.3109/07434618.2014.995224; Brown JA, 2016, J HEAD TRAUMA REHAB, V31, pE32, DOI 10.1097/HTR.0000000000000148; Buswell G.T., 1935, PEOPLE LOOK PICTURES; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; DEGRAEF P, 1990, PSYCHOL RES-PSYCH FO, V52, P317, DOI 10.1007/BF00868064; Duchowski AT, 2002, BEHAV RES METH INS C, V34, P455, DOI 10.3758/BF03195475; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Fitts P. M., 1950, AERONAUTICAL ENG REV, V9, P24; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Frank MC, 2012, INFANCY, V17, P355, DOI 10.1111/j.1532-7078.2011.00086.x; Goldberg JH, 1999, INT J IND ERGONOM, V24, P631, DOI 10.1016/S0169-8141(98)00068-7; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hanson EK, 2013, AUGMENT ALTERN COMM, V29, P310, DOI 10.3109/07434618.2013.848934; Henderson JM, 1999, J EXP PSYCHOL HUMAN, V25, P210, DOI 10.1037/0096-1523.25.1.210; Holmqvist K., 2011, EYE TRACKING COMPREH; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; Hux K., 2008, J MED SPEECH LANGUAG, V16, P83; Hux K, 2010, APHASIOLOGY, V24, P643, DOI 10.1080/02687030902869299; Jacob RJK, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P573, DOI 10.1016/B978-044451020-4/50031-1; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Lezak, 2008, MANUAL MAYO PORTLAND; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LOFTUS GR, 1978, J EXP PSYCHOL HUMAN, V4, P565, DOI 10.1037/0096-1523.4.4.565; MACKWORTH NH, 1967, PERCEPT PSYCHOPHYS, V2, P547, DOI 10.3758/BF03210264; Manor BR, 2003, J NEUROSCI METH, V128, P85, DOI 10.1016/S0165-0270(03)00151-1; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mohd Razali N., 2011, J STAT MODEL ANAL, V2, P21; Neider MB, 2006, VISION RES, V46, P614, DOI 10.1016/j.visres.2005.08.025; Poole A., 2006, ENCY HUMAN COMPUTER, P211, DOI DOI 10.4018/978-1-59140-562-7.CH034; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Thiessen A., 2016, J SPEECH LANG HEAR R, V60, P1; Thiessen A, 2017, AM J SPEECH-LANG PAT, V26, P428, DOI 10.1044/2016_AJSLP-16-0024; Thiessen A, 2014, AUGMENT ALTERN COMM, V30, P120, DOI 10.3109/07434618.2014.905798; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace SE, 2010, PERSPECT AUGMENT ALT, V19, P79; Wilkinson KM, 2014, AUGMENT ALTERN COMM, V30, P130, DOI 10.3109/07434618.2014.904434; Wilkinson KM, 2014, J SPEECH LANG HEAR R, V57, P455, DOI 10.1044/2013_JSLHR-L-12-0159; Wilkinson KM, 2011, J SPEECH LANG HEAR R, V54, P1644, DOI 10.1044/1092-4388(2011/10-0098); Williams, 2010, TUKEYS HONESTLY SIGN, P1; Yarbus A., 1967, EYE MOVEMENTS VISION; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	54	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	SEP-OCT	2017	69						58	71		10.1016/j.jcomdis.2017.07.001			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FJ3HE	WOS:000412620500005	28783543				2022-02-06	
J	Liang, F; Shi, LG; Zheng, JW; Chen, S; Wang, YX; Zhang, JM				Liang, Feng; Shi, Ligen; Zheng, Jingwei; Chen, Sheng; Wang, Yangxin; Zhang, Jianmin			Neuroprotective Effects of CGP3466B on Apoptosis Are Modulated by Protein-L-isoaspartate (D-aspartate) O-methyltransferase/Mst1 Pathways after Traumatic Brain Injury in Rats	SCIENTIFIC REPORTS			English	Article							METHYLTRANSFERASE PROTECTS; NUCLEAR TRANSLOCATION; NEURONAL DEATH; KINASE; MST1; ACTIVATION; PHOSPHORYLATION; INHIBITION; EXPRESSION; BAX	Neuronal apoptosis chiefly contributes to the cell loss following traumatic brain injury (TBI). CGP3466B is a compound related to the anti-Parkinsonism drug R-(-)-deprenyl. Previous studies have illuminated anti-apoptosis effects of CGP3466B in different cell lines, but the underlying mechanisms have not been fully elucidated. Mammalian sterile 20 (STE20)-like kinase1 (Mst1) is a core component of the Hippo signaling pathway. Protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1) is an enzyme that repairs damaged L-isoaspartyl residues in proteins. The present study was performed to investigate the neuroprotective effects of CGP3466B and to determine a potential PCMT1/Mst1 neuronal antiapoptotic pathway after TBI. Double immunofluorescence staining demonstrated that PCMT1 and Mst1 are co-located in neurons. Administration of CGP3466B improved neurological function, downregulated the ROS level and alleviated brain edema at 24 h after TBI. CGP3466B alleviates neuronal apoptosis by increasing PCMT1 expression and subsequently inhibiting MST1 activation, resulting in changing the expression levels of Bax, Bcl-2 and active-caspase3. The TUNEL staining results also support the anti-apoptosis effects of CGP3466B. The anti-apoptotic effects of CGP3466B were abolished by chelerythrine, an Mst1 activator, without changing PCMT1 levels. In conclusion, our findings suggest CGP3466B may have a promising therapeutic potential by modulating PCMT1/Mst1 signaling pathway after TBI injury.	[Liang, Feng; Shi, Ligen; Zheng, Jingwei; Chen, Sheng; Zhang, Jianmin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China; [Wang, Yangxin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed, Hangzhou 310009, Zhejiang, Peoples R China		Zhang, JM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China.	zjm135@vip.sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81500992]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LQ16H090002]	This work was supported by Grant 81500992 from National Natural Science Foundation of China; LQ16H090002 from Zhejiang Provincial Natural Science Foundation of China.	Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Huebscher KJ, 1999, GENE, V240, P333, DOI 10.1016/S0378-1119(99)00443-6; Lee JK, 2013, P NATL ACAD SCI USA, V110, P12066, DOI 10.1073/pnas.1300894110; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li JR, 2016, MOL NEUROBIOL, V53, P2668, DOI 10.1007/s12035-015-9318-8; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; MIZOBUCHI M, 1994, J NEUROCHEM, V62, P322; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Ouazia D, 2015, NEUROSCIENCE, V295, P139, DOI 10.1016/j.neuroscience.2015.03.026; Ouazia D, 2014, NEUROSCIENCE, V267, P263, DOI 10.1016/j.neuroscience.2014.03.001; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Verma P, 2010, PLANTA, V231, P329, DOI 10.1007/s00425-009-1050-z; Waldmeier PC, 2000, N-S ARCH PHARMACOL, V362, P526, DOI 10.1007/s002100000300; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xiao L, 2011, J NEUROSCI, V31, P9611, DOI 10.1523/JNEUROSCI.0035-11.2011; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yan GJ, 2013, INT J CARDIOL, V168, P3291, DOI 10.1016/j.ijcard.2013.04.045; Yu T, 2013, BIOCHEM BIOPH RES CO, V441, P53, DOI 10.1016/j.bbrc.2013.10.008; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	36	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 23	2017	7								9201	10.1038/s41598-017-08196-3			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8AQ	WOS:000408428400002	28835703	Green Published, gold			2022-02-06	
J	Wang, ML; Wei, XE; Yu, MM; Li, PY; Li, WB				Wang, Ming-Liang; Wei, Xiao-Er; Yu, Meng-Meng; Li, Peng-Yang; Li, Wen-Bin		Alzheimer's Dis Neuroimaging	Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Alzheimer's disease; Cortical thickness; CSF biomarkers; Beta-amyloid; Tau	ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; AMYLOID-BETA; PATHOLOGY; DEMENTIA; RISK; ENCEPHALOPATHY; ASSOCIATION; SEVERITY; VETERANS	In this study, we aimed to investigate whether self-reported mild traumatic brain injury (mTBI) was associated with decreased AD-vulnerable cortical thickness, and to assess the relationship between AD-vulnerable cortical thickness and AD-related biomarker in the Alzheimer's Disease Neuroimaging Initiative subjects. We identified 45 self-reported mTBI subjects, who had structural MRI, 18F-AV45 PET, and cerebrospinal fluid (CSF) data. Of them, eight subjects were normal; ten were preclinical AD; seventeen were MCI due to AD; ten were AD. Additional demographics-controlled 45 subjects were included. Cortical thickness of eight AD-vulnerable regions, mean AD-vulnerable cortical thickness, 18F-AV45 PET mean amyloid SUVR, CSF A beta 42, CSF total tau (T-tau), and CSF phosphorylated tau (P-tau) were compared between mTBI and non-TBI groups. Correlational analysis was done to investigate the relationship between mean AD-vulnerable cortical thickness and mean amyloid SUVR, CSF A beta 42, CSFT-Tau, CSF P-Tau. Our study revealed that preclinical AD subjects with self-reported mTBI had smaller cortical thickness in mean and three AD-vulnerable cortical regions than non-TBI subjects (P<0.05). The mean AD-vulnerable cortical thickness was correlated with CSF T-tau (r = -0.81, P = 0.001). There was no statistical difference in the comparison of normal, MCI due to AD, and AD groups. Our study indicated that among individuals with preclinical AD, but not normal, MCI due to AD and AD subjects, self-reported mTBI was associated with more decreased AD-vulnerable cortical thickness which was related to CSF tau pathology, suggesting the possible early involvement of tau pathology in the decreased AD-vulnerable cortical thickness of self-reported TBI subjects. (C) 2017 Elsevier B.V. All rights reserved.	[Wang, Ming-Liang; Wei, Xiao-Er; Yu, Meng-Meng; Li, Wen-Bin] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Sch Med, Shanghai 200233, Peoples R China; [Li, Peng-Yang] Peking Univ, Dept Cardiol, Aerosp Sch Clin Med, Hlth Sci Ctr, Beijing 100049, Peoples R China; [Li, Wen-Bin] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, Kashgar 844000, Peoples R China		Li, WB (corresponding author), 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sjtu.edu.cn	Li, Pengyang/AAH-4945-2021		National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271540, 81301213]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); AbbVieAbbVie; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BiogenBiogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; CereSpir, Inc.; Cogstate; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; Eurolmmun; F. Hoffmann-La Roche LtdHoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech; Fujirebio; GE HealthcareGeneral ElectricGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC; Lumosity; LundbeckLundbeck Corporation; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Transition Therapeutics; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by the National Natural Science Foundation of China (NSFC; No. 81271540, No. 81301213).; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chu SF, 2016, ASIA-PAC J PUBLIC HE, V28, P519, DOI 10.1177/1010539516662956; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Joshi A, 2012, J NUCL MED, V53, DOI 10.2967/jnumed.111.090340; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Li W., 2016, J NEUROL, V263; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nordstrom P., ANN NEUROL, V75; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Ozen L.J., 2015, NEUROPSYCHOL DEV COG, V22; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pettigrew C, 2016, NEUROIMAGE-CLIN, V12, P116, DOI 10.1016/j.nicl.2016.06.010; Poisnel G, 2012, NEUROBIOL AGING, V33, P2561, DOI 10.1016/j.neurobiolaging.2011.12.024; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Wang L, 2015, NEUROLOGY, V84, P1254, DOI 10.1212/WNL.0000000000001401; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wang X., 2015, J NEUROTRAUMA, V32; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015	36	10	10	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 10	2017	655						115	120		10.1016/j.neulet.2017.06.055			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD6UK	WOS:000407663200018	28689050	Bronze			2022-02-06	
J	Behnan, J; Stangeland, B; Langella, T; Finocchiaro, G; Tringali, G; Meling, TR; Murrell, W				Behnan, Jinan; Stangeland, Biljana; Langella, Tiziana; Finocchiaro, Gaetano; Tringali, Giovanni; Meling, Torstein R.; Murrell, Wayne			Identification and characterization of a new source of adult human neural progenitors	CELL DEATH & DISEASE			English	Article							MESENCHYMAL STEM-CELLS; SUBVENTRICULAR ZONE; GENE-EXPRESSION; WHITE-MATTER; HUMAN BRAIN; DIFFERENTIATION; NEUROGENESIS; BIOINFORMATICS; PERICYTES; ORIGIN	Adult neural progenitor cells (aNPCs) are a potential source for cell based therapy for neurodegenerative diseases and traumatic brain injuries. These cells have been traditionally isolated from hippocampus, subventricular zone and white matter. However, there is still a need for an easily accessible source with better yield to counter the limitations of small surgical samples of previously characterized aNPCs. Here we show that ultrasonic aspirate (UA) samples currently considered as ` biological waste after surgery,' offer a good source for aNPCs. Furthermore, we show that culture conditions dictated the phenotype of cells across patients. The neurosphere-enriched cells were more similar to freshly isolated brain cells, while cells expanded adherently in serum conditions were similar to mesenchymal stem cells. However, cells expanded in these adherent conditions expressed some NPC and glial markers in addition to active canonical Wnt signaling. This suggests a mesenchymal-neuroectodermal hybrid nature of these cells. Finally, we show that UA-NPCs are comparable to those from neurogenic regions. Our findings suggest that UA samples can be used as a source for fresh and in vitro propagated aNPCs that could have various clinical applications.	[Behnan, Jinan; Stangeland, Biljana] Oslo Univ Hosp, Inst Clin Med, Dept Immunol, Norwegian Ctr Stem Cell Res, Sognsvannsveien 9,1112 Blindern, N-0317 Oslo, Norway; [Behnan, Jinan] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Mol Med, Oslo, Norway; [Stangeland, Biljana] Capgemini, Dept Insights & Data, Akershus, Norway; [Langella, Tiziana; Finocchiaro, Gaetano] Neurol Inst C Besta, Unit Mol Neurooncol, Milan, Italy; [Tringali, Giovanni] Neurol Inst C Besta, Dept Neurosurg, Milan, Italy; [Meling, Torstein R.] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Murrell, Wayne] Oslo Univ Hosp, Inst Surg Res, Vilhelm Magnus Lab Neurosurg Res, Oslo, Norway		Behnan, J (corresponding author), Oslo Univ Hosp, Inst Clin Med, Dept Immunol, Norwegian Ctr Stem Cell Res, Sognsvannsveien 9,1112 Blindern, N-0317 Oslo, Norway.	jinan.bahnan@rr-research.no	Stangeland, Biljana/W-4912-2019; Tringali, Giovanni/AAF-3635-2020; Finocchiaro, Gaetano/AAG-6791-2020; Behnan, Jinan/C-9263-2009; Meling, Torstein/Q-2568-2019	Stangeland, Biljana/0000-0002-1723-9742; Tringali, Giovanni/0000-0003-1493-4034; Behnan, Jinan/0000-0001-5780-0971; Meling, Torstein/0000-0001-6595-0873; Finocchiaro, Gaetano/0000-0003-3583-4040	Helse Sor-Ost and Oslo University Hospital	We thank the patients for donating samples. We thank the Institute for Surgical Research for support of research infrastructure; further we thank Grazyna Babinska and Yan Zhang for technical support. We thank Ana H Barragan Lid and Thea Charlotte Smedsrud at the Genomics Core Facility of the Radium Hospital. We thank Lars Eide for discussing experiments and reading the manuscript. We also thank Jan Helge Solbakk and Peter Kierulf for guidance and support. This work was funded by Helse Sor-Ost and Oslo University Hospital.	Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Behnan J, 2017, ONCOGENE, V36, P570, DOI 10.1038/onc.2016.230; Behnan J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32788; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.tea.2010.0499, 10.1089/ten.TEA.2010.0499]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lojewski X, 2014, STEM CELL TRANSL MED, V3, P458, DOI 10.5966/sctm.2013-0117; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Murrell W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071334; Nelms BL, 2010, DEV BIOL; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Oliver DeLa Cruz J, 2014, PLOS ONE, V9; Orlova KA, 2010, J NEUROPATH EXP NEUR, V69, P850, DOI 10.1097/NEN.0b013e3181eac1f5; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stangeland B, 2015, ONCOTARGET, V6, P26192, DOI 10.18632/oncotarget.4613; Stavrum Anne Kristin, 2008, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0703s21; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Trost A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00020; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; van Strien ME, 2014, STEM CELL TRANSL MED, V3, P470, DOI 10.5966/sctm.2013-0038; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Ying Z, 2005, EPILEPSIA, V46, P1716, DOI 10.1111/j.1528-1167.2005.00276.x; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	41	10	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG	2017	8								e2991	10.1038/cddis.2017.368			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FG1JB	WOS:000409550500028	28796246	Green Published, gold			2022-02-06	
J	Benham, EC; Ross, SW; Mavilia, M; Fischer, PE; Christmas, AB; Sing, RF				Benham, Emily C.; Ross, Samuel W.; Mavilia, Mariana; Fischer, Peter E.; Christmas, A. Britton; Sing, Ronald F.			Injuries from all-terrain vehicles: An opportunity for injury prevention	AMERICAN JOURNAL OF SURGERY			English	Article						All-terrain vehicle; ATV; Helmet use; Injury prevention; Intoxication; Blunt trauma	UNITED-STATES; PUBLIC-HEALTH; ROAD; CRASHES; AGE; FATALITIES; SAFETY; IMPACT	Background: Patient demographics, behavior, and injury patterns were assessed to inform preventative efforts for reduced incidence of all-terrain vehicle (ATV) trauma. Methods: ATV-related injuries treated at a Level I trauma center from 2008 to 2012 were retrospectively reviewed. Patient outcomes and incidence of traumatic brain injury (TBI) were compared by helmet use and alcohol intoxication. Results: Helmet data were available for 304 patients of 404 patients included; of these, 75 (24.7%) wore a helmet. Incidence of TBI was lower in the helmeted (8.0%) versus the unhelmeted subgroup (26.6%) (P < 0.001). Helmeted patients had lower injury severity scores, lower intensive-care unit (ICU) admission rates, and shorter ICU and hospital length of stay (LOS) (P < 0.05). Intoxicated patients had higher rates of TBI and ICU admission as well as prolonged ICU LOS (P < 0.05). Conclusions: These data support the requirement for a greater emphasis on injury prevention among ATV users. (C) 2016 Elsevier Inc. All rights reserved.	[Benham, Emily C.; Ross, Samuel W.; Mavilia, Mariana; Fischer, Peter E.; Christmas, A. Britton; Sing, Ronald F.] Carolinas Med Ctr, Dept Surg, Div Acute Care Surg, Charlotte, NC 28203 USA		Sing, RF (corresponding author), Carolinas Med Ctr, Dept Surg, 1000 Blythe Blvd,MEB Suite 600, Charlotte, NC 28203 USA.	Emily.benham@carolinas.org; Samuel.ross@carolinas.org; Marimavilia@gmail.com; Fischepe23@me.com; Ashley.Christmas@carolinas.org; Ronald.Sing@CarolinasHealthCare.org					Axelband J, 2007, ACCIDENT ANAL PREV, V39, P213, DOI 10.1016/j.aap.2006.07.013; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Burgus SK, 2009, J AGROMEDICINE, V14, P97, DOI 10.1080/10599240902751047; Butts CC, 2015, INJURY, V46, P625, DOI 10.1016/j.injury.2014.11.007; Cairns H, 1943, BMJ-BRIT MED J, V1943, P591, DOI 10.1136/bmj.1.4297.591; Carr AM, 2004, NEUROSURGERY, V54, P861, DOI 10.1227/01.NEU.0000114922.46342.38; Commission USCPS, 2010, CONS PROD SAF COMM A; Commission USCPS, 2013, ANN REP ATV REL DEAT; Commission USCPS, 2008, ATV ACT PLANS 2008; Council N-H, 2004, EV SUMM REP 1990 200; DeJong W, 2014, J STUD ALCOHOL DRUGS, P108, DOI 10.15288/jsads.2014.s17.108; Denning G. M., 2015, TRAFFIC INJ PREV; Denning G, 2013, TRAFFIC INJ PREV, V14, P78, DOI 10.1080/15389588.2012.675110; Denning GM, 2014, PEDIATRICS, V134, P1094, DOI 10.1542/peds.2014-1993; Fonseca AH, 2005, AM SURGEON, V71, P937; Hall AJ, 2009, AM J PREV MED, V36, P311, DOI 10.1016/j.amepre.2008.11.019; Helmkamp JC, 2008, AM J PREV MED, V34, P39, DOI 10.1016/j.amepre.2007.09.016; HELMKAMP JC, 2008, ALL TERRAIN VEHICLE; Homer J, 2009, AM J PUBLIC HEALTH, V99, P415, DOI 10.2105/AJPH.2008.134106; Krauss EM, 2010, J TRAUMA, V69, P1338, DOI 10.1097/TA.0b013e3181fc5e7b; Mazotas I, 2014, J TRAUMA ACUTE CARE, V77, P103, DOI 10.1097/TA.0000000000000266; Olsen Cody S, 2016, Inj Epidemiol, V3, P8; Rostas Jack W, 2014, J Trauma Acute Care Surg, V76, P201, DOI 10.1097/TA.0b013e3182a994ff; Rotondo MF, 2005, AM SURGEON, V71, P940; Scutchfield SB, 2003, CLIN ORTHOP RELAT R, P61, DOI 10.1097/01.blo.0000060441.40507.3e; Smith LM, 2005, J TRAUMA, V58, P783, DOI 10.1097/01.TA.0000158252.11002.6E; SoN Carolina, 2006, N CAR STAT LAWS; Unni P, 2012, J TRAUMA ACUTE CARE, V73, pS277, DOI 10.1097/TA0b013e31826b00d7; Vanlaar W, 2015, ACCIDENT ANAL PREV, V75, P264, DOI 10.1016/j.aap.2014.12.006; Villegas CV, 2016, INJURY, V47, P178, DOI 10.1016/j.injury.2015.08.001; Williams AF, 2014, J SAFETY RES, V50, P117, DOI 10.1016/j.jsr.2014.05.001	31	10	10	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	AUG	2017	214	2					211	216		10.1016/j.amjsurg.2016.11.017			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FG7TN	WOS:000410627700008	27914583				2022-02-06	
J	Feng, JZ; Wang, WY; Zeng, J; Zhou, ZY; Peng, J; Yang, H; Deng, PC; Li, SJ; Lu, CD; Jiang, H				Feng, Jin-Zhou; Wang, Wen-Yuan; Zeng, Jun; Zhou, Zhi-Yuan; Peng, Jin; Yang, Hao; Deng, Peng-Chi; Li, Shi-Jun; Lu, Charles D.; Jiang, Hua			Optimization of brain metabolism using metabolic-targeted therapeutic hypothermia can reduce mortality from traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	75th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 14-17, 2016	Waikoloa, HI	Amer Assoc Surg Trauma		Therapeutic hypothermia; traumatic brain injury; trauma; metabolomics; H-1-nuclear magnetic resonance	TERM MILD HYPOTHERMIA; MANAGEMENT; PROGESTERONE; MECHANISMS; ESTROGEN; RECOVERY; ADULTS; DAMAGE; SEX	BACKGROUND: Therapeutic hypothermia is widely used to treat traumatic brain injuries (TBIs). However, determining the best hypothermia therapy strategy remains a challenge. We hypothesized that reducing the metabolic rate, rather than reaching a fixed body temperature, would be an appropriate target because optimizing metabolic conditions especially the brain metabolic environment may enhance neurologic protection. A pilot single-blind randomized controlled trial was designed to test this hypothesis, and a nested metabolomics study was conducted to explore the mechanics thereof. METHODS: Severe TBI patients (Glasgow Coma Scale score, 3-8) were randomly divided into the metabolic-targeted hypothermia treatment (MTHT) group, 50% to 60% rest metabolic ratio as the hypothermia therapy target, and the body temperature-targeted hypothermia treatment (BTHT) control group, hypothermia therapy target of 32 degrees C to 35 degrees C body temperature. Brain and circulatory metabolic pool blood samples were collected at baseline and on days 1, 3, and 7 during the hypothermia treatment, which were selected randomly from a subgroup of MTHT and BTHT groups. The primary outcome was mortality. Using H-1 nuclear magnetic resonance technology, we tracked and located the disturbances of metabolic networks. RESULTS: Eighty-eight severe TBI patients were recruited and analyzed from December 2013 to December 2014, 44 each were assigned in the MTHT and BTHT groups (median age, 42 years; 69.32% men; mean Glasgow Coma Scale score, 6.17 +/- 1.02). The mortality was significantly lower in the MTHT than the BTHT group (15.91% vs. 34.09%; p = 0.049). From these, eight cases of MTHT and six cases from BTHT group were enrolled for metabolomics analysis, which showed a significant difference between the brain and circulatory metabolic patterns in MTHT group on day 7 based on the model parameters and scores plots. Finally, metabolites representing potential neuroprotective monitoring parameters for hypothermia treatment were identified through 1H nuclear magnetic resonance metabolomics. CONCLUSION: MTHT can significantly reduce the mortality of severe TBI patients. Metabolomics research showed that this strategy could effectively improve brain metabolism, suggesting that reducing the metabolic rate to 50% to 60% should be set as the hypothermia therapy target. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Feng, Jin-Zhou; Wang, Wen-Yuan; Zeng, Jun; Li, Shi-Jun; Jiang, Hua] Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Dept Trauma Surg, Chengdu, Sichuan, Peoples R China; [Feng, Jin-Zhou; Zeng, Jun; Zhou, Zhi-Yuan; Peng, Jin; Yang, Hao; Lu, Charles D.; Jiang, Hua] Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Dept Computat Math & Biostat, Metab & Multidisciplinary Lab Trauma Res, 585 Da Mian Hong He Bei Lu, Chengdu 610101, Sichuan, Peoples R China; [Wang, Wen-Yuan] North Sichuan Med Coll, Nanchong, Peoples R China; [Zhou, Zhi-Yuan] Southwest Med Univ, Dept Biochem, Luzhou, Peoples R China; [Deng, Peng-Chi] Sichuan Univ, Analyt & Testing Ctr, Chengdu, Sichuan, Peoples R China		Jiang, H (corresponding author), Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Dept Computat Math & Biostat, Metab & Multidisciplinary Lab Trauma Res, 585 Da Mian Hong He Bei Lu, Chengdu 610101, Sichuan, Peoples R China.	cdjianghua@gmail.com	Jiang, Hua/ABE-5811-2021	Jiang, Hua/0000-0003-1465-0170	Sichuan Provincial Department of Science and Technology [2014FZ0125, 2015SZ0110]; Department of Science and Technology of Chengdu Municipality [12PPYB181SF-002, 11PPYB009SF-289]	This work was supported by funds from the Sichuan Provincial Department of Science and Technology (No. 2014FZ0125 to H.J. and 2015SZ0110 to J.Z.), Department of Science and Technology of Chengdu Municipality (12PPYB181SF-002, 11PPYB009SF-289 to H.J.). The funding bodies played no role in the design or execution of the study or in article writing. The authors declare no conflicts of interest.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Bales James W, 2010, Open Drug Discov J, V2, P119; Boullata J, 2007, J AM DIET ASSOC, V107, P393, DOI 10.1016/j.jada.2006.12.014; CAMPBELL RM, 1967, Q J EXP PHYSIOL CMS, V52, P114, DOI 10.1113/expphysiol.1967.sp001893; Chinese Congress of Neurological Surgeons Chinese Committee of Experts on Neurological Trauma, 2015, ZHONG HUA SHEN JING, V1, P59; Chinese Medical Doctor Association Emergency Physicians Branch, 2016, ZHONG HUA JI ZHEN YI, V25, P274; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; ERB DE, 1991, EXP BRAIN RES, V83, P253; Feng J, 2015, ZHONG HUA SHEN JING, V31, P192; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Haugen HA, 2007, NUTR CLIN PRACT, V22, P377, DOI 10.1177/0115426507022004377; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jiang H, 2010, CHINESE MED J-PEKING, V123, P2315, DOI 10.3760/cma.j.issn.0366-6999.2010.17.006; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jiang JY, 2010, MODERN CRANIOCEREBRA; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lexcen DR, 2012, J TRAUMA ACUTE CARE, V73, pS147, DOI 10.1097/TA.0b013e3182609821; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Maxwell WL, 2005, J NEUROTRAUM, V22, P873, DOI 10.1089/neu.2005.22.873; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; Neurocritical Care Committee of Chinese Society of Neurology, 2015, ZHONG HUA SHEN JING, V48, P453; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Peng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093736; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Walker HK, 1990, CLIN METHODS HIST PH, V3rd; Wang H.W., 1999, PARTIAL LEAST SQUARE; Wise PM, 2001, BRAIN RES REV, V37, P313, DOI 10.1016/S0165-0173(01)00136-9; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zhang H, 2011, CHINESE MED J-PEKING, V124, P2764, DOI 10.3760/cma.j.issn.0366-6999.2011.17.035; Zhang Shao-Yan, 2013, ISRN Radiol, V2013, P874570, DOI 10.5402/2013/874570; Zhang YJ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/463930; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	50	10	12	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2017	83	2					296	304		10.1097/TA.0000000000001522			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	FB3RB	WOS:000406059100014	28452885				2022-02-06	
J	Heimann, G; Canhos, LL; Frik, J; Jager, G; Lepko, T; Ninkovic, J; Gotz, M; Sirko, S				Heimann, Gabor; Canhos, Luisa L.; Frik, Jesica; Jaeger, Gabriele; Lepko, Tjasa; Ninkovic, Jovica; Goetz, Magdalena; Sirko, Swetlana			Changes in the Proliferative Program Limit Astrocyte Homeostasis in the Aged Post-Traumatic Murine Cerebral Cortex	CEREBRAL CORTEX			English	Article						aging; brain injury; cell division; GFAP; glia; reactive gliosis; self-renewal; Shh	NEURAL STEM-CELLS; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; GLUTAMINE-SYNTHETASE; ALZHEIMERS-DISEASE; ISCHEMIC-STROKE; AGING BRAIN; FUNCTIONAL RECOVERY; REACTIVE GLIOSIS; TRANSGENIC MICE	Aging leads to adverse outcomes after traumatic brain injury. The mechanisms underlying these defects, however, are not yet clear. In this study, we found that astrocytes in the aged post-traumatic cerebral cortex develop a significantly reduced proliferative response, resulting in reduced astrocyte numbers in the penumbra. Moreover, experiments of reactive astrocytes in vitro reveal that their diminished proliferation is due to an age-related switch in the division mode with reduced cell-cycle re-entry rather than changes in cell-cycle length. Notably, reactive astrocytes in vivo and in vitro become refractory to stimuli increasing their proliferation during aging, such as Sonic hedgehog signaling. These data demonstrate for the first time that age-dependent, most likely intrinsic changes in the proliferative program of reactive astrocytes result in their severely hampered proliferative response to traumatic injury thereby affecting astrocyte homeostasis.	[Heimann, Gabor; Canhos, Luisa L.; Frik, Jesica; Jaeger, Gabriele; Ninkovic, Jovica; Goetz, Magdalena; Sirko, Swetlana] Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Grosshadener Str 9, D-82152 Planegg, Germany; [Canhos, Luisa L.; Frik, Jesica; Lepko, Tjasa; Ninkovic, Jovica; Goetz, Magdalena; Sirko, Swetlana] German Res Ctr Environm Hlth GmbH, Inst Stem Cell Res, Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Canhos, Luisa L.; Lepko, Tjasa; Ninkovic, Jovica] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, D-82152 Planegg, Germany; [Frik, Jesica] Inst Biotechnol & Mol Biol IBBM, Dept Biol Sci, RA-1900 La Plata, Buenos Aires, Argentina; [Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr, Synergy, Excellence Cluster Syst Neurol, D-82152 Planegg, Germany		Sirko, S (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Grosshadener Str 9, D-82152 Planegg, Germany.	swetlana.sirko@med.uni-muenchen.de	Frik, Jesica/AAI-3992-2021; Ninkovic, Jovica/AAH-5220-2019; Sirko, Swetlana/O-5725-2019	Ninkovic, Jovica/0000-0002-4381-0041; Sirko, Swetlana/0000-0001-5950-616X; Frik, Jesica/0000-0002-8750-2112	Friedrich Baur Foundation [822646, 822395]; German Research FoundationGerman Research Foundation (DFG) [SPP 1757, SFB 870]; European Research CouncilEuropean Research Council (ERC)European Commission [340793]; Excellence Cluster of Systems Neurology Synergy; Helmholtz Alliance Icemed	This work was supported by the Friedrich Baur Foundation (Grant nos. 822646 and 822395 to S.S.); the German Research Foundation (SPP 1757 and SFB 870 to M.G.); the European Research Council (Grant no. 340793 to M.G.); Excellence Cluster of Systems Neurology Synergy (M.G.) and the Helmholtz Alliance Icemed (M.G.).	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; ALEXANDER MP, 1994, STROKE, V25, P128, DOI 10.1161/01.STR.25.1.128; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Chisholm NC, 2015, EPIGENETICS-US, V10, P142, DOI 10.1080/15592294.2014.1001219; Copen WA, 2001, RADIOLOGY, V221, P27, DOI 10.1148/radiol.2211001397; Cordiglieri Chiara, 2010, Current Immunology Reviews, V6, P150; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; Dostovic Z, 2009, ACTA CLIN CROAT, V48, P13; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; El-Zaatari M, 2012, PANCREAS, V41, P1019, DOI 10.1097/MPA.0b013e31824a0eeb; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Ferent J, 2014, STEM CELL REP, V3, P312, DOI 10.1016/j.stemcr.2014.05.016; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fonarow GC, 2010, CIRCULATION, V121, P879, DOI 10.1161/CIRCULATIONAHA.109.892497; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Galvan V, 2007, CLIN INTERV AGING, V2, P605; Gargano JW, 2011, J STROKE CEREBROVASC, V20, P494, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.022; Gotz M, 2013, STEM CELLS HDB, P347, DOI [10.1007/978-1-4614-7696-2_24, DOI 10.1007/978-1-4614-7696-2_24]; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hilsenbeck O, 2016, NAT BIOTECHNOL, V34, P703, DOI 10.1038/nbt.3626; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jiang T, 2014, AGING CELL, V13, P1059, DOI 10.1111/acel.12268; Juraska Janice M, 2012, Curr Top Behav Neurosci, V10, P137, DOI 10.1007/7854_2011_137; Lee SW, 2012, BEHAV BRAIN RES, V227, P497, DOI 10.1016/j.bbr.2011.10.009; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Lewis DK, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050; Lynch AM, 2010, AGING DIS, V1, P262; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Moraga A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0314-8; Nolte C, 2001, GLIA, V33, P72; O'Callaghan JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102003; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Ortega F, 2013, METHODS MOL BIOL, V1052, P1, DOI 10.1007/7651_2013_22; Pekna M, 2012, STROKE, V43, P2819, DOI 10.1161/STROKEAHA.112.654228; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rodriguez JJ, 2014, NEUROBIOL AGING, V35, P15, DOI 10.1016/j.neurobiolaging.2013.07.002; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Rose C, 2005, METAB BRAIN DIS, V20, P275, DOI 10.1007/s11011-005-7906-4; Rose CF, 2013, BIOCHEM SOC T, V41, P1518, DOI 10.1042/BST20130237; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shapira S, 2002, BRAIN RES, V925, P148, DOI 10.1016/S0006-8993(01)03270-X; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Steffek AE, 2008, SCHIZOPHR RES, V103, P71, DOI 10.1016/j.schres.2008.04.032; Steffens M, 2005, NEUROCHEM INT, V47, P379, DOI 10.1016/j.neuint.2005.06.001; Sun HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066885; Toescu EC, 2005, PHILOS T R SOC B, V360, P2347, DOI 10.1098/rstb.2005.1771; Unger JW, 1998, MICROSC RES TECHNIQ, V43, P24, DOI 10.1002/(SICI)1097-0029(19981001)43:1<24::AID-JEMT4>3.0.CO;2-P; Verkhratsky A, 2016, CURR OPIN PHARMACOL, V26, P74, DOI 10.1016/j.coph.2015.09.011; Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107; Verkhratsky A, 2014, CELL TISSUE RES, V357, P493, DOI 10.1007/s00441-014-1814-z; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yun HM, 2015, MOL NEUROBIOL, V52, P341, DOI 10.1007/s12035-014-8860-0; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang WQ, 2011, J CLIN NEUROSCI, V18, P685, DOI 10.1016/j.jocn.2010.08.027	79	10	10	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	AUG	2017	27	8					4213	4228		10.1093/cercor/bhx112			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA5PH	WOS:000405495200026	28472290	hybrid, Green Published			2022-02-06	
J	Kerr, ZY; Zuckerman, SL; Register-Mihalik, JK; Wasserman, EB; McLeod, TCV; Dompier, TP; Comstock, RD; Marshall, SW				Kerr, Zachary Y.; Zuckerman, Scott L.; Register-Mihalik, Johna K.; Wasserman, Erin B.; McLeod, Tamara C. Valovich; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.			Estimating Concussion Incidence Using Sports Injury Surveillance Systems Complexities and Potential Pitfalls	NEUROLOGIC CLINICS			English	Article						Concussion; Surveillance; Sports injury; National Collegiate Athletic Association; High School Reporting Information Online; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CERTIFIED ATHLETIC TRAINERS; COLLEGIATE FOOTBALL PLAYERS; DATA-COLLECTION PROCEDURES; STATES HIGH-SCHOOL; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; CONSENSUS STATEMENT; SEX-DIFFERENCES; RISK-FACTORS	Numerous sports injury surveillance systems exist with the capability of tracking concussion incidence data. It is important for the consumers of sport-related concussion data, be they researchers or the public, to have a comprehensive understanding of the strengths and limitations of sports injury surveillance systems. This article discusses issues of system design and analysis that affect the interpretation and understanding of sport-related concussion incidence data from sports injury surveillance systems. Such understanding will help inform the design of sports injury surveillance systems and research studies that aim to identify risk factors, develop prevention strategies, and evaluate prevention mechanisms.	[Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, Woollen 313,CB 8700, Chapel Hill, NC 27599 USA; [Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr,Med Ctr North T4224, Nashville, TN 37212 USA; [Register-Mihalik, Johna K.] Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, Fetzer 125,CB 8700, Chapel Hill, NC 27599 USA; [Wasserman, Erin B.; Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med, Athlet Training Programs, 5850 East Still Circle, Mesa, AZ 85206 USA; [Comstock, R. Dawn] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Mail Stop B119,13001 East 17th Pl, Aurora, CO 80045 USA; [Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Dept Epidemiol, Suite 500,Bank Amer Bldg,CB 7505, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, Woollen 313,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Wasserman, Erin/0000-0001-5957-5878			[Anonymous], 2014, STUD ATHL PART 1981; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Balazs GC, 2015, CURR ORTHOP PRACT, V26, P395, DOI 10.1097/BCO.0000000000000246; Baugh CM, 2016, J ATHL TRAINING, V51, P317, DOI 10.4085/1062-6050-51.4.13; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Biderman D., 2010, FOOTBALL GAMES HAVE; Boyce R., 2008, SPORT J, V11; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Carey JL, 2006, AM J SPORT MED, V34, P1911, DOI 10.1177/0363546506290186; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Currie DW, 2015, PEDIATRICS; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick R, 2007, J ATHL TRAINING, V42, P173; DICK RW, 1994, AM SOC TEST MATER, V1229, P13, DOI 10.1520/STP12799S; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Eaton-Robb P., 2010, MSNBC; Eirale C, 2015, CLIN J SPORT MED, V25, P73, DOI 10.1097/JSM.0000000000000066; Ekegren CL, 2015, SCAND J MED SCI SPOR, V25, P315, DOI 10.1111/sms.12216; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hennefer A., 2003, DANCE CHEERLEADING C; Institute of Medicine, 2013, SPORTS RELATED CONCU; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kerr ZY, 2016, J ATHL TRAIN; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4; Kerr ZY, 2015, NAT ATH TRAIN ASS 66; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lombardi NJ, 2016, ORTHOPEDICS, V39, pE944, DOI 10.3928/01477447-20160623-10; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moyer S., 2013, AM PASTIME BASEBALL; National Federation of State High School Associations, 2014, PART STAT; National Institute of Neurological Disorders and Stroke, 2016, NINDS COMM DAT EL; NCAA, 2010, 2010 11 NCAA DIV I M; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rauh M., 2011, APPL SPORTS INJURY E, P730; Register-Mihalik JK, 2016, CLIN J SPORT MED; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schiff MA, 2010, J ATHL TRAINING, V45, P238, DOI 10.4085/1062-6050-45.3.238; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Stovitz SD, 2012, BRIT J SPORT MED, V46, P960, DOI 10.1136/bjsports-2011-090693; Sullivan L, 2016, INT J ADOLESC MED HL; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Varnavas H., 2009, ILL BUSINESS LAW J, V2009, P40; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2016, NEUROSURGERY S1, V63, P169	93	10	10	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					409	+		10.1016/j.ncl.2017.03.001			27	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FC4OI	WOS:000406819500004	28673407				2022-02-06	
J	Leung, FT; Smith, MMF; Brown, M; Rahmann, A; Mendis, MD; Hides, JA				Leung, Felix T.; Smith, Melinda M. Franettovich; Brown, Mark; Rahmann, Ann; Mendis, M. Dilani; Hides, Julie A.			Epidemiology of injuries in Australian school level rugby union	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Sport injury; Concussion; Surveillance; Youth; Adolescent	CONCUSSION; PLAYERS; ACADEMY	Objectives: There is a high incidence of injuries in rugby union due to the physical nature of the game. There is a lack of large-scale injury surveillance data reported for school level rugby players of different ages. Our study aimed to investigate the frequency and nature of injuries being sustained during an Australian school level rugby union season. Design: Prospective observational study. Methods: Injury surveillance was conducted on 3585 rugby players from all 8 schools participating in an interschool rugby competition in Queensland, Australia. Match injury data were collected using paper based injury recording forms during the season using a 'medical-attention' injury definition for each age group from opens (17 and 18 year olds) through to year 5 teams (9-10 year olds). Results: There were 332 injuries recorded over 14,029 player hours during the season. The overall rate of injury was 23.7/1000 player hours (95% CI, 21.2-26.3). The incidence of upper and lower limb injuries were 6.3 and 5.6 injuries/1000 player hours respectively (95% CI, 5.1-7.8 and 4.5-7.0). The incidence of suspected concussion injuries was 4.3/1000 player hours (95% CI, 3.6-5.5). Injuries differed across age groups and tackling was the most common mechanism of injury. Conclusions: The injury patterns observed in this large sample of players could be used to guide injury prevention programs in school level rugby union. Injury prevention programs should include age appropriate interventions and focus on improving the techniques used during the contact phase of rugby. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Leung, Felix T.; Smith, Melinda M. Franettovich; Mendis, M. Dilani; Hides, Julie A.] Australian Catholic Univ, Ctr Musculoskeletal Res, Mary MacKillop Inst Hlth Res, Sydney, NSW, Australia; [Brown, Mark] Sports Med Australia Queensland, Milton, Qld, Australia; [Rahmann, Ann] Australian Catholic Univ, Sch Physiotherapy, Sydney, NSW, Australia; [Mendis, M. Dilani] Mater Hlth Serv, Physiotherapy Dept, South Brisbane, Qld, Australia; [Hides, Julie A.] Mater Hlth Serv, Mater ACU Back Stabil Clin, South Brisbane, Qld, Australia		Leung, FT (corresponding author), Australian Catholic Univ, Ctr Musculoskeletal Res, Mary MacKillop Inst Hlth Res, Sydney, NSW, Australia.	felix.leung@acu.edu.au	Smith, Melinda Franettovich/AAK-1568-2021; Hides, Julie Anne/F-2141-2011; Brown, Mark/K-7506-2019	Smith, Melinda Franettovich/0000-0002-0098-7656; Hides, Julie Anne/0000-0002-1830-8121; Brown, Mark/0000-0002-8310-4774; Rahmann, Ann/0000-0002-5458-2849			Bleakley C, 2011, J ATHL TRAINING, V46, P555; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119, DOI 10.5694/j.1326-5377.1987.tb133299.x; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Leung FT, 2016, J SPORTS SCI, V2016, P1; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; McIntosh Andrew S, 2005, Med Sport Sci, V49, P120, DOI 10.1159/000085394; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Smith AR, 2013, HORM BEHAV, V64, P323, DOI 10.1016/j.yhbeh.2013.03.006; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43	20	10	10	0	24	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	AUG	2017	20	8					740	744		10.1016/j.jsams.2017.03.006			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FC5PE	WOS:000406893400008	28392337				2022-02-06	
J	Majidi, S; Makke, Y; Ewida, A; Sianati, B; Qureshi, AI; Koubeissi, MZ				Majidi, Shahram; Makke, Yamane; Ewida, Amr; Sianati, Bahareh; Qureshi, Adnan I.; Koubeissi, Mohamad Z.			Prevalence and Risk Factors for Early Seizure in Patients with Traumatic Brain Injury: Analysis from National Trauma Data Bank	NEUROCRITICAL CARE			English	Article						Seizure; Traumatic brain injury; Post-traumatic seizure; Subdural hematoma; Hospital outcome	INTENSIVE-CARE-UNIT; ELECTROGRAPHIC SEIZURES; INPATIENT SAMPLE; METABOLIC CRISIS; INCREASE; ADULTS	Background Traumatic brain injury (TBI) is a well-known risk factor for seizures. We aimed to identify the frequency and risk factors for seizure occurrence during hospitalization for TBI. Methods We used ICD-9-CM codes to identify patients 18 years of age or older from the National Trauma Data Bank who were admitted with TBI. We also used ICD-9-CM codes to identify the subset who had seizures during hospitalization. Patient demographics, comorbidities, Glasgow Coma Scale (GCS) score, Injury Severity Score Abbreviated Injury Scale (ISSAIS), in-hospital complications, and discharge disposition were compared in the seizure group (SG) and no-seizure group (NSG). Results A total of 1559 patients had in-hospital seizures, comprising 0.4% of all patients admitted with TBI. The mean age of SG was 3 years older than NSG [51 vs. 48; p < 0.0001]. African-American ethnicity (20 vs. 12%, p < 0.0001) and moderate TBI (8 vs. 4%, p < 0.0001) were more common in SG. History of alcohol dependence was more common in the SG (25 vs. 11%, p < 0.0001). Fall was the most common mechanism of injury in SG (56 vs. 36% in NSG; p < 0.0001). Subdural hematoma was more common in SG (31 vs. 21%, p < 0.0001). SG had higher rates of pneumonia, ARDS, acute kidney injury, and increased ICP. The average length of hospital stay was significantly higher in SG (10 vs. 6 days, p < 0.0001), and these patients had higher rate of discharge to nursing facility (32 vs. 25%, p < 0.0001). Conclusion In-hospital seizures occur in 0.4% of all TBI patients. Although infrequent, seizure occurrence is associated with higher rates of hospital complications such as pneumonia and ARDS and is an independent predictor of longer hospital stay and worse hospital outcome.	[Majidi, Shahram; Makke, Yamane; Ewida, Amr; Sianati, Bahareh; Koubeissi, Mohamad Z.] George Washington Univ, Dept Neurol, 2150 Penn Ave NW,9th Floor, Washington, DC 20037 USA; [Qureshi, Adnan I.] Zeenat Qureshi Stroke Inst, St Cloud, MN USA		Majidi, S (corresponding author), George Washington Univ, Dept Neurol, 2150 Penn Ave NW,9th Floor, Washington, DC 20037 USA.	majidis@gwu.edu		Qureshi, Adnan/0000-0003-4962-540X			Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Bergey Gregory K, 2016, Continuum (Minneap Minn), V22, P38, DOI 10.1212/CON.0000000000000271; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Foundation BT, 2007, GUID MAN SERV TRAUM; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Kennedy JD, 2012, CURR NEUROL NEUROSCI, V12, P419, DOI 10.1007/s11910-012-0289-0; Lamar CD, 2014, J NEUROPSYCHIATRY CL, V26, piv, DOI DOI 10.1176/APPI.NEUR0PSYCH.260201; Majidi S, 2014, NEUROCRIT CARE, V21, P253, DOI 10.1007/s12028-013-9937-8; Mansfield RT, 1997, CRIT CARE CLIN, V13, P611, DOI 10.1016/S0749-0704(05)70331-6; Mullen MT, 2013, NEUROCRIT CARE, V19, P19, DOI 10.1007/s12028-012-9791-0; Ritter AC, 2016, INC RISK FACT POST S; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shermer CR, 2007, J TRAUMA, V63, P1268; Sherzai D, 2014, EPILEPSY BEHAV, V36, P53, DOI 10.1016/j.yebeh.2014.04.015; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750	27	10	11	1	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2017	27	1					90	95		10.1007/s12028-016-0363-6			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FB7GX	WOS:000406310200013	28000125				2022-02-06	
J	Mazhar, FN; Jafari, D; Mirzaei, A				Mazhar, Farid Najd; Jafari, Davod; Mirzaei, Alireza			Evaluation of functional outcome after nonsurgical management of terrible triad injuries of the elbow	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Nonsurgical management; terrible triad; elbow; injury; functional outcome; complication	CORONOID PROCESS; DISLOCATIONS; FRACTURES	Background: Terrible triad (TT) is one of the severe injuries of the elbow that generally requires surgery. Nonsurgical treatment has recently been applied in selected cases of TT injury. Evaluation of the results of this treatment was the main aim of this study. Methods: In a prospective cohort study, 10 patients with a mean follow-up of 30.6 months were evaluated. The inclusion criteria included a congruent joint after closed reduction, no indication for surgery of the coronoid and radial head fractures, no block in supination and pronation up to 60 degrees, no intra-articular fragments, and a free and stable joint with ulnohumeral extension up to a minimum of 45 degrees. Mayo Elbow Performance Index and Disabilities of the Arm, Shoulder, and Hand score were used for assessment of the functional outcome. Astandard physical examination to record elbow range of motion was also performed. Results: For the affected and the contralateral elbows, respectively, the mean extension of the elbow was 11 degrees +/- 7 degrees and 0.0 degrees +/- 2 degrees; the mean flexion was 131 degrees +/- 9 degrees and 140 degrees +/- 10 degrees; the mean supination was 58 degrees +/- 17 degrees and 85 +/- 7 degrees; and the mean pronation was 53 degrees +/- 23 degrees and 85 degrees +/- 7 degrees. The mean Disabilities of the Arm, Shoulder, and Hand score was 4.76 +/- 5.17. The mean Mayo Elbow Performance Index was 95 +/- 8.16. Conclusion: Nonsurgical management of the TT injury can result in acceptable functional outcomes when a patient meets the criteria set for nonsurgical treatment. (C) 2017 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.	[Mazhar, Farid Najd; Jafari, Davod; Mirzaei, Alireza] Iran Univ Med Sci, Shafa Orthoped Hosp, Bone & Joint Reconstruct Res Ctr, Tehran, Iran		Mirzaei, A (corresponding author), Shafa Orthoped Hosp, Baharestan Sq, Tehran, Iran.	mirzaeialireza26@gmail.com	Mazhar, Farid Najd/Z-2096-2019; Mirzaei, Alireza/M-4091-2018	Mirzaei, Alireza/0000-0002-1569-6130; jafari, davod/0000-0002-0056-4901; Jafari, Davod/0000-0002-2796-9597			BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; Chan K, 2014, CLIN ORTHOP RELAT R, V472, P2092, DOI 10.1007/s11999-014-3518-9; Chen HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097476; Closkey RF, 2000, J BONE JOINT SURG AM, V82A, P1749, DOI 10.2106/00004623-200012000-00009; Doornberg JN, 2006, J HAND SURG-AM, V31A, P794, DOI 10.1016/j.jhsa.2006.01.004; Filh Geraldo Motta, 2010, Rev Bras Ortop, V45, P347, DOI 10.1016/S2255-4971(15)30380-3; Guitton TG, 2010, J HAND SURG-AM, V35A, P464, DOI 10.1016/j.jhsa.2009.12.015; Keschner MT, 2007, BULL HOSP JT DIS, V65, P24; Little KJ, 2014, ORTHOP CLIN N AM, V45, P327, DOI 10.1016/j.ocl.2014.03.004; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; Mathew PK, 2009, J AM ACAD ORTHOP SUR, V17, P137, DOI 10.5435/00124635-200903000-00003; McKee Michael D, 2005, J Bone Joint Surg Am, V87 Suppl 1, P22, DOI 10.2106/JBJS.D.02933; Mousavi SJ, 2008, CLIN REHABIL, V22, P749, DOI 10.1177/0269215508085821; REGAN W, 1989, J BONE JOINT SURG AM, V71A, P1348, DOI 10.2106/00004623-198971090-00011; Rodriguez-Martin J, 2011, INT ORTHOP, V35, P851, DOI 10.1007/s00264-010-1024-6	15	10	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	AUG	2017	26	8					1342	1347		10.1016/j.jse.2017.05.012			6	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	FB7TK	WOS:000406342700009	28734536				2022-02-06	
J	Ozay, R; Turkoglu, ME; Gurer, B; Dolgun, H; Evirgen, O; Erguder, BI; Hayirli, N; Gurses, L; Sekerci, Z				Ozay, Rafet; Turkoglu, Mehmet Erhan; Gurer, Bora; Dolgun, Habibullah; Evirgen, Oya; Erguder, Berrin Imge; Hayirli, Nazli; Gurses, Levent; Sekerci, Zeki			The Protective Effect of Omeprazole Against Traumatic Brain Injury: An Experimental Study	WORLD NEUROSURGERY			English	Article						Antioxidants; Apoptosis; Methylprednisolone; Neuroprotection; Omeprazole; Traumatic brain injury	ARYL-HYDROCARBON RECEPTOR; CORTICAL IMPACT INJURY; NITRIC-OXIDE; OXIDATIVE STRESS; LIPID-PEROXIDATION; DIOXIN RECEPTOR; ANTIOXIDANT; DEATH; RATS; MITOCHONDRIA	BACKGROUND: The development of secondary brain injury via oxidative stress after traumatic brain injury (TBI) is a well-known entity. Consequently, the aim of the present study was to evaluate the role of omeprazole (OM) on rat model of TBI. METHODS: A total of 24 male rats were used and divided into 4 groups as follows; control, trauma, OM, and methylprednisolone (MP). The trauma, OM, and MP groups were subjected to closed-head contusive weight-drop injuries. Rats received treatment with saline, OM, or MP, respectively. All the animals were sacrificed at 24 hours after trauma and brain tissues were extracted. The oxidant/antioxidant parameters (malondialdehyde, glutathione peroxidase, superoxide dismutase, nitric oxide) and caspase-3 in the cerebral tissue were analyzed, and his-tomorphologic evaluation of the cerebral tissue was performed. RESULTS: Levels of MDA and activity of caspase-3 were significantly reduced in the OM and MP groups compared with the trauma group. Glutathione peroxidase and superoxide dismutase levels were increased both in the OM and MP groups compared with the trauma group. The pathology scores were statistically lower in the OM and MP groups than the trauma group. CONCLUSIONS: The results of the present study showed that OM was as effective as MP in protecting brain from oxidative stress, and apoptosis in the early phase of TBI.	[Ozay, Rafet; Turkoglu, Mehmet Erhan; Dolgun, Habibullah; Gurses, Levent; Sekerci, Zeki] Minist Hlth, Neurosurg Clin, Diskapi Yildirim Beyazit Training & Res Hosp, Ankara, Turkey; [Gurer, Bora] Minist Hlth, Neurosurg Clin, Fatih Sultan Mehmet Training & Res Hosp, Istanbul, Turkey; [Evirgen, Oya; Hayirli, Nazli] Ankara Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey; [Erguder, Berrin Imge] Ankara Univ, Fac Med, Dept Biochem, Ankara, Turkey		Ozay, R (corresponding author), Minist Hlth, Neurosurg Clin, Diskapi Yildirim Beyazit Training & Res Hosp, Ankara, Turkey.	rftozay@hotmail.com	Ozyol, Nazli Hayirli/ABG-6396-2021; Evirgen, Oya/AAH-7582-2020; dolgun, habibullah/AAF-6745-2021; Erguder, Imge/AAZ-5673-2020; Dolgun, Habibullah/AAL-6610-2021; Hayirli Ozyol, Nazli/ABG-6379-2021; Gurer, Bora/K-1177-2012	Evirgen, Oya/0000-0001-6456-1083; Dolgun, Habibullah/0000-0002-1513-2044; Gurer, Bora/0000-0003-1500-6184; /0000-0003-0628-9223			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Anderson RE, 2000, BRAIN RES, V856, P220, DOI 10.1016/S0006-8993(99)02435-X; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; Baban B, 2012, AM J PHYSIOL-REG I, V303, pR1136, DOI 10.1152/ajpregu.00315.2012; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Calikoglu Cagatay, 2015, Med Sci Monit, V21, P813, DOI 10.12659/MSM.893887; Chanchal SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30007; Cheng FC, 2002, J CHROMATOGR A, V949, P35, DOI 10.1016/S0021-9673(01)01225-0; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; COLTON CA, 1994, AM J PHYSIOL, V266, pC1650, DOI 10.1152/ajpcell.1994.266.6.C1650; Durak I, 2001, ACTA ANAESTH SCAND, V45, P119, DOI 10.1034/j.1399-6576.2001.450118.x; El-Maraghy SA, 2015, CHEM-BIOL INTERACT, V229, P26, DOI 10.1016/j.cbi.2015.01.015; Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Girotti AW, 1998, J LIPID RES, V39, P1529; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hashioka S, 2011, GLIA, V59, P833, DOI 10.1002/glia.21157; Hsiang JNK, 1997, ACTA NEUROCHIR, V139, P464, DOI 10.1007/BF01808884; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jortner BS, 2006, NEUROTOXICOLOGY, V27, P628, DOI 10.1016/j.neuro.2006.03.002; Jung CS, 2014, INT J MOL SCI, V15, P4088, DOI 10.3390/ijms15034088; Kainu T, 1995, NEUROREPORT, V6, P2557, DOI 10.1097/00001756-199512150-00026; Kanazawa H, 2002, J CHROMATOGR A, V949, P1, DOI 10.1016/S0021-9673(01)01508-4; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nakagawa S, 2012, INFLAMMATION, V35, P1062, DOI 10.1007/s10753-011-9412-7; Naoi M, 2005, MOL NEUROBIOL, V31, P81, DOI 10.1385/MN:31:1-3:081; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; PRAJDA N, 1975, FEBS LETT, V59, P245, DOI 10.1016/0014-5793(75)80385-1; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; QUATTROCHI LC, 1993, MOL PHARMACOL, V43, P504; Rai K, 2011, J CLIN BIOCHEM NUTR, V49, P25, DOI 10.3164/jcbn.10-133; REGARDH CG, 1985, SCAND J GASTROENTERO, V20, P79, DOI 10.3109/00365528509095821; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; SEGAWA K, 1987, Gastroenterologia Japonica, V22, P413; Shirihai O, 1998, GLIA, V23, P339, DOI 10.1002/(SICI)1098-1136(199808)23:4<339::AID-GLIA6>3.3.CO;2-G; Shivanna B, 2011, FREE RADICAL BIO MED, V51, P1910, DOI 10.1016/j.freeradbiomed.2011.08.013; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; SUN Y, 1988, CLIN CHEM, V34, P497; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tari A, 2002, J GASTROENTEROL, V37, P177, DOI 10.1007/s005350200018; TOMBAUGH GC, 1990, BRAIN RES, V506, P343, DOI 10.1016/0006-8993(90)91277-N; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; WALLMARK B, 1980, J BIOL CHEM, V255, P5313; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yenisehirli A, 2006, PHARMACOL RES, V54, P397, DOI 10.1016/j.phrs.2006.07.005; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x	63	10	10	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2017	104						634	643		10.1016/j.wneu.2017.04.136			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FD7NP	WOS:000407713100085	28461271				2022-02-06	
J	Portran, P; Cour, M; Hernu, R; de la Salle, S; Argaud, L				Portran, Philippe; Cour, Martin; Hernu, Romain; de la Salle, Sylvie; Argaud, Laurent			Pupillary abnormalities in non-selected critically ill patients: an observational study	JOURNAL OF THORACIC DISEASE			English	Article						Intensive care; pupillary areflexia; anisocoria; ipratropium; Bernard Horner Syndrome	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; LIGHT REFLEX; PUPILLOMETRY; RELIABILITY; COMA	Background: Repeated pupillary examination is a key element of neurologic surveillance in intensive care units (ICU). However, in non-selected critically ill patients, the clinical interest of monitoring pupillary diameter and light reflex is poorly documented. We aimed to determine the prevalence and the etiologies of pupillary abnormalities (PAs) in this ICU patient population. Methods: We performed a prospective, observational study in a medical university affiliated ICU over a 6-month period. All patients with at least one pupillary examination were included. PA was defined as areflexia and/or anisocoria present at the time of ICU admission or occurring during the ICU stay. Results: During the study period, we included 297 patients who had 6 +/- 9 pupillary examinations per day (totaling 11,360 pupillary assessments). The majority of patients (n=161, 54%) were admitted to the ICU for acute respiratory or cardiovascular failure. A total of 128 PAs were recorded in 109 patients: 78 areflexia alone (61%), 33 anisocoria alone (26%) and 17 (13%) with associated anisocoria and areflexia. The main causes of PAs were related to acute brain ischemia (n=41, 32%) and sedation/analgesia (n=50, 39%). Among the PAs, 59 (46%) were present upon ICU admission. The etiologies of the PAs at admission did not differ from those occurring during ICU stay (P=NS). Interestingly, 9 (7%) PAs were attributed to ipratropium nebulization in patients with chronic obstructive pulmonary disease exacerbation. Conclusions: The high prevalence of PAs, frequently associated with both brain organic lesions and drug side effects, highlights the clinical interest of pupillary surveillance in non-selected critically ill patients.	[Portran, Philippe; Cour, Martin; Hernu, Romain; de la Salle, Sylvie; Argaud, Laurent] Hosp Civils Lyon, Serv Reanimat Med, Hop Edouard Herriot, F-69437 Lyon, France; [Cour, Martin; Argaud, Laurent] Univ Claude Bernard Lyon 1, Fac Med Lyon Est, F-69373 Lyon, France		Argaud, L (corresponding author), Grp Hosp Ctr, Serv Reanimat Med, 5 Pl Arsonval, F-69437 Lyon 03, France.	laurent.argaud@chu-lyon.fr	Carmen, Team3/Y-7384-2019; Cour, M/T-2525-2019	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; cour, martin/0000-0003-4909-9761			Bisquerra Rebecca A, 2005, Respir Care, V50, P1662; Butty Z, 2016, EYE, V30, P31, DOI 10.1038/eye.2015.181; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Daou B, 2016, J NEUROSURG, V124, P1773, DOI 10.3171/2015.6.JNS15729; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hoonpongsimanont W, 2015, WEST J EMERG MED, V16, P721, DOI 10.5811/westjem.2015.7.24933; Larson MD, 1997, ANESTHESIOLOGY, V87, P849, DOI 10.1097/00000542-199710000-00019; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mojumder DK, 2015, J NEUROSCI RURAL PRA, V6, P208, DOI 10.4103/0976-3147.153229; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rouche O, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-5; Sharshar T, 2014, INTENS CARE MED, V40, P484, DOI 10.1007/s00134-014-3214-y; Singhal NS, 2014, J CRIT CARE, V29, P627, DOI 10.1016/j.jcrc.2014.02.014; Tokuda Y, 2003, POSTGRAD MED J, V79, P49, DOI 10.1136/pmj.79.927.49; Wilhelm H, 1998, J NEUROL, V245, P573, DOI 10.1007/s004150050248; Zafar SF, 2014, J CRIT CARE, V29, P599, DOI 10.1016/j.jcrc.2014.01.012	20	10	10	1	4	PIONEER BIOSCIENCE PUBL CO	HONG KONG	9A GOLD SHINE TOWER, 346-348 QUEEN'S RD CENTRAL, SHEUNG WAN, HONG KONG, 00000, PEOPLES R CHINA	2072-1439	2077-6624		J THORAC DIS	J. Thorac. Dis.	AUG	2017	9	8					2528	2533		10.21037/jtd.2017.07.58			6	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	FI0JI	WOS:000411610100078	28932559	Green Published			2022-02-06	
J	Schatz, P; Elbin, RJ; Anderson, MN; Savage, J; Covassin, T				Schatz, Philip; Elbin, R. J.; Anderson, Melissa N.; Savage, Jennifer; Covassin, Tracey			Exploring Sandbagging Behaviors, Effort, and Perceived Utility of the ImPACT Baseline Assessment in College Athletes	SPORT EXERCISE AND PERFORMANCE PSYCHOLOGY			English	Article						concussion; baseline testing; effort; computerized neurocognitive testing; sandbagging	POST-CONCUSSION ASSESSMENT; SPORTS-RELATED CONCUSSION; COGNITIVE TESTING IMPACT; HIGH-SCHOOL; TEST-PERFORMANCE; NEUROPSYCHOLOGICAL PERFORMANCE; SEX-DIFFERENCES; BRAIN-INJURY; TEST-SCORES; MOTIVATION	Baseline computerized neurocognitive testing (CNT) is a commonly used tool for the assessment and management of sport-related concussion (SRC). Research on the frequency of sandbagging behaviors and suboptimal effort on baseline CNT is limited, and contributing factors to these behaviors are unknown. This study described the prevalence of sandbagging behaviors on baseline CNT in college athletes and also identified predictors of maximal effort. A descriptive, quantitative survey was used to gather information from 178 college athletes (M = 19.05, SD = 1.16 years; range 18-23 years; 53% female) immediately after completing a baseline CNT. The survey included questions regarding demographics, effort provided, sandbagging behaviors, and perceived utility of the CNT baseline assessment. Six percent of athletes reported a history of sandbagging behavior, and nearly a third of athletes reported they did not provide maximal effort on their CNT baseline test. A logistic regression examining sex, concussion history, previous text exposure, and perceived utility of the baseline test was significant, chi(2)(4, 166) = 15.85, p < .001. Athletes who perceived very high utility of the baseline CNT assessment were 4.94 times (95% confidence interval [1.91-12.69]) more likely to provide maximal effort on their CNT baseline (relative risk = 2.95x more likely; 95% CI [1.41-6.15]). These data suggest that the prevalence of sandbagging behavior is not as common as previously reported, and educating athletes about the utility of the baseline CNT may improve effort.	[Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Elbin, R. J.; Anderson, Melissa N.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Savage, Jennifer; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Schatz, P (corresponding author), St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA.	schatzSJU@gmail.com	Savage, Jennifer/C-4680-2018				ALVES WM, 1987, CLIN SPORT MED, V6, P211; [Anonymous], 2012, IBM SPSS STAT WIND C; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; BRICKMAN P, 1972, J EXP SOC PSYCHOL, V8, P31, DOI 10.1016/0022-1031(72)90059-5; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CARVER CS, 1979, J PERS SOC PSYCHOL, V37, P1859; Cecchini JA, 2015, J HUM KINET, V46, P189, DOI 10.1515/hukin-2015-0047; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; FORTIER MS, 1995, INT J SPORT PSYCHOL, V26, P24; Gillet N., 2008, ATHLETIC INSIGHT ONL, V10; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; JONES EE, 1965, ADV EXP SOC PSYCHOL, V2, P219; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; Marvez A., 2012, PLAYERS MAY TRY BEAT; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Reilly R., 2011, TALKING FOOTBALL ARC; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vansteenkiste M, 2004, J EDUC PSYCHOL, V96, P755, DOI 10.1037/0022-0663.96.4.755; WATSON NV, 1991, PERS INDIV DIFFER, V12, P375, DOI 10.1016/0191-8869(91)90053-E	37	10	10	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	2157-3905	2157-3913		SPORT EXERC PERFORM	Sport Exerc. Perform. Psychol.	AUG	2017	6	3					243	251		10.1037/spy0000100			9	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FD8RW	WOS:000407792800004					2022-02-06	
J	Unsworth, DJ; Mathias, JL				Unsworth, David J.; Mathias, Jane L.			Traumatic brain injury and alcohol/substance abuse: A Bayesian meta-analysis comparing the outcomes of people with and without a history of abuse	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Alcohol abuse; Drug abuse; Meta-analysis; Outcomes; Substance abuse; Traumatic brain injury	SUBSTANCE-ABUSE; PSYCHIATRIC-DISORDERS; ALCOHOL-ABUSE; PREVALENCE; INTOXICATION; BEHAVIOR; COCAINE; COMORBIDITY; CONSUMPTION; DEPRESSION	Alcohol and substance (drugs and/or alcohol) abuse are major risk factors for traumatic brain injury (TBI); however, it remains unclear whether outcomes differ for those with and without a history of preinjury abuse. A meta-analysis was performed to examine this issue. The PubMed, Embase, and PsycINFO databases were searched for research that compared the neuroradiological, cognitive, or psychological outcomes of adults with and without a documented history of alcohol and/or substance abuse who sustained nonpenetrating TBIs. Data from 22 studies were analyzed using a random-effects model: Hedges's g effect sizes measured the mean difference in outcomes of individuals with/without a history of preinjury abuse, and Bayes factors assessed the probability that the outcomes differed. Patients with a history of alcohol and/or substance abuse had poorer neuroradiological outcomes, including reduced hippocampal (g=-0.82) and gray matter volumes (g=-0.46 to -0.82), and enlarged cerebral ventricles (g=-0.73 to -0.80). There were limited differences in cognitive outcomes: Executive functioning (g=-0.51) and memory (g=-0.39 to -0.43) were moderately affected, but attention and reasoning were not. The findings for fine motor ability, construction, perception, general cognition, and language were inconclusive. Postinjury substance and alcohol use (g=-0.97 to -1.07) and emotional functioning (g=-0.29 to -0.44) were worse in those with a history of alcohol and/or substance abuse (psychological outcomes). This study highlighted the type and extent of post-TBI differences between persons with and without a history of alcohol or substance abuse, many of which may hamper recovery. However, variation in the criteria for premorbid abuse, limited information regarding the history of abuse, and an absence of preinjury baseline data prevented an assessment of whether the differences predated the TBI, occurred as a result of ongoing alcohol/substance abuse, or reflected the cumulative impact of alcohol/substance abuse and TBI.	[Unsworth, David J.; Mathias, Jane L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au					Allen DN, 2009, APPL NEUROPSYCHOL, V16, P186, DOI 10.1080/09084280903098687; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borenstein M., 2011, INTRO META ANAL, DOI DOI 10.1002/9780470743386; Boyles AL, 2011, EPIDEMIOLOGY, V22, P746, DOI 10.1097/EDE.0b013e318225ba48; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Coffin PO, 2003, ADDICTION, V98, P739, DOI 10.1046/j.1360-0443.2003.00376.x; Cohen J, 1988, STAT POWER ANAL BEHA; Conner KR, 2008, ADDICTION, V103, P524, DOI 10.1111/j.1360-0443.2007.02118.x; Conner KR, 2009, J SUBST ABUSE TREAT, V37, P127, DOI 10.1016/j.jsat.2008.11.007; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Demirakca T, 2011, ALCOHOL CLIN EXP RES, V35, P1678, DOI 10.1111/j.1530-0277.2011.01514.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AP, 2014, CNS NEUROSCI THER, V20, P479, DOI 10.1111/cns.12256; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Drubach D A, 1993, Md Med J, V42, P989; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Geibprasert S, 2010, AM J NEURORADIOL, V31, P803, DOI 10.3174/ajnr.A1811; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Goldstein G, 2002, J CLIN EXP NEUROPSYC, V24, P1010, DOI 10.1076/jcen.24.8.1010.8378; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Green A, 2010, ALCOHOL CLIN EXP RES, V34, P443, DOI 10.1111/j.1530-0277.2009.01108.x; Gruber S. A., 2015, DRUG ALCOHOL DEPEN, V146, pe131, DOI [10.1016/j.drugalcdep.2014.09.275, DOI 10.1016/J.DRUGALCDEP.2014.09.275]; Hall MG, 2015, AM J DRUG ALCOHOL AB, V41, DOI 10.3109/00952990.2015.1044607; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jeffreys H., 1961, THEORY PROBABILITY, V3; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Krousel-Wood M A, 1999, Ochsner J, V1, P187; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Madras B., 2013, EFFECTS DRUG ABUSE H; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Mathias JL, 2018, NEUROPSYCHOL REHABIL, V28, P997, DOI 10.1080/09602011.2016.1224190; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Molina PE, 2015, ALCOHOL RES-CURR REV, V37, P263; Monnig MA, 2013, ADDICT BIOL, V18, P581, DOI 10.1111/j.1369-1600.2012.00441.x; Morey R. D., 2014, R PACKAGE VERSION, V09, P8, DOI DOI 10.3758/BF03193811; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petrakis IL, 2002, ALCOHOL RES HEALTH, V26, P81; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Potvin S, 2014, J ADDICT MED, V8, P368, DOI 10.1097/ADM.0000000000000066; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rogers G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13060; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Ross DE, 2014, NEUROIMAGE, V102, P565, DOI 10.1016/j.neuroimage.2014.07.043; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Smeraldi C., 2013, EUROPEAN PSYCHIAT, V28, P1, DOI [10.1016/S0924-9338(13)77235-3, DOI 10.1016/S0924-9338(13)77235-3]; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; TEASDALE G, 1974, LANCET, V2, P81; Valentine JC, 2010, J EDUC BEHAV STAT, V35, P215, DOI 10.3102/1076998609346961; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wilson, 2001, PRACTICAL METAANALYS; World Health Organisation, 2010, COMPR ICF COR SET TR; Xiao PR, 2015, DRUG ALCOHOL DEPEN, V153, P22, DOI 10.1016/j.drugalcdep.2015.05.030; Yang X, 2016, NEUROSCI BIOBEHAV R, V66, P92, DOI 10.1016/j.neubiorev.2016.03.034	95	10	10	0	19	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	2017	39	6					547	562		10.1080/13803395.2016.1248812			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ES7QM	WOS:000399745400004	27829310				2022-02-06	
J	Wade, SL; Cassedy, AE; Fulks, LE; Taylor, HG; Stancin, T; Kirkwood, MW; Yeates, KO; Kurowski, BG				Wade, Shari L.; Cassedy, Amy E.; Fulks, Lauren E.; Taylor, H. Gerry; Stancin, Terry; Kirkwood, Michael W.; Yeates, Keith O.; Kurowski, Brad G.			Problem-Solving After Traumatic Brain Injury in Adolescence: Associations With Functional Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Problem solving; Rehabilitation	EXECUTIVE FUNCTION; SOCIAL COMPETENCE; BEHAVIOR PROBLEMS; YOUNG-CHILDREN; SKILLS; INTEGRATION; CONSTRUCT; PATTERNS	Objective: To examine the association of problem-solving with functioning in youth with traumatic brain injury (TBI). Design: Cross-sectional evaluation of pretreatment data from a randomized controlled trial. Setting: Four children's hospitals and 1 general hospital, with level 1 trauma units. Participants: Youth, ages 11 to 18 years, who sustained moderate or severe TBI in the last 18 months (N=153). Main Outcome Measures: Problem-solving skills were assessed using the Social Problem-Solving Inventory (SPSI) and the Dodge Social Information Processing Short Stories. Everyday functioning was assessed based on a structured clinical interview using the Child and Adolescent Functional Assessment Scale (CAFAS) and via adolescent ratings on the Youth Self Report (YSR). Correlations and multiple regression analyses were used to examine associations among measures. Results: The TBI group endorsed lower levels of maladaptive problem-solving (negative problem orientation, careless/impulsive responding, and avoidant style) and lower levels of rational problem-solving, resulting in higher total problem-solving scores for the TBI group compared with a normative sample (P<.001). Dodge Social Information Processing Short Stories dimensions were correlated (r=.23.37) with SPSI subscales in the anticipated direction. Although both maladaptive (P<.001) and adaptive (P=.006) problem-solving composites were associated with overall functioning on the CAFAS, only maladaptive problem-solving (P<.001) was related to the YSR total when outcomes were continuous. For the both CAFAS and YSR logistic models, maladaptive style was significantly associated with greater risk of impairment (P=.001). Conclusions: Problem-solving after TBI differs from normative samples and is associated with functional impairments. The relation of problem solving deficits after TBI with global functioning merits further investigation, with consideration of the potential effects of problem-solving interventions on functional outcomes. (C) 2017 by the American Congress of Rehabilitation Medicine	[Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Cassedy, Amy E.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Fulks, Lauren E.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]; Rehabilitation Research Experience for Medical Students; National Institutes of Health/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER	Supported in part by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant no. H133B090010); the Rehabilitation Research Experience for Medical Students; and the National Institutes of Health/National Institute of Child Health and Human Development (grant no. K23HD074683).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Agnihotri S, 2010, DEV NEUROREHABIL, V13, P369, DOI 10.3109/17518423.2010.499409; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; D'Zurilla T.J., 1996, MANUAL SOCIAL PROBLE; D'Zurilla T.J., 1999, PROBLEM SOLVING THER, V2nd edn; Dodge KA, 2002, PSYCHOL ASSESSMENT, V14, P60, DOI 10.1037//1040-3590.14.1.60; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hawkins D, 2009, COGNITIVE THER RES, V33, P462, DOI 10.1007/s10608-008-9209-7; Hodges K., 1994, CHILD ADOLESCENT FUN; Hodges K., 2005, CAFAS MANUAL TRAININ; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Lansford JE, 2006, J ABNORM CHILD PSYCH, V34, P715, DOI 10.1007/s10802-006-9057-4; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Warschausky S, 1997, Pediatr Rehabil, V1, P77; WEISS B, 1992, CHILD DEV, V63, P1321, DOI 10.2307/1131558; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T	37	10	10	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2017	98	8					1614	1621		10.1016/j.apmr.2017.03.006			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FD1OF	WOS:000407305900014	28389109	Green Accepted			2022-02-06	
J	Rey-Funes, M; Larrayoz, IM; Contartese, DS; Solino, M; Sarotto, A; Bustelo, M; Bruno, M; Dorfman, VB; Loidl, CF; Martinez, A				Rey-Funes, Manuel; Larrayoz, Ignacio M.; Contartese, Daniela S.; Solino, Manuel; Sarotto, Anibal; Bustelo, Martin; Bruno, Martin; Dorfman, Veronica B.; Loidl, Cesar F.; Martinez, Alfredo			Hypothermia Prevents Retinal Damage Generated by Optic Nerve Trauma in the Rat	SCIENTIFIC REPORTS			English	Article							LOCAL HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; EXPERIMENTAL-MODEL; OCULAR INJURIES; ISCHEMIA; PROTECTS; NEUROPROTECTION; RBM3; ENCEPHALOPATHY; MECHANISMS	Ocular and periocular traumatisms may result in loss of vision. Hypothermia provides a beneficial intervention for brain and heart conditions and, here, we study whether hypothermia can prevent retinal damage caused by traumatic neuropathy. Intraorbital optic nerve crush (IONC) or sham manipulation was applied to male rats. Some animals were subjected to hypothermia (8 degrees C) for 3 h following surgery. Thirty days later, animals were subjected to electroretinography and behavioral tests. IONC treatment resulted in amplitude reduction of the b-wave and oscillatory potentials of the electroretinogram, whereas the hypothermic treatment significantly (p < 0.05) reversed this process. Using a descending method of limits in a two-choice visual task apparatus, we demonstrated that hypothermia significantly (p < 0.001) preserved visual acuity. Furthermore, IONC-treated rats had a lower (p < 0.0001) number of retinal ganglion cells and a higher (p < 0.0001) number of TUNEL-positive cells than sham-operated controls. These numbers were significantly (p < 0.0001) corrected by hypothermic treatment. There was a significant (p < 0.001) increase of RNA-binding motif protein 3 (RBM3) and of BCL2 (p < 0.01) mRNA expression in the eyes exposed to hypothermia. In conclusion, hypothermia constitutes an efficacious treatment for traumatic vision-impairing conditions, and the cold-shock protein pathway may be involved in mediating the beneficial effects shown in the retina.	[Rey-Funes, Manuel; Contartese, Daniela S.; Solino, Manuel; Sarotto, Anibal; Loidl, Cesar F.] Univ Buenos Aires, CONICET, Inst Biol Celular & Neurociencia Prof E De Robert, Lab Neuropatol Expt,Fac Med, Buenos Aires, DF, Argentina; [Larrayoz, Ignacio M.; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Angiogenesis Study Grp, Logrono, Spain; [Bustelo, Martin; Bruno, Martin] Univ Catolica Cuyo, Fac Ciencias Med, Lab Neurociencias, San Juan, Argentina; [Dorfman, Veronica B.] Univ Maimonides, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina		Martinez, A (corresponding author), Ctr Biomed Res La Rioja CIBIR, Angiogenesis Study Grp, Logrono, Spain.	amartinezr@riojasalud.es	Martinez, Alfredo/A-3077-2013; Larrayoz, Ignacio M/I-5613-2012	Martinez, Alfredo/0000-0003-4882-4044; Larrayoz, Ignacio M/0000-0003-1629-152X; Dorfman, Veronica/0000-0002-7950-1400; Bustelo, Martin/0000-0003-4168-7980; Rey-Funes, Manuel/0000-0002-0213-3056	US Department of DefenseUnited States Department of Defense [MR130239]; UBACyT [20020090100254]	We gratefully acknowledge Andrea Pecile and Manuel Antonio Ponce for excellent technical handling at the animal facility, Nicolas Spada for histological assistance, Ing. Lisandro Anton for electroretinography set up, and Dr. Silvina Diaz and Prof. Vet. Andrea Zaccagnini for their help with inhalatory anesthesia (all of them from Universidad de Buenos Aires, Argentina). This work was supported by the US Department of Defense, Grant MR130239 (to AM) and by UBACyT, Grant 20020090100254 (to CFL).	Arrich J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub3; Austin T, 2013, ARCH DIS CHILD-FETAL, V98, pF451, DOI 10.1136/archdischild-2012-302069; Azmoon S, 2011, CARDIOL REV, V19, P108, DOI 10.1097/CRD.0b013e31820828af; Baba T, 2008, PATHOL INT, V58, P589, DOI 10.1111/j.1440-1827.2008.02275.x; Blanch RJ, 2014, INVEST OPHTH VIS SCI, V55, P6350, DOI 10.1167/iovs.13-13708; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P2913, DOI 10.1167/iovs.11-8564; Cass SP, 2012, CURR SPORT MED REP, V11, P11, DOI 10.1249/JSR.0b013e318240dc06; Chen J. M., 2013, FA YI XUE ZA ZHI, V29, P16; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cornette L, 2012, FACTS VIEWS VIS OBGY, V4, P133; Dorfman D, 2013, EXP NEUROL, V240, P146, DOI 10.1016/j.expneurol.2012.11.017; FABEROWSKI N, 1989, INVEST OPHTH VIS SCI, V30, P2309; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; HAYES JM, 1993, BEHAV GENET, V23, P395, DOI 10.1007/BF01067442; Hendrickson A, 2015, BRAIN STRUCT FUNCT, V220, P351, DOI 10.1007/s00429-013-0659-7; Ikeda K, 2012, MED SCI MONITOR, V18, pCR409, DOI 10.12659/MSM.883208; Jung S, 2015, INVEST OPHTH VIS SCI, V56, P5182, DOI 10.1167/iovs.15-16407; Larrayoz IM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161458; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Lyden PD, 2014, INT J STROKE, V9, P117, DOI 10.1111/ijs.12151; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Maynard KI, 1999, ANN NY ACAD SCI, V890, P240, DOI 10.1111/j.1749-6632.1999.tb07999.x; Minnerup J, 2012, INT J MOL SCI, V13, P11753, DOI 10.3390/ijms130911753; Morgan-Warren PJ, 2013, INVEST OPHTH VIS SCI, V54, P6903, DOI 10.1167/iovs.13-12803; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Phillips BN, 2013, RETINA-J RET VIT DIS, V33, P371, DOI 10.1097/IAE.0b013e318261a726; Prempunpong C, 2015, EARLY HUM DEV, V91, P535, DOI 10.1016/j.earlhumdev.2015.06.008; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; Rey-Funes M, 2016, AM J PHYSIOL-REG I, V310, pR1011, DOI 10.1152/ajpregu.00266.2015; Rey-Funes M, 2013, INVEST OPHTH VIS SCI, V54, P2836, DOI 10.1167/iovs.12-11198; Rey-Funes M, 2011, J NEUROSCI RES, V89, P729, DOI 10.1002/jnr.22556; Rey-Funes M, 2010, EXP EYE RES, V90, P113, DOI 10.1016/j.exer.2009.09.019; Rogers EE, 2014, PEDIATR NEUROL, V51, P657, DOI 10.1016/j.pediatrneurol.2014.08.010; Rojas JC, 2009, NEUROTOX RES, V15, P260, DOI 10.1007/s12640-009-9027-z; Roth S, 2016, INVEST OPHTH VIS SCI, V57, P3522, DOI 10.1167/iovs.15-17381; Salido EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061656; Sheng I, 2015, RETINA-J RET VIT DIS, V35, P105, DOI 10.1097/IAE.0000000000000261; Sirvinskas E, 2014, PERFUSION-UK, V29, P124, DOI 10.1177/0267659113497074; TAMAI K, 1995, JPN J OPHTHALMOL, V39, P43; Tamai K, 1997, BRIT J OPHTHALMOL, V81, P789, DOI 10.1136/bjo.81.9.789; Tata DA, 2015, BEHAV BRAIN RES, V280, P51, DOI 10.1016/j.bbr.2014.11.033; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Wu L., 2016, MOL NEUROBIOL; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Zhang HT, 2015, BRAIN RES, V1622, P474, DOI 10.1016/j.brainres.2015.07.004; Zhu XZ, 2016, CELL MOL LIFE SCI, V73, P3839, DOI 10.1007/s00018-016-2253-7	54	10	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 31	2017	7								6966	10.1038/s41598-017-07294-6			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX3MR	WOS:000425976600004	28761115	gold, Green Published			2022-02-06	
J	De Guzman, E; Ament, A				De Guzman, Earl; Ament, Andrea			Neurobehavioral Management of Traumatic Brain Injury in the Critical Care Setting: An Update	CRITICAL CARE CLINICS			English	Article						Traumatic brain injury; Post-traumatic amnesia; Post-traumatic encephalopathy	DIFFUSE AXONAL INJURY; GLASGOW COMA SCALE; HEAD-INJURY; NEUROPSYCHIATRIC SEQUELAE; STRESS-DISORDER; SILENT EPIDEMIC; ACUTE CONFUSION; VALPROIC ACID; MECHANISMS; AMANTADINE	Traumatic brain injury (TBI) is an alteration in brain function, or other evidence of brain pathology, caused by an external force. TBI is a major cause of disability and mortality worldwide. Posttraumatic amnesia, or the interval from injury until the patient is oriented and able to form and later recall new memories, is an important index of TBI severity and functional outcome. This article will discuss the updates in the epidemiology, definition and classification, pathophysiology, diagnosis, and management of common acute neuropsychiatric sequelae of traumatic brain injury that the critical care specialist may encounter.	[De Guzman, Earl; Ament, Andrea] Stanford Univ, Sch Med, Psychosomat Med, Dept Psychiat, 401 Quarry Rd, Palo Alto, CA 94305 USA		Ament, A (corresponding author), Stanford Univ, Sch Med, Psychosomat Med, Dept Psychiat, 401 Quarry Rd, Palo Alto, CA 94305 USA.	aament@stanford.edu					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Barker-Collo S, 2008, NZ MED J, V121, P2903; Bauer Derek, 2015, Semin Neurol, V35, pe14, DOI 10.1055/s-0035-1549095; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bigler ED, 2007, COGNITIVE RESERVE TH, P85; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Capruso DX, 1995, COMPREHENSIVE TXB PS, V1, P207; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention (CDC) National Centre for Injury Prevention and Control, 2016, TRAUM BRAIN INJ US F; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; de Lanerolle NC, 2015, SEMIN NEUROL, V35, P12, DOI 10.1055/s-0035-1544240; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finkelstein E., 2006, INCIDENCE EC BURDEN; Floris G, 2008, NEUROCASE, V14, P385, DOI 10.1080/13554790802385418; Friedland D, 2013, ADV CLIN NEUROSCIENC, V4, P12; Friedland DP, 2013, J SPINE S, VS4, P5; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jonker FA, 2015, REV NEUROSCIENCE, V26, P1, DOI 10.1515/revneuro-2014-0043; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kurukumbi M, 2014, CASE REP NEUROL MED, V2014; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Lee HCB, 2008, CRIT CARE CLIN, V24, P723, DOI 10.1016/j.ccc.2008.05.006; Levin H., 1987, HEAD INJURY, P442; Li HJ, 2014, EUR J PHARMACOL, V735, P38, DOI 10.1016/j.ejphar.2014.04.017; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maldonado JR, 2008, CRIT CARE CLIN, V24, P657, DOI 10.1016/j.ccc.2008.05.008; Maldonado JR, 2009, PSYCHOSOMATICS, V50, P206, DOI 10.1176/appi.psy.50.3.206; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCarter RJ, 2007, BRAIN INJURY, V21, P1393, DOI 10.1080/02699050701793793; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCEVOY JP, 1981, ANN INTERN MED, V95, P212, DOI 10.7326/0003-4819-95-2-212; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Mott FW, 1917, BRIT MED J, V1917, P39, DOI 10.1136/bmj.2.2950.39; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; National Institute for Clinical Excellence Head Injury, 2003, TRIAG ASS INV EARL M; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Ogai M, 2005, ACTA PSYCHIAT SCAND, V111, P74, DOI 10.1111/j.1600-0447.2004.00395.x; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pajoumand M, 2016, J TRAUMA ACUTE CARE, V81, P345, DOI 10.1097/TA.0000000000001069; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sher Y, 2015, J NEUROPSYCH CLIN N, V27, P365, DOI 10.1176/appi.neuropsych.14080190; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Silver Jonathan M., 1994, P631; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; TEASDALE G, 1974, LANCET, V2, P81; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Umeda S, 2010, SOC NEUROSCI-UK, V5, P19, DOI 10.1080/17470910902990584; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vakil MT, 2017, EMERG RADIOL, P1; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; VECHT CJ, 1995, ARCH NEUROL-CHICAGO, V32, P792; Volle E, 2002, NEUROLOGY, V58, P488, DOI 10.1212/WNL.58.3.488; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Whiting WL, 2016, PSYCHOSOMATICS, V57, P330, DOI 10.1016/j.psym.2016.01.004; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wood R, 2006, J NEUROPSYCHIATRY CL, V18, P3; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	131	10	10	1	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	JUL	2017	33	3					423	+		10.1016/j.ccc.2017.03.011			19	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ1VR	WOS:000404499400002	28601130				2022-02-06	
J	Disner, SG; Kramer, MD; Nelson, NW; Lipinski, AJ; Christensen, JM; Polusny, MA; Sponheim, SR				Disner, Seth G.; Kramer, Mark D.; Nelson, Nathaniel W.; Lipinski, Alexandra J.; Christensen, Julia M.; Polusny, Melissa A.; Sponheim, Scott R.			Predictors of Postdeployment Functioning in Combat-Exposed U.S. Military Veterans	CLINICAL PSYCHOLOGICAL SCIENCE			English	Article						trauma; neuropsychology; posttraumatic stress disorder; war	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CONFIRMATORY FACTOR-ANALYSIS; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; MENTAL-HEALTH PROBLEMS; QUALITY-OF-LIFE; EDITION CVLT-II; COGNITIVE IMPAIRMENT; OEF/OIF VETERANS; MAJOR DEPRESSION	Posttraumatic stress disorder (PTSD) and sequelae of mild traumatic brain injury (mTBI) are presumed to contribute to reintegration difficulties in combat-exposed veterans. Yet their relative impacts on postdeployment functioning are not well understood. The current study used structural equation modeling (SEM) to clarify the extent to which symptoms of internalizing disorders (e.g., depression, anxiety), mTBI symptoms, and cognitive performance are associated with functional impairment in 295 combat-exposed veterans. SEM results showed that internalizing symptoms most significantly predicted functional impairment (r = 0.72). Blast mTBI and cognitive performance were associated with internalizing (r = 0.24 and -0.25, respectively), but functional impairment was only modestly related to cognition (r = -0.17) and unrelated to mTBI. These results indicate that internalizing symptoms are the strongest predictor of functioning in trauma-exposed veterans, exceeding the effects of mTBI and cognitive performance. This evidence supports prioritizing interventions that target internalizing psychopathology to improve functioning in cases of co-occurring PTSD and mTBI.	[Disner, Seth G.; Kramer, Mark D.; Lipinski, Alexandra J.; Christensen, Julia M.; Polusny, Melissa A.; Sponheim, Scott R.] Minneapolis VA Hlth Care Syst, 1 Vet Dr, Minneapolis, MN 55417 USA; [Nelson, Nathaniel W.] Univ St Thomas, St Paul, MN USA; [Lipinski, Alexandra J.] Univ Memphis, Memphis, TN 38152 USA; [Polusny, Melissa A.; Sponheim, Scott R.] Univ Minnesota, Minneapolis, MN 55455 USA		Disner, SG (corresponding author), Minneapolis VA Hlth Care Syst, 1 Vet Dr, Minneapolis, MN 55417 USA.	seth.disner@gmail.com	Sponheim, Scott/J-3857-2017; Polusny, Melissa Anderson/N-8112-2014; Polusny, Melissa/X-8158-2019; Disner, Seth/S-8441-2019	Sponheim, Scott/0000-0002-2782-0856; Polusny, Melissa Anderson/0000-0002-4932-305X; Polusny, Melissa/0000-0002-4932-305X; Disner, Seth/0000-0003-3635-9421	Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0038]; Department of Veterans Affairs, Rehabilitation RD ProgramUS Department of Veterans Affairs [I01RX000622]	This work was supported by Congressionally Directed Medical Research Program (W81XWH-08-2-0038: PI-Sponheim) and the Department of Veterans Affairs, Rehabilitation R&D Program (I01RX000622: PI-Sponheim).	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DIAGN CRIT DSM IV TR; [Anonymous], 1995, Arch Intern Med, V155, P262; Antshel KM, 2010, PSYCHOL MED, V40, P1909, DOI 10.1017/S0033291709992273; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Benton A., 1976, MULTILINGUAL APHASIA; Binder LM, 1999, ARCH CLIN NEUROPSYCH, V14, P531, DOI 10.1016/S0887-6177(98)00047-X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bramsen I, 2000, AM J PSYCHIAT, V157, P1115, DOI 10.1176/appi.ajp.157.7.1115; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burke HS, 2009, J REHABIL, V75, P5; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Byrne BM., 2013, STRUCTURAL EQUATION; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cukor J, 2010, J ANXIETY DISORD, V24, P918, DOI 10.1016/j.janxdis.2010.06.017; de Mello MF, 2005, EUR ARCH PSY CLIN N, V255, P75, DOI 10.1007/s00406-004-0542-x; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, MANUAL CALIFORNIA VE; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 2009, NEUROPSYCHOLOGICAL A, P597; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Elhai JD, 2011, J ANXIETY DISORD, V25, P340, DOI 10.1016/j.janxdis.2010.10.007; First MB, 2002, COMMUNICATION; Gameroff MJ, 2012, INT J METH PSYCH RES, V21, P52, DOI 10.1002/mpr.358; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Golden CJ, 1978, STROOP COLOR WORD TE; GOTLIB IH, 1995, J CONSULT CLIN PSYCH, V63, P90, DOI 10.1037/0022-006X.63.1.90; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Judd LL, 1996, AM J PSYCHIAT, V153, P1411; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Laes JR, 2006, SCHIZOPHR RES, V84, P121, DOI 10.1016/j.schres.2005.11.023; Lalonde G., 2016, J NEUROPSYCHOLOGY; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liddle PF, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1111/j.0065-1591.2000.007s021[dash]3.x; LOEWENSTEIN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P75, DOI 10.1016/0887-6177(93)E0005-V; Markon KE, 2010, J ABNORM PSYCHOL, V119, P447, DOI 10.1037/a0019707; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLaughlin KA, 2015, BIOL PSYCHIAT, V77, P375, DOI 10.1016/j.biopsych.2014.03.028; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Muthen L. K., 2012, MPLUS USERS GUIDE, V5th; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rauch SAM, 2012, J REHABIL RES DEV, V49, P679, DOI 10.1682/JRRD.2011.08.0152; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Schuitevoerder S, 2013, J ANXIETY DISORD, V27, P550, DOI 10.1016/j.janxdis.2013.01.001; SCOTT AIF, 1992, BRIT J PSYCHIAT, V160, P360, DOI 10.1192/bjp.160.3.360; Scott J, 2000, BRIT J PSYCHIAT, V177, P440, DOI 10.1192/bjp.177.5.440; SHERBOURNE CD, 1994, AM J PSYCHIAT, V151, P1777; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Snell DL., 2016, J BEHAV BRAIN SCI, V6, P227, DOI [10.4236/jbbs.2016.66023, DOI 10.4236/JBBS.2016.66023]; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; van Hees MLJM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-22; Van Til L, 2013, PHYS THER, V93, P1163, DOI 10.2522/ptj.20120156; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	102	10	10	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-7026	2167-7034		CLIN PSYCHOL SCI	Clin. Psychol. Sci.	JUL	2017	5	4					650	663		10.1177/2167702617703436			14	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	FE9RJ	WOS:000408540500004		Bronze			2022-02-06	
J	Feeney, C; Sharp, DJ; Hellyer, PJ; Jolly, AE; Cole, JH; Scott, G; Baxter, D; Jilka, S; Ross, E; Ham, TE; Jenkins, PO; Li, LM; Gorgoraptis, N; Midwinter, M; Goldstone, AP				Feeney, Claire; Sharp, David J.; Hellyer, Peter J.; Jolly, Amy E.; Cole, James H.; Scott, Gregory; Baxter, David; Jilka, Sagar; Ross, Ewan; Ham, Timothy E.; Jenkins, Peter O.; Li, Lucia M.; Gorgoraptis, Nikos; Midwinter, Mark; Goldstone, Anthony P.			Serum Insulin-like Growth Factor-I Levels are Associated with Improved White Matter Recovery after Traumatic Brain Injury	ANNALS OF NEUROLOGY			English	Article							DEFAULT MODE NETWORK; HORMONE REPLACEMENT THERAPY; ADULT-ONSET DEFICIENCY; LONG-TERM; HEAD-INJURY; FOLLOW-UP; PITUITARY DYSFUNCTION; COGNITIVE IMPAIRMENT; SALIENCE NETWORK; CORPUS-CALLOSUM	Objective: Traumatic brain injury (TBI) is a common disabling condition with limited treatment options. Diffusion tensor imaging measures recovery of axonal injury in white matter (WM) tracts after TBI. Growth hormone deficiency (GHD) after TBI may impair axonal and neuropsychological recovery, and serum insulin-like growth factor-I (IGF-I) may mediate this effect. We conducted a longitudinal study to determine the effects of baseline serum IGF-I concentrations on WM tract and neuropsychological recovery after TBI. Methods: Thirty-nine adults after TBI (84.6% male, median age = 30.5 years, 87.2% moderate-severe, median time since TBI = 16.3 months, n = 4 with GHD) were scanned twice, 13.3 months (range = 12.1-14.9) apart, and 35 healthy controls were scanned once. Symptom and quality of life questionnaires and cognitive assessments were completed at both visits (n = 33). Our main outcome measure was fractional anisotropy (FA), a measure of WM tract integrity, in a priori regions of interest: splenium of corpus callosum (SPCC) and posterior limb of internal capsule (PLIC). Results: At baseline, FA was reduced in many WM tracts including SPCC and PLIC following TBI compared to controls, indicating axonal injury, with longitudinal increases indicating axonal recovery. There was a significantly greater increase in SPCC FA over time in patients with serum IGF-I above versus below the median for age. Only the higher IGF-I group had significant improvements in immediate verbal memory recall over time. Interpretation: WM recovery and memory improvements after TBI were greater in patients with higher serum IGF-I at baseline. These findings suggest that the growth hormone/IGF-I system may be a potential therapeutic target following TBI.	[Feeney, Claire; Sharp, David J.; Hellyer, Peter J.; Jolly, Amy E.; Cole, James H.; Scott, Gregory; Baxter, David; Jilka, Sagar; Ross, Ewan; Ham, Timothy E.; Jenkins, Peter O.; Li, Lucia M.; Gorgoraptis, Nikos; Goldstone, Anthony P.] Imperial Coll London, Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, Div Brain Sci, London, England; [Feeney, Claire; Goldstone, Anthony P.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Imperial Ctr Endocrinol, London, England; [Feeney, Claire; Goldstone, Anthony P.] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Imperial Ctr Endocrinol, London, England; [Baxter, David; Midwinter, Mark] Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham, W Midlands, England; [Midwinter, Mark] Univ Leeds, Chapel Allerton Hosp, Acad Sect Musculoskeletal Dis, Leeds, W Yorkshire, England; [Goldstone, Anthony P.] Imperial Coll London, Hammersmith Hosp, PsychoNeuroEndocrinol Res Grp, Neuropsychopharmacol Unit,Ctr Psychiat,Div Brain, London, England		Goldstone, AP (corresponding author), Imperial Coll London, Hammersmith Hosp, Div Brain Sci, Room E313,3rd Floor,Burlington Danes Bldg, London W12 0NN, England.	tony.goldstone@imperial.ac.uk	Midwinter, Mark J/P-6264-2015; Cole, James H/I-5197-2019; Sharp, David J/A-2119-2013; Hellyer, Peter J/F-7112-2013	Midwinter, Mark J/0000-0003-1836-7137; Cole, James H/0000-0003-1908-5588; Hellyer, Peter J/0000-0002-5139-3401; Goldstone, Anthony/0000-0001-8179-7071; Li, Lucia/0000-0001-7339-4854; Scott, Gregory/0000-0001-8063-5871; Gorgoraptis, Nikos/0000-0002-2588-9235; Jolly, Amy/0000-0002-7413-9772	U.K. Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); PfizerPfizer; Imperial College Healthcare Charity; Royal Centre for Defence Medicine; MRC Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); NIHRNational Institute for Health Research (NIHR) [RP-011-048]; Association of British Neurologists; Wellcome TrustWellcome TrustEuropean Commission; Academy of Medical SciencesAcademy of Medical Sciences (AMS); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K023926/1] Funding Source: UKRI; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-SGCL13-Gorgoraptis] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K023926/1, 1110783] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2013-21-010, NIHR-RP-011-048] Funding Source: researchfish	Funding support was received from the U.K. Medical Research Council (MRC), National Institute for Health Research (NIHR), Pfizer, Imperial College Healthcare Charity, and Royal Centre for Defence Medicine. C.F. was supported by Imperial College Healthcare Charity and MRC Clinical Research Training Fellowship, A.P.G. by MRC, D.J.S. by NIHR Professorship (RP-011-048), P.O.J. by Association of British Neurologists, L.M.L. by Wellcome Trust, and N.G. by NIHR and Academy of Medical Sciences. Note that the opinions expressed are those of the authors and not the U.K. Ministry of Defence.	Aberg D, 2011, J CLIN ENDOCR METAB, V96, pE1055, DOI 10.1210/jc.2010-2802; Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Arwert LI, 2005, HORM BEHAV, V47, P343, DOI 10.1016/j.yhbeh.2004.11.015; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bodini B, 2013, HUM BRAIN MAPP, V34, P1163, DOI 10.1002/hbm.21499; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Colao A, 2009, J CLIN ENDOCR METAB, V94, P4414, DOI 10.1210/jc.2009-1134; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; De Smedt A, 2011, STROKE, V42, P2180, DOI 10.1161/STROKEAHA.110.600783; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; Drake WM, 2001, ENDOCR REV, V22, P425, DOI 10.1210/er.22.4.425; Fleminger S, 2012, J NEUROL NEUROSUR PS, V83, P1036, DOI 10.1136/jnnp-2012-303015; Gardner CJ, 2015, EUR J ENDOCRINOL, V172, P371, DOI 10.1530/EJE-14-0654; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Ham T, 2013, J NEUROSCI, V33, P7091, DOI 10.1523/JNEUROSCI.4692-12.2013; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hua K, 2009, GLIA, V57, P1062, DOI 10.1002/glia.20829; Huang XQ, 2015, INT J CLIN EXP MED, V8, P21991; Kim JH, 2007, J CLIN NEUROL, V3, P62, DOI 10.3988/jcn.2007.3.1.62; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Lasaite Lina, 2004, Medicina (Kaunas), V40, P740; Le Greves M, 2006, EXP BRAIN RES, V173, P267, DOI 10.1007/s00221-006-0438-2; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; Lobie PE, 2000, GROWTH HORM IGF RES, V10, P51; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nyberg F, 1996, HORM RES, V45, P18, DOI 10.1159/000184753; Nyberg F, 2013, NAT REV ENDOCRINOL, V9, P357, DOI 10.1038/nrendo.2013.78; Oertel H, 2004, PSYCHONEUROENDOCRINO, V29, P839, DOI 10.1016/S0306-4530(03)00151-3; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Reuter F, 2011, MULT SCLER J, V17, P755, DOI 10.1177/1352458511398265; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Webb EA, 2012, BRAIN, V135, P216, DOI 10.1093/brain/awr305; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yasuda Y, 1997, CLIN NEUROL NEUROSUR, V99, P102, DOI 10.1016/S0303-8467(97)00605-7	58	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUL	2017	82	1					30	43		10.1002/ana.24971			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB5VT	WOS:000406211100004	28574152	hybrid, Green Published			2022-02-06	
J	Ilvesmaki, T; Koskinen, E; Brander, A; Luoto, T; Ohman, J; Eskola, H				Ilvesmaki, Tero; Koskinen, Eerika; Brander, Antti; Luoto, Teemu; Ohman, Juha; Eskola, Hannu			Spinal Cord Injury Induces Widespread Chronic Changes in Cerebral White Matter	HUMAN BRAIN MAPPING			English	Article						diffusion tensor imaging; spinal cord injuries; white matter; humans; cerebrum	TRAUMATIC BRAIN-INJURY; WALLERIAN DEGENERATION; MOTOR CORTEX; STRUCTURAL EVENTS; NERVOUS-SYSTEM; DIFFUSION; DTI; PLASTICITY; REORGANIZATION; MRI	Traumatic spinal cord injuries (SCIs) lead to axonal damage at the trauma site, as well as disconnections within the central nervous system. While the exact mechanisms of the long-term pathophysiological consequences of SCIs are not fully understood, it is known that neuronal damage and degeneration are not limited to the direct proximity of the trauma. Instead, the effects can be detected even in the cerebrum. We examined SCI-induced chronic brain changes with a case-control design using 32 patients and 70 control subjects. Whole-brain white matter (WM) tracts were assessed with diffusion tensor imaging (DTI). In addition, we analysed associations between DTI metrics and several clinical SCI variables. Whole-brain analyses were executed by tract-based spatial statistics (TBSS), with an additional complementary atlas-based analysis (ABA). We observed widespread, statistically significant (P <= 0.01) changes similar to neural degeneration in SCI patients, both in the corticospinal tract (CST) and beyond. In addition, associations between DTI metrics and time since injury were found with TBSS and ABA, implying possible long-term post-injury neural regeneration. Using the ABA approach, we observed a correlation between SCI severity and DTI metrics, indicating a decrease in WM integrity along with patient sensory or motor scores. Our results suggest a widespread neurodegenerative effect of SCI within the cerebrum that is not limited to the motor pathways. Furthermore, DTI-measured WM integrity of chronic SCI patients seemed to improve as time elapsed since injury. (C) 2017 Wiley Periodicals, Inc.	[Ilvesmaki, Tero; Eskola, Hannu] Tampere Univ Technol, BioMediTech Inst, Tampere, Finland; [Ilvesmaki, Tero; Eskola, Hannu] Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland; [Ilvesmaki, Tero] Turku Univ Hosp, Dept Med Phys, Turku, Finland; [Koskinen, Eerika; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Brander, Antti; Eskola, Hannu] Pirkanmaa Hosp Dist, Med Imaging Ctr, Dept Radiol, Tampere, Finland; [Luoto, Teemu] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland		Ilvesmaki, T (corresponding author), Tampere Univ Technol, BioMediTech Inst, Tampere, Finland.; Ilvesmaki, T (corresponding author), Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland.	tero.ilvesmaki@student.tut.fi	Luoto, Teemu/W-6468-2018; Eskola, Hannu/G-4279-2014	Luoto, Teemu/0000-0002-7329-3284; Eskola, Hannu/0000-0003-1673-2305	Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Orion Research Foundation	Contract grant sponsor: Finnish Cultural Foundation; Contract grant sponsor: Orion Research Foundation.	Ahoniemi E, 2008, SPINAL CORD, V46, P781, DOI 10.1038/sc.2008.53; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Della Nave R, 2011, NEURORADIOLOGY, V53, P367, DOI 10.1007/s00234-010-0807-1; DeVivo M, 2006, SPINAL CORD, V44, P535, DOI 10.1038/sj.sc.3101958; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Guleria S, 2008, J NEUROSCI RES, V86, P2271, DOI 10.1002/jnr.21664; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Keller TA, 2016, NEUROIMAGE, V125, P256, DOI 10.1016/j.neuroimage.2015.10.015; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Koskinen E, 2014, SPINAL CORD, P1; Koskinen E, 2013, J NEUROTRAUM, V30, P1587, DOI 10.1089/neu.2013.2943; Metwalli NS, 2010, BRAIN RES, V1348, P156, DOI 10.1016/j.brainres.2010.05.067; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Ramu J, 2008, EXP NEUROL, V212, P100, DOI 10.1016/j.expneurol.2008.03.018; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; Wei CW, 2008, ARCH PHYS MED REHAB, V89, pS85, DOI 10.1016/j.apmr.2008.07.005; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; YAMAMOTO T, 1989, J NEUROL NEUROSUR PS, V52, P382, DOI 10.1136/jnnp.52.3.382; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	50	10	11	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUL	2017	38	7					3637	3647		10.1002/hbm.23619			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EZ8GR	WOS:000404963400025	28429407	Green Published			2022-02-06	
J	Jerome, E; Laing, GL; Bruce, JL; Sartorius, B; Brysiewicz, P; Clarke, DL				Jerome, E.; Laing, G. L.; Bruce, J. L.; Sartorius, B.; Brysiewicz, P.; Clarke, D. L.			An audit of traumatic brain injury (TBI) in a busy developing-world trauma service exposes a significant deficit in resources available to manage severe TBI	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							HEAD-INJURIES; PERSPECTIVE; GUIDELINES; MILD	Background. Traumatic brain injury (TBI) affects large numbers of patients, both adults and children, and significant resources are needed to manage it. Objective. To determine the burden of TBI and the adequacy of available resources to manage in the Pietermaritzburg Metropolitan Trauma Service (PMTS). Methods. All patients with a TBI were identified from the hybrid electronic medical registry at Grey's and Edendale hospitals in Pietermaritzburg (PMB), KwaZulu-Natal, South Africa. Patients were classified according to severity of head injury and age. We defined mild TBI as Glasgow coma scale (GCS) 13 - 15, moderate as GCS 9 - 12, and severe as GCS <= 8, in accordance with international standards. We divided the cohort according to ages 0 - 5 years, 6 - 10 years, >10 - 17 years and adults (>17 years). Results. From January 2012 to December 2014, 3 301 patients were treated for TBI in PMB. The mean age was 27.4 (standard deviation 14.4) years. There were 2 632 males and 564 females. There were 2 540 mild, 326 moderate, and 329 severe TBI admissions during the period under review. A total of 139 (4.2%) patients died. A total of 242 (7.3%) patients were admitted to the intensive care unit (ICU), of whom 137 (57.0%) had a GCS of <= 9. Only 27.0% of patients with a GCS of <= 9 were admitted to the ICU. Conclusion. There is a significant burden of TBI managed by the PMTS. Critical care resources available to manage patients with TBI are inadequate.	[Jerome, E.; Laing, G. L.; Bruce, J. L.; Clarke, D. L.] Univ KwaZulu Natal, Pietermaritzburg Metropolitan Trauma Serv, Dept Surg, Pietermaritzburg, South Africa; [Sartorius, B.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Brysiewicz, P.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Nursing, Durban, South Africa; [Clarke, D. L.] Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Johannesburg, South Africa		Brysiewicz, P (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Nursing, Durban, South Africa.	brysiewiczp@ukzn.ac.za		, bennsartorius/0000-0001-6761-2325; Laing, Grant/0000-0001-8075-0386; Clarke, Damian/0000-0002-8467-1455			Bergman DA, 1999, PEDIATRICS, V104, P1407; Brain Trauma Foundation, 2007, GUID MAN SERV TRAUM; Committee on Trauma, 1997, ADV TRAUM LIF SUPP D, VTenth edit; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Laing GL, 2014, WORLD J SURG, V38, P1699, DOI 10.1007/s00268-014-2448-8; Laing GL, 2014, WORLD J SURG, V38, P1388, DOI 10.1007/s00268-013-2438-2; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Okyere-Dede EK, 2013, TROP DOCT, V43, P1, DOI 10.1177/0049475513480490; Parkinson F, 2014, INJURY, V45, P342, DOI 10.1016/j.injury.2013.04.007; StataCorp, 2013, STATA STAT SOFTW REL; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Webster J, 2015, SAMJ S AFR MED J, V105, P195, DOI 10.7196/SAMJ.9014; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877; Zulu BMW, 2007, INJURY, V38, P576, DOI 10.1016/j.injury.2007.01.002	16	10	11	1	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	JUL	2017	107	7					621	625		10.7196/SAMJ.2017.v107i7.10562			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH0UH	WOS:000410855600023	29025454	Green Submitted, gold			2022-02-06	
J	Liu, Y; McAfee, SS; Guley, NM; Del Mar, N; Bu, W; Heldt, SA; Honig, MG; Moore, BM; Reiner, A; Heck, DH				Liu, Yu; McAfee, Samuel S.; Guley, Natalie M.; Del Mar, Nobel; Bu, Wei; Heldt, Scott A.; Honig, Marcia G.; Moore, Bob M., II; Reiner, Anton; Heck, Detlef H.			Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189	ENEURO			English	Article						cannabinoid type 2 receptor; Coherence; mild traumatic brain injury; Neuronal oscillations; Phase amplitude coupling	POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; SHARP-WAVE-RIPPLE; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; CORTICAL AREAS; HIPPOCAMPAL; OSCILLATIONS; GAMMA; FEAR	Mild traumatic brain injury (mTBI) can cause severe long-term cognitive and emotional deficits, including impaired memory, depression, and persevering fear, but the neuropathological basis of these deficits is uncertain. As medial prefrontal cortex (mPFC) and hippocampus play important roles in memory and emotion, we used multi-site, multi-electrode recordings of oscillatory neuronal activity in local field potentials (LFPs) in awake, head-fixed mice to determine if the functioning of these regions was abnormal after mTBI, using a closed-skull focal cranial blast model. We evaluated mPFC, hippocampus CA1, and primary somatosensory/visual cortical areas (S1/V1). Although mTBI did not alter the power of oscillations, it did cause increased coherence of theta (4-10 Hz) and beta (10-30 Hz) oscillations within mPFC and S1/V1, reduced CA1 sharp-wave ripple (SWR)-evoked LFP activity in mPFC, downshifted SWR frequencies in CA1, and enhanced theta-gamma phase-amplitude coupling (PAC) within mPFC. These abnormalities might be linked to the impaired memory, depression, and persevering fear seen after mTBI. Treatment with the cannabinoid type-2 (CB2) receptor inverse agonist SMM-189 has been shown to mitigate functional deficits and neuronal injury after mTBI in mice. We found that SMM-189 also reversed most of the observed neurophysiological abnormalities. This neurophysiological rescue is likely to stem from the previously reported reduction in neuron loss and/or the preservation of neuronal function and connectivity resulting from SMM-189 treatment, which appears to stem from the biasing of microglia from the proinflammatory M1 state to the prohealing M2 state by SMM-189.	[Liu, Yu; McAfee, Samuel S.; Guley, Natalie M.; Del Mar, Nobel; Bu, Wei; Heldt, Scott A.; Honig, Marcia G.; Reiner, Anton; Heck, Detlef H.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Moore, Bob M., II] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Reiner, Anton] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA		Heck, DH (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	dheck@uthsc.edu	Reiner, Anton/AAG-8860-2020	Reiner, Anton/0000-0002-2146-5232; Heck, Detlef/0000-0003-2438-4064	University of Tennessee Health Science Center (UTHSC) Department of Anatomy and Neurobiology; UTHSC Neuroscience Institute; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS091752]; Office of the Dean of the College of Medicine at UTHSC; Methodist Hospitals Endowed Professorship in Neuroscience; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-081370]; College of Pharmacy at UTHSC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091752] Funding Source: NIH RePORTER	This work was supported by funding from the University of Tennessee Health Science Center (UTHSC) Department of Anatomy and Neurobiology, the UTHSC Neuroscience Institute and National Institutes of Health (NIH) Grant NS091752 (to D.H.H.), The Office of the Dean of the College of Medicine at UTHSC (A.R.), The Methodist Hospitals Endowed Professorship in Neuroscience (A.R.), the NIH Grant NS-081370 (to A.R.), and the College of Pharmacy at UTHSC (B.M.M.).	Anderson DE, 2014, J NEUROSCI, V34, P7587, DOI 10.1523/JNEUROSCI.0293-14.2014; Antonakakis M, 2015, IEEE ENG MED BIO, P7426, DOI 10.1109/EMBC.2015.7320108; Bahner F, 2015, NEUROPSYCHOPHARMACOL, V40, P1674, DOI 10.1038/npp.2015.13; Baek JH, 2013, J NEUROSCI METH, V216, P87, DOI 10.1016/j.jneumeth.2013.03.021; Bailey NW, 2014, BIOL PSYCHOL, V99, P115, DOI 10.1016/j.biopsycho.2014.03.008; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Lopez-Rodriguez AB, 2016, EXP NEUROL, V279, P274, DOI 10.1016/j.expneurol.2016.03.018; Benito C, 2003, J NEUROSCI, V23, P11136; Bocchio M, 2014, NEURON, V83, P753, DOI 10.1016/j.neuron.2014.08.014; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Bruns A, 2004, INT J PSYCHOPHYSIOL, V51, P97, DOI 10.1016/j.ijpsycho.2003.07.001; Bryant JL, 2009, J NEUROSCI METH, V178, P75, DOI 10.1016/j.jneumeth.2008.11.014; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bu W, 2015, SOC NEUR ABSTR, V309, P25; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Donat CK, 2014, ACTA NEUROBIOL EXP, V74, P197; Economo MN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002354; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Lopez ME, 2014, J NEUROSCI, V34, P14551, DOI 10.1523/JNEUROSCI.0964-14.2014; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Fujinaga M, 2010, BIOORG MED CHEM LETT, V20, P1565, DOI 10.1016/j.bmcl.2010.01.074; Gould IC, 2012, J NEUROSCI, V32, P13805, DOI 10.1523/JNEUROSCI.2200-12.2012; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hsiao FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068792; Ito J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00001; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Joseph B, 2015, CURR OPIN CRIT CARE, V21, P506, DOI 10.1097/MCC.0000000000000247; Kam JWY, 2013, J PSYCHIATR RES, V47, P1893, DOI 10.1016/j.jpsychires.2013.09.009; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leon-Carrion J, 2012, BRAIN RES, V1476, P22, DOI 10.1016/j.brainres.2012.03.055; Leonard TK, 2017, CURR BIOL, V27, P257, DOI 10.1016/j.cub.2016.11.027; Li SY, 2012, BRAIN RES BULL, V89, P115, DOI 10.1016/j.brainresbull.2012.07.012; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Maingret N, 2016, NAT NEUROSCI, V19, P959, DOI 10.1038/nn.4304; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Malvache A, 2016, SCIENCE, V353, P1280, DOI 10.1126/science.aaf3319; Maroun M, 2013, NEUROSCIENTIST, V19, P370, DOI 10.1177/1073858412464527; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Miller G, 2011, SCIENCE, V333, P514, DOI 10.1126/science.333.6042.514; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Mueller EM, 2014, J NEUROSCI, V34, P7059, DOI 10.1523/JNEUROSCI.3427-13.2014; Nacher V, 2013, P NATL ACAD SCI USA, V110, P15085, DOI 10.1073/pnas.1314681110; Nicole O, 2016, SCI REP-UK, V6, DOI 10.1038/srep22728; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; O'Neill J, 2017, SCIENCE, V355, P184, DOI 10.1126/science.aag2787; Olbrich S, 2014, PSYCHIAT RES-NEUROIM, V222, P91, DOI 10.1016/j.pscychresns.2014.02.010; Onslow ACE, 2011, PROG BIOPHYS MOL BIO, V105, P49, DOI 10.1016/j.pbiomolbio.2010.09.007; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Papale AE, 2016, NEURON, V92, P975, DOI 10.1016/j.neuron.2016.10.028; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pfeiffer BE, 2015, SCIENCE, V349, P180, DOI 10.1126/science.aaa9633; Pollonini L, 2010, IEEE ENG MED BIO, P1730, DOI 10.1109/IEMBS.2010.5626702; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Ramirez-Villegas JF, 2015, P NATL ACAD SCI USA, V112, pE6379, DOI 10.1073/pnas.1518257112; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rothschild G, 2017, NAT NEUROSCI, V20, P251, DOI 10.1038/nn.4457; ROUX F, 2014, SCI ENG ETHICS, V18, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Salami A, 2014, P NATL ACAD SCI USA, V111, P17654, DOI 10.1073/pnas.1410233111; Schlingloff D, 2014, J NEUROSCI, V34, P11385, DOI 10.1523/JNEUROSCI.0867-14.2014; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Sheth BR, 2009, J COGNITIVE NEUROSCI, V21, P1269, DOI 10.1162/jocn.2009.21069; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Sim A., 2012, J NEUROSURG, V116, P511; Singer AC, 2013, NEURON, V77, P1163, DOI 10.1016/j.neuron.2013.01.027; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stempel AV, 2016, NEURON, V90, P795, DOI 10.1016/j.neuron.2016.03.034; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Tallon-Baudry C, 2004, TRENDS COGN SCI, V8, P523, DOI 10.1016/j.tics.2004.10.008; Tallon-Baudry C, 2003, J PHYSIOL-PARIS, V97, P355, DOI 10.1016/j.jphysparis.2003.09.009; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; van de Ven GM, 2016, NEURON, V92, P968, DOI 10.1016/j.neuron.2016.10.020; Varotto G, 2014, CLIN NEUROPHYSIOL, V125, P63, DOI 10.1016/j.clinph.2013.06.016; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Wu CT, 2017, NAT NEUROSCI, V20, P571, DOI 10.1038/nn.4507; Wyart V, 2012, NEURON, V76, P847, DOI 10.1016/j.neuron.2012.09.015; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014	110	10	10	3	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	JUL-AUG	2017	4	4							0387-16.2017	10.1523/ENEURO.0387-16.2017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS1DY	WOS:000419515600021	28828401	gold, Green Published			2022-02-06	
J	Miyashita, TL; Diakogeorgiou, E; Marrie, K				Miyashita, Theresa L.; Diakogeorgiou, Eleni; Marrie, Kaitlyn			Correlation of Head Impacts to Change in Balance Error Scoring System Scores in Division I Men's Lacrosse Players	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						balance; accelerometers; head impacts; subconcussive impacts	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; NEUROLOGIC FUNCTION; POSTURAL STABILITY; CONCUSSION; RELIABILITY; IMPAIRMENT; MANAGEMENT; STATEMENT; EXPOSURE	Background: Investigation into the effect of cumulative subconcussive head impacts has yielded various results in the literature, with many supporting a link to neurological deficits. Little research has been conducted on men's lacrosse and associated balance deficits from head impacts. Hypotheses: (1) Athletes will commit more errors on the postseason Balance Error Scoring System (BESS) test. (2) There will be a positive correlation to change in BESS scores and head impact exposure data. Study Design: Prospective longitudinal study. Level of Evidence: Level 3. Methods: Thirty-four Division I men's lacrosse players (age, 19.59 +/- 1.42 years) wore helmets instrumented with a sensor to collect head impact exposure data over the course of a competitive season. Players completed a BESS test at the start and end of the competitive season. Results: The number of errors from pre-to postseason increased during the double-leg stance on foam (P < 0.001), tandem stance on foam (P = 0.009), total number of errors on a firm surface (P = 0.042), and total number of errors on a foam surface (P = 0.007). There were significant correlations only between the total errors on a foam surface and linear acceleration (P = 0.038, r = 0.36), head injury criteria (P = 0.024, r = 0.39), and Gadd Severity Index scores (P = 0.031, r = 0.37). Conclusion: Changes in the total number of errors on a foam surface may be considered a sensitive measure to detect balance deficits associated with cumulative subconcussive head impacts sustained over the course of 1 lacrosse season, as measured by average linear acceleration, head injury criteria, and Gadd Severity Index scores. If there is microtrauma to the vestibular system due to repetitive subconcussive impacts, only an assessment that highly stresses the vestibular system may be able to detect these changes.	[Miyashita, Theresa L.; Diakogeorgiou, Eleni; Marrie, Kaitlyn] Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA		Miyashita, TL (corresponding author), Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA.	miyashitat@sacredheart.edu					Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baloh RW, 2010, BALOH HONRUBIAS CLIN, V77; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanes DA, 2006, J VESTIBUL RES-EQUIL, V16, P75; Herdman SJ, 1994, CURR OPIN NEUROL, V13, P3; Hicks GE, 2006, J SPINAL DISORD TECH, V19, P501, DOI 10.1097/01.bsd.0000210116.94273.ad; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mucha A, 2012, BRAIN INJURY PROFESS, V9, P12, DOI DOI 10.3109/02699052.2014.887144; Mulligan IJ, 2013, SPORTS HLTH, V38, P51; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	37	10	10	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2017	9	4					318	323		10.1177/1941738116685306			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FH9XL	WOS:000411570600004	28060567	Green Published			2022-02-06	
J	Murillo-Carretero, M; Geribaldi-Doldan, N; Flores-Giubi, E; Garcia-Bernal, F; Navarro-Quiroz, EA; Carrasco, M; Macias-Sanchez, AJ; Herrero-Foncubierta, P; Delgado-Ariza, A; Verastegui, C; Dominguez-Riscart, J; Daoubi, M; Hernandez-Galan, R; Castro, C				Murillo-Carretero, Maribel; Geribaldi-Doldan, Noelia; Flores-Giubi, Eugenia; Garcia-Bernal, Francisco; Navarro-Quiroz, Elkin A.; Carrasco, Manuel; Macias-Sanchez, Antonio J.; Herrero-Foncubierta, Pilar; Delgado-Ariza, Antonio; Verastegui, Cristina; Dominguez-Riscart, Jesus; Daoubi, Mourad; Hernandez-Galan, Rosario; Castro, Carmen			ELAC (3,12-di-O-acetyl-8-O-tigloilingol), a plant-derived lathyrane diterpene, induces subventricular zone neural progenitor cell proliferation through PKC beta activation	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							PROTEIN-KINASE-C; STEM-CELLS; PHORBOL ESTER; ADULT BRAIN; CONCISE GUIDE; NITRIC-OXIDE; NEUROGENESIS; GROWTH; MOUSE; PATHWAY	BACKGROUND AND PURPOSE Pharmacological strategies aimed to facilitate neuronal renewal in the adult brain, by promoting endogenous neurogenesis, constitute promising therapeutic options for pathological or traumatic brain lesions. We have previously shown that non-tumour-promoting PKC-activating compounds (12-deoxyphorbols) promote adult neural progenitor cell (NPC) proliferation in vitro and in vivo, enhancing the endogenous neurogenic response of the brain to a traumatic injury. Here, we show for the first time that a diterpene with a lathyrane skeleton can also activate PKC and promote NPC proliferation. EXPERIMENTAL APPROACH We isolated four lathyranes from the latex of Euphorbia plants and tested their effect on postnatal NPC proliferation, using neurosphere cultures. The bioactive lathyrane ELAC (3,12-di-O-acetyl-8-O-tigloilingol) was also injected into the ventricles of adult mice to analyse its effect on adult NPC proliferation in vivo. KEY RESULTS The lathyrane ELAC activated PKC and significantly increased postnatal NPC proliferation in vitro, particularly in synergy with FGF2. In addition ELAC stimulated proliferation of NPC, specifically affecting undifferentiated transit amplifying cells. The proliferative effect of ELAC was reversed by either the classical/novel PKC inhibitor Go6850 or the classical PKC inhibitor Go6976, suggesting that NPC proliferation is promoted in response to activation of classical PKCs, particularly PKC beta. ELAC slightly increased the proportion of NPC expressing Sox2. The effects of ELAC disappeared upon acetylation of its C7-hydroxyl group. CONCLUSIONS AND IMPLICATIONS We propose lathyranes like ELAC as new drug candidates to modulate adult neurogenesis through PKC activation. Functional and structural comparisons between ELAC and phorboids are included.	[Murillo-Carretero, Maribel; Geribaldi-Doldan, Noelia; Garcia-Bernal, Francisco; Navarro-Quiroz, Elkin A.; Carrasco, Manuel; Herrero-Foncubierta, Pilar; Delgado-Ariza, Antonio; Dominguez-Riscart, Jesus; Castro, Carmen] Univ Cadiz, Fac Med, Area Fisiol, Plaza Falla 9, Cadiz 11003, Spain; [Murillo-Carretero, Maribel; Geribaldi-Doldan, Noelia; Garcia-Bernal, Francisco; Navarro-Quiroz, Elkin A.; Carrasco, Manuel; Herrero-Foncubierta, Pilar; Delgado-Ariza, Antonio; Verastegui, Cristina; Dominguez-Riscart, Jesus; Castro, Carmen] Inst Invest & Innovac Biomed Cadiz INiBIC, Cadiz, Spain; [Flores-Giubi, Eugenia; Macias-Sanchez, Antonio J.; Daoubi, Mourad; Hernandez-Galan, Rosario] Univ Cadiz, Fac Ciencias, Dept Quim Organ, Cadiz, Spain; [Flores-Giubi, Eugenia; Macias-Sanchez, Antonio J.; Daoubi, Mourad; Hernandez-Galan, Rosario] Inst Invest Biomol INBIO, Cadiz, Spain; [Verastegui, Cristina] Univ Cadiz, Dept Anat & Embriol Humana, Cadiz, Spain; [Navarro-Quiroz, Elkin A.] Univ Simon Bolivar, Barranquilla, Colombia		Castro, C (corresponding author), Univ Cadiz, Fac Med, Area Fisiol, Plaza Falla 9, Cadiz 11003, Spain.	carmen.castro@uca.es	Doldan, Noelia Geribaldi/L-4478-2014; Flores-Giubi, Eugenia/K-7036-2019; Hernandez-Galan, Rosario/B-7697-2009; Sanchez, Antonio Jose Macias/AAM-8503-2020; Ariza, Antonio Delgado/AAK-8645-2021; Carmen, Castro/C-7813-2009; Escolano, Cristina Verastegui/L-7264-2014; Doldan, Noelia Geribaldi/O-7286-2019; Navarro Quiroz, Elkin/P-5715-2016	Sanchez, Antonio Jose Macias/0000-0001-6002-4977; Ariza, Antonio Delgado/0000-0001-6922-158X; Carmen, Castro/0000-0002-6802-0572; Escolano, Cristina Verastegui/0000-0002-9342-2127; Doldan, Noelia Geribaldi/0000-0003-2149-9050; Navarro Quiroz, Elkin/0000-0001-7567-6409; Hernandez Galan, Rosario/0000-0003-1887-4796; FLORES-GIUBI, MARIA EUGENIA/0000-0002-1572-9983; Dominguez Riscart, Jesus/0000-0002-6948-7940; Murillo-Carretero, Maria Isabel/0000-0003-4782-937X	Spanish Consejeria de Innovacion, Ciencia y Empleo; Junta de AndaluciaJunta de Andalucia [P10CTS6639, P07-FQM-02925]; Ministerio de Economia y CompetitividadSpanish Government [BFU2015-68652-R, MINECO/FEDER]	This work was supported by the Spanish Consejeria de Innovacion, Ciencia y Empleo, Junta de Andalucia (grant numbers P10CTS6639 and P07-FQM-02925) and the Ministerio de Economia y Competitividad (grant number BFU2015-68652-R and MINECO/FEDER).	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P6024, DOI 10.1111/bph.13354; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5729, DOI 10.1111/bph.13347; ALTMAN A, 1992, IMMUNOLOGY, V76, P465; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Avila L, 2010, PHYTOCHEMISTRY, V71, P243, DOI 10.1016/j.phytochem.2009.10.005; Belenguer G, 2016, DIFFERENTIATION, V91, P28, DOI 10.1016/j.diff.2016.01.005; Black AR, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00423; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Bokara KK, 2016, STEM CELL RES, V17, P256, DOI 10.1016/j.scr.2016.08.009; Bokara KK, 2011, STEM CELLS DEV, V20, P527, DOI 10.1089/scd.2010.0312; Brodie C, 1998, MOL BRAIN RES, V56, P108, DOI 10.1016/S0169-328X(98)00035-7; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Corbit KC, 2000, MOL CELL BIOL, V20, P5392, DOI 10.1128/MCB.20.15.5392-5403.2000; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Daoubi M, 2007, BIOORGAN MED CHEM, V15, P4577, DOI 10.1016/j.bmc.2007.04.009; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FINKENZELLER G, 1992, CELL SIGNAL, V4, P163, DOI 10.1016/0898-6568(92)90080-R; Geribaldi-Doldan N, 2016, INT J NEUROPSYCHOPH, P19; Goldman S, 2003, TRENDS NEUROSCI, V26, P590, DOI 10.1016/j.tins.2003.09.011; Hezareh M, 2005, DRUG NEWS PERSPECT, V18, P496, DOI 10.1358/dnp.2005.18.8.944543; Hritz J, 2004, J MED CHEM, V47, P6547, DOI 10.1021/jm049786s; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kinehara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054122; Krauter G, 1996, EUR J BIOCHEM, V242, P417, DOI 10.1111/j.1432-1033.1996.0417r.x; Lai C, 2004, BIOCHEM BIOPH RES CO, V319, P603, DOI 10.1016/j.bbrc.2004.05.027; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Minami H, 2000, J MOL NEUROSCI, V15, P121, DOI 10.1385/JMN:15:2:121; Morishita R, 2007, NEUROSCI RES, V59, P205, DOI 10.1016/j.neures.2007.06.1478; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Parent JM, 1997, J NEUROSCI, V17, P3727; Pende M, 1997, NEUROTRANSMITTER GRO; Pusztai R, 2007, ANTICANCER RES, V27, P201; Qiu JH, 2009, STEM CELLS, V27, P920, DOI 10.1002/stem.1; Rabaneda LG, 2008, FASEB J, V22, P3823, DOI 10.1096/fj.08-109306; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romero-Grimaldi C, 2008, J COMP NEUROL, V506, P339, DOI 10.1002/cne.21556; Romero-Grimaldi C, 2011, STEM CELLS, V29, P1628, DOI 10.1002/stem.710; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Sanchez-Duffhues G, 2011, CURR DRUG TARGETS, V12, P348, DOI 10.2174/138945011794815266; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Steinhart R, 2007, GLIA, V55, P224, DOI 10.1002/glia.20454; Sung SM, 2007, NEUROCHEM RES, V32, P1932, DOI 10.1007/s11064-007-9390-1; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Svensson K, 2000, CELL GROWTH DIFFER, V11, P641; SZALLASI Z, 1991, CANCER RES, V51, P5355; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Vasas A, 2014, CHEM REV, V114, P8579, DOI 10.1021/cr400541j; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Wender PA, 1998, P NATL ACAD SCI USA, V95, P6624, DOI 10.1073/pnas.95.12.6624; Yamamoto M, 1998, EXP CELL RES, V240, P349, DOI 10.1006/excr.1998.3999; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	66	10	10	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JUL	2017	174	14					2373	2392		10.1111/bph.13846			20	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EZ0PI	WOS:000404407600018	28476069	Bronze, Green Published			2022-02-06	
J	Ament, JD; Greenan, KN; Tertulien, P; Galante, JM; Nishijima, DK; Zwienenberg, M				Ament, Jared D.; Greenan, Krista N.; Tertulien, Patrick; Galante, Joseph M.; Nishijima, Daniel K.; Zwienenberg, Marike			Medical necessity of routine admission of children with mild traumatic brain injury to the intensive care unit	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; clinical decision rule; ICU monitoring; triage; resource allocation; trauma	COMPUTED-TOMOGRAPHY; SCORE; HEMORRHAGE; UTILITY	OBJECTIVE Approximately 475,000 children are treated for traumatic brain injury (TBI) in the US each year; most are classified as mild TBI (Glasgow Coma Scale [GCS] Score 13-15). Patients with positive findings on head CT, defined as either intracranial hemorrhage or skull fracture, regardless of severity, are often transferred to tertiary care centers for intensive care unit (ICU) monitoring. This practice creates a significant burden on the health care system. The purpose of this investigation was to derive a clinical decision rule (CDR) to determine which children can safely avoid ICU care. METHODS The authors retrospectively reviewed patients with mild TBI who were <= 16 years old and who presented to a Level 1 trauma center between 2008 and 2013. Data were abstracted from institutional TBI and trauma registries. Independent covariates included age, GCS score, pupillary response, CT characteristics, and Injury Severity Score. A composite outcome measure, ICU-level care, was defined as cardiopulmonary instability, transfusion, intubation, placement of intracranial pressure monitor or other invasive monitoring, and/or need for surgical intervention. Stepwise logistic regression defined significant predictors for model inclusion With p < 0.10. The authors derived the CDR with binary recursive partitioning (using a misclassification cost of 20:1). RESULTS A total of 284 patients with mild TBI were included in the analysis; 40 (14.1%) had ICU-level care. The CDR consisted of 5 final predictor variables: midline shift > 5 mm, intraventricular hemorrhage, nonisolated head injury, postresuscitation GCS score of < 15, and cisterns absent. The CDR correctly identified 37 of 40 patients requiring ICU level care (sensitivity 92.5%; 95% CI 78.5-98.0) and 154 of 244 patients who did not require an ICU-level intervention (specificity 63.1%; 95% CI 56.7-69.1). This results in a negative predictive value of 98.1% (95% CI 94.1-99.5). CONCLUSIONS The authors derived a clinical tool that defines a subset of pediatric patients with mild TBI at low risk for ICU-level care. Although prospective evaluation is needed, the potential for improved resource allocation is significant.	[Ament, Jared D.; Greenan, Krista N.; Tertulien, Patrick; Zwienenberg, Marike] Univ Calif Davis, Med Ctr, Dept Neurol Surg, Sacramento, CA 95817 USA; [Galante, Joseph M.] Univ Calif Davis, Med Ctr, Dept Trauma Surg, Sacramento, CA 95817 USA; [Nishijima, Daniel K.] Univ Calif Davis, Med Ctr, Dept Emergency Med, Sacramento, CA 95817 USA		Ament, JD (corresponding author), UC Davis Med Ctr, Neurosurg, 4860 Y St,Ste 3740, Sacramento, CA 95817 USA.	jared.ament@ucdmc.ucdavis.edu					Barker DE, 2006, AM SURGEON, V72, P1166; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bullock RM, 2000, J NEUROTRAUM, V17, P449; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Egol A, 1999, CRIT CARE MED, V27, P633; Ferrara P, 2016, PEDIATR NEUROSURG, V51, P249, DOI 10.1159/000445904; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Huynh T, 2006, AM SURGEON, V72, P1162; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rosner B, 2011, FUNDAMENTALS BIOSTAT; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	25	10	10	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2017	19	6					668	674		10.3171/2017.2.PEDS16419			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EV6OW	WOS:000401889700008	28387644	Bronze			2022-02-06	
J	Berger, RP; Pak, BJ; Kolesnikova, MD; Fromkin, J; Saladino, R; Herman, BE; Pierce, MC; Englert, D; Smith, PT; Kochanek, PM				Berger, Rachel Pardes; Pak, Brian J.; Kolesnikova, Mariya D.; Fromkin, Janet; Saladino, Richard; Herman, Bruce E.; Pierce, Mary Clyde; Englert, David; Smith, Paul T.; Kochanek, Patrick M.			Derivation and Validation of a Serum Biomarker Panel to Identify Infants With Acute Intracranial Hemorrhage	JAMA PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; ABUSIVE HEAD TRAUMA; NEURON-SPECIFIC ENOLASE; MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; PHYSICAL ABUSE; CHILDREN; PROTEIN; BLOOD; ADHESION	IMPORTANCE Abusive head trauma is the leading cause of death from physical abuse. Missing the diagnosis of abusive head trauma, particularly in its mild form, is common and contributes to increased morbidity and mortality. Serum biomarkers may have potential as quantitative point-of-care screening tools to alert physicians to the possibility of intracranial hemorrhage. OBJECTIVE To identify and validate a set of biomarkers that could be the basis of a multivariable model to identify intracranial hemorrhage in well-appearing infants using the Ziplex System. DESIGN, SETTING, AND PARTICIPANTS Binary logistic regressionwas used to develop a multivariable model incorporating 3 serum biomarkers (matrix metallopeptidase-9, neuron-specific enolase, and vascular cellular adhesion molecule-1) and 1 clinical variable (total hemoglobin). The model was then prospectively validated. Multiplex biomarker measurements were performed using Flow-Thru microarray technology on the Ziplex System, which has potential as a point-of-care system. The model was tested at 3 pediatric emergency departments in level I pediatric trauma centers (Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Primary Children's Hospital, Salt Lake City, Utah; and Lurie Children's Hospital, Chicago, Illinois) among well-appearing infants who presented for care owing to symptoms that placed them at increased risk of abusive head trauma. The study took place from November 2006 to April 2014 at Children's Hospital of Pittsburgh, June 2010 to August 2013 at Primary Children's Hospital, and January 2011 to August 2013 at Lurie Children's Hospital. MAIN OUTCOMES AND MEASURES A mathematical model that can predict acute intracranial hemorrhage in infants at increased risk of abusive head trauma. RESULTS The multivariable model, Biomarkers for Infant Brain Injury Score, was applied prospectively to 599 patients. The mean (SD) age was 4.7 (3.1) months. Fifty-two percent were boys, 78% were white, and 8% were Hispanic. At a cutoff of 0.182, the model was 89.3% sensitive (95% CI, 87.7-90.4) and 48.0% specific (95% CI, 47.3-48.9) for acute intracranial hemorrhage. Positive and negative predictive values were 21.3% and 95.6%, respectively. The model was neither sensitive nor specific for atraumatic brain abnormalities, isolated skull fractures, or chronic intracranial hemorrhage. CONCLUSION AND RELEVANCE The Biomarkers for Infant Brain Injury Score, a multivariable model using 3 serum biomarker concentrations and serum hemoglobin, can identify infants with acute intracranial hemorrhage. Accurate and timely identification of intracranial hemorrhage in infants without a history of trauma in whom trauma may not be part of the differential diagnosis has the potential to decrease morbidity and mortality from abusive head trauma.	[Berger, Rachel Pardes; Fromkin, Janet; Saladino, Richard] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Berger, Rachel Pardes; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Pak, Brian J.; Kolesnikova, Mariya D.; Englert, David; Smith, Paul T.] Axela Inc, Toronto, ON, Canada; [Herman, Bruce E.] Univ Utah, Dept Pediat, Primary Childrens Hosp, Salt Lake City, UT USA; [Pierce, Mary Clyde] Ann & Robert H Lurie Childrens Hosp, Dept Pediat, Chicago, IL USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA USA		Berger, RP (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Child Advocacy, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	rachel.berger@chp.edu	Pierce, Mary Clyde/AAQ-3509-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD055986, NIHK23HD43843]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055986] Funding Source: NIH RePORTER	The study was funded by grants R01HD055986 and NIHK23HD43843 from the National Institutes of Health. The data in this article are the basis for patent 62/334,345 filed on May 10, 2016, Compositions and Methods for Identifying Subjects at risk for Traumatic Brain Injury.	Berger R, 2009, PEDIATR CRIT CARE ME, V10, P260, DOI 10.1097/PCC.0b013e31819a376d; Berger RP, 2015, J PEDIATR-US, V166, P383, DOI 10.1016/j.jpeds.2014.10.036; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Berger RP, 2006, CLIN PEDIATR EMERG M, V7, P186, DOI 10.1016/j.cpem.2006.06.001; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Flaherty EG, 2006, CHILD ABUSE NEGLECT, V30, P789, DOI 10.1016/j.chiabu.2005.12.008; Flom L, 2016, PEDIATR RADIOL, V46, P519, DOI 10.1007/s00247-015-3500-z; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Garne E, 2010, EUR J PAEDIATR NEURO, V14, P150, DOI 10.1016/j.ejpn.2009.03.005; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 2002, PEDIATR RES, V51, P215, DOI 10.1203/00006450-200202000-00015; Giuseppe D, 2009, CURR NEUROVASC RES, V6, P110, DOI 10.2174/156720209788185614; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hayes RL, 2009, METHODS MOL BIOL, V566, P303, DOI 10.1007/978-1-59745-562-6_20; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Letson MM, 2016, CHILD ABUSE NEGLECT, V60, P36, DOI 10.1016/j.chiabu.2016.09.001; Meyer D, 2015, MISC FUNCTIONS DEP S; Missios S, 2008, J NEUROS-PEDIATR, V2, P438, DOI 10.3171/PED.2008.2.12.438; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Parks S.E., 2012, PEDIAT ABUSIVE HEAD, P5; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Team R, 2016, RSTUDIO INT DEV R, V3.6.1; Team RC, 2016, LANG ENV STAT COMP; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; U.S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2013, CHILD MALTR 2013; *US DEP HHS, 1986, NIH PUBL; Walker A, 2015, OPENXLSX READ WRITE; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Wood JN, 2016, ACAD PEDIATR, V16, P224, DOI 10.1016/j.acap.2015.05.008; Wu LM, 2015, TRANSL STROKE RES, V6, P116, DOI 10.1007/s12975-014-0347-9; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258	46	10	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JUN	2017	171	6							e170429	10.1001/jamapediatrics.2017.0429			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EW7SB	WOS:000402714300002	28395008	Bronze			2022-02-06	
J	Johnson, U; Engquist, H; Lewen, A; Howells, T; Nilsson, P; Ronne-Engstrom, E; Rostami, E; Enblad, P				Johnson, Ulf; Engquist, Henrik; Lewen, Anders; Howells, Tim; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Rostami, Elham; Enblad, Per			Increased risk of critical CBF levels in SAH patients with actual CPP below calculated optimal CPP	ACTA NEUROCHIRURGICA			English	Article						Subarachnoid hemorrhage; SAH; Cerebral blood flow; CBF; Autoregulation; Optimal; Cerebral perfusion pressure; CPPopt; Neurointensive care	CEREBRAL PERFUSION-PRESSURE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; CLINICAL DETERIORATION; REACTIVITY INDEX; SAMPLE-SIZE; BLOOD-FLOW; AUTOREGULATION; ISCHEMIA; IMPAIRMENT	Background Cerebral pressure autoregulation can be quantified with the pressure reactivity index (PRx), based on the correlation between blood pressure and intracranial pressure. Using PRx optimal cerebral perfusion pressure (CPPopt) can be calculated, i.e., the level of CPP where autoregulation functions best. The relation between cerebral blood flow (CBF) and CPPopt has not been examined. The objective was to assess to which extent CPPopt can be calculated in SAH patients and to investigate CPPopt in relation to CBF. Methods Retrospective study of prospectively collected data. CBF was measured bedside with Xenon-enhanced CT (Xe-CT). The difference between actual CPP and CPPopt was calculated (CPPa dagger). Correlations between CPPa dagger and CBF parameters were calculated with Spearman's rank order correlation coefficient (rho). Separate calculations were done using all patients (day 0-14 after onset) as well as in two subgroups (day 0-3 and day 4-14). Results Eighty-two patients with 145 Xe-CT scans were studied. Automated calculation of CPPopt was possible in adjunct to 60% of the Xe-CT scans. Actual CPP < CPPopt was associated with higher numbers of low-flow regions (CBF < 10 ml/100 g/min) in both the early phase (day 0-3, n = 39, Spearman's rho = -0.38, p = 0.02) and late acute phase of the disease (day 4-14, n = 35, Spearman's rho = -0.39, p = 0.02). CPP level per se was not associated with CBF. Conclusions Calculation of CPPopt is possible in a majority of patients with severe SAH. Actual CPP below CPPopt is associated with low CBF.	[Johnson, Ulf; Engquist, Henrik; Lewen, Anders; Howells, Tim; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Rostami, Elham; Enblad, Per] Uppsala Univ, Dept Neurosci Neurosurg, S-75185 Uppsala, Sweden; [Johnson, Ulf] Uppsala Univ, Dept Surg Sci Radiol, Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Dept Surg Sci Anaesthesia & Intens Care, Uppsala, Sweden		Johnson, U (corresponding author), Uppsala Univ, Dept Neurosci Neurosurg, S-75185 Uppsala, Sweden.; Johnson, U (corresponding author), Uppsala Univ, Dept Surg Sci Radiol, Uppsala, Sweden.	Ulf.johnson@neuro.uu.se		Engquist, Henrik/0000-0002-9826-1422			Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Calviere L, 2015, NEUROCRIT CARE, V23, P253, DOI 10.1007/s12028-015-0125-x; Choi HA, 2012, NEUROCRIT CARE, V16, P363, DOI 10.1007/s12028-012-9670-8; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Diedler J, 2014, CRIT CARE, V18, DOI 10.1186/cc13796; Eide PK, 2012, J NEUROSURG, V116, P961, DOI 10.3171/2012.1.JNS111313; Fontana J, 2016, J NEUROIMAGING, V26, P339, DOI 10.1111/jon.12295; Fontana J, 2015, NEUROCRIT CARE, V23, P355, DOI 10.1007/s12028-014-0104-7; Howells T, 2017, J CLIN MONIT COMPUT, V31, P469, DOI 10.1007/s10877-016-9863-3; Johnson U, 2016, NEUROCRIT CARE, V25, P47, DOI 10.1007/s12028-016-0240-3; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; Mees D SM, 2007, COCHRANE DB SYST REV, V3; Mizuno Makoto, 1994, Neurologia Medico-Chirurgica, V34, P164, DOI 10.2176/nmc.34.164; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; ROYALL RM, 1986, AM STAT, V40, P313, DOI 10.2307/2684616; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Schubert GA, 2009, J NEUROTRAUM, V26, P2225, DOI 10.1089/neu.2009.0924; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Tzeng YC, 2011, J PHYSIOL-LONDON, V589, P3263, DOI 10.1113/jphysiol.2011.206953; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817	31	10	11	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2017	159	6					1065	1071		10.1007/s00701-017-3139-7			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EU6BB	WOS:000401117700016	28361248	Green Submitted, Green Published, hybrid			2022-02-06	
J	Kreitzer, N; Hart, K; Lindsell, CJ; Betham, B; Gozal, Y; Andaluz, NO; Lyons, MS; Bonomo, J; Adeoye, O				Kreitzer, Natalie; Hart, Kimberly; Lindsell, Christopher J.; Betham, Brittany; Gozal, Yair; Andaluz, Norberto O.; Lyons, Michael S.; Bonomo, Jordan; Adeoye, Opeolu			Factors associated with adverse outcomes in patients with traumatic intracranial hemorrhage and Glasgow Coma Scale of 15	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Emergency department; Low risk TBI	MINIMAL HEAD-INJURY; CARE-UNIT ADMISSION; BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; ADULT PATIENTS; CT; CLASSIFICATION; ANTIPLATELET; EVOLUTION	Patients with mild traumatic brain injury (mTBI) with associated intracranial injury, or complicated mTBI, are at risk of deterioration. Clinical management differs within and between institutions. We conducted an exploratory analysis to determine which of these patients are unlikely to have an adverse outcome and may be future targets for less resource intensive care. This single center retrospective cohort study included patients presenting to the ED with blunt complicatedmTBI between January 2001 and December 2010. Patients with a Glasgow coma score (GCS) of 15, an initial head CT with a traumatic abnormality, and a repeat head CT within 24 h were eligible. We defined the composite adverse outcome as death within two weeks, neurosurgical procedure within two weeks, hospitalization >48 h, and worsened second head CT. Classification and Regression Tree methodology was used to identify factors associated with adverse outcomes. Of 1011 patients with two head CTs performed in a 24-h period, 240 (24%) had complicated mTBI and GCS 15. Of these, 56 (23%) experienced the composite adverse outcome defined above. Age, headache, and subarachnoid hemorrhage, correctly classified 93% of patients with an adverse outcome. No instance of death or neurosurgical procedure was missed. Our analysis highlighted three factors associated with adverse outcomes in persons who have complicated mTBI but a GCS of 15. Absence of these risk factors suggests low risk of adverse outcomes, and may suggest that a patient is safe for discharge home. Additional research is required before utilizing these findings in clinical practice. (C) 2017 Elsevier Inc. All rights reserved.	[Kreitzer, Natalie; Hart, Kimberly; Lindsell, Christopher J.; Betham, Brittany; Lyons, Michael S.; Bonomo, Jordan; Adeoye, Opeolu] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Kreitzer, Natalie; Bonomo, Jordan; Adeoye, Opeolu] Univ Cincinnati, Div Neurocrit Care, Cincinnati, OH USA; [Gozal, Yair; Andaluz, Norberto O.; Bonomo, Jordan; Adeoye, Opeolu] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Kreitzer, Natalie; Hart, Kimberly] 231 Albert Sabin Way,ML 0769, Cincinnati, OH 45267 USA; [Lindsell, Christopher J.] Holmes Hosp, Room 3124,231 Goodman Ave, Cincinnati, OH 45267 USA; [Betham, Brittany; Lyons, Michael S.; Bonomo, Jordan; Adeoye, Opeolu] Univ Cincinnati, 231 Albert Sabin Way,ML 0769, Cincinnati, OH 45267 USA; [Gozal, Yair] Stetson Bldg,Suite 2200, Cincinnati, OH 45267 USA; [Andaluz, Norberto O.] Univ Med Arts Bldg,Suite 3100, Cincinnati, OH 45219 USA		Kreitzer, N (corresponding author), 231 Albert Sabin Way,ML 0769, Cincinnati, OH 45267 USA.	kreitzne@ucmail.uc.edu; hartkb@ucmail.uc.edu; Christopher.lindsell@uc.edu; Brittany.betham@uc.edu; yair.gozal@uc.edu; Norberto.andaluz@uc.edu; Michael.lyons@uc.edu; Jordan.bonomo@uc.edu; opeolu.adeoye@uc.edu			Institutional Clinical and Translational Science Award; NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [8UL1-TR000077]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996] Funding Source: NIH RePORTER	This work was supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 8UL1-TR000077.	Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HOSP AMB MED CAR; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Huynh T, 2006, AM SURGEON, V72, P1162; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; R Core Team, 2014, R LANG ENV STAT COMP; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Schuster R, 2005, AM SURGEON, V71, P701; Sharifuddin Ashraf, 2012, Med J Malaysia, V67, P305; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Telmo Nunes CH, M STEVENSON CONTRIBU; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	31	10	10	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2017	35	6					875	880		10.1016/j.ajem.2017.01.051			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FA2SL	WOS:000405291000012	28143693	Green Accepted			2022-02-06	
J	Lam, PM; Carlsen, J; Gonzalez, MI				Lam, Philip M.; Carlsen, Jessica; Gonzalez, Marco I.			A calpain inhibitor ameliorates seizure burden in an experimental model of temporal lobe epilepsy	NEUROBIOLOGY OF DISEASE			English	Article						Epileptogenesis; Calpain; Proteolysis; Epilepsy; Spontaneous seizures	SPONTANEOUS RECURRENT SEIZURES; INDUCED STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; PILOCARPINE MODEL; PROTEIN EXPRESSION; MOUSE MODEL; ACTIVATION; NEURODEGENERATION; EPILEPTOGENESIS; INTERLEUKIN-1-ALPHA	In this study, we used the pilocarpine model of epilepsy to evaluate the involvement of calpain dysregulation on epileptogenesis. Detection of spectrin breakdown products (SBDPs, a hallmark of calpain activation) after induction of pilocarpine-induced status epilepticus (SE) and before appearance of spontaneous seizure suggested the existence of sustained calpain activation during epileptogenesis. Acute treatment with a cell permeable inhibitor of calpain, MDL-28170, resulted in a partial but significant reduction on seizure burden. The reduction on seizure burden was associated with a limited reduction on the generation of SBDPs but was correlated with a reduction in astrocytosis, microglia activation and cell sprouting. Together, these observations provide evidence for the role of calpain in epileptogenesis. In addition, provide proof-of-principle for the use of calpain inhibitors as a novel strategy to prevent epileptic seizures and its associated pathologies. (C) 2017 Elsevier Inc. All rights reserved.	Univ Colorado, Sch Med, Dept Pediat, Div Neurol, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Translat Epilepsy Res Program, Aurora, CO 80045 USA		Gonzalez, MI (corresponding author), Pharm Bldg V20,Mail Stop 8605, Aurora, CO 80045 USA.	marco.gonzalez@ucdenver.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01-NS069583, R01-NS089698]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS089698, K01NS069583, P30NS048154] Funding Source: NIH RePORTER	The authors gratefully acknowledge Hien Dohan, Amelia Zommer and Janeen Williams for their contribution during the initial stages of these studies. We also would like to thank the Rodent In Vivo Neurophysiology Core at the University of Colorado Anschutz Medical Campus for providing the facilities to acquire and review the EEG/Video data. The AB38 antibody was a generous gift from Dr. David R. Lynch (University of Pennsylvania, PA). Grants K01-NS069583 and R01-NS089698 from the National Institutes of Health to MIG supported this work.	ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; Araujo IM, 2008, J NEUROCHEM, V105, P666, DOI 10.1111/j.1471-4159.2007.05181.x; Baudry M, 2016, TRENDS NEUROSCI, V39, P235, DOI 10.1016/j.tins.2016.01.007; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Brandt C, 2003, NEUROSCIENCE, V118, P727, DOI 10.1016/S0306-4522(03)00027-7; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Buckmaster PS, 2014, ADV EXP MED BIOL, V813, P161, DOI 10.1007/978-94-017-8914-1_13; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Chi ZH, 2008, NEUROCHEM INT, V52, P1305, DOI 10.1016/j.neuint.2008.02.008; Curcio M, 2016, PROG NEUROBIOL, V143, P1, DOI 10.1016/j.pneurobio.2016.06.001; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Das A, 2012, NEUROSCIENCE, V220, P237, DOI 10.1016/j.neuroscience.2012.06.002; Dominici R, 2002, IMMUNOGENETICS, V54, P82, DOI 10.1007/s00251-002-0445-9; El-Hassar L, 2007, EPILEPSIA, V48, P131, DOI 10.1111/j.1528-1167.2007.01301.x; England H, 2014, J BIOL CHEM, V289, P15942, DOI 10.1074/jbc.M114.557561; Feng ZH, 2011, SEIZURE-EUR J EPILEP, V20, P395, DOI 10.1016/j.seizure.2011.01.010; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Heng K, 2013, EPILEPSIA, V54, P1535, DOI 10.1111/epi.12246; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; Kan AA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-207; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Lehmkuhle MJ, 2009, J NEUROPHYSIOL, V101, P1660, DOI 10.1152/jn.91062.2008; Li PA, 1998, NEUROSCI LETT, V247, P17, DOI 10.1016/S0304-3940(98)00266-3; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; O'Dell CM, 2012, J NEUROSCI RES, V90, P913, DOI 10.1002/jnr.22829; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Salzmann A, 2008, NEUROL SCI, V29, P397, DOI 10.1007/s10072-008-1060-9; Seinfeld J, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0088-15.2016; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; SHENG JG, 1994, J NEUROCHEM, V63, P1872; Shumate MD, 1998, EPILEPSY RES, V32, P114, DOI 10.1016/S0920-1211(98)00045-X; Silva AP, 2001, J NEUROCHEM, V79, P286, DOI 10.1046/j.1471-4159.2001.00560.x; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Tsai MH, 2009, QJM-INT J MED, V102, P57, DOI 10.1093/qjmed/hcn149; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1111/j.1365-2613.2000.00169.x; Vezzani A, 2015, EXPERT REV NEUROTHER, V15, P1081, DOI 10.1586/14737175.2015.1079130; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Walker M, 2007, EPILEPSIA, V48, P66, DOI 10.1111/j.1528-1167.2007.01354.x; Wang SH, 2008, BRAIN RES BULL, V76, P90, DOI 10.1016/j.brainresbull.2007.12.006; Wang YB, 2016, NEUROBIOL DIS, V93, P121, DOI 10.1016/j.nbd.2016.05.007; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang G, 2004, NEUROSCIENCE, V125, P299, DOI 10.1016/j.neuroscience.2004.01.040	60	10	10	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUN	2017	102						1	10		10.1016/j.nbd.2017.02.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ES1BG	WOS:000399262300001	28237317	Green Accepted			2022-02-06	
J	Lynall, RC; Pietrosimone, B; Kerr, ZY; Mauntel, TC; Mihalik, JP; Guskiewicz, KM				Lynall, Robert C.; Pietrosimone, Brian; Kerr, Zachary Y.; Mauntel, Timothy C.; Mihalik, Jason P.; Guskiewicz, Kevin M.			Osteoarthritis Prevalence in Retired National Football League Players With a History of Concussion and Lower Extremity Injury	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; joint degeneration; knee arthritis	STABILITY FOLLOWING CONCUSSION; SPORT-RELATED CONCUSSION; TRANSCRANIAL MAGNETIC STIMULATION; GAIT STABILITY; KNEE OSTEOARTHRITIS; POSTURAL STABILITY; MUSCULOSKELETAL INJURY; DIVIDED ATTENTION; IFCN COMMITTEE; RECOVERY	Context: Dynamic balance deficits have been described postconcussion, even after athletes return to play. Lower extremity (LE) musculoskeletal injury rates increase for up to 1 year after concussion, but the long-term musculoskeletal implications of concussion are unclear. Objective: To (1) examine the association of concussion and LE injury histories with osteoarthritis (OA) prevalence in retired National Football League players and (2) examine the association of concussion and LE injury histories with OA prevalence in those <= 55 years of age. Design: Case-control study. Setting: Survey. Patients or Other Participants: We administered the Health Survey of Retired National Football League Players, which collects information about demographics, OA, LE injury, and concussion history. Main Outcome Measure(s): Twelve discrete categories were created based on concussion and LE injury history, ranging from 0 concussions and 0 LE injuries (referent group) to 3+ concussions and 2+ LE injuries. Binomial regression analysis modeled lifetime OA prevalence. Covariates were body mass index, age at the time of the survey, and total years playing professional football. Results: Complete data were available for 2696 participants. Lifetime OA prevalence was smallest in the referent group (21.1%) and largest in the 3+ concussion and 2+ LE group (50.6%; 2.5 times the referent; 95% confidence interval [CI] = 2.1, 3.1). Participants in all concussion groups (1, 2, 3+) who reported a history of 0 LE injuries had a greater OA prevalence than the referent group. When participants were stratified by age, the <= 55 years of age, 3+ concussions, and 2+ LE injuries group prevalence ratio (3.6; 95% CI = 2.7, 5.2) was larger than that of the <= 55 years of age, 3+ concussions, and 2+ LE injuries group (1.8; 95% CI = 1.3, 2.4) compared with the respective referent groups. Conclusions: Concussion with or without a history of LE injury may be an important moderator of OA. Future researchers should seek to better understand the mechanisms that influence the association among concussion, LE injury, and OA.	[Lynall, Robert C.; Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Pietrosimone, Brian] Univ North Carolina Chapel Hill, Neuromuscular Res Lab, Chapel Hill, NC USA; [Pietrosimone, Brian; Mauntel, Timothy C.] Univ North Carolina Chapel Hill, Sports Med Res Lab, Chapel Hill, NC USA; [Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Lynall, Robert C.; Pietrosimone, Brian; Mauntel, Timothy C.; Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Concuss Res Lab, 330 River Rd, Athens, GA 30677 USA; [Mauntel, Timothy C.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed, Bethesda, MD USA		Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, Concuss Res Lab, 330 River Rd, Athens, GA 30677 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	University of North Carolina at Chapel Hill	The General Health Survey data collected by the Center for the Study of Retired Athletes were enabled by external (NFL Players Association) and internal (University of North Carolina at Chapel Hill) funding.	Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chu CR, 2015, J ORTHOP RES, V33, P939, DOI 10.1002/jor.22817; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Drake KM, 2012, PEDIATRICS, V130, pE296, DOI 10.1542/peds.2011-2898; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-135; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Golightly YM, 2009, J PHYS ACT HEALTH, V6, P638, DOI 10.1123/jpah.6.5.638; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Muthuri SG, 2011, OSTEOARTHR CARTILAGE, V19, P1286, DOI 10.1016/j.joca.2011.07.015; Nelson AE, 2011, ARTHRITIS RHEUM-US, V63, P3843, DOI 10.1002/art.30610; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Palmieri-Smith RM, 2009, EXERC SPORT SCI REV, V37, P147, DOI 10.1097/JES.0b013e3181aa6669; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Richmond SA, 2013, J ORTHOP SPORT PHYS, V43, P515, DOI 10.2519/jospt.2013.4796; Riemann BL, 2000, J ATHL TRAINING, V35, P19; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Zeni JA, 2010, CLIN BIOMECH, V25, P383, DOI 10.1016/j.clinbiomech.2009.11.002; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	50	10	10	0	14	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUN	2017	52	6					518	525		10.4085/1062-6050-52.2.03			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EY7FM	WOS:000404154700005	28653870	Bronze, Green Published			2022-02-06	
J	Stekovic, S; Ruckenstuhl, C; Royer, P; Winkler-Hermaden, C; Carmona-Gutierrez, D; Frohlich, KU; Kroemer, G; Madeo, F				Stekovic, Slaven; Ruckenstuhl, Christoph; Royer, Phillip; Winkler-Hermaden, Christof; Carmona-Gutierrez, Didac; Frohlich, Kai-Uwe; Kroemer, Guido; Madeo, Frank			The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cells	MICROBIAL CELL			English	Article						TBI; traumatic brain injury; cell protection; cell stress; cell death; neuroprotection; progesterone; mitochondrial uncoupling	TRAUMATIC BRAIN-INJURY; SACCHAROMYCES-CEREVISIAE; REGULATES APOPTOSIS; HUMAN SPERMATOZOA; OXIDATIVE STRESS; CLINICAL-TRIAL; BUDDING YEAST; SMOOTH-MUSCLE; IN-VIVO; DEATH	The steroid hormone progesterone is not only a crucial sex hormone, but also serves as a neurosteroid, thus playing an important role in brain function. Epidemiological data suggest that progesterone improves the recovery of patients after traumatic brain injury. Brain injuries are often connected to elevated calcium spikes, reactive oxygen species (ROS) and programmed cell death affecting neurons. Here, we establish a yeast model to study progesterone-mediated cytoprotection. External supply of progesterone protected yeast cells from apoptosis-inducing stress stimuli and resulted in elevated mitochondrial oxygen uptake accompanied by a drop in ROS generation and ATP levels during chronological aging. In addition, cellular Ca2+ concentrations were reduced upon progesterone treatment, and this effect occurred independently of known Ca2+ transporters and mitochondrial respiration. All effects were also independent of Dap1, the yeast orthologue of the progesterone receptor. Altogether, our observations provide new insights into the cytoprotective effects of progesterone.	[Stekovic, Slaven; Ruckenstuhl, Christoph; Royer, Phillip; Winkler-Hermaden, Christof; Carmona-Gutierrez, Didac; Frohlich, Kai-Uwe; Madeo, Frank] Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, A-8010 Graz, Austria; [Madeo, Frank] BioTechMed Graz, Graz, Austria; [Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France; [Kroemer, Guido] INSERM, U1138, Paris, France; [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Kroemer, Guido] Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Karolinska Inst, S-17176 Stockholm, Sweden; [Ruckenstuhl, Christoph; Madeo, Frank] Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria		Stekovic, S; Ruckenstuhl, C (corresponding author), Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, A-8010 Graz, Austria.; Ruckenstuhl, C (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria.	ru.ruckenstuhl@uni-graz.at; frank.madeo@uni-graz.at	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; Madeo, Frank/0000-0002-5070-1329; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Ruckenstuhl, Christoph/0000-0002-4338-4679	Austrian Science Fund FWF (Austria)Austrian Science Fund (FWF) [P23490-B20, P29262, P24381, P29203, P27893, I1000]; SFB LipotoxGerman Research Foundation (DFG) [F3012]; BMWFW; Karl-Franzens University for grant 'Unkonventionelle Forschung'; DKplus Metabolic and Cardiovascular Diseases [W1226]; NAWI Graz; BioTechMed-Graz flagship project "EPIAge"; Ligue contre le Cancer Comite de Charente-Maritime; Agence National de la Recherche (ANR)-Projets blancsFrench National Research Agency (ANR); ANR under the frame of E-Rare-2French National Research Agency (ANR); ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC)Fondation ARC pour la Recherche sur le Cancer; Ceropole Ile-de-France; Fondation pour la Recherche Mdicale (FRM)Fondation pour la Recherche Medicale; European Commission (ArtForce)European CommissionEuropean Commission Joint Research Centre; European Research Council (ERC)European Research Council (ERC); Fondation Carrefour; LeDucq FoundationLeducq Foundation; LabEx Immuno-Oncology; Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI)	We thank Silvia Dichtinger for technical assistance. FM is grateful to the Austrian Science Fund FWF (Austria) for grants P23490-B20, P29262, P24381, P29203 P27893, I1000 and 'SFB Lipotox' (F3012), as well as to BMWFW and the Karl-Franzens University for grant 'Unkonventionelle Forschung' and grant DKplus Metabolic and Cardiovascular Diseases (W1226). We acknowledge support from NAWI Graz and the BioTechMed-Graz flagship project "EPIAge". GK is supported by the Ligue contre le Cancer Comite de Charente-Maritime (equipe labelisee); Agence National de la Recherche (ANR) -Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Ceropole Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno- Oncology; the RHU Torino Lumiere, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).	Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Amen T, 2016, MICROB CELL, V3, P97, DOI 10.15698/mic2016.03.482; Antonenko D, 2013, AM J SURG, V206, P845; Barbagallo M, 2001, HYPERTENSION, V37, P142, DOI 10.1161/01.HYP.37.1.142; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; BATRA S, 1986, EUR J PHARMACOL, V127, P37, DOI 10.1016/0014-2999(86)90203-7; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Bonaccorsi L, 1998, MOL HUM REPROD, V4, P259, DOI 10.1093/molehr/4.3.259; Bond ME, 2015, MICROB CELL, V2, P466, DOI 10.15698/mic2015.12.241; Braun RJ, 2015, MICROB CELL, V2, P136, DOI 10.15698/mic2015.04.199; Braun RJ, 2015, CELL REP, V10, P1557, DOI 10.1016/j.celrep.2015.02.009; Braun RJ, 2011, J BIOL CHEM, V286, P19958, DOI 10.1074/jbc.M110.194852; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carmona-Gutierrez D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.43; Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009; Carswell HVO, 1999, HYPERTENSION, V33, P681, DOI 10.1161/01.HYP.33.2.681; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Eisenberg T, 2010, APOPTOSIS, V15, P257, DOI 10.1007/s10495-009-0453-4; Galluzzi L, 2016, MICROB CELL, V3, P101, DOI 10.15698/mic2016.03.483; Gregor A, 1986, Przegl Lek, V43, P703; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; He Y, 2016, STEROIDS, V108, P118, DOI 10.1016/j.steroids.2016.02.006; Heinisch JJ, 2016, MICROB CELL, V3, DOI 10.15698/mic2016.04.489; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Kainz K, 2017, METHOD ENZYMOL, V588, P367, DOI 10.1016/bs.mie.2016.09.086; Li LF, 2014, J THEOR BIOL, V351, P58, DOI 10.1016/j.jtbi.2014.02.026; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Liu W., 2012, CONTROL CALCIUM YEAS, P95; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Menezes R, 2015, MICROB CELL, V2, P262, DOI 10.15698/mic2015.08.219; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ren Ziwen, 1992, Zhonghua Xinxueguanbing Zazhi, V20, P212; Rockenfeller P, 2010, CELL CYCLE, V9, P2836, DOI 10.4161/cc.9.14.12346; Rodriguez AM, 2002, CELL MOL LIFE SCI, V59, P1714, DOI 10.1007/PL00012499; Romarowski A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136085; Roussel D, 2002, J BIOENERG BIOMEMBR, V34, P165, DOI 10.1023/A:1016027302232; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; Ruth Wade, 1956, JBC, V220, P547; Shrestha A, 2015, MICROB CELL, V2, P458, DOI 10.15698/mic2015.12.243; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; TUBIANA N, 1986, BRIT J CANCER, V54, P501, DOI 10.1038/bjc.1986.203; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wu ZX, 2010, J GASTROEN HEPATOL, V25, P1838, DOI 10.1111/j.1440-1746.2010.06299.x; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zeng YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140624	71	10	10	0	8	SHARED SCIENCE PUBLISHERS OG	GRAZ	AM BLUMENHAG 25-4, GRAZ, 8010, AUSTRIA	2311-2638			MICROB CELL	Microb. Cell	JUN	2017	4	6					191	199		10.15698/mic2017.06.577			9	Cell Biology; Microbiology	Emerging Sources Citation Index (ESCI)	Cell Biology; Microbiology	EW8JI	WOS:000402764600002	28660203	Green Published, Green Submitted, gold			2022-02-06	
J	de Dhaem, OB; Barr, WB; Balcer, LJ; Galetta, SL; Minen, MT				de Dhaem, Olivia Begasse; Barr, William B.; Balcer, Laura J.; Galetta, Steven L.; Minen, Mia T.			Post-traumatic headache: the use of the sport concussion assessment tool (SCAT-3) as a predictor of post-concussion recovery	JOURNAL OF HEADACHE AND PAIN			English	Article						Evaluation; Post-traumatic headache; SCAT-3; Concussion screening; Symptom severity; Head injury	TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; PROLONGED RECOVERY; FOOTBALL PLAYERS; EPIDEMIOLOGY; SOMATIZATION; HISTORY; SCALE; RATES; PAIN	Background: Given that post-traumatic headache is one of the most prevalent and long-lasting post-concussion sequelae, causes significant morbidity, and might be associated with slower neurocognitive recovery, we sought to evaluate the use of concussion screening scores in a concussion clinic population to assess for post-traumatic headache. Methods: This is a retrospective cross-sectional study of 254 concussion patients from the New York University (NYU) Concussion Registry. Data on the headache characteristics, concussion mechanism, concussion screening scores were collected and analyzed. Results: 72% of the patients had post-traumatic headache. About half (56.3%) were women. The mean age was 35 (SD 16.2). 90 (35%) patients suffered from sport-related concussions (SRC). Daily post-traumatic headache patients had higher Sport Concussion Assessment Tool (SCAT)-3 symptom severity scores than the non-daily post-traumatic headache and the headache-free patients (50.2 [SD 28.2] vs. 33.1 [SD 27.5] vs. 21.6 SD23], p < 0.001). Patients with SRC had lower headache intensity (4.47 [SD 2.5] vs. 6.24 [SD 2.28], p < 0.001) and SCAT symptom severity scores (33.9 [SD 27.4] vs. 51.4 [SD 27.7], p < 0.001) than the other patients, but there were no differences in post-traumatic headache prevalence, frequency, and Standardized Assessment of Concussion (SAC) scores. Conclusion: The presence and frequency of post-traumatic headache are associated with the SCAT-3 symptom severity score, which is the most important predictor for post-concussion recovery. The SCAT-3 symptom severity score might be a useful tool to help characterize patients' post-traumatic headache.	[de Dhaem, Olivia Begasse] NYU, Langone Med Ctr, Dept Internal Med, New York, NY USA; [de Dhaem, Olivia Begasse] Columbia Univ, Dept Neurol, New York Presbyterian Hosp, New York, NY USA; [Barr, William B.; Balcer, Laura J.; Galetta, Steven L.; Minen, Mia T.] NYU, Langone Med Ctr, Dept Neurol, 240 East 38th St, New York, NY 10003 USA		Minen, MT (corresponding author), NYU, Langone Med Ctr, Dept Neurol, 240 East 38th St, New York, NY 10003 USA.	Minenmd@gmail.com					Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Conidi FX, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0570-z; Conidi FX, 2012, HEADACHE, V52, P15, DOI 10.1111/j.1526-4610.2012.02138.x; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0755-9; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loder E, 2012, CEPHALALGIA, V32, P179, DOI 10.1177/0333102411434812; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Russo A, 2014, NEUROL SCI, V35, pS153, DOI 10.1007/s10072-014-1758-9; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213; Zottoli TM, 2015, CLIN NEUROPSYCHOL, V29, P678, DOI 10.1080/13854046.2015.1062562	34	10	10	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	MAY 30	2017	18								60	10.1186/s10194-017-0767-5			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC9IA	WOS:000407153300002	28560540	gold, Green Published			2022-02-06	
J	Swiatkowski, P; Nikolaeva, I; Kumar, G; Zucco, A; Akum, BF; Patel, MV; D'Arcangelo, G; Firestein, BL				Swiatkowski, Przemyslaw; Nikolaeva, Ina; Kumar, Gaurav; Zucco, Avery; Akum, Barbara F.; Patel, Mihir V.; D'Arcangelo, Gabriella; Firestein, Bonnie L.			Role of Akt-independent mTORC1 and GSK3 beta signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; METHYL-D-ASPARTATE; MAMMALIAN TARGET; TUBEROUS SCLEROSIS; DENDRITIC SPINES; ISCHEMIC-STROKE; PHOSPHOLIPASE-D; RAPAMYCIN; KINASE	Glutamate-induced excitotoxicity, mediated by overstimulation of N-methyl-D-aspartate (NMDA) receptors, is a mechanism that causes secondary damage to neurons. The early phase of injury causes loss of dendritic spines and changes to synaptic activity. The phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway has been implicated in the modulation and regulation of synaptic strength, activity, maturation, and axonal regeneration. The present study focuses on the physiology and survival of neurons following manipulation of Akt and several downstream targets, such as GSK3 beta, FOXO1, and mTORC1, prior to NMDA-induced injury. Our analysis reveals that exposure to sublethal levels of NMDA does not alter phosphorylation of Akt, S6, and GSK3 beta at two and twenty four hours following injury. Electrophysiological recordings show that NMDA-induced injury causes a significant decrease in spontaneous excitatory postsynaptic currents at both two and twenty four hours, and this phenotype can be prevented by inhibiting mTORC1 or GSK3 beta, but not Akt. Additionally, inhibition of mTORC1 or GSK3 beta promotes neuronal survival following NMDA-induced injury. Thus, NMDA-induced excitotoxicity involves a mechanism that requires the permissive activity of mTORC1 and GSK3 beta, demonstrating the importance of these kinases in the neuronal response to injury.	[Swiatkowski, Przemyslaw; Nikolaeva, Ina; Kumar, Gaurav; Zucco, Avery; Akum, Barbara F.; Patel, Mihir V.; D'Arcangelo, Gabriella; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA; [Swiatkowski, Przemyslaw; Nikolaeva, Ina] Rutgers State Univ, Grad Program Mol Biosci, 604 Allison Rd, Piscataway, NJ 08854 USA; [Zucco, Avery; Patel, Mihir V.] Rutgers State Univ, Grad Program Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA		Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565; Patel, Mihir/0000-0002-9839-8357; D'Arcangelo, Gabriella/0000-0003-1575-1010; McEwan, Przemyslaw/0000-0002-7702-070X	New Jersey Commission on Brain Injury Research grant [CBIR12MIG011]; National Institutes of Health Biotechnology Training GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM008339-20]; New Jersey Commission on Brain Injury Research predoctoral fellowship [CBIR16FEL013, CBIR15FEL009]; Aresty Undergraduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER	This work was supported by New Jersey Commission on Brain Injury Research grant # CBIR12MIG011 (to B.L.F. and G.D.). P.S. was supported in part by National Institutes of Health Biotechnology Training Grant T32 GM008339-20 and by New Jersey Commission on Brain Injury Research predoctoral fellowship # CBIR16FEL013. G.K. received funding from the Aresty Undergraduate Research Fellowship. M.V.P. was supported in part by New Jersey Commission on Brain Injury Research predoctoral fellowship #CBIR15FEL009.	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Brown CE, 2008, NEUROSCIENTIST, V14, P139, DOI 10.1177/1073858407309854; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chen SZ, 2011, CANCER RES, V71, P6270, DOI 10.1158/0008-5472.CAN-11-0838; Chen X, 2016, SCI REP-UK, V6, DOI 10.1038/srep20196; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; COYLE JT, 1991, EPILEPSY RES, V10, P41, DOI 10.1016/0920-1211(91)90093-U; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dharaneeswaran H, 2014, CIRC RES, V115, P238, DOI 10.1161/CIRCRESAHA.115.303227; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Dzyubenko E, 2016, J NEUROSCI METH, V273, P149, DOI 10.1016/j.jneumeth.2016.09.001; EMERY DG, 1995, BRAIN RES, V692, P161, DOI 10.1016/0006-8993(95)00726-7; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gisselsson L, 2010, BRAIN RES, V1316, P92, DOI 10.1016/j.brainres.2009.11.087; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hasbani MJ, 2001, NEUROREPORT, V12, P2731, DOI 10.1097/00001756-200108280-00028; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Hernandez K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00006; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Jourdain P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21250; Kang WH, 2015, J NEUROTRAUM, V32, P1011, DOI 10.1089/neu.2014.3667; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kutzing Melinda K, 2010, J Vis Exp, DOI 10.3791/2354; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Mattson M P, 1989, Prog Clin Biol Res, V317, P333; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mego M, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.10.010; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Oki Y, 2015, BRIT J HAEMATOL, V171, P463, DOI 10.1111/bjh.13603; Otmakhov N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120881; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Piper M, 2015, NEURAL DEV, V10, DOI [10.1186/s13064-015-0031-0, 10.1186/s13064-015-0043-9]; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rose ME, 2002, BRAIN RES, V935, P40, DOI 10.1016/S0006-8993(02)02445-9; Rugo HS, 2016, ANN ONCOL, V27, P519, DOI 10.1093/annonc/mdv595; Sanchez-Perez AM, 2006, NEUROCHEM INT, V49, P351, DOI 10.1016/j.neuint.2006.02.005; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shi HR, 2008, J NEURAL TRANSM, V115, P879, DOI 10.1007/s00702-008-0021-z; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Szydlowski M, 2014, INT REV IMMUNOL, V33, P146, DOI 10.3109/08830185.2014.885022; Tseng CY, 2011, J NEUROSCI, V31, P15468, DOI 10.1523/JNEUROSCI.2442-11.2011; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zhang BY, 2014, BIOCHEM BIOPH RES CO, V443, P743, DOI 10.1016/j.bbrc.2013.12.037; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhao LR, 2005, BRAIN RES, V1054, P1, DOI 10.1016/j.brainres.2005.04.056; Zhu D, 2002, AMINO ACIDS, V23, P11, DOI 10.1007/s00726-001-0103-9; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	86	10	11	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 8	2017	7								1539	10.1038/s41598-017-01826-w			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU2QK	WOS:000400873800020	28484273	Green Published, gold			2022-02-06	
J	Alexander-Shani, R; Mreisat, A; Smeir, E; Gerstenblith, G; Stern, MD; Horowitz, M				Alexander-Shani, Rivka; Mreisat, Ahmad; Smeir, Elia; Gerstenblith, Gary; Stern, Michael D.; Horowitz, Michal			Long-term HIF-1 alpha transcriptional activation is essential for heat-acclimation-mediated cross tolerance: mitochondrial target genes	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						HIF-1 alpha; PDK1; COX4 isoforms; heat acclimation-mediated cross tolerance; heart; acriflavine	CYTOCHROME-C-OXIDASE; HYPOXIA-INDUCIBLE FACTOR-1; TRAUMATIC BRAIN-INJURY; UP-REGULATION; RAT HEARTS; HIF-1; EXPRESSION; INHIBITION; ADAPTATION; STRESS	An important adaptive feature of heat acclimation (HA) is the induction of cross tolerance against novel stressors (HACT) Reprogramming of gene expression leading to enhanced innate cytoprotective features by attenuating damage and/or enhancing the response of "help" signals plays a pivotal role. Hypoxiainducible factor-1 alpha (HIF-1 alpha), constitutively upregulated by HA (1 mo, 34(omicron)C), is a crucial transcription factor in this program, although its specific role is as yet unknown. By using a rat HA model, we studied the impact of disrupting HIF-1 alpha transcriptional activation [HIF-1 alpha : HIF-1 beta dimerization blockade by intraperitoneal acriflavine (4 mg/kg)] on its mitochondrial gene targets [phosphoinositide-dependent kinase-1 (PDK1), LON, and cyclooxygenase 4 (COX4) iso-forms] in the HA rat heart. Physiological measures of cardiac HACT were infarct size after ischemia-reperfusion and time to rigor contracture during hypoxia in cardiomyocytes. We show that HACT requires transcriptional activation of HIF-1 alpha throughout the course of HA and that this activation is accompanied by two metabolic switches: 1) profound upregulation of PDK1, which reduces pyruvate entry into the mitochondria, consequently increasing glycolytic lactate production; 2) remodeling of the COX4 isoform ratio, inducing hypoxic-tolerant COX4.2 dominance, and optimizing electron transfer and possibly ATP production during the ischemic and hypoxic insults. LON and COX4.2 transcript upregulation accompanied this shift. Loss of HACT despite elevated expression of the cytoprotective protein heat shock protein-72 concomitantly with disrupted HIF-1 alpha dimerization suggests that HIF-1 alpha is essential for HACT. The role of a PDK1 metabolic switch is well known in hypoxia acclimation but not in the HA model and its ischemic setting. Remodeling of COX4 isoforms by environmental acclimation is a novel finding.	[Alexander-Shani, Rivka; Mreisat, Ahmad; Smeir, Elia; Horowitz, Michal] Hebrew Univ Jerusalem, Fac Dent Med, Lab Environm Physiol, Jerusalem, Israel; [Gerstenblith, Gary] Johns Hopkins Univ Hosp, Cardiol, Baltimore, MD 21287 USA; [Stern, Michael D.] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA		Horowitz, M (corresponding author), Hebrew Univ Jerusalem, Lab Environm Physiol, IL-91120 Jerusalem, Israel.	m.horowitz@mail.huji.ac.il			U.S.-Israel Binational Fund BSF Grant [2009-499]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000844] Funding Source: NIH RePORTER	This study was supported by the U.S.-Israel Binational Fund BSF Grant 2009-499 and (in part) by the Intramural Program of the National Institute on Aging.	Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; Assayag M, 2012, AM J PHYSIOL-REG I, V303, pR870, DOI 10.1152/ajpregu.00155.2012; Assayag M, 2010, CELL STRESS CHAPERON, V15, P651, DOI 10.1007/s12192-010-0178-x; Cai ZQ, 2013, P NATL ACAD SCI USA, V110, P17462, DOI 10.1073/pnas.1317158110; Cerretelli P, 2011, EUR J APPL PHYSIOL, V111, P421, DOI 10.1007/s00421-010-1399-5; Cohen O, 2007, J APPL PHYSIOL, V103, P266, DOI 10.1152/japplphysiol.01351.2006; Commission for Thermal Physiology of the International Union of Physiological Sciences (IUPS Thermal Commission), 2001, JPN J PHYSL, V51, P245; Eynan M, 2002, J APPL PHYSIOL, V93, P2095, DOI 10.1152/japplphysiol.00304.2002; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gray CC, 1999, INT J BIOCHEM CELL B, V31, P559, DOI 10.1016/S1357-2725(99)00004-7; Griffiths EJ, 1997, CELL CALCIUM, V21, P321, DOI 10.1016/S0143-4160(97)90120-2; Honma Y, 2003, EXP GERONTOL, V38, P299, DOI 10.1016/S0531-5565(02)00199-7; Horowitz M, 2003, NEWS PHYSIOL SCI, V18, P215, DOI 10.1152/nips.01453.2003; HOROWITZ M, 1976, PFLUG ARCH EUR J PHY, V366, P173, DOI 10.1007/BF00585874; Horowitz M, 1985, J APPL PHYSL 1985, V120, P702, DOI [10.1152/japplphysiol.00552.2015, DOI 10.1152/JAPPLPHYSI0L.00552.2015]; Horowitz M, 2006, APS INT M; Horowitz M, 2007, PROG BRAIN RES, V162, P373, DOI 10.1016/S0079-6123(06)62018-9; Horowitz M, 2014, COMPR PHYSIOL, V4, P199, DOI 10.1002/cphy.c130025; Horowitz Michal, 2010, Front Biosci (Schol Ed), V2, P1068; Horowitz M, 2010, ANN NY ACAD SCI, V1188, P199, DOI 10.1111/j.1749-6632.2009.05101.x; Jian BX, 2010, SHOCK, V34, P169, DOI 10.1097/SHK.0b013e3181cffe7d; Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kocha KM, 2015, AM J PHYSIOL-REG I, V308, pR305, DOI 10.1152/ajpregu.00281.2014; Kodesh E, 2010, MED SCI SPORTS EXERC, V42, P40; Kodesh E, 2011, AM J PHYSIOL-REG I, V301, pR1786, DOI 10.1152/ajpregu.00465.2011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lennon SL, 2004, J APPL PHYSIOL, V96, P1299, DOI 10.1152/japplphysiol.00920.2003; Li P, 2015, ONCOL REP, V33, P3099, DOI 10.3892/or.2015.3911; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Maloyan A, 1999, AM J PHYSIOL-REG I, V276, pR1506, DOI 10.1152/ajpregu.1999.276.5.R1506; Maloyan A, 2002, J APPL PHYSIOL, V93, P107, DOI 10.1152/japplphysiol.01122.2001; Ngo JK, 2013, REDOX BIOL, V1, P258, DOI 10.1016/j.redox.2013.01.015; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Ong SG, 2014, CARDIOVASC RES, V104, P24, DOI 10.1093/cvr/cvu172; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; RAY DE, 1968, GROWTH, V32, P1; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Shay JES, 2014, CARCINOGENESIS, V35, P1067, DOI 10.1093/carcin/bgu004; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; STERN MD, 1988, P NATL ACAD SCI USA, V85, P6954, DOI 10.1073/pnas.85.18.6954; Sugimoto N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01763; Tetievsky A, 2008, PHYSIOL GENOMICS, V34, P78, DOI 10.1152/physiolgenomics.00215.2007; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Yacobi Assaf, 2014, Temperature (Austin), V1, P57, DOI 10.4161/temp.29719	49	10	10	2	4	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	MAY 1	2017	312	5					R753	R762		10.1152/ajpregu.00461.2016			10	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	EW3NS	WOS:000402406100012	28274939	Green Published, Bronze			2022-02-06	
J	Che, W; Guo, YJ; Yang, WJ; Zheng, P; Zeng, JS; Tong, WS				Che, Wei; Guo, Yijun; Yang, Wenjin; Zheng, Ping; Zeng, Jinsong; Tong, Wusong			Involvement of autophagy in connexin 40 reduction in the late phase of traumatic brain injury in rats	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Autophagy; Connexin; Gap junction; Neuron degeneration	GAP-JUNCTIONS; NEURONAL INJURY; NERVOUS-SYSTEM; CELL-DEATH; IN-VIVO; MICE; ISCHEMIA; DEGRADATION; CONTRIBUTES; ASTROCYTES	Brain trauma can activate an attenuation of connexin gap junction that is implicated in neuronal injury, but the underlying cellular mechanisms remain incompletely understood. Here, we aimed to study whether autophagy, a stress-response process for recycling of intracellular proteins and organelles, is involved in the reduction of connexin 40 (Cx40) during the late phase of traumatic brain injury (TBI). In a rat model of TBI induced by controlled cortical impact (CCI), we found that Cx40 protein in the brain started to decline at post-surgery day 2 and the decrease continued for up to day 6. Such a relatively late response of Cx40 following TBI was found to be coincident with the substantial induction of neuron degeneration and autophagy, elevated autophagic vacuole numbers, and induced LC3-II and p62 levels. At day 4 post-injury, the extent of co-localization between LC3 and Cx40 was greatly enhanced, and the reduction of Cx40 was rescued by the administration of an autophagy inhibitor chloroquine. Thus, autophagy stimulated in the injured brains may act as a suppressing mechanism to decrease gap junction protein Cx40 in the late phase of TBI.	[Che, Wei; Guo, Yijun; Yang, Wenjin; Zheng, Ping; Zeng, Jinsong; Tong, Wusong] Peoples Hosp, Pudong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China		Tong, WS (corresponding author), Peoples Hosp, Pudong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China.	wstong3@sina.com		Chen, Wei/0000-0001-7438-3241; Tong, Wusong/0000-0003-1072-7310	Outstanding Medical Talent Training Project of Health System of Shanghai Pudong New Area [PWRq2015-16]; Key Construction Specialty Project of Health and Family Planning Commission of Pudong New Area, Shanghai [PWZz2013-13]; Science and Technology Committee Project of Pudong New Area, Shanghai [PKJ2016-Y31]	This work was funded by the Outstanding Medical Talent Training Project of Health System of Shanghai Pudong New Area (PWRq2015-16), Key Construction Specialty Project of Health and Family Planning Commission of Pudong New Area, Shanghai (PWZz2013-13), The Science and Technology Committee Project of Pudong New Area, Shanghai(PKJ2016-Y31).	Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Chen W, 2016, CELL MOL NEUROBIOL, V36, P1057, DOI 10.1007/s10571-015-0299-y; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Hanstein R, 2009, MOL ENDOCRINOL, V23, P1479, DOI 10.1210/me.2009-0022; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iacobas DA, 2004, NEUROCHEM INT, V45, P243, DOI 10.1016/j.neuint.2003.12.008; Iyyathurai J, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0093-9; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Martin PEM, 2005, BRIT J PHARMACOL, V144, P617, DOI 10.1038/sj.bjp.0706102; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Schulz R, 2015, PHARMACOL THERAPEUT, V153, P90, DOI 10.1016/j.pharmthera.2015.06.005; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Talhouk RS, 2008, PROG NEUROBIOL, V84, P57, DOI 10.1016/j.pneurobio.2007.10.001; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Velazquez JLP, 2003, NEUROSCIENTIST, V9, P5, DOI 10.1177/1073858402239586; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	40	10	10	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAY	2017	131						100	106		10.1016/j.brainresbull.2017.03.014			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EW2UX	WOS:000402352600013	28373150				2022-02-06	
J	Gaetz, M				Gaetz, Michael			The multi-factorial origins of Chronic Traumatic Encephalopathy (CTE) symptomology in post-career athletes: The athlete post-career adjustment (AP-CA) model	MEDICAL HYPOTHESES			English	Article						Chronic Traumatic Encephalopathy; Concussion; Athletic identity; Career transition stress; Chronic pain; Substance abuse; Opioid; Androgenic anabolic steroid	ANABOLIC-ANDROGENIC STEROIDS; LONG-TERM CONSEQUENCES; CHRONIC PAIN; SUICIDAL IDEATION; BRAIN-INJURY; NEURODEGENERATIVE DISORDERS; RETIREMENT EXPERIENCES; SEXUAL ORIENTATION; GENDER IDENTITY; POTENTIAL LATE	CTE has two prominent components: the pathophysiology that is detected in the brain postmortem and the symptomology that is present in the interval between retirement and end of life. CTE symptomology has been noted to include memory difficulties, aggression, depression, explosivity, and executive dysfunction at early stages progressing to problems with attention, mood swings, visuospatial difficulties, confusion, progressive dementia, and suicidality (e.g. McKee et al. (2012), Omalu et al. (2010a-c), McKee et al, (2009)). There are a number of assumptions embedded within the current CTE literature: The first is the assumption that CTE symptomology reported by athletes and their families is the product of the pathophysiology change detected post-mortem (e.g. McKee et al. (2009)). At present, there is little scientific evidence to suggest that all CTE symptomology is the product of CTE pathophysiology. It has been assumed that CTE pathophysiology causes CTE symptomology (Meehan et al. (2015), Iverson et al. (2016)) but this link has never been scientifically validated. The purpose of the present work is to provide a multi-factorial theoretical framework to account for the symptomology reported by some athletes who sustain neurotrauma during their careers that will lead to a more systematic approach to understanding post-career symptomology. There is significant overlap between the case reports of athletes with post-mortem diagnoses of CTE, and symptom profiles of those with a history of substance use, chronic pain, and athlete career transition stress. The athlete post-career adjustment (AP-CA) model is intended to explain some of the symptoms that athletes experience at the end of their careers or during retirement. The AP-CA model consists of four elements: neurotrauma, chronic pain, substance use, and career transition stress. Based on the existing literature, it is clear that any one of the four elements of the AP-CA model can account for a significant number of CTE symptoms. In addition, depression can be a chronic lifelong co-morbid condition that may be present prior to an athletic career, or may be developed secondary to any of the model elements as shown in Fig. 1. Notably, neurotrauma is a necessary, but not a sufficient condition, for the development of CTE symptomology. (C) 2017 Elsevier Ltd. All rights reserved.	[Gaetz, Michael] Univ Fraser Valley, Fac Hlth Sci, Chilliwack, BC, Canada		Gaetz, M (corresponding author), 45190 Caen Rd, Chilliwack, BC V2R ON3, Canada.	michael.gaetz@ufv.ca					Alam A, 2016, CAN J ANESTH, V63, P61, DOI 10.1007/s12630-015-0520-y; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; Armstrong RA, 2016, NEUROPATHOL APPL NEU; Azad TD, 2016, WORLD NEUROSURG, V515, pe11; Bailes Julian E, 2015, Neurosurgery, V62 Suppl 1, P15, DOI 10.1227/NEU.0000000000000811; BAILLIE PHF, 1993, COUNS PSYCHOL, V21, P399, DOI 10.1177/0011000093213004; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1080/j.1440-1614.2000.00691.x; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blair J, 2015, THE CLOSER; BLONSTEIN JL, 1957, BRIT MED J, V1, P362, DOI 10.1136/bmj.1.5015.362; Blosnich JR, 2013, AM J PUBLIC HEALTH, V103, pE27, DOI 10.2105/AJPH.2013.301507; Braden JB, 2008, J PAIN, V9, P1106, DOI 10.1016/j.jpain.2008.06.004; BREWER BW, 1993, J PERS, V61, P343, DOI 10.1111/j.1467-6494.1993.tb00284.x; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; Brewin CR, 2011, PSYCHOL MED, V41, P1733, DOI 10.1017/S003329171000231X; Brezo J, 2006, PSYCHOL MED, V36, P191, DOI 10.1017/S0033291705006719; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Cadet JL, 2016, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00189; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Casson Ira R, 2006, Neurosurgery, V59, pE1152; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Castellani RJ, 2015, LAB INVEST, V95, P576, DOI 10.1038/labinvest.2015.54; Cheatle MD, 2011, PAIN MED, V12, pS43, DOI 10.1111/j.1526-4637.2011.01131.x; Chen CY, 2009, CURR OPIN PSYCHIATR, V22, P287, DOI 10.1097/YCO.0b013e32832a2349; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Coakley JJ, 1983, QUEST, V35, P1, DOI DOI 10.1080/00336297.1983.10483777; Cobaugh DJ, 2014, AM J HEALTH-SYST PH, V71, P1539, DOI 10.2146/ajhp140157; Cohen T, 2011, 3 HOCKEY ENFORCERS Y; Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cosh S, 2015, PSYCHOL SPORT EXERC, V19, P33, DOI 10.1016/j.psychsport.2015.02.006; Cosh S, 2013, AUST J PSYCHOL, V65, P89, DOI 10.1111/j.1742-9536.2012.00060.x; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Cunningham RL, 2013, HORM BEHAV, V64, P350, DOI 10.1016/j.yhbeh.2012.12.009; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Dhingra L, 2015, PAIN MED, V16, pS37, DOI 10.1111/pme.12912; Dubovsky AN, 2012, PSYCHOSOMATICS, V53, P103, DOI 10.1016/j.psym.2011.12.007; Edlow BL, 2015, NEUROLOGY, V85, P1442, DOI 10.1212/WNL.0000000000001902; Ersche KD, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.58; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Fein G, 2015, NEUROPSYCHOL REV, V25, P456, DOI 10.1007/s11065-015-9304-y; Frank D., 2016, ATHNET          0721; Fredericks Carolyn A, 2015, Neurol Clin Pract, V5, P475; Galgano MA, 2016, CUREUS, V8, DOI 10.7759/cureus.532; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Garland EL, 2013, NEUROSCI BIOBEHAV R, V37, P2597, DOI 10.1016/j.neubiorev.2013.08.006; Garland EL, 2012, PRIMARY CARE, V39, P561, DOI 10.1016/j.pop.2012.06.013; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gearing B, 1999, J AGING STUD, V13, P43, DOI 10.1016/S0890-4065(99)80005-X; Griffith J, 2011, INT REV PSYCHIATR, V23, P181, DOI 10.3109/09540261.2010.541904; Gronbladh A., 2016, BRAIN RES B; Grove JR, 1997, J APPL SPORT PSYCHOL, V9, P191, DOI 10.1080/10413209708406481; Gudin JA, 2015, PAIN MED, V16, pS9, DOI 10.1111/pme.12926; Hallberg M, 2011, MINI-REV MED CHEM, V11, P399, DOI 10.2174/138955711795445961; Harped M, 2016, EXP OPIN DRUG SAFETY; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hogan A., 2012, Journal of Rural Social Sciences (JRSS), V27, P118; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jarcho JM, 2012, PAIN, V153, P744, DOI 10.1016/j.pain.2012.01.002; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; Kanayama G, 2012, CURR OPIN ENDOCRINOL, V19, P211, DOI 10.1097/MED.0b013e3283524008; Kanayama G, 2010, DRUG ALCOHOL DEPEN, V109, P6, DOI 10.1016/j.drugalcdep.2010.01.011; Kovac JR, 2015, ANDROLOGIA, V47, P872, DOI 10.1111/and.12340; Kroger J, 2004, ADOLES SOC, P1, DOI 10.4324/9780203346860; Lally P, 2007, PSYCHOL SPORT EXERC, V8, P85, DOI 10.1016/j.psychsport.2006.03.003; Lamis DA, SUICIDE PROFESSIONAL, P74; Lane JC, 2000, SEMIN NEUROL, V20, P195, DOI 10.1055/s-2000-9828; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lavallee D, 2007, PSYCHOL SPORT EXERC, V8, P119, DOI 10.1016/j.psychsport.2006.05.003; Lehman E.J., 2016, AM J SPORTS MED; Leite-Almeida H, 2015, MOD TR PHARMACOPSYCH, V30, P1, DOI 10.1159/000435929; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Liu MG, 2014, PROG NEUROBIOL, V116, P13, DOI 10.1016/j.pneurobio.2014.01.003; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Magowan A., 2015, BBC SPORT       1222; Manetti L, 2014, J ENDOCRINOL INVEST, V37, P701, DOI 10.1007/s40618-014-0091-8; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; Martin LA, 2014, J APPL SPORT PSYCHOL, V26, P96, DOI 10.1080/10413200.2013.798371; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCarthy TC, 2015, NEWSDAY; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mhillaj E, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00295; Miczek KA, 2015, ANN NY ACAD SCI, V1349, P96, DOI 10.1111/nyas.12862; Miller KE, 2009, SOCIOL SPORT J, V26, P335, DOI 10.1123/ssj.26.2.335; Miron P., 2010, TIMISOARA PHYS ED RE, V3, P7; Montenigro P. H., 2016, J NEUROTRAUMA; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moon K, 2016, WORLD NEUROSURG, V89, P720, DOI 10.1016/j.wneu.2016.03.073; Moriarty O, 2014, CURR OPIN SUPPORT PA, V8, P130, DOI 10.1097/SPC.0000000000000054; Murphy GM, 1996, SPORT PSYCHOL, V10, P239, DOI 10.1123/tsp.10.3.239; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Nes LS, 2009, ANN BEHAV MED, V37, P173, DOI 10.1007/s12160-009-9096-5; Oberlander JG, 2012, J NEUROENDOCRINOL, V24, P202, DOI 10.1111/j.1365-2826.2011.02151.x; Ogilvie BC, 1987, SPORT PSYCHOL PSYCHO, P213; Oliffe JL, 2012, SOC SCI MED, V74, P506, DOI 10.1016/j.socscimed.2010.03.057; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128; Ortinski PI, 2014, MOL NEUROBIOL, V50, P494, DOI 10.1007/s12035-014-8636-6; Park S, 2013, INT REV SPORT EXER P, V6, P22, DOI 10.1080/1750984X.2012.687053; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Parrott AC, 2012, HUM PSYCHOPHARM CLIN, V27, P209, DOI 10.1002/hup.1271; Passmore Peter, 2014, J Pain Palliat Care Pharmacother, V28, P305, DOI 10.3109/15360288.2014.941136; Piacentino D, 2015, CURR NEUROPHARMACOL, V13, P101, DOI 10.2174/1570159X13666141210222725; Pieretti S, 2013, MED SCI SPORT EXER, V45, P29, DOI 10.1249/MSS.0b013e31826c60ea; Potvin S, 2014, J ADDICT MED, V8, P368, DOI 10.1097/ADM.0000000000000066; PUVENNA V, BRAIN RES, V1630, P225, DOI DOI 10.1016/J.BRAINRES..2015.11.007; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Ramirez S, 2016, AM J THER, P1; Ray-Sannerud B. N., 2015, PSYCHOL SEX ORIENTAT, V2, P130, DOI DOI 10.1037/SGD0000096; Renaud J, 2010, CAN J PSYCHIAT, V55, P29, DOI 10.1177/070674371005500105; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rousey R, 2016, THE ELLEN SHOW; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schmidt KA, 2015, J SOCIOL INTEGR RELI, V5, P38; Silva C., 2015, PSYCHOL SEX ORIENTAT, V2, P22, DOI [10.1037/sgd0000086, DOI 10.1037/SGD0000086]; Simet SM, 2015, ALCOHOL RES-CURR REV, V37, P199; Spronk DB, 2013, NEUROSCI BIOBEHAV R, V37, P1838, DOI 10.1016/j.neubiorev.2013.07.003; Stambulova N, 2009, INT J SPORT EXERC PS, V7, P395, DOI 10.1080/1612197X.2009.9671916; Stannard C, 2016, CURR OPIN SUPPORT PA, V10, P129, DOI 10.1097/SPC.0000000000000203; Steiger B, 2016, PHYSICIAN LEADERSH J; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Stier J., 2007, International Review for the Sociology of Sport, V42, P99, DOI 10.1177/1012690207081830; Stone DM, 2014, AM J PUBLIC HEALTH, V104, P262, DOI 10.2105/AJPH.2013.301383; SU TP, 1993, JAMA-J AM MED ASSOC, V269, P2760, DOI 10.1001/jama.269.21.2760; Sugar M, 2004, ADOLESCENT PSYCHIAT, V28, P279; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Tangen S, 2014, EUR J ADAPTED PHYS A, V7, P3; Tarazi A, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0648-3; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; Trantham-Davidson H, 2015, ALCOHOL, V49, P773, DOI 10.1016/j.alcohol.2015.09.001; Van Orden KA, 2008, SUICIDE LIFE-THREAT, V38, P427, DOI 10.1521/suli.2008.38.4.427; Walker RL, 2008, CULT DIVERS ETHN MIN, V14, P75, DOI 10.1037/1099-9809.14.1.75; Wallin KG, 2015, EUR NEUROPSYCHOPHARM, V25, P583, DOI 10.1016/j.euroneuro.2015.01.002; Warriner K, 2008, J APPL SPORT PSYCHOL, V20, P301, DOI 10.1080/10413200801998564; Webb W. M., 1998, Journal of Sport Behavior, V21, P338; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; WERTHNER P, 1986, INT J SPORT PSYCHOL, V17, P337; Westergaard ML, 2015, EUR J CLIN PHARMACOL, V71, P851, DOI 10.1007/s00228-015-1858-3; Wippert PM, 2008, J CLIN SPORT PSYCHOL, V2, P1, DOI 10.1123/jcsp.2.1.1; WOLKOWITZ OM, 1994, PSYCHONEUROENDOCRINO, V19, P233, DOI 10.1016/0306-4530(94)90064-7; WOOTEN HR, 1994, J EMPLOYMENT COUNS, V31, P2, DOI 10.1002/j.2161-1920.1994.tb00406.x; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; Wylleman P, 2004, PSYCHOL SPORT EXERC, V5, P7, DOI 10.1016/S1469-0292(02)00049-3; Yang X, 2016, NEUROSCI BIOBEHAV R, V66, P92, DOI 10.1016/j.neubiorev.2016.03.034; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	168	10	10	2	47	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAY	2017	102						130	143		10.1016/j.mehy.2017.03.023			14	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	EW0ZL	WOS:000402219600029	28478818				2022-02-06	
J	Jin, YB; Hua, C; Hu, XJ; Chen, H; Ma, G; Zou, Y; Chen, B; Lyu, D; Tremp, M; Lin, XX				Jin, Yunbo; Hua, Chen; Hu, Xiaojie; Chen, Hui; Ma, Gang; Zou, Yun; Chen, Bin; Lyu, Dongze; Tremp, Mathias; Lin, Xiaoxi			Microsurgical Replantation of Total Avulsed Scalp: Extending the Limits	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Ectopic implantation; replantation; scalp; the middle temporal vein	MIDDLE TEMPORAL VEIN; RECIPIENT VESSEL; SKULL-BASE; RECONSTRUCTION; ANASTOMOSES; AVULSIONS; ANATOMY; ARTERY	Background: Avulsion of the scalp is a rare but severe trauma and challenging to the reconstructive surgeon. It poses not only physical concussion but also significant persisting psychological distress to the patients. Methods: Medical records from 5 patients who suffered scalp avulsion were reviewed retrospectively. The following data and methods were assessed: age, number of vessels repaired, method of replantation, vein grafts required, blood transfusion, ischemia time, total operating time, and percentage of scalp survival. Results: In 4 patients, the replantation was performed at the anatomic site. Two arteries and 2 veins were anastomosed in 2 patients; a single artery and a single vein were anastomosed in 2 patients. The middle temporal vein was chosen for anastomosis as a recipient vessel in 2 patients. In the fifth patient with simultaneous cervical fracture that makes primarily replantation technically not possible, the scalp was implanted ectopically in the forearm for the purpose of secondary replantation at the anatomic site. After a mean follow-up of 22.6 months (range 13-29 months), 4 of 5 patients exhibited successful survival of the replanted scalp. Conclusions: The success of scalp replantation is determined by a comprehensive management of the trauma and well-trained microsurgical technique. The middle temporal vein can be used as a reliable alternative recipient vessel for microvascular anastomosis when replanting the avulsed scalp. In patients in whom primary replantation is not possible, temporary ectopic implantation of the avulsed scalp and anatomic replantation at a second stage is considerable.	[Jin, Yunbo; Hua, Chen; Hu, Xiaojie; Chen, Hui; Ma, Gang; Zou, Yun; Chen, Bin; Lyu, Dongze; Lin, Xiaoxi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China; [Tremp, Mathias] Univ Hosp Basel, Dept Plast Reconstruct Aesthet & Hand Surg, Basel, Switzerland		Lin, XX (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	linxiaoxi@126.com	Tremp, Mathias/O-3468-2015; Tremp, Mathias/AAR-7304-2021	Tremp, Mathias/0000-0001-6593-9690; Tremp, Mathias/0000-0001-6593-9690; Lyu, Dongze/0000-0002-7546-4745			BUNCKE HJ, 1978, PLAST RECONSTR SURG, V61, P666, DOI 10.1097/00006534-197805000-00002; Cho BC, 2000, ANN PLAS SURG, V44, P361, DOI 10.1097/00000637-200044040-00002; Davison SP, 2005, PLAST RECONSTR SURG, V116, P1181, DOI 10.1097/01.prs.0000183302.24571.fc; Graf P, 1996, BRIT J PLAST SURG, V49, P174, DOI 10.1016/S0007-1226(96)90221-0; HENDERSON HP, 1983, BRIT J PLAST SURG, V36, P235, DOI 10.1016/0007-1226(83)90099-1; HOROVITZ IL, 1964, LANCET, V2, P939; Imanishi N, 2002, PLAST RECONSTR SURG, V109, P2197, DOI 10.1097/00006534-200206000-00003; KAIXIANG C, 1996, PLAST RECONSTR SURG, V97, P1099; Kim EK, 2012, J CRANIOFAC SURG, V23, P1428, DOI 10.1097/SCS.0b013e31825e3a94; Liu TY, 2009, J CRANIOFAC SURG, V20, P81, DOI 10.1097/SCS.0b013e3181843326; MILLER GDH, 1976, PLAST RECONSTR SURG, V58, P133, DOI 10.1097/00006534-197608000-00001; Mowlavi A, 2004, PLAST RECONSTR SURG, V113, P1573, DOI 10.1097/01.PRS.0000117187.36061.BD; Nasir S, 2015, J CRANIOFAC SURG, V26, P1192, DOI 10.1097/SCS.0000000000001646; Nguyen HH, 2012, J PLAST RECONSTR AES, V65, P1639, DOI 10.1016/j.bjps.2012.06.001; NUMMI P, 1971, Scandinavian Journal of Plastic and Reconstructive Surgery, V5, P67; Plant MA, 2010, CAN J PLAST SURG, V18, P112; Sabapathy SR, 2006, J PLAST RECONSTR AES, V59, P2, DOI 10.1016/j.bjps.2005.04.002; Sanger JR, 2010, J PLAST RECONSTR AES, V63, pE23, DOI 10.1016/j.bjps.2009.03.014; Ueda K, 2000, PLAST RECONSTR SURG, V106, P1651, DOI 10.1097/00006534-200012000-00041; Xu H, 2016, MICROSURGERY; Yano T, 2014, PLAST RECONSTR SURG, V134, p92E, DOI 10.1097/PRS.0000000000000283; Yano T, 2012, ANN PLAS SURG, V68, P286, DOI 10.1097/SAP.0b013e3182198c55; Yin JW, 2008, J TRAUMA, V64, P796, DOI 10.1097/TA.0b013e3180341fdb	23	10	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2017	28	3					670	674		10.1097/SCS.0000000000003487			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ET9TA	WOS:000400649800022	28468146				2022-02-06	
J	King, PR; Donnelly, KT; Warner, G; Wade, M; Pigeon, WR				King, Paul R.; Donnelly, Kerry T.; Warner, Gary; Wade, Michael; Pigeon, Wilfred R.			The natural history of sleep disturbance among OEF/OIF veterans with TBI and PTSD and the role of proxy variables in its measurement	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Insomnia; Mild traumatic brain injury; Post-traumatic stress disorder; Sleep	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; INSOMNIA; SYMPTOMS; PREVALENCE; VALIDATION; SEVERITY; LIFE	Objective: Sleep disturbance crosscuts post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Though previous cross-sectional findings demonstrate a compounding effect of PTSD and TBI comorbidity, relatively little is known about the longitudinal trajectory of sleep-related complaints in veterans with TBI history and current PTSD symptoms. In this study, we explored patterns and predictors of sleep complaints in a sample of combat veterans with and without TBI and PTSD. Methods: Secondary analysis of data gathered during a longitudinal study of U.S. veterans of Operations Enduring and Iraqi Freedom (OEF/OIF) with and without TBI. Data from a subsample of 291 participants with sleep self-report data were analyzed using multinomial logistic regression logit testing and linear mixed models. Results: Over an 18-month period, we observed an average 23-28% reduction in sleep symptoms in our sample as measured by two proxy scales, with the bulk of change (12-14% overall reduction) detected at the first six-month follow-up assessment. TBI history emerged, overall, as the most prominent predictor of worse general sleep symptoms, though baseline PTSD and pain status also demonstrated an association with worse sleep symptoms. Conclusion: Whereas changes in PTSD symptoms over time were associated with worsening sleep symptoms, improvement in sleep reports was most consistently predicted by the passage of time. Our data also provide preliminary support for using three-to-four core items (i.e., trouble sleeping, changes in sleep, fatigue, and nightmares) to screen for sleep complaints in veterans with TBI and PTSD and/or track sleep-related outcomes.	[King, Paul R.] VA Western New York Healthcare Syst, Ctr Integrated Healthcare, Buffalo, NY USA; [King, Paul R.; Donnelly, Kerry T.] Univ Buffalo State Univ New York, Dept Counseling Sch & Educ Psychol, Buffalo, NY USA; [Donnelly, Kerry T.] VA Western New York Healthcare Syst, Behav Hlth Careline, Buffalo, NY USA; [Warner, Gary] Canandaigua VA Med Ctr, Behav Hlth Careline, Canandaigua, NY USA; [Wade, Michael] Syracuse VA Med Ctr, Ctr Integrated Healthcare, Syracuse, NY USA; [Pigeon, Wilfred R.] Canandaigua VA Med Ctr, VA Ctr Excellence Suicide Prevent, Canandaigua, NY USA; [Pigeon, Wilfred R.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA		King, PR (corresponding author), VA Western New York Healthcare Syst, VA Ctr Integrated Healthcare, 3495 Bailey Ave 116N, Buffalo, NY 14215 USA.	Paul.King2@va.gov; Kerry.Donnelly@va.gov; Gary.Warner@va.gov; Michael.Wade@va.gov; Wilfred.Pigeon2@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and DevelopmentUS Department of Veterans Affairs [VA HSR D SDR 06-162]	This research was funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development [VA HSR & D SDR 06-162]. Writing of this manuscript was supported with materials and resources provided by the VA Western New York Healthcare System, VA VISN 2 Center for Integrated Healthcare, VA Canandaigua Medical Center, and VA Center of Excellence for Suicide Prevention.	Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; Allison P.D., 2012, SAS GLOB FOR 2012 20; American Psychiatric Association, 2013, DIGN STAT MAN MENT D; [Anonymous], 2005, SLEEP, V28, P1049; Babor TF, 1992, ALCOHOL USE DISORDER; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bishop TM, 2013, MIL BEHAV HLTH, V1, P81; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Curran PJ, 2011, ANNU REV PSYCHOL, V62, P583, DOI 10.1146/annurev.psych.093008.100356; Defense Centers of Excellence and Defense and Veterans Brain Injury Center, 2014, MAN SLEEPN DIST FOLL; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hughes J, 2013, BEHAV SLEEP MED, V11, P258, DOI 10.1080/15402002.2012.683903; Leger D, 2012, SLEEP MED, V13, P43, DOI 10.1016/j.sleep.2011.03.020; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Mallery P., 2003, SPSS WINDOWS STEP ST, V4th; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; McCaffrey M., 1993, PAIN CLIN MANUAL NUR; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 1993, INSOMNIA PSYCHOL ASS; National Center for PTSD, 2012, US DEP VET AFF; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pietrzak RH, 2010, J PSYCHOSOM RES, V69, P441, DOI 10.1016/j.jpsychores.2010.07.002; Pigeon WR, 2014, ARCH SUICIDE RES, V18, P170, DOI 10.1080/13811118.2013.824837; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Strong J, 2014, HEALTH SOC WORK, V39, P17, DOI 10.1093/hsw/hlu002; Tanielian TL., 2008, RAND CORPORATION INV; Taylor DJ, 2016, SLEEP, V39, P1795, DOI 10.5665/sleep.6156; The management of post-traumatic stress Working Group, 2010, VA DOD CLIN PRACT GU; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Weathers F.W., 1993, 9 ANN C ISTSS; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	44	10	10	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	MAY	2017	96						60	66		10.1016/j.jpsychores.2017.03.012			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EW9PU	WOS:000402852500010	28545794				2022-02-06	
J	Koshida, S; Ishii, T; Matsuda, T; Hashimoto, T				Koshida, Sentaro; Ishii, Takanori; Matsuda, Tadamitsu; Hashimoto, Toshihiko			Biomechanics of judo backward breakfall for different throwing techniques in novice judokas	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						Biomechanics; injury and prevention; coaching	ICE HOCKEY; HEAD; INJURIES; CONCUSSION; PLAYERS	It is generally accepted that proper learning of the breakfall technique during early judo training is essential for attenuating the risk of judo-related head injury. Therefore, it is critical to understand the kinematics and head injury risks of breakfall motion to design a more safe and effective judo teaching paradigm that results in reduction of injury risk. We aimed to investigate the biomechanics of judo backward breakfalls by comparing osoto-gari and ouchi-gari in novice judokas. Twelve male novice judokas (age: 21.3 years, SD=0.6 years; height: 1.74m, SD=0.04m; body weight: 71.3, SD=6.4kg; body mass index: 23.5, SD=2.3) volunteered to participate in this study. The kinematic data of the breakfall motion for both osoto-gari and ouchi-gari were collected using a three-dimensional motion analysis technique (200Hz). We observed significant differences between the movement patterns for the two techniques, especially in the lower extremity movements. In addition, a significantly greater peak extension momentum (osoto-gari: 1.29, SD=0.23kgm(2)s(-1); ouchi-gari: 0.84, SD=0.29kgm(2)s(-1)) and lower head position along the vertical axis (osoto-gari: 0.18, SD=0.05m; ouchi-gari: 0.31, SD=0.08m) with a large effect size were found in the breakfall for osoto-gari. Our results suggest that a different paradigm is needed for effectively teaching each breakfall technique that will enable us to substantially lower the risk of judo-related head injuries in novice judokas.	[Koshida, Sentaro; Hashimoto, Toshihiko] Ryotokuji Univ, Fac Hlth Sci, 1-5-1 Akemi, Urayasu, Chiba 2798567, Japan; [Ishii, Takanori] Ryotokuji Univ, Ctr Liberal Arts Educ, Urayasu, Japan; [Matsuda, Tadamitsu] Uekusa Gakuen Univ, Fac Hlth Sci, Wakaba Ku, Chiba, Japan		Koshida, S (corresponding author), Ryotokuji Univ, Fac Hlth Sci, 1-5-1 Akemi, Urayasu, Chiba 2798567, Japan.	koshida@ryotokuji-u.ac.jp	Koshida, Sentaro/ABA-6877-2020; Koshida, Sentaro/AAP-2471-2020	Koshida, Sentaro/0000-0003-3592-1742; Ishii, Takanori/0000-0002-6626-9294			All Japan Judo Federation, 2015, JUD ANZ SHID JIK WO; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Cohen J., 2013, STAT POWER ANAL BEHA; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Hashimoto T, 2015, J SPORT SCI, V33, P1356, DOI 10.1080/02640414.2014.990482; Imamura Rodney, 2003, Sports Biomech, V2, P191, DOI 10.1080/14763140308522817; Kamitani T, 2013, AM J SPORT MED, V41, P1915, DOI 10.1177/0363546513490662; Kano J., 1994, KODOKAN JUDO ESSENTI; Koshida S, 2011, J SPORT MED PHYS FIT, V51, P357; Koshida S., 2016, J SPORTS SCI, V21, P1; Koshida S, 2014, ARCH BUDO, V10, P187; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; Kurabayashi J., 2003, J SOC BIOMECH, V27, P29, DOI [DOI 10.3951/S0BIM.27.29, 10.3951/sobim.27.29, DOI 10.3951/SOBIM.27.29]; Mackey AH, 2005, GAIT POSTURE, V22, P1, DOI 10.1016/j.gaitpost.2004.06.002; Magill R, 2011, MOTOR LEARNING CONTR; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Miyazaki S, 2012, TOKAI J SPORTS MED S, V24, P173; Murayama H, 2014, NEUROL MED-CHIR, V54, P374, DOI 10.2176/nmc.oa.2013-0227; Nagahiro Shinji, 2011, No Shinkei Geka, V39, P1139; Nambu S, 2014, CURR SPORT MED REP, V13, P11, DOI 10.1249/JSR.0000000000000024; Nishimura K, 1988, Neurol Med Chir (Tokyo), V28, P991, DOI 10.2176/nmc.28.991; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Schmidt R., 2011, MOTOR LEARNING PERFO; Serti H., 2012, J COMBAT SPORTS MART, V3, P59, DOI [10.5604/20815735.1047649, DOI 10.5604/20815735.1047649]; Sterkowicz S, 2013, ARCH BUDO, V9, P51, DOI 10.12659/AOB.883848; Tangi H. P., 1995, JAPAN J PHYS ED, V40, P161; Tirnery R. T., 2005, MED SCI SPORTS EXERC, V37, P272, DOI [10.1249/01.MSS.0000152734.47516.AA, DOI 10.1249/01.MSS.0000152734.47516.AA]	27	10	10	1	36	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.	MAY	2017	17	4					417	424		10.1080/17461391.2016.1268652			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ES4BR	WOS:000399474600007	28276914				2022-02-06	
J	Petersen, JA; Spiess, M; Curt, A; Weidner, N; Rupp, R; Abel, R; Schubert, M				Petersen, Jens A.; Spiess, Martina; Curt, Armin; Weidner, Norbert; Rupp, Ruediger; Abel, Rainer; Schubert, Martin		EM-SCI Study Grp	Upper Limb Recovery in Spinal Cord Injury: Involvement of Central and Peripheral Motor Pathways	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						spinal cord injury; mechanisms; rehabilitation; clinical neurophysiology	TRANSCRANIAL MAGNETIC STIMULATION; ONE-YEAR EVOLUTION; INDEPENDENCE MEASURE; F-WAVE; NEURON EXCITABILITY; EVOKED-POTENTIALS; BRAIN-STIMULATION; NERVE-CONDUCTION; IFCN COMMITTEE; PLASTICITY	Background and Objective. The course of central and peripheral motor recovery after cervical spinal cord injury (SCI) may be investigated by electrophysiological measures. The goal of this study was to compare the 2 over the first year after injury in relation to motor gains. Methods. Compound motor action potentials (CMAPs), motor-evoked potentials (MEPs), and F-waves were recorded from the abductor digiti minimi and CMAP and F-waves from abductor hallucis muscles in 305 patients at about 15 days, 1 month, 3 months, 6 months, and 12 months following an acute traumatic SCI. Results. The MEP amplitudes and F-wave persistences were lower with more severe sensorimotor impairment. They steadily increased in most subgroups within 6 months after SCI. The amplitude of the CMAPs was low for the first 3 months in the most severely affected participants. This was also found for CMAPs from tibial nerve originating well below the cervical lesion level. Improvement in neurophysiological parameters correlated with improved upper extremity motor scores. Conclusion. The results point to a systematic interrelation of corticospinal transmission, spinal motoneuron excitability, and its axon function, respectively. Electrophysiological correlates of neural excitability show distinct spatial and temporal interrelations within central and peripheral motor pathways following acute cervical SCI. A strong secondary deterioration within the peripheral motor system with incomplete or no recovery depends on anatomical distance caudal to lesion and on lesion severity. Electrophysiological assessments may increase the sensitivity of interventional studies in addition to clinical measures.	[Petersen, Jens A.] Univ Zurich Hosp, Zurich, Switzerland; [Petersen, Jens A.] Univ Zurich, Zurich, Switzerland; [Petersen, Jens A.; Spiess, Martina; Curt, Armin; Schubert, Martin; EM-SCI Study Grp] Univ Hosp Balgrist, Zurich, Switzerland; [Weidner, Norbert; Rupp, Ruediger] Univ Heidelberg Hosp, Heidelberg, Germany; [Abel, Rainer] Spinal Cord Injury Ctr, Bayreuth, Germany		Schubert, M (corresponding author), Univ Hosp Balgrist, Spinal Cord Injury Ctr, Forchstr 340, CH-8008 Zurich, Switzerland.	martin.schubert@balgrist.ch		Abel, Rainer/0000-0002-8328-8438	International Foundation for Research in Paraplegia	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding of this study was provided by the International Foundation for Research in Paraplegia.	Anderson K, 2008, J SPINAL CORD MED, V31, P133, DOI 10.1080/10790268.2008.11760704; Boland RA, 2011, BRAIN, V134, P495, DOI 10.1093/brain/awq289; Boland RA, 2009, CLIN NEUROPHYSIOL, V120, P204, DOI 10.1016/j.clinph.2008.10.009; Burns AS, 2007, MUSCLE NERVE, V35, P607, DOI 10.1002/mus.20738; Calancie B, 2005, CLIN NEUROPHYSIOL, V116, P75, DOI 10.1016/j.clinph.2004.07.018; Calancie B, 2001, J NEUROSURG, V95, P161, DOI 10.3171/spi.2001.95.2.0161; CARAMIA MD, 1991, ELECTROEN CLIN NEURO, V81, P243, DOI 10.1016/0168-5597(91)90009-M; Catz A, 2007, SPINAL CORD, V45, P275, DOI 10.1038/sj.sc.3101960; Cros D, 1993, Adv Neurol, V63, P179; Curra A, 2002, NEUROLOGY, V59, P1851, DOI 10.1212/01.WNL.0000038744.30298.D4; Curt A, 1999, SPINAL CORD, V37, P157, DOI 10.1038/sj.sc.3100809; Curt A, 1996, NEUROREHABILITATION, V7, P165, DOI 10.3233/NRE-1996-7302; Curt A, 1997, ELECTROMYOGR MOTOR C, V105, P189, DOI 10.1016/S0924-980X(97)96626-1; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Drory V E, 1993, Electromyogr Clin Neurophysiol, V33, P441; Eccles JC, 1937, J PHYSIOL, V89, P45; FISHER MA, 1978, NEUROLOGY, V28, P1265, DOI 10.1212/WNL.28.12.1265; Fisher MA, 2007, THESCIENTIFICWORLDJO, V7, P144, DOI 10.1100/tsw.2007.49; Gorassini MA, 2004, BRAIN, V127, P2247, DOI 10.1093/brain/awh243; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hara Y, 2004, CLIN NEUROPHYSIOL, V115, P97, DOI 10.1016/j.clinph.2003.08.002; HESS CW, 1986, LANCET, V2, P355; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Itzkovich M, 2002, SPINAL CORD, V40, P396, DOI 10.1038/sj.sc.3101315; Kirshblum S, 2001, ARCH PHYS MED REHAB, V82, P604, DOI 10.1053/apmr.2001.22348; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kuhn F, 2012, J NEUROTRAUM, V29, P1829, DOI 10.1089/neu.2011.2277; LEIS AA, 1995, MUSCLE NERVE, V18, P1464, DOI 10.1002/mus.880181218; Leis AA, 1996, MUSCLE NERVE, V19, P1342; Lin CSY, 2007, BRAIN, V130, P985, DOI 10.1093/brain/awl339; Lin JZ, 2004, MUSCLE NERVE, V30, P289, DOI 10.1002/mus.20110; Mallik A, 2005, J NEUROL NEUROSUR PS, V76, P23, DOI 10.1136/jnnp.2005.069138; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; McNeil CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00152; NYBOER V J, 1971, Archives of Physical Medicine and Rehabilitation, V52, P256; Ollivier-Lanvin K, 2009, J APPL PHYSIOL, V107, P1190, DOI 10.1152/japplphysiol.00282.2009; Petersen JA, 2012, NEUROREHAB NEURAL RE, V26, P939, DOI 10.1177/1545968312438437; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rudhe C, 2009, NEUROREHAB NEURAL RE, V23, P413, DOI 10.1177/1545968308331143; Sasaki M, 2007, PROG BRAIN RES, V161, P419, DOI 10.1016/S0079-6123(06)61030-3; Spiess M, 2008, CLIN NEUROPHYSIOL, V119, P1051, DOI 10.1016/j.clinph.2008.01.021; Thomas SL, 2005, J NEUROPHYSIOL, V94, P2844, DOI 10.1152/jn.00532.2005; Tranulis C, 2006, NEUROPHYSIOL CLIN, V36, P1, DOI 10.1016/j.neucli.2006.01.005; Van de Meent H, 2010, NEUROREHAB NEURAL RE, V24, P657, DOI 10.1177/1545968310368534; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; van Hedel HJA, 2009, NEUROREHAB NEURAL RE, V23, P343, DOI 10.1177/1545968308324224; Wirth B, 2008, J NEUROTRAUM, V25, P467, DOI 10.1089/neu.2007.0472	51	10	12	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2017	31	5					432	441		10.1177/1545968316688796			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ES7EE	WOS:000399711600004	28132610	Bronze, Green Accepted			2022-02-06	
J	Reisner, A; Burns, TG; Hall, LB; Jain, S; Weselman, BC; De Grauw, TJ; Ono, KE; Blackwell, LS; Chern, JJ				Reisner, Andrew; Burns, Thomas G.; Hall, Larry B.; Jain, Shabnam; Weselman, Brad C.; De Grauw, Ton J.; Ono, Kim E.; Blackwell, Laura S.; Chern, Joshua J.			Quality Improvement in Concussion Care: Influence of Guideline-Based Education	JOURNAL OF PEDIATRICS			English	Article							CLINICAL GUIDELINES; HEALTH-CARE; HEAD-INJURY; SPORTS; KNOWLEDGE; MANAGEMENT; BARRIERS; IMPLEMENTATION; PEDIATRICIANS; ADHERENCE	Objective To evaluate the potential impact of a concussion management education program on community-practicing pediatricians. Study design We prospectively surveyed 210 pediatricians before and 18 months after participation in an evidenc-ebased, concussion education program. Pediatricians were part of a network of 38 clinically integrated practices in metro-Atlanta. Participation was mandatory for at least 1 pediatrician in each practice. We assessed pediatricians' self-reported concussion knowledge, use of guidelines, and comfort level, as well as self-reported referral patterns for computed tomography (CT) and/or emergency department (ED) evaluation of children who sustained concussion. Results Based on responses from 120 pediatricians participating in the 2 surveys and intervention (response rate, 57.1%), the program had significant positive effects from pre-to postintervention on knowledge of concussions (-0.26 to 0.56 on -3 to +1 scale; P < .001), guideline use (0.73-.06 on 0-6 scale; P < .01), and comfort level in managing concussions (3.76-4.16 on 1-5 scale; P < .01). Posteducation, pediatricians were significantly less likely to self-report referral for CT (1.64-1.07; P < .001) and CT/ED (4.73-3.97; P < .01), but not ED referral alone (3.07-3.09; P = ns). Conclusions Adoption of a multifaceted, evidence-based, education program translated into a positive modification of self-reported practice behavior for youth concussion case management. Given the surging demand for community-based youth concussion care, this program can serve as a model for improving the quality of pediatric concussion management.	[Reisner, Andrew; Hall, Larry B.; Chern, Joshua J.] Childrens Healthcare Atlanta, Dept Neurosurg, 5455 Meridian Mark Rd,Suite 540, Atlanta, GA 30342 USA; [Reisner, Andrew; Jain, Shabnam; De Grauw, Ton J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Reisner, Andrew; Jain, Shabnam; De Grauw, Ton J.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Burns, Thomas G.; Ono, Kim E.; Blackwell, Laura S.] Childrens Healthcare Atlanta, Dept Neuropsychol, Atlanta, GA USA; [Weselman, Brad C.] Kids Hlth First Network, Atlanta, GA USA		Reisner, A (corresponding author), Childrens Healthcare Atlanta, Dept Neurosurg, 5455 Meridian Mark Rd,Suite 540, Atlanta, GA 30342 USA.	Andrew.Reisner@choa.org					Amoako AO, 2015, OPEN ACCESS J SPORTS, V6, P81, DOI 10.2147/OAJSM.S71457; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Bloom BS, 2005, INT J TECHNOL ASSESS, V21, P380, DOI 10.1017/S026646230505049X; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Burgers JS, 2003, BRIT J GEN PRACT, V53, P15; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Demorest RA, 2005, PEDIATRICS, V115, P28, DOI 10.1542/peds.2004-0266; Fishe JN, 2016, PEDIATR EMERG CARE, V32, P149, DOI 10.1097/PEC.0000000000000724; Flaherty MR, 2016, J PEDIATR-US, V178, P268, DOI 10.1016/j.jpeds.2016.08.025; Fleishman, 2008, IMPROVING PHYS ADHER; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Furlow B, 2010, LANCET ONCOL, V11, P15, DOI 10.1016/S1470-2045(09)70395-X; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldberg SL, 2015, J ONCOL PRACT, V11, pE398, DOI 10.1200/JOP.2014.001099; Gomez JE, 2013, J ADOLESCENT HEALTH, V53, P311, DOI 10.1016/j.jadohealth.2013.06.018; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Lewis Sonja J, 2004, J Manag Care Pharm, V10, pS3; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; National Center for Injury Prevention and Control, HEADS UP; Peterson ED, 2008, J CARDIOVASC NURS, V23, P50, DOI 10.1097/01.JCN.0000305058.03872.f1; Reisner A, 2015, CLIN PEDIATR, V54, P1031, DOI 10.1177/0009922815573468; Sarris CE, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12224; Schwentner L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-487; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Simpson F, 2007, J EVAL CLIN PRACT, V13, P709, DOI 10.1111/j.1365-2753.2006.00717.x; Taba P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-455; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Timmermans S, 2005, HEALTH AFFAIR, V24, P18, DOI 10.1377/hlthaff.24.1.18; Trusko BE, 2007, IMPROVING HEALTHCARE; Visser BC, 2012, HPB, V14, P539, DOI 10.1111/j.1477-2574.2012.00496.x; Yen BM, 2006, J CLIN OUTCOMES MANA, V13, P103; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	41	10	10	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAY	2017	184						26	31		10.1016/j.jpeds.2017.01.045			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EU5WH	WOS:000401104300008	28233546				2022-02-06	
J	Shandley, S; Wolf, EG; Schubert-Kabban, CM; Baugh, LM; Richards, MF; Prye, J; Arizpe, HM; Kalns, J				Shandley, Sabrina; Wolf, E. George; Schubert-Kabban, Christine M.; Baugh, Laura M.; Richards, Michael F.; Prye, Jennifer; Arizpe, Helen M.; Kalns, John			Increased circulating stem cells and better cognitive performance in traumatic brain injury subjects following hyperbaric oxygen therapy	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						stem cell; traumatic brain injury; neurocognitive assessment; cognitive performance; hyperbaric oxygen; HBO2; TBI; PTSD	BONE-MARROW; MICROGLIA; MOBILIZATION; TRIAL	Traumatic brain injury (TBI) may cause persistent cognitive dysfunction. A pilot clinical study was performed to determine if hyperbaric oxygen (HBO2) treatment improves cognitive performance. It was hypothesized that stem cells, mobilized by HBO2 treatment, are recruited to repair damaged neuronal tissue. This hypothesis was tested by measuring the relative abundance of stem cells in peripheral blood and cognitive performance during this clinical trial. The subject population consisted of 28 subjects with persistent cognitive impairment caused by mild to moderate TBI suffered during military deployment to Iraq or Afghanistan. Fluorescence-activated cell sorting (FACS) analysis was performed for stem cell markers in peripheral blood and correlated with variables resulting from standard tests of cognitive performance and post-traumatic stress disorder: ImPACT, BrainCheckers and PCL-M test results. HBO2 treatment correlated with stem cell mobilization as well as increased cognitive performance. Together these results support the hypothesis that stem cell mobilization may be required for cognitive improvement in this population.	[Shandley, Sabrina; Prye, Jennifer; Arizpe, Helen M.; Kalns, John] Hyper Biotechnol Inc, San Antonio, TX USA; [Wolf, E. George; Richards, Michael F.] Hyperbar Med, Med Wing 59, Jbsa Lackland, TX 78236 USA; [Schubert-Kabban, Christine M.] US Air Force, Inst Technol, Wright Patterson AFB, OH 45433 USA; [Baugh, Laura M.] Med Specialty Squadron, Jbsa Lackland, TX USA		Wolf, EG (corresponding author), Hyperbar Med, Med Wing 59, Jbsa Lackland, TX 78236 USA.	earl.g.wolf.ctr@mail.mil			U.S. Air Force Surgeon General contract [FA8900-06-D-6018]	The authors do not have any conflicts of interest or any disclaimers for this work. This work was funded by the U.S. Air Force Surgeon General contract FA8900-06-D-6018.	Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Command U.S.A.M.R.a.M., COGN STAT REP GEN FT; Davoust N, 2008, TRENDS IMMUNOL, V29, P227, DOI 10.1016/j.it.2008.01.010; Elsmore TF, 2007, ARCH CLIN NEUROPSYCH, V22, pS135, DOI 10.1016/j.acn.2006.10.009; Feng ZC, 2013, NEURAL REGEN RES, V8, P1220, DOI 10.3969/j.issn.1673-5374.2013.13.007; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Heyboer M, 2014, STEM CELL RES, V12, P638, DOI 10.1016/j.scr.2014.02.005; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Milovanova TN, 2009, J APPL PHYSIOL, V106, P711, DOI 10.1152/japplphysiol.91054.2008; Pruneau G., 2008, DISTINCTIVENESS AVOI; Reeves D, 2007, ANN REV CYBERTHERAPY, V5, P173; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Temme L, 2013, FRONTIERS NEUROLOGY; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Wolf EG, 2015, UNDERSEA HYPERBAR M, V42, P313	18	10	11	0	7	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	MAY-JUN	2017	44	3					257	269					13	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	EW1BT	WOS:000402225600006	28779582				2022-02-06	
J	Wehman, PH; Targett, PS; Avellone, LE				Wehman, Paul Howard; Targett, Pamela Sherron; Avellone, Lauren Elizabeth			Educational and Vocational Issues in Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Special education; Employment; Rehabilitation	SUPPORTED EMPLOYMENT; HEAD-INJURY; CHILDREN; OUTCOMES; RETURN; PREDICTORS; SERVICES; WORK; TBI	This article describes some of the current issues related to return to school and employment for individuals with traumatic brain injury. A strong, collaborative partnership between an individual's health care providers and key stake holders is essential to a smooth transition back to school or work. Ways to improve current practices and ensure more timely and appropriate educational and employment services and supports for individuals with traumatic brain injury are described. Some recommendations on areas for future research are also offered.	[Wehman, Paul Howard] Virginia Commonwealth Univ, Med Coll Virginia, Div Rehabil Res, 1314 West Main St,Box 842011, Richmond, VA 23284 USA; [Targett, Pamela Sherron; Avellone, Lauren Elizabeth] Virginia Commonwealth Univ, VCU RRTC, 1314 West Main St,Box 842011, Richmond, VA 23284 USA		Avellone, LE (corresponding author), Virginia Commonwealth Univ, VCU RRTC, 1314 West Main St,Box 842011, Richmond, VA 23284 USA.	leavellone@vcu.edu			US Department of Health and Human Services (USDHS), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) grant [90DP0033-02-01]	Research reported in this article was supported by the US Department of Health and Human Services (USDHS), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) grant # 90DP0033-02-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of USDHS NIDILRR.	Brown J, 2016, PEDIAT ADOLESCENTS E, P286; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Dahm J, 2015, BRAIN INJURY, V29, P1539, DOI 10.3109/02699052.2015.1075141; Dillow S.A., 2016, 2016006 NCES I ED SC; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Faul M, 2010, TRAUMATIC BRAIN INJU; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P602; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Hoare PN, 2010, J OCCUP ORGAN PSYCH, V83, P759, DOI 10.1348/096317909X472094; Huang IC, 2013, DEV MED CHILD NEUROL, V55, P1000, DOI 10.1111/dmcn.12224; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rumrill P, 2016, J HEAD TRAUMA REHAB, V31, P288, DOI 10.1097/HTR.0000000000000186; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Smith TJ, 2015, J VOCAT REHABIL, V42, P201, DOI 10.3233/JVR-150740; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Sung C, 2015, J AUTISM DEV DISORD, V45, P3204, DOI 10.1007/s10803-015-2480-z; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wehman P, 2013, LIFE CLASSROOM, P473; Wehman P, 2014, INTELLECT DEV DISAB, V52, P296, DOI 10.1352/1934-9556-52.4.296; Wehman P, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P450; West M, 2015, DISABIL REHABIL, V37, P1055, DOI 10.3109/09638288.2014.955133; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	34	10	10	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					351	+		10.1016/j.pmr.2016.12.010			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700012	28390518				2022-02-06	
J	Yao, S; Song, J; Li, S; Cao, CL; Fang, L; Wang, CH; Xu, GZ				Yao, Shun; Song, Jian; Li, Shun; Cao, Chenglong; Fang, Li; Wang, Chaohu; Xu, Guozheng			Helsinki Computed Tomography Scoring System Can Independently Predict Long-Term Outcome in Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Computed tomography; Helsinki CT score; Long-term outcome prediction; Traumatic brain injury	GLASGOW COMA SCALE; PROGNOSTIC VALUE; CLASSIFICATION; VALIDATION; IMPACT; MORTALITY; MODERATE; COHORT	OBJECTIVE: The Helsinki computed tomography (CT) scoring system was developed to predict long-term outcome in patients with traumatic brain injury (TBI) 2 years ago; however, it has not yet been external validated. This study aimed to determine whether this system could be used as an independent predictor for TBI. METHODS: This retrospective cohort study was performed on 302 consecutive patients with TBI. Univariate and multivariate logistic regressions and receiver operating characteristic curve analyses were used to determine the relationship between initial Helsinki CT scores and mortality and unfavorable neurologic outcome at 6 months after injury. Outcomes were assessed using the Glasgow Outcome Scale (scores of 1-3 defined as unfavorable outcome). RESULTS: Of all patients, mortality was 17.9% and unfavorable outcome was 41.4%. The Helsinki CT score was significantly associated with the 6-month outcome in univariate analyses (P < 0.05). After adjustment for other factors in the multivariate regression analysis, the Helsinki CT score remained an independent predictor for mortality (odds ratio [OR], 1.22; 95% confidence interval [CI], 1.08-1.39; P [0.002) and unfavorable outcome (OR, 1.14; 95% CI, 1.04-1.26; P [0.007). Receiver operating characteristic curve analyses showed that the Helsinki CT score possessed good discrimination ability for mortality (area under the curve, 0.81; 95% CI, 0.75-0.87; P < 0.001) and moderate discrimination ability for unfavorable outcome (area under the curve, 0.74; 95% CI, 0.69-0.80; P < 0.001). Moreover, at 1.9 hours after TBI, the Helsinki CT score was most accurate for predicting mortality (accuracy, 74.5%) and unfavorable outcome (accuracy, 71.5%). CONCLUSIONS: The Helsinki CT score showed good prognostic discrimination and can be used as an independent predictor for long-term outcome prediction in patients with TBI.	[Yao, Shun; Song, Jian; Fang, Li; Xu, Guozheng] Wuhan Gen Hosp PLA, Dept Neurosurg, Wuhan, Hubei Province, Peoples R China; [Yao, Shun; Cao, Chenglong; Xu, Guozheng] Southern Med Univ, Wuhan Gen Hosp PLA, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Li, Shun] North Sichuan Med Coll, Affiliated Hosp, Dept Neurosurg, Nanchong, Sichuan, Peoples R China; [Wang, Chaohu] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China		Yao, S (corresponding author), Wuhan Gen Hosp PLA, Dept Neurosurg, Wuhan, Hubei Province, Peoples R China.; Yao, S (corresponding author), Southern Med Univ, Wuhan Gen Hosp PLA, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.	yaoshun2008@yeah.net	Yao, Shun/AAT-3997-2020	Yao, Shun/0000-0003-1727-4078; Yao, Shun/0000-0002-1723-0414	12-5 Key Projects of PLA [BWS11J066]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400865]	This work was supported by the 12-5 Key Projects of PLA (grant no. BWS11J066) and the National Natural Science Foundation of China (grant no. 81400865).	Chieregato A, 2010, ACTA ANAESTH SCAND, V54, P696, DOI 10.1111/j.1399-6576.2010.02234.x; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Fujimoto K, 2016, J NEUROSURG, V124, P1640, DOI 10.3171/2015.4.JNS142760; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; [徐如祥 Xu Ruxiang], 2011, [中华神经医学杂志, Chinese Journal of Neuromedicine], V10, P1189	22	10	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2017	101						528	533		10.1016/j.wneu.2017.02.072			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7CR	WOS:000401932500069	28249827				2022-02-06	
J	Lukiw, WJ; Rogaev, EI				Lukiw, Walter J.; Rogaev, Evgeny I.			Genetics of Aggression in Alzheimer's Disease (AD)	FRONTIERS IN AGING NEUROSCIENCE			English	Article						aggression-Alzheimer's disease (AD); retrogenesis and schizophrenia; androgen receptor (AR); brain derived neurotrophic factor (BDNF); tryptophan hydroxylase (TPH); neuronal specific nitric oxide synthase (NOS1); catechol-O-methyl transferase (COMT); dopamine beta-hydroxylase (DBH)	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; NEUROTROPHIC FACTOR; TRYPTOPHAN-HYDROXYLASE; PSYCHOLOGICAL SYMPTOMS; NEUROPSYCHIATRIC SYMPTOMS; RISK-FACTORS; SCHIZOPHRENIA; GENES; EXPRESSION	Alzheimer's disease (AD) is a terminal, age-related neurological syndrome exhibiting progressive cognitive and memory decline, however AD patients in addition exhibit ancillary neuropsychiatric symptoms (NPSs) and these include aggression. In this communication we provide recent evidence for the mis-regulation of a small family of genes expressed in the human hippocampus that appear to be significantly involved in expression patterns common to both AD and aggression. DNA array-and mRNA transcriptome-based gene expression analysis and candidate gene association and/or genome-wide association studies (CGAS, GWAS) of aggressive attributes in humans have revealed a surprisingly small subset of six brain genes that are also strongly associated with altered gene expression patterns in AD. These genes encoded on five different chromosomes (chr) include the androgen receptor (AR; chrXq12), brain-derived neurotrophic factor (BDNF; chr11p14.1), catechol-O-methyl transferase (COMT; chr22q11.21), neuronal specific nitric oxide synthase (NOS1; chr12q24.22), dopamine beta-hydroxylase (DBH chr9q34.2) and tryptophan hydroxylase (TPH1, chr11p15.1 and TPH2, chr12q21.1). Interestingly, (i) the expression of three of these six genes (COMT, DBH, NOS1) are highly variable; (ii) three of these six genes (COMT, DBH, TPH1) are involved in DA or serotonin metabolism, biosynthesis and/or neurotransmission; and (iii) five of these six genes (AR, BDNF, COMT, DBH, NOS1) have been implicated in the development, onset and/or propagation of schizophrenia. The magnitude of the expression of genes implicated in aggressive behavior appears to be more pronounced in the later stages of AD when compared to MCI. These recent genetic data further indicate that the extent of cognitive impairment may have some bearing on the degree of aggression which accompanies the AD phenotype.	[Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr, New Orleans, LA 70112 USA; [Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70112 USA; [Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Alzheimers Dis, New Orleans, LA 70112 USA; [Rogaev, Evgeny I.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Rogaev, Evgeny I.] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Ctr Brain Neurobiol & Neurogenet, Novosibirsk, Russia; [Rogaev, Evgeny I.] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA; [Rogaev, Evgeny I.] Lomonosov Moscow State Univ, Sch Bioengn & Bioinformat, Moscow, Russia		Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr, New Orleans, LA 70112 USA.; Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA.; Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70112 USA.; Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Alzheimers Dis, New Orleans, LA 70112 USA.	wlukiw@lsuhsc.edu	Rogaev, Evgeny/AAN-7662-2020		LSU Eye Center from Research to Prevent Blindness (RPB); Louisiana Biotechnology Research Network (LBRN); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NEI EY006311, NIA AG18031, NIA AG038834]; Russian Scientific FoundationRussian Science Foundation (RSF) [14-15-01121, 14-44-00077]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG038834] Funding Source: NIH RePORTER	This work was supported by Russian Scientific Foundation grant No. 14-15-01121 and grant No. 14-44-00077. We thank Drs. A. Grigorenko, S. Kunizheva, D. Guillot and A.I. Pogue for technical assistance in preparing the manuscript and for the preparation of Tables and Figures. Research on the genetics of the innate-immune response in AD, age-related macular degeneration (AMD), prion disease and in other forms of age-related neurological or retinal disease, amyloidogenesis, synaptogenesis, brain inflammation cognition and behavior in the Lukiw lab was supported through an unrestricted grant to the LSU Eye Center from Research to Prevent Blindness (RPB); the Louisiana Biotechnology Research Network (LBRN) and National Institutes of Health (NIH) grants NEI EY006311, NIA AG18031 and NIA AG038834 (WJL). These studies utilized total nucleic acid (RNA and/or DNA) extracted from human tissues; all tissues were handled in an institutionally approved ethical manner at source; thanks are extended to the many neuropathologists, physicians and researchers of the US and Canada who have provided high quality, short post-mortem interval (PMI) human CNS or extracted tissue fractions for scientific study.	Agarwal P, 2016, J CLIN NEUROSCI, V34, P53, DOI 10.1016/j.jocn.2016.08.009; [Anonymous], 2015, J NAT SCI; Ashford JW, 2013, J ALZHEIMERS DIS, V33, P1191, DOI 10.3233/JAD-2012-121124; Austin SA, 2016, CIRC RES, V119, P1128, DOI 10.1161/CIRCRESAHA.116.309686; Ballard C, 2013, CURR OPIN PSYCHIATR, V26, P252, DOI 10.1097/YCO.0b013e32835f414b; Baou M, 2016, SCHIZOPHR RES, V170, P18, DOI 10.1016/j.schres.2015.11.003; Barger SW, 2016, J NEUROCHEM, V139, P24, DOI 10.1111/jnc.13629; Bhattacharjee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150211; Borroni B, 2010, CURR ALZHEIMER RES, V7, P158, DOI 10.2174/156720510790691173; BURKE WJ, 1990, BRAIN RES, V537, P83, DOI 10.1016/0006-8993(90)90342-9; Butchart J, 2013, ALZ DIS ASSOC DIS, V27, P153, DOI 10.1097/WAD.0b013e318258cd63; Butzlaff M., 2016, OPERA MED PHYSL, V2, P77; Carre JM, 2017, BIOL PSYCHIAT, V82, P249, DOI 10.1016/j.biopsych.2016.06.009; Clelland CL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.157; Cocchi E, 2016, MOL NEUROBIOL, V53, P2065, DOI 10.1007/s12035-015-9174-6; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Coyle JT, 2016, HARVARD REV PSYCHIAT, V24, P80, DOI 10.1097/HRP.0000000000000102; Craig D, 2004, NEUROSCI LETT, V363, P199, DOI 10.1016/j.neulet.2004.02.054; Cui JG, 2005, CELL MOL NEUROBIOL, V25, P789, DOI 10.1007/s10571-005-4035-x; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Dart DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071694; Douaud G, 2014, P NATL ACAD SCI USA, V111, P17648, DOI 10.1073/pnas.1410378111; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Egbujo CN, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0710-5; Faria MC, 2014, J PSYCHIATR RES, V53, P166, DOI 10.1016/j.jpsychires.2014.01.019; Fedotova J, 2016, BIOMED PHARMACOTHER, V83, P1444, DOI 10.1016/j.biopha.2016.08.065; Fernandez-Castillo N, 2016, AM J MED GENET B, V171, P676, DOI 10.1002/ajmg.b.32419; Freudenberg F, 2015, GENES BRAIN BEHAV, V14, P46, DOI 10.1111/gbb.12193; Gallagher D, 2015, NEURODEGENER DIS MAN, V5, P75, DOI [10.2217/nmt.14.46, 10.2217/NMT.14.46]; Garay RP, 2016, EXPERT OPIN INV DRUG, V25, P159, DOI 10.1517/13543784.2016.1121995; Godar SC, 2016, PROG NEURO-PSYCHOPH, V69, P90, DOI 10.1016/j.pnpbp.2016.01.001; Godar SC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00071; Haavik J, 2008, HUM MUTAT, V29, P891, DOI 10.1002/humu.20700; Herrmann N, 2004, J NEUROPSYCH CLIN N, V16, P261, DOI 10.1176/appi.neuropsych.16.3.261; Howes OD, 2017, BIOL PSYCHIAT, V81, P9, DOI 10.1016/j.biopsych.2016.07.014; Huo DS, 2016, J TOXICOL ENV HEAL A, V79, P856, DOI 10.1080/15287394.2016.1193114; Janoutova J, 2016, NEUROENDOCRINOL LETT, V37, P1; Jia JX, 2016, J TOXICOL ENV HEAL A, V79, P849, DOI 10.1080/15287394.2016.1193113; Lee YH, 2014, NEUROL SCI, V35, P643, DOI 10.1007/s10072-014-1645-4; Liu CS, 2016, CURR ALZHEIMER RES, V13, P1134, DOI 10.2174/1567205013666160502122933; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Macfarlane S, 2016, AUST PRESCR, V39, P123, DOI 10.18773/austprescr.2016.052; Marder SR, 2017, ACTA NEUROPSYCHIATR, V29, P278, DOI 10.1017/neu.2016.57; Martorana A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00252; Maynard KR, 2016, NEUROPSYCHOPHARMACOL, V41, P1943, DOI 10.1038/npp.2015.349; McClam TD, 2015, HARVARD REV PSYCHIAT, V23, P377, DOI 10.1097/HRP.0000000000000097; McEvoy Joseph, 2016, Clin Schizophr Relat Psychoses, V9, P177, DOI 10.3371/CSRP.MCCI.010316; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Montine TJ, 2016, ALZHEIMERS DEMENT, V12, P164, DOI 10.1016/j.jalz.2015.07.492; Morris RW, 2015, SCHIZOPHR RES, V168, P649, DOI 10.1016/j.schres.2015.06.030; Mustapic M, 2013, PROG NEURO-PSYCHOPH, V44, P94, DOI 10.1016/j.pnpbp.2013.02.002; Nagata T, 2017, INT J GERIATR PSYCH, V32, P1264, DOI 10.1002/gps.4607; Nagata T, 2014, J NEURAL TRANSM, V121, P433, DOI 10.1007/s00702-013-1121-y; Narvaes R., 2014, PSYCHOL NEUROSCI, V7, P601, DOI 10.3922/j.psns.2014.4.20; New AS, 1998, AM J MED GENET, V81, P13, DOI 10.1002/(SICI)1096-8628(19980207)81:1<13::AID-AJMG3>3.0.CO;2-O; Nowak I, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0912-8; Pan WS, 2016, EXP THER MED, V12, P1455, DOI 10.3892/etm.2016.3470; Panza F, 2015, EXPERT OPIN PHARMACO, V16, P2581, DOI 10.1517/14656566.2015.1092520; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Perroud N, 2010, GENES BRAIN BEHAV, V9, P193, DOI 10.1111/j.1601-183X.2009.00547.x; Ross JA, 2015, NEUROBIOL STRESS, V2, P73, DOI 10.1016/j.ynstr.2015.09.002; Sachs GS, 2006, J CLIN PSYCHIAT, V67, P5; Sauerzopf U, 2017, EUR J NEUROSCI, V45, P45, DOI 10.1111/ejn.13418; Schneider LS, 2016, AM J PSYCHIAT, V173, P465, DOI 10.1176/appi.ajp.2015.15050648; Serretti A, 2012, CNS NEUROL DISORD-DR, V11, P299, DOI 10.2174/187152712800672472; Shearer J, 2016, AGING CLIN EXP RES, V28, P363, DOI 10.1007/s40520-015-0396-2; Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169; Smagin DA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00443; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Song JH, 2015, MOL NEUROBIOL, V52, P1477, DOI 10.1007/s12035-014-8958-4; Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103; Spalletta G, 2010, EUR PSYCHIAT, V25, P311, DOI 10.1016/j.eurpsy.2009.10.008; Sugden K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-50; Tanila H, 2017, NEUROBIOL DIS, V97, P114, DOI 10.1016/j.nbd.2016.05.008; van de Leemput J, 2016, EXPERT REV MOL DIAGN, V16, P677, DOI 10.1586/14737159.2016.1171714; Wang J, 2016, BRAIN RES BULL, V125, P99, DOI 10.1016/j.brainresbull.2016.05.014; Wharton T, 2018, AGING MENT HEALTH, V22, P121, DOI 10.1080/13607863.2016.1235680; Wirth A, 2017, PROG NEUROBIOL, V151, P35, DOI 10.1016/j.pneurobio.2016.03.007; Wollam Mariegold E, 2015, J Aging Res, V2015, P267062, DOI 10.1155/2015/267062; Wultsch T, 2007, J NEURAL TRANSM-SUPP, P69; Xing Y, 2012, DEMENT GERIATR COGN, V33, P35, DOI 10.1159/000336600; Yan P, 2016, J MOL NEUROSCI, V59, P366, DOI 10.1007/s12031-016-0751-6; Yan WQ, 2016, J NEUROL SCI, V361, P250, DOI 10.1016/j.jns.2016.01.014; Zhang Qin-Ting, 2014, Fa Yi Xue Za Zhi, V30, P197; Zhao YH, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00140; Zhou QG, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.106	87	10	11	1	17	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	APR 10	2017	9								87	10.3389/fnagi.2017.00087			10	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	ER3UV	WOS:000398725900001	28443016	Green Published, gold			2022-02-06	
J	Berthold-Lindstedt, M; Ygge, J; Borg, K				Berthold-Lindstedt, Marta; Ygge, Jan; Borg, Kristian			VISUAL DYSFUNCTION IS UNDERESTIMATED IN PATIENTS WITH ACQUIRED BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						stroke; traumatic brain injury; visual disorder; diplopia; hemianopia; photophobia	STROKE PATIENTS; REHABILITATION; IMPAIRMENT; PREVALENCE; DISORDERS; VETERANS	Objectives: More than 50% of human cerebral activity is related to vision. Visual impairments are therefore common after acquired brain injury, although they are often overlooked. In order to evaluate the prevalence of visual deficits in our Out-patient Brain Injury Program, a structured screening questionnaire, the Visual Interview, was administered. Methods: A total of 170 patients with acquired brain injury, mean age 47 years, who were enrolled in the programme during 2010-12, underwent the Visual Interview. The interview consists of 18 questions concerning visual impairment and was performed on admission. The different types of visual impairment were compared with regard to sex and diagnosis. Results: Fifty-four percent of the patients reported visual changes, mainly reading difficulties, photosensitivity, blurred vision and disorders of the visual field. Sixteen patients who did not experience visual changes also reported visual symptoms in 4-9 questions. Only slight differences were noted in the occurrence of visual symptoms when correlated with sex or diagnosis. Conclusion: Visual impairments are common after acquired brain injury, but some patients do not define their problems as vision-related. A structured questionnaire, covering the most common visual symptoms, is helpful for the rehabilitation team to facilitate assessment of visual changes.	[Berthold-Lindstedt, Marta; Borg, Kristian] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Dept Rehabil Med, SE-18288 Stockholm, Sweden; [Ygge, Jan] Karolinska Inst, Bernadottelab, St Erik Eye Hosp, Dept Clin Neurosci, Stockholm, Sweden		Berthold-Lindstedt, M (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Dept Rehabil Med, SE-18288 Stockholm, Sweden.	marta.berthold-lindstedt@sll.se			Stiftelsen Tornspiran; Stiftelsen Promobilia; Stockholm CountyStockholm County Council	The study was supported by Stiftelsen Tornspiran, Stiftelsen Promobilia and the Stockholm County. The results have not been published elsewhere. This article has been handled and decided upon by Chief-Editor Henk Stam.	Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bulson R, 2012, J REHABIL RES DEV, V49, P1075, DOI 10.1682/JRRD.2011.02.0017; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Jakobsson M, 2010, EXAMINATION ESSAY; KERKHOFF G, 1990, NERVENARZT, V61, P711; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Pollock A, 2011, COCHRANE LIB, DOI DOI 10.1002/14651858.CD008388.PUB2/FULL; Rizzolatti G., 2008, MIRRORS BRAIN OUR MI; Rowe F, 2015, DISABIL REHABIL, V2, P1; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; Rowe FJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/719096; Sand KM, 2016, EUR J NEUROL, V23, P1, DOI 10.1111/ene.12848; Sand KM, 2012, CEREBROVASC DIS EXTR, V2, P17, DOI 10.1159/000337016; Schuett S, 2012, BRAIN, V135, P912, DOI 10.1093/brain/awr356; Schuett S, 2009, NAT REV NEUROL, V5, P427, DOI 10.1038/nrneurol.2009.97; Siong KH, 2014, CLIN EXP OPTOM, V97, P433, DOI 10.1111/cxo.12166; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Stern CD, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P283, DOI 10.1201/b10524-9; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Valenti C., 2003, OPTOMETRY VISION DEV, V34, P105; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; Warren M, 2009, AM J OCCUP THER, V63, P626, DOI 10.5014/ajot.63.5.626; Wilhelmsen GB, 2003, SEEING IS NOT ALWAYS; Wolter M, 2006, TOP STROKE REHABIL, V13, P12, DOI 10.1310/3JRY-B168-5N49-XQWA	30	10	11	0	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2017	49	4					327	332		10.2340/16501977-2218			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	ER1RJ	WOS:000398570000005	28350414	Green Submitted, gold			2022-02-06	
J	Bouvier, D; Duret, T; Abbot, M; Stiernon, T; Pereira, B; Coste, A; Chazal, J; Sapin, V				Bouvier, Damien; Duret, Thomas; Abbot, Mathieu; Stiernon, Thibault; Pereira, Bruno; Coste, Aurelien; Chazal, Jean; Sapin, Vincent			Utility of S100B Serum Level for the Determination of Concussion in Male Rugby Players	SPORTS MEDICINE			English	Article							MINOR HEAD-INJURY; S-100B PROTEIN; ELITE PLAYERS; BRAIN-DAMAGE; ICE HOCKEY; INCREASES; BLOOD; METAANALYSIS; BIOMARKERS; EXERCISE	Background The incidence of concussion in professional direct-contact sports, particularly in rugby, has increased in recent years. To date, cognitive assessment is the most common means of determining whether a concussed player can return to the game. Serum S100B assay, an objective blood test known to be useful in brain injury management, may offer a novel additional approach to the management of concussed male rugby players. Objective The aim of this study was to investigate the S100B utility for the determination of concussion in a professional 15-players-a-side rugby team. Methods Thirty-nine male rugby players were included in a prospective study during the 2014-2015 French championship season. Serum sampling was carried out several times at baseline and after a match and/or a concussion, at set times (2, 36 h). Serum S100B concentrations were determined using chemiluminescence immunoassay on a Roche Diagnostics (R) instrument. Results The players' basal serum S100B was stable during the season and was not correlated with anthropometric data, body composition, or creatine kinase concentration. A significant increase in S100B concentration within 2 h after a game (without concussion) was observed. This increase was correlated with the number of body collisions during a match. Seventy-seven assays were performed 36 h after a game, including the follow-up of five concussed players. Thirty-six hours after a match, an increase of a minimum of 20 % compared with individual basal concentrations identified concussion with 100 % sensitivity and 81 % specificity. Conclusion S100B measured 36 h after a match is thus a discriminating test to identify concussion in a male rugby player, with a 100 % negative predictive value.	[Bouvier, Damien; Duret, Thomas; Sapin, Vincent] CHU Clermont Ferrand, Dept Biochem & Mol Biol, Clermont Ferrand, France; [Bouvier, Damien; Sapin, Vincent] Univ Auvergne, Clermont Univ, Retinoids EA7281, Reprod Dev Dis,Sch Med, Clermont Ferrand, France; [Abbot, Mathieu; Stiernon, Thibault] ASMCA, Med Dept, Clermont Ferrand, France; [Abbot, Mathieu] CHU Clermont Ferrand, Dept Sport Med & Funct Explorat, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Dept Biostat Unit DRCI, Clermont Ferrand, France; [Coste, Aurelien; Chazal, Jean] CHU Clermont Ferrand, Dept Neurosurg, Clermont Ferrand, France; [Sapin, Vincent] Univ Auvergne, Lab Biochim Med, Fac Med, 4R3,28 Pl Henri Dunant,BP38, F-63001 Clermont Ferrand, France; [Sapin, Vincent] FFR LNR, Observ Med, Marcoussis, France		Sapin, V (corresponding author), CHU Clermont Ferrand, Dept Biochem & Mol Biol, Clermont Ferrand, France.; Sapin, V (corresponding author), Univ Auvergne, Clermont Univ, Retinoids EA7281, Reprod Dev Dis,Sch Med, Clermont Ferrand, France.; Sapin, V (corresponding author), Univ Auvergne, Lab Biochim Med, Fac Med, 4R3,28 Pl Henri Dunant,BP38, F-63001 Clermont Ferrand, France.; Sapin, V (corresponding author), FFR LNR, Observ Med, Marcoussis, France.	vincent.sapin@udamail.fr		Bouvier, Damien/0000-0002-2707-4320; Pereira, Bruno/0000-0003-3778-7161			Beaudeux JL, 1999, ANN BIOL CLIN-PARIS, V57, P261; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Bey T, 2009, WEST J EMERG MED, V10, P6; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2016, CLIN CHEM LAB MED, V54, P833, DOI 10.1515/cclm-2015-0771; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Gardner AJ, 2015, BRAIN INJURY, V17, P1; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; Mussack T, 2003, EUR J MED RES, V8, P457; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Ray P, 2010, ANESTHESIOLOGY, V112, P1023, DOI 10.1097/ALN.0b013e3181d47604; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	31	10	10	0	6	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	APR	2017	47	4					781	789		10.1007/s40279-016-0579-9			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ET7RV	WOS:000400496400014	27430504				2022-02-06	
J	Doherty, C; Zhao, L; Ryan, J; Komaba, Y; Inomata, A; Caulfield, B				Doherty, Cailbhe; Zhao, Liang; Ryan, John; Komaba, Yusuke; Inomata, Akihiro; Caulfield, Brian			Concussion is associated with altered preparatory postural adjustments during gait initiation	HUMAN MOVEMENT SCIENCE			English	Article						Brain concussion; Gait; Biomechanics; Kinetics; Postural balance	DYNAMIC BALANCE CONTROL; PARKINSONS-DISEASE; CONTROL DEFICITS; OLDER-ADULTS; ACCELEROMETER; STABILITY; ADOLESCENTS; INSTABILITY; MOVEMENT; RECOVERY	Gait initiation is a useful surrogate measure of supraspinal motor control mechanisms but has never been evaluated in a cohort following concussion. The aim of this study was to quantify the preparatory postural adjustments (PPAs) of gait initiation (GI) in fifteen concussion patients (4 females, 11 males) in comparison to a group of fifteen age- and sex matched controls. All participants completed variants of the GI task where their dominant and non-dominant limbs as the 'stepping' and 'support' limbs. Task performance was quantified using the centre of pressure (COP) trajectory of each foot (computed from a force plate) and a surrogate of the centre of mass (COM) trajectory (estimated from an inertial measurement unit placed on the sacrum). Concussed patients exhibited decreased COP excursion on their dominant foot, both when it was the stepping limb (sagittal plane: 9.71 mm [95% Cl: 8.14-11.27 mm] vs 14.9 mm [95% CI: 12.31-17.49 mm]; frontal plane: 36.95 mm [95% CI: 30.87-43.03 mm] vs 54.24 mm [95% CI: 46.99-61.50 mm]) and when it was the support limb (sagittal plane: 10.43 mm [95% CI: 8.73-12.13 mm] vs 18.13 mm [95% CI: 14.92-21.35 mm]; frontal plane: 66.51 mm [95% CI: 60.45-72.57 mm] vs 88.43 mm [95% CI: 78.53-9832 mm]). This was reflected in the trajectory of the COM, wherein concussion patients exhibited lower posterior displacement (19.67 mm [95% CI: 19.65 mm-19.7 mm]) compared with controls (23.62 mm [95% CI: 23.6-23.64]). On this basis, we conclude that individuals with concussion display deficits during a GI task which are potentially indicative of supraspinal impairments in motor control. (C) 2017 Elsevier B.V. All rights reserved.	[Doherty, Cailbhe; Zhao, Liang; Caulfield, Brian] Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland; [Ryan, John] St Vincents Univ Hosp, Dublin, Ireland; [Komaba, Yusuke; Inomata, Akihiro] Fujitsu Labs Ltd, Kawasaki, Kanagawa, Japan		Doherty, C; Zhao, L (corresponding author), Univ Coll Dublin, OBrien Ctr Sci, Sci Ctr East, Insight Ctr Data Analyt, Belfield, Ireland.	Cailbhe.doherty@ucdconnect.ie; liang.zhao@ucdconnect.ie		Doherty, Cailbhe/0000-0002-5284-856X; Caulfield, Brian/0000-0003-0290-9587	Fujitsu Laboratories Ltd. Japan as part of the KIDUKU project.	This study was supported by Fujitsu Laboratories Ltd. Japan as part of the KIDUKU project. We have not conflicts of interest to declare.	Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; Chang HA, 1999, ARCH PHYS MED REHAB, V80, P490; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; GORMLEY JP, 1993, GAIT POSTURE, V1, P85; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; Hass CJ, 2010, AM J SPORT MED, V38, P829, DOI 10.1177/0363546509351562; Hass CJ, 2005, ARCH PHYS MED REHAB, V86, P2172, DOI 10.1016/j.apmr.2005.05.013; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Johnston W., 2017, J CONCUSSIO IN PRESS; Khanmohammadi R, 2015, BRAIN RES, V1629, P240, DOI 10.1016/j.brainres.2015.09.039; Ledebt A, 1998, EXP BRAIN RES, V120, P9, DOI 10.1007/s002210050372; Mancini M, 2009, EUR J NEUROL, V16, P1028, DOI 10.1111/j.1468-1331.2009.02641.x; Martinez-Mendez R, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-17; Mayagoitia RE, 2002, GAIT POSTURE, V16, P55, DOI 10.1016/S0966-6362(01)00199-0; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2013, PHYS THER SPORT, V14, P1, DOI DOI 10.1016/J.PTSP.2013.03.002; Okada Y, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/202937; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Polcyn AF, 1998, ARCH PHYS MED REHAB, V79, P1582, DOI 10.1016/S0003-9993(98)90425-7; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	29	10	10	1	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2017	52						160	169		10.1016/j.humov.2017.02.005			10	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	ET4EC	WOS:000400231100016	28222342	Green Submitted			2022-02-06	
J	Gracey, F; Fish, JE; Greenfield, E; Bateman, A; Malley, D; Hardy, G; Ingham, J; Evans, JJ; Manly, T				Gracey, Fergus; Fish, Jessica E.; Greenfield, Eve; Bateman, Andrew; Malley, Donna; Hardy, Gemma; Ingham, Jessica; Evans, Jonathan J.; Manly, Tom			A Randomized Controlled Trial of Assisted Intention Monitoring for the Rehabilitation of Executive Impairments Following Acquired Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain injuries; rehabilitation; executive function	GOAL MANAGEMENT; INCOG RECOMMENDATIONS; PROSPECTIVE MEMORY; IMPLEMENTATION INTENTIONS; COPING INVENTORY; SELF-AWARENESS; FRONTAL-LOBE; PERFORMANCE; DYSFUNCTION; DISORDERS	Background. Acquired brain injury (ABI) can impair executive function, impeding planning and attainment of intentions. Research shows promise for some goal-management rehabilitation interventions. However, evidence that alerts assist monitoring and completion of day-to-day intentions is limited. Objective. To examine the efficacy of brief goal-directed rehabilitation paired with periodic SMS text messages designed to enhance executive monitoring of intentions (assisted intention monitoring [AIM]). Methods. A randomized, double-blind, controlled trial was conducted. Following a baseline phase, 74 people with ABI and executive problems were randomized to receive AIM or control (information and games) for 3 weeks (phase 1) before crossing over to either AIM or no intervention (phase 2). The primary outcome was change in composite score of proportion of daily intentions achieved. A total of 59 people (71% male; 46% traumatic brain injury) completed all study phases. Results. Per protocol crossover analysis found a significant benefit of AIM for all intentions [F(1, 56) = 4.28; P = .04; f = 0.28; 3.7% mean difference; 95% CI = 0.1%-7.4%] and all intentions excluding a proxy prospective memory task [F(1, 55) = 4.79; P =.033; f = 0.28, medium effect size; 3% mean difference; 95% CI = 0.3%-5.6%] in the absence of significant changes on tests of executive functioning. Intention-to-treat analyses, comparing AIM against control at the end of phase 1 revealed no statistically significant differences in the attainment of intentions. Conclusion. Combining brief executive rehabilitation with alerts may be effective for some in improving achievement of daily intentions, but further evaluation of clinical effectiveness and mechanisms is required.	[Gracey, Fergus] Univ East Anglia, Norwich Res Pk, Norwich, Norfolk, England; [Gracey, Fergus; Bateman, Andrew] Acquired Brain Injury Rehabil Alliance, Cambridge, England; [Gracey, Fergus; Fish, Jessica E.; Bateman, Andrew; Malley, Donna; Hardy, Gemma; Ingham, Jessica] Prince Wales Hosp, Ely, Cambs, England; [Fish, Jessica E.; Greenfield, Eve; Hardy, Gemma; Ingham, Jessica; Manly, Tom] MRC Cognit & Brain Sci Unit, Cambridge, England; [Evans, Jonathan J.] Univ Glasgow, Glasgow, Lanark, Scotland		Gracey, F (corresponding author), Univ East Anglia, Norwich Med Sch, Dept Clin Psychol, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	f.gracey@uea.ac.uk		Gracey, Fergus/0000-0002-1416-7894; Bateman, Andrew/0000-0002-2547-5921; Fish, Jessica/0000-0002-9337-1489	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) ProgrammeNational Institute for Health Research (NIHR) [PB-PG-0107-12011]; National Institute for Health Research (NIHR) CollaborationsNational Institute for Health Research (NIHR); Care (CLAHRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC-A060-5PQ20]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UU_00005/10, MC_U105559837] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_00005/10, MC_U105559837] Funding Source: UKRI	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This article presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0107-12011). FG and DM were also supported by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) for Cambridgeshire and Peterborough. TM and JEF were supported by the Medical Research Council (MC-A060-5PQ20).	Baddeley A., 1992, SPEED CAPACITY LANGU; Brands I, 2014, J REHABIL MED, V46, P869, DOI 10.2340/16501977-1849; Brands IMH, 2014, PSYCHOL ASSESSMENT, V26, P848, DOI 10.1037/a0036275; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BURGESS PW, 1996, SIMPLIFIED 6 ELEMENT; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Council MR, 2008, DEV EVALUATING COMPL; Cuberos-Urbano G, 2018, NEUROPSYCHOL REHABIL, V28, P589, DOI 10.1080/09602011.2016.1187630; Delis DC., 2001, DELIS KAPLAN EXECUTI; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Ellis J. A., 1988, PRACTICAL ASPECTS ME, V1, P371; Endler N. S, 2004, COPING INVENTORY STR; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Kersten P, 2015, DISABIL REHABIL, V37, P1073, DOI 10.3109/09638288.2014.955137; Khoyratty NB, 2015, PSYCHIAT RES, V228, P265, DOI 10.1016/j.psychres.2015.05.101; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Manly Tom, 2005, P337, DOI 10.1016/B978-012375731-9/50059-8; McNair D, 1992, REVISED MANUAL PROFI, P731; Nelson H.E., 1982, NATL ADULT READING T; O'Connor C, 2011, NEUROPSYCHOLOGY, V25, P535, DOI 10.1037/a0022767; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Simblett SK, 2015, BRIT J CLIN PSYCHOL, V54, P249, DOI 10.1111/bjc.12070; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wechsler D., 1999, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P68, DOI 10.1017/CBO9780511581083.007	42	10	10	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	APR	2017	31	4					323	333		10.1177/1545968316680484			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES7DZ	WOS:000399711100004	27913796	Green Accepted, Bronze, Green Submitted			2022-02-06	
J	Leh, SE; Schroeder, C; Chen, JK; Chakravarty, MM; Park, MTM; Cheung, B; Huntgeburth, SC; Gosselin, N; Hock, C; Ptito, A; Petrides, M				Leh, Sandra E.; Schroeder, Clemens; Chen, Jen-Kai; Chakravarty, M. Mallar; Park, Min Tae M.; Cheung, Bob; Huntgeburth, Sonja C.; Gosselin, Nadia; Hock, Christoph; Ptito, Alain; Petrides, Michael			Microstructural Integrity of Hippocampal Subregions Is Impaired after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; hippocampal subfields; mild traumatic brain injury; shape analysis	APPARENT DIFFUSION-COEFFICIENT; GRAY-MATTER ABNORMALITIES; WHITE-MATTER; COGNITIVE IMPAIRMENT; SPATIAL STATISTICS; ALZHEIMERS-DISEASE; MEAN DIFFUSIVITY; WORKING-MEMORY; HEAD-INJURY; ANISOTROPY	Mild traumatic brain injury (mTBI) affects a large number of individuals and diffusion tensor imaging can be used to investigate microstructural integrity of brain tissue after mTBI. However, results have varied considerably between studies and gray matter (GM) integrity has been largely neglected in these investigations. Given impaired working memory processing after mTBI and its possible association with Alzheimer's disease, we investigated hippocampal integrity and parcellated this structure into five subregions: subiculum, cornu ammonis (CA) 1, CA 2/3, CA 4/dentate gyrus, and stratum radiatum/ lacunosum-moleculare. We also employed shape analysis of bilateral hippocampi to explore whether morphological changes had occurred due to the traumatic injury and conducted neuropsychological memory tests. The sample comprised 15 subjects with mTBI (18-55 years, nine female) and 13 age- and sex-matched healthy control subjects (19-57 years, nine female). Voxelwise analyses showed significantly increased mean diffusivity in patients, compared with controls, in the right hippocampus and three of its five subregions (family-wise error corrected p < 0.05). Additionally, results from probabilistic tractography indicated impaired CA 1 connectivity after mTBI (Benjamini-Hochberg false discovery rate [FDR] corrected p < 0.05). Shape of bilateral hippocampi did not significantly differ between groups (Benjamini-Hochberg FDR corrected p > 0.05). Subjects with mTBI reported more symptoms and performed worse in a non-standard verbal working memory task. Based on these preliminary findings, we were able to demonstrate altered diffusivity of hippocampal subregions following mTBI, indicating impaired GM microstructural integrity. These differences highlight the potential of diffusion imaging for investigation of subtle yet relevant changes in GM microstructure not detected otherwise following mTBI.	[Leh, Sandra E.; Schroeder, Clemens; Hock, Christoph] Univ Zurich, Inst Regenerat Med, Zurich, Switzerland; [Chen, Jen-Kai; Huntgeburth, Sonja C.; Ptito, Alain; Petrides, Michael] Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Dept Psychol, Hlth Ctr, 1025 Pine Ave West,Room P2-152, Montreal, PQ H3A 1A1, Canada; [Chakravarty, M. Mallar; Park, Min Tae M.] McGill Univ, Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Park, Min Tae M.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Cheung, Bob] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Huntgeburth, Sonja C.; Petrides, Michael] Def Res & Dev Canada DRDC Toronto, Toronto, ON, Canada; [Gosselin, Nadia] Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada		Ptito, A (corresponding author), McGill Univ, Dept Psychol, Hlth Ctr, 1025 Pine Ave West,Room P2-152, Montreal, PQ H3A 1A1, Canada.	alain.ptito@mcgill.ca		Park, Min Tae/0000-0002-4268-7432	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-64271]; CIHR FoundationCanadian Institutes of Health Research (CIHR) [FDN-143212]; Defense Research and Development Canada [W7711-088134/001/TOR]; Natural Sciences and Engineering Research Council CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Weston Brain Institute; Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Society; Fonds de recherche Sante Quebec	This research was partly funded by the Canadian Institute of Health Research grant MOP-64271 to AP and MP, CIHR Foundation Grant FDN-143212 to MP, and Defense Research and Development Canada contract W7711-088134/001/TOR to AP.; MMC is funded by the Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council Canada, Weston Brain Institute, Michael J. Fox Foundation for Parkinson's Research, and the Alzheimer's Society. MMC also receives salary support from the Fonds de recherche Sante Quebec.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf BA, 2003, AM J NEURORADIOL, V24, P1857; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cardoso-Cruz H, 2014, J NEUROSCI, V34, P5861, DOI 10.1523/JNEUROSCI.0021-14.2014; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chakravarty MM, 2015, HUM BRAIN MAPP, V36, P1458, DOI 10.1002/hbm.22715; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chiapponi C, 2014, SCHIZOPHR RES, V157, P214, DOI 10.1016/j.schres.2014.05.028; Collins DL, 2010, NEUROIMAGE, V52, P1355, DOI 10.1016/j.neuroimage.2010.04.193; Culbertson W C, 2005, TOWER LONDON DREXEL; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; De Santis S, 2011, MAGN RESON IMAGING, V29, P1410, DOI 10.1016/j.mri.2011.04.006; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Glenn GR, 2016, AM J NEURORADIOL, V37, P1216, DOI 10.3174/ajnr.A4714; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heaton RK, 1991, COMPREHENSIVE NORMS; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Lerch J.P., 2009, PACKAGE RMINC VOXEL; Lerch JP, 2008, NEUROIMAGE, V39, P32, DOI 10.1016/j.neuroimage.2007.08.033; Li YD, 2013, AM J ALZHEIMERS DIS, V28, P627, DOI 10.1177/1533317513494452; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Pipitone J, 2014, NEUROIMAGE, V101, P494, DOI 10.1016/j.neuroimage.2014.04.054; Raznahan A, 2014, P NATL ACAD SCI USA, V111, P1592, DOI 10.1073/pnas.1316911111; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; TEASDALE G, 1974, LANCET, V2, P81; Voineskos AN, 2015, HUM BRAIN MAPP, V36, P3020, DOI 10.1002/hbm.22825; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wechsler D., 1997, WECHSLER MEMORY SCAL; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Winterburn JL, 2013, NEUROIMAGE, V74, P254, DOI 10.1016/j.neuroimage.2013.02.003; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Zhang B, 2011, ACTA RADIOL, V52, P1147, DOI 10.1258/ar.2011.100430	62	10	10	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1402	1411		10.1089/neu.2016.4591			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600010	27786023				2022-02-06	
J	Miller, PR; Chang, MC; Hoth, JJ; Hildreth, AN; Wolfe, SQ; Gross, JL; Martin, RS; Carter, JE; Meredith, JW; D'Agostino, R				Miller, Preston R.; Chang, Michael C.; Hoth, J. Jason; Hildreth, Amy N.; Wolfe, Stacey Q.; Gross, Jessica L.; Martin, R. Shayn; Carter, Jeffrey E.; Meredith, J. Wayne; D'Agostino, Ralph, Jr.			Predicting Mortality and Independence at Discharge in the Aging Traumatic Brain Injury Population Using Data Available at Admission	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	128th Annual Meeting of the Southern-Surgical-Association	DEC, 2016	Palm Beach, FL	So Surg Assoc			PALLIATIVE CARE; OLDER-ADULTS; ASSOCIATION; FUTILE	BACKGROUND: Aging worsens outcome in traumatic brain injury (TBI), but available studies may not provide accurate outcomes predictions due to confounding associated injuries. Our goal was to develop a predictive tool using variables available at admission to predict outcomes related to severity of brain injury in aging patients. STUDY DESIGN: Characteristics and outcomes of blunt trauma patients, aged 50 or older, with isolated TBI, in the National Trauma Data Bank (NTDB), were evaluated. Equations predicting survival and independence at discharge (IDC) were developed and validated using patients from our trauma registry, comparing predicted with actual outcomes. RESULTS: Logistic regression for survival and IDC was performed in 57,588 patients using age, sex, Glasgow Coma Scale score (GCS), and Revised Trauma Score (RTS). All variables were independent predictors of outcome. Two models were developed using these data. The first included age, sex, and GCS. The second substituted RTS for GCS. C statistics from the models for survival and IDC were 0.90 and 0.82 in the GCS model. In the RTS model, C statistics were 0.80 and 0.67. The use of GCS provided better discrimination and was chosen for further examination. Using a predictive equation derived from the logistic regression model, outcome probabilities were calculated for 894 similar patients from our trauma registry (January 2012 to March 2016). The survival and IDC models both showed excellent discrimination (p < 0.0001). Survival and IDC generally decreased by decade: age 50 to 59 (80% IDC, 6.5% mortality), 60 to 69 (82% IDC, 7.0% mortality), 70 to 79 (76% IDC, 8.9% mortality), and 80 to 89 (67% IDC, 13.4% mortality). CONCLUSIONS: These models can assist in predicting the probability of survival and IDC for aging patients with TBI. This provides important data for loved ones of these patients when addressing goals of care. (C) 2017 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)	[Miller, Preston R.; Chang, Michael C.; Hoth, J. Jason; Hildreth, Amy N.; Gross, Jessica L.; Martin, R. Shayn; Carter, Jeffrey E.; Meredith, J. Wayne] Wake Forest Univ, Dept Surg, Winston Salem, NC 27109 USA; [Wolfe, Stacey Q.] Wake Forest Univ, Dept Neurosurg, Winston Salem, NC 27109 USA; [D'Agostino, Ralph, Jr.] Wake Forest Univ, Wake Forest Hlth Sci Dept Biostat Sci, Winston Salem, NC 27109 USA		Miller, PR (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Surg, Med Ctr Blvd, Winston Salem, NC 27157 USA.	pmiller@wakehealth.edu	Hildreth, Amy/AAM-9196-2020	Wolfe, Stacey/0000-0001-7603-2728			Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Finkelstein E., 2006, INCIDENCE EC BURDEN; Franklin GA, 2011, SURGERY, V150, P854, DOI 10.1016/j.surg.2011.07.065; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hofman CS, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S78698; Hofman CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119197; Hughes MT, 2014, ANNU REV PUBL HEALTH, V35, P459, DOI 10.1146/annurev-publhealth-032013-182406; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Huynh TN, 2013, JAMA INTERN MED, V173, P1887, DOI 10.1001/jamainternmed.2013.10261; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; United Nations Department of Economic and Social Affairs Population Division, 2005, WORLD POP PROSP; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; Vincent GK, NEXT 4 DECADES OLDER	17	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	APR	2017	224	4					680	685		10.1016/j.jamcollsurg.2016.12.053			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	EW4SR	WOS:000402491700056	28263858				2022-02-06	
J	Rawal, S; Huedo-Medina, TB; Hoffman, HJ; Swede, H; Duffy, VB				Rawal, Shristi; Huedo-Medina, Tania B.; Hoffman, Howard J.; Swede, Helen; Duffy, Valerie B.			Structural Equation Modeling of Associations Among Taste-Related Risk Factors, Taste Functioning, and Adiposity	OBESITY			English	Article							TRAUMATIC BRAIN-INJURY; CHILDHOOD OTITIS-MEDIA; BITTER TASTE; SENSITIVITY; WEIGHT; ADULTS; TONSILLECTOMY; PERCEPTION; DAMAGE; SWEET	Objective: Variation in taste perception and exposure to risk factors of taste alterations have been independently linked with elevated adiposity. Using a laboratory database, taste-adiposity associations were modeled and examined for whether taste functioning mediates the association between taste-related risk factors and adiposity. Methods: Healthy women (n = 407, 35.5 +/- 16.9 y) self-reported histories of risk factors of altered taste functioning (tonsillectomy, multiple ear infections, head trauma) and were assessed for taste functioning (tongue-tip and whole-mouth intensities of quinine and salt) and density of taste papillae. Twenty-four percent had elevated waist circumferences; thirty-nine percent had overweight or obesity. Using structural equation modeling, direct and indirect associations between taste-related risk factors, taste functioning, and adiposity were tested. Results: In models with good fit, elevated central adiposity was explained directly by history of risk factors (tonsillectomy, multiple ear infections) and directly by lower taste functioning (lower tongue-tip taste function, lower papillae density). Risk factors of taste alterations were significantly associated with lower taste functioning, with taste mediating the association between head trauma and reduced adiposity. Conclusions: This large laboratory-based study supports associations between taste-related risk factors, taste functioning, and adiposity. These findings need to be confirmed with other population-based studies, including the National Health and Nutrition Examination Survey 2013-2014 taste data.	[Rawal, Shristi; Huedo-Medina, Tania B.; Duffy, Valerie B.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT 06269 USA; [Rawal, Shristi] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, Bethesda, MD USA; [Hoffman, Howard J.] Natl Inst Deafness & Other Commun Disorders, Epidemiol & Stat Program, NIH, Bethesda, MD USA; [Swede, Helen] Univ Connecticut, Sch Med, Dept Community Med & Hlth Care, Farmington, CT USA		Duffy, VB (corresponding author), Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT 06269 USA.	valerie.duffy@uconn.edu		Hoffman, Howard/0000-0003-4105-0808; Rawal, Shristi/0000-0003-2587-4022	USDA National Institute of Food and AgricultureUnited States Department of Agriculture (USDA); Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [Y1-DC-0013]; National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Hatch projectUnited States Department of Agriculture (USDA) [1001056]	This research was supported by the USDA National Institute of Food and Agriculture, Hatch project 1001056 as well as an Interagency Agreement (Y1-DC-0013) between the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), and the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). SR was partially supported by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; Bartoshuk LM, 2012, PHYSIOL BEHAV, V107, P516, DOI 10.1016/j.physbeh.2012.06.013; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bonuck KA, 2009, ARCH DIS CHILD, V94, P83, DOI 10.1136/adc.2008.141192; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Coldwell SE, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e3182872e38; Conlon BJ, 1997, INT J PEDIATR OTORHI, V42, P17, DOI 10.1016/S0165-5876(97)00105-5; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Duffy VB, 2010, CHEMOSENS PERCEPT, V3, P137, DOI 10.1007/s12078-010-9079-8; Duffy VB, 2004, PHYSIOL BEHAV, V82, P435, DOI 10.1016/j.physbeh.2004.04.060; Hayes JE, 2008, PHYSIOL BEHAV, V95, P77, DOI 10.1016/j.physbeh.2008.04.023; Hoffman HJ, 2007, P 9 INT S REC ADV OT; Hoffman HJ, 2016, REV ENDOCR METAB DIS, V17, P221, DOI 10.1007/s11154-016-9364-1; Jeyakumar A, 2011, OTOLARYNG HEAD NECK, V144, P154, DOI 10.1177/0194599810392328; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kvestad E, 2006, INT J PEDIATR OTORHI, V70, P597, DOI 10.1016/j.ijporl.2005.08.005; KVETON JF, 1994, LARYNGOSCOPE, V104, P25; Landis BN, 2006, ADV OTO-RHINO-LARYNG, V63, P242, DOI 10.1159/000093763; LEWIN J, 1992, Brain Injury, V6, P199, DOI 10.3109/02699059209029660; Low YQ, 2014, NUTRIENTS, V6, P3431, DOI 10.3390/nu6093431; Martinez-Cordero E, 2015, APPETITE, V89, P192, DOI 10.1016/j.appet.2015.02.015; MATTES RD, 1990, AM J CLIN NUTR, V51, P233, DOI 10.1093/ajcn/51.2.233; Mueller CA, 2007, ARCH OTOLARYNGOL, V133, P668, DOI 10.1001/archotol.133.7.668; National Heart Lung and Blood Institute, GUID OV OB EL TXB; Nelson HM, 2011, PHYSIOL BEHAV, V102, P511, DOI 10.1016/j.physbeh.2011.01.002; Overberg J, 2012, ARCH DIS CHILD, V97, P1048, DOI 10.1136/archdischild-2011-301189; Peracchio HL, 2012, PHYSIOL BEHAV, V106, P264, DOI 10.1016/j.physbeh.2012.01.021; Rawal S, 2013, CHEM SENSES, V38, P719, DOI 10.1093/chemse/bjt040; Sartor F, 2011, APPETITE, V57, P237, DOI 10.1016/j.appet.2011.05.107; SCHECHTER PJ, 1974, J NEUROL NEUROSUR PS, V37, P802, DOI 10.1136/jnnp.37.7.802; Scinska A, 2008, J Laryngol Otol, V122, pe5, DOI 10.1017/S002221510700117X; Seaberg RM, 2010, INT J PEDIATR OTORHI, V74, P1393, DOI 10.1016/j.ijporl.2010.09.016; Shin IH, 2011, ARCH OTOLARYNGOL, V137, P242, DOI 10.1001/archoto.2011.23; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Snyder DJ, 2016, REV ENDOCR METAB DIS, V17, P149, DOI 10.1007/s11154-016-9377-9; STEPHENSON H, 1995, AUDIOLOGY, V34, P124; Tepper BJ, 2014, NUTRIENTS, V6, P3363, DOI 10.3390/nu6093363	40	10	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	APR	2017	25	4					781	787		10.1002/oby.21785			7	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	ET1HQ	WOS:000400018600020	28240820	Green Accepted, Bronze			2022-02-06	
J	Yu, PM; Zhou, D; Liao, WP; Wang, X; Wang, YP; Wang, TC; Wu, Y; Lang, SY; Lin, WH; Song, YJ; Zhao, HQ; Cai, M; Hong, Z				Yu, Peimin; Zhou, Dong; Liao, Weiping; Wang, Xin; Wang, Yuping; Wang, Tiancheng; Wu, Yuan; Lang, Senyang; Lin, Weihong; Song, Yijun; Zhao, Heqing; Cai, Meng; Hong, Zhen			An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China	EPILEPSY & BEHAVIOR			English	Article						Antiepileptic drugs; Cross-sectional survey; Drug utilization; Epidemiology; Observational; Tertiary hospital	QUALITY-OF-LIFE; CLINICAL CHARACTERISTICS; UNPROVOKED SEIZURES; GENERAL-PRACTICE; PREVALENCE; POPULATION; ADULTS; CHILDREN; COSTS; MANAGEMENT	Objectives: This study aimed to describe the distribution of seizure types, clinical characteristics, and antiepileptic drug (AED) utilization in patients with epilepsy visiting tertiary hospitals in China. Methods: This was an observational, cross-sectional epidemiology study conducted at 11 tertiary hospitals across China from May 2014 to November 2014. A total of 1603 patients, of either sex or any age with confirmed diagnosis of epilepsy, visiting outpatient clinics at tertiary hospitals were screened and enrolled. Demographics, seizure types, frequency, etiologies, comorbidities, and current AED therapy were analyzed using descriptive statistics. Results: Overall, the majority (n = 1201; 74.9%) of patients were adults (16-59 years of age), and the mean (SD) age was 27.5 (15.9) years. A total of 989 (61.7%) patients had partial seizures, and 653 (40.7%) had generalized seizures. The majority experienced monthly (n = 663) or yearly (n = 625) seizures, with 2.7 seizures/month or 2.9 seizures/year, respectively. The most commonly reported symptomatic etiologies were traumatic brain injury, encephalitis, and stroke, whereas the most common comorbidities were sleep disorder, headache, anxiety, and depression. Overall, monotherapy was used in 54.1% of patients, while 30.6% of patients used dual therapy. The most commonly prescribed monotherapy for patients with partial seizures was oxcarbazepine (25.9%), while that for patients with generalized seizures was valproic acid (38.9%), and the most common AED combination was valproic acid and lamotrigine. Overall, valproic acid was the most commonly prescribed AED as monotherapy and combination therapy. Conclusion: Findings from this study provide extensive information on clinical characteristics and utilization of AEDs in Chinese patients with epilepsy which may help physicians make well-informed clinical decisions. (C) 2016 Elsevier Inc. All rights reserved.	[Yu, Peimin; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China; [Zhou, Dong] Sichuan Univ, West China Hosp, Chengdu, Peoples R China; [Liao, Weiping] Guangzhou Med Univ, Affiliated Hosp 2, Neurol, Guangzhou, Guangdong, Peoples R China; [Wang, Xin] Fudan Univ, Zhongshan Hosp, Neurol Dept, Shanghai, Peoples R China; [Wang, Yuping] Capital Med Univ, Xuanwu Hosp, Neurol Dept, Beijing, Peoples R China; [Wang, Tiancheng] Lanzhou Univ, Hosp 2, Neurol, Lanzhou, Gansu, Peoples R China; [Wu, Yuan] Guangxi Prov Med Coll, Affiliated Hosp 1, Nanning, Peoples R China; [Lang, Senyang] Chinese Peoples Liberat Army Gen Hosp, Neurol Dept, Beijing, Peoples R China; [Lin, Weihong] Jilin Univ, Affiliated Hosp 1, Changchun, Jilin, Peoples R China; [Song, Yijun] Tianjin Med Univ, Gen Hosp, Neurol Dept, Tianjin, Peoples R China; [Zhao, Heqing] Soochow Univ, Affiliated Hosp 2, Neurol Dept, Suzhou, Jiangsu, Peoples R China; [Cai, Meng] GlaxoSmithKline China Investment Co Ltd, Shanghai, Peoples R China		Hong, Z (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	tracypmyu@163.com; zhoudong66@yahoo.de; wpliao@163.net; wang.xin@zs-hospital.sh.cn; wangyp01@sina.cn; w_tianch@aliyun.com; 1360771316@126.com; langsy@263.net; linweihong321@126.com; songyijun2000@126.com; zhao_heqing@163.com; sabrina.m.cai@gsk.com; hongzhen@medmail.com.cn		Liao, Wei-Ping/0000-0001-9929-9185	GlaxoSmithKline (China) Investment Co. Ltd., Shanghai, China	Funding for this study was provided by GlaxoSmithKline (China) Investment Co. Ltd., Shanghai, China.	Al Za'abi Mohammed, 2013, Int J Pharm Pract, V21, P117, DOI 10.1111/j.2042-7174.2012.00240.x; Alacqua M, 2009, EPILEPSY RES, V85, P107, DOI 10.1016/j.eplepsyres.2009.03.002; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Brodie MJ, 1997, SEIZURE-EUR J EPILEP, V6, P159, DOI 10.1016/S1059-1311(97)80001-5; Chen HF, 2016, EPILEPSY BEHAV, V58, P26, DOI 10.1016/j.yebeh.2016.02.019; Chen LC, 2000, J CLIN PHARM THER, V25, P125, DOI 10.1046/j.1365-2710.2000.00271.x; Cummings C, 2011, ARCH DIS CHILD, V96, P643, DOI 10.1136/adc.2009.176990; Forsgren L, 1996, EPILEPSIA, V37, P224, DOI 10.1111/j.1528-1157.1996.tb00017.x; Gao L, 2015, EPILEPSY RES, V110, P146, DOI 10.1016/j.eplepsyres.2014.12.001; Gazzola DM, 2007, EPILEPSIA, V48, P1303, DOI 10.1111/j.1528-1167.2007.01136.x; Ge Y, 2015, EPILEPSY RES, V116, P99, DOI 10.1016/j.eplepsyres.2015.07.006; George J, 2015, VALUE HLTH REG ISSUE, V8, P92; Gu L, 2013, EPILEPSY RES, V105, P195, DOI 10.1016/j.eplepsyres.2013.02.002; Habib Mansur, 2013, BMC Res Notes, V6, P473, DOI 10.1186/1756-0500-6-473; Hamer HM, 2014, CNS DRUGS, V28, P753, DOI 10.1007/s40263-014-0187-x; Hamer HM, 2012, J NEUROL, V259, P2376, DOI 10.1007/s00415-012-6509-3; Hao XT, 2011, EPILEPSY BEHAV, V22, P388, DOI 10.1016/j.yebeh.2011.06.035; Harden CL, 2009, NEUROLOGY, V73, P133, DOI 10.1212/WNL.0b013e3181a6b312; Haroon A, 2012, ANN INDIAN ACAD NEUR, V15, P289, DOI 10.4103/0972-2327.104338; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hong Z, 2009, EPILEPSIA, V50, P2192, DOI 10.1111/j.1528-1167.2009.02185.x; Hsieh LP, 2011, EPILEPSY RES, V96, P81, DOI 10.1016/j.eplepsyres.2011.05.003; Johnson EK, 2004, EPILEPSIA, V45, P544, DOI 10.1111/j.0013-9580.2004.47003.x; Kanner AM, 2003, EPILEPSY BEHAV, V4, pS11, DOI 10.1016/j.yebeh.2003.10.004; Kwong KL, 2012, PEDIATR NEUROL, V46, P281, DOI 10.1016/j.pediatrneurol.2012.02.019; Machado-Alba JE, 2016, NEUROLOGIA, V31, P89, DOI 10.1016/j.nrl.2015.06.015; Malerba A, 2010, EPILEPSY RES, V91, P273, DOI 10.1016/j.eplepsyres.2010.08.002; National Institute for Health and Care Excellence, 2012, EP DIAGN MAN EP AD C; Nicholas JM, 2012, SEIZURE-EUR J EPILEP, V21, P466, DOI 10.1016/j.seizure.2012.04.014; Noda AH, 2015, SEIZURE-EUR J EPILEP, V26, P49, DOI 10.1016/j.seizure.2015.01.010; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Perucca E, 2007, LANCET NEUROL, V6, P793, DOI 10.1016/S1474-4422(07)70215-6; Pi XR, 2014, SEIZURE-EUR J EPILEP, V23, P636, DOI 10.1016/j.seizure.2014.05.002; Pi XR, 2012, EPILEPSY RES, V101, P129, DOI 10.1016/j.eplepsyres.2012.03.012; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Sebastian J, 2013, NEUROL ASIA, V18, P159; St Louis EK, 2009, CURR NEUROPHARMACOL, V7, P106, DOI 10.2174/157015909788848857; Swinkels WAM, 2001, EPILEPSY BEHAV, V2, P441, DOI 10.1006/ebeh.2001.0242; Tian HJ, 2015, INT J CLIN EXP MED, V8, P2399; Tomson T, 2015, EPILEPSIA, V56, P1006, DOI 10.1111/epi.13021; van de Vrie-Hoekstra NW, 2008, EUR J CLIN PHARMACOL, V64, P1013, DOI 10.1007/s00228-008-0480-z; Wang Wenzhi, 2002, Zhonghua Yi Xue Za Zhi, V82, P449; World Health Organization Collaborating Centre for Drug Statisctics Methodology, 2016, ATC DDD IND; Yu PM, 2012, EPILEPSY BEHAV, V23, P36, DOI 10.1016/j.yebeh.2011.10.018; Zhao T, 2012, SEIZURE-EUR J EPILEP, V21, P367, DOI 10.1016/j.seizure.2012.03.006	48	10	12	2	18	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	APR	2017	69						126	132		10.1016/j.yebeh.2016.09.021			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	EU5ZX	WOS:000401114500022	28242476				2022-02-06	
J	Zhang, Q; Yuan, TB; Li, YA; Xin, X; He, JH; Wang, QJ				Zhang Qi; Yuan Tianbao; Li Yanan; Xin Xi; He Jinhua; Wang Qiujun			Pre-treatment with nimodipine and 7.5% hypertonic saline protects aged rats against postoperative cognitive dysfunction via inhibiting hippocampal neuronal apoptosis	BEHAVIOURAL BRAIN RESEARCH			English	Article						Post-operative cognition dysfunction; Hippocampus; Neuronal apoptosis; Cytoplasmic calcium	TRAUMATIC BRAIN-INJURY; MICROGLIAL ACTIVATION; INTRACELLULAR CALCIUM; INTRACRANIAL-PRESSURE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ANESTHETICS; ISOFLURANE; MICE; NEUROTOXICITY	Objective: This study aimed to investigate the effects of pre-treatment with nimodipine and 7.5% hypertonic saline (HS) on postoperative cognitive dysfunction (POCD) in aged rats. Methods: Healthy Sprague-Dawley aged rats were randomly assigned into 4 groups: POCD group, nimodipine group, HS group, and nimodipine + HS group. Rats in POCD group received normal saline injection and then splenectomy 30 min later under 1.8% isoflurane inhalation for 2 h. In remaining groups, rats received injection of 1 mg/kg nimodipine (i.p) and/or 4 ml/kg 7.5% HS (i.v) and then splenectomy. Morris water maze test was performed before and after surgery. The hippocampus was harvested for the detection of neuronal apoptosis rate (AR), cytoplasmic calcium ([Ca2+](i)), Bcl-2 and Bax mRNA expression and hippocampal neuronal ultrastructure. Results: When compared with POCD group, the latency to escape, neuronal AR, [Ca2+](i), Bax mRNA expression and Bax/Bcl-2 ratio reduced dramatically, but the times of crossing the platform and Bcl-2 mRNA expression increased significantly (P < 0.05) in nimodipine group, NS group and nimodipine + HS group. In addition, the latency to escape, neuronal AR, [Ca2+]i, Bax mRNA expression and Bax/Bcl-2 ratio reduced markedly, but the times of crossing the platform and Bcl-2 mRNA expression increased significantly in nimodipine + HS group as compared to nimodipine group and NS group (P < 0.05). Hippocampal neuronal ultrastructure damage was observed in all 4 groups, but it was the mildest in nimodipine + HS group. Conclusion: Pre-treatment with both nimodipine and 7.5% HS exerts better protective effects, which is related to the inhibition of hippocampal neuronal apoptosis. (C) 2016 Elsevier B.V. All rights reserved.	[Zhang Qi; Yuan Tianbao; Li Yanan; Xin Xi; He Jinhua; Wang Qiujun] Hebei Med Univ, Hosp 3, Dept Anesthesiol, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China		Wang, QJ (corresponding author), Hebei Med Univ, Hosp 3, Dept Anesthesiol, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China.	wanggiujunsjz@163.com	Wang, LJ/P-5481-2018				Al-Rawi PG, 2010, STROKE, V41, P122, DOI 10.1161/STROKEAHA.109.560698; Androsova G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00112; Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7; Berger Miles, 2015, Anesthesiol Clin, V33, P517, DOI 10.1016/j.anclin.2015.05.008; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Drobish JK, 2016, TOXICOL SCI, V154, P309, DOI 10.1093/toxsci/kfw164; ETIENNE P, 1987, NEUROBIOL AGING, V8, P362, DOI 10.1016/0197-4580(87)90081-9; Ge HW, 2015, PHYSIOL BEHAV, V151, P16, DOI 10.1016/j.physbeh.2015.07.008; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Haile M, 2009, J NEUROSURG ANESTH, V21, P140, DOI 10.1097/ANA.0b013e3181920d28; Hovens IB, 2015, NEUROBIOL LEARN MEM, V118, P74, DOI 10.1016/j.nlm.2014.11.009; Huang LQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-102; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kim H, 2006, TOXICOLOGY, V220, P169, DOI 10.1016/j.tox.2005.12.010; Kindler CH, 1999, ANESTHESIOLOGY, V90, P1137, DOI 10.1097/00000542-199904000-00029; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1; Landfield PW, 1996, LIFE SCI, V59, P399, DOI 10.1016/0024-3205(96)00318-9; Li YQ, 2015, MED SCI MONITOR, V21, P1752, DOI 10.12659/MSM.892924; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; MOHAMED AA, 1985, J CEREBR BLOOD F MET, V5, P26, DOI 10.1038/jcbfm.1985.4; Mojtahedzadeh M, 2014, J RES MED SCI, V19, P867; Motaharinia J, 2015, DARU, V23, DOI 10.1186/s40199-015-0130-9; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; Ovey IS, 2015, NEUROSCIENCE, V284, P225, DOI 10.1016/j.neuroscience.2014.09.078; Pan K, 2016, NEUROPHARMACOLOGY, V111, P180, DOI 10.1016/j.neuropharm.2016.09.004; Pappa M. D., 2016, GLOB J HLTH SCI, V9, P60738; Piper BJ, 2015, ANAESTH INTENS CARE, V43, P204, DOI 10.1177/0310057X1504300210; Qiu LL, 2016, BRAIN BEHAV IMMUN, V51, P109, DOI 10.1016/j.bbi.2015.08.002; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Ruiz A, 2009, CELL CALCIUM, V46, P273, DOI 10.1016/j.ceca.2009.08.005; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; SCRIABINE A, 1988, ANN NY ACAD SCI, V522, P698; Small DH, 2009, NEUROCHEM RES, V34, P1824, DOI 10.1007/s11064-009-9960-5; Steinmetz J, 2016, ANAESTHESIA, V71, P58, DOI 10.1111/anae.13308; Taya K, 2000, PHYSIOL BEHAV, V70, P19, DOI 10.1016/S0031-9384(00)00221-3; Tian Y, 2016, MOL NEUROBIOL; Tomassoni D, 2008, CLIN EXP HYPERTENS, V30, P744, DOI 10.1080/10641960802580232; Vlisides P, 2012, CURR PHARM DESIGN, V18, P6232, DOI 10.2174/138161212803832344; Vorhees CV, 2014, NEUROTOXICOL TERATOL, V45, P75, DOI 10.1016/j.ntt.2014.07.003; Wang PL, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-88; Wang QJ, 2008, CHINESE MED J-PEKING, V121, P341, DOI 10.1097/00029330-200802020-00012; Wu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138256; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xiong B, 2016, AM J TRANSL RES, V8, P70; Yang Y, 2016, NEUROREPORT, V27, P124, DOI 10.1097/WNR.0000000000000509; Yuan Tianbao, 2015, Zhonghua Yi Xue Za Zhi, V95, P217; [袁天宝 Yuan Tianbao], 2014, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V34, P1054; Zhang ZJ, 2016, INT IMMUNOPHARMACOL, V38, P426, DOI 10.1016/j.intimp.2016.06.031	51	10	13	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2017	321						1	7		10.1016/j.bbr.2016.12.029			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EL1TJ	WOS:000394403600001	28017853				2022-02-06	
J	Allan, AC; Edmed, SL; Sullivan, KA; Karlsson, LJE; Lange, RT; Smith, SS				Allan, Alicia C.; Edmed, Shannon L.; Sullivan, Karen A.; Karlsson, Lina J. E.; Lange, Rael T.; Smith, Simon S.			Actigraphically Measured Sleep-Wake Behavior After Mild Traumatic Brain Injury: A Case-Control Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						actigraphy; concussion; mild traumatic brain injury; postconcussion syndrome; sleep disturbance	INSOMNIA SEVERITY INDEX; SELF-REPORT MEASURES; SCALE ESS; DISTURBANCE; DISORDERS; DURATION; MTBI; METAANALYSIS; ADOLESCENTS; PERFORMANCE	Objective: To characterize and compare the sleep-wake behavior of individuals following a mild traumatic brain injury (mTBI) with that of noninjured healthy controls. Setting: Community. Participants: Fourteen participants with a recent mTBI (M-age = 28.07; SD = 10.45; n = 10 females) and 34 noninjured controls (M-age = 23.70; SD = 7.30; n = 31 females). Design: Cross-sectional. Main Measures: Battery of subjective sleep measures and 14 days of sleep-wake monitoring via actigraphy (objective measurement) and concurrent daily sleep diary. Results: Participants who had sustained an mTBI self-reported significantly higher sleep-related impairment, poorer nightly sleep quality, and more frequently met criteria for clinical insomnia, compared with controls (d = 0.76-1.11, large effects). The only significant between-group difference on objective sleep metrics occurred on sleep timing. On average, people with a recent history of mTBI fell asleep and woke approximately 1 hour earlier than did the controls (d = 0.62-0.92, medium to large effects). Conclusion: Participants with a history of mTBI had several subjective sleep complaints but relatively few objective sleep changes with the exception of earlier sleep timing. Future research is needed to understand the clinical significance of these findings and how these symptoms can be alleviated. Interventions addressing subjective sleep complaints (eg, cognitive behavior therapy for insomnia) should be tested in this population.	[Allan, Alicia C.; Edmed, Shannon L.; Sullivan, Karen A.; Karlsson, Lina J. E.; Smith, Simon S.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld, Australia; [Allan, Alicia C.; Edmed, Shannon L.; Sullivan, Karen A.; Smith, Simon S.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Ctr Accid Res & Rd Safety, Brisbane, Qld, Australia; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Sullivan, KA (corresponding author), Queensland Univ Technol, Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045	Institute of Health and Biomedical Innovation, Queensland University of Technology	Research funding was awarded to Professor Karen Sullivan, Associate Professor Simon Smith, Professor David Kavanagh, and Dr Melanie White (Chief Investigators) by the Institute of Health and Biomedical Innovation, Queensland University of Technology. This project was granted an occupational workplace health and safety clearance. The authors thank Professor David Kavanagh and Dr Melanie White who kindly reviewed a draft of the manuscript.	American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Dinges DF, 1997, SLEEP, V20, P267; Field A., 2017, DISCOVERING STAT USI, V5th; Foster RG, 2013, PROG MOL BIOL TRANSL, V119, P325, DOI 10.1016/B978-0-12-396971-2.00011-7; Fox-Wasylyshyn SM, 2005, RES NURS HEALTH, V28, P488, DOI 10.1002/nur.20100; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pigarev I. N., 2012, NEUROSCI BEHAV PHYSL, V42, P948, DOI [10.1007/s11055-012-9661-4, DOI 10.1007/S11055-012-9661-4]; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Sladek MR, 2015, J YOUTH ADOLESCENCE, V44, P298, DOI 10.1007/s10964-014-0244-2; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; Smith S, 2001, J SLEEP RES, V10, P229, DOI 10.1046/j.1365-2869.2001.00262.x; Smith S, 2007, SLEEP MED, V9, P102, DOI 10.1016/j.sleep.2006.11.012; Smith SS, 2008, SLEEP MED, V9, P739, DOI 10.1016/j.sleep.2007.08.004; Smith SS, 2012, INT J SOC PSYCHIATR, V58, P166, DOI 10.1177/0020764010387551; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tabachnick B.G., 2001, USING MULTIVARIATE S; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	52	10	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E35	E45		10.1097/HTR.0000000000000222			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700005	27022957				2022-02-06	
J	Lombardo, S; Scalea, T; Sperry, J; Coimbra, R; Vercruysse, G; Enniss, T; Jurkovich, GJ; Nirula, R				Lombardo, Sarah; Scalea, Thomas; Sperry, Jason; Coimbra, Raul; Vercruysse, Gary; Enniss, Toby; Jurkovich, Gregory J.; Nirula, Raminder			Neuro, trauma, or med/surg intensive care unit: Does it matter where multiple injuries patients with traumatic brain injury are admitted? Secondary analysis of the American Association for the Surgery of Trauma Multi-Institutional Trials Committee decompressive craniectomy study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						ICU; multiple injuries; TBI; outcomes	HEAD-INJURY; MANAGEMENT; OUTCOMES; MORTALITY; GUIDELINES; LENGTH; STAY	INTRODUCTION Patients with nontraumatic acute intracranial pathology benefit from neurointensivist care. Similarly, trauma patients with and without traumatic brain injury (TBI) fare better when treated by a dedicated trauma team. No study has yet evaluated the role of specialized neurocritical (NICU) and trauma intensive care units (TICU) in the management of TBI patients, and it remains unclear which TBI patients are best served in NICU, TICU, or general (Med/Surg) ICU. METHODS This study is a secondary analysis of The American Association for the Surgery of Trauma Multi-Institutional Trials Committee (AAST-MITC) decompressive craniectomy study. Twelve Level 1 trauma centers provided clinical data and head computed tomography (CT) scans of patients with Glasgow Coma Scale score of 13 or less and CT evidence of TBI. Non-ICU admissions were excluded. Multivariate logistic regression was performed to measure the association between ICU type and survival and calculate the probability of death for increasing Injury Severity Score (ISS). Multiple injuries patients (ISS > 15) with TBI and isolated TBI patients (other Abbreviated Injury Scale score < 3) were analyzed separately. RESULTS There were 3641 patients with CT evidence of TBI with 2951 admitted to an ICU. Before adjustment, patient demographics, injury severity, and survival differed significantly by unit type. After adjustment, unit type, age, and ISS remained independent predictors of death. Unit type modified the effect of ISS on mortality. TBI multiple injuries patients admitted to a TICU had improved survival across increasing ISS. Survival for isolated TBI patients was similar between TICU and NICU. Med/surg ICU carried the greatest probability of death. CONCLUSION Multiple injuries patients with TBI have lower mortality risk when admitted to a trauma ICU. This survival benefit increases with increasing injury severity. Isolated TBI patients have similar mortality risk when admitted to a neuro ICU compared with a trauma ICU. Med/surg ICU admission carries the highest mortality risk. LEVEL OF EVIDENCE Therapeutic study, level IV.	[Lombardo, Sarah; Enniss, Toby; Nirula, Raminder] Univ Utah, Dept Surg, 50 North Med Dr, Salt Lake City, UT 84132 USA; [Scalea, Thomas] Univ Maryland, Baltimore Shock Trauma, Baltimore, MD 21201 USA; [Sperry, Jason] Univ Pittsburgh, Med Ctr, Dept Surg, Div Trauma & Gen Surg, Pittsburgh, PA USA; [Coimbra, Raul] Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Cares Sur, San Diego, CA 92103 USA; [Vercruysse, Gary] Univ Arizona, Dept Surg, Med Ctr, Tucson, AZ USA; [Jurkovich, Gregory J.] UC Davis Hlth Syst, Dept Surg, Sacramento, CA USA		Lombardo, S (corresponding author), Univ Utah, Dept Surg, 50 North Med Dr, Salt Lake City, UT 84132 USA.	sarah.lombardo@hsc.utah.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851	NIH funded study (NIH National Institute of Neurological Disorders and Stroke) [1RC1NS069066-01, 5RC1NS069066-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC1NS069066] Funding Source: NIH RePORTER	This was a secondary analysis of data that was obtained from an NIH funded study (NIH National Institute of Neurological Disorders and Stroke 1RC1NS069066-01 and 5RC1NS069066-02) which was completed and published (article PMID: 24662856). The analysis for this article was not directly funded by this grant only the acquisition of the data on which it is based. The authors declare no conflicts of interest.	Ang DN, 2009, J AM COLL SURGEONS, V209, P595, DOI 10.1016/j.jamcollsurg.2009.08.003; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; Davis KA, 2008, J TRAUMA, V65, P1236, DOI 10.1097/TA.0b013e31818ba311; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Duane Therese M, 2008, J Emerg Trauma Shock, V1, P74, DOI 10.4103/0974-2700.43183; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Harrison D, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17030; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Klein AL, 2014, J TRAUMA ACUTE CARE, V77, P964, DOI 10.1097/TA.0000000000000460; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mains C, 2009, J TRAUMA, V66, P1315, DOI 10.1097/TA.0b013e31819d96d8; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Park CA, 2001, AM SURGEON, V67, P665; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Sise CB, 2011, J TRAUMA, V70, P560, DOI 10.1097/TA.0b013e31820c7b79; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713	25	10	10	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2017	82	3					489	496		10.1097/TA.0000000000001361			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EM8XV	WOS:000395595300007	28225527	Green Accepted			2022-02-06	
J	Martin, RM; Wright, MJ; Lutkenhoff, ES; Ellingson, BM; Van Horn, JD; Tubi, M; Alger, JR; McArthur, DL; Vespa, PM				Martin, Ryan M.; Wright, Matthew J.; Lutkenhoff, Evan S.; Ellingson, Benjamin M.; Van Horn, John D.; Tubi, Meral; Alger, Jeffry R.; McArthur, David L.; Vespa, Paul M.			Traumatic hemorrhagic brain injury: impact of location and resorption on cognitive outcome	JOURNAL OF NEUROSURGERY			English	Article						MRI; neuropsychological; traumatic brain injury; hemorrhage; brain; trauma	SELECTIVE REMINDING TEST; INTRACEREBRAL HEMORRHAGE; METABOLIC CRISIS; IMAGE-ANALYSIS; AXONAL INJURY; HEAD-INJURY; MRI; MODERATE; EDEMA; IRON	OBJECTIVE Hemorrhagic contusions are often the most visible lesions following traumatic brain injury. However, the incidence, location, and natural history of traumatic parenchymal hemorrhage and its impact on neurological outcome have been understudied. The authors sought to examine the location and longitudinal evolution of traumatic parenchymal hemorrhage and its association with cognitive outcome. METHODS Sixteen patients with hemorrhagic contusions due to acceleration-deceleration injuries underwent MRI in the acute (mean 6.3 days postinjury) and chronic (mean 192.9 days postinjury) phases. ImageJ was used to generate GRE and FLAIR volumes. To account for the effect of head-size variability across individuals, the authors calculated each patient's total brain tissue volume using SIENAX. GRE and FLAIR volumes were normalized to the total brain tissue volume, and values for absolute and percent lesion volume and total brain volume change were generated. Spearman's rank correlations were computed to determine associations between neuroimaging and 6-month postinjury neuropsychological testing of attention (Symbol Digit Modalities Test [SDMT], oral [0] and written [W] versions), memory (Selective Reminding Test, total learning and delayed recall), and executive function (Trail Making Test Part B [TMT-B]). RESULTS The patients' mean age was 31.4 +/- 14.0 years and their mean Glasgow Coma Scale score at admission was 7.9 +/- 2.8. Lesions were predominantly localized to the frontal (11 lesions) and temporal (9 lesions) lobes. The average percent reductions in GRE and FLAIR volumes were 44.2% +/- 46.1% and 80.5% +/- 26.3%, respectively. While total brain and frontal lesion volumes did not correlate with brain atrophy, larger temporal lobe GRE and FLAIR volumes were associated with larger volumes of atrophy (GRE: acute, -0.87, p < 0.01, chronic, -0.78, p < 0.01; FLAIR: acute, -0.81, p < 0.01, chronic, 0.88, p < 0.01). Total percent volume change of GRE lesions correlated with TMT-B (0.53, p < 0.05) and SDMT-O (0.62, p < 0.05) scores. Frontal lobe lesion volume did not correlate with neuropsychological outcome. However, robust relationships were seen in the temporal lobe, with larger acute temporal lobe GRE volumes were associated with worse scores on both oral and written versions of the SDMT (SDMT-W, -0.85, p < 0.01; SDMT-O, -0.73, p < 0.05). Larger absolute change in temporal GRE volume was strongly associated with worse SDMT scores (SDMT-W, 0.88, p < 0.01; SDMT-O, 0.75, p < 0.05). The same relationships were also seen between temporal FLAIR lesion volumes and neuropsychological outcome. CONCLUSIONS Traumatic parenchymal hemorrhages are largely clustered in the frontal and temporal lobes, and significant residual blood products are present at 6 months postinjury, a potential source of ongoing secondary brain injury. Neuropsychological outcome is closely tied to lesion volume size, particularly in the temporal lobe, where larger GRE and FLAIR volumes are associated with more brain atrophy and worse SDMT scores. Interestingly, larger volumes of hemorrhage resorption were associated with worse SDMT and TMT-B scores, suggesting that the initial tissue damage had a lasting impact on attention and executive function.	[Martin, Ryan M.; Tubi, Meral; McArthur, David L.; Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Martin, Ryan M.; Alger, Jeffry R.; Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Wright, Matthew J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Lutkenhoff, Evan S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Ellingson, Benjamin M.] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Van Horn, John D.] Univ Southern Calif, Dept Neurol, Los Angeles, CA USA		Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 757 Westwood Blvd,RR 6236A, Los Angeles, CA 90095 USA.; Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, 757 Westwood Blvd,RR 6236A, Los Angeles, CA 90095 USA.	pvespa@mednet.ucla.edu		Van Horn, John/0000-0003-1537-0816; Tubi, Meral/0000-0003-0435-8352			Army U. S, 1944, ARM IND TEST BATT MA; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Hayman LA, 1992, CLIN BRAIN IMAGING N, P130; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Lezak M, 2004, NEUROPSYCHOLOGICAL A, P158; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Meyers JE, 2009, APPL NEUROPSYCHOL, V16, P237, DOI 10.1080/09084280903098752; Mitrushina M, 2005, HDB NORMATIVE DATA N, P648; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; de la Ossa NP, 2010, STROKE, V41, P810, DOI 10.1161/STROKEAHA.109.570168; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1	43	10	11	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2017	126	3					796	804		10.3171/2016.3.JNS151781			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	EL9FT	WOS:000394926200013	27231979	Green Submitted			2022-02-06	
J	Miescier, MJ; Dudley, NC; Kadish, HA; Mundorff, MB; Corneli, HM				Miescier, Michael J.; Dudley, Nanette C.; Kadish, Howard A.; Mundorff, Michael B.; Corneli, Howard M.			Variation in Computed Tomography Use for Evaluation of Head Injury in a Pediatric Emergency Department	PEDIATRIC EMERGENCY CARE			English	Article						variation; computed tomography; head injury	RESOURCE USE; CT; CHILDREN; CARE; PHYSICIANS; PNEUMONIA; HOSPITALS; QUALITY; TRENDS	Objectives: Recent research has shown significant variation in rates of computed tomography (CT) use among pediatric hospital emergency departments (ED) for evaluation of head injured children. We examined the rates of CT use by individual ED attending physicians for evaluation of head injured children in a pediatric hospital ED. Methods: We used an administrative database to identify children younger than 18 years evaluated for head injury from January 2011 through March 2013 at our children's hospital ED, staffed by pediatric emergency medicine (PEM) fellowship trained physicians and pediatricians. We excluded encounters with trauma team activation or previous head CT performed elsewhere. We excluded physicians whose patient volume was less than 1 standard deviation below the group mean. Results: After exclusions, we evaluated 5340 encounters for head injury by 27 ED attending physicians. For individual physicians, CT rates ranged from 12.4% to 37.3%, with a mean group rate of 28.4%. Individual PEM physician CT rates ranged from 18.9% to 37.3%, versus 12.4% to 31.8% for pediatricians. Of the 1518 encounters in which CT was done, 128 (8.4%) had a traumatic brain injury on CT, and 125 (8.2%) had a simple skull fracture without traumatic brain injury on CT. Patient factors associated with CT use included age younger than 2 years, higher triage acuity, arrival time of 10: 00 PM to 6: 00 AM, hospital admission, and evaluation by a PEM physician. Conclusions: Physicians at our pediatric hospital ED varied in the use of CT for the evaluation of head-injured children.	[Miescier, Michael J.; Dudley, Nanette C.; Kadish, Howard A.; Corneli, Howard M.] Univ Utah, Sch Med, Dept Pediat, Div Pediat Emergency Med, POB 581289, Salt Lake City, UT 84158 USA; [Mundorff, Michael B.] Univ Utah, Sch Med, Syst Improvement Dept, Intermountain Healthcare, Salt Lake City, UT 84158 USA		Miescier, MJ (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Pediat Emergency Med, POB 581289, Salt Lake City, UT 84158 USA.	michael.miescier@hsc.utah.edu					Beckman HH, 2012, PARTNERING PHYS REDU; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cammisa Chris, 2011, Am J Med Qual, V26, P26, DOI 10.1177/1062860610373380; Faul M, 2010, TRAUMATIC BRAIN INJU; Florin TA, 2013, PEDIATRICS, V132, P237, DOI 10.1542/peds.2013-0179; Gilboy N, 2011, AHRQ PUBLICATION, V12; Guttmann A, 2006, PEDIATRICS, V118, P114, DOI 10.1542/peds.2005-3029; Jain S, 2010, PEDIATR EMERG CARE, V26, P902, DOI 10.1097/PEC.0b013e3181fe9108; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Knapp JF, 2013, PEDIATRICS, V132, P245, DOI 10.1542/peds.2012-2830; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levine MB, 2013, AM J EMERG MED, V31, P1437, DOI 10.1016/j.ajem.2013.07.003; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Neuman MI, 2013, PEDIATRICS, V132, P369, DOI 10.1542/peds.2013-1569; Neuman MI, 2011, PEDIATR EMERG CARE, V27, P606, DOI 10.1097/PEC.0b013e3182225578; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Prevedello LM, 2013, AM J MED, V126, P975, DOI 10.1016/j.amjmed.2013.04.018; Prevedello LM, 2012, AM J MED, V125, P356, DOI 10.1016/j.amjmed.2011.06.023; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Tieder JS, 2013, PEDIATRICS, V132, P229, DOI 10.1542/peds.2013-0359	20	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2017	33	3					156	160					5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	EN1XH	WOS:000395803200004	26196366				2022-02-06	
J	Pozzi, M; Conti, V; Locatelli, F; Galbiati, S; Radice, S; Clementi, E; Strazzer, S				Pozzi, Marco; Conti, Valentino; Locatelli, Federica; Galbiati, Sara; Radice, Sonia; Clementi, Emilio; Strazzer, Sandra			Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Pathological Features and Scheduled Pharmacological Therapies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						drug therapy; pediatric; paroxysmal sympathetic hyperactivity; rehabilitation	TRAUMATIC BRAIN-INJURY; DYSAUTONOMIA; BACLOFEN; MANAGEMENT; CHILDREN; SLEEP	Objective: Information on course and treatment of paroxysmal sympathetic hyperactivity (PSH) during rehabilitation and in pediatric patients is lacking. To increase knowledge on the course and treatment of PSH in pediatric patients during rehabilitation, we retrospectively analyzed 23 pediatric patients with PSH, describing the course of PSH and administered drugs, and explored the association of PSH remission with drug doses. Setting: Neurorehabilitation unit of IRCCS Eugenio Medea, Bosisio Parini (LC), Italy. Participants: Twenty-three pediatric patients with postacute acquired brain injury, who remitted from PSH. Design: Retrospective cohort study. Main Measures: Description of features and course of PSH, description of drug therapies, and analysis of covariance of their doses. Correlations between remission and drug doses/clinical variables. Estimation of the odds ratios of remission. Results: At admittance patients displayed at least 3 features of PSH with an overall score of 9, which diminished progressively during remission. Therapies with propranolol, baclofen, niaprazine, and diazepam were progressively uptitrated, indicating potential usefulness. When testing possible predictors of remission, we found positive effects of propranolol and diazepam and of traumatic etiology and a negative effect of maximum PSH severity. Conclusions: Results should be interpreted carefully regarding causal relationships and drug doses and combinations, but they encourage further studies on the use of propranolol and diazepam to favor PSH remission.	[Pozzi, Marco; Locatelli, Federica; Galbiati, Sara; Clementi, Emilio; Strazzer, Sandra] Sci Inst IRCCS Eugenio Medea, Lecce, Italy; [Conti, Valentino] Reg Ctr Pharmacovigilance Lombardy, Milan, Italy; [Radice, Sonia] Univ Milan, Clin Pharmacol Unit, Dept Biomed & Clin Sci L Sacco, Luigi Sacco Univ Hosp, Milan, Italy; [Clementi, Emilio] Univ Milan, Clin Pharmacol Unit, Dept Biomed & Clin Sci L Sacco, Luigi Sacco Univ Hosp,CNR Inst Neurosci, Milan, Italy		Strazzer, S (corresponding author), Sci Inst IRCCS Eugenio Medea, UO Gravi Cerebroles Acquisite NR3, I-23842 Bosisio Parini, Lecco, Italy.	sandra.strazzer@lanostrafamiglia.it	Pozzi, Marco/Z-2684-2019; Galbiati, Sara/AAA-7115-2020; FEDERICA, LOCATELLI/AAA-5601-2020; Strazzer, Sandra/AAH-5712-2019; Pozzi, Marco/J-7915-2016	Pozzi, Marco/0000-0002-3800-5697; Galbiati, Sara/0000-0001-6810-359X; FEDERICA, LOCATELLI/0000-0002-8243-5483; Strazzer, Sandra/0000-0001-8414-6565; Pozzi, Marco/0000-0002-3800-5697	Agenzia Italiana del Farmaco (AIFA); Regione Lombardia (MEAP Project, Monitoraggio degli Eventi Avversi in Pediatria)Regione Lombardia; Italian Ministry of Health (Ricerca Corrente)Ministry of Health, Italy	The financial support by Agenzia Italiana del Farmaco (AIFA) and Regione Lombardia (MEAP Project, Monitoraggio degli Eventi Avversi in Pediatria, to EC) and by the Italian Ministry of Health (Ricerca Corrente 2016, to EC and SS) is gratefully acknowledged. The funding public institutions had no role in any part of the work.	Altamura AC, 2013, EXPERT OPIN DRUG MET, V9, P423, DOI 10.1517/17425255.2013.759209; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dolce G, 2008, J NEUROTRAUM, DOI [10.1089/neu.2008.0536, DOI 10.1089/NEU.2008.0536, 10.1089/neu.2008.0536.]; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Duedahl TH, 2007, PEDIATR ANESTH, V17, P756, DOI 10.1111/j.1460-9592.2007.02213.x; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Laxe S, 2013, BRAIN INJURY, V27, P1383, DOI 10.3109/02699052.2013.823648; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; McCormick ZL, 2016, PM&R, V8, P553, DOI 10.1016/j.pmrj.2015.10.005; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; OTTAVIANO S, 1991, CHILD NERV SYST, V7, P332, DOI 10.1007/BF00304832; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P366, DOI 10.1097/HTR.0000000000000115; Pozzi M, 2014, J NEUROTRAUM, V31, P1897, DOI 10.1089/neu.2014.3540; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Siefferman JW, 2015, CASE REP NEUROL MED, V2015, DOI 10.1155/2015/421563; WALI FA, 1985, ACTA ANAESTH SCAND, V29, P785, DOI 10.1111/j.1399-6576.1985.tb02301.x	30	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					117	124		10.1097/HTR.0000000000000255			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700013	27603764				2022-02-06	
J	Cline, MM; Yumul, JC; Hysa, L; Murra, D; Garvin, GG; Cook, DG; Ladiges, WC; Minoshimaa, S; Cross, DJ				Cline, Marcella M.; Yumul, Josh C.; Hysa, Lisa; Murra, Dalia; Garvin, Gregory G.; Cook, David G.; Ladiges, Warren C.; Minoshimaa, Satoshi; Cross, Donna J.			Novel application of a Radial Water Tread maze can distinguish cognitive deficits in mice with traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Cognitive testing; Behavioral testing; Water maze; Controlled-cortical impact	CONTROLLED CORTICAL IMPACT; MOUSE MODEL; RATS; PERFORMANCE; IMPAIRMENT; RESPONSES; SEARCH; TASK	Introduction: The use of forced-swim, rat-validated cognition tests in mouse models of traumatic brain injury (TBI) raises methodological concerns; such models are vulnerable to a number of confounding factors including impaired motor function and stress-induced non-compliance (failure to swim). This study evaluated the ability of a Radial Water Tread (RWT) maze, designed specifically for mice, that requires no swimming to distinguish mice with controlled cortical impact (CCI) induced TBI and Sham controls. Methods: Ten-week-old, male C57BL6/J mice were randomly assigned to receive either Sham (n = 14) or CCI surgeries (n = 15). Mice were tested for sensorimotor deficits via Gridwalk test and Noldus CatWalk gait analysis at I and 32 days post-injury. Mice received RWT testing at either 11 days (early time point) or 35 days (late time point) post-injury. Results: Compared to Sham-treated animals, CCI-induced TBI resulted in significant impairment in RWT maze performance. Additionally, CCI injured mice displayed significant deficits on the Gridwalk test at both I day and 32 days post-injury, and impairment in the CatWalk task at 1 day, but not 32 days, compared to Shams. Conclusions: The Radial Water Tread maze capitalizes on the natural tendency of mice to avoid open areas in favor of hugging the edges of an apparatus (thigmotaxis), and replaces a forced-swim model with water shallow enough that the animal is not required to swim, but aversive enough to motivate escape. Our findings indicate the RWT task is a sensitive species-appropriate behavioral test for evaluating spatial memory impairment in a mouse model of TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Cline, Marcella M.; Yumul, Josh C.; Hysa, Lisa; Murra, Dalia; Garvin, Gregory G.; Minoshimaa, Satoshi; Cross, Donna J.] Univ Washington, Dept Radiol, Seattle, WA USA; [Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA USA; [Garvin, Gregory G.; Minoshimaa, Satoshi; Cross, Donna J.] Univ Utah, Dept Radiol, 30 North 1900 East 1A71, Salt Lake City, UT 84132 USA; [Cook, David G.] Univ Washington, Dept Pharmacol, Seattle, WA USA; [Cook, David G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA USA		Cross, DJ (corresponding author), Univ Utah, Dept Radiol, 30 North 1900 East 1A71, Salt Lake City, UT 84132 USA.	donna.cross@hsc.utah.edu		Cline, Marcella/0000-0002-9590-3725; Minoshima, Satoshi/0000-0002-0043-3047; Cross, Donna/0000-0003-1918-2214; Murra, Dalia/0000-0002-7154-289X	Institute for Translational Health Sciences [UL1TR000423]; University of Washington Center on Human Development and DisabilityUniversity of Washington; University of Washington Animal Behavior Core and Brain Imaging Core; Department of Veterans Affairs Office of Research and Development Medical Research ServiceUS Department of Veterans Affairs; University of Washington Friends of Alzheimer's Research; UW Royalty Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002319, UL1TR000423] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002311] Funding Source: NIH RePORTER	This research was supported a by the Institute for Translational Health Sciences pilot project grant opportunity (UL1TR000423), the University of Washington Center on Human Development and Disability, University of Washington Animal Behavior Core and Brain Imaging Core, the Department of Veterans Affairs Office of Research and Development Medical Research Service (DGC), University of Washington Friends of Alzheimer's Research (DGC), and the UW Royalty Research Fund (DGC). We also thank Toby Cole for his assistance with this project.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Francis C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-883; FRANCIS DD, 1995, PHYSIOL BEHAV, V58, P57, DOI 10.1016/0031-9384(95)00009-8; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pettan-Brewer C, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.20679; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Wahlsten D, 2003, TRENDS NEUROSCI, V26, P132, DOI 10.1016/S0166-2236(03)00033-X; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; Wiley JC, 2011, AGING CELL, V10, P418, DOI 10.1111/j.1474-9726.2011.00680.x; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	32	10	10	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 15	2017	1657						140	147		10.1016/j.brainres.2016.11.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DI	WOS:000394919200015	27923635	Green Accepted			2022-02-06	
J	Effgen, GB; Morrison, B				Effgen, Gwen B.; Morrison, Barclay, III			Electrophysiological and Pathological Characterization of the Period of Heightened Vulnerability to Repetitive Injury in an in Vitro Stretch Model	JOURNAL OF NEUROTRAUMA			English	Article						cell death; concussion; electrophysiology; glia; hippocampus; repetitive injury	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SLICE CULTURES; LONG-TERM POTENTIATION; FLUID PERCUSSION INJURY; SPORT-RELATED CONCUSSION; TEMPORAL WINDOW; PROFESSIONAL FOOTBALL; HEAD ACCELERATION; OXIDATIVE STRESS; SPINAL-CORD	Clinical studies suggest that repeat exposures to mild traumatic brain injury (mTBI) or concussion, such as sports-related mTBI, result in verbal, memory, and motor deficits that can progressively worsen and take longer for recovery with each additional concussion. Pre-clinical studies suggest that mild mechanical injury of the brain can initiate a period of heightened vulnerability during which the brain is more susceptible to a subsequent mild injury. It is unknown how long this period of heightened vulnerability lasts and, as a result, appropriate return-to-play guidelines for athletes who have sustained sports-related mTBI could be better clarified. To better understand this pathology and define the duration of heightened vulnerability to subsequent exposure, we employed a well-defined stretch injury model to mechanically stimulate organotypic hippocampal slice cultures (OHSCs) and evaluated both electrophysiological and pathological markers of injury. We found that an initial mild stretch initiated a period of heightened vulnerability to a subsequent stretch that lasted at least 24 h. Two mild stretch injuries delivered 24 h apart significantly increased tissue injury, including cell death, damage to dendrites, increased nitrite production, astrogliosis, and loss of long-term potentiation (LTP). Cell loss, dendrite damage, and nitrite production were not significantly increased when the inter-injury interval was increased to 72 h; however, LTP deficits and astrogliosis persisted. An interval of 144 h was sufficient to prevent the detrimental effects of repetitive stretch. Improved understanding of the brain's response to repetitive mTBI in vitro may aid in translational studies, informing rest periods for the injured athlete.	[Effgen, Gwen B.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Center for Injury Prevention and Control of the Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1 R49 CE002096]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002096] Funding Source: NIH RePORTER	This research was funded in part by Grant 1 R49 CE002096 from the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention to the Center for Injury Epidemiology and Prevention at Columbia University Medical Center. The contents of the manuscript are the sole responsibility of the authors and do not necessarily reflect the official views of the funding agency. The authors acknowledge Roy Wang, Elise Gill, Kimberly A. Lynch, Tiffany Ong, Shruthi Nammalwar, Ayelet Lobel, Andrea I. Ortuno, Lamia Ateshian, Andrew A. Dobitsch, and Stephanie Yang for their skilled technical assistance in culture preparation and maintenance, stretch injury, and data analysis.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baeck K, 2014, COMPUT METHOD BIOMEC, V17, P405, DOI 10.1080/10255842.2012.688106; Bansal R, 2008, J AM ACAD CHILD PSY, V47, P619, DOI 10.1097/CHI.0b013e31816c54ed; Berger M, 2014, NAT NEUR S SAN FRANC; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Comstock R., 2014, NATL HIGH SCH SPORTS; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Effgen GB., 2016, J NEUROTRAU IN PRESS; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Gennarelli T. A, 2015, IRCOBI C LYON FRANC; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Kang WH, 2011, J NEUROTRAUM, V28, P1219, DOI 10.1089/neu.2011.1879; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Krosshaug T, 2005, BRIT J SPORT MED, V39, P330, DOI 10.1136/bjsm.2005.018358; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Price L., 2016, TRANSLATIONAL RES TR; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Selwyn R. G., 2016, J NEUROTRAUMA; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Siegmund G. P., 2015, ANN BIOMED IN PRESS; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Teasdale TW, 1997, BRIT MED J, V315, P569; Terranova ML, 2005, CURR PROTOC TOXICOL, V13, P101; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yu Z, 2009, IEEE ENG MED BIO, P1135; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287	70	10	10	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					914	924		10.1089/neu.2016.4477			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200019	27091089				2022-02-06	
J	Oliveira, RAG; Lima, MD; Paiva, WS; Malbouisson, LMD; Teixeira, MJ; Bor-Seng-Shu, E				Oliveira, Raphael A. G.; Lima, Marcelo de Oliveira; Paiva, Wellingson Silva; de Sa Malbouisson, Luiz Marcelo; Teixeira, Manuel Jacobsen; Bor-Seng-Shu, Edson			Comparison between Brain Computed Tomography Scan and Transcranial Sonography to Evaluate Third Ventricle Width, Peri-Mesencephalic Cistern, and Sylvian Fissure in Traumatic Brain-Injured Patients	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; transcranial color-coded sonography; midline shift; perimesencephalic cisterns; sylvian fissure	COLOR-CODED SONOGRAPHY; DUPLEX SONOGRAPHY; STROKE; ADULTS	Introduction: Transcranial color-coded duplex sonography (TCCS) may help guide multimodal monitoring in the neurocritical setting. It may provide indirect information about intracranial hypertension, such as midline shift, third ventricle width, and peri-mesencephalic cistern obliteration. We aim to assess the agreement between brain computed tomography scan (CT scan) and TCCS in traumatic brain injury (TBI) patients. Methods: In this retrospective cross-sectional observational study, TCCS was performed within 6 h before a brain CT scan. Only the first CT and TCCS after ICU admission were included. The agreement between the CT scan and TCCS was assessed by BlandAltman plots and evaluating the intraclass correlation coefficient. Results: Overall, 15 consecutive patients were included (80% male, 42 +/- 23 years of age, Glasgow Coma Score 5 [4,6]). The mean difference between the brain CT scan and TCCS in measuring the midline shift was 0.30 +/- 2.1 mm (intraclass correlation coefficient: 0.93; p < 0.01). An excellent correlation was also observed between the methods in assessing the third ventricle width (intraclass correlation coefficient: 0.88; p < 0.01). BlandAltman plots did not show any systematic bias in either agreement analysis. TCCS showed good accuracy in predicting non-compressed peri-mesencephalic cisterns (AUC: 0.83, 95% CI 0.461.0) and the presence of the Sylvian fissure (AUC: 0.91, 95% CI 0.731.0) on CT scan. Conclusion: TCCS is a promising tool and may be an alternative to CT scans for evaluating TBI patients.	[Oliveira, Raphael A. G.; de Sa Malbouisson, Luiz Marcelo] Univ Sao Paulo, Sch Med, Intens Care Unit, Hosp Clin,Discipline Gen Surg & Trauma, Sao Paulo, Brazil; [Lima, Marcelo de Oliveira; Paiva, Wellingson Silva; Teixeira, Manuel Jacobsen; Bor-Seng-Shu, Edson] Univ Sao Paulo, Sch Med, Hosp Clin, Div Neurosurg, Sao Paulo, Brazil		Oliveira, RAG (corresponding author), Univ Sao Paulo, Sch Med, Intens Care Unit, Hosp Clin,Discipline Gen Surg & Trauma, Sao Paulo, Brazil.	raphael.oliveira@hc.fm.usp.br	BOR-SENG-SHU, EDSON/AAC-9762-2019; Paiva, Wellingson S/G-5517-2013	BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Paiva, Wellingson S/0000-0002-5165-7040; de-Lima-Oliveira, Marcelo/0000-0002-7418-1516			Becker G, 2001, MOVEMENT DISORD, V16, P23, DOI 10.1002/1531-8257(200101)16:1<23::AID-MDS1003>3.0.CO;2-2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOGDAHN U, 1990, STROKE, V21, P1680, DOI 10.1161/01.STR.21.12.1680; Caricato A, 2012, CRIT CARE MED, V40, P1745, DOI 10.1097/CCM.0b013e318246b6ea; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARTIN PJ, 1994, STROKE, V25, P390, DOI 10.1161/01.STR.25.2.390; Meixensberger J, 1998, ACT NEUR S, V71, P260; Nedelmann M, 2009, STROKE, V40, P3238, DOI 10.1161/STROKEAHA.109.555169; Seidel G, 1996, J NEUROIMAGING, V6, P227, DOI 10.1111/jon199664227; SEIDEL G, 1995, STROKE, V26, P2061, DOI 10.1161/01.STR.26.11.2061; Seidel G, 1995, J Neuroimaging, V5, P105; Wijnhoud AD, 2008, ULTRASOUND MED BIOL, V34, P923, DOI 10.1016/j.ultrasmedbio.2007.11.022; Zipper SG, 2002, EUR J NEUROL, V9, P1, DOI 10.1046/j.1468-1331.2002.00272.x	15	10	10	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 15	2017	8								44	10.3389/fneur.2017.00044			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK9ZQ	WOS:000394282900001	28261152	gold, Green Published			2022-02-06	
J	Wu, JG; Zhu, CJ; Yang, LS; Wang, ZG; Wang, LN; Wang, SB; Gao, P; Zhang, YL; Jiang, QY; Zhu, XT; Shu, G				Wu, Junguo; Zhu, Canjun; Yang, Liusong; Wang, Zhonggang; Wang, Lina; Wang, Songbo; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Zhu, Xiaotong; Shu, Gang			N-Oleoylglycine-Induced Hyperphagia Is Associated with the Activation of Agouti-Related Protein (AgRP) Neuron by Cannabinoid Receptor Type 1 (CB1R)	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY			English	Article						N-acyl amino acids; food intake; anxiety behavior; CB1R; AgRP secretion	ARACHIDONOYL-L-SERINE; TRAUMATIC BRAIN-INJURY; ELEVATED PLUS-MAZE; C-FOS EXPRESSION; ENDOCANNABINOID SYSTEM; SIGNALING PATHWAYS; AMINO-ACIDS; FOOD-INTAKE; CALCIUM; CELLS	N-Acyl amino acids (NAAAs) are conjugate products of fatty acids and amino acids, which are available in animal derived food. We compared the effects of N-arachidonoylglycine (NAGly), N-arachidonoylserine (NASer), and N-oleoylglycine (OLGly) on in vivo food intake and in vitro [Ca2+](i) of Agouti-related protein (AgRP) neurons to identify the role of these compounds in energy homeostasis. Hypothalamic neuropeptide expression and anxiety behavior in response to OLGly were also tested. To further identify the underlying mechanism of OLGly on food intake, we first detected the expression level of potential OLGly receptors. The cannabinoid receptor type 1 (CB1R) antagonist was cotreated with OLGly to analyze the activation of AgRP neuron, including [Ca2+](i), expression levels of PKA, CREB, and c-Fos, and neuropeptide secretion. Results demonstrated that only OLGly (intrapertioneal injection of 6 mg/kg) can induce hyperphagia without changing the expression of hypothalamic neuropeptides and anxiety-like behavior. Moreover, 20 mu M OLGly robustly enhances [Ca2+](i), c-Fos protein expression in AgRP neuron, and AgRP content in the culture medium. OLGly-induced activation of AgRP neuron was completely abolished by the CB1R-specific antagonist, AM251. In summary, this study is the first to demonstrate the association of OLGly-induced hyperphagia with activation of the AgRP neuron by CB1R These findings open avenues for investigation and application of OLGly to modulate energy homeostasis.	[Wu, Junguo; Zhu, Canjun; Yang, Liusong; Wang, Lina; Wang, Songbo; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Zhu, Xiaotong; Shu, Gang] South China Agr Univ, Coll Anim Sci, Guangzhou 510640, Guangdong, Peoples R China; [Wu, Junguo; Zhu, Canjun; Yang, Liusong; Wang, Lina; Wang, Songbo; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Zhu, Xiaotong; Shu, Gang] South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510640, Guangdong, Peoples R China; [Wu, Junguo; Zhu, Canjun; Yang, Liusong; Wang, Lina; Wang, Songbo; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Zhu, Xiaotong; Shu, Gang] South China Agr Univ, ALLTECH SCAU Anim Nutr Control Res Alliance, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Zhonggang] Huahong Engn & Res Ctr Agr & Livestock, Guangzhou 430051, Guangdong, Peoples R China		Zhu, XT; Shu, G (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou 510640, Guangdong, Peoples R China.; Zhu, XT; Shu, G (corresponding author), South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510640, Guangdong, Peoples R China.; Zhu, XT; Shu, G (corresponding author), South China Agr Univ, ALLTECH SCAU Anim Nutr Control Res Alliance, Guangzhou 510642, Guangdong, Peoples R China.	xtzhu@scau.edu.cn; shugang@scau.edu.cn			National Basic Research Program of ChinaNational Basic Research Program of China [2013CB127306]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31572480, 31472105]	This study was supported by the National Basic Research Program of China (2013CB127306) and the National Natural Science Foundation of China (31572480; 31472105).	Ashton JC, 2007, NEUROSCI LETT, V412, P114, DOI 10.1016/j.neulet.2006.10.053; Ba FL, 2005, NEUROPEPTIDES, V39, P439, DOI 10.1016/j.npep.2005.02.007; Bahi A, 2013, PHARMACOL BIOCHEM BE, V105, P83, DOI 10.1016/j.pbb.2013.01.023; BARTHEL F, 1995, J NEUROCHEM, V64, P41; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; Burstein SH, 2007, BIOORGAN MED CHEM, V15, P3345, DOI 10.1016/j.bmc.2007.03.026; Burstein SH, 2011, J CELL BIOCHEM, V112, P3227, DOI 10.1002/jcb.23245; Cai XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26802; Chatzakos V, 2012, LIPIDS, V47, P355, DOI 10.1007/s11745-011-3639-9; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; Gamber KM, 2005, NEUROPHARMACOLOGY, V49, P646, DOI 10.1016/j.neuropharm.2005.04.017; Gentile A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0682-8; Hanus L, 2014, BIOFACTORS, V40, P381, DOI 10.1002/biof.1166; Hassan S, 2014, BRIT J PHARMACOL, V171, P2426, DOI 10.1111/bph.12615; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Im DS, 2009, PROSTAG OTH LIPID M, V89, P53, DOI 10.1016/j.prostaglandins.2009.01.002; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jeong HJ, 2010, BRIT J PHARMACOL, V161, P925, DOI 10.1111/j.1476-5381.2010.00935.x; Jing YY, 2016, J AGR FOOD CHEM, V64, P1720, DOI 10.1021/acs.jafc.5b05952; Karwad MA, 2017, FASEB J, V31, P469, DOI 10.1096/fj.201500132; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Mascarenhas DC, 2013, BEHAV BRAIN RES, V250, P308, DOI 10.1016/j.bbr.2013.05.023; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McIntosh BT, 2007, BRIT J PHARMACOL, V152, P1111, DOI 10.1038/sj.bjp.0707495; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Patinkin D, 2008, EUR J PHARMACOL, V595, P1, DOI 10.1016/j.ejphar.2008.05.002; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Rhee MH, 1998, J NEUROCHEM, V71, P1525; Roman CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11905; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Smoum R, 2010, P NATL ACAD SCI USA, V107, P17710, DOI 10.1073/pnas.0912479107; Soria-Gomez E, 2007, BRIT J PHARMACOL, V151, P1109, DOI 10.1038/sj.bjp.0707313; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Takenouchi R, 2012, BIOCHEM BIOPH RES CO, V418, P366, DOI 10.1016/j.bbrc.2012.01.027; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; TOTH I, 1994, J DRUG TARGET, V2, P217, DOI 10.3109/10611869408996805; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Umathe SN, 2009, PROG NEURO-PSYCHOPH, V33, P1191, DOI 10.1016/j.pnpbp.2009.06.020; Verty ANA, 2005, NEUROPHARMACOLOGY, V49, P1101, DOI 10.1016/j.neuropharm.2005.03.025; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Waluk DP, 2013, BIOCHEM BIOPH RES CO, V430, P54, DOI 10.1016/j.bbrc.2012.11.026; Wang SB, 2016, BIOCHEM BIOPH RES CO, V471, P566, DOI 10.1016/j.bbrc.2016.02.031; Wang SB, 2015, BIOCHEM BIOPH RES CO, V466, P438, DOI 10.1016/j.bbrc.2015.09.046; Wang XB, 2005, J PHYSIOL-LONDON, V564, P541, DOI 10.1113/jphysiol.2004.081844; Zhang WT, 2012, BIOCHEM BIOPH RES CO, V425, P450, DOI 10.1016/j.bbrc.2012.07.122; Zhang X, 2010, BRIT J PHARMACOL, V160, P1583, DOI 10.1111/j.1476-5381.2010.00841.x	53	10	11	2	17	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-8561	1520-5118		J AGR FOOD CHEM	J. Agric. Food Chem.	FEB 8	2017	65	5					1051	1057		10.1021/acs.jafc.6b05281			7	Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Chemistry; Food Science & Technology	EK3SU	WOS:000393848600007	28102080				2022-02-06	
J	Mitchell, RJ; Cameron, CM; McClure, R				Mitchell, Rebecca J.; Cameron, Cate M.; McClure, Rod			Higher mortality risk among injured individuals in a population-based matched cohort study	BMC PUBLIC HEALTH			English	Article						Injury; Mortality; Comorbidity; Hospitalisation; Survival	LONG-TERM MORTALITY; TRAUMATIC BRAIN-INJURY; COMORBIDITY; TRENDS; ADULTS; AUSTRALIA; DISCHARGE; SURVIVAL; ILLNESS; BURDEN	Background: Improved understanding of long-term mortality attributable to injury is needed to accurately inform injury burden studies. This study aims to quantify and describe mortality attributable to injury 12 months after an injury-related hospitalisation in Australia. Method: A population-based matched cohort study using linked hospital and mortality data from three Australian states during 2008-2010 was conducted. The injured cohort included individuals >= 18 years who had an injury-related hospital admission in 2009. A comparison cohort of non-injured people was obtain by randomly selecting from the electoral roll. This comparison group was matched 1:1 on age, gender and postcode of residence. Pre-index injury health service use and 12-month mortality were examined. Adjusted mortality rate ratios (MRR) and attributable risk were calculated. Cox proportional hazard regression was used to examine the effect of risk factors on survival. Results: Injured individuals were almost 3 times more likely to die within 12 months following an injury (MRR 2.90; 95% CI: 2.76-3.04). Individuals with a traumatic brain injury (MRR 7.58; 95% CI: 5.92-9.70) or injury to internal organs (MRR 7.38; 95% CI: 5.90-9.22) were 7 times more likely to die than the non-injured group. Injury was likely to be a contributory factor in 92% of mortality within 30 days and 66% of mortality at 12 months following the index injury hospital admission. Adjusted mortality rate ratios varied by type of cause-specific death, with MRR highest for injury-related deaths. Conclusions: There are likely chronic consequences of sustaining a traumatic injury. Longer follow-up post-discharge is needed to consider deaths likely to be attributable to the injury. Better enumeration of long-term injury-related mortality will have the potential to improve estimates of injury burden.	[Mitchell, Rebecca J.] Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, N Ryde, NSW 2109, Australia; [Cameron, Cate M.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia; [McClure, Rod] Harvard Univ, Harvard Sch Publ Hlth, Harvard Injury Control Res Ctr, Boston, MA 02115 USA		Mitchell, RJ (corresponding author), Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, N Ryde, NSW 2109, Australia.	r.mitchell@mq.edu.au	Mitchell, Rebecca/Z-5476-2019	Mitchell, Rebecca/0000-0003-1939-1761; Cameron, Cate/0000-0003-1476-5744; McClure, Roderick/0000-0002-9067-8282	Population Health Research Network; Australian Government National Collaborative Research Infrastructure StrategyAustralian GovernmentDepartment of Industry, Innovation and Science; National Health and Medical Research Council (NHMRC) AustraliaNational Health and Medical Research Council of Australia [428254]	The research was supported by the Population Health Research Network with funding from the Australian Government National Collaborative Research Infrastructure Strategy and the Western Australian Minister for Science and Innovation. CC was supported by a Public Health Fellowship (ID 428254) from the National Health and Medical Research Council (NHMRC) Australia.	Allison P., 2010, A PRACTICAL GUIDE; Australian Bureau of Statistics, 2011, REM STRUCT REM STRUCT, V5; Australian Institute of Health and Welfare, 2015, ADM PAT CAR 2013 14; Baguley I, 2000, BRAIN INJURY, V14, P505; Bhalla K, 2016, INJURY PREV, V22, P23, DOI 10.1136/injuryprev-2015-041816; Cameron CM, 2005, J TRAUMA, V59, P639, DOI 10.1097/01.ta.0000183222.79685.23; Cryer C, 2006, INJURY PREV, V12, P202, DOI 10.1136/ip.2006.011635; Cryer C, 2011, INJURY PREV, V17, P219, DOI 10.1136/injuryprev-2011-040039; Curtis K, 2011, WORLD J SURG, V35, P2332, DOI 10.1007/s00268-011-1217-1; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Dayal S., 2008, MAPPING INJURY SEVER; Duke JM, 2015, B WORLD HEALTH ORGAN, V93, P400, DOI 10.2471/BLT.14.149146; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hong J, 2013, ACCIDENT ANAL PREV, V52, P44, DOI 10.1016/j.aap.2012.12.007; Klop C, 2014, BONE, V66, P171, DOI 10.1016/j.bone.2014.06.011; KREISFELD R, 2007, INJURY TECHNICAL PAP, V9; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Miller TR, 2001, ALCOHOL CLIN EXP RES, V25, P54, DOI 10.1111/j.1530-0277.2001.tb02127.x; Mitchell RJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013266; Mitchell RJ, 2014, AUST NZ J PUBL HEAL, V38, P275, DOI 10.1111/1753-6405.12234; National Centre for Classification in Health, 2006, ICD10AM NAT CTR CLAS; Niven DJ, 2012, AM J SURG, V204, P151, DOI 10.1016/j.amjsurg.2012.02.014; Nott MT, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12151; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; SAS Institute, 2014, STAT SOFTW; Shafi S, 2012, J TRAUMA ACUTE CARE, V73, P699, DOI 10.1097/TA.0b013e318253b5db; Stephenson S, 2003, J DIAGNOSIS BASED IN; Wan JJ, 2006, J TRAUMA, V61, P1299, DOI 10.1097/01.ta.0000240460.35245.1a; Woodward M., 2005, EPIDEMIOLOGY STUDY D	37	10	10	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2458			BMC PUBLIC HEALTH	BMC Public Health	FEB 2	2017	17								150	10.1186/s12889-017-4087-0			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	FG9RU	WOS:000410777900001	28148259	Green Published, gold			2022-02-06	
J	Brett, BL; Solomon, GS				Brett, Benjamin L.; Solomon, Gary S.			Comparison of Neurocognitive Performance in Contact and Noncontact Nonconcussed High School Athletes Across a Two-Year Interval	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TEST-RETEST RELIABILITY; SPORT-RELATED CONCUSSION; CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; DEFAULT MODE NETWORK; IMPACT TEST BATTERY; HEAD IMPACTS; BRAIN-INJURY; AGE; SCORES	Investigating short-term effects of subconcussive impacts on neurocognitive functioning, we employed a repeated measures multivariate model and regression-based measure to examine neurocognitive changes in 771 contact and noncontact high school athletes over a two-year period. Results reveal significant changes in Visual Motor Speed for both groups over a two-year period, with small effect sizes. According to regression-based measures, differences in contact sport athletes' expected Time 2 performances were significant for Visual Motor Speed, also with minimal effects. Results do not conclusively implicate subconcussive hits as the offending factor in differences observed, with gender and sport-type possibly contributing to the small effects.	[Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Memphis, TN 38152 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Sports Concuss Ctr, Nashville, TN USA		Brett, BL (corresponding author), Univ Memphis, 100 Ball Hall, Memphis, TN 38152 USA.	blbrett@memphis.edu	Solomon, Gary/K-9011-2019				Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cohen J., 2013, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Conn VS, 2014, WESTERN J NURS RES, V36, P291, DOI 10.1177/0193945913492495; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Graham R., 2014, SPORTS RELATED CONCU, P203; GRONWALL D, 1975, LANCET, V306, P995, DOI DOI 10.1016/S0140-6736(75)90288-3; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hinkle D. E, 2002, APPL STAT BEHAV SCI, V5th; Immediate Post- Concussion Assessment and Cognitive Testing (ImPACT), 2012, IMM POSTC ASS TEST I; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; L?ders H., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P69, DOI 10.1080/87565641.2015.1014089; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miles J., 2001, APPL REGRESSION CORR; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	63	10	10	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	FEB	2017	42	2			SI		70	82		10.1080/87565641.2016.1243114			13	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	ET6JJ	WOS:000400397500003	28452600				2022-02-06	
J	Favez, N; Notari, SC; Antonini, T; Charvoz, L				Favez, Nicolas; Notari, Sarah Cairo; Antonini, Tania; Charvoz, Linda			Attachment and couple satisfaction as predictors of expressed emotion in women facing breast cancer and their partners in the immediate post-surgery period	BRITISH JOURNAL OF HEALTH PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; FRENCH VERSION; CHRONIC PAIN; PATIENT; ADJUSTMENT; RELATIVES; RELIABILITY; FAMILIES; VALIDITY; QUALITY	Objectives. To investigate expressed emotion (EE) in couples facing breast cancer in the immediate post-surgery period. EE may be predictive of psychological disturbances that hinder both partners' capacities to cope with the stress of the disease. Severity of the disease, attachment tendencies, and couple satisfaction were tested as predictors of EE. Design. The design was cross-sectional. Couples (N = 61) were interviewed 2 weeks after the women's breast surgery. Methods. Expressed emotion was assessed in women and in partners with the Five-Minute Speech Sample, with a focus on overt and covert criticisms. Self-reported EE, attachment tendencies, and couple satisfaction were assessed with questionnaires. Hierarchical regression analyses were performed to test the predictors and possible interactions between them. Results. Both partners expressed overt and covert criticisms; women expressed more overt criticisms than did their partners. Cancer stage was inversely related to the number of overt criticisms in women and to the number of covert criticisms in partners. Regression analyses showed that in women, higher attachment anxiety and lower couple satisfaction were positive predictors of overt criticisms; in partners, a higher cancer stage was a negative predictor of overt and covert criticisms. Conclusions. Practitioners should pay attention to the couple relationship in breast cancer. EE is most likely to appear when the cancer stage is low, showing that even when the medical prognosis is optimal, relational and emotional disturbances may occur.	[Favez, Nicolas; Notari, Sarah Cairo; Antonini, Tania] Univ Geneva, Fac Psychol & Educ Sci, Blvd Pont dArve 40, CH-1211 Geneva 4, Switzerland; [Charvoz, Linda] Univ Appl Sci & Arts Western Switzerland, Social Work, Lausanne, Switzerland		Favez, N (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Blvd Pont dArve 40, CH-1211 Geneva 4, Switzerland.	nicolas.favez@unige.ch	Favez, Nicolas/ABB-6292-2020; Charvoz, Linda/L-9047-2018	Favez, Nicolas/0000-0003-1744-7602; Cairo Notari, Sarah/0000-0003-2623-2881; Charvoz, Linda/0000-0002-2339-5231	Swiss National Centre of Competence in Research LIVES - Overcoming vulnerability: life course perspectives; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; Swiss Cancer League [KLS 3396-02-2014]	This project benefited from the support of the Swiss National Centre of Competence in Research LIVES - Overcoming vulnerability: life course perspectives, which is financed by the Swiss National Science Foundation, and of the Swiss Cancer League, grant KLS 3396-02-2014.	Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; Ballus-Creus C, 2014, INT J SOC PSYCHIATR, V60, P197, DOI 10.1177/0020764013496371; Band R, 2014, HEALTH PSYCHOL, V33, P1092, DOI 10.1037/hea0000086; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Benazon NR, 2006, J FAM PSYCHOL, V20, P328, DOI 10.1037/0893-3200.20.2.328; Blum Kay, 2010, Semin Oncol Nurs, V26, P243, DOI 10.1016/j.soncn.2010.08.005; Bowlby J., 1988, SECURE BASE PARENT C; BROWN GW, 1966, HUM RELAT, V19, P241, DOI 10.1177/001872676601900301; BROWN GW, 1958, LANCET, V272, P685, DOI DOI 10.1016/S0140-6736(58)92279-7; Burns JW, 2013, PAIN, V154, P2715, DOI 10.1016/j.pain.2013.07.053; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Charvoz L., 2010, FRENCH VERSION RELAT; Favez N, 2016, J HEALTH PSYCHOL, V21, P2994, DOI 10.1177/1359105315589802; Favez N, 2016, SWISS J PSYCHOL, V75, P113, DOI 10.1024/1421-0185/a000177; Figueiredo MI, 2004, PSYCHO-ONCOLOGY, V13, P96, DOI 10.1002/pon.717; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Gavazzi SM, 2000, J MARRIAGE FAM, V62, P669, DOI 10.1111/j.1741-3737.2000.00669.x; Giese-Davis J, 2000, J FAM PSYCHOL, V14, P251, DOI 10.1037//0893-3200.14.2.251; Gottman JM, 1998, ANNU REV PSYCHOL, V49, P169, DOI 10.1146/annurev.psych.49.1.169; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; Hooley JM, 2006, J FAM PSYCHOL, V20, P386, DOI 10.1037/0893-3200.20.3.386; IBM Corp, 2015, IBM SPSS STAT WINDOW; Kavanagh DJ, 1997, PSYCHIAT RES, V70, P185, DOI 10.1016/S0165-1781(97)00033-4; Kayser K., 2008, HELPING COUPLES WOME; LEEB B, 1991, PSYCHIAT RES, V39, P25, DOI 10.1016/0165-1781(91)90005-A; MAGANA AB, 1986, PSYCHIAT RES, V17, P203, DOI 10.1016/0165-1781(86)90049-1; Manne S, 2004, J CONSULT CLIN PSYCH, V72, P660, DOI 10.1037/0022-006X.72.4.660; Manne S, 2014, J FAM PSYCHOL, V28, P214, DOI 10.1037/a0036053; Manne SL, 2005, HEALTH PSYCHOL, V24, P635, DOI 10.1037/0278-6133.24.6.635; Maunder RG, 2006, J PSYCHOSOM RES, V60, P283, DOI 10.1016/j.jpsychores.2005.08.013; Mikulincer M., 2008, HDB ATTACHMENT THEOR, P503; Moller-Leimkuhler AM, 2011, EUR ARCH PSY CLIN N, V261, P349, DOI 10.1007/s00406-010-0178-y; Northouse LL, 2002, J CLIN ONCOL, V20, P4050, DOI 10.1200/JCO.2002.02.054; Notari SC, 2017, J HEALTH PSYCHOL, V22, P1668, DOI 10.1177/1359105316633285; Rodin G, 2007, PSYCHO-ONCOLOGY, V16, P1080, DOI 10.1002/pon.1186; Rogosch FA, 2004, DEV PSYCHOPATHOL, V16, P689, DOI 10.1017/S0954579404004730; Rottmann N, 2015, HEALTH PSYCHOL, V34, P486, DOI 10.1037/hea0000218; RUTTER M, 1966, SOC PSYCHIATR, V1, P38, DOI 10.1007/BF00583828; Schmid-Buchi S, 2008, J CLIN NURS, V17, P2895, DOI 10.1111/j.1365-2702.2008.02490.x; Shaver P.R., 2007, ATTACHMENT ADULTHOOD; Silva SM, 2012, PSYCHOL HEALTH, V27, P1323, DOI 10.1080/08870446.2012.676644; Stenberg U, 2010, PSYCHO-ONCOLOGY, V19, P1013, DOI 10.1002/pon.1670; Tacon A, 2001, FAM SYST HEALTH, V19, P319, DOI [10.1037/h0089455, DOI 10.1037/H0089455]; Vandeleur CL, 2013, PSYCHIAT RES, V210, P641, DOI 10.1016/j.psychres.2013.07.008; Wagner CD, 2011, CANCER NURS, V34, pE21, DOI 10.1097/NCC.0b013e31820251f5; Wearden AJ, 2000, J PSYCHOSOM RES, V49, P125, DOI 10.1016/S0022-3999(00)00141-0; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; Wearden AJ, 2006, BRIT J HEALTH PSYCH, V11, P1, DOI 10.1348/135910705X73676; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020	50	10	11	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1359-107X	2044-8287		BRIT J HEALTH PSYCH	Br. J. Health Psychol.	FEB	2017	22	1					169	185		10.1111/bjhp.12223			17	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	EP3RG	WOS:000397298800011	27882634				2022-02-06	
J	Lehto, LJ; Sierra, A; Grohn, O				Lehto, Lauri Juhani; Sierra, Alejandra; Grohn, Olli			Magnetization transfer SWIFT MRI consistently detects histologically verified myelin loss in the thalamocortical pathway after a traumatic brain injury in rat	NMR IN BIOMEDICINE			English	Article						magnetization transfer; myelin; sweep imaging with Fourier transformation; traumatic brain injury	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; IN-VIVO; DIFFUSION TENSOR; WHITE-MATTER; MULTIPLE-SCLEROSIS; AXONAL INJURY; MOUSE-BRAIN; HEAD TRAUMA; SPINAL-CORD; DEMYELINATION	Traumatic brain injury (TBI) is associated with various neurocognitive deficits, and rapid assessment of the damage is potentially important for the prevention and treatment of these deficits. Imaging assessment of mild or moderate damage outside the primary lesion area after TBI, however, remains challenging. Magnetization transfer (MT) has clearly been underutilized in imaging the damage caused by TBI. Here, we applied the MT ratio (MTR) using sweep imaging with Fourier transformation (SWIFT) to study microstructural tissue damage in the thalamocortical pathway outside the primary lesion in a lateral fluid percussion injury rat model of TBI, 5 months after injury. MTR was decreased in layers VIb-IV of the barrel cortex and related subcortical areas, mainly indicating demyelination, which was verified by histology. The largest MTR change in the cortex was in layer VIb (-8.2%, p(FDR) = 0.01), and the largest MTR change in the subcortical areas was in the caudal-most portion of the internal capsule (-11.0%, p(FDR) < 0.005). These areas exhibited the greatest demyelination and substantial cellularity attributed to gliosis. Correlation analysis of group-averaged results from the subcortical areas revealed an excellent correlation of MTR with myelin (r(2) = 0.94, p < 0.001), but no correlation with increased cellularity as detected by Nissl staining. Thus, MTR using SWIFT can be a valuable tool for the assessment of subtle changes after TBI in both cortical and subcortical areas.	[Lehto, Lauri Juhani; Sierra, Alejandra; Grohn, Olli] Univ Eastern Finland, A I Virtanen Inst Mol Sci, Dept Neurobiol, PO Box 1627, FI-70211 Kuopio, Finland		Grohn, O (corresponding author), Univ Eastern Finland, A I Virtanen Inst Mol Sci, Dept Neurobiol, PO Box 1627, FI-70211 Kuopio, Finland.	olli.grohn@uef.fi		Sierra Lopez, Alejandra/0000-0001-5399-2056	Emil Aaltonen Foundation; Academy of FinlandAcademy of FinlandEuropean Commission; UEF-Brain Strategic Funding from the University of Eastern Finland; European Union's Seventh Framework Programme (FP7) [602102]	We are grateful for the financial support of the Emil Aaltonen Foundation, Academy of Finland, and UEF-Brain Strategic Funding from the University of Eastern Finland. Research leading to these results received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no602102 (EPITARGET). We also thank Mrs Maarit Pulkkinen for her work on histology and Mr Jarmo Hartikainen for technical assistance and animal handling.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Berger C, 2006, NMR BIOMED, V19, P101, DOI 10.1002/nbm.1007; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Bozzali M, 2001, NEUROLOGY, V57, P1135, DOI 10.1212/WNL.57.6.1135; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Cercignani M, 2005, NEUROIMAGE, V27, P436, DOI 10.1016/j.neuroimage.2005.04.031; Chen JTH, 2013, NEUROLOGY, V80, P246, DOI 10.1212/WNL.0b013e31827deb99; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Deloire-Grassin MSA, 2000, J NEUROL SCI, V178, P10, DOI 10.1016/S0022-510X(00)00331-2; DOUSSET V, 1995, AM J NEURORADIOL, V16, P225; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Du J, 2014, NEUROIMAGE, V87, P32, DOI 10.1016/j.neuroimage.2013.10.053; Fjaer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084162; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Gareau PJ, 2001, MAGNET RESON MED, V45, P159, DOI 10.1002/1522-2594(200101)45:1<159::AID-MRM1021>3.0.CO;2-T; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gloor M, 2008, MAGN RESON MED, V60, P691, DOI 10.1002/mrm.21705; Gochberg DF, 2007, MAGN RESON MED, V57, P437, DOI 10.1002/mrm.21143; GROSSMAN RI, 1987, AM J NEURORADIOL, V8, P1045; Helms G, 2010, MAGN RESON MED, V64, P177, DOI 10.1002/mrm.22379; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Idiyatullin D, 2008, J MAGN RESON, V193, P267, DOI 10.1016/j.jmr.2008.05.009; Idiyatullin D, 2006, J MAGN RESON, V181, P342, DOI 10.1016/j.jmr.2006.05.014; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Killackey HP, 2003, J NEUROSCI, V23, P7381; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; KOENIG SH, 1991, MAGNET RESON MED, V20, P285, DOI 10.1002/mrm.1910200210; Kumar R, 2003, MAGN RESON IMAGING, V21, P893, DOI 10.1016/S0730-725X(03)00189-9; Laalo JP, 2014, BRAIN INJURY, V28, P66, DOI 10.3109/02699052.2013.857791; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lehto LJ, 2015, J MAGN RESON, V252, P20, DOI 10.1016/j.jmr.2014.12.005; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Liimatainen T, 2015, MAGN RESON MED, V73, P254, DOI 10.1002/mrm.25129; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; McGowan J C, 2000, J Magn Reson Imaging, V12, P247, DOI 10.1002/1522-2586(200008)12:2<247::AID-JMRI6>3.3.CO;2-O; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Petrella JR, 1996, AM J NEURORADIOL, V17, P1041; Ramani A, 2002, MAGN RESON IMAGING, V20, P721, DOI 10.1016/S0730-725X(02)00598-2; Ropele S, 2003, MAGNET RESON MED, V49, P864, DOI 10.1002/mrm.10427; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Sled JG, 2001, MAGNET RESON MED, V46, P923; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tambasco N, 2003, NEURORADIOLOGY, V45, P224, DOI 10.1007/s00234-002-0925-5; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Thiessen JD, 2013, NMR BIOMED, V26, P1562, DOI 10.1002/nbm.2992; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Underhill HR, 2011, NEUROIMAGE, V54, P2052, DOI 10.1016/j.neuroimage.2010.10.065; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109; Yarnykh VL, 2002, MAGNET RESON MED, V47, P929, DOI 10.1002/mrm.10120; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3	68	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	FEB	2017	30	2							e3678	10.1002/nbm.3678			13	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	EP3HU	WOS:000397274200005	27982487				2022-02-06	
J	Rowland, JA; Stapleton-Kotloski, JR; Alberto, GE; Rawley, JA; Kotloski, RJ; Taber, KH; Godwin, DW				Rowland, Jared A.; Stapleton-Kotloski, Jennifer R.; Alberto, Greg E.; Rawley, Justin A.; Kotloski, Robert J.; Taber, Katherine H.; Godwin, Dwayne W.			Contrasting Effects of Posttraumatic Stress Disorder and Mild Traumatic Brain Injury on the Whole-Brain Resting-State Network: A Magnetoencephalography Study	BRAIN CONNECTIVITY			English	Article						brain networks; graph theory; magnetoencephalography; posttraumatic stress disorder; traumatic brain injury	DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; INDEPENDENT COMPONENT; HIPPOCAMPAL VOLUME; SYMPTOM SEVERITY; TWINS DISCORDANT; VULNERABILITY; SYNCHRONIZATION; ORGANIZATION; METAANALYSIS	The aim of this study was to evaluate alterations in whole-brain resting-state networks associated with posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). Networks were constructed from locations of peak statistical power on an individual basis from magnetoencephalography (MEG) source series data by applying the weighted phase lag index and surrogate data thresholding procedures. Networks representing activity in the alpha bandwidth as well as wideband activity (DC-80 Hz) were created. Statistical comparisons were adjusted for age and education level. Alpha network results demonstrate reductions in network structure associated with PTSD, but no differences associated with mTBI. Wideband network results demonstrate a shift in connectivity from the alpha to theta bandwidth in both PTSD and mTBI. Also, contrasting alterations in network structure are noted, with increased randomness associated with PTSD and increased structure associated with mTBI. These results demonstrate the potential of the analysis of MEG resting-state networks to differentiate two highly comorbid conditions. The importance of the alpha bandwidth to resting-state connectivity is also highlighted, while demonstrating the necessity of considering activity in other bandwidths during network construction.	[Rowland, Jared A.; Stapleton-Kotloski, Jennifer R.; Taber, Katherine H.] WG Bill Hefner VA Med Ctr, Mid Atlantic Mental Illness Res Educ & Clin Ctr, Res & Acad Affairs Serv Line, Salisbury, NC 28144 USA; [Rowland, Jared A.; Alberto, Greg E.; Godwin, Dwayne W.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Stapleton-Kotloski, Jennifer R.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA; [Rawley, Justin A.] Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC USA; [Kotloski, Robert J.] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kotloski, Robert J.] William S Middleton VA Med Ctr, Dept Neurol, Madison, WI USA; [Taber, Katherine H.] Edward Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Rowland, JA (corresponding author), WG Bill Hefner VA Med Ctr, Res & Acad Affairs Serv Line, 1601 Brenner Ave 11M-2, Salisbury, NC 28144 USA.	jared.rowland@va.gov	Rowland, Jared A./AAN-3030-2021; Stapleton-Kotloski, Jennifer/AAG-3967-2021; Taber, Katherine H/B-8260-2011	Rowland, Jared A./0000-0002-3655-3411; Taber, Katherine H/0000-0001-7382-6151; Alberto, Gregory/0000-0002-2835-7592	W.G. (Bill) Hefner Veterans Affairs Medical Center; Wake Forest School of Medicine Translational Science Institute; Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AA016852]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F30AA023708, R01AA016852] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002172] Funding Source: NIH RePORTER	This research is supported by funding from the W.G. (Bill) Hefner Veterans Affairs Medical Center, the Wake Forest School of Medicine Translational Science Institute, and the Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC); as well as the resources of the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, and the Wake Forest School of Medicine Department of Neurology and Center for Biomolecular Imaging. D.W.G. was supported by the National Institutes of Health grant R01AA016852.	Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Admon R, 2013, CEREB CORTEX, V23, P28, DOI 10.1093/cercor/bhr369; Admon R, 2009, P NATL ACAD SCI USA, V106, P14120, DOI 10.1073/pnas.0903183106; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Beal DS, 2010, NEUROIMAGE, V52, P1645, DOI 10.1016/j.neuroimage.2010.04.277; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bosma Ingeborg, 2009, Nonlinear Biomed Phys, V3, P9, DOI 10.1186/1753-4631-3-9; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ACN, 2008, NEUROIMAGE, V41, P561, DOI 10.1016/j.neuroimage.2007.12.064; Chen AC, 2013, NEUROPSYCHOPHARMACOL, V38, P1889, DOI 10.1038/npp.2013.122; Cheyne D, 2007, CLIN NEUROPHYSIOL, V118, P1691, DOI 10.1016/j.clinph.2007.05.064; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Cornwell BR, 2012, HIPPOCAMPUS, V22, P1848, DOI 10.1002/hipo.22019; Cornwell BR, 2008, BRAIN RES, V1244, P103, DOI 10.1016/j.brainres.2008.09.068; Douw L, 2013, NEUROIMAGE, V75, P195, DOI 10.1016/j.neuroimage.2013.02.067; Douw L, 2011, NEUROSCIENCE, V175, P169, DOI 10.1016/j.neuroscience.2010.11.039; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M.B., 1996, STRUCTURED CLIN INTE; GEIB BR, 2017, CEREB CORTEX, V27, P680, DOI DOI 10.1093/CERCOR/BHV272; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Hung YW, 2012, NEUROIMAGE, V60, P545, DOI 10.1016/j.neuroimage.2011.12.003; Hung YW, 2010, NEUROIMAGE, V50, P727, DOI 10.1016/j.neuroimage.2009.12.093; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; James LM, 2013, JAMA PSYCHIAT, V70, P410, DOI 10.1001/jamapsychiatry.2013.878; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Knyazev GG, 2011, BRAIN RES, V1402, P67, DOI 10.1016/j.brainres.2011.05.052; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lanius RA, 2010, J PSYCHIATR NEUROSCI, V35, P80, DOI 10.1503/jpn.090047; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lei D, 2015, RADIOLOGY, V276, P818, DOI 10.1148/radiol.15141700; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Luo Q, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00940; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Moses SN, 2009, NEUROIMAGE, V46, P863, DOI 10.1016/j.neuroimage.2009.02.042; Neuner I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088214; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Pitman RK, 2006, ANN NY ACAD SCI, V1071, P242, DOI 10.1196/annals.1364.019; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Riggs L, 2009, NEUROIMAGE, V45, P627, DOI 10.1016/j.neuroimage.2008.11.018; Robinson SE, 1998, BIOMAG 2000, P1; Robinson SE, 2002, P 13 INT C BIOM JEN, P220; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schedlbauer AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06431; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stapleton-Kotloski JR, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00244; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Toppi J, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/130985; van Wingen GA, 2011, MOL PSYCHIATR, V16, P664, DOI 10.1038/mp.2010.132; van Wingen GA, 2012, P NATL ACAD SCI USA, V109, P15508, DOI 10.1073/pnas.1206330109; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weathers F.W., 1993, ANN M INT SOC TRAUM; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833	78	10	10	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	FEB	2017	7	1					45	57		10.1089/brain.2015.0406			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0MH	WOS:000448214200005	28006976	Green Published			2022-02-06	
J	Vaughan, N; Tweed, J; Greenwell, C; Notrica, DM; Langlais, CS; St Peter, SD; Leys, CM; Ostlie, DJ; Maxson, RT; Ponsky, T; Tuggle, DW; Eubanks, JW; Bhatia, A; Greenwell, C; Garcia, NM; Lawson, KA; Motghare, P; Letton, RW; Alder, AC				Vaughan, Nathan; Tweed, Jeff; Greenwell, Cynthia; Notrica, David M.; Langlais, Crystal S.; St Peter, Shawn D.; Leys, Charles M.; Ostlie, Daniel J.; Maxson, R. Todd; Ponsky, Todd; Tuggle, David W.; Eubanks, James W., III; Bhatia, Amina; Greenwell, Cynthia; Garcia, Nilda M.; Lawson, Karla A.; Motghare, Prasenjeet; Letton, Robert W.; Alder, Adam C.			The impact of morbid obesity on solid organ injury in children using the ATOMAC protocol at a pediatric level I trauma center	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	63rd Annual Meeting of the British-Association-of-Paediatric-Surgeons (BAPS)	JUL 20-22, 2016	Amsterdam, NETHERLANDS	British Assoc Paediat Surg		Pediatric; Obesity; Blunt; Abdominal; Trauma; Guideline	CHILDHOOD; SPLEEN; LIVER	Introduction: Obesity is an epidemic in the pediatric population. Childhood obesity in trauma has been associated with increased incidence of long-bone fractures, longer ICU stays, and decreased closed head injuries. We investigated for differences in the likelihood of failure of non-operative management (NOM), and injury grade using a subset of a multi-institutional, prospective database of pediatric patients with solid organ injury (SOI). Methods: We prospectively collected data on all pediatric patients (<18 years) admitted for liver or splenic injury from September 2013 to January 2016. SOI was managed based upon the ATOMAC protocol. Obesity status was derived using CDC definitions; patients were categorized as non-obese (BMI <95th percentile) or obese (BMI >= 95th percentile). The ISS, injury grade, and NOM failure rate were calculated among other data points. Results: Of 1012 patients enrolled, 117 were identified as having data regarding BMI. Eighty-four percent of patients were non-obese; 16% were obese. The groups did not differ by age, sex, mechanism of injury, or associated injuries. There was no significant difference in the rate of failure of non-operative management (8.2% versus 5.3%). Obesity was associated with higher likelihood of severe (grade 4 or 5) hepatic injury (36.8% versus 15.3%, P = 0.048) but not a significant difference in likelihood of severe (grade 4 or 5) splenic injury (15.3% versus 10.5%, P = 0.736). Obese patients had a higher mean ISS (22.5 versus 16.1, P = 0.021) and mean abdominal AIS (3.5 versus 2.9, P = 0.024). Conclusion: Obesity is a risk factor for more severe abdominal injury, specifically liver injury, but without an associated increase in failure of NOM. This may be explained by the presence of hepatic steatosis making the liver more vulnerable to injury. A protocol based upon physiologic parameters was associated with a low rate of failure regardless of the pediatric obesity status. Level of evidence: Level II prognosis. (C) 2017 Elsevier Inc. All rights reserved.	[Vaughan, Nathan; Tweed, Jeff; Greenwell, Cynthia; Greenwell, Cynthia; Alder, Adam C.] Childrens Med Ctr Dallas, Dallas, TX 75235 USA; [Notrica, David M.; Langlais, Crystal S.; Ostlie, Daniel J.] Phoenix Childrens Hosp, Phoenix, AZ 85016 USA; [St Peter, Shawn D.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Leys, Charles M.; Ostlie, Daniel J.] Amer Family Childrens Hosp, Madison, WI 53792 USA; [Maxson, R. Todd] Arkansas Childrens Hosp, Little Rock, AR 72202 USA; [Ponsky, Todd] Akron Childrens Hosp, Akron, OH 44308 USA; [Tuggle, David W.; Garcia, Nilda M.; Lawson, Karla A.] Dell Childrens Med Ctr, Austin, TX 78723 USA; [Eubanks, James W., III] Le Bonheur Childrens Hosp, Memphis, TN 38103 USA; [Bhatia, Amina] Hughes Spalding Childrens Hosp, Atlanta, GA 30303 USA; [Motghare, Prasenjeet; Letton, Robert W.] OU Med Ctr, Childrens Hosp, Oklahoma City, OK 73104 USA			Adam.Alder@childrens.com		Lawson, Karla/0000-0002-1408-6787; Eubanks, III, James/0000-0002-2409-4510			Alselaim N, 2012, J PEDIATR SURG, V47, P1404, DOI 10.1016/j.jpedsurg.2012.02.015; Brown CVR, 2006, J PEDIATR SURG, V41, P88, DOI 10.1016/j.jpedsurg.2005.10.012; Notrica DM, 2015, J TRAUMA ACUTE CARE, V79, P683, DOI 10.1097/TA.0000000000000808; Nutrition physical activity and obesity data trends and maps website, NATL CTR CHRON DIS P; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Rana AR, 2009, J PEDIATR SURG, V44, P1601, DOI 10.1016/j.jpedsurg.2008.11.060; Ross E, 2014, J PEDIATR SURG, V49, P469, DOI 10.1016/j.jpedsurg.2013.07.012; St Peter SD, 2011, J PEDIAT SURG, V46, P173; Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4; Temple JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060947	10	10	10	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	FEB	2017	52	2					345	348		10.1016/j.jpedsurg.2016.09.002			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	EI7CK	WOS:000392654700032	27707653				2022-02-06	
J	Zamarripa, A; Clark, SJ; Rogers, AJ; Wang-Flores, H; Stanley, RM				Zamarripa, Angela; Clark, Sarah J.; Rogers, Alexander J.; Wang-Flores, Helena; Stanley, Rachel M.			Pediatric Concussion Management in the Emergency Department: A National Survey of Parents	JOURNAL OF PEDIATRICS			English	Article							EXPECTATIONS; GUIDELINES; STATEMENT; CHILDREN; BELIEFS; DISEASE; INJURY; SPORTS; CARE	Objective To examine parental expectations and beliefs about diagnosis and management of pediatric concussion. Study design We conducted a cross-sectional web-based survey of a nationally representative panel of US parents in March 2014. Parents of 10- to 17-year-old children responded to questions about their expectations and beliefs about diagnosis and management of pediatric concussion in the emergency department (ED). Weighted percentages for descriptive statistics were calculated, and chi 2 statistics were used for bivariate analysis. Results Survey participation was 53%, and of 912 parent respondents with a child 10-17 years of age who were presented with a scenario of their child having mild symptoms of concussion, 42% would seek immediate ED care. Parents who would seek immediate ED care for this scenario were more likely than parents who would consult their child's usual provider or wait at home to "definitely expect" imaging (65% vs 21%), definitive diagnosis of concussion (77% vs 61%), a timeline for return to activity (80% vs 60%), and a signed return to play form (55% vs 41%). Conclusions Many parents who bring children to the ED following a possible concussion are likely to expect comprehensive and definitive care, including imaging, a definitive diagnosis, a timeline for return to activity, and a signed return to play form. To manage these expectations, healthcare providers should continue to educate parents about the evaluation and management of concussion.	[Zamarripa, Angela] Michigan State Univ, Helen DeVos Childrens Hosp, Spectrum Hlth, Dept Emergency Med, Grand Rapids, MI 49503 USA; [Clark, Sarah J.; Rogers, Alexander J.; Wang-Flores, Helena] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Clark, Sarah J.] Univ Michigan, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Rogers, Alexander J.; Wang-Flores, Helena] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Stanley, Rachel M.] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA		Zamarripa, A (corresponding author), Michigan State Univ, Coll Human Med, Dept Emergency Med, 15 Michigan St NE, Grand Rapids, MI 49503 USA.	acmzama@gmail.com					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Centers for Disease Control and Prevention, 2010, HEADS UP CONC; Davis M, 2014, NATL POLL CHILD HLTH; de Bont EGPM, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0348-0; Dempsey AF, 2009, ACAD PEDIATR, V9, P348, DOI 10.1016/j.acap.2009.04.004; Dempsey AF, 2009, J PEDIATR-US, V155, P689, DOI 10.1016/j.jpeds.2009.05.029; Dennis J. Michael, 2010, SUMMARY KNOWLEDGEPAN; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Enarson MC, 2012, PEDIATRICS, V130, pE905, DOI 10.1542/peds.2011-2140; Freed GL, 2010, J PEDIATR-US, V156, P841, DOI 10.1016/j.jpeds.2009.11.055; Gilchrist J, 2011, MMWR MORB MORTAL WKL; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2015, BRAIN INJURY, V29, P1; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Kallestrup P, 2003, BRIT J GEN PRACT, V53, P43; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Tarini BA, 2008, ARCH PEDIAT ADOL MED, V162, P1079, DOI 10.1001/archpedi.162.11.1079; Tarini BA, 2009, PEDIATRICS, V124, pE432, DOI 10.1542/peds.2008-2389; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	28	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2017	181						229	234		10.1016/j.jpeds.2016.10.071			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EN8KL	WOS:000396249200036	27863850				2022-02-06	
J	Sebastiani, A; Hirnet, T; Jahn-Eimermacher, A; Thal, SC				Sebastiani, Anne; Hirnet, Tobias; Jahn-Eimermacher, Antje; Thal, Serge C.			Comparison of speed-vacuum method and heat-drying method to measure brain water content of small brain samples	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain water content; Brain edema; Drying technique; Oven; Vacuum; SpeedVac; Centrifugal vacuum concentrators; Speed-vacuum drying; Heat-drying; Vacuum-drying	CONTROLLED CORTICAL IMPACT; CEREBRAL EDEMA; INJURY; INHIBITION; MICE; TISSUE; AQUAPORIN-4; CONTUSION; BARRIER; TRAUMA	Background: A reliable measurement of brain water content (wet-to-dry ratio) is an important prerequisite for conducting research on mechanisms of brain edema formation. The conventionally used oven-drying method suffers from several limitations, especially in small samples. A technically demanding and time-consuming alternative is freeze-drying. New method: Centrifugal vacuum concentrators (e.g. SpeedVac/speed-vacuum drying) are a combination of vacuum-drying and centrifugation, used to reduce the boiling temperature. These concentrators have the key advantages of improving the freeze-drying speed and maintaining the integrity of dried samples, thus, allowing e.g. DNA analyses. In the present study, we compared the heat-oven with speed-vacuum technique with regard to efficacy to remove moisture from water and brain samples and their effectiveness to distinguish treatment paradigms after experimental traumatic brain injury (TBI) caused by controlled cortical impact (CCI). Results: Both techniques effectively removed water, the oven technique taking 24 h and vacuum-drying taking 48 h. Vacuum-drying showed lower variations in small samples(30-45 mg) and was suitable for genomic analysis as exemplified by sex genotyping. The effect of sodium bicarbonate (NaBic8.4%) on brain edema formation after CCI was investigated in small samples (2 x 1 mm). Only vacuum-drying showed low variation and significant improvement under NaBic8.4% treatment. Comparison with an existing method: The receiver operating curves (ROC) analysis demonstrated that vacuum-drying (area under the curve (AUC):0.867-0.967) was superior to the conventional heat-drying method (AUC:0.367-0.567). Conclusions: The vacuum method is superior in terms of quantifying water content in small samples. In addition, vacuum-dried samples can also be used for subsequent analyses, e.g., PCR analysis. (C) 2016 The Authors. Published by Elsevier B.V.	[Sebastiani, Anne; Hirnet, Tobias; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Jahn-Eimermacher, Antje] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Biostat Epidemiol & Informat, Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	serge@thal.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	German Research FoundationGerman Research Foundation (DFG) [DFG TH1430/3-1]; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EO1003]	This work was financially supported by a grant from the German Research Foundation (DFG TH1430/3-1) to SCT and by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT. The authors would also like to thank Sandra Schmidt for her linguistic assistance.	ADACHI M, 1966, J NEUROL NEUROSUR PS, V29, P446, DOI 10.1136/jnnp.29.5.446; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Bourdeaux C, 2010, NEUROCRIT CARE, V13, P24, DOI 10.1007/s12028-010-9368-8; Bourdeaux CP, 2011, NEUROCRIT CARE, V15, P42, DOI 10.1007/s12028-011-9512-0; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; Chen CH, 2006, J CEREBR BLOOD F MET, V26, P951, DOI 10.1038/sj.jcbfm.9600248; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Li Y.H., 2011, NEUROL SCI; Liu Fudong, 2012, Exp Transl Stroke Med, V4, P12, DOI 10.1186/2040-7378-4-12; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; McBride DW, 2012, J NEUROSURG, V116, P1389, DOI 10.3171/2012.2.JNS111540; Qiao M, 2001, STROKE, V32, P958, DOI 10.1161/01.STR.32.4.958; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; SHIGENO T, 1982, J NEUROSURG, V57, P99, DOI 10.3171/jns.1982.57.1.0099; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; TAKAGI H, 1981, J NEUROSURG, V54, P797, DOI 10.3171/jns.1981.54.6.0797; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Toung TJK, 2002, CRIT CARE MED, V30, P644, DOI 10.1097/00003246-200203000-00025; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	30	10	11	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 30	2017	276						73	78		10.1016/j.jneumeth.2016.11.012			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EJ9DB	WOS:000393525700008	27894783	hybrid			2022-02-06	
J	Schonfeld, LM; Jahanshahi, A; Lemmens, E; Schipper, S; Dooley, D; Joosten, E; Temel, Y; Hendrix, S				Schonfeld, Lisa-Maria; Jahanshahi, Ali; Lemmens, Evi; Schipper, Sandra; Dooley, Dearbhaile; Joosten, Elbert; Temel, Yasin; Hendrix, Sven			Long-Term Motor Deficits after Controlled Cortical Impact in Rats Can Be Detected by Fine Motor Skill Tests but Not by Automated Gait Analysis	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; behavioral assessments; CCI; locomotor function; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FUNCTIONAL OUTCOMES; STAIRCASE TEST; CORTEX; SENSORIMOTOR; THERAPY; MODELS; DEVICE	Animal models with constant, long-lasting motor deficits together with the right tests to assess behavioral abnormalities are needed to study the effectiveness of potential therapies to restore motor functions. In the current study, controlled cortical impact (CCI) was applied in rats to induce damage to the forelimb area of the motor cortex and the dorsal striatum. Motor behavior was assessed before and after CCI, using fine motor skill tests such as the adhesive removal test, the cylinder test, and the Montoya staircase test as well as the automated gait analysis system CatWalk XT over a 6 week period. CCI caused a variety of unilateral motor deficits, which were characterized in detail by using the selected fine motor skill tests. In striking contrast to previous studies on CCI in mice, neither forelimb impairments, nor general changes in gait, were detected with the CatWalk XT. These data suggest that the adhesive removal test, the cylinder test, and the Montoya staircase test are the methods of choice to detect long-term unilateral motor deficits in rats after CCI, whereas the use of automated gait analysis systems might not be suitable to measure these behavioral deviations.	[Schonfeld, Lisa-Maria; Lemmens, Evi; Dooley, Dearbhaile; Hendrix, Sven] Hasselt Univ, Biomed Res Inst BIOMED, Dept Morphol, Hasselt, Belgium; [Schonfeld, Lisa-Maria; Jahanshahi, Ali; Schipper, Sandra; Temel, Yasin] Maastricht Univ, Dept Neurosci, Maastricht, Netherlands; [Schipper, Sandra] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Dooley, Dearbhaile] Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Management, Maastricht, Netherlands; [Jahanshahi, Ali; Temel, Yasin] Maastricht Univ, Med Ctr, Dept Neurosurg, Maastricht, Netherlands		Hendrix, S (corresponding author), Hasselt Univ, Biomed Res Inst, Dept Morphol, Martelarenlaan 42, B-3500 Hasselt, Belgium.	sven.hendrix@uhasselt.be	Hendrix, Sven/F-4059-2010	Hendrix, Sven/0000-0003-2344-7369; Dooley, Dearbhaile/0000-0001-5337-1831; Lemmens, Evi/0000-0001-6044-5659	Hasselt University [BOF11603BOFMO]; Hersenstichting Nederland	This work was supported in part by a grant from Hasselt University (BOF11603BOFMO) to S.H. and a grant from the Hersenstichting Nederland to Y.T. We are grateful that a number of external specialists made a substantial contribution to conducting the experiment. We thank Drs. Rene Bernard, Chris Montoya, and Tracy Farr for their dedicated and outstanding advice on the execution of the behavioral tests.	Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Clarke J, 2007, BRAIN RES, V1145, P204, DOI 10.1016/j.brainres.2007.01.135; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Farr TD, 2011, NEUROMETHODS, V62, P91, DOI 10.1007/978-1-61779-301-1_6; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Jahanshahi A, 2013, EXP BRAIN RES, V231, P165, DOI 10.1007/s00221-013-3680-4; Kloth V, 2006, BRAIN RES BULL, V70, P68, DOI 10.1016/j.brainresbull.2006.04.006; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Parkkinen S, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/410972; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Simone L, 2015, EUR J NEUROSCI, V42, P2882, DOI 10.1111/ejn.13040; Starkey ML, 2012, BRAIN, V135, P3265, DOI 10.1093/brain/aws270; Trueman RC, 2011, TRANSL STROKE RES, V2, P651, DOI 10.1007/s12975-011-0102-4; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	38	10	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					505	516		10.1089/neu.2016.4440			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800026	27374164	Green Submitted			2022-02-06	
J	Weightman, MM; McCulloch, KL; Radomski, MV; Finkelstein, M; Cecchini, AS; Davidson, LF; Heaton, KJ; Smith, LB; Scherer, MR				Weightman, Margaret M.; McCulloch, Karen L.; Radomski, Mary V.; Finkelstein, Marsha; Cecchini, Amy S.; Davidson, Leslie F.; Heaton, Kristin J.; Smith, Laurel B.; Scherer, Matthew R.			Further Development of the Assessment of Military Multitasking Performance: Iterative Reliability Testing	PLOS ONE			English	Article							MOBILITY ASSESSMENT-TOOL; TRAUMATIC BRAIN-INJURY; ECOLOGICAL VALIDITY; HIMAT; CONCUSSION; CHILDREN; VERSION	The Assessment of Military Multitasking Performance (AMMP) is a battery of functional dual-tasks and multitasks based on military activities that target known sensorimotor, cognitive, and exertional vulnerabilities after concussion/mild traumatic brain injury (mTBI). The AMMP was developed to help address known limitations in post concussive return to duty assessment and decision making. Once validated, the AMMP is intended for use in combination with other metrics to inform duty-readiness decisions in Active Duty Service Members following concussion. This study used an iterative process of repeated interrater reliability testing and feasibility feedback to drive modifications to the 9 tasks of the original AMMP which resulted in a final version of 6 tasks with metrics that demonstrated clinically acceptable ICCs of > 0.92 (range of 0.92-1.0) for the 3 dual tasks and > 0.87 (range 0.87-1.0) for the metrics of the 3 multitasks. Three metrics involved in recording subject errors across 2 tasks did not achieve ICCs above 0.85 set apriori for multitasks (0.64) and above 0.90 set for dual-tasks (0.77 and 0.86) and were not used for further analysis. This iterative process involved 3 phases of testing with between 13 and 26 subjects, ages 18-42 years, tested in each phase from a combined cohort of healthy controls and Service Members with mTBI. Study findings support continued validation of this assessment tool to provide rehabilitation clinicians further return to duty assessment methods robust to ceiling effects with strong face validity to injured Warriors and their leaders.	[Weightman, Margaret M.; Radomski, Mary V.; Finkelstein, Marsha; Cecchini, Amy S.] Abbott NW Hosp, Courage Kenny Res Ctr, Minneapolis, MN 55407 USA; [McCulloch, Karen L.] Univ North Carolina Chapel Hill, Div Phys Therapy, Chapel Hill, NC USA; [Cecchini, Amy S.] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Davidson, Leslie F.] George Washington Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC USA; [Heaton, Kristin J.; Smith, Laurel B.] US Army, Environm Med Res Inst, Natick, MA USA; [Heaton, Kristin J.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Scherer, Matthew R.] Med Res Mat Command, Clin & Rehabilitat Med Res Program, Ft Detrick, MD USA		Weightman, MM (corresponding author), Abbott NW Hosp, Courage Kenny Res Ctr, Minneapolis, MN 55407 USA.	margaret.weightman@allina.com			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-2-0070]	Funded by the US Army Medical Research and Materiel Command (award number W81XWH-12-2-0070); http://mrmc.amedd.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; [Anonymous], 2013, DEP DEF POL GUID MAN; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Gailey RS, 2013, J REHABIL RES DEV, V50, P905, DOI 10.1682/JRRD.2012.05.0099; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Ibey RJ, 2010, PEDIATR PHYS THER, V22, P268, DOI 10.1097/PEP.0b013e3181ea8ff6; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; McCrea M., 2008, MILD TRAUMATIC BRAIN; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Sapsford R, 2006, OBSERVATIONAL ANAL D; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Smith LB, 2014, AM J OCCUP THER, V68, P439, DOI 10.5014/ajot.2014.012393; Smith LM, 2012, CONTINUITY ASSESSMEN; Surabhi McArthur CV, 2013, BRAIN INJURY, V27, P1271, DOI [10.3109/02699052.2013.809551, DOI 10.3109/02699052.2013.809551]; Tyson S, 2009, CLIN REHABIL, V23, P1018, DOI 10.1177/0269215509339004; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Wong RKY, 2014, BRAIN INJURY, V28, P1734, DOI 10.3109/02699052.2014.947620	23	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169104	10.1371/journal.pone.0169104			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	WOS:000391639100021	28056045	gold, Green Submitted, Green Published			2022-02-06	
J	Bell, ED; Donato, AJ; Monson, KL				Bell, E. David; Donato, Anthony J.; Monson, Kenneth L.			Cerebrovascular dysfunction following subfailure axial stretch	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury; Rat cerebral blood vessels; Autoregulatory dysfunction; Damage	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; RECTIFIER POTASSIUM CHANNELS; CORTICAL IMPACT INJURY; MYOGENIC RESPONSE; EXTRACELLULAR POTASSIUM; STRUCTURAL-CHANGES; VASCULAR INJURY; AUTO-REGULATION; HEAD-INJURY	Cerebral blood vessels are vital to maintaining the health of the brain. Traumatic brain injury (TBI) commonly results in autoregulatory dysfunction and associated failure of cerebral vessels to maintain homeostasis in the brain. While post-injury changes to brain biochemistry are known to contribute to this dysfunction, tissue deformation may also directly alter vascular smooth muscle cell (SMC) function. As a first step toward understanding stretch-induced dysfunction, this study investigates the effect of overstretch on the contractile behavior of SMCs in middle cerebral arteries (MCAs). We hypothesized that vessel function is altered above a threshold of stretch and strain rate. Twenty-four MCAs from Sprague Dawley rats were tested. Following development of basal SMC tone, vessels were subjected to increasing levels of isosmotic extracellular potassium (K+). Samples were then subjected to an axial overstretch of either 1.2*lambda(IV) or 1.3*lambda(IV) at strain rates of 0.2 or 20 s(-1). Following overstretch, SMC contractile behavior was measured again, both immediately and 60 min after overstretch. Control vessels were subjected to the same protocol but without overstretch. SMC contractile behavior was characterized using both percent contraction (%C) relative to the fully dilated inner diameter and the K+ dose required to evoke the half maximal contractile response (EC50). Control vessels exhibited increased sensitivity to K+ in successive characterization tests, so all effects were quantified relative to the time-matched control response. Samples exhibited the typical biphasic response to extracellular K+, dilating and contracting in response to small and large K+ concentrations, respectively. As hypothesized, axial overstretch altered SMC contractile behavior, as seen in a decrease in %C for sub-maximal contractile K+ doses (p < 0.05) and an increase in EC50 (p < 0.01), but only for the test group stretched rapidly to 1.3*lambda(IV). While the change in %C was only significantly different immediately after overstretch, the change to EC50 persisted for 60 min. These results indicate that deformation can alter SMC contractile behavior and thus potentially play a role in cerebrovascular autoregulatory dysfunction independent of the pathological chemical' environment in the brain post-TBI.	[Bell, E. David; Monson, Kenneth L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Bell, E. David; Monson, Kenneth L.] Univ Utah, Dept Mech Engn, Lab Head Injury & Vessel Biomech, 1495 E 100 S,MEK 1550, Salt Lake City, UT 84112 USA; [Donato, Anthony J.] Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA		Monson, KL (corresponding author), Univ Utah, Dept Mech Engn, Lab Head Injury & Vessel Biomech, 1495 E 100 S,MEK 1550, Salt Lake City, UT 84112 USA.	ken.monson@utah.edu	Monson, Ken/L-4702-2019		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K25HD048643]; Department of DefenseUnited States Department of Defense [W81XWH-08-1-0295]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K25HD048643] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health (5K25HD048643) and the Department of Defense (W81XWH-08-1-0295).	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Armstead WM, 1999, BRAIN RES, V842, P252, DOI 10.1016/S0006-8993(99)01825-9; ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; BARRY DI, 1982, J CEREBR BLOOD F MET, V2, P347, DOI 10.1038/jcbfm.1982.35; Bastide M, 1999, J CEREBR BLOOD F MET, V19, P1309, DOI 10.1097/00004647-199912000-00003; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bell E. D., 2015, FRONT BLOENG BIOTECH, V3; Bell ED, 2013, J BIOMECH, V46, P91, DOI 10.1016/j.jbiomech.2012.10.015; Boock R. J., 1991, THESIS; Bukoski RD, 1997, AM J PHYSIOL-HEART C, V272, pH1406; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; DAVIS MJ, 1993, AM J PHYSIOL, V264, pH2168, DOI 10.1152/ajpheart.1993.264.6.H2168; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Donato AJ, 2007, J PHYSIOL-LONDON, V579, P115, DOI 10.1113/jphysiol.2006.120055; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; FINNEY DJ, 1976, BIOMETRICS, V32, P721, DOI 10.2307/2529258; Golding EM, 2000, BRAIN RES, V880, P159, DOI 10.1016/S0006-8993(00)02793-1; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Golding EM, 1998, BRAIN RES, V785, P293, DOI 10.1016/S0006-8993(97)01419-4; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HARPER SL, 1984, AM J PHYSIOL, V246, pH17, DOI 10.1152/ajpheart.1984.246.1.H17; JAMAL A, 1992, ARTERIOSCLER THROMB, V12, P307, DOI 10.1161/01.ATV.12.3.307; Jiang XQ, 2014, BIOMETRICAL J, V56, P493, DOI 10.1002/bimj.201300123; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Johnson TD, 1998, AM J PHYSIOL-REG I, V274, pR541; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; LASSEN NA, 1974, CIRC RES, V34, P749, DOI 10.1161/01.RES.34.6.749; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marrelli SP, 1998, STROKE, V29, P1469, DOI 10.1161/01.STR.29.7.1469; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; SMIRNOV SV, 1992, J PHYSIOL-LONDON, V457, P455, DOI 10.1113/jphysiol.1992.sp019387; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Talman WT, 2007, BRAIN RES, V1139, P126, DOI 10.1016/j.brainres.2007.01.008; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; URSINO M, 1994, HUMAN BRAIN CIRCULATION, P291; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zubkov ZY, 2000, SURG NEUROL, V53, P126	58	10	10	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2017	65						627	633		10.1016/j.jmbbm.2016.09.028			7	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EF9BG	WOS:000390625100056	27736719	Green Accepted, Bronze			2022-02-06	
J	Bernard, C; McKinlay, A; Krieser, D; Testa, R; Ponsford, J				Bernard, Coco; McKinlay, Audrey; Krieser, David; Testa, Renee; Ponsford, Jennie			Acute post-concussive symptoms in young children	BRAIN INJURY			English	Article						Children; closed head injury; concussion; mild traumatic brain injury; outcome; post-concussive symptoms	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; CLOSED-HEAD INJURIES; LONG-TERM OUTCOMES; POSTCONCUSSIVE SYMPTOMS; EARLY INTERVENTION; EARLY-CHILDHOOD; SELF-REPORT; BASE RATES; MANAGEMENT	Objectives: Despite peaks of mild traumatic brain injury (mTBI) incidence in young children, few studies have examined the nature of post-concussive symptoms (PCSs) in children under the age of eight, whilst controlling for pre-injury symptoms and effects of trauma. The current study aimed to identify which PCSs differentiate children with mTBI from trauma controls early post-injury, and whether these differed among preschool and school-aged children. Methods: The sample comprised 101 children aged 2-12 presenting to an emergency department, with concussion or other minor bodily injury (control). Groups were divided by age (preschool and school-aged). PCSs were assessed within 72hours post-injury using a comprehensive PCS checklist, administered to their parents via structured interview. Results: Parents of children with mTBI reported significantly more symptoms in their children than parents of children with other minor bodily trauma, p<0.001, r=0.84. Parents of preschool and school-aged children reported an equal number of symptoms. However, subtle differences were observed between symptom profiles of preschool and school-aged children. Conclusions: Primary care clinicians should be aware of post-concussive symptom presentations in children of varying ages, in order to provide optimal care, especially in younger children. Methods of eliciting symptoms may influence the identification of symptoms. This issue warrants further examination in the paediatric population.ABBREVIATIONS ED emergency department; GCS Glasgow coma scale; mTBI mild traumatic brain injury; PCS post-concussive symptoms; PTA post-traumatic amnesia; TC trauma control	[Bernard, Coco; Testa, Renee; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia; [McKinlay, Audrey] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Krieser, David] Sunshine Hosp, Emergency Dept, Melbourne, Vic, Australia		Bernard, C (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia.	coco.bernard@monash.edu	Krieser, David/AAA-1370-2021; Ponsford, Jennie/H-8341-2014	Krieser, David/0000-0002-7173-6993; McKinlay, Audrey/0000-0001-9846-8514; Ponsford, Jennie/0000-0003-0430-125X			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brown H., 2015, APPL MIXED MODELS ME; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dahab K, 2012, PEDIAT ADOLSCENT CON; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A., 2012, MILD TRAUMATIC BRAIN, P361; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Metzl JD, 2006, PEDIATRICS, V117, P1813, DOI 10.1542/peds.2006-0480; Myers R. H., 1990, CLASSICAL MODERN REG; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; StataCorp, 2013, STATA STAT SOFTW REL; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Studer M, 2014, J INT NEUROPSYCH SOC, V20, P982, DOI 10.1017/S1355617714000927; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P73, DOI 10.1007/978-0-387-89545-1_6; Melo JRT, 2010, ARQ NEURO-PSIQUIAT, V68, P381, DOI 10.1590/S0004-282X2010000300010; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	71	10	10	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1414	1421		10.1080/02699052.2017.1350999			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200002	28876149				2022-02-06	
J	Chantsoulis, M; Polrola, P; Goral-Polrola, J; Hajdukiewicz, A; Supinski, J; Kropotov, JD; Pachalska, M				Chantsoulis, Marzena; Polrola, Pawel; Goral-Polrola, Jolanta; Hajdukiewicz, Anna; Supinski, Jan; Kropotov, Juri D.; Pachalska, Maria			Application of ERPs neuromarkers for assessment and treatment of a patient with chronic crossed aphasia after severe TBI and long-term coma - Case Report	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						cognitive control; emotional control; relative beta training; rTMS; microgenetic theory	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; REHABILITATION; ATTENTION; MEMORY	Objective. The study aimed to evaluate the application of ERPs neuromarkers for the assessment and treatment of a patient with chronic crossed aphasia after severe TBI and a long-term coma. Case report. An ambidextrous female patient, aged 29, suffered from posttraumatic chronic crossed aphasia, severe TBI and a prolonged coma after a car accident. The patient took part in two differentiated rehabilitation programmes of neurotherapy included 20 sessions of relative beta training and 20 sessions of rTMS; both programmes were combined with behavioural training. The patient was tested 3 times: before the experiment, after completion of programme A, and after completion of programme B. Results. In the 1st recording, the neuromarker of aphasia was found - an excess of the P2 wave over the left temporal area. There was a cognitive control deficit - an excess of omission errors and an increase of RT variability - all indexes of sporadic ADHD. In the 2nd recording, slight improvements in cognitive control, and language functions were found. In the 3rd recording, after the rTMS sessions most of her cognitive dysfunctions had been resolved, including language functions. It should be stressed that the activation (especially the increase in the ERP potential of the right side over the frontal lobe) was found. The neuromarker of aphasia did not change, only the location had slightly moved frontally. Conclusions. The application of ERP neuromarkers assists in the diagnosis, treatment, and academic success of an ambidextrous patient with chronic posttraumatic aphasia and sporadic ADHD. ERPs can be used to assess the functional brain changes induced by neurotherapeutical programmes.	[Chantsoulis, Marzena] Acad Phys Educ, Dept Physiotherapy, Wroclaw, Poland; [Polrola, Pawel] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland; [Goral-Polrola, Jolanta; Hajdukiewicz, Anna] Old Polish Univ, Kielce, Poland; [Supinski, Jan] Acad Phys Educ, Dept Psychol, Wroclaw, Poland; [Kropotov, Juri D.] Russian Acad Sci, Inst Human Brain, Lab Act Programming Neurobiol, St Petersburg, Russia; [Pachalska, Maria] Andrzej Frycz Modrzewski Krakow Univ, Chair Neuropsychol & Neurorehabil, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY USA		Goral-Polrola, J (corresponding author), Old Polish Univ, Kielce, Poland.	jgp@stsw.edu.pl					Bashir S, 2010, PM&R, V2, pS253, DOI 10.1016/j.pmrj.2010.10.015; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Chantsoulis M, 2015, ANN AGR ENV MED, V22, P368, DOI 10.5604/12321966.1152097; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Kropotov J. D., 2009, QUANTITATIVE EEG EVE; Kropotov JD, 2005, INT J PSYCHOPHYSIOL, V55, P23, DOI 10.1016/j.ijpsycho.2004.05.011; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Marien P, 2001, EUROPEAN J NEUROLOGY, V8, P634; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Meinzer M, 2011, APHASIOLOGY, V25, P271, DOI 10.1080/02687038.2010.530672; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Pachalska M., 2008, REHABILITACJA NEUROP; PACHALSKA M, 2014, NEUROPSYCHOLOGIA KLI; Pachalska M, 2010, MED SCI MONITOR, V16, pCS157; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Polrola P, 2016, ACTA NEUROPSYCHOL, V14, P69, DOI 10.5604/17307503.1201710; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Ruff R. M., 1989, MILD HEAD INJURY, P176; Tomaszewski W, 2014, ANN AGR ENV MED, V21, P649, DOI 10.5604/12321966.1120620; Trystula M, 2015, ACTA NEUROPSYCHOL, V13, P395, DOI 10.5604/17307503.1193831; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; WEINTRAUB S, 1981, ARCH NEUROL-CHICAGO, V38, P742, DOI 10.1001/archneur.1981.00510120042004; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Yousefzadeh-Chabok Shahrokh, 2015, Asian J Neurosurg, V10, P173, DOI 10.4103/1793-5482.161165; Zielinska J, 2016, ANN AGR ENV MED, V23, P276, DOI 10.5604/12321966.1203890	37	10	10	1	14	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2017	24	1					141	147		10.5604/12321966.1232770			7	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EU9IJ	WOS:000401352700025	28378976	gold			2022-02-06	
J	Chen, G; Song, X; Wang, B; You, GX; Zhao, JX; Xia, S; Zhang, YH; Zhao, L; Zhou, H				Chen, Gan; Song, Xiang; Wang, Bo; You, Guoxing; Zhao, Jingxiang; Xia, Sha; Zhang, Yuhua; Zhao, Lian; Zhou, Hong			Carboxyfullerene nanoparticles alleviate acute hepatic injury in severe hemorrhagic shock	BIOMATERIALS			English	Article						Hemorrhagic shock; Carboxyfullerene nanoparticles; Acute hepatic injury; Reactive oxygen species; NF-kappa B pathway	FACTOR-KAPPA-B; HYDROPHILIC CARBON CLUSTERS; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; IN-VIVO; CEREBROVASCULAR DYSFUNCTION; NANOSCALE AGGREGATION; SUPEROXIDE-DISMUTASE; AQUEOUS-SOLUTION; FULLERENE C-60	Hemorrhagic shock/resuscitation involves overwhelming reactive oxygen species (ROS) that cause oxidative stress, inflammation, and subsequent tissue injury. We investigated the effects of the potent antioxidant carboxyfullerene (C-3) on acute liver injury during hemorrhage shock/resuscitation. C-3 infusion reduced the alanine aminotransferase (ALT) activity, methemoglobin content, malondialdehyde content, myeloperoxidase activity and expression levels of tumor necrosis factor-alpha and interleukin-6; it increased superoxide dismutase activity in the liver. The histologic injury score and apoptotic index were also markedly decreased after C-3 treatment compared with the vehicle group. Additionally, C-3-treated rats showed a significant decrease in nuclear factor-kappa B DNA binding capacity, which was preceded by reduced phosphorylation of the nuclear factor kappa B (NF-kappa B) p65 subunit in the liver. C-3 nanoparticles ameliorate oxidative stress, the inflammatory response, and subsequent acute liver injury after hemorrhagic shock/resuscitation. These protective effects appear to be mediated through the inhibition of the nuclear factor-kappa B pathway. C-3 treatment may be a promising strategy to improve tissue injury in hemorrhagic shock/resuscitation. (C) 2016 Elsevier Ltd. All rights reserved.	[Chen, Gan; Song, Xiang; Wang, Bo; You, Guoxing; Zhao, Jingxiang; Xia, Sha; Zhang, Yuhua; Zhao, Lian; Zhou, Hong] Acad Mil Med Sci, Inst Transfus Med, 27th Taiping Rd, Beijing, Peoples R China		Zhao, L; Zhou, H (corresponding author), Acad Mil Med Sci, Inst Transfus Med, 27th Taiping Rd, Beijing, Peoples R China.	zhaolian@bmi.ac.cn; zhouhtt1966@163.com	Nanozymes, Nanozymes/D-8197-2019; Chen, Gan/O-8508-2019; zhao, jing/B-3868-2019	Chen, Gan/0000-0003-4586-4526; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81600148]; Youth Science Fund of AMMS [2015CX1I22]	This work was supported by grants from the National Natural Science Foundation of China (No. 81600148) and the Youth Science Fund of AMMS (No.2015CX1I22).	Ali SS, 2004, FREE RADICAL BIO MED, V37, P1191, DOI 10.1016/j.freeradbiomed.2004.07.002; Altavilla D, 2001, FREE RADICAL BIO MED, V30, P1055, DOI 10.1016/S0891-5849(01)00492-0; Baati T, 2012, BIOMATERIALS, V33, P4936, DOI 10.1016/j.biomaterials.2012.03.036; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Bjelakovic G, 2013, JAMA-J AM MED ASSOC, V310, P1178, DOI 10.1001/jama.2013.277028; BOTHA AJ, 1995, J TRAUMA, V39, P411; Cagle DW, 1999, P NATL ACAD SCI USA, V96, P5182, DOI 10.1073/pnas.96.9.5182; Chang XL, 2014, ENVIRON SCI-NANO, V1, P64, DOI 10.1039/c3en00046j; Chen G, 2014, AMINO ACIDS, V46, P2653, DOI 10.1007/s00726-014-1816-x; Chen G, 2013, CRIT CARE, V17, DOI 10.1186/cc12820; Chen YW, 2004, AM J PHYSIOL-REG I, V287, pR21, DOI 10.1152/ajpregu.00310.2003; Chima RS, 2008, CRIT CARE MED, V36, P2849, DOI 10.1097/CCM.0b013e318187810e; Dellinger A, 2013, NANOMEDICINE-UK, V8, P1191, DOI [10.2217/NNM.13.99, 10.2217/nnm.13.99]; Dugan LL, 2014, ANN NEUROL, V76, P393, DOI 10.1002/ana.24220; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; Gaddipati JP, 2003, SHOCK, V19, P150, DOI 10.1097/00024382-200302000-00011; Ganesan S, 2009, TOXICOL APPL PHARM, V241, P14, DOI 10.1016/j.taap.2009.07.012; Gharbi N, 2005, NANO LETT, V5, P2578, DOI 10.1021/nl051866b; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Helling TS, J AM COLL SURG, V201, P774; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hood E, 2011, NANOMEDICINE-UK, V6, P1257, DOI [10.2217/NNM.11.92, 10.2217/nnm.11.92]; Howard MD, 2014, J CONTROL RELEASE, V177, P34, DOI 10.1016/j.jconrel.2013.12.035; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Karmaniolou II, 2013, J ANESTH, V27, P447, DOI 10.1007/s00540-012-1543-y; Korff S, 2012, SHOCK, V38, P486, DOI 10.1097/SHK.0b013e3182699072; Lao F, 2009, ACS NANO, V3, P3358, DOI 10.1021/nn900912n; Lin AMY, 2004, NEUROCHEM INT, V44, P99, DOI 10.1016/S0197-0186(03)00113-X; Lin AMY, 2002, NEUROSCI RES, V43, P317, DOI 10.1016/S0168-0102(02)00056-1; Liu QL, 2013, ACS APPL MATER INTER, V5, P4328, DOI 10.1021/am400535j; Lu MZ, 2016, COLLOID SURFACE B, V139, P171, DOI 10.1016/j.colsurfb.2015.12.012; Lu MZ, 2014, ARTIF CELL NANOMED B, V42, P63, DOI 10.3109/21691401.2013.775577; Luo X, 2015, ANESTHESIOLOGY, V123, P1122, DOI 10.1097/ALN.0000000000000859; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; Markovic Z, 2008, BIOMATERIALS, V29, P3561, DOI 10.1016/j.biomaterials.2008.05.005; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Nathens AB, 2002, ANN SURG, V236, P814, DOI 10.1097/00000658-200212000-00014; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Samuel ELG, 2014, TRENDS BIOTECHNOL, V32, P501, DOI 10.1016/j.tibtech.2014.08.005; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Sitharaman B, 2004, NANO LETT, V4, P2373, DOI 10.1021/nl0485713; Sitharaman B, 2004, NANO LETT, V4, P1759, DOI 10.1021/nl049315t; Spohn P, 2009, ENVIRON POLLUT, V157, P1134, DOI 10.1016/j.envpol.2008.08.013; Trajkovic S, 2007, COLLOID SURFACE B, V58, P39, DOI 10.1016/j.colsurfb.2007.01.005; Tsao N, 1999, ANTIMICROB AGENTS CH, V43, P2273, DOI 10.1128/AAC.43.9.2273; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Wang YH, 2004, J DRUG DELIV SCI TEC, V14, P45, DOI 10.1016/S1773-2247(04)50004-7; YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8; Yin YJ, 2012, EXP BIOL MED, V237, P362, DOI 10.1258/ebm.2011.011193; Zhao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123694; Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015	53	10	11	1	54	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2017	112						72	81		10.1016/j.biomaterials.2016.10.022			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	ED9CB	WOS:000389166700007	27750099				2022-02-06	
J	Chen, W; Li, MD; Wang, GF; Yang, XF; Liu, L; Meng, FG				Chen, Wei; Li, Ming-De; Wang, Gui-Fang; Yang, Xia-Feng; Liu, Lin; Meng, Fan-Gang			Risk of post-traumatic epilepsy after severe head injury in patients with at least one seizure	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						post-traumatic epilepsy; risk factor; post-traumatic seizure	POST-TRAUMATIC EPILEPSY; PROGNOSTIC FACTORS; BRAIN-INJURY; EPIDEMIOLOGY; ADULTS	Background: To explore the incidence and risk factors, including type of seizures for post-traumatic epilepsy (PTE) after severe traumatic brain injury (TBI). Subjects and methods: This was a retrospective follow-up study of patients discharged from Liaocheng People's Hospital between March 2011 and June 2015 with a diagnosis of post-traumatic seizures. Risk factors for PTE were evaluated in 68 inpatients by using Kaplan-Meier curves and the Cox model. Results: Complete clinical information was available for 68 patients. A total of 54 cases (79.4%) were diagnosed as presenting with PTE, occurring from 10 days to 179 months after severe TBI. Nineteen out of 54 cases (35.2%) had been defined as PTE within the first 6 months after the trauma, 17 cases (31.5%) within 7-12 months, 8 cases (14.8%) within 13-24 months, 2 cases (3.7%) within 25-36 months, and 8 cases (14.8%) within 37-179 months after the TBI. The Kaplan-Meier curves demonstrated that simple partial seizures, surgical treatment, and onset of seizures occurring within 6 months after injury were associated with PTE. Conclusions: The Cox model indicated that, for patients aged > 34 years at the time of injury, the PTE risk was 2.55 times greater than for those aged <= 34 years. In addition, simple partial seizures, surgical treatment and onset of seizures occurring within 6 months after injury were significant risk factors for the development of PTE.	[Chen, Wei; Wang, Gui-Fang; Yang, Xia-Feng; Liu, Lin] Liaocheng Peoples Hosp, Dept Neurol, Liaocheng, Peoples R China; [Li, Ming-De] Peoples Hosp Ling Cheng Dist, Dept Neurosurg, Dezhou, Shandong, Peoples R China; [Meng, Fan-Gang] Capital Med Univ, Beijing Neurosurg Inst, Dept Funct Neurosurg, 6 Tiantan Xili, Beijing 100050, Peoples R China		Meng, FG (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Funct Neurosurg, 6 Tiantan Xili, Beijing 100050, Peoples R China.	fgmeng@ccmu.edu.cn					Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; JENNETT B, 1975, EPILEPSY NONMISSILE; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; WEISS GH, 1972, J NEUROSURG, V37, P164, DOI 10.3171/jns.1972.37.2.0164; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	20	10	10	0	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2017	13						2301	2306		10.2147/NDT.S141486			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	FF2WX	WOS:000408758600004	28919762	Green Published, gold			2022-02-06	
J	Chu, SY; Tsai, YH; Xiao, SH; Huang, SJ; Yang, CC				Chu, Shao-Ying; Tsai, Yi-Hsin; Xiao, Sheng-Huang; Huang, Sheng-Jean; Yang, Chi-Cheng			Quality of return to work in patients with mild traumatic brain injury: a prospective investigation of associations among post-concussion symptoms, neuropsychological functions, working status and stability	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion symptoms; return to work; working status; working stability; neuropsychological functions	MINOR HEAD-INJURY; ANXIETY SENSITIVITY; PRODUCTIVE WORK; EMPLOYMENT; ADULTS; REHABILITATION; PREDICTION; SEQUELAE; TIME	Primary objective: Although return to work' (RTW) has been always emphasized for patients with mild traumatic brain injury (MTBI), methodological drawbacks weakened its representativeness. This study thus aims to evaluate the work quality' (WQ) which originated from working status' and working stability' simultaneously, and to further explore the associations among post-concussion symptoms (PCS), neuropsychological functions and WQ. Methods and procedures: A total of 179 participants, which included 132 patients with MTBI and 47 healthy participants, were prospectively recruited. The work quality index (WQI) was developed to evaluate WQ. All patients were evaluated for their PCS, neuropsychological functions and WQ at two weeks post-injury (T1), while PCS and WQ were recorded by one month post-injury (T2). Results: More than half of the patients were not able to retain their pre-injury jobs at T1, while 26% of the patients still failed to regain previous works at T2. Interestingly, WQ was significantly associated with educational levels and physical PCS, such as headache and dizziness. Conclusions: Simultaneously considering working status and stability to reveal the quality of RTW is merited. A higher educational level might be a protective factor for successful RTW, and ameliorating physical symptoms is also necessary to get favourable WQ by one month after MTBI.	[Chu, Shao-Ying] Chang Gung Univ, Div Clin Psychol, Dept Occupat Therapy, Coll Med,Behav Sci, Taoyuan, Taiwan; [Tsai, Yi-Hsin] Far Eastern Mem Hosp, Dept Neurosurg, New Taipei, Taiwan; [Xiao, Sheng-Huang] Taipei City Hosp, Ren Ai Branch, Taipei, Taiwan; [Huang, Sheng-Jean] Taipei City Hosp, 145 Zhengzhou Rd, Taipei, Taiwan; [Yang, Chi-Cheng] Natl Chengchi Univ, Dept Psychol, 64,Sect 2,ZhiNan Rd, Taipei, Taiwan		Huang, SJ (corresponding author), Taipei City Hosp, 145 Zhengzhou Rd, Taipei, Taiwan.; Yang, CC (corresponding author), Natl Chengchi Univ, Dept Psychol, 64,Sect 2,ZhiNan Rd, Taipei, Taiwan.	sjhuang1@ntu.edu.tw; yangyang@nccu.edu.tw		YANG, CHI CHENG/0000-0002-4544-3978	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2410-H-182-005-MY2]	The authors report no conflicts of interest. This study is supported by the Ministry of Science and Technology, Taiwan (MOST 104-2410-H-182-005-MY2).	Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Chen HY, 2000, BECK DEPRESSION INVE; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Fleming J, 1999, BRAIN INJURY, V13, P417; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hua M.-S., 1986, WORD SEQUENCE UNPUB; Hua MS, 1997, NEUROPSYCHOLOGY, V11, P156, DOI 10.1037/0894-4105.11.1.156; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levin H. S., 1983, PACED AUDITORY UNPUB; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lin YC, 2000, BECK ANXIETY INVENTO; LOWDON IMR, 1989, INJURY, V20, P193, DOI 10.1016/0020-1383(89)90109-5; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Possl O, 2001, BRAIN INJURY, V15, P15; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wang Tzu-Lan, 2016, Appl Neuropsychol Adult, V23, P11, DOI 10.1080/23279095.2014.995792; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yuen K. M., 2012, MODIFIED CHECKLIST P; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	49	10	10	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1674	1682		10.1080/02699052.2017.1332783			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200016	28872344				2022-02-06	
J	Dahdah, MN; Bennett, M; Prajapati, P; Parsons, TD; Sullivan, E; Driver, S				Dahdah, Marie N.; Bennett, Monica; Prajapati, Purvi; Parsons, Thomas D.; Sullivan, Erin; Driver, Simon			Application of virtual environments in a multi-disciplinary day neurorehabilitation program to improve executive functioning using the Stroop task	NEUROREHABILITATION			English	Article						Brain injuries; virtual reality exposure therapy; executive function; treatment outcome; inpatients; rehabilitation	TRAUMATIC BRAIN-INJURY; REALITY STROOP; ECOLOGICAL VALIDITY; REHABILITATION; TECHNOLOGY; GENDER	BACKGROUND: Virtual reality (VR) technology has demonstrated usefulness in diagnosis, education, and training. Studies supporting use of VR as a therapeutic treatment in medical rehabilitation settings remain limited. This study examines the use of VR in a treatment capacity, and whether it can be effectively integrated into neurorehabilitation. OBJECTIVE: To determine whether immersive VR treatment interventions improve executive dysfunction in patients with brain injury and whether performance is stronger on a VR version of the Stroop than traditional Stroop formats. METHODS: 15 patients with brain injury admitted to day neurorehabilitation. Outcome measures: reaction time, inhibition, and accuracy indices on VR Stroop; Automated Neuropsychological Assessment Metrics (ANAM) Stroop, Delis-Kaplan Executive Function System Stroop, Golden Stroop, and Woodcock-Johnson, 3rd Edition (WJ-III): Pair Cancellation. RESULTS: Participants demonstrated significantly reduced response time on the word-reading condition of VR Stroop and non-significantly reduced response time on the interference condition. Non-significant improvements in accuracy and inhibition were demonstrated on the color-naming condition of VR Stroop. Significantly improved accuracy under time pressure was found for the ANAM, after VR intervention. CONCLUSION: Implementation of immersiveVRinterventions during neurorehabilitation is effective in improving specific executive functions and information processing speed in brain-injured patients during the subacute period.	[Dahdah, Marie N.; Driver, Simon] Baylor Inst Rehabil, Dallas, TX USA; [Dahdah, Marie N.; Driver, Simon] North Texas Traumat Brain Injury Model Syst, Dallas, TX USA; [Dahdah, Marie N.] Baylor Scott & White Med Ctr Plano, 4708 Alliance Blvd,Pavil 1,Suite 700, Plano, TX 75093 USA; [Bennett, Monica; Prajapati, Purvi] Baylor Scott & White Hlth, Ctr Clin Effectiveness, Dallas, TX USA; [Parsons, Thomas D.] Univ North Texas, Dept Psychol, Computat Neuropsychol & Simulat CNS Lab, Denton, TX 76203 USA; [Sullivan, Erin] Univ North Texas, Dept Psychol, Denton, TX 76203 USA		Dahdah, MN (corresponding author), Baylor Scott & White Med Ctr Plano, 4708 Alliance Blvd,Pavil 1,Suite 700, Plano, TX 75093 USA.	Marie.Dahdah@BSWHealth.org		driver, simon/0000-0003-2356-432X; Parsons, Thomas/0000-0003-0331-5019	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0045-01-0]; Ginger Murchison Foundation	The contents of this manuscript were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DP0045-01-0). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government. The project was also supported by the Ginger Murchison Foundation. There is no financial conflict of interest to report, as no financial benefit will be conferred on the authors or on any organization with which the authors are associated as a result of the research supporting this article.	[Anonymous], 2007, EMAGIN 3DVISOR TM IM; Armstrong CM, 2013, J CLIN EXP NEUROPSYC, V35, P113, DOI 10.1080/13803395.2012.740002; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Cherniack EP, 2011, DISABIL REHABIL-ASSI, V6, P283, DOI 10.3109/17483107.2010.542570; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Davidson DJ, 2003, AGING NEUROPSYCHOL C, V10, P85, DOI 10.1076/anec.10.2.85.14463; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; Hofmann M, 2003, COMPR PSYCHIAT, V44, P213, DOI 10.1016/S0010-440X(03)00006-3; JOSMAN N, 2008, P 7 INT C DIS VIRT R; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Kim BR, 2011, ANN REHABIL MED-ARM, V35, P450, DOI 10.5535/arm.2011.35.4.450; Krch D., 2013, 2013 INT C VIRT REH; Larson EB, 2014, NEUROREHABILITATION, V34, P759, DOI 10.3233/NRE-141078; Lustig C., 2000, 2000 COGN AG C ATL G; Nombela C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095657; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Parsons TD, 2011, STUD COMPUT INTELL, V337, P271; Parsons TD, 2011, STUD HEALTH TECHNOL, V163, P433, DOI 10.3233/978-1-60750-706-2-433; Rand D, 2009, AM J OCCUP THER, V63, P535, DOI 10.5014/ajot.63.5.535; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Salisbury David B, 2016, Proc (Bayl Univ Med Cent), V29, P124; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simone LK, 2006, CYBERPSYCHOL BEHAV, V9, P591, DOI 10.1089/cpb.2006.9.591	30	10	13	3	14	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	41	4					721	734		10.3233/NRE-172183			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ0UF	WOS:000418071500002	29254114				2022-02-06	
J	Dhamapurkar, SK; Wilson, BA; Rose, A; Watson, P; Shiel, A				Dhamapurkar, Samira Kashinath; Wilson, Barbara A.; Rose, Anita; Watson, Peter; Shiel, Agnes			Does Modafinil improve the level of consciousness for people with a prolonged disorder of consciousness? a retrospective pilot study	DISABILITY AND REHABILITATION			English	Article						Disorders of consciousness; Modafinil; neuro-modulation; Wessex head injury matrix; coma recovery scale-revised	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; RECOVERY; STATE; FATIGUE	Background and aim: Modafinil is best known as a sleep regulator among healthy individuals, but studies suggest that it reduces excessive daytime sleepiness in patients with brain injury. This retrospective pilot study evaluated the effectiveness of Modafinil for people with a prolonged disorder of consciousness and whether those with a traumatic brain injury did better than those with a non-traumatic brain injury. Method: Twenty four prolonged disorder of consciousness patients who were prescribed Modafinil, were assessed at least four times both before and during treatment. The Coma Recovery Scale-Revised was used to determine if patients had a disorder of consciousness and the Wessex Head Injury Matrix was used to monitor behavior during baseline and treatment periods. Patients with a traumatic brain injury (N=12) were compared with those with non-traumatic brain injury (N=12). A chi-square test with significance at 0.05 was used and when frequencies were below 5 a Fisher's Exact Test was used. Results: Cognitive improvements were noted in domains of wakefulness, awareness, concentration, tracking and following commands. Significant differences were found for the whole group between baseline and Modafinil (x(2)=9.80; p=0.002). Eleven of the 12 traumatic brain injury patients had higher Wessex Head Injury Matrix scores when on Modafinil (x(2)=8.33, p<0.004). Six non-traumatic brain injury patients had higher scores with Modafinil, two had lower scores and four showed no change. There was no significant difference in the number of patients showing an increase compared to those showing a decrease (Fisher's exact test p=0.29). Conclusion: Modafinil appears to be beneficial for enhancing cognition in prolonged disorder of consciousness patients. Traumatic brain injury patients benefited more than non-traumatic brain injury patients.	[Dhamapurkar, Samira Kashinath] Raphael Med Ctr, Occupat Therapy Dept, Coldharbour Lane, Tonbridge TN11 9LE, Kent, England; [Dhamapurkar, Samira Kashinath; Shiel, Agnes] Natl Univ Ireland Galway, Occupat Therapy Dept, Galway, Ireland; [Wilson, Barbara A.; Rose, Anita] Raphael Med Ctr, Neuropsychol Dept, Tonbridge, Kent, England; [Wilson, Barbara A.] Oliver Zangwill Ctr, Ely, Cambs, England; [Watson, Peter] MRC, Cognit & Brain Sci Unit Cambridge, London, Cambs, England		Dhamapurkar, SK (corresponding author), Raphael Med Ctr, Occupat Therapy Dept, Coldharbour Lane, Tonbridge TN11 9LE, Kent, England.	Samaira_sagi@yahoo.co.in	Shiel, Agnes/AAA-4211-2019		Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UU_00005/14] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_00005/14, MC_U105579212] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U105579212] Funding Source: researchfish		ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cephalon Inc, PROV MOD TABL PRESCR; Ciurleo R, 2013, DRUGS, V73, P1849, DOI 10.1007/s40265-013-0138-8; DUTEIL J, 1990, EUR J PHARMACOL, V180, P49, DOI 10.1016/0014-2999(90)90591-S; Ellis CM, 1999, J SLEEP RES, V8, P85, DOI 10.1046/j.1365-2869.1999.00142.x; Elovic E, 2000, J HEAD TRAUMA REHAB, V15, P1068, DOI 10.1097/00001199-200008000-00009; European Medicines A, 2011, QUEST ANSW REV MED C; Giacino JT, 2013, SEMIN NEUROL, V33, P142, DOI 10.1055/s-0033-1348960; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Howell DC., 2002, STAT METHODS PSYCHOL, V5; Ishizuka T, 2010, NEUROSCI LETT, V483, P193, DOI 10.1016/j.neulet.2010.08.005; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; JONES BE, 1985, J COMP NEUROL, V242, P56, DOI 10.1002/cne.902420105; Joo EP, 2008, J SLEEP RES, V17, P82, DOI 10.1111/j.1365-2869.2008.00624.x; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kumar R, 2008, DRUGS, V68, P1803, DOI 10.2165/00003495-200868130-00003; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Monti MM, 2009, ANN NY ACAD SCI, V1157, P81, DOI 10.1111/j.1749-6632.2008.04121.x; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Percheron G., 1993, Stereotactic and Functional Neurosurgery, V60, P32, DOI 10.1159/000100588; Prolonged Disorders of Consciousness, 2013, PROL DIS CONSC; Rammohan KW, 2002, J NEUROL NEUROSUR PS, V72, P179, DOI 10.1136/jnnp.72.2.179; *ROYAL COLL PHYS, 2003, VEG STAT GUID DIAGN; Shiel A, 2000, WESSEX HEAD INJURY M; Wisor JP, 2005, NEUROSCIENCE, V132, P1027, DOI 10.1016/j.neuroscience.2005.02.003	29	10	10	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	26					2633	2639		10.1080/09638288.2016.1236414			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FH0IK	WOS:000410822800004	27793075				2022-02-06	
J	Finch, E; Cornwell, P; Copley, A; Doig, E; Fleming, J				Finch, Emma; Cornwell, Petrea; Copley, Anna; Doig, Emmah; Fleming, Jennifer			Remediation of social communication impairments following traumatic brain injury using metacognitive strategy intervention: a pilot study	BRAIN INJURY			English	Article						metacognition; cognition; social communication; pragmatics; goal; metacognitive strategy intervention; Traumatic brain injury	GOAL ATTAINMENT; COGNITIVE-COMMUNICATION; CONTROLLED-TRIAL; SKILLS; PEOPLE	Objective: To perform a pilot study to evaluate whether a novel metacognitive, goal-based Intervention Improved and maintained the social communication skills of adults with traumatic brain injury (TBI).& para;& para;Method: Eight community-dwelling participants with TBI completed three study phases: (1) baseline, (2) eight-week intervention targeting social communication Impairments and (3) follow-up. Participants completed the Profile of Pragmatic Impairment in Communication (PPIC), LaTrobe Communication Questionnaire (LCQ) and Goal Attainment Scaling (GAS) at the commencement of baseline phase, pre- and post-intervention and completion of the follow-up phase. During the Intervention programme phase, participants attended two 1-hour therapy sessions (one individual; one group) per week focusing on remediating impaired social communication skills using metacognitive strategy Intervention and goal-based therapy.& para;& para;Results: Variable changes In PPIC feature-summary scores were observed post-intervention. A non-significant improvement in LCQ scores was also observed. There was a significant increase in GAS goal T-scores following the intervention, with six of the eight participants achieving or exceeding their expected level of performance on all goals.& para;& para;Conclusion: A goal-driven, metacognitive approach to intervention may assist individuals with TBI to achieve their personal social communication goals, with benefits reported by participants and observable during conversations. Further research Is required.	[Finch, Emma; Copley, Anna; Doig, Emmah; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Bldg 84A, St Lucia, Qld 4072, Australia; [Finch, Emma] Princess Alexandra Hosp, Speech Pathol Dept, Woolloongabba, Qld, Australia; [Finch, Emma; Doig, Emmah; Fleming, Jennifer] Metro South Hosp & Hlth Serv, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Cornwell, Petrea] Metro South Hosp & Hlth Serv, Prince Charles Hosp, Allied Hlth Res Collaborat, Chermside, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Menzles Hlth Inst Queensland, Behav Basis Hlth, Mt Gravatt, Qld, Australia; [Cornwell, Petrea] Metro North Hosp & Hlth Serv, Collaborat Allied Hlth Res & Learning, Chermside, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld, Australia		Finch, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Bldg 84A, St Lucia, Qld 4072, Australia.	e.finch@uq.edu.au	Cornwell, Petrea/AAE-5547-2019; Doig, Emmah/AAG-6674-2021; Finch, Emma/B-3067-2011	Doig, Emmah/0000-0002-7020-053X; Finch, Emma/0000-0002-9690-8165; Fleming, Jennifer/0000-0002-5603-2410	Princess Alexandra Hospital Research Support Scheme Small Project Grant	The authors have no conflicts or interest to report, This research project was supported by a Princess Alexandra Hospital Research Support Scheme Small Project Grant.	American Speech-Language-Hearing Association (ASHA, 2005, ROL SPEECH LANG PATH, DOI [10.1044/policy.PS2005-00110, DOI 10.1044/POLICY.PS2005-00110]; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Copley A, BRAIN INJ IN PRESS; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Douglas J, 2000, TROBE COMMUNICATION; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Finch E, ARCH PHYS M IN PRESS; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; Linscott RJ, 2003, PROFILE PRAGMATIC IM; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Mclennan W., 1997, AUSTR STAND CLASOC, Vsecond; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Struchen MA, 2014, HDB NEUROPSYCHOLOGY, P213, DOI DOI 10.1007/978; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Tu LV, 2013, BRAIN INJURY, V25, P560; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005	31	10	10	1	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1830	1839		10.1080/02699052.2017.1346284			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500015	28750171				2022-02-06	
J	Howell, A				Howell, Alison			Neuroscience and War: Human Enhancement, Soldier Rehabilitation, and the Ethical Limits of Dual-use Frameworks	MILLENNIUM-JOURNAL OF INTERNATIONAL STUDIES			English	Article						critical war studies; science and technology studies; neuroscience	DRONE; MATERIALITY; MEDICINE; POLITICS	Recent breakthroughs in neuroscience have led to increasing concern about its uses in warfare. This article challenges the primacy of dual-use frameworks for posing ethical questions concerning the role of neuroscience in national security. It brings together three fields - critical war studies, bio-ethics, and the history of medicine - to argue that such frameworks too starkly divide good' and bad' military uses of neurotechnology, thus focusing on the degradation of human capacities without sufficiently accounting for human enhancement and soldier rehabilitation. It illustrates this through the emergence of diagnoses of Traumatic Brain Injury and Polytrauma in the context of post-9/11 counterinsurgency wars. The article proposes an alternative approach, highlighting the historical co-production and homology of modern war and medicine so as to grapple with how war shapes neuroscience, but also how neuroscience shapes war. The article suggests new routes for thinking through the connections between war, society, science, and technology, proposing that we cease analysis that assumes any fundamental separation between military and civilian life.	[Howell, Alison] Rutgers Univ Newark, Newark, NJ 07102 USA		Howell, A (corresponding author), Rutgers Univ Newark, Dept Polit Sci, 360 Martin Luther King Blvd,7th Floor,Hill Hall, Newark, NJ 07102 USA.	alison.howell@rutgers.edu					Abi- Rached Joelle M., 2013, NEURO NEW BRAIN SCI; ARNOLD D, 1988, IMPERIAL MED INDIGEN; Barkawi T, 2016, EUR J INT SECUR, V1, P199, DOI 10.1017/eis.2016.7; Barkawi T, 2011, MILLENNIUM-J INT ST, V39, P701, DOI 10.1177/0305829811400656; Barkawi T, 2011, INT POLIT SOCIOL, V5, P126, DOI 10.1111/j.1749-5687.2011.00125.x; Barkawi Tarak, 2011, CHANGING CHARACTER W, P524, DOI DOI 10.1093/ACPROF:OSOBL/9780199596737.003.0029; Bashford A, 2003, IMPERIAL HYGIENE: A CRITICAL HISTORY OF COLONIALISM, NATIONALISM AND PUBLIC HEALTH, P1, DOI 10.1057/9780230508187; Bell C, 2012, HUMANITY, V3, P225, DOI 10.1353/hum.2012.0014; Bell D., 2006, MEMORY TRAUMA WORLD; Bourke Joanna, 2008, WAR AND MED; Bousquet A.J., 2009, SCI WAY WARFARE ORDE; Bousquet Antoine, 2015, CONCEPTS WORLD POLIT; Casper Stephen T., 2010, BRAIN, V133, P638; Choudhury S., 2010, AM J BIOETHICS NEURO, V1, P17; EDKINS JENNY, 2003, TRAUMA MEMORY POLITI; Elbe S., 2010, SECURITY GLOBAL HLTH; Fassin D., 2009, EMPIRE TRAUMA INQUIR; Felling T, 2016, IEEE INT ENER CONF; Gallagher Brianne P., 2016, CRITICAL MILITARY ST, V2; Gregory Derek, 2008, RADICAL PHILOS, V150; Gregory T, 2015, INT POLIT SOCIOL, V9, P197, DOI 10.1111/ips.12093; Gusterson Hugh, 2011, THE COSTS OF WAR; Gusterson Hugh, 2009, RADICAL TEACHER, V86, P4, DOI DOI 10.1353/RDT.0.0058; Harrison Mark, 2010, THE MED WAR; Heath-Kelly Charlotte, 2016, DEATH SECURITY BOMBS; Henry M, 2007, AM J BIOETHICS, V7, P12, DOI 10.1080/15265160701518474; Holmqvist C, 2013, MILLENNIUM-J INT ST, V41, P535, DOI 10.1177/0305829813483350; Howell A, 2014, REV INT STUD, V40, P961, DOI 10.1017/S0260210514000369; Howell A, 2012, ALTERNATIVES, V37, P214, DOI 10.1177/0304375412450842; Howell Alison, 2011, THE COSTS OF WAR; Howell Alison, 2011, MADNESS INT RELATION; Jackson Lynette A., 2000, SURFACING PSYCHIAT S; Jasanoff S., 2004, STATES KNOWLEDGE CO; Kamradt-Scott A, 2013, INT J HEALTH SERV, V43, P105, DOI 10.2190/HS.43.1.h; Kienscherf M, 2011, SECUR DIALOGUE, V42, P517, DOI 10.1177/0967010611423268; Kindervater KH, 2016, SECUR DIALOGUE, V47, P223, DOI 10.1177/0967010615616011; Koebler Jason, 2013, US NEWS WORLD REPORT; Kors J, 2007, NATION; Leys R., 2000, TRAUMA GENEALOGY; Ling LHM, 2016, INDIA CHINA RETHINKI; Lowenberg Kelly, 2010, AM J BIOETHICS AJOB, V1; Malabou C, 2012, FORM LIVING, P1; Marks Jonathan H., 2010, AM J BIOETHICS AJOB, V1; Mills C., 2014, DECOLONIZING GLOBAL; Nordin AHM, 2015, MILLENNIUM-J INT ST, V43, P392, DOI 10.1177/0305829814552435; Ortega Francisco, 2011, NEUROCULTURES GLIMPS; Owens Patricia, 2015, EC FORCE CONTERINSUR; Reid J., 2009, LIBERAL WAY WAR KILL; Sandvik KB, 2014, MILLENNIUM-J INT ST, V43, P145, DOI 10.1177/0305829814529470; Schwarz E, 2016, SECUR DIALOGUE, V47, P59, DOI 10.1177/0967010615601388; Steele Brent J., 2013, CRITICAL STUDIES SEC, V1, P83; Stiglitz J.E., 2008, 3 TRILLION DOLLAR WA; Terry J., 2009, WOMENS STUDIES Q, V37, P200, DOI DOI 10.1353/WSQ.0.0143; The Royal Society, 2012, BRAIN WAVES MODULE; Walters W, 2014, SECUR DIALOGUE, V45, P101, DOI 10.1177/0967010613519162; Wilcox Lauren, 2015, CRITICAL STUDIES SEC, V3; Wool, 2015, WAR WEIGHT LIFE WALT; Wool Zoe H., 2015, LIVING DYING CONT WO; Young Allan, 1995, HARMONY ILLUSIONS IN	59	10	10	0	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0305-8298	1477-9021		MILLENNIUM-J INT ST	Millennium-J. Int. Stud.	JAN	2017	45	2					133	150		10.1177/0305829816672930			18	International Relations	Social Science Citation Index (SSCI)	International Relations	EL7HX	WOS:000394792800001					2022-02-06	
J	Hu, PF; Yang, SM; Li, HC; Stansbury, LG; Yang, F; Hagegeorge, G; Miller, C; Rock, P; Stein, DM; Mackenzie, CF				Hu, Peter F.; Yang, Shiming; Li, Hsiao-Chi; Stansbury, Lynn G.; Yang, Fan; Hagegeorge, George; Miller, Catriona; Rock, Peter; Stein, Deborah M.; Mackenzie, Colin F.			Reliable Collection of Real-Time Patient Physiologic Data from less Reliable Networks: a "Monitor of Monitors" System (MoMs)	JOURNAL OF MEDICAL SYSTEMS			English	Article						Data collection; Vital signs; Triple redundant; Datastream; Real-time; Diagnosis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; PRESSURE; CARE	Research and practice based on automated electronic patient monitoring and data collection systems is significantly limited by system down time. We asked whether a triple-redundant Monitor of Monitors System (MoMs) to collect and summarize key information from system-wide data sources could achieve high fault tolerance, early diagnosis of system failure, and improve data collection rates. In our Level I trauma center, patient vital signs(VS) monitors were networked to collect real time patient physiologic data streams from 94 bed units in our various resuscitation, operating, and critical care units. To minimize the impact of server collection failure, three BedMaster (R) VS servers were used in parallel to collect data from all bed units. To locate and diagnose system failures, we summarized critical information from high throughput datastreams in real-time in a dashboard viewer and compared the before and post MoMs phases to evaluate data collection performance as availability time, active collection rates, and gap duration, occurrence, and categories. Single-server collection rates in the 3-month period before MoMs deployment ranged from 27.8 % to 40.5 % with combined 79.1 % collection rate. Reasons for gaps included collection server failure, software instability, individual bed setting inconsistency, and monitor servicing. In the 6-month post MoMs deployment period, average collection rates were 99.9 %. A triple redundant patient data collection system with real-time diagnostic information summarization and representation improved the reliability of massive clinical data collection to nearly 100 % in a Level I trauma center. Such data collection framework may also increase the automation level of hospital-wise information aggregation for optimal allocation of health care resources.	[Hu, Peter F.; Yang, Shiming; Li, Hsiao-Chi; Stansbury, Lynn G.; Yang, Fan; Hagegeorge, George; Rock, Peter; Stein, Deborah M.; Mackenzie, Colin F.] Univ Maryland, Sch Med, Dept Anesthesiol, 11 S Paca St Suite LL01, Baltimore, MD 21201 USA; [Hu, Peter F.; Yang, Shiming; Li, Hsiao-Chi; Stansbury, Lynn G.; Yang, Fan; Hagegeorge, George; Rock, Peter; Stein, Deborah M.; Mackenzie, Colin F.] Univ Maryland, Sch Med, Program Trauma, 11 S Paca St Suite LL01, Baltimore, MD 21201 USA; [Miller, Catriona] US Air Force Ctr Sustainment Trauma & Readiness S, Baltimore, MD USA		Yang, SM (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 11 S Paca St Suite LL01, Baltimore, MD 21201 USA.; Yang, SM (corresponding author), Univ Maryland, Sch Med, Program Trauma, 11 S Paca St Suite LL01, Baltimore, MD 21201 USA.	syang@anes.umm.edu	Li, Hsicao-chi/AAB-2402-2021; Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963	ONPOINT1 [FA8650- 11-2-6D01]; ONPOINT4 [FA8650-12-2-6D09]	This study was supported by FA8650- 11-2-6D01(ONPOINT1), FA8650-12-2-6D09(ONPOINT4)& FA8650-12-2-6D09 (Fit to Fly).	Convertino VA, 2008, J TRAUMA, V64, pS342, DOI 10.1097/TA.0b013e31816c82f4; Ditillo M, 2011, J TRAUMA, V71, P373; Excel Medical Electronics, 2013, BEDMASTEREX OP MAN; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kashif FM, 2012, SCI TRANSL MED, V129, P44; Kipnis E, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/473507; Ledikwe JH, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-7; Lehman L. H., 2014, IEEE J BIOMED HEALTH, V19, P1068; Liddle S, 2012, IEEE ENG MED BIO, P5899, DOI 10.1109/EMBC.2012.6347336; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; Schmidt PE, 2015, BMJ QUAL SAF, V24, P10, DOI 10.1136/bmjqs-2014-003073; Shooman M. L., 2002, RELIABILITY COMPUTER, P147; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stein DM, 2012, J TRAUMA ACUTE CARE, V73, P419, DOI 10.1097/TA.0b013e31825ff59a; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Yang S., 2012, 11 INT C MACH LEARN, P281; Yang SM, 2014, BRIT J HOSP MED, V75, P637, DOI 10.12968/hmed.2014.75.11.637	21	10	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0148-5598	1573-689X		J MED SYST	J. Med. Syst.	JAN	2017	41	1							3	10.1007/s10916-016-0648-5			8	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	EH7CK	WOS:000391930300006	27817131				2022-02-06	
J	Hung, AH; Cassedy, A; Schultz, HM; Yeates, KO; Taylor, HG; Stancin, T; Walz, NC; Wade, SL				Hung, Anna H.; Cassedy, Amy; Schultz, Hanna M.; Yeates, Keith Owen; Taylor, Hudson Gerry; Stancin, Terry; Walz, Nicolay Chertkoff; Wade, Shari L.			Predictors of Long-Term Victimization After Early Pediatric Traumatic Brain Injury	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						executive function; peer victimization; bullying; social information processing; traumatic brain injury	SOCIAL OUTCOMES; PEER GROUP; CHILDREN; ATTENTION; ENVIRONMENT; DISORDER; HOME	Objective: Pediatric traumatic brain injuries (TBIs) adversely affect long-term functional and social outcomes. Limited research suggests children with TBI are more likely to be victimized by peers than noninjured children. Deficits in social information processing (SIP), cognitive ability, and executive functioning (EF) may contribute to increased victimization risk. This study examined rates of peer victimization/bullying in children with early TBI compared with children with orthopedic injuries (OIs) and the role of processing speed, executive function (EF), and SIP as mediators of the association of TBI and peer victimization. Method: Children ages 10 to 14 years who sustained a complicated mild/moderate or severe TBI (N = 58) or 01 (N = 72) during early childhood (ages 3-7 yr) and their parents participated in a longitudinal prospective follow-up 6.8 years postinjury. SIP, EF and processing speed, and peer victimization were assessed. Results: Parents of children with severe TBI reported greater rates of peer victimization than parents of children with OIs. Children with severe TBI demonstrated greater EF deficits than children with complicated mild/moderate TBI or OI and poorer processing speed than children with OI. No significant indirect relationships were found between groups and any outcome variables to indicate mediation. Conclusion: Based on parent report, children with severe TBI have higher risk of peer victimization than those with less severe injuries. In addition, children with severe TBI have more impaired EF and cognitive ability than counterparts with less severe TBI. Further research is needed to explore predictors of long-term victimization after early TBI to create interventions aimed at providing social, emotional, and behavioral skill building for victimized youth.	[Hung, Anna H.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Schultz, Hanna M.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Taylor, Hudson Gerry] Case Western Reserve Univ, Dept Pediat, Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Hung, Anna H.] Univ North Carolina Chapel Hill, Sch Med, Dept Psychiat, Chapel Hill, NC USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; U.S. Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	The research reported here was supported by Grant R01 HD42729 from the National Institute of Child Health and Human Development, in part by U.S. Public Health Service National Institutes of Health Grant M01 RR 08084, and by Trauma Research grants from the State of Ohio Emergency Medical Services. The project described was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8 UL1 TR000077-04.	Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; ECCLES JS, 1993, AM PSYCHOL, V48, P90, DOI 10.1037/0003-066X.48.2.90; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Heverly-Fitt S, 2016, J PEDIATR PSYCHOL, V41, P235, DOI 10.1093/jpepsy/jsv085; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rogerson P. A., 2001, STAT METHODS GEOGRAP; Schwartz D, 1998, DEV PSYCHOPATHOL, V10, P87, DOI 10.1017/S095457949800131X; Schwartz D, 2000, DEV PSYCHOL, V36, P646, DOI [10.1037/0012-1649.36.5.646, 10.1037//0012-1649.36.5.646]; Seidman E, 2004, DEV PSYCHOPATHOL, V16, P1141, DOI 10.1017/S0954579404040179; TEASDALE G, 1974, LANCET, V2, P81; Tortura CMW, 2009, J ADOLESCENCE, V32, P193; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wechsler D, 2003, WISC 4 ADM MANUAL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	30	10	10	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	JAN	2017	38	1					49	57		10.1097/DBP.0000000000000366			9	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	EI3AD	WOS:000392360700008	27984340	Green Submitted, Green Accepted			2022-02-06	
J	Krahulik, D; Aleksijevic, D; Smolka, V; Klaskova, E; Venhacova, P; Vaverka, M; Mihal, V; Zapletalova, J				Krahulik, David; Aleksijevic, Darina; Smolka, Vratislav; Klaskova, Eva; Venhacova, Petra; Vaverka, Miroslav; Mihal, Vladimir; Zapletalova, Jirina			Prospective study of hypothalamo-hypophyseal dysfunction in children and adolescents following traumatic brain injury	BIOMEDICAL PAPERS-OLOMOUC			English	Article						traumatic brain injury; children; post-traumatic hormonal disorder; growth hormone deficiency; precocious puberty; risk factors	PITUITARY DYSFUNCTION; PUBERTAL CHANGES; HEAD TRAUMA; HYPOPITUITARISM; ABNORMALITIES; PATTERN	Background and Aims. Retrospective studies of TBI have found a neuroendocrine dysfunction following traumatic brain injury in 23 to 60% of adults and 15 to 21% of children. Our aims were to determine the prevalence of hypothalamo-hypophyseal dysfunction in children following brain injury, assess its relationship to the type of injury and the course of the acute post-traumatic phase. Patients and Methods. Body development (growth, pubertal development, and skeletal maturity) were evaluated in 58 patients (21 girls) after a brain injury rated 3 to 12 on the Glasgow Coma Scale (GCS). The patients underwent standard endocrine tests - TSH, fT4, IGF-1, PRL, morning cortisol, FSH, LH, and testosterone in boys and estradiol in girls - in the early post-traumatic period (2 to 14 days; T0) and at 3, 6, and 12 months after the injury (T3, T6, and T12). Dynamic tests were carried out in patients with abnormalities in their clinical examination and/or laboratory results. An MRI was performed on all patients at T12. Results. The median age at the time of injury was 11.3 (0.5 to 18.7) years. Of the 58 patients, 23 had GCS < 8, corresponding to severe brain injury. At T0, diabetes insipidus (DI) was diagnosed in 12 patients, and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) was found in 4 patients. Frequent hormonal changes simulated central hypothyroidism (in 45% of patients) and hypogonadotropic hypogonadism (in 25% of adolescents who were already pubertal at the time of injury > Tanner II). Examination at T3 (n = 58) confirmed a combined pituitary hormone deficiency in two boys and DI in another one. At T6 (n = 49), hormonal dysfunctions were diagnosed in two boys (precocious puberty and growth hormone deficiency). At T12 (n = 39), a new endocrine dysfunction was diagnosed in five patients (growth hormone deficiency in two, hypogonadotropic hypogonadism in two, and in one patient, already diagnosed with a growth hormone deficiency, central hypothyroidism, as well). Brain MRI revealed an empty sella in two patients with growth hormone deficiency. Patients with GCS < 8 had more symptoms of SIADH or DI in the early post-traumatic period 11/23 vs. patients with GCS of 8 to 13 (4/35), and more frequent hormonal disorder (6/23) than individuals with moderate trauma (3/35), P = 0.0135. The incidence of endocrine dysfunction at T0 significantly correlated with the severity of injury (P = 0.05), but it was not an indicator for the development of a late hormonal disorder. Conclusion. Within a year after injury, a hormonal disorder was found in 17.6% of the patients. Neuroendocrine dysfunction as a late consequence of craniocerebral trauma in children and adolescents was less frequent than in adults. Risk factors for its development are the gravity of the injury, brain scan pathology, and possibly the development of DI, SIADH, or CSWS in the acute post-traumatic phase.	[Krahulik, David; Vaverka, Miroslav] Palacky Univ Olomouc, Univ Hosp Olomouc, Fac Med & Dent, Dept Neurosurg, Olomouc, Czech Republic; [Aleksijevic, Darina; Smolka, Vratislav; Klaskova, Eva; Venhacova, Petra; Mihal, Vladimir; Zapletalova, Jirina] Palacky Univ Olomouc, Univ Hosp Olomouc, Fac Med & Dent, Dept Pediat, Olomouc, Czech Republic		Krahulik, D (corresponding author), Palacky Univ Olomouc, Univ Hosp Olomouc, Fac Med & Dent, Dept Neurosurg, Olomouc, Czech Republic.	david.krahulik@fnol.cz		David, Krahulik/0000-0002-4907-7960; Klaskova, Eva/0000-0002-6338-9055			Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aleksijevic D, 2010, CESK SLOV NEUROL N, V73, P409; Blaha P, 2003, PEDIATRICS, V58, P766; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Ceballos R, 1966, Ala J Med Sci, V3, P185; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Goldman M, 1997, PEDIATR NEUROL, V17, P339, DOI 10.1016/S0887-8994(97)00168-9; Greuliche WW, 1959, RADIOGRAPHIC ATLAS S, P156; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	26	10	11	0	5	PALACKY UNIV, MEDICAL FAC	OLOMOUC	CENTRAL LIBRARY, HNEVOTINSKA 3, OLOMOUC, 00000, CZECH REPUBLIC	1213-8118	1804-7521		BIOMED PAP	Biomed. Pap-Olomouc		2017	161	1					80	85		10.5507/bp.2016.047			6	Engineering, Biomedical; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Research & Experimental Medicine	EQ5AP	WOS:000398093500012	27646495	Green Submitted, gold			2022-02-06	
J	Leung, FT; Smith, MMF; Hides, JA				Leung, Felix T.; Smith, Melinda M. Franettovich; Hides, Julie A.			Injuries in Australian school-level rugby union	JOURNAL OF SPORTS SCIENCES			English	Article						Concussion; epidemiology; youth; sports injury; surveillance	CONSENSUS STATEMENT; MATCH INJURIES; EPIDEMIOLOGY; PLAYERS; CONCUSSION; METAANALYSIS; SPORTS; NECK	There is a high incidence of injuries in rugby union due to the physical nature of the game. In youth rugby union, there are large variations in injury rates reported. Our study investigated the rates of injuries in school-level rugby union players in Australia using the consensus statement for rugby union injuries. Injury surveillance was conducted on 480 rugby players from 1 school in Queensland, Australia. Injury data were collected using paper-based injury recording forms during the 8-week rugby season using a "medical-attention" injury definition. In total, 76 players sustained one or more injuries, with a total of 80 injuries recorded. The overall injury rate was 31.8 injuries/1000 match player hours (95% CI, 25.4-39.4). Concussion had an incidence rate of 6.0/1000 match player hours (95% CI, 3.5-9.6). The incidence of upper limb and lower limb injuries were 9.1 and 9.9/1000 match player hours, respectively (95% CI, 5.9-13.5 and 6.6-14.5). The older age divisions had higher injury rates and most injuries occurred while tackling or being tackled. The injury rates observed in this sample of Australian school rugby union players provides direction for future studies to enable informed decisions relating to development of injury prevention programmes at this level of rugby.	[Leung, Felix T.; Smith, Melinda M. Franettovich; Hides, Julie A.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Musculoskeletal Res, Level 1,631 Stanley St, Woolloongabba, Qld 4102, Australia; [Hides, Julie A.] Mater Hlth Serv, Mater ACU Back Stabil Clin, South Brisbane, Qld, Australia		Leung, FT (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Musculoskeletal Res, Level 1,631 Stanley St, Woolloongabba, Qld 4102, Australia.	felix.leung@acu.edu.au	Smith, Melinda Franettovich/AAK-1568-2021; Hides, Julie Anne/F-2141-2011	Smith, Melinda Franettovich/0000-0002-0098-7656; Hides, Julie Anne/0000-0002-1830-8121	Collaborative Research Networks/Australian Catholic University [2013000562]	This work was supported by a Collaborative Research Networks/Australian Catholic University Research Fund Grant' [2013000562 Concussion Extension].	[Anonymous], 2015, AUSTR RUGBY UNION AN; Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brown JC, 2012, S AFR J SPORTS MED, V24, P49; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119, DOI 10.5694/j.1326-5377.1987.tb133299.x; DURIE RM, 2000, NZ J SPORTS MED, V28, P84; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gianotti S, 2008, BRIT J SPORT MED, V42, P427, DOI 10.1136/bjsm.2008.046987; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Krause LM, 2015, J SCI MED SPORT, V18, P358, DOI 10.1016/j.jsams.2014.05.012; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; McIntosh Andrew S, 2005, Med Sport Sci, V49, P120, DOI 10.1159/000085394; Nicholl JP, 1995, BRIT J SPORT MED, V29, P232, DOI 10.1136/bjsm.29.4.232; Nutton RW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001149; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Phillips LH, 2000, BRIT J SPORT MED, V34, P133, DOI 10.1136/bjsm.34.2.133; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; ROUX CE, 1987, S AFR MED J, V71, P307; Sparks J P, 1981, Br J Sports Med, V15, P30; Sports Medicine Australia, RUGB UN INJ REP FORM; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, YEAR REV 2015	34	10	10	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2017	35	21					2088	2092		10.1080/02640414.2016.1255771			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FB1PF	WOS:000405915000005	27855546				2022-02-06	
J	Lewis, FD; Horn, GJ				Lewis, Frank D.; Horn, Gordon J.			Depression following traumatic brain injury: Impact on post-hospital residential rehabilitation outcomes	NEUROREHABILITATION			English	Article						Traumatic brain injury; outcomes; depression; MPAI-4; Rasch analysis; post-hospital rehabilitation	MODEL	BACKGROUND: A need exists to better understand the impact of depression on functional outcomes following TBI. OBJECTIVES: To evaluate the prevalence and severity of depression among a large group of chronic TBI adults; to determine the impact of depression on outcomes of post-hospital residential rehabilitation programs; and to assess effectiveness of post-hospital residential rehabilitation programs in treating depression. METHODS: 820 adults with moderate to severe traumatic brain injury (TBI) were assigned to one of four groups based on MPAI-4 depression ratings: (1) Not Depressed, (2) Mildly Depressed, (3) Moderately Depressed, and (4) Severely Depressed. Functional status was assessed at admission and discharge with the MPAI-4 Participation Index. Differences among groups were evaluated using conventional parametric tests. Rasch analysis established reliability and validity of MPAI-4 data. RESULTS: Rasch analysis demonstrated satisfactory construct validity and internal consistency (Person reliability = 0.89-0.92, Item reliability = 0.99). Of the 820 subjects, 39% presented with moderate to severe depressive symptoms at admission, These subjects demonstrated significantly higher MPAI-4 Participation scores than the mild and not depressed groups. Depressed groups realized significant improvement in symptoms, but, those remaining depressed at discharge had significantly greater disability than those who improved. CONCLUSIONS: Depressive symptoms had a deleterious impact on outcome. Remediation of symptoms during rehabilitation significantly improved outcomes.	[Lewis, Frank D.] Augusta Univ, Med Coll Georgia, NeuroRestorat Natl Clin Outcomes, 1227 Augusta West Pkwy, Augusta, GA 30909 USA; [Horn, Gordon J.] Florida State Univ, Coll Med, NeuroRestorat Natl Clin Outcomes, Tallahassee, FL 32306 USA		Lewis, FD (corresponding author), Augusta Univ, Med Coll Georgia, NeuroRestorat Natl Clin Outcomes, 1227 Augusta West Pkwy, Augusta, GA 30909 USA.	frank.lewis@neurorestorative.com			NeuroRestorative	The authors are employed by NeuroRestorative who provided financial support for this research. The authors' employers are not aware of the study's findings at the time of submission.	Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bond T, 2001, APPL RASCH MODEL FUN; Centers for Disease Control and Prevention, 2013, NATL HLTH STAT REPOR; Chaudhury S., 2013, MED J PY PATIL U, V6, P222; Dixon T., 1989, PHYS MED REHABILITAT, V3, P169; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lewis FD, 2015, NEUROREHABILITATION, V36, P243, DOI 10.3233/NRE-151213; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Lezak, 2008, MANUAL MAYO PORTLAND; Linacre J., 2002, ARCH RASCH MEASUREME, V16, P871; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Thase ME, 2016, JAMA-J AM MED ASSOC, V315, P349, DOI 10.1001/jama.2015.18406	18	10	10	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	40	3					401	410		10.3233/NRE-161427			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EU3OP	WOS:000400941200012	28222560				2022-02-06	
J	Liu, Y; Lu, JY; Wang, XY; Chen, L; Liu, S; Zhang, ZR; Yao, W				Liu, Yuan; Lu, Junyu; Wang, Xiaoya; Chen, Liu; Liu, Su; Zhang, Zhiren; Yao, Wei			Erythropoietin-Derived Peptide Protects Against Acute Lung Injury After Rat Traumatic Brain Injury	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Traumatic brain injury; Acute lung injury; Inflammation; Macrophages; Erythropoietin analogue	INFLAMMATORY RESPONSE; MICROGLIA/MACROPHAGES; ACCUMULATION; DYSFUNCTION; ACTIVATION; MOLECULES; CELLS	Background: Traumatic brain injury (TBI) can be complicated by TBI-triggered acute lung injury (ALI), in which inflammation plays a central role. It has been reported that an Erythropoietin-derived peptide (pHBSP) was able to ameliorate TBI; however, its function in TBI-caused ALI has not been reported yet. Methods: In this study, we studied the effect of pHBSP on TBI-caused ALI by using a weight-drop induced TBI model. At 8 h and 24 h post-TBI, pulmonary edema (PE) and bronchoalveolar lavage fluid (BALF) proteins were measured, and haematoxylin and eosin (H&E) staining of lung sections was carried out. At 24 h following TBI, the lungs were harvested for immunofluorescence staining and qRT-PCR analysis. Results: At 8 h and 24 h post-TBI, pHBSP treatment significantly decreased wet/dry ratios, decreased total BALF protein, and attenuated the histological signs of pulmonary injury. At 24 h post-TBI, pHBSP treatment decreased the accumulation of CD68(+) macrophages in the lung and reduced the mRNA levels of TNF-alpha, IL-6, IL-1 beta and iNOS in the lung. Conclusions: We identified the protective role that pHBSP played in TBI-caused ALI, suggesting that pHBSP is a potent candidate for systemic therapy in TBI patients. (C) 2017 The Author(s). Published by S. Karger AG, Basel.	[Liu, Yuan] Third Mil Med Univ, Xinqiao Hosp, Dept Stomatol, Chongqing, Peoples R China; [Lu, Junyu; Yao, Wei] Third Mil Med Univ, Xinqiao Hosp, Dept Resp Med, Chongqing, Peoples R China; [Wang, Xiaoya] North Sichuan Med Coll, Affiliated Hosp 2, Dept Neurosurg, Nanchong, Peoples R China; [Chen, Liu] Third Mil Med Univ, Dept Endocrinol, Xinan Hosp, Chongqing, Peoples R China; [Zhang, Zhiren] Third Mil Med Univ, Inst Immuol, Chongqing 400038, Peoples R China; [Liu, Su] Third Mil Med Univ, Daping Hosp, Dept Anesthesiol, Changjiang Rd, Chongqing 400042, Peoples R China; [Liu, Su] Third Mil Med Univ, Res Inst Surg, Changjiang Rd, Chongqing 400042, Peoples R China		Zhang, ZR (corresponding author), Third Mil Med Univ, Inst Immuol, Chongqing 400038, Peoples R China.; Liu, S (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Anesthesiol, Changjiang Rd, Chongqing 400042, Peoples R China.; Liu, S (corresponding author), Third Mil Med Univ, Res Inst Surg, Changjiang Rd, Chongqing 400042, Peoples R China.; Liu, S; Zhang, ZR; Yao, W (corresponding author), Third Mil Med Univ, Dep Respir Med, Chongqing 400038, Peoples R China.	443601147@qq.com; zhangzhiren@yahoo.com; 1229473158@qq.com			National Science and Technology Major Projects of New Drugs [2012ZX09103301-035]	This investigation was supported by the National Science and Technology Major Projects of New Drugs (2012ZX09103301-035).	Caillaud C, 2015, J ENDOCRINOL, V225, P77, DOI 10.1530/JOE-15-0010; Chen GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729831; Chung IS, 2013, ANESTH ANALG, V116, P327, DOI 10.1213/ANE.0b013e31827aec06; Dias C, 2015, NEUROCRIT CARE, V22, P192, DOI 10.1007/s12028-014-0045-1; HUANG TP, 1995, AM J NEPHROL, V15, P312, DOI 10.1159/000168855; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Kemp CD, 2008, AM SURGEON, V74, P866; Liu QS, 2015, TRANSPL P, V47, P283, DOI 10.1016/j.transproceed.2014.10.045; Liu YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15134; Liu YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-141; Liu YQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090942, 10.1371/journal.pone.0085282]; Liu YQ, 2013, NEUROREPORT, V24, P281, DOI 10.1097/WNR.0b013e32835f2810; Lopez-Aguilar J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.02.24; Lukacs NW, 1996, ADV IMMUNOL, V62, P257, DOI 10.1016/S0065-2776(08)60432-0; Luo BW, 2013, BBA-MOL BASIS DIS, V1832, P1260, DOI 10.1016/j.bbadis.2013.04.015; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Risor LM, 2016, SCAND J CLIN LAB INV, V76, P183, DOI 10.3109/00365513.2016.1143563; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Sanfilippo F, 2014, BRIT J ANAESTH, V112, P298, DOI 10.1093/bja/aet305; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Song Z, 2015, J TRAUMA ACUTE CARE, V78, P980, DOI 10.1097/TA.0000000000000602; Swartjes M, 2011, ANESTHESIOLOGY, V115, P1084, DOI 10.1097/ALN.0b013e31822fcefd; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Zhang Z, 2012, NEUROSCIENCE, V221, P140, DOI 10.1016/j.neuroscience.2012.07.013; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	33	10	11	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2017	41	5					2037	2044		10.1159/000475434			8	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	EY7LW	WOS:000404173800026	28419985	gold			2022-02-06	
J	Maneewong, J; Maneeton, B; Maneeton, N; Vaniyapong, T; Traisathit, P; Sricharoen, N; Srisurapanont, M				Maneewong, Jutaporn; Maneeton, Benchalak; Maneeton, Narong; Vaniyapong, Tanat; Traisathit, Patrinee; Sricharoen, Natthanidnan; Srisurapanont, Manit			Delirium after a traumatic brain injury: predictors and symptom patterns	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						Delirium Rating Scale Revised-98; DRS-R-98; brain injuries; traumatic; noncognitive symptoms; cognitive symptoms; Glasgow Coma Scale score	GLASGOW COMA SCALE; RATING-SCALE; REVISED-98; DRS-R98; IMPACT	Background: Delirium in traumatic brain injury (TBI) is common, may be predictable, and has a multifaceted symptom complex. This study aimed to examine: 1) the sum score of Glasgow Coma Scale (GCS) and if its component scores could predict delirium in TBI patients, and 2) the prominent symptoms and their courses over the first days after TBI. Methods: TBI patients were recruited from neurosurgical ward inpatients. All participants were hospitalized within 24 hours after their TBI. Apart from the sum score of GCS, which was obtained at the emergency department (ED), the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, diagnostic criteria for delirium were applied daily. The severity of delirium symptoms was assessed daily using the Delirium Rating Scale -Revised-98 (DRS-R-98). Results: The participants were 54 TBI patients with a mean GCS score of 12.7 (standard deviation [SD] = 2.9). A total of 25 patients (46.3%) met the diagnosis of delirium and had a mean age of 36.7 years (SD = 14.8). Compared with 29 non-delirious patients, 25 delirious patients had a significantly lower mean GCS score (P = 0.04), especially a significantly lower verbal component score (P= 0.03). Among 18 delirious patients, four symptoms of the DRS-R-98 cognitive domain (orientation, attention, long-term memory, and visuospatial ability) were moderate symptoms (score >= 2) at the first day of admission. After follow-up, three cognitive (orientation, attention, and visuospatial ability) and two noncognitive symptoms (lability of affect and motor agitation) rapidly resolved. Conclusion: Almost half of patients with mild to moderate head injuries may develop delirium in the first 4 days after TBI. Those having a low GCS score, especially the verbal component score, at the ED were likely to have delirium in this period. Most cognitive domains of delirium described in the DRS-R-98 were prominent within the first 4 days of TBI with delirium. Three cognitive and two noncognitive symptoms of delirium decreased significantly.	[Maneewong, Jutaporn; Maneeton, Benchalak; Maneeton, Narong; Srisurapanont, Manit] Chiang Mai Univ, Dept Psychiat, Fac Med, 110 Intawaroros Rd, Chiang Mai 50200, Thailand; [Vaniyapong, Tanat] Chiang Mai Univ, Dept Surg, Fac Med, Chiang Mai, Thailand; [Traisathit, Patrinee; Sricharoen, Natthanidnan] Chiang Mai Univ, Dept Stat, Fac Sci, Chiang Mai, Thailand		Maneeton, B (corresponding author), Chiang Mai Univ, Dept Psychiat, Fac Med, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.	benchalak.maneeton@cmu.ac.th	Vaniyapong, Tanat/AAJ-5067-2020; Srisurapanont, Manit/R-9997-2017; Vaniyapong, Tanat/E-6946-2012; Traisathit, Patrinee/S-4440-2017	Vaniyapong, Tanat/0000-0002-0559-3023; Srisurapanont, Manit/0000-0001-6203-1206; Maneeton, Narong/0000-0001-6882-6720; Traisathit, Patrinee/0000-0003-2918-1928; Maneeton, Benchalak/0000-0001-6125-6489	CMU Mid-Career Researcher Program, Chiang Mai University, Thailand	This work was supported by the CMU Mid-Career Researcher Program, Chiang Mai University, Thailand.	Adamis D, 2015, INT PSYCHOGERIATR, V27, P883, DOI 10.1017/S1041610214002853; Ashkenazi I, 2016, JAMA SURG, V151, P954, DOI 10.1001/jamasurg.2016.1742; Association A.P, 2013, DIAGN STAT MAN MENT; Bryczkowski SB, 2014, J TRAUMA ACUTE CARE, V77, P944, DOI 10.1097/TA.0000000000000427; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deb S, 1999, AM J PSYCHIAT, V156, P374; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Rajlakshmi AK, 2013, ASIAN J PSYCHIATR, V6, P106, DOI 10.1016/j.ajp.2012.09.006; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tahir TA, 2010, J PSYCHOSOM RES, V69, P485, DOI 10.1016/j.jpsychores.2010.05.006; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thurber S, 2015, J NEUROPSYCH CLIN N, V27, pE122, DOI 10.1176/appi.neuropsych.13110345; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229	18	10	10	0	9	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2017	13									10.2147/NDT.S128138			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	EK6OV	WOS:000394044800003	28243098	Green Submitted, gold, Green Published			2022-02-06	
J	Osier, ND; Bales, JW; Pugh, B; Shin, S; Wyrobek, J; Puccio, AM; Okonkwo, DO; Ren, DX; Alexander, S; Conley, YP; Dixon, CE				Osier, Nicole D.; Bales, James W.; Pugh, Bunny; Shin, Samuel; Wyrobek, Julie; Puccio, Ava M.; Okonkwo, David O.; Ren, Dianxu; Alexander, Sheila; Conley, Yvette P.; Dixon, C. Edward			Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; outcome measures; recovery; traumatic brain injury	MITOCHONDRIAL PERMEABILITY TRANSITION; FLUID PERCUSSION INJURY; BEHAVIORAL-TEST BATTERY; FULL-LENGTH HUMAN; CYCLOSPORINE-A; CALCINEURIN REGULATION; CATALYTIC SUBUNIT; SYNAPTIC FUNCTION; RAT HIPPOCAMPUS; NEURONAL CELLS	After experimental traumatic brain injury (TBI), calcineurin is upregulated; blocking calcineurin is associated with improved outcomes. In humans, variation in the calcineurin A-gamma gene (PPP3CC) has been associated with neuropsychiatric disorders, though any role in TBI recovery remains unknown. This study examines associations between PPP3CC genotype and mortality, as well as gross functional status assessed at admission using the Glasgow Coma Scale (GCS) and at 3, 6, and 12 months after severe TBI using the Glasgow Outcome Score (GOS). The following tagging single nucleotide polymorphisms (tSNPs) in PPP3CC were genotyped: rs2443504, rs2461491, rs2469749, and rs10108011. The rs2443504 AA genotype was univariately associated with GCS (p = 0.022), GOS at 3, 6, and 12 months (p = 0.002, p = 0.034, and p = 0.004, respectively), and mortality (p = 0.007). In multivariate analysis controlling for age, sex, and GCS, the AA genotype of rs2443504 was associated with GOS at 3 (p = 0.02), and 12 months (p = 0.01), with a trend toward significance at 6 months (p = 0.05); the AA genotype also was associated with mortality in the multivariate model (p = 0.04). Further work is warranted to better understand the role of calcineurin, as well as the genes encoding it and their relevance to outcomes after brain injury.	[Osier, Nicole D.; Pugh, Bunny; Shin, Samuel; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Osier, Nicole D.; Ren, Dianxu; Alexander, Sheila; Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Alexander, Sheila] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Bales, James W.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Pugh, Bunny] Seton Hill Univ, Safar Ctr Resuscitat Res, Greensburg, PA USA; [Wyrobek, Julie] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Puccio, Ava M.; Okonkwo, David O.; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Bales, James W.; Wyrobek, Julie] Univ Pittsburgh, 201 Hill Bldg,3434 Fifth Ave, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), Univ Pittsburgh, 201 Hill Bldg,3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu	Osier, Nicole/Q-7913-2017	Osier, Nicole/0000-0002-2903-6774; Conley, Yvette/0000-0002-1784-6067	PPG Grant [30315, P50NS030318]; VA RRD [B6761R]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NR008424, R01NR13342, F31NR014957, T32NR009759]; Pittsburgh Foundation; Sigma Theta Tau International Eta Chapter; International Society for Nurses in Genetics; American Association of Neuroscience Nursing/Neuroscience Nursing Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424, R01NR013342, T32NR009759, F31NR014957] Funding Source: NIH RePORTER	This work was generously supported by several grants, including: PPG Grant 30315, P50NS030318, VA RR&D#B6761R, NIH R01NR008424, R01NR13342, F31NR014957, and T32NR009759. Additional support for this work was provided by grants from the following foundations and professional societies: the Pittsburgh Foundation, Sigma Theta Tau International Eta Chapter, the International Society for Nurses in Genetics, and the American Association of Neuroscience Nursing/Neuroscience Nursing Foundation. The authors would like to thank Marilyn K. Farmer, Amanda Savarese, and Lan Pham for their continued editorial support and Michael D. Farmer for his assistance with the figures.	Anantharam V, 2007, NEUROCHEM INT, V50, P834, DOI 10.1016/j.neuint.2007.02.003; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Brait VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047841; Butcher SP, 1997, J NEUROSCI, V17, P6939; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; Eastwood SL, 2005, EUR J NEUROSCI, V22, P3017, DOI 10.1111/j.1460-9568.2005.04518.x; Egry E Y, 1991, Rev Paul Enferm, V10, P13; Fabbri C, 2014, PHARMACOGENOMICS J, V14, P463, DOI 10.1038/tpj.2014.15; Faul M, 2010, TRAUMATIC BRAIN INJU; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hashimoto T, 1998, J NEUROCHEM, V70, P1289; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Horiuchi Y, 2007, MOL PSYCHIATR, V12, P891, DOI 10.1038/sj.mp.4002019; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KAY JE, 1989, CELL IMMUNOL, V124, P175, DOI 10.1016/0008-8749(89)90121-4; Kayyali US, 1997, J NEUROCHEM, V68, P1668; Kinoshita Y, 2005, J NEURAL TRANSM, V112, P1255, DOI 10.1007/s00702-004-0261-5; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Kvajo M, 2010, CURR TOP BEHAV NEURO, V4, P629, DOI 10.1007/7854_2010_41; Kyogoku C, 2011, PSYCHIAT RES, V185, P16, DOI 10.1016/j.psychres.2009.11.003; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Mammis A, 2014, INT J NEUROSCI, V124, P863, DOI 10.3109/00207454.2014.880436; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Mathieu F, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-2; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Miletic G, 2011, NEUROSCIENCE, V188, P142, DOI 10.1016/j.neuroscience.2011.05.013; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; National Center for Biotechnology Information, 2015, PPP3CC PROT PHOSPH 3; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schaart DR, 2001, MED PHYS, V28, P638, DOI 10.1118/1.1357458; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Springer JE, 2000, J NEUROSCI, V20, P7246; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Takao K, 2006, ANN NY ACAD SCI, V1086, P144, DOI 10.1196/annals.1377.008; Takao Keizo, 2008, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V28, P135; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Vasa R. A., 2015, BRAIN INJURY, P1; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JH, 1996, LEARN MEMORY, V3, P170, DOI 10.1101/lm.3.2-3.170; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WIEDERRECHT G, 1993, ANN NY ACAD SCI, V696, P9, DOI 10.1111/j.1749-6632.1993.tb17137.x; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wockner LF, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.111; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805	81	10	10	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					86	96		10.1089/neu.2015.4343			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100011	27225880	Green Published			2022-02-06	
J	Pogoda, TK; Levy, CE; Helmick, K; Pugh, MJ				Pogoda, Terri K.; Levy, Charles E.; Helmick, Katherine; Pugh, Mary Jo			Health services and rehabilitation for active duty service members and veterans with mild TBI	BRAIN INJURY			English	Article						Assistive technology; cognition; rehabilitation; supported employment; system of care; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; ENDURING FREEDOM VETERANS; POLYTRAUMA CLINICAL TRIAD; SUPPORTED EMPLOYMENT; OIF/OEF VETERANS; IRAQI FREEDOM; NEUROPSYCHOLOGICAL PERFORMANCE; OEF/OIF VETERANS	Objective: We review health services and reintegration practices that contribute to the rehabilitation of US active: duty service members (ADSMs) and Veterans who experienced traumatic brain injury (TBI), especially mild TBI (mTB1), as discussed at the 2015 Department of Veterans Affairs (VA) TBI, State-of-the-Art (SOTA) Conference. Methodology: We reviewed the state-of-the-art at the time of the previous 2008 TBI SOTA conference, advancet in the field since then, and future directions to address gaps in knowledge. Main results: We reviewed: (1) mTBl and its comorbid conditions documented in ADSMs and Veterans, and recognized the need for additional healthcare utilization;, health cost and quality of care studies (2) VA vocational rehabilitation programmes and the,effectiveness of supported employment for helping those with workplace difficulties;, (3) the application of technology to assist in TBI rehabilitation, including mobile device applications for self-management, videoconferencing with providers, and, virtue!: reality to help With behavioural and cognitive challenges, and (4) Department of Degense (DoD)-VA partnerships on identification, evaluation and dissemination of I(31 best,practices: Conclusions: There have been significant advances in TBI rehabilitation, but multiple areas across the DoD and VA care continuum need further exploration and: development to meet the need's of ADSMs and Veterans.	[Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Bldg 9,Off 218,150 South Huntington Ave 152M, Boston, MA 02130 USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Levy, Charles E.] North Florida South Georgia Vet Hlth Syst, Ctr Innovat Disabil & Rehabil Res, Phys Med & Rehabil Serv, Gainesville, FL USA; [Levy, Charles E.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Occupat Therapy, Gainesville, FL USA; [Levy, Charles E.] Univ Florida, Coll Arts, Ctr Arts Med, Gainesville, FL USA; [Helmick, Katherine] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Pugh, Mary Jo] South Texas Vet Healthcare Syst, San Antonio, TX USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA		Pogoda, TK (corresponding author), VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Bldg 9,Off 218,150 South Huntington Ave 152M, Boston, MA 02130 USA.	terri.pogoda@va.gov	Pugh, Mary Jo/K-5336-2019; Pogoda, Terri/F-6243-2012	Pugh, Mary Jo/0000-0003-4196-7763; Pogoda, Terri/0000-0003-1397-8780			Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; [Anonymous], 2016, DOD WORLDWIDE NUMBER; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bilmes L., 2006, EC COSTS IRAQ WAR AP; Bond GR, 2014, ADM POLICY MENT HLTH, V41, P69, DOI 10.1007/s10488-012-0444-6; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bulson R, 2012, J REHABIL RES DEV, V49, P1075, DOI 10.1682/JRRD.2011.02.0017; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carlson KF, SUPPORTED E IN PRESS; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD., 2006, BRAIN INJURY MED PRI, P765; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Darkins A, 2008, ARCH PHYS MED REHAB, V89, P182, DOI 10.1016/j.apmr.2007.07.027; Dau B, 2009, J REHABIL RES DEV, V46, P673, DOI 10.1682/JRRD.2008.09.0113; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; Department of Defense, 2016, DOD POL GUID MAN MIL; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2015, AN VA HLTH CAR UT OP; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hinds Ii Sidney R, 2016, US Army Med Dep J, P97; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Kansagara D., 2013, COMPLICATIONS MILD T; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levy CE, 2015, J REHABIL RES DEV, V52, P361, DOI 10.1682/JRRD.2014.10.0239; Levy CE, 2015, AM J PHYS MED REHAB, V94, pE31, DOI 10.1097/PHM.0000000000000248; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Ottomanelli L, USING VIDEO IN PRESS; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Owen JE, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.3935; Pogoda T.K, SUPPORTED E IN PRESS; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Pogoda TK, 2011, PSYCHIAT SERV, V62, P1289, DOI 10.1176/ps.62.11.pss6211_1289; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Riley J, 2015, ANN REPORT 2015 FY 2; Rizzo A, 2010, ANN NY ACAD SCI, V1208, P114, DOI 10.1111/j.1749-6632.2010.05755.x; Rosenheck RA, 2007, PSYCHIAT SERV, V58, P325, DOI 10.1176/appi.ps.58.3.325; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P179, DOI 10.1016/j.apmr.2007.06.774; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Targett P, 2011, WORK ACCOMMODATION AND RETENTION IN MENTAL HEALTH, P277, DOI 10.1007/978-1-4419-0428-7_14; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; The CDC NI H DoD and VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; US Department of Veterans Affairs and US Department of Defense, 2016, VA DOD VA DOD CLIN P; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Veterans Health Administration Department of Veterans Affairs, VHA HDB; Warr P, 1984, ROLE TRANSITIONS, V23, P263, DOI 10.1007/978-1-4613-2697-7_19; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105	84	10	10	2	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1220	1234		10.1080/02699052.2016.1274777			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600008	28981342	hybrid			2022-02-06	
J	Sarvghad-Moghaddam, H; Rezaei, A; Ziejewski, M; Karami, G				Sarvghad-Moghaddam, Hesam; Rezaei, Asghar; Ziejewski, Mariusz; Karami, Ghodrat			CFD modeling of the underwash effect of military helmets as a possible mechanism for blast-induced traumatic brain injury	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Underwash effect; shockwaves; CFD; overpressure; flow direction; helmet	TURBULENCE MODEL; WAVES; SIMULATION; POLYUREA; FLOWS	Underwash occurs as the incoming shockwaves enter the helmet subspace and develop a high pressure region at the opposite side of the head. The mechanism leading to the underwash is yet not well understood. To investigate this effect, the turbulent, supersonic flow of compressible air approaching the head-helmet assembly from different directions was studied through computational fluid dynamics simulations. The effects of different incident overpressures and helmet gap size on the underwash incidence were further evaluated. The backflow-induced pressure from the air traveling outside of the helmet on the outflow from the helmet, as well as the momentum change in the backside curve of the helmet were postulated as the main reasons for this effect. Side shockwaves predicted the highest underwash overpressures. The increase rate of the underwash reduced with increasing the incident shockwave intensity.	[Sarvghad-Moghaddam, Hesam; Rezaei, Asghar; Ziejewski, Mariusz; Karami, Ghodrat] North Dakota State Univ, Dept Mech Engn, Fargo, ND 58105 USA		Karami, G (corresponding author), North Dakota State Univ, Dept Mech Engn, Fargo, ND 58105 USA.	g.karami@ndsu.edu					ABE K, 1995, INT J HEAT MASS TRAN, V38, P1467, DOI 10.1016/0017-9310(94)00252-Q; ANSYS C, 2012, ANS CFX REL 14 5 US; Ansys C, 2012, SOLV THEOR GUID REL; Ansys C, 2012, VERS 14 5; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Dehkordi BG, 2011, J HYDRODYN, V23, P114, DOI 10.1016/S1001-6058(10)60095-9; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Garbaruk A, 2013, PROGR FLIGHT PHYS, P3; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P213, DOI 10.1108/15736101211251220; Grujicic M, 2012, J MATER ENG PERFORM, V21, P2024, DOI 10.1007/s11665-011-0117-8; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Gupta R. K., 2014, 11 WORLD C COMP MECH; Liou WW, 2000, COMPUT FLUIDS, V29, P275, DOI 10.1016/S0045-7930(99)00010-9; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein M.K., 2010, P NATL ACAD SCI; Przekwas A., 2011, P HFM 207 NATO S SUR; Rigas F, 2005, J HAZARD MATER, V121, P23, DOI 10.1016/j.jhazmat.2005.01.031; Sarvghad-Moghaddam H, 2014, ASME 2014 INT MECH E; Sarvghad-Moghaddam H, 2014, J NEUROTRAUM, V31, pA; Sarvghad-Moghaddam H, 2014, COMPUT METHOD BIOMEC, V18, P1; Sarvghad-Moghaddam Hesam, 2017, Int J Numer Method Biomed Eng, V33, DOI 10.1002/cnm.2782; Sarvghad-Moghaddam H, 2015, J HEAD TRAUMA REHAB, V30, pE66; Sarvghad-Moghaddam H, 2014, BRAIN INJURY, V28, P631; Sarvghad-Moghaddam H, 2011, J HYDRODYN, V23, P792, DOI 10.1016/S1001-6058(10)60178-3; Sklavounos S, 2004, J LOSS PREVENT PROC, V17, P407, DOI 10.1016/j.jlp.2004.07.005	28	10	10	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2017	20	1					16	26		10.1080/10255842.2016.1193597			11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	EC9UQ	WOS:000388490200002	27269066				2022-02-06	
J	Schulz-Heik, RJ; Poole, JH; Dahdah, MN; Sullivan, C; Adamson, MM; Date, ES; Salerno, R; Schwab, K; Harris, O				Schulz-Heik, R. Jay; Poole, John H.; Dahdah, Marie N.; Sullivan, Campbell; Adamson, Maheen M.; Date, Elaine S.; Salerno, Rose; Schwab, Karen; Harris, Odette			Service needs and barriers to care five or more years after moderate to severe TBI among Veterans	BRAIN INJURY			English	Article						Traumatic brain injury; polytrauma; military personnel; health services accessibility; health services needs and demand; long-term follow-up; rehabilitation	TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; COMMUNITY INTEGRATION; FOLLOW-UP; POPULATION; OUTCOMES; HEALTH; REHABILITATION; AFGHANISTAN; COSTS	Primary objective: The objective of this paper is to identify the most frequent service needs, factors associated with needs, and barriers to care among Veterans and service members five or more years after moderate to severe traumatic brain injury (TBI). Research design: Survey administered via telephone 5-16 years after injury (median eight years) and subsequent acute inpatient rehabilitation at a regional Veterans Affairs (VA) medical centre. Methods and procedures: Participants were 119 Veterans and military personnel, aged 23-70 (median 35), 90% male. Demographics, injury characteristics, service needs, whether needs were addressed, barriers to care, health and general functioning were assessed. Main outcomes and results: The most frequent needs were for help with memory, information about available services and managing stress. Obtaining information about services was the most consistently un-addressed need; managing stress was the most consistently addressed need. Cognitive and psychiatric symptoms and alienation from community were associated with needs going un-addressed. Participants treated after an expansion of TBI services at the study site reported fewer un-addressed needs. Not knowing where to get help was the most common barrier to care. Conclusion: Repeated outreach, assessment of needs and education about available services are needed throughout Veterans' lifespan after moderate to severe TBI.	[Schulz-Heik, R. Jay; Poole, John H.; Adamson, Maheen M.; Salerno, Rose; Schwab, Karen; Harris, Odette] Def & Vet Brain Injury Ctr, Palo Alto, CA USA; [Schulz-Heik, R. Jay; Poole, John H.; Adamson, Maheen M.; Salerno, Rose; Schwab, Karen; Harris, Odette] Def & Vet Brain Injury Ctr, Rockville, MD USA; [Schulz-Heik, R. Jay; Poole, John H.; Adamson, Maheen M.; Salerno, Rose; Harris, Odette] VA Palo Alto Healthcare Syst, WRIISC MC 151Y,3801 Miranda Ave, Palo Alto, CA 94304 USA; [Dahdah, Marie N.] Baylor Inst Rehabil, Dallas, TX USA; [Dahdah, Marie N.] Baylor Reg Med Ctr Plano, Plano, TX USA; [Sullivan, Campbell] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Sullivan, Campbell] Sinai Hosp Baltimore, Baltimore, MD USA; [Adamson, Maheen M.; Harris, Odette] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Date, Elaine S.] Remedy Med Grp, Redwood City, CA USA		Schulz-Heik, RJ (corresponding author), VA Palo Alto Healthcare Syst, WRIISC MC 151Y,3801 Miranda Ave, Palo Alto, CA 94304 USA.	jay.schulzheik@gmail.com		Adamson, Maheen/0000-0002-1534-4063	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); Clayman Institute Fellowship	This material is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Materiel Command (USAMRMC), and by a Clayman Institute Fellowship. All authors report no declarations of interest.	Andelic N, 2014, PM&R, V6, P1021; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; CDC, 1999, TRAUM BRAIN INJ US R; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Geiling J, 2012, MIL MED, V177, P1235, DOI 10.7205/MILMED-D-12-00031; Han SD, 2009, J HEAD TRAUMA REHAB, V24, P57, DOI 10.1097/HTR.0b013e3181957055; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Willemsen-van Son A, 2009, J REHABILITATION MED, V41, P521; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	36	10	10	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1287	1293		10.1080/02699052.2017.1307449			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800004	28585880				2022-02-06	
J	Sillesen, M; Bambakidis, T; Dekker, SE; Li, YQ; Alam, HB				Sillesen, Martin; Bambakidis, Ted; Dekker, Simone E.; Li, Yongqing; Alam, Hasan B.			Fresh Frozen Plasma Modulates Brain Gene Expression in a Swine Model of Traumatic Brain Injury and Shock: A Network Analysis	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							LARGE-ANIMAL-MODEL; RED-BLOOD-CELLS; HEMORRHAGIC-SHOCK; NORMAL SALINE; PHARMACOLOGICAL RESUSCITATION; ENDOTHELIAL GLYCOCALYX; BARRIER PERMEABILITY; EMISSION-TOMOGRAPHY; TRANSFUSION; RATS	BACKGROUND: Resuscitation with fresh frozen plasma (FFP) decreases brain lesion size and swelling in a swine model of traumatic brain injury and hemorrhagic shock. We hypothesized that brain gene expression profiles after traumatic brain injury and hemorrhagic shock would be modulated by FFP resuscitation. STUDY DESIGN: Fifteen swine underwent a protocol of traumatic brain injury and hemorrhagic shock and 2 hours of shock followed by resuscitation with FFP, normal saline, or hetastarch (5/group). After 6 hours, brain RNA was isolated and hybridized onto a porcine gene ST 1.1 microarray. Weighted gene correlation network analysis was used to identify clusters of highly coexpressed genes. Principal component analysis identified cluster eigenvectors, indicating overall direction and magnitude of cluster gene expression. Using linear regression, cluster eigenvectors were associated with treatment as well as brain lesion size and swelling. Results were post-hoc corrected using false discovery rate. Relevant gene clusters were subjected to pathway analysis using the Reactome tool. RESULTS: Network analysis identified 322 gene expression clusters (total of 12,462 coexpressed genes). Fresh frozen plasma resuscitation (but not normal saline or hetastarch) was positively associated with 2 distinct gene clusters (termed A and B) comprising 493 genes. Gene expression in both clusters was negatively associated with brain swelling, and cluster B was also negatively associated with lesion size. Pathway analysis revealed an upregulation of genes involved in metabolic and platelet signaling, as well as collagen formation and downregulation of inflammation. CONCLUSIONS: Fresh frozen plasma resuscitation in this model was associated with downregulation of inflammatory pathway genes and expression of gene clusters mapping to increased metabolic and platelet signaling, which, in turn, was reversely associated with brain swelling. ((C) 2016 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)	[Sillesen, Martin] Rigshosp, Copenhagen Univ Hosp, Dept Surg Gastroenterol, Copenhagen, Denmark; [Sillesen, Martin] Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Copenhagen, Denmark; [Bambakidis, Ted; Dekker, Simone E.; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hlth Syst, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475	US Army Medical Research Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [T00521959]	The study was funded by a grant to Dr Alam from the US Army Medical Research Material Command (T00521959).	Alam HB, 2008, RESUSCITATION, V76, P299, DOI 10.1016/j.resuscitation.2007.07.030; Alam HB, 2002, RESUSCITATION, V54, P195, DOI 10.1016/S0300-9572(02)00095-3; BELLAMY RF, 1986, ANN EMERG MED, V15, P1392, DOI 10.1016/S0196-0644(86)80922-2; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chen HZ, 2006, J TRAUMA, V60, P701, DOI 10.1097/01.ta.0000203699.91475.f6; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Desai KH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001093; Hakon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120074; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kasotakis G, 2013, J TRAUMA ACUTE CARE, V74, P1215, DOI 10.1097/TA.0b013e3182826e13; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li ZQ, 2015, METAB BRAIN DIS, V30, P597, DOI 10.1007/s11011-014-9609-1; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Ostrowski SR, 2011, MED HYPOTHESES, V77, P798, DOI 10.1016/j.mehy.2011.07.040; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Potter DR, 2015, J TRAUMA ACUTE CARE, V78, pS7, DOI 10.1097/TA.0000000000000630; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Sperry J, 2013, J TRAUMA ACUTE CARE, V74, P1221; Torres LN, 2013, J TRAUMA ACUTE CARE, V75, P759, DOI 10.1097/TA.0b013e3182a92514; Wahlstrom MR, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-98; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	38	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	JAN	2017	224	1					49	58		10.1016/j.jamcollsurg.2016.09.015			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EO1CH	WOS:000396434700007	27725221				2022-02-06	
J	Sommer, JB; Bach, A; Mala, H; Stromgaard, K; Mogensen, J; Pickering, DS				Sommer, Jens Bak; Bach, Anders; Mala, Hana; Stromgaard, Kristian; Mogensen, Jesper; Pickering, Darryl S.			In vitro and invivo effects of a novel dimeric inhibitor of PSD-95 on excitotoxicity and functional recovery after experimental traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						controlled cortical impact; excitotoxicity; neuroprotection; PSD-95; traumatic brain injury	POSTSYNAPTIC DENSITY PROTEIN-95; CONTROLLED CORTICAL IMPACT; NITRIC-OXIDE FORMATION; NMDA RECEPTORS; ANESTHETIC AGENTS; SYNAPTIC PROTEINS; OXIDATIVE STRESS; AMINO-ACIDS; HEAD-INJURY; GLUTAMATE	PSD-95 inhibitors have been shown to be neuroprotective in stroke, but have only to a very limited extent been evaluated in the treatment of traumatic brain injury (TBI) that has pathophysiological mechanisms in common with stroke. The aims of the current study were to assess the effects of a novel dimeric inhibitor of PSD-95, UCCB01-147, on histopathology and long-term cognitive outcome after controlled cortical impact (CCI) in rats. As excitotoxic cell death is thought to be a prominent part of the pathophysiology of TBI, we also investigated the neuroprotective effects of UCCB01-147 and related compounds on NMDA-induced cell death in cultured cortical neurons. Anesthetized rats were given a CCI or sham injury, and were randomized to receive an injection of either UCCB01-147 (10mg/kg), the non-competitive NMDAR-receptor antagonist MK-801 (1mg/kg) or saline immediately after injury. At 2 and 4weeks post-trauma, spatial learning and memory were assessed in a water maze, and at 3months, brains were removed for estimation of lesion volumes. Overall, neither treatment with UCCB01-147 nor MK-801 resulted in significant improvements of cognition and histopathology after CCI. Although MK-801 provided robust neuroprotection against NMDA-induced toxicity in cultured cortical neurons, UCCB01-147 failed to reduce cell death and became neurotoxic at high doses. The data suggest potential differential effects of PSD-95 inhibition in stroke and TBI that should be investigated further in future studies taking important experimental factors such as timing of treatment, dosage, and anesthesia into consideration.	[Sommer, Jens Bak; Bach, Anders; Stromgaard, Kristian; Pickering, Darryl S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Jagtvej 160, DK-2100 Copenhagen, Denmark; [Sommer, Jens Bak; Mala, Hana; Mogensen, Jesper] Univ Copenhagen, Fac Social Sci, Dept Psychol, UCN, Copenhagen, Denmark		Sommer, JB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Jagtvej 160, DK-2100 Copenhagen, Denmark.; Sommer, JB (corresponding author), Univ Copenhagen, Fac Social Sci, Dept Psychol, UCN, Copenhagen, Denmark.	jens.sommer@sund.ku.dk		Bach, Anders/0000-0003-4305-9910; Rytter, Hana Mala/0000-0002-2910-372X; Mogensen, Jesper/0000-0003-1959-581X; Stromgaard, Kristian/0000-0003-2206-4737	Aase og Ejnar Danielsens Fond; Gangstedfonden	This work was supported by grants from Aase og Ejnar Danielsens Fond and Gangstedfonden. The funding sources had no involvement in any parts of the study. We gratefully acknowledge and are indebted to Heidi Marie Nielsen, Shahrokh Khazraie Padrah, Linda Marschner, Thi Lisa Le, Hema Mustafa, and Esben Nyborg Poulsen for their valuable assistance and technical expertise.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bach A., 2009, ANGEW CHEM INT EDIT, V121, P9865; Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bratane BT, 2011, STROKE, V42, P3265, DOI 10.1161/STROKEAHA.111.618801; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Carpenter KLH, 2008, ACTA NEUROCHIR SUPPL, V102, P207, DOI 10.1007/978-3-211-85578-2_41; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen YT, 2015, J CEREBR BLOOD F MET, V35, P739, DOI 10.1038/jcbfm.2015.16; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; DAWSON VL, 1993, J NEUROSCI, V13, P2651; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; DEMERLEPALLARDY C, 1991, BIOCHEM BIOPH RES CO, V181, P456, DOI 10.1016/S0006-291X(05)81441-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Fang M, 2003, J BIOL CHEM, V278, P36669, DOI 10.1074/jbc.M303520200; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gardoni F, 2006, EUR J NEUROSCI, V24, P2694, DOI 10.1111/j.1460-9568.2006.05140.x; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; GOLDBERG MP, 1988, J PHARMACOL EXP THER, V245, P1081; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; HEWETT SJ, 1993, BRAIN RES, V625, P337, DOI 10.1016/0006-8993(93)91078-7; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Hlatky R, 2002, ACT NEUR S, V81, P331; Jensen JB, 1998, NEUROCHEM INT, V32, P505, DOI 10.1016/S0197-0186(97)00130-7; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Khaldi A, 2002, ANN NY ACAD SCI, V962, P53, DOI 10.1111/j.1749-6632.2002.tb04055.x; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Koerner IP, 2006, CURR OPIN ANESTHESIO, V19, P481, DOI 10.1097/01.aco.0000245271.84539.4c; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Margulies S., 2015, J NEUROTRAUM, V33, P101; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Marschner L, 2016, IN VIVO, V30, P77; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Matchett GA, 2009, NEUROL RES, V31, P128, DOI 10.1179/174313209X393546; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mencl S., 2014, 8 INT S NEUR NEUR MA, P28; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Montaner J, 2013, DRUG FUTURE, V38, P485, DOI 10.1358/dof.2013.038.07.1980497; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nathoo FS, 2016, J MATH PSYCHOL, V72, P144, DOI 10.1016/j.jmp.2015.03.003; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAUWELS PJ, 1992, NEUROSCI LETT, V143, P27, DOI 10.1016/0304-3940(92)90225-V; PETERSON C, 1989, DEV BRAIN RES, V48, P187, DOI 10.1016/0165-3806(89)90075-8; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rangel-Castilla L, 2007, INTENSIVE CARE MED, P739, DOI [10.1007/978-0-387-49518-7_66, DOI 10.1007/978-0-387-49518-7_66]; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Shear D., 2011, 2011 SOC NEUR C WASH; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shohami E., 2012, TRAUMATIC BRAIN SPIN, P169; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Srejic LR, 2013, J CEREBR BLOOD F MET, V33, P1937, DOI 10.1038/jcbfm.2013.153; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Teves LM, 2016, J CEREBR BLOOD F MET, V36, P555, DOI 10.1177/0271678X15612099; Tisdall MM, 2013, NEUROCRIT CARE, V19, P65, DOI 10.1007/s12028-011-9633-5; Vidwans AS, 1999, J NEUROCHEM, V72, P1843, DOI 10.1046/j.1471-4159.1999.0721843.x; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walls AB, 2014, NEUROMETHODS, V90, P73, DOI 10.1007/978-1-4939-1059-5_4; Watanabe Y, 2003, BIOCHEM J, V372, P465, DOI 10.1042/BJ20030380; Wegener N, 2011, NEUROSCI LETT, V503, P68, DOI 10.1016/j.neulet.2011.08.012; WELLER M, 1993, BRAIN RES, V613, P143, DOI 10.1016/0006-8993(93)90464-X; Yan XB, 2004, NEUROSCI LETT, V355, P197, DOI 10.1016/j.neulet.2003.11.001; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhou HH, 2015, STROKE, V46, P1352, DOI 10.1161/STROKEAHA.115.008886	98	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JAN	2017	45	2					238	248		10.1111/ejn.13483			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EJ4HF	WOS:000393176800004	27859797				2022-02-06	
J	Talarico, MK; Lynall, RC; Mauntel, TC; Weinhold, PS; Padua, DA; Mihalik, JP				Talarico, Maria K.; Lynall, Robert C.; Mauntel, Timothy C.; Weinhold, Paul S.; Padua, Darin A.; Mihalik, Jason P.			Static and dynamic single leg postural control performance during dual-task paradigms	JOURNAL OF SPORTS SCIENCES			English	Article						Reaction time; functional assessments; Stroop test	GAIT BALANCE CONTROL; ANKLE INSTABILITY; DIVIDED ATTENTION; COGNITIVE TASK; CONCUSSION; STABILITY; HEALTHY; SWAY; INTERFERENCE; ADOLESCENTS	Combining dynamic postural control assessments and cognitive tasks may give clinicians a more accurate indication of postural control under sport-like conditions compared to single-task assessments. We examined postural control, cognitive and squatting performance of healthy individuals during static and dynamic postural control assessments in single-and dual-task paradigms. Thirty participants (female = 22, male = 8; age = 20.8 +/- 1.6 years, height = 157.9 +/- 13.0 cm, mass = 67.8 +/- 20.6 kg) completed single-leg stance and single-leg squat assessments on a force plate individually (single-task) and concurrently (dual-task) with two cognitive assessments, a modified Stroop test and the Brooks Spatial Memory Test. Outcomes included centre of pressure speed, 95% confidence ellipse, squat depth and speed and cognitive test measures (percentage of correct answers and reaction time). Postural control performance varied between postural control assessments and testing paradigms. Participants did not squat as deep and squatted slower (P < 0.001) during dual-task paradigms (<= 12.69 +/- 3.4 cm squat depth, <= 16.20 +/- 4.6 cm . s(-1) squat speed) compared to single-task paradigms (14.57 +/- 3.6 cm squat depth, 19.65 +/- 5.5 cm . s(-1) squat speed). The percentage of correct answers did not change across testing conditions, but Stroop reaction time (725.81 +/- 59.2 ms; F-2,F-58 = 7.725, P = 0.001) was slowest during single-leg squats compared to baseline (691.64 +/- 80.1 ms; P = 0.038) and single-task paradigms (681.33 +/- 51.5 ms; P < 0.001). Dynamic dual-task assessments may be more challenging to the postural control system and may better represent postural control performance during dynamic activities.	[Talarico, Maria K.; Lynall, Robert C.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Talarico, Maria K.; Mauntel, Timothy C.; Padua, Darin A.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Sports Med Res Lab, Chapel Hill, NC USA; [Lynall, Robert C.; Mauntel, Timothy C.; Padua, Darin A.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Weinhold, Paul S.] Univ North Carolina Chapel Hill, Dept Orthopaed, Chapel Hill, NC USA		Mihalik, JP (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gymnasium,Campus Box 8605, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Padua, Darin/0000-0002-9383-4236; Weinhold, Paul/0000-0002-7307-3580			[Anonymous], 1995, GAIT POSTURE; Arnold BL, 2009, MED SCI SPORT EXER, V41, P1048, DOI 10.1249/MSS.0b013e318192d044; Bernier JN, 1998, J ORTHOP SPORT PHYS, V27, P264, DOI 10.2519/jospt.1998.27.4.264; Boyd Y., 2011, INTEGRATING CORRECTI; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; BROOKS LR, 1967, Q J EXP PSYCHOL, V19, P289, DOI 10.1080/14640746708400105; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Claiborne TL, 2006, J APPL BIOMECH, V22, P41, DOI 10.1123/jab.22.1.41; Dionisio VC, 2008, J ELECTROMYOGR KINES, V18, P134, DOI 10.1016/j.jelekin.2006.07.010; Dixit A, 2015, INDIAN J PSYCHOL MED, V37, P165, DOI 10.4103/0253-7176.155615; Durall CJ, 2011, J SPORT REHABIL, V20, P406, DOI 10.1123/jsr.20.4.406; Fait PE, 2011, PERCEPT MOTOR SKILL, V112, P29, DOI 10.2466/05.10.23.25.PMS.112.1.29-43; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; HORTON MG, 1989, PHYS THER, V69, P897, DOI 10.1093/ptj/69.11.897; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Killane I, 2015, IEEE J BIOMED HEALTH, V19, P1855, DOI 10.1109/JBHI.2015.2479625; Knapp D, 2011, J ATHL TRAINING, V46, P257, DOI 10.4085/1062-6050-46.3.257; Linens SW, 2014, J ATHL TRAINING, V49, P15, DOI 10.4085/1062-6050-48.6.09; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Negahban H, 2014, KNEE SURG SPORT TR A, V22, P1491, DOI 10.1007/s00167-013-2501-4; Olmsted LC, 2002, J ATHL TRAINING, V37, P501; Overmoyer GV, 2013, J STRENGTH COND RES, V27, P2013, DOI 10.1519/JSC.0b013e3182779962; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Rogers ME, 2001, J OCCUP REHABIL, V11, P291, DOI 10.1023/A:1013300725964; Rogind H, 2003, SCAND J MED SCI SPOR, V13, P106, DOI 10.1034/j.1600-0838.2003.01139.x; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Sell TC, 2012, PHYS THER SPORT, V13, P80, DOI 10.1016/j.ptsp.2011.06.006; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swan L, 2007, GAIT POSTURE, V26, P470, DOI 10.1016/j.gaitpost.2006.11.201; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Teyhen DS, 2014, J STRENGTH COND RES, V28, P1272, DOI 10.1519/JSC.0000000000000272; Weerdesteyn V, 2003, J MOTOR BEHAV, V35, P53, DOI 10.1080/00222890309602121	41	10	11	2	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2017	35	11					1118	1124		10.1080/02640414.2016.1211307			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EO5YV	WOS:000396769800012	27498815	Green Published			2022-02-06	
J	Thiel, L; Sage, K; Conroy, P				Thiel, Lindsey; Sage, Karen; Conroy, Paul			Promoting linguistic complexity, greater message length and ease of engagement in email writing in people with aphasia: initial evidence from a study utilizing assistive writing software	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						therapy; aphasia; spelling; writing; assistive; internet	TRAUMATIC BRAIN-INJURY; DIGITAL DIVIDE; DYSGRAPHIA; INTERNET; IMPAIRMENTS; EXPRESSION; COMPUTER; AGRAPHIA; OUTCOMES; THERAPY	Background: Improving email writing in people with aphasia could enhance their ability to communicate, promote interaction and reduce isolation. Spelling therapies have been effective in improving single-word writing. However, there has been limited evidence on how to achieve changes to everyday writing tasks such as email writing in people with aphasia. One potential area that has been largely unexplored in the literature is the potential use of assistive writing technologies, despite some initial evidence that assistive writing software use can lead to qualitative and quantitative improvements to spontaneous writing. Aims: This within-participants case series design study aimed to investigate the effects of using assistive writing software to improve email writing in participants with dysgraphia related to aphasia. Methods & Procedures: Eight participants worked through a hierarchy of writing tasks of increasing complexity within broad topic areas that incorporate the spheres of writing need of the participants: writing for domestic needs, writing for social needs and writing for business/administrative needs. Through completing these tasks, participants had the opportunity to use the various functions of the software, such as predictive writing, word banks and text to speech. Therapy also included training and practice in basic computer and email skills to encourage increased independence. Outcome measures included email skills, keyboard skills, email writing and written picture description tasks, and a perception of disability assessment. Outcomes & Results: Four of the eight participants showed statistically significant improvements to spelling accuracy within emails when using the software. At a group level there was a significant increase in word length with the software; while four participants showed noteworthy changes to the range of word classes used. Enhanced independence in email use and improvements in participants' perceptions of their writing skills were also noted. Conclusions & Implications: This study provided some initial evidence that assistive writing technologies can support people with aphasia in email writing across a range of important performance parameters. However, more research is needed to measure the effects of these technologies on the writing of people with aphasia, and to determine the optimal compensatory mechanisms for specific people given the linguistic-strategic resources they bring to the task of email writing.	[Thiel, Lindsey] Leeds Beckett Univ, Sch Social Sci, Leeds, W Yorkshire, England; [Sage, Karen] Sheffield Hallam Univ, Dept Allied Hlth Profess, Sheffield, S Yorkshire, England; [Conroy, Paul] Univ Manchester, Sch Psychol Sci, NARU, Manchester, Lancs, England		Thiel, L (corresponding author), Leeds Beckett Univ, Sch Social Psychol & Commun Sci, Portland Bldg 405,City Campus, Leeds LS1 3HE, W Yorkshire, England.	l.thiel@leedsbeckett.ac.uk	Conroy, Paul/L-9500-2017	Conroy, Paul/0000-0003-2189-4149; Thiel, Lindsey/0000-0001-6804-7735	Economic and Social Research Council (ESRC)UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/I020233/1]	This work was supported by an Economic and Social Research Council (ESRC) bursary to Lindsey Thiel (Award Number ES/I020233/1).	Armstrong L, 2000, APHASIOLOGY, V14, P93, DOI 10.1080/026870300401612; Beeson PM, 2008, APHASIOLOGY, V22, P707, DOI 10.1080/02687030701800826; Beeson PM, 2013, J SPEECH LANG HEAR R, V56, P945, DOI 10.1044/1092-4388(2012/11-0360); Beeson PM, 2010, J SPEECH LANG HEAR R, V53, P450, DOI 10.1044/1092-4388(2009/08-0229); Beeson PM, 2000, APHASIOLOGY, V14, P551, DOI 10.1080/026870300401315; Behrns I, 2009, APHASIOLOGY, V23, P1276, DOI 10.1080/02687030802436892; Bruce C, 2003, INT J LANG COMM DIS, V38, P131, DOI 10.1080/1368282021000048258; Damasio AR, 1998, ACQUIRED APHASIA, V2, P27; Dietz A, 2011, TOP STROKE REHABIL, V18, P758, DOI 10.1310/tsr1806-758; Egan J, 2005, BRAIN INJURY, V19, P555, DOI 10.1080/02699050400013659; Egan J, 2004, APHASIOLOGY, V18, P265, DOI 10.1080/02687030344000562; Ellis A., 1988, HUMAN COGNITIVE NEUR; Elman RJ, 2001, APHASIOLOGY, V15, P895, DOI 10.1080/02687040143000267; Estes C, 2011, APHASIOLOGY, V25, P366, DOI 10.1080/02687038.2010.493294; Frattali C. M., 1995, AM SPEECH LANGUAGE H; Hallowell B., 2008, LANGUAGE INTERVENTIO; Howard D, 1992, PYRAMIDS PALM TREES; Jackson-Waite K, 2003, APHASIOLOGY, V17, P767, DOI 10.1080/02687030344000012a; JONES P., 2010, INTERNET ACCESS USE; Kaplan E, 2001, BDAE 3 BOSTON DIAGNO, V3rd; Kay J., 1992, PSYCHOLINGUISTIC ASS; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; King J. M., 1995, AUGMENTATIVE ALTERNA, V11, P187, DOI DOI 10.1080/07434619512331277309; Lesser R., 1993, LINGUISTICS APHASIA; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; MacArthur CA, 1996, J LEARN DISABIL, V29, P344, DOI 10.1177/002221949602900403; Manasse NJ, 2000, BRAIN INJURY, V14, P1015; Marshall J, 2005, APHASIOLOGY, V19, P1009, DOI 10.1080/02687030544000218; MENGER F., 2014, 16 INT APH REH C 201; Meyers JE., 1995, REY COMPLEX FIGURE T; MICELI G, 1985, BRAIN LANG, V25, P187, DOI 10.1016/0093-934X(85)90080-X; Mortley J, 2001, APHASIOLOGY, V15, P443, DOI 10.1080/02687040042000188; Murray LL, 2000, APHASIOLOGY, V14, P585, DOI 10.1080/026870300401333; Nicholas M, 2005, APHASIOLOGY, V19, P1052, DOI 10.1080/02687030544000245; NICHOLAS M., 1998, C SPEAK APHASIA COMM; Nicholas M, 2011, NEUROPSYCHOL REHABIL, V21, P322, DOI 10.1080/09602011.2011.559051; Rapcsak SZ, 2007, NEUROPSYCHOLOGIA, V45, P2519, DOI 10.1016/j.neuropsychologia.2007.03.019; Rapcsak SZ, 2009, CORTEX, V45, P575, DOI 10.1016/j.cortex.2008.04.006; Rapp B, 2005, APHASIOLOGY, V19, P994, DOI 10.1080/02687030544000209; RAPP B., 2002, HDB ADULT LANGUAGE D, P47; REITAN R. M., 1992, TRAILMAKING TEST MAN; Sage K, 2006, APHASIOLOGY, V20, P851, DOI 10.1080/02687030600738945; Sohlberg MM, 2003, BRAIN INJURY, V17, P609, DOI 10.1080/0269905031000070189; Swinburn K., 2004, COMPREHENSIVE APHASI; THIEL L., 2015, J OPEN PSYCHOL DATA, V3, pe4; THIEL L., 2015, NEUROPSYCHOL REHABIL, V26, P345; Thiel L, 2015, APHASIOLOGY, V29, P423, DOI 10.1080/02687038.2014.965059; van de Sandt-Koenderman M, 2004, APHASIOLOGY, V18, P245, DOI 10.1080/02687030344000571; Warrington E. K., 1996, CAMDEN MEMORY TESTS; Weekes BS, 2005, BEHAV NEUROL, V16, P51, DOI 10.1155/2005/492935; Whitworth A, 2005, COGNIITIVE NEUROPSYCHOLOGICAL APPROACH TO ASSESSMENT AND INTERVENTION IN APHASIA: A CLINICIANS GUIDE, P1	51	10	10	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	JAN-FEB	2017	52	1					106	124		10.1111/1460-6984.12261			19	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EO0AI	WOS:000396360300010	27297074	Green Accepted			2022-02-06	
J	Vaquero, J; Zurita, M; Bonilla, C; Fernandez, C; Rubio, JJ; Mucientes, J; Rodriguez, B; Blanco, E; Donis, L				Vaquero, Jesus; Zurita, Mercedes; Bonilla, Celia; Fernandez, Cecilia; Rubio, Juan J.; Mucientes, Jorge; Rodriguez, Begona; Blanco, Edelio; Donis, Luis			Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury	CYTOTHERAPY			English	Article						alzheimer's disease; brain metabolism; cell therapy; diffuse axonal injury; mesenchymal stromal cells	THERAPY; TRANSPLANTATION; DIAGNOSIS; RECOVERY; TRAUMA	Background aims. Cell therapy in neurological disability after traumatic brain injury (TBI) is in its initial clinical stage. We describe our preliminary clinical experience with three patients with diffuse axonal injury (DAI) who were treated with intrathecal administration of autologous mesenchymal stromal cells (MSCs). Methods. Three patients with established neurological sequelae due to DAI received intrathecally autologous MSCs. The total number of MSCs administered was 60 x 10(6) (one patient), 100 x 10(6) (one patient) and 300 x 10(6) (one patient). Results. All three patients showed improvement after cell therapy, and subsequent studies with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) showed a diffuse and progressive increase in brain glucose metabolism. Conclusion. Our present results suggest benefit of intrathecal administration of MSCs in patients with DAI as well as a relationship between this type of treatment and increase in brain glucose metabolism. These preliminary findings raise the question of convenience of assessing the potential benefit of intrathecal administration of MSCs for brain diseases in which a decrease in glucose metabolism represents a crucial pathophysiological finding, such as Alzheimer's disease (AD) and other dementias.	[Vaquero, Jesus; Fernandez, Cecilia] Autonomous Univ, Neurosurg Serv, Hosp Puerta de Hierro Majadahonda, Madrid, Spain; [Vaquero, Jesus; Zurita, Mercedes; Bonilla, Celia] Hosp Puerta de Hierro Majadahonda, Neurol Cell Therapy Unit, Madrid, Spain; [Rubio, Juan J.] Autonomous Univ, Med Intens Care Serv, Hosp Puerta de Hierro Majadahonda, Madrid, Spain; [Mucientes, Jorge; Rodriguez, Begona] Autonomous Univ, Nucl Med Serv, Hosp Puerta de Hierro Majadahonda, Madrid, Spain; [Blanco, Edelio; Donis, Luis] San Jose Hosp Inst Fdn, Madrid, Spain		Vaquero, J (corresponding author), Hosp Puerta de Hierro Majadahonda, Neurosurg Serv, Joaquin Rodrigo 2, Madrid 28222, Spain.	jvaqueroc@telefonica.net	RODRIGUEZ-ALFONSO, BEGONA/AAF-4500-2021; RODRIGUEZ-ALFONSO, BEGONA/H-5117-2012	RODRIGUEZ-ALFONSO, BEGONA/0000-0001-9446-5025; RODRIGUEZ-ALFONSO, BEGONA/0000-0001-9446-5025; Mucientes, Jorge/0000-0002-3107-5326			Berti V, 2011, ANN NY ACAD SCI, V1228, P81, DOI 10.1111/j.1749-6632.2011.06015.x; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Ishii K, 2014, AM J NEURORADIOL, V35, P2030, DOI 10.3174/ajnr.A3695; Jeong Y, 2005, J NUCL MED, V46, P233; Mega MS, 2001, NEUROPSY NEUROPSY BE, V14, P63; Park BN, 2013, NUKLEARMED-NUCL MED, V52, P192, DOI 10.3413/Nukmed-0543-12-11; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sharma A, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/905874; Shimada Aiko, 2011, Osaka City Med J, V57, P11; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Tzimopoulou S, 2010, J ALZHEIMERS DIS, V22, P1241, DOI 10.3233/JAD-2010-100939; Vaquero J, 2016, CYTOTHERAPY, V18, P1025, DOI 10.1016/j.jcyt.2016.05.003; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002	14	10	11	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	JAN	2017	19	1					88	94		10.1016/j.jcyt.2016.10.001			7	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	EG8ZN	WOS:000391346500009	27816409				2022-02-06	
J	Wong, KH; Ng, CC; Kanagasabapathy, G; Yow, YY; Sabaratnam, V				Wong, Kah-Hui; Ng, Chai-Chee; Kanagasabapathy, Gowri; Yow, Yoon-Yen; Sabaratnam, Vikineswary			An Overview of Culinary and Medicinal Mushrooms in Neurodegeneration and Neurotrauma Research	INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS			English	Article						central nervous system disorders; medicinal and edible mushrooms; neuroprotection; neuroregeneration; oxidative stress; peripheral neuropathy	BULL.-FR. PERS.; LIONS MANE MUSHROOM; NERVE GROWTH-FACTOR; GANODERMA-LUCIDUM POLYSACCHARIDES; HERICIUM-ERINACEUS; NEURITE OUTGROWTH; PC12 CELLS; ER STRESS; CORDYCEPS-MILITARIS; TREMELLA-FUCIFORMIS	Culinary and medicinal mushrooms have been appreciated since prehistoric times as valuable resources for food and medicine. Edible mushrooms represent an untapped source of nutraceuticals and valuable palatable food. Long considered tonics, they are now treasured as functional foods that can improve human health and quality of life. Numerous studies have provided insights into the neuroprotective effects of edible mushrooms, which are attributed to their antioxidant, antineuroinflammatory, and cholinesterase inhibitory properties, and their ability to prevent neuronal death. Here we review the recent literature on the role of culinary and medicinal mushrooms in the management of neurodegenerative diseases and neurotrauma. We highlight some of the molecular mechanisms for how these alternative medicines provide health benefits that could help us to harness their neuroprotective effects.	[Wong, Kah-Hui] Univ Malaya, Dept Anat, Fac Med, Kuala Lumpur 50603, Malaysia; [Wong, Kah-Hui; Ng, Chai-Chee; Kanagasabapathy, Gowri; Sabaratnam, Vikineswary] Univ Malaya, Mushroom Res Ctr, Fac Sci, Kuala Lumpur, Malaysia; [Ng, Chai-Chee; Sabaratnam, Vikineswary] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Yow, Yoon-Yen] Sunway Univ, Sch Sci & Technol, Dept Biol Sci, Bandar Sunway, Selangor Darul, Malaysia		Wong, KH (corresponding author), Univ Malaya, Dept Anat, Fac Med, Kuala Lumpur 50603, Malaysia.	wkahhui@um.edu.my	Yow, Yoon Yen/E-1248-2016; SABARATNAM, S. VIKINESWARY/B-9648-2010; Kah-Hui, Wong/C-1048-2010	Yow, Yoon Yen/0000-0002-3859-2094; SABARATNAM, S. VIKINESWARY/0000-0003-3966-3701; Kah-Hui, Wong/0000-0002-8292-4498			Aguirre-Moreno A, 2013, INT J MED MUSHROOMS, V15, P555, DOI 10.1615/IntJMedMushr.v15.i6.40; Bennett L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076362; Buck C., 2014, ACUPUNCTURE CHINESE; Chen CC, 2016, J NAT PROD, V79, P438, DOI 10.1021/acs.jnatprod.5b00474; Cheng JH, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1154-5; Cheng ZY, 2011, EUR J PHARMACOL, V664, P20, DOI 10.1016/j.ejphar.2011.04.052; Cheung WMW, 2000, FEBS LETT, V486, P291, DOI 10.1016/S0014-5793(00)02317-6; Eik LF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/320308; Gokce EC, 2015, INJURY, V46, P2146, DOI 10.1016/j.injury.2015.08.017; Golde TE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-8; Gryganslcy AP, 2001, INT J MED MUSHROOMS, V3, P152; HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4; Hassan A.I., 2015, AFR J BIOTECHNOL, V14, P2052, DOI [1, DOI 10.5897/AJB2015.14501]; Hazekawa M, 2010, J HEALTH SCI, V56, P296, DOI 10.1248/jhs.56.296; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Inanaga, 2014, PERS MED UNIVERSE, V3, P46, DOI [10.1016/j.pmu.2014.02.004, DOI 10.1016/j.pmu.2014.02.004]; Iwata N., 2008, Journal of Japanese Society of Nutrition and Food Science, V61, P119; Ji W, 2014, EVID-BASED COMPL ALT, V2014; Jin ML, 2014, NEUROTOXICOLOGY, V41, P102, DOI 10.1016/j.neuro.2014.01.005; Kawagishi H, 2008, DRUG FUTURE, V33, P149, DOI 10.1358/dof.2008.033.02.1173290; Kim Byung-Chul, 2011, Exp Neurobiol, V20, P100, DOI 10.5607/en.2011.20.2.100; Kim JH, 2007, BIOL PHARM BULL, V30, P708, DOI 10.1248/bpb.30.708; Kolotushkina E. V., 2003, Fiziolohichnyi Zhurnal (Kiev), V49, P38; Kumar V., 2012, ROBBINS BASIC PATHOL, V9; Kuo HC, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0831-y; Lai PL, 2013, INT J MED MUSHROOMS, V15, P539, DOI 10.1615/IntJMedMushr.v15.i6.30; Lee B, 2011, FOOD SCI BIOTECHNOL, V20, P1599, DOI 10.1007/s10068-011-0221-4; Li ZX, 2012, J MED FOOD, V15, P1057, DOI 10.1089/jmf.2011.2105; Liu ZY, 2015, INT J MED MUSHROOMS, V17, P219, DOI 10.1615/IntJMedMushrooms.v17.i3.20; Matsuzaki H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-370; Moldavan Michael G., 2002, International Journal of Medicinal Mushrooms, V4, P43, DOI 10.1615/IntJMedMushr.v4.i1.50; Mori K, 2008, BIOL PHARM BULL, V31, P1727, DOI 10.1248/bpb.31.1727; Mori K, 2011, BIOMED RES-TOKYO, V32, P67, DOI 10.2220/biomedres.32.67; Mori K, 2009, PHYTOTHER RES, V23, P367, DOI 10.1002/ptr.2634; Nagai K, 2006, J NUTR BIOCHEM, V17, P525, DOI 10.1016/j.jnutbio.2005.09.007; Nagano M, 2010, BIOMED RES-TOKYO, V31, P231, DOI 10.2220/biomedres.31.231; Nishina A, 2006, J LIPID RES, V47, P1434, DOI 10.1194/jlr.M600045-JLR200; Okamura H., 2015, PERS MED UNIVERSE, V4, P76; Park HJ, 2012, BEHAV BRAIN RES, V229, P82, DOI 10.1016/j.bbr.2011.11.017; Park Kum Ju, 2007, Mycobiology, V35, P11, DOI 10.4489/MYCO.2007.35.1.011; Park YS, 2002, CYTOTECHNOLOGY, V39, P155, DOI 10.1023/A:1023963509393; Phan CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143004; Phan CW, 2014, FOOD FUNCT, V5, P3160, DOI [10.1039/C4FO00452C, 10.1039/c4fo00452c]; Pinweha S, 2008, NEUROSCI LETT, V448, P62, DOI 10.1016/j.neulet.2008.10.028; Qu Y, 2012, BIOSCI BIOTECH BIOCH, V76, P791, DOI 10.1271/bbb.110918; Raman J, 2015, INT J NANOMED, V10, P5853, DOI 10.2147/IJN.S88371; Samberkar S, 2015, INT J MED MUSHROOMS, V17, P1047, DOI 10.1615/IntJMedMushrooms.v17.i11.40; Santi- Rampazzo AP, 2011, AUTON NEUROSCI-BASIC, V163, P63; Seow SLS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16349; Seow SLS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-157; Shimbo M, 2005, NUTR RES, V25, P617, DOI 10.1016/j.nutres.2005.06.001; Socala K, 2015, INT J MED MUSHROOMS, V17, P209, DOI 10.1615/IntJMedMushrooms.v17.i3.10; Thangthaeng N, 2015, NUTR RES, V35, P1079, DOI 10.1016/j.nutres.2015.09.012; Trovato A, 2016, NEUROTOXICOLOGY, V53, P350, DOI 10.1016/j.neuro.2015.09.012; Tsai CH, 2015, J FOOD DRUG ANAL, V23, P63, DOI 10.1016/j.jfda.2014.05.006; Ueda K, 2008, BIOORGAN MED CHEM, V16, P9467, DOI 10.1016/j.bmc.2008.09.044; Wong KH, 2009, FOOD TECHNOL BIOTECH, V47, P47; Wong KH, 2007, INT J MED MUSHROOMS, V9, P57, DOI 10.1615/IntJMedMushr.v9.i1.70; Wong KH, 2016, CHIN J INTEGR MED, V22, P759, DOI 10.1007/s11655-014-1624-2; Wong KH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/neq062; Wong KH, 2015, FOOD SCI TECH-BRAZIL, V35, P712, DOI 10.1590/1678-457X.6838; Wong KH, 2012, INT J MED MUSHROOMS, V14, P427, DOI 10.1615/IntJMedMushr.v14.i5.10; Wong KH, 2009, INT J MED MUSHROOMS, V11, P225, DOI 10.1615/IntJMedMushr.v11.i3.20; Xuan M, 2011, JPN J COMPLEMENT ALT, V8, P99; Zhang CJ, 2015, INT J MED MUSHROOMS, V17, P1, DOI 10.1615/IntJMedMushrooms.v17.i1.10; Zhang RP, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep075; Zhang XQ, 2011, NAT PROD RES, V25, P1607, DOI 10.1080/14786419.2010.496367; Zhao HB, 2005, LIFE SCI, V76, P1027, DOI 10.1016/j.lfs.2004.08.013; Zhou Y, 2012, EXP TOXICOL PATHOL, V64, P673, DOI 10.1016/j.etp.2010.12.011; Zhou ZY, 2010, J ETHNOPHARMACOL, V131, P154, DOI 10.1016/j.jep.2010.06.023	70	10	10	4	42	BEGELL HOUSE INC	DANBURY	50 NORTH ST, DANBURY, CT 06810 USA	1521-9437	1940-4344		INT J MED MUSHROOMS	Int. J. Med. Mushrooms		2017	19	3					191	202		10.1615/IntJMedMushrooms.v19.i3.10			12	Biochemistry & Molecular Biology; Plant Sciences; Mycology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Plant Sciences; Mycology; Pharmacology & Pharmacy	EU3KJ	WOS:000400927900001	28605334				2022-02-06	
J	Yuhas, PT; Shorter, PD; McDaniel, CE; Earley, MJ; Hartwick, ATE				Yuhas, Phillip T.; Shorter, Patrick D.; McDaniel, Catherine E.; Earley, Michael J.; Hartwick, Andrew T. E.			Blue and Red Light-Evoked Pupil Responses in Photophobic Subjects with TBI	OPTOMETRY AND VISION SCIENCE			English	Article						traumatic brain injury; photophobia; pupil; intrinsically photosensitive retinal ganglion cells (ipRGCs); melanopsin	TRAUMATIC BRAIN-INJURY; RETINAL GANGLION-CELLS; MACULAR PIGMENT; HEAD-INJURY; SLEEP; AVERSION; GLARE; MICE; PHOTOTRANSDUCTION; DYSFUNCTIONS	Purpose. Photophobia is a common symptom in individuals suffering from traumatic brain injury (TBI). Recent evidence has implicated blue light-sensitive intrinsically photosensitive retinal ganglion cells (ipRGCs) in contributing to the neural circuitry mediating photophobia inmigraine sufferers. The goal of this work is to test the hypothesis that ipRGC function is altered in TBI patients with photophobia by assessing pupillary responses to blue and red light. Methods. Twenty-four case participants (mean age 43.3; 58% female), with mild TBI and self-reported photophobia, and 12 control participants (mean age 42.6; 58% female) were in this study. After 10 minutes of dark adaptation, blue (470 nm, 1 x 10(13) phots/s/cm(2)) and red (625 nm, 7 x 10(13) phots/s/cm(2)) flashing (0.1 Hz) light stimuli were delivered for 30 seconds to the dilated left eye while the right pupil was recorded. The amplitude of normalized pupil fluctuation (constriction and dilation) was quantified using Fourier fast transforms. Results. In both case and control participants, the amplitude of pupil fluctuation was significantly less for the blue light stimuli as compared to the red light stimuli, consistent with a contribution of ipRGCs to these pupil responses. There was no significant difference in the mean pupil fluctuation amplitudes between the two participant groups, but case participants displayed greater variability in their pupil responses to the blue stimulus. Conclusions. Case and control participants showed robust ipRGC-mediated components in their pupil responses to blue light. The results did not support the hypothesis that ipRGCs are "hypersensitive'' to light in TBI participants with photophobia. However, greater pupil response variability in the case subjects suggests that ipRGC function may be more heterogeneous in this group.	[Yuhas, Phillip T.; Shorter, Patrick D.; McDaniel, Catherine E.; Earley, Michael J.; Hartwick, Andrew T. E.] Ohio State Univ, Coll Optometry, 338 W 10th Ave, Columbus, OH 43210 USA		Hartwick, ATE (corresponding author), Ohio State Univ, Coll Optometry, 338 W 10th Ave, Columbus, OH 43210 USA.	hartwick.4@osu.edu		Yuhas, Phillip/0000-0002-5956-4957	Department of Defense Telemedicine and Advanced Technology Research Center (TATRC) [W81XWH-12-1-0434]	Investigation funded by Department of Defense Telemedicine and Advanced Technology Research Center (TATRC) Grant W81XWH-12-1-0434. The authors thank Dr. Lise Worthen-Chaudhari and Dr. Joseph Rosenthal for advice and assistance with patient recruitment.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Brown TM, 2012, CURR BIOL, V22, P1134, DOI 10.1016/j.cub.2012.04.039; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de Kinkelder R, 2011, EYE, V25, P105, DOI 10.1038/eye.2010.164; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; DRUMMOND PD, 1987, J NEUROL NEUROSUR PS, V50, P228, DOI 10.1136/jnnp.50.2.228; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Ingham ES, 2009, J COMP NEUROL, V516, P125, DOI 10.1002/cne.22103; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Jones KA, 2013, NAT CHEM BIOL, V9, P630, DOI [10.1038/NCHEMBIO.1333, 10.1038/nchembio.1333]; JONSSON CO, 1967, ACTA NEUROL SCAND, V43, P158, DOI 10.1111/j.1600-0404.1967.tb05725.x; Kankipati L, 2010, INVEST OPHTH VIS SCI, V51, P2764, DOI 10.1167/iovs.09-4717; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lin YD, 2015, INVEST OPHTH VIS SCI, V56, P1649, DOI 10.1167/iovs.14-15963; Maleki N, 2012, HUM BRAIN MAPP, V33, P75, DOI 10.1002/hbm.21194; Matynia A, 2015, EXP EYE RES, V137, P57, DOI 10.1016/j.exer.2015.05.025; Matynia A, 2012, EXP EYE RES, V105, P60, DOI 10.1016/j.exer.2012.09.012; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Murray I. J., 2002, Lighting Research & Technology, V34, P231, DOI 10.1191/1365782802lt046oa; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Semo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015009; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Stringham JM, 2008, OPTOMETRY VISION SCI, V85, P82, DOI 10.1097/OPX.0b013e318162266e; Stringham JM, 2007, OPTOMETRY VISION SCI, V84, P859, DOI 10.1097/OPX.0b013e3181559c2b; Stringham JM, 2003, J OPT SOC AM A, V20, P1852, DOI 10.1364/JOSAA.20.001852; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Thompson S, 2010, BEHAV NEUROSCI, V124, P821, DOI 10.1037/a0021568; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x	47	10	10	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					108	117		10.1097/OPX.0000000000000934			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	EM5ZZ	WOS:000395393900015	27464575				2022-02-06	
J	Zakzanis, KK; Grimes, KM				Zakzanis, Konstantine K.; Grimes, Kyrsten M.			Relationship among apathy, cognition, and real-world disability after mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Activities of daily living; apathy; cognition; disability; mild brain injury	HEAD-INJURY; POSTCONCUSSION SYMPTOMS; PSYCHOMETRIC PROPERTIES; EXECUTIVE DYSFUNCTION; CLINICAL MANAGEMENT; EVALUATION SCALE; BASE RATES; MODERATE; PERFORMANCE; DEPRESSION	It is well established that most people recover soon after a mild traumatic brain injury (mTBI), yet protracted neuropsychological impairment is evident in many individuals. We sought to elucidate the relationship between apathy and neuropsychological impairment and disability as it pertains to real-world function in patients who sustained a mTBI reporting and demonstrating protracted neuropsychological impaired (i.e., more than three months post-injury). We employed a battery of neuropsychological and psychological measures, along with a measure of apathy in 104 patients who sustained a mTBI reporting neuropsychological complaints (38 in the not disabled group and 66 in the disabled group). Their ability to return to work was used as proxy for real-world disability. Specific deficits in verbal fluency, memory, and information processing predicted real-world disability but apathy did not, suggesting that psychological factors may play less of a mediating role than specific neuropsychological factors in the relationship between impairment and real world disability. Our research furthers our understanding of the cognitive and psychological differences that exist in patients with mTBI who have real-world disability compared to those who do not.	[Zakzanis, Konstantine K.; Grimes, Kyrsten M.] Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada		Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cohen J., 2013, STAT POWER ANAL BEHA; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Howieson D. B., 2002, NEUROPSYCHOLOGICAL E; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Rey, 1941, REY DOT COUNTING TES; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stern RA, 2003, ARCH CLIN NEUROPSYCH, V18, P805; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wrightson P, 1999, MILD HEAD INJURY GUI; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P419, DOI 10.1076/jcen.20.3.419.821; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	55	10	10	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	6					559	565		10.1080/23279095.2016.1225216			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FQ8ME	WOS:000418616100009	27636355				2022-02-06	
J	Zirpe, KG; Tambe, DV; Deshmukh, AM; Gurav, SK				Zirpe, Kapil G.; Tambe, Deepali Vishnu; Deshmukh, Abhijit M.; Gurav, Sushma K.			The Impact of Early Tracheostomy in Neurotrauma Patients: A Retrospective Study	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Early tracheostomy; neurotrauma; traumatic brain injury	MECHANICAL VENTILATION; INJURY	Background: Although majority of neurotrauma patients require long term ventilatory support but the timing of tracheostomy in such patients is controversial. Method: This retrospective study was conducted at a Tertiary Care Hospital, Pune, India. Patients > 18 years of age, who underwent percutaneous tracheostomy (PCT) from June 2010 to November 2014 at neurotrauma unit (NTU) of hospital, were included. Patients were divided in two groups according to the timing of tracheostomy, early tracheostomy (ET) group (<= 5 days; N=100) and late tracheostomy (LT) group (>5 days; N=64). The nonparametric Mann-Whitney test, and Chi-square tests were used to compare these groups. Result: There were no significant differences between the groups in terms of age, sex, APACHE II and GCS Score. Patients in the ET group had a significantly shorter stay in the NTU compared to patients in the LT group (mean, 18 vs. 21.2 days, p=0.005), fewer mechanical ventilation days (mean, 8.1 vs. 11.7 days, P=0.000) and shorter length of stay in hospital (mean, 28.8 vs. 34.37 days, P=0.019). There was no difference between ET and LT groups in post PCT ventilator free days (mean, 8.2 vs. 9.4 days; P=0.094). Mortality rates in ET vs. LT groups were also comparable (35% vs. 29.7%; P=0.480). Conclusion: Results suggest that ET in neurotrauma patients might be associated with shorter length of stay in NTU and hospital, and shorter duration of mechanical ventilation however there was no mortality difference.	[Zirpe, Kapil G.; Tambe, Deepali Vishnu; Deshmukh, Abhijit M.; Gurav, Sushma K.] Ruby Hall Clin, Neurotrauma Unit, Pune 411001, Maharashtra, India		Gurav, SK (corresponding author), Ruby Hall Clin, Neurotrauma Unit, Pune 411001, Maharashtra, India.	kirtisush_gurav@yahoo.co.in					Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Andriolo BNG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub3; Cheung NH, 2014, RESP CARE, V59, P895, DOI 10.4187/respcare.02971; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Durbin CG, 2010, RESP CARE, V55, P1056; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Gessler F, 2015, CRIT CARE MED, V43, P2429, DOI 10.1097/CCM.0000000000001195; Mahafza T, 2012, SAUDI J ANAESTH, V6, P152, DOI 10.4103/1658-354X.97029; Paydar Shahram, 2014, Bull Emerg Trauma, V2, P136; Pinheiro BD, 2010, J BRAS PNEUMOL, V36, P84, DOI 10.1590/S1806-37132010000100014; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Shan L, 2013, RESP CARE, V58, P1856, DOI 10.4187/respcare.02413; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Siempos II, 2015, LANCET RESP MED, V3, P150, DOI 10.1016/S2213-2600(15)00007-7; Victoria AM, 2016, NEUROCRIT CARE, DOI [10.1007/s12028-016-0297-z, DOI 10.1007/S12028-016-0297-Z]; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	19	10	10	0	2	JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD	NEW DEHLI	4838-24, ANSARI RD, DARYAGANJ, NEW DEHLI, 110 002, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	JAN	2017	21	1					6	10		10.4103/0972-5229.198309			5	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EM6DD	WOS:000395402100002	28197044	Bronze, Green Published			2022-02-06	
J	Brooks, BL; Low, TA; Daya, H; Khan, S; Mikrogianakis, A; Barlow, KM				Brooks, Brian L.; Low, Trevor A.; Daya, Hussain; Khan, Samna; Mikrogianakis, Angelo; Barlow, Karen M.			Test or Rest? Computerized Cognitive Testing in the Emergency Department after Pediatric Mild Traumatic Brain Injury Does Not Delay Symptom Recovery	JOURNAL OF NEUROTRAUMA			English	Article						child; brain concussion; emergency service; hospital; outcomes assessment; post-concussion syndrome	SPORT-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; ADOLESCENTS; CHILDREN; STATEMENT; CONSENSUS; TRIAL	Rest is commonly prescribed following a mild traumatic brain injury (mTBI). There is concern that cognitive exertion by an acutely or sub-acutely injured brain may negatively alter outcome. The objective of this study was to determine if computerized cognitive testing in the emergency department alters symptom outcome from mTBI. Participants included 77 youth with mTBI who underwent computerized cognitive testing (mean age, 13.6; 95% confidence interval [CI] = 13.0-14.2) and were matched to 77 youth with mTBI who did not participate in cognitive testing (mean age, 13.5; 95% CI = 12.9-14.0). Participants who underwent cognitive testing did not differ from those who did not undergo acute cognitive testing on mean symptom ratings or the proportion who were not recovered at 7-10 days, 1 month, 2 months, or 3 months. There also was no difference in symptom outcome for those who underwent a shortened (four subtests, mean time = 16 min) or full-length (seven subtests, mean time = 28 min) version of the computerized test. Brief cognitive exertion using a computerized cognitive assessment after mTBI in youth does not result in worse symptoms at these follow-up periods, does not prolong symptom recovery, should not be considered contraindicated to recovery, and could be considered as another tool to aid in the management of these injuries. Further research with different samples is warranted.	[Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Dept Neurosci, Brain Injury Rehabil Program, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Dept Neurosci, Vi Riddell Rehabil Program, Calgary, AB, Canada; [Mikrogianakis, Angelo] Alberta Childrens Prov Gen Hosp, Sect Emergency Med, Calgary, AB, Canada; [Brooks, Brian L.; Mikrogianakis, Angelo; Barlow, Karen M.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.; Barlow, Karen M.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Low, Trevor A.] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Daya, Hussain] Univ Lethbridge, Dept Psychol, Lethbridge, AB, Canada; [Khan, Samna] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Mikrogianakis, Angelo; Barlow, Karen M.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca	Barlow, Karen/C-1323-2014; Mikrogianakis, Angelo/AAW-5929-2021; Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507; Mikrogianakis, Angelo/0000-0002-8854-0620; Barlow, Karen/0000-0003-2612-8507; Low, Trevor/0000-0002-8564-845X	Pediatric Brain Injury Research Program; Canadian Institutes of Health Research training programCanadian Institutes of Health Research (CIHR); McCarthy Tetrault Award	Funding for this study was provided by: the Pediatric Brain Injury Research Program (administered by the Alberta Children's Hospital Research Institute) awarded to Drs. Barlow and Brooks; summer studentships from the Canadian Institutes of Health Research training program (administered by the Alberta Children's Hospital Research Institute; the McCarthy Tetrault Award (administered by the Alberta Children's Hospital Research Institute) awarded to Dr. Brooks; in-kind test credits from the computerized test publisher (CNS Vital Signs); and in-kind support from the neurosciences program at Alberta Children's Hospital (Conny Betuzzi). None of the funding sources were involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	[Anonymous], 2010, IBM SPSS STAT WIND V; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DiFazio M, 2015, CLIN PEDIAT PHILA; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gualtieri C Thomas, 2006, J Atten Disord, V9, P534, DOI 10.1177/1087054705283758; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Khetani A, 2014, BRAIN INJURY, V28, P844; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2013, BMJ OPEN, V3; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	40	10	10	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2091	2096		10.1089/neu.2015.4301			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800004	26936646				2022-02-06	
J	Gulati, G; Iffland, PH; Janigro, D; Zhang, B; Luggen, ME				Gulati, Gaurav; Iffland, Philip H., II; Janigro, Damir; Zhang, Bin; Luggen, Michael E.			Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction	CLINICAL RHEUMATOLOGY			English	Article						Anti-NR2 antibody; Anti-S100B antibody; Blood-brain barrier (BBB); Cognitive dysfunction; Lupus; Neuropsychiatric lupus; S100B protein; Systemic lupus erythematosus (SLE)	SYSTEMIC-LUPUS-ERYTHEMATOSUS; GLUTAMATE-RECEPTOR ANTIBODIES; CENTRAL-NERVOUS-SYSTEM; S100B PROTEIN-LEVELS; CEREBROSPINAL-FLUID; NEUROPSYCHIATRIC SYNDROMES; SERUM; AUTOANTIBODIES; DISEASE; DEPRESSION	Cognitive dysfunction (CD) is one of the most common neuropsychiatric manifestations of systemic lupus erythematosus (SLE). In animal models, antibodies to NR2 subunit of N-methyl d-aspartate receptor (anti-NR2) cause memory impairment, but only with blood-brain barrier (BBB) disruption or intrathecal administration. Several studies have failed to find association of aNR2 with CD, but none have assessed BBB integrity. S100B, an astrocyte-specific protein, has been used as biomarker of BBB disruption in traumatic brain injury and some neurodegenerative disorders. Antibodies to this immunologically privileged protein (anti-S100B) might indicate preceding BBB disruption. We hypothesized that aNR2 antibody is pathogenic in SLE patients only with BBB disruption. Demographic, clinical, and laboratory data was collected from patients with SLE. Total throughput score (TTS) of the Automated Neuropsychological Assessment Metrics (ANAM) was used as primary outcome measure. CD was defined as TTS < 1.5 SD below an age-, sex-, and race-matched RA population mean. Serum was analyzed by established ELISA techniques. Fifty-seven patients were evaluated and 12 had CD. Age, ethnicity, and family income were significantly different between the two groups (p < 0.05). In a multiple regression model adjusting for other variables, no significant effects of anti-NR2, S100B, or anti-S100B on TTS were found. Even at high levels of S100B and anti-S100B, no significant influence of anti-NR2 on TTS was found. The anti-NR2 was not associated with CD in SLE even in context of potential BBB disruption. This suggests that, if pathogenic, these antibodies may be produced intrathecally.	[Gulati, Gaurav; Luggen, Michael E.] Univ Cincinnati, Coll Med, MSB, Div Immunol Allergy & Rheumatol, 231 Albert Sabin Way,ML 0563, Cincinnati, OH 45267 USA; [Iffland, Philip H., II; Janigro, Damir] Cleveland Clin Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Zhang, Bin] Cincinnati Childrens Hosp & Med Ctr, Dept Biostat & Epidemiol, Cincinnati, OH 45229 USA		Gulati, G (corresponding author), Univ Cincinnati, Coll Med, MSB, Div Immunol Allergy & Rheumatol, 231 Albert Sabin Way,ML 0563, Cincinnati, OH 45267 USA.	gaurav.gulati@uc.edu			National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077, P30AR047363]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	The project was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health [Award Number UL1TR000077] (Bin Zhang, Ph.D.) and P30AR047363 (Susan Thompson, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Antonchak MA, 2011, J RHEUMATOL, V38, P1020, DOI 10.3899/jrheum.100560; Arinuma Y, 2008, ARTHRITIS RHEUM-US, V58, P1130, DOI 10.1002/art.23399; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Fragoso-Loyo H, 2010, J RHEUMATOL, V37, P2280, DOI 10.3899/jrheum.100148; Fragoso-Loyo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003347; GLADMAN D, 1992, J RHEUMATOL, V19, P1820; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Hanly JG, 2008, ARTHRITIS RHEUM-US, V58, P843, DOI 10.1002/art.23218; Hanly JG, 2006, J RHEUMATOL, V33, P1553; Harrison MJ, 2006, ARTHRITIS RHEUM, V54, P2515, DOI 10.1002/art.22030; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Kiani Adnan N, 2010, Curr Rheumatol Rep, V12, P250, DOI 10.1007/s11926-010-0114-1; Kosinski M, 2013, LUPUS, V22, P422, DOI 10.1177/0961203313476360; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kozora E, 2010, J NEUROL SCI, V295, P87, DOI 10.1016/j.jns.2010.04.016; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lauvsnes MB, 2012, J NEUROL, V259, P622, DOI 10.1007/s00415-011-6232-5; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; MCLEAN BN, 1995, J NEUROL NEUROSUR PS, V58, P548, DOI 10.1136/jnnp.58.5.548; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Murray SG, 2012, ARTHRIT CARE RES, V64, P1328, DOI 10.1002/acr.21691; Omdal R, 2005, EUR J NEUROL, V12, P392, DOI 10.1111/j.1468-1331.2004.00976.x; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Panopalis P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1453, DOI 10.1002/art.23090; Petri M, 2010, J RHEUMATOL, V37, P2032, DOI 10.3899/jrheum.091366; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Schenatto CB, 2006, ANN RHEUM DIS, V65, P829, DOI 10.1136/ard.2005.048330; Steup-Beekman GM, 2007, LUPUS, V16, P329, DOI 10.1177/0961203307078224; Tam LS, 2008, J RHEUMATOL, V35, P1038; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Yang XY, 2008, CLIN RHEUMATOL, V27, P353, DOI 10.1007/s10067-007-0722-y; Yelin E, 2009, ARTHRIT RHEUM-ARTHR, V61, P247, DOI 10.1002/art.24213; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547	40	10	11	0	8	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	DEC	2016	35	12					2989	2997		10.1007/s10067-016-3339-1			9	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rheumatology	ED4NL	WOS:000388826200016	27357716				2022-02-06	
J	Henderson, M; Rice, B; Sebastian, A; Sullivan, PG; King, C; Robinson, RAS; Reed, TT				Henderson, Moses; Rice, Brittany; Sebastian, Andrea; Sullivan, Patrick G.; King, Christina; Robinson, Rena A. S.; Reed, Tanea T.			Neuroproteomic study of nitrated proteins in moderate traumatic brain injured rats treated with gamma glutamyl cysteine ethyl ester administration post injury: Insight into the role of glutathione elevation in nitrosative stress	PROTEOMICS CLINICAL APPLICATIONS			English	Article						3-Nitrotyrosine (3-NT); Protein nitration; Traumatic brain injury (TBI); Reactive nitrogen species (RNS); Nitrosative stress	MOUSE MODEL; OXIDATIVE STRESS; PROTEOMIC IDENTIFICATION; LIPID-PEROXIDATION; TYROSINE NITRATION; UP-REGULATION; HEAD-INJURY; MICE; HIPPOCAMPUS; PROTECTS	Purpose: The aims of this study are to establish a time point to determine the most beneficial time to administer GCEE post incident to reduce oxidative damage and second, by using redox proteomics, to determine if GCEE can readily suppress 3-NT modification in TBI animals. Experimental design: By using a moderate traumatic brain injury model with Wistar rats, it is hypothesized that the role of 3-nitrotyrosine (3-NT) formation as an intermediate will predict the involvement of protein nitration/nitrosation and oxidative damage in the brain. Results: In this experiment, the levels of protein carbonyls, 4-hydroxynonenal, and 3-nitrotyrosine were significantly elevated in TBI injured, saline treated rats compared with those who sustained an injury and were treated with 150 mg/kg of the glutathione mimetic, GCEE. Conclusion and clinical relevance: Determining the existence of elevated 3-NT levels provides insight into the relationship between the protein nitration/nitrosation and the oxidative damage, which can determine the pathogenesis and progression of specific neurological diseases.	[Henderson, Moses; Rice, Brittany; Reed, Tanea T.] Eastern Kentucky Univ, Dept Chem, Richmond, KY 40475 USA; [Sebastian, Andrea; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brian Injury Res Ctr, Lexington, KY USA; [King, Christina; Robinson, Rena A. S.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA		Reed, TT (corresponding author), Eastern Kentucky Univ, Dept Chem, Richmond, KY 40475 USA.	tanea.reed@eku.edu		Reed, Tanea/0000-0003-2642-3100	National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS072870-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS072870] Funding Source: NIH RePORTER	This work was funded by the National Institute for Neurological Disorders and Stroke grant (1R15NS072870-01A1).	Bains M, 2013, J NEUROCHEM, V125, P125, DOI 10.1111/jnc.12118; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Boyd-Kimball D, 2005, J NEUROSCI RES, V79, P700, DOI 10.1002/jnr.20394; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Calabrese V, 2003, AMINO ACIDS, V25, P437, DOI 10.1007/s00726-003-0048-2; Cao M, 2014, J NEUROSCI, V34, P16544, DOI 10.1523/JNEUROSCI.1710-14.2014; Carr ME, 2009, MIL MED, V174, P622, DOI 10.7205/MILMED-D-02-4708; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; Drake J, 2002, J NEUROSCI RES, V68, P776, DOI 10.1002/jnr.10266; Durmaz R, 2003, J NEUROL SCI, V215, P87, DOI 10.1016/S0022-510X(03)00207-7; Fitzpatrick MO, 1998, BRIT J NEUROSURG, V12, P313; Frost B, 2016, CURR BIOL, V26, P129, DOI 10.1016/j.cub.2015.11.039; Giza CC, 2001, J ATHL TRAINING, V36, P228; HALL ED, 1993, RES P ARNMD, V71, P81; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Heng MY, 2013, J CLIN INVEST, V123, P2719, DOI 10.1172/JCI66737; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Jeter CB, 2012, J NEUROTRAUM, V29, P119, DOI 10.1089/neu.2011.2029; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; LASH LH, 1985, ARCH BIOCHEM BIOPHYS, V240, P583, DOI 10.1016/0003-9861(85)90065-7; Lee HM, 2009, TOXICOL APPL PHARM, V235, P208, DOI 10.1016/j.taap.2008.12.010; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI [10.1089/neu.2008.0828, 10.1089/neu.2008-0828]; Lin ST, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-4; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lok J, 2011, J NEUROCHEM, V118, P248, DOI 10.1111/j.1471-4159.2011.07294.x; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Ren Y, 2008, J BIOL CHEM, V283, P5685, DOI 10.1074/jbc.M707932200; Rezai AR, 2016, NEUROSURGERY, V79, P204, DOI 10.1227/NEU.0000000000001190; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1046/j.1523-1755.2002.00565.x; Zhang F, 2014, NEUROL SCI, V35, P583, DOI 10.1007/s10072-013-1566-7	48	10	10	0	6	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-8346	1862-8354		PROTEOM CLIN APPL	Proteom. Clin. Appl.	DEC	2016	10	12			SI		1218	1224		10.1002/prca.201600004			7	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED9VO	WOS:000389221400007	27739215	Green Accepted			2022-02-06	
J	Mcrae, P; Hallab, L; Simpson, G				McRae, Philippa; Hallab, Lisa; Simpson, Grahame			Navigating Employment Pathways and Supports Following Brain Injury in Australia: Client Perspectives	AUSTRALIAN JOURNAL OF REHABILITATION COUNSELLING			English	Article						traumatic brain injury; acquired brain injury; vocational rehabilitation; return to work; qualitative; Disability Employment Services; thematic analysis	NEW-SOUTH-WALES; PERSONAL EXPERIENCES; WORK; RETURN; PEOPLE; INDIVIDUALS; OUTCOMES; STROKE; URBAN; SELF	This study investigated the vocational rehabilitation experiences of 29 clients, up to 14 years post brain injury. Data obtained from participant interviews were thematically analysed by employment pathway ('return to pre-injury employment', 'job seeking' and 'not worked since injury'). A total of nine themes were identified. Across all pathways, participants identified the importance of working, impact of injury and their own determination. The content for the remaining themes (understanding, adjustment, access, support, disclosure of injury, intervention) varied by pathway, reflecting the differing perspectives arising from integrating back into a familiar workplace versus seeking new employment. In conclusion, programme approaches to vocational rehabilitation need to be tailored to the individual circumstances, opportunities and support needs of people with brain injury pursuing these different pathways.	[McRae, Philippa; Hallab, Lisa] NSW Hlth, Agcy Clin Innovat, Sydney, NSW, Australia; [McRae, Philippa; Hallab, Lisa; Simpson, Grahame] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, Merseyside, England; [Simpson, Grahame] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Liverpool, Merseyside, England; [Simpson, Grahame] Univ Sydney, Kolling Inst, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia		Mcrae, P (corresponding author), Ingham Inst Appl Med Res, Agcy Clin Innovat, Brain Injury Rehabil Directorate, Level 2,1 Campbell St, Liverpool, NSW 2170, Australia.	philippa.mcrae@health.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060	Lifetime Care and Support Authority of NSW	This project was funded by the Lifetime Care and Support Authority of NSW. The authors thank the project steering committee and the participating BIRP clinicians.	Access Economics , 2009, EC COST SPIN CORD IN; Agency for Clinical Innovation, 2013, INV VOC PROGR OUTC P; Agency for Clinical Innovation, 2014, BRAIN INJ REH DIR DI; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Department of Employment, 2015, DIS EMPL SERV DES MO; Ellingsen KL., 2009, INT J DISABIL MANAG, V4, P1, DOI DOI 10.1375/JDMR.4.1.1; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gilworth G, 2009, WORK, V34, P95, DOI 10.3233/WOR-2009-0906; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Macaden AS, 2010, DISABIL REHABIL, V32, P1140, DOI 10.3109/09638280903311594; Medin J, 2006, DISABIL REHABIL, V28, P1051, DOI 10.1080/09638280500494819; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Sabatello M, 2014, WORK, V48, P373, DOI 10.3233/WOR-131792; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Tate R. L., 2015, HDB VOCATIONAL REHAB, P263, DOI [10.1007/978-3-319-08825-9_12, DOI 10.1007/978-3-319-08825-9_12]; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821	29	10	10	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1323-8922	1838-6059		AUST J REHABIL COUNS	Aust. J. Rehabil. Couns.	DEC	2016	22	2					76	92		10.1017/jrc.2016.14			17	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EF8SY	WOS:000390601100002					2022-02-06	
J	Rosen, T; Clark, S; Bloemen, EM; Mulcare, MR; Stern, ME; Hall, JE; Flomenbaum, NE; Lachs, MS; Eachempati, SR				Rosen, Tony; Clark, Sunday; Bloemen, Elizabeth M.; Mulcare, Mary R.; Stern, Michael E.; Hall, Jeffrey E.; Flomenbaum, Neal E.; Lachs, Mark S.; Eachempati, Soumitra R.			Geriatric assault victims treated at US trauma centers: Five-year analysis of the national trauma data bank	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Violence; Assault; Elder abuse; Geriatric trauma	OLDER-ADULTS; BRAIN-INJURY; ELDER ABUSE; MAXILLOFACIAL INJURIES; DOMESTIC VIOLENCE; FACIAL FRACTURES; UNITED-STATES; LEVEL I; MORTALITY; HEAD	Introduction: While geriatric trauma patients have begun to receive increased attention, little research has investigated assault-related injuries among older adults. Our goal was to describe characteristics, treatment, and outcomes of geriatric assault victims and compare them both to geriatric victims of accidental injury and younger assault victims. Patients and methods: We conducted a retrospective analysis of the 2008-2012 National Trauma Data Bank. We identified cases of assault-related injury admitted to trauma centers in patients aged >= 60 using the variable "intent of injury." Results: 3564 victims of assault-related injury in patients aged >= 60 were identified and compared to 200,194 geriatric accident victims and 94,511 assault victims aged 18-59. Geriatric assault victims were more likely than geriatric accidental injury victims to be male (81% vs. 47%) and were younger than accidental injury victims (67 +/- 7 vs. 74 +/- 9 years). More geriatric assault victims tested positive for alcohol or drugs than geriatric accident victims (30% vs. 9%). Injuries for geriatric assault victims were more commonly on the face (30%) and head (27%) than for either comparison group. Traumatic brain injury (34%) and penetrating injury (32%) occurred commonly. The median injury severity score (ISS) for geriatric assault victims was 9, with 34% having severe trauma (ISS >= 16). Median length of stay was 3 days, 39% required ICU care, and in-hospital mortality was 8%. Injury severity was greater in geriatric than younger adult assault victims, and, even when controlling for injury severity, in-hospital mortality, length of hospitalization, and need for ICU-level care were significantly higher in older adults. Conclusions: Geriatric assault victims have characteristics and injury patterns that differ significantly from geriatric accidental injury victims. These victims also have more severe injuries, higher mortality, and poorer outcomes than younger victims. Additional research is necessary to improve identification of these victims and inform treatment strategies for this unique population. (C) 2016 Elsevier Ltd. All rights reserved.	[Rosen, Tony; Clark, Sunday; Mulcare, Mary R.; Stern, Michael E.; Flomenbaum, Neal E.] Weill Cornell Med Coll, Div Emergency Med, New York, NY USA; [Bloemen, Elizabeth M.] Univ Colorado, Sch Med, Aurora, CO USA; [Hall, Jeffrey E.] Weill Cornell Med Coll, Div Geriatr & Palliat Med, New York, NY USA; [Lachs, Mark S.] CDC, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Eachempati, Soumitra R.] Weill Cornell Med Coll, Dept Surg, New York, NY USA		Rosen, T (corresponding author), 525 East 68th St, New York, NY 10065 USA.	aer2006@med.cornell.edu	Clark, Sunday/AAA-5458-2021		John A. Hartford Foundation; American Geriatrics Society; Emergency Medicine Foundation; Society of Academic Emergency Medicine; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03 AG048109, K24 AG022399]; Jahnigen Career Development Award; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG048109, K24AG022399] Funding Source: NIH RePORTER	The authors have no conflicts of interest to report. Dr. Rosen's participation was supported by a GEMSSTAR (Grants for Early Medical and Surgical Subspecialists' Transition to Aging Research) grant from the National Institute on Aging (R03 AG048109). Dr. Rosen is also the recipient of a Jahnigen Career Development Award, supported by the John A. Hartford Foundation, the American Geriatrics Society, the Emergency Medicine Foundation, and the Society of Academic Emergency Medicine. Dr. Lachs is the recipient of a mentoring award in patient-oriented research from the National Institute on Aging (K24 AG022399).	Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Allen T, 2007, VIOLENCE AGAINST WOM, V13, P802, DOI 10.1177/1077801207302040; American College of Surgeons, 2016, NAT TRAUM DAT BANK; Atisha DM, 2016, PLAST RECONSTR SURG, V137, P587, DOI 10.1097/01.prs.0000475791.31361.9a; Berg BI, 2014, J CRANIO MAXILL SURG, V42, P870, DOI 10.1016/j.jcms.2013.12.007; Boffano P, 2015, OR SURG OR MED OR PA, V119, P385, DOI 10.1016/j.oooo.2014.12.004; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Brink O, 1998, INJURY, V29, P705, DOI 10.1016/S0020-1383(98)00176-4; Brink O, 2009, J TRAUMA, V67, P147, DOI 10.1097/TA.0b013e318182f77f; BUSS TF, 1995, J SUBST ABUSE TREAT, V12, P75, DOI 10.1016/0740-5472(94)00086-7; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Centers for Disease Control and Prevention, 1997, MMWR RECOMM REP, V14, P1; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P812; Collins KA, 2007, AM J FOREN MED PATH, V28, P157, DOI 10.1097/PAF.0b013e31805c93eb; Collins KA, 2006, ARCH PATHOL LAB MED, V130, P1290; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Ferreira MC, 2014, DENT TRAUMATOL, V30, P15, DOI 10.1111/edt.12047; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Friedman LS, 2014, J ELDER ABUSE NEGL, V26, P1, DOI 10.1080/08946566.2013.780944; Friedman LS, 2011, J AM GERIATR SOC, V59, P417, DOI 10.1111/j.1532-5415.2010.03313.x; Hadjizacharia P, 2009, J TRAUMA, V66, P1202, DOI 10.1097/TA.0b013e318180f5a0; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Hildebrand F, 2016, EUR J TRAUMA EMERG S, V42, P317, DOI 10.1007/s00068-015-0557-1; Ichwan B, 2015, ANN EMERG MED, V65, P92, DOI 10.1016/j.annemergmed.2014.04.019; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; Kilpatrick DG, 2003, J TRAUMA STRESS, V16, P119, DOI 10.1023/A:1022891005388; Lachs MS, 2015, NEW ENGL J MED, V373, P1947, DOI 10.1056/NEJMra1404688; Le BT, 2001, J ORAL MAXIL SURG, V59, P1277, DOI 10.1053/joms.2001.27490; Lo S, 2005, INT J CLIN PRACT, V59, P333, DOI 10.1111/j.1368-5031.2005.00308.x; Lustenberger T, 2011, WORLD J SURG, V35, P528, DOI 10.1007/s00268-010-0920-7; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Muelleman RL, 1996, ANN EMERG MED, V28, P486, DOI 10.1016/S0196-0644(96)70110-5; Murphy K, 2013, CAN ASSOC RADIOL J, V64, P10, DOI 10.1016/j.carj.2012.12.001; National Trauma Data Bank American College of Surgeons, NAT TRAUM DAT STAND; Niemcryk SJ, 1998, AM J PREV MED, V14, P43, DOI 10.1016/S0749-3797(97)00013-5; Ochs HA, 1996, J AM DENT ASSOC, V127, P757, DOI 10.14219/jada.archive.1996.0311; Ottochian M, 2009, INJURY, V40, P354, DOI 10.1016/j.injury.2008.10.015; PELLICANE JV, 1992, J TRAUMA, V33, P440, DOI 10.1097/00005373-199209000-00018; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; PILLEMER K, 1988, GERONTOLOGIST, V28, P51, DOI 10.1093/geront/28.1.51; Plurad DS, 2011, J OCCUP ENVIRON MED, V53, P879, DOI 10.1097/JOM.0b013e3182255d14; Rosenblatt DE, 1996, J AM GERIATR SOC, V44, P65, DOI 10.1111/j.1532-5415.1996.tb05640.x; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; SHEPHERD JP, 1987, BRIT J PLAST SURG, V40, P614, DOI 10.1016/0007-1226(87)90157-3; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Toivari M, 2014, OR SURG OR MED OR PA, V118, P539, DOI 10.1016/j.oooo.2014.06.016; Vaughn MG, 2010, ANN EPIDEMIOL, V20, P281, DOI 10.1016/j.annepidem.2009.11.011; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Yamamoto K, 2011, J ORAL MAXIL SURG, V69, P2204, DOI 10.1016/j.joms.2011.02.115; Zelken JA, 2014, J ORAL MAXIL SURG, V72, P352, DOI 10.1016/j.joms.2013.08.015	55	10	10	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2016	47	12					2671	2678		10.1016/j.injury.2016.09.001			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EF7XX	WOS:000390543800010	27720184	Green Accepted			2022-02-06	
J	Singh, K; Trivedi, R; Haridas, S; Manda, K; Khushu, S				Singh, Kavita; Trivedi, Richa; Haridas, Seenu; Manda, Kailash; Khushu, Subash			Study of neurometabolic and behavioral alterations in rodent model of mild traumatic brain injury: a pilot study	NMR IN BIOMEDICINE			English	Article						anxiety; behavioral study; cortex; hippocampus; mild traumatic brain injury; neurometabolic; spectroscopy	MAGNETIC-RESONANCE SPECTROSCOPY; FOCAL CEREBRAL-ISCHEMIA; N-ACETYL-ASPARTATE; IN-VIVO; HEAD-INJURY; ANTERIOR CINGULATE; PREFRONTAL CORTEX; GLYCINE RECEPTORS; METABOLIC-CHANGES; CULTURED NEURONS	Mild traumatic brain injury (mTBI) is the most common form of TBI (70-90%) with consequences of anxiety-like behavioral alterations in approximately 23% of mTBI cases. This study aimed to assess whether mTBI-induced anxiety-like behavior is a consequence of neurometabolic alterations. mTBI was induced using a weight drop model to simulate mild human brain injury in rodents. Based on injury induction and dosage of anesthesia, four animal groups were included in this study: (i) injury with anesthesia (IA); (ii) sham1 (injury only, IO); (iii) sham2 (only anesthesia, OA); and (iv) control rats. After mTBI, proton magnetic resonance spectroscopy (H-1-MRS) and neurobehavioral analysis were performed in these groups. At day 5, reduced taurine (Tau)/total creatine (tCr, creatine and phosphocreatine) levels in cortex were observed in the IA and IO groups relative to the control. These groups showed mTBI-induced anxiety-like behavior with normal cognition at day 5 post-injury. An anxiogenic effect of repeated dosage of anesthesia in OA rats was observed with normal Tau/tCr levels in rat cortex, which requires further examination. In conclusion, this mTBI model closely mimics human concussion injury with anxiety-like behavior and normal cognition. Reduced cortical Tau levels may provide a putative neurometabolic basis of anxiety-like behavior following mTBI.	[Singh, Kavita; Trivedi, Richa; Khushu, Subash] Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India; [Haridas, Seenu; Manda, Kailash] Inst Nucl Med & Allied Sci, Neurobehav Lab, Delhi, India		Trivedi, R (corresponding author), Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India.	triricha@gmail.com	Manda, Kailash/AAY-1523-2021; Manda, Kailash/K-4119-2014; SINGH, KAVITA/AAW-9612-2021	Manda, Kailash/0000-0002-0188-6697; Manda, Kailash/0000-0002-0188-6697; SINGH, KAVITA/0000-0002-4772-372X	Defence Research & Development Organization (DRDO), IndiaDefence Research & Development Organisation (DRDO) [INM-311]; Department of Science and Technology, IndiaDepartment of Science & Technology (India)	This work was performed as part of the R&D project INM-311, sponsored by the Defence Research & Development Organization (DRDO), India. KS would like to thank Department of Science and Technology, India for an INSPIRE fellowship grant.	Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Babar E, 2001, EUR J PHARMACOL, V431, P315, DOI 10.1016/S0014-2999(01)01340-1; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Becker A, 2003, PROG NEURO-PSYCHOPH, V27, P687, DOI 10.1016/S0278-5846(03)00080-0; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Bothwell JH, 2001, J NEUROCHEM, V77, P1632, DOI 10.1046/j.1471-4159.2001.00403.x; da Silva FCC, 2010, BRAIN RES BULL, V83, P9, DOI 10.1016/j.brainresbull.2010.05.011; CASSIDY M, 1993, J NEUROCHEM, V60, P1631, DOI 10.1111/j.1471-4159.1993.tb13385.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chatterjee M, 2011, BEHAV BRAIN RES, V216, P247, DOI 10.1016/j.bbr.2010.08.001; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Connor TJ, 1998, NEUROSCIENCE, V84, P923, DOI 10.1016/S0306-4522(97)00533-2; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DAVIDSON JRT, 1993, J CLIN PSYCHIAT, V54, P19; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Demougeot C, 2003, J CEREBR BLOOD F MET, V23, P482, DOI 10.1097/01.WCB.0000050066.57184.60; El Idrissi A, 1999, J NEUROSCI, V19, P9459; El Idrissi A, 2004, NEUROCHEM RES, V29, P189, DOI 10.1023/B:NERE.0000010448.17740.6e; Estevez AY, 1999, NEUROCHEM RES, V24, P447, DOI 10.1023/A:1020902104056; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Ghasemi M, 2014, PSYCHIAT RES, V215, P355, DOI 10.1016/j.psychres.2013.12.008; Gonul AS, 2006, PROG NEURO-PSYCHOPH, V30, P120, DOI 10.1016/j.pnpbp.2005.08.017; Graaf R. A. d., 2007, IN VIVO NMR SPECTROS; Ham BJ, 2007, PROG NEURO-PSYCHOPH, V31, P403, DOI 10.1016/j.pnpbp.2006.10.011; Hamner Mark B, 2005, Expert Rev Neurother, V5, P267, DOI 10.1586/14737175.5.2.267; HAYES KC, 1981, ANNU REV NUTR, V1, P401, DOI 10.1146/annurev.nu.01.070181.002153; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; JACKSON PS, 1994, AM J PHYSIOL-CELL PH, V267, pC1203, DOI 10.1152/ajpcell.1994.267.5.C1203; Kalisch R, 2006, NEUROPSYCHOPHARMACOL, V31, P925, DOI 10.1038/sj.npp.1300910; Kaminaga T, 2005, J COMPUT ASSIST TOMO, V29, P293, DOI 10.1097/01.rct.0000161422.95625.8a; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; MACDONALD JF, 1987, J NEUROPHYSIOL, V58, P251, DOI 10.1152/jn.1987.58.2.251; Machado-de-Sousa JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088523; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew SJ, 2004, AM J PSYCHIAT, V161, P1119, DOI 10.1176/appi.ajp.161.6.1119; MENENDEZ N, 1989, NEUROSCI LETT, V102, P64, DOI 10.1016/0304-3940(89)90308-X; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Napolitano A, 2014, SCHIZOPHRENIA BULL, V40, P566, DOI 10.1093/schbul/sbt067; PASANTESMORALES H, 1989, GLIA, V2, P45, DOI 10.1002/glia.440020105; Passani L, 1998, BRAIN RES, V794, P143, DOI 10.1016/S0006-8993(98)00308-4; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Perrine SA, 2014, PROG NEURO-PSYCHOPH, V51, P9, DOI 10.1016/j.pnpbp.2013.11.003; Popik P, 2008, PSYCHOPHARMACOLOGY, V198, P421, DOI 10.1007/s00213-008-1158-z; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Pryzbylkowski PG, 2011, ANESTH ANALG, V113, P1188, DOI 10.1213/ANE.0b013e31822b8a7d; Ritz MF, 2006, INT J NEUROSCI, V116, P191, DOI 10.1080/00207450500341555; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHOUSBOE A, 1992, CAN J PHYSIOL PHARM, V70, pS356, DOI 10.1139/y92-283; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Silvestre JS, 2002, J PSYCHOPHARMACOL, V16, P305, DOI 10.1177/026988110201600404; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; SOLIS JM, 1988, NEUROSCI LETT, V91, P53, DOI 10.1016/0304-3940(88)90248-0; SPAETH DG, 1974, P SOC EXP BIOL MED, V147, P855; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Sturman JA, 1978, TAURINE NEUROLOGICAL, P47; Tang ZQ, 2008, NEUROSCI LETT, V430, P54, DOI 10.1016/j.neulet.2007.10.009; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; van der Hart MGC, 2002, MOL PSYCHIATR, V7, P933, DOI 10.1038/sj.mp.4001130; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wang GH, 2007, NEUROPHARMACOLOGY, V52, P1199, DOI 10.1016/j.neuropharm.2006.10.022; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zubareva O E, 2009, Neurosci Behav Physiol, V39, P21, DOI 10.1007/s11055-008-9090-6	76	10	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	DEC	2016	29	12					1748	1758		10.1002/nbm.3627			11	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	ED8SK	WOS:000389141000009	27779341				2022-02-06	
J	Smith, M; Piehler, T; Benjamin, R; Farizatto, KL; Pait, MC; Almeida, MF; Ghukasyan, VV; Bahr, BA				Smith, Marquitta; Piehler, Thuvan; Benjamin, Richard; Farizatto, Karen L.; Pait, Morgan C.; Almeida, Michael F.; Ghukasyan, Vladimir V.; Bahr, Ben A.			Blast waves from detonated military explosive reduce GluR1 and synaptophysin levels in hippocampal slice cultures	EXPERIMENTAL NEUROLOGY			English	Article						Blast-induced injury; Military explosive; GluR1; RDX; Shockwave; Synaptic decline; Synaptophysin; TBI; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; ACID AMIDE HYDROLASE; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; IN-VITRO; COGNITIVE IMPAIRMENT; PROTEIN ACCUMULATION; IMPROVES MEMORY; RAT HIPPOCAMPUS; AMPA RECEPTORS	Explosives create shockwaves that cause blast-induced neurotrauma, one of the most common types of traumatic brain injury (TBI) linked to military service. Blast-induced TBIs are often associated with reduced cognitive and behavioral functions due to a variety of factors. To study the direct effects of military explosive blasts on brain tissue, we removed systemic factors by utilizing rat hippocampal slice cultures. The long-term slice cultures were briefly sealed air-tight in serum-free medium, lowered into a 37 degrees C water-filled tank, and small 1.7-gram assemblies of cyclotrimethylene trinitramine (RDX) were detonated 15 cm outside the tank, creating a distinct shock wave recorded at the culture plate position. Compared to control mock-treated groups of slices that received equal submerge time, 1-3 blast impacts caused a dose-dependent reduction in the AMPA receptor subunit GluR1. While only a small reduction was found in hippocampal slices exposed to a single RDX blast and harvested 1-2 days later, slices that received two consecutive RDX blasts 4 min apart exhibited a 26-40% reduction in GluR1, and the receptor subunit was further reduced by 64-72% after three consecutive blasts. Such loss correlated with increased levels of HDAC2, a histone deacetylase implicated in stress-induced reduction of glutamatergic transmission. No evidence of synaptic marker recovery was found at 72 h post-blast. The presynaptic marker synaptophysin was found to have similar susceptibility as GluR1 to the multiple explosive detonations. In contrast to the synaptic protein reductions, actin levels were unchanged, spectrin breakdown was not detected, and Fluoro-Jade B staining found no indication of degenerating neurons in slices exposed to three RDX blasts, suggesting that small, sub-lethal explosives are capable of producing selective alterations to synaptic integrity. Together, these results indicate that blast waves from military explosive cause signs of synaptic compromise without producing severe neurodegeneration, perhaps explaining the cognitive and behavioral changes in those blast-induced TBI sufferers that have no detectable neuropathology. (C) 2016 Elsevier Inc. All rights reserved.	[Smith, Marquitta; Farizatto, Karen L.; Pait, Morgan C.; Almeida, Michael F.; Bahr, Ben A.] Univ North Carolina Pembroke, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA; [Piehler, Thuvan; Benjamin, Richard] US Army Res Lab, Aberdeen Proving Ground, MD 21005 USA; [Ghukasyan, Vladimir V.] Univ North Carolina Chapel Hill, Neurosci Ctr, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA		Bahr, BA (corresponding author), Univ North Carolina Pembroke, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA.	Bahr@uncp.edu	Farizatto, Karen/ABG-8051-2020	Almeida, Michael F/0000-0002-0188-2717	U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL); U.S. Army Research Office [W911NF-14-2-0087]; Department of Defense Research and Education Program [W911NF-15-1-0432]; NIH RISE grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R25GM077634-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM077634] Funding Source: NIH RePORTER	This material is based upon work supported primarily by the U.S. Army Research Laboratory and the U.S. Army Research Office under grant number W911NF-14-2-0087 (BAB). University of North Carolina-Pembroke researchers were also supported in part by grant W911NF-15-1-0432 from the Department of Defense Research and Education Program (BAB) and NIH RISE grant 5R25GM077634-04 to University of North Carolina-Pembroke. The funding agencies had no role in study design, data collection and analysis, or decision to publish. We thank Heather Romine, Manager of the William C. Friday Laboratory, for excellent technical assistance, and Greg Georgevitch (retired U.S. Army career NCO) and Nicole Zander and Rohan Banton (U.S. Army Research Laboratory, Aberdeen Proving Ground, Maryland) for helpful discussions.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902; Bahr BA, 2002, EXP NEUROL, V174, P37, DOI 10.1006/exnr.2001.7852; Bahr BA, 1998, J COMP NEUROL, V397, P139; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Bonde C, 2005, NEUROSCIENCE, V136, P779, DOI 10.1016/j.neuroscience.2005.07.020; Butler D, 2007, EUR J PHARMACOL, V562, P20, DOI 10.1016/j.ejphar.2007.01.053; Caba E, 2004, ACTA NEUROPATHOL, V108, P173, DOI 10.1007/s00401-004-0876-5; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Centers for Disease Control and Prevention, 1990, TRAUM BRAIN INJ US R; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Ciocchi S, 2015, SCIENCE, V348, P560, DOI 10.1126/science.aaa3245; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Effgen GB., 2016, J NEUROTRAU IN PRESS; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hoffman KB, 2001, NEUROSCI RES, V39, P167, DOI 10.1016/S0168-0102(00)00214-5; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Karanian DA, 2005, J NEUROSCI, V25, P7813, DOI 10.1523/JNEUROSCI.2347-05.2005; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Miller G, 2011, SCIENCE, V333, P514, DOI 10.1126/science.333.6042.514; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; Naidoo V, 2012, NEUROTHERAPEUTICS, V9, P801, DOI 10.1007/s13311-011-0100-y; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Pelletier JG, 2008, PROG BRAIN RES, V169, P241, DOI 10.1016/S0079-6123(07)00014-3; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Piehler T., 2016, BIOPROTOCOL, V6, pe1907; Rao MV, 2014, J NEUROSCI, V34, P9222, DOI 10.1523/JNEUROSCI.1132-14.2014; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Schmitt WB, 2004, J NEUROSCI, V24, P7277, DOI 10.1523/JNEUROSCI.1093-04.2004; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Szinyei C, 1999, J PHYSIOL-LONDON, V516, P855, DOI 10.1111/j.1469-7793.1999.0855u.x; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; VANDERKLISH P, 1992, SYNAPSE, V12, P333, DOI 10.1002/syn.890120410; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1111/j.1365-2613.2000.00169.x; VORNOV JJ, 1994, STROKE, V25, P457, DOI 10.1161/01.STR.25.2.457; Wei J, 2016, J NEUROSCI, V36, P2119, DOI 10.1523/JNEUROSCI.3056-15.2016; Williamson V., 2009, INVISIBLE WOUNDS PSY, P1; Wisniewski ML, 2011, BBA-MOL BASIS DIS, V1812, P1664, DOI 10.1016/j.bbadis.2011.09.011; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Zander NE, 2016, ANAL BIOCHEM, V504, P4, DOI 10.1016/j.ab.2016.03.009; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	64	10	10	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2016	286						107	115		10.1016/j.expneurol.2016.10.002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC3ZB	WOS:000388064500011	27720798	Green Accepted, Bronze			2022-02-06	
J	Stevens, A; Bahlo, S; Licha, C; Liske, B; Vossler-Thies, E				Stevens, Andreas; Bahlo, Simone; Licha, Christina; Liske, Benjamin; Vossler-Thies, Elisabeth			Reaction time as an indicator of insufficient effort: Development and validation of an embedded performance validity parameter	PSYCHIATRY RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; INFORMATION-PROCESSING CTIP; VISUAL REACTION-TIME; CLOSED HEAD-INJURY; WORD MEMORY TEST; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL ASSESSMENT; ATTENTIONAL NETWORKS; SYMPTOM VALIDITY; NORMATIVE DATA	Subnormal performance in attention tasks may result from various sources including lack of effort. In this report, the derivation and validation of a performance validity parameter for reaction time is described, using a set of malingering-indices ("Slick-criteria"), and 3 independent samples of participants (total n =893). The Slick-criteria yield an estimate of the probability of malingering based on the presence of an external incentive, evidence from neuropsychological testing, from self-report and clinical data. In study (1) a validity parameter is derived using reaction time data of a sample, composed of inpatients with recent severe brain lesions not involved in litigation and of litigants with and without brain lesion. In study (2) the validity parameter is tested in an independent sample of litigants. In study (3) the parameter is applied to an independent sample comprising cooperative and non-cooperative testees. Logistic regression analysis led to a derived validity parameter based on median reaction time and standard deviation. It performed satisfactorily in studies (2) and (3) (study 2 sensitivity=0.94, specificity=1.00; study 3 sensitivity=0.79, specificity=0.87). The findings suggest that median reaction time and standard deviation may be used as indicators of negative response bias. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Stevens, Andreas; Bahlo, Simone; Licha, Christina; Liske, Benjamin; Vossler-Thies, Elisabeth] Med Begutachtungsinst Tubingen, Doblerstr 17, D-72074 Tubingen, Germany; [Stevens, Andreas; Liske, Benjamin] Univ Tubingen, Dept Psychiat, Calwerstr 14, D-72076 Tubingen, Germany		Stevens, A (corresponding author), Med Begutachtungsinst Tubingen, Doblerstr 17, D-72074 Tubingen, Germany.	stevens@med-begutachtung.de					Alexander MP, 2005, NEUROLOGY, V65, P572, DOI 10.1212/01.wnl.0000172912.07640.92; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Conners, 2004, CONNERS CONTINUOUS P; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; GREEN P, 2006, INT J FORENSIC PSYCH, V1, P1; Green P., 2003, USERS MANUAL; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Hausler J., 2007, PSYCHOL SCI, V49, P116; Kahneman D., 1973, ATTENTION EFFORT; Keller I., 1995, NEUROPSYCHOLOGISCHE; Kertzman S, 2006, ISRAEL J PSYCHIAT, V43, P112; Kottler T., 2010, FENS ABSTR, V5; KUJALA P, 1994, BRAIN, V117, P1115, DOI 10.1093/brain/117.5.1115; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Plant RR, 2013, COGN AFFECT BEHAV NE, V13, P598, DOI 10.3758/s13415-013-0166-6; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; Resnick P.J., 1988, CLIN ASSESSMENT MALI; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Steck P., 2000, Z NEUROPSYCHOLOGIE, V11, P128, DOI [10.1024//1016-264X.11.3.128, DOI 10.1024//1016-264X.11.3.128]; Stevens A., 2010, GERMAN J PSYCHIAT, V13, P1; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Tombaugh TN, 2010, COGN BEHAV NEUROL, V23, P192, DOI 10.1097/WNN.0b013e3181cc8bd4; UNESCO, 2012, INT STAND CLASS ED I; Vagnini V.L., 2007, THESIS; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Zimmermann P., 2007, TAP TESTBATTERIE AUF; [No title captured]	50	10	10	3	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	NOV 30	2016	245						74	82		10.1016/j.psychres.2016.08.022			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EA6LV	WOS:000386741600011	27529665				2022-02-06	
J	Buunk, AM; Groen, RJM; Veenstra, WS; Metzemaekers, JDM; van der Hoeven, JH; van Dijk, JMC; Spikman, JM				Buunk, Anne M.; Groen, Rob J. M.; Veenstra, Wencke S.; Metzemaekers, Jan D. M.; van der Hoeven, Johannes H.; van Dijk, J. Marc C.; Spikman, Jacoba M.			Cognitive Deficits After Aneurysmal and Angiographically Negative Subarachnoid Hemorrhage: Memory, Attention, Executive Functioning, and Emotion Recognition	NEUROPSYCHOLOGY			English	Article						subarachnoid hemorrhage; cognition; emotion recognition	TRAUMATIC BRAIN-INJURY; FACIAL AFFECT RECOGNITION; QUALITY-OF-LIFE; TERM-FOLLOW-UP; LONG-TERM; NEUROPSYCHOLOGICAL ASSESSMENT; SOCIAL COGNITION; UNKNOWN ORIGIN; PERFORMANCE; OUTCOMES	Objective: The authors' aim was to investigate cognitive outcome in patients with aneurysmal and angiographically negative subarachnoid hemorrhage (aSAH and anSAH), by comparing them to healthy controls and to each other. Besides investigating cognitive functions as memory and attention, they focused on higher-order prefrontal functions, namely executive functioning (EF) and emotion recognition. Method: Patients and healthy controls were assessed with tests measuring memory (15 Words Test, Digit Span), attention and processing speed (Trail Making Test A and B), EF (Zoo Map, Letter Fluency, Dysexecutive Questionnaire), and emotion recognition (Facial Expressions of Emotion Stimuli and Tests). Between-groups comparisons of test performances were made. Results: Patients with aSAH scored significantly lower than healthy controls on measures of memory, processing speed, and attention, but anSAH patients did not. In the higher-order prefrontal functions (EF and emotion recognition), aSAH patients were clearly impaired when compared to healthy controls. However, anSAH patients did not perform significantly better than aSAH patients on the majority of the tests. Conclusions: In the subacute phase after SAH, cognitive functions, including the higher-order prefrontal functions EF and emotion recognition, were clearly impaired in aSAH patients. Patients with anSAH did not perform better than aSAH patients, which indicates that these functions may also be affected to some extent in anSAH patients. Considering the importance of these higher-order prefrontal functions for daily life functioning, and following the results of the present study, tests that measure emotion recognition and EF should be part of the standard neuropsychological assessment after SAH.	[Buunk, Anne M.; Veenstra, Wencke S.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1,Poortweg 4,2nd Floor,Room V2-214, NL-9700 AB Groningen, Netherlands; [Groen, Rob J. M.; Veenstra, Wencke S.; Metzemaekers, Jan D. M.; van Dijk, J. Marc C.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, NL-9700 AB Groningen, Netherlands; [van der Hoeven, Johannes H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands		Buunk, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1,Poortweg 4,2nd Floor,Room V2-214, NL-9700 AB Groningen, Netherlands.	a.m.buunk@rug.nl	van Dijk, J. Marc C./C-1078-2013	van Dijk, J. Marc C./0000-0002-0814-5680; Spikman, Jacoba/0000-0002-6477-0763			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Alfieri A, 2011, J CLIN NEUROSCI, V18, P1478, DOI 10.1016/j.jocn.2011.02.036; Alfieri A, 2008, J NEUROSURG, V109, P1019, DOI 10.3171/JNS.2008.109.12.1019; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Benton A., 1976, MULTILINGUAL APHASIA; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Boerboom W, 2014, J REHABIL MED, V46, P28, DOI 10.2340/16501977-1236; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Boswell S, 2013, J STROKE CEREBROVASC, V22, P750, DOI 10.1016/j.jstrokecerebrovasdis.2012.02.001; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Burgess P, 1996, BEHAV ASSESSMENT DYS; CANHAO P, 1995, ACTA NEUROCHIR, V132, P14, DOI 10.1007/BF01404842; Canovas D, 2012, EUR J NEUROL, V19, P457, DOI 10.1111/j.1468-1331.2011.03542.x; Deelman B. G., 1980, NEUROPSYCHOLOGIE NED, P253; Dombovy ML, 1998, BRAIN INJURY, V12, P887; Egge A, 2005, ACTA NEUROL SCAND, V112, P76, DOI 10.1111/j.1600-0404.2005.00449.x; Fraser JF, 2011, WORLD NEUROSURG, V75, P462, DOI 10.1016/j.wneu.2010.10.014; Germano A, 1998, ACTA NEUROCHIR, V140, P805, DOI 10.1007/s007010050182; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HOLM S, 1979, SCAND J STAT, V6, P65; Hutter BO, 2001, J NEUROSURG, V94, P241, DOI 10.3171/jns.2001.94.2.0241; HUTTER BO, 1994, ACTA NEUROCHIR, V127, P129, DOI 10.1007/BF01808755; Jaja B. N., 2015, J NEUROSURGERY; Josman N, 2014, J STROKE CEREBROVASC, V23, P879, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.013; Krajewski K, 2014, NEUROSURG REV, V37, P55, DOI 10.1007/s10143-013-0489-3; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Kutlubaev MA, 2012, J PSYCHOSOM RES, V72, P305, DOI 10.1016/j.jpsychores.2011.12.008; Langer KG, 2008, COGN BEHAV NEUROL, V21, P206, DOI 10.1097/WNN.0b013e3181864a4b; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Manning L, 2005, EUR J NEUROL, V12, P466, DOI 10.1111/j.1468-1331.2005.01012.x; Marquardt G, 2000, J NEUROL NEUROSUR PS, V69, P127, DOI 10.1136/jnnp.69.1.127; Martinaud O, 2009, EUR J NEUROL, V16, P595, DOI 10.1111/j.1468-1331.2009.02546.x; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mukerji N, 2010, WORLD NEUROSURG, V74, P129, DOI 10.1016/j.wneu.2010.05.009; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Nurmi Laihosalo M. E., 2014, CORTEX, V61, P43; Passier PECA, 2011, J NEUROL, V258, P1091, DOI 10.1007/s00415-010-5891-y; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Quinn AC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003932; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Reitan R, 1985, HALSTEAD REITAN NEUR; RICHARDSON JTE, 1991, ACTA NEUROL SCAND, V83, P110, DOI 10.1111/j.1600-0404.1991.tb04659.x; RINGELSTEIN EB, 1990, ULTRASOUND MED BIOL, V16, P745, DOI 10.1016/0301-5629(90)90039-F; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; RINKEL GJE, 1991, ANN NEUROL, V29, P463, DOI 10.1002/ana.410290503; RUELLE A, 1985, J NEUROL, V232, P277, DOI 10.1007/BF00313865; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; SONESSON B, 1989, ACTA NEUROL SCAND, V80, P400, DOI 10.1111/j.1600-0404.1989.tb03901.x; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stienen MN, 2014, WORLD NEUROSURG, V82, pE599, DOI 10.1016/j.wneu.2014.05.011; Stienen Martin N, 2015, Acta Neurochir Suppl, V120, P125, DOI 10.1007/978-3-319-04981-6_21; Stinissen J, 1970, HANDLEIDING BIJ NEDE; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Uchikawa K, 2014, BRAIN INJURY, V28, P15, DOI 10.3109/02699052.2013.847209; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Verhage F, 1964, INTELLIGENTIE LEEFTI; Vilkki J, 2012, ACTA NEUROCHIR, V154, P1437, DOI 10.1007/s00701-012-1417-y; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Young A., 2002, FACIAL EXPRESSIONS E; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012; Zweifel-Zehnder AE, 2015, ACTA NEUROCHIR, V157, P1449, DOI 10.1007/s00701-015-2480-y	70	10	10	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2016	30	8					961	969		10.1037/neu0000296			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EB3DI	WOS:000387242200007	27195987				2022-02-06	
J	Jones, A				Jones, Alvin			Cutoff Scores for MMPI-2 and MMPI-2-RF Cognitive-Somatic Validity Scales for Psychometrically Defined Malingering Groups in a Military Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						MMPI-2; MMPI-2-R; Malingering; Military; Symptom validity	RESPONSE BIAS SCALE; TRAUMATIC BRAIN-INJURY; HENRY-HEILBRONNER INDEX; FAKE BAD SCALE; SYMPTOM VALIDITY; NEUROCOGNITIVE DYSFUNCTION; CLASSIFICATION ACCURACY; PERFORMANCE VALIDITY; TEST FAILURE; HEAD-INJURY	Objective: This research examined cutoff scores for MMPI-2 and MMPI-2-RF validity scales specifically developed to assess non-credible reporting of cognitive and/or somatic symptoms. The validity scales examined included the Response Bias Scale (RBS), the Symptom Validity Scales (FBS, FBS-r), Infrequent Somatic Responses scale (Fs), and the Henry-Heilbronner Indexes (HHI, HHI-r). Method: Cutoffs were developed by comparing a psychometrically defined non-malingering group with three psychometrically defined malingering groups (probable, probable to definite, and definite malingering) and a group that combined all malingering groups. The participants in this research were drawn from a military sample consisting largely of patients with traumatic brain injury (mostly mild traumatic brain injury). Results: Specificities for cutoffs of at least 0.90 are provided. Sensitivities, predictive values, and likelihood ratios are also provided. Conclusions: RBS had the largest mean effect size (d) when the malingering groups were compared to the non-malingering group (d range = 1.23-1.58).	[Jones, Alvin] Womack Army Med Ctr, 2817 Riley Rd,Bldg 4-2817, Ft Bragg, NC 29310 USA		Jones, A (corresponding author), Womack Army Med Ctr, Dept Behav Hlth, 2817 Riley Rd,Bldg 4-2817, Ft Bragg, NC 29310 USA.	alrobj@googlemail.com					Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Ben-Porath, 2008, MINNESOTA MULTIPHASI; Ben-Porath YS., 2009, MMPI 2 SYMPTOM VALID; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bowden SC, 2009, J INT NEUROPSYCH SOC, V15, P769, DOI 10.1017/S1355617709990373; Cohen J., 2013, STAT POWER ANAL BEHA; Crawford JR, 2009, CLIN NEUROPSYCHOL, V23, P624, DOI 10.1080/13854040802524229; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; GERVAIS R, 2005, ANN MMPI 2 S WORKSH; Gervais R. O., 2008, CLIN NEUROPSYCHOL, V3, P1; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MEDICAL SYMPT; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Heilbronner R. L., 2013, MILD TRAUMATIC BRAIN, P183; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P509, DOI 10.1080/13854046.2012.739644; Hinkle DE., 2003, APPL STAT BEHAV SCI, V5th; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kaemmer, 1989, MINNESOTA MULTIPHASI; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P746, DOI 10.1080/13854040802696829; Lee TTC, 2012, PSYCHOL ASSESSMENT, V24, P618, DOI 10.1037/a0026458; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Peck CP, 2013, CLIN NEUROPSYCHOL, V27, P693, DOI 10.1080/13854046.2013.779032; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Randolph C., 1998, REPEATABLE BATTERY A; Sackett DL., 1991, CLIN EPIDEMIOLOGY BA, V2; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; SHAW DJ, 1965, J CLIN PSYCHOL, V21, P405, DOI 10.1002/1097-4679(196510)21:4<405::AID-JCLP2270210416>3.0.CO;2-I; Silk-Eglit GM, 2016, ARCH CLIN NEUROPSYCH, V31, P231, DOI 10.1093/arclin/acv108; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Stenclik JH, 2013, APPL NEUROPSYCH-ADUL, V20, P243, DOI 10.1080/09084282.2012.704603; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tellegen, 2008, MINNESOTA MULTIPHASI; Tellegen A., 2011, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsushima WT, 2011, CLIN NEUROPSYCHOL, V25, P1403, DOI 10.1080/13854046.2011.613854; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Whitney K. A., 2008, ARCH CLIN NEUROPSYCH, V2, P8; Whitney KA, 2013, ARCH CLIN NEUROPSYCH, V28, P222, DOI 10.1093/arclin/act012; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	81	10	10	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2016	31	7					786	801		10.1093/arclin/acw035			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EC2PH	WOS:000387965300010	27405640				2022-02-06	
J	[Anonymous]				[Anonymous]			SQUIDs in biomagnetism: a roadmap towards improved healthcare	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						biomagnetism; SQUID; MRI; ULF MRI; MEG; MEG-MRI; magnetic nanoparticles	LOW-FIELD MRI; MICROTESLA MRI; HUMAN BRAIN; MAGNETOENCEPHALOGRAPHY; INTERFERENCE; SIGNAL; NOISE; MEG; RECORDINGS; FLUX	Globally, the demand for improved health care delivery while managing escalating costs is a major challenge. Measuring the biomagnetic fields that emanate from the human brain already impacts the treatment of epilepsy, brain tumours and other brain disorders. This roadmap explores how superconducting technologies are poised to impact health care. Biomagnetism is the study of magnetic fields of biological origin. Biomagnetic fields are typically very weak, often in the femtotesla range, making their measurement challenging. The earliest in vivo human measurements were made with room-temperature coils. In 1963, Baule and McFee (1963 Am. Heart J. 55 95-6) reported the magnetic field produced by electric currents in the heart ('magnetocardiography'), and in 1968, Cohen (1968 Science 161 784-6) described the magnetic field generated by alpha-rhythm currents in the brain ('magnetoencephalography'). Subsequently, in 1970, Cohen et al (1970 Appl. Phys. Lett. 16 278-80) reported the recording of a magnetocardiogram using a Superconducting QUantum Interference Device (SQUID). Just two years later, in 1972, Cohen (1972 Science 175 664-6) described the use of a SQUID in magnetoencephalography. These last two papers set the scene for applications of SQUIDs in biomagnetism, the subject of this roadmap. The SQUID is a combination of two fundamental properties of superconductors. The first is flux quantization-the fact that the magnetic flux Phi in a closed superconducting loop is quantized in units of the magnetic flux quantum, Phi(0) equivalent to h/2e, approximate to 2.07 x 10(-15) Tm-2 (Deaver and Fairbank 1961 Phys. Rev. Lett. 7 43-6, Doll R and Nabauer M 1961 Phys. Rev. Lett. 7 51-2). Here, h is the Planck constant and e the elementary charge. The second property is the Josephson effect, predicted in 1962 by Josephson (1962 Phys. Lett. 1 251-3) and observed by Anderson and Rowell (1963 Phys. Rev. Lett. 10 230-2) in 1963. The Josephson junction consists of two weakly coupled superconductors separated by a tunnel barrier or other weak link. A tiny electric current is able to flow between the superconductors as a supercurrent, without developing a voltage across them. At currents above the 'critical current'(maximum supercurrent), however, a voltage is developed. In 1964, Jaklevic et al (1964 Phys. Rev. Lett. 12 159-60) observed quantum interference between two Josephson junctions connected in series on a superconducting loop, giving birth to the dc SQUID. The essential property of the SQUID is that a steady increase in the magnetic flux threading the loop causes the critical current to oscillate with a period of one flux quantum. In today's SQUIDs, using conventional semiconductor readout electronics, one can typically detect a change in F corresponding to 10(-6) F Phi in one second. Although early practical SQUIDs were usually made from bulk superconductors, for example, niobium or Pb-Sn solder blobs, today's devices are invariably made from thin superconducting films patterned with photolithography or even electron lithography. An extensive description of SQUIDs and their applications can be found in the SQUID Handbooks (Clarke and Braginski 2004 Fundamentals and Technology of SQUIDs and SQUID Systems vol I (Weinheim, Germany: Wiley-VCH), Clarke and Braginski 2006 Applications of SQUIDs and SQUID Systems vol II (Weinheim, Germany: Wiley-VCH)). The roadmap begins (chapter 1) with a brief review of the state-of-the-art of SQUID-based magnetometers and gradiometers for biomagnetic measurements. The magnetic field noise referred to the pick-up loop is typically a few fT Hz(-1/2), often limited by noise in the metallized thermal insulation of the dewar rather than by intrinsic SQUID noise. The authors describe a pathway to achieve an intrinsic magnetic field noise as low as 0.1 fT Hz(-1/2), approximately the Nyquist noise of the human body. They also descibe a technology to defeat dewar noise. Chapter 2 reviews the neuroscientific and clinical use of magnetoencephalography (MEG), by far the most widespread application of biomagnetism with systems containing typically 300 sensors cooled to liquid-helium temperature, 4.2 K. Two important clinical applications are presurgical mapping of focal epilepsy and of eloquent cortex in brain-tumor patients. Reducing the sensor-to-brain separation and the system noise level would both improve spatial resolution. The very recent commercial innovation that replaces the need for frequent manual transfer of liquid helium with an automated system that collects and liquefies the gas and transfers the liquid to the dewar will make MEG systems more accessible. Ahighly promising means of placing the sensors substantially closer to the scalp for MEG is to use high-transition-temperature (high-T-c) SQUID sensors and flux transformers (chapter 3). Operation of these devices at liquid-nitrogen temperature, 77 K, enables one to minimize or even omit metallic thermal insulation between the sensors and the dewar. Noise levels of a few fT Hz(-1/2) have already been achieved, and lower values are likely. The dewars can be made relatively flexible, and thus able to be placed close to the skull irrespective of the size of the head, potentially providing higher spatial resolution than liquid-helium based systems. The successful realization of a commercial high-T-c MEG system would have a major commercial impact. Chapter 4 introduces the concept of SQUID-based ultra-low-field magnetic resonance imaging (ULF MRI) operating at typically several kHz, some four orders of magnitude lower than conventional, clinical MRI machines. Potential advantages of ULF MRI include higher image contrast than for conventional MRI, enabling methodologies not currently available. Examples include screening for cancer without a contrast agent, imaging traumatic brain injury (TBI) and degenerative diseases such as Alzheimer's, and determining the elapsed time since a stroke. The major current problem with ULF MRI is that its signal-to-noise ratio (SNR) is low compared with high-field MRI. Realistic solutions to this problem are proposed, including implementing sensors with a noise level of 0.1 fT Hz(-1/2). A logical and exciting prospect (chapter 5) is to combine MEG and ULF MRI into a single system in which both signal sources are detected with the same array of SQUIDs. A prototype system is described. The combination of MEG and ULF MRI allows one to obtain structural images of the head concurrently with the recording of brain activity. Since all MEG images require an MRI to determine source locations underlying the MEG signal, the combined modality would give a precise registration of the two images; the combination of MEG with high-field MRI can produce registration errors as large as 5 mm. The use of multiple sensors for ULF MRI increases both the SNR and the field of view. Chapter 6 describes another potentially far-reaching application of ULF MRI, namely neuronal current imaging (NCI) of the brain. Currently available neuronal imaging techniques include MEG, which is fast but has relatively poor spatial resolution, perhaps 10 mm, and functional MRI (fMRI) which has a millimeter resolution but is slow, on the order of seconds, and furthermore does not directly measure neuronal signals. NCI combines the ability of direct measurement of MEG with the spatial precision of MRI. In essence, the magnetic fields generated by neural currents shift the frequency of the magnetic resonance signal at a location that is imaged by the three-dimensional magnetic field gradients that form the basis of MRI. The currently achieved sensitivity of NCI is not quite sufficient to realize its goal, but it is close. The realization of NCI would represent a revolution in functional brain imaging. Improved techniques for immunoassay are always being sought, and chapter 7 introduces an entirely new topic, magnetic nanoparticles for immunoassay. These particles are bio-funtionalized, for example with a specific antibody which binds to its corresponding antigen, if it is present. Any resulting changes in the properties of the nanoparticles are detected with a SQUID. For liquid-phase detection, there are three basic methods: AC susceptibility, magnetic relaxation and remanence measurement. These methods, which have been successfully implemented for both in vivo and ex vivo applications, are highly sensitive and, although further development is required, it appears highly likely that at least some of them will be commercialized. Chapter 8 concludes the roadmap with an assessment of the commercial market for MEG systems. Despite the huge advances that have been realized since MEG was first introduced, the number of commercial systems deployed around the world remains small, around 250 units employing about 50 000 SQUIDs. The slow adoption of this technology is undoubtedly in part due to the high cost, not least because of the need to surround the entire system in an expensive magnetically shielded room. Nonetheless, the recent introduction of automatically refilling liquid-helium systems, the ongoing reduction in sensor noise, the potential availability of high-T-c SQUID systems, the availability of new and better software and the combination of MEG with ULF MRI all have the potential to increase the market size in the not-so-distant future. In particular, there is a great and growing need for better noninvasive technologies to measure brain function. There are hundreds of millions of people in the world who suffer from brain disorders such as epilepsy, stroke, dementia or depression. The enormous cost to society of these diseases can be reduced by earlier and more accurate detection and diagnosis. Once the challenges outlined in this roadmap have been met and the outstanding problems have been solved, the potential demand for SQUID-based health technology can be expected to increase by ten-if not hundred-fold.					Pfeiffer, Christoph/AAF-8989-2019; Ilmoniemi, Risto/E-9704-2012; Nieminen, Jaakko/AAX-5658-2020; Nieminen, Jaakko O./E-7311-2012; Dong, Hui/E-5928-2017; Schneiderman, Justin F/D-4508-2013	Pfeiffer, Christoph/0000-0002-7388-4578; Ilmoniemi, Risto/0000-0002-3340-2618; Nieminen, Jaakko/0000-0002-7826-3519; Nieminen, Jaakko O./0000-0002-7826-3519; Dong, Hui/0000-0002-6444-1134; Schneiderman, Justin F/0000-0002-4441-2360; Korber, Rainer/0000-0001-7052-5134; Volegov, Petr/0000-0003-0361-7500			American Academy of Neurology Professional Association (AANPA), 2009, MAGN ENC MEG POL REC; Anders S, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/6/064012; ANDERSON PW, 1963, PHYS REV LETT, V10, P230, DOI 10.1103/PhysRevLett.10.230; Arpaia R, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866277; Babiloni C, 2009, INT REV NEUROBIOL, V86, P67, DOI 10.1016/S0074-7742(09)86005-4; Bandettini PA, 2005, APPL MAGN RESON, V29, P65, DOI 10.1007/BF03166956; BAULE G, 1963, AM HEART J, V66, P95, DOI 10.1016/0002-8703(63)90075-9; Bryant RG, 1996, ANNU REV BIOPH BIOM, V25, P29, DOI 10.1146/annurev.bb.25.060196.000333; Busch S, 2012, MAGN RESON MED, V67, P1138, DOI 10.1002/mrm.24177; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Chesca B, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4932969; Chieh JJ, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0069-5; Clarke J, 2004, SQUID HDB FUNDAMENTA, VI, DOI [10.1002/3527603646, DOI 10.1002/3527603646)]; Clarke J, 2006, SQUID HDB APPL SQUID, VII, DOI [10.1002/9783527609956, DOI 10.1002/9783527609956)]; Clarke J, 2007, ANNU REV BIOMED ENG, V9, P389, DOI 10.1146/annurev.bioeng.9.060906.152010; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; COHEN D, 1970, APPL PHYS LETT, V16, P278, DOI 10.1063/1.1653195; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Dammers J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880097; DEAVER BS, 1961, PHYS REV LETT, V7, P43, DOI 10.1103/PhysRevLett.7.43; DOLL R, 1961, PHYS REV LETT, V7, P51, DOI 10.1103/PhysRevLett.7.51; Drung D, 2007, IEEE T APPL SUPERCON, V17, P699, DOI 10.1109/TASC.2007.897403; Eberbeck D, 2009, J MAGN MAGN MATER, V321, P1617, DOI 10.1016/j.jmmm.2009.02.098; Enpuku K, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.097001; Faley MI, 2012, PHYSCS PROC, V36, P66, DOI 10.1016/j.phpro.2012.06.131; Faley MI, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2229094; Fedele T, 2015, PHYSIOL MEAS, V36, P357, DOI 10.1088/0967-3334/36/2/357; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Hagberg GE, 2006, MAGN RESON IMAGING, V24, P483, DOI 10.1016/j.mri.2005.12.027; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Hathaway HJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3050; Hilschenz I, 2013, MAGN RESON IMAGING, V31, P171, DOI 10.1016/j.mri.2012.06.014; Huang KW, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/23/235101; Hwang SM, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865497; Inglis B, 2013, P NATL ACAD SCI USA, V110, P19194, DOI 10.1073/pnas.1319334110; JAKLEVIC RC, 1964, PHYS REV LETT, V12, P159, DOI 10.1103/PhysRevLett.12.159; Jin K, 2013, CLIN NEUROPHYSIOL, V124, P1283, DOI 10.1016/j.clinph.2013.04.004; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Kahn S, 2013, REV SCI INSTRUM, V84; Kim K, 2014, NEUROIMAGE, V91, P63, DOI 10.1016/j.neuroimage.2014.01.030; Kiviranta M, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2012.2190286; KNUUTILA JET, 1993, IEEE T MAGN, V29, P3315, DOI 10.1109/20.281163; Korber R, 2013, J MAGN RESON, V237, P182, DOI 10.1016/j.jmr.2013.10.011; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Koo C, 2014, IEEE T BIO-MED ENG, V61, P76, DOI 10.1109/TBME.2013.2276770; Kraus R, 2014, NEW MRI REGIME; Kraus RH, 2008, NEUROIMAGE, V39, P310, DOI 10.1016/j.neuroimage.2007.07.058; Kuma H, 2010, CLIN CHEM LAB MED, V48, P1263, DOI 10.1515/CCLM.2010.259; Lin FH, 2013, MAGN RESON MED, V70, P595, DOI 10.1002/mrm.24479; Luomahaara J, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/7/075020; Magnelind PE, 2011, IEEE T APPL SUPERCON, V21, P456, DOI 10.1109/TASC.2010.2088353; Makela LP, 2006, NEUROSURGERY, V59, P493, DOI 10.1227/01.NEU.0000232762.63508.11; Matlashov A, 2015, 15 INT C SUP EL ISEC, P1; Matlashov AN, 2012, PHYSICA C, V482, P19, DOI 10.1016/j.physc.2012.04.028; McDermott R, 2004, P NATL ACAD SCI USA, V101, P7857, DOI 10.1073/pnas.0402382101; McDermott R, 2002, SCIENCE, V295, P2247, DOI 10.1126/science.1069280; Melgaard SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep20380; Myers W, 2007, J MAGN RESON, V186, P182, DOI 10.1016/j.jmr.2007.02.007; Nenonen J, 1996, REV SCI INSTRUM, V67, P2397, DOI 10.1063/1.1147514; Nieminen JO, 2014, MAGN RESON IMAGING, V32, P54, DOI 10.1016/j.mri.2013.07.012; Oisjoen F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3698152; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Pannetier M, 2004, SCIENCE, V304, P1648, DOI 10.1126/science.1096841; Parkkonen L, 2008, P NATL ACAD SCI USA, V105, P20500, DOI 10.1073/pnas.0810966105; Sander TH, 2012, BIOMED OPT EXPRESS, V3, P981, DOI 10.1364/BOE.3.000981; Schneiderman JF, 2014, J NEUROSCI METH, V222, P42, DOI 10.1016/j.jneumeth.2013.10.007; Seton HC, 2005, CRYOGENICS, V45, P348, DOI 10.1016/j.cryogenics.2004.11.011; Seton HC, 1997, MEAS SCI TECHNOL, V8, P198, DOI 10.1088/0957-0233/8/2/015; Sims JR, 2010, IEEE T APPL SUPERCON, V20, P752, DOI 10.1109/TASC.2010.2040613; Supek S., 2014, MAGNETOENCEPHALOGRAP; Taulu S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1935742; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2014, MAGNETOENCEPHALOGRAP, P35, DOI [DOI 10.1007/978-3-642-33045-2_2, 10.1007/978-3-642-33045-2_2]; ter Brake H J M, 2008, 2008 IEEE Sensors, P1352, DOI 10.1109/ICSENS.2008.4716696; Tesan G, 2010, JOVE-J VIS EXP, pe1693; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Vesanen PT, 2014, MAGN RESON IMAGING, V32, P766, DOI 10.1016/j.mri.2014.01.012; Vesanen PT, 2013, MAGN RESON MED, V69, P1795, DOI 10.1002/mrm.24413; Volegov P, 2004, MAGN RESON MED, V52, P467, DOI 10.1002/mrm.20193; Vrba J, 2006, SQUID HDB APPL SQUID, VII; Yang SY, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2229772; Yoshida T, 2013, J APPL PHYS, V114, DOI 10.1063/1.4829484; Zevenhoven KCJ, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906058; Zevenhoven KCJ, 2014, J PHYS CONF SER, V507, DOI 10.1088/1742-6596/507/4/042050; Zhdanov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128485; Zotev VS, 2008, J MAGN RESON, V194, P115, DOI 10.1016/j.jmr.2008.06.007; Zotev VS, 2008, J MAGN RESON, V192, P197, DOI 10.1016/j.jmr.2008.02.015	89	10	11	3	97	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	NOV	2016	29	11							113001	10.1088/0953-2048/29/11/113001			30	Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Physics	DY3HF	WOS:000384980700001		Green Published, hybrid			2022-02-06	
J	Muradashvili, N; Tyagi, R; Tyagi, N; Tyagi, SC; Lominadze, D				Muradashvili, Nino; Tyagi, Reeta; Tyagi, Neetu; Tyagi, Suresh C.; Lominadze, David			Cerebrovascular disorders caused by hyperfibrinogenaemia	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; AMYLOID-BETA; CARDIOVASCULAR-DISEASE; SPATIAL MEMORY; PRION PROTEIN; FIBRINOGEN; PERMEABILITY; MICE; CAVEOLAE	Many cardiovascular diseases are associated with inflammation and as such are accompanied by an increased blood level of fibrinogen (Fg). Besides its well-known prothrombotic effects Fg seems to have other destructive roles in developing microvascular dysfunction that include changes in vascular reactivity and permeability. Increased permeability of brain microvessels has the most profound effects as it may lead to cerebrovascular remodelling and result in memory reduction. The goal of the present study was to define mechanisms of cerebrovascular permeability and associated reduction in memory induced by elevated blood content of Fg. Genetically modified, transgenic hyperfibrinogenic (HFg) mice were used to study cerebrovascular transcellular and paracellular permeability in vivo. The extent of caveolar formation and the role of caveolin-1 signalling were evaluated by immunohistochemistry (IHC) and Western blot (WB) analysis in brain samples from experimental animals. Formation of Fg complexes with amyloid beta (A beta) and with cellular prion protein (PrPC) were also assessed with IHC and WB analysis. Short-term memory of mice was assessed by novel object recognition and Y-maze tests. Caveolar protein transcytosis was found to have a prevailing role in overall increased cerebrovascular permeability in HFg mice. These results were associated with enhanced formation of caveolae. Increased formation of Fg-PrPC and Fg-A beta complexes were correlated with reduction in short-term memory in HFg mice. Using the model of hyperfibrinogenaemia, the present study shows a novel mechanistic pathway of inflammation-induced and Fg-mediated reduction in short-term memory.	[Muradashvili, Nino; Tyagi, Reeta; Tyagi, Neetu; Tyagi, Suresh C.; Lominadze, David] Univ Louisville, Sch Med, Dept Physiol, Bldg A,Room 1115,500 South Preston St, Louisville, KY 40202 USA		Lominadze, D (corresponding author), Univ Louisville, Sch Med, Dept Physiol, Bldg A,Room 1115,500 South Preston St, Louisville, KY 40202 USA.	david.lominadze@louisville.edu		Tyagi, Neetu/0000-0002-1789-0754	NIH Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-107640]; NIH Institute of Neurological Disorders and Stroke [NS-084823]; Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-107640, HL-108621, HL-074185]; NIH Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30 GM-103507]; Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-084823]; Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK-104653]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL108621, R01HL074185, R01HL107640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK104653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084823] Funding Source: NIH RePORTER	N. Tyagi was supported by NIH Heart, Lung, and Blood Institute (HL-107640). S. C Tyagi was supported by NIH Institute of Neurological Disorders and Stroke (NS-084823) and Heart, Lung, and Blood Institute (HL-108621 and HL-074185). D. Lominadze was supported by NIH Institute of General Medical Sciences (P30 GM-103507), Institute of Neurological Disorders and Stroke (NS-084823), Heart, Lung, and Blood Institute (HL-107640), and Institute of Diabetes and Digestive and Kidney Diseases (DK-104653).	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Conrad CD, 1997, BRAIN RES, V759, P76, DOI 10.1016/S0006-8993(97)00236-9; Cortes-Canteli M, 2009, J THROMB HAEMOST, V7, P146, DOI 10.1111/j.1538-7836.2009.03376.x; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Hnasko R, 2002, J ENDOCRINOL, V175, P649, DOI 10.1677/joe.0.1750649; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Jadavji NM, 2015, NEUROSCIENCE, V300, P1, DOI 10.1016/j.neuroscience.2015.04.067; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kalaria RN, 1995, BRAIN RES, V705, P349, DOI 10.1016/0006-8993(95)01250-8; Kerlin B, 2004, BLOOD, V103, P1728, DOI 10.1182/blood-2003-08-2886; Kutiyanawalla A, 2012, INT J NEUROPSYCHOPH, V15, P1073, DOI 10.1017/S1461145711001180; LANDIN K, 1990, J INTERN MED, V227, P273, DOI 10.1111/j.1365-2796.1990.tb00157.x; Ledesma MD, 2000, EMBO REP, V1, P530; LITTLE TL, 1995, CIRC RES, V76, P498, DOI 10.1161/01.RES.76.3.498; Lominadze D, 2010, ACTA PHYSIOL, V198, P1, DOI 10.1111/j.1748-1716.2009.02037.x; Lominadze D, 1998, AM J HYPERTENS, V11, P784, DOI 10.1016/S0895-7061(98)00056-9; Manczak M, 2013, J ALZHEIMERS DIS, V36, P285, DOI 10.3233/JAD-130275; MAURICE T, 1994, BRAIN RES, V647, P44, DOI 10.1016/0006-8993(94)91397-8; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2014, J CEREBR BLOOD F MET, V34, P1472, DOI 10.1038/jcbfm.2014.102; Muradashvili N, 2014, AM J PHYSIOL-CELL PH, V307, pC169, DOI 10.1152/ajpcell.00305.2013; Muradashvili N, 2014, CELL BIOCHEM BIOPHYS, V69, P283, DOI 10.1007/s12013-013-9797-z; Muradashvili N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00166; Muradashvili N, 2012, J CEREBR BLOOD F MET, V32, P150, DOI 10.1038/jcbfm.2011.144; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Patibandla PK, 2009, J CELL PHYSIOL, V221, P195, DOI 10.1002/jcp.21845; Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Tyagi N, 2008, MOL CELL BIOCHEM, V307, P13, DOI 10.1007/s11010-007-9579-2; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Yamada K, 1996, NEUROSCIENCE, V74, P365, DOI 10.1016/0306-4522(96)00161-3; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100	44	10	10	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	OCT 15	2016	594	20					5941	5957		10.1113/JP272558			17	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	DY8RV	WOS:000385399100019	27121987	Green Published, Bronze			2022-02-06	
J	Little, CE; Emery, C; Scott, SH; Meeuwisse, W; Palacios-Derflingher, L; Dukelow, SP				Little, C. Elaine; Emery, Carolyn; Scott, Stephen H.; Meeuwisse, Willem; Palacios-Derflingher, Luz; Dukelow, Sean P.			Do children and adolescent ice hockey players with and without a history of concussion differ in robotic testing of sensory, motor and cognitive function?	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Robot; Sensorimotor; Cognitive assessment; Child/adolescent; Concussion; Ice hockey	SPORTS-RELATED CONCUSSION; BASE-LINE VALUES; HIGH-SCHOOL; SEX-DIFFERENCES; BODY CHECKING; RISK-FACTORS; HEAD-INJURY; SELF-REPORT; SYMPTOMS; RECOVERY	Background: KINARM end point robotic testing on a range of tasks evaluating sensory, motor and cognitive function in children/adolescents with no neurologic impairment has been shown to be reliable. The objective of this study was to determine whether differences in baseline performance on multiple robotic tasks could be identified between pediatric/adolescent ice hockey players (age range 10-14) with and without a history of concussion. Methods: Three hundred and eighty-five pediatric/adolescent ice hockey players (ages 10-14) completed robotic testing (94 with and 292 without a history of concussion). Five robotic tasks characterized sensorimotor and/or cognitive performance with assessment of reaching, position sense, bimanual motor function, visuospatial skills, attention and decision-making. Seventy-six performance parameters are reported across all tasks. Results: There were no significant differences in performance demonstrated between children with a history of concussion [median number of days since last concussion: 480 (range 8-3330)] and those without across all five tasks. Performance by the children with no history of concussion was used to identify parameter reference ranges that spanned 95 % of the group. All 76 parameter means from the concussion group fell within the normative reference ranges. Conclusions: There are no differences in sensorimotor and/or cognitive performance across multiple parameters using KINARM end point robotic testing in children/adolescents with or without a history of concussion.	[Little, C. Elaine; Emery, Carolyn; Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Emery, Carolyn] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Palacios-Derflingher, Luz] Univ Calgary, Fac Kinesiol, Cumming Sch Med & Community Hlth Sci, Calgary, AB, Canada; [Dukelow, Sean P.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada		Little, CE (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	littlec@ucalgary.ca	Emery, Carolyn/AAI-2761-2020	Dukelow, Sean/0000-0002-0609-981X	Canadian Institutes Health Research Team GrantCanadian Institutes of Health Research (CIHR) [201210]; Healthy Living and Injury Prevention; Alberta Children's Hospital Research Institute for Child and Maternal Health; Alberta Innovates [201201160] Funding Source: researchfish	This work was supported by a Canadian Institutes Health Research Team Grant (201210): Mild Traumatic Brain Injury in Children and Youth, Hotchkiss Brain Institute (Co-PI's - CE, WM) and the Talisman Energy Fund in support of Healthy Living and Injury Prevention and the Alberta Children's Hospital Research Institute for Child and Maternal Health. The funding body played no role in the design of the study and collection, analysis, and interpretation of the data or in writing the manuscript.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Almeida LRS, 2016, PHYS THER, V96, P1074, DOI 10.2522/ptj.20150168; Andrejevic S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0142174, 10.1371/journal.pone.0139004]; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Basteris A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-111; Battikhi MNG, 2003, PROSTATE CANCER P D, V6, P256, DOI 10.1038/sj.pcan.4500656; Benson B, 2013, BRIT J SPORT MED, V47, pe1, DOI [10.1136/bjsports-2012-092101.32, DOI 10.1136/BJSPORTS-2012-092101.32.]; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Cho KH, 2015, TOHOKU J EXP MED, V237, P149, DOI 10.1620/tjem.237.149; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Dey AK, 2015, J STROKE CEREBROVASC, V24, P2860, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.022; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Field A., 2017, DISCOVERING STAT USI, V5th; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frisoli A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-36; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Fuelscher I, 2015, J EXP CHILD PSYCHOL, V140, P74, DOI 10.1016/j.jecp.2015.06.013; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hockey Canada, HOCK CAN ANN REP 201; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Johnson LSM, 2011, CAN MED ASSOC J, V183, P921, DOI 10.1503/cmaj.110282; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LITTLE CE, J NEUROENG REHABIL, V12, P1, DOI DOI 10.1186/S12984-015-0070-0.HTTP://JNEUR0ENGREHAB.C0M/C0NTENT/12/1/78.ACCESSED; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Massie CL, 2016, NEUROREHAB NEURAL RE, V30, P703, DOI 10.1177/1545968315620301; Mayfield R, 2013, ATHLETIC TRAINING SP, V5, P265, DOI DOI 10.3928/19425864-20131017-01; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Neal SE, 2015, INT PERSPECT SEX R H, V41, P210, DOI 10.1363/4121015; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Otaka E, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0059-8; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Semrau JA, 2015, STROKE, V46, P3459, DOI 10.1161/STROKEAHA.115.010750; Semrau JA, 2013, STROKE, V44, P3414, DOI 10.1161/STROKEAHA.113.002058; Stern JE, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.010; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; Subbian V, 2014, IEEE ENG MED BIO, P5353, DOI 10.1109/EMBC.2014.6944835; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Waljas M, 2015, J NEUROTRAUM, V32, P1; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	75	10	10	2	24	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	OCT 12	2016	13								89	10.1186/s12984-016-0195-9			19	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	DY7NR	WOS:000385316500001	27729040	Green Published, gold			2022-02-06	
J	Bigler, ED; Zielinski, BA; Goodrich-Hunsaker, N; Black, GM; Huff, BST; Christiansen, Z; Wood, DM; Abildskov, TJ; Dennis, M; Taylor, HG; Rubin, K; Vannatta, K; Gerhardt, CA; Stancin, T; Yeates, KO				Bigler, Erin D.; Zielinski, Brandon A.; Goodrich-Hunsaker, Naomi; Black, Garrett M.; Huff, B. S. Trevor; Christiansen, Zachary; Wood, Dawn-Marie; Abildskov, Tracy J.; Dennis, Maureen; Taylor, H. Gerry; Rubin, Kenneth; Vannatta, Kathryn; Gerhardt, Cynthia A.; Stancin, Terry; Yeates, Keith Owen			The Relation of Focal Lesions to Cortical Thickness in Pediatric Traumatic Brain Injury	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric traumatic brain injury; cortical thickness; brain development; lesion analysis	WHITE-MATTER HYPERINTENSITIES; DIFFUSE AXONAL INJURY; COMMON DATA ELEMENTS; LENGTH-OF-STAY; LONGITUDINAL CHANGES; CEREBRAL ATROPHY; CHILDREN; REHABILITATION; MIND; AGE	In a sample of children with traumatic brain injury, this magnetic resonance imaging (MRI)-based investigation examined whether presence of a focal lesion uniquely influenced cortical thickness in any brain region. Specifically, the study explored the relation of cortical thickness to injury severity as measured by Glasgow Coma Scale score and length of stay, along with presence of encephalomalacia, focal white matter lesions or presence of hemosiderin deposition as a marker of shear injury. For comparison, a group of children without head injury but with orthopedic injury of similar age and sex were also examined. Both traumatic brain injury and orthopedic injury children had normally reduced cortical thickness with age, assumed to reflect neuronal pruning. However, the reductions observed within the traumatic brain injury sample were similar to those in the orthopedic injury group, suggesting that in this sample traumatic brain injury, per se, did not uniquely alter cortical thickness in any brain region at the group level. Injury severity in terms of Glasgow Coma Scale or longer length of stay was associated with greater reductions in frontal and occipitoparietal cortical thickness. However, presence of focal lesions were not related to unique changes in cortical thickness despite having a prominent distribution of lesions within frontotemporal regions among children with traumatic brain injury. Because focal lesions were highly heterogeneous, their association with cortical thickness and development appeared to be idiosyncratic, and not associated with group level effects.	[Bigler, Erin D.; Goodrich-Hunsaker, Naomi; Black, Garrett M.; Huff, B. S. Trevor; Christiansen, Zachary; Wood, Dawn-Marie; Abildskov, Tracy J.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, 1001 SWKT, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Zielinski, Brandon A.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Zielinski, Brandon A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Stancin, Terry] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Rubin, Kenneth] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Vannatta, Kathryn; Gerhardt, Cynthia A.; Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Vannatta, Kathryn; Gerhardt, Cynthia A.] Columbus Childrens Res Inst, Ctr Behav Hlth, Columbus, OH USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Psychiat, Cleveland, OH USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.; Bigler, ED (corresponding author), Brigham Young Univ, Ctr Neurosci, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu	Yeates, Keith/AAJ-4223-2020; Rubin, Kenneth H/M-5276-2018; Stancin, Terry/L-7993-2019	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R01HD048946, 3R01HD048946-05S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH100609] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Supported in part by grants from the National Institute of Child Health and Human Development (Grant Nos. 5R01HD048946 and 3R01HD048946-05S1).	Abe C, 2016, J PSYCHIATR NEUROSCI, V41, P240, DOI 10.1503/jpn.150093; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Avants BB, 2013, ADV NORMALIZATION TO; Bava S, 2007, J CHILD NEUROL, V22, P841, DOI 10.1177/0883073807304700; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Carmack PS, 2004, NEUROIMAGE, V22, P367, DOI 10.1016/j.neuroimage.2004.01.022; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Charil A, 2007, NEUROIMAGE, V34, P509, DOI 10.1016/j.neuroimage.2006.10.006; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Gean A. D., 2014, BRAIN INJURY APPL WA; Gean AD, 1994, NEUROIMAGING TRAUMAT; Govindarajan K. A., 2016, J NEUROTRAUMA; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Jernigan TL, 2016, DEV COGN NEUROS-NETH, V18, P2, DOI 10.1016/j.dcn.2015.07.008; Kanekar S, 2014, RADIOL CLIN N AM, V52, P241, DOI 10.1016/j.rcl.2013.11.010; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Lancaster JL, 2014, MANGO COMPUTER SOFTW; Lazaridis C, 2015, J CRIT CARE, V30, P1258, DOI 10.1016/j.jcrc.2015.08.003; Levan A, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000040; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Li D, 2012, STROKE, V43, P1404, DOI 10.1161/STROKEAHA.111.645077; Lisdahl KM, 2016, DRUG ALCOHOL DEPEN, V161, P135, DOI 10.1016/j.drugalcdep.2016.01.032; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Righart R, 2013, NEUROIMAGE-CLIN, V2, P854, DOI 10.1016/j.nicl.2013.06.006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmidt P, 2013, LESION SEGMENTATION; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Squeglia LM, 2013, J INT NEUROPSYCH SOC, V19, P962, DOI 10.1017/S1355617713000878; Staudt M, 2010, SEMIN PERINATOL, V34, P87, DOI 10.1053/j.semperi.2009.10.009; Tuladhar AM, 2015, STROKE, V46, P425, DOI 10.1161/STROKEAHA.114.007146; Vijayakumar N, 2014, SOC COGN AFFECT NEUR, V9, P1845, DOI 10.1093/scan/nst183; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yoshimi A, 2015, IMAGING TRAUMATIC BR; Zielinski BA, 2014, BRAIN, V137, P1799, DOI 10.1093/brain/awu083	58	10	10	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	OCT	2016	31	11					1302	1311		10.1177/0883073816654143			10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	DV9CR	WOS:000383237700005	27342577	Green Accepted			2022-02-06	
J	Fox, LC; Davies, DR; Scholl, JL; Watt, MJ; Forster, GL				Fox, Laura C.; Davies, Daniel R.; Scholl, Jamie L.; Watt, Michael J.; Forster, Gina L.			Differential effects of glucocorticoid and mineralocorticoid antagonism on anxiety behavior in mild traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Glucocorticoids; Mild traumatic brain injury; Anxiety; Stress; Rat	POSTTRAUMATIC-STRESS-DISORDER; FEAR; MANAGEMENT; RECEPTORS; RAT	Mild traumatic brain injuries (TBIs) comprise three-quarters of all TBIs occurring in the United States annually, and psychological symptoms arising from them can last years after injury. One commonly observed symptom following mild TBI is generalized anxiety. Most mild TBIs happen in stressful situations (sports, war, domestic violence, etc.) when glucocorticoids are elevated in the brain at the time of impact, and glucocorticoids have negative effects on neuronal health following TBI. Therefore, blocking glucocorticoid receptors might prevent emergence of anxiety symptoms post-injury. Adult male rats received mifepristone (20 mg/kg) or spironolactone (50 mg/kg) to block glucocorticoid and mineralocorticoid receptors, respectively, 40 min prior to being exposed to acute social defeat stress followed immediately by mild TBI. In defeated rats with concomitant mild TBI, mifepristone restored time spent in the open arms of an elevated plus maze to control levels, demonstrating for the first time that glucocorticoid receptors play a critical role in the development of anxiety after mild TBI. Future treatments could target these receptors, alleviating anxiety as a major side effect in victims of mild TBI sustained in stressful situations. (C) 2016 Elsevier B.V. All rights reserved.	[Fox, Laura C.; Davies, Daniel R.; Scholl, Jamie L.; Watt, Michael J.; Forster, Gina L.] Univ South Dakota, Sanford Sch Med, Div Basic Biomed Sci, Ctr Brain & Behav Res, 414 East Clark St, Vermillion, SD 57069 USA		Forster, GL (corresponding author), Univ South Dakota, Sanford Sch Med, Div Basic Biomed Sci, Ctr Brain & Behav Res, 414 East Clark St, Vermillion, SD 57069 USA.	laura.fox@usd.edu; Daniel.davies@coyotes.usd.edu; Jamie.Scholl@usd.edu; Mick.Watt@usd.edu; gforster@usd.edu		Watt, Michael/0000-0003-1164-1367	United States Department of DefenseUnited States Department of Defense [W81XWH-10-1-0578]; University of South Dakota Medical Student Summer Science Research Program	The authors would like to thank Nate J. Vinzant for his contributions to the experiment. Funding was provided by the United States Department of Defense, Grant W81XWH-10-1-0578 to Dr. Gina L. Forster, and Laura C. Fox was supported by the University of South Dakota Medical Student Summer Science Research Program.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Castro CA, 2008, J TRAUMA, V64, pS205; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00071, 10.3339/fnbeh.2015.00071]; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Golier Julia A, 2012, Depress Res Treat, V2012, P393251, DOI 10.1155/2012/393251; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huizenga JE, 2002, ACAD EMERG MED, V9, P806, DOI 10.1197/aemj.9.8.806; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KORTE SM, 1995, PSYCHONEUROENDOCRINO, V20, P385, DOI 10.1016/0306-4530(94)00069-7; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009	15	10	11	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 1	2016	312						362	365		10.1016/j.bbr.2016.06.048			4	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DU1ED	WOS:000381950100040	27363926	Bronze			2022-02-06	
J	Huang, L; Obenaus, A; Hamer, M; Zhang, JH				Huang, Lei; Obenaus, Andre; Hamer, Mary; Zhang, John H.			Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury	MEDICAL GAS RESEARCH			English	Article						magnetic resonance imaging; susceptibility weighted imaging; T2-weighted imaging; diffusion weighted imaging; concussion; gliosis; adolescent; rat	ACUTE ISCHEMIC-STROKE; HEAD-INJURY; AXONAL INJURY; CONCUSSION; MRI; VULNERABILITY; ACTIVATION; MECHANISMS; SYMPTOMS; RECOVERY	Repetitive mild traumatic brain injury (rmTBI) is an important medical concern for adolescent athletes that can lead to long-term disabilities. Multiple mild injuries may exacerbate tissue damage resulting in cumulative brain injury and poor functional recovery. In the present study, we investigated the increased brain vulnerability to rmTBI and the effect of hyperbaric oxygen treatment using a juvenile rat model of rmTBI. Two episodes of mild cortical controlled impact (3 days apart) were induced in juvenile rats. Hyperbaric oxygen (HBO) was applied 1 hour/day x 3 days at 2 atmosphere absolute consecutively, starting at 1 day after initial mild traumatic brain injury (mTBI). Neuropathology was assessed by multi-modal magnetic resonance imaging (MRI) and tissue immunohistochemistry. After repetitive mTBI, there were increases in T2-weighted imaging-defined cortical lesions and susceptibility weighted imaging-defined cortical microhemorrhages, correlated with brain tissue gliosis at the site of impact. HBO treatment significantly decreased the MRI-identified abnormalities and tissue histopathology. Our findings suggest that HBO treatment improves the cumulative tissue damage in juvenile brain following rmTBI. Such therapy regimens could be considered in adolescent athletes at the risk of repeated concussions exposures.	[Huang, Lei; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92350 USA; [Huang, Lei; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92350 USA; [Obenaus, Andre; Hamer, Mary] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA; [Obenaus, Andre] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Obenaus, Andre] Loma Linda Univ, Sch Behav Hlth, Div Interdisciplinary Studies, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Dept Neurosurg, Loma Linda, CA 92350 USA		Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92350 USA.; Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92350 USA.; Zhang, JH (corresponding author), Loma Linda Univ, Dept Neurosurg, Loma Linda, CA 92350 USA.	johnzhang3910@yahoo.com			Loma Linda University GRASP award [699314-4526]	This study was supported by funding from Loma Linda University GRASP award (LH and AO, 699314-4526).	Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Dock H, 2015, TRANSL STROKE RES, V6, P296, DOI 10.1007/s12975-015-0397-7; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gennarelli T A, 1993, Acta Neurochir Suppl (Wien), V57, P49; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; Herrera BS, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0025-3; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hu Q, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0033-3; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Ichihara M, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0035-1; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kim JW, 2015, NEURAL REGEN RES, V10, P1876, DOI 10.4103/1673-5374.170321; Langston JW, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0027-1; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Li X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7648; Lioutas VA, 2015, TRANSL STROKE RES, V6, P264, DOI 10.1007/s12975-015-0409-7; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Masdeu J C, 1994, J Neuroimaging, V4, P177; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merali Z, 2015, TRANSL STROKE RES, V6, P39, DOI 10.1007/s12975-014-0358-6; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Mukherjee A, 2014, UNDERSEA HYPERBAR M, V41, P77; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parra RS, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0026-2; Ploughman M, 2015, TRANSL STROKE RES, V6, P13, DOI 10.1007/s12975-014-0357-7; Qi ZF, 2015, TRANSL STROKE RES, V6, P198, DOI 10.1007/s12975-015-0393-y; Reuter B, 2015, TRANSL STROKE RES, V6, P156, DOI 10.1007/s12975-014-0381-7; Rossignol Daniel A, 2007, BMC Pediatr, V7, P36, DOI 10.1186/1471-2431-7-36; Schlunk F, 2015, TRANSL STROKE RES, V6, P133, DOI 10.1007/s12975-014-0377-3; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Soliman S, 2015, TRANSL STROKE RES, V6, P309, DOI 10.1007/s12975-015-0408-8; Stoller KP, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0028-0; Tate DF, 2012, BRAIN IMAGING BEHAV, V6, P103, DOI 10.1007/s11682-012-9185-0; Tokutomi T, 1997, ACT NEUR S, V70, P80; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Weaver J, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0032-4; Yan L, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0024-4; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zhu WB, 2015, TRANSL STROKE RES, V6, P60, DOI 10.1007/s12975-014-0373-7	57	10	11	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	OCT-DEC	2016	6	4					187	193		10.4103/2045-9912.196900			7	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	EI4FW	WOS:000392449500002	28217290	Green Published			2022-02-06	
J	Lee, HJ; Jeong, EJ; Kim, H; Czosnyka, M; Kim, DJ				Lee, Hack-Jin; Jeong, Eun-Jin; Kim, Hakseung; Czosnyka, Marek; Kim, Dong-Joo			Morphological Feature Extraction From a Continuous Intracranial Pressure Pulse via a Peak Clustering Algorithm	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Biomedical signal processing; intracranial pressure; pulse morphology; traumatic brain injury	MONRO-KELLIE DOCTRINE; WAVE-FORM MORPHOLOGY; CEREBROSPINAL-FLUID; HEAD-INJURY; HYPERTENSION; ICP; ORIGIN; BRAIN	Objective: An increase in intracranial pressure (ICP) is frequently observed in patients with severe traumatic brain injury (TBI). The information derived from the observation of temporal changes in the mean ICP is insufficient for assessment of the compensatory reserve of the injured brain. This assessment can be achieved via continuous morphological analysis of the pulse waveform of the ICP. Methods: Continuous arterial blood pressure (ABP) and ICP recordings from 292 TBI patients were analyzed. The algorithm extracted morphological landmarks (peaks, troughs, and flats) from the ICP. Among the extracted peaks, P1, P2, and P3 were assigned through peak clustering. The performance of the proposed method was validated through a comparison of the algorithm-defined peaks and those manually identified by experienced observers. Results: The proposed algorithm successfully identified the three distinguishing peaks of the ICP with satisfactory accuracy (95.3%, 87.8%, and 87.5% for P1, P2, and P3, respectively), even from minimally filtered raw signals. Conclusion: The algorithm extracted the morphological features from both ABP and ICP recordings with high accuracy. Significance: The ABP and ICP pulse waveforms can be simultaneously analyzed in real time using the proposed algorithm. The morphological features from these signals may aid the continuous care of patients with TBI.	[Lee, Hack-Jin; Jeong, Eun-Jin; Kim, Hakseung; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul 02841, South Korea; [Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge CB2 1TN, England; [Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 1TN, England; [Kim, Dong-Joo] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 1TN, England		Kim, DJ (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul 02841, South Korea.; Kim, DJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 1TN, England.	dongjookim@korea.ac.kr	Kim, Hakseung/AAZ-8626-2021	Kim, Hakseung/0000-0001-5407-293X	Technology Innovation Program - Ministry of Trade, Industry and Energy (MI, Korea) [10049743]; Basic Science Research Program through NRF - Ministry of Education [2015R1D1A1A02062380]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390] Funding Source: UKRI	This work was supported by the Technology Innovation Program (or Industrial Strategic technology development program, "establishing a medical device development open platform, as a hub for accelerating close firm-hospital communication") funded By the Ministry of Trade, Industry and Energy (MI, Korea) under Grant 10049743, and by the Basic Science Research Program through the NRF funded by the Ministry of Education under Grant 2015R1D1A1A02062380. Asterisk indicates the corresponding author.	ADOLPH RJ, 1967, AM J PHYSIOL, V212, P840, DOI 10.1152/ajplegacy.1967.212.4.840; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Avezaat C, 1984, CEREBROSPINAL FLUID; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bratton S. L., 2006, J NEUROTRAUM, V24, pS37; Calisto A, 2013, IEEE T BIO-MED ENG, V60, P830, DOI 10.1109/TBME.2012.2191550; CARDOSO ER, 1988, J NEUROSURG, V69, P712, DOI 10.3171/jns.1988.69.5.0712; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Chapra S.C., 2011, NUMERICAL METHODS EN; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Di Ieva A, 2013, NEUROSCIENTIST, V19, P592, DOI 10.1177/1073858412474845; EVANS JP, 1951, AMA ARCH SURG, V63, P107, DOI 10.1001/archsurg.1951.01250040110016; Fan JY, 2008, AM J CRIT CARE, V17, P545; HAMER J, 1977, J NEUROSURG, V46, P36, DOI 10.3171/jns.1977.46.1.0036; Hu X., 2009, ACTA NEUROCHIRURGI S, P131; Hu X, 2008, PHYSIOL MEAS, V29, P459, DOI 10.1088/0967-3334/29/4/004; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kasprowicz M., 2012, ASS ICP PULSE WAVEFO; Kim DJ, 2012, J NEUROTRAUM, V29, P1354, DOI 10.1089/neu.2011.2018; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; LAITINEN L, 1968, ACTA NEUROL SCAND, V44, P168, DOI 10.1111/j.1600-0404.1968.tb05563.x; Li BN, 2010, BIOMED SIGNAL PROCES, V5, P76, DOI 10.1016/j.bspc.2009.06.002; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Monro A., 1783, OBSERVATIONS STRUCTU; Morgalla MH, 1999, J NEUROL SCI, V168, P90, DOI 10.1016/S0022-510X(99)00137-9; Neff S, 1996, J NEUROSURG, V85, P1195; Novak D., 2004, 17 EUR M CYB SYST VI; Piper I, 1997, HEAD INJURY; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Ross N., 2005, CURR ANAESTH CRIT CA, V16, P255; Scalzo F, 2009, MED BIOL ENG COMPUT, V47, P967, DOI 10.1007/s11517-009-0505-5; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Wagshul M. E., 2011, FLUIDS BARRIERS CNS, V8, P1; Wagshul ME, 2009, J NEUROSURG-PEDIATR, V3, P354, DOI 10.3171/2009.1.PEDS08109	41	10	10	0	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	OCT	2016	63	10					2169	2176		10.1109/TBME.2015.2512278			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	DX7LZ	WOS:000384570200020	26841386				2022-02-06	
J	Manners, JL; Forsten, RD; Kotwal, RS; Elbin, RJ; Collins, MW; Kontos, AP				Manners, Jody L.; Forsten, Robert D.; Kotwal, Russ S.; Elbin, R. J.; Collins, Michael W.; Kontos, Anthony P.			Role of Pre-Morbid Factors and Exposure to Blast Mild Traumatic Brain Injury on Post-Traumatic Stress in United States Military Personnel	JOURNAL OF NEUROTRAUMA			English	Article						blast; concussion; mTBI; PTSD	PERSISTENT POSTCONCUSSIVE SYMPTOMS; COGNITIVE SEQUELAE; SERVICE MEMBERS; CONCUSSION; DISORDER; ASSOCIATION; OUTCOMES; IRAQ; CONSEQUENCES; AFGHANISTAN	Mild traumatic brain injury (mTBI), the signature injury of the recent wars in Afghanistan and Iraq, is a prevalent and potentially debilitating condition that is associated with symptoms of post-traumatic stress/post-traumatic stress disorder (PTS/PTSD). Prior mTBI, severity and type of injury (blast vs. non-blast), and baseline psychiatric illness are thought to impact mTBI outcomes. It is unclear if the severity of pre-morbid PTS/PTSD is a risk factor of post-injury levels of PTS and mTBI symptoms. The objective of the study was to examine predictors of post-injury PTS/PTSD, including premorbid PTS symptoms, and physical and cognitive symptoms in the sub-acute phase (1 week-3 months) following an acute mTBI. A retrospective review of medical records was performed of 276 servicemen assigned to the United States Army Special Operations Command referred for mTBI evaluation between December 2009 and March 2011. Post-Concussion Symptom Scale and PTSD Checklist scores were captured pre-and post-injury. A total of 276 records were reviewed. Pre-morbid and post-injury data were available for 91% (251/276). Of the 54% (136/251) of personnel with mTBI, 29% (39/136) had positive radiology findings and 11% (15/136) met criteria for clinical PTS symptoms at baseline. Logistic regression analysis found baseline PTS symptoms predicted personnel who met clinical levels of PTSD. Receiver operating characteristic curve analysis revealed that baseline PTS (p = 0.001), baseline mTBI symptoms (p = 0.001), and positive radiology (magnetic resonance imaging or computed tomography) findings for complicated mTBI (p = 0.02) accurately identified personnel with clinical levels of PTSD following mTBI. Years of military service, combat deployment status, age, and injury mechanism (blast vs. non-blast) were not associated with increased risk of PTS following mTBI. Pre-morbid PTS symptoms are associated with an increased risk for clinical levels of PTS following a subsequent mTBI. Symptom severity and positive radiologic findings may amplify this risk. At-risk personnel may benefit from early identification and intervention.	[Manners, Jody L.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Kontos, Anthony P.] Univ Pittsburgh, Sch Med, Dept Orthoped Surg, Pittsburgh, PA USA; [Forsten, Robert D.] US Army War Coll, Carlisle, PA USA; [Kotwal, Russ S.] US Army Inst Surg Res, Joint Trauma Syst, San Antonio, TX USA; [Elbin, R. J.; Collins, Michael W.] Univ Arkansas, Off Sport Concuss Res, Fayetteville, AR 72701 USA		Kontos, AP (corresponding author), UPMC, Ctr Sports Med, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310			Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Department of Defense Worldwide TBI Numbers, 2014, DOD NUMB TRAUM BRAIN; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kansagara D., 2013, COMPLICATIONS MILD T; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Nemes S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-56; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	36	10	10	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2016	33	19					1796	1801		10.1089/neu.2015.4245			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DY8KP	WOS:000385379100009	27027526	Green Published			2022-02-06	
J	Nordhaug, LH; Vik, A; Hagen, K; Stovner, LJ; Pedersen, T; Gravdahl, GB; Linde, M				Nordhaug, Lena Hoem; Vik, Anne; Hagen, Knut; Stovner, Lars Jacob; Pedersen, Torunn; Gravdahl, Goril Bruvik; Linde, Mattias			Headaches in patients with previous head injuries: A population-based historical cohort study (HUNT)	CEPHALALGIA			English	Article						Epidemiology; headache; post-traumatic headache; head injuries; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NORD-TRONDELAG HEALTH; POSTTRAUMATIC HEADACHE; SCANDINAVIAN GUIDELINES; MILD; PREVALENCE; HOSPITALIZATION; SYMPTOMS; MODERATE	Background Headache attributed to head injury is claimed to be among the most common secondary headache disorders, yet available epidemiological evidence is scarce. We evaluated the prevalence of headache among individuals previously exposed to head injury by a comparison to an uninjured control group. Methods This population-based historical cohort study used data from hospital records on previous exposure to head injury linked to a large epidemiological survey with data on headache occurrence. Participants without head injury, according to hospital records, were used as controls. The head injuries were classified according to the Head Injury Severity Scale (HISS) and the International Classification of Headache Disorders (ICHD-3 beta). Binary logistic regression was performed to investigate the association between headache and head injury, controlling for potential confounders. Results The exposed group consisted of 940 individuals and the control group of 38,751 individuals. In the multivariate analyses, adjusting for age, sex, anxiety, depression and socioeconomic status, there were significant associations between mild head injury and any headache, migraine, chronic daily headache and medication overuse headache. Conclusion Headache was more likely among individuals previously referred to a hospital for a mild head injury compared to uninjured controls.	[Nordhaug, Lena Hoem; Vik, Anne; Hagen, Knut; Stovner, Lars Jacob; Pedersen, Torunn; Linde, Mattias] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Hagen, Knut; Stovner, Lars Jacob; Gravdahl, Goril Bruvik; Linde, Mattias] St Olavs Univ Hosp, Norwegian Advisory Unit Headaches, Trondheim, Norway		Nordhaug, LH (corresponding author), NTNU, Dept Neurosci, Fac Med, Postboks 8905, N-7491 Trondheim, Norway.	lenahoem@gmail.com		Gravdahl, Goril/0000-0001-7507-2082			[Anonymous], 2011, ATL HEAD DIS RES WOR, V2011; Bettucci D, 1998, ITAL J NEUROL SCI, V19, P20, DOI 10.1007/BF03028807; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Erikson Robert GJH, 1992, CONSTANT FLUX STUDY, P429; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hagen K, 2010, J HEADACHE PAIN, V11, P67, DOI 10.1007/s10194-009-0174-7; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Krokstad S, 2002, SCAND J PUBLIC HEALT, V30, P113, DOI 10.1080/14034940210133753; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Linde M, 2012, EUR J NEUROL, V19, P703, DOI 10.1111/j.1468-1331.2011.03612.x; Linde M, 2011, CEPHALALGIA, V31, P585, DOI 10.1177/0333102410391488; Linder Steven L, 2007, Curr Pain Headache Rep, V11, P396, DOI 10.1007/s11916-007-0223-3; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Nestvold K, 2005, ACTA NEUROL SCAND, V112, P13, DOI 10.1111/j.1600-0404.2005.00344.x; Nestvold K, 2007, NEUROEPIDEMIOLOGY, V29, P113, DOI 10.1159/000109825; Ramadan NML-AJ, 2006, HEADACHES, P873; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Strand IH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-62; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x	35	10	10	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2016	36	11					1009	1019		10.1177/0333102415618948			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ7AO	WOS:000386015400001	26634833				2022-02-06	
J	Ostahowski, PJ; Kannan, N; Wainwright, MS; Qiu, Q; Mink, RB; Groner, JI; Bell, MJ; Giza, CC; Zatzick, DF; Ellenbogen, RG; Boyle, LN; Mitchell, PH; Vavilala, MS				Ostahowski, Paige J.; Kannan, Nithya; Wainwright, Mark S.; Qiu, Qian; Mink, Richard B.; Groner, Jonathan I.; Bell, Michael J.; Giza, Christopher C.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Vavilala, Monica S.		PEGASUS Pediat Guideline Adherence	Variation in seizure prophylaxis in severe pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						seizures; antiepileptic medications; traumatic brain injury; pediatrics; epilepsy; trauma	HEAD TRAUMA; POSTTRAUMATIC SEIZURES; CHILDREN; LEVETIRACETAM; PHENYTOIN; EPILEPSY; OUTCOMES; CARE	OBJECTIVE Posttraumatic seizure is a major complication following traumatic brain injury (TBI). The aim of this study was to determine the variation in seizure prophylaxis in select pediatric trauma centers. The authors hypothesized that there would be wide variation in seizure prophylaxis selection and use, within and between pediatric trauma centers. METHODS In this retrospective multicenter cohort study including 5 regional pediatric trauma centers affiliated with academic medical centers, the authors examined data from 236 children (age < 18 years) with severe TBI (admission Glasgow Coma Scale score <= 8, ICD-9 diagnosis codes of 800.0-801.9, 803.0-804.9, 850.0-854.1, 959.01, 950.1-950.3, 995.55, maximum head Abbreviated Injury Scale score >= 3) who received tracheal intubation for >= 48 hours in the ICU between 2007 and 2011. RESULTS Of 236 patients, 187 (79%) received seizure prophylaxis. In 2 of the 5 centers, 100% of the patients received seizure prophylaxis medication. Use of seizure prophylaxis was associated with younger patient age (p < 0.001), inflicted TBI (p < 0.001), subdural hematoma (p = 0.02), cerebral infarction (p < 0.001), and use of electroencephalography (p = 0.023), but not higher Injury Severity Score. In 63% cases in which seizure prophylaxis was used, the patients were given the first medication within 24 hours of injury, and 50% of the patients received the first dose in the prehospital or emergency department setting. Initial seizure prophylaxis was most commonly with fosphenytoin (47%), followed by phenytoin (40%). CONCLUSIONS While fosphenytoin was the most commonly used medication for seizure prophylaxis, there was large variation within and between trauma centers with respect to timing and choice of seizure prophylaxis in severe pediatric TBI. The heterogeneity in seizure prophylaxis use may explain the previously observed lack of relationship between seizure prophylaxis and outcomes.	[Ostahowski, Paige J.] Univ Washington, Sch Med, Med Student Res Training Program, Seattle, WA 98195 USA; [Kannan, Nithya] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Qiu, Qian] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ellenbogen, Richard G.; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA; [Mink, Richard B.] Harbor UCLA, Dept Pediat, Torrance, CA USA; [Mink, Richard B.] Los Angeles BioMed Res Inst, Torrance, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA		Vavilala, MS (corresponding author), Univ Washington, Dept Neurol Surg, Harborview Injury Prevent & Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA.	vavilala@uw.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-05]	This study was funded by a grant from the National Institute of Neurological Disorders and Stroke (R01 NS072308-05 to M.S.V.).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Goraya JS, 2008, PEDIATR NEUROL, V38, P177, DOI 10.1016/j.pediatrneurol.2007.11.003; Greiner MV, 2015, J CHILD NEUROL, V30, P1778, DOI 10.1177/0883073815580285; Guilliams K, 2016, J CHILD NEUROL, V31, P35, DOI 10.1177/0883073814562626; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Holmes GL, 2005, PEDIATR NEUROL, V33, P1, DOI 10.1016/j.pediatrneurol.2004.12.003; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Khan AA, 2010, INT J EMERG MED, V3, P187, DOI 10.1007/s12245-010-0180-1; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Nau KM, 2009, NEUROCRIT CARE, V11, P34, DOI 10.1007/s12028-009-9185-0; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Park JT, 2015, PEDIATR NEUROL, V52, P174, DOI 10.1016/j.pediatrneurol.2014.09.013; Rowe AS, 2014, PHARMACOTHERAPY, V34, P396, DOI 10.1002/phar.1374; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507	25	10	10	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2016	18	4					499	506		10.3171/2016.4.PEDS1698			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DW8XJ	WOS:000383938500020	27258588	Bronze			2022-02-06	
J	Segev, S; Shorer, M; Rassovsky, Y; Peleg, TP; Apter, A; Fennig, S				Segev, Shira; Shorer, Maayan; Rassovsky, Yuri; Peleg, Tammy Pilowsky; Apter, Alan; Fennig, Silvana			The Contribution of Posttraumatic Stress Disorder and Mild Traumatic Brain Injury to Persistent Post Concussive Symptoms Following Motor Vehicle Accidents	NEUROPSYCHOLOGY			English	Article						concussion; posttraumatic stress disorder; mild traumatic brain injury; pediatric	CLINICAL-PRACTICE GUIDELINES; POSTCONCUSSIVE SYMPTOMS; SELF-REPORT; YOUNG-ADULTS; TEST-SCORES; CHILDREN; PERFORMANCE; ADOLESCENTS; LITIGATION; PREVALENCE	Objective: Persistent postconcussive symptoms (PPCS) are a set of physical, cognitive, emotional, and behavioral symptoms that often follow mild traumatic brain injury (mTBI). Some of these symptoms also occur in posttraumatic stress disorder (PTSD). The current study examined the unique contribution of mTBI and PTSD to PPCS. The roles of neurocognitive and motivational factors were also addressed. Method: Sixty one children and adolescents (ages 6-18), at least 3 months post motor vehicle accident (MVA), participated in the study. All participants were diagnosed with PTSD symptoms. Thirty three participants met mTBI criteria, and 28 did not. Standard instruments for assessment included a semi-structured clinical interview, self-report questionnaires, and a neuropsychological evaluation. Results: No differences were found between the mTBI and non-TBI groups on any of the emotional or neurocognitive measures, including PPCS symptoms. Multiple regression analyses revealed that emotional status, such as state anxiety and depression, were the best predictors of PPCS. Furthermore, hierarchical regression analyses revealed a double mediation model, in which suboptimal effort mediated the relationship between neurocognitive performance and PPCS, and emotional status mediated the relationship between suboptimal effort and PPCS. Conclusion: These findings underscore the importance of emotional status in the diagnosis of PPCS among children who suffer from PTSD. It is possible that PPCS reflect a more general expression of accident-related emotional distress, rather than being a direct result of the injury.	[Segev, Shira; Rassovsky, Yuri] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Segev, Shira; Shorer, Maayan; Apter, Alan; Fennig, Silvana] Schneider Childrens Med Ctr Israel, Dept Psychol Med, Posttraumat Stress Disorder Unit, Petah Tiqwa, Israel; [Rassovsky, Yuri] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, IL-52100 Ramat Gan, Israel; [Rassovsky, Yuri] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Peleg, Tammy Pilowsky] Schneider Childrens Med Ctr Israel, Neuropsychol Unit, Petah Tiqwa, Israel; [Peleg, Tammy Pilowsky] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Segev, Shira] Bar Ilan Univ, Ramat Gan, Israel		Rassovsky, Y (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	yurir@biu.ac.il		Rassovsky, Yuri/0000-0002-6362-9944	Israel Insurance Association	This study was carried out as part of a doctoral dissertation by Shira Segev at Bar Ilan University, Ramat Gan, Israel, and was supported in part by a grant from the Israel Insurance Association.	American Congress of Rehabilitation Medicine, 1993, DEF MILD TRAUM BRAIN; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blanchard EB, 1998, J TRAUMA STRESS, V11, P337, DOI 10.1023/A:1024407321677; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; BOIVIN MJ, 1995, NEUROPSYCHOLOGY, V9, P409, DOI 10.1037/0894-4105.9.3.409; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Conners C.K., 2004, CONNERS CONTINUOUS P; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kaplan E, 2004, WECHSLER INTELLIGENC; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kovacs M., 1992, MANUAL CHILDRENS DEP; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Perry Bruce D., 1999, Current Opinion in Pediatrics, V11, P310, DOI 10.1097/00008480-199908000-00008; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rapoport J. L., 1996, DSM 4 TRAINING GUIDE, P232; Raven J., 2003, MANUAL RAVENS PROGR; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spielberger CD, 1973, STATE TRAIT ANXIETY; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Wechsler D, 2003, WECHSLER INTELLIGENC; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	80	10	10	0	16	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2016	30	7					800	810		10.1037/neu0000299			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DY9FX	WOS:000385440400003	27548577				2022-02-06	
J	Shah, SU; Socha, M; Fries, I; Gibaud, S				Shah, Shefaat Ullah; Socha, Marie; Fries, Isabelle; Gibaud, Stephane			Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines	DRUG DELIVERY			English	Article						Alginate; Crohn's disease; nitric oxide; oral route; polymer	NITROSATED SERUM-ALBUMIN; TRAUMATIC BRAIN-INJURY; NANOPARTICLES; GLUTATHIONE; CHITOSAN; RELEASE; NITROSOTHIOL; MECHANISMS; PHYSIOLOGY; VIABILITY	S-nitrosothiols are a class of NO-donors currently under investigation for the treatment of various diseases. In this study, we developed a novel NO-donor (S-nitrosoglutathione-alginate, SNA) by cross-linking alginate with S-nitrosothiols, which can deliver NO in a sustained manner. This compound can be further evaluated for oral delivery to treat Crohn's disease. This new compound was prepared using a two-step procedure involving (I) linkage of reduced glutathione to alginate and (II) post-nitrosation with sodium nitrite (NaNO2). The amount of linked thiol moieties for the possible nitrosation was calculated using Ellman's method, and the amount of NO abducted on the polymer was calculated using the Griess-Saville method. An ex vivo model (i.e. Ussing chamber) was used to investigate the permeation of this new NO-donor across the rat intestinal barrier. We obtained polymers with different numbers of abducted NOs (174 +/- 21 mu mol/g for SNA F1 and 468 +/- 23 mu mol/g for SNA F2) depending on the procedure used for nitrosation. In the ex vivo studies in the Ussing chamber, SNA F2 exhibited a sustained release for at least 10 h. The effect of pH on the stability of the new compound was also investigated, and the new compound was more stable at a mildly basic pH of 8.4 where 73% remained after 1 week. However, only 50% remained after 1 week at an acidic pH of 1.2. In the cytotoxicity studies (Caco2), this compound was nontoxic at concentrations of less than 200 mu M.	[Shah, Shefaat Ullah; Socha, Marie; Fries, Isabelle; Gibaud, Stephane] Univ Lorraine, EA 3452, CITHEFOR, Nancy, France; [Shah, Shefaat Ullah] Gomal Univ, Fac Pharm, Dept Pharmaceut, Dera Ismail Khan, Kpk, Pakistan		Gibaud, S (corresponding author), Univ Lorraine, CITHEFOR, EA 3452/, Fac Pharm, 5 Rue Albert Lebrun, F-54000 Nancy, France.	stephane.gibaud@univ-lorraine.fr	SOCHA, Marie/D-3425-2016; GIBAUD, Stephane/F-2650-2010	SOCHA, Marie/0000-0002-9913-9090; GIBAUD, Stephane/0000-0003-3594-0601	Higher Education Commission of PakistanHigher Education Commission of Pakistan	SU Shah wishes to acknowledge funding support by the Higher Education Commission of Pakistan.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Appenzeller-Herzog C, 2011, J CELL SCI, V124, P847, DOI 10.1242/jcs.080895; Atyabi F, 2008, CARBOHYD POLYM, V74, P59, DOI 10.1016/j.carbpol.2008.01.015; Bernkop-Schnurch A, 2001, J CONTROL RELEASE, V71, P277, DOI 10.1016/S0168-3659(01)00227-9; Calija B, 2013, COLLOID SURFACE B, V110, P395, DOI 10.1016/j.colsurfb.2013.05.016; Everett TR, 2014, BRIT J CLIN PHARMACO, V78, P660, DOI 10.1111/bcp.12379; Freeman HJ, 2009, WORLD J GASTROENTERO, V15, P1315, DOI 10.3748/wjg.15.1315; Friedman A, 2009, EXPERT OPIN DRUG DEL, V6, P1113, DOI 10.1517/17425240903196743; Furuhashi S, 2012, INT J ONCOL, V40, P807, DOI 10.3892/ijo.2011.1243; Georgii JL, 2011, J TISSUE ENG REGEN M, V5, P612, DOI 10.1002/term.353; Heines S.V., 1958, J CHEM EDUC, V35, P187; Hornyak I, 2012, FREE RADICAL RES, V46, P214, DOI 10.3109/10715762.2011.647692; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; JOSEPHY PD, 1984, TETRAHEDRON LETT, V25, P1685, DOI 10.1016/S0040-4039(01)81144-8; Katsumi H, 2005, J PHARMACOL EXP THER, V314, P1117, DOI 10.1124/jpet.105.087429; Katsumi H, 2004, J PHARM SCI-US, V93, P2343, DOI 10.1002/jps.20147; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kilbourn R, 1996, MOL MED TODAY, V2, P324, DOI 10.1016/1357-4310(96)81795-3; Luminita J., 2002, J PREV MED, V10, P35; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marcato PD, 2013, CURR NANOSCI, V9, P1; MONCADA S, 1991, PHARMACOL REV, V43, P109; Parent M, 2013, CURR PHARM ANAL, V9, P31; Ronzani C, 2014, CELL BIOL TOXICOL, V30, P137, DOI 10.1007/s10565-014-9275-4; Safar R, 2015, MOL PHARMACEUT, V12, P554, DOI 10.1021/mp5006382; Saraiva J, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/936438; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Schulz K, 1999, NITRIC OXIDE-BIOL CH, V3, P225, DOI 10.1006/niox.1999.0226; Seabra AB, 2005, BIOMACROMOLECULES, V6, P2512, DOI 10.1021/bm050216z; Servetnyk Z, 2011, EXP MOL PATHOL, V90, P79, DOI 10.1016/j.yexmp.2010.10.005; Shah SU, 2015, EXPERT OPIN DRUG DEL, V12, P1209, DOI 10.1517/17425247.2015.1028916; Shin HW, 2001, J APPL PHYSIOL, V90, P777, DOI 10.1152/jappl.2001.90.3.777; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Sosnik Alejandro, 2014, ISRN Pharm, V2014, P926157, DOI 10.1155/2014/926157; Thomsen OO, 1998, NEW ENGL J MED, V339, P370, DOI 10.1056/NEJM199808063390603; Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853; WOLFE DL, 1973, J PHARM SCI, V62, P200, DOI 10.1002/jps.2600620203; Yousefpour P, 2011, DARU, V19, P367	42	10	10	1	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1071-7544	1521-0464		DRUG DELIV	Drug Deliv.	OCT	2016	23	8					2927	2935		10.3109/10717544.2015.1122676			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	ED3LK	WOS:000388750400033	26666370	Green Submitted, Bronze			2022-02-06	
J	Thelin, EP; Zibung, E; Riddez, L; Nordenvall, C				Thelin, E. P.; Zibung, E.; Riddez, L.; Nordenvall, C.			Assessing bicycle-related trauma using the biomarker S100B reveals a correlation with total injury severity	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Biomarkers; Traumatic brain injury; Assessment tools; Bicycle trauma; Emergency care; CT scanning; S100B	SERUM S100B; HEAD-INJURY; BRAIN-DAMAGE; S-100B PROTEIN; HELMET USE; MARKER; BLOOD; S100-BETA; RELEASE; ADULTS	Worldwide, the use of bicycles, for both recreation and commuting, is increasing. S100B, a suggested protein biomarker for cerebral injury, has been shown to correlate to extracranial injury as well. Using serum levels of S100B, we aimed to investigate how S100B could be used when assessing injuries in patients suffering from bicycle trauma injury. As a secondary aim, we investigated how hospital length of stay and injury severity score (ISS) were correlated to S100B levels. We performed a retrospective, database study including all patients admitted for bicycle trauma to a level 1 trauma center over a four-year period with admission samples of S100B (n = 127). Computerized tomography (CT) scans were reviewed and remaining data were collected from case records. Univariate- and multivariate regression analyses, linear regressions and comparative statistics (Mann-Whitney) were used where appropriate. Both intra- and extracranial injuries were correlated with S100B levels. Stockholm CT score presented the best correlation of an intracranial parameter with S100B levels (p < 0.0001), while the presences of extremity injury, thoracic injury, and non-cervical spinal injury were also significantly correlated (all p < 0.0001, respectively). A multivariate linear regression revealed that Stockholm CT score, non-cervical spinal injury, and abdominal injury all independently correlated with levels of S100B. Patients with a ISS > 15 had higher S100 levels than patients with ISS < 16 (p < 0.0001). Patients with extracranial, as well as intracranial- and extracranial injuries, had significantly higher levels of S100B than patients without injuries (p < 0.05 and p < 0.01, respectively). The admission serum levels of S100B (log, A mu g/L) were correlated with ISS (log) (r = 0.53) and length of stay (log, days) (r = 0.45). S100B levels were independently correlated with intracranial pathology, but also with the extent of extracranial injury. Length of stay and ISS were both correlated with the admission levels of S100B in bicycle trauma, suggesting S100B to be a good marker of aggregated injury severity. Further studies are warranted to confirm our findings.	[Thelin, E. P.] Karolinska Inst, Karolinska Univ Hosp Solna, Neurosurg Sect, Dept Clin Neurosci, R2 02, S-17176 Stockholm, Sweden; [Zibung, E.; Riddez, L.; Nordenvall, C.] Karolinska Inst, Dept Mol Med & Surg, Solna, Sweden; [Zibung, E.; Riddez, L.; Nordenvall, C.] Karolinska Univ Hosp Solna, S-17176 Stockholm, Sweden		Thelin, EP (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Neurosurg Sect, Dept Clin Neurosci, R2 02, S-17176 Stockholm, Sweden.	eric.thelin@ki.se; evelyne.zibung.hofmann@ki.se; louis.riddez@karolinska.se; caroline.nordenvall@ki.se	Nordenvall, Caroline/C-4058-2016; Thelin, Eric Peter/K-2144-2012	Nordenvall, Caroline/0000-0002-5112-8894; Thelin, Eric Peter/0000-0002-2338-4364	Stiftelsen Tornspiran	This study was funded by the 'Stiftelsen Tornspiran'. Authors of this manuscript, and not the funders, are responsible for its content. The funders had no role in the study design; the collection, analysis, and interpretation of the data; the writing of the manuscript; and the decision to submit the manuscript for publication.	Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Barzo P, 1997, ACT NEUR S, V70, P243; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Dang XB, 2014, INT J CLIN EXP PATHO, V7, P3818; Edirisinghe PAS, 2014, J FORENSIC LEG MED, V27, P9, DOI 10.1016/j.jflm.2014.07.002; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; HAIMOTO H, 1987, LAB INVEST, V57, P489; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kim JK, 2007, ACCIDENT ANAL PREV, V39, P238, DOI 10.1016/j.aap.2006.07.002; Krnjak L, 2008, ACTA CLIN CROAT, V47, P221; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nolen S, 2005, HEALTH PROMOT INT, V20, P33, DOI 10.1093/heapro/dah505; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Pucher J, 2011, TRANSPORT RES A-POL, V45, P451, DOI 10.1016/j.tra.2011.03.001; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Richard JB, 2013, ACCIDENT ANAL PREV, V60, P113, DOI 10.1016/j.aap.2013.08.008; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Stamataki E, 2013, SHOCK, V40, P274, DOI 10.1097/SHK.0b013e3182a35de5; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; TEASDALE G, 1974, LANCET, V2, P81; Teisch LF, 2015, PEDIATR SURG INT, V31, P1021, DOI 10.1007/s00383-015-3756-2; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Zibung E, 2015, EUR J TRAUMA EMERG S, V41, P517, DOI 10.1007/s00068-014-0471-y; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	49	10	10	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2016	42	5					617	625		10.1007/s00068-015-0583-z			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DY5WZ	WOS:000385176400013	26490563				2022-02-06	
J	Williams, LK; McCarthy, MC; Burke, K; Anderson, V; Rinehart, N				Williams, Lauren K.; McCarthy, Maria C.; Burke, Kylie; Anderson, Vicki; Rinehart, Nicole			Addressing behavioral impacts of childhood leukemia: A feasibility pilot randomized controlled trial of a group videoconferencing parenting intervention	EUROPEAN JOURNAL OF ONCOLOGY NURSING			English	Article						Psycho-oncology; Pediatric; Psychology; Acute lymphoblastic leukemia; Behavior; Parenting	ACUTE LYMPHOBLASTIC-LEUKEMIA; TRAUMATIC BRAIN-INJURY; ONSET CONDUCT PROBLEMS; QUALITY-OF-LIFE; SELF-MANAGEMENT; CYSTIC-FIBROSIS; CHILDREN; PROGRAM; CANCER; METAANALYSIS	Purpose: Child emotional and behavioral problems constitute significant sequelae of acute lymphoblastic leukemia (ALL) treatment. The aims of this study were to a) examine the feasibility, acceptability and satisfaction of a parenting intervention amongst parents of children with ALL and b) explore whether participation in a parenting intervention shows promise for improvements in child behavior. Methods: 12 parents with a child aged between 2 and 8 years receiving maintenance phase treatment for ALL participated in a phase 2 randomized controlled trial comparing eight weeks of group online participation in Triple P: Positive Parenting Program with no intervention. Results: The number of eligible parents who completed the intervention was low (31.6%). Main reasons for non-consent or dropout were program time commitment too high or content not relevant. For parents who completed the intervention, satisfaction and acceptability was high. Parents reported the intervention as highly relevant and topical, feasible, helpful and a positive experience. Results indicated a non-significant trend towards improved total child behavioral and emotional difficulties following the intervention. Qualitative results indicated that intervention group parents reported improvements in parenting skills and competence, and decreased child behavioral problems. Conclusions: These pilot data highlight the difficulties of engaging and retaining parents in an 8-week parenting intervention in this context. For parents who completed the intervention, results indicated high feasibility, acceptability and satisfaction. Suggestions for further research and intervention modifications are provided to enhance uptake and strengthen efforts to assist parents in addressing child behavioral and emotional challenges during ALL treatment. (C) 2016 Elsevier Ltd. All rights reserved.	[Williams, Lauren K.; McCarthy, Maria C.; Burke, Kylie; Anderson, Vicki; Rinehart, Nicole] Murdoch Childrens Res Inst, Remington Rd, Parkville, Vic 3052, Australia; [Williams, Lauren K.] Deakin Univ, Sch Psychol, 1 Gheringhap St, Geelong, Vic 3220, Australia; [McCarthy, Maria C.; Anderson, Vicki] Royal Childrens Hosp, Flemington Rd, Parkville, Vic 3052, Australia; [Burke, Kylie] Univ Queensland, Sch Psychol, Parenting & Family Support Ctr, St Lucia, Qld 4072, Australia; [Anderson, Vicki] Univ Melbourne, Dept Pediat, Flemington Rd, Parkville, Vic 3052, Australia; [Anderson, Vicki; Rinehart, Nicole] Deakin Univ, Sch Psychol, 221 Burwood Highway, Burwood, Vic 3125, Australia		Williams, LK (corresponding author), Murdoch Childrens Res Inst, Remington Rd, Parkville, Vic 3052, Australia.	Lauren.Williams@mcri.edu.au	Burke, Kylie/ABG-9404-2020	Burke, Kylie/0000-0003-4246-0120; Rinehart, Nicole/0000-0001-6109-3958	Ponting Foundation; Murdoch Childrens Research Institution; Victorian Government Department of Human Services and Operational Infrastructure Support Program	This study was funded by the Ponting Foundation, Murdoch Childrens Research Institution and the Victorian Government Department of Human Services and Operational Infrastructure Support Program. We gratefully acknowledge the parents who participated in the study, and Madeleine Bowden and Erin Lloyd, the project research assistants who assisted with participant recruitment and provided technical support during video-conference sessions.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Antonini TN, 2012, J TELEMED TELECARE, V18, P333, DOI 10.1258/jtt.2012.120404; Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429; Bartholomew LK, 1997, HEALTH EDUC BEHAV, V24, P652, DOI 10.1177/109019819702400511; Boyatzis R. E., 1998, TRANSFORMING QUALITA; BROWN DG, 1995, SOC WORK HEALTH CARE, V21, P81, DOI 10.1300/J010v21n01_07; Chiang LC, 2009, INT J NURS STUD, V46, P1061, DOI 10.1016/j.ijnurstu.2009.01.013; Clarke SA, 2014, CHILD CARE HLTH DEV, V40, P492, DOI 10.1111/cch.12073; Colletti CJM, 2008, PEDIATR BLOOD CANCER, V51, P269, DOI 10.1002/pbc.21577; Daniel G, 2013, RURAL REMOTE HEALTH, V13; DAVIES WH, 1991, J PEDIATR PSYCHOL, V16, P295, DOI 10.1093/jpepsy/16.3.295; De Wilde EF, 2005, EUR ADDICT RES, V11, P157, DOI 10.1159/000086396; Fedele DA, 2013, J PEDIATR PSYCHOL, V38, P531, DOI 10.1093/jpepsy/jst010; Gebert N, 1998, PATIENT EDUC COUNS, V35, P213, DOI 10.1016/S0738-3991(98)00061-5; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; HANZLIK J R, 1989, Physical and Occupational Therapy in Pediatrics, V9, P33, DOI 10.1300/J006v09n04_03; Hullmann SE, 2010, QUAL LIFE RES, V19, P1373, DOI 10.1007/s11136-010-9696-3; Law EF, 2014, J PEDIATR PSYCHOL, V39, P866, DOI 10.1093/jpepsy/jsu032; Long KA, 2011, CLIN CHILD FAM PSYCH, V14, P57, DOI 10.1007/s10567-010-0082-z; McGrath P, 2002, SUPPORT CARE CANCER, V10, P146, DOI 10.1007/s00520-001-0319-y; Morawska A, 2015, J CHILD HEALTH CARE, V19, P5, DOI 10.1177/1367493513496664; Pound CM, 2012, J PEDIAT HEMATOL ONC, V34, P517, DOI 10.1097/MPH.0b013e318257fdac; Reger MA, 2009, J CLIN PSYCHOL, V65, P53, DOI 10.1002/jclp.20536; Sanders M., 2003, PARENTING RES PRACTI, V1, P1; Sanders MR, 2014, CLIN PSYCHOL REV, V34, P337, DOI 10.1016/j.cpr.2014.04.003; Sanders MR, 2012, BEHAV RES THER, V50, P675, DOI 10.1016/j.brat.2012.07.004; Sanders MR, 2000, J CONSULT CLIN PSYCH, V68, P624, DOI 10.1037//0022-006X.68.4.624; Sassmann H, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-152; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Stehl ML, 2009, J PEDIATR PSYCHOL, V34, P803, DOI 10.1093/jpepsy/jsn130; TARNOWSKI KJ, 1992, J BEHAV THER EXP PSY, V23, P101, DOI 10.1016/0005-7916(92)90007-6; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Vance Y, 2004, PEDIATR BLOOD CANCER, V42, P249, DOI 10.1002/pbc.10440; Wade SL, 2011, PROF PSYCHOL-RES PR, V42, P487, DOI 10.1037/a0025222; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Whittingham K, 2014, PEDIATRICS, V133, pE1249, DOI 10.1542/peds.2013-3620; Williams LK, 2015, CHILD CARE HLTH DEV, V41, P611, DOI 10.1111/cch.12188; Williams LK, 2014, PEDIATR BLOOD CANCER, V61, P2065, DOI 10.1002/pbc.25164	38	10	10	1	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1462-3889	1532-2122		EUR J ONCOL NURS	Eur. J. Oncol. Nurs.	OCT	2016	24						61	69		10.1016/j.ejon.2016.08.008			9	Oncology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Nursing	EJ9JA	WOS:000393541200009	27697278				2022-02-06	
J	Yang, WH; Chen, PC; Wang, TC; Kuo, TY; Cheng, CY; Yang, YH				Yang, Wei-Hsun; Chen, Pau-Chung; Wang, Ting-Chung; Kuo, Ting-Yu; Cheng, Chun-Yu; Yang, Yao-Hsu			Endocrine dysfunction following traumatic brain injury: a 5-year follow-up nationwide-based study	SCIENTIFIC REPORTS			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE DEFICIENCY; PITUITARY-FUNCTION; POSTTRAUMATIC HYPOPITUITARISM; HEAD-INJURY; HYPOTHALAMOPITUITARY DYSFUNCTION; NEUROENDOCRINE DYSFUNCTION; FREE CORTISOL; SEPTIC SHOCK; LONG-TERM	Post-traumatic endocrine dysfunction is a complication of traumatic brain injury (TBI). However, there is lack of long-term follow-up and large sample size studies. This study included patients suffering from TBI registered in the Health Insurance Database. Endocrine disorders were identified using the ICD codes: 244 (acquired hypothyroidism), 253 (pituitary dysfunction), 255 (disorders of the adrenal glands), 258 (polyglandular dysfunction), and 259 (other endocrine disorders) with at least three outpatient visits within 1 year or one admission diagnosis. Overall, 156,945 insured subjects were included in the final analysis. The 1- and 5-year incidence rates of post-traumatic endocrinopathies were 0.4% and 2%, respectively. The risks of developing a common endocrinopathy (p < 0.001) or pituitary dysfunction (P < 0.001) were significantly higher in patients with a TBI history. Patients with a skull bone fracture had a higher risk of developing pituitary dysfunction at the 1-year follow up (p value < 0.001). At the 5-year follow up, the association between intracranial hemorrhage and pituitary dysfunction (p value: 0.002) was significant. The risk of developing endocrine dysfunction after TBI increased during the entire 5-year follow-up period. Skull bone fracture and intracranial hemorrhage may be associated with short and long-term post-traumatic pituitary dysfunction, respectively.	[Yang, Wei-Hsun; Wang, Ting-Chung; Cheng, Chun-Yu] Chang Gung Mem Hosp, Chia Yi Ctr, Dept Surg, Div Neurosurg, Chiayi, Taiwan; [Chen, Pau-Chung; Yang, Yao-Hsu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Kuo, Ting-Yu; Yang, Yao-Hsu] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan		Chen, PC; Yang, YH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.; Chen, PC (corresponding author), Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan.; Chen, PC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Yang, YH (corresponding author), Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan.; Yang, YH (corresponding author), Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan.; Yang, YH (corresponding author), Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan.	pchen@ntu.edu.tw; r95841012@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011; 楊, 曜旭/A-3450-2019	Chen, Pau-Chung/0000-0002-6242-5974; 楊, 曜旭/0000-0002-8080-0504; Cheng, Chun-Yu/0000-0003-2233-2666	Chang Gung Memorial Hospital, Chia-yi Branch	We thank the Center of Excellence for Chang Gung Research Datalink (CORPG6D0161) for the comments and assistance with the data analysis. This study was supported by a grant from Chang Gung Memorial Hospital, Chia-yi Branch, and was based on the National Health Insurance Research Database provided by the Central Bureau of National Health Insurance, the Department of Health, and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health, or National Health Research Institutes.	Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2005, THESCIENTIFICWORLDJO, V5, P777, DOI 10.1100/tsw.2005.100; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Ceballos R, 1966, Ala J Med Sci, V3, P185; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masel B. E., 2015, J NEUROTRAUM, V32, P1; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jcem.77.6.8263155; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood K. W., 2010, CLIN PEDIAT; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Servadei F, 2002, NEUROEPIDEMIOLOGY, V21, P297, DOI 10.1159/000065523; Shallice T., 2011, ORG MIND; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; Zihl J, 2015, J CLIN MED, V4, P1051, DOI 10.3390/jcm4051051	53	10	11	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 9	2016	6								32987	10.1038/srep32987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV2YG	WOS:000382787600001	27608606	Green Published, gold			2022-02-06	
J	Furlan, JC; Craven, BC; Fehlings, MG				Furlan, Julio C.; Craven, Beverly Catharine; Fehlings, Michael G.			Surgical Management of the Elderly With Traumatic Cervical Spinal Cord Injury: A Cost-Utility Analysis	NEUROSURGERY			English	Article						age; cost-utility analysis; neurotrauma; spinal cord injury	MEDICAL DECISION-ANALYSIS; UNITED-STATES; BURDEN; CARE; AGE; RECOMMENDATIONS; OUTCOMES; CANADA; ADULTS; PRIMER	BACKGROUND: Aging of the population has modified the epidemiology of traumatic spinal cord injury (SCI) as evidenced by the establishment of a bimodal distribution of injuries with increased frequency of fall-related injuries among the elderly. OBJECTIVE: To assess the economic impact of older age (65 years of age and older), using a cost-utility analysis, in the context of acute surgical management and rehabilitation of traumatic cervical SCI, given the paucity of economic studies involving elderly individuals with SCI. METHODS: The cost-utility analysis was performed from the perspective of a public health care insurer. A time horizon of 6 months from SCI onset was used. Costs were estimated in 2014 US dollars. Utilities were generated from the Surgical Timing in Acute Spinal Cord Injury study. RESULTS: The baseline analysis indicated that surgical and rehabilitative management of acute cervical SCI in the elderly (n = 17) is costlier, but similarly effective, than that in younger adults (n = 47). When considering acute spinal surgical management and rehabilitation of younger adults with SCI as the baseline, the incremental cost-effectiveness ratio analysis revealed an additional cost of $5 655 557 per quality-adjusted life-year gained when managing elderly patients with traumatic cervical SCI. The probabilistic analysis confirmed that spinal surgery in the elderly is costlier, but similarly effective, in younger adults after SCI, even though there is no definitive dominance. CONCLUSION: This economic analysis indicates that surgical management and rehabilitation of acute traumatic cervical SCI in the elderly are costlier but similarly effective compared with younger adults with similar impairment.	[Furlan, Julio C.] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Furlan, Julio C.; Craven, Beverly Catharine] Univ Toronto, Dept Med, Div Phys Med & Rehabil, Toronto, ON, Canada; [Furlan, Julio C.; Craven, Beverly Catharine] Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, 520 Sutherland Dr,Room 205, Toronto, ON M4G 3V9, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Spinal Program, Krembil Neurosci Ctr, Toronto, ON, Canada		Furlan, JC (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, 520 Sutherland Dr,Room 205, Toronto, ON M4G 3V9, Canada.	jcfurlan@gmail.com	Craven, Beverley/D-5001-2015; Furlan, Julio/Q-8290-2018	Craven, Beverley/0000-0001-8234-6803; Furlan, Julio/0000-0002-2038-0018; Fehlings, Michael/0000-0002-5722-6364	Spinal Cord Injury Solutions Network Rapid Response Award from the Rick Hansen Foundation; Toronto Rehabilitation Institute Foundation; Halbert Chair in Neural Repair and Regeneration; Dezwirek Foundation	The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Drs Furlan and Fehlings are supported by a Spinal Cord Injury Solutions Network Rapid Response Award from the Rick Hansen Foundation. Dr Furlan is supported by the Toronto Rehabilitation Institute Foundation. Dr Fehlings is supported by the Halbert Chair in Neural Repair and Regeneration and by the Dezwirek Foundation.	Brauer CA, 2005, J BONE JOINT SURG AM, V87A, P1253, DOI 10.2106/JBJS.D.02152; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P733, DOI 10.1016/S0003-9993(99)90219-8; CIHI, 2007, BURD NEUR DIS DIS IN; Detsky AS, 1997, MED DECIS MAKING, V17, P126, DOI 10.1177/0272989X9701700202; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Furlan JC, 2009, SPINAL CORD, V47, P674, DOI 10.1038/sc.2009.23; Furlan JC, 2013, AGING CLIN EXP RES, V25, P463, DOI 10.1007/s40520-013-0066-1; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Gershkoff A M, 1993, Arch Phys Med Rehabil, V74, pS402; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Kepler CK, 2012, SPINE J, V12, P676, DOI 10.1016/j.spinee.2012.05.011; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Mahabaleshwarkar R, 2014, SPINAL CORD, V52, P139, DOI 10.1038/sc.2013.144; McKinley W, 2003, NEUROREHABILITATION, V18, P83; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; National Spinal Cord Injury Statistical Center, 2013, SPIN CORD INJ FACTS; Nwachukwu BU, 2015, SPINE, V40, P31, DOI 10.1097/BRS.0000000000000663; O'Connor PJ, 2006, ACCIDENT ANAL PREV, V38, P71, DOI 10.1016/j.aap.2005.03.025; OCCI, 2005, ONT CAS COST IN DAT; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Ryen L, 2015, HEALTH ECON, V24, P1289, DOI 10.1002/hec.3085; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	29	10	10	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	SEP	2016	79	3					418	425		10.1227/NEU.0000000000001314			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	DV9PX	WOS:000383274400023	27306716				2022-02-06	
J	Hansen, M; Meckler, G; O'Brien, K; Engle, P; Dickinson, C; Dickinson, K; Jui, J; Lambert, W; Cottrell, E; Guise, JM				Hansen, Matthew; Meckler, Garth; O'Brien, Kerth; Engle, Phillip; Dickinson, Caitlin; Dickinson, Kathryn; Jui, Jonathan; Lambert, William; Cottrell, Erika; Guise, Jeanne-Marie			Pediatric Airway Management and Prehospital Patient Safety: Results of a National Delphi Survey by the Children's Safety Initiative-Emergency Medical Services for Children	PEDIATRIC EMERGENCY CARE			English	Article						emergency medical services; endotracheal intubation; pediatric prehospital care; pediatric airway management	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; FIELD; SURVIVAL; IMPACT; TRIAL; CARE	Objective The objective of this study was to determine what aspects of prehospital pediatric airway management may contribute to patient safety events. Methods We conducted a 3-phase Delphi survey in prehospital professionals across the United States to identify potential contributors to patient safety events. Respondents ranked how likely factors were to contribute on a 9-point Likert-type scale and were allowed to elaborate through open-ended questions. Analysis was conducted using a mixed-methods approach, including Likert-type responses and open-ended questions which were analyzed for specific themes. Results All 3 phases of the survey were completed by 492 participants; 50.8% of respondents were paramedics, 22% were emergency medical technician-basics/first responders, and 11.4% were physicians. Seventy-five percent identified lack of experience with advanced airway management, and 44% identified medical decision making regarding airway interventions as highly likely to lead to safety events. Within the domain of technical skills, advanced airway management was ranked in the top 3 contributors to safety events by 71% of participants, and bag-mask ventilation by 18%. Qualitative analysis of questions within the domains of equipment and technical skills identified endotracheal intubation as the top contributor to safety events, with bag-mask ventilation second. In the domains of assessment and decision making, respiratory assessment and knowing when to perform an advanced airway were ranked most highly. Conclusions This national Delphi survey identified lack of experience with pediatric airway management and challenges in decision making in advanced airway management as high risk for safety events, with endotracheal intubation as the most likely of these.	[Hansen, Matthew; Jui, Jonathan] Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Meckler, Garth] Univ British Columbia, Div Pediat Emergency Med, Vancouver, BC, Canada; [O'Brien, Kerth] Portland State Univ, Dept Psychol, Portland, OR 97207 USA; [Engle, Phillip] Oregon Hlth Author, Salem, OR USA; [Dickinson, Caitlin; Dickinson, Kathryn; Cottrell, Erika; Guise, Jeanne-Marie] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Lambert, William; Guise, Jeanne-Marie] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA		Hansen, M (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hansemat@ohsu.edu		Guise, Jeanne-Marie/0000-0002-8961-488X; Meckler, Garth/0000-0002-6057-0465	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD062478-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD062478] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER	This study is supported by the National Institute of Child Health and Human Development grant: "Epidemiology of Preventable Safety Events in Prehospital EMS of Children," Grant No. 1R01HD062478-04.	Anders J, 2014, CLIN PEDIATR EMERG M, V15, P28, DOI 10.1016/j.cpem.2014.01.010; Babl FE, 2001, PEDIATR EMERG CARE, V17, P5, DOI 10.1097/00006565-200102000-00002; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Cudnik MT, 2010, J EMERG MED, V38, P175, DOI 10.1016/j.jemermed.2008.01.022; Dalkey, 1969, DELPHI METHOD EXPT S; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Ehrlich PF, 2004, J PEDIATR SURG, V39, P1376, DOI 10.1016/j.jpedsurg.2004.05.010; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gerritse BM, 2008, RESUSCITATION, V79, P225, DOI 10.1016/j.resuscitation.2008.05.016; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Holmes J, 2012, PREHOSP EMERG CARE, V16, P210, DOI 10.3109/10903127.2011.640416; Lerner EB, 2014, PREHOSP EMERG CARE, V18, P52, DOI 10.3109/10903127.2013.836262; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	18	10	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2016	32	9					603	607		10.1097/PEC.0000000000000742			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	DX3TO	WOS:000384297300006	27253653	Green Accepted			2022-02-06	
J	Haran, FJ; Alphonso, AL; Creason, A; Campbell, JS; Johnson, D; Young, E; Tsao, JW				Haran, F. J.; Alphonso, Aimee L.; Creason, Alia; Campbell, Justin S.; Johnson, Dagny; Young, Emily; Tsao, Jack W.			Reliable Change Estimates for Assessing Recovery From Concussion Using the ANAM4 TBI-MIL	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ANAM; concussion; military; reliable change; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; CLINICAL-SIGNIFICANCE; BASE-LINE; NORMATIVE COMPARISONS; COGNITIVE IMPAIRMENT; SPORTS CONCUSSION; REACTION-TIME; IRAQ; PERFORMANCE	Objective: To establish the reliable change parameters for the Automated Neuropsychological Assessment Metrics (ANAM) using a healthy normative sample of active duty service members (SMs) and apply the parameters to sample of recently deployed SMs. Methods: Postdeployment neurocognitive performance was compared in 1893 US Marines with high rates of combat exposure during deployment. Of the sample, 289 SMs had data for 2 predeployment assessments and were used as a normative subsample and 502 SMs had data for predeployment and postdeployment assessments and were used as a deployed subsample. On the basis of self-report, the deployed subsample were further classified as concussed (n = 238) or as nonconcussed controls (n = 264). Reliable change parameters were estimated from the normative sample and applied data for both deployed groups. Postdeployment performance was quantified using a general linear model (2 group x 2 time) multivariate analysis of variance with repeated measures. Results: Both deployed groups demonstrated a pattern of meaningful decreases in performance over time. Conclusions: Information from this effort, specifically the reliable change parameters and the base rates of reliable decline, can be used to assist with the identification of postdeployment cognitive issues.	[Haran, F. J.] Navy Expt Div Unit, Biomed Res & Operat Dept, 321 Bullfinch Rd, Panama City Beach, FL 32407 USA; [Alphonso, Aimee L.] Yale Med Sch, New Haven, CT USA; [Creason, Alia] Pricewaterhouse Coopers, Hyderabad, Andhra Pradesh, India; [Campbell, Justin S.] Naval Space & Warfare Syst Ctr Pacific, San Diego, CA USA; [Johnson, Dagny; Young, Emily] Eyak Dev Corp, Arlington, VA USA; [Tsao, Jack W.] Traumat Brain Injury Programs, Wounded, IL USA; [Tsao, Jack W.] US Navy, Injured Directorate, Bur Med & Surg, Arlington, VA USA		Haran, FJ (corresponding author), Navy Expt Div Unit, Biomed Res & Operat Dept, 321 Bullfinch Rd, Panama City Beach, FL 32407 USA.	jay.haran@navy.mil			Wounded, Illinois, and Injured Directorate [M9]; US Navy Bureau of Medicine and Surgery (BUMED)	This study was funded by the Wounded, Illinois, and Injured Directorate (M9), US Navy Bureau of Medicine and Surgery (BUMED).	Ajitkumar PM, 2013, LARYNGOSCOPE, V123, P2276; [Anonymous], 2013, 6490 13 DODI COMPR P; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Chelune GJ, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P123; Cohen J., 2013, STAT POWER ANAL BEHA; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kendall PC, 1999, J CONSULT CLIN PSYCH, V67, P285, DOI 10.1037/0022-006X.67.3.285; KENDALL PC, 1988, BEHAV ASSESS, V10, P147; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McCrea M., 2008, MILD TRAUMATIC BRAIN; McHugh T, 2006, BRAIN COGNITION, V60, P209; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Polusny MA, 2010, ARCH GEN PSYCHIAT, V68, P79; Putukian M, 2011, PM R S2, V3, P32; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; US Department of Veterans Affairs, VA DOD CLIN PRACT GU; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2010, MILITARY NEUROPSYCHO, P321; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	51	10	10	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					329	338		10.1097/HTR.0000000000000172			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600011	26291627				2022-02-06	
J	Karic, T; Roe, C; Nordenmark, TH; Becker, F; Sorteberg, A				Karic, Tanja; Roe, Cecilie; Nordenmark, Tonje Haug; Becker, Frank; Sorteberg, Angelika			IMPACT OF EARLY MOBILIZATION AND REHABILITATION ON GLOBAL FUNCTIONAL OUTCOME ONE YEAR AFTER ANEURYSMAL SUBARACHNOID HAEMORRHAGE	JOURNAL OF REHABILITATION MEDICINE			English	Article						early rehabilitation; mobilization; functional outcome; subarachnoid haemorrhage	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; INTRACRANIAL ANEURYSMS; STROKE; SCALE; LIFE; INTERVENTION; DIFFERENCE; GUIDELINES; MANAGEMENT	Objective: To assess the impact of early mobilization and rehabilitation on global functional outcome one year after aneurysmal subarachnoid haemorrhage. Methods: Prospective, controlled, interventional study comprising patients managed in the neuro-intermediate ward following repair of a ruptured intracranial aneurysm. Patients in the Control group (n=76) received standard treatment, whereas those in the Early Rehab group (n=92) in addition underwent early mobilization and rehabilitation. Demographic, clinical and intervention data were registered. Global functional outcome was assessed using the modified Rankin Scale and the Glasgow Outcome Scale Extended. Results: The 2 groups were similar in their demographic and clinical characteristics. Early Rehab group patients were mobilized more quickly (p<0.001), median 1.4 days (range 0-23 days) after aneurysm repair. After 1 year, 47% of the patients had made a good recovery, whereas 6.5% had died. Regression analysis did not reveal any significant effect of early rehabilitation on functional outcome. However, in poor-grade patients, early rehabilitation more than doubled the chance of a favourable outcome (adjusted odds ratio=2.33; confidence interval 1.04-5.2, p=0.039). Conclusion: Early mobilization and rehabilitation probably increases the chance of a good functional outcome in poor grade aneurysmal subarachnoid haemorrhage patients.	[Karic, Tanja; Roe, Cecilie; Nordenmark, Tonje Haug] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Karic, Tanja; Sorteberg, Angelika] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Becker, Frank] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Roe, Cecilie; Becker, Frank; Sorteberg, Angelika] Univ Oslo, Inst Clin Med, Oslo, Norway		Karic, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Ullevaal, Norway.; Karic, T (corresponding author), Natl Hosp Norway, PB 4950 Nydalen, NO-0424 Oslo, Norway.	tanja.karic@gmail.com		Becker, Frank/0000-0002-0857-0628			Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Czapiga B, 2014, REHABIL NURS, V39, P250, DOI 10.1002/rnj.125; Diserens K, 2006, CEREBROVASC DIS, V22, P183, DOI 10.1159/000093453; Diserens K, 2012, CLIN REHABIL, V26, P451, DOI 10.1177/0269215511425541; DRAKE CG, 1988, J NEUROSURG, V68, P985; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; HENDERSON WG, 1977, STROKE, V8, P579, DOI 10.1161/01.STR.8.5.579; HEROS RC, 1983, ANN NEUROL, V14, P599, DOI 10.1002/ana.410140602; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Inagawa T, 2000, J NEUROSURG, V93, P958, DOI 10.3171/jns.2000.93.6.0958; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Jessup RL, 2007, AUST HEALTH REV, V31, P330, DOI 10.1071/AH070330; Karic T, 2015, DISABIL REHABIL, V37, P1446, DOI 10.3109/09638288.2014.966162; Mendez-Tellez PA, 2012, NEUROHOSPITALIST, V2, P96, DOI 10.1177/1941874412447631; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Olkowski BF, 2013, PHYS THER, V93, P208, DOI 10.2522/ptj.20110334; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Rand ML, 2015, ARCH PHYS MED REHAB, V96, P1191, DOI 10.1016/j.apmr.2015.02.008; Riordan Margaret A, 2015, Acta Neurochir Suppl, V120, P55, DOI 10.1007/978-3-319-04981-6_10; Schuiling WJ, 2005, NEUROSURGERY, V57, P230, DOI 10.1227/01.NEU.0000166536.42876.9C; SCHUTZ H, 1993, NEUROSURG REV, V16, P15, DOI 10.1007/BF00308606; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Sorteberg W, 2008, BRIT J NEUROSURG, V22, P53, DOI 10.1080/02688690701593553; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; van Heuven AW, 2008, STROKE, V39, P1347, DOI 10.1161/STROKEAHA.107.498345; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; 2008, CEREBROVASC DIS, V25, P457, DOI DOI 10.1159/000131083	38	10	10	2	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2016	48	8					676	682		10.2340/16501977-2121			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DY2TC	WOS:000384943900006	27494170	Green Submitted, Green Published, gold			2022-02-06	
J	Miller, B; Yelverton, E; Monico, J; Replogle, W; Jordan, JR				Miller, Brandon; Yelverton, Eden; Monico, Jesus; Replogle, William; Jordan, J. Randall			Pediatric head and neck injuries due to golf cart trauma	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Golf cart; Trauma		Introduction: Golf carts are increasingly used off the golf course and are often viewed as innocuous modes of transportation. However, research has shown they can cause significant injuries, particularly to children. Objectives: Analyze golf cart related head and neck injuries in children and adults from a national database. Methods: The National Electronic Injury Surveillance System (NEISS) was queried for golf cart injuries. The NEISS tracks consumer product related injuries from a sampling of approximately 100 emergency departments across the United States. Age, general diagnosis (concussion, fracture, laceration), body-part injured, disposition (hospitalized, discharged), location injury occurred, and mechanism of injury were analyzed. Results: Over an 11-year period, a total of 3433 total patients were identified. There were 1471 children (16 years old or younger), which compromised 42.9% of the cohort. Children were injured at home or on the road 44.7% of the time compared to only 16.6% of adults (p < 0.003). Children injured their head or neck 42.6% of the time compared to 28.6% of adults (p < 0.0001). Adults who were hit by a car while riding a golf cart or were ejected from the golf cart 44.6% of the time compared to 61.7% of children (p < 0.0001). There were 3.9% of children with a face, head, or neck fracture compared to only 2.4% of adults (p = 0.01). Conclusion: Children are more vulnerable to golf cart related injuries, specifically to the head and neck. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Miller, Brandon; Yelverton, Eden; Jordan, J. Randall] Univ Mississippi, Med Ctr, Dept Otolaryngol & Commun Sci, Jackson, MS 39216 USA; [Monico, Jesus] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Replogle, William] Univ Mississippi, Med Ctr, Dept Family Med, Jackson, MS 39216 USA		Jordan, JR (corresponding author), Univ Mississippi, Med Ctr, Dept Otolaryngol & Commun Sci, Jackson, MS 39216 USA.	bmiller1541@gmail.com	liu, ting/AAA-1112-2022				Miller BL, 2011, OTOLARYNG HEAD NECK, V144, P883, DOI 10.1177/0194599810396790; Seluga K, 2009, 21 INT TECHN C ENH S; Seluga KJ, 2006, ACCIDENT ANAL PREV, V38, P1151, DOI 10.1016/j.aap.2006.04.023; Seluga KJ, 2005, ACCIDENT ANAL PREV, V37, P801, DOI 10.1016/j.aap.2005.03.022; Seluga KJ, 2009, ACCIDENT ANAL PREV, V41, P839, DOI 10.1016/j.aap.2009.04.017; TRAVIS LW, 1977, J TRAUMA, V17, P761, DOI 10.1097/00005373-197710000-00003; Watson DS, 2008, AM J PREV MED, V35, P55, DOI 10.1016/j.amepre.2008.03.029	7	10	10	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	SEP	2016	88						38	41		10.1016/j.ijporl.2016.06.041			4	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	DT9SG	WOS:000381842000009	27497384				2022-02-06	
J	Tracy, BM; Dunne, JR; O'Neal, CM; Clayton, E				Tracy, Brett M.; Dunne, James R.; O'Neal, Cindy Marie; Clayton, Eric			Venous thromboembolism prophylaxis in neurosurgical trauma patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Venous thromboembolism; Deep venous thrombosis; Pulmonary emboli; Traumatic brain injury; Spinal injury; LMWH	DEEP-VEIN THROMBOSIS; SPINAL-CORD-INJURY; BRAIN-INJURY; HEMORRHAGE PROGRESSION; PULMONARY-EMBOLISM; RISK; PREVENTION; SAFETY; CHEMOPROPHYLAXIS; ENOXAPARIN	Background: Venous thromboembolisms (VTEs) occur more frequently in patients with traumatic brain injuries (TBIs) and spinal cord injuries, yet the use of chemoprophylaxis is controversial. The purpose of this study was to investigate the relationship between the timing of chemical VTE prophylaxis initiation and the development of VTE events in these patients. Methods: Prospective data were collected and retrospectively reviewed on 1425 patients sustaining TBIs or spinal injuries from 2010 to 2014. Patients were reviewed with respect to age, gender, injury severity score, Glasgow coma score, and mechanism of injury as well as timing of initiation of chemical VTE prophylaxis and presence or absence of VTE. Results: Patients who developed a VTE had a significantly longer time to initiation of chemical VTE prophylaxis (6.7 +/- 4.9 d versus 4.7 +/- 4.9 d, P < 0.001) compared with those that did not develop a VTE. Also, for each 1 d increase in time to prophylaxis initiation, the odds of developing a VTE increased significantly (odds ratio = 1.055, P < 0.001). The combination subarachnoid hemorrhage/subdural hemorrhage group was started on VTE prophylaxis significantly later (8.3 perpendicular to 6.1 d versus 6.7 perpendicular to 3.9 d, P < 0.01) than the overall TBI group and had a higher incidence of VTE (14.4 versus 10.4%, P = NS). In contrast, patients sustaining isolated spinal injuries received chemical VTE prophylaxis significantly earlier (3.4 +/- 4.2 d versus 6.7 +/- 3.9 d, P < 0.001) and had a significant decrease in their VTE rate (4.4 versus 10.4%, P < 0.0001) compared with the overall TBI group. Conclusions: Patients with VTEs had a significant delay in time to initiation of chemoprophylaxis compared with patients without VTEs. Patients sustaining a TBI had a 2-fold delay in initiation of chemoprophylaxis and an associated 2-fold increase in VTE events compared with patients who sustained spinal injuries. Of those patients who developed a TBI, patients who sustained a combination subarachnoid hemorrhage and/or subdural hemorrhage had a significant delay in initiation of chemoprophylaxis with a higher rate of VTE events. (C) 2016 Elsevier Inc. All rights reserved.	[Tracy, Brett M.; Dunne, James R.; O'Neal, Cindy Marie; Clayton, Eric] Mem Univ Med Ctr, Dept Surg, 4700 Waters Ave, Savannah, GA 31404 USA		Tracy, BM (corresponding author), Mem Univ Med Ctr, Dept Surg, 4700 Waters Ave, Savannah, GA 31404 USA.	d9012@memorialhealth.com		Clayton, Eric/0000-0003-0871-8060; Tracy, Brett/0000-0002-1469-3608			Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Aito S, 2002, SPINAL CORD, V40, P300, DOI 10.1038/sj.sc.3101298; [Anonymous], 2015, ACS TQIP BEST PRACTI, P1; Arnold JD, 2010, AM SURGEON, V76, P563; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Christie S, 2011, J NEUROTRAUM, V28, P1509, DOI 10.1089/neu.2009.1155-A; Chung WS, 2014, THROMB RES, V133, P579, DOI 10.1016/j.thromres.2014.01.008; Cipolle MD, 2002, J TRAUMA, V52, P453, DOI 10.1097/00005373-200203000-00007; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; DeMuro JP, 2013, J BLOOD DISORD TRANS, V4, P4; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Foreman PM, 2014, CLIN NEUROL NEUROSUR, V123, P109, DOI 10.1016/j.clineuro.2014.05.017; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Gudipati S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-39; Harris S, 1996, AM J PHYS MED REHAB, V75, P326, DOI 10.1097/00002060-199609000-00002; Haut ER, 2007, J TRAUMA, V63, P1132, DOI 10.1097/TA.0b013e31814856ad; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Lobastov K, 2016, J VASC SURG-VENOUS L, V4, P153, DOI 10.1016/j.jvsv.2015.09.004; Malinoski D, 2013, INJURY, V44, P80, DOI 10.1016/j.injury.2011.10.006; Nickele CM, 2013, NEUROCRIT CARE, V18, P184, DOI 10.1007/s12028-012-9786-x; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Raslan AM, 2010, NEUROCRIT CARE, V12, P297, DOI 10.1007/s12028-009-9316-7; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers SO, 2007, J TRAUMA, V62, P562; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Urbankova J, 2005, THROMB HAEMOSTASIS, V94, P1181, DOI 10.1160/TH05-04-0222; Weber B, 2014, ANZ J SURG, P1	34	10	10	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2016	205	1					221	227		10.1016/j.jss.2016.06.049			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DW0VE	WOS:000383360300032	27621023				2022-02-06	
J	Servatius, RJ; Marx, CE; Sinha, S; Avcu, P; Kilts, JD; Naylor, JC; Pang, KCH				Servatius, Richard J.; Marx, Christine E.; Sinha, Swamini; Avcu, Pelin; Kilts, Jason D.; Naylor, Jennifer C.; Pang, Kevin C. H.			Brain and Serum Androsterone Is Elevated in Response to Stress in Rats with Mild Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						acoustic startle response; lateral fluid percussion; corticosterone; concussions; Sprague-Dawley; allopregnanolone; pregnenolone; footshock	NEUROACTIVE STEROIDS; MILITARY PERSONNEL; BEHAVIORAL DEFICITS; SUICIDE ATTEMPTS; CONTROLLED-TRIAL; COPING STYLES; CELL-DEATH; ALLOPREGNANOLONE; NEUROSTEROIDS; PREGNENOLONE	Exposure to lateral fluid percussion (LFP) injury consistent with mild traumatic brain injury (mTBI) persistently attenuates acoustic startle responses (ASRs) in rats. Here, we examined whether the experience of head trauma affects stress reactivity. Male Sprague-Dawley rats were matched for ASRs and randomly assigned to receive mTBI through LFP or experience a sham surgery (SHAM). ASRs were measured post injury days (PIDs) 1, 3, 7, 14, 21, and 28. To assess neurosteroids, rats received a single 2.0 mA, 0.5 s foot shock on PID 34 (S34), PID 35 (S35), on both days (2S), or the experimental context (CON). Levels of the neurosteroids pregnenolone (PREG), allopregnanolone (ALLO), and androsterone (ANDRO) were determined for the prefrontal cortex, hippocampus, and cerebellum. For 2S rats, repeated blood samples were obtained at 15, 30, and 60 min post-stressor for determination of corticosterone (CORT) levels after stress or context on PID 34. Similar to earlier work, ASRs were severely attenuated in mTBI rats without remission for 28 days after injury. No differences were observed between mTBI and SHAM rats in basal CORT, peak CORT levels or its recovery. In serum and brain, ANDRO levels were the most stress-sensitive. Stress-induced ANDRO elevations were greater than those in mTBI rats. As a positive allosteric modulator of gamma-aminobutyric acid (GABA(A)) receptors, increased brain ANDRO levels are expected to be anxiolytic. The impact of brain ANDRO elevations in the aftermath of mTBI on coping warrants further elaboration.	[Servatius, Richard J.] Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, Syracuse, NY USA; [Servatius, Richard J.; Sinha, Swamini; Avcu, Pelin; Pang, Kevin C. H.] Rutgers State Univ, Rutgers Biomed Hlth Sci, Str & Motivated Behav Inst, Newark, NJ 07102 USA; [Servatius, Richard J.; Sinha, Swamini; Avcu, Pelin; Pang, Kevin C. H.] Rutgers State Univ, Grad Sch Biomed Sci, Newark, NJ 07102 USA; [Marx, Christine E.; Kilts, Jason D.; Naylor, Jennifer C.] Durham Vet Affairs Med Ctr, Vet Affairs Midatlantic Mental Illness Res Educ &, Durham, NC USA; [Marx, Christine E.; Kilts, Jason D.; Naylor, Jennifer C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Pang, Kevin C. H.] New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA		Servatius, RJ (corresponding author), Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, Syracuse, NY USA.; Servatius, RJ (corresponding author), Rutgers State Univ, Rutgers Biomed Hlth Sci, Str & Motivated Behav Inst, Newark, NJ 07102 USA.; Servatius, RJ (corresponding author), Rutgers State Univ, Grad Sch Biomed Sci, Newark, NJ 07102 USA.	richard.servatius@va.gov		Servatius, Richard/0000-0002-7023-4895	Department of Veterans Affairs (New Jersey Health Care System)US Department of Veterans Affairs; Department of Veterans Affairs (Syracuse VA Medical Center); Department of Veterans Affairs (Durham VAMC)US Department of Veterans Affairs; Merit Review (VA Rehabilitation Research Development) [RX000571]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [11K2RX000908]; Stress AMP; Motivated Behavior Institute; Rutgers-Graduate School of Biomedical Sciences; VA Biomedical Laboratory Research Development [BX000132]; New Jersey Commission on Brain Injury Research [CBIR1111T003]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000908, I01BX000132, I01RX000571] Funding Source: NIH RePORTER	The research was supported by Department of Veterans Affairs (New Jersey Health Care System, Syracuse VA Medical Center, and Durham VAMC) and through Merit Review funding (CM; VA Rehabilitation Research & Development RX000571). Dr. JN is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (11K2RX000908). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The research was further supported by the Stress & Motivated Behavior Institute (RS), Rutgers-Graduate School of Biomedical Sciences (SS and PA), VA Biomedical Laboratory Research & Development BX000132 (KP), and the New Jersey Commission on Brain Injury Research, #CBIR1111T003 (KP).	Ben Dor R, 2015, PSYCHOPHARMACOLOGY, V232, P3375, DOI 10.1007/s00213-015-3991-1; BLUMENTHAL TD, 1991, PSYCHOPHYSIOLOGY, V28, P296, DOI 10.1111/j.1469-8986.1991.tb02198.x; BOHNEN N, 1992, INT J NEUROSCI, V64, P97, DOI 10.3109/00207459209000536; Brown ES, 2014, NEUROPSYCHOPHARMACOL, V39, P2867, DOI 10.1038/npp.2014.138; Bryan CJ, 2015, SUICIDE LIFE-THREAT, V45, P315, DOI 10.1111/sltb.12127; Bryan CJ, 2014, COMPR PSYCHIAT, V55, P534, DOI 10.1016/j.comppsych.2013.10.006; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; DelCerro S, 1996, GLIA, V18, P293, DOI 10.1002/(SICI)1098-1136(199612)18:4<293::AID-GLIA4>3.0.CO;2-Z; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; GEORGE MS, 1994, BIOL PSYCHIAT, V35, P775, DOI 10.1016/0006-3223(94)91139-8; Girdler SS, 2007, PHARMACOL THERAPEUT, V116, P125, DOI 10.1016/j.pharmthera.2007.05.006; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kelley MH, 2008, J NEUROCHEM, V107, P668, DOI 10.1111/j.1471-4159.2008.05617.x; Kilts JD, 2010, PAIN MED, V11, P1469, DOI 10.1111/j.1526-4637.2010.00927.x; Lu J, 2004, METHOD ENZYMOL, V386, P200; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Marx C. E., 2016, TRANSLATIONAL RES TR; Marx CE, 2006, PSYCHOPHARMACOLOGY, V186, P462, DOI 10.1007/s00213-005-0226-x; Marx CE, 2014, PSYCHOPHARMACOLOGY, V231, P3647, DOI 10.1007/s00213-014-3673-4; Marx CE, 2006, NEUROPSYCHOPHARMACOL, V31, P1249, DOI 10.1038/sj.npp.1300952; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Melcangi RC, 2016, NEUROSCI BIOBEHAV R, V67, P25, DOI 10.1016/j.neubiorev.2015.09.023; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Morrow AL, 2007, PHARMACOL THERAPEUT, V116, P1, DOI 10.1016/j.pharmthera.2007.04.003; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Pinna G, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00166; Pinna G, 2012, J NEUROENDOCRINOL, V24, P102, DOI 10.1111/j.1365-2826.2011.02234.x; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Rasmusson AM, 2006, BIOL PSYCHIAT, V60, P704, DOI 10.1016/j.biopsych.2006.03.026; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schule C, 2011, NEUROSCIENCE, V191, P55, DOI 10.1016/j.neuroscience.2011.03.025; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Servatius RJ, 2008, BEHAV BRAIN RES, V192, P191, DOI 10.1016/j.bbr.2008.04.006; SERVATIUS RJ, 1994, PHYSIOL BEHAV, V56, P945, DOI 10.1016/0031-9384(94)90328-X; Servatius RJ, 1998, J PHARMACOL EXP THER, V287, P1020; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Sripada RK, 2014, HUM BRAIN MAPP, V35, P3249, DOI 10.1002/hbm.22399; Sripada RK, 2013, NEUROPSYCHOPHARMACOL, V38, P1798, DOI 10.1038/npp.2013.79; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Vallee M, 2000, ANAL BIOCHEM, V287, P153, DOI 10.1006/abio.2000.4841; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson MA, 1997, LIFE SCI, V60, P1679, DOI 10.1016/S0024-3205(97)00110-0; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	61	10	10	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 26	2016	10								379	10.3389/fnins.2016.00379			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU6BH	WOS:000382297500001	27616978	Green Published, gold			2022-02-06	
J	Hensley, K; Poteshkina, A; Johnson, MF; Eslami, P; Gabbita, SP; Hristov, AM; Venkova-Hristova, KM; Harris-White, ME				Hensley, Kenneth; Poteshkina, Aleksandra; Johnson, Ming F.; Eslami, Pirooz; Gabbita, S. Prasad; Hristov, Alexandar M.; Venkova-Hristova, Kalina M.; Harris-White, Marni E.			Autophagy Modulation by Lanthionine Ketimine Ethyl Ester Improves Long-Term Outcome after Central Fluid Percussion Injury in the Mouse	JOURNAL OF NEUROTRAUMA			English	Article						autophagy; behavior; diffuse axon injury; pathology	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; NEURONAL CELL-DEATH; CLOSED-HEAD INJURY; CAENORHABDITIS-ELEGANS; ALZHEIMERS-DISEASE; NEUROFILAMENT COMPACTION; MAMMALIAN TARGET; RAPAMYCIN MTOR; NERVE-FIBERS	Diffuse axonal injury is recognized as a progressive and long-term consequence of traumatic brain injury. Axonal injury can have sustained negative consequences on neuronal functions such as anterograde and retrograde transport and cellular processes such as autophagy that depend on cytoarchitecture and axon integrity. These changes can lead to somatic atrophy and an inability to repair and promote plasticity. Obstruction of the autophagic process has been noted after brain injury, and rapamycin, a drug used to stimulate autophagy, has demonstrated positive effects in brain injury models. The optimization of drugs to promote beneficial autophagy without negative side effects could be used to attenuate traumatic brain injury and promote improved outcome. Lanthionine ketimine ethyl ester, a bioavailable derivative of a natural sulfur amino acid metabolite, has demonstrated effects on autophagy both in vitro and in vivo. Thirty minutes after a moderate central fluid percussion injury and throughout the survival period, lanthionine ketimine ethyl ester was administered, and mice were subsequently evaluated for learning and memory impairments and biochemical and histological changes over a 5-week period. Lanthionine ketimine ethyl ester, which we have shown previously to modulate autophagy markers and alleviate pathology and slow cognitive decline in the 3 x TgAD mouse model, spared cognition and pathology after central fluid percussion injury through a mechanism involving autophagy modulation.	[Hensley, Kenneth; Hristov, Alexandar M.; Venkova-Hristova, Kalina M.] Univ Toledo, Dept Pathol, Hlth Sci Campus, Toledo, OH USA; [Hensley, Kenneth] Univ Toledo, Dept Neurosci, Hlth Sci Campus, Toledo, OH USA; [Gabbita, S. Prasad] P2D Biosci Inc, Cincinnati, OH USA; [Poteshkina, Aleksandra; Johnson, Ming F.; Eslami, Pirooz; Harris-White, Marni E.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Harris-White, Marni E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 11301 Wilshire Blvd 151, Los Angeles, CA 90073 USA		Harris-White, ME (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 11301 Wilshire Blvd 151, Los Angeles, CA 90073 USA.	marni@ucla.edu					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Au AK, 2010, BBA-MOL BASIS DIS, V1802, P918, DOI 10.1016/j.bbadis.2009.10.010; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Button RW, 2015, NEUROSCI BULL, V31, P382, DOI 10.1007/s12264-015-1528-y; Cavallini D, 1983, Prog Clin Biol Res, V125, P355; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cooper Arthur J. L., 2016, NEUROCHEMICAL RES; Courville C.B., 1946, ARCH NEUROL PSYCHIAT, V31, P527; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Farrell JAD, 2010, MAGN RESON MED, V63, P1323, DOI 10.1002/mrm.22389; Fogel AL, 2015, J AM ACAD DERMATOL, V72, P879, DOI 10.1016/j.jaad.2015.01.014; Fu MM, 2014, DEV CELL, V29, P577, DOI 10.1016/j.devcel.2014.04.015; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gallagher LE, 2013, ESSAYS BIOCHEM, V55, P1, DOI [10.1042/bse0550001, 10.1042/BSE0550001]; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; Gogel S, 2010, DEV NEUROBIOL, V70, P456, DOI 10.1002/dneu.20789; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Guyenet S. J., 2010, J VIS EXP; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris-White ME, 2015, NEUROBIOL DIS, V84, P60, DOI 10.1016/j.nbd.2015.03.007; Hensley K, 2015, FREE RADICAL BIO MED, V78, P123, DOI 10.1016/j.freeradbiomed.2014.10.581; Hensley K, 2013, J NEUROPATH EXP NEUR, V72, P955, DOI 10.1097/NEN.0b013e3182a74372; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hensley K, 2010, MOLECULES, V15, P5581, DOI 10.3390/molecules15085581; Hensley K, 2010, J NEUROSCI, V30, P2979, DOI 10.1523/JNEUROSCI.5247-09.2010; HOLLENBECK PJ, 1993, J CELL BIOL, V121, P305, DOI 10.1083/jcb.121.2.305; Hubbard C, 2013, J NEUROSCI RES, V91, P1183, DOI 10.1002/jnr.23239; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; LI W, 1992, GENETICS, V132, P675; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nada SE, 2012, NEUROCHEM INT, V61, P1357, DOI 10.1016/j.neuint.2012.09.013; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STRICH SJ, 1961, LANCET, V2, P443; Taghian K, 2012, J NEUROTRAUM, V29, P1728, DOI 10.1089/neu.2011.2063; Takemoto T, 2000, GENE, V261, P259, DOI 10.1016/S0378-1119(00)00494-7; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; Tsuboi D, 2005, J NEUROCHEM, V95, P1629, DOI 10.1111/j.1471-4159.2005.03490.x; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wirth M, 2013, SEMIN CANCER BIOL, V23, P301, DOI 10.1016/j.semcancer.2013.05.007; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Yang L, 2008, CLIN CANCER RES, V14, P3993, DOI 10.1158/1078-0432.CCR-07-4152; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078	90	10	10	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1501	+		10.1089/neu.2015.4196			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900004	26530250				2022-02-06	
J	Fakhran, S; Qu, C; Alhilali, LM				Fakhran, S.; Qu, C.; Alhilali, L. M.			Effect of the Suboccipital Musculature on Symptom Severity and Recovery after Mild Traumatic Brain Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							SEGMENT DYNAMIC STABILIZATION; CERVICAL EXTENSOR MUSCLES; FINITE-ELEMENT-ANALYSIS; DURA-MATER; PROFESSIONAL FOOTBALL; WHIPLASH INJURIES; MINOR MUSCLE; HEADACHE; CONCUSSION; IMPACT	BACKGROUND AND PURPOSE: Neck musculature mass has been suggested as a biomechanical contributor to injury severity in mild traumatic brain injury. We sought to determine how the cross-sectional areas of the suboccipital muscles affect symptom severity, neurocognitive performance, and recovery time in patients with mild traumatic brain injury. MATERIALS AND METHODS: Sixty-four consecutive patients with mild traumatic brain injury underwent MR imaging and serial neurocognitive testing with the Immediate Post-Concussion Assessment and Cognitive Test. Cross-sectional areas of the rectus capitis posterior musculature were retrospectively obtained at C1, and cross-sectional areas of the remaining 7 suboccipital muscles were measured at C2. Cross-sectional area reproducibility was evaluated. Overall and individual muscle cross-sectional areas were correlated with symptom severity, neuropsychological testing, recovery time, and headache. RESULTS: Sixty-four patients with mild traumatic brain injury had imaging through C1, and 43 had imaging through C2. Reproducibility of cross-sectional area measurements was substantial (correlation coefficients = 0.9517-0.9891). Lower cross-sectional area of the rectus capitis posterior minor was correlated with greater symptom severity (r = 0.596, P < .0001), longer recovery time (r = 0.387, P = .002), poor verbal memory performance (r = 0.285, P = .02), and headache (r = 0.39, P = .001). None of the other cross-sectional areas were associated with symptom severity, recovery time, neurocognitive testing, or headache. CONCLUSIONS: In mild traumatic brain injury, the rectus capitis posterior minor is the only suboccipital muscle whose cross-sectional area is associated with symptom severity and worse outcome. Given the unique connection of this muscle to the dura, this finding may suggest that pathology of the myodural bridge contributes to symptomatology and prognosis in mild traumatic brain injury.	[Fakhran, S.] East Valley Diagnost Imaging Banner Hlth & Hosp S, Dept Radiol, Mesa, AZ USA; [Qu, C.] Univ Pittsburgh, Dept Radiol, Div Neuroradiol, Med Ctr, Pittsburgh, PA 15260 USA; [Alhilali, L. M.] Barrow Neurol Inst, Dept Neuroradiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA		Alhilali, LM (corresponding author), Barrow Neurol Inst, Dept Neuroradiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	lalhilali@sniweb.net					Alix ME, 1999, J MANIP PHYSIOL THER, V22, P534, DOI 10.1016/S0161-4754(99)70006-0; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Demetrious James, 2007, Chiropr Osteopat, V15, P20, DOI 10.1186/1746-1340-15-20; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott JM, 2011, SPINE, V36, pS205, DOI 10.1097/BRS.0b013e3182387f57; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Fernandez-de-las-Penas C, 2007, CEPHALALGIA, V27, P355, DOI 10.1111/j.1468-2982.2007.01293.x; Gennarelli T, 1982, HEAD INJURY BASIC CL, V1982, P129; Gray H, 1995, GRAYS ANATOMY ANATOM, P806; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hack GD, 2004, HEADACHE, V44, P84, DOI 10.1111/j.1526-4610.2004.04015.x; Hallgren Richard C., 1993, Journal of Clinical Engineering, V18, P433; Hallgren Richard C., 1994, Journal of the American Osteopathic Association, V94, P1032; Hedenstierna S, 2009, SPINE, V34, P2626, DOI 10.1097/BRS.0b013e3181b46bdd; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Maelender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI [10.1080/13854046.2010.51607220924979, DOI 10.1080/13854046.2010.516072]; Mansell J, 2005, J ATHL TRAINING, V40, P310; Maughan R J, 1984, Br J Sports Med, V18, P149; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McBride G., 2005, HAM2005062 NIWA, V45, P307; McPartland JM, 1997, J MANIP PHYSIOL THER, V20, P24; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; PECK D, 1984, J MORPHOL, V180, P243, DOI 10.1002/jmor.1051800307; PLAGENHOEF S, 1983, RES Q EXERCISE SPORT, V54, P169, DOI 10.1080/02701367.1983.10605290; REID SE, 1981, AVIAT SPACE ENVIR MD, V52, P78; SCHANTZ P, 1983, ACTA PHYSIOL SCAND, V117, P219, DOI 10.1111/j.1748-1716.1983.tb07200.x; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Soumekh B, 1996, AM J OTOL, V17, P617; Sterling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077903; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Vibert N, 2001, J PHYSIOL-LONDON, V532, P851, DOI 10.1111/j.1469-7793.2001.0851e.x; Wall PD, 2006, WALL MELZACKS TXB PA, P102	39	10	12	0	8	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	AUG	2016	37	8					1556	1560		10.3174/ajnr.A4730			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DT5FQ	WOS:000381507400027	27012296	Green Published, hybrid			2022-02-06	
J	Hides, JA; Mendis, MD; Smith, MMF; Miokovic, T; Cooper, A; Choy, NL				Hides, Julie A.; Mendis, M. Dilani; Smith, Melinda M. Franettovich; Miokovic, Tanja; Cooper, Andrew; Choy, Nancy Low			Association between altered motor control of trunk muscles and head and neck injuries in elite footballers - An exploratory study	MANUAL THERAPY			English	Article						Concussion; Multifidus muscle; Transversus abdominis muscle; Ultrasound imaging; Sports injury	LUMBAR MULTIFIDUS MUSCLE; LOW-BACK-PAIN; POSITION SENSE; CONTRACTION; PLAYERS; SIZE; EPIDEMIOLOGY; RELIABILITY; INTRARATER; SPINE	Background: Head and neck injuries are common in football. Injuries such as concussion can have serious consequences. Previous studies have shown that size and function of trunk muscles are predictive of lower limb injuries in professional Australian Football League (AFL) players. It is unknown whether measurement of trunk muscles can also be used to predict head and neck injuries. Objectives: To examine whether trunk muscle measurements predict head and neck injuries incurred by professional AFL players. Design: Prospective cohort study. Method: Ultrasound imaging of trunk muscles was performed on 165 professional AFL players at the start of the pre-season and 168 players at the start of the playing season. Injury data were obtained from records collected by the AFL club staff during the playing season. Results/findings: The ability to contract the multifidus (MF) muscle at the L5/S1 vertebral level at the start of pre-season and start of the playing season predicted head and neck injury in the playing season. Sensitivity and specificity of the model were 56.3% and 76.6% for the pre-season and 50.0% and 77.2% for the playing season respectively. Conclusions: A model with potential clinical utility was developed for prediction of head and neck injuries in AFL players. These predictive values will need to be validated in other teams. Ability to contract MF is modifiable and this information could be incorporated into pre-season injury prevention programs. (C) 2016 Elsevier Ltd. All rights reserved.	[Hides, Julie A.; Mendis, M. Dilani; Smith, Melinda M. Franettovich; Miokovic, Tanja; Cooper, Andrew] Australian Catholic Univ, Mary Mackillop Inst Hlth Res, Ctr Musculoskeletal Res, Woolloongabba, Qld 4102, Australia; [Hides, Julie A.] Mater Hlth Serv, Mater ACU Back Stabil Clin, South Brisbane, Qld 4101, Australia; [Mendis, M. Dilani] Mater Hlth Serv, Physiotherapy Dept, South Brisbane, Qld 4101, Australia; [Choy, Nancy Low] Australian Catholic Univ, Sch Physiotherapy, Banyo 4014, Australia; [Choy, Nancy Low] Prince Charles Hosp, Physiotherapy Dept, Chermside 4032, Australia		Hides, JA (corresponding author), Level 1,631 Stanley St, Woolloongabba, Qld 4102, Australia.	julie.hides@acu.edu.au	Smith, Melinda Franettovich/AAK-1568-2021; Natarajan, Meena/J-9167-2012; Hides, Julie Anne/F-2141-2011	Smith, Melinda Franettovich/0000-0002-0098-7656; Natarajan, Meena/0000-0001-5652-9681; Hides, Julie Anne/0000-0002-1830-8121			Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Brumagne S, 1999, SPINE, V24, P1328, DOI 10.1097/00007632-199907010-00010; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Claus AP, 2009, SPINE, V34, pE208, DOI 10.1097/BRS.0b013e3181908ead; Falla D, 2007, MANUAL THER, V12, P139, DOI 10.1016/j.math.2006.06.003; HIDES JA, 1995, SPINE, V20, P54, DOI 10.1097/00007632-199501000-00010; Hides J, 2012, J ATHL TRAINING, V47, P314, DOI 10.4085/1062-6050-47.3.03; Hides JA, 2007, J ORTHOP SPORT PHYS, V37, P480, DOI 10.2519/jospt.2007.2416; Hides JA, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114537588; Hides JA, 2014, MED SCI SPORT EXER, V46, P762, DOI 10.1249/MSS.0000000000000169; Hides JA, 2012, MED SCI SPORT EXER, V44, P1141, DOI 10.1249/MSS.0b013e318244a321; Hides JA, 2011, J ORTHOP SPORT PHYS, V41, P767, DOI 10.2519/jospt.2011.3755; Hodges PW, 2003, MUSCLE NERVE, V27, P682, DOI 10.1002/mus.10375; Kiefer A, 1997, Eur Spine J, V6, P45, DOI 10.1007/BF01676574; Kiesel KB, 2007, MANUAL THER, V12, P161, DOI 10.1016/j.math.2006.06.011; Kogler A, 2000, ACTA OTO-LARYNGOL, V120, P151; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee LJ, 2010, RESP PHYSIOL NEUROBI, V170, P236, DOI 10.1016/j.resp.2010.01.001; Lemeshow S, 2000, APPL LOGISTIC REGRES; NITZ AJ, 1986, AM SURGEON, V52, P273; Orchard J, 2013, 21 AFL; Orchard J, 2015, 23 AFL; Pinsault N, 2010, SPINE, V35, P294, DOI 10.1097/BRS.0b013e3181b0c889; Sackett DL, 1996, EVIDENCE BASED MED, V1, P37; Sapsford RR, 2006, AUST J PHYSIOTHER, V52, P219, DOI 10.1016/S0004-9514(06)70031-9; von Elm E, 2008, INTERNIST, V49, P688, DOI 10.1007/s00108-008-2138-4; Wallwork TL, 2007, J ORTHOP SPORT PHYS, V37, P608, DOI 10.2519/jospt.2007.2418; Wallwork TL, 2009, MANUAL THER, V14, P496, DOI 10.1016/j.math.2008.09.006	30	10	10	0	16	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1356-689X	1532-2769		MANUAL THER	Man. Ther.	AUG	2016	24						46	51		10.1016/j.math.2016.05.001			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DO7VS	WOS:000377991700007	27317504				2022-02-06	
J	Rathbone, M; Parkinson, W; Rehman, Y; Jiang, S; Bhandari, M; Kumbhare, D				Rathbone, Michel; Parkinson, William; Rehman, Yasir; Jiang, Shucui; Bhandari, Mohit; Kumbhare, Dinesh			Magnitude and variability of effect sizes for the associations between chronic pain and cognitive test performances: a meta-analysis	BRITISH JOURNAL OF PAIN			English	Article						Chronic pain; memory; cognitive testing; cognitive performances; meta-analysis	CHRONIC NONMALIGNANT PAIN; POST-CONCUSSION SYMPTOMS; GRAY-MATTER; EXECUTIVE FUNCTION; DECISION-MAKING; WHIPLASH INJURY; COMMON WHIPLASH; MEMORY DEFICITS; BRAIN-INJURY; FIBROMYALGIA	Objectives and Methods: A systematic review and meta-analysis were performed to estimate the size and variability of the association between chronic pain (CP) and poorer cognitive test performances as a function of individual tests, pain sub-types, and study sources on 22 studies having (1) a control group, (2) reported means and standard deviations (SDs) and (3) tests studied at least 3 times. Results: CP patients performed significantly poorer with small to moderate effects (d=-.31 to -.57) on Digit Span Backward; STROOP Word; Color and Color-Word; Digit Symbol; Trait Making A and B; Rey Auditory Learning Immediate and Delayed Recall and Recognition. For these 10 measures, single effects (no interaction) were supported (I-2 = 0%-8%) and Random and Fixed models yielded similar results. No group differences were found for Corsi Blocks Forward or Wisconsin Cart Sorting Test Categories Achieved, or Perseveration. Effects for the Rey Complex Figure Immediate and Delayed Recall were significant, but effect size was inconclusive, given moderate to high heterogeneity and lack of consistency between Random and Fixed models. For the Paced Auditory Serial Addition Test, there was a homogeneous (I-2 = 0%) and significantly lower performance in fibromyalgia (d=-.47), but no effect in diagnostically undifferentiated pain samples, and wide variability across studies of whiplash (d=-.15 to -1.04, I-2 = 60%). Conclusion: The magnitude and consistency of the CP - cognition effect depended on the test, pain subgroup and study source.	[Rathbone, Michel] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Parkinson, William] McMaster Univ, Sch Rehabil Sci, 1400 Main St West, Hamilton, ON L8S 1C7, Canada; [Rehman, Yasir] McMaster Univ, Hlth Sci, Hamilton, ON, Canada; [Jiang, Shucui] McMaster Univ, Dept Biochem, Hamilton, ON, Canada; [Bhandari, Mohit] McMaster Univ, Dept Surg, Hamilton, ON, Canada; [Kumbhare, Dinesh] Univ Toronto, Dept Med, Toronto, ON, Canada		Parkinson, W (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West, Hamilton, ON L8S 1C7, Canada.	bparkins@mcmaster.ca	Bhandari, Mohit/AAQ-1675-2021; Rehman, Yasir/D-5335-2018	Rehman, Yasir/0000-0002-2817-3638; Kumbhare, Dinesh/0000-0003-3889-7557			Andersson G, 2003, EUR J PAIN, V7, P431, DOI 10.1016/S1090-3801(03)00002-8; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Berryman C, 2014, CLIN PSYCHOL REV, V34, P563, DOI 10.1016/j.cpr.2014.08.003; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Block C, 2013, NEUROREHABILITATION, V33, P343, DOI 10.3233/NRE-130965; Bosma FK, 2002, NEUROPSY NEUROPSY BE, V15, P56; Browning Michael, 2011, Psychosom Med, V73, P173, DOI 10.1097/PSY.0b013e31820824f6; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; Canovas R, 2009, RHEUMATOLOGY, V48, P1273, DOI 10.1093/rheumatology/kep218; Chapman CR, 1996, PROG BRAIN RES, V110, P63; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Dick BD, 2008, PAIN, V139, P610, DOI 10.1016/j.pain.2008.06.017; DISTEFANO G, 1995, ACTA NEUROL SCAND, V91, P346; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Field AP, 2005, PSYCHOL METHODS, V10, P444, DOI 10.1037/1082-989X.10.4.444; Gimse R, 1997, J CLIN EXP NEUROPSYC, V19, P838, DOI 10.1080/01688639708403764; Grace GM, 1999, J CLIN EXP NEUROPSYC, V21, P477, DOI 10.1076/jcen.21.4.477.876; Grisart JM, 2001, PAIN, V94, P305, DOI 10.1016/S0304-3959(01)00366-9; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu YF, 2010, EUR J ANAESTH, V27, P162, DOI 10.1097/EJA.0b013e328331a3d5; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jongsma MLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023363; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kessels RPC, 2000, J INT NEUROPSYCH SOC, V6, P271, DOI 10.1017/S1355617700633027; KEWMAN DG, 1991, INT J PSYCHIAT MED, V21, P253, DOI 10.2190/FRYK-TMGA-AULW-BM5G; Khatibi A, 2009, PAIN, V142, P42, DOI 10.1016/j.pain.2008.11.020; Kim SH, 2012, RHEUMATOL INT, V32, P1135, DOI 10.1007/s00296-010-1762-1; Landro NI, 1997, J PSYCHOSOM RES, V42, P297, DOI 10.1016/S0022-3999(96)00301-7; Lee DM, 2010, PAIN, V151, P30, DOI 10.1016/j.pain.2010.04.024; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Melkumova KA, 2011, NEUROSCIENCE BEHAV P, V41, P20, DOI DOI 10.1007/S11055-010-9376-3; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Oosterman JM, 2012, PAIN RES MANAG, V17, P159, DOI 10.1155/2012/962786; Oosterman JM, 2011, CLIN J PAIN, V27, P70, DOI 10.1097/AJP.0b013e3181f15cf5; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; Roldan-Tapia L, 2007, REUMATOL CLIN, V3, P101, DOI 10.1016/S1699-258X(07)73676-8; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sjogren P, 2005, EUR J PAIN, V9, P453, DOI 10.1016/j.ejpain.2004.10.005; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Takkouche B, 2013, AM J EPIDEMIOL, V178, P993, DOI 10.1093/aje/kwt060; The cochrane collaboration, 2014, REV MAN; Thorlund K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039471; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; Walitt B, 2008, RHEUMATOL INT, V28, P561, DOI 10.1007/s00296-007-0487-2; Walteros C, 2011, J PSYCHOSOM RES, V70, P294, DOI 10.1016/j.jpsychores.2010.07.013; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x; Wells GA, 2009, NEWCASTLE OTTAWA SCA	68	10	11	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2049-4637	2049-4645		BRIT J PAIN	Brit. J. Pain	AUG	2016	10	3					141	155		10.1177/2049463716642600			15	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VI0LG	WOS:000458587700004	27583141	Green Published			2022-02-06	
J	Bao, HJ; Qiu, HY; Kuai, JX; Song, CJ; Wang, SX; Wang, CQ; Peng, HB; Han, WC; Wu, YP				Bao, Hai-jun; Qiu, Hai-yang; Kuai, Jin-xia; Song, Cheng-jie; Wang, Shao-xian; Wang, Chao-qun; Peng, Hua-bin; Han, Wen-can; Wu, Yong-ping			Apelin-13 as a novel target for intervention in secondary injury after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; apoptosis; apelin-13; traumatic brain injury; brain edema; blood-brain barrier; brain water content; aquaporin-4; caspase-3; neural regeneration	CELL-DEATH; MODEL; AQUAPORIN-4; EDEMA; APJ; PROTECTS; RECEPTOR; AUTOPHAGY; LIGAND; GENE	The adipocytokine, apelin-13, is an abundantly expressed peptide in the nervous system. Apelin-13 protects the brain against ischemia/reperfusion injury and attenuates traumatic brain injury by suppressing autophagy. However, secondary apelin-13 effects on traumatic brain injury-induced neural cell death and blood-brain barrier integrity are still not clear. Here, we found that apelin-13 significantly decreases cerebral water content, mitigates blood-brain barrier destruction, reduces aquaporin-4 expression, diminishes caspase-3 and Bax expression in the cerebral cortex and hippocampus, and reduces apoptosis. These results show that apelin-13 attenuates secondary injury after traumatic brain injury and exerts a neuroprotective effect.	[Bao, Hai-jun; Qiu, Hai-yang; Wang, Shao-xian; Wang, Chao-qun; Peng, Hua-bin; Han, Wen-can; Wu, Yong-ping] Xuzhou Med Coll, Dept Pathol, Xuzhou, Jiangsu, Peoples R China; [Kuai, Jin-xia] Xuzhou Med Coll, Dept Forens Med, Xuzhou, Jiangsu, Peoples R China; [Song, Cheng-jie] Xuzhou Med Coll, Dept Physiol, Xuzhou, Jiangsu, Peoples R China		Wu, YP (corresponding author), Xuzhou Med Coll, Dept Pathol, Xuzhou, Jiangsu, Peoples R China.	wuyongping_123@tom.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81302612]; Natural Science Foundation of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu Province [12KJB310018]; Student Innovation Training Program of China [201410313023Z]	This work was supported by the National Natural Science Foundation of China, No. 81302612; the Natural Science Foundation of Jiangsu Province of China, No. 12KJB310018; a grant from the Student Innovation Training Program of China, No. 201410313023Z.	Aboutaleb N, 2014, INT J PEPT RES THER, V20, P127, DOI 10.1007/s10989-013-9374-8; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Choe W, 2000, J NEUROVIROL, V6, pS61; Eghwrudjakpor PO, 2010, LIBYAN J MED, V5, DOI [10.4176/091104, 10.3402/ljm.v5i0.4620]; He ZP, 2015, NEURAL REGEN RES, V10, P1082, DOI 10.4103/1673-5374.160099; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Hu Bao, 2014, NEUROCHEM RES, V40, P89; Jiao H, 2013, EXP THER MED, V5, P797, DOI 10.3892/etm.2013.902; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Khaksari M, 2012, J MOL NEUROSCI, V48, P201, DOI 10.1007/s12031-012-9808-3; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Nicchia GP, 2004, NEUROSCIENCE, V129, P935, DOI 10.1016/j.neuroscience.2004.07.055; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Saadoun S, 2003, J CLIN PATHOL, V56, P972, DOI 10.1136/jcp.56.12.972; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xin Q, 2015, PEPTIDES, V63, P55, DOI 10.1016/j.peptides.2014.09.016; Yan XG, 2015, NEURAL REGEN RES, V10, P766, DOI 10.4103/1673-5374.157243; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	30	10	11	1	6	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUL	2016	11	7					1128	1133		10.4103/1673-5374.187049			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DW6YW	WOS:000383798300028	27630697	gold, Green Published			2022-02-06	
J	Capilouto, GJ; Wright, HH; Maddy, KM				Capilouto, Gilson J.; Wright, Heather Harris; Maddy, Katherine McComas			Microlinguistic processes that contribute to the ability to relay main events: influence of age	AGING NEUROPSYCHOLOGY AND COGNITION			English	Article						Discourse; aging; main ideas; narratives; microlinguistic processes	OFF-TARGET VERBOSITY; CLOSED-HEAD-INJURY; LEXICAL DIVERSITY; NARRATIVE DISCOURSE; PICTURE DESCRIPTION; MULTILEVEL APPROACH; SPONTANEOUS SPEECH; OLDER-ADULTS; LANGUAGE; YOUNGER	The purpose of the current study was to determine the microlinguistic processes that contribute to picture description in healthy adults across the life span. Two-hundred forty healthy adults were separated into three groups, young (n=80; 20-39), middle (n=80; 40-69), and older (n=80; 70-89). Participants provided language samples in response to two single and two sequential pictures analyzed for total number of words, informativeness, lexical diversity, syntactic complexity, and main events. The older group produced a significantly lower proportion of main events for the single and sequential pictures compared to the other groups. Group differences on the microlinguistic measures varied depending on the measure and the stimulus type. Further, regardless of task, total number of words significantly related to main event production for the young and middle aged groups, but not the older group. Results of the current study extend previous findings by researchers who have investigated discourse production in cognitively healthy, older adults. Using a multi-level approach, we found that linguistic processes across different levels interact; however, the relationship is age-dependent. By including a middle-aged group we identify the potential course of documented change and our results indicate that the changes in language processes with age may not be linear.	[Capilouto, Gilson J.; Maddy, Katherine McComas] Univ Kentucky, Dept Rehabil Sci, Lexington, KY 40536 USA; [Wright, Heather Harris] E Carolina Univ, Coll Allied Hlth Sci, 3206 F Allied Hlth Sci,MS 668, Greenville, NC 27834 USA		Capilouto, GJ (corresponding author), Univ Kentucky, Dept Rehabil Sci, Lexington, KY 40536 USA.	gilson.capilouto@uky.edu		wright, heather/0000-0001-6922-6364	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG029476]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG029476] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health and National Institute on Aging [grant number R01AG029476].	Andreetta S, 2015, APHASIOLOGY, V29, P705, DOI 10.1080/02687038.2014.979394; ARBUCKLE TY, 1993, J GERONTOL, V48, pP225, DOI 10.1093/geronj/48.5.P225; Arbuckle TY, 2000, PSYCHOL AGING, V15, P65, DOI 10.1037/0882-7974.15.1.65; Beaudreau SA, 2006, EXP AGING RES, V32, P105, DOI 10.1080/03610730500326481; Brownell, 1990, DISCOURSE ABILITY BR, P69, DOI 10.1007/978-1-4612-3262-9_4; Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cohen J., 2013, STAT POWER ANAL BEHA; COOPER PV, 1990, J GERONTOL, V45, pP210, DOI 10.1093/geronj/45.5.P210; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; de Lira JO, 2011, INT PSYCHOGERIATR, V23, P404, DOI 10.1017/S1041610210001092; Dijkstra K, 2004, J NEUROLINGUIST, V17, P263, DOI 10.1016/S0911-6044(03)00048-4; Duong A, 2001, BRAIN COGNITION, V46, P121, DOI 10.1016/S0278-2626(01)80047-6; Duran P, 2004, APPL LINGUIST, V25, P220, DOI 10.1093/applin/25.2.220; Fergadiotis G, 2015, J SPEECH LANG HEAR R, V58, P840, DOI 10.1044/2015_JSLHR-L-14-0280; Fergadiotis G, 2011, APHASIOLOGY, V25, P1414, DOI 10.1080/02687038.2011.603898; Fergadiotis G, 2011, APHASIOLOGY, V25, P1261, DOI 10.1080/02687038.2011.606974; Folstein MF, 2002, MINIMENTAL STATE EXA; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GLOSSER G, 1992, J GERONTOL, V47, pP266, DOI 10.1093/geronj/47.4.P266; GOLD DP, 1993, CAN J AGING, V12, P67, DOI 10.1017/S0714980800008278; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Hulit L. M., 2011, BORN TALK INTRO SPEE; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P., 2000, NEW COGNITIVE NEUROS; James LE, 1998, PSYCHOL AGING, V13, P355, DOI 10.1037/0882-7974.13.3.355; Jarvis S, 2013, LANG LEARN, V63, P87, DOI 10.1111/j.1467-9922.2012.00739.x; Juncos-Rabadan O, 2005, BRAIN LANG, V95, P423, DOI 10.1016/j.bandl.2005.04.001; KEMPER S, 1987, EXP AGING RES, V13, P47; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; Kertesz W., 1982, W APHASIA BATTERY; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Mackenzie C, 2000, INT J LANG COMM DIS, V35, P269, DOI 10.1080/136828200247188; Mackenzie C, 2007, APHASIOLOGY, V21, P340, DOI 10.1080/02687030600911419; MacWhinney B., 2000, CHILDES PROJECT TOOL, V1; Malvern D, 1997, BRIT S AP L, V12, P58; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; Marini A, 2011, APHASIOLOGY, V25, P1372, DOI 10.1080/02687038.2011.584690; McCarthy PM, 2010, BEHAV RES METHODS, V42, P381, DOI 10.3758/BRM.42.2.381; McKee G., 2000, Literary & Linguistic Computing, V15, P323, DOI 10.1093/llc/15.3.323; Meijer WA, 2009, AGING MENT HEALTH, V13, P521, DOI 10.1080/13607860902860821; NICHOLAS LE, 1995, J SPEECH HEAR RES, V38, P146, DOI 10.1044/jshr.3801.145; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Nippold MA, 2014, CLIN LINGUIST PHONET, V28, P195, DOI 10.3109/02699206.2013.841292; Owen AJ, 2002, J SPEECH LANG HEAR R, V45, P927, DOI 10.1044/1092-4388(2002/075); PRINS RS, 1978, BRAIN LANG, V6, P192, DOI 10.1016/0093-934X(78)90058-5; Pushkar D, 1999, PSYCHOL AGING, V14, P520, DOI 10.1037/0882-7974.14.3.520; Pushkar D, 2000, PSYCHOL AGING, V15, P361, DOI 10.1037//0882-7974.15.2.361; Ross KB, 1999, APHASIOLOGY, V13, P113, DOI 10.1080/026870399402235; Saling LL, 2012, ACTA PSYCHOL, V139, P220, DOI 10.1016/j.actpsy.2011.10.005; Schneider P., 2005, EDMONTON NARRATIVE N; Shadden B B, 1997, Semin Speech Lang, V18, P143; Sherratt S, 2007, APHASIOLOGY, V21, P375, DOI 10.1080/02687030600911435; Silverman S, 2002, J FLUENCY DISORD, V27, P289, DOI 10.1016/S0094-730X(02)00162-6; Tomoeda CK, 1996, ALZ DIS ASSOC DIS, V10, P204, DOI 10.1097/00002093-199601040-00006; Trunk DL, 2009, PSYCHOL AGING, V24, P324, DOI 10.1037/a0015259; Van Dijk TA., 1983, STRATEGIES DISCOURSE; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195; Wright HH, 2012, APHASIOLOGY, V26, P656, DOI 10.1080/02687038.2012.676855; Wright HH, 2011, J SPEECH LANG HEAR R, V54, P900, DOI 10.1044/1092-4388(2010/09-0253); Wright HH, 2005, APHASIOLOGY, V19, P263, DOI 10.1080/02687030444000732; Wright HH, 2003, APHASIOLOGY, V17, P443, DOI 10.1080/0268703044000166	65	10	11	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1382-5585	1744-4128		AGING NEUROPSYCHOL C	Aging Neuropsychol. Cogn.	JUL	2016	23	4					445	463		10.1080/13825585.2015.1118006			19	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	DL9HZ	WOS:000375954400003	26653413	Green Accepted			2022-02-06	
J	Gupta, RK; Prasad, S				Gupta, Rajaneesh K.; Prasad, S.			Age-Dependent Alterations in the Interactions of NF-kappa B and N-myc with GLT-1/EAAT2 Promoter in the Pericontusional Cortex of Mice Subjected to Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						GLT-1/EAAT2; NF-kappa B; N-myc; Traumatic brain injury; Aging	CLOSED-HEAD INJURY; GLUTAMATE TRANSPORTER; C-MYC; PARKINSON-DISEASE; ALZHEIMER-DISEASE; MOUSE-BRAIN; EXPRESSION; TRANSCRIPTION; ACTIVATION; RATS	Traumatic brain injury (TBI) is one of the major risk factors of dementia, aging, and cognitive impairments, etc. We have previously reported that expression of the astrocytic glutamate transporter GLT-1/EAAT2 is downregulated in the pericontusional cortex of adult and old mice in post-TBI time-dependent manner, and the process of decline starts before in old than in adult TBI mice. However, relationship between age- and TBI-dependent alterations in GLT-1/EAAT2 expression and interactions of transcription factors NF-kappa B and N-myc with their cognate GLT-1/EAAT2 promoter sequences, an important step of its transcriptional control, is not known. To understand this, we developed TBI mouse model by modified chronic head injury (CHI) method, analyzed expression of GFAP, TNF-alpha, and AQP4 by RT-PCR for its validation, and analyzed interactions of NF-kappa B and N-myc with GLT-1/EAAT2 promoter sequences by electrophoretic mobility shift assay (EMSA). Our EMSA data revealed that interactions of NF-kappa B and N-myc with GLT-1/EAAT2 promoter sequences was significantly elevated in the ipsi-lateral cortex of both adult and old TBI mice in post-TBI time-dependent manner; however, these interactions started immediately in the old compared to that in adult TBI mice, which could be attributed to our previously reported age- and post-TBI time-dependent differential expression of GLT-1/EAAT2 in the pericontusional cortex.	[Gupta, Rajaneesh K.; Prasad, S.] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India		Prasad, S (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	s.sprasadbhu@gmail.com	Gupta, Rajaneesh/AAD-5893-2019	Gupta, Rajaneesh/0000-0003-0212-6478	Council of Scientific and Industrial ResearchCouncil of Scientific & Industrial Research (CSIR) - India [09/013(0111)2007-EMR-I]; CSIRCouncil of Scientific & Industrial Research (CSIR) - India [37/1389/09/EMR-II]; BRNS, Govt. of IndiaDepartment of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS) [2009/37/55/3298]; CAS Program in Zoology, Institute of Interdisciplinary Life Sciences, Program, Faculty of Science; UPE Program Banaras Hindu University	RKG thanks Council of Scientific and Industrial Research for Junior and Senior Research Fellowships (File No: 09/013(0111)2007-EMR-I). Partial financial assistance from CSIR (37/1389/09/EMR-II), BRNS (2009/37/55/3298), Govt. of India, CAS Program in Zoology, Institute of Interdisciplinary Life Sciences, Program, Faculty of Science and UPE Program Banaras Hindu University to SP is gratefully acknowledged.	Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chapman NR, 2002, BIOCHEM J, V366, P459, DOI 10.1042/BJ20020444; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Ferrer I, 2000, MOL BRAIN RES, V77, P270, DOI 10.1016/S0169-328X(00)00062-0; Goleburn CR, 2001, J CLIN GEROPSYCHOL, V7, P161; Gordon MN, 1997, J COMP NEUROL, V388, P106; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Guerrini L, 1997, J NEUROSCI, V17, P6057; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Gupta RK, 2014, NEUROCHEM RES, V39, P150, DOI 10.1007/s11064-013-1200-3; Gupta RK, 2013, AGE, V35, P59, DOI 10.1007/s11357-011-9330-5; Gveric D, 1998, J NEUROPATH EXP NEUR, V57, P168, DOI 10.1097/00005072-199802000-00008; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; PerezOtano I, 1996, GLIA, V16, P306, DOI 10.1002/(SICI)1098-1136(199604)16:4<306::AID-GLIA3>3.0.CO;2-Y; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; RATTNER A, 1993, EMBO J, V12, P4261, DOI 10.1002/j.1460-2075.1993.tb06110.x; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Terai K, 1996, BRAIN RES, V739, P343, DOI 10.1016/S0006-8993(96)01073-6; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Verma P, 2013, ASIAN J PHARM CLIN R, V6, P242; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wei HY, 2014, NEUROL SCI, V35, P1763, DOI 10.1007/s10072-014-1828-z; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N	41	10	10	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2016	53	5					3377	3388		10.1007/s12035-015-9287-y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO7AU	WOS:000377935400057	26081154				2022-02-06	
J	McNett, MM; Amato, S; Philippbar, SA				McNett, Molly M.; Amato, Shelly; Philippbar, Sue Ann			A Comparative Study of Glasgow Coma Scale and Full Outline of Unresponsiveness Scores for Predicting Long-Term Outcome After Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						brain injury; coma scores	SEVERE HEAD-INJURY; INTERRATER RELIABILITY; EMERGENCY-DEPARTMENT; IMPAIRED CONSCIOUSNESS; NEUROSURGICAL PATIENTS; STRUCTURED INTERVIEWS; PROGNOSTIC VALUE; NATIONAL-SURVEY; VALIDATION; IMPACT	Purpose: The aimof this study was to compare predictive ability of hospitalGlasgow Coma Scale (GCS) scores and scores obtained using a novel coma scoring tool (the Full Outline of Unresponsiveness [FOUR] scale) on long-term outcomes among patients with traumatic brain injury. Preliminary research of the FOUR scale suggests that it is comparable with GCS for predicting mortality and functional outcome at hospital discharge. No research has investigated relationships between coma scores and outcome 12 months postinjury. Methods: This is a prospective cohort study. Data were gathered on adult patients with traumatic brain injury admitted to urban level I trauma center. GCS and FOUR scores were assigned at 24 and 72 hours and at hospital discharge. Glasgow Outcome Scale scores were assigned at 6 and 12 months. Results: The sample size was n = 107. Mean age was 53.5 (SD = +21, range = 18-91) years. Spearman correlations were comparable and strongest among discharge GCS and FOUR scores and 12-month outcome (r = .73, p < .000; r = .72, p < .000). Multivariate regression models indicate that age and discharge GCS were the strongest predictors of outcome. Areas under the curve were similar for GCS and FOUR scores, with discharge scores occupying the largest areas. Conclusion: GCS and FOUR scores were comparable in bivariate associations with long-term outcome. Discharge coma scores performed best for both tools, with GCS discharge scores predictive in multivariate models.	[McNett, Molly M.] MetroHlth Syst, Nursing Res, Cleveland, OH 44109 USA; [Amato, Shelly] MetroHlth Syst, Brain Injury Rehabil, Cleveland, OH USA; [Philippbar, Sue Ann] MetroHlth Syst, Ctr Brain Injury Rehabil, Cleveland, OH USA		McNett, MM (corresponding author), MetroHlth Syst, Nursing Res, Cleveland, OH 44109 USA.	mmcnett@metrohealth.org					Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; BHATTY GB, 1993, ACTA NEUROCHIR, V120, P132, DOI 10.1007/BF02112031; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P193, DOI 10.4103/1658-354X.130708; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Juarez V J, 1995, J Neurosci Nurs, V27, P283; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McNett Molly, 2007, J Neurosci Nurs, V39, P68; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	37	10	10	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUL-AUG	2016	48	4					207	214		10.1097/JNN.0000000000000225			8	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	DR2SZ	WOS:000379755500008	27224686				2022-02-06	
J	Sawada, Y; Konno, A; Nagaoka, J; Hirai, H				Sawada, Yusuke; Konno, Ayumu; Nagaoka, Jun; Hirai, Hirokazu			Inflammation-induced reversible switch of the neuron-specific enolase promoter from Purkinje neurons to Bergmann glia	SCIENTIFIC REPORTS			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; TYROSINE-HYDROXYLASE PROMOTER; TRANSGENIC MICE; LENTIVIRAL VECTORS; GENE-EXPRESSION; BRAIN-INJURY; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; S-100 PROTEIN; MOUSE MODELS	Neuron-specific enolase (NSE) is a glycolytic isoenzyme found in mature neurons and cells of neuronal origin. Injecting adeno-associated virus serotype 9 (AAV9) vectors carrying the NSE promoter into the cerebellar cortex is likely to cause the specific transduction of neuronal cells, such as Purkinje cells (PCs) and interneurons, but not Bergmann glia (BG). However, we found BG-predominant transduction without PC transduction along a traumatic needle tract for viral injection. The enhancement of neuroinflammation by the co-application of lipopolysaccharide (LPS) with AAV9 significantly expanded the BG-predominant area concurrently with the potentiated microglial activation. The BG-predominant transduction was gradually replaced by the PC-predominant transduction as the neuroinflammation dissipated. Experiments using glioma cell cultures revealed significant activation of the NSE promoter due to glucose deprivation, suggesting that intracellularly stored glycogen is metabolized through the glycolytic pathway for energy. Activation of the glycolytic enzyme promoter in BG concurrently with inactivation in PC may have pathophysiological significance for the production of lactate in activated BG and the utilization of lactate, which is provided by the BG-PC lactate shuttle, as a primary energy resource in injured PCs.	[Sawada, Yusuke; Konno, Ayumu; Nagaoka, Jun; Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol & Neural Repair, Maebashi, Gunma 3718511, Japan; [Hirai, Hirokazu] Gunma Univ, Initiat Adv Res, Div Endocrinol Metab & Signal Res, Res Program Neural Signalling, Maebashi, Gunma 3718511, Japan		Hirai, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Neurophysiol & Neural Repair, Maebashi, Gunma 3718511, Japan.; Hirai, H (corresponding author), Gunma Univ, Initiat Adv Res, Div Endocrinol Metab & Signal Res, Res Program Neural Signalling, Maebashi, Gunma 3718511, Japan.	hirai@gunma-u.ac.jp	Konno, Ayumu/J-1667-2017	Konno, Ayumu/0000-0001-9382-396X; Hirai, Hirokazu/0000-0002-0721-4293	Ministry of Education, Culture, and Sports Science (MEXT); Japan Agency for Medical Research and Development (AMED)Japan Agency for Medical Research and Development (AMED); Ministry of Health, Labour and WelfareMinistry of Health, Labour and Welfare, Japan; Gunma University Initiative for Advanced Research (GIAR)	This study was (partially) supported by the programme for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, and Sports Science (MEXT), and the Japan Agency for Medical Research and Development (AMED) and grants from the Research on Measures for Intractable Diseases (Ataxic Diseases and Neurodegenerative Diseases) from the Ministry of Health, Labour and Welfare and Gunma University Initiative for Advanced Research (GIAR) (to H. Hirai).	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Bao XD, 2009, J NEUROSCI, V29, P13929, DOI 10.1523/JNEUROSCI.4413-09.2009; Barmashenko G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00095; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bian MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039953; Bornemann KD, 2000, ANN NY ACAD SCI, V908, P260; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Castillo X, 2015, J CEREBR BLOOD F MET, V35, P1561, DOI 10.1038/jcbfm.2015.115; Choi EY, 2012, J NEUROSCI RES, V90, P1949, DOI 10.1002/jnr.23085; Cunningham RT, 1996, EUR J CLIN INVEST, V26, P298, DOI 10.1046/j.1365-2362.1996.129282.x; Delzor A, 2012, HUM GENE THER METHOD, V23, P242, DOI 10.1089/hgtb.2012.073; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Gerard C, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.44; Goenawan H, 2012, J NEUROVIROL, V18, P521, DOI 10.1007/s13365-012-0134-x; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hirai H., 2011, GENE THERAPY APPL; Huda F, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.32; Inta D, 2014, HIPPOCAMPUS, V24, P424, DOI 10.1002/hipo.22236; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; KIRINO T, 1983, J NEUROSCI, V3, P915; Levy YS, 2003, J MOL NEUROSCI, V21, P121, DOI 10.1385/JMN:21:2:121; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; LIN RCS, 1994, NEUROSCIENCE, V60, P11, DOI 10.1016/0306-4522(94)90199-6; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lu-Nguyen NB, 2015, HUM GENE THER, V26, P719, DOI 10.1089/hum.2015.016; Matsuzaki Y, 2014, J NEUROSCI METH, V223, P133, DOI 10.1016/j.jneumeth.2013.12.004; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Miyake K, 2012, J NIPPON MED SCH, V79, P394, DOI 10.1272/jnms.79.394; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nagykery N, 2013, J NEUROSCI METH, V212, P106, DOI 10.1016/j.jneumeth.2012.09.021; Parkinson FE, 2009, J NEUROCHEM, V109, P562, DOI 10.1111/j.1471-4159.2009.05991.x; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pohlkamp T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100384; SASAOKA T, 1992, MOL BRAIN RES, V16, P274, DOI 10.1016/0169-328X(92)90236-5; Sawada Y, 2010, CEREBELLUM, V9, P291, DOI 10.1007/s12311-010-0161-1; SCHAARSCHMIDT H, 1994, STROKE, V25, P558, DOI 10.1161/01.STR.25.3.558; Tian XB, 2009, HUM GENE THER, V20, P113, DOI 10.1089/hum.2008.018; Twyman RM, 1997, J MOL NEUROSCI, V8, P63, DOI 10.1007/BF02736864; Uzakov SS, 2015, BRAIN RES, V1624, P398, DOI 10.1016/j.brainres.2015.07.051; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; VINORES SA, 1985, NEUROPATH APPL NEURO, V11, P349, DOI 10.1111/j.1365-2990.1985.tb00031.x; Wang S, 2015, GENE THER, V22, P104, DOI 10.1038/gt.2014.91; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103	47	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 13	2016	6								27758	10.1038/srep27758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO3BE	WOS:000377654300001	27291422	gold, Green Published			2022-02-06	
J	Wright, CJ; Zeeman, H; Biezaitis, V				Wright, Courtney J.; Zeeman, Heidi; Biezaitis, Valda			Holistic Practice in Traumatic Brain Injury Rehabilitation: Perspectives of Health Practitioners	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE REHABILITATION; CARE PERSPECTIVES; SELF-AWARENESS; DISABILITY; TRANSITION; OUTCOMES; ADULTS; MODEL; PROFESSIONALS	Given that the literature suggests there are various (and often contradictory) interpretations of holistic practice in brain injury rehabilitation and multiple complexities in its implementation (including complex setting, discipline, and client-base factors), this study aimed to examine the experiences of practitioners in their conceptualization and delivery of holistic practice in their respective settings. Nineteen health practitioners purposively sampled from an extensive Brain Injury Network in Queensland, Australia participated in individual interviews. A systematic text analysis process using Leximancer qualitative analysis program was undertaken, followed by manual thematic analysis to develop overarching themes. The findings from this study have identified several items for future inter-professional development that will not only benefit the practitioners working in brain injury rehabilitation settings, but the patients and their families as well.	[Wright, Courtney J.; Zeeman, Heidi] Griffith Univ, Menzies Hlth Inst Queensland, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia; [Wright, Courtney J.; Zeeman, Heidi] Griffith Univ, RECOVER Injury Res Ctr, Meadowbrook, Qld 4131, Australia; [Biezaitis, Valda] Mater Childrens Hosp, ROBIN Team, South Brisbane, Qld, Australia; [Biezaitis, Valda] Mater Res, Improving Treatment Dis, South Brisbane, Qld, Australia		Wright, CJ (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia.; Wright, CJ (corresponding author), Griffith Univ, RECOVER Injury Res Ctr, Meadowbrook, Qld 4131, Australia.	Courtney.wright@griffith.edu.au		Wright, Courtney/0000-0003-4735-4378	Mater Children's Hospital	The authors are grateful to the Mater Children's Hospital and the Brain Injury Network team led by Dr. Ron Hazelton, who supported this study throughout. Many thanks in particular, to the participants of the study who gave so generously of their time. Special thanks are also extended to Dr. Valda Biezaitis for her willingness and enthusiasm to engage in research as a practicing clinician.	Allan Chris M, 2006, J Interprof Care, V20, P235, DOI 10.1080/13561820600718139; Australian Institute of Health and Welfare, 2008, AUSTR HLTH 2008; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Ben-Yishay Y, 2011, HDB HOLISTIC NEUROPS; Ben-Yishay Y, 1990, REHABILITATION ADULT; Bolderston A, 2012, J MED IMAGING RADIAT, V43, P66, DOI 10.1016/j.jmir.2011.12.002; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Breen LJ, 2011, DISABIL REHABIL, V33, P862, DOI 10.3109/09638288.2010.520799; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Charleswell C, 2015, J EPIDEMIOL COMMUN H, V69, P290, DOI 10.1136/jech-2014-204239; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Dion GR, 2014, J VOICE, V28, P88, DOI 10.1016/j.jvoice.2013.08.005; Engel George L, 2012, Psychodyn Psychiatry, V40, P377, DOI 10.1037/h0089260; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Flick U., 1998, INTRO QUALITATIVE RE; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gibbins S, 2015, QUAL HEALTH RES, V25, P763, DOI 10.1177/1049732315580105; Goldstein K., 1939, ORG HOLISTIC APPROAC; Guion L. A., 2011, TRIANGULATION ESTABL; Gzil F, 2007, DISABIL REHABIL, V29, P1616, DOI 10.1080/09638280701618620; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Hall Pippa, 2005, J Interprof Care, V19 Suppl 1, P188; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Heinemann AW, 2005, REHABIL PSYCHOL, V50, P6, DOI 10.1037/0090-5550.50.1.6; Helps Y, 2008, INJURY RES STAT SERI, V45; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Huber JG, 2010, DISABIL REHABIL, V32, P1955, DOI 10.3109/09638281003797414; Jenesick V, 2000, HDB QUALITATIVE RES; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Kuipers P, 2014, J INTERPROF CARE, V28, P246, DOI 10.3109/13561820.2013.821601; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Leonardi M, 2009, DISABIL REHABIL, V31, pS83, DOI 10.3109/09638280903317948; Leplege A, 2007, DISABIL REHABIL, V29, P1555, DOI 10.1080/09638280701618661; Lexell J, 2007, J HEAD TRAUMA REHAB, V22, P229, DOI 10.1097/01.HTR.0000281838.00344.03; Lyons A.C., 2006, HLTH PSYCHOL CRITICA; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; McEvoy Liz, 2008, Nurse Educ Pract, V8, P412, DOI 10.1016/j.nepr.2008.02.002; McHugh J C, 2007, Ir Med J, V100, P518; McMillan SS, 2013, MED CARE RES REV, V70, P567, DOI 10.1177/1077558713496318; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Moos R, 1979, HLTH PSYCHOL HDB; Nicassio PM., 1995, MANAGING CHRONIC ILL; PETRIE HG, 1976, J AESTHET EDUC, V10, P29, DOI 10.2307/3332007; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1997, J INT NEUROPSYCH SOC, V3, P497, DOI 10.1017/S1355617797004979; Prigatano GP, 1999, REHABILITATION ADULT; Rahman B, 2013, NEUROPSYCHOL REHABIL, V23, P501, DOI 10.1080/09602011.2013.787938; RAND Corporation, 2012, LAB FORC REENTR ISS; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rowe H, 1996, J Nurs Manag, V4, P93, DOI 10.1111/j.1365-2834.1996.tb00036.x; SCHWARTZ MA, 1985, PERSPECT BIOL MED, V28, P331; Silberg T, 2015, BRAIN INJURY, V29, P481, DOI 10.3109/02699052.2014.984758; Smith AE, 2006, BEHAV RES METHODS, V38, P262, DOI 10.3758/BF03192778; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Tate DG, 2003, AM PSYCHOL, V58, P289, DOI 10.1037/0003-066X.58.4.289; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wilkinson-Meyers L, 2010, SOC SCI MED, V71, P1882, DOI 10.1016/j.socscimed.2010.08.019; Williams J, 2011, DISABIL REHABIL, V33, P423, DOI 10.3109/09638288.2010.498555; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Wilmot S, 2007, HEALTH CARE ANAL, V15, P59, DOI 10.1007/s10728-006-0032-6; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; World Health Organization, 2007, INT CLASS FUNCT DIS; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; Young NL, 2009, PHYS OCCUP THER PEDI, V29, P345, DOI 10.3109/01942630903245994; Young NL, 2005, DISABIL REHABIL, V27, P1455, DOI 10.1080/00222930500218946	89	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156826	10.1371/journal.pone.0156826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1SU	WOS:000377560200019	27270604	gold, Green Published, Green Submitted			2022-02-06	
J	Larsen, GY; Schober, M; Fabio, A; Wisniewski, SR; Grant, MJC; Shafi, N; Bennett, TD; Hirtz, D; Bell, MJ				Larsen, Gitte Y.; Schober, Michelle; Fabio, Anthony; Wisniewski, Stephen R.; Grant, Mary Jo C.; Shafi, Nadeem; Bennett, Tellen D.; Hirtz, Deborah; Bell, Michael J.			Structure, Process, and Culture Differences of Pediatric Trauma Centers Participating in an International Comparative Effectiveness Study of Children with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Pediatric traumatic brain injury; Secondary injuries; Comparative effectiveness research; Pediatric neurocritical care; Quality of care	INTENSIVE-CARE UNITS; QUALITY; SAFETY; HYPOTHERMIA	Traumatic brain injury (TBI) is an important worldwide cause of death and disability for children. The Approaches and Decisions for Acute Pediatric TBI (ADAPT) Trial is an observational, cohort study to compare the effectiveness of six aspects of TBI care. Understanding the differences between clinical sites-including their structure, clinical processes, and culture differences-will be necessary to assess differences in outcome from the study and can inform the overall community regarding differences across academic centers. We developed a survey and queried ADAPT site principal investigators with a focus on six domains: (i) hospital, (ii) pediatric intensive care unit (PICU), (iii) medical staff characteristics, (iv) quality of care, (v) medication safety, and (vi) safety culture. Summary statistics were used to describe differences between centers. ADAPT clinical sites that enrolled a subject within the first year (32 US-based, 11 international) were studied. A wide variation in site characteristics was observed in hospital and ICU characteristics, including an almost sevenfold range in ICU size (8-55 beds) and more than fivefold range of overall ICU admissions (537-2623). Nursing staffing (predominantly 1:1 or 1:2) and the presence of pharmacists within the ICU (79 %) were less variable, and most sites "strongly agreed" or "agreed" that Neurosurgery and Critical Care teams worked well together (81.4 %). However, a minority of sites (46 %) used an explicit protocol for treatment of children with severe TBI care. We found a variety of inter-center structure, process, and culture differences. These intrinsic differences between sites may begin to explain why interventional studies have failed to prove efficacy of experimental therapies. Understanding these differences may be an important factor in analyzing future ADAPT trial results and in determining best practices for pediatric severe TBI.	[Larsen, Gitte Y.; Schober, Michelle] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Grant, Mary Jo C.] Univ Utah, Dept Nursing, Salt Lake City, UT USA; [Fabio, Anthony; Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med Neurol Surg & Pediat, 3434 Fifth Ave, Pittsburgh, PA 15260 USA; [Shafi, Nadeem] Univ Tennessee, Dept Pediat, Memphis, TN USA; [Bennett, Tellen D.] Univ Colorado, Dept Pediat, Aurora, CO USA; [Hirtz, Deborah] NINDS, Div Extramural Res, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med Neurol Surg & Pediat, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu		Fabio, Anthony/0000-0002-6808-4939; Wisniewski, Stephen/0000-0002-3877-9860; Bennett, Tellen/0000-0003-1483-4236	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS081041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041] Funding Source: NIH RePORTER	This study was funded by an NIH Grant (U01 NS081041).	Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Corrigan J., 2001, CROSSING QUALITY CHA, P360; Dodek Peter M, 2010, J Intensive Care Med, V25, P149, DOI 10.1177/0885066609359267; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Isaac T, 2010, HEALTH SERV RES, V45, P1024, DOI 10.1111/j.1475-6773.2010.01122.x; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Mills B, 2015, J NEUROTRAUM, V32, P841, DOI 10.1089/neu.2014.3733; Najjar-Pellet J, 2008, INTENS CARE MED, V34, P278, DOI 10.1007/s00134-007-0883-9; Peterson TH, 2012, J PATIENT SAF, V8, P125, DOI 10.1097/PTS.0b013e31824bd744; Pronovost PJ, 2003, QUAL SAF HEALTH CARE, V12, P405, DOI 10.1136/qhc.12.6.405; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Sakr Y, 2015, CRIT CARE MED, V43, P519, DOI 10.1097/CCM.0000000000000754; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Vigorito MC, 2011, JT COMM J QUAL PATIE, V37, P509, DOI 10.1016/S1553-7250(11)37065-1	18	10	11	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2016	24	3					353	360		10.1007/s12028-015-0218-6			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN2ZP	WOS:000376932100005	26627225	Green Accepted			2022-02-06	
J	Libero, LE; Reid, MA; White, DM; Salibi, N; Lahti, AC; Kana, RK				Libero, Lauren E.; Reid, Meredith A.; White, David M.; Salibi, Nouha; Lahti, Adrienne C.; Kana, Rajesh K.			Biochemistry of the Cingulate Cortex in Autism: An MR Spectroscopy Study	AUTISM RESEARCH			English	Article						autism spectrum disorder; cingulate cortex; 1H-MRS; MR spectroscopy; neurochemicals; biochemistry	MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-FUNCTIONING AUTISM; N-ACETYLASPARTATE CONCENTRATION; REMITTING MULTIPLE-SCLEROSIS; TRAUMATIC BRAIN-INJURY; CARRIER SLC25A12 GENE; DEFAULT MODE NETWORK; SPECTRUM DISORDERS; IN-VIVO; CHILDHOOD AUTISM	Neuroimaging studies have uncovered structural and functional alterations in the cingulate cortex in individuals with autism spectrum disorders (ASD). Such abnormalities may underlie neurochemical imbalance. In order to characterize the neurochemical profile, the current study examined the concentration of brain metabolites in dorsal ACC (dACC) and posterior cingulate cortex (PCC) in high-functioning adults with ASD. Twenty high-functioning adults with ASD and 20 age-and-IQ-matched typically developing (TD) peers participated in this Proton magnetic resonance spectroscopy (1H-MRS) study. LCModel was used in analyzing the spectra to measure the levels of N-Acetyl aspartate (NAA), choline (Cho), creatine (Cr), and glutamate/glutamine (Glx) in dACC and PCC. Groups were compared using means for the ratio of each metabolite to their respective Cr levels as well as on absolute internal-water-referenced measures of each metabolite. There was a significant increase in Cho in PCC for ASD adults, with a marginal increase in dACC. A reduction in NAA/Cr in dACC was found in ASD participants, compared to their TD peers. No significant differences in Glx/Cr or Cho/Cr were found in dACC. There were no statistically significant group differences in the absolute concentration of NAA, Cr, Glx, or NAA/Cr, Cho/Cr, and Glx/Cr in the PCC. Differences in the metabolic properties of dACC compared to PCC were also found. Results of this study provide evidence for possible cellular and metabolic differences in the dACC and PCC in adults with ASD. This may suggest neuronal dysfunction in these regions and may contribute to the neuropathology of ASD. (C) 2015 International Society for Autism Research, Wiley Periodicals, Inc.	[Libero, Lauren E.; Kana, Rajesh K.] Univ Alabama Birmingham, Dept Psychol, CIRC 235G,1719 6th Ave South, Birmingham, AL 35294 USA; [Reid, Meredith A.] Auburn Univ, MRI Res Ctr, Auburn, AL 36849 USA; [White, David M.; Lahti, Adrienne C.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Salibi, Nouha] Siemens Healthcare, MR R&D, Malvern, PA USA		Kana, RK (corresponding author), Univ Alabama Birmingham, Dept Psychol, CIRC 235G,1719 6th Ave South, Birmingham, AL 35294 USA.	rkana@uab.edu	Reid, Meredith/H-8444-2017; Reid, Meredith A./P-2387-2019	Reid, Meredith/0000-0003-1946-0544; Reid, Meredith A./0000-0003-1946-0544; White, David/0000-0002-6372-5311	UAB College of Arts and Sciences Interdisciplinary Innovation Award; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH073124] Funding Source: NIH RePORTER	The authors would like to thank our funding source: the UAB College of Arts and Sciences Interdisciplinary Innovation Award to R. K. The authors would also like to thank Thomas DeRamus, Hrishikesh Deshpande, and Dr. Nina Kraguljac for their assistance in the data collection and comments on earlier versions of this manuscript. Finally, the authors thank all participants and families for taking part in this study. The authors do not have any conflicts of interest to disclose.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Barker PB, 2001, MAGNET RESON MED, V45, P765, DOI 10.1002/mrm.1104; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; BAUMAN ML, 1994, NEUROANATOMIC OBSERV, P119; Bejjani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038786; Bernardi S, 2011, BRAIN RES, V1380, P198, DOI 10.1016/j.brainres.2010.12.057; Brooks WM, 1997, J RHEUMATOL, V24, P2323; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Brown MS, 2013, AUTISM RES, V6, P1, DOI 10.1002/aur.1260; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chiu PH, 2008, NEURON, V57, P463, DOI 10.1016/j.neuron.2007.12.020; Coyle J., 2002, DIVERSE ROLES L GLUT, P71; DANIELSEN ER, 1999, MAGNETIC RESONANCE S; de la Fuente-Sandoval C, 2011, NEUROPSYCHOPHARMACOL, V36, P1781, DOI 10.1038/npp.2011.65; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; Deutsch SI, 2010, CLIN NEUROPHARMACOL, V33, P114, DOI 10.1097/WNF.0b013e3181d6f7ad; DeVito TJ, 2007, BIOL PSYCHIAT, V61, P465, DOI 10.1016/j.biopsych.2006.07.022; Doyle-Thomas KAR, 2014, RES AUTISM SPECT DIS, V8, P44, DOI 10.1016/j.rasd.2013.10.003; Fayed N, 2006, AM J APPL SCI, V3, P1836, DOI DOI 10.3844/AJASSP.2006.1836.1845; Ferguson KJ, 2002, BRAIN, V125, P2743, DOI 10.1093/brain/awf278; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Fujii E, 2010, J MED INVESTIG, V57, P35, DOI 10.2152/jmi.57.35; Geurts JJG, 2004, J MAGN RESON IMAGING, V20, P366, DOI 10.1002/jmri.20138; Hardan AY, 2008, PSYCHIAT RES-NEUROIM, V163, P97, DOI 10.1016/j.pscychresns.2007.12.002; Haznedar MM, 2000, AM J PSYCHIAT, V157, P1994, DOI 10.1176/appi.ajp.157.12.1994; Haznedar MM, 1997, AM J PSYCHIAT, V154, P1047; Horder J, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.53; Ipser JC, 2012, METAB BRAIN DIS, V27, P275, DOI 10.1007/s11011-012-9293-y; ISACSON O, 1993, TRENDS NEUROSCI, V16, P306, DOI 10.1016/0166-2236(93)90104-T; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; Jang JH, 2006, AM J PSYCHIAT, V163, P1202, DOI 10.1176/appi.ajp.163.7.1202; Jiru F, 2006, MAGN RESON MATER PHY, V19, P1, DOI 10.1007/s10334-005-0018-7; Joshi G, 2013, EUR ARCH PSY CLIN N, V263, P379, DOI 10.1007/s00406-012-0369-9; Jou RJ, 2011, AUST NZ J PSYCHIAT, V45, P153, DOI 10.3109/00048674.2010.534069; Jung RE, 1999, P ROY SOC B-BIOL SCI, V266, P1375, DOI 10.1098/rspb.1999.0790; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Khan O, 2005, MULT SCLER J, V11, P646, DOI 10.1191/1352458505ms1234oa; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kubas B, 2012, ADV MED SCI-POLAND, V57, P152, DOI 10.2478/v10039-012-0014-x; Kumar A, 2010, CEREB CORTEX, V20, P2103, DOI 10.1093/cercor/bhp278; Le Couteur A, 2003, AUTISM DIAGNOSTIC IN; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Levitt JG, 2003, BIOL PSYCHIAT, V54, P1355, DOI 10.1016/S0006-3223(03)00688-7; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Luna B, 2002, NEUROLOGY, V59, P834, DOI 10.1212/WNL.59.6.834; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Maddock Richard J, 2012, Curr Top Behav Neurosci, V11, P199; Madhavarao CN, 2006, ADV EXP MED BIOL, V576, P49; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; Mathew SJ, 2008, BIOL PSYCHIAT, V63, P891, DOI 10.1016/j.biopsych.2007.09.012; MEYERHOFF DJ, 1993, NEUROLOGY, V43, P509, DOI 10.1212/WNL.43.3_Part_1.509; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Mostert JP, 2006, NEUROSCI LETT, V402, P22, DOI 10.1016/j.neulet.2006.03.042; Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885; Nordin V, 1998, DEV MED CHILD NEUROL, V40, P587; Noriuchi M, 2010, BRAIN RES, V1362, P141, DOI 10.1016/j.brainres.2010.09.051; Oblak AL, 2011, AUTISM RES, V4, P200, DOI 10.1002/aur.188; Oblak AL, 2011, BRAIN RES, V1380, P218, DOI 10.1016/j.brainres.2010.09.021; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oner O, 2007, AM J NEURORADIOL, V28, P1494, DOI 10.3174/ajnr.A0625; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Pardini M, 2009, EUR J NEUROL, V16, P1185, DOI 10.1111/j.1468-1331.2009.02699.x; Patel T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00039; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662; Rigotti DJ, 2011, AM J NEURORADIOL, V32, P1011, DOI 10.3174/ajnr.A2452; Rinehart NJ, 2001, J AUTISM DEV DISORD, V31, P79, DOI 10.1023/A:1005617831035; Ritvo A. R, 2013, ENCY AUTISM SPECTRUM, P2489, DOI [10.1007/978-1-4419-1698-3_1993, DOI 10.1007/978-1-4419-1698-3_1993]; Ritvo RA, 2011, J AUTISM DEV DISORD, V41, P1076, DOI 10.1007/s10803-010-1133-5; Ross AJ, 2005, BRAIN RES BULL, V66, P9, DOI 10.1016/j.brainresbull.2005.01.015; Ross AJ, 2004, BRAIN RES REV, V44, P83, DOI 10.1016/j.brainresrev.2003.11.001; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Rudie JD, 2012, NEURON, V75, P904, DOI 10.1016/j.neuron.2012.07.010; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Segurado R, 2005, AM J PSYCHIAT, V162, P2182, DOI 10.1176/appi.ajp.162.11.2182; Serajee FJ, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e42; Shih P, 2011, BIOL PSYCHIAT, V70, P270, DOI 10.1016/j.biopsych.2011.03.040; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Shuang M, 2004, AM J MED GENET B, V131B, P48, DOI 10.1002/ajmg.b.30025; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Stankoff B, 2001, NEUROLOGY, V56, P112, DOI 10.1212/WNL.56.1.112; Stanley JA, 2002, CAN J PSYCHIAT, V47, P315, DOI 10.1177/070674370204700402; Suzuki K, 2010, INT J NEUROPSYCHOPH, V13, P529, DOI 10.1017/S1461145709990952; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Valenzuela MJ, 2000, NEUROIMAGE, V12, P747, DOI 10.1006/nimg.2000.0629; van Elst LT, 2014, MOL PSYCHIATR, V19, P1314, DOI 10.1038/mp.2014.62; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vasconcelos MM, 2008, J NEUROIMAGING, V18, P288, DOI 10.1111/j.1552-6569.2007.00200.x; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Waagepetersen H.S., 2007, HDB NEUROCHEMISTRY M, DOI [10.1007/978-0-387-30373-4_1, DOI 10.1007/978-0-387-30373-4_1]; Wechsler D., 2011, WECHSLER ABBREVIATED; Weiduschat N, 2014, NEUROSCI LETT, V570, P102, DOI 10.1016/j.neulet.2014.04.020; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162; Yuksel C, 2010, BIOL PSYCHIAT, V68, P785, DOI 10.1016/j.biopsych.2010.06.016; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x	112	10	11	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-3792	1939-3806		AUTISM RES	Autism Res.	JUN	2016	9	6					643	657		10.1002/aur.1562			15	Behavioral Sciences; Psychology, Developmental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology	DW0ZD	WOS:000383371400005	26526126	Green Accepted			2022-02-06	
J	Liu, J; Wang, Y; Zhuang, QW; Chen, M; Wang, YF; Hou, LN; Han, F				Liu, Jie; Wang, Yue; Zhuang, Qiwei; Chen, Meng; Wang, Yufeng; Hou, Lina; Han, Fei			Protective effects of cyclosporine A and hypothermia on neuronal mitochondria in a rat asphyxial cardiac arrest model	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							PERMEABILITY TRANSITION PORE; TRAUMATIC BRAIN-INJURY; ADENINE-NUCLEOTIDE TRANSLOCASE; CYCLOPHILIN-D; CELL-DEATH; ISCHEMIA-REPERFUSION; MILD HYPOTHERMIA; ISCHEMIA/REPERFUSION INJURY; FOREBRAIN ISCHEMIA; CEREBRAL-ISCHEMIA	Background: Cyclosporine A (CsA) was neuroprotective in the settings of traumatic brain injury and stroke. We sought to investigate the protective effects of CsA and hypothermia on neuronal mitochondria after cardiac arrest. Methods and Results: Five groups were included: sham (S), normothermia (N), CsA (C), hypothermia (H), and CsA plus hypothermia (C+H). Cardiac arrest was induced by 10 min of asphyxia. CsA (10mg/kg) was administered immediately after return of spontaneous circulation in the CsA groups. Temperature of the rats was maintained at 33 +/- 0.5 degrees C after return of spontaneous circulation in the hypothermia groups. Hippocampal mitochondria were measured after 2 h of resuscitation. Mitochondrial transmembrane potential was significantly higher in the C, the H, and the C + H groups than in the N group and was higher in the C + H group than in the C and the H groups. Cytosolic cytochrome c was significantly higher in the N group. Superoxide dismutase activity was significantly lower in the N group than in the other groups and was higher in the C and the C + H groups than in the H group. Malondialdehyde concentration was significantly higher in the N group. Conclusions: CsA or hypothermia used immediately after resuscitation enhanced mitochondrial transmembrane potential, kept cytochrome c from releasing out of the mitochondria, increased superoxide dismutase activity, and decreased malondialdehyde concentration in hippocampus. Moreover, the protective effects of CsA were reinforced by hypothermia. One of the mechanisms that hypothermia protected neuronal mitochondria from damage was inhibiting the opening of mitochondrial permeability transition pore. (C) 2016 Elsevier Inc. All rights reserved.	[Liu, Jie; Wang, Yue; Zhuang, Qiwei; Chen, Meng; Wang, Yufeng; Hou, Lina; Han, Fei] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 3, Harbin 150081, Heilongjiang, Peoples R China		Han, F (corresponding author), Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 3, Harbin 150081, Heilongjiang, Peoples R China.	fh.feih@yahoo.com			Nature Science Foundation, Department of Science and Technology, Heilongjiang, China [LC2012C40]	Funding was obtained from the Nature Science Foundation, Department of Science and Technology, Heilongjiang, China (Grant #: LC2012C40).	Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, pC994, DOI 10.1152/ajpcell.00031.2005; Akao M, 2003, CIRC RES, V92, P195, DOI 10.1161/01.RES.0000051862.16691.F9; Anaya-Prado R, 2002, J SURG RES, V105, P248, DOI 10.1006/jsre.2002.6385; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Berger C, 2002, STROKE, V33, P519, DOI 10.1161/hs0102.100878; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen J, 1998, J NEUROSCI, V18, P4914; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Garcia-Saenz-de-Sicilia M, 2012, EXPERT REV CLIN PHAR, V5, P587, DOI [10.1586/ECP.12.49, 10.1586/ecp.12.49]; Gong P, 2013, J CEREBR BLOOD F MET, V33, P928, DOI 10.1038/jcbfm.2013.33; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Hachimi-Idrissi S, 2004, BRAIN RES, V1019, P217, DOI 10.1016/j.brainres.2004.06.013; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 1999, BIOCHEM SOC SYMP, V66, P181, DOI 10.1042/bss0660181; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Horiguchi T, 2003, J NEUROTRAUM, V20, P511, DOI 10.1089/089771503765355577; Huang Chien-Hua, 2011, Resuscitation, V82 Suppl 2, pS41, DOI 10.1016/S0300-9572(11)70150-2; Kuchena A, 2014, CURR OPIN CRIT CARE, V20, P507, DOI 10.1097/MCC.0000000000000125; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Leger PL, 2011, EXP NEUROL, V230, P58, DOI 10.1016/j.expneurol.2010.06.009; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Li J, 2010, BRAIN RES, V1356, P11, DOI 10.1016/j.brainres.2010.08.012; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Merchant RM, 2006, CRIT CARE MED, V34, P1935, DOI 10.1097/01.CCM.0000220494.90290.92; Miura T, 2010, CARDIOVASC DRUG THER, V24, P255, DOI 10.1007/s10557-010-6234-z; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; OHTA H, 1994, FREE RADICAL BIO MED, V16, P501, DOI 10.1016/0891-5849(94)90128-7; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Tissier R, 2009, CARDIOVASC RES, V83, P345, DOI 10.1093/cvr/cvp046; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; van Alem AP, 2004, AM HEART J, V148, P416, DOI 10.1016/j.ahj.2004.01.031; Wang XY, 2010, STROKE, V41, P2050, DOI 10.1161/STROKEAHA.110.589051; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003	56	10	11	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2016	34	6					1080	1085		10.1016/j.ajem.2016.02.066			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DN8OO	WOS:000377338700026	26993074				2022-02-06	
J	Mitrovic, A; Mathews, M; Ohlsson, S; Holland, J; McKinlay, A				Mitrovic, Antonija; Mathews, Moffat; Ohlsson, Stellan; Holland, Jay; McKinlay, Audrey			Computer-Based Post-Stroke Rehabilitation of Prospective Memory	JOURNAL OF APPLIED RESEARCH IN MEMORY AND COGNITION			English	Article						Stroke; Prospective memory; Rehabilitation; Computer-based treatment; Visual imagery; Virtual reality	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; VIRTUAL-REALITY; COGNITIVE IMPAIRMENT; FUTURE-DIRECTIONS; CONTROLLED-TRIAL; VISUAL-IMAGERY; STROKE; DEMENTIA; ASSOCIATION	We present a computer-based environment for rehabilitation of prospective memory in stroke survivors. Prospective memory (PM), or remembering to perform actions in the future, is of crucial importance for everyday life. This kind of memory is often impaired in stroke survivors and can interfere with independent living. Fifteen participants were recruited to participate in our study consisting of 10 sessions. The participants were first trained on how to develop visual images in order to remember time- and event-based prospective memory tasks. After the visual imagery training, participants practiced their PM skills using videos, and later in a virtual reality (VR) environment. The results show a significant improvement on PM skills as measured by the CAMPROMPT test, which remained stable 4 weeks after the treatment. VR-based training was well accepted by the participants.	[Mitrovic, Antonija; Mathews, Moffat; Holland, Jay] Univ Canterbury, Intelligent Comp Tutoring Grp, 22 Kirkwood Ave,Ham Private Bag 4800, Christchurch 8140, New Zealand; [Ohlsson, Stellan] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [McKinlay, Audrey] Univ Melbourne, Dept Psychol, Melbourne, Vic 3010, Australia		Mitrovic, A (corresponding author), Univ Canterbury, Intelligent Comp Tutoring Grp, 22 Kirkwood Ave,Ham Private Bag 4800, Christchurch 8140, New Zealand.	tanja.mitrovic@canterbury.ac.nz		McKinlay, Audrey/0000-0001-9846-8514			Barker-Collo SL, 2009, STROKE, V40, P3293, DOI 10.1161/STROKEAHA.109.558239; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Brooks BM, 2003, NEUROREHABILITATION, V18, P147; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Camp CJ, 1996, APPL COGNITIVE PSYCH, V10, P193, DOI 10.1002/(SICI)1099-0720(199606)10:3<193::AID-ACP374>3.0.CO;2-4; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaggioli A, 2006, NEUROREHAB NEURAL RE, V20, P503, DOI 10.1177/1545968306290224; Gollwitzer P.M., 1996, PSYCHOL ACTION LINKI, P287; Gommans J., 2003, J NZ MED ASS, V116, P1174; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hochstenbach JB, 2001, ARCH PHYS MED REHAB, V82, P1360, DOI 10.1053/apmr.2001.25970; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kixmiller JS, 2002, BRAIN COGNITION, V49, P237, DOI 10.1006/brcg.2001.1476; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; LEWINSOHN PM, 1977, J CONSULT CLIN PSYCH, V45, P717, DOI 10.1037/0022-006X.45.5.717; Lindeboom J, 2002, J NEUROL NEUROSUR PS, V73, P126, DOI 10.1136/jnnp.73.2.126; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel M. A., 1992, ADV LEARNING BEHAVIO, V7, P87; Medalia A, 1998, SCHIZOPHRENIA BULL, V24, P147, DOI 10.1093/oxfordjournals.schbul.a033306; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Patel MD, 2002, J AM GERIATR SOC, V50, P700, DOI 10.1046/j.1532-5415.2002.50165.x; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Teng EL, 1987, CAN J PSYCHIAT, V41, P114; Titov N, 2000, BRAIN INJURY, V14, P877; Tombaugh TN, 2005, ARCH CLIN NEUROPSYCH, V20, P485, DOI 10.1016/j.acn.2004.11.004; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wolinsky FD, 2006, J GERONTOL A-BIOL, V61, P1324, DOI 10.1093/gerona/61.12.1324; Yip B. C., 2013, VIRTUAL REALITY BASE; Zhu L, 1998, STROKE, V29, P2094, DOI 10.1161/01.STR.29.10.2094	46	10	10	1	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2211-3681	2211-369X		J APPL RES MEM COGN	J. Appl. Res. Mem. Cogn.	JUN	2016	5	2					204	214		10.1016/j.jarmac.2016.03.006			11	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	DT8NO	WOS:000381747900016		Green Published, hybrid			2022-02-06	
J	Mrazik, M; Brooks, BL; Jubinville, A; Meeuwisse, WH; Emery, CA				Mrazik, Martin; Brooks, Brian L.; Jubinville, Andrea; Meeuwisse, Willem H.; Emery, Carolyn A.			Psychosocial Outcomes of Sport Concussions in Youth Hockey Players	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Brain injury; Sport concussion; Psychological issues; Injury	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; RECURRENT CONCUSSION; CONSENSUS STATEMENT; NCAA CONCUSSION; CHILDREN; SYMPTOMS; EPIDEMIOLOGY	The objective is to evaluate the psychological outcomes arising from sport concussions. Participants included AA and AAA level Bantam and Midget hockey players (n = 672) between 12 and 17 years of age (mean = 15.0 years; SD = 1.2) enrolled in a large cohort study. All participants completed baseline tests including the Behavior Assessment System for Children, 2nd Edition (BASC2) and a pre-season medical questionnaire (PSQ) completed by parents that included a retrospective report of prior concussions and injuries. Players were assigned to 4 groups: no injury (NONE), concussion (CO) and musculoskeletal (MSK) injuries or both (COMB). Participants in the CO and COMB groups demonstrated significantly higher rates of psychological difficulties compared with other groups [F(63, 1800) = 1.43, p = .016, partial eta(2) = 0.05) and on select clinical scales measuring atypicality, locus of control, anxiety, depression, sense of inadequacy, somatization, and attention. In addition, results from the composite clinical scales reached statistical significance for internalizing problems and emotional symptom index. Effect sizes were minimal with the exception of comparisons between the NONE and COMB groups where effect sizes were medium to large. Proportions above clinical cut-off scores set by the BASC2 were higher for the COMB group compared with CO, MSK, or NONE groups. Results suggest smaller percentage of youth may be more prone to psychological sequelae following concussion.	[Mrazik, Martin; Jubinville, Andrea] Univ Alberta, Dept Educ Psychol, 6-135 Educ North,11210-87 Ave, Edmonton, AB T6G 2G6, Canada; [Brooks, Brian L.; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Paediat, Neurosci,Brain Injury Program,Alberta Childrens H, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Med, Dept Paediat, Neurosci,Rehabil Program,Alberta Childrens Hosp, Calgary, AB, Canada; [Brooks, Brian L.; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Clin Neurosci, Neurosci,Brain Injury Program,Alberta Childrens H, Calgary, AB, Canada; [Brooks, Brian L.; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Clin Neurosci, Neurosci,Rehabil Program,Alberta Childrens Hosp, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Res Inst Child & Maternal Hlth, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada; [Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada		Mrazik, M (corresponding author), Univ Alberta, Dept Educ Psychol, 6-135 Educ North,11210-87 Ave, Edmonton, AB T6G 2G6, Canada.	mrazik@ualberta.ca	Meijer, Anna/K-5118-2016; Emery, Carolyn/AAI-2761-2020		Psychological Assessment Resources, Inc.; Alberta Children's Hospital Research Institute Chair in Pediatric Rehabilitation - Alberta Children's Hospital Foundation; Alberta Innovates [201201160] Funding Source: researchfish	BLB receives funding from a test publisher (Psychological Assessment Resources, Inc.), book royalties from Oxford University Press. CAE is supported by Alberta Children's Hospital Research Institute Chair in Pediatric Rehabilitation (funded by the Alberta Children's Hospital Foundation).	Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Cohen J., 2013, STAT POWER ANAL BEHA; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P493, DOI 10.1017/S1355617713000398; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	35	10	10	3	24	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2016	31	4					297	304		10.1093/arclin/acw013			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DN9RG	WOS:000377417200002	27084731	Bronze			2022-02-06	
J	Wang, MZ; Zhi, DJ; Wang, HQ; Ru, Y; Ren, H; Wang, N; Liu, YY; Li, Y; Li, HY				Wang, Meizhu; Zhi, Dejuan; Wang, Haiqing; Ru, Yi; Ren, Hui; Wang, Na; Liu, Yiyao; Li, Yang; Li, Hongyu			TAT-HSA-alpha-MSH fusion protein with extended half-life inhibits tumor necrosis factor-alpha in brain inflammation of mice	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Half-life; Neuroinflammation; Blood brain barrier; TAT-HSA-alpha-MSH	HUMAN SERUM-ALBUMIN; MELANOCYTE-STIMULATING HORMONE; NF-KAPPA-B; MELANOCORTIN SYSTEM; FUTURE PERSPECTIVES; MEDIATED DELIVERY; CEREBRAL-ISCHEMIA; IN-VIVO; NEUROPROTECTION; INJURY	Neuroinflammation constitutes a principal process involved in the progression of various central nervous system (CNS) disorders, including Parkinson's disease, Alzheimer's disease, ischemic stroke, and traumatic brain injury. The safety and efficacy of potential neuroprotective therapeutic agents is controversial and limited. Alpha-melanocyte-stimulating hormone (alpha-MSH) as a tridecapeptide derived from pro-opiomelanocortin displays potent anti-inflammatory and protective effects with a wide therapeutic window in brain damage. However, it is difficult to deliver effective concentrations of alpha-MSH into brain tissue via nondirect application. Besides, the half-life of the tridecapeptide is only a few minutes. In the present study, we generated a novel TAT-HSA-alpha-MSH by genetically fusing alpha-MSH with N-terminus 11-amino acid protein transduction domain of the human immunodeficiency virus Tat protein (TAT) and human serum albumin (HSA), which showed favorable pharmacokinetic properties and can effectively cross the blood brain barrier (BBB). The findings showed that TAT-HSA-alpha-MSH significantly inhibits NF-kappa B activation in human glioma cells A172 and tumor necrosis factor-alpha (TNF-alpha) production in experimental brain inflammation. These results indicate that TAT-HSA-alpha-MSH may be a potential therapeutic agent for treating neuroinflammation which plays a fundamental role in CNS disorders.	[Wang, Meizhu; Ru, Yi; Liu, Yiyao; Li, Hongyu] Lanzhou Univ, Sch Life Sci, Inst Microbiol, Gansu Key Lab Biomonitoring & Bioremediat Environ, Tianshui Rd 222, Lanzhou 730000, Peoples R China; [Zhi, Dejuan; Wang, Haiqing; Ren, Hui; Wang, Na; Li, Yang; Li, Hongyu] Lanzhou Univ, Sch Pharm, Gansu High Throughput Screening & Creat Ctr Hlth, Lanzhou 730000, Peoples R China		Li, HY (corresponding author), Lanzhou Univ, Sch Life Sci, Inst Microbiol, Gansu Key Lab Biomonitoring & Bioremediat Environ, Tianshui Rd 222, Lanzhou 730000, Peoples R China.; Li, HY (corresponding author), Lanzhou Univ, Sch Pharm, Gansu High Throughput Screening & Creat Ctr Hlth, Lanzhou 730000, Peoples R China.	lihy@lzu.edu.cn			Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [2012DFA30480]; key project of Gansu Province science and technology [1002WKDE055]; Gansu Province Scientific Research Project Fund [090WCGA900]; Fundamental Research Funds for the Central Universities of ChinaFundamental Research Funds for the Central Universities [lzujbky-2014-147]	This study was supported by the special international cooperation project of Ministry of Science and Technology (2012DFA30480); the key project of Gansu Province science and technology (1002WKDE055); Gansu Province Scientific Research Project Fund (090WCGA900). Fundamental Research Funds for the Central Universities of China (lzujbky-2014-147).	Ahmed TJ, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/985815; Allison DJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0151-1; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Asa FA, 2007, J MOL NEUROSCI, V33, P239, DOI 10.1007/s12031-007-0019-2; Asoh S, 2008, ADV DRUG DELIVER REV, V60, P499, DOI 10.1016/j.addr.2007.09.011; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Cai B, 2011, EXP NEUROL, V227, P224, DOI 10.1016/j.expneurol.2010.11.009; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Catania A, 2007, J LEUKOCYTE BIOL, V81, P383, DOI 10.1189/jlb.0706426; Catania A, 2010, THESCIENTIFICWORLDJO, V10, P1840, DOI 10.1100/tsw.2010.173; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Doeppner TR, 2010, NEUROBIOL DIS, V40, P265, DOI 10.1016/j.nbd.2010.05.033; Duttaroy A, 2005, DIABETES, V54, P251, DOI 10.2337/diabetes.54.1.251; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Finsen B, 2011, FEBS LETT, V585, P3806, DOI 10.1016/j.febslet.2011.05.030; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Giuliani D, 2012, FRONT NEUROENDOCRIN, V33, P179, DOI 10.1016/j.yfrne.2012.04.001; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; HOLDEMAN M, 1985, PEPTIDES, V6, P273, DOI 10.1016/0196-9781(85)90051-8; Huang Y, 2008, APPL MICROBIOL BIOT, V77, P1015, DOI 10.1007/s00253-007-1249-5; Ichiyama T, 1999, EXP NEUROL, V157, P359, DOI 10.1006/exnr.1999.7064; Jeong HJ, 2012, EXP MOL MED, V44, P586, DOI 10.3858/emm.2012.44.10.067; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kincses ZT, 2011, CNS NEUROSCI THER, V17, P345, DOI 10.1111/j.1755-5949.2010.00150.x; Koistinaho M, 2005, BRAIN RES REV, V48, P240, DOI 10.1016/j.brainresrev.2004.12.014; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Merkler DJ, 1994, ENZYME MICROB TECH, P116; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Minnerup J, 2012, INT J MOL SCI, V13, P11753, DOI 10.3390/ijms130911753; Osborn BL, 2002, EUR J PHARMACOL, V456, P149, DOI 10.1016/S0014-2999(02)02644-4; Paxinos G, 2002, MOUSE BRAIN STEREOTA; Prajapati KD, 2011, REV NEUROSCIENCE, V22, P355, DOI 10.1515/RNS.2011.028; Rajora N, 1997, J NEUROSCI, V17, P2181; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Tanaka R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00561; Thompson AM, 2015, ANN PHARMACOTHER, V49, P351, DOI 10.1177/1060028014564180; Tsubaki M, 2013, INT J BIOL MACROMOL, V52, P139, DOI 10.1016/j.ijbiomac.2012.09.016; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; WILSON JF, 1988, PSYCHOPHARMACOLOGY, V96, P262; Yin P, 2003, GENE THER, V10, P348, DOI 10.1038/sj.gt.3301902; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093334	48	10	11	2	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUN	2016	100	12					5353	5361		10.1007/s00253-015-7251-4			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DM6JB	WOS:000376456700013	26816094				2022-02-06	
J	Schmidt, S; Thyen, U; Herrmann-Garitz, C; Bomba, F; Muehlan, H				Schmidt, Silke; Thyen, Ute; Herrmann-Garitz, Carsten; Bomba, Franziska; Muehlan, Holger			The Youth Health Care measure-satisfaction, utilization, and needs (YHC-SUN)-development of a self-report version of the Child Health Care (CHC-SUN) proxy-measure	BMC HEALTH SERVICES RESEARCH			English	Article						Pediatric health service research; Coordination of care; Transition; Adolescents with chronic conditions; CHC, SUN (= Child Health Care, Satisfaction, Utilization and Needs); YHC, SUN (= Youth Health Care, Satisfaction, Utilization and Needs)	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; UNITED-STATES; ADULT HEALTH; ADOLESCENTS; TRANSITION; SERVICES	Background: The transition of health care of youth (age 15-25) with chronic conditions requires the assessment of adolescents' access, use and needs as well as satisfaction with the health services they use. The aim of this study was to test the adolescent adaptation of the parent version "Child Health Care Questionnaire - Satisfaction, Utilization and Needs" (CHC-SUN) concerning its psychometric performance and appropriateness for adolescents and young adults. Methods: The Youth Health Care Measure (YHC-SUN) was designed to allow self-report of youth and it was pilot-tested in a small sample using cognitive debriefing. A cross-sectional survey in a sample of youth with chronic conditions in the transition period was carried out. Results: One hundred eighty-two ambulatory care patients with three conditions participated in the survey. The subscales of the section on satisfaction with care showed excellent internal consistencies, uni-dimensionality and fit to the model of the parent version. There was no impact of gender and education on satisfaction with care. Associations with age, diagnosis, experiences with care and health literacy affecting the satisfaction with care indicate discriminatory and content validity. Conclusions: Potential applications of the new instrument are evaluations of health care services for adolescents and young adults using self-reports and evaluations of transition programs and interventions such as patient education.	[Schmidt, Silke; Herrmann-Garitz, Carsten; Muehlan, Holger] Ernst Moritz Arndt Univ Greifswald, Inst Psychol, Dept Hlth & Prevent, Robert Blum Str 13, D-17489 Greifswald, Germany; [Thyen, Ute; Bomba, Franziska] Univ Lubeck, Dept Child & Adolescent Med, Ratzeburger Allee 160, D-23538 Lubeck, Germany		Schmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Psychol, Dept Hlth & Prevent, Robert Blum Str 13, D-17489 Greifswald, Germany.	Silke.Schmidt@uni-greifswald.de			Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [01GX1005]	This study was funded by the Federal Ministry of Education and Research [grant number: 01GX1005].	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Berkman Nancy D, 2011, Evid Rep Technol Assess (Full Rep), P1; Bethel CD, 2015, ACAD PEDIATR, V15, P165, DOI 10.1016/j.acap.2014.10.003; Bomba F, HLTH SOCIAL IN PRESS; Clancy CM, 2013, ACAD PEDIATR, V13, P181, DOI 10.1016/j.acap.2013.03.012; Clarke SA, 2004, HEALTH QUAL LIFE OUT, V2, P1, DOI DOI 10.1186/1477-7525-2-66; Farre A, 2015, ARCH DIS CHILD, V100, P144, DOI 10.1136/archdischild-2014-306749; Ghaddar SF, 2012, J SCHOOL HEALTH, V82, P28, DOI 10.1111/j.1746-1561.2011.00664.x; Gonzalez M, 2011, EVALUATION PILOT EPI; Herrmann-Garitz C, 2015, GESUNDHEITSWESEN; Jardine J, 2014, PEDIATRICS, V134, pE1129, DOI 10.1542/peds.2014-0352; Lee Young Ah, 2013, Ann Pediatr Endocrinol Metab, V18, P106, DOI 10.6065/apem.2013.18.3.106; Lux A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-110; Mah JK, 2006, J ADOLESCENT HEALTH, V38, P607, DOI DOI 10.1016/J.JADOHEALTH.2005.08.004.E1-7; McLaughlin SE, 2008, PEDIATRICS, V121, pE1160, DOI 10.1542/peds.2007-2217; Muhlan H, 2008, CLIN PSYCHOL PSYCHOT, V15, P142, DOI 10.1002/cpp.573; Park MJ, 2014, J ADOLESCENT HEALTH, V55, P3, DOI 10.1016/j.jadohealth.2014.04.003; Park MJ, 2011, ACAD PEDIATR, V11, P115, DOI 10.1016/j.acap.2010.11.010; Petersen C, 2008, BUNDESGESUNDHEITSBLA, V51, P629, DOI 10.1007/s00103-008-0536-3; Petersen C, 2006, BRAIN INJURY, V20, P321, DOI 10.1080/02699050500488108; Rost J., 2004, LEHRBUCH TESTTHEORIE; Schmidt S, 2008, CHILD CARE HLTH DEV, V34, P355, DOI 10.1111/j.1365-2214.2008.00815.x; Schmidt S, 2004, EUR J PEDIATR, V163, P517, DOI 10.1007/s00431-004-1458-1; Schmidt S, 2007, AMBUL PEDIATR, V7, P374, DOI 10.1016/j.ambp.2007.04.007; Schmidt S, 2016, PATIENT EDUC COUNS, V99, P421, DOI 10.1016/j.pec.2015.10.024; Schwartz LA, 2014, J PEDIATR PSYCHOL, V39, P588, DOI 10.1093/jpepsy/jsu028; Shaw KL, 2007, CHILD CARE HLTH DEV, V33, P380, DOI 10.1111/j.1365-2214.2006.00699.x; Sofaer S, 2005, ANNU REV PUBL HEALTH, V26, P513, DOI 10.1146/annurev.publhealth.25.050503.153958; Stinson Jennifer, 2014, Int J Adolesc Med Health, V26, P159, DOI 10.1515/ijamh-2013-0512; Thyen U., 2009, DEV BEHAV PEDIAT, V4, P343, DOI [10.1016/B978-1-4160-3370-7.00035-3, DOI 10.1016/B978-1-4160-3370-7.00035-3]; Thyen U, 2014, VFFR NEWS, V15, P16; van der Lee JH, 2007, JAMA-J AM MED ASSOC, V297, P2741, DOI 10.1001/jama.297.24.2741; White-Koning M, 2007, PEDIATRICS, V120, pE804, DOI 10.1542/peds.2006-3272	33	10	10	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	MAY 20	2016	16								189	10.1186/s12913-016-1419-1			12	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DM7XN	WOS:000376573400001	27206474	gold, Green Published			2022-02-06	
J	Chiou, KS; Chiaravalloti, ND; Wylie, GR; DeLuca, J; Genova, HM				Chiou, Kathy S.; Chiaravalloti, Nancy D.; Wylie, Glenn R.; DeLuca, John; Genova, Helen M.			Awareness of Subjective Fatigue After Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						fatigue; self-awareness; TBI	IMPAIRED SELF-AWARENESS; BECK DEPRESSION INVENTORY; IMPACT SCALE; PREFRONTAL CORTEX; REHABILITATION; VALIDATION; DISABILITY; ADULTS	Objective: As measurements of subjective fatigue after traumatic brain injury (TBI) rely on self-assessment, deficits in self-awareness after TBI may distort subjective fatigue reports. This study investigates awareness of subjective fatigue after TBI using self-and informant reports. Participants: Fourteen adults with moderate to severe TBI and 7 healthy controls (HCs). Measures: Modified Fatigue Impact Scale (MFIS) and battery of cognitive and emotional tests. Informants completed an "other-report," rating their perception of participant's fatigue. Subjective fatigue awareness was defined as discrepancy between self-and other-MFIS scores. Results: Adults with TBI showed greater discrepancies between self-and other-MFIS scores than did HCs. Negative relations were found between fatigue awareness and symptoms of depression, but there were no relationships between fatigue awareness and cognitive performance. Conclusions: Results indicate that adults with TBI have poorer awareness of subjective fatigue than HCs. Correlations between subjective fatigue awareness and depression support existing literature implicating strong emotional components in the experience of subjective fatigue postinjury. Findings suggest cautious interpretation of subjective fatigue, as responses may not reflect fatigue symptoms exclusively.	[Chiou, Kathy S.] Kessler Fdn, Traumat Brain Injury Res, 300 Execut Dr,Ste 70, W Orange, NJ 07052 USA; [Chiaravalloti, Nancy D.] Kessler Fdn, Neuropsychol Neurosci Res & Traumat Brain Injury, W Orange, NJ 07052 USA; [Wylie, Glenn R.] Kessler Fdn, Neurosci, W Orange, NJ 07052 USA; [DeLuca, John] Kessler Fdn, Res & Training, W Orange, NJ 07052 USA; [Genova, Helen M.] Kessler Fdn, Neuropsychol Neurosci Res, W Orange, NJ 07052 USA; [Chiou, Kathy S.; Chiaravalloti, Nancy D.; Wylie, Glenn R.; DeLuca, John; Genova, Helen M.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Chiou, KS (corresponding author), Kessler Fdn, Traumat Brain Injury Res, 300 Execut Dr,Ste 70, W Orange, NJ 07052 USA.	kchiou@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission for Brain Injury Research [10.005.BIR1]	This research was supported by funding from The New Jersey Commission for Brain Injury Research (10.005.BIR1).	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A., 1994, CONTRIBUTIONS NEUROP; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Delis D, 2000, DELIS KAPLAN EXECUTI; Delis D.C., 2000, CALIFORNIA VERBAL LE; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Faul M, 2010, TRAUMATIC BRAIN INJU; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Garmoe W, 2005, J HEAD TRAUMA REHAB, V20, P348, DOI 10.1097/00001199-200507000-00006; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Huber S, 1994, NEUROPSY NEUROPSY BE, V6, P177; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Schmitter-Edgecombe M, 2007, NEUROPSYCHOLOGY, V21, P224, DOI 10.1037/0894-4105.21.2.224; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Smith A., 1982, SYMBOL DIGIT MODALIT; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Tellez N, 2005, MULT SCLER J, V11, P198, DOI 10.1191/1352458505ms1148oa; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WAIS 3 ADM SCORING M; WechslerD, 2001, WECHSLER TEST ADULT; Yancosek KE, 2009, J HAND THER, V22, P258, DOI 10.1016/j.jht.2008.11.004	42	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E60	E68		10.1097/HTR.0000000000000161			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800007	26394289				2022-02-06	
J	Jiang, DL; Wang, YT; Zang, YN; Liu, XF; Zhao, LB; Wang, Q; Liu, C; Feng, WY; Yin, XX; Fang, Y				Jiang, Daoli; Wang, Yitong; Zang, Yannan; Liu, Xiaofang; Zhao, Libo; Wang, Qian; Liu, Chang; Feng, Wanyu; Yin, Xiaoxing; Fang, Yi			Neuroprotective Effects of rhGLP-1 in Diabetic Rats with Cerebral Ischemia/Reperfusion Injury	DRUG DEVELOPMENT RESEARCH			English	Article						rhGLP-1; cerebral ischemia/reperfusion injury; diabetes	GLUCAGON-LIKE PEPTIDE-1; NEURON-SPECIFIC ENOLASE; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RECEPTOR STIMULATION; POSTSTROKE HYPERGLYCEMIA; BIOCHEMICAL MARKERS; INSULIN-SECRETION	The aim of the present study was to evaluate the neuroprotective benefits of rhGLP-1 in diabetic rats subjected to acute cerebral ischemia/reperfusion injury induced by middle cerebral artery occlusion/reperfusion (MCAO/R). Streptozotocin (STZ)-induced diabetic rats were pretreated with rhGLP-1 (10, 20, or 40 mu g/kg ip, tid) for 14 days. During this time, body weight and fasting blood glucose levels were assessed. Rats were then subjected to MCAO 90 min/R 24 h. At 2 and 24 h of reperfusion, rats were evaluated for neurological deficits and blood samples were collected to analyze markers of brain injury. Rats were then sacrificed to assess the infarction volume. rhGLP-1 pretreatment lowered blood glucose levels, improved neurological scores, attenuated infarct volumes, and reduced the blood levels of S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), and myelin basic protein (MBP). rhGLP-1 has neuroprotective benefits in diabetic rats with cerebral ischemia/reperfusion injury and could potentially be used as a prophylatic neuroprotectant in diabetic patients at high risk of ischemic stroke. (C) 2016 Wiley Periodicals, Inc.	[Jiang, Daoli; Liu, Chang; Yin, Xiaoxing] Xuzhou Med Coll, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou 221004, Peoples R China; [Wang, Yitong; Zang, Yannan; Zhao, Libo; Wang, Qian; Feng, Wanyu; Fang, Yi] Peking Univ, Peoples Hosp, Dept Pharm, Beijing 100044, Peoples R China; [Wang, Yitong; Zang, Yannan] Peking Univ, Hlth Sci Ctr, Dept Pharm Adm & Clin Pharm, Beijing 100191, Peoples R China; [Liu, Xiaofang] Southeast Univ, Sch Med, Zhongda Hosp, Nanjing 210009, Peoples R China		Fang, Y (corresponding author), Peking Univ, Peoples Hosp, Dept Pharm, Beijing 100044, Peoples R China.	phaseistudy@163.com		Feng, Wanyu/0000-0002-6171-7342	Peking University People's Hospital Research and Development Funds [2013-22]; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College	Grant sponsor: Peking University People's Hospital Research and Development Funds; Grant number: No: 2013-22; Grant sponsor: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College.	Ahren B, 2011, EXP CELL RES, V317, P1239, DOI 10.1016/j.yexcr.2011.01.010; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Baird TA, 2002, J CLIN NEUROSCI, V9, P618, DOI 10.1054/jocn.2002.1081; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Banks WA, 2004, J PHARMACOL EXP THER, V309, P469, DOI 10.1124/jpet.103.063222; BARONE FC, 1993, BRAIN RES, V623, P77, DOI 10.1016/0006-8993(93)90012-C; BELL GI, 1983, NATURE, V304, P368, DOI 10.1038/304368a0; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Biswas SC, 2008, NEUROCHEM RES, V33, P1845, DOI 10.1007/s11064-008-9646-4; Bottiger BW, 2001, CIRCULATION, V103, P2694; Briyal S, 2014, NEUROSCIENCE, V281, P269, DOI 10.1016/j.neuroscience.2014.09.064; Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Butterworth RJ, 1996, STROKE, V27, P2064, DOI 10.1161/01.STR.27.11.2064; Cunningham RT, 1996, EUR J CLIN INVEST, V26, P298, DOI 10.1046/j.1365-2362.1996.129282.x; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; DALESSIO DA, 1995, DIABETES, V44, P1433, DOI 10.2337/diabetes.44.12.1433; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2001, ENDOCRINOLOGY, V142, P521, DOI 10.1210/en.142.2.521; Dunning BE, 2005, DIABETOLOGIA, V48, P1700, DOI 10.1007/s00125-005-1878-0; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gallwitz B, 2016, CURR OPIN ENDOCRINOL, V23, P23, DOI 10.1097/MED.0000000000000217; Georgiadis D, 2000, J THORAC CARDIOV SUR, V119, P138, DOI 10.1016/S0022-5223(00)70229-7; Gray CS, 2004, STROKE, V35, P122, DOI 10.1161/01.STR.0000106916.81680.C0; Green AR, 2008, BRIT J PHARMACOL, V153, pS325, DOI 10.1038/sj.bjp.0707594; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541, DOI 10.1152/ajpregu.1999.276.5.R1541; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Hill MD, 2000, CAN MED ASSOC J, V162, P1139; Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS47, DOI 10.1016/j.jalz.2013.12.009; HORN M, 1995, STROKE, V26, P290, DOI 10.1161/01.STR.26.2.290; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Hui L, 2005, BRAIN RES, V1052, P1, DOI 10.1016/j.brainres.2005.05.043; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Kagansky N, 2001, ARCH NEUROL-CHICAGO, V58, P1209, DOI 10.1001/archneur.58.8.1209; KATO K, 1982, BRAIN RES, V237, P441, DOI 10.1016/0006-8993(82)90455-3; Leigh R, 2004, STROKE, V35, P1903, DOI 10.1161/01.STR.0000132571.77987.4c; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lian TT, 2015, INT J MOL SCI, V16, P13427, DOI 10.3390/ijms160613427; Lindsberg PJ, 2004, STROKE, V35, P363, DOI 10.1161/01.STR.0000115297.92132.84; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Lund A, 2014, EUR J INTERN MED, V25, P407, DOI 10.1016/j.ejim.2014.03.005; Ma XS, 2014, J DIABETES, V6, P394, DOI 10.1111/1753-0407.12161; MARANGOS PJ, 1979, J NEUROCHEM, V33, P319, DOI 10.1111/j.1471-4159.1979.tb11735.x; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Martin A, 2006, STROKE, V37, P1288, DOI 10.1161/01.STR.0000217389.55009.f8; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1118, DOI 10.1152/ajpendo.00576.2005; Micieli G, 2009, VASC HEALTH RISK MAN, V5, P397; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Olivecrona Z, 2014, BRAIN INJURY, V2014, P1; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Reeves MJ, 2010, STROKE, V41, pE409, DOI 10.1161/STROKEAHA.109.572693; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Rizk NN, 2006, BRAIN RES, V1096, P204, DOI 10.1016/j.brainres.2006.04.060; Sarkar S, 2003, BRAIN RES, V985, P163, DOI 10.1016/S0006-8993(03)03117-2; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; SCHAARSCHMIDT H, 1994, STROKE, V25, P558, DOI 10.1161/01.STR.25.3.558; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Selakovic V, 2005, J CLIN NEUROSCI, V12, P542, DOI 10.1016/j.jocn.2004.07.019; Sharma MK, 2014, J NEUROCHEM, V128, P459, DOI 10.1111/jnc.12469; Shobha K, 2010, NEUROSCI LETT, V473, P56, DOI 10.1016/j.neulet.2010.02.022; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Wohlfart P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-84; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Yang Y, 1998, J NEUROSCI METH, V84, P9, DOI 10.1016/S0165-0270(98)00067-3; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zhao LB, 2015, BRAIN RES, V1602, P153, DOI 10.1016/j.brainres.2015.01.014; Zierath D, 2015, J NEUROIMMUNOL, V285, P101, DOI 10.1016/j.jneuroim.2015.05.024	80	10	13	1	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4391	1098-2299		DRUG DEVELOP RES	Drug Dev. Res.	MAY	2016	77	3					124	133		10.1002/ddr.21297			10	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DP6WH	WOS:000378639600002	26971396				2022-02-06	
J	Kinoshita, T; Yoshiya, K; Fujimoto, Y; Kajikawa, R; Kiguchi, T; Hara, M; Wakayama, A; Yoshimine, T				Kinoshita, Takahiro; Yoshiya, Kazuhisa; Fujimoto, Yasunori; Kajikawa, Ryuichiro; Kiguchi, Takeyuki; Hara, Masahiko; Wakayama, Akatsuki; Yoshimine, Toshiki			Decompressive Craniectomy in Conjunction With Evacuation of Intracranial Hemorrhagic Lesions Is Associated With Worse Outcomes in Elderly Patients With Traumatic Brain Injury: A Propensity Score Analysis	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Elderly; Inverse probability of treatment weighting; Propensity score analysis; Traumatic brain injury	HEMICRANIECTOMY; CRANIOTOMY; MANAGEMENT; PRESSURE	BACKGROUND: When it comes to evacuating intracranial hemorrhagic lesions in patients with traumatic brain injury (TBI), neurosurgeons perform either a craniotomy or a decompressive craniectomy (DC). The aim of the present study was to estimate the impact of DC on outcomes in elderly patients. METHODS: This retrospective cohort study, conducted in a neurosurgical institute in Japan from April 2009 to June 2014, included 91 consecutive patients with TBI (aged 60 years or older) who underwent evacuation of intracranial hemorrhagic lesions. Patients were divided into 2 groups: craniotomy only or DC. We set the primary endpoint as an unfavorable outcome (death or vegetative state), as evaluated on the Glasgow Outcome Scale at 6 months after injury. The secondary endpoints included existence of delayed hemorrhage and occurrence of hydrocephalus requiring shunt placement. The inverse probability of treatment weighting method was used to develop a propensity model to adjust for baseline imbalances between groups. RESULTS: The DC group exhibited greater severity both in clinical and computed tomography findings according to baseline characteristics. After we adjusted for these differences by inverse probability of treatment weighting using the propensity score, DC was significantly associated with unfavorable outcomes (adjusted odds ratio, 8.00; 95% confidential interval, 2.30-27.84; P = 0.002) and delayed hemorrhage (adjusted odds ratio, 13.42; 95% confidential interval, 1.52-118.89; P = 0.022). There was no significant difference in the occurrence of hydrocephalus requiring shunt placement. CONCLUSIONS: DC in conjunction with evacuation of intracranial hemorrhagic lesions was associated with worse functional outcome in elderly patients with TBI.	[Kinoshita, Takahiro; Fujimoto, Yasunori; Kajikawa, Ryuichiro; Wakayama, Akatsuki] Osaka Neurol Inst, Dept Neurosurg, Toyonaka, Osaka, Japan; [Kinoshita, Takahiro; Kiguchi, Takeyuki] Osaka Gen Med Ctr, Dept Emergency & Crit Care, Osaka, Japan; [Yoshiya, Kazuhisa] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka, Japan; [Hara, Masahiko] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Suita, Osaka, Japan; [Yoshimine, Toshiki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka, Japan; [Hara, Masahiko] Osaka Univ Hosp, Dept Med Innovat, Suita, Osaka, Japan		Kinoshita, T (corresponding author), Osaka Neurol Inst, Dept Neurosurg, Toyonaka, Osaka, Japan.; Kinoshita, T (corresponding author), Osaka Gen Med Ctr, Dept Emergency & Crit Care, Osaka, Japan.	ogmc.dmat.t.kinoshita@gmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Wong GKC, 2010, ACTA NEUROCHIR SUPPL, V106, P235, DOI 10.1007/978-3-211-98811-4_44	24	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2016	89						187	192		10.1016/j.wneu.2016.01.071			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DM6GM	WOS:000376448700028	26851740				2022-02-06	
J	La Fountaine, MF; Toda, M; Testa, A; Bauman, WA				La Fountaine, Michael F.; Toda, Michita; Testa, Anthony; Bauman, William A.			Suppression of Serum Prolactin Levels after Sports Concussion with Prompt Resolution Upon Independent Clinical Assessment To Permit Return-to-Play	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; head trauma; hypopituitarism	HYPOPITUITARISM; DYSFUNCTION; STATEMENT; SECRETION; HORMONE; INJURY	A significant outflow of neurotransmitters and metabolites with associated enhanced cortical excitation occurs after concussive head trauma. Cellular changes in the acute post-injury period cannot be observed directly in humans, and as such, require indirect evidence from systems sufficiently sensitive to central neuronal cellular excitation. Dopamine is a neurotransmitter with numerous targets in the central and peripheral nervous system. Changes to central dopaminergic tone result in reciprocal responses to the level of serum prolactin (PRL). Thus, a concussion may lead to abnormal dopaminergic tone, resulting in dynamic perturbations in the serum PRL concentration. To determine the effect of concussion on serum PRL concentrations, venipuncture was performed in the morning in four male intercollegiate athletes (age, 20 +/- 1 years; height, 71 +/- 5 inches; weight, 174 +/- 21 pounds) within 48 h of concussion and again at 7 and 14 days post-injury. Serum PRL concentrations for each visit were categorized by quartile within the normal range. In all athletes, serum PRL concentrations increased from the lower quartiles in samples obtained closer to the time of injury to the higher quartiles at 14 days post-injury. These serum PRL changes accompanied the resolution of symptoms and the clinical decision to permit return-to-play. It may be postulated that transient augmentation of central dopaminergic tone resulted in inhibition of PRL secretion early after concussion and that disinhibition of PRL release occurred when central dopaminergic tone subsequently returned to baseline levels. This novel observation provides evidence for dopaminergic dysfunction after concussion that may be tracked by determination of serum PRL levels.	[La Fountaine, Michael F.] Seton Hall Univ, Sch Hlth & Med Sci, 400 South Orange Ave, S Orange, NJ 07079 USA; [La Fountaine, Michael F.] Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, S Orange, NJ 07079 USA; [Testa, Anthony] Seton Hall Univ, Dept Athlet, S Orange, NJ 07079 USA; [La Fountaine, Michael F.; Bauman, William A.] James J Peters VA Med Ctr, VA Rehabil Res & Dev Natl Ctr Excellence Med Cons, Bronx, NY USA; [Toda, Michita] Univ Wisconsin, Dept Athlet, Madison, WI USA; [Bauman, William A.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Bauman, William A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		La Fountaine, MF (corresponding author), Seton Hall Univ, Sch Hlth & Med Sci, 400 South Orange Ave, S Orange, NJ 07079 USA.	lafounmi@shu.edu	La Fountaine, Michael/Q-6769-2019				Birketvedt GS, 2012, APPETITE, V59, P688, DOI 10.1016/j.appet.2012.07.015; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Corona G, 2011, EUR J ENDOCRINOL, V165, P687, DOI 10.1530/EJE-11-0447; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Foley CM, 2012, SPORTS HEALTH, V4, P139, DOI 10.1177/1941738111434275; Giza CC, 2001, J ATHL TRAINING, V36, P228; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Koundourakis NE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087803, 10.1371/journal.pone.0101659]; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; PARKER DC, 1974, J CLIN ENDOCR METAB, V38, P646, DOI 10.1210/jcem-38-4-646; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; SASSIN JF, 1973, J CLIN ENDOCR METAB, V37, P436, DOI 10.1210/jcem-37-3-436; Schulte S, 2013, EUR J APPL PHYSIOL, V113, P811, DOI 10.1007/s00421-012-2503-9; Tandon A, 2009, ACTA NEUROCHIR, V151, P1411, DOI 10.1007/s00701-009-0444-9; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P1483, DOI 10.1210/jc.81.4.1483; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Zheng P, 2015, J NANOMATER, V2015, DOI 10.1155/2015/498304	20	10	10	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					904	906		10.1089/neu.2015.3968			3	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800012	26159360				2022-02-06	
J	Liu, GM; Luo, YG; Li, J; Xu, K				Liu, Guo-Min; Luo, Yun-Gang; Li, Juan; Xu, Kun			Knockdown of Nogo gene by short hairpin RNA interference promotes functional recovery of spinal cord injury in a rat model	MOLECULAR MEDICINE REPORTS			English	Article						Nogo; Growth Associated Protein 43; small hairpin RNA; spinal cord injury; neural regeneration	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AXONAL REGENERATION; NEURITE OUTGROWTH; LOCOMOTOR RECOVERY; ANTIBODY IN-1; EXPRESSION; MYELIN; INHIBITION; RECEPTOR	The specific myelin component Nogo protein is one of the major inhibitory molecules of spinal cord axonal outgrowth following spinal cord injury. The present study aimed to investigate the effects of silencing Nogo protein with shRNA interference on the promotion of functional recovery in a rat model with spinal cord hemisection. Nogo-A short hairpin RNAs (Nogo shRNAs) were constructed and transfected into rats with spinal cord hemisection by adenovirus-mediated transfection. Reverse transcription-polymerase chain reaction and western blotting were performed to analyze the expression of Nogo-A and Growth Associated Protein 43 (GAP-43). In addition, Basso Beattie Bresnahan (BBB) scores were used to assess the functional recovery of rats following spinal cord injury. The results demonstrated that expression of the Nogo-A gene was observed to be downregulated following transfection and GAP-43 expression was observed to increase. The BBB scores were increased following treatment with Nogo shRNAs, indicating functional recovery of the injured nerves. Thus, Nogo-A shRNA interference can knockdown Nogo gene expression and upregulate GAP-43 to promote the functional recovery of spinal cord injury in rats. This finding may advance progress toward assisting the regeneration of injured neurons through the use of Nogo-A shRNA.	[Liu, Guo-Min] Jilin Univ, Hosp 2, Dept Orthoped, Changchun 130041, Jilin, Peoples R China; [Luo, Yun-Gang] Jilin Univ, Hosp 2, Dept Stomatol, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China; [Li, Juan; Xu, Kun] Jilin Univ, Coll Publ Hlth, Dept Prevent Med, Changchun 130021, Jilin, Peoples R China		Luo, YG (corresponding author), Jilin Univ, Hosp 2, Dept Stomatol, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China.	luoygjlu@sina.com					Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P509, DOI 10.1016/j.mcn.2004.11.002; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Carrasco J, 2003, NEUROBIOL DIS, V13, P22, DOI 10.1016/S0969-9961(03)00015-9; Chaudhry N, 2007, J CEREBR BLOOD F MET, V27, P1096, DOI 10.1038/sj.jcbfm.9600407; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Grosso MJ, 2014, NEUROSURGERY, V75, P461, DOI 10.1227/NEU.0000000000000447; Hassiotis M, 2002, ANAT EMBRYOL, V206, P97, DOI 10.1007/s00429-002-0278-1; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Kaneko A, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015008; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; Latini L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.364; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; McIlvain VA, 2003, J COMP NEUROL, V462, P252, DOI 10.1002/cne.10725; Otori Y, 1998, INVEST OPHTH VIS SCI, V39, P972; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Tolner EA, 2003, EUR J NEUROSCI, V17, P2369, DOI 10.1046/j.1460-9568.2003.02687.x; Wang XY, 2001, ACTA PHARMACOL SIN, V22, P657; Xian-Hui D, 2014, J SPINAL CORD MED; Yamaya S, 2014, J NEUROSURG, V121, P1514, DOI 10.3171/2014.8.JNS132562; Yan M, 2014, SPINAL CORD, V52, P803, DOI 10.1038/sc.2014.135; Yang JF, 2013, J SURG RES, V182, pE69, DOI 10.1016/j.jss.2012.11.010; Zhang JY, 2015, J MOL NEUROSCI, V55, P760, DOI 10.1007/s12031-014-0416-2; Zhang Q, 2014, EXP THER MED, V8, P1731, DOI 10.3892/etm.2014.2029; Zhao YY, 2015, CNS NEUROSCI THER, V21, P454, DOI 10.1111/cns.12379	39	10	13	1	14	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2016	13	5					4431	4436		10.3892/mmr.2016.5072			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	DI6BA	WOS:000373583000092	27035338	Bronze			2022-02-06	
J	Saper, RB; Lemaster, CM; Elwy, AR; Paris, R; Herman, PM; Plumb, DN; Sherman, KJ; Groessl, EJ; Lynch, S; Wang, SW; Weinberg, J				Saper, Robert B.; Lemaster, Chelsey M.; Elwy, A. Rani; Paris, Ruth; Herman, Patricia M.; Plumb, Dorothy N.; Sherman, Karen J.; Groessl, Erik J.; Lynch, Susan; Wang, Shihwe; Weinberg, Janice			Yoga versus education for Veterans with chronic low back pain: study protocol for a randomized controlled trial	TRIALS			English	Article						Veterans; Low back pain; Military families; Randomized controlled trial; Yoga; Cost-effectiveness	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; SELF-CARE BOOK; HATHA YOGA; ANXIETY DISORDERS; OUTCOME MEASURES; COMPARING YOGA; UNITED-STATES; RATING-SCALE; HEALTH	Background: Chronic low back pain is the most frequent pain condition in Veterans and causes substantial suffering, decreased functional capacity, and lower quality of life. Symptoms of post-traumatic stress, depression, and mild traumatic brain injury are highly prevalent in Veterans with back pain. Yoga for low back pain has been demonstrated to be effective for civilians in randomized controlled trials. However, it is unknown if results from previously published trials generalize to military populations. Methods/design: This study is a parallel randomized controlled trial comparing yoga to education for 120 Veterans with chronic low back pain. Participants are Veterans >= 18 years old with low back pain present on at least half the days in the past six months and a self-reported average pain intensity in the previous week of >= 4 on a 0-10 scale. The 24-week study has an initial 12-week intervention period, where participants are randomized equally into (1) a standardized weekly group yoga class with home practice or (2) education delivered with a self-care book. Primary outcome measures are change at 12 weeks in low back pain intensity measured by the Defense and Veterans Pain Rating Scale (0-10) and back-related function using the 23-point Roland Morris Disability Questionnaire. In the subsequent 12-week follow-up period, yoga participants are encouraged to continue home yoga practice and education participants continue following recommendations from the book. Qualitative interviews with Veterans in the yoga group and their partners explore the impact of chronic low back pain and yoga on family relationships. We also assess cost-effectiveness from three perspectives: the Veteran, the Veterans Health Administration, and society using electronic medical records, self-reported cost data, and study records. Discussion: This study will help determine if yoga can become an effective treatment for Veterans with chronic low back pain and psychological comorbidities.	[Saper, Robert B.; Lemaster, Chelsey M.] Boston Univ, Sch Med, Dept Family Med, Boston, MA 02118 USA; [Saper, Robert B.; Lemaster, Chelsey M.] Boston Med Ctr, Boston, MA USA; [Elwy, A. Rani] VA Boston Healthcare Syst, Ctr Informat Disseminat & Educ Resources, Boston, MA USA; [Elwy, A. Rani] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Paris, Ruth] Boston Univ, Sch Social Work, Boston, MA 02215 USA; [Herman, Patricia M.] RAND Corp, Santa Monica, CA USA; [Plumb, Dorothy N.; Wang, Shihwe] Edith Nourse Rogers Mem Vet Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Sherman, Karen J.] Grp Hlth Res Inst, Seattle, WA USA; [Sherman, Karen J.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Groessl, Erik J.] VA San Diego Healthcare Syst, San Diego, CA USA; [Groessl, Erik J.] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Lynch, Susan] There & Back Again Inc, Wakefield, MA USA; [Weinberg, Janice] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA		Saper, RB (corresponding author), Boston Univ, Sch Med, Dept Family Med, Boston, MA 02118 USA.	robert.saper@bmc.org	Saper, Robert B/Y-4598-2018	Saper, Robert B/0000-0002-0992-6198; Elwy, A. Rani/0000-0001-7088-3118; Weinberg, Janice/0000-0002-3503-0061	National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [3R01AT005956-05S1]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT005956] Funding Source: NIH RePORTER	This publication was made possible by grant number 3R01AT005956-05S1 from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCCIH.	Afonso RF, 2012, MENOPAUSE, V19, P186, DOI 10.1097/gme.0b013e318228225f; Amick BC, 2000, SPINE, V25, P3152, DOI 10.1097/00007632-200012150-00010; ANDERSON KO, 1995, PAIN, V63, P77, DOI 10.1016/0304-3959(95)00021-J; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P18; Balasubramaniam Meera, 2012, Front Psychiatry, V3, P117, DOI 10.3389/fpsyt.2012.00117; Barlas F. M., 2013, DEP DEFENSE HLTH REL; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Birdee GS, 2008, J GEN INTERN MED, V23, P1653, DOI 10.1007/s11606-008-0735-5; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bombardier C, 2000, SPINE, V25, P3097, DOI 10.1097/00007632-200012150-00002; Bormann JE, 2005, J HOLIST NURS, V23, P395, DOI 10.1177/0898010105278929; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Briggs A, 1999, BRIT MED J, V319, P120, DOI 10.1136/bmj.319.7202.120; Buckenmaier CC, 2013, PAIN MED, V14, P110, DOI 10.1111/j.1526-4637.2012.01516.x; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell P, 2012, PAIN MED, V13, P204, DOI 10.1111/j.1526-4637.2011.01298.x; Charmaz K., 2014, BROKERAGE CLOSURE IN; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coeytaux R.R., 2014, EVIDENCE MAP YOGA HI; Cox Helen, 2010, Complement Ther Clin Pract, V16, P187, DOI 10.1016/j.ctcp.2010.05.007; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Deyo RA, 2014, SPINE, V39, P1128, DOI 10.1097/BRS.0000000000000434; Drummond M., 2005, METHODS EC EVALUATIO; Evans Subhadra, 2011, J Yoga Phys Ther, V1; Galantino ML, 2004, ALTERN THER HEALTH M, V10, P56; GALLOWAY KT, 2011, AM NURSE TODAY, V6, P3; Groessl EJ, 2012, J ALTERN COMPLEM MED, V18, P832, DOI 10.1089/acm.2010.0657; Groessl EJ, 2008, J ALTERN COMPLEM MED, V14, P1123, DOI 10.1089/acm.2008.0020; Grotle M, 2004, SPINE, V29, pE492, DOI 10.1097/01.brs.0000143664.02702.0b; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Herman PM, 2006, ALTERN THER HEALTH M, V12, P78; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Hudak PL, 2000, SPINE, V25, P3167, DOI 10.1097/00007632-200012150-00012; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Janakiramaiah N, 2000, J AFFECT DISORDERS, V57, P255, DOI 10.1016/S0165-0327(99)00079-8; Jensen MP, 2003, PAIN, V104, P453, DOI 10.1016/S0304-3959(03)00076-9; Jensen MP, 1999, PAIN, V81, P95, DOI 10.1016/S0304-3959(99)00005-6; Kalauokalani D, 2001, SPINE, V26, P1418, DOI 10.1097/00007632-200107010-00005; Kar N, 2011, NEUROPSYCH DIS TREAT, V7, P167, DOI 10.2147/NDT.S10389; Kerns RD, 2013, CLIN J PAIN, V29, P93, DOI 10.1097/AJP.0b013e31826b6ce8; Khalsa SBS, 2004, APPL PSYCHOPHYS BIOF, V29, P269, DOI 10.1007/s10484-004-0387-0; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kinser PA, 2013, ARCH PSYCHIAT NURS, V27, P137, DOI 10.1016/j.apnu.2013.01.003; Kirsch B, 2000, VET HLTH SYST J, V5, P49; Kohn M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/215348; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kosinski MR, 2005, CURR MED RES OPIN, V21, P849, DOI 10.1185/030079905X46377; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Leonard MT, 2006, J PAIN, V7, P377, DOI 10.1016/j.jpain.2006.01.442; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Libby Daniel J, 2012, Int J Yoga Therap, P79; Lincoln Andrew E, 2002, Work, V18, P99; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; MacGregor AJ, 2009, INJURY, V40, P1004, DOI 10.1016/j.injury.2009.04.006; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Michalsen A, 2005, MED SCI MONITOR, V11, pCR555; Michalsen A, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/408727; Moore JL, 1999, BACK PAIN HELPBOOK; Morasco BJ, 2011, J PAIN, V12, P352, DOI 10.1016/j.jpain.2010.07.010; Nambi Gopal S, 2014, Int J Yoga, V7, P48, DOI 10.4103/0973-6131.123481; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nassif TH, 2015, PAIN MED, V16, P2152, DOI 10.1111/pme.12866; Office of The Army Surgeon General Pain Management Task Force, 2010, PROV STAND DOD VHA V; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Paris R, 2010, AM J ORTHOPSYCHIAT, V80, P610, DOI 10.1111/j.1939-0025.2010.01066.x; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Costa LOP, 2008, SPINE, V33, P2459, DOI 10.1097/BRS.0b013e3181849dbe; Peregoy Jennifer A, 2014, NCHS Data Brief, P1; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Polusny MA, 2015, JAMA-J AM MED ASSOC, V314, P456, DOI 10.1001/jama.2015.8361; Posadzki P, 2011, CLIN RHEUMATOL, V30, P1257, DOI 10.1007/s10067-011-1764-8; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Saeed SA, 2010, AM FAM PHYSICIAN, V81, P981; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; Saper RB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-67; Saper RB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/658030; Saper RB, 2009, ALTERN THER HEALTH M, V15, P18; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Sherman KJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/130818; Sherman KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/143271; Sherman KJ, 2011, ARCH INTERN MED, V171, P2019, DOI 10.1001/archinternmed.2011.524; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Streeter CC, 2010, J ALTERN COMPLEM MED, V16, P1145, DOI 10.1089/acm.2010.0007; Tekur P, 2012, COMPLEMENT THER MED, V20, P107, DOI 10.1016/j.ctim.2011.12.009; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Tilbrook HE, 2011, ANN INTERN MED, V155, P569, DOI 10.7326/0003-4819-155-9-201111010-00003; Uebelacker LA, 2010, J PSYCHIATR PRACT, V16, P22, DOI 10.1097/01.pra.0000367775.88388.96; Vollestad J, 2012, BRIT J CLIN PSYCHOL, V51, P239, DOI 10.1111/j.2044-8260.2011.02024.x; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers FW, 1991, PTSD CHECKLIST CIVIL; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Williams KA, 2005, PAIN, V115, P107, DOI 10.1016/j.pain.2005.02.016; Williams K, 2009, SPINE, V34, P2066, DOI 10.1097/BRS.0b013e3181b315cc; Woolery A, 2004, ALTERN THER HEALTH M, V10, P60	106	10	10	4	27	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	APR 29	2016	17								224	10.1186/s13063-016-1321-5			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	DK7HF	WOS:000375095100001	27129472	gold, Green Published			2022-02-06	
J	Isaacson, BM; Potter, BK; Bloebaum, RD; Epperson, RT; Kawaguchi, BS; Swanson, TM; Pasquina, PF				Isaacson, B. M.; Potter, B. K.; Bloebaum, R. D.; Epperson, R. T.; Kawaguchi, B. S.; Swanson, T. M.; Pasquina, P. F.			Link Between Clinical Predictors of Heterotopic Ossification and Histological Analysis in Combat-Injured Service Members	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							ECTOPIC-BONE-FORMATION; TOTAL HIP-ARTHROPLASTY; SPINAL-CORD-INJURY; RISK-FACTORS; TIBIAL COMPONENTS; LOWER-EXTREMITY; AMPUTATIONS; INGROWTH; ADULT; JOINT	range of motion and delay rehabilitation. The timing and efficacy of surgical resection have varied widely, and there is a gap in knowledge between clinical predictors of HO recurrence and histological analysis. Methods: Thirty-three service members seen at Walter Reed National Military Medical Center for symptomatic HO were enrolled in an institutional review board-approved study. Participants took oxytetracycline on four scheduled days prior to HO resection to determine the mineral apposition rate (bone growth rate). Results: Detailed histological analyses included scanning electron microscopy with backscattered electron imaging and light microscopy. Data indicated that the mineral apposition rate of trauma-induced HO was approximately 1.7 mu m/day at the time of operative intervention, which was 1.7 times higher than the rate in non-pathological human bone. The mineral apposition rate and postoperative alkaline phosphatase values were demonstrated to be positively and significantly related (p = 0.509, p = 0.026, n = 19). When the analysis was limited to patients with no more than a two-year period from injury to excision (thereby removing outliers who had a longer time period than their counterparts) and traumatic brain injury and nonsteroidal anti-inflammatory drugs (known correlates with HO development) were controlled for in the statistical analysis, the mineral apposition rate and recurrence severity were significantly related (p = -0.572, p = 0.041, n = 11). Conclusions: Data demonstrated a link between benchtop research and bedside care, with the mineral apposition rate elevated in patients with HO and correlated with recurrence severity; however, a larger sample size and more clinical factors are needed to refine this model.	Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Bloebaum, R. D.; Epperson, R. T.; Kawaguchi, B. S.] Dept Vet Affairs, Bone & Joint Res Lab, Salt Lake City, UT USA; [Isaacson, B. M.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Isaacson, B. M.; Swanson, T. M.; Pasquina, P. F.] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Ctr Rehabil Sci Res, Bethesda, MD 20814 USA; [Potter, B. K.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed, Bethesda, MD USA; [Pasquina, P. F.] Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD USA; [Potter, B. K.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Bloebaum, R. D.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Bloebaum, R. D.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA		Isaacson, BM (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.; Isaacson, BM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Ctr Rehabil Sci Res, Bethesda, MD 20814 USA.	brad.isaacson.ctr@usuhs.edu	Potter, Benjamin/U-1769-2019	Potter, MD, Benjamin K./0000-0002-8771-0317	Department of the U.S. Army [W81XWH-12-2-0017, HU0001-11-1-0004, HU0001-15-2-0003]	This material is based on work supported by the Department of the U.S. Army under Award numbers W81XWH-12-2-0017 to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and HU0001-11-1-0004 and HU0001-15-2-0003 to the Center for Rehabilitation Science Research, Department of Physical Medicine & Rehabilitation, Uniformed Services University, and a private donation from the Wounded Warrior Amputee Softball Team. The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article.	AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Alfieri KA, 2012, BONE JOINT RES, V1, P174, DOI 10.1302/2046-3758.18.2000102; Argyropoulou MI, 2006, CRIT CARE, V10, DOI 10.1186/cc5083; Atkinson GJ, 2010, AM J PHYS MED REHAB, V89, P245, DOI 10.1097/PHM.0b013e3181c5657c; Bayley S.J., 1979, ORTHOP REV, V8, P113; Bloebaum RD, 2007, J BIOMED MATER RES A, V81A, P505, DOI 10.1002/jbm.a.31087; Bloebaum R D, 1992, J Arthroplasty, V7, P483, DOI 10.1016/S0883-5403(05)80222-0; BLOEBAUM RD, 1994, J BIOMED MATER RES, V28, P537, DOI 10.1002/jbm.820280503; BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P179; BRUMBACK RJ, 1990, J BONE JOINT SURG AM, V72A, P1067, DOI 10.2106/00004623-199072070-00017; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; DELEE J, 1976, CLIN ORTHOP RELAT R, P53; Dudek NL, 2003, AM J PHYS MED REHAB, V82, P897, DOI 10.1097/01.PHM.0000087459.94599.2D; ERRICO TJ, 1984, CLIN ORTHOP RELAT R, P138; Fischer H., 2014, GUIDE US MILITARY CA; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; GARLAND DE, 1984, CLIN ORTHOP RELAT R, P154; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Gaur A, 2003, J BONE JOINT SURG AM, V85A, P1538, DOI 10.2106/00004623-200308000-00016; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Goldman J, 1980, Physiotherapy, V66, P219; HIERTON C, 1983, ACTA ORTHOP SCAND, V54, P698, DOI 10.3109/17453678308996614; Hosalkar H, 2009, J BONE JOINT SURG AM, V91A, P2296, DOI 10.2106/JBJS.I.00319; HSU JD, 1975, CLIN ORTHOP RELAT R, P165; Inam M, 2010, GOMAL J MED SCI, V8, P90; Isaacson BM, 2012, J PROSTHET ORTHOT, V24, P138; Isaacson BM, 2014, ORTHOP RES REV, V6, P27, DOI 10.2147/ORR.S56636; Isaacson Brad M, 2010, US Army Med Dep J, P31; Isaacson BM, 2010, ANN BIOMED ENG, V38, P2968, DOI 10.1007/s10439-010-0050-2; KAPLAN FS, 1994, J BONE JOINT SURG AM, V76A, P425, DOI 10.2106/00004623-199403000-00013; Kircher J, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2006.10.020; KUBACEK V, 1977, ACTA CHIR PLAST, V19, P209; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Nagi ON, 2002, INDIAN J ORTHOP, V36, P225; Pasquina PF, 2008, J REHABIL RES DEV, V45, P953, DOI 10.1682/JRRD.2007.10.0163; Potter B., 2010, REHABILITATION COMBA, P153; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS188; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS191; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; Sawyer JR, 2009, J PEDIATR ORTHOPED, V29, P865, DOI 10.1097/BPO.0b013e3181c1e2ce; Shehab D, 2002, J NUCL MED, V43, P346; SPENCER JD, 1989, J BONE JOINT SURG BR, V71, P317, DOI 10.1302/0301-620X.71B2.2925755; Tintle SM, 2012, J BONE JOINT SURG AM, V94A, DOI 10.2106/JBJS.K.00197; Tintle SM, 2014, J ORTHOP TRAUMA, V28, P232, DOI 10.1097/BOT.0b013e3182a53130; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Vocke AK, 2000, ARCH ORTHOP TRAUM SU, V120, P452, DOI 10.1007/s004029900128; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Willie BM, 2004, J BIOMED MATER RES A, V69A, P567, DOI 10.1002/jbm.a.30038; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955	54	10	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	APR 20	2016	98	8					647	657		10.2106/JBJS.15.00895			11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	DP6VZ	WOS:000378638700009	27098323				2022-02-06	
J	Rowhani-Rahbar, A; Chrisman, SPD; Drescher, S; Schiff, MA; Rivara, FP				Rowhani-Rahbar, Ali; Chrisman, Sara P. D.; Drescher, Sara; Schiff, Melissa A.; Rivara, Frederick P.			Agreement between High School Athletes and Their Parents on Reporting Athletic Events and Concussion Symptoms	JOURNAL OF NEUROTRAUMA			English	Article						soccer; adolescent; football; epidemiology; brain concussion	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; PEDIATRIC CONCUSSION; SEX-DIFFERENCES; SOCCER PLAYERS; EPIDEMIOLOGY; CHILDREN; IMPLEMENTATION; SURVEILLANCE	An enhanced understanding of agreement levels between adolescents and parents for reporting athletic events and symptoms can help inform surveillance systems as well as clinical and epidemiological investigations of sports-related concussions. We sought to quantify agreement levels between high school athletes and parents for reporting: (1) number of games; (2) number of practices; (3) occurrence of an injury resulting in any concussion symptoms; and (4) presence of each specific symptom on the date of that injury among high school boys' football and girls' soccer athletes playing in Autumn 2012 in Washington State. There was substantial agreement on reporting the number of athletic events. Agreement levels were greater for games (kappa = 0.82; 95% confidence interval [CI]: 0.79-0.85 in boys' football; kappa = 0.75; 95% CI: 0.72-0.79 in girls' soccer) than for practices (kappa = 0.64; 95% CI: 0.62-0.67 in boys' football; kappa = 0.65; 95% CI: 0.62-0.67 in girls' soccer). There was moderate to substantial agreement on the occurrence of injury resulting in any concussion symptoms; however, agreement on the presence and severity of each symptom varied from poor to almost perfect. Overall, athletes reported greater severity of symptoms than parents did; notably, no difference in mean symptom scores was found when the athlete had a history of concussion. Agreement levels were greater when information was ascertained within 1 week of injury than when it was obtained later than 1 week. Including both athletes' and parents' reports of sports-related events and ascertaining information as soon as possible after injury are important considerations in designing injury surveillance systems.	[Rowhani-Rahbar, Ali; Schiff, Melissa A.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Box 357236, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali; Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali; Chrisman, Sara P. D.; Drescher, Sara; Rivara, Frederick P.] Seattle Childrens Res Inst, Seattle, WA USA; [Rowhani-Rahbar, Ali; Chrisman, Sara P. D.; Schiff, Melissa A.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Rowhani-Rahbar, A (corresponding author), Univ Washington, Dept Epidemiol, Box 357236, Seattle, WA 98195 USA.	rowhani@uw.edu		Chrisman, Sara/0000-0001-5373-7223; Rowhani-Rahbar, Ali/0000-0002-2705-4485			Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2004, NEUROLOGY, V63, P1516; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; CDC, INJ PREV CONTR TRAUM; Centers for Disease Control. Injury Prevention and Control, 2016, INJ PREV CONTR FY 20; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Colorado School of Public Health, PROGR INJ PREV ED RE; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Institute of Medicine and National Research Council, 2013, SPORTS REL CONC YOUT; Janusz JA, 2012, MILD TRAUMATIC BRAIN, DOI [10.1249/JSR.0b013-31819c7-87, DOI 10.1249/JSR.0B013-31819C7-87]; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Koepsell T.D., 2014, EPIDEMIOLOGIC METHOD; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Morris R, 2008, INT J NURS STUD, V45, P645, DOI 10.1016/j.ijnurstu.2007.07.005; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Schiff MA, 2010, J ATHL TRAINING, V45, P238, DOI 10.4085/1062-6050-45.3.238; Shrier I, 2009, J SCI MED SPORT, V12, P633, DOI 10.1016/j.jsams.2008.06.001; THOMPSON WD, 1988, J CLIN EPIDEMIOL, V41, P949, DOI 10.1016/0895-4356(88)90031-5; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	43	10	10	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2016	33	8					784	791		10.1089/neu.2015.4100			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DJ0ZM	WOS:000373932900009	26414288				2022-02-06	
J	Sauvigny, T; Gottsche, J; Vettorazzi, E; Westphal, M; Regelsberger, J				Sauvigny, Thomas; Goettsche, Jennifer; Vettorazzi, Eik; Westphal, Manfred; Regelsberger, Jan			New Radiologic Parameters Predict Clinical Outcome after Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						CT scan; Decompressive craniectomy; Middle cerebral artery infarction; Traumatic brain injury	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; EDEMA TRIAL HAMLET; GLASGOW COMA SCALE; SURGICAL DECOMPRESSION; MALIGNANT INFARCTION; HEMICRANIECTOMY; SURGERY; MULTICENTER; LIFE	OBJECTIVE: Decompressive craniectomy (DC) is an established part of the management of patients with increased intracranial pressure due to malignant middle cerebral artery (MCA) infarction or traumatic brain injury (TBI). The aim of this study was to determine prognostic radiologic parameters regarding the functional outcome of patients with increased intracranial pressure (ICP) undergoing DC. Special focus was put on the potential differences between malignant MCA infarction and TBI. METHODS: A total of 113 patients were analyzed for their clinical course where preoperative and postoperative radiologic features in computed tomography (CT) scans were correlated to the clinical outcome assessed by the Glasgow Outcome Scale. The difference between presurgical and postsurgical midline shift (Delta MLS) and the ratio between the diameter of the affected and contralateral hemisphere (HDratio) in presurgical and postsurgical CT scans were calculated. RESULTS: Delta MLS (MCA infarction group) and postsurgical HDratio (TBI group) were found to be highly correlating with the clinical outcome on Spearman-correlation testing and underwent further analysis using a binary logistic regression model to evaluate their prognostic value on the outcome, which showed the predictive power of Delta MLS in malignant MCA infarction patients (odds ratio [OR] 0.715; confidence interval [CI] 0.551-0.865). Postsurgical HDratio correlated significantly (OR 0.620; CI 0.384-0.901) with the outcome in the TBI group. CONCLUSION: Delta MLS is an objectifiable parameter, predicting outcome in malignant MCA infarction. In contrast, Delta MLS was of no predictive value in TBI patients. Here postsurgical HDratio serves as a strong predictor of clinical outcome. We recommend applying postsurgical HDratio to TBI patients in order to estimate their clinical outcome and adjust treatment.	[Sauvigny, Thomas; Goettsche, Jennifer; Westphal, Manfred; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany		Sauvigny, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	t.sauvigny@uke.de	Vettorazzi, Eik/B-8130-2019	Vettorazzi, Eik/0000-0002-3737-6402			BERECZKI D, 2001, COCHRANE DB SYST REV, V1; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Curry WT, 2005, NEUROSURGERY, V56, P681, DOI 10.1227/01.NEU.0000156604.41886.62; De Bonis P, 2010, J NEUROSURG, V112, P1150, DOI 10.3171/2009.7.JNS09505; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Fletcher TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110408; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Potts MB, 2008, ACTA NEUROCHIR SUPPL, V102, P109, DOI 10.1007/978-3-211-85578-2_22; Rabinstein AA, 2006, NEUROLOGY, V67, P891, DOI 10.1212/01.wnl.0000233895.03152.66; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Saade Nelson, 2014, Rev. Col. Bras. Cir., V41, P256, DOI 10.1590/0100-69912014004006; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P235, DOI 10.1007/978-3-7091-1434-6_44; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Treadwell SD, 2010, POSTGRAD MED J, V86, P235, DOI 10.1136/pgmj.2009.094292; Tu PH, 2012, J CLIN NEUROSCI, V19, P661, DOI 10.1016/j.jocn.2011.07.045; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; von Sarnowski B, 2012, CLIN NEUROL NEUROSUR, V114, P627, DOI 10.1016/j.clineuro.2011.12.026	34	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						519	U584		10.1016/j.wneu.2015.10.072			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700068	26548831				2022-02-06	
J	Sharma, M; Mittal, RS; Sharma, A; Gandhi, A				Sharma, Mukesh; Mittal, R. S.; Sharma, Achal; Gandhi, Ashok			Posttraumatic Contusion: Clinical and Radiologic Factors for Progression in Early Postinjury Period	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						TBI; contusion progression; predictors	TRAUMATIC SUBARACHNOID HEMORRHAGE; BRAIN-INJURY; HEAD TRAUMA	Objective To identify clinical and radiological factors to predict progression of contusion and its impact on clinical deterioration of neurological status, which will ultimately help deciding surgical intervention in initially conservatively managed patients. Methods This is a prospective, observational study containing a total of 110 patients who had contusions after traumatic brain injury with size of >= 2 mL by computed tomographic (CT) scan, managed conservatively in initial period, and had at least two subsequent CT scans within 72 hours after injury. Significant radiological progression was defined as > 30% increase in volume from baseline in CT scan. Results The progression of contusion was significantly associated with age, sex, contusion volume in initial CT, effacement of cistern, subdural hematoma (SDH), subarachnoid hemorrhage(SAH), and coagulopathy. SDH and SAH (p<0.05) were found to be as independent risk factors for contusion progression. The need for surgery after initial conservative management was required in 11.81% cases, and the deterioration of Glasgow coma scale (GCS) volume in the second CT were found to be significant independent predictors for the surgical intervention (p<0.05). Conclusions About half of the patients presenting with TBI managed conservatively in initial period show significant progression of contusion mostly within 24 hours after injury. Patients with SAH, SDH and deranged coagulation profile are particularly at high risk for progression of contusion.	[Sharma, Mukesh; Mittal, R. S.; Sharma, Achal; Gandhi, Ashok] SMS Med Coll & Hosp, Dept Neurosurg, Jaipur, Rajasthan, India		Sharma, M (corresponding author), SMS Med Coll & Hosp, Dept Neurosurg, Jaipur, Rajasthan, India.	dr_mukki@yahoo.co.in					Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Naff NJ, 2001, NEUROSURGERY, V49, P614, DOI 10.1097/00006123-200109000-00015; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Servadei F, 2002, ACT NEUR S, V81, P81; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109	14	10	11	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	APR	2016	13	1					1	6		10.1055/s-0036-1580717			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DX9BG	WOS:000384687400001					2022-02-06	
J	Subbian, V; Ratcliff, JJ; Korfhagen, JJ; Hart, KW; Meunier, JM; Shaw, GJ; Lindsell, CJ; Beyette, FR				Subbian, Vignesh; Ratcliff, Jonathan J.; Korfhagen, Joseph J.; Hart, Kimberly W.; Meunier, Jason M.; Shaw, George J.; Lindsell, Christopher J.; Beyette, Fred R., Jr.			A Novel Tool for Evaluation of Mild Traumatic Brain Injury Patients in the Emergency Department: Does Robotic Assessment of Neuromotor Performance Following Injury Predict the Presence of Postconcussion Symptoms at Follow-up?	ACADEMIC EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; POSITION SENSE; STROKE; DEFICITS; PERCEPTION; MANAGEMENT; TRAIL; TBI	ObjectivesPostconcussion symptoms (PCS) are a common complication of mild traumatic brain injury (TBI). Currently, there is no validated clinically available method to reliably predict at the time of injury who will subsequently develop PCS. The purpose of this study was to determine if PCS following mild TBI can be predicted during the initial presentation to an emergency department (ED) using a novel robotic-assisted assessment of neurologic function. MethodsAll patients presenting to an urban ED with a chief complaint of head injury within the preceding 24 hours were screened for inclusion from March 2013 to April 2014. The enrollment criteria were as follows: 1) age of 18 years or greater, 2) ability and willingness to provide written informed consent, 3) blunt head trauma and clinical diagnosis of isolated mild TBI by the treating physician, and 4) blood alcohol level of <100 mg/dL. Eligible mild TBI patients were enrolled and their neuromotor function was assessed in the ED using a battery of five tests that cover a range of proprioceptive, visuomotor, visuospatial, and executive function performance metrics. At 3 weeks postinjury, participants were contacted via telephone to complete the Rivermead Post-Concussion Symptoms Questionnaire to assess the presence of significant PCS. ResultsA total of 66 mild TBI patients were enrolled in the study with 42 of them completing both the ED assessment and the follow-up; 40 patients were included in the analyses. The area under the receiver operating characteristic curve (AUC) for the entire test battery was 0.72 (95% confidence interval [CI] = 0.54 to 0.90). The AUC for tests that primarily measure visuomotor and proprioceptive performance were 0.80 (95% CI = 0.65 to 0.95) and 0.71 (95% CI = 0.53 to 0.89), respectively. ConclusionsThe robotic-assisted test battery has the ability to discriminate between subjects who developed PCS and those who did not. Additionally, poor visuomotor and proprioceptive performance were most strongly associated with subsequent PCS.	[Ratcliff, Jonathan J.; Korfhagen, Joseph J.; Hart, Kimberly W.; Meunier, Jason M.; Shaw, George J.; Lindsell, Christopher J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Subbian, Vignesh; Beyette, Fred R., Jr.] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH USA		Subbian, V (corresponding author), Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH USA.	subbiavh@mail.uc.edu		Beyette, Fred/0000-0001-8704-7810; Subbian, Vignesh/0000-0001-9974-8382	NIH-NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [5U54EB007954]; NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [8UL1-TR000077]; University of Cincinnati Neuroscience Institute (UCNI) Pilot Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB007954] Funding Source: NIH RePORTER	This work was supported by NIH-NIBIB on grant 5U54EB007954, NIH/NCRR on grant 8UL1-TR000077 (Institutional Clinical and Translational Science Award), and the University of Cincinnati Neuroscience Institute (UCNI) Pilot Research Program.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Fermann GJ, 2014, ACAD EMERG MED, V14, pS16; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Harrell Jr FE, 2014, HMISC HARRELL MISCEL; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; National Center for Injury Prevention and Control (US), 2003, REP C MILD TRAUM BRA; R Core Team, 2014, R LANG ENV STAT COMP; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Subbian V, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2424224; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; Whitall J, 2003, HDB NEUROPSYCHOLOGY, VVol 9, P79	44	10	10	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	APR	2016	23	4					382	392		10.1111/acem.12906			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	DJ2OU	WOS:000374045200002	26806406	Green Accepted, Bronze			2022-02-06	
J	Weerdenburg, K; Schneeweiss, S; Koo, E; Boutis, K				Weerdenburg, Kirstin; Schneeweiss, Suzan; Koo, Ellen; Boutis, Kathy			Concussion and its management: What do parents know?	PAEDIATRICS & CHILD HEALTH			English	Article						Concussion; Paediatrics; Parents; Surveys	SPORT-RELATED CONCUSSION; LOGISTIC-REGRESSION; RUGBY PLAYERS; BRAIN-INJURY; KNOWLEDGE; SIMULATION; SYMPTOMS; CHILDREN	OBJECTIVES: To determine the sensitivity of parental suspicion of concussion relative to paediatric emergency physicians in children who presented to an emergency department (ED) with a head injury. A secondary objective was to examine the variables associated with parental suspicion of concussion concordant with that of a physician. METHODS: Parents of children five to 18 years of age presenting to an urban paediatric ED with a nonstructural head injury completed a 24-item questionnaire. RESULTS: Of the 577 eligible parents, 495 (85.8%) consented to participate. The sensitivity of parental suspicion for concussion was 40.0% (95% CI 33.2% to 47.2%), while the specificity was 58.3% (95% CI 52.4% to 64.0%). The variable of child age >= 10 years was associated with an increased odds (OR 3.0) of a parental suspicion of concussion concordant with that of a physician; parent age, parent sex, mechanism of head injury and history of concussion in the child were not. Although 453 (91.5%) parents would stop activity if they believed their child sustained a concussion, only 159 (32.1%) were familiar with return-to-play guidelines. CONCLUSIONS: Parents often did not suspect a concussion when it was ultimately diagnosed by a paediatric emergency physician, although they were more likely to do so in older children. Only approximately one-third were aware of return-to-play guidelines. To enhance the potential for parent-driven advocacy in the recognition and management of concussion, these data support the need for increased parental education on this injury.	[Weerdenburg, Kirstin; Schneeweiss, Suzan; Koo, Ellen; Boutis, Kathy] Hosp Sick Children, Dept Paediat, Div Emergency Med, Toronto, ON M5G 1X8, Canada; [Weerdenburg, Kirstin; Schneeweiss, Suzan; Koo, Ellen; Boutis, Kathy] Univ Toronto, Toronto, ON, Canada		Boutis, K (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	kathy.boutis@sickkids.ca			Hospital for Sick Children via the Paediatric Research Academic Initiative at SickKids Emergency (PRAISE) program; Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP)	The Hospital for Sick Children funded the research support received via the Paediatric Research Academic Initiative at SickKids Emergency (PRAISE) program. This research was also supported financially by a grant from Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP).	Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Evans ME, 2015, CONCUSSION 101 PRIME; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Koo ET, 2013, EFFECTS PARENTS ATTI; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Parachute Canada, 2014, RET PLAY GUID; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Warren DW, 2008, CAN J EMERG MED, V10, P224; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Zemek R, 2014, GUIDELINES DIAGNOSIN	29	10	10	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	APR	2016	21	3					E22	E26		10.1093/pch/21.3.e22			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DM2NE	WOS:000376182700002	27398059	Green Published, Bronze			2022-02-06	
J	Welch, TP; Wallendorf, MJ; Kharasch, ED; Leonard, JR; Doctor, A; Pineda, JA				Welch, Timothy P.; Wallendorf, Michael J.; Kharasch, Evan D.; Leonard, Jeffrey R.; Doctor, Allan; Pineda, Jose A.			Fentanyl and Midazolam Are Ineffective in Reducing Episodic Intracranial Hypertension in Severe Pediatric Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						fentanyl; intracranial hypertension; midazolam; pressure-time exposure; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; NEUROCRITICAL CARE; UNITED-STATES; CHILDREN; HEMODYNAMICS; SUFENTANIL; ANALGESIA; SEDATION; MORPHINE	Objective: To evaluate the clinical effectiveness of bolus-dose fentanyl and midazolam to treat episodic intracranial hypertension in children with severe traumatic brain injury. Design: Retrospective cohort. Setting: PICU in a university-affiliated children's hospital level I trauma center. Patients: Thirty-one children 0-18 years of age with severe traumatic brain injury (Glasgow Coma Scale score of 8) who received bolus doses of fentanyl and/or midazolam for treatment of episodic intracranial hypertension. Interventions: None. Measurements and Main Results: The area under the curve from high-resolution intracranial pressure-time plots was calculated to represent cumulative intracranial hypertension exposure: area under the curve for intracranial pressure above 20 mm Hg (area under the curve-intracranial hypertension) was calculated in 15-minute epochs before and after administration of fentanyl and/or midazolam for the treatment of episodic intracranial hypertension. Our primary outcome measure, the difference between predrug and postdrug administration epochs (area under the curve-intracranial hypertension), was calculated for all occurrences. We examined potential covariates including age, injury severity, mechanism, and time after injury; time after injury correlated with area under the curve-intracranial hypertension. In a mixed-effects model, with patient as a random effect, drug/dose combination as a fixed effect, and time after injury as a covariate, intracranial hypertension increased after administration of fentanyl and/or midazolam (overall aggregate mean area under the curve-intracranial hypertension = +17 mm Hg x min, 95% CI, 0-34 mm Hg x min; p = 0.04). The mean area under the curve-intracranial hypertension increased significantly after administration of high-dose fentanyl (p = 0.02), low-dose midazolam (p = 0.006), and high-dose fentanyl plus low-dose midazolam (0.007). Secondary analysis using age-dependent thresholds showed no significant impact on cerebral perfusion pressure deficit (mean area under the curve-cerebral perfusion pressure). Conclusions: Bolus dosing of fentanyl and midazolam fails to reduce the intracranial hypertension burden when administered for episodic intracranial hypertension. Paradoxically, we observed an overall increase in intracranial hypertension burden following drug administration, even after accounting for within-subject effects and time after injury. Future work is needed to confirm these findings in a prospective study design.	[Welch, Timothy P.; Doctor, Allan; Pineda, Jose A.] Washington Univ, Sch Med, Dept Med, Div Crit Care Med, St Louis, MO 63110 USA; [Welch, Timothy P.; Kharasch, Evan D.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Wallendorf, Michael J.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Leonard, Jeffrey R.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Dept Neurosurg, Columbus, OH 43210 USA		Pineda, JA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Crit Care Med, St Louis, MO 63110 USA.	pineda_j@wustl.edu	Pineda, Jose/W-2806-2019		St. Louis Children's Hospital Foundation; Sean Glanvill Foundation; Harold Amos Medical Faculty Development Program (Robert Wood Johnson Foundation); Intellectual and Developmental Disabilities Research Center at Washington University (National Institutes of Health [NIH]/National Institute of Child Health and Human Development [NICHD] [P30 HD062171]; Division of Biostatistics (Intellectual and Developmental Disabilities Research Center [IDDRC]); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; American Heart AssociationAmerican Heart Association; Children's Discovery Institute; Entegrion; Terumo BCT; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); Saint Louis Children's Hospital Foundation; NIH (Washington University IDDRC; NIH/National Institute of Child Health and Human Development [NICHD] [P30 HD062171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD062171, U54HD087011] Funding Source: NIH RePORTER	Supported, in part, by the St. Louis Children's Hospital Foundation, the Sean Glanvill Foundation, the Harold Amos Medical Faculty Development Program (Robert Wood Johnson Foundation), and the Intellectual and Developmental Disabilities Research Center at Washington University (National Institutes of Health [NIH]/National Institute of Child Health and Human Development [NICHD] P30 HD062171).; Dr. Wallendorf is employed by the Washington University School of Medicine. His institution received grant support from the Division of Biostatistics (Intellectual and Developmental Disabilities Research Center [IDDRC]). Dr. Doctor consulted for Terumo BCT and Novartis and lectured for Terumo BCT. His institution received grant support from the National Institutes of Health (NIH), American Heart Association, Children's Discovery Institute, Entegrion, and Terumo BCT. Dr. Pineda's institution received grant support from the Robert Wood Johnson Foundation, Saint Louis Children's Hospital Foundation, Sean Glanvill Foundation, and the NIH (Washington University IDDRC; NIH/National Institute of Child Health and Human Development [NICHD] P30 HD062171). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS34; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Anand KJS, 2013, PEDIATR CRIT CARE ME, V14, P27, DOI 10.1097/PCC.0b013e318253c80e; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; BUHRER M, 1990, CLIN PHARMACOL THER, V48, P555; de Nadal M, 1998, ACT NEUR S, V71, P10; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Fong HK, 2006, ANESTH ANALG, V102, P1255, DOI 10.1213/01.ane.0000198602.29716.53; Gish Emily C, 2011, J Pediatr Pharmacol Ther, V16, P39; Haque IU, 2007, PEDIATR CRIT CARE ME, V8, P138, DOI 10.1097/01.PCC.0000257039.32593.DC; Hemphill JC, 2005, PHYSIOL MEAS, V26, P373, DOI 10.1088/0967-3334/26/4/004; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Juul SE, 2011, PEDIATR RES, V69, P285, DOI 10.1203/PDR.0b013e31820bd165; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kress JP, 1996, AM J RESP CRIT CARE, V153, P1012, DOI 10.1164/ajrccm.153.3.8630539; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lauer KK, 1997, CAN J ANAESTH, V44, P929, DOI 10.1007/BF03011963; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Marx W, 1989, J Neurosurg Anesthesiol, V1, P3, DOI 10.1097/00008506-198903000-00002; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; ROSEN D A, 1991, Intensive Care Medicine, V17, pS15, DOI 10.1007/BF01731149; Schmittner MD, 2007, J NEUROSURG ANESTH, V19, P257, DOI 10.1097/ANA.0b013e31811f3feb; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SCOTT JC, 1987, J PHARMACOL EXP THER, V240, P159; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; TOBIAS JD, 1994, PEDIATR EMERG CARE, V10, P89, DOI 10.1097/00006565-199404000-00007; Traudt CM, 2012, J NEUROSCI RES, V90, P307, DOI 10.1002/jnr.22750; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; WERNER C, 1995, ANESTHESIOLOGY, V83, P721, DOI 10.1097/00000542-199510000-00011; Young C, 2005, BRIT J PHARMACOL, V146, P189, DOI 10.1038/sj.bjp.0706301	40	10	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2016	44	4					809	818		10.1097/CCM.0000000000001558			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG1NU	WOS:000371835600019	26757162	Green Accepted			2022-02-06	
J	Lee, S; Jun, GW; Jeon, SB; Kim, CJ; Kim, JH				Lee, Seungjoo; Jun, Go Woon; Jeon, Sang Beom; Kim, Chang Jin; Kim, Jeong Hoon			Paroxysmal sympathetic hyperactivity in brainstem-compressing huge benign tumors: clinical experiences and literature review	SPRINGERPLUS			English	Article						Paroxysmal sympathetic hyperactivity; Brain tumor; Brainstem; Opioid	INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; AUTONOMIC INSTABILITY; DIENCEPHALIC SEIZURES; DYSAUTONOMIA; HYPERTENSION; STORMS; TEMPERATURE; DYSFUNCTION; MANAGEMENT	Severe paroxysmal sympathetic overactivity occurs in a subgroup of patients with acquired brain injuries including traumatic brain injury, hypoxia, infection and tumor-related complications. This condition is characterized by sudden increase of heart rate, respiratory rate, blood pressure, body temperature and excessive diaphoresis. The episodes may be induced by external stimulation or may occur spontaneously. Frequent occurrence of this condition could result in secondary morbidities, therefore, should be diagnosed and managed insightfully. These symptoms could be confused with seizures or other medical conditions, leading to unnecessary treatment. Despite clinical significance of paroxysmal sympathetic hyperactivity (PSH), brain tumor-induced PSH has not been studied nearly. In this report, two cases of the PSH in patients with brainstem-compressing benign tumors were introduced. The most useful pharmacologic agents were opioid (e.g., fentanyl patch) in preventing PSH attack, and nonselective beta-blocker (e.g., propranolol) in relieving the symptoms. Clinical experiences of the rare cases of benign tumor-induced PSH can be helpful as an essential basis for further research.	[Lee, Seungjoo; Kim, Chang Jin; Kim, Jeong Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol Surg, 388-1 Pungnab Dong, Seoul 138736, South Korea; [Jun, Go Woon] Bestian Med Ctr, Dept Anesthesia, Daejeon City 300060, South Korea; [Jeon, Sang Beom] Univ Ulsan, Dept Intens Care Med, Coll Med, Asan Med Ctr, Seoul 138736, South Korea		Kim, JH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol Surg, 388-1 Pungnab Dong, Seoul 138736, South Korea.	jhkim1@amc.seoul.kr	Jeon, Sang-Beom/AAD-6605-2022	Jeon, Sang-Beom/0000-0003-0735-5499			Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; BHIGJEE AI, 1985, J NEUROL SCI, V71, P77, DOI 10.1016/0022-510X(85)90038-3; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Diamond AL, 2005, NEUROCRIT CARE, V2, P288, DOI 10.1385/NCC:2:3:288; DOLCE G, 2008, J NEUROTRAUMA; DOOLING EC, 1976, ARCH NEUROL-CHICAGO, V33, P196, DOI 10.1001/archneur.1976.00500030052011; Follett KA, 2003, NEUROMODULATION, V6, P32, DOI 10.1046/j.1525-1403.2003.03005.x; GANDHAVADI B, 1988, ARCH PHYS MED REHAB, V69, P130; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Goh KYC, 1999, PEDIATR NEUROL, V21, P742, DOI 10.1016/S0887-8994(99)00069-7; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kao LW, 2003, J EMERG MED, V24, P423, DOI 10.1016/S0736-4679(03)00039-8; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rabinstein AA, 2004, ARCH NEUROL-CHICAGO, V61, P1625, DOI 10.1001/archneur.61.10.1625-a; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rodriguez N, 2006, REV NEUROLOGIA, V43, P143, DOI 10.33588/rn.4303.2004453; Ryan JB, 2003, J HEART LUNG TRANSPL, V22, P922, DOI 10.1016/S1053-2498(02)00558-2; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; Soriano A, 2014, AM J HOSP PALLIAT ME, V31, P98, DOI 10.1177/1049909112472047; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Srinivasan S, 2007, CLIN AUTON RES, V17, P378, DOI 10.1007/s10286-007-0428-x; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698; Tong CY, 2000, ANESTH ANALG, V91, P1450, DOI 10.1097/00000539-200012000-00028	36	10	12	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	MAR 16	2016	5								340	10.1186/s40064-016-1898-x			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0YI	WOS:000373222800001	27064843	Green Published, gold			2022-02-06	
J	Gaines, KD; Soper, HV; Berenji, GR				Gaines, Katy D.; Soper, Henry V.; Berenji, Gholam R.			Executive Functioning of Combat Mild Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						traumatic brain injury; mild TBI; military; psychology; neuropsychology; executive	SELF-AWARENESS; DYSFUNCTION; CONCUSSION; COGNITION; RECOVERY; SEQUELAE; DEFICITS; TBI	This study investigates neuropsychological deficits in recently deployed veterans with mild traumatic brain injury (mTBI). Veterans discharged from 2007 to 2012 were recruited from Veterans Affairs clinics. Independent groups of participants with mTBI (n=57) and those without TBI (n=57) were administered the Beck Depression Inventory-II, Combat Exposure Scale, Word Memory Test, and the Self-Awareness of Deficits Interview. Neuropsychological instruments included the Rey-Osterrieth Complex Figure Test, Letter and Category Fluency, Trail-Making Test-Parts A and B, Christiansen H-abbreviated, Soper Neuropsychology Screen, Wechsler Memory Scale subtests Logical Memory I and II, and the Street Completion Test. The mTBI group performed significantly worse on all of the executive and nonexecutive measurements with the exception of Category Fluency, after controlling for age, depression effort, and combat exposure. Depression and combat exposure were greater for the mTBI group. The mTBI group scored poorer on effort, but only the Multiple Choice subtest was significant. The mTBI group had good awareness of their deficits.	[Gaines, Katy D.; Berenji, Gholam R.] Vet Affairs Greater Los Angeles Healthcare Syst, Nucl Med, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA; [Soper, Henry V.] Fielding Grad Univ, Sch Psychol, Santa Barbara, CA USA		Gaines, KD (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Nucl Med, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	drdgaines@gmail.com			Veterans Affairs of Greater Los Angeles Health Care System [PCC2011-070727]	This work was supported by the This work was supported by the Veterans Affairs of Greater Los Angeles Health Care System [PCC2011-070727]..	August-Fedio A, 2010, ARCH CLIN NEUROPSYCH, V25, P568; Barth J., 2010, MILITARY NEUROPSYCHO, P127; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Boone K.B., 2007, ASSESSMENT FEIGNED C; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Christensen AL., 1974, LURIAS NEUROPSYCHOLO; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DIKMEN S, 2009, NEUROPSYCHOLOGICAL A, P597; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dziedzic J., 2008, NEUROLOGY REV; Erez ABH, 2009, AM J OCCUP THER, V63, P634; FRENCH LM, 2010, MILITARY NEUROPSYCHO, P101; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Fry R., 2007, DISS ABSTR INT B, V68, P3395; Gervais R. P., 2005, ANN M NAT AC NEUR TA; Gladsjo JA, 1999, NORMS LETT CATEGORY; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Granacher R. P., 2008, TRAUMATIC BRAIN INJU, VSecond; Green P, 1995, MANUAL ORAL WORD MEM; Hartikainen K., 2003, DETECTION CHANGE EVE, P99, DOI DOI 10.1007/978-1-4615-0294-4; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Knight RT, 2003, IS CL CO NE, P259; Krasnegor N.A., 1996, ATTENTION MEMORY EXE; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Larrabee G.J., 2007, ASSESSMENT MALINGERE; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Luria A.R., 1973, WORKING BRAIN; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M., 2008, MILD TRAUMATIC BRAIN; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Meyers JE., 1995, REY COMPLEX FIGURE T; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Posttraumatic Stress Disorder, 2010, VET SERV COMB EXP SC; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PERECMAN E, 1987, FRONTAL LOBES REVISI, P1; Pickett T. C., 2010, MILITARY NEUROPSYCHO, P175; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sohlberg M., 2001, COGNITIVE REHABILITA; Soper H. V, 2008, NEUROPSYCHOLOGY HDB, P681; Soper HV, 2002, ARCH CLIN NEUROPSYCH, V17, P854; Spreen O., 2003, ASSESSMENT APHASIA; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Stern R., 1999, BOSTON QUALITATIVE S; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Street R. F., 1931, CONTRIBUTIONS ED COL, V181; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Unsworth N, 2009, J INDIVID DIFFER, V30, P194, DOI 10.1027/1614-0001.30.4.194; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd	79	10	11	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 3	2016	23	2					115	124		10.1080/23279095.2015.1012762			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DE4TK	WOS:000370623000005	26496530				2022-02-06	
J	Schaffer, Y; Geva, R				Schaffer, Yael; Geva, Ronny			Memory outcomes following cognitive interventions in children with neurological deficits: A review with a focus on under-studied populations	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Paediatric; Rehabilitation; Memory; Restoration; Compensation	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; WORKING-MEMORY; SICKLE-CELL; PRACTICAL-APPLICATIONS; EXECUTIVE FUNCTIONS; UGANDAN CHILDREN; TRAINING-PROGRAM; AMNESIC SYNDROME; IMPROVES MEMORY	Given the primary role of memory in children's learning and well-being, the aim of this review was to examine the outcomes of memory remediation interventions in children with neurological deficits as a function of the affected memory system and intervention method. Fifty-seven studies that evaluated the outcome of memory interventions in children were identified. Thirty-four studies met the inclusion criteria, and were included in a systematic review. Diverse rehabilitation methods for improving explicit and implicit memory in children were reviewed. The analysis indicates that teaching restoration strategies may improve, and result in the generalisation of, semantic memory and working memory performance in children older than 7 years with mild to moderate memory deficits. Factors such as longer protocols, emotional support, and personal feedback contribute to intervention efficacy. In addition, the use of compensation aids seems to be highly effective in prospective memory tasks. Finally, the review unveiled a lack of studies with young children and the absence of group interventions. These findings point to the importance of future evidence-based intervention protocols in these areas.	[Schaffer, Yael; Geva, Ronny] Bar Ilan Univ, Gonda Brain Res Ctr, Dept Psychol, IL-5290002 Ramat Gan, Israel		Geva, R (corresponding author), Bar Ilan Univ, Gonda Brain Res Ctr, Dept Psychol, Dev Neuropsychol Lab, IL-5290002 Ramat Gan, Israel.	ronny.geva@biu.ac.il			Israel Science FoundationIsrael Science Foundation [1518]	The authors gratefully acknowledge Ms. Jessica Schreiber for her editorial input. This research was funded by an Israel Science Foundation [Grant #1518] awarded to Prof. Ronny Geva.	Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Axelrod B., 2002, COGNITIVE REHABILITA; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; Baddeley A.D., 1997, HUMAN MEMORY THEORY; Bangirana P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-96; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bauer P.J., 2007, SHORT LONG TERM MEMO, P240; Belmont J. M., 1969, ADV CHILD DEV BEHAV, V4, P29; Bennett SJ, 2013, AJIDD-AM J INTELLECT, V118, P179, DOI 10.1352/1944-7558-118.3.179; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Boivin MJ, 2013, J PEDIATR-US, V163, P1409, DOI 10.1016/j.jpeds.2013.06.055; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Bryck RL, 2012, AM PSYCHOL, V67, P87, DOI 10.1037/a0024657; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Carew TJ, 2010, NEURON, V67, P685, DOI 10.1016/j.neuron.2010.08.028; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Conners FA, 2008, J INTELL DISABIL RES, V52, P244, DOI 10.1111/j.1365-2788.2007.01015.x; CONNERS FA, 2003, SPEECH LANGUAGE INTE, P31; Coyne JH, 2015, ARCH PHYS MED REHAB, V96, P742, DOI 10.1016/j.apmr.2014.09.022; DePompei R, 2008, NEUROREHABILITATION, V23, P487; DOMJAN M, 2003, PRINCIPLES LEARNING; Donders J., 2007, PEDIAT NEUROPSYCHOLO, P1; Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149; Einstein, 2007, PROSPECTIVE MEMORY O; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Feuerstein R., 1980, INSTRUMENTAL ENRICHM; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Funck-Brentano I, 2005, AIDS, V19, P1501, DOI 10.1097/01.aids.0000183124.86335.0a; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Guillery-Girard B, 2004, NEUROREPORT, V15, P377, DOI 10.1097/00001756-200402090-00033; Hampstead BM, 2012, NEUROPSYCHOLOGY, V26, P385, DOI 10.1037/a0027545; Hardy KK, 2011, J PEDIATR ONCOL NURS, V28, P27, DOI 10.1177/1043454210377178; Haslam C, 2012, NEUROPSYCHOL REHABIL, V22, P697, DOI 10.1080/09602011.2012.686820; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Ho J, 2011, NEUROPSYCHOL REHABIL, V21, P183, DOI 10.1080/09602011.2010.547345; ISAACS EB, 1989, BRIT J DEV PSYCHOL, V7, P377, DOI 10.1111/j.2044-835X.1989.tb00814.x; Jarrold C, 1999, Downs Syndr Res Pract, V6, P61, DOI 10.3104/reviews.97; Jarrold C, 2006, WORKING MEMORY AND NEURODEVELOPMENTAL DISORDERS, P239; Johnson B. T., 2000, HDB RES METHODS SOCI, P496; Jolles DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00076; Karch D, 2013, DTSCH ARZTEBL INT, V110, P643, DOI 10.3238/arztebl.2013.0643; Kerns K A, 1998, Pediatr Rehabil, V2, P77; King AA, 2007, NEUROLOGY, V68, P2008, DOI 10.1212/01.wnl.0000264421.24415.16; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kodituwakku PW, 2009, DEV DISABIL RES REV, V15, P218, DOI 10.1002/ddrr.73; Kolk A, 2011, PEDIATR NEUROL, V44, P101, DOI 10.1016/j.pediatrneurol.2010.08.012; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Landis J, 2006, ARCH PHYS MED REHAB, V87, P799, DOI 10.1016/j.apmr.2006.02.017; Laukenmann M, 2003, INT J SCI EDUC, V25, P489, DOI 10.1080/09500690210163233; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Limond J, 2014, CLIN NEUROPSYCHOL, V28, P181, DOI 10.1080/13854046.2013.873083; Loomes C, 2008, RES DEV DISABIL, V29, P113, DOI 10.1016/j.ridd.2007.01.001; Manji S, 2009, DEV NEUROREHABIL, V12, P239, DOI 10.1080/17518420902980118; Martins S, 2006, NEUROPSYCHOLOGIA, V44, P2792, DOI 10.1016/j.neuropsychologia.2006.05.022; Mattson SN, 1998, ALCOHOL CLIN EXP RES, V22, P279, DOI 10.1111/j.1530-0277.1998.tb03651.x; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2011, J CLIN EXP NEUROPSYC, V33, P639, DOI 10.1080/13803395.2010.547844; McCauley SR, 2010, CHILD NEUROPSYCHOL, V16, P293, DOI 10.1080/09297041003601470; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McKeough A., 1995, TEACHING TRANSFER FO; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MILLER E, 1992, BRIT J PSYCHIAT, V160, P1, DOI 10.1192/bjp.160.1.1; Montour-Proulx I, 2004, J CHILD NEUROL, V19, P935, DOI 10.1177/08830738040190120501; Mulhern Raymond K, 2004, Pediatr Rehabil, V7, P1, DOI 10.1080/13638490310001655528; MULHERN RK, 2006, COMPREHENSIVE HDB CH, P262; Norberg AL, 2009, EUR J CANCER CARE, V18, P371, DOI 10.1111/j.1365-2354.2008.00976.x; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; Patel SK, 2009, J PEDIAT HEMATOL ONC, V31, P670, DOI 10.1097/MPH.0b013e3181b25a1d; Pauly-Takacs K, 2012, LEARNING EPISODIC ME; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rabipour S, 2012, BRAIN COGNITION, V79, P159, DOI 10.1016/j.bandc.2012.02.006; Ramsden SR, 2002, J ABNORM CHILD PSYCH, V30, P657, DOI 10.1023/A:1020819915881; Rankin Peter M, 2005, Pediatr Rehabil, V8, P283, DOI 10.1080/13638490400022436; Rasmussen C, 2005, ALCOHOL CLIN EXP RES, V29, P1359, DOI 10.1097/01.alc.0000175040.91007.d0; REBER AS, 1992, CONSCIOUS COGN, V1, P93, DOI 10.1016/1053-8100(92)90051-B; Reeves CB, 2006, J PEDIATR PSYCHOL, V31, P272, DOI 10.1093/jpepsy/jsj019; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Sander MC, 2012, DEV COGN NEUROS-NETH, V2, pS67, DOI 10.1016/j.dcn.2011.11.005; SANDFORD JA, 2007, CAPTAINS LOG COMPUTE; Schacter, 2002, NEUROPSYCHOLOGY MEMO; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SCHACTER DL, 1994, WHAT ARE MEMORY SYST; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Smith L, 2008, S AFR J CHILD HEALTH, V2, P108; Sohlberg M., 2001, COGNITIVE REHABILITA; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; SQUIRE LR, 1992, ENCY LEARNING MEMORY; Tatla SK, 2014, BRAIN INJURY, V28, P1022, DOI 10.3109/02699052.2014.890747; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Tulving E., 1972, ORG MEMORY, P381; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van't Hooft I, 2003, ACTA PAEDIATR, V92, P935, DOI 10.1080/08035250310004586; van't Hooft I., 2009, NEUROREHABILITATION, V25, P1; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VARNI JW, 1993, J PEDIATR PSYCHOL, V18, P751, DOI 10.1093/jpepsy/18.6.751; WAALAND P, 1991, NEUROPSYCHOL REHABIL, V1, P19; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Wass SV, 2012, DEV REV, V32, P360, DOI 10.1016/j.dr.2012.07.001; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Wilson B., 1992, CLIN MANAHMENT MEMOR; Wilson B, 2009, MEMORY REHABILITATIO; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618; Yerys BE, 2003, J PEDIAT HEMATOL ONC, V25, P495, DOI 10.1097/00043426-200306000-00014; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; [No title captured]	129	10	10	1	41	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 3	2016	26	2					286	317		10.1080/09602011.2015.1016537			32	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DA5AT	WOS:000367815200006	25730385				2022-02-06	
J	Addington, CP; Cusick, A; Shankar, RV; Agarwal, S; Stabenfeldt, SE; Kodibagkar, VD				Addington, Caroline P.; Cusick, Alex; Shankar, Rohini Vidya; Agarwal, Shubhangi; Stabenfeldt, Sarah E.; Kodibagkar, Vikram D.			Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Neural progenitor/stem cells; Cell-labeling; Polydimethylsiloxane; Rhodamine; Nanoemulsions; MR oximetry; Fluorescence; Dual-modality imaging	QUANTITATIVE TISSUE OXIMETRY; RAT-BRAIN; MRI; TRACKING; HEXAMETHYLDISILOXANE; NANOPARTICLES; MIGRATION; PROBES; F-19	Cell therapy represents a promising therapeutic for a myriad of medical conditions, including cancer, traumatic brain injury, and cardiovascular disease among others. A thorough understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane core nanoemulsions as dual modality (H-1 MRI/Fluorescence), dual-functional (oximetry/detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a concentration of 10 mu L/10(4) cells with a 40% v/v polydimethylsiloxane core nanoemulsion, doped with rhodamine, had minimal effect on viability, no effect on migration, proliferation and differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by H-1 MR and fluorescence and local pO(2) reporting by labeled NPSCs. This new approach for cell labeling with a positive contrast H-1 MR probe has the potential to improve mechanistic knowledge of current therapies, and guide the design of future cell therapies due to its clinical translatability.	[Addington, Caroline P.; Cusick, Alex; Shankar, Rohini Vidya; Agarwal, Shubhangi; Stabenfeldt, Sarah E.; Kodibagkar, Vikram D.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA		Stabenfeldt, SE; Kodibagkar, VD (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	Sarah.Stabenfeldt@asu.edu; Vikram.Kodibagkar@asu.edu		Vidya Shankar, Rohini/0000-0003-0762-7052; Addington, Caroline/0000-0003-4534-8222	College of Engineering, ASU; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2HD084067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER	The authors would like to acknowledge David Menn, Arizona State University, and Qingwei Liu, Barrow Neurological Institute, for technical assistance. These studies were supported by a Rising Stars in Engineering seed grant from College of Engineering, ASU (VDK and SES) and NIH 1DP2HD084067 (SES).	Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102; Ahrens ET, 2013, NMR BIOMED, V26, P860, DOI 10.1002/nbm.2948; Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Bhirde A, 2011, NANOSCALE, V3, P142, DOI 10.1039/c0nr00493f; Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; Bonetto F, 2011, INT J CANCER, V129, P365, DOI 10.1002/ijc.25672; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Gilad AA, 2008, MAGN RESON MED, V60, P1, DOI 10.1002/mrm.21622; Granot D, 2014, MAGN RESON MED, V71, P1238, DOI 10.1002/mrm.24741; Granot D, 2011, NEUROIMAGE, V57, P817, DOI 10.1016/j.neuroimage.2011.04.063; Gulaka PK, 2011, NMR BIOMED, V24, P1226, DOI 10.1002/nbm.1678; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Kodibagkar VD, 2006, MAGN RESON MED, V55, P743, DOI 10.1002/mrm.20826; Kodibagkar VD, 2008, NMR BIOMED, V21, P899, DOI 10.1002/nbm.1279; Kodibagkar VD, 2008, FRONT BIOSCI-LANDMRK, V13, P1371, DOI 10.2741/2768; Kraitchman DL, 2009, ARTERIOSCL THROM VAS, V29, P1025, DOI 10.1161/ATVBAHA.108.165571; Laistler E, 2015, J MAGN RESON IMAGING, V41, P496, DOI 10.1002/jmri.24549; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Menon JU, 2012, THERANOSTICS, V2, P1199, DOI 10.7150/thno.4812; Nabuurs RJA, 2011, NMR BIOMED, V24, P351, DOI 10.1002/nbm.1598; Ramos-Gomez M, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0078-4; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; Shankar RV, 2015, PROC SPIE, V9417, DOI 10.1117/12.2084009; Srinivas M, 2010, ADV DRUG DELIVER REV, V62, P1080, DOI 10.1016/j.addr.2010.08.009; Srivastava AK, 2015, DIS MODEL MECH, V8, P323, DOI 10.1242/dmm.018499; Wang ZYJ, 2009, NMR BIOMED, V22, P952, DOI 10.1002/nbm.1410; Zhong J., 2013, PLOS ONE, V8; Zhong J, 2013, MAGN RESON MED, V69, P1683, DOI 10.1002/mrm.24414	34	10	11	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAR	2016	44	3					816	827		10.1007/s10439-015-1514-1			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	DI8HK	WOS:000373741900016	26597417	Green Accepted			2022-02-06	
J	Hammond, FM; Davis, C; Cook, JR; Philbrick, P; Hirsch, MA				Hammond, Flora M.; Davis, Christine; Cook, James R.; Philbrick, Peggy; Hirsch, Mark A.			A Conceptual Model of Irritability Following Traumatic Brain Injury: A Qualitative, Participatory Research Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						qualitative research; behavior; participatory research; brain injury; translational research; aggression; irritability	ANGER; ADJUSTMENT; PEOPLE; WORK; CONSEQUENCES; INDIVIDUALS; IMPAIRMENT; CAREGIVERS; CHALLENGES; COMPLAINTS	Background: Individuals with a history of traumatic brain injury (TBI) may have chronic problems with irritability, which can negatively affect their lives. Objectives: (1) To describe the experience (thoughts and feelings) of irritability from the perspectives of multiple people living with or affected by the problem, and (2) to develop a conceptual model of irritability. Design: Qualitative, participatory research. Participants: Forty-four stakeholders (individuals with a history of TBI, family members, community professionals, healthcare providers, and researchers) divided into 5 focus groups. Procedures: Each group met 10 times to discuss the experience of irritability following TBI. Data were coded using grounded theory to develop themes, metacodes, and theories. Measures: Not applicable. Results: A conceptual model emerged in which irritability has 5 dimensions: affective (related to moods and feelings); behavioral (especially in areas of self-regulation, impulse control, and time management); cognitive-perceptual (self-talk and ways of seeing the world); relational issues (interpersonal and family dynamics); and environmental (including environmental stimuli, change, disruptions in routine, and cultural expectations). Conclusions: This multidimensional model provides a framework for assessment, treatment, and future research aimed at better understanding irritability, as well as the development of assessment tools and treatment interventions.	[Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Davis, Christine; Hirsch, Mark A.] Univ North Carolina Charlotte, Dept Commun Studies, Charlotte, NC USA; [Cook, James R.] Univ North Carolina Charlotte, Dept Psychol, Charlotte, NC USA; [Philbrick, Peggy; Hirsch, Mark A.] Carolinas Healthcare Syst, Carolinas Rehabil, Charlotte, NC USA		Hammond, FM (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com	Davis, Christine/K-4850-2019; Hirsch, Mark A./D-2798-2016	Hirsch, Mark A./0000-0002-8997-7971			Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Berger C. R., 1979, LANGUAGE SOCIAL PSYC, P122; Bjorkdahl A, 2010, BRAIN INJURY, V24, P1061, DOI 10.3109/02699052.2010.494588; Charmaz KC., 2000, HDB QUALITATIVE RES, V2nd edn, P509, DOI DOI 10.1177/0891241609342193; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Davis C. S., 2012, STRAIGHT TALK COMMUN; Davis CS, 2010, STRAIGHT TALK COMMUN; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; Edwards BJ, 2000, ERGONOMICS, V43, P1501, DOI 10.1080/001401300750003934; Ehde DM, 2013, ARCH PHYS MED REHAB, V94, pS30, DOI 10.1016/j.apmr.2012.10.025; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fava M, 2010, MOL PSYCHIATR, V15, P856, DOI 10.1038/mp.2009.20; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gaventa J., 2010, IDS WORK PAP, DOI [DOI 10.1111/J.2040-0209.2010.00347_2.X, 10.1111/j.2040-0209.2010.00347_2.x]; Gentleman D, 1999, BRIT MED BULL, V55, P910, DOI 10.1258/0007142991902718; Glaser BG., 2017, DISCOVERY GROUNDED T; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Gordon WA, 2005, AM J PHYS MED REHAB, V84, P999, DOI 10.1097/01.phm.0000187851.96774.27; Hammond F, 2006, J HEAD TRAUMA REHAB, V21, P412, DOI 10.1097/00001199-200609000-00014; Hammond FM, 2012, BRAIN INJURY, V26, P1287, DOI 10.3109/02699052.2012.706352; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Handratta V, 2010, NEUROCASE, V16, P125, DOI 10.1080/13554790903329166; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Heron J, 2002, HDB ACTION RES PARTI, P179; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; HOLLAND RL, 1985, J APPL PHYSIOL, V59, P1823, DOI 10.1152/jappl.1985.59.6.1823; Jagosh J, 2012, MILBANK Q, V90, P311, DOI 10.1111/j.1468-0009.2012.00665.x; Judd LL, 2013, JAMA PSYCHIAT, V70, P1171, DOI 10.1001/jamapsychiatry.2013.1957; Kassberg AC, 2013, SCAND J OCCUP THER, V20, P272, DOI 10.3109/11038128.2012.734330; Keightley ML, 2009, BRAIN INJURY, V23, P250, DOI 10.1080/02699050902748331; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Lindlof T.L., 2002, QUALITATIVE COMMUNIC; Long C J, 1983, Psychiatr Med, V1, P35; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mathee A, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5612; McIntyre A., 2008, QUALITATIVE RES METH, V52, P15; Neumann D, 2014, BRAIN IMAGING BEHAV, V8, P460, DOI 10.1007/s11682-013-9285-5; Nykaza ET, 2013, J ACOUST SOC AM, V133, P2690, DOI 10.1121/1.4795781; O'Brien MP, 2014, J CONSULT CLIN PSYCH, V82, P90, DOI 10.1037/a0034667; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Reason P, 2002, HDB ACTION RES PARTI, P1; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Sanford K, 2005, J FAM PSYCHOL, V19, P180, DOI 10.1037/0893-3200.19.2.180; Scherer KR., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/J.PHYSBEH.2006.11.008; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; SHUKITT BL, 1988, AVIAT SPACE ENVIR MD, V59, P530; Smith CA, 2004, EMOTION, V4, P133, DOI 10.1037/1528-3542.4.2.133; SNAITH RP, 1985, BRIT J PSYCHIAT, V147, P127, DOI 10.1192/bjp.147.2.127; Sohlberg MM, 2001, J HEAD TRAUMA REHAB, V16, P498, DOI 10.1097/00001199-200110000-00008; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Strauss A., 1990, BASICS QUALITATIVE R; Sukhodolsky DG, 2013, PILOT STUDY NEUROBIO; Tamopolsky A, 1980, PSYCHOL MED, V10, P683; UOMOTO JM, 1992, ARCH PHYS MED REHAB, V73, P674; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wadsworth Y., 2002, HDB ACTION RES PARTI, P420; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Wofford JC, 2001, PSYCHOL REP, V88, P768, DOI 10.2466/PR0.88.3.768-784; Yamazaki H, 2009, BIOSCI TRENDS, V3, P202; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	78	10	10	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E1	E11		10.1097/HTR.0000000000000136			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300001	26098253				2022-02-06	
J	Ponto, LLB; Brashers-Krug, TM; Pierson, RK; Menda, Y; Acion, L; Watkins, GL; Sunderland, JJ; Koeppel, JA; Jorge, RE				Ponto, Laura L. Boles; Brashers-Krug, Thomas M.; Pierson, Ronald K.; Menda, Yusuf; Acion, Laura; Watkins, G. Leonard; Sunderland, John J.; Koeppel, Julie A.; Jorge, Ricardo E.			Preliminary Investigation of Cerebral Blood Flow and Amyloid Burden in Veterans With and Without Combat-Related Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; CONFIDENCE-INTERVALS; PROTEIN DEPOSITION; BLAST EXPOSURE; PET; BETA; PATHOLOGY; ANXIETY; STRESS	This study aimed to examine global and regional cerebral blood flow and amyloid burden in combat veterans with and without traumatic brain injury (TBI). Cerebral blood flow (in milliliters per minute per 100 mL) was measured by quantitative [O-15] water, and amyloid burden was measured by [C-11] PIB imaging. Mean global cerebral blood flow was significantly lower in veterans with TBI compared with non-TBI veterans. There were essentially no differences between groups for globally normalized regional cerebral blood flow. Amyloid burden did not differ between TBI and non-TBI veterans. Veterans who have suffered a TBI have significantly lower cerebral blood flow than non-TBI controls but did not manifest increased levels of amyloid, globally or regionally.	[Ponto, Laura L. Boles; Menda, Yusuf; Watkins, G. Leonard; Sunderland, John J.] Univ Iowa, Dept Radiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Brashers-Krug, Thomas M.; Koeppel, Julie A.] Univ Iowa, Dept Psychiat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Acion, Laura] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Brashers-Krug, Thomas M.] Iowa City Vet Adm Med Ctr, Iowa City, IA USA; [Pierson, Ronald K.] Brain Image Anal LLC, Iowa City, IA USA; [Acion, Laura] Iowa Consortium Subst Abuse Res & Evaluat, Iowa City, IA USA; [Jorge, Ricardo E.] Michael E DeBakey VA Med Ctr, Houston, TX USA		Ponto, LLB (corresponding author), Univ Iowa, Dept Radiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	laura-ponto@uiowa.edu		Sunderland, John/0000-0002-0891-1234; Acion, Laura/0000-0001-5213-6012; Ponto, Laura/0000-0003-1197-6714; Menda, Yusuf/0000-0001-7551-2789	Veterans Administration RRD Merit Award [D7201I]	This work was funded in part by Veterans Administration RR&D Merit Award D7201I to Dr. Jorge.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Babor TF, 2001, AUDIT ALCOHOL USE DI; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Department of Veterans Affairs Department of Defense, 2009, CLIN PRACT GUID MAN; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GUR RC, 1987, J CEREBR BLOOD F MET, V7, P173, DOI 10.1038/jcbfm.1987.40; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; HICHWA RD, 1995, CHEMISTS' VIEWS OF IMAGING CENTERS, P401; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Magnotta VA, 2002, COMPUT MED IMAG GRAP, V26, P251, DOI 10.1016/S0895-6111(02)00011-3; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Newcombe RG, 2006, STAT MED, V25, P559, DOI 10.1002/sim.2324; Newcombe RG, 2006, STAT MED, V25, P543, DOI 10.1002/sim.2323; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rousset OG, 1998, J NUCL MED, V39, P904; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wollenweber SD, 1997, IEEE T NUCL SCI, V44, P1613, DOI 10.1109/23.632741	39	10	10	0	6	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2016	28	2					89	96		10.1176/appi.neuropsych.15050106			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DM0PE	WOS:000376047100010	26548655	Bronze			2022-02-06	
J	Chen, TJ; Wu, WQ; Ying, GR; Fu, QY; Xiong, K				Chen, Tie-Jiang; Wu, Wu-Quan; Ying, Guang-Rong; Fu, Qing-Yang; Xiong, Kai			Serum CXCL12 concentration in patients with severe traumatic brain injury are associated with mortality	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; CXC chemolcine ligand-12; Mortality; Severity	ISCHEMIC-STROKE; CHEMOKINE CXCL12; MECHANISMS; PROGNOSIS; SYSTEM; EXPRESSION; BIOMARKERS; PREDICTOR; APOPTOSIS; COPEPTIN	Background: CXC chemokine ligand-12 (CXCL12) is released during brain injury. The objective of this study was to investigate relationship between serum CXCL12 concentration, mortality and trauma severity in patients with traumatic brain injury (TBI). Methods: We determined serum CXCL12 concentration of 132 controls and 132 patients with severe TBI. Trauma severity was assessed using Glasgow Coma Scale (GCS) score. The end-point of the study was 30-day mortality. Results: Serum CXCL12 concentration were significantly higher in the patients than in the controls (133 +/- 6.8 vs. 1.5 +/- 0.5 ng/ml, P < 0.001). There was a negative correlation between CXCL12 concentration and GCS scores (r = -0.588, P < 0.001). The optimal cutoff value of CXCL12 as a mortality indicator was estimated to be 15.4 ng/ml, which yielded a sensitivity of 71.0% and a specificity of 72.2%, with the area under curve at 0.808 [95% confidence (CI), 0.730-0.871]. Serum CXCL12 concentration > 19.5 ng/ml were associated independently with 30-day mortality (odds ratio, 6.951; 95% CI, 2.027-18.477; P < 0.001) and 30-day overall survival (hazard ratio, 4398; 95% CI, 2.088-15.286; P < 0.001). Conclusions: Increased serum CXCL12 concentration is associated highly with trauma severity and mortality following TBI. (C) 2015 Published by Elsevier B.V.	[Chen, Tie-Jiang; Wu, Wu-Quan; Ying, Guang-Rong; Fu, Qing-Yang; Xiong, Kai] Yiwu Cent Hosp, Dept Emergency Surg, 699 Jiangdong Rd, Yiwu 322000, Zhejiang, Peoples R China		Chen, TJ (corresponding author), Yiwu Cent Hosp, Dept Emergency Surg, 699 Jiangdong Rd, Yiwu 322000, Zhejiang, Peoples R China.	hzhzzhoufeng@163.com					Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Duan XX, 2015, NEUROL SCI, V36, P2227, DOI 10.1007/s10072-015-2341-8; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kim YS, 2012, EUR NEUROL, V67, P363, DOI 10.1159/000335351; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kwon HS, 2015, J STROKE CEREBROVASC, V24, P704, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.021; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Navarro-Sobrino M, 2011, ATHEROSCLEROSIS, V216, P205, DOI 10.1016/j.atherosclerosis.2011.01.030; Nonaka Masaru, 2014, Subcell Biochem, V80, P31, DOI 10.1007/978-94-017-8881-6_3; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Schutt RC, 2012, STROKE, V43, P3382, DOI 10.1161/STROKEAHA.112.660878; Shen LJ, 2014, CLIN CHIM ACTA, V427, P37, DOI 10.1016/j.cca.2013.09.047; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Shin JH, 2014, BBA-GENE REGUL MECH, V1839, P826, DOI 10.1016/j.bbagrm.2014.06.019; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang YT, 2012, CURR DRUG TARGETS, V13, P166, DOI 10.2174/138945012799201603; Wurster T, 2012, EUR J NEUROL, V19, P395, DOI 10.1111/j.1468-1331.2011.03527.x; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	31	10	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	FEB 15	2016	454						6	9		10.1016/j.cca.2015.12.033			4	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	DE0HN	WOS:000370305800002	26724366				2022-02-06	
J	Banks, WA; Dohi, K; Hansen, K; Thompson, HJ				Banks, William A.; Dohi, Kenji; Hansen, Kim; Thompson, Hilaire J.			Assessing blood granulocyte colony-stimulating factor as a potential biomarker of acute traumatic brain injury in mice and humans	BRAIN BEHAVIOR AND IMMUNITY			English	Article						G-CSF; Traumatic brain injury; Biomarker; Neuroinflammation; Blood brain barrier	INTRACEREBROVENTRICULAR INJECTION; SEVERITY SCORE; INTERLEUKIN-1-BETA; CYTOKINES; BARRIER; IMMUNE; MODEL	Previous work has found that serum G-CSF was acutely elevated in mice 24 h but not one week after controlled cortical impact (CCI). The purpose of this study was to investigate whether blood G-CSF correlates with the elevated brain cytokines in mice after CCI and also if it correlates with traumatic brain injury (TBI) in humans. Here, we found in mice undergoing CCI, a procedure that induces direct injury to the brain, that serum G-CSF correlated directly or indirectly with several brain cytokines, indicating it is a useful marker for the neuroinflammation of TBI. A pilot study in humans (phase I, n = 19) confirmed that plasma G-CSF is acutely elevated on day I (p < 0.001) of TBI and has returned to baseline by one week. In a second human sample (phase II) (n = 80), we found plasma G-CSF peaks about 12 h after arriving in the emergency department (41.6 +/ 5.4 pg/ml). Aging was weakly associated (p < 0.05) with a less robust elevation in serum G-CSF, but there was no difference with gender. ISS, a measure of total severity of injury, correlated with the degree of elevation in serum G-CSF (r = .419; p < 0.05), but severity of head injury (via AIS) did not. The latter may have been because of the statistically narrow range of head injuries among our cases and the high number of cases diagnosed with closed head injury (a non-codable diagnosis). In conclusion, plasma G-CSF may be a useful biomarker of TBI, correlating with neuroinflammation in the animal model and in the human studies with time since injury and total severity of injury. As such, it may be useful in determining whether TBI has occurred within the last 24 h. Published by Elsevier Inc.	[Banks, William A.; Dohi, Kenji; Hansen, Kim; Thompson, Hilaire J.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Banks, William A.; Dohi, Kenji; Hansen, Kim] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98104 USA; [Dohi, Kenji] Jikei Univ, Sch Med, Dept Emergency Med, Tokyo, Japan; [Thompson, Hilaire J.] Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; [Thompson, Hilaire J.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Banks, WA (corresponding author), VAPSHCS, Rm 1-810A,1660 S Columbian Way, Seattle, WA 98108 USA.	wabanks1@uw.edu; kdoppy@jikei.ac.jp; nesnah@u.washington.edu; hilairet@uw.edu	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619; dohi, kenji/0000-0002-4451-0382	National Institutes of Health, National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015]; National Institute of Neurologic Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913]; Department of Veterans AffairsUS Department of Veterans Affairs; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG029839, R01AG046619]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002317] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG029839, R01AG046619] Funding Source: NIH RePORTER	Supported by grants from the National Institutes of Health, National Center for Research Resources KL2RR025015 (HT), the National Institute of Neurologic Diseases and Stroke R01NS077913 (HT), the Department of Veterans Affairs (WAB), and the National Institute on Aging R01AG029839 (WAB) and R01AG046619 (WAB).	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; BLATTEIS CM, 1992, PROG BRAIN RES, V91, P409; Chen GJ, 1998, NEUROIMMUNOMODULAT, V5, P261, DOI 10.1159/000026346; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Frank T, 2012, BRAIN, V135, P1914, DOI 10.1093/brain/aws054; Ghorbani M, 2013, DRUG CHEM TOXICOL, V36, P102, DOI 10.3109/01480545.2012.737802; Goehler LE, 1999, J NEUROSCI, V19, P2799; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hong Y, 2012, J HUAZHONG U SCI-MED, V32, P872, DOI 10.1007/s11596-012-1050-2; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Romero LI, 1996, AM J PHYSIOL-REG I, V270, pR518, DOI 10.1152/ajpregu.1996.270.3.R518; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sobrino T, 2009, J CEREBR BLOOD F MET, V29, P1968, DOI 10.1038/jcbfm.2009.182; Sun B.-L., 2014, MOL NEUROBIOL; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Yildiz R, 2011, J BUON, V16, P138; Yu SC, 2012, BIOMARKERS, V17, P319, DOI 10.3109/1354750X.2012.668712; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	30	10	10	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	FEB	2016	52						81	87		10.1016/j.bbi.2015.10.002			7	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	DB2DB	WOS:000368317400011	26441136	Green Accepted			2022-02-06	
J	Kirelik, SB; McAvoy, K				Kirelik, Susan B.; McAvoy, Karen			ACUTE CONCUSSION MANAGEMENT WITH REMOVE-REDUCE/EDUCATE/ADJUST-ACCOMMODATE/PACE (REAP)	JOURNAL OF EMERGENCY MEDICINE			English	Article						pediatrics; concussion; traumatic brain injury; emergency department; return to school	TRAUMATIC BRAIN-INJURY	Background: With increased concussion awareness and significantly increased numbers of emergency department (ED) visits for pediatric concussion, a seamless process of managing a patient with a concussion can begin in the ED. Case Report: This article demonstrates the effectiveness of the Remove-Reduce/Educate/Adjust-Accommodate/Pace (REAP) concussion management program in the evaluation, management, and return to play of an acutely concussed pediatric patient. The REAP program was developed in Colorado and promotes a multidisciplinary teamapproach to concussion management. The team consists of parents, teachers, athletic personnel, and clinicians. The patient described in this case report had concussion management initiated in the ED. He was able to successfully return to sports, having recovered from his concussion with the guidance of the Center for Concussion (Centennial, Colorado) staff utilizing the REAP model of care and the currently recommended graduated return-to-play process. Why Should an Emergency Physician Be Aware of This?: Busy EDs are often the initial point of contact for school-aged patients with concussion. We present a program that we believe represents a good model of patient care with concussion management implemented in the ED and carried through to clearance of the patient. (C) 2016 Elsevier Inc.	[Kirelik, Susan B.; McAvoy, Karen] Rocky Mt Hosp Children Presbyterian, St Lukes Med Ctr, Ctr Concuss, 14000 E Arapahoe Rd,Suite 300, Centennial, CO 80112 USA		Kirelik, SB (corresponding author), Rocky Mt Hosp Children Presbyterian, St Lukes Med Ctr, Ctr Concuss, 14000 E Arapahoe Rd,Suite 300, Centennial, CO 80112 USA.						Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Research Council, 2014, SPORTS REL CONC YOUT; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297	8	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	FEB	2016	50	2					320	324		10.1016/j.jemermed.2015.02.054			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DI2BB	WOS:000373299600033	26589561				2022-02-06	
J	Liao, KH; Wang, JY; Lin, HW; Lui, TN; Chen, KY; Yen, DHT; Jeng, MJ				Liao, Kuo-Hsing; Wang, Jia-Yi; Lin, Hui-Wen; Lui, Tai-Ngar; Chen, Kai-Yun; Yen, David Hung Tzang; Jeng, Mei-Jy			Risk of death in patients with post-traumatic cerebrospinal fluid leakage-Analysis of 1773 cases	JOURNAL OF THE CHINESE MEDICAL ASSOCIATION			English	Article						cerebrospinal fluid; leakage; mortality; skull fracture; traumatic brain injury	HEAD-INJURY; TAIWAN; RHINORRHEA	Background: Post-traumatic cerebrospinal fluid (CSF) leakage is one of the most troublesome conditions associated with head trauma. CSF fistulae, meningitis/central nervous infection, or even death may accompany it. Few studies have discussed post-traumatic CSF leakage as a risk factor in mortality following head trauma. We conducted this cohort study to examine the issue. Methods: We reviewed the records in the Taiwan Traumatic Brain Injury (TBI) Registry System between 1993 and 2008. The study group included patients with acute TBI and post-traumatic CSF leakage, and the control group included cases with TBI but without CSF leakage, selected randomly at a 5:1 ratio with respect to the study group. The demographic data, Glasgow Coma Scale, brain computerized tomography, association of skull fractures and intracranial lesions, and 1-year mortality rates between these two cohorts were reviewed meticulously and analyzed statistically. Results: Of 174,236 cases, 1773 with post-traumatic CSF leakage were included in the study group, and 8865 cases in the control group. Of the total 10,638 sampled cases, 406 (3.8%) died during the 1-year follow-up period, 159 (9.0%) cases in the CSF leakages group, and 247 (2.8%) in the control group. The patients with CSF leakage had a significantly higher mortality rate within 1 year (adjusted hazard ratio = 1.44, p < 0.001) than those without. We divided the CSF leakage group into three subgroups: otorrhea (n = 568), rhinorrhea (n = 302), and tension pneumocephalus (n = 903). The mortality rates were 8.5% (48/568) in the otorrhea subgroup, 10.9% (33/302) in the rhinorrhea subgroup, and 8.6% (78/903) in the tension pneumocephalus subgroup. The cases with CSF rhinorrhea had a significantly higher mortality rate than the other two subgroups (p < 0.05). All three subgroups had significantly higher mortality rates than the control group during the 1-year follow-up period (adjusted hazard ratios = 2.29, 1.35, and 1.32 in the rhinorrhea, tension pneumocephalus, and otorrhea subgroups, respectively). Conclusion: Post-traumatic CSF leakages had higher mortality rates than those without CSF leakages in TBI cases, and the cases with CSF rhinorrhea had worse outcomes compared with CSF leakages with pneumocephalus or otorrhea. Copyright (C) 2015, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC ND license.	[Liao, Kuo-Hsing; Lui, Tai-Ngar] Taipei Med Univ, Taipei Municipal Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Liao, Kuo-Hsing; Yen, David Hung Tzang; Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Lin, Hui-Wen] Soochow Univ, Dept Math, Taipei, Taiwan; [Chen, Kai-Yun] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Yen, David Hung Tzang] Taipei Vet Gen Hosp, Dept Emergency Med, Taipei 112, Taiwan; [Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Jeng, Mei-Jy] Taipei Vet Gen Hosp, Dept Pediat, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan		Jeng, MJ (corresponding author), Taipei Vet Gen Hosp, Dept Pediat, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan.	mjjeng@vghtpe.gov.tw		Wang, Jia-Yi/0000-0002-9106-3351	Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan [103-wf-eva-30]	We acknowledge the support of Grant 103-wf-eva-30 from Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.	Badia L, 2001, AM J RHINOL, V15, P117, DOI 10.2500/105065801781543736; Banks CA, 2009, OTOLARYNG HEAD NECK, V140, P826, DOI 10.1016/j.otohns.2008.12.060; BECKHARDT RN, 1991, OTOLARYNG HEAD NECK, V104, P425, DOI 10.1177/019459989110400402; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Chiu WT, 2011, JAMA-J AM MED ASSOC, V306, P267, DOI 10.1001/jama.2011.989; CHIU WT, 1995, J CLIN NEUROSCI, V2, P210, DOI 10.1016/S0967-5868(95)80004-2; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; Daudia A, 2007, ANN OTO RHINOL LARYN, V116, P902, DOI 10.1177/000348940711601206; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Hegazy HM, 2000, LARYNGOSCOPE, V110, P1166, DOI 10.1097/00005537-200007000-00019; JENNETT B, 1980, J NEUROL NEUROSUR PS, V43, P289, DOI 10.1136/jnnp.43.4.289; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Loew F, 1984, Adv Tech Stand Neurosurg, V11, P169; MARENTETTE LJ, 1991, OTOLARYNG CLIN N AM, V24, P151; Metzinger SE, 2009, CRANIOMAX TRAUM REC, V2, P27, DOI 10.1055/s-0029-1202597; Neville IS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/879286; Prosser JD, 2011, OTOLARYNG CLIN N AM, V44, P857, DOI 10.1016/j.otc.2011.06.007; Rouit RL, 1987, HEAD INJURY, P141; Schlosser RJ, 2003, AM J RHINOL, V17, P191, DOI 10.1177/194589240301700403; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5	21	10	11	0	1	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1726-4901	1728-7731		J CHIN MED ASSOC	J. Chin. Med. Assoc.	FEB	2016	79	2					58	64		10.1016/j.jcma.2015.10.002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5RX	WOS:000372137400004	26617240	hybrid			2022-02-06	
J	Manning, JE; Ross, JD; McCurdy, SL; True, NA				Manning, James E.; Ross, James D.; McCurdy, Shane L.; True, Nicholas A.			Aortic Hemostasis and Resuscitation: Preliminary Experiments Using Selective Aortic Arch Perfusion With Oxygenated Blood and Intra-aortic Calcium Coadministration in a Model of Hemorrhage-induced Traumatic Cardiac Arrest	ACADEMIC EMERGENCY MEDICINE			English	Article							ENDOVASCULAR BALLOON OCCLUSION; HYPOCALCEMIA	ObjectivesSelective aortic arch perfusion (SAAP) uses a thoracic aortic balloon occlusion catheter for heart and brain perfusion in cardiac arrest to achieve return of spontaneous circulation (ROSC). SAAP with oxygenated stored blood was studied in a model of hemorrhage-induced cardiac arrest. The study hypothesis was that intra-aortic calcium coadministration would be required to maintain normal aortic arch blood ionized calcium during SAAP and to achieve ROSC. MethodsTwelve anesthetized, domestic swine underwent severe hemorrhage and liver injury resulting in cardiac arrest. Whole blood and packed red blood cells (RBCs) stored in citrate anticoagulant served as perfusates for SAAP. Experiments were performed with four combinations of SAAP with oxygenated stored blood and intra-aortic calcium gluconate infusion: 1) whole blood without calcium, 2) whole blood with calcium, 3) lactated Ringers-diluted packed RBCs with calcium, and 4) normal saline-diluted packed RBCs with calcium. Aortic arch blood ionized calcium was monitored. Occurrence of ventricular dysrhythmias, success rate for ROSC, and the need for simultaneous intra-aortic calcium infusion were assessed. ResultsSelective aortic arch perfusion using whole blood without intra-aortic calcium (n=2) resulted in severe aortic blood ionized hypocalcemia, refractory ventricular fibrillation, and no ROSC. SAAP using whole blood with intra-aortic calcium (n=4) resulted in ROSC in all four animals. Two of four developed ventricular fibrillation that was successfully defibrillated. SAAP using packed RBCs with intra-aortic calcium resulted in ROSC in all six animals, but the intra-aortic calcium dose needed to maintain normal aortic arch blood ionized calcium levels was one-third of that needed for SAAP with whole blood. Dilution of packed RBCs with lactated Ringers (n=2) resulted in formation of small clots in the perfusion circuit which were not seen with packed RBCs diluted with normal saline (n=4). ConclusionsSelective aortic arch perfusion with stored whole blood or packed RBCs requires simultaneous intra-aortic calcium infusion to overcome citrate anticoagulant calcium binding, avoid refractory ventricular fibrillation, and allow for ROSC.	[Manning, James E.; McCurdy, Shane L.; True, Nicholas A.] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC USA; [Manning, James E.; McCurdy, Shane L.] Univ N Carolina, Sch Med, Dept Surg, Chapel Hill, NC USA; [Ross, James D.] Wilford Hall Ambulatory Surg Ctr, USAF Med Wing 59, Trauma & Clin Care Res, Lackland AFB, TX USA		Manning, JE (corresponding author), Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC USA.; Manning, JE (corresponding author), Univ N Carolina, Sch Med, Dept Surg, Chapel Hill, NC USA.	jmanning@med.unc.edu					DENLINGER JK, 1976, BRIT J ANAESTH, V48, P995, DOI 10.1093/bja/48.10.995; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; MANNING JE, 1992, ANN EMERG MED, V21, P1058, DOI 10.1016/S0196-0644(05)80645-6; Manning JE, 1997, ACAD EMERG MED, V4, P883, DOI 10.1111/j.1553-2712.1997.tb03814.x; Manning JE, 2001, CRIT CARE MED, V29, P2067, DOI 10.1097/00003246-200111000-00005; Morrison JJ, 2014, SHOCK, V41, P130, DOI 10.1097/SHK.0000000000000085; Morrison JJ, 2012, J SURG RES, V177, P341, DOI 10.1016/j.jss.2012.04.035; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; ZALOGA GP, 1992, CRIT CARE MED, V20, P251, DOI 10.1097/00003246-199202000-00014	10	10	11	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	FEB	2016	23	2					208	212		10.1111/acem.12863			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DD8EX	WOS:000370159300014	26766760	Bronze			2022-02-06	
J	McGee, J; Alekseeva, N; Chernyshev, O; Minagar, A				McGee, Jeanie; Alekseeva, Nadejda; Chernyshev, Oleg; Minagar, Alireza			Traumatic Brain Injury and Behavior: A Practical Approach	NEUROLOGIC CLINICS			English	Article						Traumatic brain injury; Psychosis; Suicide; Behavioral abnormalities; Seizures; Mania; Depression; Sleep-wake disorder	SLEEP-WAKE DISTURBANCES; DEPLOYED MILITARY PERSONNEL; SUBSTANCE-ABUSE; HEAD-INJURY; DAYTIME SLEEPINESS; COGNITIVE DECLINE; RISK-FACTORS; DISORDERS; SUICIDE; MILD	Traumatic brain injury (TBI) is a complex neurologic and neuropathologic process that may affect, the patient's behavior permanently. Clinically, TBI is associated with a wide gamut of neurologic and psychiatric disorders, such as amnesia, cognitive decline, seizures, attention and concentration deficits, depression, manic behavior, psychosis, hostile and violent behavior, and personality alterations. Therapy and rehabilitative efforts should be designed based on the type of injury and the patient's specific needs. Gaining familiarity with the behavioral disorders outlined in this article and understanding how to identify and treat them plays a significant role in the management of patients with TBI.	[McGee, Jeanie; Alekseeva, Nadejda; Chernyshev, Oleg; Minagar, Alireza] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurol, Shreveport, LA 71130 USA		Minagar, A (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurol, 1501 Kings Highway, Shreveport, LA 71130 USA.	aminag@lsuhsc.edu		Chernyshev, Oleg/0000-0001-9174-1661			American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Arnulf I, 2005, BRAIN, V128, P2763, DOI 10.1093/brain/awh620; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Culebras A., 2011, PRINCIPLES PRACTICE, P1064; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; Ebrahim IO, 2005, J CLIN SLEEP MED, V1, P153; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Gagner C, 2015, J NEUROTRAUM, V32, P1; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Jessen N. A., 2015, NEUROCHEM RES; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Keshavan MS, 2013, WORLD PSYCHIATRY, V12, P4, DOI 10.1002/wps.20001; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Leduc BE, 2007, ARCH PHYS MED REHAB, V88, P333, DOI 10.1016/j.apmr.2006.12.025; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Menn SJ, 2014, J CLIN SLEEP MED, V10, P1181, DOI 10.5664/jcsm.4196; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schenck CH, 1997, SLEEP, V20, P972, DOI 10.1093/sleep/20.11.972; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; United States Department of Health and Human Services, 2012, TRAUMATIC BRAIN INJU; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	85	10	10	0	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2016	34	1					55	+		10.1016/j.ncl.2015.08.004			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ6HD	WOS:000367200900005	26613995				2022-02-06	
J	Tarzamni, MK; Derakhshan, B; Meshkini, A; Merat, H; Fouladi, DF; Mostafazadeh, S; Rezakhah, A				Tarzamni, Mohammad Kazem; Derakhshan, Babak; Meshkini, Ali; Merat, Hamid; Fouladi, Daniel Fadaei; Mostafazadeh, Samira; Rezakhah, Amir			The diagnostic performance of ultrasonographic optic nerve sheath diameter and color Doppler indices of the ophthalmic arteries in detecting elevated intracranial pressure	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Ultrasonography; Color Doppler ultrasound; Optic nerve sheath diameter; Ophthalmic artery; Intracranial pressure	TRAUMATIC BRAIN-INJURY; PULSATILITY INDEX; HEAD-INJURY; CEREBRAL PERFUSION; SONOGRAPHIC MEASUREMENT; BLOOD-FLOW; HYPERTENSION; ULTRASOUND; RELIABILITY; MORTALITY	Objectives: To assess the diagnostic accuracy of ultrasonographic optic nerve sheath diameter (ONSD) measurement and color Doppler indices of the ophthalmic arteries in detecting elevated intracranial pressure (ICP). Patients and methods: A total 60 patients with (cases, n = 30) and without (controls, n = 30) acute clinical and computed tomographic findings of elevated ICP due to intracranial mass/hemorrhage were recruited from a teaching hospital. The mean binocular and maximum ultrasonographic ONSDs, as well as the mean binocular Doppler ultrasound waveform indices of the ophthalmic arteries including pulsatility index (PI), resistive index (RI), end-systolic velocity (ESV), peak systolic velocity (PSV) and end-diastolic velocity (EDV) were compared between the two groups. Results: Compared to controls, the case group had significantly higher mean binocular ONSD (5.48 +/- 0.52 mm vs. 4.09 +/- 0.22 mm, p < 0.001), maximum ONSD (5.63 +/- 0.55 mm vs. 4.16 +/- 0.23 mm, p < 0.001), mean PI (1.53 0.16 vs. 1.45 0.20, p = 0.01), and mean RI (0.76 +/- 0.07 vs. 0.73 +/- 0.04, p = 0.01). The mean EDV, in contrast, was significantly higher in controls (8.55v3.09 m/s vs. 7.17 +/- 2.61 m/s, p = 0.01). The two groups were comparable for the mean PSV (30.73 +/- 7.93 m/s in cases vs. 32.27 +/- 10.39 m/s in controls, p = 0.36). Among the mentioned variables, the mean binocular ONSD was the most accurate parameter in detecting elevated ICP (sensitivity and specificity of 100%, cut-off point = 4.53 mm). The Doppler indices were only moderately accurate (sensitivity: 56.7- 60%, specificity: 63.3- 76.7%). Conclusion: While the ultrasonographic mean binocular ONSD (>4.53 mm) was completely accurate in detecting elevated ICP, color Doppler indices of the ophthalmic arteries were of limited value. (C) 2015 Elsevier B.V. All rights reserved.	[Tarzamni, Mohammad Kazem; Derakhshan, Babak; Mostafazadeh, Samira; Rezakhah, Amir] Tabriz Univ Med Sci, Imam Reza Teaching Hosp, Dept Radiol, Tabriz, Iran; [Meshkini, Ali] Tabriz Univ Med Sci, Imam Reza Teaching Hosp, Dept Neurosurg, Tabriz, Iran; [Merat, Hamid] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Fouladi, Daniel Fadaei] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran		Fouladi, DF (corresponding author), Tabriz Univ Med Sci, Neurosci Res Ctr, Imam Reza Teaching Hosp, Golgasht St, Tabriz, Iran.	Fouladi.daniel@yahoo.com	mostafazadeh, samira/G-2034-2017; MESHKINI, ALI -/M-1009-2017	mostafazadeh, samira/0000-0002-8620-6127; MESHKINI, ALI -/0000-0001-6996-5028; Tarzamni, Mohammad Kazem/0000-0002-8226-1014			Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Bauerle J, 2011, J NEUROL, V258, P2014, DOI 10.1007/s00415-011-6059-0; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Blehar DJ, 2008, J ULTRAS MED, V27, P407, DOI 10.7863/jum.2008.27.3.407; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Cattaneo P, 2007, TEX HEART I J, V34, P105; Czosnyka M, 2001, J NEUROSURG, V94, P685; Dubost C, 2012, J SURG RES, V173, pE43, DOI 10.1016/j.jss.2011.08.027; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Goel RS, 2008, INJURY, V39, P519, DOI 10.1016/j.injury.2007.09.029; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hassen G.W., 2014, J EMERG MED; HAYREH S S, 1964, Br J Ophthalmol, V48, P522, DOI 10.1136/bjo.48.10.522; HAYREH SS, 1968, DOC OPHTHALMOL, V24, P289, DOI 10.1007/BF02550944; Hedges TR, 2002, BRIT J OPHTHALMOL, V86, P1197, DOI 10.1136/bjo.86.11.1197; Huynh-Le P., 2005, NEUROSURGERY, V57, P41; Jang T, 2005, ANN EMERG MED, V45, P336, DOI 10.1016/j.annemergmed.2004.09.031; Javadrashid R, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140229; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Le A, 2009, ANN EMERG MED, V53, P785, DOI 10.1016/j.annemergmed.2008.11.025; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Matsumura Y, 1999, CELLS TISSUES ORGANS, V164, P112, DOI 10.1159/000016648; McMahon CJ, 2007, BRIT J NEUROSURG, V21, P21, DOI 10.1080/02688690701210539; Moreno J.A., 2000, NEUROSURG FOCUS, V8, pe8; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Phuong HL, 2005, NEUROSURGERY, V57, P236, DOI 10.1227/01.NEU.000177442.96517.3D; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Ragauskas A, 2014, NEUROL RES, V36, P607, DOI 10.1179/1743132813Y.0000000308; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Romagnuolo L, 2005, AM J EMERG MED, V23, P686, DOI 10.1016/j.ajem.2004.11.004; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Siaudvytyte L, 2015, ACTA OPHTHALMOL, V93, P9, DOI 10.1111/aos.12502; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; [The American Association of Neurological Surgeons The Brain Trauma Foundation], 2000, J NEUROTRAUM, V17, P463; Tourtier JP, 2011, J FORENSIC LEG MED, V18, P44, DOI 10.1016/j.jflm.2010.11.008; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tsivgoulis G, 2009, CURR NEUROL NEUROSCI, V9, P46, DOI 10.1007/s11910-009-0008-7; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49; Williamson TH, 1996, SURV OPHTHALMOL, V40, P255, DOI 10.1016/S0039-6257(96)82001-7; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	54	10	12	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	FEB	2016	141						82	88		10.1016/j.clineuro.2015.12.007			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DE8RJ	WOS:000370904100015	26771156				2022-02-06	
J	Tierney, KJ; Nayak, NV; Prestigiacomo, CJ; Sifri, ZC				Tierney, Kevin James; Nayak, Natasha V.; Prestigiacomo, Charles J.; Sifri, Ziad C.			Neurosurgical intervention in patients with mild traumatic brain injury and its effect on neurological outcomes	JOURNAL OF NEUROSURGERY			English	Article						mild traumatic brain injury; Glasgow Outcome Scale; mortality; elderly	MINOR HEAD-INJURY; GLASGOW COMA SCALE; RISK-FACTORS; MORTALITY; HEMORRHAGE; SEVERITY; IMPACT; CT	OBJECTIVE The object of this study was to determine the mortality and neurological outcome of patients with mild traumatic brain injury (mTBI) who require neurosurgical intervention (NSI), identify clinical predictors of a poor outcome, and investigate the effect of failed nonoperative management and delayed NSI on outcome. METHODS A cross-sectional study of 10 years was performed, capturing all adults with mTBI and NSI. Primary outcome variables were mortality and Glasgow Outcome Scale (GOS) score. Patients were divided into an immediate intervention group, which received an NSI after the initial cranial CT scan, and a delayed intervention group, which had failed nonoperative management and received an NSI after 2 or more cranial CT scans. RESULTS The mortality rate in mTBI patients requiring NSI was 13%, and the mean GOS score was 3.6 +/- 1.2. An age > 60 years was independently predictive of a worse outcome, and epidural hematoma was independently predictive of a good outcome. Logistic regression analysis using independent variables was calculated to create a model for predicting poor neurological outcomes in patients with mTBI undergoing NSI and had 74.1% accuracy. Patients in the delayed intervention group had worse mortality (25% vs 9%) and worse mean GOS scores (2.9 1.3 vs 3.7 1.2) than those in the immediate intervention group. CONCLUSIONS Data in this study demonstrate that patients with mTBI requiring NSI have higher mortality rates and worse neurological outcomes and should therefore be classified separately from mTBI patients not requiring NSI. Additionally, mTBI patients requiring NSI after the failure of nonoperative management have worse outcomes than those receiving immediate intervention and should be considered separately.	[Tierney, Kevin James] Rutgers New Jersey Med Sch, Dept Emergency Med, 30 Bergen St,ADMC 1110, Newark, NJ 07103 USA; [Nayak, Natasha V.; Sifri, Ziad C.] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA; [Prestigiacomo, Charles J.] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA; [Nayak, Natasha V.] New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, New York, NY USA		Tierney, KJ (corresponding author), Rutgers New Jersey Med Sch, Dept Emergency Med, 30 Bergen St,ADMC 1110, Newark, NJ 07103 USA.	kevin.tierney@gmail.com	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378			Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Cameron J, 2011, CURRENT SURG THERAPY; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Huynh T, 2006, AM SURGEON, V72, P1162; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Qu Xiao-dong, 2011, Chinese Medical Sciences Journal, V26, P98; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b	23	10	10	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2016	124	2					538	545		10.3171/2015.4.JNS142440			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DB9VR	WOS:000368866300037	26406795	Bronze			2022-02-06	
J	Wang, HX; Zhang, YP; Cai, J; Shields, LBE; Tuchek, CA; Shi, RY; Li, JA; Shields, CB; Xu, XM				Wang, Hongxing; Zhang, Yi Ping; Cai, Jun; Shields, Lisa B. E.; Tuchek, Chad A.; Shi, Riyi; Li, Jianan; Shields, Christopher B.; Xu, Xiao-Ming			A Compact Blast-Induced Traumatic Brain Injury Model in Mice	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Behavioral assessments; Blast injury; Edema; Neuronal degeneration; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; NEURONAL DEGENERATION; EXPLOSIVE BLAST; DEFICIENT MICE; FLUORO-JADE; ADULT MICE; RAT MODEL; EXPOSURE; RECEPTOR	Blast-induced traumatic brain injury (bTBI) is a common injury on the battlefield and often results in permanent cognitive and neurological abnormalities. We report a novel compact device that creates graded bTBI in mice. The injury severity can be controlled by precise pressures that mimic Friedlander shockwave curves. The mouse head was stabilized with a head fixator, and the body was protected with a metal shield; shockwave durations were 3 to 4 milliseconds. Reflective shockwave peak readings at the position of the mouse head were 12 +/- 2.6 psi, 50 +/- 20.3 psi, and 100 +/- 33.1 psi at 100, 200, and 250 psi predetermined driver chamber pressures, respectively. The bTBIs of 250 psi caused 80% mortality, which decreased to 27% with the metal shield. Brain and lung damage depended on the shockwave duration and amplitude. Cognitive deficits were assessed using the Morris water maze, Y-maze, and open-field tests. Pathological changes in the brain included disruption of the blood-brain barrier, multifocal neuronal and axonal degeneration, and reactive gliosis assessed by Evans Blue dye extravasation, silver and Fluoro-Jade B staining, and glial fibrillary acidic protein immunohistochemistry, respectively. Behavioral and pathological changes were injury severity-dependent. This mouse bTBI model may be useful for investigating injury mechanisms and therapeutic strategies associated with bTBI.	[Wang, Hongxing; Tuchek, Chad A.; Xu, Xiao-Ming] Indiana Univ, Sch Med, Stark Neurosci Res Inst,Dept Neurol Surg, Spinal Cord & Brain Injury Res Grp, 320 West 15th St,NB E500, Indianapolis, IN 46202 USA; [Wang, Hongxing; Li, Jianan] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Yi Ping; Shields, Lisa B. E.; Shields, Christopher B.] Norton Healthcare, Norton Neurosci Inst, Louisville, KY USA; [Cai, Jun] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA; [Shi, Riyi] Purdue Univ, Ctr Paralysis Res, Weldon Sch Biomed Engn, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Shields, Christopher B.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA		Xu, XM (corresponding author), Indiana Univ, Sch Med, Stark Neurosci Res Inst,Dept Neurol Surg, Spinal Cord & Brain Injury Res Grp, 320 West 15th St,NB E500, Indianapolis, IN 46202 USA.	xu26@iupui.edu	wang, hongxing/AAG-1069-2020	wang, hongxing/0000-0001-5962-9717; /0000-0003-1721-7786	National Key Clinical Specialist Construction Programs of China; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01 NS059622, R01 NS050243, 1R01 NS073636]; Indiana Spinal Cord and Brain Injury Research Foundation (ISCBIRF); Mari Hulman George Endowment Funds; Jiangsu Health International Exchange Program Sponsorship of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS059622, R01NS050243, R01NS073636] Funding Source: NIH RePORTER	This work was supported in part by the National Key Clinical Specialist Construction Programs and Jiangsu Health International Exchange Program Sponsorship of China (HW), National Institutes of Health (NIH) 1R01 NS059622, R01 NS050243, 1R01 NS073636, the Indiana Spinal Cord and Brain Injury Research Foundation (ISCBIRF), and Mari Hulman George Endowment Funds (XMX).	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Alphonse Vanessa D, 2014, Biomed Sci Instrum, V50, P248; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Axelsson H, 1996, J TRAUMA, V40, pS31, DOI 10.1097/00005373-199603001-00006; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; BOLM U, 1979, HNO, V27, P351; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Courtney MW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3518970; Cullen DK, 2011, NEUROIMAGE, V54, pS37, DOI 10.1016/j.neuroimage.2010.10.076; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P356, DOI 10.1098/rspa.1946.0049; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; Liu WY, 2015, CNS NEUROSCI THER, V21, P568, DOI 10.1111/cns.12405; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Marchi N, 2016, J NEUROSCI METH, V260, P118, DOI 10.1016/j.jneumeth.2015.06.011; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Moochhala SM, 2005, J TRAUMA, V59, P448, DOI 10.1097/01.ta.0000174858.79847.6d; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Podhorna J, 2002, PHARMACOL BIOCHEM BE, V72, P13, DOI 10.1016/S0091-3057(01)00783-3; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; ROJIANI AM, 1994, ACTA NEUROPATHOL, V88, P287; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; SCHMUED LC, 1993, BRAIN RES, V626, P71, DOI 10.1016/0006-8993(93)90564-4; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Strauss KI, 2013, PROSTAG OTH LIPID M, V104, P18, DOI 10.1016/j.prostaglandins.2012.07.005; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WATANABE O, 1977, STROKE, V8, P71, DOI 10.1161/01.STR.8.1.71; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	74	10	11	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	FEB	2016	75	2					183	196		10.1093/jnen/nlv019			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	DK9DN	WOS:000375230800009	26802177	Bronze, Green Published			2022-02-06	
J	Yan, R; Page, JC; Shi, R				Yan, Rui; Page, Jessica C.; Shi, Riyi			Acrolein-mediated conduction loss is partially restored by K+ channel blockers	JOURNAL OF NEUROPHYSIOLOGY			English	Article						demyelination; spinal cord injury; hydralazine; 4-aminopyridine; potassium ion	SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; AXONAL CONDUCTION; 4-AMINOPYRIDINE DERIVATIVES; MYELIN DAMAGE; PARKINSONS-DISEASE; IMPULSE CONDUCTION; POTASSIUM CHANNELS; OXIDATIVE STRESS; NERVOUS-SYSTEM	Acrolein-mediated myelin damage is thought to be a critical mechanism leading to conduction failure following neurotrauma and neurodegenerative diseases. The exposure and activation of juxtaparanodal voltage-gated K+ channels due to myelin damage leads to conduction block, and K+ channel blockers have long been studied as a means for restoring axonal conduction in spinal cord injury (SCI) and multiple sclerosis (MS). In this study, we have found that 100 mu M K+ channel blockers 4-aminopyridine-3-methanol (4-AP-3-MeOH), and to a lesser degree 4-aminopyridine (4-AP), can significantly restore compound action potential (CAP) conduction in spinal cord tissue following acrolein-mediated myelin damage using a well-established ex vivo SCI model. In addition, 4-AP-3-MeOH can effectively restore CAP conduction in acrolein-damaged axons with a range of concentrations from 0.1 to 100 mu M. We have also shown that while both compounds at 100 mu M showed no preference of small-and large-caliber axons when restoring CAP conduction, 4-AP-3-MeOH, unlike 4-AP, is able to augment CAP amplitude while causing little change in axonal responsiveness measured in refractory periods and response to repetitive stimuli. In a prior study, we show that 4-AP-3-MeOH was able to functionally rescue mechanically injured axons. In this investigation, we conclude that 4-AP-3-MeOH is an effective K+ channel blocker in restoring axonal conduction following both primary (physical) and secondary (chemical) insults. These findings also suggest that 4-AP-3-MeOH is a viable alternative of 4-AP for treating myelin damage and improving function following central nervous system trauma and neurodegenerative diseases.	[Yan, Rui; Page, Jessica C.; Shi, Riyi] Purdue Univ, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	riyi@purdue.edu		Yan, Rui/0000-0002-0167-2816	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS-073636]; state of Indiana [206424]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073636] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant R01-NS-073636 to R. Shi and by the state of Indiana (Grant no. 206424 to R. Shi).	Alonso AD, 2008, CURR ALZHEIMER RES, V5, P375, DOI 10.2174/156720508785132307; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BEVER CT, 1994, ANN NEUROL, V36, pS118, DOI 10.1002/ana.410360728; BLAKEMORE WF, 1982, NEUROPATH APPL NEURO, V8, P365, DOI 10.1111/j.1365-2990.1982.tb00305.x; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Blight AR, 1991, J NEUROTRAUM, V8, P103, DOI 10.1089/neu.1991.8.103; Blight AR, 2014, ANN NY ACAD SCI, V1329, P33, DOI 10.1111/nyas.12512; Blight Andrew R, 2011, Ther Adv Neurol Disord, V4, P99, DOI 10.1177/1756285611403960; Blight AR, 2006, J NEUROTRAUM, V23, P586, DOI 10.1089/neu.2006.23.586; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BLIGHT AR, 1987, J NEUROL SCI, V82, P145, DOI 10.1016/0022-510X(87)90014-1; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Halter JA, 2000, SPINAL CORD, V38, P728, DOI 10.1038/sj.sc.3101098; Hamann K, 2008, J NEUROCHEM, V107, P712, DOI 10.1111/j.1471-4159.2008.05622.x; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; Hamann K, 2009, J NEUROCHEM, V111, P1348, DOI 10.1111/j.1471-4159.2009.06395.x; Jensen HB, 2014, THER ADV NEUROL DISO, V7, P97, DOI 10.1177/1756285613512712; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Leung G, 2011, EXP NEUROL, V227, P232, DOI 10.1016/j.expneurol.2010.11.004; Lima RR, 2008, INFLAMMATION, V31, P24, DOI 10.1007/s10753-007-9046-y; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P209, DOI 10.1002/jnr.20863; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P219, DOI 10.1002/jnr.20862; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Luo H, 2004, NEUROCHEM INT, V44, P475, DOI 10.1016/j.neuint.2003.09.006; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mcbride JM, 2007, NEUROSCIENCE, V148, P44, DOI 10.1016/j.neuroscience.2007.05.039; McBride JM, 2006, EUR J PHARM SCI, V27, P237, DOI 10.1016/j.ejps.2005.10.003; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Nardini M, 2002, TOXICOLOGY, V170, P173, DOI 10.1016/S0300-483X(01)00540-6; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Park J, 2014, NEURAL REGEN RES, V9, P677, DOI 10.4103/1673-5374.131564; Park J, 2014, J NEUROCHEM, V129, P339, DOI 10.1111/jnc.12628; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Rudick RA, 2009, NEW ENGL J MED, V361, P1505, DOI 10.1056/NEJMcibr0905482; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2002, NEUROSCIENCE, V115, P337, DOI 10.1016/S0306-4522(02)00457-8; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2015, FREE RADICAL RES, P1; Shi RY, 2011, MOL NUTR FOOD RES, V55, P1320, DOI 10.1002/mnfr.201100217; Shi RY, 2011, NEUROSCI BULL, V27, P36, DOI 10.1007/s12264-011-1048-y; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Shi YZ, 2011, J NEUROCHEM, V117, P554, DOI 10.1111/j.1471-4159.2011.07226.x; Smith DT, 2005, EUR J MED CHEM, V40, P908, DOI 10.1016/j.ejmech.2005.04.017; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tully M, 2014, EXPERT REV NEUROTHER, P1; Tully M, 2013, INT J MOL SCI, V14, P20037, DOI 10.3390/ijms141020037; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zheng LX, 2013, J NEUROTRAUM, V30, P1334, DOI 10.1089/neu.2013.2888	64	10	10	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	FEB 1	2016	115	2					701	710		10.1152/jn.00467.2015			10	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	DF2EW	WOS:000371154800009	26581866	Green Published, Bronze			2022-02-06	
J	Zhang, YM; Dai, QF; Chen, WH; Jiang, ST; Chen, SX; Zhang, YJ; Tang, CZ; Cheng, SB				Zhang, Yi-min; Dai, Qiu-fu; Chen, Wei-hao; Jiang, Shu-ting; Chen, Sheng-xin; Zhang, Yu-juan; Tang, Chun-zhi; Cheng, Shao-bing			Effects of acupuncture on cortical expression of Wnt3a, beta-catenin and Sox2 in a rat model of traumatic brain injury	ACUPUNCTURE IN MEDICINE			English	Article							STEM-CELLS; DIFFERENTIATION; EPIDEMIOLOGY	Objective To observe the effects of acupuncture treatment on the expression of Wnt/beta-catenin signalling pathway-related genes (Wnt3a, beta-catenin and Sox2) in the injured cerebral cortex of rats with traumatic brain injury (TBI). Methods A controlled impact model of TBI was established using Feeney's free-drop method. Seventy-eight Sprague-Dawley rats were randomly divided into the following three groups: a normal group (n=18) that was left untreated; a model group (n=30) that received no treatment after TBI; and an acupuncture group (n=30) that received acupuncture (at LI4, GV20, GV26 and GV16) after TBI. Rats in each group were randomly and equally divided into 3-day, 7-day and 14-day subgroups according to the duration of therapy. Real-time fluorescence quantitative PCR (RT-qPCR) was used to measure mRNA expression of Wnt3a, beta-catenin and Sox2. Western blots were performed to determine the expression levels of WNT3a, beta-Catenin and SOX2. Results Wnt3a mRNA was upregulated in the 7-day and 14-day acupuncture subgroups compared with the corresponding model subgroups (p<0.05). beta-catenin expression was significantly increased in the 7-day and 14-day acupuncture subgroups compared with the corresponding model subgroups (p<0.01). In the 3-day and 7-day acupuncture subgroups, Sox2 expression was significantly higher than that in the normal and model groups (p<0.01 each). The levels of WNT3a, beta-catenin and SOX2 were generally consistent with the corresponding mRNA levels. Conclusions Acupuncture exerts a regulatory effect on the Wnt/beta-catenin signalling pathway, which may in turn influence the proliferation and differentiation of endogenous neural stem cells.	[Zhang, Yi-min; Dai, Qiu-fu; Chen, Wei-hao; Jiang, Shu-ting; Chen, Sheng-xin; Zhang, Yu-juan; Cheng, Shao-bing] Jinan Univ, Coll Med, Tradit Chinese Med Dept, Guangzhou, Guangdong, Peoples R China; [Tang, Chun-zhi] Guangzhou Univ Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China		Dai, QF (corresponding author), Jinan Univ, Sch Med, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China.	826090701@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273827]; Project of Science and Technology of Guangdong [2011B031800284]; Project of Scientific cultivation and innovation foundation of Jinan University [21615427]; Science and Technology Program of Guangdong, China [2010GN-E00221]	This work is supported by the Project of the National Natural Science Foundation of China (No. 81273827), the Project of Science and Technology of Guangdong (No. 2011B031800284), the Project of Scientific cultivation and innovation foundation of Jinan University (No. 21615427) and the Science and Technology Program of Guangdong, China (No. 2010GN-E00221).	An SM, 2014, SCI CHINA LIFE SCI, V57, P575, DOI 10.1007/s11427-014-4665-7; [卞合涛 Bian Hetao], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P7547; Brault V, 2001, DEVELOPMENT, V128, P1253; Chen B, 2014, ELECTROACUPUNCTURE E; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Ding DF, 2012, INT ORTHOP, V36, P1087, DOI 10.1007/s00264-011-1368-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirsch C, 2007, EXP CELL RES, V313, P572, DOI 10.1016/j.yexcr.2006.11.002; Kumar DU, 2012, FOLIA BIOL-PRAGUE, V58, P115; Liu Z, 2007, CHINA J REHABIL MED, V3, P218; Marr A., 2004, CENTRAL NERVOUS SYST; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Shih CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/262039; Wang YX, 2012, J ADV MATH APPL, V1, P1, DOI 10.1166/jama.2012.1001; Wang YZ, 2013, NEURAL REGEN RES; Wang YZ, 2012, CHIN J CLIN NEUROSUR, V9, P535; Xin Y, 2008, DI 3 JUN YI DA XUE X; Yin Zong-Sheng, 2007, Neurol Res, V29, P847, DOI 10.1179/016164107X223539; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305; Zhang Y, 2015, CHIN J INTEGR MED; Zhang YM, 2013, CHIN J INTEGR MED, V19, P132, DOI 10.1007/s11655-013-1353-6; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhou, 1991, LAB ANIM ANIM EXP, V1, P1; Zhou H, 2014, NEURAL REGEN RES, V9, P968, DOI 10.4103/1673-5374.133148; Zhuang MH, 2006, CHIN J NEUROMED, V7, P686; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	32	10	11	1	21	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0964-5284	1759-9873		ACUPUNCT MED	Acupunct. Med.	FEB	2016	34	1					48	54		10.1136/acupmed-2014-010742			7	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	DF4KO	WOS:000371317200008	26296359				2022-02-06	
J	Pan, DS; Le, HW; Yan, M; Hassan, M; Gong, JB; Wang, H				Pan, De-Sheng; Le, Hai-Wei; Yan, Min; Hassan, Muhammad; Gong, Jiang-Biao; Wang, Hao			Change of serum levels of thioredoxin in patients with severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Thioredoxin; Mortality; Severity; Function outcome	OXIDATIVE STRESS; ISCHEMIC-STROKE; PLASMA THIOREDOXIN; HEAD-INJURY; DYSFUNCTION; DAMAGE	Background: Thioredoxin (TRX), a potent anti-oxidant, is released during inflammation and oxidative stress. The purpose of this study was to establish the relationship between serum TRX concentrations and trauma severity and outcome in severe traumatic brain injury (STBI). Methods: We determined serum TRX concentrations in 112 patients and 112 controls. Multivariate analyses were performed to analyze the predictive factors of 1-week mortality, 6-month mortality and 6-month unfavorable outcome. The predictive values were investigated under receiver operating characteristic curves. Results: Serum TRX concentrations were markedly higher in patients than in controls (19.1 +/- 7.8 ng/ml vs. 8.0 +/- 2.3 ng/ml, P < 0.001). There was a significant negative association between serum TRX concentrations and Glasgow coma scale (GCS) scores (r = 0.543, P < 0.001). Increased TRX was identified as an independent prognostic marker of 1-week mortality [Odds ratio (OR), 1.220; 95% confidence interval (Cl), 1.101-1.367; P < 0.001], 6-month mortality (OR, 1.201; 95% Cl, 1.097-1.324; P < 0.001) and 6-month unfavorable outcome (OR, 1.189; 95% CI, 1.090-1.311; P < 0.001). TRX concentrations improved area under curve of GCS scores for 6-month unfavorable outcome, but not for 1-week mortality and 6-month mortality. Conclusions: Increased serum TRX concentration, associated highly with trauma severity and poor outcome, might be a novel prognostic marker in patients with STBI. (C) 2015 Elsevier B.V. All rights reserved.	[Pan, De-Sheng; Yan, Min; Hassan, Muhammad; Gong, Jiang-Biao; Wang, Hao] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Le, Hai-Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg,Beilun Branch Hosp,Peoples Hosp Be, 1288 Lushan East Rd, Ningbo 315800, Zhejiang, Peoples R China		Pan, DS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	pshenpan@sina.com					Abdiu A, 2000, ANTIOXID REDOX SIGN, V2, P707, DOI 10.1089/ars.2000.2.4-707; Brough D, 2015, IUBMB LIFE, V67, P323, DOI 10.1002/iub.1377; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Burke-Gaffney A, 2009, CRIT CARE MED, V37, P2304, DOI 10.1097/CCM.0b013e3181a606dc; Callister ME, 2006, THORAX, V61, P521, DOI 10.1136/thx.2005.053041; Callister ME, 2007, INTENS CARE MED, V33, P364, DOI 10.1007/s00134-006-0460-7; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Icme F, 2015, TURK J MED SCI, V45, P947, DOI 10.3906/sag-1402-96; Jekell A, 2004, EUR J HEART FAIL, V6, P883, DOI 10.1016/j.ejheart.2004.03.003; JENNETT B, 1975, LANCET, V1, P480; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kotur-Stevuljevic J, 2015, ATHEROSCLEROSIS, V241, P192, DOI 10.1016/j.atherosclerosis.2015.05.016; Leaver SK, 2010, INTENS CARE MED, V36, P336, DOI 10.1007/s00134-009-1640-z; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Panickar KS, 2011, INT J MOL SCI, V12, P8181, DOI 10.3390/ijms12118181; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Paspalj D, 2015, MOL CELL BIOCHEM, V406, P75, DOI 10.1007/s11010-015-2425-z; Qi AQ, 2015, FREE RADICAL BIO MED, V80, P129, DOI 10.1016/j.freeradbiomed.2014.12.021; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Senes M, 2007, ANN CLIN BIOCHEM, V44, P43, DOI 10.1258/000456307779596057; Senol N, 2014, NEURAL REGEN RES, V9, P1112, DOI 10.4103/1673-5374.135312; Tsai NW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/256879; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Zhang W, 2015, CENT EUR J IMMUNOL, V40, P35, DOI 10.5114/ceji.2015.50831; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	31	10	10	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 30	2016	453						62	66		10.1016/j.cca.2015.11.030			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	DC8EQ	WOS:000369453100009	26656445				2022-02-06	
J	Patanwala, AE; Kurita, A; Truong, E				Patanwala, Asad E.; Kurita, Alina; Truong, Elaine			Low-dose levetiracetam for seizure prophylaxis after traumatic brain injury	BRAIN INJURY			English	Article						neurocritical care; Anti-epileptic; critically ill; dosing	PHARMACOKINETICS; PHENYTOIN	Objective: The primary objective of this study was to determine the effectiveness of a lower dose of levetiracetam (500 mg every 12 hours) to prevent early seizures after traumatic brain injury (TBI). It was hypothesized that the seizure rate would be low and comparable to previous studies using phenytoin. Methods: This was a retrospective cohort study conducted in a tertiary care, academic institution that is designated as a level 1 trauma centre in the US. Consecutive patients with TBI were evaluated. Patients who were given a levetiracetam dose of 500 mg every 12 hours were included. The primary outcome was the occurrence of a seizure within 7 days of TBI. Results: There were a total of 169 patients included in the study, who were treated with levetiracetam 500 mg every 12 hours. The median time to first dose of levetiracetam was 3.5 hours after injury (interquartile range = 1-13 hours). After initiation of levetiracetam, there were four (2.4%) patients who had a seizure within 7 days. This was not significantly different than the hypothesized population value of 3.6% (p = 0.390). Conclusions: A lower dose of levetiracetam 500 mg every 12 hours after TBI may be effective for early seizure prevention after TBI.	[Patanwala, Asad E.; Kurita, Alina; Truong, Elaine] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA		Patanwala, AE (corresponding author), 1295 N Martin Ave,POB 210202, Tucson, AZ 85721 USA.	patanwala@pharmacy.arizona.edu					[Anonymous], 2015, DAILYMED; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Patsalos PN, 2004, CLIN PHARMACOKINET, V43, P707, DOI 10.2165/00003088-200443110-00002; Red Book, 2015, MICR SOL INT; Spencer DD, 2011, PHARMACOTHERAPY, V31, P934, DOI 10.1592/phco.31.10.934; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801	10	10	10	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2016	30	2					156	158		10.3109/02699052.2015.1089596			3	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DF3MM	WOS:000371248400004	26619246				2022-02-06	
J	Schulte, S; Rasmussen, NN; McBeth, JW; Richards, PQ; Yochem, E; Petron, DJ; Strathmann, FG				Schulte, Stefanie; Rasmussen, Natalie N.; McBeth, Joseph W.; Richards, Patrick Q.; Yochem, Eric; Petron, David J.; Strathmann, Frederick G.			Utilization of the clinical laboratory for the implementation of concussion biomarkers in collegiate football and the necessity of personalized and predictive athlete specific reference intervals	EPMA JOURNAL			English	Article						Sports-related concussion; Biomarker panel; Predictive diagnostics; Blood test; Collegiate athletes; Football; Traumatic brain injury; S100B; NSE	NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; BRAIN-INJURY; HIGH-SCHOOL; SPORT; RETURN; PLAY; MANAGEMENT; CHILDREN; MARKERS	Background: A continued interest in concussion biomarkers makes the eventual implementation of identified biomarkers into routine concussion assessment an eventual reality. We sought to develop and test an interdisciplinary approach that could be used to integrate blood-based biomarkers into the established concussion management program for a collegiate football team. Methods: We used a CLIA-certified laboratory for all testing and chose biomarkers where clinically validated testing was available as would be required for results used in clinical decision making. We summarized the existing methods and results for concussion assessment across an entire season to identify and demonstrate the challenges with the eventual integration of a parallel process using blood-based tests for concussion management. We analyzed the results of the biomarkers chosen for trends consistent with the outcome assessments provided from the current concussion management protocols. Results: Baseline samples were collected with three additional post-concussion samples collected at three separate time points from players with a diagnosed concussion (n = 12). A summary of results from currently used concussion assessment tools were compared to the representative biomarkers S100B and NSE results. Nine sport-related concussions occurred during practice and three during play. For S100B, 50 % had follow-up testing results lower than the post-injury result. In contrast, 92 % of NSE follow-up results were lower than post-injury. One hundred percent of the results for S100B and NSE were within the athlete-derived reference intervals upon return-to-play and season end. Conclusions: The reported workflow provides a framework for the eventual implementation of biomarkers for concussion assessment into existing assessment protocols and strengthens the need for reliance on clinical laboratory testing. Athlete-specific reference intervals will be required to adequately interpret results.	[Schulte, Stefanie] Univ Utah, Sch Med, Dept Psychol, Salt Lake City, UT 84108 USA; [Schulte, Stefanie] Univ Utah, Sch Med, Dept Exercise & Sport Sci, Salt Lake City, UT 84108 USA; [Rasmussen, Natalie N.; Strathmann, Frederick G.] Univ Utah, Sch Med, Dept Pathol, 500 Chipeta Way Mail Code 115, Salt Lake City, UT 84108 USA; [McBeth, Joseph W.; Richards, Patrick Q.; Yochem, Eric] Univ Utah, Sch Med, Dept Athlet, Salt Lake City, UT 84108 USA; [Petron, David J.] Univ Utah, Sch Med, Dept Orthopaed, Salt Lake City, UT 84108 USA; [Rasmussen, Natalie N.; Strathmann, Frederick G.] ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA		Strathmann, FG (corresponding author), Univ Utah, Sch Med, Dept Pathol, 500 Chipeta Way Mail Code 115, Salt Lake City, UT 84108 USA.; Strathmann, FG (corresponding author), ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA.	frederick.g.strathmann@aruplab.com					Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Crutchfield Kevin E, 2011, Md Med, V12, P13; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; de Mendonca B, 2010, WINT SIMUL C PROC, P2352, DOI 10.1109/WSC.2010.5678932; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kalanuria AA, 2013, CURR OPIN CRIT CARE, V19, P113, DOI 10.1097/MCC.0b013e32835eba56; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Neselius S, 2014, KNEE SURG SPORT TR A, V22, P233, DOI 10.1007/s00167-013-2792-5; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; R Development Core Team, 2013, R LANG ENV STAT COMP; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schulte S, 2013, EUR J APPL PHYSIOL, V113, P811, DOI 10.1007/s00421-012-2503-9; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shane ER, 2013, J CHIROPR MED, V12, P252, DOI 10.1016/j.jcm.2013.08.001; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Taira BR, 2012, ANN EMERG MED, V60, P236, DOI 10.1016/j.annemergmed.2012.04.004; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; WHO, 2010, WHO GUID DRAW BLOOD; Wickham H., 2013, GGPLOT2 IMPLEMENTATI; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	10	10	0	10	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1878-5077	1878-5085		EPMA J	EPMA J.	JAN 27	2016	7								1	10.1186/s13167-016-0050-x			9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	DC1LK	WOS:000368977600001	26823691	Green Published, hybrid			2022-02-06	
J	Hergenroeder, GW; Moore, AN; Schmitt, KM; Redell, JB; Dash, PK				Hergenroeder, Georgene W.; Moore, Anthony N.; Schmitt, Karl M.; Redell, John B.; Dash, Pramod K.			Identification of autoantibodies to glial fibrillary acidic protein in spinal cord injury patients	NEUROREPORT			English	Article						autoantibody; glial fibrillary acidic protein; spinal cord injury	2-DIMENSIONAL ELECTROPHORESIS; ALZHEIMERS-DISEASE; SERUM; GFAP; BRAIN	Traumatic spinal cord injury (SCI) is a devastating injury causing significant morbidity and mortality. Experimental studies have demonstrated that SCI induced cellular damage and disruption of the blood-spinal cord barrier can initiate an autoimmune response. This response is thought to be pathogenic and contribute to poor outcome. The objective of this research was to investigate whether human SCI mounts an autoimmune response to self-antigens. Plasma samples were collected longitudinally from SCI patients (n=18) at acute (T1, <48h) and subacute (T2, 2-4 weeks) time points to probe western blots of human brain homogenates in order to screen patients for the presence of putative autoantibodies. To identify the corresponding antigens, two-dimensional gel electrophoresis, western blot and liquid chromatography coupled with mass spectrometry (LC-MS/MS) analyses were performed. We found that four of 18 patients (22%) had novel immunoreactive bands ranging in size from 36 to 42kDa present in subacute, but not in acute, plasma samples suggesting postinjury production. To identify the cross-reacting antigens, we separated brain proteins by two-dimensional gel electrophoresis and identified nine immunoreactive spots. Amino acid sequence analysis of these spots identified peptides that mapped to glial fibrillary acidic protein. Our results suggest that approximate to 22% of SCI patients generated autoantibodies to glial fibrillary acidic protein. Future studies will be required to determine whether these autoantibodies contribute to the pathogenic sequelae of SCI.	[Hergenroeder, Georgene W.; Moore, Anthony N.; Redell, John B.; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA; [Hergenroeder, Georgene W.; Moore, Anthony N.; Redell, John B.; Dash, Pramod K.] Univ Texas Houston, Sch Med, Grad Sch Biomed Sci, Houston, TX USA; [Hergenroeder, Georgene W.; Schmitt, Karl M.] Univ Texas Houston, Sch Med, Vivian L Smith Dept Neurosurg, Houston, TX USA; [Hergenroeder, Georgene W.; Schmitt, Karl M.] Mem Hermann Hospital, Texas Med Ctr, Houston, TX USA		Dash, PK (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Hergenroeder, Georgene/0000-0002-6170-2191	Mission Connect/TIRR Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087149, NS088298]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087149, R01NS088298] Funding Source: NIH RePORTER	This work was supported in part by a grant from Mission Connect/TIRR Foundation and grants from NIH (NS087149 and NS088298).	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; CIESIELSKITRESKA J, 1984, EUR J BIOCHEM, V138, P465, DOI 10.1111/j.1432-1033.1984.tb07939.x; Crecelius A, 2008, PROTEOMICS, V8, P1276, DOI 10.1002/pmic.200700728; Darie CC, 2011, PROTEOMICS, V11, P4514, DOI 10.1002/pmic.201000819; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Korolainen MA, 2005, NEUROBIOL DIS, V20, P858, DOI 10.1016/j.nbd.2005.05.021; Lotosh NG, 2013, B EXP BIOL MED+, V155, P48, DOI 10.1007/s10517-013-2077-5; MECOCCI P, 1995, J NEUROIMMUNOL, V57, P165, DOI 10.1016/0165-5728(94)00180-V; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Skoda D, 2006, BRAIN RES BULL, V68, P213, DOI 10.1016/j.brainresbull.2005.05.032; Wei P, 2013, TUMOR BIOL, V34, P2283, DOI 10.1007/s13277-013-0770-7; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	18	10	11	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JAN 20	2016	27	2					90	93		10.1097/WNR.0000000000000502			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI4ZH	WOS:000373507400006	26629661	Green Accepted			2022-02-06	
J	Hoffer, ME; Szczupak, M; Kiderman, A; Crawford, J; Murphy, S; Marshall, K; Pelusso, C; Balaban, C				Hoffer, Michael E.; Szczupak, Mikhaylo; Kiderman, Alexander; Crawford, James; Murphy, Sara; Marshall, Kathryn; Pelusso, Constanza; Balaban, Carey			Neurosensory Symptom Complexes after Acute Mild Traumatic Brain Injury	PLOS ONE			English	Article							SEX-DIFFERENCES; CONCUSSION; MANAGEMENT	Mild Traumatic Brain Injury (mTBI) is a prominent public health issue. To date, subjective symptom complaints primarily dictate diagnostic and treatment approaches. As such, the description and qualification of these symptoms in the mTBI patient population is of great value. This manuscript describes the symptoms of mTBI patients as compared to controls in a larger study designed to examine the use of vestibular testing to diagnose mTBI. Five symptom clusters were identified: Post-Traumatic Headache/Migraine, Nausea, Emotional/Affective, Fatigue/Malaise, and Dizziness/Mild Cognitive Impairment. Our analysis indicates that individuals with mTBI have headache, dizziness, and cognitive dysfunction far out of proportion to those without mTBI. In addition, sleep disorders and emotional issues were significantly more common amongst mTBI patients than non-injured individuals. A simple set of questions inquiring about dizziness, headache, and cognitive issues may provide diagnostic accuracy. The consideration of other symptoms may be critical for providing prognostic value and treatment for best short-term outcomes or prevention of long-term complications.	[Hoffer, Michael E.; Szczupak, Mikhaylo; Murphy, Sara; Pelusso, Constanza] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Hoffer, Michael E.; Szczupak, Mikhaylo; Pelusso, Constanza] Univ Miami, Sports Performance & Wellness Inst, Miami, FL USA; [Hoffer, Michael E.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Kiderman, Alexander] Neurokinetics Inc, Pittsburgh, PA USA; [Crawford, James; Marshall, Kathryn] Madigan Army Med Ctr, Dept Otolaryngol, Tacoma, WA 98431 USA; [Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA		Hoffer, ME (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.	Michael.hoffer@miami.edu	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Szczupak, Mikhaylo/0000-0002-2569-2184	Head Health Challenge II grant (National Football League, Underarmor, General Electric); Department of DefenseUnited States Department of Defense [W81XWH-12-C-0205]	This work was supported by Head Health Challenge II grant (National Football League, Underarmor, General Electric) and Department of Defense grant W81XWH-12-C-0205. The authors received no specific funding for this work.	Balaban CD, 2015, 2015 MIDW M ASS RES; CELENTANO DD, 1990, SOC SCI MED, V30, P1289, DOI 10.1016/0277-9536(90)90309-G; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Hoffer ME, 2015, 2015 MIDW M ASS RES; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kiderman A, 2015, 2015 MIDW M ASS RES; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; MacGregor EA, 2011, HEADACHE, V51, P843, DOI 10.1111/j.1526-4610.2011.01904.x; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Suarez H, 2011, ACTA OTO-LARYNGOL, V131, P377, DOI 10.3109/00016489.2010.534113; Talkowski ME, 2005, J COGNITIVE NEUROSCI, V17, P1432, DOI 10.1162/0898929054985419; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Yardley L, 2001, J NEUROL NEUROSUR PS, V71, P48, DOI 10.1136/jnnp.71.1.48	17	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146039	10.1371/journal.pone.0146039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	WOS:000367681500047	26727256	gold, Green Published, Green Accepted, Green Submitted			2022-02-06	
J	Boosman, H; van Heugten, CM; Winkens, I; Smeets, SMJ; Visser-Meily, JMA				Boosman, Hileen; van Heugten, Caroline M.; Winkens, Ieke; Smeets, Sanne M. J.; Visser-Meily, Johanna M. A.			Further validation of the Motivation for Traumatic Brain Injury Rehabilitation Questionnaire (MOT-Q) in patients with acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Adult; Psychometry; Brain injury; Behaviour; Behaviour mechanisms; Stroke	PSYCHOMETRIC PROPERTIES; QUALITATIVE-ANALYSIS; SELF-AWARENESS; DEFICITS; INDIVIDUALS; RELIABILITY; ENGAGEMENT; SCALE	The Motivation for Traumatic Brain Injury Rehabilitation Questionnaire (MOT-Q) evaluates motivation for rehabilitation in four subscales: Interest in rehabilitation, Lack of anger, Lack of denial, and Reliance on professional help. The objective of this study was to further validate the MOT-Q in 122 inpatients and 92 outpatients with acquired brain injury (ABI). The main measures were motivation for rehabilitation (MOT-Q), self-awareness (Patient Competency Rating Scale), and treatment motivation (Visual Analogue Scale). The MOT-Q showed adequate feasibility in terms of few items with missing responses and few undecided responses. We found no floor or ceiling effects, and significant item-total MOT-Q correlations for 29 of 31 items. Internal consistency was good for the MOT-Q total and acceptable to good for the subscales. The MOT-Q scores were significantly intercorrelated except for the subscales Lack of denial and Reliance on professional help in the inpatient group. The MOT-Q total and subscales were significantly associated with treatment motivation. The Lack of denial subscale showed no significant association with treatment motivation and no to moderate significant associations with self-awareness. In conclusion, the overall MOT-Q is a valid instrument to assess motivation for rehabilitation in patients with ABI. Further research is needed to examine the validity of the subscales.	[Boosman, Hileen; Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Boosman, Hileen; Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Boosman, Hileen; Visser-Meily, Johanna M. A.] De Hoogstr Rehabil, Utrecht, Netherlands; [van Heugten, Caroline M.; Winkens, Ieke; Smeets, Sanne M. J.] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands		Visser-Meily, JMA (corresponding author), Rudolf Magnus Inst Neurosci, Dept Rehabil Nursing Sci & Sport, POB 85500, NL-3508 GA Utrecht, Netherlands.	j.m.a.visser-meily@umcutrecht.nl			Achmea Healthcare Foundation; National Initiative Brain and Cognition (NIBC);  [056-11-014]	This study is funded by Achmea Healthcare Foundation and the National Initiative Brain and Cognition (NIBC). This quick-result project is embedded in the pillar "The Healthy Brain, Program Cognitive Rehabilitation" [grant number 056-11-014]. The authors would like to thank the participating rehabilitation centres: Adelante Zorggroep, Hoensbroek; De Hoogstraat Rehabilitation, Utrecht; Reade, Rehabilitation Centre, Amsterdam; Rijndam Rehabilitation, Rotterdam; Rehabilitation Centre Tolbrug, 's-Hertogenbosch.	Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Bains B, 2007, NEUROPSYCHOL REHABIL, V17, P174, DOI 10.1080/09602010600562468; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Cohen J., 2013, STAT POWER ANAL BEHA; Deelman B. G., 1987, HANDLEIDING SAN TEST; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Lequerica AH, 2006, REHABIL PSYCHOL, V51, P331, DOI 10.1037/0090-5550.51.4.331; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Maclean N, 2002, STROKE, V33, P444, DOI 10.1161/hs0202.102367; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Smeets SMJ, 2014, NEUROPSYCHOLOGY, V28, P717, DOI 10.1037/neu0000068; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Toglia J, 2000, NEUROREHABILITATION, V15, P57; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Wade D T, 1988, Int Disabil Stud, V10, P64; White G.N., 2012, ASIAN J GERONTOL GER, V7, P80; Winkens I, 2014, J HEAD TRAUMA REHAB, V29, P153, DOI 10.1097/HTR.0b013e31827d1500	21	10	10	1	22	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2016	26	1					87	102		10.1080/09602011.2014.1001409			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CU7EM	WOS:000363699300004	25599578	Green Published			2022-02-06	
J	van Duijvenbode, N; Didden, R; van den Hazel, T; Engels, RCME				van Duijvenbode, Neomi; Didden, Robert; van den Hazel, Teunis; Engels, Rutger C. M. E.			Psychometric qualities of a tetrad WAIS-III short form for use in individuals with mild to borderline intellectual disability	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Intelligence; mild to borderline intellectual disability; psychometrics; short form; WAIS-III	INTELLIGENCE SCALE-III; TRAUMATIC BRAIN-INJURY; 7-SUBTEST SHORT FORMS; SUBSTANCE USE; SAMPLE; VALIDITY; RELIABILITY; SCORES; ADULTS; INDEX	Objective: To investigate the reliability and validity of a Wechsler Abbreviated Scale of Intelligence-based Wechsler Adult Intelligence Scale - third edition (WAIS-III) short form (SF) in a sample of individuals with mild to borderline intellectual disability (MBID) (N=117; M-IQ=71.34; SDIQ=8.00, range: 52-85). Methods: A full WAIS-III was administered as a standard procedure in the diagnostic process. Results: The results indicate an excellent reliability (r=0.96) and a strong, positive correlation with the full WAIS-III (r=0.89). The SF correctly identified ID in general and the correct IQ category more specifically in the majority of cases (97.4% and 86.3% of cases, respectively). In addition, 82.1% of the full scale IQ (FSIQ) estimates fell within the 95% confidence interval of the original score. Conclusions: We conclude that the SF is a reliable and valid measure to estimate FSIQ. It can be used in clinical and research settings when global estimates of intelligence are sufficient.	[van Duijvenbode, Neomi; Didden, Robert; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6500 HE Nijmegen, Netherlands; [Didden, Robert; van den Hazel, Teunis] Trajectum, Zwolle, Netherlands		van Duijvenbode, N (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, POB 9104, NL-6500 HE Nijmegen, Netherlands.	n.vanduijvenbode@pwo.ru.nl		Engels, Rutger/0000-0003-1944-9126			Alley PJ, 2007, J CLIN PSYCHOL, V63, P1145, DOI 10.1002/jclp.20410; American Psychiatric Association, 2002, DIAGN STAT MAN MENT, V4th; Axelrod BN, 2002, ASSESSMENT, V9, P17, DOI 10.1177/1073191102009001003; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P1; Cavinez GL, 2009, SCHOOL PSYCHOL QUART, V24, P252; Chaplin E, 2011, RES DEV DISABIL, V32, P2981, DOI 10.1016/j.ridd.2011.05.002; Crawford JR, 2008, BRIT J CLIN PSYCHOL, V47, P215, DOI 10.1348/014466507X258859; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21; Finch AJ, 1973, AM J MENT DEFIC, V2, P144; Fletcher RJ, INFORM DUAL DIAGNOSI; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Girard TA, 2010, ASSESSMENT, V17, P400, DOI 10.1177/1073191110369763; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Groth-Marnat, 2009, HDB PSYCHOL ASSESSME; Jones JJS, 2006, BRIT J CLIN PSYCHOL, V45, P145, DOI 10.1348/014466505X29134; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Kaufman JC, 2001, J PSYCHOEDUC ASSESS, V19, P245, DOI 10.1177/073428290101900305; Kulas JF, 2002, J CLIN PSYCHOL, V58, P773, DOI 10.1002/jclp.2009; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; Lichtenberger EO., 2006, ASSESSING ADOLESCENT; Loring DW, 2010, NEUROLOGY, V74, P685, DOI 10.1212/WNL.0b013e3181d0cd12; MacLean H, 2011, RES DEV DISABIL, V32, P1081, DOI 10.1016/j.ridd.2011.01.022; NAGLE RJ, 1995, J CLIN PSYCHOL, V51, P396, DOI 10.1002/1097-4679(199505)51:3<396::AID-JCLP2270510312>3.0.CO;2-A; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Reid-Arndt SA, 2011, APPL NEUROPSYCHOL, V18, P291, DOI 10.1080/09084282.2011.595456; Ringe WK, 2002, ASSESSMENT, V9, P254, DOI 10.1177/1073191102009003004; Rush KS, 2004, BEHAV MODIF, V28, P621, DOI 10.1177/0145445503259830; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Ryan JJ, 1998, J PSYCHOEDUC ASSESS, V16, P315, DOI 10.1177/073428299801600403; Sattler J.M., 2001, ASSESSMENT CHILDREN; Schalock R.L., 2010, INTELLECTUAL DISABIL, V11th ed.; Schopp LH, 2001, REHABIL PSYCHOL, V46, P279, DOI 10.1037/0090-5550.46.3.279; Schrimsher GW, 2008, J PSYCHOPATHOL BEHAV, V30, P235, DOI 10.1007/s10862-007-9066-9; SILVERSTEIN AB, 1990, J CLIN PSYCHOL, V46, P194, DOI 10.1002/1097-4679(199003)46:2<194::AID-JCLP2270460212>3.0.CO;2-7; TELLEGEN A, 1967, J CONSULT PSYCHOL, V31, P499, DOI 10.1037/h0024963; Uterwijk J., 2000, WAIS 3 NEDERLANDSTAL; van der Heijden P, 2013, APPL NEUROPSYCH-ADUL, V20, P41, DOI 10.1080/09084282.2012.670166; VanDerNagel J, 2011, J POLICY PRACT INTEL, V8, P143, DOI 10.1111/j.1741-1130.2011.00304.x; WATKINS CE, 1988, J MENT DEFIC RES, V32, P239; Wechsler D, 1997, WAIS 3 TECHNICAL MAN; Wechsler D, 1997, WECHSLER ABBREVIATED; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 2012, WECHSLER ADULT INTEL; Wymer JH, 2003, ARCH CLIN NEUROPSYCH, V18, P917, DOI 10.1016/S0887-6177(02)00221-4	49	10	10	1	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	JAN 2	2016	19	1					26	30		10.3109/17518423.2014.893265			5	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	DA1HL	WOS:000367546800004	24725162				2022-02-06	
J	De Tanti, A; Saviola, D; Basagni, B; Cavatorta, S; Chiari, M; Casalino, S; De Bernardi, D; Galvani, R				De Tanti, Antonio; Saviola, Donatella; Basagni, Benedetta; Cavatorta, Sabina; Chiari, Margherita; Casalino, Stefano; De Bernardi, Daniele; Galvani, Romina			Recovery of consciousness after 7 years in vegetative state of non-traumatic origin: A single case study	BRAIN INJURY			English	Article						Late recovery; disorders of consciousness; severe acquired brain injury	BRAIN-INJURY; SCALE; COMA; DISORDERS; WITHDRAWAL	Primary objective: To report consistent recovery of consciousness to a state of severe disability in a young patient after 7 years in vegetative state due to severe acquired brain injury, with reflections on protraction of intensive care and expert follow-up for the purpose of intercepting possible, albeit infrequent, cases of late recovery of consciousness.Research design: Single case studyMethods: This study describes the 9-year history of a healthy 15-year-old who suffered cerebellar haemorrhage due to rupture of an arteriovenous malformation, followed by a brief period of coma then protracted vegetative state; late stabilization of general condition with resolution of neurosurgical complications. Clinical monitoring employed scales for structured assessment of severe disability and disorders of consciousness.Results: The transition from vegetative state to full consciousness occurred over a period of similar to 3 months, 7 years after onset. In the subsequent 2 years the patient has shown slow but progressive overall improvement in a framework of severe residual motor and cognitive disability.Conclusions: Cases of recovery of consciousness after periods of vegetative state exceeding 1 year are rare, but remind one that a negative prognosis decided too early may be a self-fulfilling forecast.	[De Tanti, Antonio; Saviola, Donatella; Basagni, Benedetta; Cavatorta, Sabina; Chiari, Margherita; Galvani, Romina] S Stefano Inst, Cardinal Ferrari Rehabil Ctr, Parma, Italy; [Casalino, Stefano; De Bernardi, Daniele] Nursing Home Anni Azzurri, Volpiano, TO, Italy		De Tanti, A (corresponding author), S Stefano Inst, Cardinal Ferrari Rehabil Ctr, Via 4 Novembre, I-43012 Fontanellato, PR, Italy.	antonio.detanti@centrocardinalferrari.it	Basagni, Benedetta/AAJ-5799-2021	CHIARI, MARGHERITA/0000-0001-8374-8548			[Anonymous], 2010, SOSPENSIONE CURE OVV; ARTS WFM, 1985, J NEUROL NEUROSUR PS, V48, P1300, DOI 10.1136/jnnp.48.12.1300; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Avanzi S., 1997, Archivio di Psicologia Neurologia e Psichiatria, V58, P85; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Capitani E., 1994, B PSICOL APPL, V209, P47; Childs LN, 1996, BRIT MED J, V313, P944; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Formisano R, 2011, FUNCT NEUROL, V26, P15; Fussi F, 1999, PROFILO VALUTAZIONE; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hagen C., 1979, COGNITIVE ASSESSMENT; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; JENNETT B, 1975, LANCET, V1, P480; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Lombardi F, 2002, COCHRANE DATABASE SY, V2; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Maeda A, 2000, AM J PHYS MED REHAB, V79, P519, DOI 10.1097/00002060-200011000-00008; MAHONEY F I, 1965, Md State Med J, V14, P61; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Moreschi C, 2013, FORENSIC SCI INT, V231, pE24, DOI 10.1016/j.forsciint.2013.05.021; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robertson SJ, 1982, DYSARTHRIA PROFILE; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sattin D, 2014, J NEUROL, V261, P2378, DOI 10.1007/s00415-014-7478-5; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spinnler H, 1987, ITAL J NEUROL SCI, V8, P1; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Wade DT, 1988, INT DISABILITY STUDI, V11, P89; Wechsler D, 1981, WECHSLER ADULT INTEL; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003	44	10	11	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	8					1029	1034		10.3109/02699052.2016.1147078			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DS6OP	WOS:000380901800012	27119381				2022-02-06	
J	Elbin, RJ; Knox, J; Kegel, N; Schatz, P; Lowder, HB; French, J; Burkhart, S; Collins, MW; Kontos, AP				Elbin, R. J.; Knox, Jordan; Kegel, Nathan; Schatz, Philip; Lowder, Harrison B.; French, Jonathan; Burkhart, Scott; Collins, Michael W.; Kontos, Anthony P.			Assessing Symptoms in Adolescents Following Sport-Related Concussion: A Comparison of Four Different Approaches	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						adolescents; mTBI; post-concussion symptom scale; sport-related concussion; symptoms	TRAUMATIC BRAIN-INJURY; ASSOCIATION POSITION STATEMENT; POSTCONCUSSION SYNDROME; SELF-REPORT; MANAGEMENT; CHILDREN; INTERVIEW; PARENTS	This study compared post-concussion symptom endorsements on the Post-Concussion Symptom Scale (PCSS) between a clinical open-ended interview, clinician-guided PCSS, parent-report PCSS, and computer-based PCSS in youth athletes with sport-related concussion (SRC). Participants included 54 patients aged 13-17 years (M=15.19, SD=1.29, 51.8% male) with a diagnosed SRC seen at a concussion clinic. Participants were administered a computer-based version (COMP) of the PCSS followed by clinical open-ended symptom interview (OPEN) and clinician-guided PCSS (GUIDED). Participants' parents concurrently and independently endorsed their children's symptoms by completing the PCSS in the waiting room (PARENT). Total number of symptoms reported and total symptom severity score were analyzed and compared across the four PCSS administration methods. Results revealed significantly lower total number of symptoms for OPEN compared to GUIDED (p=.002), PARENT (p<.001), and COMP (p=.006); and significantly lower total severity score for OPEN compared to GUIDED (p=.04) and PARENT (p<.001). These data support using the PCSS as a structured method of assessing post-concussion symptoms and question the utility of unstructured interview methods for assessing symptoms in youth athletes with SRC.	[Elbin, R. J.; Lowder, Harrison B.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Knox, Jordan] Univ Pittsburgh, Sch Med, Dept Orthopedia Surg, Pittsburgh, PA USA; [Kegel, Nathan; French, Jonathan; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthoped Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Burkhart, Scott] Tallahassee Orthoped Clin, Tallahassee, FL USA		Elbin, RJ (corresponding author), Univ Arkansas, 155 Stadium Dr, Fayetteville, AR 72701 USA.	rjelbin@uark.edu		Kontos, Anthony/0000-0002-3749-4310			ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; BOWLING A., 2002, RES METHODS HLTH INV; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014	24	10	10	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2016	5	4					294	302		10.1080/21622965.2015.1077334			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DR9SX	WOS:000380237500006	27105069				2022-02-06	
J	Farley, M; Deer, S; Golding, JM; Matthews, N; Lopez, G; Stark, C; Hudon, E				Farley, Melissa; Deer, Sarah; Golding, Jacqueline M.; Matthews, Nicole; Lopez, Guadalupe; Stark, Christine; Hudon, Eileen			THE PROSTITUTION AND TRAFFICKING OF AMERICAN INDIAN/ALASKA NATIVE WOMEN IN MINNESOTA	AMERICAN INDIAN AND ALASKA NATIVE MENTAL HEALTH RESEARCH			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INDIAN RESERVATION POPULATIONS; TRAUMATIC BRAIN-INJURY; ADULT SEXUAL ASSAULT; SELF-RATED HEALTH; FOLLOW-UP; MENTAL-HEALTH; SUBSTANCE USE; HELP-SEEKING; ABUSE	We examined social and physical violence experienced by American Indian/Alaska Native (AI/AN) women in prostitution and their impacts on the mental and physical health of 105 women (81% Anishinaabe, mean age = 35 years) recruited through service agencies in three Minnesota cities. In childhood, abuse, foster care, arrests, and prostitution were typical. Homelessness, rape, assault, racism, and pimping were common. The women's most prevalent physical symptoms included muscle pain, impaired memory or concentration, and headaches. Symptoms of post-traumatic stress disorder and dissociation were common, with more severe psychological symptoms associated with worse health. Most of the women wanted to leave prostitution and they most often identified counseling and peer support as necessary to accomplish this. Most saw colonization and prostitution of AI/AN women as connected.	[Farley, Melissa] Prostitut Res & Educ, POB 16254, San Francisco, CA 94116 USA; [Deer, Sarah] William Mitchell Coll Law, St Paul, MN USA; [Golding, Jacqueline M.] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA USA; [Matthews, Nicole; Lopez, Guadalupe] Minnesota Indian Womens Sexual Assault Coalit, St Paul, MN USA		Farley, M (corresponding author), Prostitut Res & Educ, POB 16254, San Francisco, CA 94116 USA.	mfarley@prostitutionresearch.com			Women's Foundation of Minnesota; Tides Foundation; Nathan Cummings Foundation; Butler Family Foundation	Funding for this study was provided by Women's Foundation of Minnesota, Tides Foundation, Nathan Cummings Foundation, and Butler Family Foundation. This paper is based on data used in the report, Garden of Truth: The Prostitution and Trafficking of Native Women in Minnesota. Member agencies of the Minnesota Indian Women's Sexual Assault Coalition MIWSAC) and other groups who provide services and referrals to victims of violence assisted in recruitment of participants. These agencies and groups include Breaking Free, Minnesota Indian Women's Resource Center, Mending the Sacred Hoop Coalition, Domestic Abuse Intervention Project, American Indian Community Housing Organization, Dabinoo'igan Shelter, Min-No-Aya-Win Human Services, Fond Du Lac sexual assault advocate, and Program for Aid to Victims of Sexual Assault (PAVSA).	Adams David Wallace, 1997, ED EXTINCTION AM IND; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Amnesty International, 2007, MAZ INJ FAIL PROT IN; Bachman R, 2010, AUST NZ J CRIMINOL, V43, P199, DOI 10.1375/acri.43.2.199; Baldwin M. A., 2003, PROSTITUTION TRAFFIC, V2, P267; Beals J, 2005, ARCH GEN PSYCHIAT, V62, P99, DOI 10.1001/archpsyc.62.1.99; Benoit C, 2003, SOC SCI MED, V56, P821, DOI 10.1016/S0277-9536(02)00081-3; Bortel A., 2008, SEX TRAFFICKING NEED; BOYER D, 1993, SURVIVAL SEX KING CO; BRIERE J, 1990, CHILD ABUSE NEGLECT, V14, P357, DOI 10.1016/0145-2134(90)90007-G; Chenault Venida S., 2011, WEAVING STRENGTH WEA; Clark Rose, 2008, SHARING OUR STORIES, P87; Cole N, 2006, MENTAL HLTH CARE URB, P115, DOI DOI 10.1037/11422-006; DEER S, 2010, W MITCHELL LAW REV, V362, P621; Deer Sarah, 2004, KAN JL PUB POLY, V14, P121; Deer Sarah, 2004, SOC JUST, V31, P17; Denham AR, 2008, TRANSCULT PSYCHIATRY, V45, P391, DOI 10.1177/1363461508094673; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Dworkin A., 1997, LIFE DEATH; ELLIOTT DM, 1992, CHILD ABUSE NEGLECT, V16, P391, DOI 10.1016/0145-2134(92)90048-V; Evans-Campbell T, 2006, AM J PUBLIC HEALTH, V96, P1416, DOI 10.2105/AJPH.2004.054213; Fadiman Anne, 1997, SPIRIT CATCHES YOU Y; Farley M, 2005, VIOLENCE AGAINST WOM, V11, P950, DOI 10.1177/1077801205276987; Farley M., 2014, ALBANY LAW REV, V77, P101; Farley M., 2003, PROSTITUTION TRAFFIC, P199; Farley Melissa, 2005, Transcult Psychiatry, V42, P242, DOI 10.1177/1363461505052667; Farley M, 2011, PSYCHOL TRAUMA-US, V3, P369, DOI 10.1037/a0022645; Farley Melissa, 2003, J TRAUMA PRACTICE, P33, DOI [10.1300/j189v02n03_03, DOI 10.1300/J189v02n03_03]; Follette VM, 1996, J TRAUMA STRESS, V9, P25, DOI 10.1002/jts.2490090104; Freng A, 2012, J CONTEMP CRIM JUST, V28, P446, DOI 10.1177/1043986212458193; Gnanadesikan M, 2005, J CLIN PSYCHIAT, V66, P1176, DOI 10.4088/JCP.v66n0914; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Golding JM, 1999, CURR DIR PSYCHOL SCI, V8, P191, DOI 10.1111/1467-8721.00045; Gone JP, 2004, PROF PSYCHOL-RES PR, V35, P10, DOI 10.1037/0735-7028.35.1.10; Goodman RD, 2015, INT CULT PSYCHOL, P1, DOI 10.1007/978-1-4939-1283-4; Grandbois Donna, 2005, Issues Ment Health Nurs, V26, P1001, DOI 10.1080/01612840500280661; Haozous EA, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/321604; Herman J.L., 1992, TRAUMA RECOVERY AFTE; Hodge DR, 2009, SOC WORK, V54, P211, DOI 10.1093/sw/54.3.211; Huda S., 2006, 42ECN4200662 UN; Hwang SL, 2003, J SEX RES, V40, P201, DOI 10.1080/00224490309552181; IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446; Johnson A.L., 2012, COLUMBIA HUMAN RIGHT, V43, P617; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292, DOI 10.1093/oxfordjournals.aje.a113541; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kingsley C., 2000, SACRED LIVES CANADIA; Kirmayer Laurence J., 1994, P91; Koepplinger S., 2009, MINNESOTA PUBLIC RAD; Kramer L. A., 2003, J TRAUMA PRACTICE, V2, P187; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPointe C. A., 2008, SHARING OUR STORIES, P31; LOUIE L, 1991, ANN CONV AS AM PSYCH; Manson SM, 2005, AM J PUBLIC HEALTH, V95, P851, DOI 10.2105/AJPH.2004.054171; Marsella A. J., ETHNOCULTURAL ASPECT; McFarlane AC, 2001, TREATING PSYCHOLOGICAL TRAUMA AND PTSD, P237; McKeganey Neil., 1996, SEX WORK STREETS PRO; McKeown Iris, 2004, Int J Circumpolar Health, V63 Suppl 2, P399; Minnesota Coalition for the Homeless, 2008, HOM MINN; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Mulder RT, 1998, AM J PSYCHIAT, V155, P806; Najavits LM, 2014, AM J ADDICTION, V23, P415, DOI 10.1111/j.1521-0391.2014.12127.x; Najavits LisaM., 2001, SEEKING SAFETY TREAT; Norris F. H., 2002, GENDER PTSD, P1; Palacios JF, 2009, J TRANSCULT NURS, V20, P15, DOI 10.1177/1043659608325844; Penman Sarah, 2000, HONOR GRANDMOTHERS D, P47; Perry B., 2002, CONT JUSTICE REV, V5, P231; Perry B., 2008, SILENT VICTIMS HATE; Perry S. W, 2004, AM INDIANS CRIME BJS; Pierce Alexandra, 2009, SHATTERED HEARTS COM; Plumridge L, 2001, AUST NZ J PUBL HEAL, V25, P78, DOI 10.1111/j.1467-842X.2001.tb00555.x; Polacca M., 2003, VIOLENCE WOMEN PHYS, P274; Potterat JJ, 2004, AM J EPIDEMIOL, V159, P778, DOI 10.1093/aje/kwh110; POUPART L, 2003, HYPATIA, V18, P86, DOI DOI 10.1111/J.1527-2001.2003.TB00803.X; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; ROBIN RW, 1996, ETHNOCULTURAL ASPECT, P239, DOI [DOI 10.1037/10555-009, DOI 10.1037/10555009]; Root Maria P. P., 1996, ETHNOCULTURAL ASPECT, DOI DOI 10.1037/10555-014; Ross C.A., 1991, DISSOCIATION, V4, P55; Royal Commission on Aboriginal Peoples, 1996, REP ROYAL COMM AB PE; Ryser R., 1995, 4 WORLD GEOPOLITICAL, P1; Saylors K, 2006, AM INDIAN ALASKA NAT, V13, P32; Schnurr Paula P, 2004, Adv Mind Body Med, V20, P18; Sethi A, 2007, FIRST PEOPLES CHILD, V3, P57; SILBERT MH, 1982, YOUTH SOC, V13, P471, DOI 10.1177/0044118X82013004005; SILBERT MH, 1983, SOC WORK, V28, P285, DOI 10.1093/sw/28.4.285; SIMONS RL, 1991, J FAM ISSUES, V12, P361, DOI 10.1177/019251391012003007; Smith Andrea, 2005, CONQUEST SEXUAL VIOL; Stark C., 2003, PROSTITUTION TRAFFIC, P17; Stewart S.H., 2002, GENDER PTSD, P232; Tjaden P, 2000, FULL REPORT PREVALEN; Ullman SE, 2009, J CHILD SEX ABUS, V18, P367, DOI 10.1080/10538710903035263; UN, 2000, PROT PREV SUPPR PUN; Vaaramo K, 2015, J NEUROTRAUM, V32, P1579, DOI 10.1089/neu.2014.3757; Walters KL, 2002, PUBLIC HEALTH REP, V117, pS104; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weisaeth L, 2006, TRAUMATIC STRESS EFF; Western Interstate Commission for Higher Education, 1998, CULT COMP GUID MAN C; Widom CS, 1996, AM J PUBLIC HEALTH, V86, P1607, DOI 10.2105/AJPH.86.11.1607; Wilder Research Foundation, 2010, HOM MINN 2009; Willmon-Haque S., 2008, J EMOTIONAL ABUSE, V8, P51, DOI DOI 10.1080/10926790801982410; Zatzick DF, 1997, MIL MED, V162, P661, DOI 10.1093/milmed/162.10.661; Zerger S., 2004, HLTH CARE HOMELESS N; [No title captured]; [No title captured]; [No title captured]; [No title captured]	106	10	10	1	17	UNIV PRESS COLORADO	NIWOT	PO BOX 849, NIWOT, CO 80544 USA	1533-7731			AM INDIAN ALASKA NAT	Am. Indian Alsk. Nativ. Ment. Health Res.		2016	23	1					65	104					40	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DO3NG	WOS:000377687700004	28562843	gold			2022-02-06	
J	Fragala-Pinkham, MA; Dumas, HM; Lomhard, KA; O'Brien, JE				Fragala-Pinkham, Maria A.; Dumas, Helene M.; Lomhard, Kelly A.; O'Brien, Jane E.			Responsiveness of the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test in measuring functional outcomes for inpatient pediatric rehabilitation	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Functional outcomes; pediatric post-acute care; inpatient pediatric rehabilitation; PEDI-CAT		PURPOSE: Responsiveness of the PEDI-CAT Mobility, Daily Activities, and Social/Cognitive domains and Wheelchair subdomain was evaluated for youth admitted to a pediatric post-acute care hospital. METHODS: Inpatients ages 2-21 years, with a length of stay of 5 days and with both admission and discharge scores were included. The difference between mean admission and discharge PEDI-CM scaled scores were analyzed using paired ttests. Effect sizes, standard response means (SRMs), and minimal detectable change values were calculated. Score comparison between diagnostic subgroups (Traumatic Brain Injury, Neurological, Orthopedic, Medical) and age groups (<= 5, > 5 but < 13, >= 13 years) were evaluated for the Mobility domain. RESULTS: Sample size differed by domain with 66 Mobility, 30 Daily Activities, 19 Social/Cognitive and 9 Wheelchair subdomain pairs. Significant differences were found for all domains when mean admission and discharge scaled scores were compared. Moderate to large effect sizes and SRMs were found for the Mobility and Daily Activities domains and Wheelchair subdomain. Small effect size but large SRM was found for the Social/Cognitive domain. The Mobility domain was also responsive to changes in all diagnostic and age groups. CONCLUSION: The PEDI-CAT was responsive to functional changes for youth discharged from an inpatient pediatric rehabilitation hospital.	[Fragala-Pinkham, Maria A.; Dumas, Helene M.; Lomhard, Kelly A.; O'Brien, Jane E.] Franciscan Hosp Children, Res Ctr, 30 Warren St, Brighton, MA 02135 USA; [Lomhard, Kelly A.] Boston Childrens Hosp, Phys Therapy Dept, Boston, MA USA		Fragala-Pinkham, MA (corresponding author), Franciscan Hosp Children, Res Ctr, 30 Warren St, Brighton, MA 02135 USA.	mfragala@fhfc.org	Fragala-Pinkham, Maria/AAY-4354-2020		Executive Office of Health and Human Services of Massachusetts [BD-14-1039-EHS02-00000000260]	We received grant support from the Executive Office of Health and Human Services of Massachusetts - grant #BD-14-1039-EHS02-00000000260.	Beaton DE, 2001, J CLIN EPIDEMIOL, V54, P1204, DOI 10.1016/S0895-4356(01)00407-3; Choksi A, 2010, PEDIATR PHYS THER, V22, P214, DOI 10.1097/PEP.0b013e3181dc011a; Dumas H M, 2001, Pediatr Rehabil, V4, P177, DOI 10.1080/13638490210121720; Dumas H, 2010, PHYS OCCUP THER PEDI, V30, P168, DOI 10.3109/01942631003640493; Dumas HM, 2015, PHYS THER, V95, P1559, DOI 10.2522/ptj.20140339; Dumas Helene M, 2002, Pediatr Phys Ther, V14, P85, DOI 10.1097/00001577-200214020-00004; Dumas HM, 2012, J PEDIATR REHAB MED, V5, P29, DOI 10.3233/PRM-2011-0184; Dumas HM, 2012, PEDIATR PHYS THER, V24, P171, DOI 10.1097/PEP.0b013e31824c94ca; Dumas HM, 2012, DISABIL REHABIL, V34, P393, DOI 10.3109/09638288.2011.607217; Dumas Helene M., 2001, Physical and Occupational Therapy in Pediatrics, V21, P7; Dumas HM, 2010, INT J REHABIL RES, V33, P332, DOI 10.1097/MRR.0b013e32833ba5a5; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Galvin J, 2011, DEV NEUROREHABIL, V14, P67, DOI 10.3109/17518423.2010.547241; Galvin J, 2010, BRAIN INJURY, V24, P1008, DOI 10.3109/02699052.2010.489793; Haley S.M., 2012, PEDI CAT DEV STANDAR; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Haley SM, 2011, DEV MED CHILD NEUROL, V53, P1100, DOI 10.1111/j.1469-8749.2011.04107.x; Haley SM, 2010, PEDIATR PHYS THER, V22, P69, DOI 10.1097/PEP.0b013e3181cbfbf6; Iyer LV, 2003, PHYS THER, V83, P888, DOI 10.1093/ptj/83.10.888; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Nordmark E, 2000, DEV MED CHILD NEUROL, V42, P245, DOI 10.1017/S0012162200000426; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Stratford PW, 1996, PHYS THER, V76, P1109, DOI 10.1093/ptj/76.10.1109; Thomas-Stonell N, 2006, Pediatr Rehabil, V9, P14, DOI 10.1080/13638490500050097; Vos-Vromans DCW, 2005, DISABIL REHABIL, V27, P1245, DOI 10.1080/09638280500076178	25	10	10	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2016	9	3					215	222		10.3233/PRM-160382			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7LQ	WOS:000448297800007	27612081				2022-02-06	
S	Ganos, C; Edwards, MJ; Bhatia, KP		Hallett, M; Stone, J; Carson, A		Ganos, C.; Edwards, M. J.; Bhatia, K. P.			Posttraumatic functional movement disorders	FUNCTIONAL NEUROLOGIC DISORDERS	Handbook of Clinical Neurology		English	Article; Book Chapter							REGIONAL PAIN SYNDROME; ADULT-ONSET TICS; PERIPHERAL TRAUMA; CLINICAL-FEATURES; FIXED DYSTONIA; RISK-FACTORS; MOVING TOES; SYMPTOMS; DIAGNOSIS; CAUSALGIA	Traumatic injury to the nervous system may account for a range of neurologic symptoms. Trauma location and severity are important determinants of the resulting symptoms. In severe head injury with structural brain abnormalities, the occurrence of trauma-induced movement disorders, most commonly hyperkinesias such as tremor and dystonia, is well recognized and its diagnosis straightforward. However, the association of minor traumatic events, which do not lead to significant persistent structural brain damage, with the onset of movement disorders is more contentious. The lack of clear clinical-neuroanatomic (or symptom lesion) correlations in these cases, the variable timing between traumatic event and symptom onset, but also the presence of unusual clinical features in a number of such patients, which overlap with signs encountered in patients with functional neurologic disorders, contribute to this controversy. The purpose of this chapter is to provide an overview of the movement disorders, most notably dystonia, that have been associated with peripheral trauma and focus on their unusual characteristics, as well as their overlap with functional neurologic disorders. We will then provide details on pathophysiologic views that relate minor peripheral injuries to the development of movement disorders and compare them to knowledge from primary organic and functional movement disorders. Finally, we will comment on the appropriate management of these disorders.	[Ganos, C.; Bhatia, K. P.] Natl Hosp Neurol & Neurosurg, Sobell Dept Motor Neurosci & Movement Disorders, Queen Sq, London, England; [Ganos, C.] Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurol, Hamburg, Germany; [Edwards, M. J.] St Georges Univ London, Dept Mol & Clin Sci, London, England; [Edwards, M. J.] St Georges Univ Hosp NHS Fdn Trust, Atkinson Morley Reg Neurosci Ctr, London, England		Bhatia, KP (corresponding author), UCL Inst Neurol, Clin Movement Disorders Grp, Sobell Dept Motor Neurosci & Movement Disorders, Queen Sq, London, England.	k.bhatia@ucl.ac.uk	Edwards, Mark J/F-1052-2012	Edwards, Mark J/0000-0002-8283-9015; Ganos, Christos/0000-0001-8077-8530	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/M02363X/1] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M02363X/1] Funding Source: UKRI		Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson KE, 2007, MOVEMENT DISORD, V22, P2204, DOI 10.1002/mds.21687; BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231; BHATIA KP, 1993, BRAIN, V116, P843, DOI 10.1093/brain/116.4.843; Bodde MI, 2011, J BONE JOINT SURG AM, V93A, P1799, DOI 10.2106/JBJS.J.01329; Bramstedt KA, 2006, CONTEMP CLIN TRIALS, V27, P161, DOI 10.1016/j.cct.2005.11.005; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; CARDOSO F, 1995, ARCH NEUROL-CHICAGO, V52, P263, DOI 10.1001/archneur.1995.00540270055019; Charcot J., 1877, LECT DIS NERVOUS SYS; Defazio G, 1998, J NEUROL NEUROSUR PS, V64, P25, DOI 10.1136/jnnp.64.1.25; Demartini B, 2015, EUR J NEUROL, V22, P527, DOI 10.1111/ene.12609; Demartini B, 2014, J NEUROL, V261, P2370, DOI 10.1007/s00415-014-7495-4; Edwards MJ, 2013, CURR OPIN NEUROL, V26, P442, DOI 10.1097/WCO.0b013e3283633953; Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Edwards MJ, 2011, MOVEMENT DISORD, V26, P1410, DOI 10.1002/mds.23671; Edwards MJ, 2011, MOVEMENT DISORD, V26, P917, DOI 10.1002/mds.23562; Erer S, 2008, PARKINSONISM RELAT D, V14, P75, DOI 10.1016/j.parkreldis.2006.12.009; Erro R, 2014, PARKINSONISM RELAT D, V20, P596, DOI 10.1016/j.parkreldis.2014.02.026; Factor SA, 1997, MOVEMENT DISORD, V12, P1052, DOI 10.1002/mds.870120634; Fahn S, 1976, Adv Neurol, V14, P1; Fahn S, 1988, Adv Neurol, V50, P431; Fahn S., 1983, NEUROLOGY, V33, P161, DOI [10.1212/WNL.33.10.1255, DOI 10.1212/WNL.33.10.1255]; Feinstein A, 2001, NEUROPSY NEUROPSY BE, V14, P169; FLETCHER NA, 1991, J NEUROL NEUROSUR PS, V54, P713, DOI 10.1136/jnnp.54.8.713; Frei KP, 2004, MOVEMENT DISORD, V19, P1492, DOI 10.1002/mds.20239; Ganos C, 2014, MOV DISORD CLIN PRAC, V1, P36, DOI 10.1002/mdc3.12013; Ganos C, 2014, PARKINSONISM RELAT D, V20, P41, DOI 10.1016/j.parkreldis.2013.09.012; GOLDMAN S, 1993, MAYO CLIN PROC, V68, P443, DOI 10.1016/S0025-6196(12)60192-X; Gowers W.R., 1888, MANUAL DIS NERVOUS S; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Hawley JS, 2011, NEUROLOGY, V77, P496, DOI 10.1212/WNL.0b013e3182287aaf; HEADLEY B, 1987, PHYS THER, V67, P1370, DOI 10.1093/ptj/67.9.1370; Ibrahim NM, 2009, PARKINSONISM RELAT D, V15, P592, DOI 10.1016/j.parkreldis.2009.02.010; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; Jankovic J, 2009, NEUROL CLIN, V27, P821, DOI 10.1016/j.ncl.2009.04.005; Kranick S, 2011, MOVEMENT DISORD, V26, P1844, DOI 10.1002/mds.23830; LANG A, 1990, NEUROLOGY, V40, P1476; LESSER RP, 1978, AM J PSYCHIAT, V135, P349; Marsden C D, 1976, Adv Neurol, V14, P259; MARSDEN CD, 1984, BRIT MED J, V288, P173, DOI 10.1136/bmj.288.6412.173; Martino D, 2005, MOVEMENT DISORD, V20, P1564, DOI 10.1002/mds.20635; Martino D, 2007, J NEUROL NEUROSUR PS, V78, P260, DOI 10.1136/jnnp.2006.103713; Merskey H, 1994, CLASSIFICATION CHRON; Molloy A, 2015, J NEUROL NEUROSUR PS, V86, P331, DOI 10.1136/jnnp-2014-307699; Pandey S, 2014, MOV DISORD CLIN PRAC, V1, P102, DOI 10.1002/mdc3.12016; Parees I, 2014, J NEUROL SCI, V338, P174, DOI 10.1016/j.jns.2013.12.046; Roze E, 2009, BRAIN, V132, P756, DOI 10.1093/brain/awn363; Sa DS, 2003, MOVEMENT DISORD, V18, P1482, DOI 10.1002/mds.10594; Saifee TA, 2012, J NEUROL, V259, P1958, DOI 10.1007/s00415-012-6530-6; SCHEROKMAN B, 1986, ARCH NEUROL-CHICAGO, V43, P830, DOI 10.1001/archneur.1986.00520080068025; Schicatano EJ, 1997, J NEUROPHYSIOL, V77, P2842, DOI 10.1152/jn.1997.77.5.2842; SCHOTT GD, 1981, J NEUROL NEUROSUR PS, V44, P344, DOI 10.1136/jnnp.44.4.344; SCHOTT GD, 1986, LANCET, V2, P712; Schrag A, 2004, BRAIN, V127, P2360, DOI 10.1093/brain/awh262; Schrag A, 2006, NEUROL REF SER, P53; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; SHEEHY MP, 1980, LANCET, V1, P777; SINGER C, 1989, MOVEMENT DISORD, V4, P342, DOI 10.1002/mds.870040409; Stone J, 2014, MOVEMENT DISORD, V29, P1701, DOI 10.1002/mds.26023; Stone J, 2012, J NEUROL NEUROSUR PS, V83, P67, DOI 10.1136/jnnp-2011-300125; Stone J, 2009, J PSYCHOSOM RES, V66, P383, DOI 10.1016/j.jpsychores.2008.07.010; Tanner K, 2012, LARYNGOSCOPE, V122, P1082, DOI 10.1002/lary.22471; Tarsy D, 1998, MOVEMENT DISORD, V13, P481, DOI 10.1002/mds.870130318; Thomas M, 2006, PARKINSONISM RELAT D, V12, P382, DOI 10.1016/j.parkreldis.2006.03.005; Trimble M., 2004, SOMATOFORM DISORDERS; Trimble MR, 1981, TRAUMATIC NEUROSIS R; TRUONG DD, 1991, ARCH NEUROL-CHICAGO, V48, P221, DOI 10.1001/archneur.1991.00530140117025; van der Salm SMA, 2014, NEUROLOGY, V83, P1862, DOI 10.1212/WNL.0000000000000982; van Rooijen DE, 2011, J NEUROL NEUROSUR PS, V82, P892, DOI 10.1136/jnnp.2010.232504; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Verdugo RJ, 2000, MUSCLE NERVE, V23, P198; Voon V, 2005, J CLIN PSYCHIAT, V66, P1529, DOI 10.4088/JCP.v66n1206; Weiner WJ, 2001, MOVEMENT DISORD, V16, P13, DOI 10.1002/1531-8257(200101)16:1<13::AID-MDS1016>3.0.CO;2-W	74	10	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-801849-1; 978-0-12-801772-2	HAND CLINIC			2016	139						499	507		10.1016/B978-0-12-801772-2.00041-2			9	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BH3HD	WOS:000399651400042	27719867				2022-02-06	
J	Halstead, ME				Halstead, Mark E.			Pharmacologic Therapies for Pediatric Concussions	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; medication; pharmacology; pediatric	POSTTRAUMATIC HEADACHE; HYPERTONIC SALINE; CHILDREN; EPIDEMIOLOGY; ADOLESCENTS; MANAGEMENT	Context: Pediatric concussions are common, and emphasis on correct diagnosis and management is stressed in consensus guidelines. Medications may have a role in management of concussion, but no consensus exists regarding appropriate pharmacologic therapy. Evidence Acquisition: Nonsystematic review. Study Design: Clinical review. Level of Evidence: Level 4. Results: There is limited evidence for hypertonic saline to improve posttraumatic headache in the emergency department setting. There is essentially no evidence for the use of any other medication in management of pediatric sport-related concussion. Conclusion: Further research is necessary to determine whether there is benefit to the use of any pharmacotherapy in the management of pediatric-aged athletes with concussions.	[Halstead, Mark E.] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO USA; [Halstead, Mark E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO USA		Halstead, ME (corresponding author), 14532 South Outer Forty Dr, Chesterfield, MO 63017 USA.	halsteadm@wustl.edu					Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Bramley H, 2015, PEDIATR NEUROL, V52, P493, DOI 10.1016/j.pediatrneurol.2015.01.008; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	13	10	10	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2016	8	1					50	52		10.1177/1941738115622158			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DH1EI	WOS:000372526800006	26660460	Green Published			2022-02-06	
J	Lanussa, OH; Avila-Rodriguez, M; Garcia-Segura, LM; Gonzalez, J; Echeverria, V; Aliev, G; Barreto, GE				Hidalgo Lanussa, Oscar; Avila-Rodriguez, Marco; Miguel Garcia-Segura, Luis; Gonzalez, Janneth; Echeverria, Valentina; Aliev, Gjumrakch; Emilio Barreto, George			Microglial Dependent Protective Effects of Neuroactive Steroids	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Neurosteroids; microglia; neuroinflammation; brain damage; neuroprotection; neurodegeneration	TRAUMATIC BRAIN-INJURY; ESTROGEN-RECEPTOR MODULATORS; ACUTE REGULATORY PROTEIN; CENTRAL-NERVOUS-SYSTEM; NEUROPROTECTIVE ACTIONS; NEURODEGENERATIVE DISEASES; MEDIATED NEUROPROTECTION; INFLAMMATORY RESPONSE; CLINICAL-IMPLICATIONS; PARKINSONS-DISEASE	Microglial cells are extremely important for homeostasis of the CNS. Upon brain damage, microglia become reactive in response to inflammatory stimuli and lead to the secretion of inflammatory cytokines. Because microglia have the ability of adjusting their steady state to an active phenotype that modulates the CNS environment, chronic activation of microglia has an important role in mediating neuroinflammatory brain diseases. Depending upon the nature and degree of the injury stimulus, microglial activity may alternate, either to acute and mild responses - sometimes beneficial- or chronic and severe that may result in neurodegeneration. In this context, proper and controlled activation of microglia should be considered as a potential neuroprotective strategy against neurodegeneration. More recently, the use of estrogenic compounds to regulate microgliosis has shown promising results, and is currently being investigated due to their potential pharmacologic ability in the regulation of inflammation. In this review, we highlight the role of microglia-mediated damage and discuss the effect of neurosteroids in reducing the adverse impact of inflammation in the brain.	[Hidalgo Lanussa, Oscar; Avila-Rodriguez, Marco; Gonzalez, Janneth; Emilio Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Severniy Proezd 1, Chernogolovka 142432, Russia; [Emilio Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com; gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./B-5747-2014; Aliev, Gjumrakch/AAE-7734-2020; GONZALEZ, JANNETH/AAB-9948-2020; Garcia-Segura, Luis M/U-3711-2017; Barreto, George E./AAD-7420-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; GONZALEZ, JANNETH/0000-0003-2009-3374; Garcia-Segura, Luis M/0000-0002-2450-2916; Barreto, George E./0000-0002-6644-1971; Gonzalez, Janneth/0000-0003-4482-256X; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X; Avila-Rodriguez, Marco/0000-0003-4612-3236	ColcienciasDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [4509, 5024, 5608, 511, 226 de 2014]; GALLY International Biomedical Research Inc., San Antonio, TX, USA	This work was supported in part by grants PUJ IDs 4509, 5024 and 5608 to GEB, and PhD fellowship (Colciencias, convocatoria 511) to MA and Young Investigator fellowship (Colciencias, cooperacion No. 226 de 2014) to OHL. G. Aliev work supported by the GALLY International Biomedical Research Inc., San Antonio, TX, USA. Part of the experimental work described in this paper was performed using the equipment of Center for collective use of IPAC RAS (Agreement. 14.621.21.0008, ID RFMEFI62114 X0008).	Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Akwa Yvette, 1999, Journal de la Societe de Biologie, V193, P293; Almado CEL, 2012, J NEUROSCI, V32, P16736, DOI 10.1523/JNEUROSCI.2654-12.2012; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Amantea D, 2014, CURR MED CHEM, V21, P2098, DOI 10.2174/0929867321666131227162634; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Azcoitia I, 2005, J NEURAL TRANSM, V112, P171, DOI 10.1007/s00702-004-0179-y; Azcoitia I, 2001, Prog Brain Res, V132, P469; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Azcoitia I, 2011, TRENDS ENDOCRIN MET, V22, P467, DOI 10.1016/j.tem.2011.08.002; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Barreto GE, 2011, HUM EXP TOXICOL, V30, P1737, DOI 10.1177/0960327111398676; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bechade C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00032; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Casbas-Hernandez P, 2015, CANCER EPIDEM BIOMAR, V24, P406, DOI 10.1158/1055-9965.EPI-14-0934; Ceylan U, 2012, NEUROENDOCRINOL LETT, V33, P505; Chen SH, 2015, GLIA, V63, P118, DOI 10.1002/glia.22738; Cox DJ, 2015, GLIA, V63, P812, DOI 10.1002/glia.22786; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; DonCarlos LL, 2003, ENDOCRINOLOGY, V144, P3632, DOI 10.1210/en.2002-0105; Drew PD, 2003, ANN NY ACAD SCI, V1007, P329, DOI 10.1196/annals.1286.031; Duncan KA, 2014, ESTROGEN EFFECTS TRA, P73; Espinet C, 2015, CURR DRUG TARGETS, V16, P20, DOI 10.2174/1389450116666150107153233; Espinosa-Raya J, 2012, HORM BEHAV, V61, P76, DOI 10.1016/j.yhbeh.2011.10.005; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Avila MF, 2014, J THEOR BIOL, V345, P43, DOI 10.1016/j.jtbi.2013.12.010; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; Goujon E, 1997, PSYCHONEUROENDOCRINO, V22, pS75, DOI 10.1016/S0306-4530(97)00009-7; Habib P, 2014, J MOL NEUROSCI, V52, P277, DOI 10.1007/s12031-013-0137-y; Hammond J, 2001, J NEUROCHEM, V77, P1319, DOI 10.1046/j.1471-4159.2001.00345.x; Heese K, 1997, NEUROSCI LETT, V231, P83, DOI 10.1016/S0304-3940(97)00545-4; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Jalloh I, 2014, METAB BRAIN DIS, P1; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; King SR, 2002, J NEUROSCI, V22, P10613; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar G Phani, 2012, Pharmacogn Rev, V6, P81, DOI 10.4103/0973-7847.99898; Lambrinoudaki I, 2014, MATURITAS, V77, P311, DOI 10.1016/j.maturitas.2014.01.001; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luconi M, 2002, J STEROID BIOCHEM, V80, P369, DOI 10.1016/S0960-0760(02)00041-9; Mahesh VB, 2006, MOL CELL ENDOCRINOL, V246, P1, DOI 10.1016/j.mce.2005.11.017; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Manthey D, 2006, NEUROSCIENCE, V138, P845, DOI 10.1016/j.neuroscience.2005.10.058; McCluskey LP, 2000, J NEUROPATH EXP NEUR, V59, P177, DOI 10.1093/jnen/59.3.177; McDowell ML, 2011, NEUROCHEM INT, V59, P175, DOI 10.1016/j.neuint.2011.04.011; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Menghini L, 2014, J BIOL REG HOMEOS AG, V28, P775; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Ng TF, 2009, INVEST OPHTH VIS SCI, V50, P5472, DOI 10.1167/iovs.08-2877; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petrone AB, 2014, AGING DIS, V5, P340, DOI 10.14336/AD.2014.0500340; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Raffo D, 2015, ONCOL REP, V33, P439, DOI 10.3892/or.2014.3558; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Schumacher M, 2003, PROG NEUROBIOL, V71, P3, DOI 10.1016/j.pneurobio.2003.09.004; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shen MQ, 2014, HORM MOL BIOL CLIN I, V17, P99, DOI 10.1515/hmbci-2014-0007; Shinozaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04329; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Simpkins JW, 2012, NEUROENDOCRINOLOGY, V96, P119, DOI 10.1159/000338409; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Smith JA, 2011, NEUROCHEM RES, V36, P1587, DOI 10.1007/s11064-010-0336-7; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Streit WJ, 2002, MICROGLIA REGENERATI, P188; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sugino N, 2002, MOL HUM REPROD, V8, P68, DOI 10.1093/molehr/8.1.68; Suuronen T, 2005, INFLAMM RES, V54, P194, DOI 10.1007/s00011-005-1343-z; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Takeuchi K, 2015, BRAIN RES, V1621, P222, DOI 10.1016/j.brainres.2014.11.016; Tang H, 2014, MOL CELL ENDOCRINOL, V389, P92, DOI 10.1016/j.mce.2014.05.005; Tapia-Gonzalez S, 2008, J ENDOCRINOL, V198, P219, DOI 10.1677/JOE-07-0294; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; van Noort JM, 2009, PROG BRAIN RES, V175, P139, DOI 10.1016/S0079-6123(09)17509-X; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Wang XJ, 2007, J NEUROIMMUNE PHARM, V2, P259, DOI 10.1007/s11481-007-9075-1; Weiss EP, 2011, AGING-US, V3, P533, DOI 10.18632/aging.100327; West LA, 2001, ENDOCRINOLOGY, V142, P502, DOI 10.1210/en.142.1.502; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-154; Zhuang Z, 2013, J NEUROSCI RES, V91, P1599, DOI [10.1002/jnr.23186, 10.1002/jnr.23281]	116	10	10	0	7	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	2					242	249		10.2174/1871527315666160202122032			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DG5HI	WOS:000372107500005	26831265				2022-02-06	
J	Ito, K; Asano, Y; Ikegame, Y; Shinoda, J				Ito, Keiichi; Asano, Yoshitaka; Ikegame, Yuka; Shinoda, Jun			Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI	BIOMED RESEARCH INTERNATIONAL			English	Article							DIFFUSE AXONAL INJURY; MILD; PET	Introduction. Many patients with mild/moderate traumatic brain injury (m/mTBI) in the chronic stage suffer from executive brain function impairment. Analyzing brain metabolism is important for elucidating the pathological mechanisms associated with their symptoms. This study aimed to determine the differences in brain glucose metabolism between m/mTBI patients with and without visible traumatic brain lesions based on MRI. Methods. Ninety patients with chronic m/mTBI due to traffic accidents were enrolled and divided into two groups based on their MRI findings. Group A comprised 50 patients with visible lesions. Group B comprised 40 patients without visible lesions. Patients underwent FDG-PET scans following cognitive tests. FDG-PET images were analyzed using voxel-by-voxel univariate statistical tests. Results. There were no significant differences in the cognitive tests between Group A and Group B. Based on FDG-PET findings, brain metabolism significantly decreased in the orbital gyrus, cingulate gyrus, and medial thalamus but increased in the parietal and occipital convexity in Group A compared with that in the control. Compared with the control, patients in Group B exhibited no significant changes. Conclusions. These results suggest that different pathological mechanisms may underlie cognitive impairment in m/mTBI patients with and without organic brain damage.	[Ito, Keiichi; Asano, Yoshitaka; Shinoda, Jun] Gifu Univ, Dept Clin Brain Sci, Grad Sch Med, Gifu, Gifu 5011194, Japan; [Asano, Yoshitaka; Ikegame, Yuka; Shinoda, Jun] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Gifu 5050034, Japan		Ito, K (corresponding author), Gifu Univ, Dept Clin Brain Sci, Grad Sch Med, Gifu, Gifu 5011194, Japan.	q2111601@edu.gifu-u.ac.jp	Ikegame, Yuka/AAU-8880-2020	Ito, Keiichi/0000-0002-2530-0929; Ikegame, Yuka/0000-0002-8932-9798			Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chatfield C., 1980, INTRO MULTIVARIATE A; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Faul M, 2010, TRAUMATIC BRAIN INJU; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1996, HUM BRAIN MAPP, V4, P140, DOI 10.1002/(SICI)1097-0193(1996)4:2<140::AID-HBM5>3.0.CO;2-3; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Holmes A., 1997, HUMAN BRAIN FUNCTION, P67; Hosokawa T, 2009, PROG NEURO-PSYCHOPH, V33, P243, DOI 10.1016/j.pnpbp.2008.11.014; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Ishii K, 2014, AM J NEURORADIOL, V35, P2030, DOI 10.3174/ajnr.A3695; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Schmidt EZ, 2008, J AFFECT DISORDERS, V106, P203, DOI 10.1016/j.jad.2007.06.009; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thompson C. J., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V671, P244; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141	28	10	10	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2016	2016								3794029	10.1155/2016/3794029			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	DT0CY	WOS:000381151400001	27529067	Green Submitted, gold, Green Published			2022-02-06	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Degeneration of an injured spinothalamic tract in a patient with mild traumatic brain injury	BRAIN INJURY			English	Article						Spinothalamic tract; diffusion tensor imaging; head trauma; traumatic axonal injury	DIFFUSION TENSOR TRACTOGRAPHY; AXONAL INJURY; CENTRAL PAIN; RELIABILITY	Objectives: This study reports on a patient who developed degeneration of an injured spinothalamic tract (STT) detected on diffusion tensor tractography (DTT) following mild traumatic brain injury (TBI).Case description: A 56-year-old female had suffered from head trauma resulting from a pedestrian car accident. The patient did not experience loss of consciousness or post-traumatic amnesia and the patient's Glasgow Coma Scale score was 15. She had begun to feel pain in her left hand and foot at similar to 7 days after onset. The characteristics and severity of pain were as follows: constant tingling and pricking sensation without allodynia or hyperalgesia (Visual Analogue Scale score: 3 similar to 4). No specific focal lesion was observed on brain and spine MRI and an electromyography study showed no evidence of peripheral nerve injury or radiculopathy. At 6 months after onset, the central pain in the left hand and foot became aggravated, with a Visual Analogue Scale score of 6.Results: On 1-month DTT, partial tearing was observed in both STTs. In contrast, both partially torn STTs had become atrophy on 9-month DTT.Conclusions: This study recommends further studies conducted on the prognosis (regeneration or degeneration) of injured STTs and on the effect of change of an injured STT on central pain.	[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea		Kwon, HG (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea.	khg0715@hanmail.net			Medical Research Center Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; DELLON AL, 1987, J HAND SURG-AM, V12A, P693, DOI 10.1016/S0363-5023(87)80049-7; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Lincoln N., 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Seo JP, 2015, BRAIN INJURY, V29, P110, DOI 10.3109/02699052.2014.973447; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Weinstein S, 1993, J Hand Ther, V6, P11	13	10	10	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	8					1026	1028		10.3109/02699052.2016.1146961			3	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DS6OP	WOS:000380901800011	27029559				2022-02-06	
J	Jang, SH; Yi, JH; Kwon, HG				Jang, Sung Ho; Yi, Ji Hyun; Kwon, Hyeok Gyu			Injury of the inferior cerebellar peduncle in patients with mild traumatic brain injury: A diffusion tensor tractography study	BRAIN INJURY			English	Article						Inferior cerebellar peduncle; mild traumatic brain injury; diffusion tensor imaging; balance	WHITE-MATTER; POSTURAL CONTROL; AXONAL INJURY	Objectives: No study on injury of the inferior cerebellar peduncle (ICP) in patients with mild traumatic brain injury (mTBI) has been reported. This study, using diffusion tensor tractography (DTT), attempted to demonstrate injury of the ICP in patients with mTBI.Methods: Three patients with mTBI resulting from a car accident and 18 normal healthy control subjects were enrolled in this study. Diffusion tensor imaging data were acquired at 2 months (patient 1) and 3 months (patients 2 and 3) after onset and the ICP was reconstructed. The Balance Error Scoring System was used for evaluation of balance at the same time diffusion tensor imaging scanning was performed.Results: The ICPs were discontinued at the upper portion of the vertical cerebellar branch and the transverse cerebellar branch (patient 1) and the proximal portion of the transverse cerebellar branch (patients 2 and 3) compared to the normal control subjects. Regarding DTT parameters, in the three patients, the fibre number of the ICPs was decreased by more than 2 SD compared with those of subjects in the control group.Conclusion: Evaluation of the ICP using DTT would be useful in patients with a balance problem after mTBI.	[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea; [Yi, Ji Hyun] Yeungnam Univ, Dept Diagnost Radiol, Coll Med, Daegu, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea.	khg0715@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A4A01020385]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A4A01020385). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Jang SH, 2015, BRAIN INJURY, V29, P1725, DOI 10.3109/02699052.2015.1075170; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Kwon HG, 2012, NEURAL REGEN RES, V7, P475, DOI 10.3969/j.issn.1673-5374.2012.06.012; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mendoza J., 2007, CLIN NEUROANATOMY NE; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; Peterson Michelle, 2015, Arch Phys Med Rehabil, V96, P379, DOI 10.1016/j.apmr.2013.06.012; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106	17	10	10	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1271	1275		10.1080/02699052.2016.1178805			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300017	27294795				2022-02-06	
J	Jovanovic, B; Milan, Z; Djuric, O; Markovic-Denic, L; Karamarkovic, A; Gregoric, P; Doklestic, K; Avramovic, J; Velickovic, J; Bumbasirevic, V				Jovanovic, Bojan; Milan, Zoka; Djuric, Olivera; Markovic-Denic, Ljiljana; Karamarkovic, Aleksandar; Gregoric, Pavle; Doklestic, Krstina; Avramovic, Jovana; Velickovic, Jelena; Bumbasirevic, Vesna			Twenty-Eight-Day Mortality of Blunt Traumatic Brain Injury and Co-Injuries Requiring Mechanical Ventilation	MEDICAL PRINCIPLES AND PRACTICE			English	Article						Brain injury; Polytrauma; Mortality; Critical care; Pneumonia	RISK-FACTORS; PNEUMONIA; EPIDEMIOLOGY; POPULATION; PATTERNS; MODERATE	Objective: This paper aims to assess the impact of co-injuries and consequent emergency surgical interventions and nosocomial pneumonia on the 28-day mortality of patients with severe traumatic brain injuries (TBIs). Subjects and Methods: One hundred and seventy-seven patients with TBI admitted to the emergency trauma intensive care unit at the Clinical Center of Serbia for more than 48 h were studied over a 1-year period. On admission, the Glasgow Coma Scale (GCS), Injury Severity Score (ISS) and Acute Physiology and Chronic Health Evaluation II score (APACHE II) were calculated. At admission, an isolated TBI was recorded in 45 of the patients, while 44 had three or more co-injuries. Results: Of the 177 patients, 78 (44.1%) died by the end of the 28-day follow-up period. They had a significantly higher ISS score (25 vs. 20; p = 0.024) and more severe head (p = 0.034) and chest (p = 0.013) injuries compared to those who survived. Nonsurvivors had spent more days on mechanical ventilation (9.5 vs. 8; p = 0.041) and had a significantly higher incidence of ventilator-associated pneumonia (VAP) than survivors (67.9 vs. 40.4%; p < 0.001). A high Rotterdam CT score (OR 2.062; p < 0.001) and a high APACHE II score (OR 1.219; p < 0.001) were identified as independent predictors of early TBI-related mortality. Conclusion: Patients who had TBI with a high Rotterdam score and a high APACHE II score were at higher risk of 28-day mortality. VAP was a very common complication of TBI and was associated with an early death and higher mortality in the subgroup of patients with a GCS = 8. (C) 2016 S. Karger AG, Basel	[Djuric, Olivera; Markovic-Denic, Ljiljana] Univ Belgrade, Inst Epidemiol, Belgrade, Serbia; [Jovanovic, Bojan; Karamarkovic, Aleksandar; Gregoric, Pavle; Doklestic, Krstina; Velickovic, Jelena; Bumbasirevic, Vesna] Univ Belgrade, Fac Med, Belgrade, Serbia; [Jovanovic, Bojan; Avramovic, Jovana; Velickovic, Jelena; Bumbasirevic, Vesna] Clin Ctr Serbia, Ctr Anaesthesiol, Belgrade, Serbia; [Karamarkovic, Aleksandar; Gregoric, Pavle; Doklestic, Krstina] Clin Ctr Serbia, Clin Emergency Surg, Belgrade, Serbia; [Milan, Zoka] Kings Coll Hosp London, London, England		Jovanovic, B (corresponding author), Clin Ctr Serbia, Emergency Ctr, Pasterova 2, RS-11000 Belgrade, Serbia.	bjovanovic@outlook.com	MD.PhD.FACS, Karamarkovic Aleksandar/E-1670-2018; Djuric, Olivera/H-8580-2019	MD.PhD.FACS, Karamarkovic Aleksandar/0000-0001-5716-2009; Djuric, Olivera/0000-0002-8574-5938; Velickovic, Jelena/0000-0001-7862-5420	Ministry of Science and Technological Development of SerbiaMinistry of Education, Science & Technological Development, Serbia [175046]	This work was supported by the Ministry of Science and Technological Development of Serbia, contract No. 175046, 2011-2014.	Al-Faris L, 2012, MED PRIN PRACT, V21, P560, DOI 10.1159/000338887; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Berrouane Y, 1998, J HOSP INFECT, V40, P275, DOI 10.1016/S0195-6701(98)90303-6; Buki A, 2012, CURR GERIATR REP, V1, P159, DOI 10.1007/s13670-012-0016-3; Canadian Critical Care Trials Group, 2013, NEW ENGL J MED, V355, P2619; Contentin L, 2014, AM J RESP CRIT CARE, V189, P998, DOI 10.1164/rccm.201308-1499LE; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; Fiebich BL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00260; Gruenbaum SE, 2014, CURR OPIN ANESTHESIO, V27, P470, DOI 10.1097/ACO.0000000000000109; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kristiansen T, 2014, INJURY, V45, P23, DOI 10.1016/j.injury.2013.07.007; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; PORIES SE, 1991, ARCH SURG-CHICAGO, V126, P97; RELLO J, 1992, EUR RESPIR J, V5, P1249; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	24	10	12	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-7571	1423-0151		MED PRIN PRACT	Med. Princ. Pract.		2016	25	5					435	441		10.1159/000447566			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW8KJ	WOS:000383904000006	27383217	gold, Green Published			2022-02-06	
J	Kafaki, SB; Alaedini, K; Qorbani, A; Asadian, L; Haddadi, K				Kafaki, Simin Babaie; Alaedini, Kamaledin; Qorbani, Ashkan; Asadian, Leila; Haddadi, Kaveh			Hyperglycemia: A Predictor of Death in Severe Head Injury Patients	CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES			English	Article						hyperglycemia; injury severity score; mortality	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; ADMISSION HYPERGLYCEMIA; DIABETIC-PATIENTS; BLOOD-GLUCOSE; MORTALITY; CATECHOLAMINES; INSULIN; STRESS; ASSOCIATION	OBJECTIVES: Management of hyperglycemia during an acute sickness in adults is accompanied by improved outcomes. We have designed a prospective study with meticulous attention to exclude all diabetes patients by checking hemoglobin A1c (HbA1c or glycated hemoglobin) to avoid the ill-effects of hyperglycemia in patients with traumatic head injury admitted to the intensive care unit (ICU). METHODS: This prospective study included adults with traumatic primary brain injury with a Glasgow coma score of <= 8 necessitating mechanical ventilation treated in the period 2012-2015. After screening 311 patients, 220 were included in the study. Both blood glucose and HbA1c levels of all the patients at admission, as well as blood glucose level after 72 hours, were obtained from the records. The patients were later grouped based on their admission blood glucose levels (<200 mg/dL or >= 200 mg/dL). Injury severity score (ISS) was documented for every patient. As a final point, the outcomes were determined based on the hospital length of stay (HLS) and ICU length of stay (ILS), plusmortality rates. RESULTS: About 39% (n = 85) of patients were admitted with hyperglycemia during the study period. The mortality rate in patients with glucose $200 mg/dL was 65.8% (N = 56), against 23.7% (N = 32) in the group with glucose <200 mg/dL, with mortality rising as the blood glucose level increased (P = 0.014). CONCLUSIONS: We conclude that admission hyperglycemia is related with increased mortality rate in head injury patients, and comprehensive treatment of hyperglycemia can improve the outcome of severe head injury patients.	[Kafaki, Simin Babaie; Alaedini, Kamaledin; Asadian, Leila] Mazandaran Univ Med Sci, Sari, Iran; [Qorbani, Ashkan] Mazandaran Univ Med Sci, Sch Med, Sari, Iran; [Haddadi, Kaveh] Mazandaran Univ Med Sci, Emam Hosp, Diabet Res Ctr, Dept Neurosurg, Sari, Iran		Haddadi, K (corresponding author), Mazandaran Univ Med Sci, Emam Hosp, Diabet Res Ctr, Dept Neurosurg, Sari, Iran.	kh568hd@yahoo.com			Mazandaran University of Medical Sciences, Sari, Iran	This study is a part of the thesis in General Medicine submitted by Mr. Ashkan Qorbani. This study was supported by a grant from the Mazandaran University of Medical Sciences, Sari, Iran. The authors confirm that the funder had no influence over the study design, content of the article, or selection of this journal.	BAGDADE JD, 1974, DIABETES, V23, P9, DOI 10.2337/diab.23.1.9; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bochicchio GV, 2005, AM SURGEON, V71, P171; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Golden SH, 1999, DIABETES CARE, V22, P1408, DOI 10.2337/diacare.22.9.1408; Gore DC, 2001, J TRAUMA, V51, P540, DOI 10.1097/00005373-200109000-00021; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; KJERSEM H, 1988, INFECTION, V16, P215, DOI 10.1007/BF01650754; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; PENTELENYI T, 1984, INJURY, V15, P397, DOI 10.1016/0020-1383(84)90205-5; Pomposelli JJ, 1998, JPEN-PARENTER ENTER, V22, P77, DOI 10.1177/014860719802200277; Senkowski CK, 1999, J AM COLL SURGEONS, V189, P491, DOI 10.1016/S1072-7515(99)00190-8; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Van Camp L A, 1998, Eur J Emerg Med, V5, P341; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	27	10	11	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-5514			CLIN MED INSIGHTS-EN	Clin. Med. Insights-Endocrinol. Diabetes		2016	9									10.4137/CMEDED.S40330			4	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	DY0PO	WOS:000384798900001	27695379				2022-02-06	
J	Kamal, VK; Agrawal, D; Pandey, RM				Kamal, Vineet Kumar; Agrawal, Deepak; Pandey, Ravindra Mohan			Prognostic models for prediction of outcomes after traumatic brain injury based on patients admission characteristics	BRAIN INJURY			English	Article						Glasgow outcome scale; head injury; outcome; prognostic models; traumatic brain injury	SEVERE HEAD-INJURY; VALIDATION; MORTALITY; DISCRIMINATION; MODERATE; IMPACT; NEEDS; TREE	Objective: To identify the best performing prognostic model using admission characteristics to predict mortality at 30 days and functioning outcome at 6-months post-admission in patients with moderate or severe brain injury. Methods: Using a retrospective database (n = 1466 patients) of a tertiary trauma care centre, three different models were developed using logistic regression methods for predicting mortality and functioning outcome. The performance of the models was assessed in terms of discrimination and calibration. The models were validated using split sample method. For facilitating clinical usefulness, score charts were derived from the regression models. Results: The variables motor score, hypotension, pupillary reactivity, age, creatinine level, limb movement (hemiparesis), and tSAH/IVH were found to be the most predictive independent prognostic factors of both mortality and functioning outcome. For both the outcomes, discriminative ability of the three prognostic models was excellent in the development dataset (AUC = 0.845--0.905) as well as the validation data set (AUC = 0.836-0.880). Calibration in the validation data set for model-2 was good (H-L test p-value > 0.05); however, for model-1 and model-3, it was poor (H-L test p-value < 0.05). Conclusion: For clinical decision-making, model-2 is recommended on the basis of good performance in predicting outcomes in patients with moderate or severe TBI in India and other similar countries.	[Kamal, Vineet Kumar; Pandey, Ravindra Mohan] All India Inst Med Sci, Neurosci & Gamma Knife Ctr, Dept Biostat, New Delhi 110029, India; [Agrawal, Deepak] All India Inst Med Sci, Neurosci & Gamma Knife Ctr, Dept Neurosurg, New Delhi 110029, India		Pandey, RM (corresponding author), All India Inst Med Sci, Dept Biostat, New Delhi 110029, India.	rmpandey@yahoo.com	/AAG-3032-2021	/0000-0002-5499-0746; Kamal, Vineet Kumar/0000-0002-7295-1644			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Arboretti Giancristofaro R., 2007, STATISTICA, V63, P375, DOI [10.6092/issn.1973-2201/358, DOI 10.6092/ISSN.1973-2201/358]; Baltas I, 1998, J Neurosurg Sci, V42, P85; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; DIAMOND GA, 1992, J CLIN EPIDEMIOL, V45, P85, DOI 10.1016/0895-4356(92)90192-P; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Gururaj G., 2005, BACKGROUND PAPERS BU, P325; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE Jr, 2017, REGRESSION MODELING; Helmy A, 2010, ACTA NEUROCHIR, V152, P2007, DOI 10.1007/s00701-010-0746-y; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; JONES JM, 1995, J TRAUMA, V38, P89, DOI 10.1097/00005373-199501000-00023; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Mukherjee K, 2000, NEUROL INDIA, V48, P43; Murray C. J., 1996, GLOBAL HLTH STAT COM; Murray CJL, 1996, GLOBAL BURDEN DIS CO, P52; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pillai SV, 2003, NEUROL INDIA, V51, P345; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TITTERINGTON DM, 1981, J ROY STAT SOC A STA, V144, P145, DOI 10.2307/2981918; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zasler N, 2006, BRAIN INJURY MED PRI, P1304	45	10	10	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					393	406		10.3109/02699052.2015.1113568			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200004	27003280				2022-02-06	
J	Lim, PA; McLean, AM; Kilpatrick, C; DeForge, D; Iverson, GL; Silverberg, ND				Lim, Patricia A.; McLean, Alison M.; Kilpatrick, Christiane; DeForge, Daniel; Iverson, Grant L.; Silverberg, Noah D.			Temporal stability and responsiveness of the Montreal Cognitive Assessment following acquired brain injury	BRAIN INJURY			English	Article						Brain injuries; cognition disorders; neuropsychological tests; psychometrics; stroke	MEDICAL REHABILITATION REPORT; MENTAL-STATE-EXAMINATION; BRIEF SCREENING TOOL; UNIFORM DATA SYSTEM; ASSESSMENT MOCA; IMPAIRMENT; VALIDITY; VERSION; RELIABILITY; STROKE	Objectives: To evaluate the temporal stability and responsiveness of the Montreal Cognitive Assessment (MoCA) in acquired brain injury (ABI). Research design and methods: English-speaking adults with stroke or moderate-to-severe traumatic brain injury were administered alternate forms of the MoCA (version 1, then 2), 6 weeks apart. Chronic group participants (n = 40) were community-dwelling, at least 1 year post-ABI (mean = 12.1 years, SD = 9.0), and presumed clinically stable. Sub-acute group participants (n = 36) were 30.8 days post-ABI (SD = 12.4) and were undergoing intensive rehabilitation. Individuals with an unstable medical or psychiatric condition or severe receptive aphasia were not eligible. Results: The chronic group scored 21.6 (SD = 4.5) initially and 22.7 (SD = 3.8) on the second administration, demonstrating a small but significant practise effect (p = 0.009). The Pearson test-re-test correlation coefficient was 0.83. Using reliable change methodology in the chronic group, the 80% confidence interval (CI) for change across the two administrations was -2 to +4, adjusting for practise. Applied to the sub-acute group, 39% improved and 0% declined. Conclusions: The MoCA is a brief standardized tool that appears useful for monitoring cognitive change after ABI. The findings enable clinicians to detect statistically reliable change across serial MoCA administrations in individuals with an ABI.	[Lim, Patricia A.; DeForge, Daniel; Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC V5Z 1M9, Canada; [McLean, Alison M.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada; [McLean, Alison M.; Kilpatrick, Christiane; DeForge, Daniel; Silverberg, Noah D.] GF Strong Rehabil Ctr, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA		Silverberg, ND (corresponding author), Rehabil Res Ctr, GF Strong Rehabil Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Iverson, Grant/0000-0001-7348-9570	B.C. Rehab Foundation through Research and Innovation Fund [20R67148]; ImPACT(R) Applications Systems	Financial support was gratefully received from the B.C. Rehab Foundation through its Research and Innovation Fund (Project Grant #20R67148). GLI has been reimbursed by the government, professional scientific bodies and commercial organizations for discussing or presenting research relating to traumatic brain injury (TBI) and sport-related concussion at meetings, scientific conferences and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received honorariums for serving on research panels that provide scientific peer review of programmes. He is a co-investigator, collaborator or consultant on grants relating to mild TBI funded by several organizations. He has received research support from test publishing companies in the past, including ImPACT (R) Applications Systems (not in the past 5 years). The other authors have no conflicts of interest to report.	Beaton DE, 2002, CURR OPIN RHEUMATOL, V14, P109, DOI 10.1097/00002281-200203000-00006; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Costa AS, 2012, DEMENT GERIATR COGN, V33, P379, DOI 10.1159/000340006; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Duro D, 2010, J NEUROL, V257, P728, DOI 10.1007/s00415-009-5399-5; Freitas S, 2012, J INT NEUROPSYCH SOC, V18, P242, DOI 10.1017/S1355617711001573; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Gomez F, 2013, INT J GERIATR PSYCH, V28, P813, DOI 10.1002/gps.3885; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; Hu JB, 2013, ARCH GERONTOL GERIAT, V56, P38, DOI 10.1016/j.archger.2012.05.008; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Koski L, 2009, J GERIATR PSYCH NEUR, V22, P151, DOI 10.1177/0891988709332944; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; MARTINIC-POPOVIC I, 2006, ACTA CLIN CROAT, V45, P77; McLennan SN, 2011, J GERIATR PSYCH NEUR, V24, P33, DOI 10.1177/0891988710390813; Milanini B, 2014, JAIDS-J ACQ IMM DEF, V67, P67, DOI 10.1097/QAI.0000000000000220; Nasreddine Z, 2014, MONTREAL COGNITIVE A; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Olson RA, 2011, J NEURO-ONCOL, V105, P337, DOI 10.1007/s11060-011-0595-4; Passalent LA, 2011, DISABIL REHABIL, V33, P579, DOI 10.3109/09638288.2010.500346; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Phillips N, 2011, J INT NEUROPSYCH SOC, V44, P291; Popovic IM, 2007, J NEUROL SCI, V257, P185, DOI 10.1016/j.jns.2007.01.029; Rahman TTA, 2009, GERIATR GERONTOL INT, V9, P54, DOI 10.1111/j.1447-0594.2008.00509.x; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Tu QY, 2013, DEMENT GER COGN D EX, V3, P25, DOI 10.1159/000346845; Videnovic A, 2010, MOVEMENT DISORD, V25, P402, DOI 10.1002/mds.22748; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Wong GKC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059946; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837; Zhao SJ, 2011, J CLIN NEUROSCI, V18, P774, DOI 10.1016/j.jocn.2010.07.149	40	10	10	3	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	1					29	35		10.3109/02699052.2015.1079732			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DJ8YT	WOS:000374501200005	26556208				2022-02-06	
J	Neilson, SJ; See, AAQ; King, NKK				Neilson, Sam J.; See, Angela A. Q.; King, Nicolas K. K.			Effect of prior statin use on outcome after severe traumatic brain injury in a South-East Asian population	BRAIN INJURY			English	Article						Traumatic brain injury; disability; outcome	INTRACEREBRAL HEMORRHAGE; FUNCTIONAL OUTCOMES; THERAPY; REDUCE; ROSUVASTATIN; METAANALYSIS; SIMVASTATIN; SURVIVAL; MODELS; IMPACT	Introduction: Traumatic brain injury (TBI) is a global concern associated with high mortality and morbidity. Costs to individuals and society are extensive due to poor recovery, long-term disability and the young age group affected. Statins have emerged as potential therapeutic agents in TBI. This study aimed to investigate the protective effect of statins in severe TBI.Methods: This case-control study included adults with severe TBI. A sliding dichotomy approach was used to dichotomize mortality at 14-days and Glasgow Outcome Score (GOS) at 6 months. Logistic regression analysis was used to calculate the odds ratios (OR) for 14-day mortality and 6-month GOS.Results: Equivalent cohorts of 59 age- and sex-matched statin and non-statin users were selected, resulting in population of 118 (mean age = 70.2 years, SD = 10.3), with a median Glasgow Coma Score of 5. Statins did not reduce the likelihood of mortality at 14 days (adjusted OR = 1.23, p = 0.68) or unfavourable outcome at 6 months (adjusted OR = 1.19, p = 0.78).Conclusions: Despite increasing evidence for benefit of statins in TBI, this study in an Asian population does not support this association, demonstrating no significant improvement in outcome for statin users. Further research is required to understand the mechanisms and impact of statins in TBI.	[Neilson, Sam J.; See, Angela A. Q.; King, Nicolas K. K.] Natl Neurosci Inst, Dept Neurosurg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore		King, NKK (corresponding author), Natl Neurosci Inst, Dept Neurosurg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	nicolas_kon@nni.com.sg		Kon Kam King, Nicolas/0000-0002-6009-4411			Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Edwards P, 2005, LANCET, V365, P1957; Efron DT, 2008, J TRAUMA, V64, P66, DOI 10.1097/TA.0b013e31815b842a; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leker RR, 2009, STROKE, V40, P2581, DOI 10.1161/STROKEAHA.108.546259; Li YF, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-6; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Neal MD, 2009, J TRAUMA, V67, P476, DOI 10.1097/TA.0b013e3181ad66bb; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Sillberg VAH, 2008, STROKE, V39, P2622, DOI 10.1161/STROKEAHA.107.508341; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Tapia-Perez JH, 2010, NEUROSURG REV, V33, P259, DOI 10.1007/s10143-010-0259-4; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003	27	10	10	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	8					993	998		10.3109/02699052.2016.1147599			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DS6OP	WOS:000380901800007	27119267				2022-02-06	
J	Osborne-Crowley, K; McDonald, S; Francis, H				Osborne-Crowley, Katherine; McDonald, Skye; Francis, Heather			Development of an observational measure of social disinhibition after traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Social disinhibition; Traumatic brain injury; Observational measure; Neuropsychiatric Inventory	CLOSED HEAD-INJURY; QUALITY-OF-LIFE; NEUROPSYCHIATRIC INVENTORY; ORBITOFRONTAL CORTEX; BEHAVIORAL-CHANGES; FOLLOW-UP; PERSONALITY; COGNITION; SYMPTOMS; PATIENT	Introduction: This study aimed to validate a new observational measure of socially disinhibited behavior for use in a population of individuals with traumatic brain injury (TBI). Method: Participants were twenty-two adults with severe TBI (mean age = 50.45 years) and 21 healthy comparison participants (mean age = 45.29 years). Ratings of observed social disinhibition were correlated with the disinhibition domain scores of the Neuropsychiatric Inventory-Disinhibition (NPI-D) and with Sydney Psychosocial Reintegration Scale (SPRS) scores. A regression analysis was undertaken to determine whether formal measures of disinhibition could predict observed disinhibition. Results: The interrater absolute agreement for the social disinhibition ratings was good, intraclass correlation coefficient (ICC) = .69. Participants with TBI were rated as significantly more disinhibited than comparison participants, t(25.05) = -2.07, p = .049. The ratings were positively correlated with the NPI frequency score (r = .45, p = .038) and distress score (r = .45, p = .035). The ratings were not related to change in employment or in interpersonal relationships on the SPRS, and formal measures of disinhibition were unable to predict observed social disinhibition. Conclusions: This study demonstrates good interrater reliability and construct validity of the observational measure. The results evidence the usefulness of this measure and the NPI-D for detecting social disinhibition after TBI.	[Osborne-Crowley, Katherine; McDonald, Skye; Francis, Heather] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		Osborne-Crowley, K (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	k.osbornecrowley@unsw.edu.au		Osborne-Crowley, Katherine/0000-0003-0295-1849; Francis, Heather/0000-0002-7223-7782			Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Barker C., 1994, RES METHODS CLIN COU, pxiv, 282; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Bigler E D, 1989, Brain Inj, V3, P73, DOI 10.3109/02699058909008077; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Brooks N, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI [10.1136/jnnp.46.4.336, DOI 10.1136/JNNP.46.4.336]; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Burgess P.W., 1997, HAYLING BRIXTON TEST; Monsalve BC, 2012, REV PSIQUIATR SALUD, V5, P160, DOI 10.1016/j.rpsm.2012.02.004; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crowe SF, 2013, J CLIN EXP NEUROPSYC, V35, P298, DOI 10.1080/13803395.2013.771616; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUMMINGS JL, 1997, NEUROLOGY, V48, P10, DOI DOI 10.1212/WNL.48.5_SUPPL_6.10S; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Dimarco, 2002, EURA MEDICOPHYS, V38, P167; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fleiss JH., 1981, STAT METHODS RATES P; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Jennett B, 1981, MANAGEMENT HEAD INJU; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Namiki C, 2008, NEUROCASE, V14, P474, DOI 10.1080/13554790802459494; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Shin IS, 2005, AM J GERIAT PSYCHIAT, V13, P469, DOI 10.1176/appi.ajgp.13.6.469; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Spreen O, 1991, COMPENDIUM NEUROPSYC, P219; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Votruba KL, 2008, J HEAD TRAUMA REHAB, V23, P65, DOI 10.1097/01.HTR.0000314525.93381.69; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	57	10	10	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2016	38	3					341	353		10.1080/13803395.2015.1115824			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO7TQ	WOS:000377986300009	26678068	Green Submitted			2022-02-06	
S	Pandya, JD; Sullivan, PG; Leung, LY; Ortella, FCT; Shear, DA; Deng-Bryant, Y		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Pandya, Jignesh D.; Sullivan, Patrick G.; Leung, Lai Yee; Ortella, Frank C. T.; Shear, Deborah A.; Deng-Bryant, Ying			Advanced and High-Throughput Method for Mitochondrial Bioenergetics Evaluation in Neurotrauma	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Neurotrauma; Traumatic brain injury; Mitochondria; Mitochondrial bioenergetics; Brain metabolism; Oxidative phosphorylation; Therapeutic drugs preclinical screening	TRAUMATIC BRAIN-INJURY; PERMEABILITY TRANSITION PORE; CYCLOSPORINE-A; OXIDATIVE DAMAGE; TIME-COURSE; PROTEOMIC IDENTIFICATION; CELL-DEATH; DYSFUNCTION; POSTINJURY; MODEL	Mitochondrial dysfunction is one of the key posttraumatic neuropathological events observed in various experimental models of traumatic brain injury (TBI). The extent of mitochondrial dysfunction has been associated with the severity and time course of secondary injury following brain trauma. Critically, several mitochondrial targeting preclinical drugs used in experimental TBI models have shown improved mitochondrial bioenergetics, together with cortical tissue sparing and cognitive behavioral outcome. Mitochondria, being a central regulator of cellular metabolic pathways and energy producer of cells, are of a great interest for researchers aiming to adopt cutting-edge methodology for mitochondrial bioenergetics assessment. The traditional way of mitochondrial bioenergetics analysis utilizing a Clark-type oxygen electrode (aka. oxytherm) is time-consuming and labor-intensive. In the present chapter, we describe an advanced and highthroughput method for mitochondrial bioenergetics assessments utilizing the Seahorse Biosciences XF e 24 Flux Analyzer. This allows for simultaneous measurement of multiple samples with higher efficiency than the oxytherm procedure. This chapter provides helpful guidelines for conducting mitochondrial isolation and studying mitochondrial bioenergetics in brain tissue homogenates following experimental TBI.	[Pandya, Jignesh D.; Leung, Lai Yee; Ortella, Frank C. T.; Shear, Deborah A.; Deng-Bryant, Ying] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA		Pandya, JD (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.						Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Berg J.M, 2002, BIOCHEMISTRY-US; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189; CLARK LC, 1953, SURG FORUM, V4, P93; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1289, DOI 10.1016/j.bbabio.2009.07.011; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	41	10	10	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						597	610		10.1007/978-1-4939-3816-2_32	10.1007/978-1-4939-3816-2		14	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500034	27604740				2022-02-06	
J	Paterson, TSE; Yeung, SE; Thornton, WL				Paterson, Theone S. E.; Yeung, Sophie E.; Thornton, Wendy Loken			Positive affect predicts everyday problem-solving ability in older adults	AGING & MENTAL HEALTH			English	Article						cognitive functioning; affective processing; normal aging; everyday problem-solving; positive affect	STUDIES-DEPRESSION SCALE; TRAUMATIC BRAIN-INJURY; AGE-DIFFERENCES; CES-D; INTELLECTUAL ABILITY; RENAL-DISEASE; COGNITION; VALIDITY; MORTALITY; RELIABILITY	Objectives: Increased symptom endorsement on the short form of the Centre for Epidemiologic Studies Depression (CES-D) Scale has been previously associated with lower everyday problem-solving (EPS) ability in older adults. However, given the multifactorial and complex nature of depressive symptoms, it remains unclear whether certain symptoms/aspects of depression account for this relationship. We examined established factor scores on the full version of the CES-D to assess their utility as predictors of EPS in an older adult cohort.Methods: Community-dwelling older adults (n = 103; age: 51-91) were administered the CES-D along with a measure of EPS ability assessing both social and practical EPS. Regression analyses were used to determine the relationships between variables.Results: Analyses revealed that increased CES-D scores predicted worse EPS ability in older adults ( = -.17, p < .05) beyond the effects of age, gender, and education. Regression analyses examining each CES-D factor score revealed that decreased positiveaffect (loss of hope/enjoyment in life; = -.21, p < .01) remained the only significant predictor of decreased overall EPS scores beyond demographic variables, while depressed affect, interpersonal, and somatic factors were not significant predictors. Positive affect predicted both practical, as well as social EPS scores.Conclusions: Current results extend previous findings by showing that the relationship between increased depressive symptoms and decreased EPS ability in older age may be primarily driven by anhedonia as opposed to other depressive symptoms.	[Paterson, Theone S. E.; Yeung, Sophie E.; Thornton, Wendy Loken] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada		Thornton, WL (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.	wthornto@sfu.ca		Paterson, Theone/0000-0002-5876-1991	Social Sciences and Humanities Research Council of Canada (SSHRC)Social Sciences and Humanities Research Council of Canada (SSHRC) [410-2010-0407]	This work was supported by the Social Sciences and Humanities Research Council of Canada (SSHRC) [grant number 410-2010-0407].	Allaire JC, 2006, AGING NEUROPSYCHOL C, V13, P207, DOI 10.1080/13825580490904228; Allaire JC, 2002, PSYCHOL AGING, V17, P101, DOI [10.1037//0882-7974.17.1.101, 10.1037/0882-7974.17.1.101]; Allaire JC, 1999, PSYCHOL AGING, V14, P627, DOI 10.1037/0882-7974.14.4.627; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Artistico D, 2003, PSYCHOL AGING, V18, P68, DOI 10.1037/0882-7974.18.1.68; Blanchard-Fields F, 2007, CURR DIR PSYCHOL SCI, V16, P26, DOI 10.1111/j.1467-8721.2007.00469.x; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; CLARK LA, 1989, MOTIV EMOTION, V13, P205, DOI 10.1007/BF00995536; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; DENNEY NW, 1989, PSYCHOL AGING, V4, P438, DOI 10.1037/0882-7974.4.4.438; DENNEY NW, 1981, J GERONTOL, V36, P323, DOI 10.1093/geronj/36.3.323; Devins G., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349; DIEHL M, 1995, PSYCHOL AGING, V10, P478, DOI 10.1037/0882-7974.10.3.478; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gallassi R, 2001, ARCH GERONTOL GERIAT, P163; Ganguli M, 2009, INT J GERIATR PSYCH, V24, P1277, DOI 10.1002/gps.2257; GATZ M, 1990, PSYCHOL AGING, V5, P284, DOI 10.1037/0882-7974.5.2.284; Gelb SR, 2010, NEUROPSYCHOLOGY, V24, P514, DOI 10.1037/a0018670; Gilhooly ML, 2007, BRIT J HEALTH PSYCH, V12, P587, DOI 10.1348/135910706X154477; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Haught PA, 2000, EXP AGING RES, V26, P89, DOI 10.1080/036107300243704; Haught PA, 2007, EDUC GERONTOL, V33, P395, DOI 10.1080/03601270701252856; HERTZOG C, 1990, J CONSUL CLIN PSYCHO, V2, P64, DOI DOI 10.1037/1040-3590.2.1.64; Kant GL, 1997, COGNITIVE THER RES, V21, P73, DOI 10.1023/A:1021820326754; Kasahara H., 2006, PSYCHOGERIATRICS, V6, P128; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; MARSISKE M, 1995, PSYCHOL AGING, V10, P269, DOI 10.1037/0882-7974.10.2.269; Marsiske M., 2006, HDB PSYCHOL AGING, P315, DOI [10.1016/B978-012101264-9/50017-3, DOI 10.1016/B978-012101264-9/50017-3]; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; National Institute of Mental Health, 2014, NUMB COUNT MENT DIS; O'Rourke N, 2004, EDUC PSYCHOL MEAS, V64, P973, DOI 10.1177/0013164404268668; O'Rourke N, 2005, INT J TEST, V5, P265, DOI 10.1207/s15327574ijt0503_5; Paterson TSE, 2011, CAN J BEHAV SCI, V43, P318, DOI 10.1037/a0025104; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SCHAIE KW, 1978, J GERONTOL, V33, P695, DOI 10.1093/geronj/33.5.695; Statistics Canada, 2012, LIF EXP BIRTH SEX PR; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Suija K, 2012, SCAND J PRIM HEALTH, V30, P259, DOI 10.3109/02813432.2012.732473; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P438, DOI 10.1002/art.23329; Thornton AE, 2010, J CLIN EXP NEUROPSYC, V32, P299, DOI 10.1080/13803390903002209; Thornton WL, 2007, PSYCHOL AGING, V22, P470, DOI 10.1037/0882-7974.22.3.470; Thornton WL, 2013, INT J BEHAV DEV, V37, P13, DOI 10.1177/0165025412454028; Thornton WJL, 2005, PSYCHOL AGING, V20, P85, DOI 10.1037/0882-7974.20.1.85; Verdier-Taillefer MH, 2001, NEUROEPIDEMIOLOGY, V20, P262, DOI 10.1159/000054800; Vitaliano PP, 2009, GERONTOLOGIST, V49, P12, DOI 10.1093/geront/gnp004; Weatherbee SR, 2008, PSYCHOL AGING, V23, P216, DOI 10.1037/0882-7974.23.1.216; Wilson A J 3rd, 1976, Exp Aging Res, V2, P367, DOI 10.1080/03610737608257996; Yen YC, 2011, AM J GERIAT PSYCHIAT, V19, P142, DOI 10.1097/JGP.0b013e3181e89894; Yount SE, 1998, J CLIN PSYCHOL MED S, V5, P497, DOI 10.1023/A:1026215129503; Ziv N, 1999, OCCUP THER INT, V6, P243, DOI [10.1002/oti.100, DOI 10.1002/OTI.100]	55	10	10	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1360-7863	1364-6915		AGING MENT HEALTH	Aging Ment. Health		2016	20	8					871	879		10.1080/13607863.2015.1043619			9	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	DQ5LI	WOS:000379246300013	26033072				2022-02-06	
J	Perez-Polo, JR; Rea, HC; Johnson, KM; Parsley, MA; Unabia, GC; Xu, GY; Prough, D; DeWitt, DS; Paulucci-Holthauzen, AA; Werrbach-Perez, K; Hulsebosch, CE				Perez-Polo, J. R.; Rea, H. C.; Johnson, K. M.; Parsley, M. A.; Unabia, G. C.; Xu, G. -Y.; Prough, D.; DeWitt, D. S.; Paulucci-Holthauzen, A. A.; Werrbach-Perez, K.; Hulsebosch, C. E.			Inflammatory Cytokine Receptor Blockade in a Rodent Model of Mild Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						mild traumatic brain injury; inflammation; cytokines; righting reflex response; Kineret; etanercept	NECROSIS-FACTOR-ALPHA; CLOSED-HEAD INJURY; GLIAL TNF-ALPHA; SPINAL-CORD; PERISPINAL ETANERCEPT; RAT HIPPOCAMPUS; CHRONIC STROKE; MESSENGER-RNA; PHASE-II; INTERLEUKIN-1	In rodent models of traumatic brain injury (TBI), both Interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF alpha) levels increase early after injury to return later to basal levels. We have developed and characterized a rat mild fluid percussion model of TBI (mLFP injury) that results in righting reflex response times (RRRTs) that are less than those characteristic of moderate to severe LFP injury and yet increase IL-1 alpha/beta and TNF alpha levels. Here we report that blockade of IL-1 alpha/beta and TNF alpha binding to IL-1R and TNFR1, respectively, reduced neuropathology in parietal cortex, hippocampus, and thalamus and improved outcome. IL-1 beta binding to the type I IL-1 receptor (IL-1R1) can be blocked by a recombinant form of the endogenous IL-1R antagonist IL-1Ra (Kineret). TNF alpha binding to the TNF receptor (TNFR) can be blocked by the recombinant fusion protein etanercept, made up of a TNFR2 peptide fused to an Fc portion of human IgG1. There was no benefit from the combined blockades compared with individual blockades or after repeated treatments for 11 days after injury compared with one treatment at 1 hr after injury, when measured at 6 hr or 18 days, based on changes in neuropathology. There was also no further enhancement of blockade benefits after 18 days. Given that both Kineret and etanercept given singly or in combination showed similar beneficial effects and that TNF alpha also has a gliotransmitter role regulating AMPA receptor traffic, thus confounding effects of a TNF alpha blockade, we chose to focus on a single treatment with Kineret. (C) 2015 Wiley Periodicals, Inc.	[Perez-Polo, J. R.; Rea, H. C.; Johnson, K. M.; Parsley, M. A.; Unabia, G. C.; Xu, G. -Y.; Prough, D.; DeWitt, D. S.; Paulucci-Holthauzen, A. A.; Werrbach-Perez, K.; Hulsebosch, C. E.] Univ Texas Med Branch, Galveston, TX 77555 USA		Perez-Polo, JR (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	regino.perez-polo@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X			Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Akuzawa S, 2008, J VASC SURG, V48, P694, DOI 10.1016/j.jvs.2008.04.011; Bains JS, 2007, TRENDS NEUROSCI, V30, P417, DOI 10.1016/j.tins.2007.06.007; BANKS WA, 1995, NEUROIMMUNOMODULAT, V2, P161, DOI 10.1159/000096887; Banwell V, 2009, J STROKE CEREBROVASC, V18, P269, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.009; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Brochu ME, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-55; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cavanagh C, 2011, FUTUR NEUROL, V6, P757, DOI 10.2217/FNL.11.50; Centers for Disease Control and Prevention (CDC), 2003, REP C MILD TRAUM BRA, P1; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Fabian RH, 2004, INT J DEV NEUROSCI, V22, P225, DOI 10.1016/j.ijdevneu.2004.03.006; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hu XM, 2005, J NEUROCHEM, V93, P26, DOI 10.1111/j.1471-4159.2004.02968.x; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Nesic O, 2002, J NEUROSCI RES, V68, P406, DOI 10.1002/jnr.10171; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rafati DS, 2008, J NEUROSCI RES, V86, P566, DOI 10.1002/jnr.21508; Rossi D, 2011, CNS DRUGS, V25, P641, DOI 10.2165/11593090-000000000-00000; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Spulber S, 2009, BRAIN BEHAV IMMUN, V23, P573, DOI 10.1016/j.bbi.2009.02.015; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Sumbria RK, 2013, MOL PHARMACEUT, V10, P1425, DOI 10.1021/mp400004a; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tobinick E, 2004, CURR MED RES OPIN, V20, P1075, DOI 10.1185/030079903125004286; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	65	10	10	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2016	94	1					27	38		10.1002/jnr.23617			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU7VH	WOS:000363749400003	26172557				2022-02-06	
J	Philpott, AL; Andrews, SC; Staios, M; Churchyard, A; Fisher, F				Philpott, April L.; Andrews, Sophie C.; Staios, Mathew; Churchyard, Andrew; Fisher, Fiona			Emotion Evaluation and Social Inference Impairments in Huntington's Disease	JOURNAL OF HUNTINGTONS DISEASE			English	Article						Social cognition; theory of mind; TASIT; emotion recognition; sarcasm; executive function; social communication; empathy; clinical assessment	TRAUMATIC BRAIN-INJURY; TROBE COMMUNICATION QUESTIONNAIRE; FRONTOTEMPORAL DEMENTIA; EXECUTIVE FUNCTION; BASAL GANGLIA; TEST TASIT; PERCEPTION; COGNITION; MIND; RELIABILITY	Background: Huntington's disease (HD) is an inherited neurodegenerative disorder characterised by motor, cognitive and neuropsychiatric symptoms. Recent research has established that individuals with HD display reduced discrimination of emotional facial expressions and impaired higher-order social cognitive skills, including 'theory of mind'. Objective: This study aimed to further characterise the emotion evaluation and theory of mind deficits in HD in an ecologically-valid context, and determine their impact on socially-relevant functional abilities. Methods: A sample of 17 HD participants and 24 healthy controls were assessed using The Awareness of Social Inference Test (TASIT), together with additional self-and informant rated measures of cognition, social communication, empathy and neuropsychiatric symptoms. Results: Participants with HD showed significant difficulties in evaluating negative emotions, and understanding sincere, sarcastic and 'paradoxical sarcastic' statements, compared with controls. The ability to evaluate positive emotions was negatively correlated with behavioural problems, but no other clinical, behavioural or communication measures correlated significantly with TASIT subscales. Conclusions: These findings suggest that social cognitive difficulties in symptomatic HD may be underpinned by more generalised impairments, related to deciphering social exchanges, as opposed to a selective theory of mind deficit. Such difficulties have the potential to place significant strain on interpersonal relationships, and thus warrant thorough clinical assessment, using ecologically-valid tools, to promote early detection and development of person-centred interventions.	[Philpott, April L.; Andrews, Sophie C.; Staios, Mathew; Churchyard, Andrew; Fisher, Fiona] Calvary Hlth Care Bethlehem, 476 Kooyong Rd, Caulfield, Vic 3162, Australia; [Andrews, Sophie C.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Andrews, Sophie C.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia		Fisher, F (corresponding author), Calvary Hlth Care Bethlehem, 476 Kooyong Rd, Caulfield, Vic 3162, Australia.	fiona.fisher@calvarycare.org.au	Andrews, Sophie C/H-8322-2014; Andrews, Sophie/L-8031-2019	Andrews, Sophie C/0000-0002-2103-7748; Staios, Mathew/0000-0003-3008-0753	Bethlehem Griffiths Research Foundation	The authors would like to thank all the participants who made this study possible. The authors would also like to acknowledge the Bethlehem Griffiths Research Foundation for providing the funding support for this research. Thank you to Roxanne Maule, Sally Brinkmann, Michelle Schilders, and Renee Lichter for their contributions to data collection and management during this project.	Adjeroud N, 2016, SOC COGN AFFECT NEUR, V11, P89, DOI 10.1093/scan/nsv093; Allain P, 2011, NEUROPSYCHOLOGY, V25, P741, DOI 10.1037/a0024408; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Bora E, 2016, BEHAV BRAIN RES, V297, P131, DOI 10.1016/j.bbr.2015.10.001; Brune M, 2011, MOVEMENT DISORD, V26, P671, DOI 10.1002/mds.23494; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Eddy CM, 2012, ACTA NEUROL SCAND, V126, P376, DOI 10.1111/j.1600-0404.2012.01659.x; Fisher F, 2012, J HUNTINGTONS DIS, V1, P187, DOI 10.3233/JHD-120022; Genova HM, 2016, J INT NEUROPSYCH SOC, V22, P83, DOI 10.1017/S1355617715001137; Georgiou-Karistianis N, 2013, NEUROBIOL DIS, V51, P82, DOI 10.1016/j.nbd.2012.10.001; Henley SMD, 2012, NEUROSCI BIOBEHAV R, V36, P237, DOI 10.1016/j.neubiorev.2011.06.002; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Larsen IU, 2015, NEUROPSYCHO IN PRESS, V29, P1; Loffler LAK, 2016, J COMP NEUROL, V524, P1727, DOI 10.1002/cne.23816; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Mancuso F, 2011, SCHIZOPHR RES, V125, P143, DOI 10.1016/j.schres.2010.11.007; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P619, DOI 10.1080/13803395.2011.553586; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Pell MD, 2014, NEUROPSYCHOLOGY, V28, P905, DOI 10.1037/neu0000090; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Snowden JS, 2008, NEUROPSYCHOLOGIA, V46, P2638, DOI 10.1016/j.neuropsychologia.2008.04.018; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Spreng RN, 2009, J PERS ASSESS, V91, P62, DOI 10.1080/00223890802484381; Staios M, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00178, 10.3389/fnhum.2013.00464]; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; van den Berg E, 2009, J INT NEUROPSYCH SOC, V15, P695, DOI 10.1017/S1355617709990269; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wear Helen J., 2008, Dement. neuropsychol., V2, P102, DOI 10.1590/S1980-57642009DN20200005; Westerhof-Evers HJ, 2014, J CLIN EXP NEUROPSYC, V36, P1031, DOI 10.1080/13803395.2014.966661; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	10	10	2	18	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1879-6397	1879-6400		J HUNTINGTONS DIS	J. Huntingtons Dis.		2016	5	2					175	183		10.3233/JHD-160190			9	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DQ2MW	WOS:000379037400004	27163947				2022-02-06	
J	Pourahmad, S; Hafizi-Rastani, I; Khalili, H; Paydar, S				Pourahmad, Saeedeh; Hafizi-Rastani, Iman; Khalili, Hosseinali; Paydar, Shahram			Identifying Important Attributes for Prognostic Prediction in Traumatic Brain Injury Patients	METHODS OF INFORMATION IN MEDICINE			English	Article						Prognostic prediction; traumatic brain injury patients; hybrid method; artificial neural network; decision tree	GLASGOW COMA SCALE; DECISION TREES; LOGISTIC-REGRESSION; NEURAL-NETWORKS; MODEL; RECOVERY; CANCER	Background: Generally, traumatic brain injury (TBI) patients do not have a stable condition, particularly after the first week of TBI. Hence, indicating the attributes in prognosis through a prediction model is of utmost importance since it helps caregivers with treatment-decision options, or prepares the relatives for the most-likely outcome. Objectives: This study attempted to determine and order the attributes in prognostic prediction in TBI patients, based on early clinical findings. A hybrid method was employed, which combines a decision tree (DT) and an artificial neural network (ANN) in order to improve the modeling process. Methods: The DT approach was applied as the initial analysis of the network architecture to increase accuracy in prediction. Afterwards, the ANN structure was mapped from the initial DT based on a part of the data. Subsequently, the designed network was trained and validated by the remaining data. 5-fold cross-validation method was applied to train the network. The area under the receiver operating characteristic (ROC) curve, sensitivity, specificity, and accuracy rate were utilized as performance measures. The important attributes were then determined from the trained network using two methods: change of mean squared error (MSE), and sensitivity analysis (SA). Results: The hybrid method offered better results compared to the DT method. The accuracy rate of 86.3% vs. 82.2%, sensitivity value of 55.1% vs. 47.6%, specificity value of 93.6% vs. 91.1 %, and the area under the ROC curve of 0.705 vs. 0.695 were achieved for the hybrid method and DT, respectively. However, the attributes' order by DT method was more consistent with the clinical literature. Conclusions: The combination of different modeling methods can enhance their performance. However, it may create some complexities in computations and interpretations. The outcome of the present study could deliver some useful hints in prognostic prediction on the basis of early clinical findings for TBI patients.	[Pourahmad, Saeedeh] Shiraz Univ Med Sci, Colorectal Res Ctr, Shiraz 713451874, Iran; [Pourahmad, Saeedeh; Hafizi-Rastani, Iman] Shiraz Univ Med Sci, Sch Med, Dept Biostat, Shiraz 713451874, Iran; [Khalili, Hosseinali] Shiraz Univ Med Sci, Dept Neurosurg, Shiraz Neuro Sci Res Ctr, Shiraz, Iran; [Paydar, Shahram] Shiraz Univ Med Sci, Dept Surg, Trauma Res Ctr, Shiraz, Iran		Pourahmad, S (corresponding author), Shiraz Univ Med Sci, Colorectal Res Ctr, Shiraz 713451874, Iran.; Pourahmad, S (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Biostat, Shiraz 713451874, Iran.	pourahmad@sums.ac.ir	Khalili, Hosseinali/I-1087-2016; paydar, shahram/U-3074-2018; Pourahmad, Saeedeh/S-9117-2017	Khalili, Hosseinali/0000-0002-3390-4212; paydar, shahram/0000-0002-6980-2576; Pourahmad, Saeedeh/0000-0002-7366-1059	Shiraz University of Medical Sciences Research Council [91-6166]	This work was supported by the grant number 91-6166 from Shiraz University of Medical Sciences Research Council.	Allison P, 2014, ALTERNATIVES HOSMER; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 2007, DATA MINING HOMELAND; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Bozsik J, 2013, ELECTRON ENG, V55, P95; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Jelodar S, 2014, EMERGENCY, V2, P170; Jerez-Aragones JM, 2003, ARTIF INTELL MED, V27, P45, DOI 10.1016/S0933-3657(02)00086-6; Khosravi B, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.25164; Kokol P, 2012, WIRES DATA MIN KNOWL, V2, P237, DOI 10.1002/widm.1056; Kotsiantis SB, 2013, ARTIF INTELL REV, V39, P261, DOI 10.1007/s10462-011-9272-4; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu CB, 2011, INT J MED SCI, V8, P39, DOI 10.7150/ijms.8.39; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Oh H, 2009, CRIT CARE NURSE, V29, P12, DOI 10.4037/ccn2009279; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pena Y, 2012, MEDICC REV, V14, P18, DOI 10.37757/MR2012V14.N1.5; Pourahmad S, 2013, ANN COLORECTAL RES, V1; Pourahmad Saeedeh, 2015, Glob J Health Sci, V7, P46, DOI 10.5539/gjhs.v7n6p46; Rahimi I, 2012, INT J APPL OPERAITON, V2, P69; Sakai S, 2007, METHOD INFORM MED, V46, P723, DOI 10.3414/ME9066; SETHI IK, 1990, P IEEE, V78, P1605, DOI 10.1109/5.58346; Shibuya TY, 2007, J ORAL MAXIL SURG, V65, P1693, DOI 10.1016/j.joms.2006.06.309; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Sung AH, 1998, EXPERT SYST APPL, V15, P405, DOI 10.1016/S0957-4174(98)00041-4; van der Ploeg T, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-143; Witten I., 2005, DATA MINING PRACTICA, Vsecond; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Zhu K, 2015, METHOD INFORM MED, V54, P560, DOI 10.3414/ME14-02-0017	34	10	10	0	2	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0026-1270			METHOD INFORM MED	Methods Inf. Med.		2016	55	5					440	449		10.3414/ME15-01-0080			10	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	DZ5JS	WOS:000385899000006	27492342				2022-02-06	
J	Prins, ML; Matsumoto, J				Prins, Mayumi L.; Matsumoto, Joyce			Metabolic Response of Pediatric Traumatic Brain Injury	JOURNAL OF CHILD NEUROLOGY			English	Article						traumatic brain injury; pathophysiology; child	ISCHEMIA-REPERFUSION INJURY; CEREBRAL GLUCOSE-METABOLISM; KETONE-BODY UTILIZATION; CORTICAL IMPACT INJURY; CLOSED-HEAD INJURY; KETOGENIC DIET; RAT-BRAIN; DOCOSAHEXAENOIC ACID; COGNITIVE DEFICITS; TEMPORAL WINDOW	Traumatic brain injury (TBI) in the pediatric brain presents unique challenges as the complex cascades of metabolic and biochemical responses to TBI are further complicated ongoing maturational changes of the developing brain. TBIs of all severities have been shown to significantly alter metabolism and hormones which impair the ability of the brain to process glucose for cellular energy. Under these conditions, the brain's primary fuel (glucose) becomes a less favorable fuel and the ability of the younger brain to revert to ketone metabolism can an advantage. This review addresses the potential of alternative substrate metabolic intervention as a logical pediatric TBI neuroprotective strategy.	[Prins, Mayumi L.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Prins, Mayumi L.] Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Matsumoto, Joyce] Univ Calif Los Angeles, Dept Pediat, Div Pediat Neurol, Los Angeles, CA 90095 USA		Prins, ML (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, 10833 Le Conte Ave,NPI 18-218, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS104311, P01 NS058489] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER		ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOOTH RFG, 1981, J NEUROCHEM, V37, P179, DOI 10.1111/j.1471-4159.1981.tb05306.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cekin AH, 2013, TURK J GASTROENTEROL, V24, P51, DOI 10.4318/tjg.2013.0645; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; DAHLQUIST G, 1976, PEDIATR RES, V10, P910, DOI 10.1203/00006450-197611000-00002; DANIEL PM, 1971, LANCET, V2, P637; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gorur S, 2005, CELL BIOCHEM FUNCT, V23, P151, DOI 10.1002/cbf.1159; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Green P, 1998, J NEUROSCI RES, V52, P129, DOI 10.1002/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Hattori N, 2003, J NUCL MED, V44, P1709; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; HAWKINS RA, 1971, BIOCHEM J, V121, pP17; Hovda D.A., 1996, NEUROTRAUMA, P1459; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; HOVDA DA, 1990, ACT NEUR S, V51, P331; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; JUSTO MCM, 2011, NUTR HOSP, V26, P1120, DOI DOI 10.3305/NH.2011.26.5.5133; Katakura M, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/490476; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kim Yu Jin, 2012, Korean J Pediatr, V55, P238, DOI 10.3345/kjp.2012.55.7.238; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; KLENK E, 1958, J NEUROCHEM, V2, P233, DOI 10.1111/j.1471-4159.1958.tb12369.x; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LAMERS KJB, 1985, CLIN CHIM ACTA, V145, P17, DOI 10.1016/0009-8981(85)90015-4; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Leino RL, 1999, DEV BRAIN RES, V113, P47, DOI 10.1016/S0165-3806(98)00188-6; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mehta NM, 2012, CRIT CARE MED, V40, P2204, DOI 10.1097/CCM.0b013e31824e18a8; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; MOHRHAUER H, 1963, J NEUROCHEM, V10, P523, DOI 10.1111/j.1471-4159.1963.tb09855.x; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; NEHLIG A, 1991, NEUROSCIENCE, V40, P871, DOI 10.1016/0306-4522(91)90018-J; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Onem G, 2006, J SURG RES, V131, P124, DOI 10.1016/j.jss.2005.12.017; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; PAGE MA, 1971, BIOCHEM J, V121, P49, DOI 10.1042/bj1210049; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; SAUDUBRAY JM, 1981, J PEDIATR-US, V98, P904, DOI 10.1016/S0022-3476(81)80583-5; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; SOKOLOFF L, 1973, ANNU REV MED, V24, P271, DOI 10.1146/annurev.me.24.020173.001415; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Taha AA, 2011, J NEUROSCI NURS, V43, P291, DOI 10.1097/JNN.0b013e318234e9b2; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vannucci RC, 2000, SEMIN PERINATOL, V24, P107, DOI 10.1053/sp.2000.6361; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; WORLEY G, 1995, DEV MED CHILD NEUROL, V37, P213; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	89	10	10	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		28	34		10.1177/0883073814549244			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400003	25336427	Green Accepted			2022-02-06	
J	Rumrill, P; Elias, E; Hendricks, DJ; Jacobs, K; Leopold, A; Nardone, A; Sampson, E; Scherer, M; Stauffer, C; McMahon, BT				Rumrill, Phillip; Elias, Eileen; Hendricks, Deborah J.; Jacobs, Karen; Leopold, Anne; Nardone, Amanda; Sampson, Elaine; Scherer, Marcia; Stauffer, Callista; McMahon, Brian T.			Promoting cognitive support technology use and employment success among postsecondary students with traumatic brain injuries	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Traumatic brain injury (TBI); vocational rehabilitation (VR); assistive technology (AT)	VOCATIONAL-REHABILITATION SERVICES; U.S.-INTERAGENCY-COMMITTEE; POSITIVE PSYCHOLOGY; TRANSITION; VETERANS; BENEFITS; YOUTH; STATE	OBJECTIVE: This article applies positive psychology principles to the purpose and objectives of a five-year, federally-funded initiative to provide cognitive support technology (CST) training and career preparatory services for undergraduate college students with mild and moderate traumatic brain injuries (TBI). METHODS: A total of 48 students with TBI have participated in the project during its first 18 months of operation - 14 of whom are military veterans with disabilities who were in the Iraq and/or Afghanistan theaters. CONCLUSION: Positive psychology interventions such as Best Possible Self, Intensely Positive Experiences, and Asset-based Assessments provide a framework for examining the activities of this multi-site development project.	[Rumrill, Phillip; Stauffer, Callista] Kent State Univ, Kent, OH 44242 USA; [Elias, Eileen; Leopold, Anne] JBS Int Inc, North Bethesda, MD USA; [Hendricks, Deborah J.; Sampson, Elaine] West Virginia Univ, Morgantown, WV 26506 USA; [Jacobs, Karen; Nardone, Amanda] Boston Univ, Boston, MA 02215 USA; [Scherer, Marcia] Univ Rochester, Rochester, NY USA; [McMahon, Brian T.] Virginia Commonwealth Univ, Richmond, VA USA		Rumrill, P (corresponding author), Kent State Univ, Ctr Disabil Studies, 413 White Hall,POB 5190, Kent, OH 44242 USA.	Prumrill@kent.edu		Jacobs, Karen/0000-0002-4718-990X			Adya M, 2012, COGN PROCESS, V13, pS75, DOI 10.1007/s10339-012-0466-8; Ashman TA, 2006, MT SINAI J MED, V73, P999; Blanck P, 2014, BEHAV SCI LAW, V32, P4, DOI 10.1002/bsl.2101; Bodine C, 2006, DISABIL REHABIL, V28, P1567, DOI 10.1080/09638280601071151; Brown J., 2013, VETERANS MILD TRAUMA; Bureau of Labor Statistics, 2011, USDL121125 BUR LAB S; CARROLL JM, 1993, INTERACT COMPUT, V5, P3, DOI 10.1016/0953-5438(93)90022-L; Chapin M., 2012, NEW DIRECTIONS REHAB, P236; Chiu CY, 2013, MULT SCLER J, V19, P1655, DOI 10.1177/1352458513482372; Chou CC, 2013, REHABIL RES POL EDUC, V27, P131, DOI 10.1891/2168-6653.27.3.131; Chou CC, 2013, REHABIL RES POL EDUC, V27, P126, DOI 10.1891/2168-6653.27.3.126; Defense and Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRAIN; Ditchman N., 2013, CAREER DEV EMPLOYMEN, P343; Faul M, 2010, TRAUMATIC BRAIN INJU; Federici S, 2014, TECHNOL DISABIL, V26, P27, DOI DOI 10.3233/TAD-140402; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; JOHNSTONE B, 1994, J CLIN PSYCHOL MED S, V1, P375, DOI 10.1007/BF01991080; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; King LA, 2001, PERS SOC PSYCHOL B, V27, P798, DOI 10.1177/0146167201277003; National Association of State Head Injury Administrators, 2006, TRAUM BRAIN INJ FACT; Parks AC, 2011, J POSIT PSYCHOL, V6, P429, DOI 10.1080/17439760.2011.637729; Rath T, 2010, WELLBEING 5 ESSENTIA; ROESSLER RT, 2006, CASE MANAGEMENT REHA; RUBIN SE, 2008, FDN VOCATIONAL REHAB; Rumrill P., 2014, AM PSYCHOL ASS HDB C, P139; Rumrill P., 2015, J HEAD TRAUMA REHABI; Sauer A. L., 2010, DISABILITY REHABILIT, V5, P1; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Scherer M, 2007, DISABIL REHABIL-ASSI, V2, P1, DOI 10.1080/17483100600845414; Scherer MJ, 2006, DISABIL REHABIL-ASSI, V1, P257, DOI 10.1080/17483100600982977; Scherer MJ, 2014, DISABIL REHABIL-ASSI, V9, P1, DOI 10.3109/17483107.2013.870239; Scherer MJ, 2005, DISABIL REHABIL, V27, P731, DOI 10.1080/09638280400014816; Scherer MJ, 2005, MATCHING PERSON TECH; Scherer MJ, 2005, CRIT REV PHYS REHABI, V17, P195, DOI [DOI 10.1615/CritRevPhysRehabilMed.v17.i3.30, DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.30]; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Smart J., 2009, DISABILITY SOC INDIV; Stock S., 2006, EMPLOYMENT PERSONS B; Strauser D. R., 2013, CAREER DEV EMPLOYMEN; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thurman, 2001, HEAD TRAUMA BASIC PR, P1193; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Toriello P, 2012, NEW DIRECTIONS REHAB, P1; Toriello P., 2012, NEW DIRECTIONS REHAB; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P., 2013, LIFE CLASSROOM; Wehman P., J POSTSECON IN PRESS; Wehman P, 2015, J OCCUP REHABIL, V25, P323, DOI 10.1007/s10926-014-9541-6; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029; Wehmeyer M. L., 2003, INT REV RES MENTAL R; White GW, 2010, J DISABIL POLICY STU, V20, P233, DOI 10.1177/1044207309350561; [No title captured]	54	10	10	1	14	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2016	45	1					53	61		10.3233/JVR-160810			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EB7NJ	WOS:000387574300006		Green Published			2022-02-06	
J	Saine, L; Helie, P; Vachon, P				Saine, Laurence; Helie, Pierre; Vachon, Pascal			Effects of fentanyl on pain and motor behaviors following a collagenase-induced intracerebral hemorrhage in rats	JOURNAL OF PAIN RESEARCH			English	Article						analgesia; brain trauma; cephalagia; grimace scale; histopathology; neurological exam	CEREBRAL-ISCHEMIA; BRAIN; MANAGEMENT; ANALGESIA; MORPHINE; DEXAMETHASONE; GUIDELINES; HEMATOMA; SEDATION; HEALTH	Purpose: Intracerebral hemorrhage (IH) and cephalalgia are common consequences of traumatic brain injury. One of the primary obstacles for patient recovery is the paucity of treatments to support an appropriate analgesic protocol. The present study aimed to assess pain and motor behaviors following different doses of fentanyl on a rat model of IH. Methods: Twenty-one male Sprague Dawley rats underwent a stereotaxic surgery to produce a collagenase-induced IH in the right caudoputamen nucleus. The control group (n=6) received saline subcutaneously (SC), and experimental groups received either 5 (n=6), 10 (n=6), or 20 (n=3) mu g/kg of fentanyl SC, 2 hours following surgery and on 2 subsequent days. Only 3 animals received 20 mu g/kg because this dose caused catalepsy for 15-20 minutes following the injection. The rat grimace scale, a neurological examination, balance beam test, and rotarod test were performed for 5 consecutive days postoperatively to evaluate pain and motor performance. At the end of the experimentation, the brains were evaluated to determine hematoma volume, and the number of reactive astrocytes and necrotic neurons. Results: When compared to controls, the grimace scale showed that 5 mu g/kg fentanyl significantly alleviated pain on day 2 only (P<0.01) and that 10 mu g/kg alleviated pain on days 1 (P<0.01), 2 (P<0.001), and 3 (P<0.01). For the rotarod test, only the 10 mu g/kg group showed significant decreases in performance on days 5 (P<0.05) and 6 (P<0.02). The neurological examination was not significantly different between the groups, but only the hopping test showed poor recuperation for the 5 and 10 mu g/kg fentanyl group when compared to saline (P<0.01). No differences were found between the groups for the balance beam test, the histopathological results. Conclusion: Fentanyl, at a dose of 10 mu g/kg SC, provides substantial analgesia following a collagenase-induced IH in rats; however, it can alter motor performance following analgesic treatments.	[Saine, Laurence; Vachon, Pascal] Univ Montreal, Fac Vet Med, Dept Vet Biomed, 3200 Sicotte, St Hyacinthe, PQ J2S 7C6, Canada; [Helie, Pierre] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada		Vachon, P (corresponding author), Univ Montreal, Fac Vet Med, Dept Vet Biomed, 3200 Sicotte, St Hyacinthe, PQ J2S 7C6, Canada.	pascal.vachon@umontreal.ca			Fond de Developpement pour la Medecine des Animaux de Laboratoire	This study was supported by the Fond de Developpement pour la Medecine des Animaux de Laboratoire (Pascal Vachon). The authors would like to acknowledge the assistance of Guy Beauchamp (Faculty of Veterinary Medicine University of Montreal) for statistical analyses.	Armitage-Chan EA, 2007, J VET EMERG CRIT CAR, V17, P5, DOI 10.1111/j.1476-4431.2006.00194.x; Attal N, 1998, EUR NEUROL, V40, P191, DOI 10.1159/000007979; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burstein R, 2004, PROG PAIN RES MANAG, V31, P211; Castel A, 2014, J PAIN RES, V7, DOI 10.2147/JPR.S55201; Chauvin M, 2005, PHARM DOULEUR, P39; Christensen H, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00008; Clark JD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-28; Deschamps J-Y, 2010, VADE MECUM GESTION D; Engelhard K, 2003, ANESTH ANALG, V96, P524, DOI 10.1097/00000539-200302000-00041; GRANT D, 2006, PAIN MANAGEMENT SMAL; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Keep RF, 2008, ACT NEUR S, V105, P73; Lema PP, 2005, CAN J VET RES, V69, P253; Lema PP, 2004, J VET PHARMACOL THER, V27, P321, DOI 10.1111/j.1365-2885.2004.00597.x; Lu J, 2005, ACT NEUR S, V95, P281; Martin JL, 2010, AM J PATHOL, V176, P786, DOI 10.2353/ajpath.2010.090457; Meert TF, 2005, PHARMACOL BIOCHEM BE, V80, P309, DOI 10.1016/j.pbb.2004.12.002; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Niu L, 2009, HIPPOCAMPUS, V19, P649, DOI 10.1002/hipo.20540; Oliver V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097882; Ronaldson PT, 2011, THER DELIV, V2, P1015, DOI [10.4155/tde.11.67, 10.4155/TDE.11.67]; Savard C, 2009, COMPARATIVE MED, V59, P444; SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Teitelbaum JS, 2011, CAN J NEUROL SCI, V38, P815, DOI 10.1017/S0317167100012385; Torbey MT, 2015, NEUROCRIT CARE, V22, P146, DOI 10.1007/s12028-014-0085-6; Vachon P, 1999, SCI TECH ANIM LAB, V24, P171; VANDENHOOGEN RHWM, 1987, ANESTHESIOLOGY, V66, P186, DOI 10.1097/00000542-198702000-00013; Williams E, 2011, ESSENTIALS OF PAIN MANAGEMENT, P367, DOI 10.1007/978-0-387-87579-8_17; Witt KA, 2006, AAPS J, V8, pE76, DOI 10.1208/aapsj080109; Yang F, 2014, NEUROSCI BULL, V30, P887, DOI 10.1007/s12264-014-1477-5	35	10	10	0	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-7090			J PAIN RES	J. Pain Res.		2016	9						1039	1048		10.2147/JPR.S121415			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE7XZ	WOS:000389840000002	27895509	Green Published, gold, Green Submitted			2022-02-06	
J	Sfera, A; Cummings, M; Osorio, C				Sfera, Adonis; Cummings, Michael; Osorio, Carolina			Dehydration and Cognition in Geriatrics: A Hydromolecular Hypothesis	FRONTIERS IN MOLECULAR BIOSCIENCES			English	Article						dehydration; aquaporins; extracellular space; protein folding; protein conformational dynamics	MESSENGER-RNA EXPRESSION; TRAUMATIC BRAIN-INJURY; SUBFORNICAL ORGAN; AQUAPORIN EXPRESSION; AQP4 EXPRESSION; WATER; EDEMA; ASTROCYTES; MELATONIN; MODEL	Dehydration is one of the ten most frequent diagnoses responsible for the hospital admission of elderly in the United States. It is associated with increased mortality, morbidity and an estimated cost of 1.14 billion per year (Xiao et al., 2004; Schlanger et al., 2010; Pretorius et al., 2013; Frangeskou et al., 2015). Older individuals are predisposed to dehydration encephalopathy as a result of decreased total body water (TBW) and diminished sensation of thirst. We hypothesize that thirst blunting in older individuals is the result of a defective microRNA-6842-3p failing to silence the expression of the vesicular GABA transporters (VGAT) and alpha 7 cholinergic nicotinic receptors in the subfornical organ (SFO) of the hypothalamus. We hypothesize further that resultant dehydration facilitates protein misfolding and aggregation, predisposing to neurocognitive disorders. We completed a search of predicted microRNA targets, utilizing the public domain tool miRDB and found that microRNA-6842-3p modulates the SLC6A1 and CHRNA7 genes both of which were previously hypothesized to inhibit the thirst sensation by their action on SFO. The primary aim of this article is to answer two questions: Can prevention and correction of dehydration in elderly lower age-related cognitive deterioration? Can exosomal miR-6842 in the peripheral blood predict dehydration encephalopathy in elderly?	[Sfera, Adonis; Osorio, Carolina] Loma Linda Univ, Dept Psychiat, Loma Linda, CA 92350 USA; [Sfera, Adonis; Cummings, Michael] Patton State Hosp, Patton, CA 92369 USA		Sfera, A (corresponding author), Loma Linda Univ, Dept Psychiat, Loma Linda, CA 92350 USA.; Sfera, A; Cummings, M (corresponding author), Patton State Hosp, Patton, CA 92369 USA.	dr.sfera@gmail.com; Michael.Cummings@DSH.ca.gov					Akhmedov K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084793; Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Aoki-Yoshino K, 2005, ACTA NEUROPATHOL, V110, P281, DOI 10.1007/s00401-005-1052-2; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Bhattacharya P, 2014, LIFE SCI, V100, P97, DOI 10.1016/j.lfs.2014.01.085; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Chen YS, 2012, NAT NANOTECHNOL, V7, P197, DOI [10.1038/NNANO.2012.7, 10.1038/nnano.2012.7]; Chong SH, 2015, ACCOUNTS CHEM RES, V48, P956, DOI 10.1021/acs.accounts.5b00032; Collet O, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554731; Cowen LE, 2013, ENDOCRIN METAB CLIN, V42, P349, DOI 10.1016/j.ecl.2013.02.005; Craddock TJA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002421; Davis DHJ, 2012, BRAIN, V135, P2809, DOI 10.1093/brain/aws190; de Ronde W, 2012, BIOPHYS J, V103, P1097, DOI 10.1016/j.bpj.2012.07.040; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Florence CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051124; Foglio E, 2010, CURR NEUROPHARMACOL, V8, P112, DOI 10.2174/157015910791233150; Frangeskou M, 2015, J NUTR HEALTH AGING, V19, P619, DOI 10.1007/s12603-015-0491-2; Fuxe K, 2007, J NEURAL TRANSM, V114, P49, DOI 10.1007/s00702-006-0589-0; Genereux JC, 2015, PRION, V9, P10, DOI 10.1080/19336896.2015.1011887; George J, 2004, J GERONTOL A-BIOL, V59, P811; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; Guo W, 2014, IMMUNOPHARM IMMUNOT, V36, P211, DOI 10.3109/08923973.2014.913616; Han JH, 2013, CLIN GERIATR MED, V29, P101, DOI 10.1016/j.cger.2012.09.005; He L, 2014, NEUROCHEM RES, V39, P2251, DOI 10.1007/s11064-014-1427-7; Hindmarch C, 2008, AM J PHYSIOL-REG I, V295, pR1914, DOI 10.1152/ajpregu.90560.2008; Honda E, 2003, J NEUROENDOCRINOL, V15, P770, DOI 10.1046/j.1365-2826.2003.01057.x; Hooper L, 2014, MECH AGEING DEV, V136, P50, DOI 10.1016/j.mad.2013.11.009; Hu Hua, 2005, J Zhejiang Univ Sci B, V6, P33, DOI 10.1631/jzus.2005.B0033; Inouye SK, 1998, CLIN GERIATR MED, V14, P745; Ker YC, 1998, FOOD SCI TECHNOL-LEB, V31, P107; Kidd BA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000484; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lan YL, 2016, MOL NEUROBIOL, V53, P5300, DOI 10.1007/s12035-015-9446-1; Lee MR, 2013, NEUROPSYCHOPHARMACOL, V38, P437, DOI 10.1038/npp.2012.198; Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Lin L, 2013, INT J MOL SCI, V14, P14575, DOI 10.3390/ijms140714575; Mancuso JJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00130; McCook O, 2012, CRIT CARE, V16, DOI 10.1186/cc11430; Meng SZ, 2004, EUR J NEUROSCI, V19, P2261, DOI 10.1111/j.0953-816X.2004.03315.x; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; Morelli M, 2010, PROG BRAIN RES, V183, P183, DOI 10.1016/S0079-6123(10)83010-9; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nakamura K, 2014, NEUROIMAGE-CLIN, V6, P166, DOI 10.1016/j.nicl.2014.08.014; Ogawa E, 2011, CLINICS PRACT, V1, P15, DOI 10.4081/cp.2011.e9; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108; Ono K, 2008, NEUROSCIENCE, V154, P994, DOI 10.1016/j.neuroscience.2008.04.028; Phillips RS, 2002, J MOL CATAL B-ENZYM, V19, P103, DOI 10.1016/S1381-1177(02)00156-X; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Pretorius RW, 2013, AM FAM PHYSICIAN, V87, P329; Qi HL, 2013, ANAL METHODS-UK, V5, P612, DOI 10.1039/c2ay26054a; Reyes-Haro D, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/474917; Riebl SK, 2013, ACSMS HEALTH FIT J, V17, P21, DOI 10.1249/FIT.0b013e3182a9570f; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Schlanger LE, 2010, ADV CHRONIC KIDNEY D, V17, P308, DOI 10.1053/j.ackd.2010.03.008; Sen S, 2014, J THEOR BIOL, V363, P169, DOI 10.1016/j.jtbi.2014.07.025; Sfera A, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00057; Smythies J, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00038; St Hillaire C, 2005, J NEUROVIROL, V11, P535, DOI 10.1080/13550280500385203; Stoppini M, 2009, CLIN CHEM LAB MED, V47, P627, DOI 10.1515/CCLM.2009.164; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044195; Subburaman TT, 2011, ANN NEUROSCI, V18, P109, DOI 10.5214/ans.0972.7531.1118306; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tanaka J, 2003, BRAIN RES BULL, V61, P497, DOI 10.1016/S0361-9230(03)00186-2; Tanaka M, 2007, J NEUROL NEUROSUR PS, V78, P990, DOI 10.1136/jnnp.2006.114165; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Trinh-Trang-Tan MM, 2003, AM J PHYSIOL-REG I, V285, pR1355, DOI 10.1152/ajpregu.00207.2003; Utsugisawa K, 1999, NEUROSCI LETT, V270, P145, DOI 10.1016/S0304-3940(99)00473-5; Vajda T, 2014, J PEPT SCI, V20, P747, DOI 10.1002/psc.2671; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; WARREN JL, 1994, AM J PUBLIC HEALTH, V84, P1265, DOI 10.2105/AJPH.84.8.1265; Xiao H, 2004, AM J HEALTH-SYST PH, V61, P2534, DOI 10.1093/ajhp/61.23.2534; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang M, 2013, J CELL BIOCHEM, V114, P111, DOI 10.1002/jcb.24308; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang J, 2016, NEUROSCI LETT, V614, P7, DOI 10.1016/j.neulet.2015.12.057; Zhang N, 2015, MULT SCLER J, V21, P1839, DOI 10.1177/1352458515576982; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060553	84	10	10	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-889X		FRONT MOL BIOSCI	Front. Mol. Biosci.		2016	3								18	10.3389/fmolb.2016.00018			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VH8CX	WOS:000455328600018	27252943	Green Published, gold			2022-02-06	
J	Shetty, T; Raince, A; Manning, E; Tsiouris, AJ				Shetty, Teena; Raince, Avtar; Manning, Erin; Tsiouris, Apostolos John			Imaging in Chronic Traumatic Encephalopathy and Traumatic Brain Injury	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						CTE; chronic traumatic encephalopathy; concussion; concussion in sports; traumatic brain injury (TBI); head trauma; tauopathy	MINOR HEAD-INJURY; WHITE-MATTER ABNORMALITIES; PROTON MR SPECTROSCOPY; FOOTBALL-LEAGUE PLAYER; DIFFUSE AXONAL INJURY; NEW-ORLEANS CRITERIA; WAR VETERANS; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; MULTIDETECTOR CT	Context: The diagnosis of chronic traumatic encephalopathy (CTE) can only be made pathologically, and there is no concordance of defined clinical criteria for premorbid diagnosis. The absence of established criteria and the insufficient imaging findings to detect this disease in a living athlete are of growing concern. Evidence Acquisition: The article is a review of the current literature on CTE. Databases searched include Medline, PubMed, JAMA evidence, and evidence-based medicine guidelines Cochrane Library, Hospital for Special Surgery, and Cornell Library databases. Study Design: Clinical review. Level of Evidence: Level 4. Results: Chronic traumatic encephalopathy cannot be diagnosed on imaging. Examples of imaging findings in common types of head trauma are discussed. Conclusion: Further study is necessary to correlate the clinical and imaging findings of repetitive head injuries with the pathologic diagnosis of CTE.	[Shetty, Teena; Manning, Erin] Hosp Special Surg, Belaire Bldg,525 East 71st St, New York, NY 10021 USA; [Raince, Avtar] New York Hosp Queens, New York, NY USA; [Tsiouris, Apostolos John] New York Presbyterian Hosp, New York, NY USA		Shetty, T (corresponding author), Hosp Special Surg, Belaire Bldg,525 East 71st St, New York, NY 10021 USA.	shettyt@hss.edu			GE-NFL	The following authors declared potential conflicts of interest: Teena Shetty, MD, MPhil, is a member of the GE-NFL Medical Advisory Board and has grants/grant pending from GE-NFL; Apostolos John Tsiouris, MD, has provided expert testimony for criminal, medical malpractice, and personal injury litigation.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Bosemani T, 2014, J NEUROIMAGING, V24, P221, DOI 10.1111/jon.12051; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P330, DOI 10.1097/TA.0b013e31823de8a0; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chen WW, 2014, RADIOLOGY, V270, P496, DOI 10.1148/radiol.13122640; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Chin LS, 2011, US NEUROL, V7, P33; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Compagnone C, 2005, NEUROSURGERY, V57, P1183; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Glauser J, 2004, CLEV CLIN J MED, V71, P353, DOI 10.3949/ccjm.71.4.353; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Granacher Jr RP, 2007, TRAUMATIC BRAIN INJU; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kazemi NJ, 1997, EPILEPSIA, V38, P670, DOI 10.1111/j.1528-1157.1997.tb01236.x; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; LAINE FJ, 1995, AM J ROENTGENOL, V165, P967, DOI 10.2214/ajr.165.4.7677003; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lin A.P, 2010, NEUROCHEMICAL CHANGE; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinney A, 2007, EUR J RADIOL, V62, P385, DOI 10.1016/j.ejrad.2007.01.008; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Ragaisis Vytautas, 2002, Medicina (Kaunas), V38, P243; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Singer MB, 1998, RADIOLOGY, V208, P417, DOI 10.1148/radiology.208.2.9680570; Sliker CW, 2008, RADIOGRAPHICS, V28, P1689, DOI 10.1148/rg.286085521; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stuckey SL, 2007, AM J ROENTGENOL, V189, P913, DOI 10.2214/AJR.07.2424; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Yilmazlar S, 2005, ACTA NEUROCHIR, V147, P1241, DOI 10.1007/s00701-005-0623-2; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	106	10	10	6	28	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2016	8	1					26	36		10.1177/1941738115588745			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DH1EI	WOS:000372526800003	26733590	Green Published			2022-02-06	
J	Siman-Tov, M; Radomislensky, I; Knoller, N; Bahouth, H; Kessel, B; Klein, Y; Michaelson, M; Rivkind, BMA; Shaked, G; Simon, D; Soffer, D; Stein, M; Jeroukhimov, I; Peleg, K				Siman-Tov, Maya; Radomislensky, Irina; Knoller, Nachshon; Bahouth, Hany; Kessel, Boris; Klein, Yoram; Michaelson, Moshe; Rivkind, Bala Miklosh Avraham; Shaked, Gad; Simon, Daniel; Soffer, Dror; Stein, Michael; Jeroukhimov, Igor; Peleg, Kobi			Incidence and injury characteristics of traumatic brain injury: Comparison between children, adults and seniors in Israel	BRAIN INJURY			English	Article						Epidemiology; mortality; trauma; trends	HEAD-INJURY; MORTALITY; MANAGEMENT; TRENDS; IMPACT	Aim: To assess the incidence and injury characteristics of hospitalized trauma patients diagnosed with TBI. Methods: A retrospective study of all injured hospitalized patients recorded in the National Trauma Registry at 19 trauma centres in Israel between 2002-2011. Incidence and injury characteristics were examined among children, adults and seniors. Results: The annual incidence rate of hospitalized TBI for the Israeli population in 2011 was 31.8/100 000. Age-specific incidence was highest among seniors with a dramatic decrease in TBI-related mortality rate among them. Adults, in comparison to children and seniors, had higher rates of severe TBI, severe and critical injuries, more admission to the intensive care unit, underwent surgery, were hospitalization for more than 2 weeks and were discharged to rehabilitation. After adjusting for age, gender, ethnicity, mechanism of injury and injury severity score, TBI-related in-hospital mortality was higher among seniors and adults compared to children. Conclusion: Seniors are at high risk for TBI-related in-hospital mortality, although adults had more severe and critical injuries and utilized more hospital resources. However, seniors showed the most significant reduction in mortality rate during the study period. Appropriate intervention programmes should be designed and implemented, targeted to reduce TBI among high risk groups.	[Siman-Tov, Maya; Radomislensky, Irina; Bahouth, Hany; Kessel, Boris; Klein, Yoram; Michaelson, Moshe; Rivkind, Bala Miklosh Avraham; Shaked, Gad; Simon, Daniel; Soffer, Dror; Stein, Michael; Jeroukhimov, Igor; Peleg, Kobi] Gertner Inst Epidemiol & Publ Hlth Policy, Israel Natl Ctr Trauma & Emergency Med, Tel Hashomer, Israel; [Knoller, Nachshon] Chaim Sheba Med Ctr, Dept Neurosurg, IL-52621 Tel Hashomer, Israel; [Peleg, Kobi] Tel Aviv Univ, Sch Publ Hlth, Dept Disaster Management, IL-69978 Tel Aviv, Israel		Peleg, K (corresponding author), Chaim Sheba Med Ctr, Israel Natl Ctr Trauma & Emergency Med Res, Gertner Inst Epidemiol & Hlth Policy Res, IL-52621 Tel Hashomer, Israel.	kobip@gertner.health.gov.il					[Anonymous], FALLS OLD AD OV HOM; [Anonymous], 2013, COUNTR AND AR; CDC, 1995, MOD STAT VIT STAT AC; CDC, 2003, MED EX COR HDB DEATH; Champion HR, 1995, TRAUMA, P53; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hall SE, 2000, AUST NZ J MED, V30, P327, DOI 10.1111/j.1445-5994.2000.tb00833.x; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Information Center, 2012, STAT ABSTR ISR; Israeli Ministry of Health, 2003, HOM INJ FALLS ISR PO; Jaffe DH, 2010, ANN SURG, V251, P138, DOI 10.1097/SLA.0b013e3181b5d7ab; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kelly DF, 2001, WORLD J SURG, V25, P1179; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rozenfeld M, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041042; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAS, 2008, SAS STAT US GUID VER; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Siman-Tov M, 2013, INJURY, V44, P1448, DOI 10.1016/j.injury.2012.08.054; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; US Department of Transportation; National Highway Traffic Safety Administration, 2008, 810877W DOT HS NAT H; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wilkins K, 1998, Health Rep, V10, P47	34	10	10	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	1					83	89		10.3109/02699052.2015.1104551			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DJ8YT	WOS:000374501200012	26734841				2022-02-06	
J	Simon, D; do Nascimento, RIM; Rodrigues, EM; Bencke, J; Regner, A				Simon, Daniel; Moreira do Nascimento, Rita Iara; Rodrigues Filho, Edison Moraes; Bencke, Jane; Regner, Andrea			Plasma brain-derived neurotrophic factor levels after severe traumatic brain injury	BRAIN INJURY			English	Article						BDNF; biomarker; multi-trauma; outcome; severe TBI	NERVE GROWTH-FACTOR; SEVERE HEAD-INJURY; UP-REGULATION; SERUM S100B; RAT-BRAIN; TNF-ALPHA; EXPRESSION; NEUROPROTECTION; CHILDREN; NEURONS	Objective: Severe traumatic brain injury (TBI) is associated with a 30-70% mortality rate. Nevertheless, in clinical practice there are no effective biomarkers for the prediction of fatal outcome following severe TBI. Therefore, the aim was to determine whether brain-derived neurotrophic factor (BDNF) plasma levels are associated with intensive care unit (ICU) mortality in patients with severe TBI. Methods: This prospective study enrolled 120 male patients who suffered severe TBI (Glasgow Coma Scale 3-8 at emergency room admission). The plasma BDNF level was determined at ICU admission (mean 6.4 hours after emergency room admission). Results: Severe TBI was associated with a 35% mortality rate and 64% of the patients presented severe TBI with multi-trauma. The mean plasma BDNF concentration among the severe TBI victims was 704.2 +/- 63.4 pg ml(-1) (+/-SEM). Nevertheless, there were no significant differences between BDNF levels in the survivor (700.2 +/- 82.8 pg ml(-1)) or non-survivor (711.6 +/- 97.4 pg ml(-1)) groups (p = 0.238) or in the isolated TBI (800.4 +/- 117.4 pg ml(-1)) or TBI with multi-trauma groups (650.5 +/- 73.9 pg ml(-1)) (p = 0.109). Conclusions: Plasma BDNF concentrations did not correlate with either short-term fatal outcome or type of injury following severe TBI.	[Simon, Daniel; Moreira do Nascimento, Rita Iara; Rodrigues Filho, Edison Moraes; Regner, Andrea] Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicada Saud, Canoas, Brazil; [Simon, Daniel; Bencke, Jane; Regner, Andrea] Univ Luterana Brasil, Lab Biomarcadores Trauma, Canoas, Brazil; [Simon, Daniel; Regner, Andrea] Univ Luterana Brasil, Curso Med, Canoas, Brazil		Regner, A (corresponding author), Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicada Saud, Ave Farroupilha,8001,Predio 22,5o Andar, BR-92425900 Canoas, RS, Brazil.	regner@uol.com.br	Simon, Daniel/A-9087-2011; Regner, Andrea/M-2596-2014	Simon, Daniel/0000-0003-1122-8468; Regner, Andrea/0000-0002-6657-7991	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [568691/2008-3]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [09/0041-5, 1630-25.51/09-0]	The present study received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; research grant 568691/2008-3) and from Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS; research grant 09/0041-5, 1630-25.51/09-0).	Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Faul M, 2010, TRAUMATIC BRAIN INJU; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Herrmann M, 2001, NEUROSURGERY, V49, P1272, DOI 10.1097/00006123-200111000-00058; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kalish H, 2010, J CHROMATOGR B, V878, P194, DOI 10.1016/j.jchromb.2009.10.022; Kim DH, 2005, NEUROCRIT CARE, V3, P71, DOI 10.1385/NCC:3:1:071; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Moris G, 2003, NEUROLOGIA, V18, P18; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Crespo ART, 2007, BRAIN INJURY, V21, P441, DOI 10.1080/02699050701311125; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Rodrigues EM, 2014, J NEUROTRAUM, V31, P1639, DOI 10.1089/neu.2013.3178; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Scharfman Helen E, 2005, Epilepsy Curr, V5, P83, DOI 10.1111/j.1535-7511.2005.05312.x; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Sharma HS, 2007, PROG BRAIN RES, V162, P459, DOI 10.1016/S0079-6123(06)62023-2; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Song C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-59; Woertgen C, 2000, J TRAUMA, V49, P570, DOI 10.1097/00005373-200009000-00033; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160; ZAFRA F, 1992, J NEUROSCI, V12, P4793	51	10	13	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	1					23	28		10.3109/02699052.2015.1077993			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DJ8YT	WOS:000374501200004	26555864				2022-02-06	
J	Spikman, JM; Timmerman, ME; Coers, A; van der Naalt, J				Spikman, Jacoba M.; Timmerman, Marieke E.; Coers, Annemiek; van der Naalt, Joukje			Early Computed Tomography Frontal Abnormalities Predict Long-Term Neurobehavioral Problems But Not Affective Problems after Moderate to Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						affective problems; CT; frontal abnormalities; neurobehavioral problems; traumatic brain injury (TBI)	II PSYCHIATRIC-DISORDERS; BLUNT HEAD-INJURY; FOLLOW-UP; AXIS-I; MRI FINDINGS; IMPAIRMENTS; PSYCHOPATHOLOGY; INDIVIDUALS; DEPRESSION; DEFICITS	Behavioral problems are serious consequences of moderate to severe traumatic brain injury (TBI) and have a negative impact on outcome. There may be two types: neurobehavioral problems, manifesting as inadequate social behavior resulting from prefrontal system damage, and affective behavioral problems, resulting from emotional distress as a reaction to the brain injury. In the present study we investigated whether these two types of behavioral problems, as indicated by proxies, could be distinguished in a group of chronic TBI patients and whether early indicators of prefrontal damage on imaging could predict long-term neurobehavioral problems. Computed tomography (CT) imaging data on admission were used to identify frontal lesions. Three hundred twenty-three moderate to severe TBI survivors received 2 to 16 years post-trauma an aftercare survey with seven questions asking for changes in behavior and affect, presented both to patients and their proxies. One hundred eighty-six patients (59%) answered the behavioral questions; 42% had frontal lesions on CT. Ordinal common factor analysis on proxy scores yielded two factors, with behavior and affective items clearly separated and the anger item mediocre related to both factors. Three scales were created: Behavior, Affective and Anger. Frontal patients scored significantly higher on the Behavior and Anger scales. Logistic regression analysis showed a fourfold increase of long-term neurobehavioral problems in patients with frontal lesions. Long-term neurobehavioral problems were significantly correlated to one-year outcome and return to work in the long term. We conclude that in patients with moderate to severe TBI neurobehavioral and affective problems can be distinguished. Early CT frontal abnormalities predict long-term neurobehavioral problems, but not affective problems.	[Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, NL-9700 AB Groningen, Netherlands; [Spikman, Jacoba M.; Coers, Annemiek; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands; [Timmerman, Marieke E.] Univ Groningen, Dept Psychometr & Stat, NL-9700 AB Groningen, Netherlands		Spikman, JM (corresponding author), Univ Med Ctr Groningen, Dept Clin Neuropsychol, POB 30-001, NL-9700 RB Groningen, Netherlands.	j.m.spikman@rug.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418			Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Besharat MA, 2013, ASIAN J PSYCHIATR, V6, P35, DOI 10.1016/j.ajp.2012.07.013; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1988, Acta Neurochir Suppl (Wien), V44, P59; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; RILEY WT, 1989, J NERV MENT DIS, V177, P668, DOI 10.1097/00005053-198911000-00002; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	41	10	10	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					22	28		10.1089/neu.2014.3788			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200003	26058315	Green Submitted			2022-02-06	
J	Staples, JA; Wang, J; Zaros, MC; Jurkovich, GJ; Rivara, FP				Staples, John A.; Wang, Jin; Zaros, Mark C.; Jurkovich, Gregory J.; Rivara, Frederick P.			The application of IMPACT prognostic models to elderly adults with traumatic brain injury: A population-based observational cohort study	BRAIN INJURY			English	Article						Traumatic brain injury; geriatric patients; IMPACT score; prognosis	OLDER-ADULTS; EXTERNAL VALIDATION; OUTCOME PREDICTION; SCORING SYSTEMS; CARE; MORTALITY; COMORBIDITY; COSTS; CRASH	Objective: To examine the performance of the International Mission for Prognosis and Clinical Trial Design in Traumatic Brain Injury (IMPACT) prognostic models in older patients. Methods: Using data from the National Study on Costs and Outcomes of Trauma (NSCOT), this study identified adult patients presenting to US hospitals in 2001 and 2002 with non-penetrating moderate or severe traumatic brain injury (GCS <= 12). IMPACT model calibration and discrimination in the older stratum (65-84 years) was compared to that in the younger stratum (18-64 years). Results: IMPACT model discrimination did not differ significantly between the older (n = 202; weighted n = 268) and younger strata (n = 613; weighted n = 1632) and was generally adequate (c-statistic for the core-death model = 0.81 [0.77-0.84] vs 0.75 [0.66-0.84], respectively; p = 0.26). IMPACT model calibration was poor for both older and younger strata (Hosmer-Lemeshow p-value for the core-death model = 0.01 vs < 0.0001, respectively). Pre-specified qualitative graphical evaluation suggested substantial under-prediction of mortality in the oldest decades of life, but not among younger patients. Conclusions: The examined IMPACT prognostic models demonstrated adequate discrimination and poor calibration in both older and younger patients, yet particular caution may be required when applying these models to the elderly.	[Staples, John A.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Staples, John A.; Zaros, Mark C.] Univ Washington, Dept Med, Seattle, WA USA; [Staples, John A.; Wang, Jin; Rivara, Frederick P.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Jurkovich, Gregory J.] Univ Colorado, Dept Surg, Denver, CO 80202 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Staples, JA (corresponding author), St Pauls Hosp, Room 5910B,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	john.a.staples@gmail.com		Staples, John/0000-0003-1397-1503	US Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The authors report no conflicts of interest. The study was funded by the US Centers for Disease Control and Prevention and the National Institutes of Health. Neither funding organization was involved in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review and approval of the manuscript; or decision to submit the manuscript for analysis.	Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Creutzfeldt CJ, 2011, CRIT CARE MED, V39, P158, DOI 10.1097/CCM.0b013e3181fb7b49; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dijkers M, 2008, BRAIN INJURY PROFESS, V5, P14; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Downar J, 2009, CRIT CARE, V13, DOI 10.1186/cc7944; Evans DC, 2012, J AM GERIATR SOC, V60, P1465, DOI 10.1111/j.1532-5415.2012.04075.x; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; HCUPnet, 2012, HEALTHC COST UT PROJ; Holmes M, 2014, J AM COLL SURGEONS, V219, P631, DOI 10.1016/j.jamcollsurg.2014.05.014; Tarazona-Santabalbina FJ, 2015, GERIATR GERONTOL INT, V15, P289, DOI 10.1111/ggi.12271; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sinuff T, 2006, CRIT CARE MED, V34, P878, DOI 10.1097/01.CCM.0000201881.58644.41; Skrobik Y, 2006, CAN J ANAESTH, V53, P432, DOI 10.1007/BF03022613; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Turner EL, 2012, J CLIN EPIDEMIOL, V65, P474, DOI 10.1016/j.jclinepi.2011.08.012; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	43	10	10	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					899	907		10.3109/02699052.2016.1146964			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400009	27058813				2022-02-06	
S	Whiting, MD; Kokiko-Cochran, ON		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Whiting, Mark D.; Kokiko-Cochran, Olga N.			Assessment of Cognitive Function in the Water Maze Task: Maximizing Data Collection and Analysis in Animal Models of Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Morris water maze; Cognitive impairment; Memory; Animal models	CONTROLLED CORTICAL IMPACT; SPATIAL MEMORY; IMPAIRMENT; HIPPOCAMPAL; CORTEX; PERFORMANCE; CONSOLIDATION; RETRIEVAL; DEFICITS; LESIONS	Animal models play a critical role in understanding the biomechanical, pathophysiological, and behavioral consequences of traumatic brain injury (TBI). In preclinical studies, cognitive impairment induced by TBI is often assessed using the Morris water maze (MWM). Frequently described as a hippocampally dependent spatial navigation task, the MWM is a highly integrative behavioral task that requires intact functioning in numerous brain regions and involves an interdependent set of mnemonic and non-mnemonic processes. In this chapter, we review the special considerations involved in using the MWM in animal models of TBI, with an emphasis on maximizing the degree of information extracted from performance data. We include a theoretical framework for examining deficits in discrete stages of cognitive function and offer suggestions for how to make inferences regarding the specific nature of TBI-induced cognitive impairment. The ultimate goal is more precise modeling of the animal equivalents of the cognitive deficits seen in human TBI.	[Whiting, Mark D.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Kokiko-Cochran, Olga N.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA		Whiting, MD (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.						Bast T, 2005, J NEUROSCI, V25, P5845, DOI 10.1523/JNEUROSCI.0698-05.2005; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Liu P, 1998, BEHAV NEUROSCI, V112, P304, DOI 10.1037/0735-7044.112.2.304; Maei Hamid R, 2009, Front Integr Neurosci, V3, P4, DOI 10.3389/neuro.07.004.2009; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald RJ, 2008, EXP BRAIN RES, V187, P419, DOI 10.1007/s00221-008-1314-z; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; Terry AV, 2009, FRONT NEUROSCI, P267; Vafaei AA, 2004, BEHAV BRAIN RES, V149, P61, DOI 10.1016/S0166-4328(03)00209-2; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2013, NEUROBIOL LEARN MEM, V106, P71, DOI 10.1016/j.nlm.2013.07.006; Whiting MD, 2008, BRAIN RES, V1213, P69, DOI 10.1016/j.brainres.2008.01.107; Whiting MD, 2006, J NEUROTRAUM, V23, P1233	31	10	10	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						553	571		10.1007/978-1-4939-3816-2_30	10.1007/978-1-4939-3816-2		19	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500032	27604738				2022-02-06	
J	Wilde, EA; Bigler, ED; Huff, T; Wang, HN; Black, GM; Christensen, ZP; Goodrich-Hunsaker, N; Petrie, JA; Abildskov, T; Taylor, BA; Stone, JR; Tustison, NJ; Newsome, MR; Levin, HS; Chu, ZLD; York, GE; Tate, DF				Wilde, Elisabeth A.; Bigler, Erin D.; Huff, Trevor; Wang, Haonan; Black, Garrett M.; Christensen, Zachary P.; Goodrich-Hunsaker, Naomi; Petrie, Jo Ann; Abildskov, Tracy; Taylor, Brian A.; Stone, James R.; Tustison, Nicholas J.; Newsome, Mary R.; Levin, Harvey S.; Chu, Zili D.; York, Gerald E.; Tate, David F.		CENC Neuroimaging Core	Quantitative structural neuroimaging of mild traumatic brain injury in the Chronic Effects of Neurotrauma Consortium (CENC): Comparison of volumetric data within and across scanners	BRAIN INJURY			English	Article						Neuroimaging; brain imaging; magnetic resonance imaging; veterans; volumetrics; phantoms	ATROPHY	Background: An important component of the multicentre Chronic Effects of Neurotrauma Consortium (CENC) project is the development of improved quantitative magnetic resonance imaging (MRI) methods, including volumetric analysis. Although many studies routinely employ quality assurance (QA) procedures including MR and human phantoms to promote accuracy and monitor site differences, few studies perform rigorous direct comparisons of these data nor report findings that enable inference regarding site-to-site comparability. These gaps in evaluating cross-site differences are concerning, especially given the well-established differences that can occur between data acquired on scanners with different manufacturer, hardware or software.Methods: This study reports findings on (1) a series of studies utilizing two MR phantoms to interrogate machine-based variability using data collected on the same magnet, (2) a human phantom repeatedly imaged on the same scanner to investigate within-subject, within-site variability and (3) a human phantom imaged on three different scanners to examine within subject, between-site variability.Results: Although variability is relatively minimal for the phantom scanned on the same magnet, significantly more variability is introduced in a human subject, particularly when regions are relatively small or multiple sites used.Conclusion: Vigilance when combining data from different sites is suggested and that future efforts address these issues.	[Wilde, Elisabeth A.; Taylor, Brian A.; Newsome, Mary R.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Wilde, Elisabeth A.; Black, Garrett M.; Taylor, Brian A.; Newsome, Mary R.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Taylor, Brian A.; Chu, Zili D.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Bigler, Erin D.; Goodrich-Hunsaker, Naomi; Petrie, Jo Ann] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Huff, Trevor; Wang, Haonan; Christensen, Zachary P.; Abildskov, Tracy] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Stone, James R.; Tustison, Nicholas J.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Stone, James R.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA; [York, Gerald E.] Alaska Radiol Associates, Anchorage, AK USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA		Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.; Wilde, EA (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.; Wilde, EA (corresponding author), Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA.	ewilde@bcm.edu	Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920; Taylor, Brian/0000-0001-9745-1075; TUSTISON, NICHOLAS/0000-0001-9418-5103; Christensen, Zachary/0000-0003-3257-4714	Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX 002174]; Veterans AffairsUS Department of Veterans Affairs [I21RX001608, I01RX002174] Funding Source: NIH RePORTER	This project was jointly supported by the Department of Defense (W81XWH-13-2-0095), and the US Department of Veterans Affairs (I01 RX 002174). The authors report no conflicts of interest. The views expressed here are those of the authors and do not necessarily reflect the official policy of position of the Department of Defense, The Department of Veterans Affairs, nor the US Government.	Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Cook GA, 2014, MIL MED, V179, P1083, DOI 10.7205/MILMED-D-13-00435; Defense Centers of Excellence for Psychological Health & Traumatic Brain Injury, 2013, TRAUM BRAIN INJ RES; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gooijers J, 2015, NEUROREHABILITATION; Guild EB, 2015, J INT NEUROPSYCH SOC, V21, P650, DOI 10.1017/S1355617715000600; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Iscan Z, 2015, HUM BRAIN MAPP, V36, P3472, DOI 10.1002/hbm.22856; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Koerte IK, 2016, TRANSLATIONAL RES TR, V2016; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Maclaren J, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.37; Malatt C, 2014, J EMERG MED, V47, P646, DOI 10.1016/j.jemermed.2014.06.042; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	24	10	10	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1442	1451		10.1080/02699052.2016.1219063			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100006	27834540				2022-02-06	
J	Williams, CS; Weaver, LK; Lindblad, AS; Kumar, S; Langford, DR				Williams, Christopher S.; Weaver, Lindell K.; Lindblad, Anne S.; Kumar, Siva; Langford, Douglas R.			Baseline neurological evaluations in a hyperbaric trial of post-concussive syndrome	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						brain concussion; neurological examination; post-concussive syndrome	TRAUMATIC BRAIN-INJURY; BALANCE; REHABILITATION; DYSFUNCTION; SYMPTOMS; OUTCOMES; IMPACT; TESTS; BLAST	Standard neurologic examinations may not detect abnormalities in U.S. military service members with persistent post-concussive symptoms following mild traumatic brain injury. The Brain Injury and Mechanisms of Action of Hyperbaric Oxygen for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury Study (BIMA) enrolled 71 participants September 2012-May 2014. Participants received: comprehensive neurological and oculomotor exam; balance testing (Berg Balance Scale-BBS; Romberg Test-RT, Sharpened Romberg Test-SRT); olfactory function (Brief Smell Identification Test-BSIT). Two trained neurologists conducted the examinations at a central facility in Colorado Springs. Median age was 32 years (range 21-53), 99% male, 82% Caucasian, 49% PTSD, 28% most recent qualifying injury three months to one year prior to enrollment, 32% blast injuries only, and 73% multiple injuries. Some participants presented with abnormal facial sensation (15%), abnormal tandem gait (13%), and tremor (11%). 54% had abnormal near point of convergence (abnormal range 13-80 cm). 86% scored >= 55 on the BBS, with no participant scoring < 50. 49% scored < 30 seconds on the best trial of the SRT. RT was abnormal in 10%. 15% of participants scored <= 9 (out of 12) on BSIT, about twice what is expected in a normal population. The neurological examination found abnormalities across a range of testing, with convergence insufficiency and SRT having the most sensitivity.	[Williams, Christopher S.] Lovelace Biomed Res, Albuquerque, NM USA; [Williams, Christopher S.] Univ Colorado, CHMG Neurosci, Colorado Springs, CO 80907 USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [Lindblad, Anne S.; Kumar, Siva] Emmes Corp, Rockville, MD USA; [Langford, Douglas R.] Evans Army Community Hosp, Neurol, Ft Carson, CO USA		Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA.	lindell.weaver@imail.org			U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the U.S. Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication have not yet been locked and are therefore subject to change.	Adamson Maheen M, 2014, Fed Pract, V31, p3S; Badke MB, 2004, ARCH PHYS MED REHAB, V85, P227, DOI 10.1016/j.apmr.2003.06.006; Barbey E, 1944, CONFIN NEUROL, V6, P162; Bartiss MJ, 2013, MEDSCAPE J MED, V18, P1; BERG K, 1989, Physiotherapy Canada, V41, P304; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Carlson NB, 1990, CLIN PROCEDURES OCUL; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Doty R.L., 2001, BRIEF SMELL IDENTIFI; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Edwards R H, 1977, Physiotherapy, V63, P51; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Finch E, 2002, PHYS REHABILITATION; Franchignoni F, 1998, AGING-CLIN EXP RES, V10, P26, DOI 10.1007/BF03339630; FREGLY AR, 1968, AEROSPACE MED, V39, P277; Graybiel A, 1966, Acta Otolaryngol, V61, P292, DOI 10.3109/00016486609127066; Grosvenor TP., 1996, PRIMARY CARE OPTOMET; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Kammerlind AS, 2005, EUR J PHYSIOTHER, V7, P96, DOI 10.1080/14038190510010403; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Khasnis A, 2003, J Postgrad Med, V49, P169; KLAVORA P, 1995, AM J OCCUP THER, V49, P534, DOI 10.5014/ajot.49.6.534; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee C T, 1998, SPUMS J, V28, P125; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; ROGERS JH, 1980, J LARYNGOL OTOL, V94, P1401, DOI 10.1017/S002221510009023X; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Warren M, 2008, COMMUNICATION; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Weaver LK, 2014, UNDERSEA HYPERBAR M, V41, P431	39	10	10	0	5	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		511	519					9	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300003	28768070				2022-02-06	
J	Yang, YF; Ma, T; Ge, J; Quan, X; Yang, L; Zhu, S; Huang, LL; Liu, ZY; Liu, L; Geng, D; Huang, JH; Luo, ZJ				Yang, Yafeng; Ma, Teng; Ge, Jun; Quan, Xin; Yang, Le; Zhu, Shu; Huang, Liangliang; Liu, Zhongyang; Liu, Liang; Geng, Dan; Huang, Jinghui; Luo, Zhuojing			Facilitated Neural Differentiation of Adipose Tissue-Derived Stem Cells by Electrical Stimulation and Nurr-1 Gene Transduction	CELL TRANSPLANTATION			English	Article						Adipose tissue-derived stem cells (ADSCs); Electrical stimulation (ES); Nurr-1 gene; Neuronal differentiation; Polypyrrole/chitosan polymers; Lentivirus	CONDUCTIVE POLYPYRROLE/CHITOSAN POLYMERS; MIDBRAIN DOPAMINERGIC-NEURONS; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; NEURITE OUTGROWTH; OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; BONE-MARROW; HUMAN MSCS; INDUCTION	Neuron-like cells derived from adipose tissue-derived stem cells (ADSCs) have been considered one of the most promising cells for the treatment of neurodegenerative diseases and neurotrauma in the central nervous system (CNS). Thus far, extensive efforts have been made to facilitate neuronal differentiation of ADSCs, but limited progress has been achieved. In the present study, we tested the possibility of using a combination of electrical stimulation (ES) with Nurr-1 gene transduction to promote neuronal differentiation of ADSCs. The tolerance of ADSCs to ES was first examined by a cell apoptosis assay. The proliferation of cells was characterized using a CCK-8 assay. The morphology of cells was examined by scanning electron microscopy (SEM). The differentiation of ADSCs into neuron-like cells was examined by immunocytochemistry (ICC)-immunofluorescence staining, quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting, and enzyme linked immunosorbent assay (ELISA). The gene expression of microtubule-associated protein 2 (MAP-2), beta-tubulin, neurofilament 200 (NF-200), octamer binding transcription factor 4 (OCT-4), and glial fibrillary acidic protein (GFAP) after stimulation was examined by qRT-PCR. We found that the optimal intensity of ES for neuronal differentiation of ADSCs was 1 V/cm. In addition, ES combined with Nurr-1 gene transduction increased the neuronal differentiation rate of ADSCs, the length of neurite-like processes, and the secretion of dopamine. Further studies showed that a combination of ES with Nurr-1 gene transduction was capable of promoting the expression of MAP-2, beta-tubulin, and NF-200 but decreased the expression of OCT-4 and GFAP. All of these findings indicate that a combination of ES with Nurr-1 gene transduction could facilitate neuronal differentiation of ADSCs, which raises the possibility of its application in the treatment of neurodegenerative diseases and neurotrauma in the CNS.	[Yang, Yafeng; Ma, Teng; Ge, Jun; Quan, Xin; Zhu, Shu; Huang, Liangliang; Liu, Zhongyang; Liu, Liang; Geng, Dan; Huang, Jinghui; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, 127 Changle West Rd, Xian 710032, Peoples R China; [Yang, Le] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China		Huang, JH; Luo, ZJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, 127 Changle West Rd, Xian 710032, Peoples R China.	huangjh@fmmu.edu.cn; zjluo@fmmu.edu.cn		Luo, Zhuojing/0000-0002-0671-8553	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201389, 30973052]; National Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB542206]; Program for Changjiang Scholar and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT1053, IRT13051]; National Excellent Doctoral Dissertation of PR ChinaFoundation for the Author of National Excellent Doctoral Dissertation of China [201480]	This work was supported by grants from the National Natural Science Foundation of China (81201389 and 30973052), the National Basic Research Program of China (973 Program No. 2014CB542206), the Program for Changjiang Scholar and Innovative Research Team in University (IRT1053 and IRT13051), and A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201480). We thank technicians Ms. Jing Fan, Ms. Lifeng Lan, Ms. Ying Hao, and Ms. Ping Qu for their excellent technical assistance. The authors declare no conflicts of interest.	Abdanipour A, 2012, BRAIN RES, V1440, P23, DOI 10.1016/j.brainres.2011.12.051; Ahmadi N, 2012, TISSUE CELL, V44, P87, DOI 10.1016/j.tice.2011.11.006; Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Backman C, 1999, BRAIN RES, V851, P125, DOI 10.1016/S0006-8993(99)02149-6; Bae EJ, 2009, FEBS LETT, V583, P1505, DOI 10.1016/j.febslet.2009.04.004; Chang YJ, 2013, BBA-GEN SUBJECTS, V1830, P4130, DOI 10.1016/j.bbagen.2013.04.007; Choi YK, 2012, LIFE SCI, V91, P329, DOI 10.1016/j.lfs.2012.07.022; Gao AJ, 2013, NEUROSCIENCE, V228, P47, DOI 10.1016/j.neuroscience.2012.09.076; Hess R, 2012, BIOMATERIALS, V33, P8975, DOI 10.1016/j.biomaterials.2012.08.056; Huang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039526; Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; KALCHEVA N, 1995, P NATL ACAD SCI USA, V92, P10894, DOI 10.1073/pnas.92.24.10894; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Li YM, 2011, NEUROSCI LETT, V488, P49, DOI 10.1016/j.neulet.2010.10.078; Lim ST, 2010, PHARMACOL RES, V61, P14, DOI 10.1016/j.phrs.2009.10.002; Lu LL, 2005, BRAIN RES PROTOC, V15, P46, DOI 10.1016/j.brainresprot.2005.03.002; Luo Y, 2012, INT REV NEUROBIOL, V102, P1, DOI 10.1016/B978-0-12-386986-9.00001-6; Matsumoto M, 2013, NEUROSCI LETT, V533, P71, DOI 10.1016/j.neulet.2012.10.023; McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]; Mooney E, 2012, BIOMATERIALS, V33, P6132, DOI 10.1016/j.biomaterials.2012.05.032; Ning HX, 2009, DIFFERENTIATION, V78, P253, DOI 10.1016/j.diff.2009.07.009; Ou YT, 2012, BRAIN RES, V1480, P22, DOI 10.1016/j.brainres.2012.08.041; Park JS, 2012, BIOMATERIALS, V33, P7300, DOI 10.1016/j.biomaterials.2012.06.069; Pires F, 2015, BBA-GEN SUBJECTS, V1850, P1158, DOI 10.1016/j.bbagen.2015.01.020; Qi FY, 2013, BIOMATERIALS, V34, P1799, DOI 10.1016/j.biomaterials.2012.11.042; Saygili E, 2010, J MOL CELL CARDIOL, V49, P79, DOI 10.1016/j.yjmcc.2010.01.019; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; Shihabuddin LS, 2010, NEUROPHARMACOLOGY, V58, P845, DOI 10.1016/j.neuropharm.2009.12.015; Strutt AM, 2009, SURG NEUROL, V71, P551, DOI 10.1016/j.surneu.2008.03.039; Sugaya K, 2003, INT REV CYTOL, V228, P1, DOI 10.1016/S0074-7696(03)28001-3; Taha MF, 2010, TISSUE CELL, V42, P211, DOI 10.1016/j.tice.2010.04.003; Thrivikraman G, 2014, BIOMATERIALS, V35, P6219, DOI 10.1016/j.biomaterials.2014.04.018; Tornqvist N, 2002, DEV BRAIN RES, V133, P37; Udina E, 2008, EXP NEUROL, V210, P238, DOI 10.1016/j.expneurol.2007.11.007; Waldmeier PC, 2004, DRUG DISCOV TODAY, V9, P210, DOI 10.1016/S1359-6446(03)03000-9; Yamada M, 2007, STEM CELLS, V25, P562, DOI 10.1634/stemcells.2006-0011; Zhang HT, 2012, CYTOTHERAPY, V14, P1203, DOI 10.3109/14653249.2012.711470; Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x	39	10	10	0	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2016	25	6					1177	1191		10.3727/096368915X688957			15	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	DO5UG	WOS:000377847700013	26337634	Green Accepted, Bronze			2022-02-06	
J	Yurgil, KA; Clifford, RE; Risbrough, VB; Geyer, MA; Huang, MX; Barkauskas, DA; Vasterling, JJ; Baker, DG				Yurgil, Kate A.; Clifford, Royce E.; Risbrough, Victoria B.; Geyer, Mark A.; Huang, Mingxiong; Barkauskas, Donald A.; Vasterling, Jennifer J.; Baker, Dewleen G.			Prospective Associations Between Traumatic Brain Injury and Postdeployment Tinnitus in Active-Duty Marines	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast; combat; military; posttraumatic stress disorder; PTSD; TBI; tinnitus; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; OPERATION IRAQI FREEDOM; HEARING PROBLEMS; SCORING RULES; HEAD-INJURY; DEPRESSION; ANXIETY; BLAST; VETERANS; PREVALENCE	Objective: To examine whether cause, severity, and frequency of traumatic brain injury (TBI) increase risk of postdeployment tinnitus when accounting for comorbid posttraumatic stress disorder. Design: Self-report and clinical assessments were done before and after an "index" deployment to Iraq or Afghanistan. Setting, Participants, and Measures: Assessments took place on Marine Corps bases in southern California and the VA San Diego Medical Center. Participants were 1647 active-duty enlisted Marine and Navy servicemen who completed pre- and postdeployment assessments of the Marine Resiliency Study. The main outcome was the presence of tinnitus at 3 months postdeployment. Results: Predeployment TBI increased the likelihood of new-onset postdeployment tinnitus (odds ratio [OR] = 1.86; 95% confidence interval [CI], 1.28-2.70). Deployment-related TBIs increased the likelihood of postdeployment tinnitus (OR = 2.65; 95% CI, 1.19-5.89). Likelihood of new-onset postdeployment tinnitus was highest for those who were blast-exposed (OR = 2.93; 95% CI, 1.82-6.17), who reported moderate-severe TBI symptoms (OR = 2.22; 95% CI, 1.22-3.40), and who sustained multiple TBIs across study visits (OR = 2.27; 95% CI, 1.44-4.24). Posttraumatic stress disorder had no effect on tinnitus outcome. Conclusions: Participants who were blast-exposed, sustained multiple TBIs, and reported moderate-severe TBI symptoms were most at risk for new-onset tinnitus.	[Yurgil, Kate A.; Risbrough, Victoria B.; Geyer, Mark A.; Baker, Dewleen G.] VA San Diego Healthcare Syst, San Diego, CA USA; [Yurgil, Kate A.; Risbrough, Victoria B.; Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Yurgil, Kate A.] Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA; [Clifford, Royce E.] Naval Med Ctr San Diego, San Diego, CA USA; [Clifford, Royce E.] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Risbrough, Victoria B.; Geyer, Mark A.; Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Barkauskas, Donald A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Boston, MA USA; [Vasterling, Jennifer J.] VA Natl Ctr PTSD, Boston, MA USA; [Vasterling, Jennifer J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA		Baker, DG (corresponding author), VA Ctr Stress & Mental Hlth 116A, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	dgbaker@ucsd.edu	Risbrough, Victoria/X-3344-2019; Clifford, Royce/X-8799-2019; Baker, Dewleen/O-4957-2019	Clifford, Royce/0000-0002-5515-4336; Baker, Dewleen/0000-0002-1736-9838	VA Health Service Research and Development [SDR 09-0128]; Marine Corps; Navy Bureau of Medicine and Surgery; Veterans AffairsUS Department of Veterans Affairs [I01BX002558] Funding Source: NIH RePORTER	This work was supported by VA Health Service Research and Development project no. SDR 09-0128, the Marine Corps, and the Navy Bureau of Medicine and Surgery. The authors acknowledge all MRS coinvestigators, as well as administrative core, of the MRS Team, including logistic coordinators, clinician-interviewers, and data collection staff listed in the Methods article (Baker et al, Prev Chronic Dis. 2012;9(10):E97). The authors also thank the Marine and Navy Corpsmen volunteers for military service and participation in this study.	Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336; Alpini D, 2006, ORL-J OTO-RHIN-LARYN, V68, P31, DOI 10.1159/000090488; Andersson G, 2009, J AM ACAD AUDIOL, V20, P315, DOI 10.3766/jaaa.20.5.5; [Anonymous], 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2012, IBM SPSS STAT WIND V; Baker DG, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110134; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Browne CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033272; Brozoski T, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00009; Canlon B, 2013, HEARING RES, V295, P9, DOI 10.1016/j.heares.2012.08.015; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Cripps N P, 1999, J R Nav Med Serv, V85, P13; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Das SK, 2012, LARYNGOSCOPE, V122, P2533, DOI 10.1002/lary.23555; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; *DEF VET BRAIN INJ, 2006, CLIN PRACT GUID REC; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Geckle L, 2004, FORC HLTH PROT C AUG; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Johnston M, 1996, GEN HOSP PSYCHIAT, V18, P257, DOI 10.1016/0163-8343(96)00039-4; Jury MA, 2001, NEW ZEAL MED J, V114, P286; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Knipper M, 2010, HEARING RES, V266, P60, DOI 10.1016/j.heares.2009.07.013; Kreuzer PM, 2014, J HEAD TRAUMA REHAB, V29, P432, DOI 10.1097/HTR.0b013e31829d3129; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Langlois JA, 2004, NATL CTR INJURY PREV; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Marciano E, 2003, INT J AUDIOL, V42, P4, DOI 10.3109/14992020309056079; Marques L, 2011, EXPERT REV NEUROTHER, V11, P313, DOI [10.1586/ern.10.122, 10.1586/ERN.10.122]; Mcferran DJ, 2007, J LARYNGOL OTOL, V121, P201, DOI 10.1017/S0022215106002714; Minen MT, 2014, J NEUROL NEUROSUR PS, V85, P1138, DOI 10.1136/jnnp-2013-307339; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Roberts AL, 2011, PSYCHOL MED, V41, P71, DOI 10.1017/S0033291710000401; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Scholl B, 2008, J NEUROPHYSIOL, V100, P646, DOI 10.1152/jn.90406.2008; Sereda M, 2013, HEARING RES, V302, P50, DOI 10.1016/j.heares.2013.04.006; Shah A, 2014, LARYNGOSCOPE, V124, P272, DOI 10.1002/lary.24169; Shulman Abraham, 2009, Int Tinnitus J, V15, P119; Tan J, 2007, NEUROSCIENCE, V145, P715, DOI 10.1016/j.neuroscience.2006.11.067; US Department of Veteran Affairs, 2012, ANN BEN REP FISC YEA; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Yurgil KA, 2013, JAMA PSYCHIAT, V150, P149	72	10	10	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					30	39		10.1097/HTR.0000000000000117			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000011	25699623	Green Published			2022-02-06	
J	Kang, XG; Yang, F; Li, W; Ma, C; Li, L; Jiang, W				Kang, Xiao-gang; Yang, Feng; Li, Wen; Ma, Chen; Li, Li; Jiang, Wen			Predictive value of EEG-awakening for behavioral awakening from coma	ANNALS OF INTENSIVE CARE			English	Article						Coma; Prognosis; Electroencephalogram reactivity; Sleep spindles	TRAUMATIC BRAIN-INJURY; MINIMALLY CONSCIOUS STATE; CARDIAC-ARREST; VEGETATIVE STATE; SLEEP SPINDLES; INTENSIVE-CARE; THERAPEUTIC HYPOTHERMIA; EVOKED-POTENTIALS; PROGNOSTIC VALUE; DISORDERS	Background: A reliable predictor for early recovery of consciousness in comatose patients is of great clinical significance. Here we aimed to investigate the potentially prognostic value of electroencephalogram-reactivity (EEG-R) in combination with sleep spindles, termed EEG-awakening, for behavioral awakening in etiologically diverse comatose patients. Methods: We performed a prospectively observational study on a sample of patients, all of whom were in coma lasting longer than 3 days. Continuous EEG monitoring was performed for at least 24 h to detect the presence of EEG-R and sleep spindles. We then followed patients for 1 month to determine their subsequent level of consciousness, classifying them as either awakened or non-awakened. Finally, Univariate and multivariate analyses were employed to assess the association of predictors with consciousness recovery. Results: One hundred and six patients with different etiologies leading to coma were included in the study. Of these, 48 patients (45.3 %) awoke and 58 patients (54.7 %) did not awake in the month after the onset of the study. Of note, 26 patients (24.5 %) had a good neurological outcome, and 31 patients (29.3 %) died. Univariate analysis revealed that the Glasgow Coma Scale (GCS) score, EEG-R, sleep spindles, and EEG-awakening were all associated with one-month awakening. Comparisons of the area under the receiving operator characteristic curve (AUC) showed that EEG-awakening (0.839; 0.757-0.921) was superior to all of the following: EEG-R (0.798; 0.710-0.886), sleep spindles (0.772; 0.680-0.864), and GCS scores (0.720; 0.623-0.818). However, age, gender, etiology, and pupillary light reflex did not correlate significantly with one-month awakening. Further logistic regression analysis showed that only EEG-awakening and GCS scores at study entry were significant independent predictors of awakening and that the prognostic model containing these two variables yielded an outstanding predictive performance with an AUC of 0.903. Conclusions: EEG-awakening incorporates both EEG-R and sleep spindles and is an excellent predictor for early behavioral awakening in comatose patients. The prognostic model combining EEG-awakening and GCS scores shows an outstanding discriminative power for awakening.	[Kang, Xiao-gang; Yang, Feng; Li, Wen; Ma, Chen; Li, Li; Jiang, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China		Li, L (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China.	lili@fmmu.edu.cn; jiangwen@fmmu.edu.cn			Xijing Hospital Research Foundation [XKZT09Z07]	This work was supported by the Xijing Hospital Research Foundation (Grant Number XKZT09Z07).	Bartho P, 2014, NEURON, V82, P1367, DOI 10.1016/j.neuron.2014.04.046; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; BRENDLER SJ, 1970, BRAIN, V93, P381, DOI 10.1093/brain/93.2.381; Brown RE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00135; Cologan V, 2010, SLEEP MED REV, V14, P97, DOI 10.1016/j.smrv.2009.04.003; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Edlow BL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0375-y; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goodman D, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00162; Guerit JM, 2004, ANN FR ANESTH, V23, P99, DOI 10.1016/j.annfar.2004.01.002; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Hofmeijer J, 2015, NEUROLOGY, V85, P137, DOI 10.1212/WNL.0000000000001742; Horsting MWB, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0041-9; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; HULIHAN JF, 1994, NEUROLOGY, V44, P758, DOI 10.1212/WNL.44.4.758; Juan E, 2015, NEUROCRIT CARE, V22, P403, DOI 10.1007/s12028-014-0095-4; Kamps MJA, 2013, INTENS CARE MED, V39, P1671, DOI 10.1007/s00134-013-3004-y; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Koenig MA, 2013, SEMIN NEUROL, V33, P121, DOI 10.1055/s-0033-1348962; Kowalski RG, 2015, ANN NEUROL, V77, P804, DOI 10.1002/ana.24381; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; LONGSTRETH WT, 1983, NEW ENGL J MED, V308, P1378, DOI 10.1056/NEJM198306093082302; Mathis P., 1959, ELECTROENCEPHALO S11, V11, P27; Peigne V, 2011, CRIT CARE MED, V39, P1365, DOI 10.1097/CCM.0b013e3182120b68; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Plum F, 1972, Contemp Neurol Ser, V10, P1; Puettgen HA, 2007, J NEUROL SCI, V261, P108, DOI 10.1016/j.jns.2007.04.041; RamachandranNair R, 2005, PEDIATR NEUROL, V33, P345, DOI 10.1016/j.pediatrneurol.2005.05.007; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Sandroni C, 2014, RESUSCITATION, V85, P1779, DOI 10.1016/j.resuscitation.2014.08.011; Schefold JC, 2009, RESUSCITATION, V80, P658, DOI 10.1016/j.resuscitation.2009.03.006; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Synek V M, 1990, Clin Exp Neurol, V27, P99; TEASDALE G, 1974, LANCET, V2, P81; Thenayan EAL, 2010, J CRIT CARE, V25, P300, DOI 10.1016/j.jcrc.2009.06.049; Trubel HK, 2003, CURR OPIN PEDIATR, V15, P283, DOI 10.1097/00008480-200306000-00010; Tsetsou S, 2013, NEUROCRIT CARE, V19, P283, DOI 10.1007/s12028-013-9883-5; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; VANDENBERGE JH, 1979, J NEUROL NEUROSUR PS, V42, P1163, DOI 10.1136/jnnp.42.12.1163; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Young GB, 2009, ANN NY ACAD SCI, V1157, P32, DOI 10.1111/j.1749-6632.2009.04471.x; Young GB, 1999, J CLIN NEUROPHYSIOL, V16, P354, DOI 10.1097/00004691-199907000-00008	50	10	14	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	DEC 21	2015	5								52	10.1186/s13613-015-0094-4			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9BW	WOS:000367393800002	26690797	gold, Green Published			2022-02-06	
J	Flaherty, JM; Spencer, RJ; Drag, LL; Pangilinan, PH; Bieliauskas, LA				Flaherty, Jennifer M.; Spencer, Robert J.; Drag, Lauren L.; Pangilinan, Percival H.; Bieliauskas, Linas A.			Limited usefulness of the Rey Fifteen- Item Test in detection of invalid performance in veterans suspected of mild traumatic brain injury	BRAIN INJURY			English	Article							MALINGERING CUTOFF SCORES; PSYCHIATRIC-SYMPTOMS; 15-ITEM MEMORIZATION; VALIDITY TESTS; MEMORY TEST; INDIVIDUALS; SENSITIVITY; SAMPLE; TRIAL		[Flaherty, Jennifer M.; Spencer, Robert J.; Pangilinan, Percival H.; Bieliauskas, Linas A.] Vet Affairs Ann Arbor Healthcare Syst, Mental Hlth Serv, Ann Arbor, MI USA; [Drag, Lauren L.] Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Pangilinan, Percival H.] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA		Flaherty, JM (corresponding author), EVMS Neuropsychol Program, Andrews Hall,Suite 461,721 Fairfax Ave, Norfolk, VA 23507 USA.	flaherjm@evms.edu		Flaherty, Jennifer/0000-0001-6698-4549			Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Franzen M D, 1996, Appl Neuropsychol, V3, P82, DOI 10.1207/s15324826an0302_6; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; Green P, 1997, WORD MEMORY TEST USE; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; HAYS JR, 1993, PERCEPT MOTOR SKILL, V76, P1331, DOI 10.2466/pms.1993.76.3c.1331; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HISCOCK CK, 1994, J PSYCHOPATHOL BEHAV, V16, P95, DOI 10.1007/BF02232721; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kelly PJ, 2005, BRIT J CLIN PSYCHOL, V44, P333, DOI 10.1348/014466505X35687; Kraal AZ, 2015, REHABIL PSYCHOL, V60, P36, DOI 10.1037/rep0000017; Lee A, 2000, CLIN NEUROPSYCHOL, V14, P303, DOI 10.1076/1385-4046(200008)14:3;1-P;FT303; McCarter RJ, 2009, CLIN NEUROPSYCHOL, V23, P1050, DOI 10.1080/13854040802665790; Medici R, 2013, J FORENSIC PSYCHOL P, V13, P68, DOI 10.1080/15228932.2013.746909; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; PAUL DS, 1992, INT J CLIN NEUROPSYC, V14, P1; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2012, NEUROPSYCHOLOGICAL P, P77; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Suhr JA, 2012, ASSESSMENT MALINGERE, P131; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Wechsler D., 2008, WECHSLER ADULT INTEL; Weisenbach S, FACTORS PREDIC UNPUB	42	10	10	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1630	1634		10.3109/02699052.2015.1075249			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800013	26513604				2022-02-06	
J	Studer, M; Simonetti, BG; Heinks, T; Steinlin, M; Leichtle, A; Berger, S; Joeris, A				Studer, Martina; Simonetti, Barbara Goeggel; Heinks, Theda; Steinlin, Maja; Leichtle, Alexander; Berger, Steffen; Joeris, Alexander			Acute S100B in serum is associated with cognitive symptoms and memory performance 4 months after paediatric mild traumatic brain injury	BRAIN INJURY			English	Article							POST-CONCUSSIVE SYMPTOMS; HEAD-INJURY; POSTCONCUSSION SYNDROME; CHILDREN; PROTEIN; PREDICTION; BIOMARKERS		[Studer, Martina; Simonetti, Barbara Goeggel; Heinks, Theda; Steinlin, Maja] Univ Childrens Hosp Bern, Dept Paediat Neurol Dev & Rehabil, Bern, Switzerland; [Leichtle, Alexander] Univ Hosp Bern, Dept Clin Chem, CH-3010 Bern, Switzerland; [Berger, Steffen; Joeris, Alexander] Univ Childrens Hosp Bern, Dept Paediat Surg, Bern, Switzerland		Studer, M (corresponding author), Univ Childrens Hosp, Inselspital, Dept Paediat Neurol Dev & Rehabil, CH-3010 Bern, Switzerland.	martina.studer@insel.ch	Leichtle, Alexander/C-7262-2011; Joeris, Alexander/J-4688-2019	Joeris, Alexander/0000-0002-7748-7115	Johanna Durmuller-Bol Foundation; Batzebar Foundation of the University Children's Hospital of Bern; Anna Muller-Grocholski Foundation; Batzebar Foundation	The project this manuscript is based on was funded by the following foundations: the Johanna Durmuller-Bol Foundation, the Batzebar Foundation of the University Children's Hospital of Bern and the Anna Muller-Grocholski Foundation. Martina Studer received salary support from the Anna Muller-Grocholski Foundation and the Batzebar Foundation. The authors report no conflicts of interest.	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, PEDIATR EMERG CARE, V29, P458, DOI 10.1097/PEC.0b013e31828a202d; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; Conners C.K., 2004, CONNERS CONTINUOUS P; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; FILIPPIDIS AS, 2010, NEUROSURG FOCUS, V29, P1; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Helmstaedter C., 2001, VERBALER LERN MERKFA; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Ryb GE, 2014, BRAIN INJURY, V28, P1430, DOI 10.3109/02699052.2014.919525; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Studer M, 2014, J INT NEUROPSYCH SOC, V20, P982, DOI 10.1017/S1355617714000927; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	28	10	10	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1667	1673		10.3109/02699052.2015.1075250			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800019	26502808	Green Published			2022-02-06	
J	Bucher, J; Koyfman, A				Bucher, Joshua; Koyfman, Alex			INTUBATION OF THE NEUROLOGICALLY INJURED PATIENT	JOURNAL OF EMERGENCY MEDICINE			English	Article						airway management; intracerebral hemorrhage; neurologically injured patients; rapid sequence intubation; traumatic brain injury	RAPID-SEQUENCE INTUBATION; CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID PRESSURE; CRITICALLY-ILL PATIENTS; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; ENDOTRACHEAL INTUBATION; TRACHEAL INTUBATION; HEMODYNAMIC-RESPONSES	Background: Intubation of the neurologically injured patient is a critical procedure that must be done in a manner to prevent further neurologic injury. Although many different medications and techniques have been used to meet specific needs, there is little to no evidence to support many claims. Objective: To review the literature regarding important topics relating to intubating patients with neurologic injury. Discussion: Airway management requires ideal preoxygenation and airway maneuvers to minimize manipulation of the larynx and to maximize first-pass success. There is no evidence that lidocaine pretreatment decreases intracerebral pressure (ICP). Fentanyl can be used to help blunt the hemodynamic response to intubation. Esmolol is another medication that can blunt the hemodynamic response. Ketamine can be used and is possibly the ideal agent, having a neutral hemodynamic profile. A prefasciculation dose for neuromuscular blockade has not been shown to have any effect on ICP. Conclusions: Ideal intubation conditions should be obtained through the use of airway manipulation techniques and appropriate medication choice for rapid sequence intubation in patients who are neurologically injured. (C) 2015 Elsevier Inc.	[Bucher, Joshua] Rutgers Robert Wood Johnson Med Sch, Piscataway, NJ USA; [Koyfman, Alex] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA		Bucher, J (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Emergency Med, 1 RWJ Plaza MEB 103, New Brunswick, NJ 08901 USA.			Bucher, Joshua/0000-0003-2761-3387			Abbasivash R, 2014, J CLIN ANESTH, V26, P628, DOI 10.1016/j.jclinane.2014.05.014; Adachi YU, 2002, ANESTH ANALG, V95, P233, DOI 10.1097/00000539-200207000-00043; Agbeko RS, 2012, PEDIATR CRIT CARE ME, V13, pE39, DOI 10.1097/PCC.0b013e31820ac2ad; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Baillard C, 2006, AM J RESP CRIT CARE, V174, P171, DOI 10.1164/rccm.200509-1507OC; Blissitt PA, 2006, AM J CRIT CARE, V15, P206; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Brezina A, 2010, PHYSIOL RES, V59, P703, DOI 10.33549/physiolres.931927; Brown MM, 1996, EUR J ANAESTH, V13, P474, DOI 10.1046/j.1365-2346.1996.00973.x; Caricato A, 2013, CRIT CARE, V17, DOI 10.1186/cc13097; Cheung AT, 1999, ANESTH ANALG, V89, P1116, DOI 10.1213/00000539-199911000-00008; CHUNG KS, 1992, CAN J ANAESTH, V39, P774, DOI 10.1007/BF03008287; Clancy M, 2001, EMERG MED J, V18, P373, DOI 10.1136/emj.18.5.373; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; CORK RC, 1984, ANESTH ANALG, V63, P60; Curran MP, 2006, DRUGS, V66, P1755, DOI 10.2165/00003495-200666130-00010; DAHLGREN N, 1981, ANAESTHESIA, V36, P1022, DOI 10.1111/j.1365-2044.1981.tb08676.x; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dixon BJ, 2005, ANESTHESIOLOGY, V102, P1110, DOI 10.1097/00000542-200506000-00009; El-Khatib ME, 2007, CAN J ANAESTH, V54, P744, DOI 10.1007/BF03026871; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Feng C K, 1996, Acta Anaesthesiol Sin, V34, P61; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; Garg K, 2013, J CLIN DIAGN RES, V7, P2548, DOI 10.7860/JCDR/2013/6860.3607; GIBBS JM, 1972, BRIT J ANAESTH, V44, P1298, DOI 10.1093/bja/44.12.1298; GOLD MI, 1986, ANESTHESIOLOGY, V64, P718, DOI 10.1097/00000542-198606000-00007; Gregoretti C, 1998, INTENS CARE MED, V24, P785, DOI 10.1007/s001340050666; Gurulingappa, 2012, J CLIN DIAGN RES, V6, P1749, DOI 10.7860/JCDR/2012/4070.2619; Habibi Mohammad Reza, 2014, J Clin Diagn Res, V8, pGC01, DOI 10.7860/JCDR/2014/10237.5006; Hamaya Y, 2000, ANESTHESIOLOGY, V93, P95, DOI 10.1097/00000542-200007000-00018; HASSAN HG, 1991, ACTA ANAESTH SCAND, V35, P442, DOI 10.1111/j.1399-6576.1991.tb03325.x; Hassani Valiallah, 2013, Anesth Pain Med, V2, P115, DOI 10.5812/aapm.6442; Hayakawa-Fujii Y, 2001, J Anesth, V15, P191, DOI 10.1007/s005400170001; HELFMAN SM, 1991, ANESTH ANALG, V72, P482; Hosseinzadeh H, 2013, J CARDIOVASC THORAC, V5, P51, DOI 10.5681/jcvtr.2013.011; Hovda DA, 2007, CRIT CARE MED, V35, P663, DOI 10.1097/01.CCM.0000254442.66789.52; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; KOENIG KL, 1992, ANN EMERG MED, V21, P929, DOI 10.1016/S0196-0644(05)82930-0; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; KORPINEN R, 1995, CAN J ANAESTH, V42, P298, DOI 10.1007/BF03010706; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; Lin CC, 2012, AM J EMERG MED, V30, P1782, DOI 10.1016/j.ajem.2012.02.013; Lopera JL, 2006, AM J RESP CRIT CARE, V174, P1274, DOI 10.1164/ajrccm.174.11.1274; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; McSwain NE, 2004, J TRAUMA, V57, P8; MINTON MD, 1986, ANESTHESIOLOGY, V65, P165, DOI 10.1097/00000542-198608000-00006; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Monro A., 1783, OBSERVATIONS STRUCTU; Moon YE, 2012, J CLIN ANESTH, V24, P8, DOI 10.1016/j.jclinane.2010.12.010; Mort TC, 2005, CRIT CARE MED, V33, P2672, DOI 10.1097/01.CCM.0000187131.67594.9E; Mort TC, 2009, CRIT CARE MED, V37, P68, DOI 10.1097/CCM.0b013e318192845e; Nishimura M, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0084-5; Perkins ZB, 2013, J TRAUMA ACUTE CARE, V74, P1074, DOI 10.1097/TA.0b013e3182827305; Pouraghaei Mahboob, 2014, Anesth Pain Med, V4, pe14618, DOI 10.5812/aapm.14618; Price B, 2013, AM J EMERG MED, V31, P1124, DOI 10.1016/j.ajem.2013.03.041; Prys-Roberts C, 1998, BRIT J ANAESTH, V80, P106; Prys-Roberts C, 1998, BRIT J ANAESTH, V80, P104; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; Schmittner MD, 2007, J NEUROSURG ANESTH, V19, P257, DOI 10.1097/ANA.0b013e31811f3feb; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; SINGH H, 1995, J CLIN ANESTH, V7, P5, DOI 10.1016/0952-8180(94)00013-T; STRANDGAARD S, 1989, AM J HYPERTENS, V2, P486, DOI 10.1093/ajh/2.6.486; Ugur B, 2007, CLIN DRUG INVEST, V27, P269, DOI 10.2165/00044011-200727040-00006; Walz M, 1998, UNFALLCHIRURG, V101, P527, DOI 10.1007/s001130050305; Wang X, 2014, J ANESTH, V28, P821, DOI 10.1007/s00540-014-1845-3; Weingart SD, 2015, ANN EMERG MED, V65, P349, DOI 10.1016/j.annemergmed.2014.09.025; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; WIEBER J, 1975, ANAESTHESIST, V24, P260; Wimalasena Y, 2015, ANN EMERG MED, V65, P371, DOI 10.1016/j.annemergmed.2014.11.014; Wright D, 2011, TINTINALLIS EMERGENC, P1692; Zhang GH, 2009, CHINESE MED J-PEKING, V122, P2330, DOI 10.3760/cma.j.issn.0366-6999.2009.19.026	72	10	11	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2015	49	6					920	927		10.1016/j.jemermed.2015.06.078			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CX0TC	WOS:000365408800028	26416129				2022-02-06	
J	Farivar, S; Mohamadzade, Z; Shiari, R; Fahimzad, A				Farivar, Shirin; Mohamadzade, Zahra; Shiari, Reza; Fahimzad, Alireza			Neural Differentiation of Human Umbilical Cord Mesenchymal Stem Cells by Cerebrospinal Fluid	IRANIAN JOURNAL OF CHILD NEUROLOGY			English	Article						Cerebrospinal fluid; Neurogenesis; Mesenchymal stem cells; Nestin; Microtubule-associated protein 2; Glial fibrillary astrocytic protein	HUMAN BONE-MARROW; STROMAL CELLS; PROLIFERATION; SUPPRESSION; PARTICLES; BLOOD; FETAL	Objective Whartons jelly (WJ) is the gelatinous connective tissue from the umbilical cord. It is composed of mesenchymal stem cells, collagen fibers, and proteoglycans. The stem cells in WJ have properties that are interesting for research. For example, they are simple to harvest by noninvasive methods, provide large numbers of cells without risk to the donor, the stem cell population may be expanded in vitro, cryogenically stored, thawed, genetically manipulated, and differentiated in vitro. In our study, we investigated the effect of human cerebrospinal fluid (CSF) on neural differentiation of human WJ stem cells. Material & Methods The cells in passage 2 were induced into neural differentiation with different concentrations of human cerebrospinal fluid. Differentiation along with neural lineage was documented by expression of three neural markers: Nestin, Microtubule-Associated Protein 2 (MAP2), and Glial Fibrillary Astrocytic Protein (GFAP) for 21 days. The expression of the identified genes was confirmed by Reverse Transcriptase PCR (RT-PCR). Results Treatment with 100 and 200 mu g/ml CSF resulted in the expression of GFAP and glial cells marker on days 14 and 21. The expression of neural-specific genes following CSF treatment was dose-dependent and time-dependent. Treatment of the cells with a twofold concentration of CSF, led to the expression of MAP2 on day 14 of induction. No expression of GFAP was detected before day 14 or MAP2 before day 21, which shows the importance of the treatment period. In the present study, expression analysis for the known neural markers: Nestin, GFAP, and MAP2 using RT-PCR were performed. The data demonstrated that CSF could play a role as a strong inducer. Conclusion RT-PCR showed that cerebrospinal fluid promotes the expression of Nestin, MAP2, and GFAP mRNA in a dose-dependent manner, especially at a concentration of 200 mu l/ml. In summary, CSF induces neurogenesis of WJ stem cells that encourages tissue engineering applications with these cells for treatments of neurodegenerative defects and traumatic brain injury.	[Farivar, Shirin; Mohamadzade, Zahra] Shahid Beheshti Univ, Fac Biol Sci, Dept Genet, Tehran, Iran; [Farivar, Shirin] Shahid Beheshti Univ, Laser & Plasma Res Inst, Tehran, Iran; [Shiari, Reza] Shahid Beheshti Univ Med Sci, Dept Pediat, Tehran, Iran; [Shiari, Reza; Fahimzad, Alireza] Shahid Beheshti Univ Med Sci, Mofid Childrens Hosp, Pediat Infect Res Ctr PIRC, Tehran, Iran		Farivar, S (corresponding author), Shahid Beheshti Univ, Fac Biol Sci, Tehran, Iran.	s_farivar@sbu.ac.ir			Shahid Beheshti University; cooperation of Pediatric Infectious Research center (PIRC) personnel at Mofid Children's hospitals; Laser and Plasma Research Institute	We would like to thank and acknowledge the support of Shahid Beheshti University and the cooperation of Pediatric Infectious Research center (PIRC) personnel at Mofid Children's hospitals well as the Laser and Plasma Research Institute for this study. We sincerely appreciate your support.	Alcazar A, 1998, NEUROSCI LETT, V255, P75, DOI 10.1016/S0304-3940(98)00708-3; Bachy I, 2008, BRAIN RES BULL, V75, P289, DOI 10.1016/j.brainresbull.2007.10.010; Bongso A, 2008, J CELL BIOCHEM, V105, P1352, DOI 10.1002/jcb.21957; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Colombo JA, 1998, EXP NEUROL, V154, P452, DOI 10.1006/exnr.1998.6910; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gato A, 2004, J EXP ZOOL PART A, V301A, P280, DOI 10.1002/jez.a.20035; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Kang XQ, 2006, CELL BIOL INT, V30, P569, DOI 10.1016/j.cellbi.2006.02.007; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491; Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x; Martin C, 2006, DEV BIOL, V297, P402, DOI 10.1016/j.ydbio.2006.05.010; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Nordin C, 2007, NEUROPSYCHOBIOLOGY, V56, P152, DOI 10.1159/000115782; Parada C, 2005, J PROTEOME RES, V4, P2420, DOI 10.1021/pr050213t; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; THOMPSON EJ, 1995, J NEUROL NEUROSUR PS, V59, P349, DOI 10.1136/jnnp.59.4.349; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Yuan XL, 2005, J CHROMATOGR B, V815, P179, DOI 10.1016/j.jchromb.2004.06.044	33	10	14	0	1	IRANIAN CHILD NEUROLOGY SOC	TEHRAN	3D FL, CHILD NEUROLOGY OFF, MOFID CHILDREN HOSPITAL, TEHRAN, 15468-15514, IRAN	1735-4668	2008-0700		IRAN J CHILD NEUROL	Iran. J.Child Neurol.	WIN	2015	9	1					87	93					7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V27DE	WOS:000215339700012	25767544				2022-02-06	
J	Honeybul, S; Gillett, GR; Ho, KM; Janzen, C; Kruger, K				Honeybul, Stephen; Gillett, Grant R.; Ho, Kwok M.; Janzen, Courtney; Kruger, Kate			Long-term survival with unfavourable outcome: a qualitative and ethical analysis	JOURNAL OF MEDICAL ETHICS			English	Article							TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; GLASGOW; SCALE; HEMICRANIECTOMY; INFARCTION	Objective To assess the issue of 'retrospective consent' among a cohort of patients who had survived with unfavourable outcome and to assess attitudes among next of kin regarding their role as surrogate decision makers. Methods Twenty patients who had survived for at least 3 years with an unfavourable outcome following a decompressive craniectomy for severe traumatic brain injury were assessed with their next of kin. During the course of a semistructured interview, participants were asked whether they would have provided consent if they had known their eventual outcome. They were also asked for general comments regarding all aspects of the clinical journey. Eighteen patients had next of kin who were available for interview. For two patients, there was no longer any family involvement. Results Of the 20 patients, 13 were able to provide a response and 11 felt that they would have provided consent even if they had known their eventual outcome. Of the 18 next of kin who were able to express an opinion, 10 felt that they would have provided retrospective consent. Conclusions Many patients appeared to have adapted to a level of disability that competent individuals might deem unacceptable. This does not necessarily mean that such outcomes should be regarded as 'favourable', nor that decompressive craniectomy must be performed for patients with predicted poor outcome. Nevertheless, those burdened with the initial clinical decisions and thereafter the long-term care of these patients may draw some support from the knowledge that unfavourable may not necessarily be unacceptable.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA 6009, Australia; [Honeybul, Stephen] Royal Perth Hosp, Perth, WA 6001, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand; [Ho, Kwok M.] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Janzen, Courtney; Kruger, Kate] Sir Charles Gairdner Hosp, Dept Occupat Therapy, Perth, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Beauchamp T. L., 2001, PRINCIPLES BIOMEDICA, V5th, P69; Cooper P R, 1976, Surg Neurol, V5, P25; Cowart D, 1998, HASTINGS CENT REP, V28, P14, DOI 10.2307/3527969; Druml Christiane, 2004, Curr Opin Crit Care, V10, P570, DOI 10.1097/01.ccx.0000144765.73540.89; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Dworkin R., 1993, LIFES DOMINION ARGUM; Foerch C, 2004, J NEUROSURG, V101, P248, DOI 10.3171/jns.2004.101.2.0248; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Honeybul S, 2012, MED J AUSTRALIA, V196, P531, DOI 10.5694/mja11.11485; Honeybul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032375; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V1, P480; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Rogers SJ, 2001, BRAIN INJURY, V25, P651; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	33	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	DEC	2015	41	12					963	969		10.1136/medethics-2013-101960			7	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	DA5GW	WOS:000367832200018	24965718				2022-02-06	
J	Schrieff-Elson, LE; Thomas, KGF; Rohlwink, UK; Figaji, AA				Schrieff-Elson, L. E.; Thomas, K. G. F.; Rohlwink, U. K.; Figaji, A. A.			Low brain oxygenation and differences in neuropsychological outcomes following severe pediatric TBI	CHILDS NERVOUS SYSTEM			English	Article						Brain injuries, traumatic; Neurosurgery; Child; Neuropsychology; Brain oxygenation	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; TISSUE OXYGEN; INTRACRANIAL-PRESSURE; CHILDREN; ADOLESCENTS; ATTENTION; CHILDHOOD; RECOVERY; DEFICITS	Purpose Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in children. Preventing secondary injury by controlling physiological parameters (e.g. intracranial pressure [ICP], cerebral perfusion pressure [CPP] and brain tissue oxygen [PbtO(2)]) has a potential to improve outcome. Low PbtO(2) is independently associated with poor clinical outcomes in both adults and children. However, no studies have investigated associations between low PbtO(2) and neuropsychological and behavioural outcomes following severe pediatric TBI (pTBI). We used a quasi-experimental case-control design to investigate these relationships. A sample of 11 TBI patients with a Glasgow Coma Scale score a parts per thousand currency sign8 who had PbtO(2) and ICP monitoring at the Red Cross War Memorial Children's Hospital underwent neuropsychological evaluation a parts per thousand yen1 year post-injury. Their performance was compared to that of 11 demographically matched healthy controls. We then assigned each TBI participant into one of two subgroups, (1) children who had experienced at least one episode of PbtO(2) a parts per thousand currency sign 10 mmHg or (2) children for whom PbtO(2) > 10 mmHg throughout the monitoring period, and compared their results on neuropsychological evaluation. TBI participants performed significantly more poorly than controls in several cognitive domains (IQ, attention, visual memory, executive functions and expressive language) and behavioural (e.g. externalizing behaviour) domains. The PbtO(2) a parts per thousand currency sign 10 mmHg group performed significantly worse than the PbtO2 > 10 mmHg group in several cognitive domains (IQ, attention, verbal memory, executive functions and expressive language), but not on behavioural measures. Results demonstrate that low PbtO(2) may be prognostic of not only mortality but also neuropsychological outcomes.	[Schrieff-Elson, L. E.; Thomas, K. G. F.] Univ Cape Town, Dept Psychol, ACSENT Lab, ZA-7925 Cape Town, South Africa; [Rohlwink, U. K.; Figaji, A. A.] Red Cross War Mem Childrens Hosp, Dept Surg, Div Neurosurg, Cape Town, South Africa		Schrieff-Elson, LE (corresponding author), Univ Cape Town, Dept Psychol, ACSENT Lab, ZA-7925 Cape Town, South Africa.	leigh.schrieff-elson@uct.ac.za	Rohlwink, Ursula Karin/U-8917-2019; Rohlwink, Ursula/AAE-2513-2020; Schrieff, Leigh/AAQ-5577-2020; Thomas, Kevin Garth Flusk/AAA-8655-2020	Rohlwink, Ursula Karin/0000-0002-4469-4935; Schrieff, Leigh/0000-0003-0192-4830; Thomas, Kevin Garth Flusk/0000-0002-0807-6101; Figaji, Anthony/0000-0002-3357-6490	South African National Research FoundationNational Research Foundation - South Africa; University of Cape Town's University Research Committee; A. W. Mellon Foundation	The South African National Research Foundation, the University of Cape Town's University Research Committee and the A. W. Mellon Foundation supported this research.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Cook LG, 2008, NEUROREHABILITATION, V23, P467; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ferrett HL, 2010, DRUG ALCOHOL DEPEN, V110, P8, DOI 10.1016/j.drugalcdep.2010.01.019; Figaji AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E4; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia GA, 2000, THE BEHAVIOUR RATING; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Jacobson JL, 2005, NEUROTOXICOL TERATOL, V27, P395, DOI 10.1016/j.ntt.2005.01.009; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Korkman M., 2007, NEPSY 2; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manly T., 1999, TEST EVERYDAY ATTENT; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Medina KL, 2007, J INT NEUROPSYCH SOC, V13, P807, DOI 10.1017/S1355617707071032; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; Wechsler D., 1974, WECHSLER INTELLIGENC; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	57	10	10	1	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2015	31	12					2257	2268		10.1007/s00381-015-2892-2			12	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CW6AM	WOS:000365079000010	26337700				2022-02-06	
J	Stephens, JA; Williamson, KNC; Berryhill, ME				Stephens, Jaclyn A.; Williamson, Karen-Nicole C.; Berryhill, Marian E.			Cognitive Rehabilitation After Traumatic Brain Injury: A Reference for Occupational Therapists	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						TBI; evidence-based practice; cognition; rehabilitation; occupational therapy; interdisciplinary systematic review	RANDOMIZED-CONTROLLED-TRIAL; MEMORY-IMPAIRED INDIVIDUALS; SPORT-RELATED CONCUSSION; OF-THE-LITERATURE; SELF-AWARENESS; EXECUTIVE DYSFUNCTION; COMMUNITY INTEGRATION; NEUROLOGICAL DAMAGE; TASK-PERFORMANCE; AEROBIC EXERCISE	Nearly 1.7 million Americans sustain a traumatic brain injury (TBI) each year. These injuries can result in physical, emotional, and cognitive consequences. While many individuals receive cognitive rehabilitation from occupational therapists (OTs), the interdisciplinary nature of TBI research makes it difficult to remain up-to-date on relevant findings. We conducted a literature review to identify and summarize interdisciplinary evidence-based practice targeting cognitive rehabilitation for civilian adults with TBI. Our review summarizes TBI background, and our cognitive remediation section focuses on the findings from 37 recent (since 2006) empirical articles directly related to cognitive rehabilitation for individuals (i.e., excluding special populations such as veterans or athletes). This manuscript is offered as a tool for OTs engaged in cognitive rehabilitation and as a means to highlight arenas where more empirical, interdisciplinary research is needed.	[Stephens, Jaclyn A.; Williamson, Karen-Nicole C.; Berryhill, Marian E.] Univ Nevada, Reno, NV 89557 USA		Stephens, JA (corresponding author), Univ Nevada, Dept Psychol, Program Cognit & Brain Sci, 1664 N Virginia St,Mail Stop 296, Reno, NV 89557 USA.	jaclynanne09@gmail.com		Williamson, Karen-Nicole/0000-0002-9272-2144; Berryhill, Marian/0000-0002-8218-6587	National Institute of Health Centers of Biomedical Research Excellence Grant [P20GM103650-01]; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R15EY022775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103650] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Authors J.A.S. and M.E.B. have received grant support from The National Institute of Health Centers of Biomedical Research Excellence Grant (P20GM103650-01, PI Webster, Project Leader MEB), and NEI R15EY022775 (MEB).; Institutes of Health.	Aadal L, 2011, BRAIN INJURY, V25, P717, DOI 10.3109/02699052.2011.580314; Amorim BJ, 2011, ARQ NEURO-PSIQUIAT, V69, P682, DOI 10.1590/S0004-282X2011000500020; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Appleby I, 2008, ANAEST INTENS CARE M, V9, P193, DOI 10.1016/j.mpaic.2008.03.003; Barrett TW, 2009, AM J EMERG MED, V27, P428, DOI 10.1016/j.ajem.2008.03.025; Bartfai A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-102; Bauer K, 2012, CRIT CARE NURS Q, V35, P281, DOI 10.1097/CNQ.0b013e3182542eb5; Bay E, 2011, ADV EMERG NURS J, V33, P181, DOI 10.1097/TME.0b013e318217c958; Beers M. H, 2006, MERCK MANUAL DIAGNOS, P2572; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bergman K, 2010, J EMERG NURS, V36, P221, DOI 10.1016/j.jen.2009.07.001; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bertens D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-64; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; Boman IL, 2010, SCAND J OCCUP THER, V17, P140, DOI 10.3109/11038120902875144; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Boosman H, 2013, BRAIN INJURY, V27, P685, DOI 10.3109/02699052.2013.775504; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Constantinidou F, 2012, BRAIN INJURY, V26, P1549, DOI 10.3109/02699052.2012.698786; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dry A, 2006, ASSIST TECHNOL, V18, P170, DOI 10.1080/10400435.2006.10131916; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Engstrom ALL, 2010, SCAND J OCCUP THER, V17, P233, DOI [10.1080/11038120903191806, 10.3109/11038120903191806]; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Faul M, 2010, TRAUMATIC BRAIN INJU; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Foley JA, 2010, BRAIN INJURY, V24, P851, DOI 10.3109/02699051003789278; Fong KNK, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-19; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillebert CR, 2013, NEUROSCIENTIST, V19, P509, DOI 10.1177/1073858412463168; Giuffrida CG, 2009, AM J OCCUP THER, V63, P398, DOI 10.5014/ajot.63.4.398; Gordon W. A., 2011, TXB TRAUMATIC BRAIN, P579; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Goverover Y, 2009, AM J OCCUP THER, V63, P543, DOI 10.5014/ajot.63.5.543; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Green REA, 2006, BRAIN COGNITION, V60, P199; Grilli MD, 2011, NEUROPSYCHOL REHABIL, V21, P847, DOI 10.1080/09602011.2011.627263; Grilli MD, 2011, J INT NEUROPSYCH SOC, V17, P929, DOI 10.1017/S1355617711000737; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Klonoff PS, 2007, BRAIN INJURY, V21, P1097, DOI 10.1080/02699050701687342; Klonoff PS, 2010, BRAIN INJURY, V24, P63, DOI 10.3109/02699050903512863; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lannin N, 2014, CLIN REHABIL, V28, P470, DOI 10.1177/0269215513512216; Lei J, 2012, CHIN J TRAUMATOL, V15, P17, DOI 10.3760/cma.j.issn.1008-1275.2012.01.004; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Leon-Carrion J, 2012, J REHABIL MED, V44, P505, DOI 10.2340/16501977-0982; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Lojovich JM, 2010, J HEAD TRAUMA REHAB, V25, P184, DOI 10.1097/HTR.0b013e3181dc78cd; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Michels TC, 2010, AM FAM PHYSICIAN, V82, P495; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Morris DM, 2006, NEUROREHABILITATION, V21, P131; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pachalska M, 2011, MED SCI MONITOR, V17, pCS120, DOI 10.12659/MSM.881970; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Pastotter B, 2013, NEUROPSYCHOLOGY, V27, P280, DOI 10.1037/a0031797; Pero S, 2006, BRAIN INJURY, V20, P1207, DOI 10.1080/02699050600983271; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Powell J, 2008, NEUROPSYCHOL REHABIL, V18, P182, DOI 10.1080/09602010701419485; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Raffin E, 2013, FRONT NEUROL NEUROSC, V32, P26, DOI 10.1159/000348818; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Robertson I., 1996, GOAL MANAGEMENT TRAI; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2012, NEUROREHABILITATION, V31, P295, DOI 10.3233/NRE-2012-0797; Sumowski JF, 2014, ARCH PHYS MED REHAB, V95, P397, DOI 10.1016/j.apmr.2013.10.021; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; TEASDALE G, 1974, LANCET, V2, P81; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Wick Jeannette Y, 2012, Consult Pharm, V27, P392, DOI 10.4140/TCP.n.2012.392; Wright JE, 2005, CRIT CARE NURS Q, V28, P150, DOI 10.1097/00002727-200504000-00007; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yip BCB, 2013, NEUROREHABILITATION, V32, P103, DOI [10.3233/NRE-130827, 10.3233/NRE-30827]	156	10	10	3	241	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	WIN	2015	35	1					5	22		10.1177/1539449214561765			18	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	CB4UA	WOS:000349622500002	26623474	Green Accepted			2022-02-06	
J	Ducic, I; Sinkin, JC; Crutchfield, KE				Ducic, Ivica; Sinkin, Jeremy C.; Crutchfield, Kevin E.			INTERDISCIPLINARY TREATMENT OF POST-CONCUSSION AND POST-TRAUMATIC HEADACHES	MICROSURGERY			English	Article							TRAUMATIC BRAIN-INJURY; MIGRAINE HEADACHES; OCCIPITAL NEURALGIA; SURGICAL-TREATMENT; ANATOMICAL VARIATIONS; NERVE	Introduction: Chronic headaches following concussion are debilitating and difficult to treat. Commonly employed initial therapeutic modalities include pharmacologic, physical, and psychological interventions. Despite these efforts, a subset of patients with chronic pain remains. Peripheral nerve surgery has never before been reported as an effective treatment for the management of post-concussion headaches. In this study, we report on our early outcomes following peripheral nerve surgery for this novel indication. Methods: A retrospective review of 28 consecutive patients with post-concussion headaches who underwent occipital nerve surgery was performed. Preoperative and postoperative headache pain was evaluated on visual analog scale (VAS) in 24 patients with at least 6 months follow-up. Results: The average VAS headache pain reduced from 6.4 preoperatively, to 1.4 (P < 0.0001). Twenty-one patients (88%) had a successful outcome of at least a 50% reduction in their VAS following peripheral nerve surgery. Additionally, twelve patients (50%) were pain free at time of final follow-up. There were no surgical complications. Conclusions: Early results indicate peripheral nerve surgery is a safe and effective new therapy for post-concussion headaches in the properly selected patients, whose chronic pain persists despite initial treatments by a neurologist, specialized in headache management. Future studies should focus on larger patient populations, and examine the long-term durability of outcome. In the meantime, an interdisciplinary approach involving neurologists and a peripheral nerve surgeon is suggested for the care of patients with refractory chronic post-concussion occipital neuralgia and other post-traumatic chronic headaches. (C) 2015 Wiley Periodicals, Inc.	[Ducic, Ivica] George Washington Univ, Plast Surg Nerve & Headache Inst, Mclean, VA USA; [Sinkin, Jeremy C.] Georgetown Univ Hosp, Dept Plast Surg, Georgetown, WA USA; [Crutchfield, Kevin E.] Sinai Hosp, Berman Brain & Spine Inst, Sinai Neurol Associates, Baltimore, MD 21215 USA		Ducic, I (corresponding author), Plast Surg Nerve & Headache Inst, 7601 Lewinsville Rd,Suite 460, Mclean, VA 22102 USA.	dr.ducic@gmail.com					Chim H, 2012, PLAST RECONSTR SURG, V130, P336, DOI 10.1097/PRS.0b013e3182589dd5; Ducic I, 2008, PLAST RECONSTR SURG, V121, P1943, DOI 10.1097/PRS.0b013e3181707063; Ducic I, 2014, ANN PLAS SURG, V72, P184, DOI 10.1097/SAP.0b013e3182898736; Ducic I, 2012, HEADACHE, V52, P1136, DOI 10.1111/j.1526-4610.2011.02068.x; Ducic I, 2009, PLAST RECONSTR SURG, V123, P1453, DOI 10.1097/PRS.0b013e3181a0720e; Guyuron B, 2002, PLAST RECONSTR SURG, V109, P2183, DOI 10.1097/00006534-200206000-00001; Guyuron B, 2009, PLAST RECONSTR SURG, V124, P461, DOI 10.1097/PRS.0b013e3181adcf6a; Janis JE, 2013, PLAST RECONSTR SURG, V131, P743, DOI 10.1097/PRS.0b013e3182818b0c; Janis JE, 2010, PLAST RECONSTR SURG, V126, P435, DOI 10.1097/PRS.0b013e3181e094d7; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V30, P711; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	18	10	10	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	NOV	2015	35	8					603	607		10.1002/micr.22503			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DB2LA	WOS:000368338800003	26409037				2022-02-06	
J	Lang, GE; Vella, D; Waters, SL; Goriely, A				Lang, Georgina E.; Vella, Dominic; Waters, Sarah L.; Goriely, Alain			Propagation of damage in brain tissue: coupling the mechanics of oedema and oxygen delivery	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Oxygen delivery; Triphasic model; Brain mechanics; Mathematical modelling; Tissue swelling	STROKE; CAPILLARIES; ELASTICITY; MODEL	Brain tissue swelling, or oedema, is a dangerous consequence of traumatic brain injury and stroke. In particular, a locally swollen region can cause the injury to propagate further through the brain: swelling causes mechanical compression of the vasculature in the surrounding tissue and so can cut off that tissue's oxygen supply. We use a triphasic mathematical model to investigate this propagation, and couple tissue mechanics with oxygen delivery. Starting from a fully coupled, finite elasticity, model, we show that simplifications can be made that allow us to express the volume of the propagating region of damage analytically in terms of key parameters. Our results show that performing a craniectomy, to alleviate pressure in the brain and allow the tissue to swell outwards, reduces the propagation of damage; this finding agrees with experimental observations.	[Lang, Georgina E.; Vella, Dominic; Waters, Sarah L.; Goriely, Alain] Univ Oxford, Inst Math, Oxford OX1 3LB, England		Goriely, A (corresponding author), Univ Oxford, Inst Math, 24-29 St Giles, Oxford OX1 3LB, England.	Alain.Goriely@maths.ox.ac.uk	Vella, Dominic/A-9070-2008	Vella, Dominic/0000-0003-1341-8863; Waters, Sarah/0000-0001-5285-0523			Atala A., 2002, METHODS TISSUE ENG; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Ben Amar M, 2005, J MECH PHYS SOLIDS, V53, P2284, DOI 10.1016/j.jmps.2005.04.008; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cowin SC, 2009, TISSUE MECH; Dhawan V, 2012, J NEUROINTERV SURG, V4, P407, DOI 10.1136/neurintsurg-2011-010158; Donnan FG, 1924, CHEM REV, V1, P73, DOI 10.1021/cr60001a003; Elkin BS, 2010, PHILOS T R SOC A, V368, P585, DOI 10.1098/rsta.2009.0223; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fisher M, 1996, NEUROLOGY, V47, P884, DOI 10.1212/WNL.47.4.884; Flechsenhar J, 2013, J CLIN NEUROSCI, V20, P6, DOI 10.1016/j.jocn.2012.02.019; Ganfield R, 1970, AM J PHYSIOL, V219; Garcia JJ, 2009, ANN BIOMED ENG, V37, P375, DOI 10.1007/s10439-008-9610-0; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; Goriely A, MECH BRAIN PERSPECTI; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; HOMER LD, 1983, AM J PHYSIOL, V244, pR15, DOI 10.1152/ajpregu.1983.244.1.R15; Huyghe JM, 1997, INT J ENG SCI, V35, P793, DOI 10.1016/S0020-7225(96)00119-X; Keener J., 1998, INTERD APPL, DOI 10.1007/b98841; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Lang GE, 2014, THESIS U OXFORD; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; MacLaurin J, 2012, P ROY SOC A-MATH PHY, V468, P4123, DOI 10.1098/rspa.2012.0418; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ogden, 1984, NONLINEAR ELASTIC DE; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P635, DOI 10.1038/jcbfm.2013.18; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Pardridge WM, 1997, J CEREBR BLOOD F MET, V17, P713, DOI 10.1097/00004647-199707000-00001; Raslan A., 2007, NEUROSURG FOCUS, V22, P1; Secomb TW, 2000, MICROCIRCULATION, V7, P237, DOI 10.1038/sj.mn.7300114; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Sun DN, 1999, INT J NUMER METHODS, V45; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Walberer M, 2008, J NEUROSURG, V109, P287, DOI 10.3171/JNS/2008/109/8/0287	41	10	10	2	16	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	NOV	2015	14	6					1197	1216		10.1007/s10237-015-0665-1			20	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CS3JP	WOS:000361969700003	25822263	Green Submitted			2022-02-06	
J	Mhanna, MJ; El Mallah, W; Verrees, M; Shah, R; Super, DM				Mhanna, Maroun J.; El Mallah, Wael; Verrees, Margaret; Shah, Rajiv; Super, Dennis M.			Outcome of children with severe traumatic brain injury who are treated with decompressive craniectomy	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						decompressive craniectomy; pediatric; traumatic brain injury; outcome; trauma	REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL PERFUSION; MANAGEMENT	OBJECT Decompressive craniectomy (DC) for the management of severe traumatic brain injury (TBI) is controversial. The authors sought to determine if DC improves the outcome of children with severe TBI. METHODS In a retrospective, case-control study, medical records of all patients admitted to the pediatric ICU between May 1998 and May 2008 with severe TBI and treated with DC were identified and matched to patients who were treated medically without DC. Medical records were reviewed for patients' demographic data and baseline characteristics. RESULTS During the study period, 17,patients with severe TBI treated with DC at a median of 2 hours (interquartile range [IQR] 1-14 hours) after admission were identified and matched to 17 contemporary controls. On admission, there were no differences between DC and control patients regarding age (10.2 +/- 5.9 years vs 12.4 +/- 5.4 years, respectively [mean +/- SD]), sex, weight, Glasgow Coma Scale score (median 5 [IQR 3-7] vs 4 [IQR 3-6], respectively; p = 0.14), or the highest intracranial pressure (median 42 [IQR 22-54] vs 30 [IQR 21-36], respectively; p = 0:77). However, CT findings were significant for a higher rate of herniation and cerebral edema among patients with DC versus controls (7/17 vs 2/17, respectively, had herniation [p = 0.05] and 14/17 vs 6/17, respectively, had cerebral edema [p 0.006]). Overall there were no significant differences in survival between patients with DC and controls (71% [12/17] vs 82% [14/17], respectively; p = 0.34). However, among survivors, at 4 years (IQR 1-6 years) after the TBI, 42% (5/12) of the DC patients had mild disability or a Glasgow Outcome Scale score of 5 vs none (0/14) of the controls (p = 0.012). CONCLUSIONS In this retrospective, small case-control study, the authors have shown that early DC in pediatric patients with severe TBI improves outcome in survivors. Future prospective randomized controlled studies are needed to confirm these findings.	[Mhanna, Maroun J.; El Mallah, Wael; Super, Dennis M.] Metrohlth Med Ctr, Dept Pediat, Cleveland, OH USA; [Verrees, Margaret] Metrohlth Med Ctr, Dept Neurosurg, Cleveland, OH USA; [Shah, Rajiv] Metrohlth Med Ctr, Dept Radiol, Cleveland, OH USA		Mhanna, MJ (corresponding author), Metrohlth Med Ctr, 2500 MetroHealth Dr, Cleveland, OH 44109 USA.	mmhanna@metrohealth.org					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LITOFSKY NS, 1994, NEUROSURGERY, V34, P628, DOI 10.1227/00006123-199404000-00009; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Perez SE, 2011, J TRAUMA, V71, P133; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	27	10	10	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2015	16	5					508	514		10.3171/2014.10.PEDS14117			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CU3QK	WOS:000363439700008	26230458	Bronze			2022-02-06	
J	Paczkowska, E; Roginska, D; Pius-Sadowska, E; Jurewicz, A; Piecyk, K; Safranow, K; Dziedziejko, V; Grzegrzolka, R; Bohatyrewicz, A; Machalinski, B				Paczkowska, Edyta; Roginska, Dorota; Pius-Sadowska, Ewa; Jurewicz, Alina; Piecyk, Katarzyna; Safranow, Krzysztof; Dziedziejko, Violetta; Grzegrzolka, Ryszard; Bohatyrewicz, Andrzej; Machalinski, Boguslaw			Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Endothelial cells; Angiogenic factors; Endothelial progenitor cells; Immune response; Spinal cord injury	ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; STEM-CELLS; RAT-BRAIN; DYSFUNCTION; EXPRESSION; BDNF; ANGIOPOIETIN-2	Context/objective: Traumatic spinal cord injury (SCI) leads to disruption of local vasculature inducing secondary damage of neural tissue. Circulating endothelial progenitor cells (EPCs) play an important role in post-injury regeneration of vasculature, whereas endothelial cells (ECs) reflect endothelial damage. Methods: Twenty patients with SCI were assessed during the first 24 hours, at day 3, and day 7 post-injury and compared to 25 healthy subjects. We herein investigated EPC and EC counts by flow cytometry as well as the levels of soluble factors (SDF-1, HGF, VEGF, Ang2, EGF, endoglin, PLGF, FGF-2, ET-1, BDNF, IGF-1) regulating their migration and proangiogenic function. To better characterize peripheral blood (PB) cells, global gene expression profiles of PB-derived cells were determined using genome-wide RNA microarray technology. Results: We found significantly higher EPC (CD34(+)/CD133(+)/VEGFR2(+)) as well as EC (VEGFR2(+)) count in PB of patients with SCI within 7 days post-injury and the increased HGF, ET-1, Ang2, EGF, and PLGF plasma levels. Global gene expression analysis revealed considerably lower expression of genes associated with both innate and adaptive immune response in PB cells in patients. Conclusion: Collectively, our findings demonstrate that SCI triggers bone marrow-derived EPC mobilization accompanied by increased circulating EC numbers. Significant changes in both chemoattractive and proangiogenic cytokines plasma levels occurring rapidly after SCI suggest their role in SCI-related regenerative responses to injury. Broadened knowledge concerning the mechanisms governing of human organism response to the SCI might be helpful in developing effective therapeutic strategies.	[Paczkowska, Edyta; Roginska, Dorota; Pius-Sadowska, Ewa; Piecyk, Katarzyna; Grzegrzolka, Ryszard; Machalinski, Boguslaw] Pomeranian Med Univ, Dept Gen Pathol, PL-70111 Szczecin, Poland; [Jurewicz, Alina; Bohatyrewicz, Andrzej] Pomeranian Med Univ, Dept Orthopaed Traumatol & Musculoskeletal Oncol, PL-70111 Szczecin, Poland; [Safranow, Krzysztof; Dziedziejko, Violetta] Pomeranian Med Univ, Dept Biochem & Med Chem, PL-70111 Szczecin, Poland		Machalinski, B (corresponding author), Pomeranian Med Univ, Dept Gen Pathol, Powstancow Wlkp 72, PL-70111 Szczecin, Poland.	machalin@pum.edu.pl	JUREWICZ, ALINA/Y-8965-2019; Roginska, Dorota/B-4424-2016; Safranow, Krzysztof/B-5127-2015; Bohatyrewicz, Andrzej/J-4658-2014; Dziedziejko, Violetta V./A-7626-2015; Paczkowska, Edyta/AAX-2347-2021; Pius-Sadowska, Ewa/O-8254-2014; Paczkowska, Edyta/N-1209-2014	JUREWICZ, ALINA/0000-0002-2822-858X; Roginska, Dorota/0000-0001-8884-837X; Safranow, Krzysztof/0000-0001-9415-2758; Bohatyrewicz, Andrzej/0000-0002-4773-0970; Dziedziejko, Violetta V./0000-0003-4809-415X; Pius-Sadowska, Ewa/0000-0003-3106-8705; Machalinski, Boguslaw/0000-0002-6013-0419; Paczkowska, Edyta/0000-0001-7052-9741	European Union structural funds-Innovative Economy Operational Programme grant "Innovative methods of stem cells applications in medicine" [POIG.01.01.02-00-109/09]; National Science CenterNational Science Centre, Poland [N 401 613 740]	This work was supported by European Union structural funds-Innovative Economy Operational Programme grant POIG.01.01.02-00-109/09 "Innovative methods of stem cells applications in medicine" and the National Science Center grant No. N 401 613 740 (to E.P.).	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Chamankhah M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-583; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; Durham-Lee JC, 2012, NEUROSCIENCE, V202, P454, DOI 10.1016/j.neuroscience.2011.09.058; Erdbruegger U, 2006, CLIN CHIM ACTA, V373, P17, DOI 10.1016/j.cca.2006.05.016; Fassbender JM, 2011, NEUROTHERAPEUTICS, V8, P240, DOI 10.1007/s13311-011-0029-1; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; Gaal EI, 2013, BLOOD, V122, P658, DOI 10.1182/blood-2012-07-441527; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Graumann U, 2011, CURR NEUROVASC RES, V8, P334, DOI 10.2174/156720211798121007; HAMA H, 1992, BIOCHEM BIOPH RES CO, V186, P355, DOI 10.1016/S0006-291X(05)80815-0; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105; Jalili A, 2010, STEM CELLS DEV, V19, P1143, DOI 10.1089/scd.2009.0376; Kamei N, 2012, J NEUROTRAUM, V29, P1758, DOI 10.1089/neu.2011.2139; Kang MK, 2008, CELL PROLIFERAT, V41, P377, DOI 10.1111/j.1365-2184.2008.00537.x; Kapczinski Flavio, 2008, Expert Rev Neurother, V8, P1101, DOI 10.1586/14737175.8.7.1101; Kapur NK, 2013, VASC HEALTH RISK MAN, V9, P195, DOI 10.2147/VHRM.S29144; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Masjkur J, 2012, CNS NEUROL DISORD-DR, V11, P805, DOI 10.2174/1871527311201070805; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Ng MTL, 2011, TRANSL STROKE RES, V2, P474, DOI 10.1007/s12975-011-0109-x; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; Onuoha GN, 1999, LIFE SCI, V65, P1351, DOI 10.1016/S0024-3205(99)00374-4; Paczkowska E, 2013, J NEUROL SCI, V325, P90, DOI 10.1016/j.jns.2012.12.005; Paczkowska E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083833; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Ritz MF, 2010, CURR NEUROVASC RES, V7, P301, DOI 10.2174/156720210793180756; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Rosner J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/826754; Salzman SK, 1996, J NEUROTRAUM, V13, P93, DOI 10.1089/neu.1996.13.93; Sasaki H, 2009, SPINE, V34, P249, DOI 10.1097/BRS.0b013e3181913cde; Schaaf MJM, 2000, MOL BRAIN RES, V75, P342, DOI 10.1016/S0169-328X(99)00314-9; Schulte-Herbruggen O, 2005, J NEUROIMMUNOL, V160, P204, DOI 10.1016/j.jneuroim.2004.10.026; Seghers L, 2012, J CELL MOL MED, V16, P2440, DOI 10.1111/j.1582-4934.2012.01561.x; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Takeuchi H, 2007, NEUROSCI LETT, V426, P69, DOI 10.1016/j.neulet.2007.08.048; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Uesugi M, 1996, BRAIN RES, V728, P255, DOI 10.1016/0006-8993(96)00524-0; Van Belle E, 1998, CIRCULATION, V97, P381; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Wang TD, 2007, J FORMOS MED ASSOC, V106, P919, DOI 10.1016/S0929-6646(08)60062-5; WESTMARK R, 1995, NEUROSCI LETT, V192, P173, DOI 10.1016/0304-3940(95)11638-D; YAMADA G, 1995, J CARDIOVASC PHARM, V26, pS486; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083	56	10	11	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	NOV	2015	38	6					729	744		10.1179/2045772314Y.0000000227			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8KC	WOS:000363790300007	24968203	Green Published			2022-02-06	
J	Schonfeld, D; Bressan, S; Da Dalt, L; Henien, MN; Winnett, JA; Nigrovic, LE				Schonfeld, Deborah; Bressan, Silvia; Da Dalt, Liviana; Henien, Mira N.; Winnett, Jill A.; Nigrovic, Lise E.			Pediatric Emergency Care Applied Research Network head injury clinical prediction rules are reliable in practice	POSTGRADUATE MEDICAL JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; SKELETAL SURVEYS; CHILDREN; MANAGEMENT; CHILDHOOD; SCANS; RISK	Objective The Pediatric Emergency Care Applied Research Network (PECARN) traumatic brain injury (TBI) age-based clinical prediction rules identify children at very low risk of a significant head injury who can safely avoid CT. Our goal was to independently validate these prediction rules. Design Cross-sectional study. Setting Two paediatric emergency departments located in USA and in Italy. Patients All children presenting within 24 h of a head injury with a Glasgow Coma Score of >= 14. Intervention Assessment of PECARN TBI clinical predictors. Main outcome measure Clinically important TBI defined as head injury resulting in death, intubation for > 24 h, neurosurgery or two or more nights of hospitalisation for the management of head trauma. Results During the study period, we included 2439 children (91% of eligible patients), of which 959 (39%) were < 2 years of age and 1439 (59%) were male. Of the study patients, 373 (15%) had a CT performed, 69 (3%) had traumatic findings on their CT and 19 (0.8%) had a clinically important TBI. None of the children with a clinically important TBI were classified as very low risk by the PECARN TBI prediction rules (overall sensitivity 100%; 95% CI 83.2% to 100%, specificity 55%, 95% CI 52.5% to 56.6%, and negative predictive value 100%, 95% CI 99.6% to 100%). Conclusions In our external validation, the age-based PECARN TBI prediction rules accurately identified children at very low risk for a clinically significant TBI and can be used to assist CT decision making for children with minor blunt head trauma.	[Schonfeld, Deborah; Henien, Mira N.; Winnett, Jill A.; Nigrovic, Lise E.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Schonfeld, Deborah] Hosp Sick Children, Div Emergency Med, Toronto, ON M5G 1X8, Canada; [Bressan, Silvia; Da Dalt, Liviana] Univ Padua, Dept Womans & Childs Hlth, Padua, Italy		Nigrovic, LE (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	Lise.nigrovic@childrens.harvard.edu		Nigrovic, Lise/0000-0002-6369-3997	Hood Childhood Research Grant; Boston Children's Hospital House-officers Grant	Hood Childhood Research Grant, Boston Children's Hospital House-officers Grant.	Boutis K, 2013, PEDIATRICS, V132, P305, DOI 10.1542/peds.2013-0378; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Forsyth R, 2013, ARCH DIS CHILD; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Karpas A, 2013, PEDIATR EMERG CARE, V29, P30, DOI 10.1097/PEC.0b013e31827b5090; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laskey AL, 2013, J PEDIATR-US, V162, P86, DOI 10.1016/j.jpeds.2012.06.038; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467	21	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0032-5473	1469-0756		POSTGRAD MED J	Postgrad. Med. J.	NOV	2015	91	1081					634	638		10.1136/postgradmedj-2013-305004rep			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU9EH	WOS:000363846100005	26500010				2022-02-06	
J	Simon-Pimmel, J; Lorton, F; Guiziou, N; Levieux, K; Vrignaud, B; Masson, D; Dupas, B; Gras-Leguen, C				Simon-Pimmel, Jeanne; Lorton, Fleur; Guiziou, Nicolas; Levieux, Karine; Vrignaud, Benedicte; Masson, Damien; Dupas, Benoit; Gras-Leguen, Christele			SERUM S100 beta NEUROPROTEIN REDUCES USE OF CRANIAL COMPUTED TOMOGRAPHY IN CHILDREN AFTER MINOR HEAD TRAUMA	SHOCK			English	Article						Minor head trauma; children; serum S100 neuroprotein; cranial computed tomography; clinical decision rule; MHT; minor head trauma; GCS; Glasgow Coma Scale; ED; emergency department; TBI; traumatic brain injury; CCT; cranial computed tomography; ciTBI; clinically important traumatic brain injury; 95% CI; 95% confidence interval	RADIATION-EXPOSURE; REFERENCE RANGES; S100B PROTEIN; INJURY; MANAGEMENT; MILD; ADULTS; PREDICTION; BIOMARKERS; CHILDHOOD	Minor head trauma is a common reason for consultation in pediatric emergency departments. In 2009, the Pediatric Emergency Care Applied Research Network (PECARN) published a clinical decision rule for its management. It aimed to help clinicians identify children with a very low risk of developing intracranial lesions, so that unnecessary cranial computed tomography (CCT) scan radiation could be avoided, as such exposure is associated with a rising risk of cancer in this young population. In the meantime, the serum S100 neuroprotein showed encouraging results, with a 30% potential decrease in CCTs for the management of minor head traumas in adults and children. The aim of this study was to determine if the serum S100 neuroprotein, associated with the PECARN clinical decision rule, could safely reduce the use of CCTs. We included children who were examined at the pediatric emergency department for minor head trauma, who underwent a CCT, whose blood samples were analyzed to determine the level of the serum S100 protein. They were managed according to the PECARN clinical decision rule. We afterward assessed the potential decrease in the number of CCTs, according to a modified PECARN clinicobiological decision rule, had we taken into account the result of the blood tests. One hundred nine children were included, and nine of them had clinically important traumatic brain injury. Four of them had a negative S100 value but were classified as high risk of developing intracranial lesion according to the PECARN clinical decision rule. Had we taken into account the modified PECARN clinicobiological decision rule, none of them would have been missed. However, there were 32 true negatives of the rule, allowing a potential decrease in CCTs rated at 29% (95% confidence interval, 21-38). Integrating the serum S100 neuroprotein assessment in the PECARN clinical decision rule could avoid deleterious exposure to CCT radiation, with the condition of using a clinicobiological rule to avoid missing clinically important traumatic brain injuries. Those results have yet to be confirmed relying on a large multicentric study.	[Simon-Pimmel, Jeanne; Lorton, Fleur; Guiziou, Nicolas; Levieux, Karine; Vrignaud, Benedicte; Gras-Leguen, Christele] Univ Hosp Nantes, Dept Paediat Emergency, Nantes, France; [Masson, Damien] Univ Hosp Nantes, Dept Biol, Nantes, France; [Dupas, Benoit] Univ Hosp Nantes, Dept Radiol, Nantes, France		Simon-Pimmel, J (corresponding author), CHU Nantes, F-44093 Nantes 01, France.	jeanne.pimmel@chu-nantes.fr		SIMON-PIMMEL, Jeanne/0000-0003-0699-5793; GRAS-LE GUEN, Christele/0000-0001-9060-2344			Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Astrand R, 2011, CLIN CHIM ACTA, V412, P2190, DOI 10.1016/j.cca.2011.08.009; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gras-Le Guen C, 2012, UTILISATION BIOMARQU, P323; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22	29	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	NOV	2015	44	5					410	416		10.1097/SHK.0000000000000442			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CX4LU	WOS:000365673200005	26196846				2022-02-06	
J	Liang, P; Gustafsson, L; Liddle, J; Fleming, J				Liang, Phyllis; Gustafsson, Louise; Liddle, Jacki; Fleming, Jennifer			Family members' needs and experiences of driving disruption due to health conditions or ageing	DISABILITY AND REHABILITATION			English	Article						Caregiver; driving; family; older adults	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; COMMUNITY INTEGRATION; DEPRESSIVE SYMPTOMS; LIFE SATISFACTION; CLOSE RELATIVES; CESSATION; CAREGIVERS; DEMENTIA; PEOPLE	Purpose: Family members often assume the caregiving role and provide practical assistance and emotional support when an individual is experiencing driving disruption due to health conditions or ageing. The purpose of this study was to understand the experiences, viewpoints and needs of family members with regards to an individual undergoing driving disruption across various population groups. Method: A scoping review was conducted through searching across six databases and hand searching articles published from 1985 to 2013. Findings from the articles specific to the aims of the review were extracted and summarised into common topics. Results: Twenty-seven articles were included; dementia or cognitive impairment (16 articles), older adults (8 articles) and brain injury (3 articles). The most common topic raised was related to decisions and consequences for the individual. Other concerns were related to family members' occupational role changes, emotional and communication issues and support needs of family members and their recommendations for services. Conclusions: This review revealed the impact of driving disruption on family members but research is limited, especially in the area of brain injury. The majority of articles did not set out to explore family members' experiences and needs and this highlights an area that requires critical attention.Implications for RehabilitationHealth professionals should be aware of the potential impact of driving disruption on family members.Family members frequently raise concerns regarding the decisions and consequences for their relative, but also bring up personal concerns such as changes to their own occupational roles and the communication and emotional issues they face during driving disruption.Unique challenges arise between family members of individuals of different health conditions, thus highlighting the importance of family caregiving research in various population groups.	[Liang, Phyllis; Gustafsson, Louise; Fleming, Jennifer] Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Liddle, Jacki] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia		Liang, P (corresponding author), Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	p.liang@uq.edu.au	Gustafsson, Louise A./F-9683-2010; Liddle, Jacki/F-6872-2010	Gustafsson, Louise A./0000-0001-5232-0987; Liang, Phyllis/0000-0003-3311-8788; Liddle, Jacki/0000-0002-6336-9898	University of Queensland Research Scholarship (UQRS)University of Queensland	The authors report no declarations of interest. The first author is a recipient of the University of Queensland Research Scholarship (UQRS). There are no additional funding sources.	Aberg AC, 2004, QUAL HEALTH RES, V14, P792, DOI 10.1177/1049732304265854; Adler G, 1999, CLIN GERONTOLOGIST, V20, P23, DOI DOI 10.1300/J018V20N02_03; Adler G., 2010, DEMENTIA, V9, P45, DOI [10.1177/1471301209350289, DOI 10.1177/1471301209350289]; Adler G., 2000, J CLIN GEROPSYCHOLOG, V6, P83; Adler G, 2006, J AGING STUD, V20, P227, DOI 10.1016/j.jaging.2005.09.003; Adler G, 2011, AM J ALZHEIMERS DIS, V26, P58, DOI 10.1177/1533317510390350; Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Andren S, 2005, SCAND J CARING SCI, V19, P157, DOI 10.1111/j.1471-6712.2005.00328.x; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Australian Bureau of Statistics, 2013, MOT VEH CENS; Austroads, 2012, ASS FITN DRIV; Backstrom B, 2007, NURS INQ, V14, P243, DOI 10.1111/j.1440-1800.2007.00373.x; Betz ME, 2013, J GEN INTERN MED, V28, P1573, DOI 10.1007/s11606-013-2498-x; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Buys L, 2012, AUSTRALAS J AGEING, V31, P181, DOI 10.1111/j.1741-6612.2011.00567.x; Byszewski AM, 2010, CLIN GERONTOLOGIST, V33, P152, DOI 10.1080/07317110903552198; Chumbler NR, 2004, INT J GERIATR PSYCH, V19, P944, DOI 10.1002/gps.1187; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Colquhoun HL, 2010, CAN J OCCUP THER, V77, P270, DOI 10.2182/cjot.2010.77.5.3; Connell CM, 2013, J APPL GERONTOL, V32, P975, DOI 10.1177/0733464812448962; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Croston J, 2009, TOP GERIATR REHABIL, V25, P154; D'Ambrosio LA, 2009, TOP GERIATR REHABIL, V25, P33; Duggleby W, 2010, QUAL HEALTH RES, V20, P148, DOI 10.1177/1049732309358329; Elder G.H., 2009, CRAFT LIFE COURSE RE; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Finestone HM, 2010, PM&R, V2, P497, DOI 10.1016/j.pmrj.2010.03.030; Funk LM, 2010, J AGING STUD, V24, P57, DOI 10.1016/j.jaging.2008.03.003; GARDEZI F, 2006, CLIN GERONTOLOGIST, V30, P5, DOI DOI 10.1300/J018V30N01_02; Gaugler JE, 2010, REHABIL PSYCHOL, V55, P108, DOI 10.1037/a0019023; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Griffen JA, 2009, TOP STROKE REHABIL, V16, P212, DOI 10.1310/tsr1603-212; Gustafsson L, 2012, INT PSYCHOGERIATR, V24, P794, DOI 10.1017/S1041610211002560; Hebert K., 2003, CLIN GERONTOLOGIST, V26, P17, DOI [DOI 10.1300/J018v26n01_03, 10.1300/J018v26n01_03, DOI 10.1300/J018V26N01_03]; Jett K, 2005, GERIATR NURS, V26, P111, DOI 10.1016/j.gerinurse.2005.01.004; Johnson J E, 1998, J Community Health Nurs, V15, P205, DOI 10.1207/s15327655jchn1504_2; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kerschner HK, 2009, TOP GERIATR REHABIL, V25, P173; Kim J, 2011, J AM GERIATR SOC, V59, pS60; Kostyniuk LP, 2009, TOP GERIATR REHABIL, V25, P24; Kostyniuk LP, 2009, 200902 MCASTL ANN AR; Kowalski K, 2012, ACCIDENT ANAL PREV, V49, P308, DOI 10.1016/j.aap.2011.11.011; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Liddle J., 2008, BRIT J OCCUP THER, V71, P379, DOI DOI 10.1177/030802260807100905; Liddle J, 2013, INT PSYCHOGERIATR, V25, P2033, DOI 10.1017/S1041610213001464; Liddle J, 2012, AUST OCCUP THER J, V59, P384, DOI 10.1111/j.1440-1630.2011.00956.x; Liddle J, 2012, AUST OCCUP THER J, V59, P79, DOI 10.1111/j.1440-1630.2011.00978.x; Liddle J, 2011, DISABIL REHABIL, V33, P2574, DOI 10.3109/09638288.2011.582922; Liddle J, 2009, BRAIN IMPAIR, V10, P271, DOI 10.1375/brim.10.3.271; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Macmillan R, 2005, J MARRIAGE FAM, V67, P858, DOI 10.1111/j.1741-3737.2005.00180.x; Majid M, 2012, J AM GERIATR SOC, V60, pS239; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; Marshall S, 2012, CAN GERIATR J, V15, P101, DOI 10.5770/cgj.15.30; Mason A, 2001, J DEMENTIA CARE, V9, P33; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McKinstry C, 2014, AUST OCCUP THER J, V61, P58, DOI 10.1111/1440-1630.12080; Mezuk B, 2008, J GERONTOL B-PSYCHOL, V63, pS298, DOI 10.1093/geronb/63.5.S298; Mizuno Y, 2008, INT J GERIATR PSYCH, V23, P987, DOI 10.1002/gps.1999; Moghimi C, 2007, TOP GERIATR REHABIL, V23, P269; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Perkinson MA, 2005, GERONTOLOGIST, V45, P676, DOI 10.1093/geront/45.5.676; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Ralston L. S., 2001, PHYS OCCUPATIONAL TH, V19, P59, DOI DOI 10.1080/J148V19N04_05; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; REES J, 1995, J MENTAL HLTH, V4, P165, DOI DOI 10.1080/09638239550037703; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Seiler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052710; STERNS HL, 2001, 809307 DOT HS OFF RE; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337; Taylor BD, 2001, ACCIDENT ANAL PREV, V33, P519, DOI 10.1016/S0001-4575(00)00065-8; Truzzi A, 2012, REV BRAS PSIQUIATR, V34, P405, DOI 10.1016/j.rbp.2012.02.006; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Weiss P., 2011, COGNITION OCCUPATION, P71; Whitehead Bianca., 2006, AUST OCCUP THER J, V53, P173, DOI [10.1111/j.1440-1630.2006.00564.x, DOI 10.1111/J.1440-1630.2006.00564.X]; Wittenberg E, 2013, PATIENT, V6, P257, DOI 10.1007/s40271-013-0030-3; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	90	10	10	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 23	2015	37	22					2114	2129		10.3109/09638288.2014.998778			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DD2JM	WOS:000369748600010	26415831				2022-02-06	
J	Lu, XCM; Shear, DA; Graham, PB; Bridson, GW; Uttamsingh, V; Chen, ZY; Leung, LY; Tortella, FC				Lu, Xi-Chun May; Shear, Deborah A.; Graham, Philip B.; Bridson, Gary W.; Uttamsingh, Vinita; Chen, Zhiyong; Leung, Lai Yee; Tortella, Frank C.			Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						C-10068; dextromethorphan; EEG; neuroinflammation; nonconvulsive seizures; penetrating brain injury	METHYL-D-ASPARTATE; KAINATE-INDUCED SEIZURES; NEURONAL DAMAGE; FOCAL ISCHEMIA; ION CHANNELS; DEXTRORPHAN; SIGMA; PHENYTOIN; NEUROPROTECTION; DEFICITS	Post-traumatic seizures can exacerbate injurious outcomes of severe brain trauma, yet effective treatments are limited owing to the complexity of the pathology underlying the concomitant occurrence of both events. In this study, we tested C-10068, a novel deuterium-containing analog of (+)-N-methyl-3-ethoxymorphinan, in a rat model of penetrating ballistic-like brain injury (PBBI) and evaluated the effects of C-10068 on PBBI-induced nonconvulsive seizures (NCS), acute neuroinflammation, and neurofunctional outcomes. NCS were detected by electroencephalographic monitoring. Neuroinflammation was evaluated by immunohistochemical markers, for example, glial fibrillary acidic protein and major histocompatibility complex class I, for activation of astrocytes and microglia, respectively. Neurofunction was tested using rotarod and Morris water maze tasks. Three infusion doses of C-10068 (1.0, 2.5, and 5.0mg/kg/hx72h) were tested in the antiseizure study. Neuroinflammation and neurofunction were evaluated in animals treated with 5.0mg/kg/hx72h C-10068. Compared to vehicle treatment, C-10068 dose dependently reduced PBBI-induced NCS incidence (40-50%), frequency (20-70%), and duration (30-82%). The most effective antiseizure dose of C-10068 (5.0mg/kg/hx72h) also significantly attenuated hippocampal astrocyte activation and perilesional microglial reactivity post-PBBI. Within C-10068-treated animals, a positive correlation was observed in reduction in NCS frequency and reduction in hippocampal astrocyte activation. Further, C-10068 treatment significantly attenuated astrocyte activation in seizure-free animals. However, C-10068 failed to improve PBBI-induced motor and cognitive functions with the dosing regimen used in this study. Overall, the results indicating that C-10068 exerts both potent antiseizure and antiinflammatory effects are promising and warrant further investigation.	[Lu, Xi-Chun May; Shear, Deborah A.; Chen, Zhiyong; Leung, Lai Yee; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD 20910 USA; [Graham, Philip B.; Bridson, Gary W.; Uttamsingh, Vinita] Concert Pharmaceut Inc, Lexington, MA USA		Lu, XCM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	may.lu@us.army.mil			U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Combat Casualty Care Research ProgramUnited States Department of Defense; Concert Pharmaceuticals Inc.	This work was supported by funding provided by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program and Concert Pharmaceuticals Inc.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ARAM JA, 1989, J PHARMACOL EXP THER, V248, P320; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Block F, 1998, NEUROSCIENCE, V82, P791; Block F, 1996, BRAIN RES, V741, P153, DOI 10.1016/S0006-8993(96)00916-X; Britton P, 1997, LIFE SCI, V60, P1729, DOI 10.1016/S0024-3205(97)00132-X; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; CARPENTER CL, 1988, BRAIN RES, V439, P372, DOI 10.1016/0006-8993(88)91497-7; CHAPMAN AG, 1989, EUR J PHARMACOL, V166, P201, DOI 10.1016/0014-2999(89)90060-5; CHOI DW, 1987, BRAIN RES, V403, P333, DOI 10.1016/0006-8993(87)90070-9; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; D'Ambrosio R, 2004, PHARMACOL THERAPEUT, V103, P95, DOI 10.1016/j.pharmthera.2004.05.004; Debonnel G, 1996, LIFE SCI, V58, P721, DOI 10.1016/0024-3205(95)02248-1; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; GOLDBERG MP, 1987, NEUROSCI LETT, V80, P11, DOI 10.1016/0304-3940(87)90486-1; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hirsch Lawrence J, 2008, Epilepsy Curr, V8, P97, DOI 10.1111/j.1535-7511.2008.00254.x; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; Kim HC, 2003, LIFE SCI, V72, P769, DOI 10.1016/S0024-3205(02)02309-3; Kim HC, 2001, LIFE SCI, V69, P915, DOI 10.1016/S0024-3205(01)01181-X; Klette KL, 1997, BRAIN RES, V756, P231, DOI 10.1016/S0006-8993(97)00142-X; Klette KL, 1995, BRAIN RES, V704, P31, DOI 10.1016/0006-8993(95)01103-X; Lerche H, 2013, J PHYSIOL-LONDON, V591, P753, DOI 10.1113/jphysiol.2012.240606; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; McCluggage LK, 2009, NEUROCRIT CARE, V10, P222, DOI 10.1007/s12028-008-9165-9; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Schmid-Elsaesser R, 1998, EXP BRAIN RES, V122, P121, DOI 10.1007/s002210050498; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Shen YC, 2008, J NEUROCHEM, V104, P558, DOI 10.1111/j.1471-4159.2007.05058.x; Shin EJ, 2005, BRIT J PHARMACOL, V144, P908, DOI 10.1038/sj.bjp.0705998; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thurgur C, 1998, BRIT J PHARMACOL, V124, P917, DOI 10.1038/sj.bjp.0701902; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; TORTELLA FC, 1988, LIFE SCI, V42, P2509, DOI 10.1016/0024-3205(88)90350-5; TORTELLA FC, 1994, J PHARMACOL EXP THER, V268, P727; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; Young GB, 1998, ARCH NEUROL-CHICAGO, V55, P117, DOI 10.1001/archneur.55.1.117	59	10	10	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1621	1632		10.1089/neu.2014.3766			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500010	25794265	Green Published			2022-02-06	
J	Yanturali, S; Canacik, O; Karsli, E; Suner, S				Yanturali, Sedat; Canacik, Omer; Karsli, Emre; Suner, Selim			Injury and illness among athletes during a multi-day elite cycling road race	PHYSICIAN AND SPORTSMEDICINE			English	Article						Road bicycle race; Bicycle race; Injury; Sports medicine; Event medicine; Cycling	DATA-COLLECTION PROCEDURES; MOUNTAIN BIKING INJURIES; CONSENSUS STATEMENT; CARDIAC-ARREST; SPORTS; DEFINITIONS; CONCUSSION; DEATH	Objectives: Although road bicycle races have been held for more than a century, injury and illness patterns during multi-day bicycle events have not been widely studied. The aim of this study was to determine the incidence of injury and illness among riders and describe the medical care interventions provided to participants of cycling road races. Methods: A prospective observational study was conducted on the Presidential Cycling Tour of Turkey, which was held between April 26 and May 3, 2015. The race lasted 8days and covered 1258km of road. There were 166 elite cycling athletes representing 21 teams from various countries. Data collected pertaining to incidents involving injury or illness included the following: type of injury; anatomical location of injury; details of the medical encounter; location of the intervention; treatment provided; medication administered and disposition of the rider. An injury was defined as a physical complaint or observable damage to the body produced by the transfer of energy of the rider. An illness was defined as a physical complaint or presentation not related to injury. Results: The overall incidence (injury and illness) was 5.83 per 1000 cycling hours. (Injury incidence was 2.82 vs illness incidence of 3.01 per 1000hours cycling). A total of 31 incidents occurred. Of these, 15 were injuries, while 16 were complaints of a non-traumatic nature. A total of 43 interventions were made in the 15 cases of injury. The most commonly injured body regions were limbs; the majority of injuries involved the skin and soft tissue. The most common medical intervention was wound care (64% of all interventions). Two riders had to withdraw from the race, and one was hospitalized due to a traumatic pneumothorax. None of the non-traumatic cases resulted in withdrawal from the race. Conclusions: A broad spectrum of illness and injury occurs during elite multi-day road races, ranging from simple skin injuries to serious injuries requiring hospital admission. Most injuries and illnesses are minor; however, medical teams must be prepared to treat life-threatening trauma.	[Yanturali, Sedat; Canacik, Omer; Karsli, Emre] Dokuz Eylul Univ Hosp, Dept Emergency Med, Izmir, Turkey; [Suner, Selim] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA		Yanturali, S (corresponding author), Dokuz Eylul Univ, Dept Emergency Med, TR-35340 Izmir, Turkey.	sedat.yanturali@deu.edu.tr	KARSLI, Emre/AAP-9696-2021	KARSLI, Emre/0000-0002-0441-3019; Suner, Selim/0000-0001-7334-1517			Aleman KB, 2010, SPORTS MED, V40, P77, DOI 10.2165/11319640-000000000-00000; Ashwell Z, 2012, WILD ENVIRON MED, V23, P140, DOI 10.1016/j.wem.2012.02.002; Barrios C, 2015, INT J SPORTS MED, V36, P241, DOI 10.1055/s-0034-1389983; Becker J, 2013, BRIT J SPORT MED, V47, P458, DOI 10.1136/bjsports-2012-091755; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Clarke S, 2015, CYCLING WEEKLY; Cohen SI, 2012, PACE, V35, P241, DOI 10.1111/j.1540-8159.2011.03248.x; Cook N, 2014, BIKERADAR; Emond SD, 1999, ANN EMERG MED, V33, P56, DOI 10.1016/S0196-0644(99)70417-8; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Marijon E, 2015, CIRCULATION, V131, P1384, DOI 10.1161/CIRCULATIONAHA.114.011988; Martinez John M, 2006, Curr Sports Med Rep, V5, P125; McGrath TM, 2012, WILD ENVIRON MED, V23, P356, DOI 10.1016/j.wem.2012.05.003; Mueller-Wohlfahrt HW, 2013, BRIT J SPORT MED, V47, P342, DOI 10.1136/bjsports-2012-091448; Nelson NG, 2011, AM J SPORT MED, V39, P404, DOI 10.1177/0363546510383478; NOAKES TD, 1995, SPORTS MED, V20, P348, DOI 10.2165/00007256-199520050-00006; PFEIFFER RP, 1995, SPORTS MED, V19, P311, DOI 10.2165/00007256-199519050-00002; Reifferscheid F, 2010, ANASTH INTENSIV NOTF, V45, P456, DOI 10.1055/s-0030-1262472; Roi GS, 2014, ACCIDENT ANAL PREV, V73, P170, DOI 10.1016/j.aap.2014.08.010; Semsarian C, 2015, BRIT J SPORT MED, V49, P1017, DOI 10.1136/bjsports-2015-h1218rep; Silberman MR, 2013, CURR SPORT MED REP, V12, P337, DOI 10.1249/JSR.0b013e3182a4bab7; Timpka T, 2014, BRIT J SPORT MED, V48, P483, DOI 10.1136/bjsports-2013-093241; Ueblacker R, 2008, UNFALLCHIRURG, V111, P414, DOI 10.1007/s00113-008-1410-3; Wall L, 2009, CYCLING SKILLS; Yan Chris B, 2005, Curr Sports Med Rep, V4, P131	27	10	10	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT 2	2015	43	4					348	354		10.1080/00913847.2015.1096182			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	CV9UL	WOS:000364632400005	26468912	Green Submitted			2022-02-06	
J	Bartels, A; Sarpong, Y; Coberly, J; Hughes, N; Litt, J; Quick, J; Kessel, J; Nelson, C; Coughenour, J; Barnes, SL; Litofsky, NS; Hammer, RD; Ahmad, S				Bartels, Ashley; Sarpong, Yaw; Coberly, Jared; Hughes, Natalie; Litt, Jeffrey; Quick, Jacob; Kessel, James; Nelson, Christopher; Coughenour, Jeffery; Barnes, Stephen L.; Litofsky, N. Scott; Hammer, Richard D.; Ahmad, Salman			Failure of the Platelet Function Assay (PFA)-100 to detect antiplatelet agents	SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; CLOPIDOGREL RESISTANCE; VASP PHOSPHORYLATION; ASPIRIN RESISTANCE; PFA P2Y; TRANSFUSION; DYSFUNCTION; PREVALENCE; DISORDERS	Background. Antiplatelet therapy is a complicating factor in patients with traumatic brain injuries (TBI), as well as those with hemorrhagic cerebrovascular accidents (CVAs). Platelet Function Assay (PFA)-100 is a coagulation device that can detect platelet dysfunction caused by aspirin and adenosine diphosphate inhibition. Our retrospective study reviewed the effectiveness of PEA-100 in detecting platelet dysfunction caused by aspirin and clopidogrel and determined its clinical importance. Methods. All patients with PFA-100 tests from January 2013 to February 2014 were collected. Diagnoses indicative of a TBI or CVA were chosen for analysis. Patients with a normal PFA-100 indicating no platelet dysfunction but with documented aspirin and/or clopidogrel use were selected. An extensive chart review was performed to determine the relevance to their clinical care. Results. A total of 475 patients were evaluated with a PFA-100 from January 2013 to February 2014. PFA-100 detected platelet dysfunction as the result of pre-injury use of antiplatelet agents in TBI and CVA patients with a sensitivity of only 48.6% and a specificity of 74.8%. Had these antiplatelet medications been known during initial workup, these patients would have had a change in management that may have impacted their outcomes. Conclusion. Despite its common usage, the PFA-100 is an unreliable tool to assist in the management of TBI and CVA patients. Additional investigation into alternative methods for detecting platelet dysfunction is warranted.	[Bartels, Ashley; Sarpong, Yaw; Coberly, Jared; Hughes, Natalie; Litt, Jeffrey; Quick, Jacob; Kessel, James; Nelson, Christopher; Coughenour, Jeffery; Barnes, Stephen L.; Litofsky, N. Scott; Hammer, Richard D.; Ahmad, Salman] Univ Missouri, Columbia, MO USA		Bartels, A (corresponding author), 1 Hosp Dr,McHaney Hall 404, Columbia, MO 65212 USA.	bartelsan@health.missouri.edu		Barnes, Stephen/0000-0001-6186-1435; Ahmad, Salman/0000-0003-3862-0937; Hammer, Richard D./0000-0002-7173-9414			Aleil B, 2005, J THROMB HAEMOST, V3, P85, DOI 10.1111/j.1538-7836.2004.01063.x; Alstrom U, 2007, THROMB RES, V120, P353, DOI 10.1016/j.thromres.2006.10.009; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Brewer DB, 2006, BRIT J HAEMATOL, V133, P251, DOI 10.1111/j.1365-2141.2006.06036.x; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Coller BS, 1997, CIRCULATION, V95, P860; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Duke WW., 1983, JAMA-J AM MED ASSOC, V55, P1185; Faul M, 2010, TRAUMATIC BRAIN INJU; Hayward CPM, 2006, J THROMB HAEMOST, V4, P312, DOI 10.1111/j.1538-7836.2006.01771.x; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jang J, 2012, J CLIN LAB ANAL, V26, P262, DOI 10.1002/jcla.21515; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kinsella JA, 2013, J STROKE CEREBROVASC, V22, pE84, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.012; Kottke-Marchant K, 2002, ARCH PATHOL LAB MED, V126, P133; Lordkipanidze M, 2008, EUR HEART J, V29, P2877, DOI 10.1093/eurheartj/ehn419; Macchi L, 2006, CURR PHARM DESIGN, V12, P251, DOI 10.2174/138161206775193064; Mammen EF, 1998, SEMIN THROMB HEMOST, V24, P195, DOI 10.1055/s-2007-995840; Mani H, 2006, PLATELETS, V17, P303, DOI 10.1080/09537100600746524; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mueller Thomas, 2003, Vasc Endovascular Surg, V37, P117, DOI 10.1177/153857440303700206; Mueller T, 2009, CLIN APPL THROMB-HEM, V15, P652, DOI 10.1177/1076029608322547; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nguyen TA, 2005, J AM COLL CARDIOL, V45, P1157, DOI 10.1016/j.jacc.2005.01.034; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Paniccia R, 2007, J THROMB HAEMOST, V5, P1839, DOI 10.1111/j.1538-7836.2007.02656.x; Poulsen TS, 2007, THROMB RES, V119, P555, DOI 10.1016/j.thromres.2006.04.005; Sanderson S, 2005, ANN INTERN MED, V142, P370, DOI 10.7326/0003-4819-142-5-200503010-00012; Schwarz UR, 1999, THROMB HAEMOSTASIS, V82, P1145, DOI 10.1055/s-0037-1614344; Shantsita E, 2007, THROMB RES, V119, P551, DOI 10.1016/j.thromres.2006.08.009; Tsantes A, 2012, PLATELETS, V23, P481, DOI 10.3109/09537104.2012.689037; van Werkum JW, 2008, PLATELETS, V19, P479, DOI 10.1080/09537100802317918	35	10	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	OCT	2015	158	4					1012	1018		10.1016/j.surg.2015.07.011			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CR3VF	WOS:000361260500034	26299285				2022-02-06	
J	Glass, T; Ruddy, RM; Alpern, ER; Gorelick, M; Callahan, J; Lee, L; Gerardi, M; Melville, K; Miskin, M; Holmes, JF; Kuppermann, N				Glass, Todd; Ruddy, Richard M.; Alpern, Elizabeth R.; Gorelick, Marc; Callahan, James; Lee, Lois; Gerardi, Mike; Melville, Kraig; Miskin, Michelle; Holmes, James F.; Kuppermann, Nathan		Pediat Emergency Care Appl Res	Traumatic brain injuries and computed tomography use in pediatric sports participants	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							BLUNT HEAD TRAUMA; UNITED-STATES; EMERGENCY-DEPARTMENTS; HIGH-SCHOOL; RADIATION-EXPOSURE; CHILDREN; RISK; CONCUSSIONS; ADOLESCENTS	Background: Childhood sports-related head trauma is common, frequently leading to emergency department (ED) visits. We describe the spectrum of these injuries and trends in computed tomography (CT) use in the Pediatric Emergency Care Applied Research Network. Methods: This was a secondary analysis of a large prospective cohort of children with head trauma in 25 Pediatric Emergency Care Applied Research Network EDs between 2004 and 2006, We described and compared children 5 to 18 years old by CT rate, traumatic brain injury (TBI) on CT, and clinically important TBI (ciTBI). We used multivariable logistic regression to compare CT rates, adjusting for clinical severity. Outcomes included frequency of CT, TBIs on CT, and ciTBIs (defined by [a] death, [b] neurosurgery, [c] intubation >24 hours, or [d] hospitalization for >= 2 nights). Findings: A total of 3289 (14%) of 23082 children had sports-related head trauma. Two percent had Glasgow Coma Scale scores less than 14.53% received ED CTs, 4% had TBIs on CT and 1% had ciTBIs. Equestrians had increased adjusted odds (1.8; 95% confidence interval [CI] 1.0-3.0]) of CTs; the rate of TBI on CT was 4% (95% CI, 3%-5%). Compared with team sports, snow (adjusted odds ratio, 4.1; 95% CI 1.5-11.4) and nonmotorizecl wheeled (adjusted odds ratio, 12.8; 95% CI, 5.5-32.4) sports had increased adjusted odds of ciTBIs. Conclusions: Children with sports-related head trauma commonly undergo CT. Only 4% of those imaged had TBIs on CT. Clinically important TBIs occurred in 1%, with significant variation by sport. There is an opportunity for injury prevention efforts in high risk sports and opportunities to reduce CT use in general by use of evidence based prediction rules. What is known about this subject: Pediatric sports-related head injuries are a common and increasingly frequent ED presentation, as is the use of CT in their evaluation. Little is known about TBIs resulting from different types of sports activities in children. What this study adds to existing knowledge: This study broadens the understanding of the epidemiology of Pediatric TBIs resulting from different sports activities through a prospective assessment of frequency and severity of ciTBIs and ED CT use in a large cohort of head injured children in a network of pediatric EDs. (C) 2015 Elsevier Inc. All rights reserved.	[Glass, Todd; Ruddy, Richard M.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Glass, Todd] Nemours Childrens Hosp, Dept Pediat, Orlando, FL USA; [Ruddy, Richard M.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Alpern, Elizabeth R.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Gorelick, Marc] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Callahan, James] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA; [Callahan, James] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA; [Lee, Lois] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gerardi, Mike] Morristown Mem Hosp, Atlantic Hlth Syst, Dept Emergency Med, Morristown, NJ USA; [Melville, Kraig] Calvert Mem Hosp, Dept Emergency Med, Prince Frederick, MD USA; [Miskin, Michelle] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Miskin, Michelle] Univ Utah, PECARN Data Coordinating Ctr, Salt Lake City, UT USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA		Ruddy, RM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, ML 2008,3333 Burnet Ave, Cincinnati, OH 45229 USA.	Richard.ruddy@cchmc.org		Holubkov, Richard/0000-0003-0431-3381; Tsung, James/0000-0002-4718-8325; Alpern, Elizabeth/0000-0001-7887-3563	Health Resources and Services Administration/Maternal and Child Health Bureau (MCHB), Division of Research, Education, and Training; Emergency Medical Services of Children (EMSC) Program [R40MC02461]; Health Resources and Services Administration/MCHB/EMSC Program [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, U03MC22685]	This work was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau (MCHB), Division of Research, Education, and Training and the Emergency Medical Services of Children (EMSC) Program (R40MC02461).; Pediatric Emergency Care Applied Research Network is supported by the Health Resources and Services Administration/MCHB/EMSC Program through the following cooperative agreements: U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, and U03MC22685.	Atabaki SM, 2013, PEDIATR CLIN N AM, V60, P1107, DOI 10.1016/j.pcl.2013.06.001; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US R; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins CL, 2008, PEDIATRICS, V121, P1181, DOI 10.1542/peds.2007-2572; Day C, 2008, PEDIATRICS, V122, pE388, DOI 10.1542/peds.2008-0024; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dayan PS, 2008, ACAD EMERG MED, V15, pS141; Frush D, 2013, J PATIENT SAF, V9, P232, DOI 10.1097/PTS.0b013e3182a8c2c4; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pollard KA, 2011, CLIN PEDIATR, V50, P844, DOI 10.1177/0009922811406262; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Skokan EG, 2003, AM J EMERG MED, V21, P95, DOI 10.1053/ajem.2003.50032; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008	27	10	10	0	30	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	OCT	2015	33	10					1458	1464		10.1016/j.ajem.2015.06.069			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CS1PM	WOS:000361839300025	26256635				2022-02-06	
J	Liu, GB; Ghimire, P; Pang, HP; Wu, GY; Shi, HC				Liu, Guobing; Ghimire, Prasanna; Pang, Haopeng; Wu, Guangyao; Shi, Hongcheng			Improved sensitivity of 3.0 Tesla susceptibility-weighted imaging in detecting traumatic bleeds and its use in predicting outcomes in patients with mild traumatic brain injury	ACTA RADIOLOGICA			English	Article						Susceptibility-weighted imaging (SWI); T2*-weighted imaging (T2*WI); mild traumatic brain injury; post-concussive syndrome	HEAD-INJURY; CEREBRAL MICROBLEEDS; COMPUTED-TOMOGRAPHY; EPIDEMIOLOGY; DIAGNOSIS	Background The efficacy of susceptibility-weighted imaging (SWI) for detecting intracranial bleeds (ICBs) in patients with mild traumatic brain injury (MTBI) has not been directly compared to that of T2*-weighted gradient-recalled-echo imaging (T2*WI). Further, its prognostic value for MTBI patients remains unproven. Purpose To compare the sensitivity of ICB identification between SWI and T2*WI and examine the prognostic value of SWI for MTBI patients. Material and Methods T2*WI, SWI, and clinical information of 63 MTBI patients were collected. Sensitivity was compared between T2*WI and SWI for ICB identification, and statistical analysis was conducted to understand the correlations between SWI and clinical characteristics. Results ICBs were detected in more patients (47 vs. 35, P<0.001) and more ICBs were detected (276 vs. 147, P<0.001) on SWI than T2*WI. On SWI, patients with conscious disturbance showed higher ICBs prevalence (84.6% vs. 58.3%, P=0.020), and more patients from the post-concussive syndrome (PCS)(+) group than the PCS(-)group were ICBs positive (86.1% vs. 59.3%, P=0.015). The numbers of ICBs were significantly higher in the PCS(+) group than the PCS(-) group (P<0.001). Significant correlation was found between PCS and ICBs number (r=0.510, P<0.001). Multiple logistic regression analysis showed that ICB number was an independent variable predicting occurrence of PCS. Conclusion SWI is more sensitive than T2*WI in detecting hemorrhagic foci in MTBI patients and may offer valuable prognostic information regarding these patients, for example, information on PCS. Further, cerebral parenchymal hemorrhage may affect long-term outcomes in MTBI patients.	[Liu, Guobing; Shi, Hongcheng] Fudan Univ, Zhongshan Hosp, Dept Nucl Med, Shanghai 200032, Peoples R China; [Ghimire, Prasanna] Nepalgunj Med Coll, Dept Radiol, Nepalganj, Nepal; [Ghimire, Prasanna] Teaching Hosp, Maarajgunj, Nepal; [Pang, Haopeng] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200032, Peoples R China; [Wu, Guangyao] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430072, Peoples R China		Shi, HC (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Nucl Med, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	shihongcheng1234@163.com	Ghimire, Prasanna/AAB-8084-2019	Ghimire, Prasanna/0000-0002-9263-3432; Wu, Guangyao/0000-0002-0456-3682			Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Imaizumi T, 2004, J NEUROSURG, V101, P915, DOI 10.3171/jns.2004.101.6.0915; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; McHugh T, 2006, BRAIN COGNITION, V60, P209; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mori N, 2008, INVEST RADIOL, V43, P574, DOI 10.1097/RLI.0b013e31817fb432; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sifri ZC, 2011, J TRAUMA, V71, P1605, DOI 10.1097/TA.0b013e31822b3728; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Vernooij MW, 2008, RADIOLOGY, V248, P272, DOI 10.1148/radiol.2481071158; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	29	10	12	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	OCT	2015	56	10					1256	1263		10.1177/0284185114552883			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CQ2AP	WOS:000360402000015	25318746				2022-02-06	
J	Liu, SW; Wan, XY; Wang, S; Huang, LL; Zhu, MX; Zhang, SJ; Liu, X; Xiao, QG; Gan, C; Li, CX; Shu, K; Lei, T				Liu, Shengwen; Wan, Xueyan; Wang, Sheng; Huang, Lulu; Zhu, Mingxin; Zhang, Suojun; Liu, Xing; Xiao, Qungen; Gan, Chao; Li, Chaoxi; Shu, Kai; Lei, Ting			Posttraumatic cerebral infarction in severe traumatic brain injury: characteristics, risk factors and potential mechanisms	ACTA NEUROCHIRURGICA			English	Article						Posttraumatic cerebral infarction; Severe traumatic brain injury; Risk factors; Mechanism	SEVERE HEAD TRAUMA; SUBARACHNOID HEMORRHAGE; BLOOD-FLOW; EPIDURAL HEMATOMA; CLINICAL ARTICLE; VASOSPASM; MODERATE; PATHOGENESIS; VELOCITIES; MANAGEMENT	Posttraumatic cerebral infarction (PTCI) is a severe secondary insult of traumatic brain injury (TBI). This study aimed to evaluate the characteristics and risk factors of PTCI after severe TBI (sTBI) and explore possible mechanism. This retrospective study included a cohort of 339 patients with sTBI; they were divided into the PTCI and non-PTCI groups. Clinical data and follow-up charts were reviewed for comparison. The logistic regression model was used for multivariate analysis to detect the risk factors of PTCI. The Glasgow Outcome Scale (GOS) and Barthel index (BI) for activities of daily living (ADL) were applied to evaluate their outcome. PTCI led to an increased mortality (43.5 % vs. 10.7 %, P < 0.001) and days of intensive care unit stay (14.3 days vs. 7.1 days, P < 0.001), decreased GOS (3.1 vs. 4.1, P < 0.001) and BI (25.0 vs. 77.9, P < 0.001). Increased infarction volume led to poor outcome assessed by GOS (r = -0.46, P < 0.0001) and BI for ADL (r = -0.36, P = 0.026) for surviving patients. Compared with non-PTCI patients, PTCI patients had a high incidence of midline shift (36.2 % vs. 20.7 %, P = 0.011) and posttraumatic vasospasm (PTV) (42.0 % vs. 27.4 %, P = 0.027). Daily prevalence of PTCI occurred in two peaks: one (73.9 %) was in the first 24 h after injury, while the other (18.8 %) was in the span of 43 to 60 h postinjury. In multivariate analysis, hyperthermia [adjusted odds ratio (OR), 3.11; P = 0.001] in the first 24 h, thrombocytopenia (OR, 27.08; P < 0.001), abnormal prothrombin time (OR, 7.66; P < 0.001) and traumatic subarachnoid hemorrhage (OR, 2.33; P = 0.022) were independent predictors for PTCI. PTCI deteriorates the outcome of sTBI patients. Mechanical compression and hemocoagulative disturbance serve as potential mechanisms mediating this pathophysiological process. PTV may also contribute to PTCI, but its association with PTCI is weak and needs further exploration. Early recognition and intervention of these factors might be beneficial for preventing PTCI.	[Liu, Shengwen; Wan, Xueyan; Wang, Sheng; Huang, Lulu; Zhu, Mingxin; Zhang, Suojun; Liu, Xing; Xiao, Qungen; Gan, Chao; Li, Chaoxi; Shu, Kai; Lei, Ting] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430030, Hubei Province, Peoples R China		Wang, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Jiefang Ave 1095, Wuhan 430030, Hubei Province, Peoples R China.	wangsheng@tjh.tjmu.edu.cn		Wan, Xueyan/0000-0002-7148-9857	National Key Specialist Construction Projects	This study was supported by research grants from the National Key Specialist Construction Projects 2011. All authors declare that they have no conflicts of interest or relationships between investigators and research sponsors. The authors have no personal financial or institutional interest in any of the drugs, devices or materials described in this article.	Aaslid Rune, 2002, Eur J Ultrasound, V16, P3, DOI 10.1016/S0929-8266(02)00045-9; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ham HY, 2011, J KOREAN NEUROSURG S, V50, P370, DOI 10.3340/jkns.2011.50.4.370; Harrahill M, 1997, J Emerg Nurs, V23, P282, DOI 10.1016/S0099-1767(97)90032-5; Izzy S, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0278-x; Landi A, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-2; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marino R, 2006, NEUROLOGY, V67, P1165, DOI 10.1212/01.wnl.0000238081.35281.b5; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Mobbs RJ, 2001, NEUROL INDIA, V49, P158; Morton RP, 2014, J NEUROSURG, V120, P1446, DOI 10.3171/2014.2.JNS131658; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Paiva WS, 2013, WORLD J RADIOL, V5, P226, DOI 10.4329/wjr.v5.i5.226; Pan AH, 2013, J NEUROSCI RES, V91, P249, DOI 10.1002/jnr.23148; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Server A, 2001, ACTA RADIOL, V42, P254; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Tu CJ, 2011, J INT MED RES, V39, P1757, DOI 10.1177/147323001103900518; Vora NA, 2011, STROKE, V42, P645, DOI 10.1161/STROKEAHA.110.596312; Wang WH, 2014, J NEUROTRAUM, V31, P1444, DOI 10.1089/neu.2013.3142; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	34	10	13	0	17	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2015	157	10					1697	1704		10.1007/s00701-015-2559-5			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CR5NK	WOS:000361389600011	26306582				2022-02-06	
J	Sun, S; Kanagaraj, J; Cho, L; Kang, D; Xiao, S; Cho, M				Sun, Shan; Kanagaraj, Johnwesly; Cho, Lindsey; Kang, Dongkoo; Xiao, Shu; Cho, Michael			Characterization of Subcellular Responses Induced by Exposure of Microbubbles to Astrocytes	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; atomic force microscope; fluorescent microscopy; microbubbles; principle of symmetry; shock waves	BRAIN-INJURY; BIOMECHANICS; CAVITATION; WATER; MODEL; GENERATION; MODULATION; IMPACT; CELLS	Blast traumatic brain injury (bTBI) has now been identified to associate with adverse health consequences among combat veterans. Post-traumatic stress disorder linked with explosive blasts, for example, may result from such brain injury. The fundamental questions about the nature, diagnosis, and long-term consequences of bTBI and causative relationship to post-traumatic stress disorder remain elusive, however. A better understanding of brain tissue injury requires elucidation of potential mechanisms. One such mechanism may be generation of microcavitation bubbles in the brain after an explosive blast and their subsequent interaction with brain cells. Using a controlled electrical discharge system, we have successfully generated shock waves (approximate to 10MPa) and microbubbles (20-30m) in the cell culture of mouse astrocytes. Detachment of astrocytes from the substrate after exposure to microbubbles was observed, and it depended on repetitive exposures. Of the cells that survived the initial assault, several subcellular changes were monitored and determined using fluorescent microscopy, including cell viability, cytoskeletal reorganization, changes in focal adhesion, membrane permeability, and potential onset of apoptosis. While the astrocytes impacted by the shock wave only demonstrated essentially unaltered cellular behavior, the astrocytes exposed to microbubbles exhibited significantly different responses, including production of reactive oxygen species by collapse of microbubbles. In the present study, we characterized and report for the first time the altered biophysical and subcellular properties in astrocytes in response to exposure to the combination of shock waves and microbubbles.	[Sun, Shan; Kanagaraj, Johnwesly; Cho, Michael] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Cho, Lindsey] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Kang, Dongkoo; Xiao, Shu] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA		Cho, M (corresponding author), Univ Illinois, Dept Bioengn, 851 S Morgan St,MC 063, Chicago, IL 60607 USA.	mcho@uic.edu		Cho, Myoung Rae/0000-0002-8191-8045	Office of Naval ResearchOffice of Naval Research [N00014-13-1-0404]	This work was supported by a grant (N00014-13-1-0404) from the Office of Naval Research.	Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bachtel AD, 2011, IEEE T BIO-MED ENG, V58, P2120, DOI 10.1109/TBME.2011.2148719; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Ferrari M., 2012, DROPS BUBBLES CONTAC; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Israelachvili J. Van der, 1991, INTERMOLECULAR SURFA, P176; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kang D, 2014, IEEE T PLASMA SCI, V42, P3231, DOI 10.1109/TPS.2014.2339171; KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66; Kimura T., 2002, ULTRA TECHNOL, V14, P7; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/NMETH.2690, 10.1038/nmeth.2690]; Kodiha M., 2012, J SIGNAL TRANSDUC; Kunze A, 2013, INTEGR BIOL-UK, V5, P964, DOI 10.1039/c3ib40022k; Leventhal I., 2006, SOFT MATTER; Lollis S Scott, 2008, Handb Clin Neurol, V90, P217, DOI 10.1016/S0072-9752(07)01712-5; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; NUSHOLTZ GS, 1995, J NEUROTRAUM, V12, P707, DOI 10.1089/neu.1995.12.707; Ohl CD, 2003, BBA-GEN SUBJECTS, V1624, P131, DOI 10.1016/j.bbagen.2003.10.005; OKUSKY J, 1982, J COMP NEUROL, V210, P278, DOI 10.1002/cne.902100307; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pedersen T., MILD BRAIN INJURY CO; Sankin GN, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.078101; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; Stuhmiller J. H., 2002, DAMD1796C6607; Sun S, 2014, J BIOMECH, V47, P3650, DOI 10.1016/j.jbiomech.2014.09.036; Sun S, 2014, J BIOMECH, V47, P2205, DOI 10.1016/j.jbiomech.2013.10.050; Takahashi M, 2005, J PHYS CHEM B, V109, P21858, DOI 10.1021/jp0445270; Takahashi M, 2003, J PHYS CHEM B, V107, P2171, DOI 10.1021/jp022210z; Takahashi M, 2007, J PHYS CHEM B, V111, P11443, DOI 10.1021/jp074727m; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Titushkin I, 2011, J BIOMECH, V44, P2692, DOI 10.1016/j.jbiomech.2011.07.024; Vakarelski IU, 2010, P NATL ACAD SCI USA, V107, P11177, DOI 10.1073/pnas.1005937107; Yuan F., 2013, THESIS DUKE U	43	10	10	0	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1441	1448		10.1089/neu.2014.3699			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500002	25843567				2022-02-06	
J	Tsenkina, Y; Ricard, J; Runko, E; Quiala-Acosta, MM; Mier, J; Liebl, DJ				Tsenkina, Y.; Ricard, J.; Runko, E.; Quiala-Acosta, M. M.; Mier, J.; Liebl, D. J.			EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury	CELL DEATH & DISEASE			English	Article							CENTRAL-NERVOUS-SYSTEM; STAUROSPORINE INDUCES APOPTOSIS; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; UP-REGULATION; ADULT NEUROGENESIS; COMPRESSION TRAUMA; COMMISSURAL AXONS; RATS; EXPRESSION	We demonstrate that EphB3 receptors mediate oligodendrocyte (OL) cell death in the injured spinal cord through dependence receptor mechanism. OLs in the adult spinal cord express EphB3 as well as other members of the Eph receptor family. Spinal cord injury (SCI) is associated with tissue damage, cellular loss and disturbances in EphB3-ephrinB3 protein balance acutely (days) after the initial impact creating an environment for a dependence receptor-mediated cell death to occur. Genetic ablation of EphB3 promotes OL survival associated with increased expression of myelin basic protein and improved locomotor function in mice after SCI. Moreover, administration of its ephrinB3 ligand to the spinal cord after injury also promotes OL survival. Our in vivo findings are supported by in vitro studies showing that ephrinB3 administration promotes the survival of both oligodendroglial progenitor cells and mature OLs cultured under pro-apoptotic conditions. In conclusion, the present study demonstrates a novel dependence receptor role of EphB3 in OL cell death after SCI, and supports further development of ephrinB3-based therapies to promote recovery.	[Tsenkina, Y.; Ricard, J.; Runko, E.; Quiala-Acosta, M. M.; Mier, J.; Liebl, D. J.] Univ Miami, Miami Project Cure Paralysis, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Ricard, J.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA		Liebl, DJ (corresponding author), Univ Miami, Miami Project Cure Paralysis, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@miami.edu		Ricard, Jerome/0000-0002-9019-4165	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049545, NS30291, T32 NS007459]; DODUnited States Department of Defense [W81XWH-05-1-0061]; Christopher and Dana Reeve Foundation Fellowship Award; Craig H Neilsen Foundation; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007459] Funding Source: NIH RePORTER	We would like to thank Dr. Carla Blits-Huizinga for her early contributions toward our analyses. This work was supported by NIH/NINDS NS049545 and NS30291 (DJL), DOD W81XWH-05-1-0061 (DJL), Christopher and Dana Reeve Foundation Fellowship Award (ER), NIH/NINDS T32 NS007459 (ER), The Craig H Neilsen Foundation and The Miami Project to Cure Paralysis.	Abe Y, 1999, J NEUROTRAUM, V16, P945, DOI 10.1089/neu.1999.16.945; Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Cohen RI, 2003, J NEUROCHEM, V85, P1262, DOI 10.1046/j.1471-4159.2003.01722.x; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; del Valle K, 2011, INT J DEV NEUROSCI, V29, P9, DOI 10.1016/j.ijdevneu.2010.10.005; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Du YZ, 2003, DEV NEUROSCI-BASEL, V25, P116, DOI 10.1159/000072261; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Figueroa JD, 2006, J NEUROSCI RES, V84, P1438, DOI 10.1002/jnr.21048; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Genevois AL, 2013, P NATL ACAD SCI USA, V110, P3017, DOI 10.1073/pnas.1212333110; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Irizarry-Ramirez M, 2005, J NEUROTRAUM, V22, P929, DOI 10.1089/neu.2005.22.929; Jevince AR, 2006, J COMP NEUROL, V497, P734, DOI 10.1002/cne.21001; Katoh K, 1996, NEUROSCI LETT, V216, P9; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Liu XZ, 1997, J NEUROSCI, V17, P5395; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mendes SW, 2006, J NEUROSCI, V26, P882, DOI 10.1523/JNEUROSCI.3162-05.2006; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Nelersa CM, 2012, J BIOMOL SCREEN, V17, P785, DOI 10.1177/1087057112440880; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Rabizadeh S, 2000, J MOL NEUROSCI, V15, P215, DOI 10.1385/JMN:15:3:215; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Wada S, 1999, J NEUROSURG, V91, P98, DOI 10.3171/spi.1999.91.1.0098; Willson CA, 2003, CELL TRANSPLANT, V12, P279, DOI 10.3727/000000003108746830; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhang XD, 2004, MOL CANCER THER, V3, P187	60	10	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	OCT	2015	6								e1922	10.1038/cddis.2015.262			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ5NU	WOS:000367150100026	26469970	Green Published, gold			2022-02-06	
J	Algethamy, HM; Alzawahmah, M; Young, GB; Mirsattari, SM				Algethamy, Haifa M.; Alzawahmah, Mohamed; Young, G. Bryan; Mirsattari, Seyed M.			Added Value of MRI over CT of the Brain in Intensive Care Unit Patients	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Central nervous system pathology; computed tomography; intensive care unit patients; magnetic resonance imaging; prognosis; unresponsive patients	DIFFUSION-WEIGHTED MRI; COMPUTERIZED-TOMOGRAPHY; HEAD-INJURY; STROKE; ENCEPHALOPATHY; HEMORRHAGE; MANAGEMENT; DIAGNOSIS; TRAUMA; IMPACT	Background: Intensive care unit (ICU) patients with neurological impairments often require neuroimaging. However, the relative sensitivity of various imaging modalities of the brain has not yet been explored in this population. Methods: In this study, we compare the findings of CT and MRI scans in ICU patients to (1) identify the number and rate of clinically relevant lesion detected by MRI while missed by CT and vice versa and (2) determine specific lesion types for which CT versus MRI discrepancies exist. A review of medical records included CT and MRI reports of patients who underwent these procedures while they were patients in our ICUs between July 2004 and July 2009. MRI and CT were compared regarding their ability to detect clinically relevant abnormalities. Odds ratios with 95% confidence limits were calculated to compare diagnostic categories regarding the rate of discrepant MRI versus CT findings, followed by power analyses to estimate sample sizes necessary to allow for further testing in a larger trial. Results: MRI revealed clinically relevant additional abnormalities over CT in 129 of 136 patients (95%) that included the detection of additional finding for 15/27 hemorrhagic lesions (55.6%), 33/36 (92%) ischemic strokes, 19/27 (70%) traumatic lesions, 8/14 (57%) infections, 15/24 (62.5%) metabolic abnormalities, and all seven neoplasms. Odds ratio analysis revealed the added sensitivity of MRI to be greater for ischemic and neoplastic lesions than for trauma, metabolic-related abnormalities, infection, or hemorrhage. Conclusions: MRI is more sensitive than CT in identifying clinically meaningful lesions in at least a subset of ICU patients, regardless of pathology.	[Algethamy, Haifa M.] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Dept Anesthesia & Crit Care, Fac Med, Jeddah 21589, Saudi Arabia; [Alzawahmah, Mohamed] Riyadh Mil Hosp, Dept Clin Neurol Sci, Riyadh, Saudi Arabia; [Young, G. Bryan; Mirsattari, Seyed M.] Univ Western Ontario, Dept Clin Neurol Sci Med Biophys Med Imaging & Ps, London Hlth Sci Ctr, London, ON, Canada; [Algethamy, Haifa M.] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Dept Anesthesia & Crit Care, POB 80215, Jeddah 21589, Saudi Arabia		Algethamy, HM (corresponding author), King Abdulaziz Univ, King Abdulaziz Univ Hosp, Dept Anesthesia & Crit Care, POB 80215, Jeddah 21589, Saudi Arabia.	halgethamy2020@gmail.com		ALGETHAMY, HAIFA/0000-0003-1381-521X; Alzawahmah, Mohamed/0000-0002-2054-7391			Assouline E, 2005, CEREBROVASC DIS, V20, P6, DOI 10.1159/000086120; Atlas SW, 2002, MAGNETIC RESONANCE I, P773; Bermingham S L, 2014, Ont Health Technol Assess Ser, V14, P1; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Brazzelli M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007424.pub2; Cihangiroglu M, 2002, NEUROL RES, V24, P7, DOI 10.1179/016164102101199440; DAVIS SM, 1989, AUST NZ J MED, V19, P219, DOI 10.1111/j.1445-5994.1989.tb00249.x; Devore J. L, 1995, PROBABILITY STAT ENG; Donmez FY, 2009, J CHILD NEUROL, V24, P656, DOI 10.1177/0883073808329531; Duhem R, 2006, NEUROCHIRURGIE, V52, P93, DOI 10.1016/S0028-3770(06)71203-6; Engelter ST, 2008, SWISS MED WKLY, V138, P729, DOI 2008/49/smw-12249; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Gofton TE, 2009, EXP NEUROL, V217, P320, DOI 10.1016/j.expneurol.2009.03.011; Ibrahim R, 2014, BMC HEALTH SERV RES, V12, P11; KENT DL, 1994, ANN INTERN MED, V120, P856, DOI 10.7326/0003-4819-120-10-199405150-00007; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Lansberg MG, 2000, NEUROLOGY, V54, P1557, DOI 10.1212/WNL.54.8.1557; LEIRA HL, 1992, SCAND J WORK ENV HEA, V18, P68, DOI 10.5271/sjweh.1606; Lovblad KO, 2000, NEURORADIOLOGY, V42, P134, DOI 10.1007/s002340050032; Lysdahl KB, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-21; Mirsattari SM, 2009, EPILEPSY RES, V84, P28, DOI 10.1016/j.eplepsyres.2008.12.002; Moreau F, 2013, CEREBROVASC DIS EXTR, V3, P130, DOI 10.1159/000355024; Muller-Horvat C, 2006, EUR J CANCER, V42, P342, DOI 10.1016/j.ejca.2005.10.008; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Palombo G, 2008, AM J NEURORADIOL, V29, P1340, DOI 10.3174/ajnr.A1102; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Renou P, 2010, CEREBROVASC DIS, V29, P597, DOI 10.1159/000312867; Restrepo L, 2002, STROKE, V33, P2909, DOI 10.1161/01.STR.0000040408.75704.15; Rodes-Cabau J, 2011, J AM COLL CARDIOL, V57, P18, DOI 10.1016/j.jacc.2010.07.036; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Saur D, 2003, AM J NEURORADIOL, V24, P878; Schaefer PW, 1997, STROKE, V28, P1082, DOI 10.1161/01.STR.28.5.1082; Schwartz RB, 1998, AM J NEURORADIOL, V19, P859; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smajlovic Dzevdet, 2004, Med Arh, V58, P282; Stolz E, 2004, STROKE, V35, P888, DOI 10.1161/01.STR.0000120306.82787.5A; Sun XM, 2012, J AM COLL CARDIOL, V60, P791, DOI 10.1016/j.jacc.2012.02.079; Sundgren PC, 2002, NEURORADIOLOGY, V44, P674, DOI 10.1007/s00234-002-0777-z; Suwanwela Nitaya, 2001, Journal of the Medical Association of Thailand, V84, pS228; Urbach H, 2000, NEURORADIOLOGY, V42, P722, DOI 10.1007/s002340000401; Wang XH, 2011, RADIOL ONCOL, V45, P91, DOI 10.2478/v10019-011-0007-6; Yokoi K, 1999, CHEST, V115, P714, DOI 10.1378/chest.115.3.714; Yuan Mei-Kang, 2005, J Chin Med Assoc, V68, P131	44	10	10	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	SEP	2015	42	5					324	332		10.1017/cjn.2015.52			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB5DA	WOS:000368532900008	26059742	Bronze			2022-02-06	
J	Davenport, ND; Lim, KO; Sponheim, SR				Davenport, Nicholas D.; Lim, Kelvin O.; Sponheim, Scott R.			Personality and neuroimaging measures differentiate PTSD from mTBI in veterans	BRAIN IMAGING AND BEHAVIOR			English	Article						PTSD; mTBI; White matter; Personality; Military	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER ABNORMALITIES; AFGHANISTAN WAR VETERANS; POSTCONCUSSIVE SYMPTOMS; MILITARY PERSONNEL; DIFFUSION; IRAQ; INTEGRITY; TBI	Mild traumatic brain injury (mTBI) is common among recent veterans and often is associated with chronic post-concussive symptoms (PCS). Elevated PCS may also be a consequence of post-traumatic stress disorder (PTSD) which shares symptoms with PCS. Identification of personality, biological, and psychopathology factors that contribute to the relationship between mTBI and PCS could help isolate the sources of chronic post concussive syndrome in veterans. Clinician rated diagnoses (PTSD, Major Depression, Alcohol Dependence), personality characteristics (Multidimensional Personality Questionnaire [MPQ] subscales), white matter brain imaging measures (Mean Diffusivity, Generalized Fractional Anisotropy), and diagnoses of mTBI were collected from 125 American military veterans of Iraq or Afghanistan. Linear and logistic regression models were tested to determine contributions to PCS and whether there were similar contributors to PTSD and mTBI. PCS score was associated with personality characteristics of high Stress Reaction and Traditionalism and low Control as well as mTBI. A diagnosis of PTSD was associated with low Social Closeness, PCS, Alcohol Dependence, and abnormal white matter mean diffusivity. Diagnosis of mTBI was associated with fewer white matter mean diffusivity abnormalities, PCS, and number of deployments. As commonly observed clinically, both PTSD and mTBI were associated with higher rates of PCS, though the contribution of PTSD appears to be secondary to personality traits, particularly Stress Reaction. Furthermore, the observation of factors that are uniquely associated with Blast mTBI (number of deployments) or with PTSD (Lifetime Alcohol Dependence and low Social Closeness), as well as a factor (region of abnormal MD) that had opposite effects on the likelihood of each diagnosis, indicates that the complex relationships between personality, psychopathology, and nature of mTBI need to be considered when interpreting chronic post-concussive symptoms.	[Davenport, Nicholas D.; Lim, Kelvin O.; Sponheim, Scott R.] VA Med Ctr B68 2, Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Davenport, Nicholas D.; Lim, Kelvin O.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN USA		Davenport, ND (corresponding author), VA Med Ctr B68 2, Minneapolis Vet Affairs Hlth Care Syst, 1 Vet Dr, Minneapolis, MN 55417 USA.	daven012@umn.edu	Davenport, Nicholas/AAY-8057-2020; Sponheim, Scott/J-3857-2017; Lim, Kelvin/AAF-6833-2020	Davenport, Nicholas/0000-0002-3441-7256; Sponheim, Scott/0000-0002-2782-0856; Lim, Kelvin/0000-0002-2390-7268	Congressionally Directed Medical Research ProgramUnited States Department of Defense [PT074550, W81XWH-08-2-0038]; Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1I01RX000622-01A1, 1IK2RX000709-01A3]; Veterans AffairsUS Department of Veterans Affairs [I01RX000622] Funding Source: NIH RePORTER	This study was supported in part by Grants funded by the Congressionally Directed Medical Research Program (number PT074550, contract W81XWH-08-2-0038) and the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service (1I01RX000622-01A1 to SRS; 1IK2RX000709-01A3 to NDD). Drs. Davenport, Sponheim, and Lim report no biomedical financial interests or potential conflicts of interest.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Assemlal H-E, 2007, Proceedings 2007 IEEE International Conference on Image Processing, ICIP 2007, P133; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Christensen J, 2004, PSYCHIAT RES-NEUROIM, V130, P71, DOI 10.1016/j.pscychresns.2003.08.002; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fayol P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P497, DOI 10.1016/j.annrmp.2008.06.003; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; James LM, 2013, MIL MED, V178, P159, DOI 10.7205/MILMED-D-12-00282; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Larson E, 2013, REHABIL PSYCHOL, V58, P245, DOI 10.1037/a0032953; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Miller MW, 2003, PSYCHOL ASSESSMENT, V15, P205, DOI 10.1037/1040-3590.15.2.205; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Patrick CJ, 2013, ASSESSMENT, V20, P405, DOI 10.1177/1073191112467051; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Robinson M. E., 2014, HUMAN BRAIN MAPPING; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	58	10	10	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					472	483		10.1007/s11682-015-9371-y			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CR8LQ	WOS:000361604300009	25796167				2022-02-06	
J	Fimreite, V; Ciuffreda, KJ; Yadav, NK				Fimreite, Vanessa; Ciuffreda, Kenneth J.; Yadav, Naveen K.			Effect of luminance on the visually-evoked potential in visually-normal individuals and in mTBI/concussion	BRAIN INJURY			English	Article						Amplitude; latency; luminance; magnocellular pathway; mild traumatic brain injury (mTBI); objective biomarker; visually-evoked potential; VEP		Purpose: To assess quantitatively the effect of luminance on VEP amplitude and latency in visually-normals (VN) and patients with mild traumatic brain injury (mTBI). Methods: VN individuals (n=20) and those with mTBI (n=19) participated. Those with mTBI were assessed 1-10 years post-injury (mean = 4.97 years), with the exception of one subject. Pattern VEP testing was employed using the DIOPSYS (TM) NOVA-TR system, with a 74cd m(-2) baseline luminance. Luminance levels were reduced with five different neutral density (ND) filters (0.5, 1.0, 1.5, 2.0 and 2.5) and compared to the baseline response. All testing was performed under binocular-viewing conditions with full refractive correction in place. Results: In both groups, mean VEP amplitude reduced with decrease in luminance (p<0.05). At each luminance level, the mean VEP amplitude was significantly lower in mTBI than in the VN population (p<0.05). In both groups, the mean VEP latency increased progressively with reduction in luminance (p<0.05), with it being significantly higher in mTBI than in the VN population (p<0.05). Conclusions: High luminance levels produced an optimal VEP response in both populations. VEP amplitude was robust, whereas latency progressively increased in both groups as luminance decreased. The latency increase with decreased luminance was significantly larger in those with mTBI, thus suggesting that latency can be used to differentiate reliably between VN individuals and those with mTBI.	[Fimreite, Vanessa; Ciuffreda, Kenneth J.; Yadav, Naveen K.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Fimreite, V (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	vfimreite@sunyopt.edu			National Eye Institute T35 Research Program [5T35EYO20481-04]; Graduate Program at the SUNY College of Optometry; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T35EY020481] Funding Source: NIH RePORTER	We thank the National Eye Institute T35 Research Program for support to Vanessa Fimreite (5T35EYO20481-04), DIOPSYS Inc., (Pine Brook, NJ) for supplying the VEP system, and the Graduate Program at the SUNY College of Optometry for partial funding. We thank Dr Kevin Willeford for his critical reading of the manuscript.		0	10	10	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1199	1210		10.3109/02699052.2015.1035329			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400009	26083046	Green Accepted			2022-02-06	
J	Guild, EB; Levine, B				Guild, Emma B.; Levine, Brian			Functional Correlates of Midline Brain Volume Loss in Chronic Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Psychology; Psychosocial aspects; Motivation; Craniocerebral trauma; Diffuse axonal injury; Magnetic resonance imaging	DEFAULT-MODE NETWORK; QUANTIFIED MRI; HEAD-INJURY; SEVERITY; VARIABLES; AWARENESS; RECOVERY; DIFFUSE; IMPACT	Traumatic brain injury (TBI) is associated with long-term changes in daily life functioning, yet the neuroanatomical correlates of these changes are poorly understood. This study related outcome assessed across several domains to brain structure derived from quantitative magnetic resonance imaging (MRI). Sixty individuals spanning a wide range of TBI severity participated 1-year post-injury as part of the Toronto TBI study. Volumetric data over 38 brain regions were derived from high resolution T1-weighted MRI scans. Functioning was assessed with a battery of self- and significant-other rated measures. Multivariate analysis (partial least squares) was used to identify shared variance between the neuroimaging and outcome measures. TBI was associated with item endorsement on outcome questionnaires without strong evidence for severity or focal lesion effects. Prefrontal midline, cingulate, medial temporal, right inferior parietal and basal ganglia/thalamic volumes were associated with measures of initiative, energization, and physical complaints. In the chronic stage of TBI, self-initiation, energization, and physical complaints related to a specific pattern of volume loss in midline and lateral regions known to be involved in motivation, apathy, and attention. These results suggest that crucial functional changes in chronic TBI may be associated with volume loss in established midline-frontal and attentional circuits.	[Guild, Emma B.; Levine, Brian] Baycrest, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Guild, Emma B.; Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med Neurol, Toronto, ON M5S 1A1, Canada		Levine, B (corresponding author), Baycrest, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	blevine@research.baycrest.org	Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MT-14744, MOP-37535, MOP-108540]; NIH-NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD42385-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042385] Funding Source: NIH RePORTER	Ann Campbell, Catherine Hynes, Sabitha Kanagasabai, Charlene O'Connor, Colleen O'Toole, Marina Mandic, Karen Philp, Adriana Restagno, Jovanka Skocic, and Gary Turner are thanked for technical assistance. Natasa Kovacevic, Fuqiang Gao, Joel Ramirez, and Sandra Black are thanked for assistance with the neuroimaging pipeline. We gratefully thank the TBI participants and non-injured volunteers for participating in this research. This research was supported by grants from the Canadian Institutes of Health Research (Grant #s MT-14744, MOP-37535, and MOP-108540), and the NIH-NICHD (Grant #HD42385-01) to B.L. Conflicts of interest: Dr. Levine provides neuropsychological consultation in medicolegal cases involving TBI. Emma B. Guild is now at the Krembil Neuroscience Centre, University Health Network, Toronto, Ontario, Canada.	ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Burgess P. W., 1997, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; JENNETT B, 1975, LANCET, V1, P480; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J., 2014, UNDERSTANDING TRAUMA, P190; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Schwindt GC, 2013, CEREB CORTEX, V23, P1685, DOI 10.1093/cercor/bhs160; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; TEASDALE G, 1974, LANCET, V2, P81; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6	29	10	11	1	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2015	21	8					650	655		10.1017/S1355617715000600			6	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	CT6HB	WOS:000362913000008	26250783				2022-02-06	
J	Max, JE; Wilde, EA; Bigler, ED; Hanten, G; Dennis, M; Schachar, RJ; Saunders, AE; Ewing-Cobbs, L; Chapman, SB; Thompson, WK; Yang, TT; Levin, HS				Max, Jeffrey E.; Wilde, Elisabeth A.; Bigler, Erin D.; Hanten, Gerri; Dennis, Maureen; Schachar, Russell J.; Saunders, Ann E.; Ewing-Cobbs, Linda; Chapman, Sandra B.; Thompson, Wesley K.; Yang, Tony T.; Levin, Harvey S.			Personality Change Due to Traumatic Brain Injury in Children and Adolescents: Neurocognitive Correlates	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							1ST 6 MONTHS; DISORDERS; PERFORMANCE; RELIABILITY; PREDICTORS; DEPRESSION; SCHEDULE; VALIDITY; EMOTION; MEMORY	Personality change due to traumatic brain injury (PC) in children is an important psychiatric complication of injury and is a form of severe affective dysregulation. This study aimed to examine neurocognitive correlates of PC. The sample included 177 children 5-14 years old with traumatic brain injury who were enrolled from consecutive admissions to five trauma centers. Patients were followed up prospectively at baseline and at 6 months, and they were assessed with semistructured psychiatric interviews. Injury severity, socioeconomic status, and neurocognitive function (measures of attention, processing speed, verbal memory, IQ, verbal working memory, executive function, naming/reading, expressive language, motor speed, and motor inhibition) were assessed with standardized instruments. Unremitted PC was present in 26 (18%) of 141 participants assessed at 6 months postinjury. Attention, processing speed, verbal memory, IQ, and executive function were significantly associated with PC even after socioeconomic status, injury severity, and preinjury attention deficit hyperactivity disorder were controlled. These findings are a first step in characterizing concomitant cognitive impairments associated with PC. The results have implications beyond brain injury to potentially elucidate the neurocognitive symptom complex associated with mood instability regardless of etiology.	[Max, Jeffrey E.; Thompson, Wesley K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Wilde, Elisabeth A.; Hanten, Gerri; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Schachar, Russell J.] Hosp Sick Children, Dept Psychiat, Res Inst, Brain & Behav Program, Toronto, ON M5G 1X8, Canada; [Saunders, Ann E.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75230 USA; [Yang, Tony T.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA		Max, JE (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.	jmax@ucsd.edu			NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085734, K08MH001800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by NIMH grant K-08 MH01800 to Dr. Max and by National Institute of Neurological Disorders and Stroke grant NS-21889 to Dr. Levin.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Boyle MH, 1996, J AM ACAD CHILD PSY, V35, P1440, DOI 10.1097/00004583-199611000-00012; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Delis DC., 1994, CALIFORNIA VERBAL LE; DENCKLA M B, 1974, Cortex, V10, P186; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Ethridge LE, 2014, SCHIZOPHR RES, V159, P491, DOI 10.1016/j.schres.2014.08.025; HISCOCK M, 1987, BRAIN COGNITION, V6, P24, DOI 10.1016/0278-2626(87)90044-3; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Joseph MF, 2008, J CHILD ADOL PSYCHOP, V18, P595, DOI 10.1089/cap.2008.064; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Logan Gordon D., 1994, P189; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1997, NEUROCASE, V3, P119; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Max JE, 2010, COGNITIVE BEHAV ABNO; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Noble KG, 2006, COGNITIVE DEV, V21, P349, DOI 10.1016/j.cogdev.2006.01.007; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Semel E., 1995, CLIN EVALUATION LANG, VThird; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D., 1999, WESCHLER ABBREVIATED; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	42	10	10	0	12	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2015	27	4					272	279		10.1176/appi.neuropsych.15030073			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DM0ON	WOS:000376045400004	26185905	Bronze, Green Accepted, Green Submitted			2022-02-06	
J	McIntosh, AS; Patton, DA				McIntosh, Andrew S.; Patton, Declan A.			The impact performance of headguards for combat sports	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							AMATEUR; FOOTBALL; HEADGEAR; INJURIES; CONCUSSION; TAEKWONDO	Background/aim To assess the impact energy attenuation performance of a range of headguards for combat sports. Methods Seven headguards worn during combat sport training or competition, including two Association Internationale de Boxe Amateur (AIBA)-approved boxing models, were tested using drop tests. An International Organization for Standardization (ISO) rigid headform was used with a 5.6 kg drop assembly mass. Tests were conducted against a flat rigid anvil both with and without a boxing glove section. The centre forehead and lateral headguard areas were tested. Peak headform acceleration was measured. Tests from a selection of drop heights and repeated tests on the same headguard were conducted. Results Headguard performance varied by test condition. For the 0.4 m rigid anvil tests, the best model headguard was the thickest producing an average peak headform acceleration over 5 tests of 48 g compared with 456 g for the worst model. The mean peak acceleration for the 0.4, 0.5 and 0.6 frontal and lateral rigid anvil impact tests was between 32% and 40% lower for the Top Ten boxing model compared with the Adidas boxing model. The headguard performance deterioration observed with repeat impact against the flat anvil was reduced for impacts against the glove section. The overall reduction in acceleration for the combination of glove and headguard in comparison to the headguard condition was in the range of 72-93% for 0.6 and 0.8 m drop tests. Conclusions The impact tests show the benefits of performance testing in identifying differences between headguard models.	[McIntosh, Andrew S.; Patton, Declan A.] Federat Univ Australia, ACRISP, Ballarat, Vic 3353, Australia; [McIntosh, Andrew S.] McIntosh Consultancy & Res, Sydney, NSW, Australia		McIntosh, AS (corresponding author), Federat Univ Australia, ACRISP, POB 663, Ballarat, Vic 3353, Australia.	as.mcintosh@bigpond.com			IOC	The authors would like to thank: the IOC for funding the project, in particular Dr Torbjorn Soligard, who has been the point of contact, Cherine Fahmy and Professor Lars Engebretsen; Roads and Maritime Services Crashlab staff, in particular Devaraj Muniswamy, and David Felice from Zoe's martial arts and boxing supplies in Sydney. Their assistance is gratefully acknowledged.	AIBA, 2013, AIBA OP BOX AOB COMP; ASTM International, 2012, F239709 ASTM; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Dau N, 2006, AM SOC BIOM ANN M; ESTWANIK J J, 1984, Physician and Sportsmedicine, V12, P123; JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974; Mcintosh A.S., 2014, CONCUSSIONS ATHLETIC, P167, DOI [DOI 10.1007/978-1-4939-0295-8_9, 10.1007/978-1-4939-0295-8_9]; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; O'Sullivan D, 2014, BRIT J SPORT MED, V48, P648, DOI DOI 10.1136/BJSPORTS-2014-093494.233; O'Sullivan DM, 2013, BRIT J SPORT MED, V47, P447, DOI 10.1136/bjsports-2012-091416; Pieter W, 2014, BRIT J SPORT MED, V48, P652, DOI DOI 10.1136/BJSPORTS-2014-093494.246; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Schmid L, 1968, J Sports Med Phys Fitness, V8, P171; SCHMIDTOLSEN S, 1990, AM J SPORT MED, V18, P98, DOI 10.1177/036354659001800117; Standards Australia, 2007, 251231 ASNZS; Timm Kent E., 1993, Journal of Athletic Training, V28, P330; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; World Taekwondo Federation, 2014, WORLD TAEKW FED COMP; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924	25	10	10	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2015	49	17					1113	1117		10.1136/bjsports-2015-095093			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CP3AW	WOS:000359750200006	26192195				2022-02-06	
J	Wutzler, S; Lefering, R; Wafaisade, A; Maegele, M; Lustenberger, T; Walcher, F; Marzi, I; Laurer, H				Wutzler, Sebastian; Lefering, Rolf; Wafaisade, Arasch; Maegele, Marc; Lustenberger, Thomas; Walcher, Felix; Marzi, Ingo; Laurer, Helmut		TraumaRegister DGU	Aggressive operative treatment of isolated blunt traumatic brain injury in the elderly is associated with favourable outcome	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Decompressive craniectomy; Age; Outcome; Surgery	DECOMPRESSIVE CRANIECTOMY; MANAGEMENT	Outcome after traumatic brain injury (TBI) in the elderly has not been fully elucidated. The present retrospective observational study investigates the age-dependent outcome of patients suffering from severe isolated TBI with regard to operative and non-operative treatment. Data were prospectively collected in the TraumaRegister DGU (R). Anonymous datasets of 8629 patients with isolated severe blunt TBI (AIS(Head) >= 3, AIS(Body) <= 1) documented from 2002 to 2011 were analysed. Patients were grouped according to age: 1-17, 18-59, 60-69, 70-79 and >= 80 years. Cranial fractures (44.8%) and subdural haematomas (42.6%) were the most common TBIs. Independent from the type of TBI the group of patients with operative treatment declined with rising age. Subgroup analysis of patients with critical TBI (AIS(Head) = 5) revealed standardised mortality ratios (SMRs) of 0.81 (95% CI 0.75-0.87) in case of operative treatment (n = 1201) and 1.13 (95% CI 1.09-1.18) in case of non-operative treatment (n = 1096). All age groups >= 60 years showed significantly reduced SMRs in case of operative treatment. Across all age groups the group of patients with low/moderate disability according to the GOS (4 or 5 points) was higher in case of operative treatment. Results of this retrospective observational study have to be interpreted cautiously. However, good outcome after TBI with severe space-occupying haemorrhage is more frequent in patients with operative treatment across all age groups. Age alone should not be the reason for limited care or denial of operative intervention. (C) 2015 Elsevier Ltd. All rights reserved.	[Wutzler, Sebastian; Lustenberger, Thomas; Walcher, Felix; Marzi, Ingo; Laurer, Helmut] Goethe Univ Frankfurt, Dept Trauma Hand & Reconstruct Surg, Hosp, Frankfurt, Germany; [Lefering, Rolf; Wafaisade, Arasch; Maegele, Marc] Univ Witten Herdecke, Inst Res Operat Med, Witten, Germany		Wutzler, S (corresponding author), Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.	sebastian.wutzler@kgu.de			Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [Ne 385/5]; Novo Nordisk A/S, Bagsvaerd, DenmarkNovo Nordisk	The TraumaRegister DGU (R) of the German Trauma Society (Deutsche Gesellschaft fur Unfallchirurgie, DGU) was partly funded by the Deutsche Forschungsgemeinschaft Ne 385/5 and by a grant from Novo Nordisk A/S, Bagsvaerd, Denmark.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock M Ross, 2006, Neurosurgery, V58, pS7; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; De Bonis P, 2010, J NEUROSURG, V112, P1150, DOI 10.3171/2009.7.JNS09505; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Evans JA, 2015, INJURY, V46, P76, DOI 10.1016/j.injury.2014.07.009; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Marion DW, 2006, NEUROSURGERY, V58, P655; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sovik S, 2014, INJURY; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Timmons SD, 2011, NEW ENGL J MED, P365; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Walcott BP, 2013, WORLD NEUROSURG, V79, P80, DOI 10.1016/j.wneu.2012.11.014; Wutzler S, 2008, UNFALLCHIRURG, V111, P592, DOI 10.1007/s00113-008-1448-2; Wutzler S, 2009, J AM COLL SURGEONS, V209, P75, DOI 10.1016/j.jamcollsurg.2009.03.015	28	10	10	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2015	46	9					1706	1711		10.1016/j.injury.2015.02.013			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CS9LO	WOS:000362412800003	25799473				2022-02-06	
J	Yadav, K; Chamberlain, JM; Lewis, VR; Abts, N; Chawla, S; Hernandez, A; Johnson, J; Tuveson, G; Burd, RS				Yadav, Kabir; Chamberlain, James M.; Lewis, Vicki R.; Abts, Natalie; Chawla, Shawn; Hernandez, Angie; Johnson, Justin; Tuveson, Genevieve; Burd, Randall S.			Designing Real-time Decision Support for Trauma Resuscitations	ACADEMIC EMERGENCY MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; COGNITIVE WORK ANALYSIS; INFORMATION-TECHNOLOGY; TASK-ANALYSIS; IMPLEMENTATION; EMERGENCY; SYSTEMS; HEALTH; CARE; METHODOLOGY	BackgroundUse of electronic clinical decision support (eCDS) has been recommended to improve implementation of clinical decision rules. Many eCDS tools, however, are designed and implemented without taking into account the context in which clinical work is performed. Implementation of the pediatric traumatic brain injury (TBI) clinical decision rule at one Level I pediatric emergency department includes an electronic questionnaire triggered when ordering a head computed tomography using computerized physician order entry (CPOE). Providers use this CPOE tool in less than 20% of trauma resuscitation cases. A human factors engineering approach could identify the implementation barriers that are limiting the use of this tool. ObjectivesThe objective was to design a pediatric TBI eCDS tool for trauma resuscitation using a human factors approach. The hypothesis was that clinical experts will rate a usability-enhanced eCDS tool better than the existing CPOE tool for user interface design and suitability for clinical use. MethodsThis mixed-methods study followed usability evaluation principles. Pediatric emergency physicians were surveyed to identify barriers to using the existing eCDS tool. Using standard trauma resuscitation protocols, a hierarchical task analysis of pediatric TBI evaluation was developed. Five clinical experts, all board-certified pediatric emergency medicine faculty members, then iteratively modified the hierarchical task analysis until reaching consensus. The software team developed a prototype eCDS display using the hierarchical task analysis. Three human factors engineers provided feedback on the prototype through a heuristic evaluation, and the software team refined the eCDS tool using a rapid prototyping process. The eCDS tool then underwent iterative usability evaluations by the five clinical experts using video review of 50 trauma resuscitation cases. A final eCDS tool was created based on their feedback, with content analysis of the evaluations performed to ensure all concerns were identified and addressed. ResultsAmong 26 EPs (76% response rate), the main barriers to using the existing tool were that the information displayed is redundant and does not fit clinical workflow. After the prototype eCDS tool was developed based on the trauma resuscitation hierarchical task analysis, the human factors engineers rated it to be better than the CPOE tool for nine of 10 standard user interface design heuristics on a three-point scale. The eCDS tool was also rated better for clinical use on the same scale, in 84% of 50 expert-video pairs, and was rated equivalent in the remainder. Clinical experts also rated barriers to use of the eCDS tool as being low. ConclusionsAn eCDS tool for diagnostic imaging designed using human factors engineering methods has improved perceived usability among pediatric emergency physicians. (C) 2015 by the Society for Academic Emergency Medicine Resumen Diseno de un Sistema de Apoyo para la Toma de Decisiones a Tiempo Real Para las Resucitaciones Traumatologicas IntroduccionEl uso de un sistema electronico de apoyo para la toma de decisiones clinicas (SEDC) se ha recomendado para mejorar la implementacion de las reglas de decision clinica. Sin embargo, muchos SEDC estan disenados e implementados sin tener en cuenta el contexto en el cual se desarrolla la labor asistencial. La implementacion de la regla de decision clinica para la lesion cerebral traumatica (LCT) pediatrica en un servicio de urgencias (SU) pediatrico de nivel 1 incluye un cuestionario electronico cuando se solicita una TC craneal mediante una entrada de ordenes medicas computarizada (EOMC). Los sanitarios usan esta herramienta de EOMC en menos de un 20% de las causas de resucitacion en traumatologia. Una consideracion tecnica de los factores humanos podria identificar las barreras en la implementacion que limitan el uso de esta herramienta. ObjetivosEl objetivo fue disenar un SEDC en la LCT pediatrica para la resucitacion en traumatologia mediante la consideracion de los factores humanos. La hipotesis fue que los expertos clinicos clasificaran mejor con un SEDC que potencie su uso que con el SEDC existente debido al diseno de interfaz de usuario y a la idoneidad para el uso clinico. MetodologiaEste estudio de metodologia mixta cumplio los principios de evaluacion de facilidad de uso. Los urgenciologos pediatricos fueron encuestados para identificar las barreras en el uso del SEDC existente. Mediante el uso de los protocolos de resucitacion de traumatologia habituales, se desarrollo un analisis de tareas jerarquicas de la evaluacion de la LCT pediatrica. Cinco expertos clinicos, todos miembros universitarios acreditados en medicina de urgencias y emergencias pediatricas, modificaron despues de forma iterativa el analisis de tareas jerarquicas hasta alcanzar un consenso. El equipo informatico desarrollo una pantalla prototipo de SEDC usando un analisis de tareas jerarquico. Tres tecnicos en factores humanos proporcionaron retroalimentacion en el prototipo a traves de la evaluacion heuristica, y el equipo informatico refino el SEDC usando un proceso de hacer prototipos rapido. El SEDC se sometio despues a una evaluacion de facilidad de uso iterativa por los cinco expertos clinicos usando una revision de video de 50 casos de resucitacion en traumatologia. Se creo un SEDC basandose en sus retroalimentaciones, con el analisis de contenido de las evaluaciones realizadas para asegurar que todas las inquietudes se identificasen y valorasen. ResultadosEntre los 26 urgenciologos (76% de porcentaje de respuesta), las principales barreras para el uso de la herramienta existente fueron que la informacion visualizada es redundante y no se adapta al flujo de trabajo clinico. Despues que el nuevo prototipo de SEDC se desarrollara basandose en el analisis de tareas jerarquizadas en la resucitacion de traumatologia, los tecnicos de factores humanos la consideraron mejor que el SEDC previo para 9 de cada 10 usuarios habituales en el diseno de interfaces heuristicas en una escala de 3 puntos. El nuevo SEDC tambien se considero mejor para el uso clinico, mediante la misma escala, en un 84% de los 50 pares de videos de expertos y se clasifico equivalente en el resto de casos. Los expertos clinicos tambien consideraron barreras para el uso del nuevo SEDC, aunque fueron bajas. ConclusionesEl diseno de un SEDC para imagenes diagnosticas usando una metodologia tecnica de factores humanos ha mejorado la percepcion de utilizacion entre los urgenciologos pediatricos.	[Yadav, Kabir] Harbor UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA 90095 USA; [Chamberlain, James M.] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA; [Tuveson, Genevieve; Burd, Randall S.] Childrens Natl Med Ctr, Div Trauma & Burn Surg, Washington, DC 20010 USA; [Lewis, Vicki R.] Healthcare Safety Strategies LLC, Blacksburg, VA USA; [Abts, Natalie] Natl Ctr Human Factors Healthcare, MedStar Inst Innovat, Washington, DC USA; [Chawla, Shawn] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Hernandez, Angie] Design Interact, Oviedo, FL USA; [Johnson, Justin] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA		Yadav, K (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA 90095 USA.	kabir@emedharbor.edu		Yadav, Kabir/0000-0002-1092-9935	National Institutes of Health Clinical and Translational Science Award (CTSA) programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000075, KL2TR000076]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000076, UL1TR000075] Funding Source: NIH RePORTER	This project was supported by the National Institutes of Health Clinical and Translational Science Award (CTSA) program, grants UL1TR000075 and KL2TR000076. Dr. Yadav, an associate editor for this journal, had no role in the peer-review process or publication decision for this paper.	Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Atabaki S, 2012, ANN M INT BRAIN INJ; Baxter GD, 2005, ARTIF INTELL MED, V35, P243, DOI 10.1016/j.artmed.2005.01.004; Bernstein SL, 2015, ACAD EMERG MED, V22, P229, DOI 10.1111/acem.12588; Bessen T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3056; Bisantz AM, 2009, ANN EMERG MED, V53, P477, DOI 10.1016/j.annemergmed.2008.07.019; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carpenter CR, 2009, J EMERG MED, V36, P317, DOI 10.1016/j.jemermed.2008.06.017; Carter EA, 2013, RESUSCITATION, V84, P66, DOI 10.1016/j.resuscitation.2011.10.032; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; DAHLBACK N, 1993, KNOWL-BASED SYST, V6, P258, DOI 10.1016/0950-7051(93)90017-N; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Effken J, 2001, STUD HEALTH TECHNOL, V84, P127; Eichner J. S., 2010, CHALLENGES BARRIERS; Faul M, 2010, TRAUMATIC BRAIN INJU; Federal Register, 2012, FED REG; Gaddis GM, 2007, ACAD EMERG MED, V14, P1015, DOI 10.1197/j.aem.2007.07.010; Gaikwad Rekha, 2007, Health Informatics J, V13, P163, DOI 10.1177/1460458207079836; Gardner RM, 2009, J AM MED INFORM ASSN, V16, P153, DOI 10.1197/jamia.M3045; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Handler JA, 2004, ACAD EMERG MED, V11, P1135, DOI 10.1197/j.aem.2004.08.007; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HIX D, 1993, DEV USER INTERFACES; Holroyd BR, 2007, ACAD EMERG MED, V14, P942, DOI 10.1197/j.aem.2007.06.023; Institute of Medicine, 2001, CROSS QUAL CHASM; Karsh BT, 2009, CLIN PRACTICE IMPROV; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lang ES, 2007, ANN EMERG MED, V49, P355, DOI 10.1016/j.annemergmed.2006.08.022; Li AC, 2012, INT J MED INFORM, V81, P761, DOI 10.1016/j.ijmedinf.2012.02.009; Malhotra S, 2007, J BIOMED INFORM, V40, P81, DOI 10.1016/j.jbi.2006.06.002; McQueen L, 2004, J AM MED INFORM ASSN, V11, P339, DOI 10.1197/jamia.M1499; Nielsen, 1993, USABILITY ENG; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Salmon P, 2010, THEOR ISS ERGON SCI, V11, P504, DOI 10.1080/14639220903165169; Scholes J, 2007, NURS CRIT CARE, V281, P1458, DOI [10.1111/j.1478-5153.2007.00227.x, DOI 10.1111/j.1478-5153.2007.00227.x]; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; VIRZI RA, 1992, HUM FACTORS, V34, P457, DOI 10.1177/001872089203400407; Wears R.L., 2003, P HUM FACT ERG SOC 4, P1415; Wears RL, 2005, JAMA-J AM MED ASSOC, V293, P1261, DOI 10.1001/jama.293.10.1261; Wears RL, 2015, ANN EMERG MED, V65, P143, DOI 10.1016/j.annemergmed.2014.08.024; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Winters BD, 2009, CRIT CARE, V13, DOI 10.1186/cc7792	53	10	10	2	44	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	SEP	2015	22	9					1076	1084		10.1111/acem.12747			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	CQ8CO	WOS:000360834000009	26300010	Green Accepted, Bronze			2022-02-06	
J	Zhong, YJ; Feng, Z; Wang, L; Wei, TQ				Zhong, Ying-Jun; Feng, Zhen; Wang, Liang; Wei, Tian-Qi			Wake-promoting actions of median nerve stimulation in TBI-induced coma: An investigation of orexin-A and orexin receptor 1 in the hypothalamic region	MOLECULAR MEDICINE REPORTS			English	Article						wake-promoting; median nerve stimulation; traumatic brain injury; coma; orexin-A; orexin receptor 1	BRAIN-INJURY; ELECTRICAL-STIMULATION; ENERGY HOMEOSTASIS; NEURONS; AROUSAL; SLEEP; CONSCIOUSNESS; WAKEFULNESS; HYPOCRETINS; MECHANISMS	A coma is a serious complication, which can occur following traumatic brain injury (TBI), for which no effective treatment has been established. Previous studies have suggested that neural electrical stimulation, including median nerve stimulation (MNS), may be an effective method for treating patients in a coma, and orexin-A, an excitatory hypothalamic neuropeptide, may be involved in wakefulness. However, the exact mechanisms underlying this involvement remain to be elucidated. The present study aimed to examine the arousal-promoting role of MNS in rats in a TBI-induced coma and to investigate the potential mechanisms involved. A total of 90 rats were divided into three groups, comprising a control group, sham-stimulated (TBI) group and a stimulated (TBI + MNS) group. MNS was performed on the animals, which were in a TBI-induced comatose state. Changes in the behavior of the rats were observed following MNS. Subsequently, hypothalamic tissues were extracted from the rats 6, 12 and 24 h following TBI or MNS, respectively. The expression levels of orexin-A and orexin receptor-1 (OX1R) in the hypothalamus were examined using immunohistochemistry, western blotting and an enzyme-linked immunosorbent assay. The results demonstrated that 21 rats subjected to TBI-induced coma exhibited a restored righting reflex and response to pain stimuli following MNS. In addition, ignificant differences in the expression levels of orexin-A and OXIR were observed among the three groups and among the time-points. Orexin-A and OX1R were upregulated following MNS. The rats in the stimulated group reacted to the MNS and exhibited a re-awakening response. The results of the present study indicated that MNS may be a therapeutic option for TBI-induced coma. The mechanism may be associated with increasing expression levels of the excitatory hypothalamic neuropeptide, orexin-A, and its receptor, OX1R, in the hypothalamic region.	[Zhong, Ying-Jun; Feng, Zhen; Wang, Liang; Wei, Tian-Qi] Nanchang Univ, Dept Rehabil, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China		Feng, Z (corresponding author), Nanchang Univ, Dept Rehabil, Affiliated Hosp 1, 17th Yong Wai Zheng St, Nanchang 330006, Jiangxi, Peoples R China.	fengzhenly@sina.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260295]; Natural Science Foundation of Jiangxi ProvinceNatural Science Foundation of Jiangxi Province [2013BAB205063]	This study was supported by a grant from the Natural Science Foundation of China (grant no. 81260295) and the Natural Science Foundation of Jiangxi Province (grant no. 2013BAB205063).	Belle MDC, 2014, J NEUROSCI, V34, P3607, DOI 10.1523/JNEUROSCI.3388-13.2014; Butler MP, 2012, EUR J NEUROSCI, V36, P2556, DOI 10.1111/j.1460-9568.2012.08166.x; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cooper EB, 2003, ACT NEUR S, V87, P7; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; de Lecea L, 2010, ACTA PHYSIOL, V198, P203, DOI 10.1111/j.1748-1716.2009.02004.x; Donjacour CEHM, 2012, CHRONOBIOL INT, V29, P356, DOI 10.3109/07420528.2012.655869; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao XB, 2010, ACTA PHYSIOL, V198, P251, DOI 10.1111/j.1748-1716.2009.02047.x; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kayama Y, 1998, EUR UROL, V33, P12, DOI 10.1159/000052235; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; Liu JT, 2008, NEUROMODULATION, V11, P296, DOI 10.1111/j.1525-1403.2008.00179.x; Moreno-Balandran E, 2008, EUR J NEUROSCI, V28, P331, DOI 10.1111/j.1460-9568.2008.06334.x; Moriya T, 1998, SOC TREAT COMA, V7, P65; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; Peyron C, 1998, J NEUROSCI, V18, P9996; Randeva HS, 2001, J CLIN ENDOCR METAB, V86, P4808, DOI 10.1210/jc.86.10.4808; Rejdak K, 2005, J NEUROL NEUROSUR PS, V76, P597, DOI 10.1136/jnnp.2004.049247; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samson WK, 1999, BRAIN RES, V831, P248, DOI 10.1016/S0006-8993(99)01457-2; Sauvage M, 2001, NEUROSCIENCE, V104, P643, DOI 10.1016/S0306-4522(01)00137-3; Smart D, 2002, PHARMACOL THERAPEUT, V94, P51, DOI 10.1016/S0163-7258(02)00171-7; STEPHENS JR, 1994, EPILEPSIA, V35, P164, DOI 10.1111/j.1528-1157.1994.tb02928.x; Suzuki A, 1994, SOC TREATMENT COMA, V3, P75; Taheri S, 2000, LANCET, V355, P847, DOI 10.1016/S0140-6736(05)72463-6; Vittoz NM, 2008, EUR J NEUROSCI, V28, P1629, DOI 10.1111/j.1460-9568.2008.06453.x; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yan AF, 2011, PEPTIDES, V32, P1363, DOI 10.1016/j.peptides.2011.05.004; Yokoyama T, 1996, SOC TREAT COMA, V5, P117; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859	35	10	22	2	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	SEP	2015	12	3					4441	4447		10.3892/mmr.2015.3898			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CP5OW	WOS:000359933900172	26059340	Bronze			2022-02-06	
J	Khoyratty, NB; Wang, Y; O'Gorman, JG; Lloyd, C; Williams, PL; Chan, RCK; Shum, DHK				Khoyratty, Nasseema-Bee; Wang, Ya; O'Gorman, John G.; Lloyd, Chris; Williams, Philip Lee; Chan, Raymond C. K.; Shum, David H. K.			Forming implementation intentions improves prospective memory in early psychosis	PSYCHIATRY RESEARCH			English	Article						Mental rehearsal; Event-based PM; Brief Assessment of Prospective Memory (BAPM); Cambridge Prospective Memory Test (CAMPROMPT); Remediation; Dual-task	TRAUMATIC BRAIN-INJURY; SCHIZOPHRENIA; PERFORMANCE; EVENT; TASKS; TIME; INDIVIDUALS	The study examined whether individuals with early psychosis are impaired in prospective memory (PM), that is, remembering to execute a planned intention in the future, and whether implementation intentions can improve their PM performance. Thirty participants with early psychosis and 33 healthy controls were randomly allocated to either an implementation intentions or control condition and completed a computerised event-based PM task. Participants were also administered two standardised tests of PM and an abbreviated IQ test. Results demonstrated that individuals with early psychosis showed PM deficits relative to healthy controls on the computerised PM task and on some standardised measures of PM. The PM performance of the early psychosis group benefited from forming implementation intentions. Implementation intentions was concluded to be an effective strategy for improving PM performance in individuals with early psychosis. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Khoyratty, Nasseema-Bee] Griffith Univ, Sch Appl Psychol, Gold Coast, Qld, Australia; [Wang, Ya; Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [O'Gorman, John G.; Lloyd, Chris; Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Behav Basis Hlth Program, Gold Coast, Qld, Australia; [Williams, Philip Lee] Early Psychosis Serv Gold Coast, Gold Coast, Qld, Australia		Shum, DHK (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt Campus, Mt Gravatt, Qld 4122, Australia.	d.shum@griffith.edu.au	Chan, Raymond CK/B-6717-2009; Shum, David/A-3914-2008	Chan, Raymond CK/0000-0002-3414-450X; Shum, David/0000-0002-4810-9262	School of Applied Psychology, Griffith University	A special thank you is extended to the participants of the study and to the staff at the Early Psychosis Service Gold Coast, Gold Coast Health Service District, for helping to recruit the participants. The study was funded by the School of Applied Psychology, Griffith University.	Addington J, 2005, SCHIZOPHR RES, V78, P35, DOI 10.1016/j.schres.2005.05.008; Chan RCK, 2008, SCHIZOPHR RES, V103, P229, DOI 10.1016/j.schres.2008.02.019; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; Chen XJ, 2015, PSYCHIAT RES, V226, P14, DOI 10.1016/j.psychres.2015.01.011; Chen XJ, 2014, MEMORY, V22, P349, DOI 10.1080/09658211.2013.792841; Cohen J., 2013, STAT POWER ANAL BEHA; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein G. O., 1995, MEM COGNITION, V21, P996, DOI [10.1037/0278-7393.21.4.996, DOI 10.1037/0278-7393.21.4.996]; Einstein G. O., 1990, MEM COGNITION, V16, P717, DOI [10.1037/0278-7393.16.4.717, DOI 10.1037/0278-7393.16.4.717]; Elvevag B, 2003, PSYCHOL MED, V33, P1249, DOI 10.1017/S0033291703008122; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Kumar D, 2005, J CLIN EXP NEUROPSYC, V27, P867, DOI 10.1080/13803390490919100; Kvavilashvili L., 1996, VARIETIES INTENTION; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; Lui SSY, 2011, NEUROPSYCHOLOGIA, V49, P2217, DOI 10.1016/j.neuropsychologia.2011.04.002; Man DWK, 2011, NEUROPSYCHOL REHABIL, V21, P884, DOI 10.1080/09602011.2011.627270; McDaniel MA, 2013, PSYCHOL SCI, V24, P1791, DOI 10.1177/0956797613481233; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith RE, 2014, CONSCIOUS COGN, V27, P213, DOI 10.1016/j.concog.2014.05.003; Wang Y, 2009, SCHIZOPHR RES, V114, P64, DOI 10.1016/j.schres.2009.07.009; Waugh N., 1999, THESIS GRIFFITH U BR; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilson~ BA, 2005, CAMBRIDGE TEST PROSP; Zhou FC, 2012, SCHIZOPHR RES, V135, P34, DOI 10.1016/j.schres.2011.12.001	30	10	11	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	AUG 30	2015	228	3					265	271		10.1016/j.psychres.2015.05.101			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CP9YI	WOS:000360251400005	26142837				2022-02-06	
J	Dretsch, MN; Kelly, MP; Coldren, RL; Parish, RV; Russell, ML				Dretsch, Michael N.; Kelly, Mark P.; Coldren, Rodney L.; Parish, Robert V.; Russell, Michael L.			No Significant Acute and Subacute Differences between Blast and Blunt Concussions across Multiple Neurocognitive Measures and Symptoms in Deployed Soldiers	JOURNAL OF NEUROTRAUMA			English	Article						ANAM; cognitive screening; concussion mechanism; deployment; military	TRAUMATIC BRAIN-INJURY; ASSOCIATION; MECHANISM	Seventy-one deployed U.S. Army soldiers who presented for concussion care due to either blast or blunt mechanisms within 72h of injury were assessed using the Military Acute Concussion Evaluation, the Automated Neuropsychological Assessment Metrics (ANAM), traditional neuropsychological tests, and health status questionnaires. Follow-up ANAM testing was performed 10d after initial testing (+/- 5d). Twenty-one soldiers were excluded: two for poor effort and 19 who had combined blast/blunt injuries. Of the remaining 50 male participants, 34 had blast injuries and 16 had blunt injuries. There were no statistically significant differences between blast injury and blunt injury participants in demographic, physical, or psychological health factors, concussive symptoms, or automated and traditional neurocognitive testing scores within 72h post-injury. In addition, follow-up ANAM scores up to 15d post-injury were not significantly different (available on 21 blast-injured and 13 blunt-injured subjects). Pre-injury baseline ANAM scores were compared where available, and revealed no statistically significant differences between 22 blast injury and eight blunt injury participants. These findings suggest there are no significant differences between mechanisms of injury during both the acute and subacute periods in neurobehavioral concussion sequelae while deployed in a combat environment. The current study supports the use of sports/mechanical concussion models for early concussion management in the deployed setting and exploration of variability in potential long-term outcomes.	[Dretsch, Michael N.] US Army Aeromed Res Lab, Warfighter Hlth Div, Ft Rucker, AL USA; [Dretsch, Michael N.] Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [Kelly, Mark P.] Walter Reed Natl Mil Med Ctr, Neuropsychol Serv Assessment Div, Bethesda, MD USA; [Coldren, Rodney L.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Parish, Robert V.] Irwin Army Community Hosp, Dept Behav Hlth, Ft Riley, KS USA; [Russell, Michael L.] Vet Hlth Adm, Ctr Excellence Res Returning War Vet, Waco, TX USA		Dretsch, MN (corresponding author), Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA.	Michael.n.dretsch.mil@health.mil			U.S. Army Medical Research Acquisition Activity [W81XWIH-09-2-0057]	The authors acknowledge the assistance of numerous individuals whose efforts were critical in the performance of this study. We thank SSG David Lopez and SGT Pedro Cruz of the U.S. Army Aeromedical Research Laboratory for their diligent data collection efforts. This work was supported by the U.S. Army Medical Research Acquisition Activity [W81XWIH-09-2-0057]. The content of this paper was adapted from a poster presentation at the 2012 annual Meeting of the International Neuropsychological Society, Montreal, Canada, February, 2012.	[Anonymous], 2011, STAT STAT SOFTW REL; Assistant Secretary of Defense for Health Affairs, 2007, TRAUM BRAIN INJ DEF; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Gerberding J.L., 2003, C MILD TRAUM BRAIN I; GOLDEN CJ, 1975, J PERS ASSESS, V39, P386, DOI 10.1207/s15327752jpa3904_10; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mendez MF, 2013, BRAIN INJURY, V27, P10, DOI 10.3109/02699052.2012.722252; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reitan R, 1985, HALSTEAD REITAN NEUR; Smith A., 1982, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, P501; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	27	10	10	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1217	1222		10.1089/neu.2014.3637			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400005	25367048				2022-02-06	
J	Hashimoto, T; Ishii, T; Okada, N; Itoh, M				Hashimoto, Toshihiko; Ishii, Takanori; Okada, Naoyuki; Itoh, Masahiro			Impulsive force on the head during performance of typical ukemi techniques following different judo throws	JOURNAL OF SPORTS SCIENCES			English	Article						sports kinesiology; sports injury prevention; judo injuries	RISK-FACTORS; INJURY; BIOMECHANICS; CONCUSSION; FOOTBALL; SPORT	In this study, eight judo athletes who are major candidates for the Japan national team were recruited as participants. Kinematic analysis of exemplary ukemi techniques was carried out using two throws, o-soto-gari, a throw linked to frequent injury, and o-uchi-gari. The aim of this study was to kinematically quantify the timing patterns of exemplary ukemi techniques and to obtain kinematic information of the head, in a sequence of ukemi from the onset of the throw to the completion of ukemi. The results indicated that the vertical velocity with which the uke's head decelerated was reduced by increasing the body surface exposed to the collision with the tatami and by increasing the elapsed time. In particular, overall upper limb contact with the tatami is greatly associated with deceleration. In o-soto-gari, the impulsive force on the faller's head as the head reached the lowest point was 204.82 +/- 19.95kgm center dot s(-)(2) while in o-uchi-gari it was 118.46 +/- 63.62kgm center dot s(-2), z=-1.75, P=0.08, and it did present a large-sized effect with r=0.78. These findings indicate that the exemplary o-soto-gari as compared to o-uchi-gari is the technique that causes more significant damage to the uke's head.	[Hashimoto, Toshihiko; Okada, Naoyuki; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Shinjuku Ku, Tokyo 1608402, Japan; [Ishii, Takanori] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan		Hashimoto, T (corresponding author), Tokyo Med Univ, Dept Anat, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	hashishi@ryotokuji-u.ac.jp		Ishii, Takanori/0000-0002-6626-9294			Ae, 1996, J SPORTS SCI, V15, P155; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; de Subijana CL, 2010, BIOL SPORT, V27, P279, DOI 10.5604/20831862.927494; Delaney JS, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.015735; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Fukubayashi T., 2011, RES REPORT SPORTS ME, P17; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gabbett TJ, 2005, AM J SPORT MED, V33, P428, DOI 10.1177/0363546504268407; Gelabert-Gonzalez M, 2004, NEUROCIRUGIA, V15, P165; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Ishida K, 2006, SPORT BIOMECH, V5, P183, DOI 10.1080/14763140608522873; Kajiyama H., 1984, RONSETSU JUDO, P127; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Miyazaki S., 2011, RES REPORT SPORTS ME, P59; Nagahiro Shinji, 2011, No Shinkei Geka, V39, P1139; Nishimura K, 1988, Neurol Med Chir (Tokyo), V28, P991, DOI 10.2176/nmc.28.991; Okuwaki T., 2011, RES REPORT SPORTS ME, P4; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pourcelot P, 2000, J BIOMECH, V33, P1751, DOI 10.1016/S0021-9290(00)00132-9; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Winter D.A., 1980, HUMAN LOCOMOTION, P92	31	10	10	0	31	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	AUG 9	2015	33	13					1356	1365		10.1080/02640414.2014.990482			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CI4EU	WOS:000354700900006	25562389				2022-02-06	
J	Gottshall, KR; Sessoms, PH				Gottshall, Kim R.; Sessoms, Pinata H.			Improvements in dizziness and imbalance results from using a multi disciplinary and multi sensory approach to Vestibular Physical Therapy - a case study	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						CAREN; vestibular physical therapy; virtual reality; treadmill; traumatic brain injury; TBI	TRAUMATIC BRAIN-INJURY	This paper discusses a case study of a 41-year-old active duty male service member who sustained head trauma from a motorcycle accident and underwent multidisciplinary vestibular physical therapy rehabilitation. He was initially treated with traditional physical therapy applications of treadmill walking and standing balance with some symptom improvements, but was not able to maintain a running speed that would allow him to return to full active duty status. Further treatment utilizing a Computer Assisted Rehabilitation Environment was performed in order to increase level of difficulty and further enhance function. This treatment is able to elicit vestibular deficits seen in the community as it requires subjects to walk and balance while performing tasks within a virtual scenario incorporating platform motion, visual surround and flow, and cognitive processing. After 6 weeks of therapy, twice weekly, improvements in clinical vestibular measures were observed as well as walking speed and patient confidence. The patient was able to return to full duty after treatment. This case study provides supportive evidence that multidimensional tasking in a virtual environment provides a safe but demanding form of vestibular therapy for patients needing more challenging tasks than those provided with traditional therapy techniques. Those persons requiring higher levels of performance before returning to full duty (e.g., pilots, special operators, etc.) may find this type of therapy beneficial.	[Gottshall, Kim R.] Naval Med Ctr San Diego, Phys Therapy Dept, 35420 Bob Wilson Dr, San Diego, CA 92101 USA; [Sessoms, Pinata H.] Naval Hlth Res Ctr, Warfighter Performance Dept, Physiol & Cognit Operat Res Environm Lab, San Diego, CA USA; [Sessoms, Pinata H.] San Diego State Univ, Dept Exercise & Nutr Sci, San Diego, CA 92182 USA		Gottshall, KR (corresponding author), Naval Med Ctr San Diego, Phys Therapy Dept, 35420 Bob Wilson Dr, San Diego, CA 92101 USA.	kim.r.gottshall.civ@mail.mil		Sessoms, Pinata/0000-0002-6960-0659	Bureau of Medicine and Surgery Wounded, Ill, and Injured Grant [R116, 60818]	The authors would like to thank LCDR Jose A. Dominguez and the rest of the Physiological and Cognitive Operational Research Environment (PhyCORE) Team at the Naval Health Research Center Warfighter Performance Laboratory for their assistance with this work on the CAREN. This project was supported by the Bureau of Medicine and Surgery Wounded, Ill, and Injured Grant R116, under Work Unit Number 60818. The views expressed are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government.	DVBIC, 2015, DOD WORLDW NUMB TBI; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Koppelmans V, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-205; Morris L, 2014, CLENDANIEL VESTIBULA, P504; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; PALOSKI WH, 1993, AM J OTOL, V14, P9; Pellecchia GL, 2005, J MOTOR BEHAV, V37, P239, DOI 10.3200/JMBR.37.3.239-246; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Reschke MF, 1998, BRAIN RES REV, V28, P102, DOI 10.1016/S0165-0173(98)00031-9; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Whitney SL, 2009, GAIT POSTURE, V29, P194, DOI 10.1016/j.gaitpost.2008.08.002; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687	13	10	10	1	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	AUG 6	2015	9								106	10.3389/fnsys.2015.00106			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	CU9EV	WOS:000363847700001	26300743	gold, Green Published			2022-02-06	
J	Dehqanzada, ZA; Meisinger, Q; Doucet, J; Smith, A; Casola, G; Coimbra, R				Dehqanzada, Zia A.; Meisinger, Quinn; Doucet, Jay; Smith, Alan; Casola, Giovanna; Coimbra, Raul			Complete ultrasonography of trauma in screening blunt abdominal trauma patients is equivalent to computed tomographic scanning while reducing radiation exposure and cost	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	73rd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 09-13, 2014	Philadelphia, PA	Amer Assoc Surg Trauma		Abdominal trauma; ultrasound; CT scan; trauma screening; fast ultrasound	INITIAL EVALUATION; RISK; US; SONOGRAPHY; ULTRASOUND; INJURIES; CANCER	BACKGROUND Liberal use of computed tomography of the abdomen and pelvis (CTAP) in the screening of blunt abdominal trauma (BAT) has heightened concerns for increased radiation exposure and costs. We sought to demonstrate that in a select group of BAT patients, complete ultrasonography of trauma (CUST) is equivalent to routine CTAP but with significantly decreased radiation and costs. METHODS A retrospective analysis of patients screened for BAT from 2000 to 2011 in a Level 1 trauma center was performed. CUST was available from 8:00 am to 11:00 pm daily, while CTAP was performed thereafter. Decision to perform CTAP or CUST overnight was made by the attending surgeon based on clinical examination. False negatives (FNs) were described as either a negative CUST or CTAP finding, which later required exploratory laparotomy. Medicare rates and previous data were used for the estimation of cost and radiation exposure. RESULTS There were 19,128 patients screened for BAT. A total of 12,577 patients (65.8%) initially underwent CUST, and 6,548 (34.2%) underwent CTAP; 11,059 patients (58% of the total BAT patients) avoided a CTAP, yielding an estimated savings of $6.5 million and 188,003 mSv less radiation during the course of the study. Compared with the CTAP group, patients undergoing CUST had lower Injury Severity Score (ISS) (8.1 vs. 9.6), were older (44.7 years vs. 35.2 years), and experienced less traumatic brain injury (61.4% vs. 69.3%) (all with p < 0.002). Mortality was higher in the CUST group (1.8% vs. 1.2%, p = 0.02), but it was insignificant when adjusted for age older than 65 years (1.1% vs. 0.9%, p = 0.23) or head injury (0.6% and 0.3%, p = 0.4). FN CUST and FN CTAP were 0.29% and 0.1%, respectively (p = nonsignificant), with similar mortality (20% vs. 0%, p = 0.44). CONCLUSION CUST is equivalent to routine CTAP for BAT screening and leads to an average of 42% less radiation exposure and more than $591,000 savings per year. LEVEL OF EVIDENCE Diagnostic study, level IV; therapeutic/care management study, level IV.	[Dehqanzada, Zia A.; Doucet, Jay; Smith, Alan; Coimbra, Raul] Univ Calif San Diego, Med Ctr, Div Trauma Surg Crit Care Burns & Acute Care Surg, Dept Surg, San Diego, CA 92103 USA; [Meisinger, Quinn; Casola, Giovanna] Univ Calif San Diego, Med Ctr, Dept Radiol, San Diego, CA 92103 USA		Doucet, J (corresponding author), Univ Calif San Diego, Med Ctr, Div Trauma Surg Crit Care Burns & Acute Care Surg, Dept Surg, 200 W Arbor Dr, San Diego, CA 92103 USA.	jdoucet@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Doucet, Jay J/O-3005-2018; Doucet, Jay/Y-7951-2019	Coimbra, Raul/0000-0002-3759-6851; Doucet, Jay J/0000-0001-9617-001X; Doucet, Jay/0000-0001-9617-001X; Meisinger, Quinn/0000-0002-6298-2017			American Medical Association, 2012, CPT 2012 PROF ED; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Deunk J, 2009, J TRAUMA, V66, P1108, DOI 10.1097/TA.0b013e31817e55c3; Farahmand N, 2005, RADIOLOGY, V235, P436, DOI 10.1148/radiol.2352040583; Farrath Samiris, 2012, Rev. Col. Bras. Cir., V39, P295; Healey MA, 1996, J TRAUMA, V40, P875, DOI 10.1097/00005373-199606000-00004; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Laack TA, 2011, J TRAUMA, V70, P1362, DOI 10.1097/TA.0b013e3181e1707f; MACKERSIE RC, 1989, ARCH SURG-CHICAGO, V124, P809; McKenney KL, 1998, AM J ROENTGENOL, V170, P979, DOI 10.2214/ajr.170.4.9580140; McKenney MG, 2001, AM SURGEON, V67, P930; Rozycki GS, 1998, ANN SURG, V228, P557, DOI 10.1097/00000658-199810000-00012; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Sharma OP, 2011, J EMERG MED, V41, P640, DOI 10.1016/j.jemermed.2011.03.004; Sirlin CB, 2004, RADIOLOGY, V230, P661, DOI 10.1148/radiol.2303021707; Sirlin CB, 2001, RADIOLOGY, V219, P229, DOI 10.1148/radiology.219.1.r01ap45229; Sise MJ, 2013, J TRAUMA ACUTE CARE, V74, P92, DOI 10.1097/TA.0b013e3182788f6f; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Soto JA, 2012, RADIOLOGY, V265, P678, DOI 10.1148/radiol.12120354; Tien HC, 2007, J TRAUMA, V62, P151, DOI 10.1097/TA.0b013e31802d9700	23	10	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2015	79	2					199	205		10.1097/TA.0000000000000715			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	CS2II	WOS:000361892800006	26218686				2022-02-06	
J	Mitkovski, M; Dahm, L; Heinrich, R; Monnheimer, M; Gerhart, S; Stegmuller, J; Hanisch, UK; Nave, KA; Ehrenreich, H				Mitkovski, Miso; Dahm, Liane; Heinrich, Ralf; Monnheimer, Mathieu; Gerhart, Simone; Stegmueller, Judith; Hanisch, Uwe-Karsten; Nave, Klaus-Armin; Ehrenreich, Hannelore			Erythropoietin dampens injury-induced microglial motility	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						ATP; brain injury; migration; process protrusion; Rac1	IN-VIVO; BRAIN; ACTIVATION; GTPASES; ATP; RHO; NEURODEGENERATION; LESION; CELLS; RAC1	Traumatic brain injury causes progressive brain atrophy and cognitive decline. Surprisingly, an early treatment with erythropoietin (EPO) prevents these consequences of secondary neurodegeneration, but the mechanisms have remained obscure. Here we show by advanced imaging and innovative analytical tools that recombinant human EPO, a clinically established and neuroprotective growth factor, dampens microglial activity, as visualized also in vivo by a strongly attenuated injury-induced cellular motility.	[Mitkovski, Miso] Max Planck Inst Expt Med, Light Microscopy Facil, D-37075 Gottingen, Germany; [Dahm, Liane; Monnheimer, Mathieu; Gerhart, Simone; Ehrenreich, Hannelore] Max Planck Inst Expt Med, Clin Neurosci, D-37075 Gottingen, Germany; [Heinrich, Ralf] Univ Gottingen, Inst Zool, Dept Cellular Neurobiol, D-37073 Gottingen, Germany; [Stegmueller, Judith] Max Planck Inst Expt Med, Cellular & Mol Neurobiol Grp, D-37075 Gottingen, Germany; [Stegmueller, Judith; Nave, Klaus-Armin; Ehrenreich, Hannelore] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany; [Hanisch, Uwe-Karsten] Univ Gottingen, Inst Neuropathol, D-37073 Gottingen, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany		Ehrenreich, H (corresponding author), Max Planck Inst Expt Med, Clin Neurosci, Hermann Rein Str 3, D-37075 Gottingen, Germany.	ehrenreich@em.mpg.de		Mitkovski, Miso/0000-0001-9195-2434; Ehrenreich, Hannelore/0000-0001-8371-5711; Monnheimer, Mathieu/0000-0003-0366-6644	Max Planck SocietyMax Planck Society; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)German Research Foundation (DFG); Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony;  [SFB TRR 43]	This study was supported by the Max Planck Society and the DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), the SFB TRR 43, as well as by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony.	Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Persson AK, 2014, GLIA, V62, P2080, DOI 10.1002/glia.22728; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Sargin D, 2009, GLIA, V57, P693, DOI 10.1002/glia.20797; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Tang ZH, 2013, NEUROPHARMACOLOGY, V67, P8, DOI 10.1016/j.neuropharm.2012.10.017; Vairano M, 2002, EUR J NEUROSCI, V16, P584, DOI 10.1046/j.1460-9568.2002.02125.x; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4	18	10	10	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2015	35	8					1233	1236		10.1038/jcbfm.2015.100			4	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CN9WN	WOS:000358801300003	25966953	Green Published, Green Submitted, hybrid			2022-02-06	
J	Silachev, DN; Plotnikov, EY; Babenko, VA; Danilina, TI; Zorova, LD; Pevzner, IB; Zorov, DB; Sukhikh, GT				Silachev, D. N.; Plotnikov, E. Yu.; Babenko, V. A.; Danilina, T. I.; Zorova, L. D.; Pevzner, I. B.; Zorov, D. B.; Sukhikh, G. T.			Intra-Arterial Administration of Multipotent Mesenchymal Stromal Cells Promotes Functional Recovery of the Brain After Traumatic Brain Injury	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						traumatic brain injury; stem cells; migration; sensorimotor deficit	STEM-CELLS; RAT; STROKE; MODEL; ISCHEMIA; THERAPY; MRI	We compared the efficiency of delivery of multipotent mesenchymal stem cells into the brain after their intravenous and intra-arterial injection. Analysis of the therapeutic effects of cells after experimental traumatic brain injury revealed improvement of the neurological status and motor functions of the damaged hemisphere, the effect being more pronounced after intraarterial injection of cells. Intra-arterial administration was followed by rapid infiltration of the cells into the brain tissue and their number considerably surpassed that after intravenous infusion. Targeted delivery of multipotent mesenchymal stromal cells into the brain after their injection into the carotid arteries substantially potentiated their neuroprotective effects in traumatic brain injury.	[Silachev, D. N.; Plotnikov, E. Yu.; Pevzner, I. B.; Zorov, D. B.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Babenko, V. A.] Moscow MV Lomonosov State Univ, Fac & Bioengn & Bioinformat, Moscow, Russia; [Zorova, L. D.] Moscow MV Lomonosov State Univ, Int Laser Res Ctr, Moscow, Russia; [Danilina, T. I.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Babenko, V. A.; Sukhikh, G. T.] Minist Hlth Russian Federat, VI Kulakov Res Ctr Obstet Gynecol & Perinatol, Moscow, Russia		Zorova, LD (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	zorov@genebee.msu.ru	Plotnikov, Egor Y/F-8592-2019; Zorov, Dmitry B./AAB-1738-2019; Silachev, Denis N/C-9464-2012; Zorova, Ljubava/AAC-7286-2022; Zorova, Ljubava D/J-3554-2017; Silachev, Denis/ABE-8515-2020; Pevzner, Irina B/S-6178-2018	Plotnikov, Egor Y/0000-0003-2838-3704; Zorov, Dmitry B./0000-0003-0863-8490; Zorova, Ljubava D/0000-0001-9046-712X; Silachev, Denis/0000-0003-0581-9755; Suhih, Gennadii Tihonovic/0000-0002-7712-1260	Russian Scientific FoundationRussian Science Foundation (RSF) [14-15-00107]	The study was supported by the Russian Scientific Foundation (grant No. 14-15-00107).	Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Chua JY, 2011, J CEREBR BLOOD F MET, V31, P1263, DOI 10.1038/jcbfm.2010.213; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Guzman Raphael, 2009, Expert Rev Cardiovasc Ther, V7, P1187, DOI 10.1586/erc.09.121; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	15	10	14	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	AUG	2015	159	4					528	533		10.1007/s10517-015-3009-3			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CS1IX	WOS:000361818700031	26388566				2022-02-06	
J	Lang, YH; Fu, FM; Sun, DL; Xi, CH; Chen, FY				Lang, Yuhuang; Fu, Fengming; Sun, Dalong; Xi, Chenhui; Chen, Fengyuan			Labetalol Prevents Intestinal Dysfunction Induced by Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; TIGHT-JUNCTION; BARRIER FUNCTION; NERVOUS-SYSTEM; MAGUK PROTEIN; NITRIC-OXIDE; X-RECEPTOR; APOPTOSIS; ALPHA; RAT	Background Beta-adrenergic blockade has been hypothesized to have a protective effect on intestinal dysfunction and increased intestinal permeability associated with the epinephrine surge after traumatic brain injury (TBI). Methods Wister rats were subjected to either a weight drop TBI, and intraperitoneally injected or not with labetalol, or a sham procedure (18 rats per group). After 3, 6, or 12h (6 rats per subgroup), intestinal permeability to 4.4 kDa FITC-Dextran and plasma epinephrine levels were measured as was intestinal tight junction protein ZO-1 expression at 12h. Terminal ileum was harvested to measure levels of intestinal tumor necrosis factor (TNF)-alpha and to evaluate histopathology. Results In TBI group vs. sham group, intestinal permeability (P<0.01) was significantly higher at all time-points, and intestinal ZO-1 expression was lower at 12h. In TBI with vs. without labetalol group, 1) intestinal permeability was significantly lower at 6 and 12h (94.31 +/- 7.64 vs. 102.16 +/- 6.40 mu g/mL; 110.21 +/- 7.52 vs. 118.95 +/- 7.11 mu g/mL, respectively); 2) levels of plasma epinephrine and intestinal TNF-alpha were significantly lower at 3, 6 and 12h; and 3) intestinal ZO-1 expression was higher at 3, 6 and 12h (p=0.018). Histopathological evaluation showed that labetalol use preserved intestinal architecture throughout. Conclusion In a rat model of TBI, labetalol reduced TBI-induced sympathetic hyperactivity, and prevented histopathological intestinal injury accompanied by changes in gut permeability and gut TNF-alpha expression.	[Lang, Yuhuang; Xi, Chenhui] Fudan Univ, Shanghai Hosp Affiliated 5, Dept Emergency, Shanghai 200433, Peoples R China; [Fu, Fengming] Fudan Univ, Shanghai Canc Ctr, Intens Care Unit, Shanghai 200433, Peoples R China; [Sun, Dalong; Chen, Fengyuan] Fudan Univ, Shanghai Hosp Affiliated 5, Dept Gastroenterol, Shanghai 200433, Peoples R China		Chen, FY (corresponding author), Fudan Univ, Shanghai Hosp Affiliated 5, Dept Gastroenterol, Shanghai 200433, Peoples R China.	cfy429@163.com			Science and Technology Committee of Minhang District, Shanghai, China [2012MHZ013]	This work has been kindly supported by Grant 2012MHZ013 from the Science and Technology Committee of Minhang District, Shanghai, China.	Adachi M, 2006, MOL CELL BIOL, V26, P9003, DOI 10.1128/MCB.01811-05; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Chavez AM, 1999, CRIT CARE MED, V27, P2246, DOI 10.1097/00003246-199910000-00030; Chen LW, 2003, ARCH SURG-CHICAGO, V138, P1219, DOI 10.1001/archsurg.138.11.1219; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; ELENKOV IJ, 1995, J NEUROIMMUNOL, V61, P123, DOI 10.1016/0165-5728(95)00080-L; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; He Q, 2014, CIRC-HEART FAIL, V7, P1032, DOI 10.1161/CIRCHEARTFAILURE.114.001260; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jiang XW, 2011, J CARDIOVASC MED, V12, P732, DOI 10.2459/JCM.0b013e32834a6697; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; Lang YH, 2012, J TRAUMA SURG, V14, P51; MACCARTHY EP, 1983, PHARMACOTHERAPY, V3, P193; Maheras KJ, 2013, J NEUROSCI METH, V219, P61, DOI 10.1016/j.jneumeth.2013.07.004; McNeil JJ, 1979, BR J CLIN PHARM, V8, P157; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; MOREL DR, 1984, INTENS CARE MED, V10, P133, DOI 10.1007/BF00265802; Pedersen ME, 2007, CURR HYPERTENS REP, V9, P269, DOI 10.1007/s11906-007-0050-2; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2013, EUR HEART J, V34, P1834, DOI 10.1093/eurheartj/ehs011; Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387; Shan PR, 2008, BIOCHEM BIOPH RES CO, V375, P628, DOI 10.1016/j.bbrc.2008.08.074; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tong S, 2014, LAB ANIM SCI, V31, P52; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Wang Yan-bin, 2010, Zhonghua Nei Ke Za Zhi, V49, P869; Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887; Zacharia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065969; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	49	10	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133215	10.1371/journal.pone.0133215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	WOS:000358198700110	26186619	gold, Green Published, Green Submitted			2022-02-06	
J	Majdan, M; Rusnak, M; Rehorcikova, V; Brazinova, A; Leitgeb, J; Mauritz, W				Majdan, Marek; Rusnak, Martin; Rehorcikova, Veronika; Brazinova, Alexandra; Leitgeb, Johannes; Mauritz, Walter			Epidemiology and Patterns of Transport-Related Fatalities in Austria 1980-2012	TRAFFIC INJURY PREVENTION			English	Article						traumatic brain injury; public health; mortality; road traffic accidents; epidemiology; transport accidents	TRAUMATIC BRAIN-INJURIES; PREVENTION	Objectives: Transport-related accidents remain the largest single cause of death among people aged 15 to 29 in the European Union, and despite the decrease in number of fatalities from 1990 onwards they remain a significant public health problem. The aim of this article was to analyze the long-term trends and patterns of transport-related fatalities, identify the anatomic distribution of most significant injuries in different road users, and identify the primary populations at risk of transport-related death in Austria between 1980 and 2013. Methods: Data on transport-related fatalities based on death certificates were obtained from Statistics Austria for the analyzed period. Crude and age-standardized mortality rates per 100,000 were calculated and broken down by age, gender, and month of death, and the anatomic distribution of most significant injuries were identified. Potential years of life lost before age 75 (PYLL-75) were used as a measure of public health impact. Results: A total of 39,709 transport-related fatalities were identified for the studied years; 74% were males and the mean age was 42.1years (range 0-103). A decrease in the number of fatalities (from 2018 in 1980 to 554 in 2012), mortality rates (from 26 in 1980 to 7 in 2012), and PYLL-75 (from 68,960 in 1980 to 14,931 in 2012) was observed. Introduction of major prevention milestones (compulsory use of seat belts or child restraints) may have contributed to this decrease. Men 16-24years old were at the highest risk of transport-related death. Pedestrian victims were more likely to be women and car drivers and motorcyclists were more often men. Most fatal transport accidents occurred between the months of May and October and prevailingly in towns of fewer than 20,000 inhabitants. Injuries to the head were the most significant injuries in all user groups (>50% of cases in all road user types). Reduced mortality rates could translate into higher prevalence of long-term disabilities in survivors of transport accidents. Conclusions: Despite the decreasing trend observed, transport-related fatalities remain a serious public health issue in Austria. An increase in the mortality of motor vehicle drivers warrants more preventive action in this group. Further research is needed on other outcomes of transport accidents such as long-term disabilities to elucidate the true public health burden of transport accidents.	[Majdan, Marek; Rusnak, Martin; Rehorcikova, Veronika; Brazinova, Alexandra] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava 91843, Slovakia; [Majdan, Marek; Rusnak, Martin; Brazinova, Alexandra; Mauritz, Walter] INRO, Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012; Rusnak, Martin/K-9349-2016	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Rusnak, Martin/0000-0003-3321-1042			Aeron-Thomas AS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003862.pub2; Ahmad O. B., 2001, GPE DISCUSSION PAPER, V31; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Belanger F, 2008, TRANSPORT RELATED DE; Beyer FR, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004728.pub2; Centers for Disease Control and Prevention, 2011, COSTS TRANSP REL INJ; Eurostat, 2009, TRANSP ACC STAT; Eurostat, 2009, PAN TRANSP; Kobusingye, 2001, INJURY SURVEILLANCE; Kopits E., 2003, 3035 WORLD BANK; Kwan I, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003438.pub2; Lassarre S, 2001, ACCIDENT ANAL PREV, V33, P743, DOI 10.1016/S0001-4575(00)00088-9; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Majdan M, 2014, J NEUROTRAUM, V31, P1046, DOI 10.1089/neu.2013.3200; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; McAndrews C, 2013, ACCIDENT ANAL PREV, V60, P103, DOI 10.1016/j.aap.2013.08.005; McLeod AI, 2011, Kendall: Kendall rank correlation and Mann-Kendall trend test; Naci H, 2009, INJURY PREV, V15, P55, DOI 10.1136/ip.2008.018721; Phillips RO, 2011, ACCIDENT ANAL PREV, V43, P1204, DOI 10.1016/j.aap.2011.01.002; Rice TM, 2009, AM J PUBLIC HEALTH, V99, P252, DOI 10.2105/AJPH.2007.131128; Statistics Austria, 2006, 30 JAHR GURT OST ERF; Teschke K, 2013, CAN J PUBLIC HEALTH, V104, pE75, DOI 10.1007/BF03405659; WHO, 2004, WORLD REPORT ROAD TR; WHO, 1992, INT STAT CLASS DIS R; Wilson C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004607.pub3; World Health Organization, 1975, INT STAT CLASS DIS R; World Health Organization, 2009, GLOB STAT REP ROAD S; Yannis G, 2011, J SAFETY RES, V42, P17, DOI 10.1016/j.jsr.2010.11.003	30	10	12	0	43	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	JUL 4	2015	16	5					450	455		10.1080/15389588.2014.962133			6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	CB0JJ	WOS:000349311600005	25256803	Green Submitted			2022-02-06	
J	Bonds, BW; Yang, SM; Hu, PF; Kalpakis, K; Stansbury, LG; Scalea, TM; Stein, DM				Bonds, Brandon W.; Yang, Shiming; Hu, Peter F.; Kalpakis, Konstantinos; Stansbury, Lynn G.; Scalea, Thomas M.; Stein, Deborah M.			Predicting secondary insults after severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	28th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 13-17, 2015	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		TBI; prediction; ICP	MONITORING INTRACRANIAL-PRESSURE; MORTALITY	BACKGROUND Secondary insults such as hypotension, hypoxia, cerebral hypoperfusion, and intracranial hypertension are associated with poor outcome following severe traumatic brain injury (TBI). Preventing and minimizing the effect of secondary insults are essential in the management of severe TBI. At present, clinicians have no way to predict the development of these events, limiting their ability to plan appropriate timing of interventions. We hypothesized that processing continuous vital signs (VS) data using machine learning methods could predict the development of future intracranial hypertension. METHODS Continuous VS including intracranial pressure (ICP), heart rate, systolic blood pressure, and mean arterial pressure data were collected from adult patients admitted to a single Level I trauma center requiring an ICP monitor. We tested the ability of Nearest Neighbor Regression (NNR) to predict changes in ICP by algorithmically learning from the patients' past physiology. RESULTS Continuous VS were collected on 132 adult patients over a minimum of 3 hours per patient (5,466 hours total; 65,600 data points). Bland-Altman plots show that NNR provides good agreement in predicting actual ICP with a bias of 0.02 (2 SD = 4 mm Hg) for the subsequent 5 minutes and -0.02 (2 SD = 10 mm Hg) for the subsequent 2 hours. CONCLUSION We have demonstrated that with the use of physiologic data, it is possible to predict with reasonable accuracy future ICP levels following severe TBI. NNR predicts ICP changes in clinically useful time frames. This ability to predict events may allow clinicians to make better decisions about the timing of necessary interventions, and this method could support the future development of minimally invasive ICP monitoring systems, which may lead to better overall clinical outcomes after severe TBI. LEVEL OF EVIDENCE Prognostic study, level III.	Univ Maryland, Sch Med, Shock Trauma Anesthesia Res Organized Res Ctr, Baltimore, MD 21201 USA; [Bonds, Brandon W.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Bonds, BW (corresponding author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	bbonds@stapa.umm.edu	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963	USAF [FA8650-13-2-6D15]	This study is supported in part by USAF grant FA8650-13-2-6D15 (ICP Comparison).	Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care AANS/CNS, 2007, J NEUROTRAUMA S, V24, pS1, DOI DOI 10.1089/NEU.2007.9976; Breiman L., 1984, CLASSIFICATION REGRE; Colton K, 2014, J TRAUMA ACUTE CARE, V77, P47, DOI 10.1097/TA.0000000000000270; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2007, NEUROSURG FOCUS, V22, P1; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kashif FM, 2012, SCI TRANSL MED, V129, P44; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lu J, 2005, ACT NEUR S, V95, P281; McNames J, 2002, 4 INT WORKSH BIOS IN, P303; Pattinson K, 2005, BJA EDUC, V5, P130, DOI 10.1093/bjaceaccp/mki035; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; URSINO M, 1988, ANN BIOMED ENG, V16, P379, DOI 10.1007/BF02364625; Weerakkody RA, 2009, HEAD INJURY: A MULTIDISCIPLINARY APPROACH, P87	22	10	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2015	79	1					85	90		10.1097/TA.0000000000000698			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	CL7LN	WOS:000357153700013	26091319				2022-02-06	
J	Chiaravalloti, ND; Dobryakova, E; Wylie, GR; DeLuca, J				Chiaravalloti, Nancy D.; Dobryakova, Ekaterina; Wylie, Glenn R.; DeLuca, John			Examining the Efficacy of the Modified Story Memory Technique (mSMT) in Persons With TBI Using Functional Magnetic Resonance Imaging (fMRI): The TBI-MEM Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							OF-THE-LITERATURE; COGNITIVE REHABILITATION; MULTIPLE-SCLEROSIS; PERFORMANCE; RETRIEVAL; DEFICITS; NETWORK; DEACTIVATIONS; ROLES	Background: New learning and memory deficits are common following traumatic brain injury (TBI). Yet few studies have examined the efficacy of memory retraining in TBI through the most methodologically vigorous randomized clinical trial. Our previous research has demonstrated that the modified Story Memory Technique (mSMT) significantly improves new learning and memory in multiple sclerosis. Methodology: The present double-blind, placebo-controlled, randomized clinical trial examined changes in cerebral activation on functional magnetic resonance imaging following mSMT treatment in persons with TBI. Eighteen individuals with TBI were randomly assigned to treatment (n = 9) or placebo (n = 9) groups. Results: Baseline and follow-up functional magnetic resonance imaging was collected during a list-learning task. Significant differences in cerebral activation from before to after treatment were noted in regions belonging to the default mode network and executive control network in the treatment group only. Results are interpreted in light of these networks. Conclusions: Activation differences between the groups likely reflect increased use of strategies taught during treatment. This study demonstrates a significant change in cerebral activation resulting from the mSMT in a TBI sample. Findings are consistent with previous work in multiple sclerosis. Behavioral interventions can show significant changes in the brain, validating clinical utility.	[Chiaravalloti, Nancy D.; Dobryakova, Ekaterina; Wylie, Glenn R.; DeLuca, John] Kessler Fdn, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; [Chiaravalloti, Nancy D.; Dobryakova, Ekaterina; Wylie, Glenn R.; DeLuca, John] Rutgers State Univ, Dept Phys Med & Rehabil, New Jersey Med Sch, Newark, NJ 07102 USA; [DeLuca, John] Rutgers State Univ, Dept Neurol, New Jersey Med Sch, Newark, NJ 07102 USA		Chiaravalloti, ND (corresponding author), Kessler Fdn, Neuropsychol & Neurosci Lab, 300 Execut Dr,Ste 70, W Orange, NJ 07052 USA.	nchiaravalloti@kesslerfoundation.org	Dobryakova, Ekaterina/ABD-2853-2021	Dobryakova, Ekaterina/0000-0002-6005-2115; Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute on Disability and Rehabilitation Research (NIDRR) [H133A070037, H133G090078]; Kessler Foundation; NIDRR [H133A070037, H133G090078]	The authors thank grant support from the National Institute on Disability and Rehabilitation Research (NIDRR) to N.D. Chiaravalloti (H133A070037 and H133G090078) and Kessler Foundation. The contents of this article were developed under the NIDRR grant # H133A070037 and H133G090078 to N.D. Chiaravalloti. However, these contents do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Government should not be assumed.	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chiaravalloti N, NEUROREHAB NEU UNPUB; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Chiaravalloti ND, 2012, J NEUROL, V259, P1337, DOI 10.1007/s00415-011-6353-x; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Diamond BJ, 1997, BRAIN, V120, P1015, DOI 10.1093/brain/120.6.1015; Dobryakova E, 2014, BRAIN IMAGING BEHAV, V8, P403, DOI 10.1007/s11682-014-9309-9; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Glosser G, 2002, NEUROPSYCHOLOGY, V16, P190, DOI 10.1037//0894-4105.16.2.190; Gould RL, 2006, NEUROIMAGE, V31, P818, DOI 10.1016/j.neuroimage.2005.12.045; Hinds O, 2013, J NEUROPHYSIOL, V109, P1250, DOI 10.1152/jn.00533.2011; Huijbers W, 2012, NEUROPSYCHOLOGIA, V50, P3764, DOI 10.1016/j.neuropsychologia.2012.08.021; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Jonides J, 2004, NAT NEUROSCI, V7, P10, DOI 10.1038/nn0104-10; Kim DY, 2010, AM J PHYS MED REHAB, V89, P879, DOI 10.1097/PHM.0b013e3181f70aa7; Kragel JE, 2015, CEREB CORTEX, V25, P667, DOI 10.1093/cercor/bht258; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Laatsch LK, 2004, BRAIN INJURY, V18, P957, DOI 10.1080/02699050410001672369; Lange G, 2000, ARCH PHYS MED REHAB, V81, P89, DOI 10.1016/S0003-9993(00)90227-2; Leavitt VM, 2014, BRAIN IMAGING BEHAV, V8, P394, DOI 10.1007/s11682-012-9183-2; Liu KPY, 2004, BRAIN INJURY, V18, P1163, DOI 10.1080/02699050410001671883; Maillet D, 2014, NEUROIMAGE, V89, P244, DOI 10.1016/j.neuroimage.2013.11.050; McDermott KB, 1999, MEMORY, V7, P661; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; McKinlay W, 1999, COGNITIVE BEHAV EFFE, P74; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Parisi L, 2014, MULT SCLER J, V20, P686, DOI 10.1177/1352458513505692; Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Rosenthal M, 2000, HDB REHABILITATION P; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Schacter D. L., 1990, NEUROPSYCHOLOGY EVER, P231; Schneider W., 2002, E PRIME REFERENCE GU; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5	47	10	10	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					261	269		10.1097/HTR.0000000000000164			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JA	WOS:000357944700004	26147316				2022-02-06	
J	Jacobs, CA; Christensen, CP; Karthikeyan, T				Jacobs, Cale A.; Christensen, Christian P.; Karthikeyan, Tharun			Chronic Non-Orthopedic Conditions More Common in Patients with Less Severe Degenerative Changes That Have Elected to Undergo Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						osteoarthritis; total knee arthroplasty; reoperation; complication; satisfaction	CENTRAL SENSITIZATION; SATISFACTION 2; PAIN; OSTEOARTHRITIS; REPLACEMENT; ARTHRITIS; JOINT	The purpose of this study was to determine whether the prevalence of chronic non-orthopedic conditions that may play a role in an abnormal pain response differs between patients based on the severity of degenerative changes at the time of surgery. Of 1020 OA knees that had undergone primary TKA with a minimum 2 year follow-up, we identified 117 (11.5%) that had less severe degenerative changes. The prevalence of dissatisfaction was significantly greater in less severe group compared to those with moderate or severe changes (18.8% vs. 9.3%, P = .003). Chronic non-orthopedic conditions were significantly more prevalent in the less severe group with 41.9% reporting depression/anxiety, 30.8% with fibromyalgia or low back pathology, and 12.8% with a prior traumatic brain injury or stroke. (C) 2015 Elsevier Inc. All rights reserved.	[Jacobs, Cale A.; Christensen, Christian P.; Karthikeyan, Tharun] Lexington Clin, Lexington, KY 40504 USA		Jacobs, CA (corresponding author), 700 Bob O Link Dr, Lexington, KY 40504 USA.						Alcelik I, 2012, KNEE SURG SPORT TR A, V20, P2502, DOI 10.1007/s00167-012-1944-3; [Anonymous], 2003, NIH CONSENS STATE SC, V20, P1; Bascuas I, 2013, ORTHOPEDICS, V36, pE6, DOI 10.3928/01477447-20121217-11; Burnett RSJ, 2013, CLIN ORTHOP RELAT R, V471, P264, DOI 10.1007/s11999-012-2528-8; Clauw DJ, 2009, ARTHRITIS RHEUM-US, V60, P321, DOI 10.1002/art.24326; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Jacobs CA, 2014, J ARTHROPLASTY, V29, P1576, DOI 10.1016/j.arth.2014.03.022; Jacobs CA, 2014, J ARTHROPLASTY, V29, P1189, DOI 10.1016/j.arth.2014.01.008; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; Keurentjes JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059500; Kim KW, 2011, J BONE JOINT SURG AM, V93A, P556, DOI 10.2106/JBJS.I.01344; Koralewicz LM, 2000, J BONE JOINT SURG AM, V82A, P1582, DOI 10.2106/00004623-200011000-00011; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Levinger P, 2011, KNEE SURG SPORT TR A, V19, P1082, DOI 10.1007/s00167-010-1325-8; Liu Z, 2011, J INT MED RES, V39, P1607, DOI 10.1177/147323001103900503; Malfait AM, 2013, NAT REV RHEUMATOL, V9, P654, DOI 10.1038/nrrheum.2013.138; Merle-Vincent F, 2011, JOINT BONE SPINE, V78, P383, DOI 10.1016/j.jbspin.2010.11.013; Schnurr C, 2013, INT ORTHOP, V37, P1257, DOI 10.1007/s00264-013-1862-0; Scott CEH, 2010, J BONE JOINT SURG BR, V92B, P1253, DOI 10.1302/0301-620X.92B9.24394; Thewlis D, 2014, KNEE SURG SPORT TR A, V22, P609, DOI 10.1007/s00167-013-2616-7; Victor J, 2014, CLIN ORTHOP RELAT R, V472, P263, DOI 10.1007/s11999-013-2997-4; Weiler HT, 2000, RHEUMATOLOGY, V39, P850, DOI 10.1093/rheumatology/39.8.850; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005; Zywiel MG, 2011, J BONE JOINT SURG AM, V93A, P1988, DOI 10.2106/JBJS.J.01473	26	10	10	0	2	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	JUL	2015	30	7					1146	1149		10.1016/j.arth.2015.01.051			4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	CK4HG	WOS:000356184300012	25702593				2022-02-06	
J	Kim, H; Jin, ST; Kim, YW; Kim, SR; Park, IS; Jo, KW				Kim, Hoon; Jin, Seon Tak; Kim, Young Woo; Kim, Seong Rim; Park, Ik Seong; Jo, Kwang Wook			Risk Factors for Early Hemorrhagic Progression after Traumatic Brain Injury: A Focus on Lipid Profile	JOURNAL OF NEUROTRAUMA			English	Article						brain contusion; hemorrhagic progression; smoking; traumatic brain injury; triglyceride	INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; CARDIOVASCULAR-DISEASE; CEREBRAL CONTUSIONS; CIGARETTE-SMOKING; HEAD TRAUMA; BLOOD-FLOW; STROKE; MICROBLEEDS; MEN	The purpose of this study was to identify the risk factors related to the hemorrhagic progression (HP) of brain contusion in patients after traumatic brain injury (TBI). Recently, many studies have reported abnormal lipid levels associated with hemorrhagic stroke. Unlike hemorrhage stroke, however, the lipid profiles in patients with TBI have not been examined. Therefore, we evaluated the risk factors of HP in patients with TBI and focused on lipid profiles. Fifty-six patients with TBI with mild to moderate injuries (Glasgow Coma Scale 9) who initially did not need surgical intervention were enrolled in this study. Patients underwent repeated computed tomography (CT) scans at 4h and 24h after injury. Magnetic resonance imaging (MRI) was performed 7 days after the initial injury. In each noncontrast CT scan, the hemorrhage volume was quantified using the ABC/2 technique. Clinical features, previous medical history, initial CT, and microbleeding on follow-up MRI were analyzed retrospectively. There were 31 (55%) patients in whom significant HP developed (volume >30%). Current smoking (p=0.034), higher initial systolic blood pressure (p=0.035), and lower triglyceride levels (p=0.039) were significantly associated with HP. Current smoking and a triglyceride (TG) level <150mg/dL were the only statistically significant predictors of HP in the multivariate analysis (p=0.019, p=0.021, respectively). HP with TBI is common in patients who currently smoke and have lower TG levels (150mg/dL). These patients should be monitored closely, and surgery may be considered before deterioration occurs.	[Kim, Hoon; Kim, Young Woo; Kim, Seong Rim; Park, Ik Seong; Jo, Kwang Wook] Catholic Univ Korea, Dept Neurosurg, Bucheon St Marys Hosp, Bucheon Si, Gyeonggi Do, South Korea; [Jin, Seon Tak] Pohang Stroke & Spine Hosp, Dept Neurosurg, Pohang, South Korea		Jo, KW (corresponding author), Catholic Univ Korea, Dept Neurosurg, Bucheon St Marys Hosp, Sosa Ro 327, Bucheon Si, Gyeonggi Do, South Korea.	jkw94@naver.com					Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Bonaventure A, 2010, ATHEROSCLEROSIS, V210, P243, DOI 10.1016/j.atherosclerosis.2009.10.043; BRUCKDORFER KR, 1969, BIOCHIM BIOPHYS ACTA, V183, P334, DOI 10.1016/0005-2736(69)90089-3; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Juvela S, 2001, STROKE, V32, P485, DOI 10.1161/01.STR.32.2.485; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kurth T, 2003, STROKE, V34, P1151, DOI [10.1161/01.STR.0000065200.93070.32, 10.1161/01.STR.0000100165.36466.95]; Kwon HM, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-8; Lim JB, 2009, J KOREAN NEUROSURG S, V46, P38, DOI 10.3340/jkns.2009.46.1.38; Nakaya N, 2005, CIRC J, V69, P1016, DOI 10.1253/circj.69.1016; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; Rosenson RS, 1998, ATHEROSCLEROSIS, V140, P271, DOI 10.1016/S0021-9150(98)00144-0; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; Suzuki K, 2011, CEREBROVASC DIS, V31, P100, DOI 10.1159/000321506; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; WANNAMETHEE G, 1994, J INTERN MED, V235, P163, DOI 10.1111/j.1365-2796.1994.tb01050.x; WANNAMETHEE SG, 1995, JAMA-J AM MED ASSOC, V274, P155; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Wieberdink RG, 2011, ARTERIOSCL THROM VAS, V31, P2982, DOI 10.1161/ATVBAHA.111.234948; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	33	10	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					950	955		10.1089/neu.2014.3697			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200003	25557755				2022-02-06	
J	Larson-Dupuis, C; Chamard, E; Falardeau, V; Frasnelli, J; Beaulieu, C; Poirier, J; Carrier, J; Lassonde, M; Theoret, H; Bacon, BA; De Beaumont, L				Larson-Dupuis, Camille; Chamard, Emilie; Falardeau, Viviane; Frasnelli, Johannes; Beaulieu, Christelle; Poirier, Judes; Carrier, Julie; Lassonde, Maryse; Theoret, Hugo; Bacon, Benoit-Antoine; De Beaumont, Louis			Impact of BDNF Val66Met polymorphism on olfactory functions of female concussed athletes	BRAIN INJURY			English	Article						Athletes; BDNF val66met; concussion; long-term effects; olfaction	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL PLAYERS; ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; RECURRENT CONCUSSION; ODOR IDENTIFICATION; COGNITIVE IMPAIRMENT; MEMORY PERFORMANCE; SPORTS CONCUSSION	Background: Concussions exert persistent effects on asymptomatic athletes, especially women. Among chief mechanisms of concussion recovery are alterations of neuronal plasticity. Olfactory function, often impaired following a concussion, greatly involves plasticity and, therefore, appears as a good candidate to study the deleterious effects of concussions. The BDNF Val66Met polymorphism (BDNFMet), which reduces availability of BDNF in the brain, has surprisingly been associated with better recovery following concussion. Objective: This study examines the mediating effect of BDNFMet on olfactory functions in asymptomatic concussed female athletes. Methods: Participants, 105 female university athletes, were divided into four groups based on their history of concussion (Concussion/No concussion) and BDNF polymorphism (BDNF Val66Val/Val66Met). Odour threshold, discrimination and identification were measured using the Sniffin' Sticks Inventory Test. Results: Concussed female BDNFMet athletes performed significantly better than BDNFVal counterparts on threshold (F(1, 34)=4.73, p<0.05), discrimination (F(1, 52)=5.36, p<0.05), identification tests (F(1, 521=5.65, p<0.05) and total olfactory scores (F(1, 34)=9.54, p<0.05). Conclusion: These results support a genotypic effect of the BDNF Val66Met polymorphism on long-term olfactory function following a concussion in young female athletes.	[Larson-Dupuis, Camille; Frasnelli, Johannes; Carrier, Julie; De Beaumont, Louis] Montreal Sacred Heart Hosp, Res Ctr, Montreal, PQ, Canada; [Larson-Dupuis, Camille; Chamard, Emilie; Frasnelli, Johannes; Carrier, Julie; Lassonde, Maryse; Theoret, Hugo] Univ Quebec Trois Rivieres, Dept Psychol, Res Ctr Neuropsychol & Cognit CERNEC, Trois Rivieres, PQ G9A 5H7, Canada; [Falardeau, Viviane; Bacon, Benoit-Antoine] Bishops Univ, Dept Psychol, Sherbrooke, PQ, Canada; [Frasnelli, Johannes] Univ Quebec Trois Rivieres, Dept Anat, Trois Rivieres, PQ G9A 5H7, Canada; [Beaulieu, Christelle; De Beaumont, Louis] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ G9A 5H7, Canada; [Poirier, Judes] Douglas Mental Hlth Univ Inst, Verdun, PQ, Canada		De Beaumont, L (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Michel Sarrazin Hall,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	louis.debeaumont@uqtr.ca	Meijer, Anna/K-5118-2016	Carrier, Julie/0000-0001-5311-2370; Theoret, Hugo/0000-0002-7458-8797; Frasnelli, Johannes/0000-0002-8863-3982	Bishop's Senate Research Committee; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec	The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper. This work was supported by the Bishop's Senate Research Committee (L.D.B., B.A.B.), the Canadian Institute of Health Research (L.D.B., M.L, H.T.) and the Fonds de la Recherche en Sante du Quebec (L.D.B., M.L., H.T., E.C.).	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2013, PSYCHOL SCI, V24, P1770, DOI 10.1177/0956797613480367; Farace E, 2000, Neurosurg Focus, V8, pe6; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hedner M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00024; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2013, NEUROSCIENCE, V237, P51, DOI [10.1016/J.neuroscience.2013.01.044, 10.1016/j.neuroscience.2013.01.044]; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P669; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Tonacci A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-57; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Zhang JJ, 2010, NEUROSCIENCE, V170, P259, DOI 10.1016/j.neuroscience.2010.06.002; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	62	10	10	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					963	970		10.3109/02699052.2015.1016452			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800024	25950261				2022-02-06	
J	Rismanchi, N; Gold, JJ; Sattar, S; Glaser, CA; Sheriff, H; Proudfoot, J; Mower, A; Crawford, JR; Nespeca, M; Wang, SG				Rismanchi, Neggy; Gold, Jeffrey J.; Sattar, Shifteh; Glaser, Carol A.; Sheriff, Heather; Proudfoot, James; Mower, Andrew; Crawford, John R.; Nespeca, Mark; Wang, Sonya G.			Epilepsy After Resolution of Presumed Childhood Encephalitis	PEDIATRIC NEUROLOGY			English	Article						Epilepsy; childhood; encephalitis; seizures	HERPES-SIMPLEX ENCEPHALITIS; ACUTE SYMPTOMATIC SEIZURE; TRAUMATIC BRAIN-INJURY; STATUS EPILEPTICUS; POSTTRAUMATIC SEIZURES; EPILEPTOGENESIS; RISK; PREVENTION; ETIOLOGIES; VALPROATE	OBJECTIVE: To evaluate factors associated with the development of epilepsy after resolution of presumed childhood encephalitis. METHODS: A total of 217 patients with suspected encephalitis who met criteria for the California Encephalitis Project were identified. Evaluable outcome information was available for 99 patients (40 girls, 59 boys, ages 2 months to 17 years) without preexisting neurological conditions, including prior seizures or abnormal brain magnetic resonance imaging scans. We identified factors correlated with the development of epilepsy after resolution of the acute illness. RESULTS: Development of epilepsy was correlated with the initial presenting sign of seizure (P < 0.001). With each additional antiepileptic drug used to control seizures, the odds ratio of developing epilepsy was increased twofold (P < 0.001). An abnormal electroencephalograph (P < 0.05) and longer hospital duration (median of 8 versus 21 days) also correlated with development of epilepsy (P < 0.01). The need for medically induced coma was associated with epilepsy (P < 0.001). Seizures in those patients were particularly refractory, often requiring longer than 24 hours to obtain seizure control. Individuals who required antiepileptic drugs at discharge (P < 0.001) or were readmitted after their acute illness (p < 0.001) were more likely to develop epilepsy. Of our patients who were able to wean antiepileptic drugs after being started during hospitalization, 42% were successfully tapered off within 6 months. CONCLUSIONS: Limited data are available on the risk of developing epilepsy after childhood encephalitis. This is the first study that not only identifies risk factors for the development of epilepsy, but also provides data regarding the success rate of discontinuing antiepileptic medication after resolution of encephalitis.	[Rismanchi, Neggy; Gold, Jeffrey J.; Sattar, Shifteh; Crawford, John R.; Nespeca, Mark; Wang, Sonya G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92123 USA; [Glaser, Carol A.; Sheriff, Heather] Calif Dept Publ Hlth, Richmond, CA USA; [Proudfoot, James] Univ Calif San Diego, Clin & Translat Res Inst, Biostat Unit, San Diego, CA 92123 USA; [Mower, Andrew] Childrens Hosp Orange Cty, Childrens Neurol Ctr, Orange, CA 92668 USA		Wang, SG (corresponding author), Univ Calif San Diego, Dept Neurosci, 3020 Childrens Way,MC 5009, San Diego, CA 92123 USA.	sgwang@ucsd.edu	Crawford, John/ABH-2134-2021	Wang, Sonya/0000-0003-4429-0508	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR000100]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000100] Funding Source: NIH RePORTER	This project was partially supported by the National Institutes of Health, Grant UL1TR000100.	ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; Barberio M, 2012, J CHILD NEUROL, V27, P721, DOI 10.1177/0883073811424941; Bortel A, 2010, NEUROBIOL DIS, V40, P478, DOI 10.1016/j.nbd.2010.07.015; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Elbers JM, 2007, PEDIATRICS, V119, pE399, DOI 10.1542/peds.2006-1494; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fodor PA, 1998, NEUROLOGY, V51, P554, DOI 10.1212/WNL.51.2.554; Forsgren L, 1996, EPILEPSIA, V37, P224, DOI 10.1111/j.1528-1157.1996.tb00017.x; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Gold JJ, 2013, RISK RECURRENT SEIZU; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; Hayashi K, 2007, PEDIATR NEUROL, V36, P366, DOI 10.1016/j.pediatrneurol.2007.02.012; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Kalita J, 2003, ARCH NEUROL-CHICAGO, V60, P1760, DOI 10.1001/archneur.60.12.1760; Kim SJ, 2001, PEDIATR NEUROL, V25, P217, DOI 10.1016/S0887-8994(01)00311-3; Libbey JE, 2008, EPILEPSIA, V49, P1066, DOI 10.1111/j.1528-1167.2008.01535.x; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Misra UK, 2009, SEIZURE-EUR J EPILEP, V18, P583, DOI 10.1016/j.seizure.2009.06.003; Pitkanen A, 2005, EPILEPSY RES, V63, P27, DOI 10.1016/j.eplepsyres.2004.10.003; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Sasaki J, 2014, J CHILD NEUROL, V29, P1638, DOI 10.1177/0883073813513069; Team RC, 2014, R LANG ENV STAT COMP; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thompson C, 2012, ARCH DIS CHILD, V97, P150, DOI 10.1136/archdischild-2011-300100	37	10	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	JUL	2015	53	1					65	72		10.1016/j.pediatrneurol.2015.03.016			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	DB4EE	WOS:000368465500009	26092415				2022-02-06	
J	Rosema, S; Muscara, F; Anderson, V; Godfrey, C; Hearps, S; Catroppa, C				Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Hearps, Stephen; Catroppa, Cathy			The Trajectory of Long-Term Psychosocial Development 16 Years following Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						childhood traumatic brain injury; developmental trajectories; psychosocial development; young adults	1ST 6 MONTHS; PSYCHIATRIC-DISORDERS; SELF-REGULATION; FUNCTIONAL RECOVERY; YOUNG-CHILDREN; HEAD-INJURY; ADOLESCENTS; PREDICTORS; OUTCOMES; DEPRESSION	Childhood traumatic brain injury (CTBI) is one of the most common causes of impairment in children and adolescents, with psychosocial difficulties found to be the most persisting. Given that the transition into adolescence and adulthood can be a stressful period, it is likely that young people who have sustained a CTBI will be more vulnerable to developing psychosocial problems. To date, most research has focused on psychosocial development up to five years following a CTBI and it is unclear how survivors develop in the long-term as young adults. The aim of this research was to track the long-term psychosocial outcomes of children with CTBI and compare them with healthy controls over a period of 16 years. Seventy-five participants with a CTBI and 29 control participants were followed up at five time-points over a period of 16 years. To measure psychosocial functioning (social skills, internalizing, and externalizing symptoms), questionnaires were completed by the primary caregiver acutely (pre-injury baseline), then six months, five years, 10 years, and 16 years post-injury. No significant group differences were found regarding the developmental trajectory of social skills, or internalizing and externalizing symptoms between the CTBI and control groups. The severe CTBI group demonstrated a trend of lower social skills, while the mild CTBI group showed a trend of higher internalizing and externalizing skills at six months, five years, and ten years post-CTBI event, compared with other groups. The mild CTBI group scored in the borderline range for externalizing symptoms six months post-CTBI; however, all other mean scores were within the normal range. Over a period of 16 years, young adults with CTBI showed similar developmental trajectories regarding psychosocial outcomes, compared with healthy controls. This study confirmed previous literature that CTBI is associated with increased levels of psychosocial problems.	[Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Hearps, Stephen; Catroppa, Cathy] Murdoch Childrens Res Inst, Dept Child Neuropsychol, Melbourne, Vic, Australia; [Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic, Australia		Rosema, S (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Child Neuropsychol, Flemington Rd,4th Floor West, Parkville, Vic, Australia.	stefanie.rosema@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021; Hearps, Stephen/L-6853-2016	Catroppa, Cathy/0000-0002-9750-0436; Hearps, Stephen/0000-0003-2984-1172	Victorian Neurotrauma Initiative (VNI); National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; NHMRC Career Development AwardNational Health and Medical Research Council of Australia; Victorian Government Operational Infrastructure Scheme	This study was supported by the Victorian Neurotrauma Initiative (VNI), a National Health and Medical Research Council (NHMRC) Fellowship (to V.A.), a NHMRC Career Development Award (to C.C.), and the Victorian Government Operational Infrastructure Scheme.	Achenbach TM., 2003, MANUAL ASEBA ADULT F; Anderson V., 2012, DEV SOCIAL NEUROSCIE, P3; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; Daniel A., 1983, POWER PRIVILEGE PRES; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; HAYWARD C, 1992, AM J PSYCHIAT, V149, P1239; IBM C, 2011, IBM SPSS STAT WIND V; Lachar D., 1992, PERSONALITY INVENTOR; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Max J. E., 2012, DEV SOCIAL NEUROSCIE; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, NEUROCASE, V3, P119; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1998, BRAIN INJURY, V12, P41; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Noller, 1988, ICPS FAMILY FUNCTION; Peters SAE, 2012, J CLIN EPIDEMIOL, V65, P686, DOI 10.1016/j.jclinepi.2011.11.012; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Rubin K. H., 2012, DEV SOCIAL NEUROSCIE; Rutherford R. B., 2004, HDB RES EMOTIONAL BE; SUSMAN EJ, 1985, J YOUTH ADOLESCENCE, V14, P245, DOI 10.1007/BF02090322; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	48	10	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					976	983		10.1089/neu.2014.3567			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200006	25590265				2022-02-06	
J	Slotty, PJ; Kamp, MA; Beez, T; Beenen, H; Steiger, HJ; Turowski, B; Hanggi, D				Slotty, Philipp Joerg; Kamp, Marcel Alexander; Beez, Thomas; Beenen, Henrieke; Steiger, Hans-Jakob; Turowski, Bernd; Haenggi, Daniel			The influence of decompressive craniectomy for major stroke on early cerebral perfusion	JOURNAL OF NEUROSURGERY			English	Article						stroke; decompressive craniectomy; cerebral perfusion; traumatic brain injury	ACUTE ISCHEMIC-STROKE; LOBAR INTRACEREBRAL HEMORRHAGE; ACUTE HEMISPHERIC STROKE; ARTERY INFARCTION; PERIHEMORRHAGIC PERFUSION; SUBARACHNOID HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; SURGICAL DECOMPRESSION; MALIGNANT INFARCTION; CT PERFUSION	OBJECT Multiple trials have shown improved survival and functional outcome in patients treated with decompressive craniectomy (DC) for brain swelling following major stroke. It has been assumed that decompression induces an improvement in cerebral perfusion. This observational study directly measured cerebral perfusion before and after decompression. METHODS Sixteen patients were prospectively examined with perfusion CT within 6 hours prior to surgery and 12 hours after surgery. Preoperative and postoperative perfusion measurements were compared and correlated. RESULTS Following DC there was a significant increase in cerebral blood flow in all measured territories and additionally an increase in cerebral blood volume in the penumbra (p = 0.03). These changes spread as far as the contralateral hemisphere. No significant changes in mean transit time or Tmax (time-to-peak residue function) were observed. CONCLUSIONS The presurgical perfusion abnormalities likely reflected local pressure-induced hypoperfusion with impaired autoregulation. The improvement in perfusion after decompression implied an increase in perfusion pressure, likely linked to partial restoration of autoregulation. The increase in perfusion that was observed might partially be responsible for improved clinical outcome following decompressive surgery for major stroke. The predictive value of perfusion CT on outcome needs to be evaluated in larger trials.	[Slotty, Philipp Joerg; Kamp, Marcel Alexander; Beez, Thomas; Beenen, Henrieke; Steiger, Hans-Jakob; Haenggi, Daniel] Univ Dusseldorf, Fac Med, Dept Neurosurg, Dusseldorf, Germany; Univ Dusseldorf, Dept Neuroradiol, Fac Med, Dusseldorf, Germany; [Slotty, Philipp Joerg; Turowski, Bernd] Univ British Columbia, Dept Surg, Div Neurosurg, Vancouver, BC V6T 1W5, Canada		Slotty, PJ (corresponding author), Vancouver Gen Hosp, Gordon & Leslie Diamond Hlth Care Ctr, 8101-2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.	philipp.slotty@med.uni-duesseldorf.de	Steiger, Hans-Jakob/AAN-8307-2021; Beez, Thomas/ABG-7004-2021	Steiger, Hans-Jakob/0000-0002-8249-2998; Beez, Thomas/0000-0002-8715-5237; Kamp, Marcel/0000-0002-1252-2944			Amorim RL, 2014, STROKE, V45, P1375, DOI 10.1161/STROKEAHA.113.003670; Bendszus M, 2003, EUR RADIOL, V13, P1895, DOI 10.1007/s00330-002-1656-z; Beseoglu K, 2014, NEURORADIOLOGY, V56, P535, DOI 10.1007/s00234-014-1371-x; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Doerfler A, 2002, J NEUROSURG, V96, P933, DOI 10.3171/jns.2002.96.5.0933; Engelhorn T, 2003, NEUROSCI LETT, V344, P127, DOI 10.1016/S0304-3940(03)00441-5; Etminan N, 2013, STROKE, V44, P1260, DOI 10.1161/STROKEAHA.111.675975; Etminan N, 2012, STROKE, V43, P759, DOI 10.1161/STROKEAHA.111.616730; Ford AL, 2014, TRANSL STROKE RES, V5, P415, DOI 10.1007/s12975-014-0325-2; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Juttler E, 2011, STROKE, V42, P843, DOI 10.1161/STROKEAHA.110.603597; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kan P, 2010, WORLD NEUROSURG, V74, P550, DOI 10.1016/j.wneu.2010.10.012; Kilincer C, 2005, ACTA NEUROCHIR, V147, P587, DOI 10.1007/s00701-005-0493-7; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; LARTAUD I, 1993, AM J PHYSIOL, V264, pH851, DOI 10.1152/ajpheart.1993.264.3.H851; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; Molina CA, 2011, STROKE, V42, P847, DOI 10.1161/STROKEAHA.110.603613; SAUNDERS DE, 1995, STROKE, V26, P1007, DOI 10.1161/01.STR.26.6.1007; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Turk A, 2012, J NEUROINTERV SURG, V4, P261, DOI 10.1136/neurintsurg-2011-010067; Turowski B, 2007, ROFO-FORTSCHR RONTG, V179, P847, DOI 10.1055/s-2007-963197; Turowski B, 2007, ROFO-FORTSCHR RONTG, V179, P525, DOI 10.1055/s-2007-962853; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van der Worp HB, 2011, STROKE, V42, P845, DOI 10.1161/STROKEAHA.110.603605; Vertinsky P, 2007, CAN BULL MED HIST, V24, P291, DOI 10.3138/cbmh.24.2.291; Vibbert Matthew, 2010, Curr Neurol Neurosci Rep, V10, P1, DOI 10.1007/s11910-009-0081-y; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; WOLLNER L, 1979, BRIT MED J, V1, P1117, DOI 10.1136/bmj.1.6171.1117	33	10	11	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2015	123	1					59	64		10.3171/2014.12.JNS141250			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CL5DY	WOS:000356981200008	25635482				2022-02-06	
J	Watts, LT; Long, JA; Manga, VH; Huang, SL; Shen, Q; Duong, TQ				Watts, Lora Talley; Long, Justin Alexander; Manga, Venkata Hemanth; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.			Normobaric oxygen worsens outcome after a moderate traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						MRI; normobaric oxygen; mitochondria; oxidative stress; TBI; vasogenic edema	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; TIME-COURSE; METABOLISM; HYPEROXIA; ISCHEMIA; TISSUE; IMPROVEMENT; REDUCTION	Traumatic brain injury (TBI) is a multifaceted injury and a leading cause of death in children, young adults, and increasingly in Veterans. However, there are no neuroprotective agents clinically available to counteract damage or promote repair after brain trauma. This study investigated the neuroprotective effects of normobaric oxygen (NBO) after a controlled cortical impact in rats. The central hypothesis was that NBO treatment would reduce lesion volume and functional deficits compared with air-treated animals after TBI by increasing brain oxygenation thereby minimizing ischemic injury. In a randomized double-blinded design, animals received either NBO (n = 8) or normal air (n = 8) after TBI. Magnetic resonance imaging (MRI) was performed 0 to 3 hours, and 1, 2, 7, and 14 days after an impact to the primary forelimb somatosensory cortex. Behavioral assessments were performed before injury induction and before MRI scans on days 2, 7, and 14. Nissl staining was performed on day 14 to corroborate the lesion volume detected from MRI. Contrary to our hypothesis, we found that NBO treatment increased lesion volume in a rat model of moderate TBI and had no positive effect on behavioral measures. Our results do not promote the acute use of NBO in patients with moderate TBI.	[Watts, Lora Talley; Long, Justin Alexander; Manga, Venkata Hemanth; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, San Antonio, TX USA		Watts, LT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	wattsl@uthscsa.edu	Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021	Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45879]; TL1 grant via Clinical Translational Science Awards (CTSA); Clinical Translational Science Awards (CTSA) [KL2 TR001118, 8UL1TR000149, TL1TR001119]; UTHSCSA; NIH/NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA54174]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG19316]; CTSA KL2 [TR001118]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001118, UL1TR001120, TL1TR001119, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG019316] Funding Source: NIH RePORTER	This work was supported in part by NIH/NINDS R01 NS45879 (TQD), a TL1 grant (JAL) and KL2 TR001118 (LTW) via the Clinical Translational Science Awards (CTSA, parent grant 8UL1TR000149 and TL1TR001119). Immunohistochemical images were generated in the Core Optical Imaging Facility, which is supported by UTHSCSA, NIH/NCI P30CA54174, and NIH/NIA P01AG19316. This work was supported by the CTSA KL2 (TR001118).	Adelson PD, 1998, ACT NEUR S, V71, P104; Bardt TF, 1998, ACT NEUR S, V71, P153; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Center for Disease Control and Prevention Injury Prevention and Control, TRAUMATIC BRAIN INJU; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Kuroiwa T, 2000, ACT NEUR S, V76, P191; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Long JA, 2014, J NEUROTRAUM, V31, pA27; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Muthuraju S, 2013, J BIOSCIENCES, V38, P93, DOI 10.1007/s12038-012-9290-7; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shen Q, 2003, J CEREBR BLOOD F MET, V23, P1479, DOI 10.1097/01.WCB.0000100064.36077.03; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Wang XD, 2001, GENE DEV, V15, P2922; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	40	10	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2015	35	7					1137	1144		10.1038/jcbfm.2015.18			8	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CL7FI	WOS:000357137500011	25690469	Green Published, Bronze			2022-02-06	
J	Tung, YC; Tu, HP; Tsai, WC; Chen, CS; Su, CH; Shi, HY; Lin, CL				Tung, Yi-Ching; Tu, Hung-Pin; Tsai, Wen-Chan; Chen, Cheng-Sheng; Su, Chen-Hsiang; Shi, Hon-Yi; Lin, Chih-Lung			Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							NUTRITIONAL FACTORS; UNITED-STATES; RISK-FACTORS; EPIDEMIOLOGY; PERSPECTIVE; VACCINATION; DISEASE; IMPACT; COHORT; COSTS	The aims of this study were to estimate the incidences of herpes zoster (HZ) and postherpetic neuralgia (PHN) in patients after traumatic brain injury (TBI). Furthermore, we aimed to explore the risk factors of the development of HZ and PHN in patients after TBI. This population-based, longitudinal analysis was conducted using the Taiwan National Health Insurance Research Database (consisting of 1,000,000 beneficiaries) from 1996 to 2010. Using the longitudinal National Health Insurance Research Database, we conducted a retrospective population-based cohort study to evaluate the incidence of HZ and PHN in adult TBI patients and controls. Kaplan-Meier analysis and Cox regression were used to compare differences in the development of HZ and PHN. The effects of gender, comorbidity and surgery on the risk of HZ and PHN development were assessed by subgroup analyses. Over a 15-year follow-up, the cumulative incidence of HZ in 28,234 TBI patients (604.00/100,000 person-years) was significantly higher than 34,085 controls (322.21/100,000 person-years) (P<0.0001, by log-rank test). Females showed a significantly higher incidence of HZ than males (p for interaction = 0.0010). The time to HZ development in the follow-up period was 5.9 years in TBI patients compared to 9.9 years in the control set (p <0.0001). TBI patients were 2.93 and 2.11 times likely to develop HZ and PHN, respectively, than the general population. The incidences of HZ and PHN in TBI patients were also significantly greater than for controls in the CCI = 0 subgroup. To our knowledge, this is the first population-based cohort study to reveal that TBI is an independent risk factor for HZ and PHN in TBI patients, especially in females. Physician should pay attention to the possibility of HZ and PHN in TBI patients and be aware that HZ vaccination early after brain trauma may lower the incidence of HZ and PHN.	[Tung, Yi-Ching; Tu, Hung-Pin] Kaohsiung Med Univ, Dept Publ Hlth & Environm Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Wen-Chan] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Cheng-Sheng; Su, Chen-Hsiang] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Shi, Hon-Yi] Kaohsiung Med Univ Hosp, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan		Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan.	chihlung1@yahoo.com		Tu, Hung-Pin/0000-0003-1044-2673			Araujo Lara Quirino, 2007, Herpes, V14 Suppl 2, P40; Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091; Asadullah K, 1995, Eur J Emerg Med, V2, P184, DOI 10.1097/00063110-199512000-00003; ASADULLAH K, 1995, CRIT CARE MED, V23, P1976, DOI 10.1097/00003246-199512000-00006; Borkar DS, 2013, OPHTHALMOLOGY, V120, P451, DOI 10.1016/j.ophtha.2012.09.007; Chen JY, 2013, INT J EPIDEMIOL, V42, P1873, DOI 10.1093/ije/dyt213; Chen JY, 2012, POPUL HEALTH MANAG, V15, P391, DOI 10.1089/pop.2012.1563; Chen JY, 2009, CLIN J PAIN, V25, P562, DOI 10.1097/AJP.0b013e318193cf32; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Hata A, 2011, INFECTION, V39, P537, DOI 10.1007/s15010-011-0162-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Kinchington Paul R, 2012, Herpesviridae, V3, P5, DOI 10.1186/2042-4280-3-5; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Lesourd B, 2006, P NUTR SOC, V65, P319, DOI 10.1079/PNS2006507; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Opstelten W, 2009, VACCINE, V27, P192, DOI 10.1016/j.vaccine.2008.10.047; Vila MP, 2014, NUTR HOSP, V29, P3, DOI 10.3305/nh.2014.29.1.6934; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; SCHMADER K, 1995, J INFECT DIS, V171, P701, DOI 10.1093/infdis/171.3.701; Schmader KE, 2002, CLIN J PAIN, V18, P350, DOI 10.1097/00002508-200211000-00002; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wung Peter K, 2005, Am J Med, V118, P1416, DOI 10.1016/j.amjmed.2005.06.012; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137; Yawn BP, 2009, MAYO CLIN PROC, V84, P787, DOI [10.4065/84.9.787, 10.1016/S0025-6196(11)60488-6]	41	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2015	10	6							e0129043	10.1371/journal.pone.0129043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK3FB	WOS:000356100900040	26065420	Green Published, gold			2022-02-06	
J	Chaieb, L; Antal, A; Masurat, F; Paulus, W				Chaieb, Leila; Antal, Andrea; Masurat, Florentin; Paulus, Walter			Neuroplastic effects of transcranial near-infrared stimulation (tNIRS) on the motor cortex	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						neuroplasticity; transcranial near-infrared laser light stimulation; brain; learning; human	LOW-LEVEL LASER; TERM NEUROLOGICAL DEFICITS; TRAUMATIC BRAIN-INJURY; CORTICAL EXCITABILITY; MAGNETIC STIMULATION; PYRAMIDAL NEURONS; LIGHT THERAPY; STROKE; INHIBITION; CELLS	Near-infrared light stimulation of the brain has been claimed to improve deficits caused by traumatic brain injury and stroke. Here, we exploit the effect of transcranial near-infrared stimulation (tNIRS) as a tool to modulate cortical excitability in the healthy human brain. tNIRS was applied at a wavelength of 810 nm for 10 min over the hand area of the primary motor cortex (M1). Both single-pulse and paired-pulse measures of transcranial magnetic stimulation (TMS) were used to assess levels of cortical excitability in the corticospinal pathway and intracortical circuits. The serial reaction time task (SRTT) was used to investigate the possible effect of tNIRS on implicit learning. By evaluating the mean amplitude of single-pulse TMS elicited motor-evoked-potentials (MEPs) a significant decrease of the amplitude was observed up to 30 min post-stimulation, compared to baseline. Furthermore, the short interval cortical inhibition (SICI) was increased and facilitation (ICF) decreased significantly after tNIRS. The results from the SRTT experiment show that there was no net effect of stimulation on the performance of the participants. Results of a study questionnaire demonstrated that tNIRS did not induce serious side effects apart from light headache and fatigue. Nevertheless, 66% were able to detect the difference between active and sham stimulation conditions. In this study we provide further evidence that tNIRS is suitable as a tool for influencing cortical excitability and activity in the healthy human brain.	[Chaieb, Leila; Antal, Andrea; Masurat, Florentin; Paulus, Walter] Univ Gottingen, Dept Clin Neurophysiol, D-37075 Gottingen, Germany; [Chaieb, Leila] Univ Bonn, Dept Epileptol, Bonn, Germany		Antal, A (corresponding author), Univ Gottingen, Dept Clin Neurophysiol, Robert Koch Str 40, D-37075 Gottingen, Germany.	aantal@gwdg.de	Paulus, Walter/A-3544-2009	Paulus, Walter/0000-0001-5549-8377	German Research FoundationGerman Research Foundation (DFG); University of Gottingen	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the University of Gottingen. We would like to thank Dr. G. G. Ambrus for his technical assistance, to Suhaidah Jofrry for executing the control experiments, and Alexander Opitz for the theoretical comments. We would also like to thank Dr. M. Weber of WeberMedical, GmbH for providing the stimulation equipment.	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; BLOMFIELD S, 1974, BRAIN RES, V69, P115, DOI 10.1016/0006-8993(74)90375-8; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bozkurt A, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-9; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305; Gur AY, 2007, CLIN NEUROL NEUROSUR, V109, P317, DOI 10.1016/j.clineuro.2006.12.008; Haiyan Li, 2007, International Journal of Vehicle Safety, V2, P345, DOI 10.1504/IJVS.2007.016747; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hao J, 2009, P NATL ACAD SCI USA, V106, P21906, DOI 10.1073/pnas.0912022106; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hashmi JT, 2010, LASER SURG MED, V42, P450, DOI 10.1002/lsm.20950; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Iino M, 2006, J PHARMACOL SCI, V100, P538, DOI 10.1254/jphs.CPJ06006X; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KARU T, 1989, Journal of Photochemistry and Photobiology B Biology, V3, P638, DOI 10.1016/1011-1344(89)80088-0; KARU TI, 1987, IEEE J QUANTUM ELECT, V23, P1703, DOI 10.1109/JQE.1987.1073236; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Konstantinovic LM, 2013, LASER SURG MED, V45, P648, DOI 10.1002/lsm.22190; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Le Roux N, 2008, EUR J NEUROSCI, V27, P3244, DOI 10.1111/j.1460-9568.2008.06288.x; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Litscher D, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/575798; Litscher G, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/128721; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Moliadze V, 2012, BRAIN STIMUL, V5, P505, DOI 10.1016/j.brs.2011.11.004; Moliadze V, 2010, J PHYSIOL-LONDON, V588, P4891, DOI 10.1113/jphysiol.2010.196998; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Rothwell JC, 1999, EEG CL N SU, P113; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Sommer AP, 2012, PHOTOMED LASER SURG, V30, P54, DOI 10.1089/pho.2011.3073; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Strangman GE, 2014, NEUROIMAGE, V85, P136, DOI 10.1016/j.neuroimage.2013.04.090; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; VALLSSOLE J, 1992, ELECTROEN CLIN NEURO, V85, P355, DOI 10.1016/0168-5597(92)90048-G; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009; Ziemann U, 1998, ELECTROMYOGR MOTOR C, V109, P321, DOI 10.1016/S0924-980X(98)00023-X; Zivin JA, 2014, INT J STROKE, V9, P950, DOI 10.1111/j.1747-4949.2012.00896.x	52	10	10	1	19	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUN 2	2015	9						1	8	147	10.3389/fnbeh.2015.00147			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CL2PN	WOS:000356786600001	26082699	Green Published, gold			2022-02-06	
J	Heuer, L; Beyerbach, M; Luhder, F; Beineke, A; Strube, C				Heuer, Lea; Beyerbach, Martin; Luehder, Fred; Beineke, Andreas; Strube, Christina			Neurotoxocarosis alters myelin protein gene transcription and expression	PARASITOLOGY RESEARCH			English	Article						Toxocara canis; Toxocara cati; Larva migrans; Demyelination; Myelin protein transcription; Parasitic neuroinfection	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TOXOCARA-CANIS LARVAE; CEREBRAL TOXOCARIASIS; MULTIPLE-SCLEROSIS; BASIC-PROTEIN; BALB/C MICE; ADULT HUMAN; MOUSE; REMYELINATION	Neurotoxocarosis is an infection of the central nervous system caused by migrating larvae of the common dog and cat roundworms (Toxocara canis and Toxocara cati), which are zoonotic agents. As these parasites are prevalent worldwide and neuropathological and molecular investigations on neurotoxocarosis are scare, this study aims to characterise nerve fibre demyelination associated with neurotoxocarosis on a molecular level. Transcription of eight myelin-associated genes (Cnp, Mag, Mbp, Mog, Mrf-1, Nogo-A, Plp1, Olig2) was determined in the mouse model during six time points of the chronic phase of infection using qRT-PCR. Expression of selected proteins was analysed by Western blotting or immunohistochemistry. Additionally, demyelination and neuronal damage were investigated histologically. Significant differences (p a parts per thousand currency signaEuro parts per thousand 0.05) between transcription rates of T. canis-infected and uninfected control mice were detected for all analysed genes while T. cati affected five of eight investigated genes. Interestingly, 2', 3 A '-cyclic nucleotide 3'-phosphodiesterase (Cnp) and myelin oligodendrocyte glycoprotein (Mog) were upregulated in both T. canis- and T. cati-infected mice preceding demyelination. Later, CNPase expression was additionally enhanced. As expected, myelin basic protein (Mbp) was downregulated in cerebra and cerebella of T. canis-infected mice when severe demyelination was present 120 days post infectionem (dpi). The transcriptional pattern observed in the present study appears to reflect direct traumatic and hypoxic effects of larval migration as well as secondary processes including host immune reactions, demyelination and attempts to remyelinate damaged areas.	[Heuer, Lea; Strube, Christina] Univ Vet Med Hannover, Inst Parasitol, D-30559 Hannover, Germany; [Beyerbach, Martin] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, D-30559 Hannover, Germany; [Luehder, Fred] Hertie Fdn, Dept Neuroimmunol, Inst Multiple Sclerosis Res, D-37073 Gottingen, Germany; [Luehder, Fred] Univ Gottingen, Sch Med, Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Beineke, Andreas] Univ Vet Med Hannover, Dept Pathol, D-30559 Hannover, Germany		Strube, C (corresponding author), Univ Vet Med Hannover, Inst Parasitol, Buenteweg 17, D-30559 Hannover, Germany.	christina.strube@tiho-hannover.de		Strube, Christina/0000-0002-9093-1006	Society of Friends of the University of Veterinary Medicine Hannover ["Gesellschaft der Freunde der Tierarztlichen Hochschule Hannover" (GdF)]; Hannover Graduate School for Veterinary Pathobiology, Neuroinfectiology and Translational Medicine (HGNI)	The authors thank Annika Lehmbecker, PhD, for valuable support in histological photography and Bettina Buck, Petra Grunig and Sabine Handel for excellent technical assistance. Furthermore, the PhD grants of the Society of Friends of the University of Veterinary Medicine Hannover ["Gesellschaft der Freunde der Tierarztlichen Hochschule Hannover" (GdF)] and the Hannover Graduate School for Veterinary Pathobiology, Neuroinfectiology and Translational Medicine (HGNI) for LH are gratefully acknowledged.	Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BEAUTYMAN W, 1951, J PATHOL BACTERIOL, V63, P635, DOI 10.1002/path.1700630410; BEAVER PAUL C., 1956, EXPTL PARASITOL, V5, P587, DOI 10.1016/0014-4894(56)90032-7; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Cardillo N, 2009, ZOONOSES PUBLIC HLTH, V56, P198, DOI 10.1111/j.1863-2378.2008.01182.x; DOLINSKY ZS, 1985, PHYSIOL BEHAV, V35, P33, DOI 10.1016/0031-9384(85)90168-4; Dousset V, 2003, J Radiol, V84, P89; EPE C, 1994, PARASITOL RES, V80, P691, DOI 10.1007/BF00932955; Fatemi SH, 2006, NEUROPSYCHOPHARMACOL, V31, P1888, DOI 10.1038/sj.npp.1301002; Finsterer Josef, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P279, DOI 10.1590/S0036-46652007000500002; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; FORTENBERRY JD, 1991, PEDIATR INFECT DIS J, V10, P403, DOI 10.1097/00006454-199105000-00011; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; GOULD IM, 1985, BRIT MED J, V291, P1239, DOI 10.1136/bmj.291.6504.1239; Gregersen R, 2001, EXP BRAIN RES, V138, P384, DOI 10.1007/s002210100715; Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230; HAQUE NS, 1994, J BIOL CHEM, V269, P31149; HAVASIOVAREITEROVA K, 1995, PARASITOL RES, V81, P13, DOI 10.1007/BF00932411; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Huang K, 2008, HUM GENET, V122, P659, DOI 10.1007/s00439-007-0434-z; Israelsson C, 2014, RESTOR NEUROL NEUROS, V32, P717, DOI 10.3233/RNN-140419; Janecek E, 2015, INT J PARAS IN PRESS; Janecek E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-194; Kayes SG, 1997, CHEM IMMUNOL, V66, P99; Knoferle J, 2010, NEUROBIOL DIS, V38, P395, DOI 10.1016/j.nbd.2010.02.011; Kolbekova P, 2011, PARASITOL RES, V109, P1267, DOI 10.1007/s00436-011-2371-y; Kuhlmann T, 2010, BIOL OLIGODENDROCYTE, V1st, P171; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Laabs EM, 2012, PARASITOL RES, V110, P1249, DOI 10.1007/s00436-011-2622-y; Liao CW, 2008, PARASITE IMMUNOL, V30, P525, DOI 10.1111/j.1365-3024.2008.01048.x; Liao CW, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-84; Lin KY, 2009, J COMP PATHOL, V141, P248, DOI 10.1016/j.jcpa.2009.05.006; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Mikhael N Z, 1974, Can J Neurol Sci, V1, P114; Moreira-Silva Sandra F., 2004, Rev. Soc. Bras. Med. Trop., V37, P169, DOI 10.1590/S0037-86822004000200011; Morell P, 1998, MOL CELL NEUROSCI, V12, P220, DOI 10.1006/mcne.1998.0715; Nicoletti Alessandra, 2013, Handb Clin Neurol, V114, P217, DOI 10.1016/B978-0-444-53490-3.00016-9; PROKOPIC J, 1982, FOLIA PARASIT, V29, P309; Richartz E, 2002, NERVENARZT, V73, P458, DOI 10.1007/s001150001028; RUSSEGGER L, 1989, LANCET, V2, P398; SCHANTZ P M, 1989, American Journal of Tropical Medicine and Hygiene, V41, P21; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Sick C, 2014, CASE REP NEUROL, V6, P259, DOI 10.1159/000369060; SOMMER C, 1994, J NEUROL NEUROSUR PS, V57, P229, DOI 10.1136/jnnp.57.2.229; Sondergaard HP, 2004, MED HYPOTHESES, V63, P59, DOI 10.1016/j.mehy.2004.02.014; Targett MP, 1996, NEUROPATH APPL NEURO, V22, P199; Verrier JD, 2013, GLIA, V61, P1595, DOI 10.1002/glia.22523; Villano M, 1992, J Neurosurg Sci, V36, P67; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Yang LJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0148-9; Zhao C, 2005, J ANAT, V207, P251, DOI 10.1111/j.1469-7580.2005.00456.x	54	10	10	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	JUN	2015	114	6					2175	2186		10.1007/s00436-015-4407-1			12	Parasitology	Science Citation Index Expanded (SCI-EXPANDED)	Parasitology	CI0CT	WOS:000354404100016	25773181				2022-02-06	
J	Klose, M; Stochholm, K; Janukonyte, J; Christensen, LL; Cohen, AS; Wagner, A; Laurberg, P; Christiansen, JS; Andersen, M; Feldt-Rasmussen, U				Klose, Marianne; Stochholm, Kirstine; Janukonyte, Jurgita; Christensen, Louise Lehman; Cohen, Arieh S.; Wagner, Aase; Laurberg, Peter; Christiansen, Jens Sandahl; Andersen, Marianne; Feldt-Rasmussen, Ulla			Patient reported outcome in posttraumatic pituitary deficiency: results from The Danish National Study on posttraumatic hypopituitarism	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; TESTOSTERONE LEVELS; BINDING GLOBULIN; BODY-COMPOSITION; PAIN; DEPRESSION; FATIGUE; MEN	Objective: Posttraumatic pituitary hormone deficiency is often suggested. The impact of these predominantly mild and often irreproducible deficiencies on outcome is less clear. The aim of the present study was to describe patient reported outcome in a national a priori unselected cohort of patients with traumatic brain injury (TBI) in relation to deficiencies identified upon pituitary assessment. Design and methods: We conducted a nationwide population-based cohort study. Participants were Danish patients with a head trauma diagnosis recorded in the Danish Board of Health diagnostic code registry; 439 patients (and 124 healthy controls) underwent assessment of anterior pituitary function 2.5 years (median) after TBI. Questionnaires on health-related quality of life (QoL) (SF36, EuroQoL-5D, QoL assessment of GH deficiency in adults) and fatigue (MFI-20) were completed in parallel to pituitary assessment. Results: Patients with TBI had significant detriments in QoL. Impairment (mainly physical scales) related to pituitary deficiency, although only partially confirmed after adjustment for demographic differences. Hypogonadotropic hypogonadism related to several QoL scores. Increasing impairments were observed with declining total testosterone concentrations (men), but not free testosterone concentrations or any other hormone concentrations. Total testosterone was not independently related to impaired QoL and fatigue, after adjustment for demographics, and treatment with antidiabetics, opioids, antidepressants, and anticonvulsants. Conclusions: Only a very limited relationship between pituitary hormone deficiencies and QoL/fatigue was demonstrated. Due to the dominating influence of concurrent comorbidities, pituitary deficiencies were not independently related to QoL/fatigue. Causality is still to be shown, and whether substitution therapy could be of additional relevance in selected patients needs to be proven.	[Klose, Marianne; Feldt-Rasmussen, Ulla] Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol, PE2131, DK-2100 Copenhagen, Denmark; [Stochholm, Kirstine; Janukonyte, Jurgita; Christiansen, Jens Sandahl] Aarhus Univ Hosp, Dept Internal Med & Endocrinol, DK-8000 Aarhus, Denmark; [Christensen, Louise Lehman; Andersen, Marianne] Odense Univ Hosp, Dept Med Endocrinol, DK-5000 Odense, Denmark; [Laurberg, Peter] Copenhagen Univ Hosp, Sect Newborn Screening & Hormone Anal, Clin Mass Spectrometry Unit, Dept Clin Biochem,Statens Serum Inst, DK-2100 Copenhagen, Denmark; [Cohen, Arieh S.] Copenhagen Univ Hosp, Rigshosp, Dept Diagnost Radiol, Neuroradiol Unit, DK-2100 Copenhagen, Denmark; [Wagner, Aase] Aalborg Univ Hosp, Dept Med Endocrinol, Aalborg, Denmark		Klose, M (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol, PE2131, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	klose@rh.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021; Andersen, Marianne Skovsager/AAE-1751-2019	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Andersen, Marianne Skovsager/0000-0002-4603-9504; Lehmann Christensen, louise/0000-0001-6489-7054; Stochholm, Kirstine/0000-0002-4408-3413	Danish Agency for Science, Technology and Innovation; Research Council of the Capital Region of Denmark; Lundbeck FoundationLundbeckfonden; Novo Nordic; A.P. Moller Foundation for the Advancement of Medical Science; Arvid Nilsson's Foundation; Christenson-Ceson's Foundation; Axel-Muusfeldt's Foundation; Else and Mogens Wedell-Wedellsborg's Foundation; Novo Nordisk FondenNovo Nordisk Foundation [NNF15OC0014622] Funding Source: researchfish	The study was funded by unrestricted grants from: The Danish Agency for Science, Technology and Innovation, The Research Council of the Capital Region of Denmark, The Lundbeck Foundation, Novo Nordic, The A.P. Moller Foundation for the Advancement of Medical Science, Arvid Nilsson's Foundation, Christenson-Ceson's Foundation, Axel-Muusfeldt's Foundation and Else and Mogens Wedell-Wedellsborg's Foundation. Immunodiagnostic Systems provided iSYS GH kits free of charge, but had no influence on results or their interpretation. The study was registered at ClinicalTrials.gov NCT01028742.	Apovian CM, 2013, AM J MANAG CARE, V19, pS219; BARTSCH W, 1980, MATURITAS, V2, P109, DOI 10.1016/0378-5122(80)90044-4; Bauer J, 2004, NEUROLOGY, V62, P243, DOI 10.1212/01.WNL.0000091866.48962.79; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Glintborg D, 2014, AGE AGEING, V43, P280, DOI 10.1093/ageing/aft203; Hardy MP, 1997, J ANDROL, V18, P475; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, J CLIN ENDOCR METAB, V92, P1326, DOI 10.1210/jc.2006-1791; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Lissett CA, 1999, CLIN ENDOCRINOL, V51, P551, DOI 10.1046/j.1365-2265.1999.00836.x; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; MORLEY JE, 1981, METABOLISM, V30, P195, DOI 10.1016/0026-0495(81)90172-4; Naess H, 2012, VASC HEALTH RISK MAN, V8, P407, DOI 10.2147/VHRM.S32780; Nielsen TL, 2007, J CLIN ENDOCR METAB, V92, P2696, DOI 10.1210/jc.2006-1847; Nourollahi S, 2014, BRAIN INJURY, V28, P1425, DOI 10.3109/02699052.2014.917201; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Reyes-Gibby CC, 2006, J PAIN SYMPTOM MANAG, V32, P118, DOI 10.1016/j.jpainsymman.2006.01.008; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Simsek Y, 2015, CLIN ENDOCRINOL, V82, P45, DOI 10.1111/cen.12528; Sjogren P, 2010, CLIN J PAIN, V26, P763, DOI 10.1097/AJP.0b013e3181f15daf; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Vestergaard P, 1997, HORM METAB RES, V29, P106, DOI 10.1055/s-2007-979000; Ware JE, 2001, SF 36 PHYSICAL AND M; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zitzmann M, 2001, EUR J ENDOCRINOL, V144, P183, DOI 10.1530/eje.0.1440183	38	10	11	0	4	BIOSCIENTIFICA LTD	BRISTOL	STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	JUN	2015	172	6					753	762		10.1530/EJE-14-1069			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	CL8GR	WOS:000357212600019	25766045	Bronze			2022-02-06	
J	Kondziolka, D; Cooper, BT; Lunsford, LD; Silverman, J				Kondziolka, Douglas; Cooper, Benjamin T.; Lunsford, L. Dade; Silverman, Joshua			Development, Implementation, and Use of a Local and Global Clinical Registry for Neurosurgery	BIG DATA			English	Article						registry; database; outcomes; neurosurgery; radiosurgery; radiation therapy	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; STEREOTACTIC RADIOSURGERY; DATABASE; SOCIETY; CARE; QUALITY; KNOWLEDGE; DISEASE; FUTURE	Physicians are being challenged to obtain data for outcomes research and measures of quality practice in medicine. We developed a prospective data collection system (registry) that provides data points across all elements of a neurosurgical stereotactic radiosurgery practice. The registry architecture is scalable and suitable for any aspect of neurosurgical practice. Our purpose was to outline the challenges in creating systems for high quality data acquisition and describe experiences in initial testing and use. Over a two year period, a multicenter team working with software engineers developed a comprehensive radiosurgery registry based on a MS-Sequel (R) server platform. Three neurosurgeons at one center were responsible for final editing. Alpha testing began in September 2012 and server-based beta testing began in February 2013. The major elements included demographics, disease-based items (47 categories for different brain tumors, vascular malformations, and functional disorders) with relevant clinical grading systems, treatment-based items (imaging, physics, clinical), and follow-up data (clinical, imaging, subsequent therapeutics). Nine hundred patients were entered into the registry at one test center, with new entries and follow-up data entered daily at the point of contact. With experience, the mean time for one new entry was 6 minutes. Mean time for one follow-up entry was 45 seconds. The system was made secure for individual use and amenable for both data entry and research. Analytics used different filters to create customized outcomes charts as selected by the user (e.g., survival, neurologic function, complications). A local or multicenter prospective data collection registry was created for use across 47 clinical indications for stereotactic cranial radiosurgery. Further refinement of fields and logic is ongoing. The system is reliable, robust, and allows use of rapid analytical tools. Large medical registries will become widely used for collection and analysis of large data sets and should have broad applicability to many other elements of neurosurgical and medical practice.	[Kondziolka, Douglas] NYU, Langone Med Ctr, Dept Neurosurg, New York, NY 10016 USA; [Cooper, Benjamin T.; Silverman, Joshua] NYU, Langone Med Ctr, Dept Radiat Oncol, New York, NY 10016 USA; [Lunsford, L. Dade] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Kondziolka, D (corresponding author), NYU, Langone Med Ctr, Dept Neurosurg, 530 First Ave,Suite 8R, New York, NY 10016 USA.	douglas.kondziolka@nyumc.org		Cooper, Benjamin/0000-0002-7044-7989; Silverman, Joshua/0000-0002-6962-3826			Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Asher A, 2009, NEUROSURGERY, V65, P223, DOI 10.1227/01.NEU.0000348010.12339.1E; Asher AL, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.10.FOCUS12300; Berkowitz O, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.11.FOCUS12295; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; CLARK RE, 1994, ANN THORAC SURG, V57, P20, DOI 10.1016/0003-4975(94)90359-X; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Dokholyan RS, 2009, AM HEART J, V157, P971, DOI 10.1016/j.ahj.2009.03.023; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1498, DOI 10.1016/j.apmr.2011.01.023; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hassani H, 2014, BIG DATA, V2, P34, DOI 10.1089/big.2013.0038; Jacobs Jeffrey Phillip, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P3, DOI 10.1053/j.pcsu.2010.02.003; Jacobs JP, 2008, CARDIOL YOUNG, V18, P81, DOI 10.1017/S1047951108003041; KANNEL WB, 1969, DIS CHEST, V56, P43, DOI 10.1378/chest.56.1.43; KANNEL WB, 1974, STROKE, V5, P679, DOI 10.1161/01.STR.5.6.679; Kondziolka D, 2012, DISRUPT SCI TECHNOL, V1, P3; Kondziolka D, 2011, STEREOT FUNCT NEUROS, V89, P56, DOI 10.1159/000322277; Lunsford L D, 1988, Hosp Physician, V24, P32; Lunsford LD, 2012, J NEUROSURG, V117, P2, DOI 10.3171/2012.6.GKS12838; Lunsford LD, 1988, HOSP PHYS, V24, P32; Lunsford LD, 1988, HOSP PHYS, V24, P30; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Mavroudis C, 1999, ANN THORAC SURG, V68, P601, DOI 10.1016/S0003-4975(99)00631-1; McGirt MJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.10.FOCUS12297; Schnell K, 2014, BIG DATA, V2, P7, DOI 10.1089/big.2014.1518; Selden NR, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.11.FOCUS12309; Shahian DM, 2013, HEART, V99, P1494, DOI 10.1136/heartjnl-2012-303456; Shahian DM, 2010, J THORAC CARDIOV SUR, V140, P955, DOI 10.1016/j.jtcvs.2010.09.004; Torrens M, 2014, J NEUROSURG, V121, P2, DOI 10.3171/2014.7.GKS141199; Van Gompel JJ, 2014, J NEUROL SURG PART B, V75, P409, DOI 10.1055/s-0034-1378151; van Hedelt HJA, 2008, NEUROL RES, V30, P61, DOI 10.1179/016164107X230775; Yeager D., 2014, RADIOL TODAY, V15, P6; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	34	10	11	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2167-6461	2167-647X		BIG DATA-US	Big Data	JUN 1	2015	3	2					80	89		10.1089/big.2014.0069			10	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	CU7RT	WOS:000363739800004	27447432				2022-02-06	
J	Mazer, B; Gelinas, I; Duquette, J; Vanier, M; Rainville, C; Chilingaryan, G				Mazer, Barbara; Gelinas, Isabelle; Duquette, Josee; Vanier, Marie; Rainville, Constant; Chilingaryan, Gevorg			A randomized clinical trial to determine effectiveness of driving simulator retraining on the driving performance of clients with neurological impairment	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Driving; simulator; neurological impairment	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; COMMUNITY INTEGRATION; STROKE; DRIVERS	Introduction Following a neurological event, returning to driving is an important activity contributing to improved participation within the community. The purpose of this study was to examine the effectiveness of driving simulator retraining on driving in clients with neurological impairment and to examine factors associated with treatment effectiveness. Method Individuals with non-degenerative brain injury were randomized to either a simulator training or control group. The simulator group received individualized training (16 sessions) using a driving simulator. The control group did not receive intervention. A blind evaluator assessed participants on the DriveAble On-Road Driving Evaluation. Results There was no significant difference between groups in the proportion of individuals who passed the driving evaluation (Chi(2)=0.65; p=0.42; CI=-0.41 to +0.17). However, participants with moderate impairment who received simulator training were more likely to pass the driving test compared with those in the control group (86% versus 17%; Chi(2)=6.2; p=0.03; CI=-1.00 to -0.30). There were no differences in pass rate according to diagnosis, gender, or for those with severe impairments. Conclusion Results provide clinicians with preliminary information on the potential clinical usefulness of driving simulator training. While the findings do not support simulator retraining for the group as a whole, they suggest that clients with moderate impairment have the potential to benefit.	[Mazer, Barbara; Gelinas, Isabelle; Chilingaryan, Gevorg] Jewish Rehabil Hosp, Ctr Interdisciplinary Res Rehabil Greater Montrea, Laval, PQ H4W 1V9, Canada; [Mazer, Barbara; Gelinas, Isabelle] McGill Univ, Montreal, PQ, Canada; [Duquette, Josee] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Vanier, Marie] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Rainville, Constant] Inst Univ Geriatrie Montreal, Montreal, PQ, Canada		Mazer, B (corresponding author), Jewish Rehabil Hosp, Ctr Interdisciplinary Res Rehabil Greater Montrea, 3205 Pl Alton Goldbloom, Laval, PQ H4W 1V9, Canada.	barbara.mazer@mcgill.ca		Duquette, Josee/0000-0002-0258-1166			Akinwuntan AE, 2005, NEUROLOGY, V65, P843, DOI 10.1212/01.wnl.0000171749.71919.fa; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Ball K., 1992, J AM OPTOM ASSOC, V64, P71; BOUSKA MJ, 1982, MANUAL APPL MOTOR FR; Bracy OL, 1990, MANUAL COGNITIVE BEH; Carroz A., 2008, Annales de Readaptation et de Medecine Physique, V51, P358, DOI 10.1016/j.annrmp.2008.04.007; CIMOLINO N, 1988, CANADIAN J OCCUPATIO, V55, P119; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Devos H, 2009, NEUROREHAB NEURAL RE, V23, P699, DOI 10.1177/1545968309334208; Dobbs AR, 1997, ALZ DIS ASSOC DIS, V11, P8, DOI 10.1097/00002093-199706001-00003; Dobbs AR, 1997, EVALUATIONS AT RISK; Flinn NA, 2008, OCCUPATIONAL THERAPY, P382; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Griffen JA, 2009, TOP STROKE REHABIL, V16, P212, DOI 10.1310/tsr1603-212; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Higgins KE, 2000, LIGHTHOUSE HDB VISIO, V1; Hunt LA, 2008, AM J OCCUP THER, V62, P136, DOI 10.5014/ajot.62.2.136; Ivancic K, 2000, ERGONOMICS, V43, P1966, DOI 10.1080/00140130050201427; Jacobs K, 1997, Work, V8, P281, DOI 10.3233/WOR-1997-8308; Kawano N, 2012, AGING CLIN EXP RES, V24, P285, DOI 10.1007/BF03325260; KOEPSEL TD, 1994, J AM GERIATR SOC, V42, P695, DOI 10.1111/j.1532-5415.1994.tb06526.x; KUMAR R, 1991, GERONTOLOGIST, V31, P807, DOI 10.1093/geront/31.6.807; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; RANNEY TA, 1994, ACCIDENT ANAL PREV, V26, P733, DOI 10.1016/0001-4575(94)90051-5; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Simms B., 1985, BR J OCCUP THER, V48, P363; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wilson T, 1983, Int Rehabil Med, V5, P170	34	10	10	0	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	JUN	2015	78	6					369	376		10.1177/0308022614562401			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CK4WG	WOS:000356223400006					2022-02-06	
J	Nott, MT; Gates, TM; Baguley, IJ				Nott, Melissa T.; Gates, Thomas M.; Baguley, Ian J.			Age-related trends in late mortality following traumatic brain injury: A multicentre inception cohort study	AUSTRALASIAN JOURNAL ON AGEING			English	Article						ageing; brain injury; mortality	LONG-TERM SURVIVAL; ELDERLY-PATIENTS; ACUTE-CARE; POPULATION; DEATH; REHABILITATION; DISCHARGE	AimTo investigate age-related mortality risk following traumatic brain injury (TBI). MethodsReview of 2545 consecutive discharges from three metropolitan rehabilitation centres in New South Wales, between 1 January 1990 and 1 October 2007. Survival status was censored on 1 October 2009. Between-group differences were assessed for older/younger patients. Multivariate Cox hazard regression was used to evaluate age-related mortality risk. Crude mortality rates, standardised mortality ratios and cause of death data were derived for each age decade. ResultsAfter controlling for known mortality risk factors, older patients were three times more likely to die than younger patients. Crude mortality rates increased exponentially with advancing age. However, when compared to normative population data, younger adults with TBI (<50 years) had the highest risk of death relative to their non-injured peers. ConclusionsCrude mortality rates, which do not account for the naturally increasing rate of death associated with ageing, artificially inflate estimates of age-related mortality risk following TBI.	[Nott, Melissa T.] Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia; [Gates, Thomas M.; Baguley, Ian J.] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia		Nott, MT (corresponding author), Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia.	mnott@csu.edu.au	Baguley, Ian/AAM-5828-2021; Nott, Melissa T/M-6778-2018; Gates, Thomas/AAB-5623-2022	Nott, Melissa T/0000-0001-7088-5826; Gates, Thomas/0000-0003-0113-8282	New South Wales Government Lifetime Care and Support Authority [08157, 10588]	This work was supported by research grants from the New South Wales Government Lifetime Care and Support Authority (grant numbers 08157, 10588).	AIHW, 2010, CARD SER, V31; AIHW AACR, 2012, CANC SER, V72; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Helps Y, 2008, INJURY RES STAT SERI, V45; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Moon L., 1999, AUSTR YOUNG PEOPLE T; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shavelle R, 2000, J Insur Med, V32, P163; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Uniform Data System for Medical Rehabilitation, 1997, GUID UN DAT SET MED; VANDENBROUCKE JP, 1982, AM J EPIDEMIOL, V115, P303, DOI 10.1093/oxfordjournals.aje.a113306; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Yashin AI, 2002, SOC BIOL, V49, P206	28	10	10	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-6381	1741-6612		AUSTRALAS J AGEING	Australas. Ageing	JUN	2015	34	2					E1	E6		10.1111/ajag.12151			6	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	CJ8EI	WOS:000355732300001	24754518				2022-02-06	
J	Post, A; Hoshizaki, TB; Gilchrist, MD; Brien, S; Cusimano, M; Marshall, S				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan; Cusimano, Michael; Marshall, Shawn			The dynamic response characteristics of traumatic brain injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Traumatic brain injury; Fall; Brain injury; Impact biomechanics	SUBDURAL-HEMATOMA; MULTIBODY DYNAMICS; IMPACT INJURY; HEAD; FALLS; RECONSTRUCTION; BIOMECHANICS; ACCELERATION; DEFORMATION	Traumatic brain injury (TBI) continues to be a leading cause of morbidity and mortality throughout the world. Research has been undertaken in order to better understand the characteristics of the injury event and measure the risk of injury to develop more effective environmental technological, and clinical management strategies. This research used methods that have limited applications to predicting human responses. This limits the current understanding of the mechanisms of TBI in humans. As a result, the purpose of this research was to examine the characteristics of impact and dynamic response that leads to a high risk of sustaining a TBI in a human population. Twenty TBI events collected from hospital reports and eyewitness accounts were reconstructed in the laboratory using a combination of computational mechanics models and Hybrid III anthropometric dummy systems. All cases were falls, with an average impact velocity of approximately 4.0 m/s onto hard impact surfaces. The results of the methodology were consistent with current TBI research, describing TBI to occur in the range of 335-445 g linear accelerations and 23.7-51.2 krad/s(2) angular accelerations. More significantly, this research demonstrated that lower responses in the antero-posterior direction can cause TB!, with lateral impact responses requiring larger magnitudes for the same types of brain lesions. This suggests an increased likelihood of sustaining TBI for impacts to the front or back of the head, a result that has implications affecting current understanding of the mechanisms of TBI and associated threshold parameters. (C) 2015 Elsevier Ltd. All rights reserved.	[Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland; [Brien, Susan] Hull Hosp, Gatineau, PQ, Canada; [Cusimano, Michael] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Marshall, Shawn] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada		Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019	Post, Andrew/0000-0002-5960-5552; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	Funding for this research was supplied by the Canadian Institutes of Health Research (CIHR). This research was conducted as part of the Canadian Brain Injury and Violence Research Team.	Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; Centres for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; Faul M, 2010, TRAUMATIC BRAIN INJU; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gennarelli T, 1971, P 15 STAPP CAR CRASH; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli TA, 1979, P 23 STAPP CAR CRASH; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Got C., 1983, P 27 STAPP CAR CRASH; Gurdjian E S, 1980, Surg Annu, V12, P223; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Hodgson V.R., 1983, SAE TECHNICAL PAPER; Hodgson V.R., 1971, SAE TECHNICAL PAPER; HODGSON VR, 1967, AM J ANAT, V120, P113, DOI 10.1002/aja.1001200109; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; MacManus D.B., 2014, P 17 US NAT C THEOR, P15; Mertz H.J., 1985, SAE TECHNICAL PAPER; Mertz HJ, 1996, SAE TECHNICAL PAPER; NAHUM A, 1980, P 24 STAPP CAR CRASH; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P45; Ommaya AK, 1967, SAE TECHNICAL PAPER, DOI http://dx.doi.org/10.4271/670906; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A., 2013, THESIS U OTTAWA OTTA; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prasad P., 1985, SAE TECHNICAL PAPER; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneider D., 1972, P 16 STAPP CAR CRASH, P186; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Usman J., 2014, J SCI MED SPORT; Willinger R., 1992, P INT IRCOBI C BIOM, P179; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Yoganandan N, 2011, CLIN ANAT, V24, P282, DOI 10.1002/ca.21106; Zhou C, 1995, 39 STAPP CAR CRASH C, P121	49	10	11	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUN	2015	79						33	40		10.1016/j.aap.2015.03.017			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CJ2ZF	WOS:000355352500003	25795923	Green Submitted			2022-02-06	
J	Turtzo, LC; Budde, MD; Dean, DD; Gold, EM; Lewis, BK; Janes, L; Lescher, J; Coppola, T; Yarnell, A; Grunberg, NE; Frank, JA				Turtzo, L. Christine; Budde, Matthew D.; Dean, Dana D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Lescher, Jacob; Coppola, Tiziana; Yarnell, Angela; Grunberg, Neil E.; Frank, Joseph A.			Failure of Intravenous or Intracardiac Delivery of Mesenchymal Stromal Cells to Improve Outcomes after Focal Traumatic Brain Injury in the Female Rat	PLOS ONE			English	Article							MARROW MONONUCLEAR-CELLS; ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; PROMOTES FUNCTIONAL RECOVERY; STEM-CELLS; DONOR GENDER; ADULT RATS; TRANSPLANTATION; THERAPY; SURVIVAL; INCREASES	Mesenchymal stromal cells secrete a variety of anti-inflammatory factors and may provide a regenerative medicine option for the treatment of traumatic brain injury. The present study investigates the efficacy of multiple intravenous or intracardiac administrations of rat mesenchymal stromal cells or human mesenchymal stromal cells in female rats after controlled cortical impact by in vivo MRI, neurobehavior, and histopathology evaluation. Neither intravenous nor intracardiac administration of mesenchymal stromal cells derived from either rats or humans improved MRI measures of lesion volume or neurobehavioral outcome compared to saline treatment. Few mesenchymal stromal cells (<0.0005% of injected dose) were found within 3 days of last dosage at the site of injury after either delivery route, with no mesenchymal stromal cells being detectable in brain at 30 or 56 days post-injury. These findings suggest that non-autologous mesenchymal stromal cells therapy via intravenous or intracardiac administration is not a promising treatment after focal contusion traumatic brain injury in this female rodent model.	[Turtzo, L. Christine; Gold, Eric M.; Janes, Lindsay; Lescher, Jacob] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Turtzo, L. Christine; Budde, Matthew D.; Dean, Dana D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Lescher, Jacob; Coppola, Tiziana; Frank, Joseph A.] NIH, Frank Lab, Bethesda, MD 20892 USA; [Yarnell, Angela; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA		Turtzo, LC (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	l.turtzo@nih.gov	Frank, Joseph/W-2021-2019		Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [300604-8.01-60855, 305500-8.01-60855]; National Institutes of Health's Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the the Center for Neuroscience and Regenerative Medicine (http://www.usuhs.mil/cnrm/) as administered by the Henry M. Jackson Foundation (http://www.hjf.org) (Henry M. Jackson Award #300604-8.01-60855 [JAF] and #305500-8.01-60855 [LCT]) and by the National Institutes of Health's Intramural Research Program (http://irp.nih.gov/) (JAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Arbab AS, 2009, CURR MED IMAGING, V5, P19, DOI 10.2174/157340509787354697; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Bonilla C, 2012, J TRAUMA ACUTE CARE, V72, P1203, DOI 10.1097/TA.0b013e318248bdcf; Bonilla C, 2012, J NEUROTRAUM, V29, P394, DOI 10.1089/neu.2011.2101; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Britt JM, 2010, J NEUROPHYSIOL, V104, P695, DOI 10.1152/jn.01051.2009; Budde MD, 2009, J NUCL MED, V50, P171, DOI 10.2967/jnumed.108.053546; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; CDC, RAT TBI REL EM DEP V; Cheng JL, 2010, CHIN J TRAUMATOL, V13, P173, DOI 10.3760/cma.j.issn.1008-1275.2010.03.008; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Everaert BR, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-93; Fessart D, 2011, TRANSPL P, V43, P3899, DOI 10.1016/j.transproceed.2011.08.101; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gahrton G, 2005, BONE MARROW TRANSPL, V35, P609, DOI 10.1038/sj.bmt.1704861; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Goldmacher GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060049; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Jiang JD, 2012, NEURAL REGEN RES, V7, P46, DOI 10.3969/j.issn.1673-5374.2012.01.008; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kerkela E, 2013, STEM CELL TRANSL MED, V2, P510, DOI 10.5966/sctm.2012-0187; Kim S, 2014, STEM CELLS DEV, V23, P530, DOI 10.1089/scd.2013.0297; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lundberg J, 2009, NEURORADIOLOGY, V51, P661, DOI 10.1007/s00234-009-0551-6; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Miller JD, 2010, AM J RESP CELL MOL, V43, P253, DOI 10.1165/rcmb.2010-0015RC; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Naumova AV, 2014, NAT BIOTECHNOL, V32, P804, DOI 10.1038/nbt.2993; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Rahman MA, 1997, PHARMACOL BIOCHEM BE, V56, P409, DOI 10.1016/S0091-3057(96)00222-5; Sabatino M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-23; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; SCHRODER R, 1980, ACTA NEUROPATHOL, V52, P147, DOI 10.1007/BF00688013; Stroncek DF, 2014, TISSUE ENG PART B-RE, V20, P200, DOI [10.1089/ten.TEB.2013.0529, 10.1089/ten.teb.2013.0529]; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Walker PA, 2010, TISSUE ENG PART C-ME, V16, P989, DOI [10.1089/ten.tec.2009.0423, 10.1089/ten.TEC.2009.0423]; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Yang B, 2013, MESENCHYMAL STROMAL, P617; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69; Zhou JY, 2013, CLIN TRANSPLANT, V27, P764, DOI 10.1111/ctr.12191; Ziadloo A, 2012, STEM CELLS, V30, P1216, DOI 10.1002/stem.1099	69	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2015	10	5							e0126551	10.1371/journal.pone.0126551			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5BQ	WOS:000354049700137	25946089	Green Published, Green Submitted, gold			2022-02-06	
J	Mioni, G; Rendell, PG; Stablum, F; Gamberini, L; Bisiacchi, PS				Mioni, Giovanna; Rendell, Peter G.; Stablum, Franca; Gamberini, Luciano; Bisiacchi, Patrizia S.			Test-retest consistency of Virtual Week: A task to investigate prospective memory	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Ageing; Test-retest; Virtual Week; Prospective memory	TRAUMATIC BRAIN-INJURY; RETROSPECTIVE MEMORY; EMOTIONAL VALENCE; OLDER-ADULTS; AGE; IMPAIRMENT; INTENTIONS; INDIVIDUALS; INVOLVEMENT; PEOPLE	The present study reports test-retest consistency of Virtual Week, a well-known measure of prospective memory (PM) performance. PM is the memory associated with carrying out actions at a specific moment in the future. Patients with neurological disorders as well as healthy older adults often report PM dysfunctions that affect their everyday living. In Experiment 1, 19 younger and 20 older adults undertook the standard version of Virtual Week (version A). Older adults showed lower performance compared to younger participants. However, the discrepancy between groups was eliminated at retest. Experiment 2 was conducted to investigate if remembering of PM content determined the improvement observed in older adults at retest in Experiment 1. To this end we created a parallel version (version B) in which we varied the content of the PM actions. Fifty older adults were assigned to one of the two experimental conditions: Version A at test and version B at retest or vice versa (25 participants in each condition). Results showed no group differences in PM performance between version A and version B; moreover, no effect of test-retest was found. The study confirmed that Virtual Week is a reliable measure of PM performance and also provided a new parallel version that can be useful in clinical setting.	[Mioni, Giovanna] Univ Laval, Ecole Psychol, Quebec City, PQ G1V 0A6, Canada; [Mioni, Giovanna; Stablum, Franca; Gamberini, Luciano; Bisiacchi, Patrizia S.] Univ Padua, Dept Gen Psychol, Padua, Italy; [Rendell, Peter G.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia		Mioni, G (corresponding author), Univ Laval, Ecole Psychol, Pavillon Felix Antoine Savard, Quebec City, PQ G1V 0A6, Canada.	mioni.giovanna@gmail.com	Rendell, Peter/E-7539-2010	Rendell, Peter/0000-0002-4829-4322; bisiacchi, patrizia/0000-0003-2760-8000; Stablum, Franca/0000-0003-0123-5090; mioni, Giovanna/0000-0002-1212-4591	Australian Research Council Discovery GrantAustralian Research Council	Peter Rendell's contribution was supported by an Australian Research Council Discovery Grant. The authors gratefully acknowledge all the participants who kindly participated in the study and Chiara Seminati, Veronica Rossetti, Rosita Garbuio and Irene Scarpa who cooperated with the present study. The authors also acknowledge the help of Trevor Daniels with programming Virtual Week and the help of Kathryn Biernacki in analysing the data.	Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Bisiacchi PS, 2008, AGING CLIN EXP RES, V20, P569; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cona G, 2012, NEUROPSYCHOLOGIA, V50, P2692, DOI 10.1016/j.neuropsychologia.2012.07.033; Delprado J, 2012, J INT NEUROPSYCH SOC, V18, P295, DOI 10.1017/S135561771100172X; Einstein, 2008, PROSPECTIVE MEMORY C, P161; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein, 2008, PROSPECTIVE MEMORY C, P283; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Ellis RD, 1999, HUM FACTORS, V41, P345, DOI 10.1518/001872099779610996; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster ER, 2013, NEUROPSYCHOLOGY, V27, P170, DOI 10.1037/a0031946; Griffiths A, 2012, ADDICTION, V107, P1809, DOI 10.1111/j.1360-0443.2012.03941.x; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Henry JD, 2012, Q J EXP PSYCHOL, V65, P1274, DOI 10.1080/17470218.2011.651091; Henry JD, 2012, COGN NEUROPSYCHIATRY, V17, P133, DOI 10.1080/13546805.2011.581536; Kardiasmenos KS, 2008, NEUROPSYCHOLOGY, V22, P746, DOI 10.1037/a0013211; Katai S, 2003, J NEUROL NEUROSUR PS, V74, P704, DOI 10.1136/jnnp.74.6.704; Kim HJ, 2009, NEUROCASE, V15, P145, DOI 10.1080/13554790802709039; Kixmiller JS, 2002, BRAIN COGNITION, V49, P237, DOI 10.1006/brcg.2001.1476; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; Leitz JR, 2009, PSYCHOPHARMACOLOGY, V205, P379, DOI 10.1007/s00213-009-1546-z; Logie RH, 2011, MEM COGNITION, V39, P1561, DOI 10.3758/s13421-011-0120-1; Margrett JA, 2011, Z PSYCHOL, V219, P100, DOI 10.1027/2151-2604/a000054; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Maylor E.A., 2008, PROSPECTIVE MEMORY C, P217; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Mills V, 1997, BRAIN COGNITION, V35, P322; Mioni G., 2014, TRAUMATIC BRAIN INJU, P401, DOI [10.5772/5730, DOI 10.5772/57307]; Mioni G, 2014, MEMORY, V22, P536, DOI 10.1080/09658211.2013.801987; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Ozgis S, 2009, GERONTOLOGY, V55, P229, DOI 10.1159/000163446; Paraskevaides T, 2010, PSYCHOPHARMACOLOGY, V208, P301, DOI 10.1007/s00213-009-1731-0; Radford KA, 2011, CLIN NEUROPSYCHOL, V25, P127, DOI 10.1080/13854046.2010.529463; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Rendell PG, 2007, J INT NEUROPSYCH SOC, V13, P410, DOI 10.1017/S1355617707070579; Rendell PG, 2007, PSYCHOPHARMACOLOGY, V194, P497, DOI 10.1007/s00213-007-0859-z; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Rendell PG, 2012, J CLIN EXP NEUROPSYC, V34, P738, DOI 10.1080/13803395.2012.670388; Rendell PG, 2011, COGNITION EMOTION, V25, P916, DOI 10.1080/02699931.2010.508610; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Rendell PG, 2009, PSYCHOPHARMACOLOGY, V203, P609, DOI 10.1007/s00213-008-1408-0; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Rose NS, 2010, PSYCHOL AGING, V25, P595, DOI 10.1037/a0019771; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Thompson C, 2010, J INT NEUROPSYCH SOC, V16, P318, DOI 10.1017/S1355617709991354; Torres A., 2008, INT J DISABILITY HUM, P191, DOI [10.1515/ijdhd.2011.003, DOI 10.1515/IJDHD.2011.003]; Trawley SL, 2014, J COGN PSYCHOL, V26, P39, DOI 10.1080/20445911.2013.852199; West R.L., 2008, PROSPECTIVE MEMORY C, P261; West R, 2007, NEUROCASE, V13, P115, DOI 10.1080/13554790701399247; Will CM, 2009, APPL COGNITIVE PSYCH, V23, P804, DOI 10.1002/acp.1514; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wilson B., 2004, J INT NEUROPSYCH SOC, V10, P44; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 2003, RIVERMEAD BEHAV MEMO; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042	78	10	10	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 4	2015	25	3					419	447		10.1080/09602011.2014.941295			29	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CF1QL	WOS:000352322600005	25066698				2022-02-06	
J	Cavaleri, F				Cavaleri, Franco			Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration	MEDICAL HYPOTHESES			English	Article							AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; ANTIOXIDANT RESPONSE ELEMENT; NF-KAPPA-B; OXIDATIVE STRESS; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; BETA-SECRETASE; CEREBROSPINAL-FLUID; TRANSGENIC MICE	It is estimated that 5.5 Million North Americans suffer from varying degrees of Alzheimer's disease (AD) and by the year 2050 it may be one in 85 people globally (100 Million). It will be shown that heavy metal toxicity plays a significant role in sporadic AD. Although current literature speaks to involvement of metal ions (via Fenton reaction), studies and reviewers have yet to link cellular events including known structural changes such as amyloid plaque development to this metal toxicity the way it is proposed here. Contrary to the current AD model which positions BACE1 beta-secretase) as an aberrant or AD-advancing enzyme, it is proposed herein that the neuron's protective counteraction to this metal toxicity is, in fact, a justified increase in BACE1 activity and amyloid precursor protein (APP) processing to yield more secreted APP (sAPP) and beta-amyloid peptide in response to metal toxicity. This new perspective which justifies a functional role for APP, BACE1 enzyme activity and the peptide products from this activity may at first appear to be counterintuitive. Compelling evidence, however, is presented and a mechanism is shown herein that validate BACE1 recruitment and the resulting beta-amyloid protein as strategic countermeasures serving the cell effectively against neuro-impeding disease. It is proposed that beta-amyloid peptide chelates and sequesters free heavy metals in the extracellular medium to aggregate as amyloid plaque while unchelated beta-amyloid migrates across the cell membrane to chelate intracellular free divalent metals. The sequestered intracellular metal is subsequently chaperoned as a metallo-peptide to cross the plasma membrane and aggregate as amyloid plaques extracellularly. The BACE1 countermeasure is not genetic or metabolic aberration; and this novel conclusion demonstrates that it must not be inhibited as currently targeted. APP, BACE1, beta-amyloid peptide, and sAPP play positive roles against the preclinical oxidative load that predates AD symptoms for as long as 20 years. A healthy neuron may tolerate free metal toxicity, such as iron in the case of injury-induced amyloid, for as long as twenty years due to this very BACE1 activity. In later stages, the uncontrolled metals and ROS are compounded by other factors which together overcome this BACE1/beta-amyloid protein countermeasure. This results in a sudden increase in IL-1 leading to Tau's hyperphosphorylation as cited and eventually to Tau dissociation from the microtubule cytoskeleton interrupting cell trafficking. At this later stage of AD the beta-amyloid protein which once served as a vehicle to escort toxic metals to the extracellular medium and a trap to form a relatively benign extraneuronal disposal site is no longer translocated due to interruption of trafficking and now accumulates intracellularly facilitating hyper-oxidative ROS levels and contributes to irreversible neuron apoptosis. (C) 2015 Elsevier Ltd. All rights reserved.	UBC Hosp, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada		Cavaleri, F (corresponding author), UBC Hosp, Brain Res Ctr, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	Franco.c@biologicnr.com					Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Bamberger ME, 2003, J NEUROSCI, V23, P2665; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Christiansen L, 2004, J GERONTOL A-BIOL, V59, P886; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Citron M, 2002, J NEUROSCI RES, V70, P373, DOI 10.1002/jnr.10393; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Compta Y, 2009, MOVEMENT DISORD, V24, P2203, DOI 10.1002/mds.22594; Cornett CR, 1998, BIOL TRACE ELEM RES, V62, P107, DOI 10.1007/BF02820026; Cuadrado A, 2009, EXPERT OPIN THER TAR, V13, P319, DOI [10.1517/13543780802716501, 10.1517/13543780802716501 ]; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dickson DW, 2004, J CLIN INVEST, V114, P23, DOI 10.1172/JC1200422317; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; ElKhoury J, 1996, NATURE, V382, P716; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Goth L, 2000, LANCET, V356, P1820, DOI 10.1016/S0140-6736(00)03238-4; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Guo Q, 1998, J BIOL CHEM, V273, P12341, DOI 10.1074/jbc.273.20.12341; Haggerty T, 2011, EUR J NEUROSCI, V33, P1598, DOI 10.1111/j.1460-9568.2011.07660.x; Halliwell B., 1992, FREE RADICALS BRAIN, P21; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Houlden H, 2001, NEUROSCI LETT, V313, P93, DOI 10.1016/S0304-3940(01)02254-6; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Itoh N, 2001, ANN NEUROL, V50, P150, DOI 10.1002/ana.1054; Jhoo JH, 2004, BEHAV BRAIN RES, V155, P185, DOI 10.1016/j.bbr.2004.04.012; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kontush A, 2001, FREE RADICAL BIO MED, V31, P1120, DOI 10.1016/S0891-5849(01)00688-8; KORENBERG JR, 1989, GENOMICS, V5, P124, DOI 10.1016/0888-7543(89)90095-5; Lee KW, 2009, J NEUROCHEM, V108, P165, DOI 10.1111/j.1471-4159.2008.05769.x; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu DX, 1999, FREE RADICAL BIO MED, V27, P478, DOI 10.1016/S0891-5849(99)00073-8; Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; MANTYH PW, 1993, J NEUROCHEM, V61, P1171, DOI 10.1111/j.1471-4159.1993.tb03639.x; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Melov S, 2001, J NEUROSCI, V21, P8348, DOI 10.1523/JNEUROSCI.21-21-08348.2001; Mutter J, 2004, INT J HYG ENVIR HEAL, V207, P391, DOI 10.1078/1438-4639-00305; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Olivieri G, 2000, J NEUROCHEM, V74, P231, DOI 10.1046/j.1471-4159.2000.0740231.x; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Paik SR, 2000, ARCH BIOCHEM BIOPHYS, V378, P269, DOI 10.1006/abbi.2000.1822; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Paul A, 2007, MECH AGEING DEV, V128, P706, DOI 10.1016/j.mad.2007.10.013; Pelech Steven, 2008, Expert Opin Med Diagn, V2, P577, DOI 10.1517/17530059.2.5.577; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Piaceri I, 2012, J NEUROL SCI, V322, P31, DOI 10.1016/j.jns.2012.05.033; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Raby CA, 1998, J NEUROCHEM, V71, P2505; Reznichenko L, 2006, J NEUROCHEM, V97, P527, DOI 10.1111/j.1471-4159.2006.03770.x; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; ROBERTS NA, 1985, BRIT J RHEUMATOL, V24, P128; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sagara Y, 1996, J NEUROSCI, V16, P497; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shastry BS, 1999, BRAIN RES BULL, V48, P121, DOI 10.1016/S0361-9230(98)00156-7; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008; Yang LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005757; Zaidi SMKR, 2004, CLIN CHIM ACTA, V340, P229, DOI 10.1016/j.cccn.2003.11.003	113	10	10	2	17	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAY	2015	84	5					460	469		10.1016/j.mehy.2015.01.044			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CF6NH	WOS:000352672900012	25691377				2022-02-06	
J	Conway, A; Walshe, M				Conway, Aifric; Walshe, Margaret			Management of non-progressive dysarthria: practice patterns of speech and language therapists in the Republic of Ireland	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						non-progressive dysarthria; speech and language therapy; survey; stroke; traumatic brain injury	DYSPHAGIA EVALUATION PRACTICES; EXAMINATION DECISION-MAKING; ACQUIRED DYSARTHRIA; CLINICAL-ASSESSMENT; INTELLIGIBILITY; REHABILITATION; COMMUNICATION; PERSPECTIVE; PRINCIPLES; DISORDERS	BackgroundDysarthria is a commonly acquired speech disorder. Rising numbers of people surviving stroke and traumatic brain injury (TBI) mean the numbers of people with non-progressive dysarthria are likely to increase, with increased challenges for speech and language therapists (SLTs), service providers and key stakeholders. The evidence base for assessment and intervention approaches with this population remains limited with clinical guidelines relying largely on clinical experience, expert opinion and limited research. Furthermore, there is currently little evidence on the practice behaviours of SLTs available. AimsTo investigate whether SLTs in the Republic of Ireland (ROI) vary in how they assess and manage adults with non-progressive dysarthria; to explore SLTs' use of the theoretical principles that influence therapeutic approaches; to identify challenges perceived by SLTs when working with adults with non-progressive dysarthria; and to determine SLTs' perceptions of further training needs. Methods & ProceduresA 33-item survey questionnaire was devised and disseminated electronically via SurveyMonkey to SLTs working with non-progressive dysarthria in the ROI. SLTs were identified through e-mail lists for special-interest groups, SLT manager groups and general SLT mailing lists. A reminder e-mail was sent to all SLTs 3 weeks later following the initial e-mail containing the survey link. The survey remained open for 6 weeks. Questionnaire responses were analysed using descriptive statistics. Qualitative comments to open-ended questions were analysed through thematic analysis. Outcomes & ResultsEighty SLTs responded to the survey. Sixty-seven of these completed the survey in full. SLTs provided both quantitative and qualitative data regarding their assessment and management practices in this area. Practice varied depending on the context of the SLT service, experience of SLTs and the resources available to them. Not all SLTs used principles such as motor programming or neural plasticity to direct clinical work and some requested further direction in this area. SLTs perceived that the key challenges associated with working in this area were the compliance, insight and motivation of adults with dysarthria. Conclusions & ImplicationsThe use of specific treatment programmes varies amongst SLTs. A lack of resources is reported to restrict practice in both assessment and management. Ongoing research into the effectiveness of SLT interventions with adults with non-progressive dysarthria is required to guide clinical decision-making. SLTs identified further training needs which may provide direction for the development of professional training courses in the future.	[Conway, Aifric; Walshe, Margaret] Univ Dublin Trinity Coll, Dept Clin Speech & Language Studies, Dublin 2, Ireland		Conway, A (corresponding author), Univ Dublin Trinity Coll, Dept Clin Speech & Language Studies, Dublin 2, Ireland.	conwaya2@tcd.ie	Walshe, Margaret/M-9102-2016	Walshe, Margaret/0000-0003-3924-8073			Bateman C, 2007, DYSPHAGIA, V22, P174, DOI 10.1007/s00455-006-9070-3; Baylor CR, 2009, J SPEECH LANG HEAR R, V52, P1302, DOI 10.1044/1092-4388(2009/07-0275); Brady MC, 2011, CLIN REHABIL, V25, P935, DOI 10.1177/0269215511405079; Brumfitt S, 2006, DISABIL REHABIL, V28, P523, DOI 10.1080/09638280500219349; Collis J, 2012, INT J LANG COMM DIS, V47, P725, DOI 10.1111/j.1460-6984.2012.00183.x; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Dean M., 2010, B ROYAL COLL SPEECH, V702, P20; Dickson S, 2008, INT J LANG COMM DIS, V43, P135, DOI 10.1080/13682820701862228; Dillman DA., 2007, MAIL INTERNET SURVEY; Drummond S.S., 1993, DYSARTHRIA EXAMINATI; Duffy J. R., 2007, MOTOR SPEECH DISORDE, P7; Enderby, 2007, INT J SPEECH LANGUAG, V9, P140, DOI [DOI 10.1080/14417040600970606, 10.1080/14417040600970606]; Enderby P, 1983, FRENCHAY DYSARTHRIA; Enderby P., 2008, FRENCHAY DYSARTHRIA; Irish Association of Speech and Language Therapists (IASLT), 2008, SPEECH LANG THER COM; Irish Association of Speech and Language Therapists (IASLT), 2007, SPEECH LANG THER SCO; Ludlow CL, 2008, J SPEECH LANG HEAR R, V51, pS240, DOI 10.1044/1092-4388(2008/019); Maas E, 2008, AM J SPEECH-LANG PAT, V17, P277, DOI 10.1044/1058-0360(2008/025); Mackenzie C, 2010, INT J LANG COMM DIS, V45, P617, DOI 10.3109/13682820903470577; Martino R, 2004, DYSPHAGIA, V19, P165, DOI 10.1007/s00455-004-0004-7; Mathers-Schmidt BA, 2003, DYSPHAGIA, V18, P114, DOI 10.1007/s00455-002-0094-z; McCauley RJ, 2009, AM J SPEECH-LANG PAT, V18, P343, DOI 10.1044/1058-0360(2009/09-0006); Miller N, 2011, INT J LANG COMM DIS, V46, P189, DOI 10.3109/13682822.2010.484849; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Pettigrew CM, 2007, DYSPHAGIA, V22, P235, DOI 10.1007/s00455-007-9079-2; PRING T., 2005, RES METHODS COMMUNIC; RCSLT, 2009, RES MAN COMM PLANN S; Robertson S, 2001, INT J LANG COMM DIS, V36, P292, DOI 10.3109/13682820109177900; Robertson SJ, 1982, DYSARTHRIA PROFILE; Royal College of Speech and Language Therapists (RCSLT), 2005, CLIN GUID; Royal College of Speech & Language Therapists (RCSLT), 2006, COMM QUAL, V3; Sapir S, 2008, CURR OPIN OTOLARYNGO, V16, P205, DOI 10.1097/MOO.0b013e3282febd3a; Sellars C., 2005, COCHRANE DATABASE SY, V3; Tanner D, 1999, QUICK ASSESSMENT DYS; Walshe M., 2011, ASSESSMENT MOTOR SPE, P97; Walshe M, 2011, DISABIL REHABIL, V33, P195, DOI 10.3109/09638288.2010.511685; Walshe M, 2009, INT J LANG COMM DIS, V44, P693, DOI 10.1080/13682820802317536; Ward E, 2008, AM J SPEECH-LANG PAT, V17, P265, DOI 10.1044/1058-0360(2008/024); WARLOW C. P., 2001, STROKE PRACHEAL MANA; Wenke RJ, 2011, J MED SPEECH-LANG PA, V19, P1; World Health Organization, 2007, INT CLASS FUNCT DIS; Yorkston K. M., 1996, SENTENCE INTELLIGIBI; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P296, DOI 10.1044/jshd.4603.296	43	10	10	0	39	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAY-JUN	2015	50	3					374	388		10.1111/1460-6984.12143			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	CG6NH	WOS:000353418200008	25652223				2022-02-06	
J	Das, R; Collins, A; Verma, A; Fernandez, J; Taylor, M				Das, Raj; Collins, Alistair; Verma, Anurag; Fernandez, Justin; Taylor, Michael			Evaluating Simulant Materials for Understanding Cranial Backspatter from a Ballistic Projectile	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; forensic biomechanics; backspatter; cranial injury; skull simulant; hypervelocity impact; numerical modeling; mesh-free method; smoothed particle hydrodynamics	CLOSE-RANGE SHOTS; SMOOTH PARTICLE HYDRODYNAMICS; SKULL-BRAIN MODEL; CONTACT GUNSHOT; HIGH-SPEED; HEAD; SKIN; INJURY; FIREARM; WOUNDS	In cranial wounds resulting from a gunshot, the study of backspatter patterns can provide information about the actual incidents by linking material to surrounding objects. This study investigates the physics of backspatter from a high-speed projectile impact and evaluates a range of simulant materials using impact tests. Next, we evaluate a mesh-free method called smoothed particle hydrodynamics (SPH) to model the splashing mechanism during backspatter. The study has shown that a projectile impact causes fragmentation at the impact site, while transferring momentum to fragmented particles. The particles travel along the path of least resistance, leading to partial material movement in the reverse direction of the projectile motion causing backspatter. Medium-density fiberboard is a better simulant for a human skull than polycarbonate, and lorica leather is a better simulant for a human skin than natural rubber. SPH is an effective numerical method for modeling the high-speed impact fracture and fragmentations.	[Das, Raj; Collins, Alistair; Verma, Anurag] Univ Auckland, Dept Mech Engn, Ctr Adv Composite Mat, Auckland 1010, New Zealand; [Fernandez, Justin] Univ Auckland, Auckland Bioengn Inst, Auckland 1010, New Zealand; [Taylor, Michael] Inst Environm Sci & Res, Christchurch 8041, New Zealand		Das, R (corresponding author), Univ Auckland, Dept Mech Engn, Auckland 1010, New Zealand.	r.das@auckland.ac.nz		Das, Raj/0000-0001-9977-6201			Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; AMATO JJ, 1974, AM J SURG, V127, P454, DOI 10.1016/0002-9610(74)90296-7; Bevel T., 2008, BLOODSTAIN PATTERN A, P199; Bonet J, 2002, APPL MATH COMPUT, V126, P133, DOI 10.1016/S0096-3003(00)00143-0; BURNETT BR, 1991, J FORENSIC SCI, V36, P1745; Coupland RM, 2011, WOUND BALLISTICS, P1; Das R, 2013, INT J FRACTURE, V179, P9, DOI 10.1007/s10704-012-9766-3; Das R, 2014, INT J MECH MATER DES, DOI [10.1007/s10999-014-9279-5, DOI 10.1007/S10999-014-9279-5.]; Das R, 2014, J SCI COMPUT, DOI 10.1007/s10915-014-9948-4; Davidson PL, 2012, J FORENSIC SCI, V57, P1339, DOI 10.1111/j.1556-4029.2012.02143.x; Fagan T, 2012, J MATER SCI, V47, P4514, DOI 10.1007/s10853-012-6296-3; Faller-Marquardt M, 2004, INT J LEGAL MED, V118, P343, DOI 10.1007/s00414-004-0486-8; Fernandez JW, 2013, INT J NUMER METH BIO, V29, P129, DOI 10.1002/cnm.2503; Fernandez JW, 2012, LECT NOTES COMPUTATI, P39; Foote NR, 2012, THESIS U AUCKLAND AU; HARRIS GF, 1993, J BIOMED ENG, V15, P67, DOI 10.1016/0141-5425(93)90096-H; Incorporated AWPA, 2008, EWPAA FACTS PART MDF; Islam S, 2012, APPL MATH MODEL, V36, P5589, DOI 10.1016/j.apm.2012.01.005; JOHNSON GR, 1985, ENG FRACT MECH, V21, P31, DOI 10.1016/0013-7944(85)90052-9; Jussila J, 2005, FORENSIC SCI INT, V150, P63, DOI 10.1016/j.forsciint.2004.06.039; Karekal S, 2011, INT J ROCK MECH MIN, V48, P703, DOI 10.1016/j.ijrmms.2011.04.011; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 1997, INT J LEGAL MED, V110, P188, DOI 10.1007/s004140050065; Karger B, 1997, INT J LEGAL MED, V110, P27; Karger B., 2008, FORENSIC BALLISTICS; Kilic N, 2013, MATER DESIGN, V44, P35, DOI 10.1016/j.matdes.2012.07.045; Kleiber M, 2001, FORENSIC SCI INT, V119, P260, DOI 10.1016/S0379-0738(00)00363-7; Lee M, 2001, INT J IMPACT ENG, V25, P819, DOI 10.1016/S0734-743X(01)00025-2; Mark JE, 2009, POLYM DATA HDB; MONAGHAN JJ, 1992, ANNU REV ASTRON ASTR, V30, P543, DOI 10.1146/annurev.aa.30.090192.002551; Monaghan JJ, 2005, REP PROG PHYS, V68, P1703, DOI 10.1088/0034-4885/68/8/R01; MONAGHAN JJ, 1988, COMPUT PHYS COMMUN, V48, P89, DOI 10.1016/0010-4655(88)90026-4; Mota A, 2003, COMPUT MECH, V31, P115, DOI 10.1007/s00466-002-0398-8; Oehmichen M, 2004, FORENSIC SCI INT, V146, P111, DOI 10.1016/j.forsciint.2004.06.023; Padosch SA, 2006, FORENSIC SCI INT, V158, P224, DOI 10.1016/j.forsciint.2005.05.024; Perdekamp MG, 2005, INT J LEGAL MED, V119, P217, DOI 10.1007/s00414-005-0542-z; PEX JO, 1987, J FORENSIC SCI, V32, P1587; Plattner T, 2003, FORENSIC SCI INT, V138, P68, DOI 10.1016/j.forsciint.2003.08.011; Radford GE, 2009, THESIS U OTAGO DUNED; Raul JS, 2007, INT J LEGAL MED, V121, P143, DOI 10.1007/s00414-005-0070-x; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; Tang Z., 2012, J MED COLL PLA, V27, P87, DOI DOI 10.1016/S1000-1948(12)60010-0; Tang Z, 2012, INJURY, V43, P660, DOI 10.1016/j.injury.2011.03.012; Taylor MC, 2011, INT J LEGAL MED, V125, P617, DOI 10.1007/s00414-010-0462-4; Thali MJ, 2003, FORENSIC SCI INT, V138, P8, DOI 10.1016/S0379-0738(03)00225-1; Thali MJ, 2003, FORENSIC SCI INT, V132, P93, DOI 10.1016/S0379-0738(03)00012-4; Thali MJ, 2002, FORENSIC SCI INT, V125, P195, DOI 10.1016/S0379-0738(01)00639-9; Thali MJ, 2002, FORENSIC SCI INT, V125, P190, DOI 10.1016/S0379-0738(01)00638-7; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Thali MJ, 2002, FORENSIC SCI INT, V127, P168, DOI 10.1016/S0379-0738(02)00117-2; vans Dyk H, 2008, DEV WOOD FIBER COMPO; Verhoff MA, 2003, INT J LEGAL MED, V117, P229, DOI 10.1007/s00414-003-0383-6; Yang J, 2010, COMPUT AIDED DES APP, V7, P59, DOI DOI 10.3722/cadaps.2010.59-73; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f; Yoganandan N, 1997, CRIT REV BIOMED ENG, V25, P485, DOI 10.1615/CritRevBiomedEng.v25.i6.10; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335	58	10	10	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	MAY	2015	60	3					627	637		10.1111/1556-4029.12701			11	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	CH4HI	WOS:000353994200011	25739515				2022-02-06	
J	Lee, PC; Bordelon, Y; Bronstein, J; Sinsheimer, JS; Farrer, M; Ritz, B				Lee, P. C.; Bordelon, Y.; Bronstein, J.; Sinsheimer, J. S.; Farrer, M.; Ritz, B.			Head injury, alpha-synuclein genetic variability and Parkinson's disease	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						gene-environment interaction; head injury; Parkinson's disease	TRAUMATIC BRAIN-INJURY; ALLELIC VARIATION; SUSCEPTIBILITY; POPULATION; CALIFORNIA; NACP-REP1; PARAQUAT; EXPOSURE; RISK	Background and purposeHead injury has been linked to Parkinson's disease (PD) in some but not all studies. Differences in the genetic and environmental susceptibility to PD between populations might be one explanation. The joint effects of head injuries and SNCA genetic variants were investigated. MethodsFrom 2001 to 2012, 561 incident idiopathic PD cases and 721 population controls from central California were enrolled. Subjects reported on head injuries throughout their lifetime and were assessed for genetic variability in the SNCA 5 region (D4S3481; Rep1) and 3 untranslated region (rs356165). In unconditional logistic regression models adjusted for confounders, interactions between head injuries and genetic risk variants were investigated. ResultsParkinson's disease risk in individuals with head injury who are carriers of at least one 263bp allele in D4S3481 or rs356165 variants was 3-4.5-fold higher compared with non-carriers without head injuries. However, tests for interaction between head injury and SNCA D4S3481or rs356165 were not statistically significant. ConclusionsOur study finds some evidence that head injury and D4S3481 or rs356165 variants jointly increase the risk of PD but little evidence of interaction.	[Lee, P. C.] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Coll Healthcare Adm & Management, Taipei, Taiwan; [Bordelon, Y.; Bronstein, J.] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Sinsheimer, J. S.; Ritz, B.] Univ Calif Los Angeles, Sch Med, Dept Human Genet & Biomath, Los Angeles, CA 90095 USA; [Sinsheimer, J. S.; Ritz, B.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Farrer, M.] Univ British Columbia, Dept Med Genet, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Ritz, B.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA		Ritz, B (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.	britz@ucla.edu	Ritz, Beate R/E-3043-2015	Farrer, Matthew/0000-0003-1159-5321	NIH NIEHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES010544, P01ES016732, U54ES012078]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS038367]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30ES007048, GM053275]; American Parkinson Disease Association; Canada Excellence Research Chairs programCanada Research Chairs; Leading Edge Endowment Funds; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES010544, U54ES012078, P30ES007048, P01ES016732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS038367] Funding Source: NIH RePORTER	We thank the subjects who contributed to this research. This work was supported by NIH NIEHS (grants R01ES010544, P01ES016732 and U54ES012078) and NINDS (P50NS038367); initial pilot funding was provided from NIH P30ES007048 and by the American Parkinson Disease Association. MJF was supported through the Canada Excellence Research Chairs program and Leading Edge Endowment Funds; JSS is supported in part by NIH grant GM053275.	Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kang GA, 2005, MOVEMENT DISORD, V20, P1133, DOI 10.1002/mds.20513; Kay DM, 2008, AM J MED GENET B, V147B, P1222, DOI 10.1002/ajmg.b.30758; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McCarthy JJ, 2011, NEUROGENETICS, V12, P59, DOI 10.1007/s10048-010-0263-4; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Myhre R, 2008, ACTA NEUROL SCAND, V118, P320, DOI 10.1111/j.1600-0404.2008.01019.x; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4	24	10	11	1	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAY	2015	22	5					874	878		10.1111/ene.12585			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CF5BC	WOS:000352568600022	25370538	Green Accepted, Green Published			2022-02-06	
J	Matic, GT; Sommerfeldt, MF; Best, TM; Collins, CL; Comstock, RD; Flanigan, DC				Matic, George T.; Sommerfeldt, Mark F.; Best, Thomas M.; Collins, Christy L.; Comstock, R. Dawn; Flanigan, David C.			Ice hockey injuries among United States high school athletes from 2008/2009-2012/2013	PHYSICIAN AND SPORTSMEDICINE			English	Article						Ice hockey; injury rates; concussion; body checking; high school athletes	US EMERGENCY-DEPARTMENTS; SPORTS-RELATED FRACTURES; BODY-CHECKING; EPIDEMIOLOGY; RATES; MENS; PLAYERS; ASSOCIATION; CONCUSSIONS; RISK	Background. The popularity of ice hockey has grown in recent years and injuries are a concern given the physical nature of the sport. We sought to report the rates, mechanisms, and severity of boys' US high school ice hockey injuries. We hypothesized that body checking would be a major source of injury and that concussions would be common. We also expected to find that competition would have a higher rate of injury than practice. Design. Descriptive epidemiology study. Methods. Boys' US high school ice hockey injury data from 2008/2009 through 2012/2013 academic years were obtained from the National High School Sports-Related Injury Surveillance System, High School Reporting Information Online database. The primary outcome was rate of injury per 10,000 athlete exposures (AEs). Results. Overall, 724 boys ice hockey injuries occurred during 311,817 AEs for an injury rate of 23.2 per 10,000 AEs. Injury rates were significantly higher during competition compared to practice (rate ratio = 7.8, 95% confidence interval: 6.5-9.4). Concussion was the most frequent injury reported at a rate of 6.4 per 10,000 AEs. Body checking was the mechanism of injury in over 46% of injuries. The head/face/neck region (33.8%) and upper arm/shoulder region (20.6%) were the most commonly injured body sites. Just over 6% of injuries resulted in surgical intervention. Conclusion. Injuries among high school ice hockey athletes are common. Increases in the number of high school ice hockey injuries will likely parallel the increase in high school ice hockey participation in the United States.	[Matic, George T.; Sommerfeldt, Mark F.] Ohio State Univ, Dept Orthopaed, Columbus, OH 43221 USA; [Best, Thomas M.] Ohio State Univ, Dept Family Med, Div Sports Med, Columbus, OH 43221 USA; [Best, Thomas M.] Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43221 USA; [Collins, Christy L.] Ohio Hlth Res & Innovat Inst, Columbus, OH USA; [Comstock, R. Dawn] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Pediat Emergency Med, Aurora, CO USA; [Flanigan, David C.] Ohio State Univ, Ctr Sports Med, Dept Orthopaed, Columbus, OH 43221 USA; [Flanigan, David C.] Cartilage Restorat Program, Columbus, OH 43221 USA		Flanigan, DC (corresponding author), Ohio State Univ, Ctr Sports Med, Dept Orthopaed, 2050 Kenny Rd,Suite 3100, Columbus, OH 43221 USA.	David.flanigan@osumc.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; NFHS; NOCSAE; DonJoy Orthotics; EyeBlack; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000674, R49CE001172] Funding Source: NIH RePORTER	The content of this report provided by the High School RIO surveillance System was funded in part by the Centers for Disease Control and Prevention (grant No. R49/CE000674-01 and R49/CE001172-01). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors also acknowledge the generous research funding contributions of the NFHS, NOCSAE, DonJoy Orthotics, and EyeBlack. An additional acknowledgement goes to the hundreds of certified athletic trainers who have reported data to High School RIO - without their dedication this dataset would not exist.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2010, CAN J SURG, V53, P319; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Collins CL, 2014, INJURY EPIDEMIOL, V1, pe13; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Dwyer T, 2013, CLIN SPORT MED, V32, P803, DOI 10.1016/j.csm.2013.07.013; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; FINKE R C, 1988, Journal of Orthopaedic and Sports Physical Therapy, V10, P54; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hochmuth K, 2006, EUR RADIOL, V16, P998, DOI 10.1007/s00330-005-0067-3; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McKay CD, 2014, BRIT J SPORT MED, V48, P57, DOI 10.1136/bjsports-2013-092860; Molsa J, 2003, AM J SPORT MED, V31, P751; National. National Hockey League, 2012, 2012 MOLS CAN NHL AL; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Pinto M, 1999, CLIN J SPORT MED, V9, P70, DOI 10.1097/00042752-199904000-00005; Rechel JA, 2011, J TRAUMA, V71, P982, DOI 10.1097/TA.0b013e318230e716; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; SIM FH, 1987, AM J SPORT MED, V15, P30, DOI 10.1177/036354658701500105; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	37	10	10	0	13	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	MAY	2015	43	2					119	125		10.1080/00913847.2015.1035210			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	CK6NC	WOS:000356343800004	25913938				2022-02-06	
J	Mouthaan, J; Sijbrandij, M; Reitsma, JB; Luitse, JSK; Goslings, JC; Gersons, BPR; Olff, M				Mouthaan, Joanne; Sijbrandij, Marit; Reitsma, Johannes B.; Luitse, Jan S. K.; Goslings, J. Carel; Gersons, Berthold P. R.; Olff, Miranda			The role of early pharmacotherapy in the development of posttraumatic stress disorder symptoms after traumatic injury: an observational cohort study in consecutive patients	GENERAL HOSPITAL PSYCHIATRY			English	Article						Opiates; Posttraumatic stress disorder; Prevention; Pharmacotherapy; Injury	VEHICLE ACCIDENT VICTIMS; ADMINISTERED PTSD SCALE; URINARY CORTISOL-LEVELS; HEART-RATE; NORADRENALINE RELEASE; BRAIN-REGIONS; SECONDARY PREVENTION; SEPTIC SHOCK; ANIMAL-MODEL; MORPHINE	Objective: Pharmacological intervention during traumatic memory consolidation has been suggested to prevent posttraumatic stress disorder (PTSD). The aim of this study was to examine the association between prescription of early pharmacotherapy and the risk of developing PTSD symptoms following traumatic injury. Method: The use of opiate analgesics, beta-adrenergic blockers, corticosteroids and benzodiazepines within 48 h postinjury was documented based on hospital charts for 629 Level 1 trauma center patients. PTSD symptoms were assessed using structured clinical interviews. Primary outcome was 6-week PTSD symptoms. Secondary outcomes were PTSD diagnoses at 6 weeks and during 1 year posttrauma. Results: Linear regression analyses showed that opiate administration within 48 h was negatively associated with PTSD symptoms at 6 weeks (beta=-0.14, P=.009) after controlling for demographic and injury-related characteristics and concurrent pharmacotherapy. Fewer patients with opiates had a PTSD diagnosis at 6 weeks (P=.047) and during 1 year posttrauma (P=.013) than patients with none of the specified pharmacotherapies. Low prescription frequency of beta-blockers (3.8%), corticosteroids (2.2%) and benzodiazepines (7.8%) precluded further examination of their role in the development of PTSD symptoms because of limited statistical power. Conclusions: This study suggests a possible beneficial influence of opiate administration within 48 h posttrauma on the development of PTSD symptoms. Future studies may evaluate the effectiveness of inhospital opiate analgesics compared to placebo in preventing PTSD and may focus on the mechanisms underlying the effect of opiates in preventing PTSD. (C) 2015 Elsevier Inc. All rights reserved.	[Mouthaan, Joanne; Gersons, Berthold P. R.; Olff, Miranda] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Mouthaan, Joanne] Leiden Univ, Inst Psychol, Dept Clin Psychol, NL-2333 AK Leiden, Netherlands; [Sijbrandij, Marit] Vrije Univ Amsterdam, Dept Clin Psychol, NL-1081 BT Amsterdam, Netherlands; [Sijbrandij, Marit] EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Luitse, Jan S. K.; Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Dept Surg, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands; [Gersons, Berthold P. R.; Olff, Miranda] Arq Psychotrauma Expert Grp, NL-1112 XE Diemen, Netherlands		Mouthaan, J (corresponding author), Leiden Univ, Inst Psychol, Dept Clin Psychol, Wassenaarseweg 52, NL-2333 AK Leiden, Netherlands.	j.mouthaan@fsw.leidenuniv.nl; e.m.sijbrandij@vu.nl; j.b.reitsma-2@umcutrecht.nl; j.s.luitse@amc.uva.nl; j.c.goslings@amc.uva.nl; b.gersons@arq.org; m.olff@amc.uva.nl	Olff, Miranda/S-6235-2019; Sijbrandij, Marit/N-6131-2018	Sijbrandij, Marit/0000-0001-5430-9810; Olff, Miranda/0000-0003-1016-9515; Mouthaan, Joanne/0000-0003-2491-7457			Aardal-Eriksson E, 2001, BIOL PSYCHIAT, V50, P986, DOI 10.1016/S0006-3223(01)01253-7; al Arab AS, 2012, J PSYCHIATR RES, V46, P790, DOI 10.1016/j.jpsychires.2012.02.006; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; CHRISTIE MJ, 1991, PROG BRAIN RES, V88, P197; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Cohen H, 2006, BIOL PSYCHIAT, V59, P1208, DOI 10.1016/j.biopsych.2005.12.003; Cohen H, 2011, EUR NEUROPSYCHOPHARM, V21, P230, DOI 10.1016/j.euroneuro.2010.11.011; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Delahanty DL, 2003, J ANXIETY DISORD, V17, P149, DOI 10.1016/S0887-6185(02)00185-8; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Delahanty DL, 2013, CNS SPECTRUMS, V18, P103, DOI 10.1017/S1092852913000096; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehring T, 2008, PSYCHIAT RES, V161, P67, DOI 10.1016/j.psychres.2007.08.014; Gelpin E, 1996, J CLIN PSYCHIAT, V57, P390; GOOD AJ, 1995, BEHAV NEUROSCI, V109, P631, DOI 10.1037/0735-7044.109.4.631; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; KOHNO Y, 1983, EUR J PHARMACOL, V92, P265, DOI 10.1016/0014-2999(83)90296-0; Matar MA, 2009, EUR NEUROPSYCHOPHARM, V19, P283, DOI 10.1016/j.euroneuro.2008.12.004; McFarlane AC, 1997, ANN NY ACAD SCI, V821, P437, DOI 10.1111/j.1749-6632.1997.tb48299.x; McFarlane AC, 2011, PSYCHONEUROENDOCRINO, V36, P720, DOI 10.1016/j.psyneuen.2010.10.007; McGhee LL, 2009, J TRAUMA, V66, pS186, DOI 10.1097/TA.0b013e31819ce2f0; McGhee LL, 2009, J BURN CARE RES, V30, P92, DOI 10.1097/BCR.0b013e3181921f51; McNally GP, 2003, J EXP PSYCHOL ANIM B, V29, P130, DOI 10.1037/0097-7403.29.2.130; Mellman TA, 1998, J TRAUMA STRESS, V11, P563, DOI 10.1023/A:1024460814230; Mouthaan J, 2014, PSYCHONEUROENDOCRINO, V45, P179, DOI 10.1016/j.psyneuen.2014.04.001; Mouthaan J, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8294; Nixon RDV, 2010, BEHAV RES THER, V48, P810, DOI 10.1016/j.brat.2010.05.002; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Nugent NR, 2010, J TRAUMA STRESS, V23, P282, DOI 10.1002/jts.20517; O'Donnell ML, 2007, PSYCHOSOM MED, V69, P256, DOI 10.1097/PSY.0b013e3180417d04; Olff M, 2005, PSYCHONEUROENDOCRINO, V30, P974, DOI 10.1016/j.psyneuen.2005.04.009; Page C., 2005, INTEGRATED PHARM; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Resnick HS, 1997, ANN NY ACAD SCI, V821, P433, DOI 10.1111/j.1749-6632.1997.tb48298.x; Rose S, 2003, PSYCHOTHER PSYCHOSOM, V72, P176, DOI 10.1159/000070781; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014; Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7; Schelling G, 1999, CRIT CARE MED, V27, P2678, DOI 10.1097/00003246-199912000-00012; Schelling G, 2006, ANN NY ACAD SCI, V1071, P46, DOI 10.1196/annals.1364.005; Sijbrandij M, 2006, BRIT J PSYCHIAT, V189, P150, DOI 10.1192/bjp.bp.105.021121; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Stoddard FJ, 2009, J BURN CARE RES, V30, P836, DOI 10.1097/BCR.0b013e3181b48102; TANAKA M, 1991, PHARMACOL BIOCHEM BE, V39, P191, DOI 10.1016/0091-3057(91)90420-7; TANAKA M, 1983, BRAIN RES, V275, P105, DOI 10.1016/0006-8993(83)90422-5; TEASDALE G, 1974, LANCET, V2, P81; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; van Buuren S, 2011, HDB ADV MULTILEVEL A, P173, DOI DOI 10.4324/9780203848852-18; van Stegeren AH, 2008, ACTA PSYCHOL, V127, P532, DOI 10.1016/j.actpsy.2007.10.004; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WESTBROOK RF, 1991, J EXP PSYCHOL ANIM B, V17, P219; Yehuda R, 1998, BIOL PSYCHIAT, V43, P855, DOI 10.1016/S0006-3223(97)00554-4; Yehuda R, 2002, PSYCHIAT QUART, V73, P123, DOI 10.1023/A:1015055711424; Zatzick DF, 2005, BIOL PSYCHIAT, V57, P91, DOI 10.1016/j.biopsych.2004.10.005; Zatzick D, 2006, PSYCHIAT SERV, V57, P1726, DOI 10.1176/appi.ps.57.12.1726; Zatzick DF, 2007, J TRAUMA STRESS, V20, P401, DOI 10.1002/jts.20256; Zohar Joseph, 2011, Dialogues Clin Neurosci, V13, P301; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001	67	10	11	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	MAY-JUN	2015	37	3					230	235		10.1016/j.genhosppsych.2015.02.010			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CI9VN	WOS:000355118300005	25805128				2022-02-06	
J	Munch, TN; Gortz, S; Wohlfahrt, J; Melbye, M				Munch, Tina Noergaard; Gortz, Sanne; Wohlfahrt, Jan; Melbye, Mads			The long-term risk of malignant astrocytic tumors after structural brain injury-a nationwide cohort study	NEURO-ONCOLOGY			English	Article						anaplastic astrocytoma; astrogliosis; brain injury; epidemiology; glioblastoma	GLIOBLASTOMA-MULTIFORME; POSTTRAUMATIC GLIOMA; GENETIC-VARIANTS; REACTIVE GLIOSIS; ADULT GLIOMA; HEAD TRAUMA; POPULATION; ALLERGY; ORIGIN; SYSTEM	Background. Neoplastic transformation of damaged astrocytes has been proposed as a possible pathological mechanism behind malignant astrocytic tumors. This study investigated the association between structural brain injuries causing reactive astrogliosis and long-term risk for malignant astrocytic tumors. Methods. The cohort consisted of all individuals living in Denmark between 1978 and 2011. The personal identification number assigned to all individuals allowed retrieval of diagnoses of traumatic brain injury, cerebral ischemic infarction, and intracerebral hemorrhage from the National Patient Discharge Register. Diagnoses of anaplastic astrocytoma and glioblastoma multiforme (World Health Organization grades III and IV) were retrieved from the Danish Cancer Registry. Rate ratios (RR's) were estimated using log-linear Poisson regression. Results. In a cohort of 8.2 million individuals, 404 812 experienced a structural brain injury and 6152 developed a malignant astrocytic tumor. No significant association was observed 1-4 years after a structural brain injury (RR = 1.14; 95% CI: 0.87-1.46), whereas the long-term (5 + y) risk for malignant astrocytic tumors was significantly reduced (RR = 0.68; 95% CI: 0.49-0.90) compared with no injury. The specific long-term risks by type of injury were: traumatic brain injury RR = 0.32 (95% CI: 0.10-0.75); cerebral ischemic infarction RR = 0.69 (95% CI: 0.47-0.96); and intracerebral hemorrhage RR = 1.39 (95% CI: 0.64-2.60). Conclusion. We found no evidence for an association between structural brain injury and malignant astrocytic tumors within the first 5 years of follow-up. However, our study indicated a protective effect of astrogliosis-causing injuries 5 or more years after structural brain injury.	[Munch, Tina Noergaard; Gortz, Sanne; Wohlfahrt, Jan; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Munch, Tina Noergaard] Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark		Munch, TN (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Div Hlth Surveillance & Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	tnm@ssi.dk		melbye, mads/0000-0001-8264-6785; Munch, Tina Norgaard/0000-0001-5938-000X			Aalen OO, 2008, SURVIVAL EVENT HIST, P223; Amirian E, 2010, NEURO-ONCOLOGY, V12, P444, DOI 10.1093/neuonc/nop057; Andersen TF, 1999, DAN MED BULL, V46, P263; Anselmi E, 2006, TUMORI J, V92, P175, DOI 10.1177/030089160609200215; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chen YH, 2012, J NEUROTRAUM, V29, P1328, DOI 10.1089/neu.2011.2235; DiTrapani G, 1996, ITAL J NEUROL SCI, V17, P283, DOI 10.1007/BF01997787; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; Hu JF, 1998, CANCER DETECT PREV, V22, P100, DOI 10.1046/j.1525-1500.1998.CDOA22.x; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Katz AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032453; Lachance DH, 2011, AM J EPIDEMIOL, V174, P574, DOI 10.1093/aje/kwr124; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Magnavita N, 2003, NEUROL SCI, V24, P31, DOI 10.1007/s100720300018; Moorthy RK, 2004, SURG NEUROL, V61, P180, DOI 10.1016/S0090-3019(03)00423-3; Mrowka R, 1978, Zentralbl Neurochir, V39, P57; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Pedersen CB, 2006, DAN MED BULL, V53, P441; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Sabel M, 1999, J NEUROSURG, V91, P1041, DOI 10.3171/jns.1999.91.6.1041; Schoemaker MJ, 2010, AM J EPIDEMIOL, V171, P1165, DOI 10.1093/aje/kwq075; Shafqat S, 1999, NEUROLOGY, V52, P867, DOI 10.1212/WNL.52.4.867; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Storm HH, 1997, DAN MED BULL, V44, P535; Thorsteinsson Rikke, 2005, Ugeskr Laeger, V167, P3782; WITZMANN A, 1981, NEUROCHIRURGIA, V24, P202; ZAMPIERI P, 1994, J NEURO-ONCOL, V19, P61, DOI 10.1007/BF01051049; Zhou B, 2010, INT J MED SCI, V7, P248	35	10	10	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1522-8517	1523-5866		NEURO-ONCOLOGY	Neuro-Oncology	MAY	2015	17	5					718	724		10.1093/neuonc/nou312			7	Oncology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Neurosciences & Neurology	CK5KO	WOS:000356263100012	25416827	Bronze, Green Published			2022-02-06	
J	Pedersen, AR; Severinsen, K; Nielsen, JF				Pedersen, Asger R.; Severinsen, Kaare; Nielsen, Jorgen F.			The Effect of Age on Rehabilitation Outcome After Traumatic Brain Injury Assessed by the Functional Independence Measure (FIM)	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain injuries; rehabilitation; treatment outcome; inpatients; physical and rehabilitation medicine	INPATIENT REHABILITATION; OLDER-ADULTS; MORTALITY; IMPACT	Background. The impact of age on rehabilitation outcome after traumatic brain injury (TBI) as measured by changes in the Functional Independence Measure (FIM) has been addressed in several seemingly conflicting reports. Differences may be explained by different study populations and different ways of analyzing data. Objective. To investigate the role of data analysis in the interpretation of the age effect on rehabilitation outcome after TBI by comparing classical analyses of the total FIM score with a new item-wise analysis that unfolds the comprehensive amount of information contained in the FIM measurement otherwise concealed by the total score. Methods. We analyzed admission and discharge FIM data from 411 consecutive TBI patients admitted to inpatient rehabilitation during 1998-2011 by both methods. Results. The classical analysis indicated similar rehabilitation outcome in the 18 to 39, 40 to 64, and 65+ years age groups, which could be explained by selection of strong elderly patients and/or methodological problems with classical data analyses, whereas the item-wise analysis demonstrated profound age effect on most FIM items throughout the age interval covered. Conclusions. The item-wise analysis meets requirements of proper data analysis, avoids concealing diversity in rehabilitation outcome behind the total FIM score, and provides a flexible, informative, and clinically relevant data analysis.	[Pedersen, Asger R.; Severinsen, Kaare; Nielsen, Jorgen F.] Aarhus Univ, DK-8450 Hammel, Denmark		Pedersen, AR (corresponding author), Aarhus Univ, Hammel Neurorehabil & Res Ctr, Voldbyvej 15, DK-8450 Hammel, Denmark.	asgepede@rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021	Nielsen, Jorgen Feldbak/0000-0001-5339-171X			Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Fischer GH, 1995, RASCH MODELS FDN REC; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE Jr, 2017, REGRESSION MODELING; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Lemeshow S, 2000, APPL LOGISTIC REGRES; Linn R T, 1999, J Outcome Meas, V3, P339; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nilsson AL, 2011, J REHABIL MED, V43, P884, DOI 10.2340/16501977-0871; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004	17	10	12	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2015	29	4					299	307		10.1177/1545968314545171			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CE8DL	WOS:000352071400001	25096275				2022-02-06	
J	Skaare, AB; Aas, ALM; Wang, NJ				Skaare, Anne B.; Aas, Anne-Lise Maseng; Wang, Nina J.			Enamel defects on permanent successors following luxation injuries to primary teeth and carers' experiences	INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY			English	Article							TRAUMATIC DENTAL INJURIES; PRIMARY PREDECESSORS; PRIMARY DENTITION; CHILDREN; MANAGEMENT; INCISORS; ANXIETY	BackgroundTrauma to primary teeth may have consequences. AimTo study frequency of enamel defects in permanent successors after luxation injuries, and to report carers' experiences. MethodsChildren 8-15years (n=170) suffering luxation injury to primary dentition in 2003 were reexamined in 2010. Permanent successors (n=300) were clinically examined and photographed. Data from dental records, registration form and a questionnaire were analysed by cross-tabulation and tested by chi-square and t-test. ResultsEnamel defects were registered in 130 successor teeth, 22% due to trauma, 21% due to other aetiological factors (MIH, dental fluorosis, idiopathic). Successors with enamel defects were after concussion 8%, subluxation 18%, lateral luxation 41%, intrusion 38% and avulsion 47%. Enamel defects were associated with the child's age and severity of the injury (P<0.05). Six children had enamel defects in successors of non-injured primary teeth. Anxiety recorded by carers was associated with severity and number of injured teeth (P<0.05). According to carers eight children developed dental fear, seven were younger than 3.5years and had had their injured teeth removed. ConclusionMinor luxation injuries and indirect trauma may cause enamel defects in permanent successors. Lower age at injury, severity and number of injured teeth affect carer and child negatively.	[Skaare, Anne B.; Aas, Anne-Lise Maseng; Wang, Nina J.] Univ Oslo, Inst Clin Dent, Dept Paediat Dent & Behav Sci, N-0317 Oslo, Norway		Skaare, AB (corresponding author), Univ Oslo, Inst Clin Dent, Dept Paediat Dent & Behav Sci, POB 1109 Blindern, N-0317 Oslo, Norway.	askaare@odont.uio.no					Abanto J, 2012, COMMUNITY DENT ORAL, V40, P323, DOI 10.1111/j.1600-0528.2012.00672.x; Altun C, 2009, ORAL SURG ORAL MED O, V107, P493, DOI 10.1016/j.tripleo.2008.10.016; ANDREASEN J O, 1971, Scandinavian Journal of Dental Research, V79, P219; ANDREASEN J O, 1971, Scandinavian Journal of Dental Research, V79, P284; Andreasen J O, 1972, Int J Oral Surg, V1, P235, DOI 10.1016/S0300-9785(72)80042-5; ANDREASEN JO, 1973, SCAND J DENT RES, V81, P203; Brin I, 1984, Pediatr Dent, V6, P78; Christophersen P, 2005, DENT TRAUMATOL, V21, P320, DOI 10.1111/j.1600-9657.2005.00323.x; CLARKSON J, 1989, J DENT RES, V68, P445, DOI 10.1177/00220345890680030201; Cordeiro Mabel Mariela Rodriguez, 2005, J Clin Pediatr Dent, V29, P193; Assuncao LRD, 2009, DENT TRAUMATOL, V25, P165, DOI 10.1111/j.1600-9657.2008.00759.x; de Jongh A, 2003, COMMUNITY DENT ORAL, V31, P52; Jacomo DRDS, 2009, DENT TRAUMATOL, V25, P300, DOI 10.1111/j.1600-9657.2009.00764.x; Flores MT, 2002, DENT TRAUMATOL, V18, P287, DOI 10.1034/j.1600-9657.2002.00153.x; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; de Amorim LDG, 2011, DENT TRAUMATOL, V27, P117, DOI 10.1111/j.1600-9657.2010.00959.x; Malmgren B, 2012, DENT TRAUMATOL, V28, P174, DOI 10.1111/j.1600-9657.2012.01146.x; Needleman HL, 2011, DENT TRAUMATOL, V27, P295, DOI 10.1111/j.1600-9657.2011.01005.x; Ramos-Jorge ML, 2013, DENT TRAUMATOL, V29, P266, DOI 10.1111/edt.12005; Robson F, 2009, DENT TRAUMATOL, V25, P118, DOI 10.1111/j.1600-9657.2008.00725.x; Sennhenn-Kirchner S, 2006, DENT TRAUMATOL, V22, P237, DOI 10.1111/j.1600-9657.2006.00383.x; Sheinvald-Shusterman K, 2012, DENT TRAUMATOL, V28, P273, DOI 10.1111/j.1600-9657.2011.01080.x; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; Skaare AB, 2013, DENT TRAUMATOL, V29, P79, DOI 10.1111/j.1600-9657.2012.01153.x; Skaret E, 1999, EUR J ORAL SCI, V107, P422, DOI 10.1046/j.0909-8836.1999.eos107602.x; VALDERHAUG J, 1974, INT J ORAL MAXILLOF, V3, P171, DOI 10.1016/S0300-9785(74)80022-0; VONARX T, 1993, AUST DENT J, V38, P1; Wendt FP, 2010, DENT TRAUMATOL, V26, P168, DOI 10.1111/j.1600-9657.2009.00852.x; Wilson S, 2013, PEDIATR DENT, V35, P170	29	10	10	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7439	1365-263X		INT J PAEDIATR DENT	Int. J. Paediatr. Dent.	MAY	2015	25	3					221	228		10.1111/ipd.12136			8	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	CF5FW	WOS:000352583600009	25201083				2022-02-06	
J	Varano, P; Cabrera, KI; Kuppermann, N; Dayan, PS				Varano, Paul; Cabrera, Keven I.; Kuppermann, Nathan; Dayan, Peter S.			Acute outcomes of isolated cerebral contusions in children with Glasgow Coma Scale scores of 14 to 15 after blunt head trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; cerebral contusion; pediatrics; prognosis; emergency	PROGRESSION; INJURY	BACKGROUND: Little data exist to guide the management of children with cerebral contusions after minor blunt head trauma. We therefore aimed to determine the risk of acute adverse outcomes in children with minor blunt head trauma who had cerebral contusions and no other traumatic brain injuries on computed tomography (i.e., isolated cerebral contusions). METHODS: We conducted a secondary analysis of a public use data set originating from a prospective cohort study performed in 25 PECARN (Pediatric Emergency Care Applied Research Network) emergency departments of children younger than 18 years with blunt head trauma resulting from nontrivial injury mechanisms and with Glasgow Coma Scale (GCS) scores of 14 or 15. In this analysis, we included only children with isolated cerebral contusions. We defined a normal mental status as a GCS score of 15 and no other signs of abnormal mental status. Acute adverse outcomes included intubation longer than 24 hours because of the head trauma, neurosurgery, or death from the head injury. RESULTS: Of 14,983 children with GCS scores of 14 or 15 who received cranial computed tomography scans in the parent study, 152 (1.0%; 95% confidence interval, 0.8-1.2%) had cerebral contusions, of which 54 (35.8%) of 151 with available data were isolated. The median age of those with isolated cerebral contusions was 9 years (interquartile range, 1-13); 31 (57.4%) had a normal mental status. Of 36 patients with available data on isolated cerebral contusion size, 34 (94.4%) were described as small. 43 (79.6%) of 54 patients with isolated cerebral contusions were hospitalized, including 16 (29.6%) of 54 to an intensive care unit. No patients with isolated cerebral contusions died, were intubated longer than 24 hours for head trauma, or required neurosurgery (95% confidence interval for all outcomes, 0-6.6%). CONCLUSION: Children with small isolated cerebral contusions after minor blunt head trauma are unlikely to require further acute intervention, including neurosurgery, suggesting that neither intensive care unit admission nor prolonged hospitalization is generally required. (J Trauma Acute Care Surg. 2015;78: 1039-1043. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Varano, Paul] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Cabrera, Keven I.; Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Dept Pediat, Div Emergency Med, New York, NY 10032 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA		Dayan, PS (corresponding author), Morgan Stanley Childrens Hosp, 3959 Broadway CHN 1-116, New York, NY 10032 USA.	psd6@columbia.edu			HRSA/MCHB/EMSCUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)	This manuscript was prepared using the "Identification of children at very low risk of clinically important brain injuries after head trauma: a prospective cohort study" Data Set and does not necessarily reflect the opinions or views of the TBI Trial investigators, the Health Resources Services Administration (HRSA), the Maternal Child Health Bureau (MCHB), or Emergency Medical Services for Children (EMSC). The PECARN is funded by the HRSA/MCHB/EMSC.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Faul M, 2010, TRAUMATIC BRAIN INJU; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Pediatric Emergency Care Research Network (PECARN), ID CHILDR VER LOW RI; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	13	10	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2015	78	5					1039	1043		10.1097/TA.0000000000000604			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CH3KR	WOS:000353930100022	25909428				2022-02-06	
J	Choi, YM; Hong, SH; Lee, CH; Kang, JH; Oh, JS				Choi, Yong Min; Hong, Seok Hyun; Lee, Chang Hyun; Kang, Jin Ho; Oh, Ju Sun			Extracorporeal Shock Wave Therapy for Painful Chronic Neurogenic Heterotopic Ossification After Traumatic Brain Injury: A Case Report	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Heterotopic ossification; Extracorporeal shock wave therapy; Brain injury		Neurogenic heterotopic ossification (NHO) is a process of benign bone formation and growth in soft tissues surrounding major synovial joints and is associated with central nervous system (CNS) injuries. It is a common complication in major CNS injuries, such as traumatic brain injury, spinal cord injury, and stroke. Here, we report the case of a 72-year-old male, who experienced a traumatic brain injury and painful chronic NHO around the left hip joint. Three applications of extracorporeal shock wave therapy (ESWT) were administered to the area of NHO, which resulted in pain relief and an improvement in the loss of motion in the left hip joint. Improvements were also noted in walking performance and activities of daily living, although the size of NHO remained unchanged. Therapeutic effects of ESWT lasted for 12 weeks.	[Choi, Yong Min; Hong, Seok Hyun; Lee, Chang Hyun; Kang, Jin Ho; Oh, Ju Sun] Seoul Med Ctr, Dept Rehabil Med, 371-6 Sinnae Dong, Seoul 131130, South Korea		Oh, JS (corresponding author), Seoul Med Ctr, Dept Rehabil Med, 371-6 Sinnae Dong, Seoul 131130, South Korea.	sunnywind78@gmail.com					Mariotto S, 2009, CURR MED CHEM, V16, P2366, DOI 10.2174/092986709788682119; Riedel W, 2001, Z RHEUMATOL, V60, P404, DOI 10.1007/s003930170003; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Takahashi N, 2003, AUTON NEUROSCI-BASIC, V107, P81, DOI 10.1016/S1566-0702(03)00134-6; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; VARGHESE G, 1991, ARCH PHYS MED REHAB, V72, P1009; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Wess OJ, 2008, UROL RES, V36, P327, DOI 10.1007/s00240-008-0156-2	10	10	10	0	1	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	APR	2015	39	2					318	322		10.5535/arm.2015.39.2.318			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC6DL	WOS:000433889100022	25932431	gold, Green Published, Green Submitted			2022-02-06	
J	Coyne, JH; Borg, JM; DeLuca, J; Glass, L; Sumowski, JF				Coyne, Julia H.; Borg, Jacquelyn M.; DeLuca, John; Glass, Leslie; Sumowski, James F.			Retrieval Practice as an Effective Memory Strategy in Children and Adolescents With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Memory; Rehabilitation; Testing effect; Traumatic brain injury	PEDIATRIC TBI; RECOVERY	Objective: To investigate whether retrieval practice (RP) is a more effective memory strategy than restudy in children and adolescents with traumatic brain injury (TBI). Design: Three x two within-subjects experiment: 3 (learning condition: massed restudy [MR], spaced restudy [SR], retrieval practice [RP]) x 2 (stimulus type: verbal paired associates [VPAs] and face-name pairs [FNPs]). The dependent measure was delayed recall of VPAs and FNPs. Setting: Subacute pediatric neurorehabilitation center. Participants: Pediatric survivors of TBI (N=15) aged 8 to 16 years with below-average memory. Intervention: During RP, participants were quizzed on to-be-learned information (VPAs and FNPs) shortly after it was presented, such that they practiced retrieval during the learning phase. MR consisted of repeated restudy (tantamount to cramming). SR consisted of restudy trials separated in time (ie, distributed learning). Main Outcome Measures: Delayed recall of 24 VPAs and 24 FNPs after a 25-minute delay. VPAs and FNPs were equally divided across 3 learning conditions (16 per condition). Results: There was a large main effect of learning condition on delayed recall (P<.001; eta(2)(p)=.84), with better mean recall of VPAs and FNPs studied through RP (6.23 +/- 1.39) relative to MR (3.60 +/- 1.53; P<.001) and SR (4.77 +/- 1.39; P<.001). Moreover, RP was the single best learning strategy for every participant. Conclusions: Memory problems and related academic learning difficulties are common after pediatric TBI. Herein, we identify RP as a promising and simple strategy to support learning and improve memory in children and adolescents with TBI. Our experimental findings were quite robust and set the stage for subsequent randomized controlled trials of RP in pediatric TBI. Archives of Physical Medicine and Rehabilitation 2015;96:742-5 (C) 2015 by the American Congress of Rehabilitation Medicine	[Coyne, Julia H.; DeLuca, John; Sumowski, James F.] Kessler Fdn, W Orange, NJ 07052 USA; [Coyne, Julia H.; Borg, Jacquelyn M.; Glass, Leslie; Sumowski, James F.] Childrens Specialized Hosp, Mountainside, NJ USA; [Coyne, Julia H.; DeLuca, John; Sumowski, James F.] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA; [DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07102 USA		Sumowski, JF (corresponding author), Kessler Fdn, 300 Execut Dr,Ste 70, W Orange, NJ 07052 USA.	jsumowski@kesslerfoundation.org			Children's Specialized Hospital	Supported by Children's Specialized Hospital.	Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Faul M, 2010, TRAUMATIC BRAIN INJU; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Nybo T, 1999, BRAIN INJURY, V13, P759; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Sumowski JF, 2014, ARCH PHYS MED REHAB, V95, P397, DOI 10.1016/j.apmr.2013.10.021; Sumowski JF, 2010, J INT NEUROPSYCH SOC, V16, P1147, DOI 10.1017/S1355617710001128	10	10	11	1	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4					742	745		10.1016/j.apmr.2014.09.022			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CE9RC	WOS:000352180100022	25312580				2022-02-06	
J	Kheirabadi, BS; Valdez-Delgado, KK; Terrazas, LB; Miranda, N; Dubick, MA				Kheirabadi, Bijan S.; Valdez-Delgado, Krystal K.; Terrazas, Lrasema B.; Miranda, Nahir; Dubick, Michael A.			Is limited prehospital resuscitation with plasma more beneficial than using a synthetic colloid? An experimental study in rabbits with parenchymal bleeding	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Prehospital resuscitation; plasma; albumin; Hextend; uncontrolled hemorrhage; rabbit	TRAUMATIC BRAIN-INJURY; FREEZE-DRIED PLASMA; DAMAGE CONTROL RESUSCITATION; FLUID RESUSCITATION; DILUTIONAL COAGULOPATHY; INCREASING HEMORRHAGE; ALBUMIN RESUSCITATION; TRANSFUSION; STRATEGIES; HEXTEND(R)	BACKGROUND: Reports of survival benefits of early transfusion of plasma with red blood cells (1: 1 ratio) in trauma patients suggest that plasma may be a better fluid to replace Hextend for battlefield resuscitation. We studied possible advantages of prehospital resuscitation with plasma compared with Hextend or albumin in a model of uncontrolled hemorrhage. METHODS: Male New Zealand white rabbits (3.3 +/- 0.1 kg) were anesthetized, instrumented, and subjected to a splenic injury with uncontrolled bleeding. Ten minutes after injury (mean arterial pressure [MAP] < 40 mm Hg), the rabbits received small and equal volumes (15 mL/kg) of rabbit plasma (n = 10), Hextend (n = 10), or 5% human albumin (n = 9) or no fluid. Fluids were administered in two bolus injections (20 minutes apart) and targeted to a MAP of 65 mm Hg. Animals were monitored for 2.5 hours or until death, and their blood losses were measured. Arterial blood samples were collected at different times and analyzed for ABG, CBC, and coagulation tests. RESULTS: There were no differences in baseline measures among groups. Splenic injury caused similar hemorrhages (9.1 +/- 0.4 mL/kg at 10 minutes) and decreased MAP in all subjects. Subsequent resuscitation initiated additional bleeding. At 60 minutes after injury (20 minutes after resuscitation), longer activated partial thromboplastin time and lower fibrinogen concentrations were apparent compared with baseline values with differences among groups. Thrombelastography analysis indicated faster and stronger clot formation with plasma and albumin resuscitation than with Hextend use. Shock indices were increased in all groups, but smaller changes were measured in the albumin group. Total blood loss did not differ among resuscitated rabbits but was higher (p < 0.05) than among nonresuscitated animals. Survival rates were 11% (untreated), 40% (Hextend and plasma), and 89% (albumin, p < 0.05). CONCLUSION: Resuscitation with plasma or albumin better preserved coagulation function than did Hextend. However, despite these improvements, plasma resuscitation did not reduce blood loss or improve survival, while albumin administration seemed beneficial. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Kheirabadi, Bijan S.; Valdez-Delgado, Krystal K.; Terrazas, Lrasema B.; Miranda, Nahir; Dubick, Michael A.] US Army Inst Surg Res, Jbsa Ft Sam Houston, TX USA		Kheirabadi, BS (corresponding author), 3650 Chambers Pass,BHT2,Bldg 3610, Ft Sam Houston, TX 78234 USA.	Bijan.s.kheirabadi.civ@mail.mil			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	The authors have no conflict of interest to report. The funding for this work was provided the US Army Medical Research and Materiel Command.	Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Boldt J, 2002, BRIT J ANAESTH, V89, P722, DOI 10.1093/bja/aef242; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Champion HR, 2003, J TRAUMA, V54, pS7, DOI 10.1097/01.TA.0000056154.34788.C6; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038; Demling R H, 1986, Curr Stud Hematol Blood Transfus, P36; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P207, DOI 10.1177/0148607191015002207; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Dutton RP, 2012, BRIT J SURG, V99, P21, DOI 10.1002/bjs.7731; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Glassberg E, 2013, SHOCK, V40, P444, DOI 10.1097/SHK.0000000000000047; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; Hervig T, 2014, SHOCK, V41, P39, DOI 10.1097/SHK.0000000000000144; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; HOLT ME, 1984, BRIT J EXP PATHOL, V65, P231; HU ML, 1993, J LAB CLIN MED, V121, P257; Inaba K, 2010, J AM COLL SURGEONS, V210, P957, DOI 10.1016/j.jamcollsurg.2010.01.031; Kheirabadi BS, 2008, J TRAUMA, V64, P1218, DOI 10.1097/TA.0b013e31816c5c6c; Kheirabadi BS, 2008, J TRAUMA, V64, P1228; Kheirabadi BS, 2014, 2014 AAST ANN M; Kim BD, 2012, J TRAUMA ACUTE CARE, V73, pS49, DOI 10.1097/TA.0b013e31826060ff; Martinaud C, 2011, J TRAUMA, V71, P1761, DOI 10.1097/TA.0b013e31822f1285; McCammon AT, 2002, ANESTH ANALG, V95, P844, DOI 10.1097/00000539-200210000-00010; McSwain NE, 2006, PHTLS BASIC ADV PREH; Myburgh J, 2007, NEW ENGL J MED, V357, P874; National Research Council (US), 2011, GUIDE CARE USE LAB A, V8; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Powner DJ, 2011, NEUROCRIT CARE, V14, P482, DOI 10.1007/s12028-011-9513-z; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Shuja F, 2008, J TRAUMA, V65, P975, DOI 10.1097/TA.0b013e3181801cd9; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; Sumida M P, 2000, Air Med J, V19, P140, DOI 10.1016/S1067-991X(00)90007-5; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430; Zhang Y, 2008, J ZHEJIANG UNIV-SC B, V9, P871, DOI 10.1631/jzus.B0820130	38	10	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2015	78	4					752	759		10.1097/TA.0000000000000591			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CE8EJ	WOS:000352074000014	25807404				2022-02-06	
J	Ozbal, S; Cankurt, U; Tugyan, K; Pekcetin, C; Sisman, AR; Gunduz, K; Micili, SC				Ozbal, S.; Cankurt, U.; Tugyan, K.; Pekcetin, C.; Sisman, A. R.; Gunduz, K.; Micili, S. C.			The effects of alpha-lipoic acid on immature rats with traumatic brain injury	BIOTECHNIC & HISTOCHEMISTRY			English	Article						apoptosis; brain injury; hippocampus; alpha-lipoic acid; rats; trauma	ANTIOXIDANT THERAPIES; OXIDATIVE STRESS; PROTECTS; ISCHEMIA/REPERFUSION; NEURONS	Traumatic brain injury (TBI) is a leading cause of morbidity and mortality during childhood. TBI enhances formation of reactive oxygen species that cause neuron damage and apoptosis. alpha-Lipoic acid (LA) is a free radical scavenger and biological antioxidant. We investigated the effects of LA treatment on the parietal and prefrontal cortex, and on the hippocampal regions of the brain in 7-day-old rat pups that had been subjected to contusion injury. Forty-two male rats were divided randomly into a control group, a TBI group and a TBI + LA treated group. LA was administered 30 min after TBI through an intragastric tube once daily for 2 days. Forty-eight hours after TBI, the animals were sacrificed and tissues were examined for apoptosis and density of neurons. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) and active caspase-3 immunostaining were used to detect apoptosis. Glutathione peroxidase (GPx), superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels also were measured. Histological evaluation showed that LA treatment significantly reduced TBI-induced neuronal death in the hippocampus, prefrontal and parietal cortex; TUNEL-and caspase-3-positive cells also were decreased in the same regions. In addition, LA administration increased GPx and SOD activity in the prefrontal cortex. It appears that LA may be beneficial for TBI in rats.	[Ozbal, S.; Cankurt, U.; Tugyan, K.; Pekcetin, C.; Micili, S. C.] Dokuz Eylul Univ, Fac Med, Dept Histol & Embryol, Izmir, Turkey; [Sisman, A. R.; Gunduz, K.] Dokuz Eylul Univ, Sch Med, Dept Biochem, Izmir, Turkey		Ozbal, S (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Histol & Embryol, Izmir, Turkey.	seda.ozbal@deu.edu.tr	Ozbal, Seda/AAA-7762-2020; Tugyan, Kazim/AAB-3849-2020	Ozbal, Seda/0000-0002-9483-5564; 	Dokuz Eylul University Research FoundationDokuz Eylul University [2012.KB.SAG.055]	This research was supported by Dokuz Eylul University Research Foundation: Grant No: 2012.KB.SAG.055 and conducted, in part, at Dokuz Eylul University Medical School Learning Resources Center Research Laboratory.	Antonio AM, 2011, BRAIN RES, V1383, P13, DOI 10.1016/j.brainres.2011.01.113; Bae EH, 2009, NEPHROL DIAL TRANSPL, V24, P2692, DOI 10.1093/ndt/gfp176; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Connell BJ, 2012, NEUROSCI LETT, V507, P43, DOI 10.1016/j.neulet.2011.11.047; Connell BJ, 2011, BRAIN RES, V1375, P128, DOI 10.1016/j.brainres.2010.12.045; Dadhania VP, 2010, CHEM-BIOL INTERACT, V183, P85, DOI 10.1016/j.cbi.2009.10.020; De Araujo DP, 2011, INT J NEUROSCI, V121, P51, DOI 10.3109/00207454.2010.535934; Ersahin M, 2010, NEUROCHEM RES, V35, P418, DOI 10.1007/s11064-009-0072-z; Gencpinar P, 2011, NEUROSCI LETT, V505, P205, DOI 10.1016/j.neulet.2011.10.027; Goraca A, 2011, PHARMACOL REP, V63, P849; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Li CJ, 2009, CHINESE MED J-PEKING, V122, P2580, DOI 10.3760/cma.j.issn.0366-6999.2009.21.010; Lovell MA, 2003, J ALZHEIMERS DIS, V5, P229, DOI 10.3233/JAD-2003-5306; Maczurek A, 2008, ADV DRUG DELIVER REV, V60, P1463, DOI 10.1016/j.addr.2008.04.015; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Radu F, 2011, MOL CELL BIOCHEM, V355, P65, DOI 10.1007/s11010-011-0839-9; Shaafi S, 2011, MED PRIN PRACT, V20, P19, DOI 10.1159/000319772; Shay KP, 2008, IUBMB LIFE, V60, P362, DOI 10.1002/iub.40; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tugyan K, 2013, NEUROSCI LETT, V533, P28, DOI 10.1016/j.neulet.2012.10.004; Wang X, 2011, FOOD CHEM TOXICOL, V49, P2750, DOI 10.1016/j.fct.2011.07.065; Watson, 2002, RAT BRAIN STEREOTAXI; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; Wong A, 2001, EUR J NEUROSCI, V14, P1961, DOI 10.1046/j.0953-816x.2001.01820.x; Zhang L, 2001, NEUROSCI LETT, V312, P125, DOI 10.1016/S0304-3940(01)02205-4	31	10	10	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1052-0295	1473-7760		BIOTECH HISTOCHEM	Biotech. Histochem.	APR	2015	90	3					206	215		10.3109/10520295.2014.977950			10	Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Cell Biology	CE8QX	WOS:000352110200007	25420894				2022-02-06	
J	Whiffin, CJ; Bailey, C; Ellis-Hill, C; Jarrett, N; Hutchinson, PJ				Whiffin, Charlotte Jane; Bailey, Christopher; Ellis-Hill, Caroline; Jarrett, Nickey; Hutchinson, Peter J.			Narratives of family transition during the first year post-head injury: perspectives of the non-injured members	JOURNAL OF ADVANCED NURSING			English	Article						head injury; narrative analysis; nurses; nursing; qualitative; recovery; rehabilitation; trauma	TRAUMATIC BRAIN-INJURY; ILLNESS NARRATIVES; MOTHERS; DAMAGE; PREDICTORS; RELATIVES; IMPACT; MODEL; TBI	AimTo explore the narratives created by non-injured family members in relation to themselves and their family in the first year after head injury. BackgroundA head injury is a potentially devastating injury. The family responds to this injury by supporting the individual and their recovery. While the perspective of individual family members has been well documented, there is growing interest in how the family as a whole makes sense of their experiences and how these experiences change over time. DesignLongitudinal narrative case study using unstructured in-depth interviews. MethodsData were collected during an 18-month period (August 2009-December 2010). Nine non-injured family members from three families were recruited from an acute neurosurgical ward and individual narrative interviews were held at one, three and 12months postinjury where participants were asked to talk about their experience of head injury. Analysis was completed on three levels: the individual; the family and between family cases with the aim of identifying a range of interwoven narrative threads. FindingsFive interwoven narratives were identified: trauma, recovery, autobiographical, suffering and family. The narrative approach emphasized that the year posthead injury was a turbulent time for families, who were active agents in the process of change. ConclusionThis study has shown the importance of listening to people's stories and understanding their journeys irrespective of the injured person's outcome. Change postinjury is not limited to the injured person: family members need help to understand that they too are changing as a result of their experiences.	[Whiffin, Charlotte Jane] Univ Derby, Derbyshire Chambers & Business Link, Canal Wharf, Chesterfield, England; [Bailey, Christopher] Univ Southampton, Fac Hlth Sci, Programmes Res Dev, Southampton, Hants, England; [Ellis-Hill, Caroline] Bournemouth Univ, Poole BH12 5BB, Dorset, England; [Jarrett, Nickey] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Hutchinson, Peter J.] Addenbrookes Hosp, Div Neurosurg, Cambridge, England		Whiffin, CJ (corresponding author), Univ Derby, Derbyshire Chambers & Business Link, Canal Wharf, Chesterfield, England.	c.whiffin@derby.ac.uk		Hutchinson, Peter/0000-0002-2796-1835; Jarrett, Nikki/0000-0003-2513-8113; Whiffin, Charlotte/0000-0002-9767-2123	NIHRNational Institute for Health Research (NIHR); NIHR Cambridge BRC; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI	The families who gave their time to participate in this study, the acute hospital trust where participants were recruited, Christine Harkin the Clinical Nurse Practitioner for Neuro-trauma, The Wellcome Trust and Headway. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge BRC.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Appleton J. V., 2002, QUAL RES J, V2, P80; Bingley AF, 2008, PALLIATIVE MED, V22, P653, DOI 10.1177/0269216308089842; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brown J, 2008, J ADV NURS, V62, P200, DOI 10.1111/j.1365-2648.2007.04588.x; Bury M, 2001, SOCIOL HEALTH ILL, V23, P263, DOI 10.1111/1467-9566.00252; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Charmaz K, 1999, QUAL HEALTH RES, V9, P362, DOI 10.1177/104973299129121910; Creswell J.W ., 2007, QUAL INQ; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Duff Diane, 2006, Axone, V27, P9; Ellis-Hill C, 2008, DISABIL REHABIL, V30, P150, DOI 10.1080/09638280701195462; Frank, 1995, WOUNDED STORYTELLER; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gergen K. J., 1983, STUDIES SOCIAL IDENT, P254; JENNETT B, 1975, LANCET, V1, P480; KOSCIULEK JF, 1993, J REHABIL, V59, P40; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Mishler EG, 1995, J NARRAT LIFE HIST, V5, P87, DOI 10.1075/jnlh.5.2.01mod; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Powell T. J., 2004, HEAD INJURY PRACTICA; Riessman C.K., 1993, NARRATIVE ANAL; Riessman CK., 2005, QUALITATIVE SOCIAL W, V4, P391, DOI DOI 10.1177/1473325005058643; Riessman K. C., 2008, NARRATIVE METHODS HU; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Smith B., 2008, HDB CONSTRUCTIONIST, P295; Stake R.E., 2005, SAGE HDB QUALITATIVE, V3rd ed., P443; Streubert HJ, 2011, QUALITATIVE RES NURS, V5rd; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; WALKER S, 2004, APPL FAMILY THERAPY; Wengraf T., 2006, INTERVIEWING L UNPUB; Whiffin C. J., 2012, THESIS SOUTHAMPTON; Whiffin Charlotte Jane, 2014, Nurse Res, V21, P20, DOI 10.7748/nr2014.03.21.4.20.e1238; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x; Wongvatunyu S, 2008, J FAM NURS, V14, P314, DOI 10.1177/1074840708321473; Wongvatunyu S, 2008, QUAL HEALTH RES, V18, P1062, DOI 10.1177/1049732308320111; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wright LM, 2009, NURSES FAMILIES GUID; Yin R., 2017, CASE STUDY RES DESIG	49	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	APR	2015	71	4					849	859		10.1111/jan.12551			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CD3LD	WOS:000350979000012	25339079	Green Submitted, Green Accepted			2022-02-06	
J	Zirkel, PA; Brown, BE				Zirkel, Perry A.; Brown, Brenda Eagan			K-12 Students With Concussions: A Legal Perspective	JOURNAL OF SCHOOL NURSING			English	Article						academic achievement; attendance; school nurse education; policies; procedures; legal; ethical issues; collaboration; multidisciplinary teams; middle; junior; high school; best practices; practice guidelines; high school	SCHOOL	This article provides a multipart analysis of the public schools' responsibility for students with concussions. The first part provides the prevailing diagnostic definitions of concussions and postconcussive syndrome. The second and central part provides (a) the legal framework of the two overlapping federal lawsthe Individuals with Disabilities Education Act and Section 504 of the Rehabilitation Act and the varying state laws or local policies for individual health plans and (b) a summary of the developing body of hearing officer decisions, court decisions, and Office for Civil Rights rulings that have applied this framework to K-12 students with concussions. The final part offers recommendations for proactive return to school policies, with the school nurse playing a central supporting role.	[Zirkel, Perry A.] Lehigh Univ, Educ, Bethlehem, PA 18015 USA; [Brown, Brenda Eagan] Brain Injury Assoc Penn, Brain Injury Sch Reentry, New Castle, PA 16101 USA		Brown, BE (corresponding author), Brain Injury Assoc Penn, 1891 Old State Rd, New Castle, PA 16101 USA.	eaganbrown@biapa.org					Amberg P., 2012, MARQUETTE SPORTS LAW, V23, P171; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 1997, COMMUNICATION; [Anonymous], 2009, WESTPORT BD ED, V53; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bowling B., 2014, PITTSBURGH TRIBUNE R; BrainSTEPS, 2013, RET SCH CONC REC PRO; BrainSTEPS, 2012, BRAINSTEPS PRES CONC; Brandwein K., 2013, WILLAMETTE SPORTS LA, V10, P28; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Centers for Disease Control and Prevention, 2013, HELP STUD REC CONC C; Centers for Disease Control and Prevention, 2010, HEADS CONC KNOW YOUR; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention, 2009, HEADS FACTS PHYS MIL; Cerra David S., 2012, MICH ST U J MED L, V16, P265; Children's Safety Network, 2013, INT MAPS STAT LAWS C; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Davies S., 2012, W ED LAW REPORTER, V282, P759; Diaz Anne L, 2013, NASN Sch Nurse, V28, P110; Giza CC, 2001, J ATHL TRAINING, V36, P228; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hotz R. L., 2013, WALL STREET J, pD1; Hotz R. L., 2013, WALL STREET J, pD4; Institute of Medicine, 2013, SPORTS REL CONC YOUT; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2009, REAP BENEFITS GOOD C; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Office for Civil Rights, 2009, FREQ ASK QUEST SECT; Orentlicher David, 2012, FIU L REV, V8, P23; Pennsylvania Department of Education, 2013, TEACH DESK REF CONC; Reddy CC, 2011, PM&R, V3, pS396, DOI 10.1016/j.pmrj.2011.07.012; Reich J., 2013, VIRGINIA SPORTS ENTE, V12, P198; Reilly C. L., 2012, UCLA ENTERTAINMENT L, V19, P245; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Toporek B., 2011, ED WEEK, P10; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zirkel P., 2012, W ED LAW REPORTER, V276, P577; Zirkel P. A., 2012, ELA NOTES, V47, P16; Zirkel P. A., 2010, J SPECIAL ED LEADERS, V23, P100; Zirkel P. A., 2013, EXCEPT CHILDREN, V79, P503	46	10	10	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	APR	2015	31	2					99	109		10.1177/1059840514521465			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CE0CZ	WOS:000351473300004	24502973				2022-02-06	
J	Brolin, K; Stockman, I; Andersson, M; Bohman, K; Gras, LL; Jakobsson, L				Brolin, Karin; Stockman, Isabelle; Andersson, Marianne; Bohman, Katarina; Gras, Laure-Lise; Jakobsson, Lotta			Safety of children in cars: A review of biomechanical aspects and human body models	IATSS RESEARCH			English	Article						Child safety; Human body models; Anthropometry; On-road driving; Crash; Pre-crash		The protection of children in motor vehicle crashes has improved since the introduction of child restraint systems. However, motor vehicle crashes remain one of the top leading causes of death for children. Today, computer-aided engineering is an essential part of vehicle development and it is anticipated that safety assessments will increasingly rely on simulations. Therefore, this study presents a review of important biomechanical aspects for the safety of children in cars, including child human body models, for scenarios ranging fromon-road driving, emergency maneuvers, and pre-crash events to crash loading. The review is divided into four parts: Crash safety, On-road driving for forward facing children, Numerical whole body models, and Discussion and future outlook. The first two parts provide ample references and a state-of-the-art description of important biomechanical aspects for the safety of children in cars. That children are not small adults has been known for decades and has been considered during the development of current restraints that protect the child in the crash phase. The head, neck, thorax, and pelvis are body areas where developmentwith age changes the biomechanics and the interaction with restraint systems. The rear facing child seat distributes the crash load over a large area of the body and has proved to be a very efficient means of reducing child injuries and fatalities. Children up to age 4 years need to be seated rearward facing for optimal protection, mainly because of the proportionally large head, neck anthropometry and cartilaginous pelvis. Children aged 4 up to 12 years should use a belt positioning booster together with the vehicle seat belt to ensure good protection, as the pelvis is not fully developed and because of the smaller size of these children compared to adults. On-road driving studies have illustrated that children frequently change seated posture and may choose slouched positions that are poor for lap belt interaction if seated directly on the rear seat. Emergency maneuvers with volunteers illustrate that pre-crash loading forces forward-facing children into involuntary postures with large head displacements, having potential influence on the risk of head impact. Children, similar to adults, benefit from the safety systems offered in the vehicle. By providing child adaptability of the vehicle, such as integrated booster cushions, the child-restraint interaction can be further optimized. An example of this is the significant reduction of lap belt misuse when using integrated boosters, due to the simplified and natural positioning of the lap belt in close contact with the pelvis. The research presented in this review illustrates that there is a need for enhanced tools, such as child human body models, to take into account the requirements of children of different ages and sizes in the development of countermeasures. To study how children interact with restraints during on-road driving and during pre- and in-crash events, numerical child models implementing age-specific anthropometric features will be essential. The review of human whole body models covers multi body models (age 1.5 to 15 years) and finite element models (ages 3, 6, and 10 years). All reviewed child models are developed for crash scenarios. The only finite element models to implement age dependent anthropometry details for the spine and pelvis were a 3 year-old model and an upcoming 10 year-old model. One ongoing project is implementing active muscles response in a 6 year-old multi body model to study pre-crash scenarios. These active models are suitable for the next important step in providing the automotive industry with adequate tools for development and assessment of future restraint systems in the full sequence of events from pre-to in-crash. (C) 2014 Production and hosting by Elsevier Ltd. on behalf of International Association of Traffic and Safety Sciences.	[Brolin, Karin; Stockman, Isabelle; Andersson, Marianne; Gras, Laure-Lise; Jakobsson, Lotta] Chalmers Univ Technol, Dept Appl Mech, SE-41296 Gothenburg, Sweden; [Jakobsson, Lotta] Volvo Car Corp, Volvo Cars Safety Ctr, Gothenburg, Sweden; [Bohman, Katarina] Autoliv Res, Varagarda, Sweden; [Bohman, Katarina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden		Brolin, K (corresponding author), Chalmers Univ Technol, Dept Appl Mech, SE-41296 Gothenburg, Sweden.	karin.brolin@chalmers.se; isabelle.stockman@chalmers.se; marianne.andersson@chalmers.se; katarina.bohman@autoliv.com; laure-lise.gras@univ-lyon1.fr; lotta.jakobsson@volvocars.com	Gras, Laure-Lise/AAG-8544-2021; /A-4801-2016	Gras, Laure-Lise/0000-0003-4927-9826; /0000-0002-9173-2498	FFI (Fordonsstrategisk Forsknings och Innovation), Vinnova, Sweden [2012-03668]; Folksam's Research Fund, Sweden; Strategic Area of Advance at Chalmers University of Technology, Sweden	This work has been carried out at SAFER - Vehicle and Traffic Safety Centre at Chalmers, Sweden and funded by FFI (Fordonsstrategisk Forsknings och Innovation), Vinnova, Sweden (2012-03668); Folksam's Research Fund, Sweden; and the Strategic Area of Advance at Chalmers University of Technology, Sweden.	Aldman B., 1964, P 8 STAPP CAR CRASH, P320; Andersson M., 2012, THESIS; Andersson M, 2012, TRAFFIC INJ PREV, V13, P182, DOI 10.1080/15389588.2011.637411; Andersson Marianne, 2010, Ann Adv Automot Med, V54, P171; [Anonymous], 2012, MADYMO HUM MOD MAN R; [Anonymous], 2003, MADYMO HUM MOD MAN R, P42; ARBOGAST KB, 2004, P INT RES C BIOM IMP; Arbogast Kristy B, 2012, Stapp Car Crash J, V56, P443; Arbogast KB, 2009, STAPP CAR CRASH JO, V53, P329; BAILEY DK, 1952, RADIOLOGY, V59, P712, DOI 10.1148/59.5.712; Beusenberg M., 1993, 933104 SAE; Bilston Lynne E, 2007, Traffic Inj Prev, V8, P47, DOI 10.1080/15389580600990352; Bohman K., 2013, THESIS; Bohman K., 2007, P 20 INT TECHN C ENH; Bohman Katarina, 2011, Ann Adv Automot Med, V55, P15; Bohman K, 2011, TRAFFIC INJ PREV, V12, P62, DOI 10.1080/15389588.2010.526159; Bostrom O., 2013, P 23 INT TECHN C ENH; Bostrom O., 2011, P 22 INT TECHN C ENH; Brolin K., 2014, 7 WORLD C BOIM BOST; BURDI AR, 1969, J BIOMECH, V2, P267, DOI 10.1016/0021-9290(69)90083-9; Charlton JL, 2010, ANN ADV AUTOMOT MED, V54, P181; Crandall J.R., 2013, PEDIAT INJURY BIOMEC; Cui YG, 2012, INT J CRASHWORTHINES, V17, P233, DOI 10.1080/13588265.2011.648515; Dong L., 2013, P INT RES C BOM IMP, P673; Dong LQ, 2013, ANN BIOMED ENG, V41, P2538, DOI 10.1007/s10439-013-0858-7; Durbin DR, 2003, JAMA-J AM MED ASSOC, V289, P2835, DOI 10.1001/jama.289.21.2835; Forman Jason, 2008, Ann Adv Automot Med, V52, P141; Forman J, 2009, STAPP CAR CRASH JO, V53, P49; Forman Jason L, 2011, Ann Adv Automot Med, V55, P3; Gray H., 2012, THE HIP BONE; Happee R., 1999, VDA TECHN C CAR FUT, P31; Happee R., 2001, P INT RES C BIOM IMP; Henary B, 2007, INJURY PREV, V13, P398, DOI 10.1136/ip.2006.015115; Howard A, 2004, J TRAUMA, V56, P1276, DOI 10.1097/01.TA.0000078883.74947.EB; Hu J, 2009, INT J CRASHWORTHINES, V14, P391, DOI 10.1080/13588260902824021; Irwin A. L., 1997, STAPP CAR CRASH C; Iwamoto M., 2003, 4 EUR LS DYNA US C; Iwamoto M, 2007, 6 EUR LS DYNA US C, P47; Iwamoto M., 2002, INT RES COUNC BIOM I, P31; Jakobsson L., 2005, P 19 INT TECHN C ENH; Jakobsson L., 2011, P INT RES C BOIM IMP; Jiang BH, 2014, COMPUT METHOD BIOMEC, V17, P1185, DOI 10.1080/10255842.2012.739164; Jun OY, 2005, SPINE, V30, pE716, DOI 10.1097/01.brs.0000192280.53831.70; KALLIERIS D, 1976, 20 STAPP CAR CRASH C; Kapandji I. A., 1970, PHYSL JOINTS TRUNK V, V3; Kapoor T., 2008, SAE TECHNICAL PAPER, V2008-01-1121; Kapoor T, 2010, INT J CRASHWORTHINES, V15, P17, DOI 10.1080/13588260902986010; Kasai T, 1996, SPINE, V21, P2067, DOI 10.1097/00007632-199609150-00003; Kent R., 2007, P 20 ENH SAF VEH C L; Kent Richard, 2006, Stapp Car Crash J, V50, P1; Kim J.-E., 2013, PEDIAT INJURY BIOMEC; Koizumi T, 2005, IMAC 23 C EXP STRUCT; Kuczmarski RJ, 2002, VITAL HLTH STAT, V11, P1; Lesire P, 2012, PROCD SOC BEHV, V48, P2654, DOI 10.1016/j.sbspro.2012.06.1235; Li ZB, 2011, INT J CRASHWORTHINES, V16, P457, DOI 10.1080/13588265.2011.606998; Liu XJ, 2002, TRAFFIC INJ PREV, V3, P321; Locey Caitlin M, 2012, Ann Adv Automot Med, V56, P299; Lopez-Valdes FJ, 2010, TRAFFIC INJ PREV, V11, P320, DOI 10.1080/15389580903575793; Lundell B., 1991, P 13 ESV C, P1194; Maltese MR, 2008, STAPP CAR C, V52, P83; Mao H., 2012, COLL SAF RES CTR SES; Mizuno K., 2006, INT CRASHW THIN C AT; Mizuno Koji, 2005, Traffic Inj Prev, V6, P361, DOI 10.1080/15389580500255922; Neathery RF, 1974, P 18 STAPP CAR CRASH, P383; Norin H., 1979, SAE C EXP SAE INT WA; O'Neil J, 2009, ACCIDENT ANAL PREV, V41, P425, DOI 10.1016/j.aap.2009.01.003; Okamoto M., 2003, P 18 INT TECHN C ENH; Osth J., 2014, TRAFFIC INJ PREV; Osvalder A.-L., 2013, P INT RES C BIOM IMP; Osvalder Anna-Lisa, 2008, Ann Adv Automot Med, V52, P49; Ouyang J, 2006, J TRAUMA, V61, P1492, DOI 10.1097/01.ta.0000233711.07823.40; Rouhana Stephen W, 2006, Stapp Car Crash J, V50, P267; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Sander U., 2009, P 21 INT TECHN C ENH; Sasaki Yasuhiro, 2009, International Journal of Vehicle Safety, V4, P300, DOI 10.1504/IJVS.2009.032758; Seacrist T, 2013, ANN BIOMED ENG, V41, P2381, DOI 10.1007/s10439-013-0841-3; Seacrist Thomas, 2012, Ann Adv Automot Med, V56, P285; Seacrist Thomas, 2010, Ann Adv Automot Med, V54, P97; SNYDER RG, 1977, UMHSRI7717; Stockman I., 2012, THESIS, P18; Stockman I, 2013, TRAFFIC INJ PREV, V14, P92, DOI 10.1080/15389588.2012.688151; Swanson J., 2003, P 18 INT TECHN C ENH; Tarriere C., 1995, P INT RES C BOIM IMP; Tingvall C., 1987, THESIS, P339; Turchi R, 2004, INT J CRASHWORTHINES, V9, P419, DOI 10.1533/ijcr.2004.0300; Twisk D., 1993, ECOSA PROD SAF RES C; Tylko S., 2012, P INT RES C BIOM IMP; Tylko S., 2012, 10 INT C MUN GERM DE; Untaroiu CD, 2010, SAFETY SCI, V48, P259, DOI 10.1016/j.ssci.2009.09.003; van Hoof Jack, 2003, Stapp Car Crash J, V47, P401; Van Rooij L., 2005, 19 INT TECHN C ENH S; Van Rooij L., 2004, SAE TECHNICAL PAPER; World Health Organisation, 2008, WORLD REPORT CHILD I; World Health Organization, 2009, GLOB STAT REP ROAD S; Yang J., 1992, P 36 STAPP CAR CRASH, P203; Yang J.K., 2000, J CRASH PREVENTION I, V2, P131, DOI [10.1080/10286580008902559, DOI 10.1080/10286580008902559]; YOUNG JW, 1976, DEV EVALUATION MASTE; Zhang W., 2007, SAE TECHNICAL PAPER, V2007-01-0977; Zhang W., 2009, SAE TECHNICAL PAPER, V2009-01-0472	99	10	10	1	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0386-1112	2210-4240		IATSS RES	IATSS Res.	MAR	2015	38	2					92	102		10.1016/j.iatssr.2014.09.001			11	Transportation	Emerging Sources Citation Index (ESCI)	Transportation	V48XU	WOS:000210052900002		gold, Green Published			2022-02-06	
J	Qi, M; Luis, V; Bilbao, S; Omori, K; Rawson, J; McFadden, B; Juan, J; Nair, I; Mullen, Y; El-Shahawy, M; Dafoe, D; Kandeel, F; Al-Abdullah, IH				Qi, Meirigeng; Luis, Valiente; Bilbao, Shiela; Omori, Keiko; Rawson, Jeffrey; McFadden, Brian; Juan, Jemily; Nair, Indu; Mullen, Yoko; El-Shahawy, Mohamed; Dafoe, Donald; Kandeel, Fouad; Al-Abdullah, Ismail H.			Sodium levels of human pancreatic donors are a critical factor for determination of islet efficacy and survival	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article						hypernatremia; islet isolation and transplantation; nonobese diabetic mice; sodium chloride; ion channels	POSTOPERATIVE GRAFT FUNCTION; APOPTOTIC VOLUME DECREASE; TRAUMATIC BRAIN-INJURY; SERUM SODIUM; LIVER-TRANSPLANTATION; CELL-VOLUME; HYPERNATREMIA; PRESERVATION; CHANNELS; DISTURBANCES	Organs from hypernatremia (elevated Na+) donors when used for transplantation have had dismal outcomes. However, islet isolation from hypernatremic donors for both transplantation and research applications has not yet been investigated. A retrospective analysis of in vivo and in vitro islet function studies was performed on islets isolated from hypernatremic (serum sodium levels >= 160 meq/l) and normal control (serum sodium levels <= 155 meq/l) donors. Twelve isolations from 32 hypernatremic and 53 isolations from 222 normal donors were randomly transplanted into diabetic NOD Scid mice. Sodium levels upon pancreas procurement were significantly elevated in the hypernatremia group (163.5 +/- 0.6 meq/l) compared with the normal control group (145.9 +/- 0.4 meq/l) (P < 0.001). The postculture islet recovery rate was significantly lower in the hypernatremia (59.1 +/- 3.8%) group compared with the normal (73.6 +/- 1.8%) group (P = 0.005). The duration of hypernatremia was inversely correlated with the recovery rate (r(2) = 0.370, P < 0.001). Furthermore, the percentage of successful graft function when transplanted into diabetic NOD Scid mice was significantly lower in the hypernatremia (42%) group compared with the normal control (85%) group (P < 0.001). The ability to predict islet graft function posttransplantation using donor sodium levels and duration of hypernatremia was significant (ROC analysis, P = 0.022 and 0.042, respectively). In conclusion, duration of donor hypernatremia is associated with reduced islet recovery postculture. The efficacy of islets from hypernatremia donors diminished when transplanted into diabetic recipients.	[Qi, Meirigeng; Luis, Valiente; Bilbao, Shiela; Omori, Keiko; Rawson, Jeffrey; McFadden, Brian; Juan, Jemily; Nair, Indu; Mullen, Yoko; El-Shahawy, Mohamed; Dafoe, Donald; Kandeel, Fouad; Al-Abdullah, Ismail H.] Beckman Res Inst City Hope, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA		Al-Abdullah, IH (corresponding author), Beckman Res Inst City Hope, Dept Diabet & Metab Dis Res, 1500 E Duarte Rd, Duarte, CA 91010 USA.	IAl-Abdullah@coh.org	Qi, Meirigeng/B-5446-2014	Qi, Meirigeng/0000-0002-8531-8733	Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute of the City of Hope; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	This work was financially supported by the Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute of the City of Hope. Human pancreatic islets were provided by the National Institute of Diabetes and Digestive and Kidney Diseases-funded Integrated Islet Distribution Program at the City of Hope.	ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Anazawa T, 2011, TRANSPLANTATION, V92, P871, DOI 10.1097/TP.0b013e31822e6eb4; AVOLIO AW, 1991, TRANSPLANT P, V23, P2451; BANK HL, 1987, DIABETOLOGIA, V30, P812; Bentsi-Barnes K, 2011, ISLETS, V3, P284, DOI 10.4161/isl.3.5.15938; Bradshaw K, 2008, BJA EDUC, V8, P129, DOI 10.1093/bjaceaccp/mkn019; Brandhorst H, 1995, EXP CLIN ENDOCR DIAB, V103, P23, DOI 10.1055/s-0029-1211388; Brandhorst H, 1998, TRANSPL P, V30, P364, DOI 10.1016/S0041-1345(97)01309-2; Brandhorst H, 2010, TRANSPLANTATION, V89, P155, DOI 10.1097/TP.0b013e3181c9266c; Caballero-Corbalan J, 2012, J SURG RES, V175, P163, DOI 10.1016/j.jss.2011.03.012; Dawwas MF, 2007, LIVER TRANSPLANT, V13, P1115, DOI 10.1002/lt.21154; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Dhalla AK, 2014, DIABETES, V63, P3545, DOI 10.2337/db13-1562; Fiedor P, 1996, Ann Transplant, V1, P59; Figueras J, 1996, TRANSPLANTATION, V61, P410, DOI 10.1097/00007890-199602150-00016; Friberg AS, 2012, TRANSPLANTATION, V93, P632, DOI 10.1097/TP.0b013e3182455912; GONZALEZ FX, 1994, HEPATOLOGY, V20, P565, DOI 10.1016/0270-9139(94)90089-2; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x; Hilling DE, 2014, CELL TRANSPLANT, V23, P921, DOI 10.3727/096368913X666412; Hoefer D, 2010, TRANSPL INT, V23, P589, DOI 10.1111/j.1432-2277.2009.01024.x; Hubert T, 2008, AM J TRANSPLANT, V8, P872, DOI 10.1111/j.1600-6143.2007.02131.x; Iglesias I, 2012, CELL TRANSPLANT, V21, P649, DOI 10.3727/096368911X623826; Johnson NP, 2004, STAT MED, V23, P2257, DOI 10.1002/sim.1835; Kazemeyni Seyed Mohammad, 2008, Urol J, V5, P173; Kelemen J, 1965, Radiol Diagn (Berl), V6, P439; Kinard TA, 2001, DIABETES, V50, P992, DOI 10.2337/diabetes.50.5.992; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Kwiatkowska E, 2013, TRANSPL P, V45, P51, DOI 10.1016/j.transproceed.2012.07.153; Lakey JRT, 1996, TRANSPLANTATION, V61, P1047, DOI 10.1097/00007890-199604150-00010; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mojibian M, 2013, DIABETOLOGIA, V56, P2213, DOI 10.1007/s00125-013-3004-z; Niclauss N, 2011, TRANSPLANTATION, V91, P360, DOI 10.1097/TP.0b013e31820385e6; O'Gorman D, 2005, TRANSPLANTATION, V80, P801, DOI 10.1097/01.tp.0000172216.47547.d5; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Pastukh V, 2010, AM J PHYSIOL-CELL PH, V299, pC289, DOI 10.1152/ajpcell.00362.2009; Paushter DH, 2013, CELL TRANSPLANT, V22, P1113, DOI 10.3727/096368912X657332; Qi M, CELL TRANSP IN PRESS; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; Ricordi C, 2003, TRANSPLANTATION, V75, P1524, DOI 10.1097/01.TP.0000058813.95063.7A; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Sakuma Y, 2008, TRANSPL P, V40, P343, DOI 10.1016/j.transproceed.2007.12.019; Smith M, 2004, J HEART LUNG TRANSPL, V23, pS217, DOI 10.1016/j.healun.2004.06.017; Spatenkova V, 2013, ACTA NEUROL BELG, V113, P139, DOI 10.1007/s13760-012-0137-7; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Todorov I, 2010, TRANSPLANTATION, V90, P836, DOI 10.1097/TP.0b013e3181f1db5d; Toso C, 2002, TRANSPLANT P, V34, P826, DOI 10.1016/S0041-1345(01)02925-6; Totsuka E, 1999, LIVER TRANSPLANT SUR, V5, P421, DOI 10.1002/lt.500050510; Wang Y, 2013, CELL TRANSPLANT, V22, P2323, DOI 10.3727/096368912X662417; Wright WL, 2012, CURR NEUROL NEUROSCI, V12, P466, DOI 10.1007/s11910-012-0284-5; Yang SN, 2014, CELL MOL LIFE SCI, V71, P4149, DOI 10.1007/s00018-014-1680-6; ZENG YJ, 1994, TRANSPLANTATION, V57, P954, DOI 10.1097/00007890-199403270-00031	57	10	11	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1849	1522-1555		AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	MAR 1	2015	308	5					E362	E369		10.1152/ajpendo.00443.2014			8	Endocrinology & Metabolism; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Physiology	CD1BE	WOS:000350807900003	25537495				2022-02-06	
J	Huang, YH; Liao, CC; Chen, WF; Ou, CY				Huang, Yu-Hua; Liao, Chen-Chieh; Chen, Wu-Fu; Ou, Chien-Yu			Characterization of acute post-craniectomy seizures in traumatically brain-injured patients	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Traumatic brain injury; Decompressive craniectomy; Seizure; Mortality; Glasgow outcome scale	DECOMPRESSIVE CRANIECTOMY; POSTTRAUMATIC EPILEPSY; HEAD-INJURY; EPIDEMIOLOGY; TOMOGRAPHY; PRESSURE; INCREASE; RISK	Purpose: Decompressive craniectomy (DC) is a life-saving measure for traumatic brain injury (TBI), but acute seizures following this procedure may have a devastating effect. We aim to investigate the clinical characteristics of acute post-craniectomy seizures. Methods: For this retrospective study, we enrolled 195 patients undergoing DC for TBI. Acute post-craniectomy seizure was defined as seizures occurring within 7 days of DC. Results: The incidence of acute seizure was 10.8% (21/195). 19 of 21 seizures occurred within 3 days following DC. None progressed to status epilepticus, but 16 of 21 patients (76.2%) with acute seizure developed epilepsy. There was no independent risk factor in the multivariate regression model. The mean hospital stay was 44.8 +/- 34.6 and 28.8 +/- 32.3 days for patients with and without acute seizures, respectively (p = 0.035). The neurological outcome at discharge showed no inter-group difference (p = 0.917). The in-hospital mortality rate was 28.6% for patients with seizures and 31.0% for patients without seizures (p = 0.817). Conclusion: Acute seizures occur mostly within the first 3 days following DC. Neurological outcome and mortality rate at discharge does not differ between patients with or without seizures, but the duration of hospital stay is significantly longer for acute seizure patients. (C) 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Huang, Yu-Hua; Liao, Chen-Chieh; Chen, Wu-Fu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Huang, Yu-Hua; Liao, Chen-Chieh; Chen, Wu-Fu] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Huang, Yu-Hua] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Ou, Chien-Yu] Kaohsiung Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan		Ou, CY (corresponding author), Kaohsiung Armed Forces Gen Hosp, Dept Surg, 2,Zhongzheng 1st Rd, Kaohsiung, Taiwan.	oucu2003@yahoo.com.tw					Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Manaka S, 2003, NEUROL MED-CHIR, V43, P589, DOI 10.2176/nmc.43.589; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	18	10	11	0	2	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	FEB	2015	25						150	154		10.1016/j.seizure.2014.10.008			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB8LM	WOS:000349881100026	25455726	Bronze			2022-02-06	
J	Hull, K; Schmittel, A				Hull, Kevin; Schmittel, Annelie			A Fumbled Opportunity? A Case Study of Twitter's Role in Concussion Awareness Opportunities During the Super Bowl	JOURNAL OF SPORT & SOCIAL ISSUES			English	Article						Twitter; concussion; football; NFL; social media; sport; health	INTERNET; MEDIA; REVOLUTION; MOVEMENTS; ACTIVISM; SPORT	Doctors, journalists, and other advocates are attempting to draw attention to the dangers of head trauma in football, and the popularity of social media has given them a new outlet to perform advocacy. This case study explores how advocates for concussion awareness in football used Twitter to help spread their message during the 2013 Super Bowl. A content analysis of tweets from 92 concussion advocates on the day of the Super Bowl was conducted. Analysis revealed that the advocates used Twitter for (a) linking to football concussion content, (b) Super Bowl game-related commentary, (c) non-concussion or non-Super Bowl related links or messages, (d) linking to non-football concussion content, (e) concussion-related commentary, (f) engagement, and (g) self or website promotion. Results demonstrate that while advocates have a tremendous opportunity to use the agenda-setting possibilities that are afforded through Twitter, concussion advocates did not utilize Twitter in this manner.	[Hull, Kevin; Schmittel, Annelie] Univ Florida, Coll Journalism & Commun, Gainesville, FL 32611 USA		Hull, K (corresponding author), Univ Florida, POB 118400, Gainesville, FL 32611 USA.	kevhull@ufl.edu					Anderson P. D., 2013, NFL CONCUSSION LITIG; Ashtari Omid, 2013, SUPER TWEETS SB47; Belson K., 2014, NY TIMES; Belson K, 2012, NY TIMES; Belson K., 2013, NY TIMES; Breslow J. M., 2014, NFL CONCUSSIONS 2013; Brock A, 2012, J BROADCAST ELECTRON, V56, P529, DOI 10.1080/08838151.2012.732147; Brough M, 2013, INT J COMMUN-US, V7, P281; Browning B., 2012, International Journal of Sport Communication, V5, P503; Bruns A, 2012, JOURNALISM STUD, V13, P801, DOI 10.1080/1461670X.2012.664428; Cameron D., 2013, HARVARD GAZETTE 0129; Clavio G., 2010, International Journal of Sport Communication, V3, P485; Coleman R, 2009, INT COMMUN ASSOC HAN, P147; Collins S., 2013, LOS ANGELES TIMES; Cozma R., 2011, ANN M INT COMM ASS B; Cunningham N., 2012, AMA SUMMER ED C P, P416; Delsohn S., 2014, OTL BELCHERS BRAIN H; DeLuca K. M., 2012, COMMUNICATION CULTUR, V5, P483, DOI DOI 10.1111/J.1753-9137.2012.01141.X; Dugan L., 2012, TWITTER SURPASS 500; Elliott S, 2013, NY TIMES; Fainaru S., 2012, RES DISCOVER 28 NEW; Favale D., 2012, R WHITES TWITTER EXP; Fiegerman S., 2017, TWITTER NOW HAS MORE; Foer F., 2013, B OBAMA IS NOT PLEAS; Frederick EL, 2015, COMMUN SPORT, V3, P312, DOI 10.1177/2167479513508393; Fuentes M., 2007, ENCY ACTIVISM SOCIAL, P456, DOI [10.4135/9781412956215, DOI 10.4135/9781412956215.N256]; Gaines C., 2012, MOST POPULAR ATHLETE; Glaser B., 1967, DISCOVERY GROUNDED T; Graziano T, 2012, SOC SCI INFORM, V51, P534, DOI 10.1177/0539018412456773; Gregory S., 2009, TWITTER CRAZE IS RAP; Gustin Sam, 2011, SOCIAL MEDIA SPARKED; Hambrick M. E., 2010, International Journal of Sport Communication, V3, P454; Hamdi Naila, 2010, GLOBAL MEDIA J ARABI, V1, P3; Holt R., 2013, TWITTER NUMBERS; Hootsuite, 2014, SCHED TWEETS SAV TIM; Jansen F., 2010, KNOWLEDGE MANAGEMENT, V6, P37, DOI DOI 10.1080/19474199.2010.493854; Kassim Saleem, 2012, TWITTER REVOLUTION A; Klein J. Z., 2013, NY TIMES; Langman L, 2005, SOCIOL THEOR, V23, P42, DOI 10.1111/j.0735-2751.2005.00242.x; Lim M, 2012, J COMMUN, V62, P231, DOI 10.1111/j.1460-2466.2012.01628.x; Lovejoy K, 2012, J COMPUT-MEDIAT COMM, V17, P337, DOI 10.1111/j.1083-6101.2012.01576.x; Lovejoy K, 2012, PUBLIC RELAT REV, V38, P313, DOI 10.1016/j.pubrev.2012.01.005; Mansfield E., 2010, O P BUSINESS NEWS, V19, P76; Marmura S, 2008, NEW MEDIA SOC, V10, P247, DOI 10.1177/1461444807086469; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mellinger S., 2014, KANSAS CITY STA 0929; Meraz S, 2013, INT J PRESS/POLIT, V18, P138, DOI 10.1177/1940161212474472; Midha A., 2014, STUDY LIVE TWEETING; Moore J., 2011, SOCIAL MEDIA DID TWI; Morosi J. P., 2012, MLB GETS STRINGENT C; Nguyen T., 2011, TUNISIAS TWITTER REV; Norris J., 2012, CONCUSSION INFORM SO; Pearlman J., 2013, YEAR J BELCHERS FINA; Pegoraro A., 2010, International Journal of Sport Communication, V3, P501; Plaschke B., 2012, LOS ANGELES TIMES; Postmes T, 2002, SOC SCI COMPUT REV, V20, P290, DOI 10.1177/08939302020003006; Saleh N, 2012, TELECOMMUN POLICY, V36, P476, DOI 10.1016/j.telpol.2012.04.001; Sanderson, 2011, ITS WHOLE NEW BALLGA; Sanderson J., 2012, International Journal of Sport Communication, V5, P384; Sanderson J., 2011, SPORTS MEDIA TRANSFO, P114; Sandomir R., 2013, NY TIMES; Schmittel A, 2015, J SPORT SOC ISSUES, V39, P332, DOI 10.1177/0193723514557821; Schultz B., 2010, International Journal of Sport Communication, V3, P226; Sears K., 2011, TWITTERS IMPACT SPOR; Sheffer M. L., 2010, International Journal of Sport Communication, V3, P472; Sonderman J., 2012, 1 3 ADULTS 30 GET NE; Sullivan L., 2013, MOBILE PLAYS BIG SUP; Tape K. T., 2012, GAME CHANGE SOCIAL M; Thorpe H, 2013, J SPORT SOC ISSUES, V37, P115, DOI 10.1177/0193723512455923; Vendel Christine, 2012, KANSAS CITY STA 1204; Wall MA, 2007, NEW MEDIA SOC, V9, P258, DOI 10.1177/1461444807075007; WELCH S, 1975, PUBLIC OPIN QUART, V39, P237, DOI 10.1086/268221; Werner B., 2012, 2012 CATALYST FAN EN; Whitmer M., 2014, BOSTON GLOBE    0912; Wilson B, 2009, SOCIOL SPORT J, V26, P155, DOI 10.1123/ssj.26.1.155; Wilson C, 2011, INT J COMMUN-US, V5, P1248	77	10	10	1	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-7235	1552-7638		J SPORT SOC ISSUES	J. Sport Soc. Issues	FEB	2015	39	1			SI		78	94		10.1177/0193723514558928			17	Hospitality, Leisure, Sport & Tourism; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	AZ0XU	WOS:000347966100005					2022-02-06	
J	Johnson, LA; Eick-Cost, A; Jeffries, V; Russell, K; Otto, JL				Johnson, Lucas A.; Eick-Cost, Angelia; Jeffries, Vicki; Russell, Kevin; Otto, Jean Lin			Risk of Alcohol Use Disorder or Other Drug Use Disorder Among US Service Members Following Traumatic Brain Injury, 2008-2011	MILITARY MEDICINE			English	Article							HEALTH-CARE UTILIZATION; SUBSTANCE-ABUSE; PREVALENCE; VETERANS; DEPLOYMENT; MORTALITY; PAIN; IRAQ	Objectives: Evaluate the risk of developing an alcohol use disorder (AUD) or other drug use disorder (ODUD) in U. S. service members (SMs) after incident traumatic brain injury (TBI) in both the deployed and the nondeployed setting. Participants and methods: Retrospective cohort study of U.S. SMs who served on active duty from January 1, 2008 to December 31, 2010. The exposed cohort consisted of SMs who received an incident diagnosis of TBI during the exposure period. The unexposed cohort was populated with a 10% random sample of SMs with any other medical diagnosis over the exposure period. Results: After adjusting for various demographic factors, TBI severity, historic diagnosis of post-traumatic stress disorder (PTSD), comorbid PTSD, and comorbid mental health outcomes, the TBI cohort (n = 53,817) demonstrated elevated incident rate ratio of developing AUD (adjusted incidence rate ratios (IRR) 1.5, 95% confidence interval (CI) 1.4, 1.6, p < 0.0001) as compared to an unexposed cohort (n = 151,776). The TBI cohort did not demonstrate elevated risk of ODUD as compared to the unexposed cohort (adjusted IRR 1.0, 95% CI 1.0, 1.2, p = 0.178). Conclusions: U.S. SMs diagnosed with incident TBI demonstrated increased risk of developing an AUD within 1 year of incident TBI as compared to SMs without diagnosed TBI.	[Johnson, Lucas A.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Eick-Cost, Angelia; Jeffries, Vicki; Russell, Kevin; Otto, Jean Lin] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20904 USA		Johnson, LA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, 4301 Jones Bridge Rd,A-1040 A, Bethesda, MD 20814 USA.			johnson, lucas/0000-0001-9356-5518			Ames GM, 2007, J STUD ALCOHOL DRUGS, V68, P336, DOI 10.15288/jsad.2007.68.336; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; [Anonymous], 2009, Medical Surveillance Montly Report, V16, P2; Armed Forces Health Surveillance Center, 2012, ARM FORC HLTH SURV C; Servies Tammy, 2012, MSMR, V19, P11; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Armed Forces Health Surveillence Center, 2012, MED SURVEILL MON REP, V19; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bray RM., 2009, 2008 DEP DEFENSE SUR; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, MILD TRAUM BRAIN INJ; DeFraites R. F., 2010, Medical Surveillance Monthly Report, V17, P16; Department of Defense, 2012, DEP DEF INSTR 6490 1; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Falk DE, 2006, ALCOHOL RES HEALTH, V29, P162; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; FRENCH LM, 2010, MILITARY NEUROPSYCHO, P101; Haley RW, 1998, AM J EPIDEMIOL, V148, P315, DOI 10.1093/oxfordjournals.aje.a009645; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; IBM, 2011, SPSS STAT VERS 20 0; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Military Health System Strategic Communications Office, 2012, DOD NUMB TRAUM BRAIN; Missed Opportunity, 2000, NAT SURV PRIM CAR PH, P113; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Olson-Madden JH, 2012, J HEAD TRAUMA REHAB, V27, P370, DOI 10.1097/HTR.0b013e318268d496; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Substance Abuse and Mental Health Services Administration, 2012, NSDUH SER H, VH-44; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; U.S. Department of Defense, 2012, TRAUM BRAIN INJ DEP; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wilson ALG, 2009, SOC PSYCH PSYCH EPID, V44, P473, DOI 10.1007/s00127-008-0461-7	43	10	10	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2015	180	2					208	215		10.7205/MILMED-D-14-00268			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7MR	WOS:000349101900014	25643389	Bronze			2022-02-06	
J	Joseph, B; Khalil, M; Pandit, V; Kulvatunyou, N; Zangbar, B; O'Keeffe, T; Asif, A; Tang, A; Green, DJ; Gries, L; Friese, RS; Rhee, P				Joseph, Bellal; Khalil, Mazhar; Pandit, Viraj; Kulvatunyou, Narong; Zangbar, Bardiya; O'Keeffe, Terence; Asif, Anum; Tang, Andrew; Green, Donald J.; Gries, Lynn; Friese, Randall S.; Rhee, Peter			Adverse effects of admission blood alcohol on long-term cognitive function in patients with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Alcohol intoxication; cognitive function; FIM	INDEPENDENCE MEASURE; SUBSTANCE-ABUSE; HEAD-INJURY; INTOXICATION; RELIABILITY; MORTALITY; LEVEL; FIM; AGE; NEURODEGENERATION	BACKGROUND: Alcohol is known to be protective in patients with traumatic brain injury (TBI); however, its impact on the long-term cognitive function is unknown. We hypothesize that intoxication at the time of injury is associated with adverse long-term cognitive function in patients sustaining TBI. METHODS: We performed a 2-year retrospective study of all trauma patients with isolated TBI presenting to our Level I trauma center and discharged to a single rehabilitation facility. Patients with moderate-to-severe TBI (head Abbreviated Injury Scale [AIS] score >= 3), measured admission blood alcohol concentration, and measured cognitive function on hospital discharge and rehabilitation center discharge were included. Cognitive function was assessed using Functional Independence Measure (FIM) scores. Delta cognitive FIM was defined as the difference between rehabilitation center discharge and hospital discharge cognitive FIM scores. Multivariate linear regression was performed. RESULTS: A total of 64 patients were included. Mean (SD) age was 51.8 (23) years, median head AIS score was 3 (IQR, 3-5), and median Glasgow Coma Scale (GCS) score was 11 (IQR, 3-15). Mean (SD) cognitive FIM score on hospital discharge was 17 (6), and mean (SD) cognitive improvement was 8.6 (4.7). Sixty percent (n = 39) were under the influence of alcohol on admission, and the mean (SD) admission blood alcohol concentration was 132 (102). On multivariate linear regression analysis, admission blood alcohol concentration (beta = -0.4; 95% confidence interval, -6.7 to -0.8; p = 0.01) and age (beta = -0.13; 95% confidence interval, -0.2 to -0.04; p = 0.04) were negatively associated with improvement in long-term cognitive function. CONCLUSION: Alcohol intoxication at the time of injury is associated with lower improvement in long-term cognitive function. Older intoxicated patients are likely to have a lower cognitive improvement. (Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.) LEVEL OF EVIDENCE: Prognostic and epidemiologic study, level III.	[Joseph, Bellal; Khalil, Mazhar; Pandit, Viraj; Kulvatunyou, Narong; Zangbar, Bardiya; O'Keeffe, Terence; Asif, Anum; Tang, Andrew; Green, Donald J.; Gries, Lynn; Friese, Randall S.; Rhee, Peter] Univ Arizona, Div Trauma Emergency Surg Crit Care & Burns, Dept Surg, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room 5411 POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Zangbar, Bardiya/K-7147-2014	Zangbar, Bardiya/0000-0003-1215-1693			Adunsky A, 2002, CLIN REHABIL, V16, P414, DOI 10.1191/0269215502cr514oa; Berry C, 2011, AM SURGEON, V77, P1416; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; CDC, TBI US REP TRAUM BRA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Crews FT, 2004, ALCOHOL CLIN EXP RES, V28, P350, DOI 10.1097/01.ALC.0000113416.65546.01; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Joseph B, 2013, J SURG RES, V184, P541, DOI 10.1016/j.jss.2013.03.069; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nixon K, 2006, HIPPOCAMPUS, V16, P287, DOI 10.1002/hipo.20162; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Tate PS, 1999, BRAIN INJURY, V13, P767; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	33	10	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2015	78	2					403	408		10.1097/TA.0000000000000504			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CA3TF	WOS:000348828300027	25757129				2022-02-06	
J	Langhorn, L; Holdgaard, D; Worning, L; Sorensen, JC; Pedersen, PU				Langhorn, Leanne; Holdgaard, Dorte; Worning, Lene; Sorensen, Jens C.; Pedersen, Preben U.			Testing a Reality Orientation Program in Patients With Traumatic Brain Injury in a Neurointensive Care Unit	JOURNAL OF NEUROSCIENCE NURSING			English	Article						neurointensive care unit; nursing intervention; outcome; posttraumatic amnesia; traumatic brain injury; reality orientation; rehabilitation	SEVERE HEAD-INJURY; POSTTRAUMATIC AMNESIA DURATION; GLASGOW OUTCOME SCALE; WESTMEAD PTA SCALE; OF-THE-LITERATURE; MEASURING RECOVERY; SLEEP DISTURBANCE; COMA SCALE; REHABILITATION; MULTICENTER	Primary Objective: The aim of this study was to examine the effect of a systematic reality orientation program (RO) introduced in a neurointensive care unit on duration of posttraumatic amnesia (PTA) and outcomes of patients with traumatic brain injury (TBI). Research Design: This study used a quasiexperimental, prospective design. Methods and Procedures: Twenty-four patients (intervention) with a significant TBI classified as moderate-to-severe injuries as measured by scores of less than 12 on the Glasgow Coma Scale underwent an RO program compared with a similar group of 38 patients (control) who received a conventional rehabilitation program. The Rancho Los Amigos Score was used to assess the cognitive level 24 hours after the end of sedation, and the Galveston Orientation and Amnesia Test was used daily to assess orientation and duration of PTA. The Glasgow Outcome Scale Extended was then used as an indicator of clinical outcome after 12 months. Main Outcomes and Results: The preliminary results indicated that patients who received the RO had a higher mean of the Glasgow Outcome Scale Extended (SD = 1.53) than those receiving the usual care (SD = 1.35) despite that the groups differed significantly (p = .01) in PTA duration. Conclusion: Patients with TBI may benefit from early assessment and systematic RO nursing intervention. The RO may facilitate patients with PTA to regain orientation and interact with their surroundings in the neurointensive care unit to optimize the recovery. However, further studies with focus on timing, intensity, and duration are needed to evaluate the influence of an early RO approach on PTA and outcomes in patients experiencing TBI.	[Langhorn, Leanne; Holdgaard, Dorte; Worning, Lene; Sorensen, Jens C.] Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus, Denmark; [Pedersen, Preben U.] Aalborg Univ, Dept Hlth Sci & Technol, Director Ctr Clin Guidelines, Aalborg, Denmark		Langhorn, L (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus, Denmark.	leanlang@rm.dk		Langhorn, Leanne/0000-0002-6381-6678			Ahmed S, 2000, BRAIN INJURY, V14, P765; Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; De Guise E, 2005, BRAIN INJURY, V19, P263, DOI 10.1080/02699050400004971; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Furbringer e Silva S. C., 2007, REV LAT-AM ENFERM, V15, P651; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; Hagen C, 1972, RANCHO LOS AMIGOS SC; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Jacobs B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-69; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan KS, 2003, SYSTEMATIC REV SUPPO; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Murray GD, 2000, BRIT MED J, V321, P1223, DOI 10.1136/bmj.321.7270.1223; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Newberry A, 2010, J NEUROSCI NURS, V42, P47, DOI 10.1097/JNN.0b013e3181c1fdd9; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Patton D, 2006, J CLIN NURS, V15, P1440, DOI 10.1111/j.1365-2702.2005.01450.x; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; Spector A., 2007, COCHRANE DB SYST REV, V3; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; Tittle A, 2011, BRAIN INJURY, V25, P933, DOI 10.3109/02699052.2011.597042; Turner-Stokes L., 2005, MULTIDISCIPLINARY RE; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Vance D, 2011, J NEUROSCI NURS, V43, P215, DOI 10.1097/JNN.0b013e3182212a04; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woodrow P, 1998, Br J Nurs, V7, P1018; Woods B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001120.pub2; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011; Zanetti O, 2002, AGE AGEING, V31, P193, DOI 10.1093/ageing/31.3.193; Zencius AH, 1998, BRAIN INJURY, V12, P53, DOI 10.1080/026990598122854	62	10	10	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	FEB	2015	47	1					E2	E10		10.1097/JNN.0000000000000106			9	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	AZ1DJ	WOS:000347980200001	25565599				2022-02-06	
J	Moreno, A; Crosby, S; Xenakis, S; Iacopino, V				Moreno, Alejandro; Crosby, Sondra; Xenakis, Stephen; Iacopino, Vincent			Implementing Istanbul Protocol standards for forensic evidence of torture in Kyrgyzstan	Journal of Forensic and Legal Medicine			English	Article						Torture; Forensic evaluations; Post-traumatic stress disorder; Major depression; Traumatic brain injury; Istanbul Protocol		The Kyrgyz government declared a policy of "zero tolerance" for torture and began reforms to stop such practice, a regular occurrence in the country's daily life. This study presents the results of 10 forensic evaluations of individuals alleging torture; they represent 35% of all criminal investigations into torture for the January 2011-July 2012 period. All individuals evaluated were male with an average age of 34 years. Police officers were implicated as perpetrators in all cases. All individuals reported being subjected to threats and blunt force trauma from punches, kicks, and blows with objects such as police batons. The most common conditions documented during the evaluations were traumatic brain injury and chronic seizures. Psychological sequelae included post-traumatic stress disorder and major depressive disorder, which was diagnosed in seven individuals. In all cases, the physical and psychological evidence was highly consistent with individual allegations of abuse. These forensic evaluations, which represent the first ever to be conducted in Kyrgyzstan in accordance with Istanbul Protocol standards, provide critical insight into torture practices in the country. The evaluations indicate a pattern of brutal torture practices and inadequate governmental and nongovernmental forensic evaluations. (C) 2014 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Moreno, Alejandro; Crosby, Sondra; Xenakis, Stephen; Iacopino, Vincent] Phys Human Rights, New York, NY 10018 USA; [Moreno, Alejandro] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Crosby, Sondra] Boston Univ, Sch Med, Boston, MA 02215 USA; [Crosby, Sondra] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Iacopino, Vincent] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Iacopino, Vincent] Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA		Iacopino, V (corresponding author), Phys Human Rights, Headquarters Off, 256 W 38th St,9th Floor, New York, NY 10018 USA.	viacopino@phrusa.org					de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; IACOPINO V, 2001, UN PUBLICATIONS; Iacopino V, 2015, ENCY FORENS IN PRESS; Iacopino V, 2012, ENDING IMPUNITY USE; U.N Committee Against Torture, 2012, 2 UN COMM TORT; U.S. Dept of State Bureau of Democracy Human Rights And Labor, 2012, COUNTR REP HUM RIGHT	6	10	10	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	FEB	2015	30						39	42		10.1016/j.jflm.2014.12.009			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	AZ8HN	WOS:000348456400010	25623194				2022-02-06	
J	Mukherjee, KK; Dhandapani, S; Sarda, AC; Tripathi, M; Salunke, P; Srinivasan, A; Tewari, MK; Mathuriya, SN				Mukherjee, Kanchan K.; Dhandapani, Sivashanmugam; Sarda, Alok C.; Tripathi, Manjul; Salunke, Pravin; Srinivasan, Anand; Tewari, Manoj K.; Mathuriya, Suresh N.			Prospective comparison of simple suturing and elevation debridement in compound depressed fractures with no significant mass effect	ACTA NEUROCHIRURGICA			English	Article						Compound depressed fracture; Simple suturing; Elevation debridement; Infection; Outcome; Survival; Seizure; Hospital stay	SKULL FRACTURES; NONMISSILE INJURIES; MANAGEMENT; INFECTION	Compound depressed fractures have conventionally been managed surgically with elevation and debridement to avoid infection, especially when there is dural penetration, nonetheless with little evidence. This study was to prospectively compare outcomes after simple suturing and elevation debridement in patients with compound depressed fractures. Patients of compound depressed fracture with GCS of five or more, no serious systemic injury, and no significant mass effect were prospectively studied for various factors in relation to infection, hospital stay, survival, and late post-traumatic seizures. Univariate and multivariate analyses were performed using SPSS21. Of the total 232 patients with complete clinico-radiological and follow-up data, 183 underwent simple cleansing and suturing, and 49 underwent surgical elevation debridement. The surgical group at baseline had significantly lower GCS, greater dural violation, and brain matter herniation compared to the conservative arm. Univariate analysis showed simple suturing group to have significantly shorter hospital stay (2.4 vs. 10.3 days) (p < 0.001), lesser infection among survivors (4 vs. 21 %) (p = 0.001), and greater 'survival with no infection' (85 vs. 69 %) (p = 0.01). Multivariate analysis adjusting for age, sex, GCS, dural penetration, and surgical intervention confirmed significantly shorter hospital stay (p < 0.001) and lesser infection among survivors (p = 0.02) in the simple suturing group. Overall, there was no benefit offered by surgical debridement. Simple suturing had a better outcome in most subgroups, except in those with brain matter herniation and GCS 5-8, which showed non-significant benefit with surgical intervention. Simple suturing seems to be an equally good option in patients with compound depressed fracture with no significant mass effect or brain matter herniation.	[Mukherjee, Kanchan K.; Dhandapani, Sivashanmugam; Sarda, Alok C.; Tripathi, Manjul; Salunke, Pravin; Srinivasan, Anand; Tewari, Manoj K.; Mathuriya, Suresh N.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India		Mukherjee, KK (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India.	kk_mukherjee@hotmail.com	Dhandapani, Sivashanmugam/I-2395-2013; Tripathi, Manjul/AAE-7128-2019; Tripathi, Manjul/AAN-8701-2021	Dhandapani, Sivashanmugam/0000-0002-3497-4255; Tripathi, Manjul/0000-0002-5679-3439; 			Ali B, 2002, EMERG MED J, V19, P552, DOI 10.1136/emj.19.6.552; Atta HM, 1999, AM SURGEON, V65, P1190; BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V35, P395, DOI 10.1136/jnnp.35.3.395; Bullock M Ross, 2006, Neurosurgery, V58, pS56; COOPER PR, 1993, HEAD INJURY, P115; Cushing H, 1918, BRIT J SURG, V5, P558; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P23, DOI 10.1016/S0973-0508(10)80007-3; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Dhandapani S, 2014, J CLIN NEUROSCI, V21, P745, DOI 10.1016/j.jocn.2013.07.038; HEARY RF, 1993, J TRAUMA, V35, P441, DOI 10.1097/00005373-199309000-00018; JENNETT B, 1972, J NEUROSURG, V36, P333, DOI 10.3171/jns.1972.36.3.0333; JENNETT B, 1974, J NEUROSURG, V41, P208, DOI 10.3171/jns.1974.41.2.0208; Mendelow A D, 1983, J R Coll Surg Edinb, V28, P80; Prioreschi P, 1993, Gesnerus, V50 ( Pt 3-4), P167; Rehman L, 2007, JCPSP-J COLL PHYSICI, V17, P140; Shokunbi M T, 2000, Afr J Med Med Sci, V29, P293; STEINBOK P, 1987, J NEUROSURG, V66, P506, DOI 10.3171/jns.1987.66.4.0506; TEASDALE G, 1974, LANCET, V2, P81; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; Wylen EL, 1999, SURG NEUROL, V51, P452, DOI 10.1016/S0090-3019(98)00040-8	20	10	10	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2015	157	2					305	309		10.1007/s00701-014-2296-1			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CA5VQ	WOS:000348976300022	25510645				2022-02-06	
J	Park, JT; Chugani, HT				Park, Jun T.; Chugani, Harry T.			Post-Traumatic Epilepsy in Children-Experience From a Tertiary Referral Center	PEDIATRIC NEUROLOGY			English	Article						post-traumatic epilepsy (PTE); nonaccidental trauma (NAT); seizure semiology; hypomotor seizures; epileptic spasms; traumatic brain injury (TBI); brain injury and seizures	HEAD-INJURY; SEIZURES; EPIDEMIOLOGY; PREVENTION; PHENYTOIN; INFANTS; TRAUMA	BACKGROUND: Post-traumatic epilepsy after a traumatic brain injury occurs in 10%-20% of children. Unfortunately, a biomarker that could provide prognostic information about both post-traumatic epilepsy and cognitive development is lacking. In this first of a series of studies, we have reviewed and analyzed clinical variables in children following traumatic brain injury to understand the epidemiologic and clinical characteristics of post-traumatic epilepsy in our urban population. METHODS: We performed a retrospective electronic chart review of patients who had suffered traumatic brain injury and subsequently evaluated at Children's Hospital of Michigan from 2002 to 2012. Various epidemiologic and clinical variables were analyzed. RESULTS: Patients who had severe traumatic brain injury and post-traumatic epilepsy had an abnormal acute head computed tomography. These patients had increased number of different seizure types, increased risk of intractability of epilepsy, and were on multiple antiepileptic drugs. Hypomotor seizure was the most common seizure type in these patients. There was a high prevalence of patients who suffered nonaccidental trauma, all of whom had severe traumatic brain injury. CONCLUSIONS: This study demonstrates a need for biomarkers in children following traumatic brain injury to reliably evaluate the risk of post-traumatic epilepsy.	[Park, Jun T.] Case Western Reserve Univ, Sch Med, Dept Pediat, Div Pediatr Epilepsy,Rainbow Babies & Childrens H, Cleveland, OH 44106 USA; [Park, Jun T.; Chugani, Harry T.] Wayne State Univ, Sch Med, Dept Pediat, Div Pediat Neurol,Childrens Hosp Michigan, Detroit, MI 48201 USA		Park, JT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, Div Pediatr Epilepsy,Rainbow Babies & Childrens H, Cleveland, OH 44106 USA.	jun.park@uhhospitals.org	Park, Jun T./C-1894-2018	Park, Jun T./0000-0002-9325-0038			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], TXB EPILEPSY SURG SP, P488; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Kallen K, 2002, EPILEPSIA, V43, P882, DOI 10.1046/j.1528-1157.2002.16301.x; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Luders H, 1998, EPILEPSIA, V39, P1006, DOI 10.1111/j.1528-1157.1998.tb01452.x; LUDERS HO, 1993, NEUROLOGY, V43, P1650, DOI 10.1212/WNL.43.9.1650; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Temkin NRHM, 1996, NEUROLOGICAL SURG, P1834; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236	28	10	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	FEB	2015	52	2					174	181		10.1016/j.pediatrneurol.2014.09.013			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CB4EI	WOS:000349580600006	25693582				2022-02-06	
J	Kobori, N; Moore, AN; Dash, PK				Kobori, Nobuhide; Moore, Anthony N.; Dash, Pramod K.			Altered Regulation of Protein Kinase A Activity in the Medial Prefrontal Cortex of Normal and Brain-Injured Animals Actively Engaged in a Working Memory Task	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; PKA signaling; prefrontal cortex; CREB; memory	CONTROLLED CORTICAL IMPACT; GLUTAMIC-ACID DECARBOXYLASE; SYNAPTIC PLASTICITY; FACTOR CREB; DEFICITS; RAT; CAMP; EXPRESSION; PKA; DYSFUNCTION	Cyclic adenosine monophosphate (cAMP)-dependent protein kinase A (PKA) signaling is required for short- and long-term memory. In contrast, enhanced PKA activity has been shown to impair working memory, a prefrontal cortex (PFC)-dependent, transient form of memory critical for cognition and goal-directed behaviors. Working memory can be impaired after traumatic brain injury (TBI) in the absence of overt damage to the PFC. The cellular and molecular mechanisms that contribute to this deficit are largely unknown. In the present study, we examined whether altered PKA signaling in the PFC as a result of TBI is a contributing mechanism. We measured PKA activity in medial PFC (mPFC) tissue homogenates prepared from sham and 14-day postinjury rats. PKA activity was measured both when animals were inactive and when actively engaged in a spatial working memory task. Our results demonstrate, for the first time, that PKA activity in the mPFC is actively suppressed in uninjured animals performing a working memory task. By comparison, both basal and working memory-related PKA activity was elevated in TBI animals. Inhibition of PKA activity by intra-mPFC administration of Rp-cAMPS into TBI animals had no influence on working memory performance 30 min postinfusion, but significantly improved working memory when tested 24 h later. This improvement was associated with reduced glutamic acid decarboxylase 67 messenger RNA levels. Taken together, these results suggest that TBI-associated working memory dysfunction may result, in part, from enhanced PKA activity, possibly leading to altered expression of plasticity-related genes in the mPFC.	[Kobori, Nobuhide; Dash, Pramod K.] Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77225 USA; [Moore, Anthony N.; Dash, Pramod K.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS052313, NS087149]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087149] Funding Source: NIH RePORTER	The authors are thankful for the technical help provided by Dr. Jing Zhao, Michael Darilek, Rachel Marks, and Mosope Soda. The authors are grateful for the comments and suggestions provided by Dr. John Redell. The work was supported by grants from the National Institutes of Health (NS052313 [to N.K.] and NS087149 [to P.K.D.]).	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; Costa E., 2004, Critical Reviews in Neurobiology, V16, P1, DOI 10.1615/CritRevNeurobiol.v16.i12.10; Dacher M, 2013, J NEUROSCI, V33, P2650, DOI 10.1523/JNEUROSCI.2037-12.2013; DELMAS V, 1994, REV PHYSIOL BIOCH P, V124, P1, DOI 10.1007/BFb0031030; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Luo YQ, 2008, J BIOL CHEM, V283, P24789, DOI 10.1074/jbc.M800649200; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2002, J SCI MED SPORT, V5, P169, DOI 10.1016/S1440-2440(02)80002-0; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; RANGELALDAO R, 1977, J BIOL CHEM, V252, P7140; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Runyan JD, 2005, LEARN MEMORY, V12, P232, DOI 10.1101/lm.92405; Runyan JD, 2005, LEARN MEMORY, V12, P103, DOI 10.1101/lm.89405; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Taylor JR, 1999, J NEUROSCI, V19; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; Volk DW, 2010, CURR TOP BEHAV NEURO, V4, P485, DOI 10.1007/7854_2010_44; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	50	10	10	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2015	32	2					139	148		10.1089/neu.2014.3487			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AY6QM	WOS:000347690700009	25027811	Green Published			2022-02-06	
J	Rozas, NS; Redell, JB; Hill, JL; McKenna, J; Moore, AN; Gambello, MJ; Dash, PK				Rozas, Natalia S.; Redell, John B.; Hill, Julia L.; McKenna, James, III; Moore, Anthony N.; Gambello, Michael J.; Dash, Pramod K.			Genetic Activation of mTORC1 Signaling Worsens Neurocognitive Outcome after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; memory; AMPK; S6; mTOR; mTBI	CLOSED-HEAD INJURY; TUBEROUS-SCLEROSIS; MAMMALIAN TARGET; CONTEXT DISCRIMINATION; DORSAL HIPPOCAMPUS; RAT; MODEL; RAPAMYCIN; DEFICITS; MEMORY	Although the mechanisms that contribute to the development of traumatic brain injury (TBI)-related deficits are not fully understood, it has been proposed that altered energy utilization may be a contributing factor. The tuberous sclerosis complex, a heterodimer composed of hamartin/Tsc-1 and tuberin/Tsc-2, is a critical regulatory node that integrates nutritional and growth signals to govern energy using processes by regulating the activity of mechanistic Target of Rapamycin complex 1 (mTORC1). mTORC1 activation results in enhanced protein synthesis, an energy consuming process. We show that mice that have a heterozygous deletion of Tsc2 exhibit elevated basal mTORC1 activity in the cortex and the hippocampus while still exhibiting normal motor and neurocognitive functions. In addition, a mild closed head injury (mCHI) that did not activate mTORC1 in wild-type mice resulted in a further increase in mTORC1 activity in Tsc2(+/KO) mice above the level of activity observed in uninjured Tsc2(+/KO) mice. This enhanced level of increased mTORC1 activity was associated with worsened cognitive function as assessed using the Morris water maze and context discrimination tasks. These results suggest that there is a threshold of increased mTORC1 activity after a TBI that is detrimental to neurobehavioral performance, and interventions to inhibit excessive mTORC1 activation may be beneficial to neurocognitive outcome.	[Rozas, Natalia S.; Redell, John B.; Hill, Julia L.; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Med Sch, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Hill, Julia L.] Lieber Inst Brain Dev, Baltimore, MD USA; [McKenna, James, III; Gambello, Michael J.] Emory Univ, Dept Human Genet, Atlanta, GA USA		Dash, PK (corresponding author), Univ Texas Med Sch, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Rozas, Natalia/0000-0003-0848-0478; Hill, Julia/0000-0003-4744-0532	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087149, NS060804]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086301, R01NS060804, R01NS087149] Funding Source: NIH RePORTER	This work was supported in part by grants (NS087149 and NS060804) from the National Institutes of Health. The authors would like to thank Dr. Jing Zhao and Ms. Cristina Nelson for performing the animal surgeries, and Sara Orsi for her helpful discussions.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Blum S, 1999, J NEUROSCI, V19, P3535; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P156, DOI 10.1016/j.nbd.2011.07.018; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Di Nardo A, 2014, HUM MOL GENET, V23, P3865, DOI 10.1093/hmg/ddu101; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Guo W, 2014, IMMUNOPHARM IMMUNOT, V36, P211, DOI 10.3109/08923973.2014.913616; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lu Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-44; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Waltereit R, 2006, J NEUROCHEM, V96, P407, DOI 10.1111/j.1471-4159.2005.03538.x; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	41	10	10	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2015	32	2					149	158		10.1089/neu.2014.3469			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AY6QM	WOS:000347690700010	25025304	Green Published			2022-02-06	
J	Merritt, VC; Rabinowitz, AR; Arnett, PA				Merritt, Victoria C.; Rabinowitz, Amanda R.; Arnett, Peter A.			Personality Factors and Symptom Reporting at Baseline in Collegiate Athletes	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							POSTCONCUSSION-LIKE SYMPTOMS; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL FUNCTION; CONCUSSION SYMPTOMS; SAMPLE	The purpose of this study was to evaluate the relationship between personality and symptom reporting at baseline in collegiate athletes. Participants were 759 athletes who completed the Post-Concussion Symptom Scale and NEO-Five Factor Inventory. Results showed that neuroticism and agreeableness personality dimensions were predictive of athletes' symptom reports at baseline.	[Merritt, Victoria C.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Rabinowitz, Amanda R.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Merritt, VC (corresponding author), Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA.	vcabarnes@gmail.com		Merritt, Victoria/0000-0001-5683-4168	Penn State Sports Medicine	No formal funding was obtained for this project; however, we would like to thank Dr. Wayne Sebastianelli and Penn State Sports Medicine for their generous support of our research.	Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006	10	10	10	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JAN 2	2015	40	1			SI		45	50		10.1080/87565641.2014.979928			6	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CA6IR	WOS:000349015800009	25649780				2022-02-06	
J	Agarwal, S; Mishra, P; Shivange, G; Kodipelli, N; Moros, M; de la Fuente, JM; Anindya, R				Agarwal, Srishti; Mishra, Priyanka; Shivange, Gururaj; Kodipelli, Naveena; Moros, Maria; de la Fuente, Jesus M.; Anindya, Roy			Citrate-capped gold nanoparticles for the label-free detection of ubiquitin C-terminal hydrolase-1	ANALYST			English	Article							NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CELL LUNG-CANCER; GENE-PRODUCT 9.5; COLORIMETRIC DETECTION; HEAD-INJURY; BIOMARKER; PROTEIN; PGP9.5; ASSAY	Ubiquitin C-terminal hydrolase-1 (UCH-L1) is a specific neuronal endoprotease that cleaves the specific peptide bond between ubiquitin molecules. UCH-L1 is released in serum and cerebrospinal fluid after severe brain injury and is considered to be an important biomarker of brain injury. A common polymorphism of UCH-L1 (S18Y) is also linked to a reduced risk of Parkinson's disease. In addition to its function in neuronal tissues, UCH-L1 may also play a part in the progression of certain non-neuronal cancers. UCH-L1 is highly expressed in primary lung tumors and colo-rectal cancers, suggesting a role in tumorigenesis. We report here the development of a sensitive and accurate UCH-L1 assay based on the surface plasmon resonance (SPR) absorbance of gold nanoparticles. We created a unique UCH-L1 substrate containing a ubiquitin molecule with two terminal thiol groups. This UCH-L1 substrate interacted with gold nanoparticles via the terminal thiol groups and induced clustering of the nanoparticles, which was detected by SPR absorbance at 650 nm. UCH-L1 proteolytically cleaved the substrate and the clustered gold nanoparticles were dispersed and could be detected by a shift in the SPR absorbance to 530 nm. This change in absorbance was proportional to the concentration of UCH-L1 and can be used for the quantification of functional UCH-L1. The currently available fluorescence-based UCH-L1 assay is affected by a high background signal and a poor detection limit, especially in the presence of serum. The assay reported here can detect concentrations of UCH-L1 as low as 20 ng ml(-1) (0.8 nM) and the presence of serum had no effect on the detection limit. This assay could be adapted for the rapid determination of the severity of brain injury and could also be applied to high-throughput screening of inhibitors of UCH-L1 enzymatic activity in Parkinson's disease and cancer.	[Agarwal, Srishti; Mishra, Priyanka; Shivange, Gururaj; Kodipelli, Naveena; Anindya, Roy] Indian Inst Technol, Dept Biotechnol, Hyderabad 502205, Andhra Pradesh, India; [Kodipelli, Naveena; Moros, Maria; de la Fuente, Jesus M.] Univ Zaragoza, INA, Nanotherapy & Nanodiagnost Grp, Zaragoza, Spain		Anindya, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Ordnance Factory Estate, Hyderabad 502205, Andhra Pradesh, India.	anindya@iith.ac.in	de la Fuente, Jesus M/L-8361-2016; Moros, Maria/A-1422-2019; Anindya, Roy/ABD-1326-2020; Anindya, Roy/F-8241-2012	de la Fuente, Jesus M/0000-0003-1081-8482; Moros, Maria/0000-0002-2861-2469; Anindya, Roy/0000-0001-8561-907X; Anindya, Roy/0000-0001-8561-907X	Department of Biotechnology (DBT), Government of IndiaDepartment of Biotechnology (DBT) India [102/IFD/SAN/634/2013-2014, DT 09-05-2013]	This work was funded by the Department of Biotechnology (DBT), Government of India (Project no. 102/IFD/SAN/634/2013-2014; DT 09-05-2013).	Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Case A, 2006, BIOCHEMISTRY-US, V45, P2443, DOI 10.1021/bi052135t; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; Chen CK, 2010, BIOSENS BIOELECTRON, V25, P1922, DOI 10.1016/j.bios.2010.01.005; Chen YM, 2008, LANGMUIR, V24, P3654, DOI 10.1021/la7034642; Choi Y, 2007, ANGEW CHEM INT EDIT, V46, P707, DOI 10.1002/anie.200603735; Chuang YC, 2010, BIOMATERIALS, V31, P6087, DOI 10.1016/j.biomaterials.2010.04.026; Dash P. K., 1997, NEUROTHERAPEUTICS, V7, P100; Day I. N., 1997, PROG NEUROBIOL, V90, P327; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Guarise C, 2006, P NATL ACAD SCI USA, V103, P3978, DOI 10.1073/pnas.0509372103; Guarise C, 2005, LANGMUIR, V21, P5537, DOI 10.1021/la0470232; Hibi K, 1998, CANCER RES, V58, P5690; Hong S, 2009, ANAL CHEM, V81, P1378, DOI 10.1021/ac802099c; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kim GB, 2013, BIOSENS BIOELECTRON, V41, P833, DOI 10.1016/j.bios.2012.10.025; Laromaine A, 2007, J AM CHEM SOC, V129, P4156, DOI 10.1021/ja0706504; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Laskowitz D T, 1998, J Stroke Cerebrovasc Dis, V7, P234, DOI 10.1016/S1052-3057(98)80032-3; Leiblich A, 2007, PROSTATE, V67, P1761, DOI 10.1002/pros.20654; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu RR, 2007, ANGEW CHEM INT EDIT, V46, P8799, DOI 10.1002/anie.200702773; Liu XO, 2007, COLLOID SURFACE B, V58, P3, DOI 10.1016/j.colsurfb.2006.08.005; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Martens P, 1996, ACAD EMERG MED, V3, P126, DOI 10.1111/j.1553-2712.1996.tb03399.x; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; Mohammad RM, 1996, ENZYME PROTEIN, V49, P262, DOI 10.1159/000468636; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Otsuki T, 2004, BRIT J HAEMATOL, V127, P292, DOI 10.1111/j.1365-2141.2004.05205.x; Pandey P, 2007, LANGMUIR, V23, P3333, DOI 10.1021/la062901c; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Sasaki H, 2001, JPN J CLIN ONCOL, V31, P532, DOI 10.1093/jjco/hye113; Takano T, 2004, EUR J CANCER, V40, P614, DOI 10.1016/j.ejca.2003.11.016; Tezel E, 2000, CLIN CANCER RES, V6, P4764; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang M, 2009, LANGMUIR, V25, P2504, DOI 10.1021/la803870v; Wang ZX, 2006, J AM CHEM SOC, V128, P2214, DOI 10.1021/ja058135y; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Xu XY, 2007, ANGEW CHEM INT EDIT, V46, P3468, DOI 10.1002/anie.200605249; Yamazaki T, 2002, CLIN CANCER RES, V8, P192; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yanagisawa TY, 1998, TOHOKU J EXP MED, V184, P229	47	10	10	1	42	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0003-2654	1364-5528		ANALYST	Analyst		2015	140	4					1166	1173		10.1039/c4an01935k			8	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	CB1BX	WOS:000349362700026	25516911				2022-02-06	
J	Al-Khodairy, AT; Wicky, G; Nicolo, D; Vuadens, P				Al-Khodairy, A. T.; Wicky, G.; Nicolo, D.; Vuadens, P.			Influence of intrathecal baclofen on the level of consciousness and mental functions after extremely severe traumatic brain injury: Brief report	BRAIN INJURY			English	Article						Intrathecal baclofen; minimally conscious state; muscle spasticity; traumatic brain injury; vegetative state	ALLEVIATES AUTONOMIC DYSFUNCTION; WESSEX HEAD-INJURY; SUPRASPINAL SPASTICITY; VEGETATIVE STATE; GABA(B) RECEPTORS; RECOVERY; INFUSION; SCALE; DYSAUTONOMIA; THERAPY	Background: Whenever oral treatment or botulinum toxin injections fail to control severe spasticity, a trial with intrathecal baclofen is recommended no earlier than 1 year after brain injury. When irreversible contractures are to be avoided, such a trial might be done earlier. Some have briefly reported cognitive modifications with this treatment. Methods: During the trial period, intrathecal baclofen is continuously infused by a portable external pump through an intrathecal catheter. The daily dose is adjusted according to the clinical response. If the expected response is obtained by reduction of spasticity, a programmable pump is then implanted. Throughout the procedure, close neuropsychological follow-up is pursued. Results: Two persons with extremely severe brain injury and spasticity received a programmable pump less than 10 months after trauma. Unexpectedly, one emerged from the minimally conscious state and the other from post-traumatic amnesia. Conclusions: Intrathecal baclofen should be considered within the first year after brain injury whenever spasticity does not respond to medication. ITB lessens the degree of spasticity which in turn facilitates care and, thus, has the potential to limit contractures. After severe brain injury, this treatment might trigger recovery from altered states of consciousness, improve cognition and facilitate rehabilitation.	[Al-Khodairy, A. T.] Clin Romande Readaptat Suvacare, Dept Spinal Cord Injury Rehabil, Sion, Switzerland; [Wicky, G.; Nicolo, D.] Clin Romande Readaptat Suvacare, Dept Neuropsychol, Sion, Switzerland; [Vuadens, P.] Clin Romande Readaptat Suvacare, Dept Neurorehabil, Sion, Switzerland		Al-Khodairy, AT (corresponding author), Route Oiseaux 2, CH-1958 Uvrier, Switzerland.	aw.alkhodairy@netplus.ch					Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Bensmail D, 2009, NEUROREHAB NEURAL RE, V23, P546, DOI 10.1177/1545968308328724; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; Cuny E, 2003, NEUROCHIRURGIE, V49, P289; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dario A, 2007, ACTA NEUROCHIR SUPPL, V97, P461; Francisco GE, 2005, BRAIN INJURY, V19, P359, DOI 10.1080/02699050400003999; Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035; Giacino JT, 2005, PROG BRAIN RES, V150, P381, DOI 10.1016/S0079-6123(05)50027-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Guillaume D, 2005, ARCH PHYS MED REHAB, V86, P2165, DOI 10.1016/j.apmr.2005.05.018; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kawecki Zdzislaw, 2007, Przegl Lek, V64 Suppl 2, P13; Levin ED, 2004, PHARMACOL BIOCHEM BE, V79, P343, DOI 10.1016/j.pbb.2004.08.013; Lopez-Bendito G, 2003, CEREB CORTEX, V13, P932, DOI 10.1093/cercor/13.9.932; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Obrietan K, 1998, J NEUROPHYSIOL, V79, P1360, DOI 10.1152/jn.1998.79.3.1360; Panourias IG, 2007, ACTA NEUROCHIR SUPPL, V97, P145; PENN RD, 1987, J NEUROSURG, V66, P181, DOI 10.3171/jns.1987.66.2.0181; Petropoulou KB, 2007, ACTA NEUROCHIR SUPPL, V97, P243; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Priest CA, 2004, J NEUROBIOL, V60, P154, DOI 10.1002/neu.20011; Rifici C, 1994, Funct Neurol, V9, P29; Saltuari L, 1992, Acta Neurol (Napoli), V14, P195; Sampson FC, 2002, J NEUROSURG, V96, P1052, DOI 10.3171/jns.2002.96.6.1052; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; Stineman MG, 1997, ARCH PHYS MED REHAB, V78, P636, DOI 10.1016/S0003-9993(97)90430-5; Taira T, 2006, ACTA NEUROCHIR SUPPL, V99, P61, DOI 10.1007/978-3-211-35205-2_12; Taira T, 2003, ACT NEUR S, V87, P37; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; Tang AC, 1996, BEHAV BRAIN RES, V74, P145, DOI 10.1016/0166-4328(95)00038-0; TEASDALE G, 1974, LANCET, V2, P81; Turner MS, 2003, ACT NEUR S, V87, P81; Wilson FC, 2009, NEUROPSYCHOL REHABIL, V19, P754, DOI 10.1080/09602010902805318; Yarkony GM, 1987, CLIN ORTHOP RELAT R, V219, P93; Zarrindast MR, 2001, EUR J PHARMACOL, V411, P283, DOI 10.1016/S0014-2999(00)00906-7	46	10	11	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	4					527	532		10.3109/02699052.2014.984759			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF8JE	WOS:000352803300015	25437354				2022-02-06	
J	Barichello, T; Generoso, JS; Simoes, LR; Sharin, VG; Ceretta, RA; Dominguini, D; Comim, CM; Vilela, MC; Teixeira, AL; Quevedo, J				Barichello, Tatiana; Generoso, Jaqueline S.; Simoes, Lutiana R.; Sharin, Vladislav G.; Ceretta, Renan A.; Dominguini, Diogo; Comim, Clarissa M.; Vilela, Marcia C.; Teixeira, Antonio Lucio; Quevedo, Joao			Interleukin-1 beta Receptor Antagonism Prevents Cognitive Impairment Following Experimental Bacterial Meningitis	CURRENT NEUROVASCULAR RESEARCH			English	Article						Bacterial meningitis; cytokines; BDNF; hippocampus; behaviour	TUMOR-NECROSIS-FACTOR; EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; STREPTOCOCCUS-PNEUMONIAE; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; HUMAN-MONOCYTES; NMDA RECEPTORS; IMMUNE-SYSTEM	Pneumococcal meningitis is characterized by high rates of mortality and long-term cognitive impairment. In this study, we evaluated the effects of interleukin (IL)-1 beta receptor antagonist (IL-1Ra) on memory, cytokine, and brain-derived neurotrophic factor (BDNF) levels in hippocampus after experimental pneumococcal meningitis. In a first experiment the animals were divided into four groups: control/saline, control treated with IL-1Ra, meningitis/saline, and meningitis treated with IL-1Ra. In the meningitis/saline group IL-1 beta and cytokine-induced neutrophil chemoattractant-1 (CINC-1) levels increased at 24 h post-infection; adjuvant treatment with IL-1Ra reversed the increased levels in the hippocampus. The levels of tumour necrosis factor-alpha (TNF-alpha), IL-4, IL-6, IL-10, and BDNF did not change in all groups at 24 h post-infection. In a second experiment, the animals were subjected to behavioural tasks (open field, step-down inhibitory avoidance task, and object recognition task), cytokine, and BDNF levels analysis 10 days after experimental meningitis induction. In the open-field task, the meningitis/saline group did not exhibit difference between the training and test sessions, in the motor and exploratory activity indicating memory injury. The meningitis/IL-1Ra group presented difference between training and test session indicating habituation memory. The meningitis/saline group showed impairment in long-term memory for novel object recognition and in aversive memory. The adjuvant treatment with IL-1Ra prevented memory impairment. After behavioural tasks the hippocampus was evaluated. The levels of IL-4, IL-6, IL-10, and BDNF were maintained elevated 10 days post-infection. CINC-1 levels were elevated only in meningitis/saline group and IL-1 beta decreased in meningitis/IL-Ra group. The levels of TNF-alpha did not change at 10 days post-infection. These findings illustrate the anti-inflammatory activity of IL-1Ra inhibitor in the first hours after meningitis induction. Adjuvant treatment with IL-1 beta receptor antagonist could be a new avenue as therapeutic target during bacterial meningitis.	[Barichello, Tatiana; Generoso, Jaqueline S.; Simoes, Lutiana R.; Ceretta, Renan A.] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Microbiol Expt, BR-88806000 Criciuma, SC, Brazil; [Dominguini, Diogo; Quevedo, Joao] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Neurociencias, BR-88806000 Criciuma, SC, Brazil; [Comim, Clarissa M.] Univ Sul Santa Catarina, Lab Neurociencias Expt, Programa Posgrad Ciencias Saude, BR-88137270 Palhoca, SC, Brazil; [Vilela, Marcia C.] Univ Fed Vicosa, Dept Biol Anim, BR-36570000 Vicosa, MG, Brazil; [Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, BR-31270901 Belo Horizonte, MG, Brazil; [Barichello, Tatiana; Sharin, Vladislav G.; Quevedo, Joao] Univ Texas Houston, Sch Med, Dept Psychiat & Behav Sci, Ctr Translat Psychiat, Houston, TX USA		Barichello, T (corresponding author), Univ Extremo Sul Catarinense, UNASAU, PPGCS, Lab Microbiol Expt, BR-88806000 Criciuma, SC, Brazil.	tba@unesc.net	Comim, Clarissa M/S-9007-2019; Dominguini, Diogo/AAC-9866-2022; de Quevedo, Joao Luciano/E-5491-2013; Teixeira, Antonio L/N-3315-2014; Generoso, Jaqueline S/N-3142-2013; Barichello, Tatiana/E-2725-2013	Comim, Clarissa M/0000-0003-4991-042X; Dominguini, Diogo/0000-0002-5232-3026; de Quevedo, Joao Luciano/0000-0003-3114-6611; Teixeira, Antonio L/0000-0002-9621-5422; Generoso, Jaqueline S/0000-0003-0571-6764; Barichello, Tatiana/0000-0001-7776-8454; Ceretta, Renan Antonio/0000-0002-5586-9550	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESCFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC); FAPEMIGFundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Instituto Cerebro e Mente; UNESC; Department of Psychiatry and Behavioural Sciences, The University of Texas Medical School at Houston	Laboratory of Experimental Microbiology, Laboratory of Neuroscience (Brazil) are centers of the National Institute for Translational Medicine (INCT-TM) and members of the Center of Excellence in Applied Neurosciences of Santa Catarina (NENASC), as well as their research was supported by grants from CNPq (JQ and TB), FAPESC (JQ and TB), FAPEMIG (ALT), Instituto Cerebro e Mente (JQ and TB) and UNESC (JQ and TB). Center for Experimental Models in Psychiatry (USA) is funded by Department of Psychiatry and Behavioural Sciences, The University of Texas Medical School at Houston. JQ and TB are CNPq Research Fellows. JSG is holder of a CAPES studentship and LRS is holder of a FAPESC studentship.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ballendine SA, 2015, PROG NEURO-PSYCHOPH, V57, P155, DOI 10.1016/j.pnpbp.2014.11.002; Barichello T, 2012, EUR J CLIN MICROBIOL; Barichello T, 2010, NEUROSCI LETT, V478, P93, DOI 10.1016/j.neulet.2010.04.072; Barichello T, 2010, J NEUROIMMUNOL, V223, P73, DOI 10.1016/j.jneuroim.2010.04.004; Barichello T, 2010, J NEUROIMMUNOL, V221, P42, DOI 10.1016/j.jneuroim.2010.02.009; Barrientos RM, 2012, J NEUROSCI, V32, P14641, DOI 10.1523/JNEUROSCI.2173-12.2012; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2002, J NEUROCHEM, V83, P432, DOI 10.1046/j.1471-4159.2002.01166.x; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; de Lima MNM, 2005, BEHAV BRAIN RES, V156, P139, DOI 10.1016/j.bbr.2004.05.016; Frank MG, 2012, J NEUROIMMUNOL, V252, P33, DOI 10.1016/j.jneuroim.2012.07.010; Geldhoff M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-358; Grandgirard D, 2007, ACTA NEUROPATHOL, V114, P609, DOI 10.1007/s00401-007-0304-8; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hirata I, 2001, DIGESTION, V63, P73, DOI 10.1159/000051915; Irazuzta J, 2008, CRIT CARE MED, V36, P1603, DOI 10.1097/CCM.0b013e318170ab08; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; Kastenbauer S, 2002, NEUROLOGY, V58, P186, DOI 10.1212/WNL.58.2.186; Katayama T, 2009, J PHARMACOL SCI, V109, P88, DOI 10.1254/jphs.08298FP; Kauer-Sant'Anna M, 2007, PEPTIDES, V28, P1447, DOI 10.1016/j.peptides.2007.06.010; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mina F, 2014, MOL NEUROBIOL, V49, P1069, DOI 10.1007/s12035-013-8581-9; MUSTAFA MM, 1990, AM J DIS CHILD, V144, P883, DOI 10.1001/archpedi.1990.02150320047024; Oztuzcu S, 2011, GENET TEST MOL BIOMA, V15, P327, DOI 10.1089/gtmb.2010.0198; Pugh CR, 2001, NEUROSCI BIOBEHAV R, V25, P29, DOI 10.1016/S0149-7634(00)00048-8; Quevedo J, 1997, BEHAV PHARMACOL, V8, P713, DOI 10.1097/00008877-199712000-00006; RIESENFELDORN I, 1989, INFECT IMMUN, V57, P1890, DOI 10.1128/IAI.57.7.1890-1893.1989; Roesler R, 2003, BRAIN RES, V975, P207, DOI 10.1016/S0006-8993(03)02656-8; Sakamoto Y, 1996, NEUROSCIENCE, V75, P133, DOI 10.1016/0306-4522(96)00252-7; Schaaf BM, 2003, AM J RESP CRIT CARE, V168, P476, DOI 10.1164/rccm.200210-1164OC; Schmidt H, 1999, SCAND J IMMUNOL, V49, P481; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; SHIEH JH, 1991, J IMMUNOL, V147, P1273; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Yamada S, 2000, HEPATOLOGY, V32, P278, DOI 10.1053/jhep.2000.9604; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Zwijnenburg PJG, 2003, INFECT IMMUN, V71, P2276, DOI 10.1128/IAI.71.4.2276-2279.2003; Zysk G, 1997, J NEUROIMMUNOL, V73, P77, DOI 10.1016/S0165-5728(96)00173-7	48	10	11	0	7	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.		2015	12	3					253	261		10.2174/1567202612666150605122200			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM3KT	WOS:000357581600006	26044807				2022-02-06	
S	Barr, T; Livingston, W; Guardado, P; Baxter, T; Mysliwiec, V; Gill, J		Conley, YP		Barr, Taura; Livingston, Whitney; Guardado, Pedro; Baxter, Tristin; Mysliwiec, Vincent; Gill, Jessica			Military Personnel With Traumatic Brain Injuries and Insomnia Have Reductions in PTSD and Improved Perceived Health Following Sleep Restoration A Relationship Moderated by Inflammation	ANNUAL REVIEW OF NURSING RESEARCH, VOL 33: TRAUMATIC BRAIN INJURY	Annual Review of Nursing Research-Series		English	Article; Book Chapter							C-REACTIVE PROTEIN; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; IMMUNE ACTIVATION; HEART-DISEASE; DEPRESSION; BIOMARKERS; VETERANS; ASSOCIATION; MORTALITY	Background: Up to one-third of deployed military personnel sustain a traumatic brain injury (TBI). TBIs and the stress of deployment contribute to the vulnerability for chronic sleep disturbance, resulting in high rates of insomnia diagnoses as well as symptoms of posttraumatic stress disorder (PTSD), depression, and declines in health-related quality of life (HRQOL). Inflammation is associated with insomnia; however, the impact of sleep changes on comorbid symptoms and inflammation in this population is unknown. Methods: In this study, we examined the relationship between reported sleep changes and the provision of the standard of care, which could include one or more of the following: cognitive behavioral therapy (CBT), medications, and continuous positive airway pressure (CPAP). We compared the following: (a) the group with a decrease in the Pittsburgh Sleep Quality Index (PSQI; restorative sleep) and (b) the group with no change or increase in PSQI (no change). Independent t tests and chi-square tests were used to compare the groups on demographic and clinical characteristics, and mixed between-within subjects analysis of variance tests were used to determine the effect of group differences on changes in comorbid symptoms. Linear regression models were used to examine the role of inflammation in changes in symptoms and HRQOL. Results: The sample included 70 recently deployed military personnel with TBI, seeking care for sleep disturbances. Thirty-seven participants reported restorative sleep and 33 reported no sleep changes or worse sleep. The two groups did not differ in demographic characteristics or clinical symptoms at baseline. The TBI + restored sleep group had significant reductions in PTSD and depression over the 3-month period, whereas the TBI + no change group had a slight increase in both PTSD and depression. The TBI + restored sleep group also had significant changes in HRQOL, including the -following HRQOL subcomponents: physical functioning, role limitations in physical health, social functioning, emotional well-being, energy/fatigue, and general health perceptions. In a linear regression model using a forced entry method, the dependent variable of change in C-reactive protein (CRP) concentrations was significantly related to changes in PTSD symptoms and HRQOL in the TBI + restored sleep group, with R-2 = 0.43, F-33,F-3 = 8.31, p < .01. Conclusions: Military personnel with TBIs who have a reduction in insomnia symptoms following a standard-of-care treatment report less severe symptoms of depression and PTSD and improved HRQOL, which relate to decreased plasma concentrations of CRP. These findings suggest that treatment for sleep disturbances in this TBI + military population is associated with improvements in health and decreases in inflammation. The contributions of inflammation-induced changes in PTSD and depression in sleep disturbances in TBI + military personnel require further study.	[Barr, Taura] West Virginia Univ, Sch Nursing, Morgantown, WV 26506 USA; [Livingston, Whitney; Guardado, Pedro; Gill, Jessica] NINR, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Baxter, Tristin] Madigan Army Med Ctr, Tacoma, WA 98431 USA; [Mysliwiec, Vincent] Madigan Army Med Ctr, Dept Pulm Crit Care & Sleep Med, Tacoma, WA 98431 USA		Barr, T (corresponding author), West Virginia Univ, Sch Nursing, Morgantown, WV 26506 USA.		Lang, Steven/AAE-8102-2021; Gill, Gill M/Q-2020-2017	Lang, Steven/0000-0003-1669-9146; 	NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027] Funding Source: NIH RePORTER		Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Aversa LH, 2013, QUAL LIFE RES, V22, P1381, DOI 10.1007/s11136-012-0280-x; Axelsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082291; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Boscarino JA, 2010, PSYCHOSOM MED, V72, P481, DOI 10.1097/PSY.0b013e3181d9a80c; Bot M, 2011, J PSYCHOSOM RES, V71, P13, DOI 10.1016/j.jpsychores.2010.11.006; Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Capuron L, 2001, PSYCHONEUROENDOCRINO, V26, P797, DOI 10.1016/S0306-4530(01)00030-0; Chavarria A, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00064; Chennaoui M, 2011, CYTOKINE, V56, P318, DOI 10.1016/j.cyto.2011.06.002; Chocano-Bedoya PO, 2014, J AFFECT DISORDERS, V163, P25, DOI 10.1016/j.jad.2014.03.023; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P450, DOI 10.1038/jcbfm.2013.217; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Edwards R. D, 2010, WORKING PAPER SERIES, V38; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; FERRER CF, 1995, AVIAT SPACE ENVIR MD, V66, P571; Fisher H., 2010, US MILITARY CASUALTY; Germain A, 2012, J PSYCHOSOM RES, V72, P89, DOI 10.1016/j.jpsychores.2011.11.010; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Gill J, 2010, BIOL PSYCHIAT, V68, P999, DOI 10.1016/j.biopsych.2010.07.033; Gill JM, 2013, J PSYCHOSOM RES, V74, P301, DOI 10.1016/j.jpsychores.2012.10.013; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Grandner MA, 2013, SLEEP, V36, P769, DOI 10.5665/sleep.2646; Hamer M, 2011, BRAIN BEHAV IMMUN, V25, P168, DOI 10.1016/j.bbi.2010.09.013; Insomnia active component U.S. Armed Forces, 2010, MSMR, V17, P12; Institute of Medicine, 2013, PAN DIET ANT REL COM; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Joint Mental Health Advisory Team 7 (J-MHAT 7) Operation Enduring Freedom, 2010, OFF SURG GEN US ARM; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Laugsand LE, 2012, PSYCHOSOM MED, V74, P543, DOI 10.1097/PSY.0b013e31825904eb; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Lopresti AL, 2014, PROG NEURO-PSYCHOPH, V48, P102, DOI 10.1016/j.pnpbp.2013.09.017; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; Maes M, 2012, PROG NEURO-PSYCHOPH, V36, P169, DOI 10.1016/j.pnpbp.2011.09.006; Miller NL, 2010, SLEEP, V33, P1623, DOI 10.1093/sleep/33.12.1623; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Papa L., 2014, NEUROCRITICAL CARE; Paulus EJ, 2013, J TRAUMA STRESS, V26, P169, DOI 10.1002/jts.21785; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Phillips AC, 2009, PSYCHOSOM MED, V71, P395, DOI 10.1097/PSY.0b013e31819e6706; Pizzi C, 2009, CLIN PHARMACOL THER, V86, P527, DOI 10.1038/clpt.2009.121; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rusiecki Jennifer A, 2013, Front Psychiatry, V4, P56, DOI 10.3389/fpsyt.2013.00056; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Shanahan L, 2014, PSYCHONEUROENDOCRINO, V40, P76, DOI 10.1016/j.psyneuen.2013.10.019; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Smagula SF, 2014, J PSYCHOSOM RES, V76, P368, DOI 10.1016/j.jpsychores.2014.02.005; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tsai JCG, 2010, NEUROREHABILITATION, V26, P85, DOI [10.3233/NRE-2010-0538, 10.3233/NRE-2011-0538]; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wium-Andersen MK, 2013, JAMA PSYCHIAT, V70, P176, DOI 10.1001/2013.jamapsychiatry.102; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Xue Y, 2012, AM J CARDIOL, V109, P1215, DOI 10.1016/j.amjcard.2011.11.063; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zen AL, 2012, HEALTH PSYCHOL, V31, P194, DOI 10.1037/a0025989	71	10	10	0	3	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2922-2; 978-0-8261-7162-7	ANNU REV NURS RES-SE			2015	33						249	266		10.1891/0739-6686.33.249			18	Nursing	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Nursing	BI5YI	WOS:000412973800009	25946388				2022-02-06	
J	Bonfield, CM; Shin, SS; Kanter, AS				Bonfield, Christopher M.; Shin, Samuel S.; Kanter, Adam S.			Helmets, head injury and concussion in sport	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; traumatic brain injury; helmet; headgear; protective equipment; sports	BICYCLE-RELATED INJURIES; SCHOOL FOOTBALL PLAYERS; MENS ICE HOCKEY; LEAGUE BASEBALL; PROTECTIVE EQUIPMENT; IMPACT PERFORMANCE; SAFETY HELMETS; UNITED-STATES; SKIERS; RISK	Research on the mechanism of concussion in recent years has been focused on the mechanism of injury as well as strategies to minimize or reverse injury. Sports-related head injury research has led to the development of head protective gear that has evolved over the years. Headgears have been designed to protect athletes from skull fractures, subdural hemorrhages and concussions. Over the years, through experience of athletes and continued scientific research, improvements in helmet design have been made. Although these advances have decreased the number of catastrophic injuries throughout sports, the effects on concussions are promising, but largely unproven. In this review, we will discuss development of helmets and studies analyzing their level of protection for both concussion and head injury. This will help us understand what future developments are still needed to minimize the risk of concussion among athletes in various forms of sports.	[Bonfield, Christopher M.; Shin, Samuel S.; Kanter, Adam S.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA		Shin, SS (corresponding author), Univ Pittsburgh, UPMC Presbyterian, Med Ctr, Dept Neurol Surg, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	shinss@upmc.edu					Abu-Zidan FM, 2007, EMERG MED AUSTRALAS, V19, P366, DOI 10.1111/j.1742-6723.2007.00967.x; Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Agel J, 2010, CAN J SURG, V53, P319; Alles W F, 1979, J Orthop Sports Phys Ther, V1, P103; Allison MA, 2014, ANN BIOMED ENG; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Berg P, 2007, HEALTH PROMOT INT, V22, P191, DOI 10.1093/heapro/dam020; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; BOND GR, 1995, PEDIATRICS, V95, P487; Brandenburg MA, 2002, CLIN J SPORT MED, V12, P360, DOI 10.1097/00042752-200211000-00007; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Butterwick DJ, 2005, CLIN J SPORT MED, V15, P192, DOI 10.1097/01.jsm.0000160553.87755.2a; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Commission UCPS., 1999, SKIING HELM EV POT R; Cook A, 2000, BRIT MED J, V321, P1055, DOI 10.1136/bmj.321.7268.1055; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Curnow WJ, 2006, ACCIDENT ANAL PREV, V38, P833, DOI 10.1016/j.aap.2006.04.007; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Depreitere B, 2007, J TRAUMA, V62, P1440, DOI 10.1097/01.ta.0000221472.68873.fb; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; Downey Daniel J, 2007, Curr Sports Med Rep, V6, P328; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Finvers KA, 1996, CLIN J SPORT MED, V6, P102, DOI 10.1097/00042752-199604000-00007; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Fukuda O, 2007, NEUROL MED-CHIR, V47, P491, DOI 10.2176/nmc.47.491; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Greve MW, 2009, WILD ENVIRON MED, V20, P234, DOI 10.1580/08-WEME-OR-244R1.1; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hagel BE, 2004, EPIDEMIOLOGY, V15, P279, DOI 10.1097/01.ede.0000120044.62029.b4; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Hansen Kari Schroder, 2003, Traffic Inj Prev, V4, P285, DOI 10.1080/714040486; Heng K. W. J., 2006, SMJ Singapore Medical Journal, V47, P367; Hennessey T, 2002, AM J PREV MED, V22, P110, DOI 10.1016/S0749-3797(01)00411-1; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hrysomallis C, 2013, SPORTS MED, V43, P339, DOI 10.1007/s40279-013-0034-0; Kahanov Leamor, 2005, Res Sports Med, V13, P77, DOI 10.1080/15438620590956025; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kraus J F, 1970, Med Sci Sports, V2, P162; Lawson BR, 2009, PEDIATRICS, V123, pE1028, DOI 10.1542/peds.2007-3796; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Levy ML, 2004, NEUROSURGERY, V55, P661; Linn S, 1998, Inj Prev, V4, P122; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Marshall SW, 2002, INT J EPIDEMIOL, V31, P587, DOI 10.1093/ije/31.3.587; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; MOCK CN, 1995, J TRAUMA, V39, P29, DOI 10.1097/00005373-199507000-00004; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Mueller FO, 2001, PHYSICIAN SPORTSMED, V29, P41, DOI 10.3810/psm.2001.07.874; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Nicholls RL, 2004, SPORTS MED, V34, P17, DOI 10.2165/00007256-200434010-00003; Niedfeldt MW, 2011, CURR SPORT MED REP, V10, P324, DOI 10.1249/JSR.0b013e318237be53; Nightingale RW, 1997, SPINE, V22, P2380, DOI 10.1097/00007632-199710150-00012; Olson DE, 2011, CURR SPORT MED REP, V10, P290, DOI 10.1249/JSR.0b013e31822d4029; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pettersen JA, 2002, BRIT J SPORT MED, V36, P19, DOI 10.1136/bjsm.36.1.19; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Ranson C, 2013, BRIT J SPORT MED, V47, P644, DOI 10.1136/bjsports-2012-091898; Ranson C, 2013, BRIT J SPORT MED, V47, P609, DOI 10.1136/bjsports-2012-091889; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Rivara F P, 1999, Inj Prev, V5, P194; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Shealy Jasper E, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101504; Shealy JE, KNEE SURG SPORTS TRA, V14, P97; Sibbald BJB, 2012, CAN MED ASSOC J, V184, P627, DOI 10.1503/cmaj.120144; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stretch RA, 2000, J SPORT SCI, V18, P931, DOI 10.1080/026404100446766; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Tim W, 2012, FIN CONC SUSP LIST; Torg J S, 1999, Am J Orthop (Belle Mead NJ), V28, P128; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Walker HL, 2010, ACCIDENT ANAL PREV, V42, P2094, DOI 10.1016/j.aap.2010.06.022; Wani AA, 2008, PEDIATR NEUROSURG, V44, P204, DOI 10.1159/000120151; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; ZAGELBAUM BM, 1994, NEW ENGL J MED, V330, P1021, DOI 10.1056/NEJM199404073301421; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	109	10	11	1	55	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2015	43	3					236	246		10.1080/00913847.2015.1039922			11	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	CR4TF	WOS:000361331100006	25913712				2022-02-06	
J	Bressan, S; Steiner, IP; Mion, T; Berlese, P; Romanato, S; Da Dalt, L				Bressan, Silvia; Steiner, Ivan P.; Mion, Teresa; Berlese, Paola; Romanato, Sabrina; Da Dalt, Liviana			The Pediatric Emergency Care Applied Research Network intermediate-risk predictors were not associated with scanning decisions for minor head injuries	ACTA PAEDIATRICA			English	Article						Children; Clinically important traumatic brain injury; Computed tomography scan; Minor head injury; Pediatric Emergency Care Applied Research Network	TRAUMATIC BRAIN-INJURIES; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CHILDREN; CHILDHOOD; RULES; SCANS	Aim: This study determined the predictors associated with the decision to perform a computed tomography (CT) scan in children with a minor head injury (MHI). We focused on those facing an intermediate risk of clinically important traumatic brain injury (ciTBI), according to the Pediatric Emergency Care Applied Research Network (PECARN) prediction rule. Methods: A 1-year, cross-sectional study was performed in an Italian paediatric emergency department, focusing on children presenting within 24 h of an MHI and meeting the PECARN intermediate-risk criteria. Results: We included 308 children, and 47% were younger than 2 years of age. CT scans were carried out on 13%, 1.3% had a ciTBI and one was initially missed but did not need neurosurgery following diagnosis. Single and multiple PECARN intermediate-risk predictors were not associated with whether a CT scan was carried out. The only clinical variable associated with the decision to perform a CT scan was if the child was <3 months of age (OR 18.1, 95% CI, 4.91-66.61). Conclusion: The PECARN intermediate-risk predictors did not play a major role in the decision to perform a CT scan. The only factor significantly associated with the decision to perform a CT scan was when the patient was younger than 3 months of age.	[Bressan, Silvia; Mion, Teresa; Berlese, Paola; Romanato, Sabrina; Da Dalt, Liviana] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Bressan, Silvia] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Steiner, Ivan P.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Da Dalt, Liviana] Osped Ca Foncello, Pediat Unit, Treviso, Italy		Bressan, S (corresponding author), Dept Womens & Childrens Hlth, Div Pediat Emergency Med, Via Giustiniani 3, I-35128 Padua, Italy.	silviabress@gmail.com					Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2014, CHILD NERV SYST, V30, P477, DOI [10.1007/s00381-014-2368-9, 10.1007/s00381-013-2314-2]; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dean A, OPENEPI OPEN SOURCE; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4	20	10	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	JAN	2015	104	1					47	52		10.1111/apa.12797			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AX5SJ	WOS:000346987300019	25178836				2022-02-06	
J	Capo-Aponte, JE; Jurek, GM; Walsh, DV; Temme, LA; Ahroon, WA; Riggs, DW				Capo-Aponte, Jose E.; Jurek, Gina M.; Walsh, David V.; Temme, Leonard A.; Ahroon, William A.; Riggs, Daniel W.			vbEffects of repetitive low-level blast exposure on visual systems and ocular structures	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						accommodation; blast; Cone Contrast Test; endothelial cell density; frequency doubling technique; military; oculomotor function; pachymetry; specular microscopy; stereopsis	TRAUMATIC BRAIN-INJURY; COLOR-VISION; MOUSE MODEL; DYSFUNCTION; EYE; QUANTIFICATION; SYMPTOMS; DAMAGE	The purpose of this study was to determine whether repetitive exposure to low-level blasts during military breacher training produces acute and cumulative damage to the ocular tissues or visual system. The effects of low-level blast exposure on high-contrast visual acuity, contrast sensitivity, oculomotor function, color vision, visual field (VF), pupillary light reflex, corneal endothelial cell density (ECD), macular thickness, retinal nerve fiber layer thickness, and cup-to-disc ratio were assessed using a battery of standard clinical ophthalmic tests administered 10 times over a 2-year period. Data from nine male breacher instructors (Cadre) were compared with data from four male breacher engineers (Control). The Cadre group showed higher vertical deviation at near than the Control group over time. The VF mean deviation on the left eye tended to be worse in the Cadre group throughout the study, suggesting a decrease in VF sensitivity (Cadre: -0.20 +/- 0.15 dB; Control: 1.05 +/- 0.15 dB; p = 0.03). The Cadre group had a reduced ECD (right eye: Cadre 2,478 cells/mm(2) vs Control 2,808 cells/mm(2), p = 0.02; left eye: Cadre 2,562 cells/mm(2) vs Control 2,892 cells/mm(2), p = 0.03). These results suggest that even low-level primary blast has the potential to produce occult eye injury.	[Capo-Aponte, Jose E.; Jurek, Gina M.; Walsh, David V.; Temme, Leonard A.; Ahroon, William A.; Riggs, Daniel W.] US Army Aeromed Res Lab, Sensory Res Div, Ft Rucker, AL USA; [Capo-Aponte, Jose E.] Womack Army Med Ctr, Dept Optometry, Ft Bragg, NC 28310 USA		Capo-Aponte, JE (corresponding author), Womack Army Med Ctr, Dept Optometry, 2817 Reilly Rd, Ft Bragg, NC 28310 USA.	jose.e.capoaponte.mil@mail.mil		Riggs, Daniel/0000-0002-3503-0600	U.S. Army Aeromedical Research Laboratory; DoD Intramural War Supplemental Program [W81XWH-09-2-0192]; Postgraduate Research Participation Program at the U.S. Army Aeromedical Research Laboratory	This material was based on work supported by the U.S. Army Aeromedical Research Laboratory (Dr. Capo-Aponte) and DoD Intramural War Supplemental Program (grant W81XWH-09-2-0192) (Dr. Ahroon). This research was also sponsored in part by the appointment to the Postgraduate Research Participation Program at the U.S. Army Aeromedical Research Laboratory administered by the Oak Ridge Institute of Science and Education through an interagency agreement with the U.S. Department of Energy and USAMRMC.	Anderson Andrew J, 2003, Ophthalmol Clin North Am, V16, P213, DOI 10.1016/S0896-1549(03)00011-7; [Anonymous], MAR BREACH TRAIN; BERGMANSON JPG, 1992, CORNEA, V11, P133, DOI 10.1097/00003226-199203000-00007; Capo-Aponte JE, 2013, J SPINE, V2, P004; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chauhan BC, 1999, INVEST OPHTH VIS SCI, V40, P648; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Duke-Elder WS, 1954, TXB OPHTHALMOLOGY, V6, P5751; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hines-Beard J, 2014, EXP EYE RES, V127, P301, DOI 10.1016/j.exer.2014.04.023; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Liesegang Thomas J., 2002, CLAO Journal, V28, P12; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Matheron E, 2007, NEUROSCI LETT, V423, P236, DOI 10.1016/j.neulet.2007.07.016; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Patel N, 2004, J BEHAV OPTOM, V15, P31; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Philllips C, 2005, CORNEA, V2nd, P261; Rabin J, 2004, VISUAL NEUROSCI, V21, P483, DOI 10.1017/S0952523804213128; Rabin J, 2011, INVEST OPHTH VIS SCI, V52, P816, DOI 10.1167/iovs.10-6283; Rossi T, 2012, INVEST OPHTH VIS SCI, V53, P8057, DOI 10.1167/iovs.12-10591; Rossi T, 2011, INVEST OPHTH VIS SCI, V52, P3994, DOI 10.1167/iovs.10-6477; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; St Onge Paul, 2011, US Army Med Dep J, P97; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Walsh DV, 2015, MIL MED, V180, P178, DOI 10.7205/MILMED-D-14-00230; Win-Hall DM, 2010, OPTOMETRY VISION SCI, V87, P873, DOI 10.1097/OPX.0b013e3181f6f98f; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	35	10	10	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2015	52	3					273	290		10.1682/JRRD.2014.09.0204			18	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CN0NR	WOS:000358111100003	26237153	Bronze			2022-02-06	
J	Fu, XM; Liu, SJ; Dan, QQ; Wang, YP; Lin, N; Lv, LY; Zou, Y; Liu, S; Zhou, X; Wang, TH				Fu, Xue-Mei; Liu, Su-Juan; Dan, Qi-Qin; Wang, Yan-Ping; Lin, Na; Lv, Long-Yun; Zou, Yu; Liu, Su; Zhou, Xue; Wang, Ting-Hua			Combined Bone Mesenchymal Stem Cell and Olfactory Ensheathing Cell Transplantation Promotes Neural Repair Associated With CNTF Expression in Traumatic Brain-Injured Rats	CELL TRANSPLANTATION			English	Article						Bone mesenchymal stem cells (BMSCs); Olfactory ensheathing cells (OECs); Transplantation; Traumatic brain injury (TBI)	SPINAL-CORD-INJURY; MARROW STROMAL CELLS; AXONAL REGENERATION; CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY; NERVE LESION; OPTIC-NERVE; NEURONS; PATHWAY; SCAR	This study examined the role of bone mesenchymal stem cell (BMSC) and olfactory ensheathing cell (OEC) cografting on neural function and underlying molecular mechanisms in acute stage of traumatic brain injury (TBI) rats. Eighty Sprague-Dawley (SD) female rats were randomly divided into five groups (n=16 per category): sham operated group (Sham), weight-drop-induced TBI group (TBI), BMSC transplantation group (BMSC), OEC transplantation group (OEC), and cotransplantation group (CO). Eight rats were randomly selected from each group for behavioral and morphological assessment. Another category (n=8 rats) was employed in the genetic expression detection. BMSCs were isolated from GFP mice and identified by CD44 antibody. OECs were isolated from the SD rats, identified by P75 antibody and labeled by Hoechst 33342. They were then transplanted into the surrounding tissue of the epicenter of TBI rats. The result of neurological severity scores revealed that BMSC or OEC transplantation alone and BMSC and OEC cografting significantly ameliorated the neurological deficits of TBI rats. Quantitative immunohistochemical analysis showed that graft-recipient animals possessed dramatically more neurons and regenerated axons and smaller amounts of astrocytes than controls 14 days posttransplantation (p<0.05). However, the expressional level of ciliary neurotrophic factor significantly decreased in the cografting group as determined by RT-PCR (p<0.05), and the Janus kinase/signal transducer and activator of transcription pathway was significantly activated at 7 days after cell transplantation (p<0.05). This study is the first to report the role of cotransplantation of BMSCs and OECs in the therapy of TBI and explore its potential molecular mechanisms, therefore providing the important morphological and molecular biological evidence for the clinical application of BMSC and/or OEC transplantation in TBI.	[Fu, Xue-Mei] Shenzhen Childrens Hosp, Shenzhen, Guangdong, Peoples R China; [Liu, Su-Juan; Zhou, Xue; Wang, Ting-Hua] West China Sch Preclin & Forens Med, Dept Histol & Neurobiol, Chengdu, Sichuan, Peoples R China; [Dan, Qi-Qin; Zou, Yu; Wang, Ting-Hua] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Inst Neurol Dis,State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Wang, Yan-Ping; Lin, Na; Lv, Long-Yun; Liu, Su; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Kunming 650031, Yunnan, Peoples R China		Wang, TH (corresponding author), Kunming Med Univ, Inst Neurosci, Kunming 650031, Yunnan, Peoples R China.	tinghua_neuron@263.net	ZHOU, XUE/F-6129-2013		China National Science FoundationNational Natural Science Foundation of China (NSFC) [8126019, 81271358, 81172828, 81171176]	This research was supported by a grant from the China National Science Foundation (No. 81260191, 81271358, 81172828, 81171176). We thank Professor Seng-Kee Leong for his valuable comments on this manuscript. The authors declare no conflicts of interest.	Allio T, 2000, MUTAT RES-FUND MOL M, V447, P227, DOI 10.1016/S0027-5107(99)00212-2; Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Beurrier C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008550; Chandrasekharan B, 2013, AM J PHYSIOL-GASTR L, V304, pG949, DOI 10.1152/ajpgi.00493.2012; Chen Xu hong, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P831; Chiba Y, 2010, NEUROPATHOLOGY, V30, P241, DOI 10.1111/j.1440-1789.2009.01077.x; Chiba Y, 2009, NEUROSURGERY, V64, P991, DOI 10.1227/01.NEU.0000341905.57162.1D; Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Frontczak-Baniewicz M, 2006, J PHYSIOL PHARMACOL, V57, P97; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Kirsch M, 2010, GLIA, V58, P768, DOI 10.1002/glia.20961; Koppula PR, 2010, CELL BIOL INT, V34, P275, DOI 10.1042/CBI20090142; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Lee N, 2013, J COMP NEUROL, V521, P2947, DOI 10.1002/cne.23324; Li R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023148; Lo WC, 2008, J NUCL MED, V49, P1512, DOI 10.2967/jnumed.108.051896; Mansilla E, 2005, TRANSPL P, V37, P292, DOI 10.1016/j.transproceed.2005.01.070; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Nandoe RDS, 2006, CELL TRANSPLANT, V15, P563, DOI 10.3727/000000006783981602; Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Pernet V, 2013, NEUROBIOL DIS, V51, P202, DOI 10.1016/j.nbd.2012.11.011; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Raisman G, 2000, NOVART FDN SYMP, V231, P94, DOI 10.1002/0470870834.ch6; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Santos GJ, 2011, CELL SIGNAL, V23, P1669, DOI 10.1016/j.cellsig.2011.06.001; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Tang Zhaohua, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P928; Tharion G, 2011, NEUROL INDIA, V59, P77, DOI 10.4103/0028-3886.84339; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Wakeman DR, 2014, CELL TRANSPLANT, V23, P981, DOI 10.3727/096368913X664865; Yano S, 2006, J NEUROTRAUM, V23, P1682, DOI 10.1089/neu.2006.23.1682; Yu Dan, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P354; Zhao CP, 2007, CELL BIOL INT, V31, P1428, DOI 10.1016/j.cellbi.2007.06.003	41	10	12	3	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2015	24	8					1533	1544		10.3727/096368914X679345			12	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	CP4UU	WOS:000359878900009	24612678	Bronze			2022-02-06	
J	Hawley, CA; de Burgh, HT; Russell, RJ; Mead, A				Hawley, Carol A.; de Burgh, H. Thomas; Russell, Robert J.; Mead, Andrew			Traumatic Brain Injury Recorded in the UK Joint Theatre Trauma Registry Among the UK Armed Forces	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; combat trauma; conflict; head trauma; logistic regression; military; service personnel	OPERATION-IRAQI-FREEDOM; SEVERITY SCORE; COMBAT WOUNDS; NECK INJURIES; TRISS; AFGHANISTAN; EPIDEMIOLOGY; SYSTEM; DEATH; ASCOT	Objectives: To use the UK Joint Theatre Trauma Registry (UK-JTTR) to identify service personnel sustaining traumatic brain injury (TBI) in recent conflicts and to examine injury characteristics, outcomes, and severity measures predictive of survival. Setting: Operations HERRICK (Afghanistan) and TELIC (Iraq). Design: The UK-JTTR records data for every UK service person either killed on operations or treated by Defence Medical Services after a trauma call, including those evacuated for inpatient care following traumatic injury. UK-JTTR data were retrospectively analyzed to identify those who sustained TBI. Main Measures: The Mayo system was used to define TBI. Glasgow Coma Scale score, injury severity score, new injury severity score, trauma injury severity score, abbreviated injury scale, and a severity characterization of trauma were used to predict survival. Results: In total, 464 UK service personnel sustained TBI, representing 19% of the 2440 casualties in Afghanistan and Iraq, recorded in the UK-JTTR. Most TBI casualties had moderate-severe TBI (402, 87%). There were 181 (39%) survivors, 56% of these received neurorehabilitation. Improvised explosive devices accounted for 55% of TBIs sustained in Afghanistan and 31% of TBIs in Iraq. Logistic regression analyses were performed using the 412 cases (149 survivors: 263 fatalities) with scores on all severity measures. The best-fitting model was based on trauma injury severity score. A trauma injury severity score more than 11.13 indicates a more than 95% probability of survival. Conclusion: This is the first study of UK combat TBIs between 2003 and 2011. Almost 1 in 5 UK service personnel recorded in the UK-JTTR had TBI; most were moderate-severe. However, mild TBI is likely to be underrepresented in the UK-JTTR. These findings may be used to plan future rehabilitation needs, as almost half the survivors did not receive neurorehabilitation.	[Hawley, Carol A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Mead, Andrew] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [de Burgh, H. Thomas] Peterborough City Hosp, Army Med Directorate, Peterborough, Cambs, England; [de Burgh, H. Thomas] Peterborough City Hosp, Minist Def Hosp, Unit Peterborough, Peterborough, Cambs, England; [Russell, Robert J.] Acad Dept Mil Emergency Med, Birmingham, W Midlands, England; [Russell, Robert J.] Royal Ctr Def Med, Birmingham, W Midlands, England		Hawley, CA (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carol/AAG-3830-2019	Mead, Andrew/0000-0002-4909-8235	University of Warwick Research Scholarship Scheme	The University of Warwick Research Scholarship Scheme provided a bursary to CPT H. Thomas de Burgh. CPT H. Thomas de Burgh and COL Robert J. Russell are members of the British Army.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellamy RF., 1995, TXB MILITARY MED, P1; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS388, DOI 10.1097/TA.0b013e31827548df; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brunger H, 2014, BRAIN INJURY, V28, P71, DOI 10.3109/02699052.2013.857788; CAREY ME, 1987, MIL MED, V152, P6; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Defence Analytical Services and Advice, 2009, OP TEL CAS FAT TABL; Defence Analytical Services and Advice (DASA), 2012, AFGH CAS FAT TABL; Demetriades D, 1998, BRIT J SURG, V85, P379; Dennis KC, 2013, CURRENT PERSPECTIVES; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Hodgetts Timothy J, 2007, J R Army Med Corps, V153, P237; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine Committee on Gulf War and Health, 2008, GULF WAR HLTH LONG T, V7; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MARKLE J, 1992, J TRAUMA, V33, P326, DOI 10.1097/00005373-199208000-00025; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Reister FA, 1975, MED STAT WW 2; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Russell RJ, 2011, PHILOS T R SOC B, V366, P171, DOI 10.1098/rstb.2010.0232; Singleton JAG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003130; Smith Jason, 2007, J R Army Med Corps, V153, P239; TEASDALE G, 1974, LANCET, V2, P81; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	43	10	11	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					E47	E56		10.1097/HTR.0000000000000023			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400006	24714212				2022-02-06	
J	Henning, J; Frangos, S; Simon, R; Pachter, HL; Bholat, OS				Henning, Justin; Frangos, Spiros; Simon, Ronald; Pachter, H. Leon; Bholat, Omar S.			Patterns of Traumatic Injury in New York City Prisoners Requiring Hospital Admission	JOURNAL OF CORRECTIONAL HEALTH CARE			English	Article						injury; trauma; hospitalization; prisoners; correctional health care	BRAIN-INJURY; PREVALENCE; POPULATION	Bellevue Hospital's prison ward cares for male prisoners requiring medical attention that exceeds the capabilities of New York City Department of Correction (NYC-DOC) infirmaries. This study evaluated the injury patterns that occur in this patient population. Data were collected on consecutive prisoners transferred from NYC-DOC for traumatic injuries from June 1, 2003, to June 1, 2006, and analyzed by retrospective chart review. Overall, 251 patients were evaluated for traumatic injuries. Injury mechanisms were violent (75.7%), nonviolent (23.5%), and self-inflicted (0.8%). Of the 241 (96%) patients admitted, 213 (84.9%) required operative intervention. The most common injuries were mandible fractures (46.5%) and facial fractures (14.9%).	[Henning, Justin; Frangos, Spiros; Simon, Ronald; Pachter, H. Leon; Bholat, Omar S.] NYU, Sch Med, Dept Surg, New York, NY 10016 USA		Bholat, OS (corresponding author), NYU, Sch Med, Dept Surg, 462 First Ave,New Bellevue 15N1, New York, NY 10016 USA.	omarbholat@yahoo.com	Lorente, Rosa/AAL-5850-2021	Frangos, Spiros/0000-0003-2860-8969			Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Butler T., 2004, HEALTH PROMOT J AUST, V15, P151; Geisler G. T., 2011, COST CORRECTIONAL HL; Green L., 1996, MMWR-MORBID MORTAL W, V45, P69; Kinsella C, 2004, TRENDS ALERT CORRECT; Kuzak N, 2001, CJEM, V3, P199; Ludwig A, 2012, AM J PUBLIC HEALTH, V102, P1108, DOI 10.2105/AJPH.2011.300306; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sung Hung-En, 2010, J Correct Health Care, V16, P178, DOI 10.1177/1078345810366287; Thorburn KM, 1999, JAMA-J AM MED ASSOC, V282, P430, DOI 10.1001/jama.282.5.430; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	13	10	12	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3458	1940-5200		J CORRECT HEALTH CAR	J. Correct. Health Care	JAN	2015	21	1					53	58		10.1177/1078345814558046			6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AY1FG	WOS:000347338500007	25559630				2022-02-06	
J	Johnson, CP; Juranek, J; Swank, P; Kramer, L; Cox, CS; Ewing-Cobbs, L				Johnson, Chad Parker; Juranek, Jenifer; Swank, Paulr.; Kramer, Larry; Cox, Charles S., Jr.; Ewing-Cobbs, Linda			White matter and reading deficits after pediatric traumatic brain injury: A diffusion tensor imaging study	NEUROIMAGE-CLINICAL			English	Article						Reading; Diffusion Tensor Imaging; Traumatic brain injury; Pediatric	VISUAL WORD RECOGNITION; DEVELOPMENTAL DYSLEXIA; NEURAL SYSTEMS; COMPREHENSION; CHILDREN; MICROSTRUCTURE; CONNECTIVITY; CHILDHOOD; LANGUAGE; ABILITY	Pediatric traumatic brain injury often results in significant long-term deficits in mastery of reading ability. This study aimed to identify white matter pathways that, when damaged, predicted reading deficits in children. Based on the dual-route model of word reading, we predicted that integrity of the inferior fronto-occipital fasciculus would be related to performance in sight word identification while integrity of the superior longitudinal fasciculus would be related to performance in phonemic decoding. Reading fluency and comprehension were hypothesized to relate to the superior longitudinal fasciculus, inferior fronto-occipital fasciculus, and cingulum bundle. The connectivity of white matter pathways was used to predict reading deficits in children aged 6 to 16 years with traumatic brain injury (n = 29) and those with orthopedic injury (n = 27) using tract-based spatial statistics. Results showed that children with traumatic brain injury and reduced microstructural integrity of the superior longitudinal fasciculus demonstrated reduced word-reading ability on sight word and phonemic decoding tasks. Additionally, children with traumatic brain injury and microstructural changes involving the cingulum bundle demonstrated reduced reading fluency. Results support the association of a dorsal pathway via the superior longitudinal fasciculus with both sight word reading and phonemic decoding. No association was identified between the inferior fronto-occipital fasciculus and sight word reading or phonemic decoding. Reading fluency was associated with the integrity of the cingulum bundle. These findings support dissociable pathways predicting word reading and fluency using Diffusion Tensor Imaging and provide additional information for developing models of acquired reading deficits by specifying areas of brain damage which may predict reading deficits following recovery from the acute phase of TBI. (C) 2015 The Authors. Published by Elsevier Inc.	[Johnson, Chad Parker] Univ Hawaii, Dept Psychol, 200 W Kawili St, Hilo, HI 96720 USA; [Juranek, Jenifer; Swank, Paulr.; Kramer, Larry; Cox, Charles S., Jr.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA		Johnson, CP (corresponding author), Univ Hawaii, Dept Psychol, 200 W Kawili St, Hilo, HI 96720 USA.	ChadPJ@hawaii.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded by the National Institutes of Health R01 NS046308 awarded to LEC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute. The authors report no financial or other conflict of interest.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Basser PJ, 1997, ANN NY ACAD SCI, V820, P123, DOI 10.1111/j.1749-6632.1997.tb46192.x; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Carter JC, 2009, PSYCHIAT RES-NEUROIM, V172, P215, DOI 10.1016/j.pscychresns.2008.09.005; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Castles A, 2006, LOND REV EDUC, V4, P49, DOI 10.1080/13603110600574454; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Cutting L. E., 2012, REACHING UNDERSTANDI, P101; Cutting LE, 2013, BRAIN CONNECT, V3, P199, DOI 10.1089/brain.2012.0116; Das T, 2011, NEUROIMAGE, V54, P1476, DOI 10.1016/j.neuroimage.2010.09.022; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Durlak J. A, 2009, J PEDIATR PSYCHOL; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fan QY, 2014, BRAIN CONNECT, V4, P428, DOI 10.1089/brain.2013.0203; Fletcher J. M., 2006, LEARNING DISABILITIE; Frost R, 1998, PSYCHOL BULL, V123, P71, DOI 10.1037/0033-2909.123.1.71; Frye RE, 2011, HUM BRAIN MAPP, V32, P1220, DOI 10.1002/hbm.21103; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Horowitz-Kraus T, 2014, BRAIN RES, V1582, P34, DOI 10.1016/j.brainres.2014.05.034; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Keenan JM, 2008, SCI STUD READ, V12, P281, DOI 10.1080/10888430802132279; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Klauda SL, 2008, J EDUC PSYCHOL, V100, P310, DOI 10.1037/0022-0663.100.2.310; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kuperberg GR, 2006, NEUROIMAGE, V33, P343, DOI 10.1016/j.neuroimage.2006.06.001; Lebel C, 2013, BRAIN LANG, V125, P215, DOI 10.1016/j.bandl.2012.10.009; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lipsey M.W., 1990, DESIGN SENSITIVITY S, V19; MARSHALL JC, 1973, J PSYCHOLINGUIST RES, V2, P175, DOI 10.1007/BF01067101; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mechelli A, 2000, P ROY SOC B-BIOL SCI, V267, P1909, DOI 10.1098/rspb.2000.1229; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Misra M, 2004, SCI STUD READ, V8, P241, DOI 10.1207/s1532799xssr0803_4; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Moss J, 2011, NEUROIMAGE, V58, P675, DOI 10.1016/j.neuroimage.2011.06.034; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Peters BD, 2014, BIOL PSYCHIAT, V75, P248, DOI 10.1016/j.biopsych.2013.05.020; Philipose LE, 2007, ANN NEUROL, V62, P481, DOI 10.1002/ana.21182; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Pritchard SC, 2012, J EXP PSYCHOL HUMAN, V38, P1268, DOI 10.1037/a0026703; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Rashotte C.A., 1999, TEST WORD READING EF; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; Schmalz X, 2013, Q J EXP PSYCHOL, V66, P338, DOI 10.1080/17470218.2012.711843; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Stoodley CJ, 2013, CEREBELLUM, V12, P267, DOI 10.1007/s12311-012-0407-1; Swett K., 2013, FRONT HUM NEUROSCI, V7; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wechsler D., 2011, WECHSLER ABBREVIATED; Wiederholt J.L., 2001, GRAY ORAL READING TE; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wolf M., 2001, SCI STUD READ, V5, P211, DOI [DOI 10.1207/S1532799XSSR0503_2, 10.1207/S1532799XSSR0503_2]; Woodcock R. W., 2007, WOODCOCK JOHNSON 3 N; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeatman JD, 2012, P NATL ACAD SCI USA, V109, pE3045, DOI 10.1073/pnas.1206792109; Zhang MX, 2014, NEUROIMAGE, V98, P435, DOI 10.1016/j.neuroimage.2014.04.080; Zoccolotti P, 2010, CORTEX, V46, P1211, DOI 10.1016/j.cortex.2010.09.003	87	10	11	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2015	9						668	677		10.1016/j.nicl.2015.10.009			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DI0LR	WOS:000373188400071	26740920	Green Published, gold			2022-02-06	
J	Kunz, SN; Brandtner, H; Meyer, HJ				Kunz, Sebastian N.; Brandtner, Herwig; Meyer, Harald J.			Characteristics of Backspatter on the Firearm and Shooting Hand-An Experimental Analysis of Close-range Gunshots	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic Science; bloodstains; backspatter; gunshot wound; reconstruction	BLOOD; SPATTER; WOUNDS; SHOTS; HEAD	Contact and close-range gunshot injuries can produce bloodstains on the shooting hand and weapon. In this study, backspatter was analyzed in experimental horizontal pistol shots into blood-filled sponges. The shooting distances were set between 0 and 45cm. With increasing shooting distance, there was a significant decrease in the degree of backspatter. Microspatter could be detected on the weapon and shooting hand up to a shooting distance of 40cm. They were predominantly located on thumb and index finger as well as the radial dorsal aspects of the hand. Fine spray of microspatter combined with elongated droplets in the shape of exclamation marks was found at contact and 2-cm distance shots. An angular calculation based on the shape of the bloodstains was possible up to a shooting distance of 2cm. No bloodstains were detected beyond 45cm.	[Kunz, Sebastian N.; Brandtner, Herwig; Meyer, Harald J.] Paris Lodron Univ Salzburg, IFFB Gerichtsmed & Forens Neuropsychiat, A-5020 Salzburg, Austria		Kunz, SN (corresponding author), Paris Lodron Univ Salzburg, IFFB Gerichtsmed & Forens Neuropsychiat, Ignaz Harrer Str 79, A-5020 Salzburg, Austria.	sebastian.kunz@sbg.ac.at					Betz P, 1995, FORENSIC SCI INT, V76, P47, DOI 10.1016/0379-0738(95)01793-3; Courts C, 2012, INT J LEGAL MED, V126, P391, DOI 10.1007/s00414-011-0655-5; Davidson PL, 2012, J FORENSIC SCI, V57, P1339, DOI 10.1111/j.1556-4029.2012.02143.x; James SH., 2005, PRINCIPLES BLOODSTAI, P1; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 1997, INT J LEGAL MED, V110, P27; Kunz SN, 2013, FORENSIC SCI INT, V228, pE54, DOI 10.1016/j.forsciint.2013.02.012; Kunz SN, 2012, RECHTSMEDIZIN, V22, P61, DOI 10.1007/s00194-011-0794-5; Peschel O, 2011, FORENSIC SCI MED PAT, V7, P257, DOI 10.1007/s12024-010-9198-1; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; Taylor MC, 2011, INT J LEGAL MED, V125, P617, DOI 10.1007/s00414-010-0462-4; Verhoff MA, 2003, INT J LEGAL MED, V117, P229, DOI 10.1007/s00414-003-0383-6; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f; Zwingli M, 1941, ARCH KRIMINOL, V108, P1	15	10	10	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	JAN	2015	60	1					166	170		10.1111/1556-4029.12572			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	AZ8AR	WOS:000348437700025	25039561				2022-02-06	
J	Liu, H; Qiu, GP; Zhuo, F; Yu, WH; Sun, SQ; Li, FH; Yang, M				Liu, Hui; Qiu, Gou Ping; Zhuo, Fei; Yu, Wei Hua; Sun, Shan Quan; Li, Fen Hong; Yang, Mei			Lost Polarization of Aquaporin4 and Dystroglycan in the Core Lesion after Traumatic Brain Injury Suggests Functional Divergence in Evolution	BIOMED RESEARCH INTERNATIONAL			English	Article							ASTROCYTE POLARIZATION; EXPRESSION; AQP4; PATTERNS; COMPLEX; BARRIER; IMPACT; MATRIX; ROLES; MODEL	Objective. To understand how aquaporin4 (AQP4) and dystroglycan (DG) polarized distribution change and their roles in brain edema formation after traumatic brain injury (TBI). Methods. Brain water content, Evans blue detection, real-time PCR, western blot, and immunofluorescence were used. Results. At an early stage of TBI, AQP4 and DG maintained vessel-like pattern in perivascular endfeet; M1, M23, and M1/M23 were increased in the core lesion. At a later stage of TBI, DG expression was lost in perivascular area, accompanied with similar but delayed change of AQP4 expression; expression of M1, M23, and DG and the ratio of M1/M2 were increased. Conclusion. At an early stage, AQP4 and DG maintained the polarized distribution. Upregulated M1 and M23 could retard the cytotoxic edema formation. At a later stage AQP4 and DG polarized expression were lost from perivascular endfeet and induced the worst cytotoxic brain edema. The alteration of DG expression could regulate that of AQP4 expression after TBI.	[Liu, Hui; Qiu, Gou Ping; Zhuo, Fei; Yu, Wei Hua; Sun, Shan Quan; Yang, Mei] Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China; [Li, Fen Hong] Shangluo Univ, Dept Math & Computat Sci, Shangluo 726000, Shanxi, Peoples R China		Yang, M (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China.	53950795@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30470608, 81000566]; Ph.D. Programs Foundation of Ministry of Education of ChinaMinistry of Education, China [20105503120009]; Chongqing Natural Science FoundationNatural Science Foundation of Chongqing [cstc2011jjA10093]	This research was supported by the National Natural Science Foundation of China (no. 30470608 and no. 81000566), Ph.D. Programs Foundation of Ministry of Education of China (no. 20105503120009), and Chongqing Natural Science Foundation (cstc2011jjA10093).	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Berezowski Vincent, 2012, Int J Cell Biol, V2012, P176287, DOI 10.1155/2012/176287; Cai LP, 2011, NEUROPATHOLOGY, V31, P250, DOI 10.1111/j.1440-1789.2010.01172.x; Fallier-Becker P, 2011, BRAIN RES, V1367, P2, DOI 10.1016/j.brainres.2010.09.092; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fu D, 2007, MOL MEMBR BIOL, V24, P366, DOI 10.1080/09687680701446965; Hawkins BT, 2013, BRAIN RES, V1503, P89, DOI 10.1016/j.brainres.2013.01.049; Hu Hua, 2005, J Zhejiang Univ Sci B, V6, P33, DOI 10.1631/jzus.2005.B0033; Jones JCR, 2005, J CELL SCI, V118, P2557, DOI 10.1242/jcs.02395; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012; Nakazawa E, 1998, J NEUROCYTOL, V27, P431, DOI 10.1023/A:1006936527746; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Noell S, 2012, CELL TISSUE RES, V347, P429, DOI 10.1007/s00441-011-1321-4; Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Peng H, 2012, METHODS MOL BIOL, V814, P177, DOI 10.1007/978-1-61779-452-0_13; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Rash JE, 2010, NEUROSCIENCE, V168, P982, DOI 10.1016/j.neuroscience.2009.10.028; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Thullier F, 1997, DEV BRAIN RES, V100, P22, DOI 10.1016/S0165-3806(97)00010-2; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Witholt R, 2000, NEUROTOXICOL TERATOL, V22, P851, DOI 10.1016/S0892-0362(00)00108-2; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Yang M, 2011, ANAT HISTOL EMBRYOL, V40, P299, DOI 10.1111/j.1439-0264.2011.01070.x; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhao WJ, 2012, FOLIA NEUROPATHOL, V50, P176	36	10	12	3	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								471631	10.1155/2015/471631			10	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CW0CY	WOS:000364658200001	26583111	Green Submitted, Green Published, gold			2022-02-06	
J	Liu, YY; Yan, H; Chen, S; Sabel, BA				Liu, Yuanyuan; Yan, Hua; Chen, Song; Sabel, Bernhard A.			Caspase-3 inhibitor Z-DEVD-FMK enhances retinal ganglion cell survival and vision restoration after rabbit traumatic optic nerve injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Caspase-3 inhibitor; optic nerve injury; apoptosis; neuroprotection; vision restoration	GENE-THERAPY; BRAIN; DEATH; DAMAGE; MODEL; NEUROPROTECTION; DECOMPRESSION; DEGENERATION; PLASTICITY; NEUROPATHY	Purpose: Vision loss after traumatic optic nerve injury is considered irreversible because of the retrograde loss of retinal ganglion cells (RGCs) which undergo apoptosis. Because the second messenger caspase-3 plays a major role in apoptosis, we now evaluated the efficacy of the specific caspase-3 inhibitor, Z-DEVD-FMK, in a rabbit model of fluid percussion injury (FPI) which mimics traumatic optic nerve injury in humans to enhance cell survival and improve vision. Methods: Survival of RGCs and recovery of vision were studied using retinal morphological markers and visual evoked potentials (VEP), respectively. The FPI traumatized animals were treated in their right eye with a single intravitreal or peribulbar injection of Z-DEVD-FMK 30 min post-injury compared to 2% DMSO control injections in their left eye. Results: Intravitreal Z-DEVD-FMK, but not control injections, led to down-regulation of capase-3 and reduced, in a dose-dependent manner, RGCs apoptosis from 7 to 21 days post-injury. These morphological improvements were accompanied by vision restoration as documented by VEP. The neuroprotection after intravitreal injection of Z-DEVD-FMK was more effective than the peribulbar application. Conclusions: The caspase-3 inhibitor Z-DEVD-FMK is neuroprotective by inhibiting RGCs apoptosis when injected 30 min after optic nerve damage and significantly promotes restoration of vision. A controlled clinical trial is now needed to evaluate the efficacy and safety of Z-DEVD-FMK in humans.	[Liu, Yuanyuan; Yan, Hua; Chen, Song] Tianjin Med Univ Gen Hosp, Dept Ophthalmol, Tianjin 300052, Peoples R China; [Sabel, Bernhard A.] Univ Magdeburg, Fac Med, Inst Med Psychol, D-39106 Magdeburg, Germany		Yan, H (corresponding author), Tianjin Med Univ Gen Hosp, Dept Ophthalmol, 154 Anshan Rd, Tianjin 300052, Peoples R China.	phuayan2000@163.com					Ansari MH, 2005, J ORAL MAXIL SURG, V63, P229, DOI 10.1016/j.joms.2004.05.221; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Bode C, 2003, MOL VIS, V9, P144; Bola M, 2014, NEUROLOGY, V83, P542, DOI 10.1212/WNL.0000000000000672; Chaudhary P, 1999, MOL BRAIN RES, V67, P36, DOI 10.1016/S0169-328X(99)00032-7; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Guo ZL, 2011, J CRANIOFAC SURG, V22, P1463, DOI 10.1097/SCS.0b013e31821d184a; Heiduschka P, 2004, KLIN MONATSBL AUGENH, V221, P684, DOI 10.1055/s-2004-813054; Henrich-Noack Petra, 2013, Neurosci Lett, V543, P1, DOI 10.1016/j.neulet.2013.03.013; Kermer P, 1999, EXP NEUROL, V158, P202, DOI 10.1006/exnr.1999.7094; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Koch JC, 2010, AUTOPHAGY, V6, P658, DOI 10.4161/auto.6.5.12188; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Li H, 2008, J LARYNGOL OTOL, V122, P1325, DOI 10.1017/S0022215108002296; Li H, 2000, STROKE, V31, P176, DOI 10.1161/01.STR.31.1.176; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; May CA, 2008, OPEN OPHTHALMOL J, V2, P94, DOI 10.2174/1874364100802010094; Mayordomo R, 2003, EUR J NEUROSCI, V18, P1744, DOI 10.1046/j.1460-9568.2003.02891.x; Nickells RW, 1999, SURV OPHTHALMOL, V43, pS151, DOI 10.1016/S0039-6257(99)00029-6; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Pirouzmand F, 2012, J CRANIOFAC SURG, V23, P516, DOI 10.1097/SCS.0b013e31824cd4a7; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Rousseau V, 2001, RESTOR NEUROL NEUROS, V18, P177; Sabel BA, 1999, RESTOR NEUROL NEUROS, V15, P177; Sabel BA, 2011, RESTOR NEUROL NEUROS, V29, P493, DOI 10.3233/RNN-2011-0624; Sabel BA, 2011, PROG BRAIN RES, V192, P199, DOI 10.1016/B978-0-444-53355-5.00013-0; Sabel BA, 2008, RESTOR NEUROL NEUROS, V26, P243; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; Singer CF, 2002, GYNECOL ONCOL, V85, P423, DOI 10.1006/gyno.2002.6598; Solomon AS, 1996, J NEUROSCI METH, V70, P21, DOI 10.1016/S0165-0270(96)00098-2; Sullivan TA, 2012, EXP EYE RES, V96, P36, DOI 10.1016/j.exer.2012.01.006; Vuojola J, 2012, ANAL CHIM ACTA, V725, P67, DOI 10.1016/j.aca.2012.03.010; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Yan H, 2012, CURR EYE RES, V37, P941, DOI 10.3109/02713683.2012.691599; Yang QT, 2012, J TRAUMA ACUTE CARE, V72, P1350, DOI 10.1097/TA.0b013e3182493c70	41	10	10	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	2					205	220		10.3233/RNN-159001			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB7UX	WOS:000349835000010	25588462				2022-02-06	
J	Simon, D; Nicol, JMB; da Silva, SS; Graziottin, C; Silveira, PC; Ikuta, N; Regner, A				Simon, Daniel; Botome Nicol, Josi Mara; da Silva, Sabrina Sabino; Graziottin, Camila; Silveira, Patricia Corso; Ikuta, Nilo; Regner, Andrea			Serum ferritin correlates with Glasgow coma scale scores and fatal outcome after severe traumatic brain injury	BRAIN INJURY			English	Article						Biomarker; ferritin; outcome; traumatic brain injury	PERIHEMATOMA EDEMA; IRON; DEFEROXAMINE; HEMORRHAGE; STROKE	Objectives: Severe traumatic brain injury (TBI) is associated with a 30-70% mortality rate. Nevertheless, in clinical practice there are no effective biomarkers for the prediction of fatal outcome following severe TBI. Therefore, the aim was to determine whether ferritin serum levels are associated with ICU mortality in patients with severe TBI. Methods: This prospective study enrolled 69 male patients who suffered severe TBI [Glasgow Coma Scale (GCS) 3-8 at emergency room admission]. The serum ferritin protein level was determined at ICU admission (mean 5.6 +/- 2.5 hours after emergency room admission). Results: Severe TBI was associated with a 39% mortality rate. Higher serum ferritin concentrations were significantly associated with lower hospital admission GCS scores (p = 0.049). Further, there was a significant association between higher ferritin concentrations and fatal outcome (289.5 +/- 27.1 mu gL(-1) for survivors and 376.5 +/- 31.5 mu gL(-1) for non-survivors, respectively, mean +/- SEM, p = 0.032). Conclusions: Increased serum ferritin levels were associated with lower hospital admission GCS scores and predicted short-term fatal outcome following severe TBI.	[Simon, Daniel; Botome Nicol, Josi Mara; Ikuta, Nilo; Regner, Andrea] Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicada Saud, Porto Velho, Rondonia, Brazil; [Simon, Daniel; da Silva, Sabrina Sabino; Graziottin, Camila; Silveira, Patricia Corso; Ikuta, Nilo; Regner, Andrea] Univ Luterana Brasil, Lab Biomarcadores Trauma, Porto Velho, Rondonia, Brazil; [da Silva, Sabrina Sabino; Graziottin, Camila; Silveira, Patricia Corso; Regner, Andrea] Univ Luterana Brasil, Curso Med, Porto Velho, Rondonia, Brazil; [Ikuta, Nilo] Simbios Biotecnol, Canoas, RS, Brazil		Regner, A (corresponding author), Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicada Saud, Ave Farroupilha,8001 Predio 22,5 Andar, BR-92425900 Canoas, RS, Brazil.	regner@uol.com.br	Simon, Daniel/A-9087-2011; Regner, Andrea/M-2596-2014	Simon, Daniel/0000-0003-1122-8468; Regner, Andrea/0000-0002-6657-7991	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [568691/2008-3]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [09/0041-5, 1630-25.51/09-0]	The authors report no conflicts of interest. The present study received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; research grant 568691/2008-3) and from Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS; research grant 09/0041-5, 1630-25.51/09-0).	Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025324; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Faul M, 2010, TRAUMATIC BRAIN INJU; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hirose Wataru, 2003, Leg Med (Tokyo), V5 Suppl 1, pS360, DOI 10.1016/S1344-6223(02)00133-5; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Lou M, 2009, CEREBROVASC DIS, V27, P266, DOI 10.1159/000199464; Mehdiratta M, 2008, STROKE, V39, P1165, DOI 10.1161/STROKEAHA.107.501213; Millan M, 2008, DIS MARKERS, V25, P181, DOI 10.1155/2008/380356; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Raabe A, 2003, RESTORATIVE NEUROLOG, V21, P3; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sharkey RA, 1999, AM J RESP CRIT CARE, V159, P1506, DOI 10.1164/ajrccm.159.5.9809027; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Wu G, 2011, J NEUROSURG, V114, P1805, DOI 10.3171/2011.1.JNS101530; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160; Zheng W, 2012, PHARMACOL THERAPEUT, V133, P177, DOI 10.1016/j.pharmthera.2011.10.006	32	10	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					612	617		10.3109/02699052.2014.995228			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000010	25625879				2022-02-06	
J	Stumbo, NJ; Wilder, A; Zahl, M; DeVries, D; Pegg, S; Greenwood, J; Ross, JE				Stumbo, Norma J.; Wilder, Allison; Zahl, Melissa; DeVries, Dawn; Pegg, Shane; Greenwood, Janell; Ross, Jo-Ellen			Community Integration Showcasing the Evidence for Therapeutic Recreation Services	THERAPEUTIC RECREATION JOURNAL			English	Article						community integration; cerebrovascular accident; traumatic brain injury; mental illness; intellectual and/or developmental disability; spinal cord injury; older adults with chronic conditions and/or illnesses; therapeutic recreation practice	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SENIOR CENTER; INPATIENT REHABILITATION; INCLUSIVE RECREATION; SECONDARY CONDITIONS; HEALTH-PROMOTION; MENTAL-ILLNESS; OLDER-ADULTS	Community integration (CI) is an important aspect of therapeutic recreation services for many client groups. CI speaks to the full social, physical, and psychological presence of individuals with disabilities and/or illnesses in their communities, whether that may be their personal homes, group homes, halfway houses, or long-term care facilities. The benefits of CI are numerous and include physical, social, psychological, health, and quality of life related outcomes. The purpose of this paper is to review the recent research regarding CI for individuals with (a) cerebrovascular accidents and traumatic brain injury, (b) intellectual and/or developmental disabilities, (c) mental illnesses, and (d) spinal cord injuries, and for (e) aging individuals with chronic diseases and/or illnesses. Specific implications for therapeutic recreation practice from this research are highlighted.	[Stumbo, Norma J.] Educ Associates, Louisville, KY 40243 USA; [Wilder, Allison] Univ New Hampshire, Recreat Management & Policy, Durham, NH 03824 USA; [Zahl, Melissa] Oklahoma State Univ, Sch Appl Hlth & Educ Psychol, Stillwater, OK 74078 USA; [DeVries, Dawn] Grand Valley State Univ, Allendale, MI 49401 USA; [Pegg, Shane] Univ Queensland, St Lucia, Qld, Australia; [Greenwood, Janell] Brigham Young Univ, Dept Hlth Recreat & Human Performance, Therapeut Recreat Program, Provo, UT 84602 USA; [Ross, Jo-Ellen] Temple Univ, Philadelphia, PA 19122 USA		Stumbo, NJ (corresponding author), Educ Associates, Louisville, KY 40243 USA.	njstumbo@gmail.com		PEGG, Shane/0000-0002-7627-6711			Administration for Community Living Administration on Aging, PROGR ALL INCL CAR E; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Allen K, 1996, JAMA-J AM MED ASSOC, V275, P1001, DOI 10.1001/jama.275.13.1001; Armstrong M, 1994, COMMUNITY INTEGRATIO; Ashida S, 2008, ACT ADAPT AGING, V32, P40, DOI 10.1080/01924780802039261; Austin D. R, 2013, INCLUSIVE SPECIAL RE; Austin EN, 2006, THER RECREAT J, V40, P48; Barker RN, 2009, SPINAL CORD, V47, P149, DOI 10.1038/sc.2008.82; Bennett JL, 2014, THER RECREAT J, V48, P169; Bond GR, 2004, COMMUNITY MENT HLT J, V40, P569, DOI 10.1007/s10597-004-6130-8; Boyd R., 1997, Activities, Adaptation & Aging, V21, P7, DOI 10.1300/J016v21n03_02; Braddock D, 2010, DISABILITY SPENDING; Brock K, 2009, DISABIL REHABIL, V31, P880, DOI 10.1080/09638280802356179; Bruseker R, 1999, Aust N Z J Ment Health Nurs, V8, P58, DOI 10.1046/j.1440-0979.1999.00132.x; Bullock C. C, 2010, INTRO RECREATION SER; Chan HT, 2008, INT J GERONTOL, V2, P167, DOI 10.1016/S1873-9598(09)70005-5; Charlifue S, 2004, NEUROREHABILITATION, V19, P91; Chow Y., 2002, Therapeutic Recreation Journal, V36, P203; Chun S, 2008, THER RECREAT J, V42, P217; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Coleman D, 2000, THESIS; Consortium for Spinal Cord Injury Medicine, 2000, OUTC FOLL TRAUM SPIN; Dalgard OS, 1998, J EPIDEMIOL COMMUN H, V52, P476, DOI 10.1136/jech.52.8.476; Davey Barbara, 2005, J Interprof Care, V19, P22, DOI 10.1080/1356182040021734; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Drum CE, 2009, AM J HEALTH PROMOT, V24, P93, DOI 10.4278/ajhp.090303-CIT-94; Dupuis SL, 2005, THER RECREAT J, V39, P277; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Ellaway A, 2007, SOC SCI MED, V64, P1384, DOI 10.1016/j.socscimed.2006.11.022; Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700; Factor A., 1993, OLDER ADULTS DEV DIS, P107; Francis J, 2012, J ENVIRON PSYCHOL, V32, P401, DOI 10.1016/j.jenvp.2012.07.002; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; Ginis KAM, 2012, PM&R, V4, P894, DOI 10.1016/j.pmrj.2012.08.006; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Gray KM, 2014, J AUTISM DEV DISORD, V44, P3006, DOI 10.1007/s10803-014-2159-x; Gulcur L, 2007, COMMUNITY MENT HLT J, V43, P211, DOI 10.1007/s10597-006-9073-4; Hale-Fought M, 1999, EXPANDING HORIZONS T, VXVIII, P47; Hanson CS, 2001, AM J OCCUP THER, V55, P332, DOI 10.5014/ajot.55.3.332; Harrington R, 2010, CLIN REHABIL, V24, P3, DOI 10.1177/0269215509347437; Haveman M., 2009, REPORT STATE SCI HLT; Hebblethwaite S, 2005, THER RECREAT J, V39, P264; Heinemann AW, 2012, SPINAL CORD, V50, P390, DOI 10.1038/sc.2012.12; Hubert G, 2013, J REHABIL RES DEV, V50, P341, DOI 10.1682/JRRD.2011.07.0124; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Iwasaki Y, 2010, HEALTH PROMOT INT, V25, P483, DOI 10.1093/heapro/daq037; Janicki MP, 2000, COMMUNITY SUPPORTS FOR AGING ADULTS WITH LIFELONG DISABILITIES, P529; Jansen DA, 2005, ACT ADAPT AGING, V29, P35, DOI 10.1300/J016v29n02_03; Jivanjee P, 2008, J BEHAV HEALTH SER R, V35, P402, DOI 10.1007/s11414-007-9062-6; Jivanjee P, 2009, J CHILD FAM STUD, V18, P435, DOI 10.1007/s10826-008-9247-5; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kemeny E, 2012, THER RECREAT J, V46, P268; Kennedy P, 2010, SPINAL CORD, V48, P144, DOI 10.1038/sc.2009.90; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kirshblum SC, 2002, ARCH PHYS MED REHAB, V83, pS50, DOI 10.1053/apmr.2002.32156; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Kolakowsky-Hayner SA, 2013, BRAIN INJURY, V27, P578, DOI 10.3109/02699052.2013.765595; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Korabek Barbara, 2004, Nurs Leadersh (Tor Ont), V17, P65; Kuipers P, 2011, INT J REHABIL RES, V34, P167, DOI 10.1097/MRR.0b013e3283460e39; Kunstler R., 2002, Therapeutic Recreation Journal, V36, P186; Kunstler R, 2013, THER RECREAT J, V47, P122; Ljungberg I, 2011, J CLIN NURS, V20, P351, DOI 10.1111/j.1365-2702.2010.03432.x; Mallik K, 1998, PSYCHIATR REHABIL J, V22, P175, DOI 10.1037/h0095250; Mathieu SI, 2008, ACT ADAPT AGING, V32, P134, DOI 10.1080/01924780802143089; Mayer WE, 2014, THER RECREAT J, V48, P150; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCorkle BH, 2009, INT J SOC PSYCHIATR, V55, P291, DOI 10.1177/0020764008097090; Muir K, 2010, J SOC POLICY, V39, P375, DOI 10.1017/S0047279410000073; Mukamel DB, 2007, MILBANK Q, V85, P499, DOI 10.1111/j.1468-0009.2007.00497.x; Murugesan G, 2007, AUST NZ J PSYCHIAT, V41, P343, DOI 10.1080/00048670701213260; Parvaneh S, 2012, AUST OCCUP THER J, V59, P131, DOI 10.1111/j.1440-1630.2012.01001.x; Pegg S, 2000, Contemp Nurse, V9, P295; Petigara T., 2009, HLTH POLICY MONITOR, P13; Power AK, 2010, PSYCHIATRY, V73, P114, DOI 10.1521/psyc.2010.73.2.114; Putnam RD., 2000, BOWLING ALONE COLLAP; Rimmer JH, 2010, J INTELL DISABIL RES, V54, P787, DOI 10.1111/j.1365-2788.2010.01305.x; Rimmer JH, 2007, J ADOLESCENT HEALTH, V41, P224, DOI 10.1016/j.jadohealth.2007.05.005; Rimmer JH, 2006, MENT RETARD DEV D R, V12, P22, DOI 10.1002/mrdd.20091; RIZZOLO MC, 2004, STATE STATES DEV DIS; RUFFINGRAHAL MA, 1994, PUBLIC HEALTH NURS, V11, P38, DOI 10.1111/j.1525-1446.1994.tb00388.x; Ryan CA, 2008, THER RECREAT J, V42, P119; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schleien S. J, 1995, LIFELONG LEISURE SKI; Schonberger M, 2014, NEUROPSYCHOL REHABIL, V24, P202, DOI 10.1080/09602011.2013.878252; Song HY, 2005, DISABIL REHABIL, V27, P131, DOI 10.1080/09638280400007372; Substance Abuse & Mental Health Services Administration, 2005, DHHS PUBL SMA; Thorn SH, 2009, RES DEV DISABIL, V30, P891, DOI 10.1016/j.ridd.2009.01.001; Townley G, 2013, AM J COMMUN PSYCHOL, V52, P84, DOI 10.1007/s10464-013-9578-2; Townley G, 2009, J COMMUNITY PSYCHOL, V37, P362, DOI 10.1002/jcop.20301; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID AM; U.S. Department of Health and Human Services, 2002, 13217 US DEP HLTH HU; U.S. Department of Labor, 2013, FED PARTN TRANS NAT; UPenn Collaborative on Community Integration. (n.d.), RECR LEIS OLD AD PSY; US Department of Health and Human Services, 1999, MENT HLTH REP SURG G; Vine XKL, 2005, J INTELLECT DEV DIS, V30, P171, DOI 10.1080/13668250500204125; Wilder A, AM J RECREATION THER, DOI [10.5055/ajrt.2014.0000, DOI 10.5055/AJRT.2014.0000]; Wilder A, 2011, ANN THERAPEUTIC RECR, V19, P28; Wilhite B, 2012, THER RECREAT J, V46, P245; Won Yin-Ling Irene, 2002, Ment Health Serv Res, V4, P13, DOI 10.1023/A:1014093008857; Wong YLI, 2006, SOC WORK MENT HEALTH, V4, P45, DOI 10.1300/J200v04n03_03; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638; [No title captured]	106	10	11	0	4	SAGAMORE PUBL LLC	URBANA	1807 N FEDERAL DR, URBANA, IL 61801 USA	0040-5914	2159-6433		THER RECREAT J	Ther. Recreat. J.		2015	49	1					35	60					26	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VF4PL	WOS:000442920300003					2022-02-06	
J	Subbian, V; Ratcliff, JJ; Meunier, JM; Korfhagen, JJ; Beyette, FR; Shaw, GJ				Subbian, Vignesh; Ratcliff, Jonathan J.; Meunier, Jason M.; Korfhagen, Joseph J.; Beyette, Fred R., Jr.; Shaw, George J.			Integration of New Technology for Research in the Emergency Department: Feasibility of Deploying a Robotic Assessment Tool for Mild Traumatic Brain Injury Evaluation	IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE			English	Article						Clinical engineering; emergency department; neurological assessment; technology integration	MANAGEMENT	The objective of this paper is to demonstrate the effective deployment of a robotic assessment tool for the evaluation of mild traumatic brain injury (mTBI) patients in a busy, resource-constrained, urban emergency department (ED). Methods: Functional integration of new robotic technology for research in the ED presented several obstacles that required a multidisciplinary approach, including participation from electrical and computer engineers, emergency medicine clinicians, and clinical operations staff of the hospital. Our team addressed many challenges in deployment of this advanced technology including: 1) adapting the investigational device for the unique clinical environment; 2) acquisition and maintenance of appropriate testing space for point-of-care assessment; and 3) dedicated technical support and upkeep of the device. Upon successful placement of the robotic device in the ED, the clinical study required screening of all patients presenting to the ED with complaints of head injury. Eligible patients were enrolled and tested using a robot-assisted test battery. Three weeks after the injury, patients were contacted to complete follow-up assessments. Results: Adapting the existing technology to meet anticipated physical constraints of the ED was performed by engineering a mobile platform. Due to the large footprint of the device, it was frequently moved before ultimately being fully integrated into the ED. Over 14 months, 1423 patients were screened. Twenty-eight patients could not be enrolled because the device was unavailable due to operations limitations. Technical problems with the device resulted in failure to include 20 patients. A total of 66 mTBI patients were enrolled and 42 of them completed both robot-assisted testing and follow-up assessment. Successful completion of screening and enrollment demonstrated that the challenges associated with integration of investigational devices into the ED can be effectively addressed through a collaborative patient-oriented research model. Conclusion: Effective deployment and use of new robotic technology for research in an urban academic ED required significant planning, coordination, and collaboration with key personnel from multiple disciplines. Clinical Impact: A pilot clinical study on mTBI patients using the robotic device provided useful data without disrupting the ED workflow. Integration of this technology into the ED serves as an important step toward pursing active clinical research in an acute care setting.	[Subbian, Vignesh; Beyette, Fred R., Jr.] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH 45221 USA; [Ratcliff, Jonathan J.; Meunier, Jason M.; Korfhagen, Joseph J.; Shaw, George J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA		Subbian, V (corresponding author), Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH 45221 USA.	subbiavh@mail.uc.edu		Beyette, Fred/0000-0001-8704-7810; Subbian, Vignesh/0000-0001-9974-8382	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54 EB007954] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB007954] Funding Source: NIH RePORTER		Advisory Committee to the NIH Director, 2013, INT REP BRAIN RES AD; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Fermann G. J., 2009, P SOC AC EM MED ANN; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korfhagen J. J., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43; Lannsjo M, 2012, BRAIN INJURY, V26, P396; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Nichols JH, 2007, CLIN LAB MED, V27, P893, DOI 10.1016/j.cll.2007.07.003; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Subbian V, 2014, IEEE ENG MED BIO, P5353, DOI 10.1109/EMBC.2014.6944835; Subbian V, 2013, IEEE ENG MED BIO, P938, DOI 10.1109/EMBC.2013.6609656; Subbian V, 2012, IEEE ENG MED BIO, P996, DOI 10.1109/EMBC.2012.6346101; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47	25	10	10	0	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2372			IEEE J TRANSL ENG HE	IEEE J. Transl. Eng. Health Med.-JTEHM		2015	3								3200109	10.1109/JTEHM.2015.2424224			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CS8WP	WOS:000362370900001	27170908	gold, Green Published			2022-02-06	
J	Bista, S; Zhuo, JC; Gullapalli, RP; Varshney, A				Bista, Sujal; Zhuo, Jiachen; Gullapalli, Rao P.; Varshney, Amitabh			Visualization of Brain Microstructure through Spherical Harmonics Illumination of High Fidelity Spatio-Angular Fields	IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS			English	Article						Diffusion Kurtosis Imaging; Diffusion Tensor Imaging; Spatio-Angular Fields; Spherical Harmonics Fields; Tensor Fields	DIFFUSION KURTOSIS; VOLUME; UNCERTAINTY; EXPLORATION; SALIENCY	Diffusion kurtosis imaging (DKI) is gaining rapid adoption in the medical imaging community due to its ability to measure the non-Gaussian property of water diffusion in biological tissues. Compared to traditional diffusion tensor imaging (DTI), DKI can provide additional details about the underlying microstructural characteristics of the neural tissues. It has shown promising results in studies on changes in gray matter and mild traumatic brain injury where DTI is often found to be inadequate. The DKI dataset, which has high-fidelity spatio-angular fields, is difficult to visualize. Glyph-based visualization techniques are commonly used for visualization of DTI datasets; however, due to the rapid changes in orientation, lighting, and occlusion, visually analyzing the much more higher fidelity DKI data is a challenge. In this paper, we provide a systematic way to manage, analyze, and visualize high-fidelity spatio-angular fields from DKI datasets, by using spherical harmonics lighting functions to facilitate insights into the brain microstructure.	[Bista, Sujal; Varshney, Amitabh] Univ Maryland, College Pk, MD 20742 USA; [Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Bista, S (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	sujal@cs.umd.edu; jzzhuo@umm.edu; rgullapalli@umm.edu; varshney@cs.umd.edu			US ArmyUnited States Department of Defense [W81XWH-12-1-0098]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1P50-CA180523]; NSFNational Science Foundation (NSF) [09-59979, 14-29404]; State of Maryland's MPower initiative; NVIDIA CUDA Center of Excellence; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA180523] Funding Source: NIH RePORTER	We cordially thank Carlos Correa, Cheuk Yiu (Horace) Ip, Joseph JaJa, Gordon Kindlmann, Kwan-Liu Ma, and Raghu Machiraju, for their valuable feedback and suggestions on earlier versions of this paper. We are grateful to the anonymous reviewers whose constructive comments have greatly improved the presentation of our approach and results in this paper. We appreciate the support of the US Army grant W81XWH-12-1-0098, NIH grant 1P50-CA180523, NSF grants 09-59979 and 14-29404, the State of Maryland's MPower initiative, and the NVIDIA CUDA Center of Excellence. Any opinions, findings, conclusions, or recommendations expressed in this article are those of the authors and do not necessarily reflect the views of the research sponsors.	Baker L. M., 2014, NEUROLOGY, P10; Cabral Brian, 1987, COMPUT GRAPH, P273; Carr Nathan A, 2003, P ACM SIGGRAPH EUROG, P51; Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; Correa CD, 2008, IEEE T VIS COMPUT GR, V14, P1380, DOI 10.1109/TVCG.2008.162; Ennis DB, 2005, MAGNET RESON MED, V53, P169, DOI 10.1002/mrm.20318; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hlawitschka M., 2012, VISUALIZATION MED LI, P209; Huang RZ, 2003, 11TH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, PROCEEDINGS, P355; Ip CY, 2012, IEEE T VIS COMPUT GR, V18, P2355, DOI 10.1109/TVCG.2012.231; Irfanoglu MO, 2011, LECT NOTES COMPUT SC, V6892, P174, DOI 10.1007/978-3-642-23629-7_22; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Jensen J., 2003, P 11 ANN M ISMRM, V2154; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jones D., 2011, DIFFUSION MRI THEORY; Kautz J., 2002, Rendering Techniques 2002. Eurographics Workshop Proceedings, P291; Nguyen KT, 2013, LECT NOTES COMPUT SC, V8033, P266, DOI 10.1007/978-3-642-41914-0_27; Kim Y, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1670671.1670676; Kindlmann G, 1998, IEEE SYMPOSIUM ON VOLUME VISUALIZATION, P79, DOI 10.1109/SVV.1998.729588; Kindlmann G., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P183, DOI 10.1109/VISUAL.1999.809886; Kindlmann G, 2000, IEEE T VIS COMPUT GR, V6, P124, DOI 10.1109/2945.856994; Kindlmann G., 2004, P 6 JOINT EUR IEEE T, P147, DOI DOI 10.2312/VISSYM/VISSYM04/147-154; Kniss J, 2002, IEEE T VIS COMPUT GR, V8, P270, DOI 10.1109/TVCG.2002.1021579; Lazar M, 2008, MAGN RESON MED, V60, P774, DOI 10.1002/mrm.21725; Lee CH, 2004, IEEE VISUALIZATION 2004, PROCEEEDINGS, P281, DOI 10.1109/VISUAL.2004.62; Lee CH, 2009, IEICE T INF SYST, VE92D, P369, DOI 10.1587/transinf.E92.D.369; LEVOY M, 1988, IEEE COMPUT GRAPH, V8, P29, DOI 10.1109/38.511; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Lum EB, 2004, IEEE VISUALIZATION 2004, PROCEEEDINGS, P289, DOI 10.1109/VISUAL.2004.64; Mohlenkamp M. J., 1997, J FOURIER ANAL APPL; Prckovska V, 2011, IEEE T VIS COMPUT GR, V17, P1407, DOI 10.1109/TVCG.2010.244; Raab P., 2010, CEREBRAL GLIOMAS DIF; Reichenbach A., 2014, COMPUTATIONAL DIFFUS, P115; Schlegel P, 2011, IEEE T VIS COMPUT GR, V17, P1795, DOI 10.1109/TVCG.2011.198; Schultz T, 2013, COMPUT GRAPH FORUM, V32, P121, DOI 10.1111/cgf.12099; Schultz T, 2011, COMPUT GRAPH FORUM, V30, P841, DOI 10.1111/j.1467-8659.2011.01933.x; Schultz T, 2010, COMPUT GRAPH FORUM, V29, P1143, DOI 10.1111/j.1467-8659.2009.01675.x; Schultz T, 2007, IEEE T VIS COMPUT GR, V13, P1496, DOI 10.1109/TVCG.2007.70602; Schultz T, 2010, IEEE T VIS COMPUT GR, V16, P1595, DOI 10.1109/TVCG.2010.199; Schussman G, 2004, IEEE VISUALIZATION 2004, PROCEEEDINGS, P107, DOI 10.1109/VISUAL.2004.5; Schwartzman A, 2005, MAGN RESON MED, V53, P1423, DOI 10.1002/mrm.20503; SILLION FX, 1991, COMP GRAPH, V25, P187; Sloan PP, 2002, ACM T GRAPHIC, V21, P527, DOI 10.1145/566654.566612; Staempfli P, 2006, NEUROIMAGE, V30, P110, DOI 10.1016/j.neuroimage.2005.09.027; Tao YB, 2009, IEEE PAC VIS SYMP, P193, DOI 10.1109/PACIFICVIS.2009.4906856; Tikhonova A, 2010, COMPUT GRAPH FORUM, V29, P783, DOI 10.1111/j.1467-8659.2009.01690.x; Tricoche X, 2008, IEEE T VIS COMPUT GR, V14, P1627, DOI 10.1109/TVCG.2008.148; van Almsick M, 2011, IEEE T VIS COMPUT GR, V17, P612, DOI 10.1109/TVCG.2010.61; Zhang YB, 2013, IEEE T VIS COMPUT GR, V19, P2946, DOI 10.1109/TVCG.2013.172; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	51	10	11	0	9	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1077-2626	1941-0506		IEEE T VIS COMPUT GR	IEEE Trans. Vis. Comput. Graph.	DEC	2014	20	12					2516	2525		10.1109/TVCG.2014.2346411			10	Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	AT5OI	WOS:000344991700097	26356965				2022-02-06	
J	Huang, YS; Xu, Y; Cheng, QC; Yu, SS; Gao, Y; Shu, QM; Yang, C; Sun, Y; Wang, JW; Xu, F; Liang, XL				Huang, Yongsheng; Xu, Yue; Cheng, Qiaochu; Yu, Shanshan; Gao, Yi; Shu, Qinmeng; Yang, Cheng; Sun, Yuan; Wang, Jiawei; Xu, Fan; Liang, Xiaoling			The Expression Changes of Myelin and Lymphocyte Protein (MAL) Following Optic Nerve Crush in Adult Rats Retinal Ganglion Cells	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Optic nerve crush; MAL; Retinal ganglion cells; Apoptosis; Rats	TRAUMATIC BRAIN-INJURY; IN-VIVO; CASPASE ACTIVATION; OXIDATIVE STRESS; UP-REGULATION; DEATH; APOPTOSIS; GENE; CANCER; IDENTIFICATION	Myelin and lymphocyte protein (MAL), a component of compact myelin, is highly expressed in oligodendrocytes and Schwann cells. It has been reported that MAL may play a vital role in the process of neuronal apoptosis following acute spinal cord injury. However, acquaintance regarding its distribution and possible function in the retina is limited. Therefore, in a rodent model of optic nerve crush (ONC), the dynamic changes of MAL in retina was detected. The expression of MAL was mainly located in the retinal ganglion cells (RGCs) and was increased strongly after ONC. The peak of MAL expression appeared on the third day. In addition, there was a concomitant upregulation of active-caspase-3, which also co-localized with MAL in RGCs. Moreover, co-localization of MAL with terminal deoxynucleotidyl transferase-mediated biotinylated-dUTP nick-end labeling (TUNEL) was detected in RGCs after ONC. Collectively, all these results suggested that the upregulation of MAL might play an important role in the pathophysiology of RGCs after ONC.	[Huang, Yongsheng; Xu, Yue; Cheng, Qiaochu; Yu, Shanshan; Gao, Yi; Sun, Yuan; Wang, Jiawei; Xu, Fan; Liang, Xiaoling] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Shu, Qinmeng] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Yang, Cheng] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China		Liang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	liangxlsums@qq.com		Yu, Shanshan/0000-0001-6182-8328	Specialized Research Foundation for Doctoral Program of Higher Education of ChinaSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20120171110086]; Science and Technology Planning Project of Guangzhou China [11C22060787]	This work was supported by the Specialized Research Foundation for Doctoral Program of Higher Education of China (No. 20120171110086) and Science and Technology Planning Project of Guangzhou China (No. 11C22060787).	ALLCUTT D, 1984, DEV BRAIN RES, V16, P231, DOI 10.1016/0165-3806(84)90028-2; ALONSO MA, 1987, P NATL ACAD SCI USA, V84, P1997, DOI 10.1073/pnas.84.7.1997; Alonso MA, 2001, J CELL SCI, V114, P3957; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Buffart TE, 2008, BRIT J CANCER, V99, P1802, DOI 10.1038/sj.bjc.6604777; Cao W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-296; Castano A, 1996, NEUROBIOL AGING, V17, P745; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Frank M, 2000, PROG NEUROBIOL, V60, P531, DOI 10.1016/S0301-0082(99)00039-8; Frank M, 1998, J NEUROSCI, V18, P4901; Goldenberg-Cohen N, 2011, J NEURO-OPHTHALMOL, V31, P331, DOI 10.1097/WNO.0b013e318227e4fb; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Gupta VK, 2013, J MOL NEUROSCI, V49, P96, DOI 10.1007/s12031-012-9899-x; Horne HN, 2009, MOL CANCER RES, V7, P199, DOI 10.1158/1541-7786.MCR-08-0314; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Joachim SC, 2014, J MOL NEUROSCI, V52, P216, DOI 10.1007/s12031-013-0125-2; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P2697; Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4; KIM T, 1995, J NEUROSCI RES, V42, P413, DOI 10.1002/jnr.490420316; Krupinski J, 2002, NEUROPHARMACOLOGY, V42, P846, DOI 10.1016/S0028-3908(02)00032-1; Kwon KB, 2002, BIOCHEM PHARMACOL, V63, P41, DOI 10.1016/S0006-2952(01)00860-7; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Li AH, 2013, J MOL NEUROSCI, V51, P208, DOI 10.1007/s12031-013-9994-7; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Mao H, 2013, J MOL NEUROSCI, V51, P558, DOI 10.1007/s12031-013-0024-6; Mimori K, 2003, ONCOGENE, V22, P3463, DOI 10.1038/sj.onc.1206378; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Rong XF, 2012, INVEST OPHTH VIS SCI, V53, P6025, DOI 10.1167/iovs.12-9898; Schaeren-Wiemers N, 2004, J CELL BIOL, V166, P731, DOI 10.1083/jcb.200406092; SCHAERENWIEMERS N, 1995, J NEUROCHEM, V65, P10; SCHAERENWIEMERS N, 1995, J NEUROSCI, V15, P5753; Sharifi AM, 2009, NEUROSCI LETT, V459, P47, DOI 10.1016/j.neulet.2009.03.100; Shu Q, 2014, J MOL NEUROSCI; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tsai RK, 2010, EXP EYE RES, V90, P537, DOI 10.1016/j.exer.2010.01.004; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Wilson AM, 2013, J NEUROSCI, V33, P2205, DOI 10.1523/JNEUROSCI.2635-12.2013; Xu Y, 2013, J MOL NEUROSCI; Xu Y, 2014, J MOL NEUROSCI, V52, P331, DOI 10.1007/s12031-013-0153-y; Xu Y, 2013, J MOL NEUROSCI, V51, P37, DOI 10.1007/s12031-012-9941-z; Zacchetti D, 1995, FEBS LETT, V377, P465, DOI 10.1016/0014-5793(95)01396-2; Zhang JL, 2013, J MOL HISTOL, V44, P125, DOI 10.1007/s10735-012-9469-0; Zhang ZZ, 2012, NEUROSCIENCE, V224, P282, DOI 10.1016/j.neuroscience.2012.07.056; Zou FH, 2013, J MOL NEUROSCI, V49, P395, DOI 10.1007/s12031-012-9906-2	53	10	11	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	DEC	2014	54	4					614	621		10.1007/s12031-014-0332-5			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW0PP	WOS:000345995700003	24878628				2022-02-06	
J	Kerr, HA				Kerr, Hamish A.			Concussion Risk Factors and Strategies for Prevention	PEDIATRIC ANNALS			English	Article							SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; NECK STRENGTH; MOUTHGUARDS; INJURIES; ZURICH; ACCELERATION; REDUCTION	Concussion in children is frequently related to participation in sports. It requires a traumatic event to occur that transmits acceleration to the brain. Some children may have intrinsic risk factors that place them at greater risk for this type of injury. Comorbidities such as attention-deficit/hyperactivity disorder, migraine headaches, and mood disorders may place athletes at increased risk of more severe injury. A previous concussion is probably the most important influence on risk for future injury. Extrinsic risk factors include coaching techniques, officiating, and choice of sport. Helmet choice does not diminish concussion risk, nor does the use of mouth guards. Education of athletes, coaches, parents, and physicians is very important in improving recognition of potential concussive injury and helping child athletes and their parents understand the risks involved in sport participation.	Albany Med Coll, Latham, NY 12110 USA		Kerr, HA (corresponding author), Albany Med Coll, 724 Watervliet Shaker Rd, Latham, NY 12110 USA.	kerrh@mail.amc.edu	Meijer, Anna/K-5118-2016				Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Brooks M, 2013, AM AC PED NAT C EXH, VOrlando, FL; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Geary K, 2014, CLIN J SPORT MED, V24, P502, DOI 10.1097/JSM.0000000000000071; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton DF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004975; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kahanda M, 2014, MED SCI SPORTS EXE S, V46; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Kumar S, 2000, ACCIDENT ANAL PREV, V32, P233, DOI 10.1016/S0001-4575(99)00114-1; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Santa Barbara M, 2012, CLIN J SPORTS MED, V22; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Washington State Dept. Health, CONC MAN SCH SPORTS	43	10	10	0	33	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	DEC	2014	43	12					E309	E315		10.3928/00904481-20141124-10			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AY4MP	WOS:000347553000004	25486039				2022-02-06	
J	Lennox, C				Lennox, Charlotte			The health needs of young people in prison	BRITISH MEDICAL BULLETIN			English	Article						young people; prison; physical health; mental health; substance misuse; neurodevelopmental disorders	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; JUVENILE DETENTION; MENTAL-DISORDERS; OFFENDERS; YOUTH; ADOLESCENTS; PREVALENCE; PERSISTENT; FACILITIES	There has been an unprecedented reduction in the number of young people in prison; however, questions remain about the appropriateness and effectiveness of custody, given the high prevalence of health needs, self-inflected deaths while in custody and high reoffending rates. Articles relating to the health needs of young people, aged 10-17 years in prison in England and Wales were sourced through PubMed and ISI Web of Knowledge, plus additional key reports were included if deemed relevant. Young people in prison have much higher rates of multiple and complex health problems compared with young people in the general population. However, many of their health-care needs are unrecognized and unmet. There is an urgent need for up-to-date and robust prevalence data of all health needs across the age ranges in England and Wales. Research has neglected physical health and neurodevelopmental disorders and the quality of research for females and Black and Minority Ethnic group's requires improvement. There is a dearth of high-quality evaluations of health interventions with robust and sensitive short- and long-term outcome measures.	[Lennox, Charlotte] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Mental Hlth & Risk, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England		Lennox, C (corresponding author), Univ Manchester, Room 2-315,Jean McFarlane Bldg,Oxford Rd, Manchester, Lancs, England.	charlotte.lennox@manchester.ac.uk		Lennox, Charlotte/0000-0001-9014-9965			Allen R., 2011, LAST RESORT EXPLORIN; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Bryan K, 2007, INT J LANG COMM DIS, V42, P505, DOI 10.1080/13682820601053977; Chitsabesan P, 2006, BRIT J PSYCHIAT, V188, P534, DOI 10.1192/bjp.bp.105.010116; Chitsabesan P, 2014, J FORENSIC PSYCHI PS, V25, P1, DOI 10.1080/14789949.2014.882387; Colins O, 2010, CAN J PSYCHIAT, V55, P255, DOI 10.1177/070674371005500409; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Fazel S, 2008, J AM ACAD CHILD PSY, V47, P1010, DOI [10.1097/CHI.ObO13e31817eecf3, 10.1097/CHI.0b013e31817eeef3]; Golzari M, 2006, J ADOLESCENT HEALTH, V38, P776, DOI 10.1016/j.jadohealth.2005.06.008; Grisso T., 2012, MASSACHUSETTS YOUTH; Hughes N., 2012, PREVALENCE NEURODEVE; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Kinner SA, 2014, J ADOLESCENT HEALTH, V54, P521, DOI 10.1016/j.jadohealth.2013.10.003; Kroll L, 2002, LANCET, V359, P1975, DOI 10.1016/S0140-6736(02)08829-3; Lader D, 2003, INT REV PSYCHIATR, V15, P144, DOI 10.1080/0954026021000046074; Lennox C, 2013, OUR CHILDREN DESERVE; Lennox C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002358; Ministry of Justice, 2014, YOUTH CUST REP DEC 2; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; Mooney A, 2007, HLTH CHILDREN YOUNG; National Treatment Agency, 2012, SUBST MIS YOUNG PEOP; Prison Reform Trust, 2012, FAT FLAW HAS STAT LE; Prison Reform Trust, 2013, BROML BRIEF PRIS FAC; Royal College of Paediatrics and Child Health, 2013, HEALTHC STAND CHILDR; Snowling M.J., 2000, CRIM BEHAV MENT HEAL, V10, P229, DOI [10.1002/cbm.362, DOI 10.1002/CBM.362]; Teplin LA, 2005, PSYCHIAT SERV, V56, P823, DOI 10.1176/appi.ps.56.7.823; The National Autistic Society, 2008, AUT GUID CRIM JUST P; Vreugdenhil C, 2004, J AM ACAD CHILD PSY, V43, P97, DOI 10.1097/00004583-200401000-00019; Young Minds, 2013, SAM OLD EXP YOUNG OF; Youth Justice Board, 2009, SUBST MIS SERV SEC E; Youth Justice Board, 2014, YOUTH JUST STAT 2012	32	10	10	0	31	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-1420	1471-8391		BRIT MED BULL	Br. Med. Bull.	DEC	2014	112	1					17	25		10.1093/bmb/ldu028			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1LU	WOS:000346051800002	25267312	Green Published, Bronze			2022-02-06	
J	Liu, C; Tang, JW				Liu, Chang; Tang, Jianwei			Expression levels of tumor necrosis factor-alpha and the corresponding receptors are correlated with trauma severity	ONCOLOGY LETTERS			English	Article						trauma; tumor necrosis factor-alpha; tumor necrosis factor receptors; tumor necrosis factor receptor 1; tumor necrosis factor receptor 2; p55; p75; patient	SOLUBLE RECEPTORS; BRAIN-INJURY; TNF-ALPHA; THERAPEUTIC TARGET; MOLECULAR-CLONING; CYTOKINE; RELEASE; INTERLEUKIN-6; PATHOGENESIS; INFLAMMATION	This study investigated the plasma levels of tumor necrosis factor a (INF-alpha) and the expression levels of TNF receptors (TNFRs) in patients with multiple trauma, together with the association between the levels of this cytokine and these cytokine receptors with the severity of traumatic injury. Blood samples were obtained from 60 multiple trauma patients at hospital admission (within 2 h of injury), and 6-8 h and 1-5 days after admission. The plasma levels of TNF-alpha and TNFR1/TNFR2 were detected using enzyme immunoassay. TNFR1 and TNFR2 expression levels on leukocytes, including neutrophils, lymphocytes and monocytes, were determined by flow cytometry. Clinical parameters were determined by injury severity score (ISS). At hospital admission, the plasma TNF-alpha and soluble TNFR levels in the trauma patients were elevated compared with those of healthy controls. Increased expression levels of TNFR1 and TNFR2 were also detected on leukocytes, particularly on lymphocytes and monocytes. The expression levels of the cytokine and the corresponding receptors were correlated with the ISS. TNF-alpha and TNFR expression levels remained significantly elevated for up to the third to fifth day following the traumatic injury. In the trauma patients, increased levels of TNF-alpha and TNFRs were correlated with the severity of traumatic injury in the early post-injury period, supporting the hypothesis that trauma-provoked organ dysfunction may be caused by an overwhelming auto-destructive inflammatory response.	[Liu, Chang; Tang, Jianwei] Fudan Univ, Jinshan Hosp, Dept Emergency Surg, Shanghai 200540, Peoples R China		Liu, C (corresponding author), Fudan Univ, Jinshan Hosp, Dept Emergency Surg, 1508 Longhang Rd, Shanghai 200540, Peoples R China.	changliucn@163.com			Shanghai Health Bureau [20114261]	This study was supported by the Shanghai Health Bureau (grant no. 20114261).	Balk RA, 2000, CRIT CARE CLIN, V16, P337, DOI 10.1016/S0749-0704(05)70113-5; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Choi SJ, 2005, YONSEI MED J, V46, P818, DOI 10.3349/ymj.2005.46.6.818; CINAT M, 1995, J TRAUMA, V39, P112, DOI 10.1097/00005373-199507000-00015; CINAT ME, 1994, J AM COLL SURGEONS, V179, P529; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Feldman AM, 2008, CTS-CLIN TRANSL SCI, V1, P145, DOI 10.1111/j.1752-8062.2008.00012.x; FROON AHM, 1994, CRIT CARE MED, V22, P803, DOI 10.1097/00003246-199405000-00015; GERLACH H, 1993, EUR J ANAESTH, V10, P273; GOODWIN RG, 1991, MOL CELL BIOL, V11, P3020, DOI 10.1128/MCB.11.6.3020; HOCH RC, 1993, CRIT CARE MED, V21, P839, DOI 10.1097/00003246-199306000-00010; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Majetschak M, 1997, J TRAUMA, V43, P880, DOI 10.1097/00005373-199712000-00002; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Pellegrini JD, 1996, SHOCK, V6, P389, DOI 10.1097/00024382-199612000-00001; RABINOVICI R, 1993, J TRAUMA, V35, P698, DOI 10.1097/00005373-199311000-00008; ROGY MA, 1994, J AM COLL SURGEONS, V178, P132; Shuh M, 2013, OCHSNER J, V13, P119; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; Spielmann S, 2001, ACTA ANAESTH SCAND, V45, P364, DOI 10.1034/j.1399-6576.2001.045003364.x; SPINAS GA, 1992, J CLIN INVEST, V90, P533, DOI 10.1172/JCI115891; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; SVOBODA P, 1994, J TRAUMA, V36, P336, DOI 10.1097/00005373-199403000-00009; TAN LR, 1993, J TRAUMA, V34, P634, DOI 10.1097/00005373-199305000-00004; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zerey M, 2006, SURG INNOV, V13, P5, DOI 10.1177/155335060601300102	35	10	11	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2014	8	6					2747	2751		10.3892/ol.2014.2575			5	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	AU9YT	WOS:000345948600079	25364459	gold, Green Published, Green Submitted			2022-02-06	
J	Mishra, C; Ganesh, GS				Mishra, Chittaranjan; Ganesh, G.			Inter-Rater Reliability of Modified Modified Ashworth Scale in the Assessment of Plantar Flexor Muscle Spasticity in Patients with Spinal Cord Injury	PHYSIOTHERAPY RESEARCH INTERNATIONAL			English	Article						Ashworth scale; reliability; spasticity; spinal cord injury		Introduction. Spasticity occurs in disorders of the central nervous system such as stroke, spinal cord injury (SCI), multiple sclerosis and traumatic brain injury. The recently developed clinical measurement for the measurement of spasticity is the Modified Modified Ashworth Scale (MMAS) Purpose of study. The purpose of this study is to determine the inter-rater reliability of the MMAS in the assessment of plantar flexor spasticity in patients with SCI. Methodology. Thirty-eight subjects (32 males and six females, mean age 31.9 +/- 12.6 years) were recruited for the study. Excluded from the study were patients with contracture in the lower limb and where passive movements were contraindicated. Procedure. Each patient was assessed by two raters in a single session. After the performance of the procedure by the first assessor and rating of the patient's muscle tone with the MMAS, the same procedure was repeated by the second assessor after 1 hour. The evaluation was carried out in side-lying position. The extent of agreement was analysed by non-weighted Cohen kappa. Results. The agreement between the raters was good (soleus -: 0.75, SE = 0.084, p < 0.0001, gastrocnemius -: 0.70, SE = 0.105, p < 0.0001). Conclusion. The MMAS has good inter-rater reliability in the assessment of plantar flexor muscle spasticity in patients with SCI. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Mishra, Chittaranjan; Ganesh, G.] SVNIRTAR, Odisha 754010, India		Ganesh, GS (corresponding author), SVNIRTAR, Physiotherapy, Odisha 754010, India.	shankarpt@rediffmail.com	Ganesh, Shankar/R-1013-2019	Ganesh, Shankar/0000-0002-9264-2312			Ansari Noureddin Nakhostin, 2006, Physiotherapy Theory and Practice, V22, P119, DOI 10.1080/09593980600724188; Ansari NN, 2009, NEUROREHABILITATION, V24, P225, DOI 10.3233/NRE-2009-0472; Ansari Noureddin Nakhostin, 2008, Physiotherapy Theory and Practice, V24, P205, DOI 10.1080/09593980701523802; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Bakheit AMO, 2003, J NEUROL NEUROSUR PS, V74, P646, DOI 10.1136/jnnp.74.5.646; Barnes MP, 2001, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY, P1; Blackburn M, 2002, PHYS THER, V82, P25, DOI 10.1093/ptj/82.1.25; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Burridge JH, 2005, DISABIL REHABIL, V27, P69, DOI 10.1080/09638280400014592; Craven BC, 2010, SPINAL CORD, V48, P207, DOI 10.1038/sc.2009.107; Elbasiouny SM, 2010, NEUROREHAB NEURAL RE, V24, P23, DOI 10.1177/1545968309343213; Ghotbi N, 2006, Electromyogr Clin Neurophysiol, V46, P279; Ghotbi N, 2011, J REHABIL RES DEV, V48, P83, DOI 10.1682/JRRD.2010.02.0020; Ghotbi N, 2009, BRAIN INJURY, V23, P815, DOI 10.1080/02699050903200548; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Gregson JM, 1999, ARCH PHYS MED REHAB, V80, P1013, DOI 10.1016/S0003-9993(99)90053-9; Haas BM, 1996, SPINAL CORD, V34, P560, DOI 10.1038/sc.1996.100; Hagen Ellen Merete, 2012, Tidsskr Nor Laegeforen, V132, P831, DOI 10.4045/tidsskr.10.0859; Johnson GR, 2002, EUR J NEUROL, V9, P10, DOI 10.1046/j.1468-1331.2002.0090s1010.x; Kumar RTS, 2006, AGE AGEING, V35, P371, DOI 10.1093/ageing/afj084; Lance J.W., 1980, SPASTICITY DISORDERE, P485; LANCE JW, 1974, ARCH PHYS MED REHAB, V55, P332; LESLIE GC, 1992, CLIN REHABIL, V0006, P00041, DOI DOI 10.1177/026921559200600106; Morris, 2002, PHYS THER REV, V7, P53, DOI [10.1179/108331902125001770, DOI 10.1179/108331902125001770]; Mutlu A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-44; Naghdi S, 2008, Electromyogr Clin Neurophysiol, V48, P35; Naghdi S, 2007, Electromyogr Clin Neurophysiol, V47, P187; Naghdi Soofia, 2008, Physiotherapy Theory and Practice, V24, P372, DOI 10.1080/09593980802278959; Nuyens G., 1994, CLIN REHABIL, V8, P286, DOI [10.1177/026921559400800403, DOI 10.1177/026921559400800403]; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Pandyan AD, 2003, CLIN REHABIL, V17, P290, DOI 10.1191/0269215503cr610oa; Pandyan AD, 2001, CLIN BIOMECH, V16, P859, DOI 10.1016/S0268-0033(01)00084-5; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Pierrot-Deseilligny, 1985, TRIANGLE, V22, P165; Platz T, 2005, DISABIL REHABIL, V27, P7, DOI 10.1080/09638280400014634; Rushworth G, 1980, Int Rehabil Med, V2, P23; Schmit BD, 2000, ARCH PHYS MED REHAB, V81, P269; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Vattanasilp W, 1999, AUST J PHYSIOTHER, V45, P135, DOI 10.1016/S0004-9514(14)60345-7; Vattanasilp W, 2000, J NEUROL NEUROSUR PS, V69, P34, DOI 10.1136/jnnp.69.1.34; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600	42	10	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1358-2267	1471-2865		PHYSIOTHER RES INT	Physiother. Res. Int.	DEC	2014	19	4					231	237		10.1002/pri.1588			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V75UA	WOS:000211868300004	24619735				2022-02-06	
J	Yu, AY; Xu, QH; Hu, SL; Li, F; Chen, YJ; Yin, Y; Zhu, G; Lin, JK; Feng, H				Yu, An-Yong; Xu, Quan-Hong; Hu, Sheng-Li; Li, Fei; Chen, Yu-Jie; Yin, Yi; Zhu, Gang; Lin, Jiang-Kai; Feng, Hua			Characteristics of a rat model of an open craniocerebral injury at simulated high altitude	NEUROREPORT			English	Article						animal model; brain water content; high altitude; open craniocerebral injury; PbtO(2); rCBF	TRAUMATIC BRAIN-INJURY; ACUTE MOUNTAIN-SICKNESS; HYPERBARIC-OXYGEN; CEREBRAL-ISCHEMIA; EDEMA FORMATION	To establish a rat model of an open craniocerebral injury at simulated high altitude and to examine the characteristics of this model. Rats were divided randomly into a normobaric group and a high-altitude group and their corresponding control groups. A rat model of an open craniocerebral injury was established with a nail gun shot. Simulated high-altitude conditions were established with a hypobaric chamber at 0.6 ATA to mimic pressure at an altitude of 4000 m. Mortality, brain water content (BWC), Evans blue content, pathology, regional cerebral blood flow (rCBF), partial pressure of brain tissue oxygen (PbtO(2)), and brainstem auditory-evoked potential were observed after injury. The mortality of the high-altitude group was significantly greater than that of the normobaric group within 72 h after injury (P< 0.05). BWC and Evans blue content increased by 48 h after injury (P< 0.05); pathological changes in damaged brains were more serious. In contrast, rCBF and PbtO(2) had decreased markedly by 72 h (P< 0.01); brainstem auditory-evoked potential values were significantly prolonged (P< 0.05). Moreover, an inverse correlation between rCBF and BWC and a positive correlation between rCBF and PbtO(2) were found. The rat model of an open craniocerebral injury at simulated high altitude can be established successfully using a nail gun shot and a hypobaric chamber. The injury characteristics at high altitude were more serious, rapid, and prolonged than those in the normobaric group. (c) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Yu, An-Yong; Hu, Sheng-Li; Li, Fei; Chen, Yu-Jie; Yin, Yi; Zhu, Gang; Lin, Jiang-Kai; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China; [Xu, Quan-Hong] PLA, Hosp 41, Tibet, Peoples R China		Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.	fenghua8888@aliyun.com	Feng, Hua/AAX-4121-2021; Chen, Yujie/AAS-6995-2021	Feng, Hua/0000-0003-4489-9217; Chen, Yujie/0000-0002-9905-9138	Sci & Tech Research Project of the 'Eleventh Five-year Plan' for Medical Science Development of PLA [08G087]; Sci & Tech Research Project of the 'Twelfth Five-year Plan' for Medical Science Development of PLA [AWS11J008]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471261]; Health Sector Public Welfare fund of China [200802093]	This study was supported by the Sci & Tech Research Project of the 'Eleventh Five-year Plan' for Medical Science Development of PLA (08G087), the Sci & Tech Research Project of the 'Twelfth Five-year Plan' for Medical Science Development of PLA (AWS11J008), the National Natural Science Foundation of China (No. 81471261) and Health Sector Public Welfare fund of China grant 200802093.	Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Cevik NG, 2013, BRAIN RES, V1531, P113, DOI 10.1016/j.brainres.2013.07.052; Clarke C, 2006, POSTGRAD MED J, V82, P748, DOI 10.1136/pgmj.2006.047662; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; HACKETT PH, 1976, LANCET, V2, P1149; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kirkness CJ, 2009, CRIT CARE MED, V37, P371, DOI 10.1097/CCM.0b013e3181930eff; Lew HL, 2004, AM J PHYS MED REHAB, V83, P210, DOI 10.1097/01.PHM.0000113402.85460.59; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Tolvanen AD, 2013, NEUROSCIENCE, V229, P49, DOI 10.1016/j.neuroscience.2012.10.062; Wani Abrar Ahad, 2012, Surg Neurol Int, V3, P89, DOI 10.4103/2152-7806.99930; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	22	10	12	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	NOV 12	2014	25	16					1272	1280		10.1097/WNR.0000000000000259			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR0YE	WOS:000343301300005	25191925	Green Published			2022-02-06	
J	Bickford, JS; Ali, NF; Nick, JA; Al-Yahia, M; Beachy, DE; Dore, S; Nick, HS; Waters, MF				Bickford, Justin S.; Ali, Narjis F.; Nick, Jerelyn A.; Al-Yahia, Musab; Beachy, Dawn E.; Dore, Syhiain; Nick, Harry S.; Waters, Michael F.			Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism	BRAIN RESEARCH			English	Article						Eicosanoid; Gene expression; Iron homeostasis; Focal ischemia	TRANSFERRIN RECEPTOR 2; ENDOTHELIN-CONVERTING ENZYME; TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE-C; SUBARACHNOID HEMORRHAGE; ARTERY OCCLUSION; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; IN-VIVO; MECHANISMS	Endothelins are potent vasoconstrictors and signaling molecules. Their effects are broad, impacting processes ranging from neurovascular and cardiovascular health to cell migration and survival. In stroke, traumatic brain injury or subarachnoid hemorrhage, endothelin-1 (ET-1) is induced resulting in cerebral vasospasm, ischemia, reperfusion and the activation of various pathways. Given the central role that ET-1 plays in these patients and to identify the downstream molecular events specific to transient vasoconstriction, we studied the consequences of ET-1-mediated vasoconstriction of the middle cerebral artery in a rat model. Our observations demonstrate that ET-1 can lead to increases in gene expression, including genes associated with the inflammatory response (Ifnb Il6, Tnf) and oxidative stress (Hifla, Myc, Sod2). We also observed inductions (>2 fold) of genes involved in eicosanoid biosynthesis (Pla2g4a, Pla2g4b, Ptgs2, Ptgis, Alox12, Alox15), heme metabolism (Hpx, Hmox1, Prdx1) and iron homeostasis (Hamp, TM. Our findings demonstrate that mRNA levels for the hormone hepcidin (Hamp) are induced in the brain in response to ET-1, providing a novel target in the treatment of multiple conditions. These changes on the ipsilateral side were also accompanied by corresponding changes in a subset of genes in the contralateral hemisphere. Understanding ET-1-mediated events at the molecular level may lead to better treatments for neurological diseases and provide significant impact on neurological function, morbidity and mortality. (C) 2014 Elsevier B.V. All rights reserved.	[Bickford, Justin S.; Beachy, Dawn E.; Dore, Syhiain; Nick, Harry S.; Waters, Michael F.] Univ Florida, Coll Med, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA; [Bickford, Justin S.; Nick, Harry S.] Univ Florida, Coll Med, Dept Biochem, Gainesville, FL 32610 USA; [Bickford, Justin S.; Nick, Harry S.] Univ Florida, Coll Med, Dept Mol Biol, Gainesville, FL 32610 USA; [Dore, Syhiain] Univ Florida, Coll Med, Gainesville, FL 32610 USA; [Ali, Narjis F.; Nick, Jerelyn A.; Al-Yahia, Musab; Waters, Michael F.] Univ Florida, Coll Med, Dept Neurol, McKnight Brain Inst, Gainesville, FL 32610 USA		Waters, MF (corresponding author), Univ Florida, Coll Med, Dept Neurol, POB 100296, Gainesville, FL 32610 USA.	mwaters@neurology.ufl.edu	Dore, Sylvain/AAG-1470-2020	Dore, Sylvain/0000-0003-3771-5109	McKnight Brain Institute at the University of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [RC1HL100195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046400] Funding Source: NIH RePORTER	The authors would like to thank Dr. Jeffrey A Kleim, Dr. Nagheme J. Thomas and Dr. Carolyn Zahler for technical support and Swati Khare for assistance with statistical analyses. These studies were supported by the McKnight Brain Institute at the University of Florida.	Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calzolari A, 2010, TRANSL ONCOL, V3, P123, DOI 10.1593/tlo.09274; Cao S, 2009, AM J PHYSIOL-REG I, V296, pR1412, DOI 10.1152/ajpregu.00003.2009; Capra V, 2013, MED RES REV, V33, P364, DOI 10.1002/med.21251; Chang CZ, 2004, J CARDIOVASC PHARM, V44, pS487, DOI 10.1097/01.fjc.0000166307.86678.d1; Chatfield DA, 2011, NEUROCRIT CARE, V14, P55, DOI 10.1007/s12028-010-9413-7; Cipolla MJ, 2013, J CEREBR BLOOD F MET, V33, P1486, DOI 10.1038/jcbfm.2013.99; Corradini E, 2011, GASTROENTEROLOGY, V141, P1907, DOI 10.1053/j.gastro.2011.06.077; Dang TN, 2011, GLIA, V59, P1540, DOI 10.1002/glia.21198; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025324; Fang YC, 2006, J CEREBR BLOOD F MET, V26, P491, DOI 10.1038/sj.jcbfm.9600205; Fassbender K, 2000, STROKE, V31, P2971, DOI 10.1161/01.STR.31.12.2971; Frontera JA, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/263974; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Kolias AG, 2009, J NEUROSCI RES, V87, P1, DOI 10.1002/jnr.21823; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; Leonard MG, 2011, BRAIN RES, V1420, P48, DOI 10.1016/j.brainres.2011.08.075; Li MX, 2012, FEBS LETT, V586, P3888, DOI 10.1016/j.febslet.2012.08.036; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Lin CL, 2004, CURR MED CHEM, V11, P1779, DOI 10.2174/0929867043364919; Luo JH, 2010, J ALZHEIMERS DIS, V21, P887, DOI 10.3233/JAD-2010-091486; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; Madden JA, 2012, NEUROLOGY, V79, pS58, DOI 10.1212/WNL.0b013e3182695836; Masaki T, 2004, TRENDS PHARMACOL SCI, V25, P219, DOI 10.1016/j.tips.2004.02.008; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; Mecca AP, 2011, EXP PHYSIOL, V96, P1084, DOI 10.1113/expphysiol.2011.058578; Moldes O, 2008, STROKE, V39, P2006, DOI 10.1161/STROKEAHA.107.495044; Moldes O, 2012, NEUROPHARMACOLOGY, V63, P1279, DOI 10.1016/j.neuropharm.2012.08.019; Neuschmelting V, 2009, ACTA NEUROCHIR, V151, P795, DOI 10.1007/s00701-009-0350-1; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Nishizawa S, 2005, TRENDS CARDIOVAS MED, V15, P24, DOI 10.1016/j.tcm.2004.12.002; Nishizawa S, 2000, ACTA NEUROCHIR, V142, P1409, DOI 10.1007/s007010070013; Olmez I, 2012, NEUROCHEM INT, V60, P208, DOI 10.1016/j.neuint.2011.11.009; Palmer JC, 2012, J ALZHEIMERS DIS, V29, P853, DOI 10.3233/JAD-2012-111760; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/Y09-022, 10.1139/y09-022]; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Pisarcik S, 2013, AM J PHYSIOL-LUNG C, V304, pL549, DOI 10.1152/ajplung.00081.2012; Pluta R.M., 1997, J NEUROSURG, V87; Prass K, 2002, J CEREBR BLOOD F MET, V22, P520, DOI 10.1097/00004647-200205000-00003; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Rikimaru T, 2009, BIOMED RES-TOKYO, V30, P349, DOI 10.2220/biomedres.30.349; ROUX S, 1995, NEUROSURGERY, V37, P78, DOI 10.1227/00006123-199507000-00012; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; SCHRAMEK H, 1994, KIDNEY INT, V46, P1644, DOI 10.1038/ki.1994.464; Sehba FA, 2013, ACTA NEUROCHIR SUPPL, V115, P199, DOI 10.1007/978-3-7091-1192-5_37; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Spektor G, 2005, NAT CLIN PRACT CARD, V2, P290, DOI 10.1038/ncpcardio0214; Stankova J, 1996, AM J PHYSIOL-CELL PH, V271, pC1073, DOI 10.1152/ajpcell.1996.271.4.C1073; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; Sugiyama T, 2004, J CARDIOVASC PHARM, V44, pS332, DOI 10.1097/01.fjc.0000166267.17174.0e; SUZUKI R, 1992, J NEUROSURG, V77, P96, DOI 10.3171/jns.1992.77.1.0096; Tassoni D, 2008, ASIA PAC J CLIN NUTR, V17, P220; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wei SG, 2014, REJUV RES, V17, P19, DOI 10.1089/rej.2013.1450; Wengenmayer C, 2011, NEUROL RES, V33, P201, DOI 10.1179/016164111X12881719352534; Wickman G, 2003, CIRC RES, V92, P809, DOI 10.1161/01.RES.0000066663.12256.B2; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zumerle S, 2014, BLOOD, V123, P3646, DOI 10.1182/blood-2014-01-550467	74	10	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 7	2014	1588						25	36		10.1016/j.brainres.2014.09.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2SX	WOS:000345468900003	25230250				2022-02-06	
J	Kim, HY				Kim, Hee-Yong			Neuroprotection by Docosahexaenoic Acid in Brain Injury	MILITARY MEDICINE			English	Article							N-3 FATTY-ACIDS; TRAUMATIC AXONAL INJURY; ALZHEIMERS-DISEASE; PEROXISOMAL DISORDERS; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; LEARNING-ABILITY; OXIDATIVE STRESS; LIPID MEDIATORS; RAT HIPPOCAMPUS	Docosahexaenoic acid (DHA, 22:6 n-3) is an omega-3 polyunsaturated fatty acid highly enriched in the brain and is recognized as an essential nutrient for proper development of brain function. Common brain injuries often cause lifelong neurological and cognitive impairments, especially in learning and memory. Optimizing the nutritional DHA status in neural tissues may allow significantly improved resilience for the central nervous system to injury and optimized recovery. This article discusses neuroprotective effects of DHA, which are potentially important for improving injury outcome, thus reducing the risk of lifelong neurological impairment associated with brain injury.	NIAAA, Lab Mol Signaling, DICBR, NIH, Bethesda, MD 20892 USA		Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, DICBR, NIH, Bethesda, MD 20892 USA.				Intramural Research Program of the National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000501] Funding Source: NIH RePORTER	The author thanks Dr. Arthur Spector and Ms. Lori Flax Levin for editorial assistance. This work was supported by the Intramural Research Program of the National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health.	Abedin L, 1999, LIPIDS, V34, P475, DOI 10.1007/s11745-999-0387-3; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Akbar M, 2002, J NEUROCHEM, V82, P655, DOI 10.1046/j.1471-4159.2002.01015.x; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bas O, 2007, NEUROCHEM INT, V50, P548, DOI 10.1016/j.neuint.2006.11.005; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; Cao DH, 2007, J NUTR BIOCHEM, V18, P297, DOI 10.1016/j.jnutbio.2006.05.005; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Cao DH, 2006, J NUTR BIOCHEM, V17, P234, DOI 10.1016/j.jnutbio.2005.04.006; Cao DH, 2004, PHARMACOL BIOCHEM BE, V79, P651, DOI 10.1016/j.pbb.2004.09.016; Catalan J, 2002, BEHAV NEUROSCI, V116, P1022, DOI 10.1037//0735-7044.116.6.1022; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; DAVIS S, 1992, J NEUROSCI, V12, P21; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Gamoh S, 1999, NEUROSCIENCE, V93, P237, DOI 10.1016/S0306-4522(99)00107-4; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Hamilton J, 2000, LIPIDS, V35, P863, DOI 10.1007/S11745-000-0595-x; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Improta-Brears T, 1999, MOL CELL BIOCHEM, V198, P171, DOI 10.1023/A:1006981411691; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kim HY, 2013, PROSTAG LEUKOTR ESS, V88, P121, DOI 10.1016/j.plefa.2012.08.002; Kim HY, 2011, PROSTAG OTH LIPID M, V96, P114, DOI 10.1016/j.prostaglandins.2011.07.002; Kim HY, 2011, BIOCHEM J, V435, P327, DOI 10.1042/BJ20102118; Kim HY, 2010, PROSTAG LEUKOTR ESS, V82, P165, DOI 10.1016/j.plefa.2010.02.025; Kim HY, 2004, BIOCHEMISTRY-US, V43, P1030, DOI 10.1021/bi035197x; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; Kim HY, 2003, LIPIDS, V38, P453, DOI 10.1007/s11745-003-1083-z; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Kothapalli KSD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000370; Leaf A, 2005, J MEMBRANE BIOL, V206, P129, DOI 10.1007/s00232-005-0789-9; Leaf A, 2002, PROSTAG LEUKOTR ESS, V67, P113, DOI 10.1054/plef.2002.0407; Lim SY, 2005, PEDIATR RES, V58, P741, DOI 10.1203/01.PDR.0000180547.46725.CC; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Martinez JL, 1996, ANNU REV PSYCHOL, V47, P173, DOI 10.1146/annurev.psych.47.1.173; MARTINEZ M, 1990, NEUROLOGY, V40, P1292, DOI 10.1212/WNL.40.8.1292; Martinez M, 2000, AM J CLIN NUTR, V71, p376S, DOI 10.1093/ajcn/71.1.376s; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murthy M, 2002, J LIPID RES, V43, P611; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okada M, 1996, NEUROSCIENCE, V71, P17, DOI 10.1016/0306-4522(95)00427-0; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; RELTON JK, 1993, BRAIN RES BULL, V32, P223, DOI 10.1016/0361-9230(93)90180-J; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; UMEMURA K, 1995, THROMB RES, V78, P379, DOI 10.1016/0049-3848(95)00071-X; Willatts P, 1998, LANCET, V352, P688, DOI 10.1016/S0140-6736(97)11374-5; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313	73	10	10	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11		S			106	111		10.7205/MILMED-D-14-00162			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7LS	WOS:000349099400008	25373093	Bronze			2022-02-06	
J	Beier, AD; Dirks, PB				Beier, Alexandra D.; Dirks, Peter B.			Pediatric brainstem hemorrhages after traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						Duret hemorrhage; brainstem hemorrhage; decompressive craniectomy; traumatic brain injury; trauma	DURET HEMORRHAGE; DECOMPRESSIVE CRANIECTOMY; SUBDURAL HEMATOMA; HERNIATION; PROGNOSIS; RECOVERY; SURVIVAL; CHILDREN; LESIONS	Traumatic brain injuries afflict a large number of pediatric patients. The most severe injuries lead to increased intracranial pressure and herniation, with resultant changes in the brainstem. Traumatic brainstem hemorrhages have previously been associated with poor neurological outcome and fatality. However, this report discusses 2 pediatric patients who sustained severe head trauma with subsequent brainstem hemorrhages, and yet experienced good neurological outcome; the possible mechanism is described.	[Beier, Alexandra D.] Univ Florida Hlth, Div Pediat Neurol Surg, Jacksonville, FL USA; [Dirks, Peter B.] Univ Toronto, Hosp Sick Children, Dept Surg, Div Neurosurg, Toronto, ON M5S 1A1, Canada		Beier, AD (corresponding author), Wolfson Childrens Hosp, Lucy Gooding Pediat Neurol Surg Ctr, Div Pediat Neurol Surg, 836 Prudential Dr,Ste 1205, Jacksonville, FL 32207 USA.	alexandra.beier@jax.ufl.edu					CAPLAN LR, 1977, ANN NEUROL, V1, P587, DOI 10.1002/ana.410010613; FREEDMAN H, 1952, J NEUROSURG, V9, P52, DOI 10.3171/jns.1952.9.1.0052; Fujimoto Y, 2000, NEUROL MED-CHIR, V40, P508, DOI 10.2176/nmc.40.508; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Jacob AT, 2011, PEDIATR NEUROSURG, V47, P81, DOI 10.1159/000329624; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kamijo Y, 2005, AM J EMERG MED, V23, P908, DOI 10.1016/j.ajem.2005.07.014; KLINTWOR.GK, 1965, AM J PATHOL, V47, P525; Lonjaret L, 2012, J CLIN NEUROSCI, V19, P1293, DOI 10.1016/j.jocn.2012.01.014; Marion DW, 2006, NEUROSURGERY, V58, P655; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Park KJ, 2009, NEUROL MED-CHIR, V49, P594, DOI 10.2176/nmc.49.594; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z; Zhao H, 2009, CHIN J TRAUMATOL, V12, P296, DOI 10.3760/cma.j.issn.1008-1275.2009.05.008	15	10	10	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2014	14	4					421	424		10.3171/2014.7.PEDS13376			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AQ7CN	WOS:000342970300015	25105513				2022-02-06	
J	Bower, J; Catroppa, C; Grocke, D; Shoemark, H				Bower, Janeen; Catroppa, Cathy; Grocke, Denise; Shoemark, Helen			Music therapy for early cognitive rehabilitation post-childhood TBI: An intrinsic mixed methods case study	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Case study; familiar song; mixed method; music therapy; post-traumatic amnesia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MINIMALLY CONSCIOUS STATE; AGITATED BEHAVIOR SCALE; CLOSED-HEAD INJURY; OF-THE-LITERATURE; POSTTRAUMATIC AMNESIA; RECOVERY; PATIENT	Objective: The primary aim of this case study was to explore the behavioural changes of a paediatric patient in post-traumatic amnesia (PTA) during a music therapy session. A secondary objective was to measure the effect of the music therapy intervention on agitation. Method: Video data from pre, during and post-music therapy sessions were collected and analysed using video micro-analysis and the Agitated Behaviour Scale. Results: The participant displayed four discrete categories of behaviours: Neutral, Acceptance, Recruitment and Rejection. Further analysis revealed brief but consistent and repeated periods of awareness and responsiveness to the live singing of familiar songs, which were classified as Islands of Awareness. Song offered an Environment of Potential to maximise these periods of emerging consciousness. The quantitative data analysis yielded in conclusive results in determining if music therapy was effective in reducing agitation during and immediately post the music therapy sessions. Conclusion: The process of micro-analysis illuminated four discrete participant behaviours not apparent in the immediate clinical setting. The results of this case suggest that the use of familiar song as a music therapy intervention may harness early patient responsiveness to foster cognitive rehabilitation in the early acute phase post-TBI.	[Bower, Janeen; Shoemark, Helen] Royal Childrens Hosp Melbourne, Music Therapy Dept, Parkville, Vic 3052, Australia; [Catroppa, Cathy; Shoemark, Helen] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Shoemark, Helen] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Catroppa, Cathy] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Grocke, Denise] Univ Melbourne, Melbourne, Vic, Australia		Bower, J (corresponding author), Royal Childrens Hosp Melbourne, Music Therapy Dept, Flemington Rd, Parkville, Vic 3052, Australia.	janeen.bower@rch.org.au	Catroppa, Cathy/AAX-9458-2021; Shoemark, Helen/AAN-5761-2021	Catroppa, Cathy/0000-0002-9750-0436; Shoemark, Helen/0000-0001-5038-9374			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Ahmed S, 2000, BRAIN INJURY, V14, P765; [Anonymous], 2007, BRAIN INJ POST TRAUM; [Anonymous], 1995, OV TRAUM BRAIN INJ; Ashwal Stephen, 2002, Semin Pediatr Neurol, V9, P19, DOI 10.1053/spen.2002.30334; Baker F, 2009, MANAGING BEHAV SONG; Baker F, 1999, THESIS U MELBOURNE M; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bradt J., 2005, MED MUSIC THERAPY ME; CORRIGAN JD, 1995, NEUROREHABILITATION, V5, P205, DOI 10.3233/NRE-1995-5303; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Corrigan JD, 1988, ARCH PHYS MED REHAB, V69, P489; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Gelling L, 2003, J CLIN NURS, V12, P394; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gilbertson S., 2009, MUSIC MED, V1, P129; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; Kaitz ES, 2006, ARCH PHYS MED REHAB, V87, pE3; Kennelly J, 1997, AUSTR J MUSIC THERAP, V8, P18; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Levy M, 2005, NEUROREHABILITATION, V20, P279; Magee WL, 2011, MUSIC THER PERSPECT, V29, P5, DOI 10.1093/mtp/29.1.5; Magee WL, 2005, NEUROPSYCHOL REHABIL, V15, P522, DOI 10.1080/09602010443000461; Morse JM, 2002, INT J QUAL METH, V1, P13, DOI DOI 10.1177/160940690200100202; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; Rosenfeld JV, 1999, MUSICMEDICINE 3 EXPA, V3, P35; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SANDEL ME, 1995, NEUROREHABILITATION, V5, P299, DOI 10.3233/NRE-1995-5404; Schiff ND, 2005, PROG BRAIN RES, V150, P473, DOI 10.1016/S0079-6123(05)50033-5; Shoemark H., 2012, MUSIC MED, V4, P146, DOI [10.1177/1943862112442227, DOI 10.1177/1943862112442227]; Shoemark H, 2010, J MUSIC THER, V47, P306, DOI 10.1093/jmt/47.4.306; SNOW JH, 1994, PEDIAT TRAUMATIC BRA; Stake R., 1995, ART CASE STUDY RES; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Turkstra LS, 2003, ARCH PHYS MED REHAB, V84, P604, DOI 10.1053/apmr.2003.50146; World Health Organisation, 2006, NEUR DIS PUBL HLTH C	46	10	10	1	38	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	OCT	2014	17	5					339	346		10.3109/17518423.2013.778910			8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	AP0SS	WOS:000341774900006	23815784				2022-02-06	
J	French, LM; Lange, RT; Marshall, K; Prokhorenko, O; Brickell, TA; Bailie, JM; Asmussen, SB; Ivins, B; Cooper, DB; Kennedy, JE				French, Louis M.; Lange, Rael T.; Marshall, Kathryn; Prokhorenko, Olga; Brickell, Tracey A.; Bailie, Jason M.; Asmussen, Sarah B.; Ivins, Brian; Cooper, Douglas B.; Kennedy, Jan E.			Influence of the Severity and Location of Bodily Injuries on Post-Concussive and Combat Stress Symptom Reporting after Military-Related Concurrent Mild Traumatic Brain Injuries and Polytrauma	JOURNAL OF NEUROTRAUMA			English	Article						bodily injury; postconcussion symptoms; service members; traumatic stress symptoms; uncomplicated mild traumatic brain injury	POSTTRAUMATIC-STRESS; POSTCONCUSSIVE SYMPTOMS; SERVICE MEMBERS; HEALTH; US; DISORDER; OUTCOMES; PAIN; DISFIGUREMENT; DISTRESS	Traumatic brain injuries (TBI) sustained in combat frequently co-occur with significant bodily injuries. Intuitively, more extensive bodily injuries might be associated with increased symptom reporting. In 2012, however, French et al. demonstrated an inverse relation between bodily injury severity and symptom reporting. This study expands on that work by examining the influence of location and severity of bodily injuries on symptom reporting after mild TBI. Participants were 579 US military service members who sustained an uncomplicated mild TBI with concurrent bodily injuries and who were evaluated at two military medical centers. Bodily injury severity was quantified using a modified Injury Severity Score (ISSmod). Participants completed the Neurobehavioral Symptom Inventory (NSI) and the Posttraumatic Stress Disorder Checklist (PCL-C), on average, 2.5 months post-injury. There was a significant negative association between ISSmod scores and NSI (r= -0.267, p < 0.001) and PCL-C (r= -0.273, p < 0.001) total scores. Using linear regression to examine the relation between symptom reporting and injury severity across the six ISS body regions, three body regions were significant predictors of the NSI total score (face; p < 0.001; abdomen; p = 0.003; extremities; p < 0.001) and accounted for 9.3% of the variance (p < 0.001). For the PCL-C, two body regions were significant predictors of the PCL-C total score (face; p < 0.001; extremities; p < 0.001) and accounted for 10.5% of the variance. There was an inverse relation between bodily injury severity and symptom reporting in this sample. Hypothesized explanations include underreporting of symptoms, increased peer support, disruption of fear conditioning because of acute morphine use, or delayed expression of symptoms.	[French, Louis M.; Lange, Rael T.; Marshall, Kathryn; Prokhorenko, Olga; Brickell, Tracey A.; Bailie, Jason M.; Asmussen, Sarah B.; Ivins, Brian; Cooper, Douglas B.; Kennedy, Jan E.] Def & Vet Brain Injury Ctr, Bethesda, MD 20814 USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Marshall, Kathryn; Cooper, Douglas B.; Kennedy, Jan E.] San Antonio Mil Med Ctr, San Antonio, TX USA; [Bailie, Jason M.] San Diego Naval Med Ctr, San Diego, CA USA; [Asmussen, Sarah B.] Marine Corps Base Camp Pendleton, Camp Pendleton, CA USA		Lange, RT (corresponding author), Def & Vet Brain Injury Ctr, Walter Reed Natl Mil Med Ctr, Bldg 8,Room 2264 8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rael.t.lange@us.army.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benner C, 2014, J UROLOGY, V191, P937, DOI 10.1016/j.juro.2013.10.101; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Camacho A.A., 2013, PALLIAT SUPPORT CARE, P1; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Castillo RC, 2013, J TRAUMA ACUTE CARE, V74, P1534, DOI 10.1097/TA.0b013e3182921606; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Frappell-Cooke W, 2013, J ROY ARMY MED CORPS, V159, P52, DOI 10.1136/jramc-2013-000028; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Fu L, 2011, EYE, V25, P1322, DOI 10.1038/eye.2011.158; Gosselin N, 2012, J NEUROTRAUM, V29, P2625, DOI 10.1089/neu.2012.2312; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Lange RT, 2011, NATO SCI PEACE SEC, V86, P171, DOI 10.3233/978-1-60750-797-0-171; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Melcer T, 2013, J TRAUMA ACUTE CARE, V75, pS247, DOI 10.1097/TA.0b013e318299d95e; Melcer T, 2010, MIL MED, V175, P147, DOI 10.7205/MILMED-D-09-00120; Messinger SD, 2009, DISABIL REHABIL, V31, P2130, DOI [10.3109/09638280902943223a, 10.3109/09638280902943223]; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pasquina PF, 2008, J REHABIL RES DEV, V45, P953, DOI 10.1682/JRRD.2007.10.0163; Rauh MJ, 2013, J REHABIL RES DEV, V50, P161, DOI 10.1682/JRRD.2011.11.0212; Rogan C, 2013, NEUROPSYCHOL REHABIL, V23, P639, DOI 10.1080/09602011.2013.799076; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Stein MB, 2005, MED CARE, V43, P1164, DOI 10.1097/01.mlr.0000185750.18119.fd; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; United States Department of Defense, 2013, US CAS STAT; van den Elzen MEP, 2012, J CRANIO MAXILL SURG, V40, P777, DOI 10.1016/j.jcms.2012.02.010; WARDEN DL, 2005, TXB TRAUMATIC BRAIN, P231; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Williams M, 2013, NAT REV UROL, V10, P504, DOI 10.1038/nrurol.2013.148; World Health Organization, 2004, ICD 10 INT STAT CLAS; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	50	10	10	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2014	31	19					1607	1616		10.1089/neu.2014.3401			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AP5VI	WOS:000342146400002	24831890				2022-02-06	
J	Moles, RL; Asnes, AG				Moles, Rebecca L.; Asnes, Andrea G.			Has This Child Been Abused? Exploring Uncertainty in the Diagnosis of Maltreatment	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Child abuse; Physical abuse; Sexual abuse; Uncertainty; Bias; Child protective services	TRAUMATIC BRAIN-INJURY; ABUSIVE HEAD TRAUMA; SEXUAL-ABUSE; PHYSICAL ABUSE; GENITAL FINDINGS; YOUNG-CHILDREN; FRACTURES; RISK; ADMISSIONS; INFANTS	Uncertainty in the diagnosis of abuse can have profound implications for the health and safety of the child, the emotional burden of a family, and investigative and criminal proceedings. A logical algorithm for addressing physical and sexual abuse cases that details aspects contributing to the uncertainty may aid the clinician in making a diagnosis and in communicating the crucial details to the relevant investigative agencies. This article defines and discusses uncertainty in the realms of physical and sexual abuse, and suggests an approach to managing uncertainty while still providing valuable information for the medical and child protective service systems.	[Moles, Rebecca L.; Asnes, Andrea G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA		Moles, RL (corresponding author), Yale Univ, Sch Med, Dept Pediat, POB 208064, New Haven, CT 06510 USA.	Rebecca.Moles@yale.edu					Adams J A, 2001, Child Maltreat, V6, P31, DOI 10.1177/1077559501006001003; ADAMS JA, 1993, CHILD ABUSE NEGLECT, V17, P663, DOI 10.1016/0145-2134(93)90087-L; Adams JA, 1996, ARCH PEDIAT ADOL MED, V150, P850, DOI 10.1001/archpedi.1996.02170330076013; ADAMS JA, 1994, PEDIATRICS, V94, P310; Adams JA, 2011, J CHILD SEX ABUS, V20, P588, DOI 10.1080/10538712.2011.606107; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Appleyard K, 2007, SUPPORTING HLTH RELA; BERESFORD EB, 1991, HASTINGS CENT REP, V21, P6, DOI 10.2307/3562993; Berkowitz SJ, 2011, J CHILD PSYCHOL PSYC, V52, P676, DOI 10.1111/j.1469-7610.2010.02321.x; Biron DL, 2007, J PAEDIATR CHILD H, V43, P60, DOI 10.1111/j.1440-1754.2007.01004.x; Coulton CJ, 2007, CHILD ABUSE NEGLECT, V31, P1117, DOI 10.1016/j.chiabu.2007.03.023; Ertem IO, 2000, LANCET, V356, P814, DOI 10.1016/S0140-6736(00)02656-8; Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311; Flaherty EG, 2014, PEDIATRICS, V133, pE477, DOI 10.1542/peds.2013-3793; Fortin K, 2012, PEDIATR REV, V33, P19, DOI 10.1542/pir.33-1-19; Friedrich W N, 2001, Child Maltreat, V6, P37, DOI 10.1177/1077559501006001004; Ghosh A K, 2004, J Assoc Physicians India, V52, P739; Ghosh Amit K, 2004, Minn Med, V87, P48; Govindshenoy M, 2007, CHILD CARE HLTH DEV, V33, P552, DOI 10.1111/j.1365-2214.2006.00693.x; Grant P, 2001, PEDIATRICS, V108, P1009, DOI 10.1542/peds.108.4.1009; GUYAT GH, 1993, JAMA-J AM MED ASSOC, V270, P2096, DOI 10.1001/jama.270.17.2096; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Jenny C, 2013, PEDIATRICS, V132, pE558, DOI 10.1542/peds.2013-1741; LADSON S, 1987, AM J DIS CHILD, V141, P411, DOI 10.1001/archpedi.1987.04460040069016; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Mannarino AP, 2012, CHILD MALTREATMENT, V17, P231, DOI 10.1177/1077559512451787; MCCANN J, 1990, PEDIATR CLIN N AM, V37, P863; MCCANN J, 1988, AM J DIS CHILD, V142, P659, DOI 10.1001/archpedi.1988.02150060093040; MCCANN J, 1992, PEDIATRICS, V89, P307; MCCANN J, 1993, PEDIATRICS, V91, P390; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; Rumm PD, 2000, CHILD ABUSE NEGLECT, V24, P1375, DOI 10.1016/S0145-2134(00)00192-7; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STIER DM, 1993, PEDIATRICS, V91, P642; THOMAS SA, 1991, PEDIATRICS, V88, P471; US Department of Health and Human Services, 2013, CHILD MALTR 2012	39	10	10	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	OCT	2014	61	5					1023	+		10.1016/j.pcl.2014.06.009			16	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	AR1VG	WOS:000343372100014	25242713				2022-02-06	
J	Tazoe, J; Yamada, K; Sakai, K; Akazawa, K; Mineura, K				Tazoe, Jun; Yamada, Kei; Sakai, Koji; Akazawa, Kentaro; Mineura, Katsuyoshi			Brain core temperature of patients with mild traumatic brain injury as assessed by DWI-thermometry	NEURORADIOLOGY			English	Article						MRI; Brain; Diffusion-weighted imaging; Lateral ventricular temperature; Mild traumatic brain injury	DIFFUSION; HYPOTHERMIA; METABOLISM; STROKE; FLUID	Introduction The aim of this study was to assess the brain core temperature of patients with mild traumatic brain injury (mTBI) using a noninvasive temperature measurement technique based on the diffusion coefficient of the cerebrospinal fluid. Methods This retrospective study used the data collected from April 2008 to June 2011. The patient group comprised 20 patients with a Glasgow Coma Scale score of 14 or 15 who underwent magnetic resonance imaging within 30 days after head trauma. The normal control group comprised 14 subjects who volunteered for a brain checkup (known in Japan as "brain dock"). We compared lateral ventricular (LV) temperature between patient and control groups. Follow-up studies were performed for four patients. Results LV temperature measurements were successfully performed for both patients and controls. Mean (+/- standard deviation) measured LV temperature was 36.9+/-1.5 degrees C in patients, 38.7+/- 1.8 degrees C in follow-ups, and 37.9+/- 1.2 degrees C in controls, showing a significant difference between patients and controls (P=0.017). However, no significant difference was evident between patients and follow-ups (P=0.595) or between follow- ups and controls (P=0.465). Conclusions A reduction in brain core temperature was observed in patients with mTBI, possibly due to a global decrease in metabolism.	[Tazoe, Jun; Yamada, Kei; Akazawa, Kentaro] Kyoto Prefectural Univ Med, Dept Radiol, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan; [Sakai, Koji] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Mineura, Katsuyoshi] Kyoto Prefectural Univ Med, Dept Neurosurg, Grad Sch Med Sci, Kyoto 6028566, Japan		Tazoe, J (corresponding author), Kyoto Prefectural Univ Med, Dept Radiol, Grad Sch Med Sci, Kamigyo Ku, Kajii Cho, Kyoto 6028566, Japan.	tazoe@koto.kpu-m.ac.jp	Yamada, Kei/AAY-8398-2020	Sakai, Koji/0000-0002-9348-0829			Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bertolizio G, 2011, PEDIATR ANESTH, V21, P347, DOI 10.1111/j.1460-9592.2011.03542.x; Ciccarelli O, 2010, J NEUROSCI, V30, P15030, DOI 10.1523/JNEUROSCI.3330-10.2010; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Corbett RJT, 1999, AM J NEURORADIOL, V20, P1851; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hasan KM, 2014, MAGN RESON IMAGING, V32, P405, DOI 10.1016/j.mri.2014.01.014; Hayashi N, 2004, BRAIN HYPOTHERMIA TR, P57; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kozak LR, 2010, ACTA PAEDIATR, V99, P237, DOI 10.1111/j.1651-2227.2009.01528.x; Kuo JR, 2011, J CLIN NEUROSCI, V18, P1059, DOI 10.1016/j.jocn.2010.11.014; Kuroda Kagayaki, 2003, Magn Reson Med Sci, V2, P17, DOI 10.2463/mrms.2.17; Leroy Y, 1998, PHYSIOL MEAS, V19, P127, DOI 10.1088/0967-3334/19/2/001; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Sai A, 2014, J MAGN RESON IMAGING, V40, P649, DOI 10.1002/jmri.24396; Sakai K, 2013, IEEE ENG MED BIO, P499, DOI 10.1109/EMBC.2013.6609546; Sakai K, 2012, NMR BIOMED, V25, P340, DOI 10.1002/nbm.1755; Sakai K, 2011, NMR BIOMED, V24, P1063, DOI 10.1002/nbm.1656; Shima H, 2003, J NEUROTRAUM, V20, P1179, DOI 10.1089/089771503770802862; SHIRAKI K, 1988, J APPL PHYSIOL, V65, P482, DOI 10.1152/jappl.1988.65.1.482; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Yamada K, 2010, NEUROREPORT, V21, P851, DOI 10.1097/WNR.0b013e32833d6b7a; Zweifler RM, 2004, J NEUROSURG ANESTH, V16, P232, DOI 10.1097/00008506-200407000-00008	36	10	10	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	OCT	2014	56	10					809	815		10.1007/s00234-014-1384-5			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS5ZZ	WOS:000344346100001	25015424	Green Published, hybrid			2022-02-06	
J	Topjian, AA; Stuart, A; Pabalan, AA; Clair, A; Kilbaugh, TJ; Abend, NS; Berg, RA; Heuer, GG; Storm, PB; Huh, JW; Friess, SH				Topjian, Alexis A.; Stuart, Amber; Pabalan, Alyssa A.; Clair, Ashleigh; Kilbaugh, Todd J.; Abend, Nicholas S.; Berg, Robert A.; Heuer, Gregory G.; Storm, Phillip B., Jr.; Huh, Jimmy W.; Friess, Stuart H.			Risk Factors Associated with Infections and Need for Permanent Cerebrospinal Fluid Diversion in Pediatric Intensive Care Patients with Externalized Ventricular Drains	NEUROCRITICAL CARE			English	Article						Externalized ventricular drain; Ventricular catheter infection; Pediatric intensive care unit; Neurocritical care; Ventriculoperitoneal shunt; Pediatric	TRAUMATIC BRAIN-INJURY; ANTIBIOTIC-PROPHYLAXIS; NEUROSURGICAL PATIENTS; NEUROCRITICAL CARE; DOUBLE-BLIND; CHILDREN	Externalized ventricular drains (EVDs) are commonly used in pediatric intensive care units (PICU) but few data are available regarding infection rates, infection risks, or factors associated with conversion to permanent cerebrospinal fluid (CSF) diversion. Retrospective observational study of patients managed with EVDs admitted to a tertiary care PICU from January 2005 to December 2009. Three hundred eighty patients were identified. Neurologic diagnostic groups were externalization of existing shunt in 196 patients (52 %), brain tumor in 122 patients (32 %), intracranial hemorrhage in 23 patients (6 %), traumatic brain injury in 17 patients (5 %), meningitis in 9 patients (2 %), or other in 13 patients (3 %). Six percent of all patients (24/380) had new infections associated with EVD management for an infection rate of 8.6 per 1,000 catheter days. The median time to positive cultures was 7 days (interquartile range 4.75, 9) after EVD placement. Patients with EVD infections had significantly longer EVD duration 6 versus 11.5 days (p = 0.0001), and higher maximum EVD outputs 1.9 versus 1.5 mL/kg/h (p = 0.0017). Need for permanent CSF diversion was associated with higher maximum EVD drainage (1.3 vs. 1.6 mL/kg/h p < 0.0001), longer EVD duration (5 vs. 4 days, p < 0.005), and younger age (4.5 vs. 8 years, p < 0.02) but not intracranial hypertension (72 vs. 82 % of patients, p = 0.4). In our large pediatric cohort, EVD infections were associated with longer EVD duration and higher maximum EVD output. Permanent CSF diversion was more likely in patients with higher maximum EVD drainage, longer EVD duration, and younger age.	[Topjian, Alexis A.; Stuart, Amber; Pabalan, Alyssa A.; Clair, Ashleigh; Kilbaugh, Todd J.; Berg, Robert A.; Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA; [Topjian, Alexis A.; Kilbaugh, Todd J.; Berg, Robert A.; Huh, Jimmy W.] Univ Penn, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA; [Abend, Nicholas S.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Abend, Nicholas S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Abend, Nicholas S.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Heuer, Gregory G.; Storm, Phillip B., Jr.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Heuer, Gregory G.; Storm, Phillip B., Jr.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Friess, Stuart H.] Washington Univ, Sch Med St Louis, Dept Pediat, St Louis, MO 63110 USA		Friess, SH (corresponding author), Washington Univ, Sch Med St Louis, Dept Pediat, Campus Box 8028,5th Floor MPRB,660 S Euclid Ave, St Louis, MO 63110 USA.	Friess_S@kids.wustl.edu		Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23-NS075363, K23-NS076550, RO1-HD061963, K08-NS064051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS075363, K08NS064051, K23NS076550] Funding Source: NIH RePORTER	Supported by NIH K23-NS075363 (AAT), K23-NS076550 (NSA), RO1-HD061963 (JWH), and K08-NS064051 (SHF).	AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; BLOMSTEDT GC, 1985, J NEUROSURG, V62, P694, DOI 10.3171/jns.1985.62.5.0694; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Khalil BA, 2005, CHILD NERV SYST, V21, P355, DOI 10.1007/s00381-004-1080-6; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; LaRovere KL, 2013, PEDIATR NEUROL, V48, P206, DOI 10.1016/j.pediatrneurol.2012.12.006; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Miller C, 2008, NEUROCRIT CARE, V8, P235, DOI 10.1007/s12028-007-9018-y; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Poon WS, 1998, ACT NEUR S, V71, P146; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Sonabend AM, 2011, NEUROSURGERY, V68, P996, DOI 10.1227/NEU.0b013e3182096d84; Walker CT, 2012, PEDIATR NEUROSURG, V48, P342, DOI 10.1159/000353608; Wong GKC, 2006, J CLIN PHARM THER, V31, P231, DOI 10.1111/j.1365-2710.2006.00729.x; WYLER AR, 1972, J NEUROSURG, V37, P185, DOI 10.3171/jns.1972.37.2.0185	22	10	11	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					294	299		10.1007/s12028-013-9946-7			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900017	24522759	Green Accepted			2022-02-06	
J	Wylie, MC; Merritt, C; Clark, M; Garro, AC; Rutman, MS				Wylie, Matthew C.; Merritt, Chris; Clark, Melissa; Garro, Aris C.; Rutman, Maia S.			Imaging of Pediatric Head Injury in the Emergency Department	PEDIATRIC EMERGENCY CARE			English	Article						head injury; traumatic brain injury; computed tomography; magnetic resonance imaging	FAST SPIN-ECHO; COMPUTED-TOMOGRAPHY; ALARA CONCEPT; CT SCANS; BRAIN; PREDICTION; CHILDREN; IMPACT; RULE	Objectives: Computed tomography (CT) is the standard for immediate imaging of head-injured children, but it uses radiation that predisposes to malignancy. The study goals were to describe imaging practices in this population and to identify barriers to rapid magnetic resonance imaging (MRI) use. Methods: A cross-sectional survey of physicians who care for pediatric patients in emergency departments was conducted. Survey questions included hospital characteristics, access to imaging technology, use of imaging studies, and use of radiation reduction practices. Results: A total of 459 eligible respondents completed the questionnaire, which represented a response rate of 24.1%. Almost all the respondents (97.7%) reported that radiation concerns influence clinical management of children and adolescents with head trauma. Head CT use was more frequently reported than MRI (55.3% vs 1.5% reported use in more than 10% of patients, respectively). Frequent CT use was associated with practice in community hospitals (P = 0.005), whereas pediatric residency training and pediatric volumes greater than 30,000 visits per year were associated with less frequent use (P = 0.015 and P = 0.028, respectively). In 94.5% of the respondents, reported CT was always available compared with 24.3% reporting MRI as always available (P < 0.001). Reported obstacles to MRI as a screening tool for head-injured children included limited scanner availability (93.5%), patient intolerance of MRI (87.2%), and longer acquisition times (83.3%). Conclusions: Concerns about radiation exposure motivate change of practice in the management of head-injured children and adolescents. Head CT use is greater at hospitals with lower pediatric volumes, community hospitals, and by providers without pediatric residency training. Obstacles to increased use of MRI or head-injured children include availability, patient intolerance, and long scan acquisition times.	[Wylie, Matthew C.; Merritt, Chris; Garro, Aris C.] Brown Univ, Hasbro Childrens Hosp, Alpert Sch Med, Sect Pediat Emergency Med,Dept Emergency Med, Providence, RI 02912 USA; [Clark, Melissa] Brown Univ, Dept Epidemiol, Sect Emergency Med, Providence, RI 02912 USA; [Rutman, Maia S.] Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA		Wylie, MC (corresponding author), Brown Univ, Dept Publ Hlth, 45 Prospect St, Providence, RI 02912 USA.	wyliematt@gmail.com			University Emergency Medicine Foundation, Providence, RI	Financial support: Stipend from the University Emergency Medicine Foundation, Providence, RI.	Ba-Ssalamah A, 2000, MAGN RESON IMAGING, V18, P237, DOI 10.1016/S0730-725X(99)00140-X; Broder J, 2007, EMERG RADIOL, V14, P227, DOI 10.1007/s10140-007-0618-9; Callahan Michael J, 2011, Pediatr Radiol, V41 Suppl 2, P488, DOI 10.1007/s00247-011-2099-y; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Engelbrecht V, 1996, PEDIATR RADIOL, V26, P259, DOI 10.1007/BF01372107; Faul M, 2010, TRAUMATIC BRAIN INJU; Frush DP, 2008, PEDIATR RADIOL, V38, pS629, DOI 10.1007/s00247-008-1006-7; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Harned RK, 2001, PEDIATR RADIOL, V31, P247, DOI 10.1007/s002470100426; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; JONES KM, 1992, RADIOLOGY, V182, P53, DOI 10.1148/radiology.182.1.1727309; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Lemaire C, 2009, J MAGN RESON IMAGING, V30, P649, DOI 10.1002/jmri.21870; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Missios S, 2008, J NEUROS-PEDIATR, V2, P438, DOI 10.3171/PED.2008.2.12.438; Mittal TK, 1999, NEURORADIOLOGY, V41, P480, DOI 10.1007/s002340050787; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Penzkofer AK, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.2.1790509; Research. TAAfPO, 2011, STAND DEF FIN DISP C; Saito JM, 2013, PEDIATRICS, V131, pE37, DOI 10.1542/peds.2012-1665; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Simoni M, 2009, J NEUROTRAUM, V26, pA4; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; Tompane T, 2013, PEDIATRICS, V131, pE45, DOI 10.1542/peds.2012-1228; Willis CE, 2004, PEDIATR RADIOL, V34, pS162, DOI 10.1007/s00247-004-1264-y	29	10	10	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2014	30	10					680	685		10.1097/PEC.0000000000000227			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AR0DZ	WOS:000343238700002	25272077				2022-02-06	
J	Cotrina, ML; Chen, M; Han, XN; Iliff, J; Ren, ZG; Sun, W; Hagemann, T; Goldman, J; Messing, A; Nedergaard, M				Cotrina, Maria Luisa; Chen, Michael; Han, Xiaoning; Iliff, Jeffrey; Ren, Zeguang; Sun, Wei; Hagemann, Tracy; Goldman, James; Messing, Albee; Nedergaard, Maiken			Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease	BRAIN RESEARCH			English	Article						Epilepsy; Glia; Astrocyte; GFAP; Trauma	FIBRILLARY ACIDIC PROTEIN; NEURONAL-ACTIVITY; MURINE MODEL; GFAP; MUTATIONS; DISCHARGES; ACTIVATION; EPILEPSY; PROMOTE; CD44	Alexander disease (AxD) is the only known human pathology caused by mutations in an astrocyte-specific gene, glial fibrillary acidic protein (GFAP). These mutations result in abnormal GFAP accumulations that promote seizures, motor delays and, ultimately, death. The exact contribution of increased, abnormal levels of astrocytic mutant GFAP in the development and progression of the epileptic phenotype is not clear, and we addressed this question using two mouse models of AxD. Comparison of brain seizure activity spontaneously and after traumatic brain injury (TBI), an effective way to trigger seizures, revealed that abnormal GFAP accumulation contributes to anomalous brain activity (increased non-convulsive hyperactivity) but is not a risk factor for the development of epilepsy after TBI. These data highlight the need to further explore the complex and heterogeneous response of astrocytes towards injury and the involvement of GFAP in the progression of AxD. (C) 2014 Elsevier B.V. All rights reserved.	[Cotrina, Maria Luisa; Chen, Michael; Han, Xiaoning; Iliff, Jeffrey; Ren, Zeguang; Sun, Wei; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Translat Neuromed,Div Glial Dis & Therapeut, Rochester, NY 14642 USA; [Hagemann, Tracy; Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Hagemann, Tracy; Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA; [Goldman, James] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA		Cotrina, ML (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Translat Neuromed,Div Glial Dis & Therapeut, 601 Elmwood Aye,Box 645, Rochester, NY 14642 USA.	Marisa_Cotrina@URMC.Rochester.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS42803, NS075177, HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD076892, P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078304, R01NS078167, R01NS075177, P01NS042803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG048769] Funding Source: NIH RePORTER; Novo Nordisk FondenNovo Nordisk Foundation [NNF13OC0004258] Funding Source: researchfish	This work was sponsored by the National Institutes of Health, grant numbers NS42803, NS075177 and HD03352. The authors declare no competing financial interests. We thank Markel Olabarria for his technical assistance with quantification.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Avoli M, 2001, EPILEPSIA, V42, P2, DOI 10.1046/j.1528-1157.2001.042suppl.3002.x; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Erbayat-Altay E, 2007, EPILEPSIA, V48, P1470, DOI 10.1111/j.1528-1167.2007.01110.x; Estrada FS, 2012, NEUROSCI LETT, V514, P51, DOI 10.1016/j.neulet.2012.02.055; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Kang WS, 2008, BRAIN RES, V1228, P208, DOI 10.1016/j.brainres.2008.06.106; Khanlou N, 2009, HUM PATHOL, V40, P1200, DOI 10.1016/j.humpath.2009.02.012; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2003, GLIA, V43, P87, DOI 10.1002/glia.10219; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Motalli R, 1999, J NEUROPHYSIOL, V82, P638, DOI 10.1152/jn.1999.82.2.638; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pressler RM, 2005, J PEDIATR-US, V146, P112, DOI 10.1016/j.jpeds.2004.08.084; PRIDMORE CL, 1993, J CHILD NEUROL, V8, P134, DOI 10.1177/088307389300800205; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosunov AA, 2013, J NEUROSCI, V33, P7439, DOI 10.1523/JNEUROSCI.4506-12.2013; Springer S, 2000, NEUROPEDIATRICS, V31, P86, DOI 10.1055/s-2000-7479; Staley K, 2005, NEUROSCIENTIST, V11, P272, DOI 10.1177/1073858405278239; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Tanaka KF, 2007, GLIA, V55, P617, DOI 10.1002/glia.20486; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Wang LQ, 2011, J NEUROSCI, V31, P2868, DOI 10.1523/JNEUROSCI.3410-10.2011; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	36	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 25	2014	1582						211	219		10.1016/j.brainres.2014.07.029			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR1PM	WOS:000343357100020	25069089	Green Accepted			2022-02-06	
J	Chern, JJ; Sarda, S; Howard, BM; Jea, A; Tubbs, RS; Brahma, B; Wrubel, DM; Reisner, A; Boydston, W				Chern, Joshua J.; Sarda, Samir; Howard, Brian M.; Jea, Andrew; Tubbs, R. Shane; Brahma, Barunashish; Wrubel, David M.; Reisner, Andrew; Boydston, William			Utility of surveillance imaging after minor blunt head trauma	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						hospital readmission; blunt head trauma; return to system; surveillance imaging; pediatrics	GROWING SKULL FRACTURE; BRAIN-INJURY; MANAGEMENT; CHILDREN; DIAGNOSIS	Object. Nonoperative blunt head trauma is a common reason for admission in a pediatric hospital. Adverse events, such as growing skull fracture, are rare, and the incidence of such morbidity is not known. As a result, optimal follow-up care is not clear. Methods. Patients admitted after minor blunt head trauma between May 1, 2009, and April 30, 2013, were identified at a single institution. Demographic, socioeconomic, and clinical characteristics were retrieved from administrative and outpatient databases. Clinical events within the 180-day period following discharge were reviewed and analyzed. These events included emergency department (ED) visits, need for surgical procedures, clinic visits, and surveillance imaging utilization. Associations among these clinical events and potential contributing factors were analyzed using appropriate statistical methods. Results. There were 937 admissions for minor blunt head trauma in the 4-year period. Patients who required surgical interventions during the index admission were excluded. The average age of the admitted patients was 5.53 years, and the average length of stay was 1.7 days; 15.7% of patients were admitted for concussion symptoms with negative imaging findings, and 26.4% of patients suffered a skull fracture without intracranial injury. Patients presented with subdural, subarachnoid, or intraventricular hemorrhage in 11.6%, 9.19%, and 0.53% of cases, respectively. After discharge, 672 patients returned for at least 1 follow-up clinic visit (71.7%), and surveillance imaging was obtained at the time of the visit in 343 instances. The number of adverse events was small and consisted of 34 ED visits and 3 surgeries.. Some of the ED visits could have been prevented with better discharge instructions, but none of the surgery was preventable. Furthermore, the pattern of postinjury surveillance imaging utilization correlated with physician identity but not with injury severity. Because the number of adverse events was small, surveillance imaging could not be shown to positively influence outcomes. Conclusions. Adverse events after nonoperative mild traumatic injury are rare. The routine use of postinjury surveillance imaging remains controversial, but these data suggest that such imaging does not effectively identify those who require operative intervention.	[Chern, Joshua J.; Sarda, Samir; Brahma, Barunashish; Wrubel, David M.; Reisner, Andrew; Boydston, William] Emory Univ, Childrens Hlthcare Atlanta, Pediat Neurosurg Assoc, Atlanta, GA 30322 USA; [Chern, Joshua J.; Howard, Brian M.; Brahma, Barunashish; Wrubel, David M.; Reisner, Andrew; Boydston, William] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Jea, Andrew] Texas Childrens Hosp, Dept Neurosurg, Houston, TX 77030 USA; [Tubbs, R. Shane] Childrens Alabama, Pediat Neurosurg, Birmingham, AL USA		Chern, JJ (corresponding author), Emory Univ, Childrens Hlthcare Atlanta, Pediat Neurosurg Assoc, Atlanta, GA 30322 USA.	joshua.chern@choa.org					af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Clarke NMP, 2012, INJURY, V43, P762, DOI 10.1016/j.injury.2011.08.024; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Diyora B, 2011, NEUROL INDIA, V59, P424, DOI 10.4103/0028-3886.82762; Donahue DJ, 1995, CHILD NERV SYST, V11, P692, DOI 10.1007/BF00262233; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Leung GKK, 2011, J CLIN NEUROSCI, V18, P855, DOI 10.1016/j.jocn.2010.09.020; Liu XS, 2012, J NEUROSURG-PEDIATR, V9, P670, DOI 10.3171/2012.2.PEDS11538; Morrison J, 2013, PEDIATR EMERG CARE, V29, P1189, DOI 10.1097/PEC.0b013e3182a9f7c1; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Strahle J, 2012, TRANSL STROKE RES, V3, pS25, DOI 10.1007/s12975-012-0182-9; Vogelbaum MA, 1998, PEDIATR NEUROSURG, V29, P96, DOI 10.1159/000028697	17	10	10	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2014	14	3					306	310		10.3171/2014.6.PEDS13682			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AN6EX	WOS:000340688800016	25014322				2022-02-06	
J	Dahdah, MN; Barisa, MT; Schmidt, K; Barnes, SA; Dubiel, R; Dunklin, C; Harper, C; Callender, L; Wilson, A; Diaz-Arrastia, R; Shafi, S				Dahdah, Marie N.; Barisa, Mark T.; Schmidt, Kathryn; Barnes, Sunni A.; Dubiel, Rosemary; Dunklin, Cynthia; Harper, Caryn; Callender, Librada; Wilson, Amy; Diaz-Arrastia, Ramon; Shafi, Shahid			Comparative Effectiveness of Traumatic Brain Injury Rehabilitation: Differential Outcomes Across TBI Model Systems Centers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; outcome; outcome measures; quality of rehab care; rehabilitation	QUALITY-OF-CARE; SEVERE HEAD-INJURY; INPATIENT REHABILITATION; STROKE REHABILITATION; NEUROPSYCHOLOGICAL ASSESSMENT; UNITED-STATES; OLDER-ADULTS; IMPACT; LENGTH; SCALE	Objective: To measure patient functional outcomes across rehabilitation centers. Setting: Traumatic Brain Injury Model System (TBIMS) centers. Participants: Patients with traumatic brain injury (TBI) admitted to 21 TBIMS rehabilitation centers (N = 6975, during 1999-2008). Design: Retrospective analysis of prospectively collected data. Main Measures: Center-specific functional outcomes of TBI patients using Functional Independence Measure, Disability Rating Scale, and Glasgow Outcome Scale-Extended. Results: There were large differences in patient characteristics across centers (demographics, TBI severity, and functional deficits at admission to rehabilitation). However, even after taking those factors into account, there were significant differences in functional outcomes of patients treated at different TBIMS centers. Conclusion: There are significant differences in functional outcomes of TBI patients across rehabilitation centers.	[Dahdah, Marie N.; Barisa, Mark T.; Dubiel, Rosemary; Wilson, Amy] Baylor Hlth Care Syst, Baylor Inst Rehabil, Dallas, TX USA; [Schmidt, Kathryn; Barnes, Sunni A.; Shafi, Shahid] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX USA; [Dahdah, Marie N.; Barisa, Mark T.; Dubiel, Rosemary; Dunklin, Cynthia; Harper, Caryn; Callender, Librada; Wilson, Amy; Diaz-Arrastia, Ramon; Shafi, Shahid] North Texas Traumat Brain Injury Model Syst Ctr, Dallas, TX USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA		Shafi, S (corresponding author), Baylor Inst Hlth Care Res & Improvement, 8080 Cent Expressway,Ste 500, Dallas, TX 75206 USA.	shahid.shafi@baylorhealth.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	Department of Education, NIDRR [H133A120098-11]	The contents of the this manuscript were developed under a grant from the Department of Education, NIDRR grant number H133A120098-11. However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	Brain Injury Association of America, TBI MOD SYST; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gage B., 2009, ANAL CLASSIFICATION; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; Hawkins ML, 2005, AM SURGEON, V71, P920; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoenig H, 2002, MED CARE, V40, P1036, DOI 10.1097/00005650-200211000-00005; Hoenig H, 2001, HEALTH SERV RES, V35, P1293; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Kuhne CA, 2007, UNFALLCHIRURG, V110, P341, DOI 10.1007/s00113-007-1244-4; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Mayer SA, 2011, CRIT CARE MED, V39, P2330, DOI 10.1097/CCM.0b013e3182227238; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; McNaughton H, 2005, ARCH PHYS MED REHAB, V86, pS115, DOI 10.1016/j.apmr.2005.08.115; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Pasquale MD, 2005, CRIT CARE MED, V33, pA40, DOI 10.1097/00003246-200512002-00148; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; United States Government Accountability Office, 2013, VA HLTH CAR MILD TRA; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Wright J., INTRO FIM TM; Yu F, 2005, J NURS SCHOLARSHIP, V37, P229, DOI 10.1111/j.1547-5069.2005.00040.x; Zgaljardic DJ, 2011, REHABIL PSYCHOL, V56, P359, DOI 10.1037/a0025466; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	48	10	11	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					451	459		10.1097/HTR.0b013e3182a61983			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700014	24052093				2022-02-06	
J	Moody, BJ; Liberman, C; Zvara, P; Smith, PP; Freeman, K; Zvarova, K				Moody, Benjamin J.; Liberman, Caleb; Zvara, Peter; Smith, Phillip P.; Freeman, Kalev; Zvarova, Katarina			Acute Lower Urinary Tract Dysfunction (LUTD) Following Traumatic Brain Injury (TBI) in Rats	NEUROUROLOGY AND URODYNAMICS			English	Article						bladder dysfunction; cystometry; fluid percussion injury; telemetry; traumatic brain injury	URODYNAMIC EVALUATION; INCONTINENCE; MICTURITION; CYSTOMETRY; MODELS; PHASE	Aims: The aim of this study was to assess experimental traumatic brain injury (TBI)-induced lower urinary tract dysfunction (LUTD) by monitoring systemic and urodynamic parameters using an implantable telemetry system. Methods: A single lateral fluid percussion TBI (FP-TBI; 3.4 atm) was administered to 10 female rats. Pressure micro-catheters were implanted in the abdominal aorta and bladder dome for simultaneous data recording. Hemodynamic and urodynamic variables recorded 24 hr before and 24 hr after injury were analyzed and compared. Results: TBI in the acute phase resulted in LUTD affecting bladder emptying, characterized by failure of voiding reflex, high capacity bladder, increased voided volume, prolonged intermicturition intervals, and loss of compliance. The dominant symptom was urinary retention (100%) and incontinence (60%). The effects followed a pattern of initial loss of bladder function followed by either altered recovery of reflex micturition or a period of incontinence. With a moderate injury symptoms were temporary in 90% of animals and permanent in 10% of animals. Injury produced only transient hypertension (<= 1 hr) with a maximum systolic pressure of 172.64 +/- 14.53 mmHg (70% of animals). Conclusions: The results demonstrate that experimental FP-TBI causes temporary bladder dysfunction that in more severe cases becomes permanent. Telemetry recordings revealed a sequence of events following injury that establishes moderate TBI as a risk factor for neurogenic bladder disorder. Results also suggest a correlation between lateral FP-TBI and incontinence. (C) 2013 Wiley Periodicals, Inc.	[Moody, Benjamin J.; Liberman, Caleb; Zvara, Peter; Freeman, Kalev; Zvarova, Katarina] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Smith, Phillip P.] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT USA		Zvarova, K (corresponding author), Univ Vermont, Dept Surg, Coll Med, 89 Beaumont Ave,Given Bldg D319, Burlington, VT 05405 USA.	kzvarova@uvm.edu	Zvara, Peter/G-6858-2016	Zvara, Peter/0000-0002-6972-6980	University of Vermont Institutional; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [KO1DK-079150]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K01DK079150] Funding Source: NIH RePORTER	Contract grant sponsor: University of Vermont Institutional; Contract grant sponsor: National Institute of Diabetes and Digestive and Kidney Diseases; Grant number: KO1DK-079150	Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; [Anonymous], 1998, NIH CONSENS STATEMEN, V16, P1; Brittain KR, 1998, STROKE, V29, P524, DOI 10.1161/01.STR.29.2.524; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; de Groat WC, 1998, BEHAV BRAIN RES, V92, P127, DOI 10.1016/S0166-4328(97)00185-X; Faul M, 2010, TRAUMATIC BRAIN INJU; Fowler CJ, 1999, BRAIN, V122, P1213, DOI 10.1093/brain/122.7.1213; Fry CH, 2010, NEUROUROL URODYNAM, V29, P603, DOI 10.1002/nau.20903; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giannantoni A, 2011, ARCH PHYS MED REHAB, V92, P1134, DOI 10.1016/j.apmr.2011.02.013; Hugh D, 1988, NEUROUROL URODYNAM, V7, P377; Jiang HH, 2013, EXP NEUROL, V240, P57, DOI 10.1016/j.expneurol.2012.11.012; KHADRA MH, 1995, ACTA PHYSIOL SCAND, V155, P31, DOI 10.1111/j.1748-1716.1995.tb09945.x; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Leary SM, 2006, CLIN REHABIL, V20, P1094, DOI 10.1177/0269215506071258; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Linsenmeyer TA, 2012, NEUROREHABILITATION, V30, P1, DOI 10.3233/NRE-2012-0721; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mills IW, 2000, J UROLOGY, V164, P1745, DOI 10.1016/S0022-5347(05)67100-5; MIYAGAWA I, 1986, UROL INT, V41, P263, DOI 10.1159/000281214; Moiyadi AV, 2007, NEUROREHABILITATION, V22, P93; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Perneczky R, 2008, EUR J NUCL MED MOL I, V35, P605, DOI 10.1007/s00259-007-0626-8; Pettersen R, 2007, BJU INT, V99, P1073, DOI 10.1111/j.1464-410X.2007.06754.x; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Singhania P, 2010, UROL INT, V84, P89, DOI 10.1159/000273473; Smith PP, 2012, NEUROUROL URODYNAM, V31, P30, DOI 10.1002/nau.21223; Sugaya Kimio, 2005, Journal of Smooth Muscle Research, V41, P117, DOI 10.1540/jsmr.41.117; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VAUGHAN CW, 1995, PROG NEUROBIOL, V46, P215, DOI 10.1016/0301-0082(95)00004-F	34	10	12	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	SEP	2014	33	7					1159	1164		10.1002/nau.22470			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	AR9AK	WOS:000343862800017	24038177				2022-02-06	
J	Neumann, D; Keiski, MA; McDonald, BC; Wang, Y				Neumann, Dawn; Keiski, Michelle A.; McDonald, Brenna C.; Wang, Yang			Neuroimaging and facial affect processing: implications for traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Neuroimaging; Emotion; Facial affect recognition; Traumatic brain injury	HUMAN NEURAL SYSTEM; EMOTION RECOGNITION; FUNCTIONAL NEUROANATOMY; PERCEPTION DEFICITS; SOCIAL INFORMATION; AMYGDALA ACTIVITY; FACE; EXPRESSION; IDENTITY; NEUROBIOLOGY	The ability to recognize others' emotions is critical to successful interpersonal interactions. Given its importance, there has been an extensive amount of research using functional magnetic resonance imaging (fMRI) to investigate the neurobiological mechanisms associated with facial affect recognition in healthy individuals, and some in patient populations with affective disorders. Findings from these studies reveal that the underlying mechanisms involve a distributed neural network, engaging structures within limbic and subcortical regions, prefrontal cortex, temporal and parietal lobes, and occipital cortex. In the last several decades, researchers have become increasingly interested in how emotion recognition is affected after a traumatic brain injury (TBI), which often involves damage to these structures, as well as the neural circuitry connecting them. Not surprisingly, research has reliably demonstrated that facial affect recognition deficits are common after TBI. To date, however, no neuroimaging studies have investigated facial affect recognition deficits in the TBI population. Consequently, the purpose of this paper is to consider how functional magnetic resonance imaging (fMRI) might inform our knowledge about affect recognition deficits after TBI, and potentially enhance treatment approaches.	[Neumann, Dawn] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, Indianapolis, IN 46254 USA; [Keiski, Michelle A.] Indiana Univ Sch Med, Indiana Univ Ctr Neuroimaging, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [McDonald, Brenna C.; Wang, Yang] Indiana Univ Sch Med, Indiana Univ Ctr Neuroimaging, Dept Radiol & Imaging Sci, Indianapolis, IN 46254 USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu; mkeiski@iupui.edu; mcdonalb@iupui.edu; ywang1@iupui.edu					Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Bornhofen C., 2008, NEUROPSYCHOLOGICAL R, V18; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chakravarthy V., 2010, BIOL CYBERN, P1; Cooper C. L., 2013, BRAIN INJURY, V0, P1; Corbett BA, 2009, PSYCHIAT RES-NEUROIM, V173, P196, DOI 10.1016/j.pscychresns.2008.08.005; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Delaveau P, 2009, J CLIN PSYCHOPHARM, V29, P548, DOI 10.1097/JCP.0b013e3181bf1c5f; Dima D, 2011, J NEUROSCI, V31, P14378, DOI 10.1523/JNEUROSCI.2400-11.2011; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Fakra E, 2008, SCHIZOPHR RES, V100, P191, DOI 10.1016/j.schres.2007.11.040; Foland-Ross LC, 2010, J NEUROSCI, V30, P16673, DOI 10.1523/JNEUROSCI.4578-09.2010; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hubl D, 2003, NEUROLOGY, V61, P1232, DOI 10.1212/01.WNL.0000091862.22033.1A; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Iidaka T, 2001, J COGNITIVE NEUROSCI, V13, P1035, DOI 10.1162/089892901753294338; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2009, NEUROPSYCHOL REHABIL, V19, P321, DOI 10.1080/09602010802193989; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Morecraft RJ, 2004, NEUROLOGIST, V10, P235, DOI 10.1097/01.nrl.0000138734.45742.8d; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mueser KT, 1996, J ABNORM PSYCHOL, V105, P271, DOI 10.1037/0021-843X.105.2.271; Neumann D, 2013, J HEAD TRAUMA REHABI; Nowicki S, 1998, GENET SOC GEN PSYCH, V124, P39; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; Piggot J, 2004, J AM ACAD CHILD PSY, V43, P473, DOI 10.1097/00004583-200404000-00014; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schneider F, 1997, PSYCHIAT RES-NEUROIM, V76, P75, DOI 10.1016/S0925-4927(97)00063-2; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Wright P, 2006, NEUROIMAGE, V29, P628, DOI 10.1016/j.neuroimage.2005.07.047; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	95	10	10	0	23	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		460	473		10.1007/s11682-013-9285-5			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP9ZR	WOS:000342441400014	24363220				2022-02-06	
J	O'Kane, JW; Levy, MR; Neradilek, M; Polissar, NL; Schiff, MA				O'Kane, John W.; Levy, Marni R.; Neradilek, Moni; Polissar, Nayak L.; Schiff, Melissa A.			Evaluation of the Zachery Lystedt Law Among Female Youth Soccer Players	PHYSICIAN AND SPORTSMEDICINE			English	Article						soccer; concussion; concussion law; female adolescents	HIGH-SCHOOL; CONCUSSION; INJURY; RETURN	Background: Despite recent increased awareness about sports concussions, few studies have evaluated the effect of concussion laws on concussion outcomes among young athletes. The purpose of our study was to evaluate the effect of the Washington State Zachery Lystedt Concussion Law on playing with concussion symptoms and being evaluated by a health care provider. Methods: We performed a prospective cohort study of 351 elite female soccer players, aged 12 to 15 years, from 33 randomly selected youth soccer teams in the Puget Sound region of Washington State from 2008 to 2012. The Washington State Zachery Lystedt Concussion Law went into effect on July 1, 2009. Among concussed players (N = 59), we assessed the risk of playing with symptoms, the evaluation by a health care professional, and receiving a concussion diagnosis before and after the law was passed using logistic regression to estimate odds ratios and 95% CIs. Results: The majority of concussed players (59.3%) continued to play with symptoms, and we found no statistically significant difference in the proportion of players who played with symptoms before and after the law was passed. Only 44.1% of concussed players were evaluated by a health care provider, with no difference before and after the law was passed. Among those evaluated by a health care professional, players were 2.1-fold (95% CI, 1.0-10.1) more likely to receive a concussion diagnosis after the law was passed. Conclusion: The majority of concussed female youth soccer players report playing with symptoms. Legislation mandating concussion education and evaluation prior to returning to play was not associated with an increase in concussion evaluations by health care providers.	[O'Kane, John W.] Univ Washington, Sch Med, Dept Family Med, Seattle, WA 98195 USA; [Levy, Marni R.; Schiff, Melissa A.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Neradilek, Moni; Polissar, Nayak L.] Mt Whisper Light Stat, Seattle, WA USA; [Schiff, Melissa A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA		O'Kane, JW (corresponding author), Univ Washington, Sports Med Clin, Room 148,3950 Montlake Blvd, Seattle, WA 98195 USA.	jokane@u.washington.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR051059]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR051059] Funding Source: NIH RePORTER	We would like to thank the soccer associations and the players and parents who participated in this study. We would also like to thank Christopher Mack, MS, for assistance with data management, and we thank our research assistants Rebecca O'Halloran, Kristen Gray, and Amy Spieker. None of the authors have any conflicts of interest to report. Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number R01AR051059.	Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Newton JD, 2014, J SCI MED SPORT, V17, P469, DOI 10.1016/j.jsams.2013.10.240; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Schiff MA, 2010, J ATHL TRAINING, V45, P238, DOI 10.4085/1062-6050-45.3.238; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	14	10	10	0	8	JTE MULTIMEDIA	WEST CONSHOHOCKEN	18 ELIZABETH ST, STE 110, WEST CONSHOHOCKEN, PA 19428 USA	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	SEP	2014	42	3					39	44		10.3810/psm.2014.09.2074			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	AR2FQ	WOS:000343399400005	25295765				2022-02-06	
J	Yang, S; Stepien, D; Hanseman, D; Robinson, B; Goodman, MD; Pritts, TA; Caldwell, CC; Remick, DG; Lentsch, AB				Yang, Sung; Stepien, David; Hanseman, Dennis; Robinson, Bryce; Goodman, Michael D.; Pritts, Timothy A.; Caldwell, Charles C.; Remick, Daniel G.; Lentsch, Alex B.			Substance P Mediates Reduced Pneumonia Rates After Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						infection; innate immunity; leukocytes; lung inflammation; neuropeptide; vagus nerve	VENTILATOR-ASSOCIATED PNEUMONIA; SYSTEMIC INFLAMMATORY RESPONSE; HEAD-INJURY; IMMUNE-SYSTEM; RISK-FACTORS; INNATE IMMUNITY; LUNG INJURY; COMPLICATIONS; SUPPRESSION; NEUTROPHILS	Objectives: Traumatic brain injury results in significant morbidity and mortality and is associated with infectious complications, particularly pneumonia. However, whether traumatic brain injury directly impacts the host response to pneumonia is unknown. The objective of this study was to determine the nature of the relationship between traumatic brain injury and the prevalence of pneumonia in trauma patients and investigate the mechanism of this relationship using a murine model of traumatic brain injury with pneumonia. Design: Data from the National Trauma Data Bank and a murine model of traumatic brain injury with postinjury pneumonia. Setting: Academic medical centers in Cincinnati, OH, and Boston, MA. Patients/Subjects: Trauma patients in the National Trauma Data Bank with a hospital length of stay greater than 2 days, age of at least 18 years at admission, and a blunt mechanism of injury. Subjects were female ICR mice 8-10 weeks old. Interventions: Administration of a substance P receptor antagonist in mice. Measurements and Main Results: Pneumonia rates were measured in trauma patients before and after risk adjustment using propensity scoring. In addition, survival and pulmonary inflammation were measured in mice undergoing traumatic brain injury with or without pneumonia. After risk adjustment, we found that traumatic brain injury patients had significantly lower rates of pneumonia compared to blunt trauma patients without traumatic brain injury. A murine model of traumatic brain injury reproduced these clinical findings with mice subjected to traumatic brain injury demonstrating increased bacterial clearance and survival after induction of pneumonia. To determine the mechanisms responsible for this improvement, the substance P receptor was blocked in mice after traumatic brain injury. This treatment abrogated the traumatic brain injury-associated increases in bacterial clearance and survival. Conclusions: The data demonstrate that patients with traumatic brain injury have lower rates of pneumonia compared to non-head-injured trauma patients and suggest that the mechanism of this effect occurs through traumatic brain injury-induced release of substance P, which improves innate immunity to decrease pneumonia.	[Yang, Sung; Hanseman, Dennis; Robinson, Bryce; Goodman, Michael D.; Pritts, Timothy A.; Caldwell, Charles C.; Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Inst Mil Med,Div Trauma & Crit Care, Cincinnati, OH 45220 USA; [Stepien, David; Remick, Daniel G.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA		Lentsch, AB (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Inst Mil Med,Div Trauma & Crit Care, Cincinnati, OH 45220 USA.	remickd@bu.edu; alex.lentsch@uc.edu		Caldwell, Charles/0000-0003-1692-4550; Stepien, David/0000-0002-3521-6210; Pritts, Timothy/0000-0003-2495-3255	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NHLBI T32 HL07501]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; United States Air ForceUnited States Department of Defense; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL007501, GM82962, GM97320, GM08478]; United States Air ForceUnited States Department of Defense [FA8650-10-2-6B01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM097320, T32GM008478, R01GM082962] Funding Source: NIH RePORTER	Dr. Stepien received grant and support for article research from the National Institutes of Health (NIH) (NHLBI T32 HL07501). Dr. Pritts provided expert testimony for the Attorney General and State of Ohio (for legal work with Ohio State Attorney General). His institution received grant support from the NIH and the United States Air Force (Research Grants). Dr. Remick received support for article research from the NIH (HL007501, GM82962, and GM97320). His institution received grant support from the NIH. Dr. Lentsch received support for article research from the NIH (GM08478). He received grant support from United States Air Force (FA8650-10-2-6B01). His institution received grant support from the NIH (T32 Training Grant). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Centers for Disease Control and Prevention, BAR INJ DIAGN MATR C; CHEVRET S, 1993, INTENS CARE MED, V19, P256, DOI 10.1007/BF01690545; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Douglas SD, 2011, ANN NY ACAD SCI, V1217, P83, DOI 10.1111/j.1749-6632.2010.05826.x; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; Goble S, 2009, J TRAUMA, V67, P637, DOI 10.1097/TA.0b013e3181b84294; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hegde A, 2007, J LEUKOCYTE BIOL, V82, P678, DOI 10.1189/jlb.0407217; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hoth JJ, 2009, J TRAUMA, V67, P14, DOI 10.1097/TA.0b013e31819ea600; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Kox M, 2012, J NEUROTRAUM, V29, P747, DOI 10.1089/neu.2011.2035; LEVASSEUR JE, 1993, J NEUROSURG, V78, P610, DOI 10.3171/jns.1993.78.4.0610; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maung AA, 2008, J IMMUNOL, V180, P2450, DOI 10.4049/jimmunol.180.4.2450; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Natarajan S, 2008, J IMMUNOL, V181, P8402, DOI 10.4049/jimmunol.181.12.8402; Nemzek JA, 2001, J IMMUNOL METHODS, V255, P149, DOI 10.1016/S0022-1759(01)00419-7; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Pape HC, 2000, CRIT CARE MED, V28, P3441, DOI 10.1097/00003246-200010000-00012; Parsons LS, 2004, SUGI29 PAPER 165 29; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; PAYAN DG, 1987, AM REV RESPIR DIS, V136, pS39, DOI 10.1164/ajrccm/136.6_Pt_2.S39; Perl M, 2012, SHOCK, V38, P98, DOI 10.1097/SHK.0b013e318254be6a; PERNOW B, 1985, J IMMUNOL, V135, pS812; Puneet P, 2006, J IMMUNOL, V176, P3813, DOI 10.4049/jimmunol.176.6.3813; Rello J, 1999, AM J RESP CRIT CARE, V159, P1742, DOI 10.1164/ajrccm.159.6.9808030; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Sio SWS, 2008, J IMMUNOL, V180, P8333, DOI 10.4049/jimmunol.180.12.8333; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Tominaga GT, 2008, J TRAUMA, V64, P578; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Wang Q, 2004, SEMIN RESP CRIT CARE, V25, P33, DOI 10.1055/s-2004-822303; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wu J, 2012, CARDIOVASC PATHOL, V21, P149, DOI 10.1016/j.carpath.2011.05.001; Yang CC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-289; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	53	10	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2014	42	9					2092	2100		10.1097/CCM.0000000000000486			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7LF	WOS:000340780800033	25014065	Green Accepted			2022-02-06	
J	Moss, WC; King, MJ; Blackman, EG				Moss, William C.; King, Michael J.; Blackman, Eric G.			Towards reducing impact-induced brain injury: lessons from a computational study of army and football helmet pads	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						helmet; pad; head injury; traumatic brain injury; head injury criterion; impact		We use computational simulations to compare the impact response of different football and U. S. Army helmet pad materials. We conduct experiments to characterise the material response of different helmet pads. We simulate experimental helmet impact tests performed by the U. S. Army to validate our methods. We then simulate a cylindrical impactor striking different pads. The acceleration history of the impactor is used to calculate the head injury criterion for each pad. We conduct sensitivity studies exploring the effects of pad composition, geometry and material stiffness. We find that (1) the football pad materials do not outperform the currently used military pad material in militarily relevant impact scenarios; (2) optimal material properties for a pad depend on impact energy and (3) thicker pads perform better at all velocities. Although we considered only the isolated response of pad materials, not entire helmet systems, our analysis suggests that by using larger helmet shells with correspondingly thicker pads, impact-induced traumatic brain injury may be reduced.	[Moss, William C.] Lawrence Livermore Natl Lab, Weap & Complex Integrat Directorate, Livermore, CA 94551 USA; [King, Michael J.] Lawrence Livermore Natl Lab, Engn Directorate, Livermore, CA 94551 USA; [Blackman, Eric G.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA		Moss, WC (corresponding author), Lawrence Livermore Natl Lab, Weap & Complex Integrat Directorate, 7000 East Ave,L-99, Livermore, CA 94551 USA.	wmoss@llnl.gov; king74@llnl.gov; Blackman@pas.rochester.edu		Blackman, Eric/0000-0002-9405-8435	U.S. ArmyUnited States Department of Defense; U.S. Army and the Joint IED Defeat Organization [JIEDDO] through COL R. Todd Dombroski, DO, JIEDDO Surgeon; U.S. Department of Energy by Lawrence Livermore National LaboratoryUnited States Department of Energy (DOE) [DE-AC52-07NA27344]	We acknowledge funding from the U.S. Army and the Joint IED Defeat Organization [JIEDDO] through COL R. Todd Dombroski, DO, JIEDDO Surgeon. We thank LLNL staff members B. Cracchiola for loaning us his ACH helmet, D. Urabe for performing the compression tests on the manufacturer supplied pads and component foams and W. Brown for CT scanning the ACH helmet and post-processing the files. We also thank N. Kraemer (Riddell), S. Reynolds (Xenith), R. Szalkowski (Team Wendy) and T. Erickson (Oregon Aero) for supplying pad and foam samples used in this study. We thank the U.S. Army Aeromedical Research Laboratory [USAARL] for providing us data from impact tests on infantry helmets. This study was carried out under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Blackman EG., INCORPORATING HUMAN; DeGroot AJ, 2009, LLNLSM417205; Fischer H, 2010, RS22452 C RES SERV; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McEntire BJ, 2005, 200512 USAARL; Moss WC, 2011, LLNLSR471496 JIEDOO; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Puso MA, 1995, ASME INT MECH ENG C, V68, P215; U.S. Combat Helmet Suspension System Comparison, 2006, US COMB HELM SUSP SY; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881	11	10	10	1	45	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	AUG 18	2014	17	11					1173	1184		10.1080/10255842.2012.739162			12	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	AE5HO	WOS:000334018600002	23244512	Green Submitted			2022-02-06	
J	Pakraftar, S; Atencio, D; English, J; Corcos, A; Altschuler, EM; Stahlfeld, K				Pakraftar, Sam; Atencio, Daniela; English, John; Corcos, Alain; Altschuler, Eric M.; Stahlfeld, Kurt			Dabigatran etixilate and traumatic brain injury: Evolving anticoagulants require evolving care plans	WORLD JOURNAL OF CLINICAL CASES			English	Article						Dabigatran; Brain injury; Anticoagulation; Dabigatran reversal	REVERSAL; WARFARIN; PREVENTION; MANAGEMENT	AIM: To investigate the outcomes of trauma patients with traumatic brain injury (TBI) on Dabigatran Etexilate (DE). METHODS: Following IRB approval, all patients taking DE who were admitted to our level 1 trauma service were enrolled in the study. Injury complexity, length of stay (LOS), intensive care length of stay, operative intervention, therapeutic interventions and outcomes were analyzed retrospectively. RESULTS: Twenty-eight of 4310 admissions were taking DE. Eleven patients were excluded on concurrent antiplatelet therapy. Average age was 77.14 years (64-94 years), and average LOS was 4.7 d (1-35 d). Thirty-two percent were admitted with intracranial hemorrhage. Eighteen percent received factor., and 22% received dialysis in attempts to correct coagulopathy. Mortality was 21%. CONCLUSION: The low incidence, absence of reversal agents, and lack of practice guidelines makes managing patients with TBI taking DE frustrating and provider specific. Local practice guidelines may be helpful in managing such patients. (c) 2014 Baishideng Publishing Group Inc. All rights reserved.	[Pakraftar, Sam; Atencio, Daniela; English, John; Stahlfeld, Kurt] UPMC Mercy, Dept Surg, 1400 Locust St,Suite 6512, Pittsburgh, PA 15219 USA; [Corcos, Alain] UPMC Mercy, Dept Trauma & Acute Care Surg, Pittsburgh, PA 15219 USA; [Altschuler, Eric M.] UPMC Mercy, Dept Neurosurg, Pittsburgh, PA 15219 USA		Stahlfeld, K (corresponding author), UPMC Mercy, Dept Surg, 1400 Locust St,Suite 6512, Pittsburgh, PA 15219 USA.	stahlfeldk@upmc.edu					Adcock DM, 2013, AM J CLIN PATHOL, V139, P102, DOI 10.1309/AJCPY6G6ZITVKPVH; Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Amin AN, 2009, JT COMM J QUAL PATIE, V35, P558, DOI 10.1016/S1553-7250(09)35076-X; Chang DN, 2013, AM J KIDNEY DIS, V61, P487, DOI 10.1053/j.ajkd.2012.08.047; CONNOLLY SJ, 2009, NEW ENGL J MED, V361, P1139, DOI [10.1056/NEJMoa0905561, DOI 10.1056/NEJM0A0905561]; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; FDA Drug Safety Communication, 2012, SAF REV POSTM REP SE; Gage BF, 2000, AM J MED, V109, P481, DOI 10.1016/S0002-9343(00)00545-3; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Huang GS, 2013, AM SURGEON, V79, P113; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Siegal DM, 2013, J THROMB THROMBOLYS, V35, P391, DOI 10.1007/s11239-013-0885-0; Siegal DM, 2013, EUR HEART J, V34, P489, DOI 10.1093/eurheartj/ehs408; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Wann LS, 2011, J AM COLL CARDIOL, V57, P1330, DOI [10.1016/j.jacc.2011.01.010, 10.1016/j.hrthm.2011.01.032]; Warkentin TE, 2012, BLOOD, V119, P2172, DOI 10.1182/blood-2011-11-393587; Weitz JI, 2008, CHEST, V133, p234S, DOI 10.1378/chest.08-0673; Wood S., 2011, DABIGATRAN 260 FATAL	18	10	10	0	4	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES	2307-8960			WORLD J CLIN CASES	World J. Clin. Cases	AUG 16	2014	2	8					362	366		10.12998/wjcc.v2.i8.362			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VJ1BI	WOS:000535484900008	25133148	Green Published, hybrid			2022-02-06	
J	Bergman, L; Akhter, T; Wikstrom, AK; Wikstrom, J; Naessen, T; Akerud, H				Bergman, Lina; Akhter, Tansim; Wikstrom, Anna-Karin; Wikstrom, Johan; Naessen, Tord; Akerud, Helena			Plasma Levels of S100B in Preeclampsia and Association With Possible Central Nervous System Effects	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; hypertension; neurological dysfunction; preeclampsia; S100B	TRAUMATIC BRAIN-INJURY; REVERSIBLE ENCEPHALOPATHY SYNDROME; ECLAMPSIA; PROTEIN; SERUM; BIOMARKERS; PREDICTOR; MORTALITY; URINE; BLOOD	BACKGROUND S100B is supposed to be a peripheral biomarker of central nervous system (CNS) injury. The purpose of this study was to compare levels of S100B in women with preeclampsia with levels in healthy pregnant control subjects and furthermore to analyze levels of S100B in relation to possible CNS effects. METHODS A cross-sectional case-control study in antenatal care centers in Uppsala, Sweden, was performed. Fifty-three women with preeclampsia and 58 healthy pregnant women were recruited at similar gestational length; women with preeclampsia were recruited at time of diagnosis, and control subjects were recruited during their routine visit to an antenatal clinic. Plasma samples were collected, and levels of S100B were analyzed with an enzyme-linked immunosorbent assay. Information about demographic and clinical characteristics, including symptoms related to CNS affection, was collected from the medical records. The main outcome measures were plasma levels of S100B and possible CNS effects. RESULTS Levels of S100B were significantly higher among women with preeclampsia than among control subjects (0.12 mu g/L vs. 0.07 mu g/L; P < 0.001). In preeclampsia, there was a significant association between high levels of S100B and visual disturbances (P < 0.05). CONCLUSIONS S100B is increased among women with preeclampsia, and high levels of S100B associate with visual disturbances, which might reflect CNS affection in women with preeclampsia.	[Bergman, Lina; Akhter, Tansim; Wikstrom, Anna-Karin; Naessen, Tord; Akerud, Helena] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Akhter, Tansim] Clin Res Ctr, Dalarna, Sweden; [Wikstrom, Johan] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden		Bergman, L (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	lina.bergman@kbh.uu.se	Bergman, Lina/ABF-7954-2021; /ABC-6294-2021	Bergman, Lina/0000-0001-5202-9428; Wikstrom, Johan/0000-0002-9481-6857	Swedish Society of Medicine; Uppsala-Orebro Regional Research Council, Sweden; Centre for Clinical Research, Dalarna, Sweden	This work was supported by grants provided by the Swedish Society of Medicine; the Uppsala-Orebro Regional Research Council, Sweden; and the Centre for Clinical Research, Dalarna, Sweden. We would like to thank Malin Olsson, Department of Women's and Children's Health, Uppsala University, for valuable technical assistance.	Amburgey OA, 2010, HYPERTENSION, V56, P1003, DOI 10.1161/HYPERTENSIONAHA.110.158931; Bartynski WS, 2008, AM J NEURORADIOL, V29, P924, DOI 10.3174/ajnr.A0960; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Beer C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-71; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; COLOSIMO C, 1985, NEURORADIOLOGY, V27, P313, DOI 10.1007/BF00339563; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Heilmann L, 2007, CLIN APPL THROMB-HEM, V13, P285, DOI 10.1177/1076029607299986; Hugonnet E, 2013, Diagn Interv Imaging, V94, P45, DOI 10.1016/j.diii.2012.02.005; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x; Kullberg G, 2002, HYPERTENS PREGNANCY, V21, P13, DOI 10.1081/PRG-120002906; Kur JK, 2006, J RHEUMATOL, V33, P2178; Machado-Vieira R, 2002, EUR NEUROPSYCHOPHARM, V12, P269, DOI 10.1016/S0924-977X(02)00029-9; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Missler U, 2002, CLIN CHIM ACTA, V321, P29, DOI 10.1016/S0009-8981(02)00061-X; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Roos NM, 2012, OBSTET GYNECOL SURV, V67, P242, DOI 10.1097/OGX.0b013e318250a457; Roth C, 2011, Pract Neurol, V11, P136, DOI 10.1136/practneurol-2011-000010; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sanchez-Carpintero R, 2001, PEDIATR NEUROL, V24, P145, DOI 10.1016/S0887-8994(00)00242-3; Sannia A, 2013, CLIN CHIM ACTA, V417, P31, DOI 10.1016/j.cca.2012.12.013; Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Vettorazzi J, 2012, PREGNANCY HYPERTENS, V2, P101, DOI 10.1016/j.preghy.2011.11.004; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; WEINGARTEN K, 1994, AM J ROENTGENOL, V162, P665, DOI 10.2214/ajr.162.3.8109519; Wikstrom AK, 2012, PREGNANCY HYPERTENS, V2, P398, DOI 10.1016/j.preghy.2012.03.001; Zeeman GG, 2009, SEMIN PERINATOL, V33, P166, DOI 10.1053/j.semperi.2009.02.003	32	10	10	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	AUG	2014	27	8					1105	1111		10.1093/ajh/hpu020			7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	AP7DL	WOS:000342237900022	24610883	Green Published, hybrid, Green Submitted			2022-02-06	
J	Brickell, TA; Lange, RT; French, LM				Brickell, Tracey A.; Lange, Rael T.; French, Louis M.			Three-Year Outcome Following Moderate-to-Severe TBI in US Military Service Members: A Descriptive Cross-Sectional Study	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION-LIKE SYMPTOMS; POST-CONCUSSION SYNDROME; COMPLAINT BASE RATES; MILD HEAD-INJURY; CHRONIC PAIN; HEALTH; PERSISTENT	This study examined the prospective course of neurobehavioral symptom reporting and health-related quality of life within the first 3 years following moderate-to-severe traumatic brain injury (TBI). Participants were 52 U.S. service members who were evaluated following a moderate-to-severe TBI sustained in the combat theater during Operations Iraqi and Enduring Freedom (90.4%), or from other noncombat-related incidents. Participants completed the Neurobehavioral Symptom Inventory and Post-Traumatic Stress Disorder-Checklist within 3 months postinjury, and at least one follow-up telephone interview at 12 (n = 27), 24 (n = 31), or 36 months (n = 22) postinjury. Approximately half of the sample (41.9%-63.0%) reported "persistent" symptoms from baseline to follow-up. A substantial minority also "improved" (22.2%-31.8%) or "developed" new symptoms (3.7%-16.1%). Ongoing physical and mental health problems were also reported. The number of service members receiving mental health treatment significantly reduced between 12 and 36 months postinjury (48.1%-18.2%), while complaints of bodily pain significantly increased (40.7%-68.2%). Despite ongoing symptom reporting, few reported suicidal/homicidal ideation (6.5%-9.1%), and a substantial majority reported good/excellent health status (74.1%-90.9%) and satisfaction with their life (81.5%-90.9%). Continued support and care for all service members who sustain a combat-related moderate-to-severe TBI is recommended, regardless of the presence or absence of symptom reporting within the first few months postinjury.	[Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Def & Vet Brain Injury Ctr, Bethesda, MD 20889 USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20889 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Brickell, TA (corresponding author), Def & Vet Brain Injury Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.		french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; Henry M. Jackson Foundation	This research was funded by the Defense and Veterans Brain Injury Center, in part, through contract support provided by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; CELLA DF, 1995, SEMIN ONCOL, V22, P73; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; IVERSON GL, 2007, BRAIN INJURY MED; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	54	10	10	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2014	179	8					839	848		10.7205/MILMED-D-14-00016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7UO	WOS:000340806700005	25102526				2022-02-06	
J	Ghobrial, GM; Amenta, PS; Maltenfort, M; Williams, KA; Harrop, JS; Sharan, A; Jallo, J; Heller, J; Ratliff, J; Prasad, S				Ghobrial, George M.; Amenta, Peter S.; Maltenfort, Mitchell; Williams, Kim A., Jr.; Harrop, James S.; Sharan, Ashwini; Jallo, Jack; Heller, Joshua; Ratliff, John; Prasad, Srinivas			Longitudinal incidence and concurrence rates for traumatic brain injury and spine injury - A twenty year analysis	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Spinal cord injury; Traumatic brain injury; Longitudinal study; Nationwide inpatient sample; Neurotrauma	CLOSED HEAD-INJURY; CORD-INJURY; CERVICAL-SPINE; RISK; MORTALITY	Background: The reported incidence of concurrent traumatic brain (TBI) and spine or spinal cord injuries (SCI) is poorly defined, with widely variable literature rates from 16 to 74%. Objectives: To define the incidence of concurrent TB! and SCI, and compare the incidence over a twenty-year time period. Methods: To define the longitudinal incidence and concurrent rate of TBI and SCI via a retrospective review of the Nationwide Inpatient Sample (NIS) database over a twenty year period. Results: Over the study period, the incidence of TBI declined from 143 patients/100k admissions to 95 patients/100k. However, there was a concurrent increase in SCI from 61 patients/100k admissions to 75 patients/100k admissions (P <0.0001). Regional variations in SCI trends were noted, with specific regions demonstrating an increasing trend. Cervical fractures had the greatest increase by nearly a three-fold rise (1988: 4562-2008: 12,418). There was an increase in the incidence of TBI among SCI admission from 3.7% (1988) to 12.5% (2008) (OR = 1.067 per year; 95% Cl = 1.065-1.069 per year; P <0.0001). Concurrently, SCI patients had an increase in TBI (9.1% (1988)-15.9% (2008) (OR = 1.038 per year (95% Cl 1.036-1.040; P < 0.001))). Conclusion: A retrospective review of the NIS demonstrates a rising trend in the incidence of concurrent TBI and SCI. More investigative work is necessary to examine causative factors for this trend. (C) 2014 Elsevier B.V. All rights reserved.	[Ghobrial, George M.; Amenta, Peter S.; Williams, Kim A., Jr.; Harrop, James S.; Sharan, Ashwini; Jallo, Jack; Heller, Joshua; Prasad, Srinivas] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA; [Maltenfort, Mitchell] Rothman Inst, Philadelphia, PA USA; [Ratliff, John] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Prasad, S (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurosurg, 909 Walnut St,2nd Floor, Philadelphia, PA 19107 USA.			Jallo, Jack/0000-0002-5512-1729; Heller, Joshua/0000-0003-3403-2556			Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; AYYOUB Z, 2002, SPINAL CORD MED PRIN; Bowman BK, 2004, TOP SPINAL CORD INJ, V10, P58; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Center TNSCIS, 2008, FACTS FIG GLANC, V2008; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Elovic E, 1999, TOP SPINAL CORD INJ, V5, P1, DOI DOI 10.1310/V75J-RE76-20GH-X7BY; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Go Bette K., 1995, P21; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Halpern CH, 2010, SPINE, V35, P1721, DOI 10.1097/BRS.0b013e3181e9acb2; Harris P, 1968, Paraplegia, V5, P215; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Lin KC, 2007, CLIN REHABIL, V21, P1075, DOI 10.1177/0269215507079843; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Mahmoud A, 1999, TOP SPINAL CORD INJ, V5, P42; Meinecke F W, 1968, Paraplegia, V5, P196; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; PAGNI CA, 1991, ACTA NEUROCHIR, V111, P1, DOI 10.1007/BF01402506; Panczykowski DM, 2011, J NEUROSURG, V115, P541, DOI 10.3171/2011.4.JNS101672; Piatt JH, 2006, J NEUROSURG-SPINE, V5, P210, DOI 10.3171/spi.2006.5.3.210; Pimentel L, 2010, EMERG MED CLIN N AM, V28, P719, DOI 10.1016/j.emc.2010.07.003; POVOLNY MA, 1993, J REHABIL, V59, P23; REISS SJ, 1986, NEUROSURGERY, V18, P327, DOI 10.1227/00006123-198603000-00012; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Ricker JH, 1999, TOP SPINAL CORD INJ, V5, P76; Rimel R W, 1981, J Neurosurg Nurs, V13, P132; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; RYAN M, 1993, AM SURGEON, V59, P371; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; Saunders LL, 2009, J TRAUMA, V66, P184, DOI 10.1097/TA.0b013e31815644e5; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Services USDoHaH, 1999, TRAUM BRAIN INJ US A, V2008; SHRAGO GG, 1973, AM J ROENTGENOL, V118, P670, DOI 10.2214/ajr.118.3.670; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; Sipski ML, 2006, AM J PHYS MED REHAB, V85, P310, DOI 10.1097/01.phm.0000202105.87011.bf; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Steudel W I, 1988, Acta Neurochir Suppl (Wien), V43, P85; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Young JS, 1982, SPINAL CORD INJURY S, P14	49	10	16	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2014	123						174	180		10.1016/j.clineuro.2014.05.013			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AM6QG	WOS:000339989100032	24973569				2022-02-06	
J	Sherman, AL; Wang, MY				Sherman, Andrew L.; Wang, Michael Y.			Hypothermia as a Clinical Neuroprotectant	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Spinal cord injury; Hypothermia; Neuroprotection; ASIA score; Trauma; Methylprednisolone	SPINAL-CORD-INJURY; SYSTEMIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; METHYLPREDNISOLONE; TEMPERATURE; NALOXONE; FLOW; RAT	Applying therapeutic hypothermia (TH) for the purposes of neuroprotection, originally termed "hibernation," started nearly 100 years ago. Because TH cooling systems have improved to the point where it is practical and safe for general application, interest in providing such treatment in conditions such as spinal cord injury, traumatic brain injury, stroke, and cardiac arrest has increased. This article reviews the mechanisms by which TH mitigates secondary neurologic injury, the clinical scenarios where TH is being applied, and reviews selected published studies using TH for central nervous system neuroprotection.	[Sherman, Andrew L.] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA; [Wang, Michael Y.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA		Sherman, AL (corresponding author), Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, 1611 Northwest 12th Ave,9th Floor, Miami, FL 33136 USA.	asherman@med.miami.edu					ALBIN MS, 1968, J NEUROSURG, V29, P113, DOI 10.3171/jns.1968.29.2.0113; ALBIN MS, 1969, J TRAUM, V9, P1000, DOI 10.1097/00005373-196912000-00004; BABE J, 1956, Acta Otorinolaryngol Iber Am, V7, P212; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; Cappuccino A, 2010, SPINE, V35, pE57, DOI 10.1097/BRS.0b013e3181b9dc28; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Diener PS, 1998, J NEUROSCI, V18, P763; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; HENDERSON AR, 1963, J NEUROSURG, V20, P627; Hugenholtz H, 2002, CAN J NEUROL SCI, V29, P227, DOI 10.1017/S0317167100001992; Hurlbert RJ, 2001, SPINE, V26, pS39, DOI 10.1097/00007632-200112151-00009; JESSEN K, 1980, ACTA ANAESTH SCAND, V24, P138, DOI 10.1111/j.1399-6576.1980.tb01522.x; Kranke P, 2002, ANESTH ANALG, V94, P453, DOI 10.1097/00000539-200202000-00043; Levi AD, 2009, J NEUROTRAUM, V26, P407, DOI 10.1089/neu.2008.0745; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P604, DOI 10.1038/jcbfm.1994.75; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Seule M, 2014, NEUROCRIT CARE, V20, P255, DOI 10.1007/s12028-013-9927-x; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; Westergren H, 2000, ACTA NEUROCHIR, V142, P567, DOI 10.1007/s007010050471; Yenari M, 2008, THERAPEUTIC HYPOTHER, P141; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; ZDRAVEV P, 1951, Ann Otolaryngol, V68, P201	35	10	11	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	AUG	2014	25	3					519	+		10.1016/j.pmr.2014.04.003			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	AN6UU	WOS:000340734700004	25064786				2022-02-06	
J	Di Perri, C; Heine, L; Amico, E; Soddu, A; Laureys, S; Demertzi, A				Di Perri, Carol; Heine, Lizette; Amico, Enrico; Soddu, Andrea; Laureys, Steven; Demertzi, Athena			Technology-based assessment in patients with disorders of consciousness	ANNALI DELL ISTITUTO SUPERIORE DI SANITA			English	Article						disorders of consciousness; functional neuroimaging; electroencephalography; vegetative state/unresponsive wakefulness syndrome; minimally conscious state	MAGNETIC-RESONANCE SPECTROSCOPY; CORTICAL EFFECTIVE CONNECTIVITY; TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; WHITE-MATTER INJURY; LOCKED-IN SYNDROME; VEGETATIVE STATE; RESTING-STATE; FUNCTIONAL CONNECTIVITY; CEREBRAL METABOLISM	Introduction. A number of studies highlight the difficulty in forming a diagnosis for patients with disorders of consciousness when this is established merely on behavioral assessments. Background. Positron emission tomography (PET), functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), and electroencephalography combined with transcranial magnetic stimulation (TMS-EEG) techniques are promoting the clinical characterization of this challenging population. With such technology-based "objective" tools, patients are also differentially able to follow simple commands and in some cases even communicate through modified brain activity. Consequently, the vegetative state and minimally conscious state have been revised and new nosologies have been proposed, namely the unresponsive wakefulness syndrome, the minimally conscious state plus and minus, and the functional locked-in syndrome. Aim. To our mind, an integration of different technical modalities is important to gain a holistic vision of the underlying pathophysiology of disorders of consciousness in general and to promote single-patient medical management in particular.	[Di Perri, Carol] Ist Neurol Nazl C Mondino, Pavia, Italy; [Heine, Lizette; Amico, Enrico; Laureys, Steven; Demertzi, Athena] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium; [Heine, Lizette; Amico, Enrico; Laureys, Steven; Demertzi, Athena] Univ Liege, Dept Neurol, B-4000 Liege, Belgium; [Soddu, Andrea] Univ Western Ontario, Brain & Mind Inst, Dept Phys & Astron, London, ON, Canada		Demertzi, A (corresponding author), Coma Sci Grp, Cyclotron Res Ctr & Neurol Dept, Allee 6 Aout 8,Sart Tilman B30, B-4000 Liege, Belgium.	a.demertzi@ulg.ac.be	Demertzi, Athena/I-1251-2019; Amico, Enrico/AAB-2581-2019; Soddu, Andrea/K-7087-2014; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Demertzi, Athena/0000-0001-8021-3759; Amico, Enrico/0000-0001-6705-9689; Soddu, Andrea/0000-0001-6833-745X; Laureys, Steven/0000-0002-3096-3807; Heine, Lizette/0000-0003-1369-8199; Di Perri, Carol/0000-0003-0284-770X	European CommissionEuropean CommissionEuropean Commission Joint Research Centre; James McDonnell Foundation; European Space AgencyEuropean Space AgencyEuropean Commission; Mind Science Foundation; French Speaking Community Concerted Research Action; Belgian interuniversity attraction poleBelgian Federal Science Policy Office; Public Utility Foundation "Universite Europeenne du Travail"; Fondazione Europea di Ricerca Biomedica; University and University Hospital of Liege	This work was also supported by the European Commission, the James McDonnell Foundation, the European Space Agency, Mind Science Foundation, the French Speaking Community Concerted Research Action, the Belgian interuniversity attraction pole, the Public Utility Foundation "Universite Europeenne du Travail", "Fondazione Europea di Ricerca Biomedica" and the University and University Hospital of Liege.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; [Anonymous], 2003, Clin Med (Lond), V3, P249; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bekinschtein TA, 2008, J NEUROL NEUROSUR PS, V79, P826, DOI 10.1136/jnnp.2007.132738; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Boly M, 2012, BRAIN CONNECT, V2, P1, DOI 10.1089/brain.2011.0049; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Castillo M, 1996, AM J NEURORADIOL, V17, P1; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Charland-Verville V, 2013, CORTEX, V49, P1997, DOI 10.1016/j.cortex.2013.03.003; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Demertzi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00538; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Gantner IS, 2013, FUTUR NEUROL, V8, P43, DOI 10.2217/FNL.12.77; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Heine L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00295; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Jellinger KA, 2013, BRAIN INJURY, V27, P917, DOI 10.3109/02699052.2013.793395; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kulkarni VP, 2007, J CLIN NEUROPHYSIOL, V24, P433, DOI 10.1097/WNP.0b013e31815c2810; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2005, NAT REV NEUROSCI, V6, P899, DOI 10.1038/nrn1789; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2008, NAT CLIN PRACT NEURO, V4, P544, DOI 10.1038/ncpneuro0887; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lehembre R, 2012, ARCH ITAL BIOL, V150, P122, DOI 10.4449/aib.v150i2.1374; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Luyt CE, 2012, ANESTHESIOLOGY, V117, P1311, DOI 10.1097/ALN.0b013e318275148c; Maquet P, 1997, J NEUROSCI, V17, P2807; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Phillips CL, 2011, NEUROIMAGE, V56, P797, DOI 10.1016/j.neuroimage.2010.05.083; Ragazzoni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057069; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Signoretti S, 2002, ACT NEUR S, V81, P373; Sinson G, 2001, AM J NEURORADIOL, V22, P143; TEASDALE G, 1974, LANCET, V2, P81; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tshibanda L, 2010, NEURORADIOLOGY, V52, P15, DOI 10.1007/s00234-009-0614-8; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wood SJ, 2003, SCHIZOPHRENIA BULL, V29, P831, DOI 10.1093/oxfordjournals.schbul.a007049	97	10	10	2	7	EDITRICE KURTIS S R L	MILAN	VIA LUIGI ZOJA 30, 20153 MILAN, ITALY	0021-2571			ANN I SUPER SANITA	Ann. Ist. Super. Sanita	JUL-SEP	2014	50	3					209	220		10.4415/ANN_14_03_03			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	AW5GE	WOS:000346303100003	25292268				2022-02-06	
J	Jiang, YZ; Lan, Q; Wang, QH; Song, DL; Lu, H; Wu, WJ				Jiang, Yun-Zhao; Lan, Qing; Wang, Qi-Hong; Song, Dong-Lei; Lu, Hua; Wu, Wei-Jiang			Gradual and Controlled Decompression for Brain Swelling Due to Severe Head Injury	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						Decompressive craniectomy; Intraoperative brain swelling; Duraplasty	INCREASED INTRACRANIAL-PRESSURE; CHRONIC SUBDURAL-HEMATOMA; CEREBRAL BLOOD-VOLUME; EPIDURAL HEMATOMA; CRANIECTOMY; MANAGEMENT; HYPERTENSION; EDEMA; CRANIOTOMY; ADULTS	Patients suffering from uncontrollable intracranial hypertension due to posttraumatic brain swelling (BS) generally either die or survive in an extremely disabled state. Decompressive craniectomy (DC) with dural augmentation may be the best method to assist these patients. However, the efficacy of DC on functional outcomes remains controversial. One of the factors contributing to poor outcomes could be intraoperative brain extrusion, which is an acute potential complication of DC. The authors have adopted a new surgical technique for traumatic BS that can prevent and control massive intraoperative BS (IOS). In the past 3 years, the authors have used a unique technique, called "gradual and controlled decompression", in the treatment of posttraumatic BS. This procedure consists of creating numerous small dural openings and removing clots; enlarging fenestration in the frontal and temporal basal regions to detect and treat brain contusion; making U-shaped, discontinuous, small dural incisions around the circumference of the craniotomy; and performing an augmentation duraplasty through the discontinuous small opening with dural prosthetic substances. This technique has been employed in 23 patients suffering from posttraumatic BS. In all cases, IOS was prevented and controlled through gradual stepwise decompression, and expanded duraplasty was performed successfully. This new surgical approach for posttraumatic BS can prevent severe extrusion of the brain through the craniotomy defect and allows the gradual and gentle release of the subdural space. Further clinical studies should be conducted to estimate the impact of this new technique on morbidity and mortality rates.	[Jiang, Yun-Zhao; Lu, Hua; Wu, Wei-Jiang] Wuxi Third Peoples Hosp, Dept Neurosurg, Wuxi 214041, Jiangsu, Peoples R China; [Jiang, Yun-Zhao; Lan, Qing] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Jiangsu, Peoples R China; [Wang, Qi-Hong; Song, Dong-Lei] Jiaotong Univ, Ruijin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China		Lan, Q (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, 1055 Sanxiang Rd, Suzhou 215004, Jiangsu, Peoples R China.	drqinglan@163.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alves OL, 2003, ACTA NEUROCHIR, V145, P583, DOI 10.1007/s00701-003-0055-9; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bouma GJ, 1998, ACT NEUR S, V71, P272; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Citerio G, 2007, INTENS CARE MED, V33, P45, DOI 10.1007/s00134-006-0381-5; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Liu JT, 2006, ACTA NEUROCHIR, V148, P313, DOI 10.1007/s00701-005-0723-z; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Mitchell P, 2004, ACTA NEUROCHIR, V146, P159, DOI 10.1007/s00701-003-0186-z; Ogasawara K, 2000, SURG NEUROL, V54, P155, DOI 10.1016/S0090-3019(00)00281-0; Ogasawara K, 1999, NEUROSURGERY, V45, P484, DOI 10.1097/00006123-199909000-00014; Park J, 2009, J NEUROSURG, V110, P101, DOI 10.3171/2008.4.17540; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Raposio E, 1998, ANN PLAS SURG, V41, P17, DOI 10.1097/00000637-199807000-00004; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Visocchi M, 2008, ACT NEUR S, V101, P137; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	31	10	14	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	JUL	2014	69	3					461	466		10.1007/s12013-014-9818-6			6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AJ6GC	WOS:000337787700011	24442991				2022-02-06	
J	Wang, L; Yao, X; Xiao, L; Tang, XG; Ding, H; Zhang, HX; Yuan, JS				Wang, Lei; Yao, Xiang; Xiao, Li; Tang, Xingguo; Ding, Hua; Zhang, Hongxi; Yuan, Jishan			The effects of spinal cord injury on bone healing in patients with femoral fractures	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injury; Femoral fracture; Bone healing; Callus	TRAUMATIC BRAIN-INJURY; HETEROTOPIC OSSIFICATION; CALLUS FORMATION; RISK-FACTORS; HEAD-INJURY; RESPONSES; MEN	Background: Orthopedic literature states that fractures of long bones, when associated with traumatic brain injuries, frequently heal with excessive callus and faster than normal. Few studies, however, have reported these phenomena being induced by spinal cord injury (SCI). Our objective is to compare the extent of callus and the rate of healing of long-bone fractures in patients with or without SCI. Subgroup comparisons were performed among the patients with SCI in terms of different levels of SCI. Methods: The final mean volume of callus formation and the rate of union of nailed fractures of the femur were determined radiologically in 22 femoral fracture patients with SCI (seven cervical, six thoracic, and nine lumbar spine injury) and compared with those in a group of 22 patients with similar types of fractures but without SCI. Results: The final mean callus volume in the fracture/SCI group was significantly higher than the fracture-only group (P < 0.001). The fractures in the fracture/SCI group united in an average time of 22.86 weeks compared with 25.04 weeks in the fracture-only group (P < 0.05). We observed 84.6% (11 of 13) of patients with cervical and thoracic SCI patients with accelerated fracture healing (cervical 6 of 7, thoracic 5 of 6), but only 44.4% (4 of 9) of patients with lumbar SCI appeared to show this phenomenon (P < 0.05). Conclusions: These results confirm that SCI may be associated with accelerated fracture healing and enhanced callus formation. Furthermore, our study revealed a trend toward enhanced osteogenesis in cervical or thoracic SCI compared with lumbar SCI.	[Wang, Lei; Yao, Xiang; Xiao, Li; Tang, Xingguo; Ding, Hua; Zhang, Hongxi; Yuan, Jishan] Jiangsu Univ, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China		Yuan, JS (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China.	yuanjishan890@yahoo.com.cn					ABRAMSON DJ, 1949, J BONE JOINT SURG AM, V31-A, P275, DOI 10.2106/00004623-194931020-00005; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Campagnolo DI, 1999, AM J PHYS MED REHAB, V78, P361, DOI 10.1097/00002060-199907000-00013; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Ding WG, 2011, OSTEOPOROSIS INT, V22, P507, DOI 10.1007/s00198-010-1256-8; Freehafer A A, 1966, Med Serv J Can, V22, P471; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Huang TS, 1998, AM J PHYS MED REHAB, V77, P108, DOI 10.1097/00002060-199803000-00004; INGRAM RR, 1989, PARAPLEGIA, V27, P133, DOI 10.1038/sc.1989.20; Kim JS, 1996, STROKE, V27, P1553, DOI 10.1161/01.STR.27.9.1553; KNUDSEN L, 1982, SCAND J RHEUMATOL, V11, P27, DOI 10.3109/03009748209098110; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Li S, 2001, Hua Xi Yi Ke Da Xue Xue Bao, V32, P240; Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301; Miyamoto T, 1987, Nihon Seikeigeka Gakkai Zasshi, V61, P1135; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; NOTTAGE WM, 1981, CLIN ORTHOP RELAT R, P65; OLLE MM, 1993, ARCH PHYS MED REHAB, V74, P706, DOI 10.1016/0003-9993(93)90030-E; PASINETTI GM, 1993, NEUROSCIENCE, V54, P893, DOI 10.1016/0306-4522(93)90583-2; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; RAGNARSSON KT, 1981, ARCH PHYS MED REHAB, V62, P418; Wang L, 2011, J SPINAL CORD MED, V34, P501, DOI 10.1179/2045772311Y.0000000034; WANG YH, 1992, AM J PHYS MED REHAB, V71, P328, DOI 10.1097/00002060-199212000-00004; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193	28	10	12	0	6	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2014	37	4					414	419		10.1179/2045772313Y.0000000155			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ1XJ	WOS:000342577700011	24621032	Green Published			2022-02-06	
J	Wang, RH; Hong, J; Lu, MM; Neil, JE; Vitek, MP; Liu, XZ; Warner, DS; Li, FQ; Sheng, HX				Wang, Ruihua; Hong, Jun; Lu, Miaomiao; Neil, Jessica E.; Vitek, Michael P.; Liu, Xiaozhi; Warner, David S.; Li, Fengqiao; Sheng, Huaxin			ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						outcome; apoE; spinal cord injury; rat; mimetic	CENTRAL-NERVOUS-SYSTEM; E-BASED PEPTIDE; IMPROVES COGNITIVE PERFORMANCE; GLOBAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE PRODUCTION; APOLIPOPROTEIN-E; MURINE MODEL; LIPID-METABOLISM; KNOCKOUT MICE; EXPRESSION	Apolipoprotein E (apoE), a plasma protein responsible for transporting lipid and cholesterol, modulates responses of the central nervous system to injury. Small peptides derived from the receptor-binding region of apoE can simulate some important bioactivities of apoE holoprotein and offer neuroprotection against brain injury. We tested whether COG1410, an apoE-mimetic peptide, provides protection in a rat model of spinal cord injury (SCI). Traumatic injury was created at T8 by a cortical impact device. Injured rats were randomized to four treatment groups: vehicle, 0.15, 0.3, or 0.6 mg/kg COG1410; sham surgery rats received vehicle. Basso, Beattie, Bresnahan neurological score was evaluated prior to injury and at 1, 3, 7, and 14 days after injury. Histological changes were evaluated at 14 days. All injured rats lost body weight during the first week following injury. Body weight recovery was significantly improved in rats treated with COG1410. Mechanical impact resulted in severe motor deficit, and most animals had a BBB score of 0-1 at 24 hours postinjury. COG1410-treated rats showed significantly improved functional recovery and ameliorated motor deficit at 14 days postinjury. Histological analysis showed that COG1410 groups had a significantly reduced lesion size at the site of injury, a larger preserved luxol fast blue-stained area, and more visible neurons in the surrounding area of injury. Microglial activation was also significantly suppressed. These findings indicate that this apoE mimetic effectively improved neurological and histological outcome following SCI in rats, and the effect was associated with inhibition of microglial activation. (c) 2014 Wiley Periodicals, Inc.	[Wang, Ruihua] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Wang, Ruihua; Hong, Jun; Lu, Miaomiao; Liu, Xiaozhi; Warner, David S.; Sheng, Huaxin] Duke Univ, Med Ctr, Dept Anesthesiol, Multidisciplinary Neuroprotect Labs, Durham, NC 27710 USA; [Hong, Jun] Tangshan Gongren Hosp, Tangshan, Hebei, Peoples R China; [Lu, Miaomiao] Zhengzhou Univ, Affiliated Hosp 2, Zhengzhou 450052, Peoples R China; [Neil, Jessica E.; Vitek, Michael P.; Li, Fengqiao] Cognosci Inc, Res Triangle Pk, NC USA; [Liu, Xiaozhi] Fifth Cent Hosp Tianjin, Tianjin, Peoples R China; [Warner, David S.] Duke Univ, Med Ctr, Dept Surg Neurosurg, Durham, NC 27710 USA; [Warner, David S.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA		Sheng, HX (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094, Durham, NC 27710 USA.	sheng001@mc.duke.edu		Hong, Jun/0000-0003-1575-5695; Vitek, Michael/0000-0001-8140-8048	United States Public Health ServiceUnited States Department of Health & Human ServicesUnited States Public Health Service [R43 NS058239]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R43NS058239] Funding Source: NIH RePORTER	Contract grant sponsor: United States Public Health Service, contract grant number: R43 NS058239.	Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Bales KR, 2010, NEUROPHARMACOLOGY, V59, P295, DOI 10.1016/j.neuropharm.2010.01.005; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Colton CA, 2002, NEUROBIOL AGING, V23, P777, DOI 10.1016/S0197-4580(02)00016-7; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gondim FD, 2002, ARCH PHYS MED REHAB, V83, P1479, DOI 10.1053/apmr.; Hiruma S, 1999, NEUROL RES, V21, P313, DOI 10.1080/01616412.1999.11740938; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Kaufman NA, 2010, BEHAV BRAIN RES, V214, P395, DOI 10.1016/j.bbr.2010.06.017; Koch S, 2001, J LIPID RES, V42, P1143; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 2000, J LIPID RES, V41, P613; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laskowitz DT, 1998, NEUROREPORT, V9, P615, DOI 10.1097/00001756-199803090-00010; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Nakai M, 1996, NEUROSCI LETT, V211, P41, DOI 10.1016/0304-3940(96)12716-6; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; Seitz A, 2005, HUM MOL GENET, V14, P2661, DOI 10.1093/hmg/ddi296; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; SNIPS GJ, 1986, P NATL ACAD SCI USA, V83, P1130, DOI 10.1073/pnas.83.4.1130; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Van Dijk KW, 2000, INT J TISSUE REACT, V22, P49; Wang H, 2013, EXP NEUROL, V241, P67, DOI 10.1016/j.expneurol.2012.11.027; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100	42	10	14	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2014	92	7					884	892		10.1002/jnr.23371			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG8YL	WOS:000335704400007	24633884				2022-02-06	
J	Wang, YC; Xia, QJ; Ba, YC; Wang, TY; Lin, N; Zou, Y; Shang, FF; Zhou, XF; Wang, TH; Fu, XM; Qi, JG				Wang, You-Cui; Xia, Qing-Jie; Ba, Ying-Chun; Wang, Ting-Yong; Lin, Na; Zou, Yu; Shang, Fei-Fei; Zhou, Xin-Fu; Wang, Ting-Hua; Fu, Xue-Mei; Qi, Jian-Guo			Transplantation of olfactory ensheathing cells promotes the recovery of neurological functions in rats with traumatic brain injury associated with downregulation of Bad	CYTOTHERAPY			English	Article						behavior; olfactory ensheathing cells; rats; transplantation; traumatic brain injury	NERVE GROWTH-FACTOR; ADULT-RAT; SPINAL-CORD; SCHWANN-CELLS; IN-VITRO; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; PC12 CELLS; APOPTOSIS; EXPRESSION	Background aims. The neuroprotective effects of olfactory ensheathing cells (OECs) after transplantation have largely been known in the injured nervous system. However, the underlying mechanisms still must be further elucidated. We explored the effects of OEC transplantation on the recovery of neurophysiologic function and the related anti-apoptosis mechanism in acute traumatic brain injury. Methods. The OECs from neonatal Sprague-Dawley rats were isolated, identified and labeled and then were immediately transplanted into the regions surrounding the injured brain site that is resulted from free-weight drop injury. Results. Nerve growth factor and it's recepor, p75 was expressed in cultured OECs. Transplanted OECs survived, migrated around the injury site and significantly improved the neurological severe scores compared with the control group (P < 0.05). OEC transplantation significantly increased, the number of GAP-43-immunopositive fibers and synaptophysin-positive vesicles (P < 0.05) but significantly decreased the number of apoptotic cells (P < 0.05). On the molecular level, the expression of Bad in the OEC transplantation group was significantly downregulated (P < 0.05). Conclusions. OEC transplantation could effectively improve neurological deficits in TBI rats; the underlying mechanism may be related with their effects on neuroprotection and regeneration induction, which is associated with the downregulation of the apoptotic molecule Bad.	[Wang, You-Cui; Wang, Ting-Hua; Qi, Jian-Guo] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Histol Embryol & Neurobiol, Chengdu 610041, Peoples R China; [Xia, Qing-Jie; Zou, Yu; Shang, Fei-Fei; Wang, Ting-Hua] Sichuan Univ, Translat Neurosci Ctr, Inst Neurobiol Dis, Chengdu 610041, Peoples R China; [Xia, Qing-Jie; Zou, Yu; Shang, Fei-Fei; Wang, Ting-Hua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Ba, Ying-Chun; Wang, Ting-Yong; Lin, Na; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Kunming, Peoples R China; [Fu, Xue-Mei] Shenzhen Childrens Hosp, Shenzhen, Guangdong, Peoples R China; [Zhou, Xin-Fu] Univ S Australia, Div Hlth Sci, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia		Qi, JG (corresponding author), Sichuan Univ, West China Sch Preclin & Forens Med, Dept Histol Embryol & Neurobiol, Chengdu 610041, Peoples R China.	fxm2j2004@163.com; jgqi@scu.edu.cn	zhou, xin-fu/F-4119-2013; Zhou, Xiaofang/C-6169-2013	zhou, xin-fu/0000-0002-8687-0175; Zhou, Xiaofang/0000-0001-6343-1455; Shang, Fei-Fei/0000-0002-2706-2100	Natural Science Fund of Yunnan ProvinceNatural Science Foundation of Yunnan Province [2010ZC109]; China Nation Science Foundation [81271358, 81070991, 81260191]	This study was supported by Natural Science Fund of Yunnan Province (No. 2010ZC109) and by a grant from China Nation Science Foundation (No. 81271358, 81070991 and 81260191).	Agrawal AK, 2004, NEUROBIOL DIS, V16, P516, DOI 10.1016/j.nbd.2004.04.014; [Anonymous], 1999, JAMA, V282, P974; Deumens R, 2006, EXP NEUROL, V200, P89, DOI 10.1016/j.expneurol.2006.01.030; Ebel C, 2013, NEUROCHEM RES, V38, P1078, DOI 10.1007/s11064-013-1023-2; Elyaman W, 2002, MOL BRAIN RES, V109, P233, DOI 10.1016/S0169-328X(02)00582-X; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; Faul M, 2010, TRAUMATIC BRAIN INJU; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gomez M, 2008, NEUROSCIENCE, V153, P687, DOI 10.1016/j.neuroscience.2008.02.038; Gong QZ, 1996, J COMP NEUROL, V366, P1; Gudino-Cabrera G, 2000, GLIA, V30, P49, DOI 10.1002/(SICI)1098-1136(200003)30:1<49::AID-GLIA6>3.0.CO;2-M; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Imaizumi T, 1998, J NEUROSCI, V18, P6176; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kumar R, 2005, GLIA, V50, P12, DOI 10.1002/glia.20154; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Li Y, 2007, GLIA, V55, P312, DOI 10.1002/glia.20458; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu Y, 2010, MOL VIS, V16, P2903; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Lu Wen-Guo, 2007, Shengli Xuebao, V59, P51; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; MARINPADILLA M, 1989, J COMP NEUROL, V288, P339, DOI 10.1002/cne.902880211; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043; Olanow CW, 1996, J NEURAL TRANSM-SUPP, P75; Pierucci D, 2001, DIABETOLOGIA, V44, P1281, DOI 10.1007/s001250100650; Provenzano MJ, 2008, LARYNGOSCOPE, V118, P87, DOI 10.1097/MLG.0b013e31814b8d9f; Provenzano MJ, 2011, MOL CELL NEUROSCI, V47, P306, DOI 10.1016/j.mcn.2011.05.010; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 2000, PROG BRAIN RES, V128, P265; RAMONCUETO A, 1993, EUR J NEUROSCI, V5, P1172, DOI 10.1111/j.1460-9568.1993.tb00971.x; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Rao YJ, 2013, CELL TRANSPLANT, V22, pS21, DOI 10.3727/096368913X672127; Roberts ML, 2000, MOL CELL NEUROSCI, V16, P97, DOI 10.1006/mcne.2000.0867; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Shyu WC, 2008, J CLIN INVEST, V118, P2482, DOI 10.1172/JCI34363; Singh SK, 2011, GROWTH FACTORS, V29, P278, DOI 10.3109/08977194.2011.616200; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stichel CC, 1996, EXP NEUROL, V140, P21, DOI 10.1006/exnr.1996.0111; Tisay KT, 1999, J NEUROSCI, V19, P9890; VALVERDE F, 1991, J COMP NEUROL, V307, P658, DOI 10.1002/cne.903070411; Wales SQ, 2007, J NEUROCHEM, V103, P365, DOI 10.1111/j.1471-4159.2007.04745.x; Wang B, 2006, NEUROSCI LETT, V401, P65, DOI 10.1016/j.neulet.2006.02.085; Wei Y, 2012, CHINESE MED J-PEKING, V125, P3875, DOI 10.3760/cma.j.issn.0366-6999.2012.21.024; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Wu EHT, 2005, CELL SIGNAL, V17, P881, DOI 10.1016/j.cellsig.2004.11.008; Xiao M, 2005, EXP NEUROL, V194, P12, DOI 10.1016/j.expneurol.2005.01.021; Xiao M, 2007, NEUROBIOL DIS, V26, P363, DOI 10.1016/j.nbd.2007.01.012; Zhang Q, 2012, CELL BIOL INT, V36, P419, DOI 10.1042/CBI20100900	54	10	12	1	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	JUL	2014	16	7					1000	1010		10.1016/j.jcyt.2013.12.009			11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	AJ4OK	WOS:000337655500013	24582457				2022-02-06	
J	Yuan, Y; Pan, SM; Sun, ZM; Dan, QQ; Liu, J				Yuan, Yuan; Pan, Shumao; Sun, Zhaoming; Dan, Qiqin; Liu, Jia			Brain-derived neurotrophic factor-modified umbilical cord mesenchymal stem cell transplantation improves neurological deficits in rats with traumatic brain injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						contusion brain injury; umbilical cord mesenchymal stem cells (UCMSC); BDNF; neurological function improvement	ADULT RATS; BDNF; EXPRESSION; NT-3; NGF; INCREASES; GLUTAMATE; NEURONS; MODEL	This study explored the effect of brain-derived neurotrophic factor (BDNF) gene-modified umbilical cord mesenchymal stem cell (UCMSC) transplantation on neurological functional improvement in rats after brain trauma. A rat model of cerebral contusion in the motor-sensory cortex was established by the weight hammer-falling method. UCMSCs were cultured and transferred with BDNF gene. After determining BDNF expression and activity, the BDNF gene-modified UCMSCs were implanted into brains of rats receiving the brain injury. The neurological function was evaluated 1 and 2 weeks after brain injury. BDNF expression was then determined by immunohistochemistry. Severe neurological dysfunction was observed in animals subjected to contusion brain injury (10.50 +/- 0.53). A significant improvement in neurological function was found in the UCMSC transplantation animals (7.75 +/- 0.71) compared with the brain injury only group (p < 0.01). Rats with BDNF gene-modified UCMSCs showed the highest improvement in behavior (5.50 +/- 0.76; p < 0.01). BDNF gene-modified UCMSCs can survive and migrate in rat cerebral tissues. The transplantation of these UCMSCs can improve the neurological functions of rats with traumatic brain injury.	[Yuan, Yuan; Pan, Shumao; Sun, Zhaoming] Yantai Yuhuangding Hosp, Dept Neurosurg, Yantai 264005, Peoples R China; [Dan, Qiqin; Liu, Jia] Sichuang Univ, West China Hosp, Inst Neurol Dis, Chengdu, Peoples R China; [Dan, Qiqin] Kunming Med Coll, Inst Neurosci, Kunming, Peoples R China		Yuan, Y (corresponding author), Yantai Yuhuangding Hosp, Dept Neurosurg, Yantai 264005, Peoples R China.	yuanyuandoc@yeah.net			Yantai Science and Technology Development Project [2007-139-4]; Chinese Medical Board of New York [CMB00-72]	This study was supported by the Yantai Science and Technology Development Project (No. 2007-139-4) and the Chinese Medical Board of New York (CMB00-72).	Alrashdan MS, 2011, ACTA NEUROCHIR, V153, P2021, DOI 10.1007/s00701-011-1054-x; Ba YC, 2010, NEUROCHEM RES, V35, P273, DOI 10.1007/s11064-009-0052-3; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen J, 2007, NEUROSCI RES, V59, P399, DOI 10.1016/j.neures.2007.08.006; DAVIES AM, 1994, NATURE, V368, P193, DOI 10.1038/368193a0; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Jin HJ, 2010, CELL MOL LIFE SCI, V67, P1845, DOI 10.1007/s00018-010-0292-z; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Li XL, 2007, NEUROPEPTIDES, V41, P135, DOI 10.1016/j.npep.2007.02.001; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Myoung WL, 2004, BIOCHEM BIOPH RES CO, V320, P273; Qin DX, 2006, NEUROSCI LETT, V410, P222, DOI 10.1016/j.neulet.2006.10.006; Wang TH, 2008, J MOL NEUROSCI, V35, P161, DOI 10.1007/s12031-007-9032-8; Zhang HT, 2007, J HISTOCHEM CYTOCHEM, V55, P1, DOI 10.1369/jhc.6A6952.2006; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhou X, 2009, NEUROPEPTIDES, V43, P363, DOI 10.1016/j.npep.2009.07.001	22	10	10	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	JUL	2014	124	7					524	531		10.3109/00207454.2013.859144			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI6YQ	WOS:000337024700010	24200297				2022-02-06	
J	Wetterhall, M; Bergquist, J; Hillered, L; Hjort, K; Dahlin, AP				Wetterhall, Magnus; Bergquist, Jonas; Hillered, Lars; Hjort, Klas; Dahlin, Andreas P.			Identification of human cerebrospinal fluid proteins and their distribution in an in vitro microdialysis sampling system	EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Protein adsorption; Surface analysis on-Surface enzymatic digestion (oSED); Microdialysis (MD); Cerebrospinal fluid (CSF); Mass spectrometry (MS)	TRAUMATIC BRAIN-INJURY; ENHANCED MICRODIALYSIS; SOLID-SURFACES; CEREBRAL MICRODIALYSIS; ADSORPTION; QUANTIFICATION; NEUROPEPTIDES; BIOMATERIALS; CYTOKINES; FUTURE	A qualitative study is presented on how proteins from a complex biological sample are distributed in a microdialysis sample system. A comparison between proteins identified in the human ventricular cerebrospinal fluid (CSF) sample, the collected dialysate and the proteins adsorbed onto the membrane was conducted. The microdialysis experiment was performed in vitro at 37 C for the duration of 24 h. Thereafter, the membranes were removed from the catheter and the adsorbed proteins were tryptically digested using the on-surface enzymatic digestion (oSED) protocol. The CSF samples and the dialysates were digested using a standard in-solution trypsin digestion protocol. In the final phase, the samples were analysed using nano-liquid chromatography in combination with tandem mass spectrometry. In the four sample compartments analysed (CSF start, Membrane, Dialysate, CSF end) a total of 134 different proteins were found. However, most of the identified proteins (n = 87) were uniquely found in one sample compartment only. Common CSF proteins such as albumin, apolipoproteins and cystatin C together with plasma proteins such as hemoglobin and fibrinogen were among the 11 proteins that were found in all samples. These proteins are present in high concentrations in CSF, which means that they effectively block out the detection signal of less abundant proteins. Therefore, only 25% of the proteins adsorbed onto the membrane were detected in the CSF compared with the dialysate that shared 44% of its proteins with the CSF. The proteins adsorbed onto the membrane were significantly more hydrophobic, had a lower instability index and more thermostable compared to the proteins in the CSF and the dialysate. The results suggest that proteins adsorbed onto the microdialysis membranes may escape detection because they are prevented from passing the membrane into the dialysate. Thus, the membrane needs to be examined after sample collection in order to better verify the protein content in the original sample. This is particularly important when searching for new protein biomarkers for neurodegenerative diseases. (C) 2013 Elsevier B.V. All rights reserved.	[Wetterhall, Magnus; Bergquist, Jonas] Uppsala Univ, Dept Chem BMC, SE-75124 Uppsala, Sweden; [Wetterhall, Magnus; Bergquist, Jonas] Uppsala Univ, SciLifeLab, SE-75124 Uppsala, Sweden; [Hillered, Lars] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden; [Hjort, Klas; Dahlin, Andreas P.] Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden		Dahlin, AP (corresponding author), Uppsala Univ, Dept Engn Sci, POB 534, SE-75121 Uppsala, Sweden.	andreas.dahlin@angstrom.uu.se	Bergquist, Jonas/C-5894-2015	Dahlin, Andreas/0000-0002-0041-0902; Hillered, Lars/0000-0002-2808-9292; Bergquist, Jonas/0000-0002-4597-041X	Uppsala Berzelii Technology Centre for Neurodiagnostics; Swedish Governmental Agency for Innovation SystemsVinnova; Swedish Research CouncilSwedish Research CouncilEuropean Commission [P29797-1, 621-2008-3562, 621-2011-4423]	This research was supported by Uppsala Berzelii Technology Centre for Neurodiagnostics, with financing from the Swedish Governmental Agency for Innovation Systems and the Swedish Research Council Grant number P29797-1, 621-2008-3562, 621-2011-4423. We acknowledge CMA Microdialysis and Pharmacosmos for material support and Visualize your Science for graphical assistance.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Duo J, 2011, ANAL BIOANAL CHEM, V399, P783, DOI 10.1007/s00216-010-4333-0; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Huhmer AF, 2006, DIS MARKERS, V22, P3; Klammer AA, 2006, J PROTEOME RES, V5, P695, DOI 10.1021/pr050315j; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Michel R, 2006, SURF INTERFACE ANAL, V38, P1386, DOI 10.1002/sia.2382; Monzo A, 2009, TRAC-TREND ANAL CHEM, V28, P854, DOI 10.1016/j.trac.2009.03.002; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersson A, 2004, ANAL CHEM, V76, P1678, DOI 10.1021/ac035305l; Pettersson A, 2001, ACTA BIOCHIM POL, V48, P1117; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; Schmerberg CM, 2013, ANAL CHEM, V85, P915, DOI 10.1021/ac302403e; Schutte RJ, 2004, ANAL CHEM, V76, P6058, DOI 10.1021/ac0493626; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; SHIRAHAMA H, 1989, J COLLOID INTERF SCI, V129, P483, DOI 10.1016/0021-9797(89)90462-1; Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059; Wang XD, 2006, ANAL CHEM, V78, P6026, DOI 10.1021/ac0602930; Wang YX, 2009, ANAL CHIM ACTA, V651, P105, DOI 10.1016/j.aca.2009.08.009; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	33	10	10	1	22	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-0987	1879-0720		EUR J PHARM SCI	Eur. J. Pharm. Sci.	JUN 16	2014	57				SI		34	40		10.1016/j.ejps.2013.12.011			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AH9OJ	WOS:000336471400005	24361471				2022-02-06	
J	Dai, SH; Qin, N; Chen, T; Luo, P; Zhang, L; Rao, W; Yang, YF; Jiang, XF; Fei, Z				Dai, Shu-Hui; Qin, Na; Chen, Tao; Luo, Peng; Zhang, Lei; Rao, Wei; Yang, Yue-Fan; Jiang, Xiao-Fan; Fei, Zhou			Activation of mGluR5 Attenuates NMDA-Induced Neurotoxicity through Disruption of the NMDAR-PSD-95 Complex and Preservation of Mitochondrial Function in Differentiated PC12 Cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						glutamate; mGlu receptor; NMDAR (N-methyl-D-aspartate receptor) receptor; post-synaptic density protein 95; mitochondrial dysfunction	METABOTROPIC GLUTAMATE RECEPTORS; TRAUMATIC NEURONAL INJURY; LONG-TERM POTENTIATION; ISCHEMIC BRAIN-INJURY; IN-VITRO; PERMEABILITY TRANSITION; MEDIATED EXCITOTOXICITY; POSTSYNAPTIC DENSITY-95; DOWN-REGULATION; PSD-95	Glutamate-mediated toxicity is implicated in various neuropathologic conditions, and activation of ionotropic and metabotropic glutamate receptors is considered to be the most important mechanism. It has been reported that pharmacological saturation of metabotropic glutamate receptors (mGluRs) can facilitate N-methyl-D-aspartate receptor (NMDAR) related signaling cascades, but the mechanism leading to mGluR-NMDAR interactions in excitotoxic neuronal injury has remained unidentified. In the present study, we investigated the role of mGluR5 in the regulation of N-methyl-D-aspartate (NMDA)-induced excitotoxicity in differentiated PC12 cells. We found that activation of mGluR5 with the specific agonist R, S-2-chloro-5-hydroxyphenylglycine (CHPG) increased cell viability and inhibited lactate dehydrogenase (LDH) release in a dose-dependent manner. CHPG also inhibited an increase in the Bax/Bcl-2 ratio, attenuated cleavage of caspase-9 and caspase-3, and reduced apoptotic cell death after NMDA treatment. The NMDA-induced mitochondrial dysfunction, as indicated by mitochondrial reactive oxygen species (ROS) generation, collapse of mitochondrial membrane potential (MMP), and cytochrome c release, was also partly prevented by CHPG treatment. Furthermore, CHPG blocked the NMDA-induced interaction of NMDAR with postsynaptic density protein-95 (PSD-95), but had no effects on intracellular calcium concentrations. All these results indicated that activation of mGluR5 protects differentiated PC12 cells from NMDA-induced neuronal excitotoxicity by disrupting NMDAR-PSD-95 interaction, which might be an ideal target for investigating therapeutic strategies in various neurological diseases where excitotoxicity may contribute to their pathology.	[Dai, Shu-Hui; Chen, Tao; Luo, Peng; Zhang, Lei; Rao, Wei; Yang, Yue-Fan; Jiang, Xiao-Fan; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xijing Inst Clin Neurosci, Xian 710032, Peoples R China; [Qin, Na] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China; [Chen, Tao] PLA, Hosp 123, Dept Surg, Bengbu 233000, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xijing Inst Clin Neurosci, Xian 710032, Peoples R China.	fmmudaishuhui@163.com; fmmuqinna@163.com; fmmuchentao@163.com; fmmuluopeng@163.com; fmmuzhanglei@163.com; fmmuraowei@163.com; fmmuyangyf@126.com; fmmujiangxiaofan@163.com; zhoufei@fmmu.edu.cn	Yang, Yuefan/AAJ-9136-2020	Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071034, 81371447, 81301037, 81200949, 30930093]; governmental research funds [AWS11J008, 2012BAI11B02]; Program for Changjiang Scholars and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT1053]	This work was supported by the National Natural Science Foundation of China (No. 81071034, No. 81371447, No. 81301037, No. 81200949, and No. 30930093), governmental research funds (No. AWS11J008, and No. 2012BAI11B02), and the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1053).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Alagarsamy S, 2002, PHARMACOL BIOCHEM BE, V73, P299, DOI 10.1016/S0091-3057(02)00826-2; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Ben-Mabrouk F, 2012, EUR J NEUROSCI, V35, P1725, DOI 10.1111/j.1460-9568.2012.08091.x; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Blaabjerg M, 2001, BRAIN RES, V898, P91, DOI 10.1016/S0006-8993(01)02148-5; Bonsi P, 2008, NEUROPHARMACOLOGY, V55, P392, DOI 10.1016/j.neuropharm.2008.05.020; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055601; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Degos V, 2013, ANN NEUROL, V73, P667, DOI 10.1002/ana.23868; Durand D, 2008, NEUROPHARMACOLOGY, V55, P577, DOI 10.1016/j.neuropharm.2008.06.022; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hsieh MH, 2012, PHARMACOL BIOCHEM BE, V102, P64, DOI 10.1016/j.pbb.2012.03.022; Hu SQ, 2009, J NEUROSCI RES, V87, P3626, DOI 10.1002/jnr.22163; Huang H, 2007, J NEUROSCI, V27, P11560, DOI 10.1523/JNEUROSCI.2147-07.2007; Izumi Y, 2012, NEUROPSYCHOPHARMACOL, V37, P609, DOI 10.1038/npp.2011.243; Jin DZ, 2013, J NEUROCHEM, V127, P620, DOI 10.1111/jnc.12434; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Khoboko T, 2008, METAB BRAIN DIS, V23, P9, DOI 10.1007/s11011-007-9050-9; Li B, 2003, J NEUROSCI, V23, P11244; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Luo P, 2013, FEBS J, V280, P6114, DOI 10.1111/febs.12531; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; Meng FJ, 2004, ACTA PHARMACOL SIN, V25, P176; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Movsesyan VA, 2001, J PHARMACOL EXP THER, V296, P41; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; O'Leary DM, 2000, BRIT J PHARMACOL, V131, P1429, DOI 10.1038/sj.bjp.0703715; Padanyi R, 2009, BBA-MOL CELL RES, V1793, P1023, DOI 10.1016/j.bbamcr.2008.11.007; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Sheng M, 2001, J CELL SCI, V114, P1251; Sung DK, 2010, J NEUROSCI METH, V193, P232, DOI 10.1016/j.jneumeth.2010.08.020; Sureda FX, 1996, NEUROREPORT, V7, P1824, DOI 10.1097/00001756-199607290-00027; Wang PL, 2013, MOLECULES, V18, P13027, DOI 10.3390/molecules181013027; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245; Zieminska E, 2003, NEUROCHEM INT, V43, P481, DOI 10.1016/S0197-0186(03)00038-X	51	10	10	3	12	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2014	15	6					10892	10907		10.3390/ijms150610892			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AK7WS	WOS:000338639000100	24941251	Green Published, gold, Green Submitted			2022-02-06	
J	Majdan, M; Mauritz, W; Rusnak, M; Brazinova, A; Rehorcikova, V; Leitgeb, J				Majdan, Marek; Mauritz, Walter; Rusnak, Martin; Brazinova, Alexandra; Rehorcikova, Veronika; Leitgeb, Johannes			Long-Term Trends and Patterns of Fatal Traumatic Brain Injuries in the Pediatric and Adolescent Population of Austria in 1980-2012: Analysis of 33 Years	JOURNAL OF NEUROTRAUMA			English	Article						epidemiology; pediatric brain injury; traumatic brain injury	CHILD SAFETY SEATS; HEAD-INJURIES; UNITED-STATES; EPIDEMIOLOGY; SURVEILLANCE; DEATH; OUTCOMES; SUICIDE; CRASHES; BELTS	Traumatic brain injuries (TBIs) are of special concern in the pediatric and adolescent population because of high incidence, mortality, and potential years of life lost (PYLL). Knowledge on causes and mortality trends is essential for effective prevention. The aim of this study was to analyze the long-term trends and causes of TBI-related mortality between 1980 and 2012 in the pediatric and adolescent populations of Austria. Death certificate data on TBI-related deaths of children and adolescents 0-19 years of age and exact population numbers were obtained from the Austrian Statistical Office. Five age groups were created. Mortality trends and causes of TBI were analyzed. PYLL were used to indicate the public health impact. Of 5319 identified TBI-related deaths, 75% were male victims. The annual mortality rates per 100,000 between 1980 and 2012 decreased from 25 to 2.6 in males, from 8.5 to 1.0 in females, and from 16.9 to 1.8 in the total population. Those 15-19 years of age had the highest mortalities, followed by 0-2 years of age. Over 80% of deaths were caused by accidents, inflicted TBIs were most common in those 0-2 years of age, and traffic accidents in those 15-19 years of age. In the studied period, 295,793 PYLL could be attributed to TBIs. Measures to prevent traffic accidents contributed significantly to the decrease of mortality and PYLL, especially in 15-to 19-year-old men. Causes and trends of TBI-related mortality exhibit age-group-specific patterns, and this knowledge could contribute to planning further preventive action to reduce TBI fatalities in the studied population.	[Majdan, Marek; Rusnak, Martin; Brazinova, Alexandra; Rehorcikova, Veronika] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava 91843, Slovakia; [Majdan, Marek; Mauritz, Walter; Rusnak, Martin; Brazinova, Alexandra] Int Neurotrauma Res Org, Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012; Rusnak, Martin/K-9349-2016	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Rusnak, Martin/0000-0003-3321-1042; Mauritz, Walter/0000-0001-9043-3712			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; AHMAD OE, 2000, GPE DISCUSSION PAPER; American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Chisholm D, 2008, ROAD TRAFFIC INJURY; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ehrlich PF, 2006, J PEDIATR SURG, V41, P1854, DOI 10.1016/j.jpedsurg.2006.06.012; Elliott MR, 2006, ARCH PEDIAT ADOL MED, V160, P617, DOI 10.1001/archpedi.160.6.617; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Hameed SM, 2004, AM J PUBLIC HEALTH, V94, P554, DOI 10.2105/AJPH.94.4.554; Hertz E., 1996, REVISED ESTIMATED CH; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Klanner W., 2004, UNFALLVERLETZUNGEN F; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Levitt SD, 2008, REV ECON STAT, V90, P158, DOI 10.1162/rest.90.1.158; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Partyka S.C., 1988, LIVES SAVE CHILD RES; Pelkonen Mirjami, 2003, Paediatr Drugs, V5, P243, DOI 10.2165/00148581-200305040-00004; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rodriguez SR, 2006, PUBLIC HEALTH REP, V121, P282, DOI 10.1177/003335490612100310; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shaw D, 2005, AM J FOREN MED PATH, V26, P309, DOI 10.1097/01.paf.0000188169.41158.58; Skinner R, 2012, CAN MED ASSOC J, V184, P1029, DOI 10.1503/cmaj.111867; Statistics Austria, 2013, KRAF NEUZ; Statistics Austria, 2013, STOCK ROAD VEH AUSTR; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stewart TC, 2003, J TRAUMA, V54, P266, DOI 10.1097/01.TA.0000038699.47295.2D; Stocchetti N, 2010, MINERVA ANESTESIOL, V76, P1052; US Department of Transportation; Federal Motor Carrier Safety Administration, 1984, FED MOT VEH SAF STAN	33	10	11	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2014	31	11					1046	1055		10.1089/neu.2013.3200			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AJ7RS	WOS:000337895300007	24405431				2022-02-06	
J	Pagani, M; Leonardi, M; Covelli, V; Giovannetti, AM; Sattin, D				Pagani, Marco; Leonardi, Matilde; Covelli, Venusia; Giovannetti, Ambra Mara; Sattin, Davide			Risk factors for mortality in 600 patients in vegetative and minimally conscious states	JOURNAL OF NEUROLOGY			English	Article						Vegetative State; Minimally conscious state; Prognosis; Mortality rate	LIFE EXPECTANCY; CHILDREN; DISABILITY; CAREGIVERS; DISORDERS; RECOVERY; BURDEN; COMA	A significant proportion of patients who survive traumatic or nontraumatic severe acquired brain injuries experiences disorders of consciousness. The vegetative state and the minimally conscious state may have different prognoses, and while some patients regain awareness, others have negative outcomes and die. The aim of this work is to identify age-related, medical and behavioural risk factors for mortality in those patients. Participants were enrolled from June 2009 to March 2012 in 107 Italian health care institutions. Univariate and multivariate Cox proportional hazard models were adopted to screen and test candidate risk factors. The study enrolled 600 subjects in vegetative and minimally conscious states for an overall mortality rate of 180.1 per 1,000 person-years. The following traits were associated with a significantly lower chance of survival: age at the acute event higher than 51 years, disease duration less than 1 year, post-anoxic aetiology, absence of visual fixation, and the presence of endocrine, nutritional, and metabolic diseases, and immunity disorders. Clinical history, behavioural assessment, and age-related factors provide important prognostic information on negative outcomes that helps clinicians and researchers to predict patients who are at higher risk of mortality. This knowledge has important clinical, managerial, and ethical implications.	[Pagani, Marco; Leonardi, Matilde; Covelli, Venusia; Giovannetti, Ambra Mara; Sattin, Davide] Neurol Inst Carlo Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, I-20133 Milan, Italy		Pagani, M (corresponding author), Neurol Inst Carlo Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Via Celoria 11, I-20133 Milan, Italy.	marco.pagani@istituto-besta.it	leonardi, matilde/J-9997-2018; COVELLI, VENUSIA/AAG-9232-2020; Sattin, Davide/K-5963-2016	leonardi, matilde/0000-0003-0552-8923; COVELLI, VENUSIA/0000-0002-5965-2658; Sattin, Davide/0000-0001-7736-4337; Giovannetti, Ambra Mara/0000-0002-7496-6727; Pagani, Marco/0000-0002-6052-6931	Italian Ministry of Health-Centre for Disease Control and Prevention (CCM)	The authors are grateful to all partners of the Italian National Consortium "Functioning and disability of patients in vegetative state and minimally conscious state'' for their collaborative support and to the professionals who participated in the study. The centres involved in this study and all persons who participated in data collection are cited in "Appendix 1''. The study was funded by the Italian Ministry of Health-Centre for Disease Control and Prevention (CCM) in the framework of the Italian national project "Functioning and disability in patients in vegetative state and minimally conscious state'' coordinated by the Neurological Institute Carlo Besta IRCCS Foundation and "PRECIOUS-Taking care of people with acquired severe brain injury'' coordinated by Region of Emilia Romagna.	American Medical Association, 2009, ICD9CM WHO AM MED AS; ASHWAL S, 1994, PEDIATR NEUROL, V10, P27, DOI 10.1016/0887-8994(94)90063-9; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Bruno M-A., 2012, COMA DISORDERS CONSC, P11, DOI [DOI 10.1007/978-1-4471-2440-5_2, 10.1007/978-1-4471-2440-5_2]; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Dolce G, 2011, J NEUROTRAUM, V28, P1149, DOI 10.1089/neu.2010.1405; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fantini MP, 2010, BRAIN INJURY, V24, P620, DOI 10.3109/02699051003652831; Formisano R, 2011, FUNCT NEUROL, V26, P15; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giovannetti AM, 2013, ACTA NEUROL SCAND, V127, P10, DOI 10.1111/j.1600-0404.2012.01666.x; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; Leonardi M, 2013, BRAIN INJURY, V27, P473, DOI 10.3109/02699052.2012.750758; Leonardi M, 2012, INT J REHABIL RES, V35, P352, DOI 10.1097/MRR.0b013e328356425d; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SAZBON L, 1991, ACTA NEUROCHIR, V112, P110, DOI 10.1007/BF01405137; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; StataCorp, 2009, STAT STAT SOFTW REL; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; von Wild K, 2012, J Med Life, V5, P3; Zampolini M, 2003, GIORNALE ITALIANO ME, V17, P15	30	10	12	0	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUN	2014	261	6					1144	1152		10.1007/s00415-014-7309-8			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ5TH	WOS:000337750700013	24711058				2022-02-06	
J	Park, MS; Oh, HA; Ko, IG; Kim, SE; Kim, SH; Kim, CJ; Kim, HB; Kim, H				Park, Mi-Sook; Oh, Hyean-Ae; Ko, Il-Gyu; Kim, Sung-Eun; Kim, Sang-Hoon; Kim, Chang-Ju; Kim, Hyun-Bae; Kim, Hong			Influence of mild traumatic brain injury during pediatric stage on short-term memory and hippocampal apoptosis in adult rats	JOURNAL OF EXERCISE REHABILITATION			English	Article						Traumatic brain injury; Hippocampus; Apoptosis; Pediatric stage; Short-term memory		Traumatic brain injury (TBI) is a leading cause of neurological deficit in the brain, which induces short- and long-term brain damage, cognitive impairment with/without structural alteration, motor deficits, emotional problems, and death both in children and adults. In the present study, we evaluated whether mild TBI in childhood causes persisting memory impairment until adulthood. Moreover, we investigated the influence of mild TBI on memory impairment in relation with hippocampal apoptosis. For this, step-down avoidance task, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay, and immunohistochemistry for caspase-3 were performed. Male Sprague-Dawley rats were used in the experiments. The animals were randomly divided into two groups: sham-operation group and TBI-induction group. The mild TBI model was created with an electromagnetic contusion device activated at a velocity of 3.0 m/sec. The results showed that mild TBI during the pediatric stage significantly decreased memory retention. The numbers of TUNEL-positive and caspase-3-positive cells were increased in the TBI-induction group compared to those in the sham-operation group. Defective memory retention and apoptosis sustained up to the adult stage. The present results shows that mild TBI induces long-lasting cognitive impairment from pediatric to adult stages in rats through the high level of apoptosis. The finding of this study suggests that children with mild TBI may need intensive treatments for the reduction of long-lasting cognitive impairment by secondary neuronal damage.	[Park, Mi-Sook; Oh, Hyean-Ae] Daegu Haany Univ, Grad Sch, Dept Hlth & Welf Elderly, Gyongsan, South Korea; [Ko, Il-Gyu; Kim, Sung-Eun; Kim, Sang-Hoon; Kim, Chang-Ju] Kyung Hee Univ, Dept Physiol, Coll Med, Seoul, South Korea; [Kim, Hyun-Bae] Kyung Hee Univ, Dept Taekwondo, Coll Phys Educ, Suwon, South Korea; [Kim, Hong] Daegu Haany Univ, Dept Oriental Sports Med, Coll Biomed Sci, 1 Haanydae Ro, Gyongsan 712715, South Korea		Kim, H (corresponding author), Daegu Haany Univ, Dept Oriental Sports Med, Coll Biomed Sci, 1 Haanydae Ro, Gyongsan 712715, South Korea.	joshua@dhu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2011-0021908]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0021908).	Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Carbonell WS, 1999, ANN NY ACAD SCI, V890, P287, DOI 10.1111/j.1749-6632.1999.tb08005.x; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; IZQUIERDO I, 1995, P NATL ACAD SCI USA, V92, P5047, DOI 10.1073/pnas.92.11.5047; Jin JJ, 2014, J EXERC REHABIL, V10, P69, DOI 10.12965/jer.140103; Johnson A, 2005, HIPPOCAMPUS, V15, P86, DOI 10.1002/hipo.20033; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sim YJ, 2004, NEUROSCI LETT, V372, P256, DOI 10.1016/j.neulet.2004.09.060; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Zhang ZR, 2008, ACTA NEUROPATHOL, V115, P335, DOI 10.1007/s00401-007-0301-y; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	37	10	10	0	0	KOREAN SOC EXERCISE REHABILITATION	SEOUL	264 BAEKJEGOBUN-RO, SONGPA-GU, SEOUL, 138-841, SOUTH KOREA	2288-176X	2288-1778		J EXERC REHABIL	J. Exerc. Rehabil.	JUN	2014	10	3					148	154		10.12965/jer.140109			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VG4GV	WOS:000446803600003	25061593	gold, Green Submitted, Green Published			2022-02-06	
J	Sattin, D; Covelli, V; Pagani, M; Giovannetti, AM; Raggi, A; Meucci, P; Cerniauskaite, M; Quintas, R; Schiavolin, S; Leonardi, M				Sattin, D.; Covelli, V.; Pagani, M.; Giovannetti, A. M.; Raggi, A.; Meucci, P.; Cerniauskaite, M.; Quintas, R.; Schiavolin, S.; Leonardi, M.			Do diagnostic differences between vegetative state and minimally conscious state patients correspond to differences in functioning and disability profiles? Results from an observational multi-center study on patients with DOC	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Persistent vegetative state; Consciousness disorder; Disability	TRAUMATIC BRAIN-INJURY; REVISED CRS-R; DISORDERED CONSCIOUSNESS; STROKE MORTALITY; ITALIAN VERSION; SCALE; COMA; REHABILITATION; RECOVERY; IDENTIFICATION	Background. Patients in vegetative (VS) and minimally conscious state (MCS) have different degrees of consciousness recovery but both display severe levels of disability. Aim. To describe and compare VS and MCS patients' functioning and disability according to ICF model (International Classification of Functioning, Disability and Health). Design. Observational cross-sectional multi-center study involving sixty-nine Italian centers. Setting. Patients recruited in post-acute, long-term care facilities and at home in Italy. Population. Adult patients in VS and MCS. Methods. ICF Functioning profiles were completed and, for each ICF chapter and domain, extension and severity indexes were developed. Indexes have been compared between VS and MCS patients with Mann Whitney U test. Descriptive statistics have been applied to describe the most relevant categories that had a percentage of missing below 25% and that were reported as a problem by at least 50% of patients. Results. A total of 564 patients were enrolled: 396 in VS (mean age 56.8), 168 in MCS (mean age 54.2). Fifty-eight ICF categories were selected: of them, 24 were from Activity and Participation (A&P). Few differences between patients in VS and MCS were reported in Body Functions (BF), mostly referred to mental, sensory and digestive functions; among A&P, differences were found only in learning chapter. For VS patients less environmental barriers were reported than MCS patients. Conclusion. Patients in VS and MCS have similar functioning and disability profiles and similar needs thus levels of care and assistance should not be different across the two conditions. Clinical rehabilitation impact. An ICF-based methodology of data collection enables to describe VS and MCS patients' functioning and disability: this is helpful when rehabilitation programs based on the features of single patients with DOC need to be planned.	[Sattin, D.; Covelli, V.; Pagani, M.; Giovannetti, A. M.; Raggi, A.; Meucci, P.; Cerniauskaite, M.; Quintas, R.; Schiavolin, S.; Leonardi, M.] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Sci Directorate, I-20133 Milan, Italy		Sattin, D (corresponding author), Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Sci Directorate, Via Celoria 11, I-20133 Milan, Italy.	davide.sattin@istituto-besta.it	Cerniauskaite, Milda/AAS-2802-2021; Quintas, Rui/AAJ-6630-2021; leonardi, matilde/J-9997-2018; Schiavolin, Silvia/K-6595-2016; COVELLI, VENUSIA/AAG-9232-2020; Sattin, Davide/AAX-4083-2020; Sattin, Davide/K-5963-2016; Raggi, Alberto/K-5787-2016	Cerniauskaite, Milda/0000-0003-1871-3650; Quintas, Rui/0000-0002-9985-334X; leonardi, matilde/0000-0003-0552-8923; Schiavolin, Silvia/0000-0002-5391-7539; COVELLI, VENUSIA/0000-0002-5965-2658; Sattin, Davide/0000-0001-7736-4337; Sattin, Davide/0000-0001-7736-4337; Raggi, Alberto/0000-0002-7433-7779; Giovannetti, Ambra Mara/0000-0002-7496-6727; Pagani, Marco/0000-0002-6052-6931	Grant of the Italian Center for Disease Control and Prevention (Centro Nazionale per la Prevenzione ed il Controllo delle Malattie), Ministry of Health, Rome, Italy	The study was supported by a Grant of the Italian Center for Disease Control and Prevention (Centro Nazionale per la Prevenzione ed il Controllo delle Malattie, 2009), Ministry of Health, Rome, Italy.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avesani R, 2013, EUR J PHYS REHABIL M; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Brady SL, 2009, J HEAD TRAUMA REHAB, V24, P384, DOI 10.1097/HTR.0b013e3181a8d38e; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Di Carlo A, 2003, CEREBROVASC DIS, V16, P141, DOI 10.1159/000070594; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Ewert T, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410015362; Francescutti C, 2009, DISABIL REHABIL, V31, pS46, DOI 10.3109/09638280903317757; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giovannetti AM, 2012, ACTA NEUROL SCAND; Grill E, 2005, DISABIL REHABIL, V27, P459, DOI 10.1080/09638280400014063; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kunst AE, 2011, STROKE, V42, P2126, DOI 10.1161/STROKEAHA.110.599712; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; Leonardi M, 2012, INT J REHABIL RES; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Leonardi M, 2009, DISABIL REHABIL, V31, pS128, DOI 10.3109/09638280903317765; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lombardi F, 2007, FUNCT NEUROL, V22, P47; MALKMUS D, 1979, REHABILITATION HEAD; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; Ministry of Health of Italy, 2009, REP TECHN SCI COMM V; O'Neil-Pirozzi TM, 2003, BRAIN INJURY, V17, P389, DOI 10.1080/0269905031000070251; Owen AM, 2008, ANN NY ACAD SCI, V1129, P130, DOI 10.1196/annals.1417.018; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Redon J, 2011, EUR HEART J, V32, P1424, DOI 10.1093/eurheartj/ehr045; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; World Health Organization, 2007, INT CLASS FUNCT DIS; Zampolini M, 2013, EUR J PHYS REHAB MED, V49, P365	40	10	12	0	7	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	JUN	2014	50	3					309	321					13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	AN2UN	WOS:000340441500007	24518146				2022-02-06	
J	Wang, IK; Lin, CL; Wu, YY; Kuo, HL; Lin, SY; Chang, CT; Yen, TH; Chuang, FR; Cheng, YK; Huang, CC; Sung, FC				Wang, I. -K.; Lin, C. -L.; Wu, Y. -Y.; Kuo, H. -L.; Lin, S. -Y.; Chang, C. -T.; Yen, T. -H.; Chuang, F. -R.; Cheng, Y. -K.; Huang, C. -C.; Sung, F. -C.			Subdural hematoma in patients with end-stage renal disease receiving hemodialysis	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						cohort study; end-stage renal disease; hemodialysis; subdural hematoma	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; FALLS; COMPLICATIONS; MORTALITY; FAILURE	Background and purposeHemodialysis (HD) may increase the risk of acute subdural hematoma (SDH) with high fatality, but the extent of this disease in non-western populations is unclear. The incidence of and fatality from SDH in patients with end-stage renal disease (ESRD) on HD were examined for an Asian population. MethodsA cohort of 4709 newly diagnosed ESRD patients on HD from 1998 to 2010 and a control cohort of 18663 subjects without any kidney disease were identified from a universal insurance claims database in Taiwan. The incidence and hazard of SDH for the two cohorts and 30-day mortality from SDH were measured by the end of 2010. ResultsThe incidence of SDH was 4.47-fold higher in the HD cohort than in the control cohort (56.3 vs. 12.6 per 10000 person-years) with an adjusted hazard ratio (HR) of 3.81 (95% CI2.77-5.25). HD patients with SDH had a high odds of 30-day mortality with an adjusted odds ratio of 6.34 (95% CI 2.37-16.9). ConclusionsESRD patients with HD were demonstrated to be at high risk of subsequent SDH and to have a high mortality risk from SDH. Proper care for HD patients is necessary to prevent the devastating disorder.	[Wang, I. -K.; Sung, F. -C.] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung 404, Taiwan; [Wang, I. -K.] China Med Univ, Coll Med, Dept Internal Med, Taichung 404, Taiwan; [Wang, I. -K.; Kuo, H. -L.; Lin, S. -Y.; Chang, C. -T.; Huang, C. -C.] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Lin, C. -L.; Sung, F. -C.] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, C. -L.; Sung, F. -C.] China Med Univ, Coll Publ Hlth, Taichung 404, Taiwan; [Wu, Y. -Y.] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 404, Taiwan; [Yen, T. -H.] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; [Yen, T. -H.] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chuang, F. -R.] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Nephrol,Med Ctr, Kaohsiung, Taiwan; [Cheng, Y. -K.] China Med Univ Hosp, Div Neurosurg, Taichung, Taiwan		Sung, FC (corresponding author), China Med Univ, Coll Publ Hlth, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	fcsung1008@yahoo.com	Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505	National Sciences Council, Executive Yuan, Taiwan [NSC 100-2621-M-039-001]; China Medical University Hospital [1MS1]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH102-TD-B-111-004, DOH102-TD-C111-005]	The study was supported partly by the National Sciences Council, Executive Yuan, Taiwan (Grant numbers NSC 100-2621-M-039-001), China Medical University Hospital (Grant number 1MS1) and Taiwan Department of Health Clinical Trial and Research Center for Excellence (Grant numbers DOH102-TD-B-111-004 and DOH102-TD-C111-005).	Abdel-Rahman EM, 2011, QJM-INT J MED, V104, P829, DOI 10.1093/qjmed/hcr108; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Boudville N, 2010, CLIN ENDOCRINOL, V73, P299, DOI 10.1111/j.1365-2265.2010.03821.x; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Desmet C, 2005, AM J KIDNEY DIS, V45, P148, DOI 10.1053/j.ajkd.2004.09.027; Elliott MJ, 2007, AM J KIDNEY DIS, V50, P433, DOI 10.1053/j.ajkd.2007.06.017; GAWAZ MP, 1994, J AM SOC NEPHROL, V5, P36; Gottesman RF, 2003, INT REV PSYCHIATR, V15, P302, DOI 10.1080/09540260310001606683; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hiremath S, 2009, CLIN J AM SOC NEPHRO, V4, P1347, DOI 10.2215/CJN.00810209; LEONARD A, 1975, ANN INTERN MED, V82, P650, DOI 10.7326/0003-4819-82-5-650; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marion DW, 2006, NEUROSURGERY, V58, P655; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Nordio M, 2012, AM J KIDNEY DIS, V59, P819, DOI 10.1053/j.ajkd.2011.12.023; Phelan PJ, 2011, CLIN NEPHROL, V75, P204, DOI 10.5414/CN106481; Power A, 2010, NEPHROL DIAL TRANSPL, V25, P2272, DOI 10.1093/ndt/gfq013; Rossier A, 2012, NEPHROL DIAL TRANSPL, V27, P352, DOI 10.1093/ndt/gfr326; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sood P, 2007, CLIN J AM SOC NEPHRO, V2, P956, DOI 10.2215/CJN.03781106; Takeda K, 1997, NEPHROL DIAL TRANSPL, V12, P952, DOI 10.1093/ndt/12.5.952; Wijdicks EFM, 2000, AM J KIDNEY DIS, V35, P40, DOI 10.1016/S0272-6386(00)70299-X; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	28	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JUN	2014	21	6					894	900		10.1111/ene.12406			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG5LJ	WOS:000335460200016	24689932				2022-02-06	
J	Bartfai, A; Markovic, G; Landahl, KS; Schult, ML				Bartfai, Aniko; Markovic, Gabriela; Landahl, Kristina Sargenius; Schult, Marie-Louise			The protocol and design of a randomised controlled study on training of attention within the first year after acquired brain injury	BMC NEUROLOGY			English	Article						Brain injury; Attention; Statistical process control; Cognitive rehabilitation; Early rehabilitation; Work return; Health economics	STATISTICAL PROCESS-CONTROL; COGNITIVE REHABILITATION; RETURN; WORK; EPIDEMIOLOGY; PROGRAM	Background: To describe the design of the study aiming to examine intensive targeted cognitive rehabilitation of attention in the acute (< 4 months) and subacute rehabilitation phases (4-12 months) after acquired brain injury and to evaluate the effects on function, activity and participation (return to work). Methods/Design: Within a prospective, randomised, controlled study 120 consecutive patients with stroke or traumatic brain injury were randomised to 20 hours of intensive attention training by Attention Process Training or by standard, activity based training. Progress was evaluated by Statistical Process Control and by pre and post measurement of functional and activity levels. Return to work was also evaluated in the post-acute phase. Primary endpoints were the changes in the attention measure, Paced Auditory Serial Addition Test and changes in work ability. Secondary endpoints included measurement of cognitive functions, activity and work return. There were 3, 6 and 12-month follow ups focussing on health economics. Discussion: The study will provide information on rehabilitation of attention in the early phases after ABI; effects on function, activity and return to work. Further, the application of Statistical Process Control might enable closer investigation of the cognitive changes after acquired brain injury and demonstrate the usefulness of process measures in rehabilitation. The study was registered at ClinicalTrials. gov Protocol.	[Bartfai, Aniko; Markovic, Gabriela; Landahl, Kristina Sargenius; Schult, Marie-Louise] Danderyd Hosp, Dept Rehabil Med, Karolinska Inst, Dept Clin Sci,Danderyd Hosp Div Rehabil, S-18288 Stockholm, Sweden		Bartfai, A (corresponding author), Danderyd Hosp, Dept Rehabil Med, Karolinska Inst, Dept Clin Sci,Danderyd Hosp Div Rehabil, S-18288 Stockholm, Sweden.	aniko.bartfai@ki.se		Bartfai, Aniko/0000-0002-0815-2485	ALF; KID; Promobilia; Stroke forbundet	This study is funded by ALF, KID, Promobilia, Stroke forbundet.	Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Burgess P, 1996, BEHAV ASSESSMENT DYS; Callahan CD, 2005, REHABIL PSYCHOL, V50, P24, DOI 10.1037/0090-5550.50.1.24; Canadian Association of Occupational Therapists, 2002, CANADIAN OCCUPATIONA; Chu J, 2002, Electromyogr Clin Neurophysiol, V42, P393; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Delis DC., 2001, DELIS KAPLAN EXECUTI; Drummond MF, 2015, METHODS EC EVALUATIO; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Foy CM, 2013, J OCCUP REHABIL; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Johansson U, 2001, DISABIL REHABIL, V23, P474; Kolb B, 2011, NEUROPLASTICITY REHA; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MAHONEY F I, 1965, Md State Med J, V14, P61; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; Nowack T. A., 1996, J HEAD TRAUMA REHAB, V11, P52; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Raskin S., 2011, NEUROPLASTICITY REHA; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; RS ridger, PSYCHOMETRIC PROPERT; Ruff RM, 1999, 2 7 SELECTIVE ATTENT; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sandqvist Jan L, 2006, Work, V26, P379; Sandqvist Jan L, 2004, Work, V23, P147; SCHONBERGER M, 2010, J PSYCHIATR RES, V179, P342; Sohlberg M, 1995, ATTENTION PROCESS TR; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sturm W, 1991, NEUROPSYCHOL REHABIL, V1, P259, DOI DOI 10.1080/09602019108402258; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; Tuomi K., 1998, WORK ABILITY INDEX, Vrevised 2nd; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Wheeler DJ., 1992, UNDERSTANDING STAT P, V2nd edn; Wilson B, 1991, RIVERMEAD BEHAV MEMO	40	10	10	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	MAY 8	2014	14								102	10.1186/1471-2377-14-102			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AH0FC	WOS:000335793600001	24885585	Green Published, gold			2022-02-06	
J	Chen, LLK; Baca, CB; Choe, J; Chen, JW; Ayad, ME; Cheng, EM				Chen, Leo L. K.; Baca, Christine B.; Choe, Jessica; Chen, James W.; Ayad, Miriam E.; Cheng, Eric M.			Posttraumatic Epilepsy in Operation Enduring Freedom/Operation Iraqi Freedom Veterans	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; EMOTIONAL RISK-FACTORS; HEAD-INJURY; NONEPILEPTIC SEIZURES; CODES; ASCERTAINMENT; DIAGNOSIS; ACCURACY; DISORDER; VALIDITY	Penetrating traumatic brain injury (TBI) is a well-established risk factor for post-traumatic epilepsy (PTE). However, many veterans in Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) who suffer from TBI do so from blast injury, and its consequences are not fully known. Two neurologists performed a chart review to describe patterns of injury and health care among all 16 OEF/OIF veterans at the VA Greater Los Angeles Healthcare System who were assigned an outpatient diagnosis of both epilepsy and TBI in 2008-2009. All Veterans were male, and the mean age was 30 years. Blast exposure was the most common mechanism of TBI (81%). Although all Veterans were assigned a diagnosis code of seizures, the diagnosis of PTE was clinically confirmed in only 3 veterans. On the other hand, the diagnosis of post-traumatic stress disorder was confirmed in 81% of the sample and a diagnosis of nonepileptic seizures was suspected in 44% of the sample. Researchers who study PTE among the OEF/OIF population using administrative data also should perform chart reviews to account for the prevalence of psychogenic nonepileptic seizures.	[Chen, Leo L. K.] Kaiser Permanente Fdn Hosp, Dept Neurol, Sacramento, CA 95825 USA; [Chen, Leo L. K.] UC Davis Hlth Syst, Dept Neurol, Sacramento, CA 95817 USA; [Baca, Christine B.; Choe, Jessica] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA; [Baca, Christine B.; Choe, Jessica; Chen, James W.; Ayad, Miriam E.; Cheng, Eric M.] VA Greater Los Angeles Healthcare Syst, Dept Neurol, Los Angeles, CA 90073 USA; [Chen, James W.; Ayad, Miriam E.; Cheng, Eric M.] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Chen, LLK (corresponding author), Kaiser Permanente Fdn Hosp, Dept Neurol, 2025 Morse Ave, Sacramento, CA 95825 USA.		Ritter, Stefanie L/D-9312-2012	Chen, James/0000-0002-3220-138X	VA Epilepsy Center of Excellence at VA Los Angeles; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS058571]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS058571] Funding Source: NIH RePORTER	The study was supported by the VA Epilepsy Center of Excellence at VA Los Angeles. Dr. Cheng was supported by Career Development Award from NIH/NINDS (K23NS058571).	Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Benbadis SR, 2001, NEUROLOGY, V57, P915, DOI 10.1212/WNL.57.5.915; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Kee VR, 2012, PHARMACOEPIDEM DR S, V21, P183, DOI 10.1002/pds.2329; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Martin R, 2003, NEUROLOGY, V61, P1791, DOI 10.1212/01.WNL.0000098890.13946.F5; O'Hanlon M, 2007, IRAQ INDEX TRACKING, P1; Ottman R, 2010, EPILEPSIA, V51, P191, DOI 10.1111/j.1528-1167.2009.02274.x; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x	28	10	10	0	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2014	179	5					492	496		10.7205/MILMED-D-13-00413			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7UL	WOS:000340806400007	24806494	Bronze			2022-02-06	
J	Chen, PC; Tsai, SH; Chen, YL; Liao, WI				Chen, Po-Chuan; Tsai, Shih-Hung; Chen, Yu-Long; Liao, Wen-I			Post-Traumatic Cerebral Infarction Following Low-Energy Penetrating Craniocerebral Injury Caused by a Nail	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Post-traumatic cerebral infarction; Penetrating craniocerebral injury; Nail injury; Decompressive craniectomy; Brain edema	BRAIN	Post-traumatic cerebral infarction (PTCI) is a secondary insult which causes global cerebral hypoxia or hypoperfusion after traumatic brain injury, and carries a remarkable high mortality rate. PTCI is usually caused by blunt brain injury with gross hematoma and/or brain herniation. Herein, we present the case of a 91-year-old male who had sustained PTCI following a low-energy penetrating craniocerebral injury due to a nail without evidence of hematoma. The patient survived after a decompressive craniectomy, but permanent neurological damage occurred. This is the first case of profound PTCI following a low-energy penetrating craniocerebral nail injury and reminds clinicians of possibility this rare dreadful complication for care of head-injured patients.	[Chen, Po-Chuan; Tsai, Shih-Hung; Chen, Yu-Long; Liao, Wen-I] Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei 11490, Taiwan		Liao, WI (corresponding author), Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, 325,Chenggong Rd,Sec 2, Taipei 11490, Taiwan.	qqww0139@yahoo.com.tw		Tsai, Shih-Hung/0000-0003-0215-3193			ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ham HY, 2011, J KOREAN NEUROSURG S, V50, P370, DOI 10.3340/jkns.2011.50.4.370; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Kishore Kamal, 2010, J Emerg Trauma Shock, V3, P193, DOI 10.4103/0974-2700.62115; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; MIRVIS SE, 1990, AM J NEURORADIOL, V11, P355; Selvanathan S, 2007, J CLIN NEUROSCI, V14, P678, DOI 10.1016/j.jocn.2006.02.017; Server A, 2001, ACTA RADIOL, V42, P254; Shehu BB, 2006, BRAIN INJURY, V20, P1455, DOI 10.1080/02699050601082198; Shenoy SN, 2003, NEUROL INDIA, V51, P411; Son S, 2011, PSYCHIAT INVEST, V8, P272, DOI 10.4306/pi.2011.8.3.272; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E	16	10	12	0	6	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAY	2014	55	5					293	295		10.3340/jkns.2014.55.5.293			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AM9RJ	WOS:000340218400012	25132939	Green Published, gold, Green Submitted			2022-02-06	
J	Le, K; Coelho, C; Mozeiko, J; Krueger, F; Grafman, J				Le, Karen; Coelho, Carl; Mozeiko, Jennifer; Krueger, Frank; Grafman, Jordan			Does Brain Volume Loss Predict Cognitive and Narrative Discourse Performance Following Traumatic Brain Injury?	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						traumatic brain injury; cognition; communication; executive functions; language disorders; memory; neuroimaging	CLOSED-HEAD INJURY; STORY NARRATIVES; WORKING-MEMORY; MEASURING GOODNESS; PREFRONTAL CORTEX; ELICITATION TASK; CHILDREN; LANGUAGE; LESION; COMPREHENSION	Purpose: In this study, the authors investigated the relationship between brain volume loss and performance on cognitive measures, including working memory, immediate memory, executive functions, and intelligence, and a narrative discourse production task. An underlying goal was to examine the prognostic potential of a brain lesion metric for discourse outcomes. It was hypothesized that brain volume loss would correlate with and predict cognitive and narrative discourse measures and have prognostic value for discourse outcomes. Method: One hundred sixty-seven individuals with penetrating head injury participated. Correlational and regression analyses were performed for the percentages of total brain and hemispheric volume loss and scores on 4 cognitive measures (WMS-III Working Memory and Immediate Memory primary indexes, D-KEFS Sorting Test, and WAIS-III Full Scale IQ) and 7 narrative discourse measures (T-units, grammatical complexity, cohesion, local and global coherence, story completeness, and story grammar). Results: The volumetric measures had significant small-to-moderate correlations with all cognitive measures but only one significant correlation with the discourse measures. Findings from regression analyses were analogous but revealed several models that approached significance. Conclusion: Findings suggest that an overall measure of brain damage may be more predictive of general cognitive status than of narrative discourse ability. Atrophy measures in specific brain regions may be more informative.	[Le, Karen; Coelho, Carl; Mozeiko, Jennifer] Univ Connecticut, Storrs, CT 06269 USA; [Krueger, Frank] George Mason Univ, Arlington, VA USA; [Grafman, Jordan] Rehabil Inst Chicago, Chicago, IL USA		Le, K (corresponding author), Univ Connecticut, Storrs, CT 06269 USA.	karen.le@uconn.edu			NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F31DC012748] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F31DC012748] Funding Source: NIH RePORTER		Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; ARSENI C, 1970, PSYCHIAT NEUROL NEUR, V73, P105; Barrett J., 1998, OLD MCDONALD HAD AN; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Coelho C, 2012, NEUROPSYCHOLOGIA, V50, P3564, DOI 10.1016/j.neuropsychologia.2012.09.005; Cohen J., 1988, SET CORRELATION MULT; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Delis DC., 2001, DELIS KAPLAN EXECUTI; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dimitrov M, 1999, NEUROPSYCHOLOGY, V13, P135, DOI 10.1037/0894-4105.13.1.135; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; Farias ST, 2012, NEUROBIOL AGING, V33, P1758, DOI 10.1016/j.neurobiolaging.2011.03.017; Frattali C., 2005, APHASIA RELATED NEUR, P51; FREDERIKSEN CH, 1975, COGNITIVE PSYCHOL, V7, P371, DOI 10.1016/0010-0285(75)90016-X; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; HUNT KW, 1970, MONOGR SOC RES CHILD, V35, P1; Kaplan E. F., 1983, THE BOSTON NAMING TE; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kurczek J, 2012, BRAIN LANG, V123, P222, DOI 10.1016/j.bandl.2012.09.003; Kurczek J, 2011, APHASIOLOGY, V25, P700, DOI 10.1080/02687038.2010.537345; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Marini A, 2012, J COGNITIVE NEUROSCI, V24, P2211, DOI 10.1162/jocn_a_00283; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moran C, 2005, BRAIN INJURY, V19, P743, DOI 10.1080/02699050500110199; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; PLAG JA, 1967, PERS PSYCHOL, V20, P323, DOI 10.1111/j.1744-6570.1967.tb01527.x; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rorden C, 2009, NEUROIMAGE, V44, P1355, DOI 10.1016/j.neuroimage.2008.09.031; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Talairach J., 1988, COPLANAR STEREOTAXIC; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wright HH, 2011, J SPEECH LANG HEAR R, V54, P900, DOI 10.1044/1092-4388(2010/09-0253); Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	65	10	10	1	19	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2014	23	2					271	284		10.1044/2014_AJSLP-13-0095			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AU5ZP	WOS:000345682200015	24686463				2022-02-06	
J	Mckay, CD; Schneider, KJ; Brooks, BL; Mrazik, M; Emery, CA				Mckay, Carly D.; Schneider, Kathryn J.; Brooks, Brian L.; Mrazik, Martin; Emery, Carolyn A.			Baseline Evaluation in Youth Ice Hockey Players: Comparing Methods for Documenting Prior Concussions and Attention or Learning Disorders	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						baseline testing; medical history; youth sport	INTERNATIONAL-CONFERENCE; INJURY RATES; RISK-FACTORS; SPORTS; AGREEMENT; MULTIPLE; CHILDREN; RECALL; DISABILITIES; ADOLESCENTS	STUDY DESIGN: Cross-sectional. OBJECTIVE: To examine differences in concussion history and attention or learning disorders reported by elite youth ice hockey players, using a questionnaire that allows parental input compared to a clinic-based test battery that does not. BACKGROUND: A history of previous concussion and the presence of attention or learning disorders can affect concussion-management decisions; however, youth athletes may not accurately report their medical history because they may not know or recall important details. METHODS: The sample included 714 Bantam (ages 12-14 years) and Midget (ages 15-17 years) ice hockey players (601 male, 113 female) from the most elite divisions of play (AA and AAA). Players completed a take-home preseason questionnaire (PSQ) with the input of a parent/guardian, and also independently completed the baseline Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) at the beginning of the 2011-2012 hockey season. RESULTS: In 21.1% (95% confidence interval: 18.1%, 24.1%) of cases, there was disagreement between the PSQ and ImPACT in the number of previous concussions reported. Among those who reported an attention disorder on the PSQ, 85.7% also reported an attention disorder on the ImPACT. Only 9.5% of those who reported a learning disorder on the PSQ also reported a learning disorder on the ImPACT. CONCLUSION: In 1 of 5 players, reported concussion history differed between the PSQ and ImPACT, and there was substantial disagreement between instruments for those reporting learning disorders. The method of obtaining medical history may, therefore, affect baseline and postconcussion evaluations.	[Mckay, Carly D.; Schneider, Kathryn J.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.; Emery, Carolyn A.] Univ Calgary, Fac Med, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Edmonton, AB, Canada; [Mrazik, Martin] Univ Calgary, Edmonton, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada		Mckay, CD (corresponding author), Univ Calgary, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	cdmckay@ucalgary.ca	Emery, Carolyn/AAI-2761-2020	Schneider, Kathryn/0000-0002-5951-5899; McKay, Carly/0000-0001-7664-3211	International Olympic Committee; McCarthy Tetrault Award; Alberta Innovates-Health Solutions; Max Bell Foundation; Alberta Children's Hospital Research Institute for Child & Maternal Health; Psychological Assessment Resources, Inc	The Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. We acknowledge the funding from the McCarthy Tetrault Award (BLB), Alberta Innovates-Health Solutions, Max Bell Foundation, and the Alberta Children's Hospital Research Institute for Child & Maternal Health. This study was approved by the Conjoint Health Research Ethics Board at the University of Calgary and the Health Research Ethics Board at the University of Alberta. Dr Brooks receives funding from a test publisher (Psychological Assessment Resources, Inc), book royalties from Oxford University Press, and in-kind test credits for research from another computerized test publisher (CNS Vital Signs).	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Cooney G, 2006, J INTELL DISABIL RES, V50, P432, DOI 10.1111/j.1365-2788.2006.00789.x; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; HAREL Y, 1994, AM J PUBLIC HEALTH, V84, P599, DOI 10.2105/AJPH.84.4.599; HERJANIC B, 1982, J ABNORM CHILD PSYCH, V10, P307, DOI 10.1007/BF00912324; Infante-Rivard C, 2000, AM J EPIDEMIOL, V152, P480, DOI 10.1093/aje/152.5.480; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jahoda A, 2010, J SOC ISSUES, V66, P521, DOI 10.1111/j.1540-4560.2010.01660.x; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P669; Martinez RS, 2004, J LEARN DISABIL-US, V37, P411, DOI 10.1177/00222194040370050401; Mayers LB, 2011, J CLIN EXP NEUROPSYC, V33, P532, DOI 10.1080/13803395.2010.535506; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod JD, 2007, PSYCHIAT SERV, V58, P626, DOI 10.1176/appi.ps.58.5.626; Mishna F, 2003, J LEARN DISABIL-US, V36, P336, DOI 10.1177/00222194030360040501; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Scior K, 2011, RES DEV DISABIL, V32, P2164, DOI 10.1016/j.ridd.2011.07.005; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wright DL, 1998, PUBLIC OPIN QUART, V62, P331, DOI 10.1086/297849	41	10	10	0	19	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	MAY	2014	44	5					329	335		10.2519/jospt.2014.5053			7	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	AG3AT	WOS:000335288900003	24673445	Green Accepted			2022-02-06	
J	Pierce, SR; Palombaro, KM; Black, JD				Pierce, Samuel R.; Palombaro, Kerstin M.; Black, Jill D.			Barriers to Bicycle Helmet Use in Young Children in an Urban Elementary School	HEALTH PROMOTION PRACTICE			English	Article						bicycle helmet; prevention; brain injury		Purpose. Traumatic brain injury is a leading cause of death in bicycle crashes. The factors associated with bicycle helmet use in young children with diverse ethnic and socioeconomic backgrounds have not been studied. The purpose of this study was to identify barriers to helmet use in young children in an urban elementary school. Design. Qualitative content analysis with semistructured interviews, observational field notes, and artifacts. Setting. Urban elementary school. Participants. Seventeen students whose age ranged from 5 to 7 years and whose ethnic background was identified as African American (14) or Caucasian (3). Method. Children participated in a brain safety fair that included presentations and activities. Semistructured, pre- and postexperience interviews were completed. Observations of the students participating in the activities and reflective art projects from the students were collected. Results. The analysis found the following barriers to helmet use: (a) lack of access to a helmet, (b) poor fit of helmets due to hairstyles, and (c) lack of knowledge regarding helmet use. Conclusion. The present study suggests that the issue of helmet design and comfort for younger children with variable hairstyles needs to be addressed in order to increase helmet use in this population.	[Pierce, Samuel R.; Palombaro, Kerstin M.; Black, Jill D.] Widener Univ, Chester, PA 19013 USA		Pierce, SR (corresponding author), Widener Univ, Inst Phys Therapy Educ, One Univ Pl, Chester, PA 19013 USA.	srpierce@mail.widener.edu	Palombaro, Kerstin/ABB-7361-2021	Palombaro, Kerstin/0000-0002-0027-4568			Berg P, 2001, Inj Prev, V7, P218, DOI 10.1136/ip.7.3.218; Bergenstal John, 2012, W V Med J, V108, P78; Dellinger AM, 2010, J SAFETY RES, V41, P375, DOI 10.1016/j.jsr.2010.05.003; Ehrlich Peter F, 2004, Inj Control Saf Promot, V11, P23, DOI 10.1076/icsp.11.1.23.26307; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hall RR, 2013, JAMA DERMATOL, V149, P310, DOI 10.1001/jamadermatol.2013.1946; Harley AE, 2009, WOMEN HEALTH, V49, P84, DOI 10.1080/03630240802690861; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Lang IA, 2007, INJURY PREV, V13, P355, DOI 10.1136/ip.2007.015941; Lee RS, 2009, INJURY PREV, V15, P125, DOI 10.1136/ip.2008.019695; Malpede CZ, 2007, ETHNIC DIS, V17, P1; Owen R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003985.pub3; Parkinson GW, 2003, PEDIATRICS, V112, P320, DOI 10.1542/peds.112.2.320; Persaud N, 2012, CAN MED ASSOC J, V184, pE921, DOI 10.1503/cmaj.120988; Rezendes Jennifer L, 2006, J Pediatr Nurs, V21, P35, DOI 10.1016/j.pedn.2005.06.005; Rivara F P, 1999, Inj Prev, V5, P194; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Schuster MA, 2012, NEW ENGL J MED, V367, P735, DOI 10.1056/NEJMsa1114353	20	10	10	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	MAY	2014	15	3					406	412		10.1177/1524839913512329			7	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	V97JG	WOS:000213327500013	24334544				2022-02-06	
J	Zhao, SF; Fu, JD; Liu, F; Rastogi, R; Zhang, JL; Zhao, YL				Zhao, Shangfeng; Fu, Jidi; Liu, Fang; Rastogi, Radhika; Zhang, Jialiang; Zhao, Yuanli			Small interfering RNA directed against CTMP reduces acute traumatic brain injury in a mouse model by activating Akt	NEUROLOGICAL RESEARCH			English	Article						Akt; Nuclear translocation; CTMP; CTMP siRNA; Traumatic brain injury	MODULATOR PROTEIN GENE; AKT/PROTEIN-KINASE-B; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; RATS; APOPTOSIS; CELLS; MITOCHONDRIAL; ISCHEMIA; DYNAMICS	Objective: Protein kinase B (PKB/Akt), which is phosphorylated and activated by upstream activators, exerts critical neuroprotective effects by phosphorylating downstream targets after traumatic brain injury (TBI). Studies on the regulation of Akt will be crucial for our understanding of neuronal survival. The goal of this study is to investigate the effects of carboxyl-terminal modulator protein (CTMP) on phosphorylation of Akt and neurological function in a mouse model of TBI. Methods: Traumatic brain injury in mice was performed by a controlled cortical impact device. The expression of Akt, phospho-Akt, and CTMP was examined in the injured cortices by immunohistochemistry and Western blot analysis. To determine the effects of CTMP, small interfering RNAs (siRNAs) directed against CTMP were injected in mice with TBI, and the expression of phosphorylated Akt and neurological function were evaluated. Results: Phospho-Akt significantly increased at 4 hours post-TBI in the nucleus (P < 0.01) and remained at high levels until 72 hours after TBI, as shown by Western blot analysis. In the cytosol, the expression of phospho-Akt reached its peak at 4 hours post-TBI, but decreased markedly at 24 hours and maintained below pre-TBI levels until 72 hours post-TBI. Interestingly, the expression of CTMP significantly increased 4 hours after TBI (P < 0.01) and sustained those levels until 72 hours without dramatic changes. Treatment with CTMP siRNA effectively augmented the phosphorylation of Akt and significantly improved the neurological functional recovery up to 28 days post-TBI. Conclusion: We conclude that Akt is phosphorylated and translocated to nucleus after TBI to exert neuroprotective effects. However, CTMP is simultaneously triggered to inhibit the phosphorylation of Akt. Inhibition of CTMP by siRNA improves the recovery of neurological functions after TBI.	[Zhao, Shangfeng; Fu, Jidi; Zhang, Jialiang] Capital Med Univ, Beijing Tongren Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Liu, Fang] Capital Med Univ, Xuanwu Hosp, Cerebrovasc Dis Res Inst, Key Lab Neurodegenerat Dis,Minist Educ, Beijing 100050, Peoples R China; [Rastogi, Radhika] Wayne State Univ, Detroit, MI USA; [Zhao, Yuanli] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China		Zhao, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China.	zhaolang88@hotmail.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81200913, 81070978]	This work was supported by the Natural Science Foundation of China (grant nos. 81200913, 81070978).	Abe N, 2011, INT J GYNECOL CANCER, V21, P194, DOI 10.1097/IGC.0b013e318207964c; Ahmad N, 2006, AM J PHYSIOL-HEART C, V290, pH2402, DOI 10.1152/ajpheart.00737.2005; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Chae KS, 2005, J NEUROPHYSIOL, V93, P1174, DOI 10.1152/jn.00796.2004; Chan PH, 2004, STROKE, V35, P2748, DOI 10.1161/01.STR.0000143325.25610.ac; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Friguls B, 2002, NEUROBIOL DIS, V11, P443, DOI 10.1006/nbdi.2002.0553; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Humm RJ, 1994, J NEUROTRAUM, V11, P187; Hwang SK, 2007, GENE THER, V14, P1721, DOI 10.1038/sj.gt.3303042; Hwang SK, 2012, INT J ONCOL, V40, P1515, DOI 10.3892/ijo.2011.1319; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Knobbe CB, 2004, J NATL CANCER I, V96, P483, DOI 10.1093/jnci/djh064; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Liu XR, 2013, STROKE, V44, P1973, DOI 10.1161/STROKEAHA.111.000613; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Missiroli S, 2009, INT J BIOCHEM CELL B, V41, P570, DOI 10.1016/j.biocel.2008.07.002; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Parcellier A, 2009, CELL SIGNAL, V21, P639, DOI 10.1016/j.cellsig.2009.01.016; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Regev-Rudzki N, 2008, J CELL SCI, V121, P2423, DOI 10.1242/jcs.029207; Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	34	10	10	2	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY	2014	36	5			SI		483	490		10.1179/1743132814Y.0000000353			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI7VR	WOS:000337109400015	24670215				2022-02-06	
J	Zheng, P; He, B; Tong, WS				Zheng, Ping; He, Bin; Tong, Wusong			Dynamic pituitary hormones change after traumatic brain injury	NEUROLOGY INDIA			English	Article						Hypopituitarism; pituitary; pituitary dysfunction; traumatic brain injury	REPLACEMENT THERAPY	Objective: To study the dynamic changes of pituitary hormones in traumatic brain injury (TBI) and to correlate the severity and neurological outcome. Patients and Methods: Dynamic changes in the pituitary hormones were evaluated in 164 patients with TBI on day-1, day-7, day-14, day-21, and day-28 post injury. Admission TBI severity and long-term outcome were assessed with Glasgow Coma Scale (GCS) score and Glasgow Outcome Scale (GOS) score. The pituitary hormonal changes were correlated with TBI severity and outcome. Results: Of the 164 patients included in the study, pituitary dysfunction was found in 84 patients and in the remaining 80 patients pituitary function was normal. Most of the pituitary hormone deficiencies observed resolved over time; however, a significant proportion of patients had pituitary dysfunction at one month post injury. The hormones associated with poor outcome included growth hormone, thyrotropic hormone, and gonadotropic hormone. Conclusion: Dynamic changes of pituitary hormones in patients with TBI may reflect the severity of injury and also determine the outcome. Deficiency of growth hormone, gonadotropic hormone, and thyrotropic hormone can adversely affect neurological outcome.	[Zheng, Ping; He, Bin; Tong, Wusong] Shanghai Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China		Zheng, P (corresponding author), Shanghai Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China.	jojo_ras@126.com			Grant for the Promotion of Science, the Ministry of Health, Pudong New area, Shanghai China [PW2011A-13]	Source of Support: This study was supported by a Grant for the Promotion of Science, the Ministry of Health, Pudong New area, Shanghai China (grant PW2011A-13), Conflict of Interest: None declared.	Gut P, 2012, WSPOLCZESNA ONKOL, V16, P273, DOI 10.5114/wo.2012.29299; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Li ZM, 2010, MED PRIN PRACT, V19, P17, DOI 10.1159/000252829; Mirzaie B, 2013, ARCH MED SCI, V9, P68, DOI 10.5114/aoms.2012.30833; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Su DH, 2005, J FORMOS MED ASSOC, V104, P463; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Zheng P, 2014, J ENDOCRINOL INVEST, V37, P309, DOI 10.1007/s40618-014-0059-8	12	10	11	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAY-JUN	2014	62	3					280	284		10.4103/0028-3886.136922			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN4XT	WOS:000340593800008	25033850				2022-02-06	
J	Mutschler, M; Nienaber, U; Wafaisade, A; Brockamp, T; Probst, C; Paffrath, T; Bouillon, B; Maegele, M				Mutschler, Manuel; Nienaber, Ulrike; Wafaisade, Arasch; Brockamp, Thomas; Probst, Christian; Paffrath, Thomas; Bouillon, Bertil; Maegele, Marc		TraumaRegister DGU	The impact of severe traumatic brain injury on a novel base deficit-based classification of hypovolemic shock	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Shock; Classification; Vital signs; Base deficit; Transfusion; Traumatic brain injury	PEDIATRIC TRAUMA; HEMORRHAGIC-SHOCK; ARTERIAL LACTATE; LIFE-SUPPORT; RESUSCITATION; PREDICTORS; MORTALITY; DEATHS; MARKER	Background: Recently, our group has proposed a new classification of hypovolemic shock based on the physiological shock marker base deficit (BD). The classification consists of four groups of worsening BD and correlates with the extent of hypovolemic shock in severely injured patients. The aim of this study was to test the applicability of our recently proposed classification of hypovolemic shock in the context of severe traumatic brain injury (TBI). Methods: Between 2002 and 2011, patients >= 16 years in age with an AIS(head) >= 3 have been retrieved from the German TraumaRegister DGU (R) database. Patients were classified into four strata of worsening BD [(class I (BD <= 2 mmol/l), class II (BD > 2.0 to 6.0 mmol/l), class III (BD > 6.0 to 10 mmol/l) and class IV (BD > 10 mmol/l)] and assessed for demographic and injury characteristics as well as blood product transfusions and outcomes. The cohort of severely injured patients with TBI was compared to a population of all trauma patients to assess possible differences in the applicability of the BD based classification of hypovolemic shock. Results: From a total of 23,496 patients, 10,201 multiply injured patients with TBI (AIS(head) >= 3) could be identified. With worsening of BD, a consecutive increase of mortality rate from 15.9% in class I to 61.4% in class IV patients was observed. Simultaneously, injury severity scores increased from 20.8 (+/- 11.9) to 41.6 (+/- 17). Increments in BD paralleled decreasing hemoglobin, platelet counts and Quick's values. The number of blood units transfused correlated with worsening of BD. Massive transfusion rates increased from 5% in class I to 47% in class IV. Between multiply injured patients with TBI and all trauma patients, no clinically relevant differences in transfusion requirement or massive transfusion rates were observed. Conclusion: The presence of TBI has no relevant impact on the applicability of the recently proposed BD-based classification of hypovolemic shock. This study underlines the role of BD as a relevant clinical indicator of hypovolaemic shock during the initial assessment in respect to haemostatic resuscitation and transfusion requirements.	[Mutschler, Manuel; Wafaisade, Arasch; Brockamp, Thomas; Probst, Christian; Paffrath, Thomas; Bouillon, Bertil; Maegele, Marc] Univ Witten Herdecke, CMMC, Dept Trauma & Orthoped Surg, D-51109 Cologne, Germany; [Mutschler, Manuel] Univ Witten Herdecke, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [Nienaber, Ulrike] Acad Trauma Surg, D-10623 Berlin, Germany		Mutschler, M (corresponding author), Univ Witten Herdecke, CMMC, Dept Trauma & Orthoped Surg, Ostmerheimer Str 200, D-51109 Cologne, Germany.	manuelmutschler@web.de	Brockamp, Thomas/AAI-3624-2020				ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; BARDENHEUE M, 1994, UNFALLCHIRURG, V97, P230; Brasel KJ, 2007, J TRAUMA, V62, P812, DOI 10.1097/TA.0b013e31803245a1; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Davis JW, 1998, J TRAUMA, V45, P873, DOI 10.1097/00005373-199811000-00005; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Guly HR, 2010, RESUSCITATION, V81, P1142, DOI 10.1016/j.resuscitation.2010.04.007; Jansen TC, 2008, CRIT CARE, V12, DOI 10.1186/cc7159; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jung J, 2009, PEDIATR EMERG CARE, V25, P579, DOI 10.1097/PEC.0b013e3181b9b38a; Kincaid EH, 2001, J TRAUMA, V51, P332, DOI 10.1097/00005373-200108000-00018; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Mutschler M, 2013, RESUSCITATION, V84, P309, DOI 10.1016/j.resuscitation.2012.07.012; Mutschler M, 2014, TRANSFUSION MED, V24, P58, DOI 10.1111/tme.12089; Mutschler M, 2014, EMERG MED J, V31, P35, DOI 10.1136/emermed-2012-202130; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022; Parks JK, 2006, AM J SURG, V192, P727, DOI 10.1016/j.amjsurg.2006.08.034; Randolph LC, 2002, J TRAUMA, V53, P838, DOI 10.1097/00005373-200211000-00006; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Tremblay LB, 2002, AM SURGEON, V68, P689; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zehtabchi S, 2007, EMERG MED J, V24, P333, DOI 10.1136/emj.2006.044578	39	10	10	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 30	2014	22								28	10.1186/1757-7241-22-28			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AH1CD	WOS:000335856400001	24779431	gold, Green Published			2022-02-06	
J	Cooper, JM; Catroppa, C; Beauchamp, MH; Eren, S; Godfrey, C; Ditchfield, M; Anderson, VA				Cooper, Janine M.; Catroppa, Cathy; Beauchamp, Miriam H.; Eren, Serem; Godfrey, Celia; Ditchfield, Michael; Anderson, Vicki A.			Attentional Control Ten Years Post-Childhood Traumatic Brain Injury: The Impact of Lesion Presence, Location, and Severity in Adolescence and Early Adulthood	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; neuropsychology; pediatric brain injury; MRI; traumatic brain injury	EXECUTIVE FUNCTION; HEAD-INJURY; YOUNG-CHILDREN; NEUROBEHAVIORAL OUTCOMES; PRESCHOOL-CHILDREN; PREDICTORS; RECOVERY; PERFORMANCE; COGNITION	The relationship between brain injury and attentional control (AC) long after a childhood traumatic brain injury (TBI) has received limited investigation. The aim of this article was to investigate the impact that lesion presence, location, and severity has on AC in a group of young persons who had sustained a moderate to severe TBI 10 years earlier during childhood. The participants in this study were a subset of a larger 10-year, follow-up assessment comprised of 31 persons in late adolescence and early adulthood (21 males), with a mean age at testing of 15.4 years (standard error 0.6; range 10.7-21.2 years). Analyses revealed that in regard to AC abilities, the presence of a lesion(s) appears to have a differential effect depending on the testing measure used. When using standardized testing with subtests of the TEA-ch, no differences in performance between those with and those without a lesion at 10 years post-TBI were found. On standardized behavioral measures such as parental reports of perceived AC (Behavior Rating Inventory of Executive Function), however, the presence of a lesion was found to have a detrimental effect on the ability to self-regulate and monitor behavior in late adolescence and the early stages of adulthood. We discuss these results and propose that there is a network of brain regions associated with AC, and generalized lesions have the greatest influence on such abilities.	[Cooper, Janine M.; Catroppa, Cathy; Beauchamp, Miriam H.; Eren, Serem; Godfrey, Celia; Ditchfield, Michael; Anderson, Vicki A.] Murdoch Childrens Res Inst, Dept Child Neuropsychol, Melbourne, Vic 3052, Australia		Cooper, JM (corresponding author), Murdoch Childrens Res Inst, Dept Child Neuropsychol, Flemington Rd, Melbourne, Vic 3052, Australia.	janine.cooper@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Research Foundation Royal Children's Hospital; Victorian Government's Operational Infrastructure Support program	This work was funded through research grants awarded by National Health and Medical Research Council, Research Foundation Royal Children's Hospital, and the Victorian Government's Operational Infrastructure Support program.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Daniel A., 1983, POWER PRIVILEGE PRES; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fidell L.S., 2000, USING MULTIVARIATE S; Gioia G. A., 2001, PSYCHOL DEV ASSESSME PSYCHOL DEV ASSESSME; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goldberg E, 2005, PSYCHIAT CLIN N AM, V28, P567, DOI 10.1016/j.psc.2005.05.005; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; JOHNSON DA, 1992, BRIT J EDUC PSYCHOL, V62, P404, DOI 10.1111/j.2044-8279.1992.tb01033.x; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Manly T., 1999, TEST EVERYDAY ATTENT; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Senn TE, 2004, DEV NEUROPSYCHOL, V26, P445, DOI 10.1207/s15326942dn2601_5; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wechsler D., 1992, MANUAL WECHSLER INTE; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K. O., 2006, BEHAVIOUR, V14, P141; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	54	10	10	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					713	721		10.1089/neu.2013.3101			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200002	24367920				2022-02-06	
J	Cahill, SM; Rotter, JM; Lyons, KK; Marrone, AR				Cahill, Susan M.; Rotter, Jamie M.; Lyons, Kara K.; Marrone, Antonina R.			Survivors of brain injury: The narrative experiences of being a college or university student	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Lived experience; Stigma; Student role; Transition; Traumatic brain injury	TRANSITION; OUTCOMES; TBI	Background. The deficits associated with a brain injury may pose many challenges to young adult students. Purpose. The purpose of this study was to conduct an in-depth exploration of the experiences and processes individuals who self-identify as having a brain injury go through during college or university to overcome obstacles. Method. This study used a basic interpretative qualitative design. Data were collected through semi-structured interviews and analyzed with the constant comparative method. Findings. Three themes emerged: balancing act, reality versus injury, and square peg in a round hole. Participants discussed personal strategies that they used to help them be successful. Despite these strategies, the participants continued to feel out of place and felt that seeking disability services would further set them apart from their non-injured peers. Implications. Individuals post brain injury may benefit from occupational therapy services to reduce the challenges associated with functioning in the student role in college and university environments.	[Cahill, Susan M.; Rotter, Jamie M.; Lyons, Kara K.; Marrone, Antonina R.] Midwestern Univ, Occupat Therapy Program, Downers Grove, IL 60515 USA		Cahill, SM (corresponding author), Midwestern Univ, Occupat Therapy Program, 555 31st St, Downers Grove, IL 60515 USA.	scahil@midwestern.edu					Balaban T, 2009, PHYS OCCUP THER PEDI, V29, P367, DOI 10.3109/01942630903245333; Bunch J, 2000, TBI CHALLENGE, V4; Callaway L., 2005, AUSTR OCCUPATIONAL T, V52, P257, DOI [10.1111/j.1440-1630.2005.00492, DOI 10.1111/J.1440-1630.2005.00492]; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Glang A, 2004, NEUROREHABILITATION, V19, P219; Haag H. K. L., 2009, THESIS WILFERD LAURI; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Jumisko E., 2005, J NEUROSCIENCE NURSI, V37, P353, DOI [10.1177/1074840707303842, DOI 10.1177/1074840707303842]; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Merriam S. B., 2002, QUALITATIVE RES PRAC; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Richardson J., 2005, PSYCHOL TEACHING REV, V11, P64; Ruoff J., 2001, STUDENT BRAIN INJURY; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; U.S. Centers for Disease Control and Prevention, 2013, TRAUMATIC BRAIN INJU	24	10	10	0	10	CANADIAN ASSOC OCCUPATIONAL THERAPISTS	OTTAWA	CTTC BLDG, 3400-1125 COLONEL BY DRIVE, OTTAWA, ONTARIO K1S 5R1, CANADA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2014	81	2					93	101		10.1177/0008417414533185			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AK4KR	WOS:000338394100006	25004585				2022-02-06	
J	Chu, JT; Hjort, K; Larsson, A; Dahlin, AP				Chu, Jiangtao; Hjort, Klas; Larsson, Anders; Dahlin, Andreas P.			Impact of static pressure on transmembrane fluid exchange in high molecular weight cut off microdialysis	BIOMEDICAL MICRODEVICES			English	Article						Microdialysis; Fluid recovery; Transmembrane pressure; Colloid osmotic pressure	TRAUMATIC BRAIN-INJURY; CEREBRAL MICRODIALYSIS; IN-VITRO; PROTEINS; QUANTIFICATION; CYTOKINES; VIVO	With the interest of studying larger biomolecules by microdialysis (MD), this sampling technique has reached into the ultrafiltration region of fluid exchange, where fluid recovery (FR) has a strong dependence on pressure. Hence in this study, we focus on the fluid exchange across the high molecular weight cut off MD membrane under the influence of the static pressure in the sampling environment. A theoretical model is presented for MD with such membranes, where FR has a linear dependence upon the static pressure of the sample. Transmembrane (TM) osmotic pressure difference and MD perfusion rate decide how fast FR increases with increased static pressure. A test chamber for in vitro MD under static pressure was constructed and validated. It can hold four MD probes under controlled pressurized conditions. Comparison showed good agreement between experiment and theory. Moreover, test results showed that the fluid recovery of the test chamber MD can be set accurately via the chamber pressure, which is controlled by sample injection into the chamber at precise rate. This in vitro system is designed for modelling in vivo MD in cerebrospinal fluid and studies with biological samples in this system may be good models for in vivo MD.	[Chu, Jiangtao; Hjort, Klas; Dahlin, Andreas P.] Uppsala Univ, Dept Engn Sci, S-75121 Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden		Dahlin, AP (corresponding author), Uppsala Univ, Dept Engn Sci, Box 534, S-75121 Uppsala, Sweden.	andreas.dahlin@angstrom.uu.se		Dahlin, Andreas/0000-0002-0041-0902	Uppsala Berzelii Technology Centre for Neurodiagnostics; Swedish Governmental Agency for Innovation SystemsVinnova; Swedish Research CouncilSwedish Research CouncilEuropean Commission [P29797-1]	This research was supported by the Uppsala Berzelii Technology Centre for Neurodiagnostics, funded by the Swedish Governmental Agency for Innovation Systems and the Swedish Research Council Grant number P29797-1. We acknowledge CMA Microdialysis and Pharmacosomos AS for sharing their knowledge and for material support and Visualize your Science for graphical assistance.	Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; Baker R.W., 2004, MEMBRANE TECHNOLOGY, P242; Bungay PM, 2010, J MEMBRANE SCI, V348, P131, DOI 10.1016/j.memsci.2009.10.050; Clough GF, 2007, J INVEST DERMATOL, V127, P2799, DOI 10.1038/sj.jid.5700930; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Kjellstrom S, 1999, CHROMATOGRAPHIA, V50, P539, DOI 10.1007/BF02493658; Lee GJ, 2008, NEUROL RES, V30, P661, DOI 10.1179/174313208X289570; Li ZH, 2008, J MEMBRANE SCI, V310, P237, DOI 10.1016/j.memsci.2007.10.051; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Nikaina I, 2012, J CRIT CARE, V27, P83, DOI 10.1016/j.jcrc.2011.04.004; Pettersson A, 2004, ANAL CHEM, V76, P1678, DOI 10.1021/ac035305l; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Revuelto-Rey J, 2012, MED INTENSIVA, V36, P213, DOI 10.1016/j.medin.2011.08.002; Rosdahl H, 2000, INT J BIOL MACROMOL, V28, P69, DOI 10.1016/S0141-8130(00)00148-3; Schutte RJ, 2004, ANAL CHEM, V76, P6058, DOI 10.1021/ac0493626; Siaghy EM, 1999, MED BIOL ENG COMPUT, V37, P196, DOI 10.1007/BF02513287; Slaney TR, 2011, ANAL CHEM, V83, P5207, DOI 10.1021/ac2003938; STENKEN JA, 1993, ANAL CHEM, V65, P2324, DOI 10.1021/ac00065a026; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Ungerstedt U., 1982, ADV DOPAMINE RES, V1st ed., P219	25	10	11	1	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	APR	2014	16	2					301	310		10.1007/s10544-013-9833-1			10	Engineering, Biomedical; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics	AE9WK	WOS:000334362000013	24370572				2022-02-06	
J	Fang, B; Liang, M; Yang, GT; Ye, YQ; Xu, HY; He, XS; Huang, JH				Fang, Bo; Liang, Ming; Yang, Guitao; Ye, Yuqin; Xu, Hongyu; He, Xiaosheng; Huang, Jason H.			Expression of S100A6 in Rat Hippocampus after Traumatic Brain Injury Due to Lateral Head Acceleration	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						S100A6; hippocampus; cognitive deficits; traumatic brain injury (TBI); rats	CALCYCLIN-BINDING-PROTEIN; BETA-CATENIN; CACYBP/SIP; CELLS; PHOSPHORYLATION; TRANSLOCATION; MECHANISM; TUBULIN; NEURONS; TARGET	In a rat model of traumatic brain injury (TBI), we investigated changes in cognitive function and S100A6 expression in the hippocampus. TBI-associated changes in this protein have not previously been reported. Rat S100A6 was studied via immunohistochemical staining, Western blot, and reverse transcription-polymerase chain reaction (RT-PCR) after either lateral head acceleration or sham. Reduced levels of S100A6 protein and mRNA were observed 1 h after TBI, followed by gradual increases over 6, 12, 24, and 72 h, and then a return to sham level at 14 day. Morris water maze (MWM) test was used to evaluate animal spatial cognition. TBI-and sham-rats showed an apparent learning curve, expressed as escape latency. Although TBI-rats displayed a relatively poorer cognitive ability than sham-rats, the disparity was not significant early post-injury. Marked cognitive deficits in TBI-rats were observed at 72 h post-injury compared with sham animals. TBI-rats showed decreased times in platform crossing in the daily MWM test; the performance at 72 h post-injury was the worst. In conclusion, a reduction in S100A6 may be one of the early events that lead to secondary cognitive decline after TBI, and its subsequent elevation is tightly linked with cognitive improvement. S100A6 may play important roles in neuronal degeneration and regeneration in TBI.	[Fang, Bo; Liang, Ming; Ye, Yuqin; Xu, Hongyu; He, Xiaosheng] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Yang, Guitao] Fourth Mil Med Univ, Xijing Hosp, Dept Med Teaching & Res Adm, Xian 710032, Peoples R China; [Huang, Jason H.] Univ Rochester, Dept Neurosurg, Rochester, NY 14642 USA		He, XS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.	happyfangbo@gmail.com; liangming777@163.com; guitaoy@hotmail.com; chinayeyuqin@163.com; xuhy@fmmu.edu.cn; hexiaos@fmmu.edu.cn; jason_huang@urmc.rochester.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	NSFCNational Natural Science Foundation of China (NSFC) [30971173]	The present study was supported by the funds of 2010 NSFC proposal (Item No. 30971173).	Bayir H., 2003, CRIT CARE MED, V31, P1; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Courtois-Coutry N, 2002, J BIOL CHEM, V277, P25728, DOI 10.1074/jbc.M112435200; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Douma BRK, 1998, PSYCHONEUROENDOCRINO, V23, P33, DOI 10.1016/S0306-4530(97)00091-7; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 1996, BIOCHEM J, V320, P585, DOI 10.1042/bj3200585; Filipek A, 2002, J BIOL CHEM, V277, P21103, DOI 10.1074/jbc.M111010200; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Filipek A, 2008, J NEURAL TRANSM, V115, P1257, DOI 10.1007/s00702-008-0062-3; Fukushima T, 2006, IMMUNITY, V24, P29, DOI 10.1016/j.immuni.2005.12.002; Gao W, 2013, NEUROSCI LETT, V533, P50, DOI 10.1016/j.neulet.2012.11.020; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Jastrzebska B, 2000, J HISTOCHEM CYTOCHEM, V48, P1195, DOI 10.1177/002215540004800903; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; OKAZAKI K, 1994, J BIOL CHEM, V269, P6149; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Schneider G, 2007, BBA-MOL CELL RES, V1773, P1628, DOI 10.1016/j.bbamcr.2007.07.013; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wu J, 2003, J BIOCHEM MOL BIOL, V36, P354; Xiao-Sheng H, 2004, J CLIN NEUROSCI, V11, P402, DOI 10.1016/j.jocn.2004.01.001; Yamada J, 2012, NEUROSCIENCE, V226, P119, DOI 10.1016/j.neuroscience.2012.08.068	28	10	10	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	APR	2014	15	4					6378	6390		10.3390/ijms15046378			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AI4ND	WOS:000336841200078	24739809	gold, Green Published, Green Submitted			2022-02-06	
J	Martinez-Vargas, M; Soto-Nunez, M; Tabla-Ramon, E; Solis, B; Gonzalez-Rivera, R; Perez-Arredondo, A; Estrada-Rojo, F; Castell, A; Molina-Guarneros, J; Navarro, L				Martinez-Vargas, Marina; Soto-Nunez, Maribel; Tabla-Ramon, Erika; Solis, Barbara; Gonzalez-Rivera, Ruben; Perez-Arredondo, Adan; Estrada-Rojo, Francisco; Castell, Andres; Molina-Guarneros, Juan; Navarro, Luz			Cystatin C Has a Dual Role in Post-Traumatic Brain Injury Recovery	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						Cystatin C; Cathepsin B; Traumatic brain injury; neuroprotection	CATHEPSIN-B; NEURONAL DEATH; CEREBRAL-ISCHEMIA; CELL-DEATH; RAT-BRAIN; EXPRESSION; CALPAIN; HIPPOCAMPUS; INHIBITORS; APOPTOSIS	Cathepsin B is one of the major lysosomal cysteine proteases involved in neuronal protein catabolism. This cathepsin is released after traumatic injury and increases neuronal death; however, release of cystatin C, a cathepsin inhibitor, appears to be a self-protective brain response. Here we describe the effect of cystatin C intracerebroventricular administration in rats prior to inducing a traumatic brain injury. We observed that cystatin C injection caused a dual response in post-traumatic brain injury recovery: higher doses (350 fmoles) increased bleeding and mortality, whereas lower doses (3.5 to 35 fmoles) decreased bleeding, neuronal damage and mortality. We also analyzed the expression of cathepsin B and cystatin C in the brains of control rats and of rats after a traumatic brain injury. Cathepsin B was detected in the brain stem, cerebellum, hippocampus and cerebral cortex of control rats. Cystatin C was localized to the choroid plexus, brain stem and cerebellum of control rats. Twenty-four hours after traumatic brain injury, we observed changes in both the expression and localization of both proteins in the cerebral cortex, hippocampus and brain stem. An early increase and intralysosomal expression of cystatin C after brain injury was associated with reduced neuronal damage.	[Martinez-Vargas, Marina; Tabla-Ramon, Erika; Solis, Barbara; Gonzalez-Rivera, Ruben; Perez-Arredondo, Adan; Estrada-Rojo, Francisco; Navarro, Luz] Univ Nacl Autonoma Mexico, Sch Med, Dept Physiol, Mexico City 04510, DF, Mexico; [Soto-Nunez, Maribel; Molina-Guarneros, Juan] Univ Nacl Autonoma Mexico, Sch Med, Dept Pharmacol, Mexico City 04510, DF, Mexico; [Castell, Andres] Univ Nacl Autonoma Mexico, Sch Med, Dept Cell & Tissue Biol, Mexico City 04510, DF, Mexico		Navarro, L (corresponding author), Univ Nacl Autonoma Mexico, Sch Med, Dept Physiol, Apdo Postal 70-250, Mexico City 04510, DF, Mexico.	marvar_69@yahoo.com.mx; inmunofarmacologia@yahoo.com; erimar_1503@yahoo.com.mx; bsolluna@hotmail.com; rubengonzalezrivera@yahoo.com.mx; aparredondo23@yahoo.com.mx; fesro@hotmail.com; castell@unam.mx; jamg@unam.mx; lnavarro@unam.mx	MOLINA-GUARNEROS, JUAN A/A-3357-2016; Navarro, Luz/Q-9086-2019	MOLINA GUARNEROS, JUAN ARCADIO/0000-0002-1946-0408; Perez-Arredondo, Adan/0000-0002-0479-6734; MARTINEZ-VARGAS, MARINA/0000-0002-3729-2161	CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [152510];  [PAPIIT IN 222007];  [IN221212];  [IG201014]	This work was supported by grants PAPIIT IN 222007, IN221212, IG201014 and CONACyT 152510.	ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; BERNSTEIN HG, 1989, J HIRNFORSCH, V30, P313; Chaitanya GV, 2008, NEUROCHEM RES, V33, P2178, DOI 10.1007/s11064-007-9567-7; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6; Faul M, TRAUMATIC BRAIN INJU; Gauthier S., 2012, FRONT BIOSCI SCHOL E, V3, P541; Gonzalez-Rivera R., 2012, WEBMEDCENTRAL PAIN, V3; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hill IE, 1997, BRAIN RES, V751, P206, DOI 10.1016/S0006-8993(96)01403-5; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/neu.2013.2944, 10.1089/NEU.2013.2944]; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Ishimaru H, 1996, BRAIN RES, V709, P155, DOI 10.1016/0006-8993(95)01232-X; Jung H, 1999, BRAIN RES, V844, P43, DOI 10.1016/S0006-8993(99)01888-0; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Kohda Y, 1996, BIOCHEM BIOPH RES CO, V228, P616, DOI 10.1006/bbrc.1996.1706; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lignelid H, 1997, ACTA NEUROPATHOL, V93, P494, DOI 10.1007/s004010050644; Liu ZA, 2010, BRAIN RES, V1361, P133, DOI 10.1016/j.brainres.2010.09.035; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; Nagai A., 2002, ANN NY ACAD SCI, V977, P321; Nitatori T, 1996, ADV EXP MED BIOL, V389, P177; Olsson T, 2004, NEUROSCIENCE, V128, P65, DOI 10.1016/j.neuroscience.2004.06.024; PALM DE, 1995, BRAIN RES, V691, P1, DOI 10.1016/0006-8993(95)00520-Z; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETANCESKA S, 1994, NEUROSCIENCE, V59, P729, DOI 10.1016/0306-4522(94)90190-2; Pirttila TJ, 2006, NEUROSCI LETT, V395, P108, DOI 10.1016/j.neulet.2005.10.091; Pirttila TJ, 2005, NEUROBIOL DIS, V20, P241, DOI 10.1016/j.nbd.2005.03.006; Seyfried D, 1997, J NEUROSURG, V87, P716, DOI 10.3171/jns.1997.87.5.0716; Sritharan K, 2009, BRIT J HOSP MED, V70, pM156, DOI 10.12968/hmed.2009.70.Sup10.44641; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; YASUHARA O, 1993, BRAIN RES, V628, P85, DOI 10.1016/0006-8993(93)90941-F; Zhang Y. B., 2006, FA YI XUE ZA ZHI, V22, P410; Zhang Yan-bo, 2006, Fa Yi Xue Za Zhi, V22, P404	39	10	11	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	APR	2014	15	4					5807	5820		10.3390/ijms15045807			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AI4ND	WOS:000336841200041	24714089	Green Published, Green Submitted, gold			2022-02-06	
J	Ni, HB; Jin, W; Yuan, BY; Zhu, TS; Wang, J; Jiang, J; Liang, WB; Ma, ZL				Ni, Hongbin; Jin, Wei; Yuan, Baoyu; Zhu, Tiansheng; Wang, Jing; Jiang, Jian; Liang, Weibang; Ma, Zhengliang			Curcumin inhibits the increase of labile zinc and the expression of inflammatory cytokines after traumatic spinal cord injury in rats	JOURNAL OF SURGICAL RESEARCH			English	Article						Curcumin; Labile zinc; Inflammatory cytokines; Spinal cord injury	BRAIN-INJURY; OXIDATIVE STRESS; CHELATABLE ZINC; NEUROPROTECTION; ZN2+; ACCUMULATION; HOMEOSTASIS; ACTIVATION; PROTECTS; TARGETS	Background: The present study aimed to investigate the effects of curcumin on the levels of spinal cord labile zinc (Zn) and inflammatory cytokines in rats after traumatic spinal cord injury (SCI). Methods: Adult male Sprague-Dawley rats were subjected to laminectomy at T8-T9 and compression with a vascular clip. There were three groups: (a) sham group; (b) SCI group; and (c) SCI + curcumin group. We measured spinal labile Zn by N-(6- methoxy-8-quinolinyl)-4-methylbenzenesulfonamide (TSQ) fluorescence staining, inflammatory cytokines such as interleukin 1 beta, interleukin-6, and tumor necrosis factor a by enzyme-linked immunosorbent assay, hindlimb locomotion function by Basso, Beattie, and Bresnahan rating, spinal cord edema by wet dry weight method, and apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling analysis. Results: The results showed that SCI caused a significant increase in labile Zn and inflammatory cytokines in the injured rat spinal cord. Treatment with curcumin after SCI markedly downregulated the levels of these agents and ameliorated SCI-induced hindlimb locomotion deficits, spinal cord edema, and apoptosis. Conclusions: Curcumin treatment attenuates the increase of labile Zn and the expression of inflammatory cytokines in the injured spinal cord, and this may be a mechanism whereby curcumin improves the outcome after SCI. (C) 2014 Elsevier Inc. All rights reserved.	[Ma, Zhengliang] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Dept Anesthesiol, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Ni, Hongbin; Jin, Wei; Yuan, Baoyu; Zhu, Tiansheng; Wang, Jing; Jiang, Jian; Liang, Weibang] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Ma, ZL (corresponding author), Drum Tower Hosp, Dept Anesthesiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	njneurosurgery@163.com; njglyy110@163.com		yuan, baoyu/0000-0002-2498-7829	Drum Tower Hospital of China	This work was supported by grants from Drum Tower Hospital of China. The authors thank Dr Lizhi Xu for technical assistance.	Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Failla ML, 2003, J NUTR, V133, p1443S, DOI 10.1093/jn/133.5.1443S; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2002, NEUROSCIENCE, V115, P471, DOI 10.1016/S0306-4522(02)00399-8; Fukuyama Satoru, 2011, Allergology International, V60, P259, DOI 10.2332/allergolint.09-OA-0167; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Jeong CW, 2012, J CARDIOVASC PHARM T, V17, P387, DOI 10.1177/1074248412438102; Jin W, 2011, INJURY, V42, P714, DOI 10.1016/j.injury.2011.03.009; Jin W, 2011, ANN CLIN LAB SCI, V41, P25; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Kalpana C, 2004, J MED FOOD, V7, P467, DOI 10.1089/jmf.2004.7.467; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Liang WB, 2010, BIOMATERIALS, V31, P8634, DOI 10.1016/j.biomaterials.2010.07.084; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; Nitzan YB, 2004, J HISTOCHEM CYTOCHEM, V52, P529, DOI 10.1177/002215540405200411; Nutini M, 2011, NEUROPHARMACOLOGY, V60, P1200, DOI 10.1016/j.neuropharm.2010.11.001; Ormond DR, 2012, J NEUROSURG-SPINE, V16, P497, DOI 10.3171/2012.1.SPINE11769; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Shukla PK, 2008, NEUROCHEM RES, V33, P1036, DOI 10.1007/s11064-007-9547-y; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Sun YH, 2011, J NEUROTRAUM, V28, P2513, DOI 10.1089/neu.2011.1958; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Wang YS, 2011, MED HYPOTHESES, V77, P589, DOI 10.1016/j.mehy.2011.06.037; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Xiao XF, 2012, J SURG RES, V176, pE31, DOI 10.1016/j.jss.2011.11.1032; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Yu Wen-Guang, 2011, Indian J Med Res, V134, P717, DOI 10.4103/0971-5916.91009; Zhu L, 2007, ANN CLIN LAB SCI, V37, P356; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	46	10	11	0	18	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2014	187	2					646	652		10.1016/j.jss.2013.12.023			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AC8GD	WOS:000332770600038	24484908				2022-02-06	
J	Partridge, B; Hall, W				Partridge, Bradley; Hall, Wayne			Conflicts of Interest in Recommendations to Use Computerized Neuropsychological Tests to Manage Concussion in Professional Football Codes	NEUROETHICS			English	Article						Concussion; Sport; Conflict of interest; Chronic traumatic encephalopathy; Neuropsychological test; ImPACT; CogState; NFL; AFL; NRL	CLINICAL-PRACTICE GUIDELINES; SPORT-RELATED CONCUSSION; TACKLE CONCUSSION; ISSUES; NEED	Neuroscience research has improved our understanding of the long term consequences of sports-related concussion, but ethical issues related to the prevention and management of concussion are an underdeveloped area of inquiry. This article exposes several examples of conflicts of interest that have arisen and been tolerated in the management of concussion in sport (particularly professional football codes) regarding the use of computerized neuropsychological (NP) tests for diagnosing concussion. Part 1 outlines how the recommendations of a series of global protocols for dealing with sports-related concussions (the 1st, 2nd and 3rd Consensus Statements on Concussion in Sport) have endorsed the use of NP testing. The development of these protocols has involved experts who have links with companies that sell computerised NP tests for concussion management. Part 2 describes how some professional football leagues-in particular the National Football League (NFL), the Australian Football League (AFL) and the National Rugby League (NRL)-have mandated specific NP testing products. They have done so on the basis of these international guidelines and by engaging experts who have conflicts of interest with NP testing companies. These decisions have also been taken despite evidence that casts doubt on the reliability and validity of NP tests when used in these ways.	[Partridge, Bradley; Hall, Wayne] Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia		Partridge, B (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia.	b.partridge@uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096	NHMRCNational Health and Medical Research Council of Australia	Thanks to Mal Parker, Eric Racine, Julia Hocking, and Adrian Carter for their comments on an earlier version of this work. This work was supported by an NHMRC Postdoctoral Fellowship.	AFL, 2011, RESP APPR CONC AFL; Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Anderson LC, 2005, J MED ETHICS, V31, P88, DOI 10.1136/jme.2002.000836; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Australian Football League (AFL), 2011, MAN CONC AUSTR FOOTB; Axon, 2010, P MCCROR NEUR SPORTS; Brody H, 2011, AM J BIOETHICS, V11, P23, DOI [10.1080/15265161.2010.534530, 10.1080/15265161.2011.568587]; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Buchan HA, 2010, MED J AUSTRALIA, V192, P490, DOI 10.5694/j.1326-5377.2010.tb03604.x; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.4, DOI 10.3171/FOC.2006.21.4.4]; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; CogState, 2011, INV PRES; CogState, 2011, TOYOT ANN SPONS AX S; CogState, 2011, COGSTATE ACQ 100 HOL; CogState, 2011, COGSTATE LAUNCH AX S; CogState, 2011, NRL MAND US COGSTATE; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis M., 2001, CONFLICT INTEREST PR; Davis M., 1993, BUS PROF ETHICS J, V12, P21, DOI [10.5840/bpej19931243, DOI 10.5840/BPEJ19931243]; Davis M., 1982, BUS PROF ETHICS J, V1, P17, DOI [10.5840/bpej1982149, DOI 10.5840/BPEJ1982149]; Dunn WR, 2007, AM J SPORT MED, V35, P840, DOI 10.1177/0363546506295177; Gilbert F., 2011, AJOB NEUROSCIENCE, V2, P48, DOI [DOI 10.1080/21507740.2011.611125, https://doi.org/10.1080/21507740.2011.611125]; Gilbert F, 2012, MED J AUSTRALIA, V196, P561, DOI 10.5694/mja11.11218; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Institute of Medicine, 2009, CONFLICT INTEREST ME; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Kaye AH, 2012, MED J AUSTRALIA, V196, P547, DOI 10.5694/mja12.10539; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Lane S, 2012, SYDNEY MORNING HERAL; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moriarity JM, 2012, BRIT J SPORT MED, V46, P1011, DOI 10.1136/bjsports-2011-090893; Muratore R, 2012, MED J AUSTRALIA, V197, P146, DOI 10.5694/mja12.10861; NRL, 2012, NRL MAILB CONC; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Prichard G., 2012, SYDNEY MORNING HERAL; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Valerio J, 2012, J HEAD TRAUMA REHAB, V27, P216, DOI 10.1097/HTR.0b013e3182229b6c; Williams MJ, 2011, MED J AUSTRALIA, V195, P442, DOI 10.5694/mja10.11130	56	10	10	1	25	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1874-5490	1874-5504		NEUROETHICS-NETH	Neuroethics	APR	2014	7	1					63	74		10.1007/s12152-013-9182-z			12	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	AB7WM	WOS:000332001700007					2022-02-06	
J	Perry, SB; Zeleznik, H; Breisinger, T				Perry, Susan B.; Zeleznik, Hallie; Breisinger, Terry			Supporting Clinical Practice Behavior Change Among Neurologic Physical Therapists: A Case Study in Knowledge Translation	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						behavior change; knowledge translation; neurologic physical therapy	TRAUMATIC BRAIN-INJURY; LOW-BACK-PAIN; CHALLENGE POINT; STROKE PATIENTS; NECK PAIN; REHABILITATION; OUTCOMES; INTERVENTIONS; STRATEGIES; GUIDELINES	Background and Purpose: Physical therapists tend to underuse research evidence in clinical practice. Emerging research on knowledge translation activities (KTAs) provides guidance to address this problem. We describe a yearlong effort to promote clinical practice behavior change in neurologic physical therapists. Case Description: Physical therapy stroke and brain injury teams in an inpatient rehabilitation setting implemented a quality improvement project to encourage use of a novel, evidence-supported gait training method (nonsupported gait training [NSGT]) for patients with hemiparesis. Intervention: The project consisted of multidimensional KTAs, including (1) quarterly staff meetings at which NSGT was introduced, reviewed, and discussed; (2) group and individual dialogue regarding successes, challenges, solutions, and clinical decision-making; (3) ongoing monitoring of and aggregate feedback about appropriate NSGT attempts via chart audit; and (4) ongoing reminders, role modeling, and clinical consultation. Specific staff perceptions about the approach, captured by a mid-year survey, further informed targeted problem-solving and clinical case presentations. Outcomes: In the first, second, and fourth quarter, 50%, 60%, and 73% of eligible patients were trained with NSGT, respectively. A mid-year survey showed that 19% of therapists were very/moderately familiar with NSGT before the quality improvement project, versus 78% at the 6-month point. Thirty-three percent stated that they used NSGT almost always/often before the project, versus 66% at the 6-month point. Discussion: Extensive multidimensional KTAs were feasible in inpatient rehabilitation and were accompanied by a moderate increase in documented and self-reported frequency of NSGT attempts. Clinical teams may benefit from adopting KTAs that best support clinical practice change. Video Abstract available (see Supplemental Digital Content 1, http://links.lww.com/JNPT/A69) for more insights from the authors.	[Perry, Susan B.] Chatham Univ, Phys Therapy Program, Pittsburgh, PA 15232 USA; [Zeleznik, Hallie] UPMC Ctr Rehab Serv, Outpatient Neuro Vestibular Program, Pittsburgh, PA USA; [Breisinger, Terry] UPMC Ctr Rehab Serv, Stroke Rehabil Program, Pittsburgh, PA USA		Perry, SB (corresponding author), Chatham Univ, Phys Therapy Program, Pittsburgh, PA 15232 USA.	perry@chatham.edu					Austin TM, 2007, PHYS THER, V87, P1023, DOI 10.2522/ptj.20060053; Bekkering GE, 2005, QUAL SAF HEALTH CARE, V14, P107, DOI 10.1136/qshc.2003.009357; Bekkering GE, 2005, PHYS THER, V85, P544, DOI 10.1093/ptj/85.6.544; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Brennan GP, 2006, PHYS THER, V86, P1251, DOI 10.2522/ptj.20050382; Brown CJ, 2005, PHYS THER, V85, P394, DOI 10.1093/ptj/85.5.394; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Cleland JA, 2009, PHYS THER, V89, P38, DOI 10.2522/ptj.20080033; DAVIDOFF F, 2009, BMJ-BRIT MED J, V338, P402; Davis D, 2003, BMJ-BRIT MED J, V327, P33, DOI 10.1136/bmj.327.7405.33; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FLETCHER SW, 2008, CONT ED HLTH PROF IM; Flodgren G, 2011, COCHRANE DB SYST REV; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; French B, 2007, COCHRANE DB SYST REV, V17; Glasziou P, 2011, BMJ QUAL SAF, V20, pI13, DOI 10.1136/bmjqs.2010.046524; Green LA, 2002, J FAM PRACTICE, V51, P938; Grimshaw JM, 2001, MED CARE, V39, pII2; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Harrison MB, 2010, CAN MED ASSOC J, V182, pE78, DOI 10.1503/cmaj.081232; Hesse S, 2011, CLIN REHABIL, V25, P146, DOI 10.1177/0269215510382148; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P373, DOI 10.1016/j.apmr.2004.10.018; Jette DU, 2003, PHYS THER, V83, P786, DOI 10.1093/ptj/83.9.786; Kornor-Bitensky N, 2007, J REHABIL MED, V39, P685, DOI 10.2340/16501977-0106; Langhammer B, 2007, CLIN REHABIL, V21, P495, DOI 10.1177/0269215507075207; Lin CH, 2007, PHYS THER, V87, P1120, DOI 10.2522/ptj.20060228; Menon A, 2009, J REHABIL MED, V41, P1024, DOI 10.2340/16501977-0451; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Nudo RJ, 1996, J NEUROSCI, V16, P785; Onla-or S, 2008, NEUROREHAB NEURAL RE, V22, P385, DOI 10.1177/1545968307313508; Pentland D, 2011, J ADV NURS, V67, P1408, DOI 10.1111/j.1365-2648.2011.05631.x; Rappolt Susan, 2002, J Contin Educ Health Prof, V22, P170, DOI 10.1002/chp.1340220306; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Retsas A, 2000, J ADV NURS, V31, P599, DOI 10.1046/j.1365-2648.2000.01315.x; Russell DJ, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-92; Sackett D, 2000, EVIDENCE BASED MED P, P173; Salbach NM, 2009, PHYS THER, V89, P1039, DOI 10.2522/ptj.20090081; Scheidt RA, 2007, J NEUROPHYSIOL, V97, P2824, DOI 10.1152/jn.00870.2006; Schreiber J, 2009, PHYS THER, V89, P918, DOI 10.2522/ptj.20080260; Schwartz I, 2009, PM&R, V1, P516, DOI 10.1016/j.pmrj.2009.03.009; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Tyson S, 2009, CLIN REHABIL, V23, P1018, DOI 10.1177/0269215509339004; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; Zidarov D, 2013, DISABIL REHABIL, V35, P1571, DOI 10.3109/09638288.2012.748841	49	10	10	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	APR	2014	38	2					134	143		10.1097/NPT.0000000000000034			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AL3TV	WOS:000339053200006	24637932				2022-02-06	
J	Agrawal, M; Joshi, M				Agrawal, Mahima; Joshi, Mrinal			Impact of rehabilitation on functional outcome during the first year of moderate and severe traumatic brain injury	BRAIN INJURY			English	Article						Disability rating scale (DRS); functional independence measure (FIM); Glasgow outcome scale extended (GOSE); rehabilitation; traumatic brain injury (TBI)	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; INDEPENDENCE MEASURE; RECOVERY; RELIABILITY; ADMISSION; COMMUNITY; MEDICINE; VALIDITY; HEALTH	Objectives: To describe the functional level after 1 year in moderate and severe traumatic brain injury (TBI). Study design: Prospective, cross-sectional study. Setting and participants: Seventy individuals with TBI were admitted directly from acute care hospitals to a rehabilitation facility in Sawai Mansingh Medical College and Hospital, Jaipur (SMS). A follow-up of 58 patients was done up to 1 year later in the period from July 2011 to July 2012. Results: Mean change in FIM scores from admission to discharge was 51.26 and from admission to 12 months it was 85.3 in the moderate injury group. Mean change in DRS from admission to discharge was -8.19 and from admission to 12 months it was -17.76 in the moderate injury group and -8.55 and -19 in the severe injury group, respectively. The correlation coefficient (r) between FIM and GOSE was 0.570 and between FIM and DRS was -0.8190, both of which were significant. Conclusions: All individuals improved significantly in the inpatient rehabilitation facility in the acute phase, with maximum gain in function seen from admission to discharge as assessed on FIM and DRS. The majority of the individuals continued to improve up to 6 months post-injury.	[Agrawal, Mahima; Joshi, Mrinal] SMSMC & Hosp, Dept Phys Med & Rehabil, Jaipur, Rajasthan, India		Agrawal, M (corresponding author), SMSMC & Hosp, Dept Phys Med & Rehabil, Jaipur, Rajasthan, India.	docmahima@yahoo.com					Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sorbo AK, 2009, INT J REHABIL RES, V32, P139, DOI 10.1097/MRR.0b013e328325a5d1; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V20; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	28	10	10	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2014	28	3					292	297		10.3109/02699052.2013.865266			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AC0RI	WOS:000332202100004	24378157				2022-02-06	
J	Leijdesdorff, HA; van Dijck, JTJM; Krijnen, P; Vleggeert-Lankamp, CLAM; Schipper, IB				Leijdesdorff, Henry A.; van Dijck, Jeroen T. J. M.; Krijnen, Pieta; Vleggeert-Lankamp, Carmen L. A. M.; Schipper, Inger B.		Regional Trauma Ctr	Injury Pattern, Hospital Triage, and Mortality of 1250 Patients with Severe Traumatic Brain Injury Caused by Road Traffic Accidents	JOURNAL OF NEUROTRAUMA			English	Article						epidemiology, head trauma; outcome measures; surgery; traumatic brain injury	SPORT-RELATED CONCUSSION; WORKING-MEMORY TASK; HEAD-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; FRONTAL-CORTEX; FUNCTIONAL MRI; CHILDREN; FMRI	This epidemiological study analyzed the incidence, risk factors, hospital triage, and outcome of patients with severe traumatic brain injuries (sTBIs) caused by road traffic accidents (RTAs) admitted to hospitals in the Trauma Center West-Netherlands (TCWN) region. Trauma registry data were used to identify TBI in all RTA victims admitted to hospitals in the mid-West region of the Netherlands from 2003 to 2011. Type of head injury and severity were classified using the Abbreviated Injury Scale (AIS). Head injuries with AIS severity scores >= 3 were considered sTBI. Ten percent of all 12,503 hospital-admitted RTA victims sustained sTBI, ranging from 5.4% in motorcyclists, 7.4% in motorists, 9.6% in cyclists, and 12.7% in moped riders to 15.1% in pedestrians (p<0.0001). Among RTA victims admitted to hospital, sTBI was most prevalent in pedestrians (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.78-2.86) and moped riders (OR, 1.86; 95% CI, 1.51-2.30). Injury patterns differed between road user groups. Incidence of contusion ranged from 46.6% in cyclists to 74.2% in motorcyclists, whereas basilar and open-skull fractures were least common in motorcyclists (22.6%) and most common in moped riders (51.5%). Hemorrhage incidence ranged from 44.9% (motorists) to 63.6% (pedestrians). Subdural and -arachnoid bleedings were most frequent. Age, Glasgow Coma Scale, and type of hemorrhage were independent prognostic factors for in-hospital mortality after sTBI. In-hospital mortality ranged from 4.2% in moped riders to 14.1% in motorists. Pedestrians have the highest risk to sustain sTBI and, more specifically, intracranial hemorrhage. Hemorrhage and contusion both occur in over 50% of patients with sTBI. Specific brain injury patterns can be distinguished for specific road user groups, and independent prognostic risk factors for sTBI were identified. This knowledge may be used to improve vigilance for particular injuries in specific patient groups and stimulate development of focused diagnostic strategies.	[Leijdesdorff, Henry A.; van Dijck, Jeroen T. J. M.; Krijnen, Pieta; Schipper, Inger B.] Leiden Univ, Med Ctr, Dept Trauma Surg, NL-2300 RC Leiden, Netherlands; [Leijdesdorff, Henry A.] Gelre Ziekenhuizen Apeldoorn, Dept Surg, Apeldoorn, Netherlands; [Vleggeert-Lankamp, Carmen L. A. M.] Leiden Univ, Med Ctr, Dept Neurosurg, NL-2300 RC Leiden, Netherlands		Schipper, IB (corresponding author), Leiden Univ, Med Ctr, Dept Trauma Surg, K6-R POB 9600, NL-2300 RC Leiden, Netherlands.	i.b.schipper@lumc.nl	Meijer, Anna/K-5118-2016; van Dijck, Jeroen/AAM-4123-2021; Schipper, Inger/ABE-7796-2021	van Dijck, Jeroen/0000-0002-9893-632X; Schipper, Inger/0000-0001-9952-3079; Leijdesdorff, Henry/0000-0001-8229-0707			Achenbach T, 1983, MANUAL CHILD BEHAV C; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Bryden PJ, 2005, BRAIN COGNITION, V58, P258, DOI 10.1016/j.bandc.2004.12.004; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Ciesielski KT, 2006, NEUROIMAGE, V33, P980, DOI 10.1016/j.neuroimage.2006.07.028; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Freund J, 1994, COGNITIVE COMMUNICAT; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Golden CJ, 1978, STROOP COLOR WORD TE; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meyers J., 1995, REY COMPLEX FIGURE R; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Nagel BJ, 2005, J CLIN EXP NEUROPSYC, V27, P823, DOI 10.1080/13803390490919038; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Petrides M, 2001, NEUROIMAGE, V13, pS721; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Romine CB, 2004, NEUROPSYCHOL REV, V14, P43, DOI 10.1023/B:NERV.0000026648.94811.32; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Steer, 2005, BECK YOUTH INVENTORI; Stern CE, 2000, NEUROIMAGE, V11, P392, DOI 10.1006/nimg.2000.0569; Talavage TM, 2013, J NEUROTRAUMA; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Waschbusch DA, 2008, J PSYCHOPATHOL BEHAV, V30, P180, DOI 10.1007/s10862-007-9064-y; Wechsler D., 2011, WECHSLER ABBREVIATED; WILLIAMS J, 1995, ARCH CLIN NEUROPSYCH, V10, P211, DOI 10.1016/0887-6177(94)00041-N; Wiseman-Hakes C., 2000, FRONT LOB ROTM RES I; Worsley KJ, 2005, NEUROIMAGE, V26, P635, DOI 10.1016/j.neuroimage.2005.02.007; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395	58	10	15	2	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					459	465		10.1089/NEU.2013.3111			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600244	24093437				2022-02-06	
J	Lopez, NE; Lindsay, G; Karina, LR; Mary, HA; Putnam, J; Eliceiri, B; Coimbra, R; Bansal, V				Lopez, Nicole E.; Lindsay, Gaston; Karina, Lopez R.; Mary, Hageny A.; Putnam, James; Eliceiri, Brian; Coimbra, Raul; Bansal, Vishal			Ghrelin decreases motor deficits after traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						TBI; Ghrelin; Motor outcomes	INTESTINAL DYSFUNCTION; CELL-DEATH; BARRIER; RATS; ISCHEMIA/REPERFUSION; DISRUPTION; APOPTOSIS; ENDOTOXIN; PROTECTS; RECOVERY	Background: Pharmacologic therapy for traumatic brain injury (TBI) has remained relatively unchanged for decades. Ghrelin, an endogenously produced peptide, has been shown to prevent apoptosis and blood-brain barrier dysfunction after TBI. We hypothesize that ghrelin treatment will prevent neuronal degeneration and improve motor coordination after TBI. Materials and methods: A weight drop model created severe TBI in three groups of BALB/c mice: Sham, TBI, and TBI + ghrelin (20 mu g intraperitoneal ghrelin). Brain tissue was examined by hematoxylin and eosin and Fluoro-Jade B (FJB) staining to evaluate histologic signs of injury, cortical volume loss, and neuronal degeneration. Additionally, motor coordination was assessed. Results: Ghrelin treatment prevented volume loss after TBI (19.4 +/- 9.8 mm(3) versus 71.4 +/- 31.4 mm(3); P < 0.05). Similarly, although TBI increased FJB-positive neuronal degeneration, ghrelin treatment decreased FJB staining in TBI resulting in immunohistologic patterns similar to sham. Compared with sham, TBI animals had a significant increase in foot faults at d 1, 3, and 7 (2.75 +/- 0.42; 2.67 +/- 0.94; 3.33 +/- 0.69 versus 0.0 +/- 0.0; 0.17 +/- 0.19; 0.0 +/- 0.0; P < 0.001). TBI + ghrelin animals had significantly decreased foot faults compared with TBI at d 1, 3, and 7 (0.42 +/- 0.63; 0.5 +/- 0.43; 1.33 +/- 0.58; P versus TBI < 0.001; P versus sham = NS). Conclusions: Ghrelin treatment prevented post-TBI cortical volume loss and neurodegeneration. Furthermore, ghrelin improved post-TBI motor deficits. The mechanisms of these effects are unclear; however, a combination of the anti-apoptotic and inflammatory modulatory effects of ghrelin may play a role. Further studies delineating the mechanism of these observed effects are warranted. (C) 2014 Elsevier Inc. All rights reserved.	[Lopez, Nicole E.; Lindsay, Gaston; Karina, Lopez R.; Mary, Hageny A.; Putnam, James; Eliceiri, Brian; Coimbra, Raul; Bansal, Vishal] Univ Calif San Diego, Div Trauma Surg Crit Care & Burns, Dept Surg, San Diego, CA 92103 USA		Bansal, V (corresponding author), Univ Calif San Diego, Div Trauma Surg Crit Care & Burns, Dept Surg, 200 W Arbor Dr 8896, San Diego, CA 92103 USA.	v3bansal@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916; Lopez, Nicole/0000-0002-4807-7360	American Surgical Association Foundation Award	The authors would like to acknowledge the generous support of the American Surgical Association Foundation Award.	[Anonymous], 2010, TRAUMATIC BRAIN INJU; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cheyuo C, 2012, AM J PHYSIOL-ENDOC M, V302, pE265, DOI 10.1152/ajpendo.00508.2011; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Costantini TW, 2010, J TRAUMA, V68, P1349, DOI 10.1097/TA.0b013e3181dccea0; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Ersahin M, 2010, J NEUROTRAUM, V27, P1143, DOI 10.1089/neu.2009.1210; Gahete MD, 2011, PEPTIDES, V32, P2225, DOI 10.1016/j.peptides.2011.09.019; Lee BW, 2008, GROWTH HORM IGF RES, V18, P291, DOI 10.1016/j.ghir.2007.11.005; Lee JY, 2010, ENDOCRINOLOGY, V151, P3815, DOI 10.1210/en.2009-1416; Lee J, 2010, J ENDOCRINOL, V205, P262, DOI 10.1677/JOE-10-0040; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Phan TG, 2002, CLIN EXP PHARMACOL P, V29, P1, DOI 10.1046/j.1440-1681.2002.03609.x; Popescu I, 2010, DIS COLON RECTUM, V53, P126, DOI 10.1007/DCR.0b013e3181b54166; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Shaw M, 2013, DIS COLON RECTUM, V56, P888, DOI 10.1097/DCR.0b013e31829196d0; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu JJ, 2009, NEUROSCI LETT, V453, P58, DOI 10.1016/j.neulet.2009.01.067; Yilmaz Z, 2008, CRIT CARE MED, V36, P828, DOI 10.1097/01.CCM.0B013E3181611F5AA	34	10	10	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2014	187	1					230	236		10.1016/j.jss.2013.09.030			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AB2FB	WOS:000331607500034	24176206				2022-02-06	
J	Novakovic-Agopian, T; Chen, AJW; Rome, S; Rossi, A; Abrams, G; D'Esposito, M; Turner, G; McKim, R; Muir, J; Hills, N; Kennedy, C; Garfinkle, J; Murphy, M; Binder, D; Castelli, H				Novakovic-Agopian, Tatjana; Chen, Anthony J. -W.; Rome, Scott; Rossi, Annemarie; Abrams, Gary; D'Esposito, Mark; Turner, Gary; McKim, Ryan; Muir, Jim; Hills, Nancy; Kennedy, Cathy; Garfinkle, John; Murphy, Michelle; Binder, Deborah; Castelli, Holli			Assessment of Subcomponents of Executive Functioning in Ecologically Valid Settings: The Goal Processing Scale	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury rehabilitation; ecologically valid assessment; executive functions; functional performance	TRAUMATIC BRAIN-INJURY; MULTIPLE ERRANDS TEST; FRONTAL-LOBE DAMAGE; SIMPLIFIED VERSION; PREFRONTAL CORTEX; WORKING-MEMORY; ATTENTION; RELIABILITY; EMPLOYMENT; DEFICITS	Objectives: To validate a new functional assessment tool, the Goal Processing Scale (GPS), and to apply it for testing for sources of dysfunction in patients with acquired brain injury. Determining which component processes of executive functioning underlie poor performance in complex, low-structure settings would be valuable for the assessment of deficits and for evaluating the effectiveness of treatments. Participants: Nineteen individuals with chronic acquired brain injury (mean age = 41.4 years; chronicity: 6 months to 39 years). Main Measures: Two functional assessment tasks: (1) GPS, which evaluates functional performance in the context of achieving a goal in a real-world setting, with rating scales measuring overall performance and 8 subdomains of executive functioning; (2) Multiple Errands Test, an unstructured assessment of ability to adhere to rules and complete multiple real-world tasks in a short time; and (3) a neuropsychological battery. Results: Intraclass correlation coefficients for 2 independent raters ranged from 0.75 to 0.98 for the GPS overall composite score and the subdomain scores. Performance on GPS overall and several subdomain scores correlated with performance on the Multiple Errands Test. Working memory and learning/memory neuropsychological measures predicted functional performance as measured using the GPS. Discussion: The GPS shows high interrater reliability, suggesting convergent validity with an established functional performance measure, and produces useful information regarding strengths and weaknesses in different subdomains of executive functioning. Working memory and learning/memory appear to be key determinants of goal-directed functioning for these individuals with brain injury.	[Novakovic-Agopian, Tatjana; Chen, Anthony J. -W.; Rossi, Annemarie; Abrams, Gary; McKim, Ryan; Murphy, Michelle; Binder, Deborah] Vet Adm Med Ctr, San Francisco, CA 94121 USA; [Novakovic-Agopian, Tatjana; Chen, Anthony J. -W.; D'Esposito, Mark; Muir, Jim; Binder, Deborah] Vet Adm Northern Calif Hlth Care Syst, Martinez, CA USA; [Novakovic-Agopian, Tatjana; Rome, Scott; Rossi, Annemarie; Kennedy, Cathy; Garfinkle, John; Castelli, Holli] Calif Pacif Reg Rehabil Ctr, San Francisco, CA USA; [Novakovic-Agopian, Tatjana; Chen, Anthony J. -W.; Abrams, Gary; Hills, Nancy] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chen, Anthony J. -W.; D'Esposito, Mark] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Turner, Gary] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada		Novakovic-Agopian, T (corresponding author), SFVA Med Ctr, 4150 Clement St,Mail Code 127, San Francisco, CA 94121 USA.	tna@cns-site.com			Office of Research and Development Rehabilitation R&D Service Department of Veterans AffairsUS Department of Veterans Affairs; California Pacific Medical Center (CPMC) Foundation; Veterans AffairsUS Department of Veterans Affairs [I01RX001111] Funding Source: NIH RePORTER	This material is based upon work supported by the Office of Research and Development Rehabilitation R&D Service Department of Veterans Affairs, and the California Pacific Medical Center (CPMC) Foundation. The authors thank participating patients and a number of individuals who made this study possible, in particular Gerald Carlin, OTR/L, for help with earlier versions of functional assessment tool and with participant recruitment; Richard Fitzsimons, MS, for conducting study neuropsychological evaluations; Guiomar Scheid, for help with participant scheduling; and Byron Morgenroth, MS, for help with organizing the portions of the study conducted at the CPMC.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Alexander M, 2006, J INT NEUROPSYCH SOC, V12, P192, DOI 10.1017/S1355617706060292; Anderten Loeb P., 1996, INDEPENDENT LIVING S; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chelune GJ, 1986, ADV CLIN NEUROPSYCHO, V3, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis DC., 2001, DELIS KAPLAN EXECUTI; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Evans J, 2005, EFFECTIVENESS REHABI, P247; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Hamer RM, 1991, SAS MACRO INTRACC SA; Heaton, 2010, NEUROPSYCHOLOGY EVER, P5; Heaton RK, 2004, COMPREHENSIVE NORMS; Hecaen H., 1978, HUMAN NEUROPSYCHOLOG; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Novakovic-Agopian T, 2010, J INT NEUROPSYCHO S1, V16, P126; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stuss D, 1988, CLIN NEUROPSYCHOL, V1, P139, DOI DOI 10.1080/13854048708520046; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212	45	10	10	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					136	146		10.1097/HTR.0b013e3182691b15			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600007	23076096				2022-02-06	
J	Sezer, A; Guclu, B; Kazanci, B; Cakir, M; Coban, MK				Sezer, Aykut; Guclu, Bulent; Kazanci, Burak; Cakir, Murteza; Coban, Mustafa Kemal			Neuroprotective Effects of Agmatine in Experimental Peripheral Nerve Injury in Rats: A Prospective Randomized and Placebo-Controlled Trial	TURKISH NEUROSURGERY			English	Article						Agmatine; Axonotmesis; Neurotmesis; Peripheral nerve injury; Rat	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; LASER PHOTOTHERAPY; REGENERATION	AIM: The purpose of this study was to demonstrate the activity of agmatine, an inducible nitric oxide synthase (iNOS) inhibitor and selective N-methyl-D-aspartate receptor (NMDAR) antagonist, on reducing tissue damage in distal part of traumatic nerve in an experimental rat peripheral nerve injury model. MATERIAL and METHODS: Sciatic nerves of 30 Sprague Dawley male rats were used. Rats were divided into 5 groups; group 1 (n=6), control group; group 2 (n=6), axonotmesis + placebo group; group 3 (n=6), axonotmesis + 50 mg/kg agmatine treatment group; group 4 (n=6), neurotmesis + placebo group; group 5 (n=6), neurotmesis + 50 mg/kg agmatine treatment group. Axonolysis, axon degeneration, edema, hemorrhage, and inflammation were evaluated in histopathologic examinations of all the groups. RESULTS: When group 2 was compared with group 3 in histopathologic sections, axonolysis was less in group 3 (p=0.007), as was axon degeneration (p=0.022) and edema (p=0.018). When group 4 was compared with group 5, axonolysis was less in group 5 (p=0.009), as was axon degeneration (p=0.006) and edema (p=0.021). CONCLUSION: This study demonstrated agmatine to have antioxidant and antineurotoxic effects in an experimental rat peripheral nerve injury model.	[Sezer, Aykut; Guclu, Bulent] Sevket Yilmaz Res & Training Hosp, Dept Neurosurg, Minist Hlth, Bursa, Turkey; [Kazanci, Burak] Ufuk Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Cakir, Murteza] Ataturk Univ Hosp, Dept Neurosurg, Erzurum, Turkey; [Coban, Mustafa Kemal] Erzurum Res & Training Hosp, Dept Neurosurg, Minist Hlth, Erzurum, Turkey		Guclu, B (corresponding author), Sevket Yilmaz Res & Training Hosp, Dept Neurosurg, Minist Hlth, Bursa, Turkey.	guclubulent@hotmail.com					Dagum A B, 1998, J Hand Ther, V11, P111; Fairbanks CA, 2000, P NATL ACAD SCI USA, V97, P10584, DOI 10.1073/pnas.97.19.10584; Fenrich K, 2004, CAN J NEUROL SCI, V31, P142, DOI 10.1017/S0317167100053798; GILAD GM, 1995, LIFE SCI, V58, pPL41, DOI 10.1016/0024-3205(95)02274-0; Gilad GM, 2000, NEUROSCI LETT, V296, P97, DOI 10.1016/S0304-3940(00)01625-6; Gilad GM, 1996, NEUROSCI LETT, V216, P33; Gocmen S, 2012, TURK NEUROSURG, V22, P167, DOI 10.5137/1019-5149.JTN.5039-11.1; Kotil K, 2006, J NEUROSURG-SPINE, V4, P392, DOI 10.3171/spi.2006.4.5.392; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Mendonca AC, 2003, J NEUROSCI METH, V129, P183, DOI 10.1016/S0165-0270(03)00207-3; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; Raso VVM, 2005, J NEUROSCI METH, V142, P185, DOI 10.1016/j.jneumeth.2004.08.016; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P436, DOI 10.1089/pho.2007.2093; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P137, DOI 10.1089/pho.2007.2076; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Sung B, 2007, PAIN, V131, P121, DOI 10.1016/j.pain.2006.12.020; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Yu CG, 2000, NEUROREPORT, V11, P3203, DOI 10.1097/00001756-200009280-00031	23	10	12	1	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2014	24	2					196	201		10.5137/1019-5149.JTN.7324-12.1			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AF2RX	WOS:000334560800008	24831360	Bronze			2022-02-06	
J	Woodruff, SI; Galarneau, MR; Luu, BN; Sack, D; Han, P				Woodruff, Susan I.; Galarneau, Michael R.; Luu, Bethi N.; Sack, Daniel; Han, Peggy			A Study Protocol for Tracking Quality of Life Among US Service Members Wounded in Iraq and Afghanistan: The Wounded Warrior Recovery Project	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; WELL-BEING SCALE; MILITARY PERSONNEL; SEVERITY SCORE; HEALTH-STATUS; COMBAT; WAR; CONCUSSION; DIAGNOSES	There is a need for more work to understand the quality of life (QOL) outcomes of survivors of Operations Enduring Freedom and Iraqi Freedom combat injury to improve care and treatment, and prevent poor physical, psychological, and social outcomes. We describe the study design and methods of the Wounded Warrior Recovery Project, a study supported by the Department of Defense that will track close to 10,000 military personnel wounded in Operations Enduring Freedom and Iraqi Freedom. The overall objective of the 6-year longitudinal study is to track changes in QOL and describe variations in those changes as they relate to sociodemographic factors, injury characteristics, service-related factors, clinical/diagnostic measures including traumatic brain injury and posttraumatic stress disorder, and medical procedures and services. The Wounded Warrior Recovery Project study will be among the first longitudinal population-based investigations of QOL outcomes after combat injury and will provide a basis upon which large-scale epidemiological studies can be conducted.	[Woodruff, Susan I.; Galarneau, Michael R.; Luu, Bethi N.; Sack, Daniel; Han, Peggy] Naval Hlth Res Ctr, Med Modeling Simulat & Miss Support Dept, San Diego, CA 92106 USA		Woodruff, SI (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Miss Support Dept, Code 161,140 Sylvester Rd, San Diego, CA 92106 USA.				U.S. Navy Bureau of Medicine and Surgery [60922]	Initial conception of this research is credited to Dr. Troy Holbrook. Editing of this manuscript suitable for publication was provided by Mr. Charles Jackson, Ms. Michelle LeWark, and Ms. Carrie Brown of the Naval Health Research Center. This material was based on work supported by the U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured Psychological Health and Traumatic Brain Injury Program (Work Unit No. 60922).	Andresen EM, 1998, MED CARE, V36, P1349, DOI 10.1097/00005650-199809000-00007; Asano M, 2008, PROSTHET ORTHOT INT, V32, P231, DOI 10.1080/03093640802024955; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BILMES L, 2007, FACULTY RES WORKING; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borut LTJ, 2010, J TRAUMA, V69, P174, DOI 10.1097/TA.0b013e3181e03e71; Carr AJ, 2001, BRIT MED J, V322, P1357, DOI 10.1136/bmj.322.7298.1357; Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P375; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Doucet JJ, 2011, J TRAUMA, V70, P1241, DOI 10.1097/TA.0b013e3182095b52; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Epstein RA, 2010, J REHABIL RES DEV, V47, P373, DOI 10.1682/JRRD.2009.03.0023; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gennarelli TA, 2005, ABBREVIATED INJURY S; Goodwin PJ, 2003, JNCI-J NATL CANCER I, V95, P263, DOI 10.1093/jnci/95.4.263; Gray GC, 2002, MIL MED, V167, P483, DOI 10.1093/milmed/167.6.483; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Institute of Medicine, 2010, RET HOM IR AFGH READ; Iredell H, 2004, HEALTH EDUC RES, V19, P159, DOI 10.1093/her/cyg015; Kaplan RM, 1997, PSYCHOL HEALTH, V12, P783, DOI 10.1080/08870449708406739; Larson GE, 2011, PSYCHIAT SERV, V62, P15, DOI 10.1176/ps.62.1.pss6201_0015; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; MacGregor AJ, 2012, 22 PAC COAST BRAIN I; MacGregor AJ, 2012, MIL MED, V177, P845, DOI 10.7205/MILMED-D-12-00021; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Melcer T, 2011, J REHABIL RES DEV, V48, P1, DOI 10.1682/JRRD.2010.03.0033; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; PERMANYERMIRALDA G, 1991, J CLIN EPIDEMIOL, V44, P779, DOI 10.1016/0895-4356(91)90130-2; Proctor SP, 2001, MIL MED, V166, P510, DOI 10.1093/milmed/166.6.510; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Robertson B, 2000, AUST NZ J PUBL HEAL, V24, P552, DOI 10.1111/j.1467-842X.2000.tb00512.x; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 1987, MULTIPLE IMPUTATION; Schmitz KJ, 2012, MIL MED, V177, P380, DOI 10.7205/MILMED-D-11-00294; Schok ML, 2005, MIL PSYCHOL, V17, P89, DOI 10.1207/s15327876mp1702_2; Sieber WJ, 2000, HEADACHE, V40, P662, DOI 10.1046/j.1526-4610.2000.040008662.x; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Woodruff SI, 2010, EMERG MED J, V27, P121, DOI 10.1136/emj.2008.060657; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	54	10	10	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2014	179	3					265	272		10.7205/MILMED-D-13-00444			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7UJ	WOS:000340806200010	24594460	Bronze			2022-02-06	
J	Zheng, P; He, B; Tong, WS				Zheng, P.; He, B.; Tong, W. S.			Decrease in pituitary apparent diffusion coefficient in normal appearing brain correlates with hypopituitarism following traumatic brain injury	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Traumatic brain injury; Hypopituitarism; Magnetic resonance imaging; Apparent diffusion coefficient; Pituitary	MANAGEMENT; STROKE	Introduction Following traumatic brain injury (TBI), there may be persistent pituitary deficits despite the presence of normal conventional magnetic resonance (MR) images. Little is known about the association of microstructural changes in the pituitary with pituitary function in TBI patients with normal appearing brain on conventional MR images. Our aim was to quantify changes in pituitary apparent diffusion coefficient (ADC) of normal appearing brain in human traumatic brain injury. Methods Forty-two patients admitted with a diagnosis of mild head injury having normal appearing brain imaging were scanned at 7 days after injury using a quantitative echo planar imaging acquisition to obtain ADC parametric map. Mean pituitary ADC values were compared with a control group (n = 30). Results The TBI group showed a significant decrease in pituitary ADC compared to the controls. Furthermore, the mean ADC was much less in TBI patients with pituitary dysfunction compared to those with normal pituitary function. There was also a correlation between the development of pituitary dysfunction and decreasing ADC (r = 0.82, P < 0.01). Conclusion Our findings suggest that pituitary ADC is a sensitive and independent marker of pituitary damage following traumatic insult, which is useful to detect the microstructural damage in pituitary in normal appearing brain.	[Zheng, P.; He, B.; Tong, W. S.] Shanghai Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China		Zheng, P (corresponding author), Shanghai Pudong New Area Peoples Hosp, Dept Neurosurg, 490 South Chuanhuan Rd, Shanghai, Peoples R China.	jojo_ras@126.com			Ministry of Health, Pudong New area, Shanghai China [PW2011A-13]	This study was supported by a Grant for the Promotion of Science, the Ministry of Health, Pudong New area, Shanghai China (Grant PW2011A-13).	Benson CM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-51; Brandstack N, 2011, CLIN NEURORADIOL, V21, P75, DOI 10.1007/s00062-011-0058-5; Desai V, 2012, BRAIN RES, V1458, P86, DOI 10.1016/j.brainres.2012.04.004; Hori M, 2011, ACAD RADIOL, V18, P837, DOI 10.1016/j.acra.2011.02.005; Kibayashi K, 2012, AM J FOREN MED PATH, V33, P206, DOI 10.1097/PAF.0b013e3181fe33e8; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	12	10	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0391-4097	1720-8386		J ENDOCRINOL INVEST	J. Endocrinol. Invest.	MAR	2014	37	3					309	312		10.1007/s40618-014-0059-8			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	AG1CI	WOS:000335152200012	24557849				2022-02-06	
J	Valiyaveettil, M; Alamneh, YA; Wang, Y; Arun, P; Oguntayo, S; Wei, YL; Long, JB; Nambiar, MP				Valiyaveettil, Manoj; Alamneh, Yonas A.; Wang, Ying; Arun, Peethambaran; Oguntayo, Samuel; Wei, Yanling; Long, Joseph B.; Nambiar, Madhusoodana P.			Cytoskeletal protein alpha-II spectrin degradation in the brain of repeated blast exposed mice	BRAIN RESEARCH			English	Article						Cytoskeleton; alpha-II spectrin; Repeated blast exposure; Caspase-3; Calpain-2; Diffuse axonal injury; Traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; DIFFUSE AXONAL INJURY; COGNITIVE DEFICITS; BREAKDOWN PRODUCTS; HEAD-INJURY; MODEL; CALPAIN; ACCUMULATION; PERFORMANCE; ACTIVATION	Repeated blast exposures commonly induce traumatic brain injury (TBI) characterized by diffuse axonal injury (DAI). We hypothesized that degradation of cytoskeletal proteins in the brain can lead to DAI, and evaluated alpha-II spectrin degradation in the pathophysiology of blast-induced TBI using the tightly-coupled three repetitive blast exposure mice model with a 1-30 min window in between exposures. Degradation of alpha-II spectrin and the expression profiles of caspase-3 and calpain-2, the major enzymes involved in the degradation were analyzed in the frontal cortex and cerebellum using Western blotting with specific antibodies. DAI at different brain regions was evaluated by neuropathology with silver staining. Repeated blast exposures resulted in significant increases in the alpha-II spectrin degradation products in the frontal cortex and cerebellum compared to sham controls. Expression of active caspase-3, which degrades alpha-II spectrin, showed significant increase in the frontal cortex after blast exposure at all the time points studied, while cerebellum showed an acute increase which was normalized over time. The expression of another alpha-II spectrin degrading enzyme, calpain-2, showed a rapid increase in the frontal cortex after blast exposure and it was significantly higher in the cerebellum at later time points. Neuropathological analysis showed significant levels of DAI at the frontal cortex and cerebellum at multiple time points after repeated blast injury. In summary, repeated blast exposure results in specific degradation of alpha-II spectrin in the brain along with differential expression of caspase-3/calpain-2 suggesting cytoskeletal breakdown as a possible contributor of DAI after repeated blast exposure. (C) 2013 Elsevier B.V. All rights reserved.	[Valiyaveettil, Manoj; Alamneh, Yonas A.; Wang, Ying; Arun, Peethambaran; Oguntayo, Samuel; Wei, Yanling; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Valiyaveettil, M (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	m.valiyaveettil@us.army.mil; madhunambiar1@gmail.com					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Arun P, 2012, INTERV MED APPL SCI, V4, P125, DOI 10.1556/IMAS.4.2012.3.2; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033798; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Castillo MR, 1998, NEUROSCIENCE, V86, P1133, DOI 10.1016/S0306-4522(98)00070-0; Cemak I., 2011, NEUROBIOL DIS, V538, P51; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Treadwell I, 1989, Nurs RSA, V4, P32; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang Y, 2014, J NEUROTRAUM, V31, P498, DOI [10.1089/NEU.2013.3074, 10.1089/neu.2013.3074]; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134	64	10	10	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 26	2014	1549						32	41		10.1016/j.brainres.2013.12.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD3MC	WOS:000333142200004	24412202				2022-02-06	
J	Ekeh, AP; Ilyas, S; Saxe, JM; Whitmill, M; Parikh, P; Schweitzer, JS; McCarthy, MC				Ekeh, Akpofure Peter; Ilyas, Sadia; Saxe, Jonathan M.; Whitmill, Melissa; Parikh, Priti; Schweitzer, Jeffrey S.; McCarthy, Mary C.			Successful placement of intracranial pressure monitors by trauma surgeons	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Top intracranial monitoring; acute care surgery; complications; ICP placement; neurosurgeons	BRAIN-INJURY; MIDLEVEL PRACTITIONERS; NON-NEUROSURGEONS; HEAD TRAUMA; OUTCOMES; GUIDELINES; CARE; MANAGEMENT; MORTALITY; PROTOCOL	BACKGROUND: The Brain Trauma Foundation guidelines advocate for the use of intracranial pressure (ICP) monitoring following traumatic brain injury (TBI) in patients with a Glasgow Coma Scale (GCS) score of 8 or less and an abnormal computed tomographic scan finding. The absence of 24-hour in-house neurosurgery coverage can negatively impact timely monitor placement. We reviewed the safety profile of ICP monitor placement by trauma surgeons trained and credentialed in their insertion by neurosurgeons. METHODS: In 2005, the in-house trauma surgeons at a Level I trauma center were trained and credentialed in the placement of ICP parenchymal monitors by the neurosurgeons. We abstracted all TBI patients who had ICP monitors placed during a 6-year period. Demographic information, Injury Severity Score (ISS), outcome, and monitor placement by neurosurgery or trauma surgery were identified. Misplacement, hemorrhage, infections, malfunctions, and dislodgement were considered complications. Comparisons were performed by chi(2) testing and Student's t tests. RESULTS: During the 6-year period, 410 ICP monitors were placed for TBI. The mean (SD) patient age was 40.9 (18.9) years, 73.7% were male, mean (SD) ISS was 28.3 (9.4), mean (SD) length of stay was 19 (16) days, and mortality was 36.1%. Motor vehicle collisions and falls were the most common mechanisms of injury (35.2% and 28.7%, respectively). The trauma surgeons placed 71.7% of the ICP monitors and neurosurgeons for the remainder. The neurosurgeons placed most of their ICP monitors (71.8%) in the operating room during craniotomy. The overall complication rate was 2.4%. There was no significant difference in complications between the trauma surgeons and neurosurgeons (3% vs. 0.8%, p = 0.2951). CONCLUSION: After appropriate training, ICP monitors can be safely placed by trauma surgeons with minimal adverse effects. With current and expected specialty shortages, acute care surgeons can successfully adopt procedures such as ICP monitor placement with minimal complications. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Ekeh, Akpofure Peter; Ilyas, Sadia; Saxe, Jonathan M.; Whitmill, Melissa; Parikh, Priti; McCarthy, Mary C.] Wright State Univ, Sch Med, Sect Acute Care Surg, Dept Surg, Dayton, OH USA; [Schweitzer, Jeffrey S.] Wright State Univ, Sch Med, Dept Neurosurg, Dayton, OH USA		Ekeh, AP (corresponding author), Miami Valley Hosp, CHE 7000,1 Wyoming St, Dayton, OH 45409 USA.	peter.ekeh@wright.edu					American College of Surgeons Health Policy Research Institute, 2010, SURG WORKF US PROF R; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Barber MA, 2012, J TRAUMA ACUTE CARE, V73, P558, DOI 10.1097/TA.0b013e318265cb75; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cohn SM, 2007, J TRAUMA, V62, P951, DOI 10.1097/01.ta.0000260131.79063.50; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dams-O'Connor K, 2013, J NEUROTRAUMA; EDDY VA, 1995, AM SURGEON, V61, P24; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Firsching R, 2011, J NEUROSURG, V115, P371, DOI 10.3171/2011.3.JNS101275; Harris CH, 2002, AM SURGEON, V68, P787; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; O'Neill BR, 2008, SURG NEUROL, V70, P268, DOI 10.1016/j.surneu.2007.05.007; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Querfurth HW, 2004, NEUROCRIT CARE, V1, P183, DOI 10.1385/NCC:1:2:183; Sadaka F, 2013, BRAIN INJURY, V27, P600, DOI 10.3109/02699052.2013.772238; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; The Brain Trauma Foundation; The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P479; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004; Young PJ, 2012, J TRAUMA ACUTE CARE, V73, P431, DOI 10.1097/TA.0b013e318262437b	26	10	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2014	76	2					286	291		10.1097/TA.0000000000000092			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AH8KG	WOS:000336386100005	24458035				2022-02-06	
J	Holm, AC				Holm, Alvin C.			Neurodegenerative and psychiatric overlap in frontotemporal lobar degeneration: a case of familial frontotemporal dementia presenting with catatonia	INTERNATIONAL PSYCHOGERIATRICS			English	Article						lorazepam; electroconvulsive therapy; genetics; frontotemporal dementia; catatonia		The behavioral variant of frontotemporal dementia (FTD) begins with psychiatric symptoms, including changes in personal conduct and/or interpersonal behavior. Prior to developing cognitive impairment, differentiating FTD from primary psychiatric disorders, like schizophrenia, can be challenging. This paper presents a case of traumatic brain injury with subsequent depression and catatonia. Initial response to electroconvulsive therapy and lorazepam suggested primarily psychiatric pathology. Subsequent symptom progression, reduced treatment response, and detailed family history evaluation led to the diagnosis of familial FTD with C9ORF72 mutation. This case highlights that familial FTD can present with depression with suicidal tendencies and catatonia, and that the responsiveness of these behavioral manifestations to standard therapies can change over time.	[Holm, Alvin C.] Bethesda Hosp, Cognit & Behav Disorders Program, St Paul, MN 55103 USA		Holm, AC (corresponding author), Bethesda Hosp, 559 Capitol Blvd, St Paul, MN 55103 USA.	aholm@healtheast.org					Bush G, 1996, ACTA PSYCHIAT SCAND, V93, P129, DOI 10.1111/j.1600-0447.1996.tb09814.x; Holm A, 1999, GERONTOLOGIST, V39, P668, DOI 10.1093/geront/39.6.668; Hsiung GYR, 2012, BRAIN, V135, P709, DOI 10.1093/brain/awr354; Kobayashi T., 2012, CASE REPORTS PSYCHIA, V2012, DOI 10.1155/2012/627460.23119214; Lauer M, 2001, J NEURAL TRANSM, V108, P661, DOI 10.1007/s007020170043; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Suzuki K, 2009, WORLD J BIOL PSYCHIA, V10, P245, DOI 10.1080/15622970701701021; Synofzik M, 2012, AM J PSYCHIAT, V169, P1211, DOI 10.1176/appi.ajp.2012.12060733; Takada LT, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt141; Vanderzeypen F, 2003, ENCEPHALE, V29, P172	14	10	10	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	FEB	2014	26	2					345	347		10.1017/S1041610213001403			3	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Geriatrics & Gerontology; Psychiatry	AD0QS	WOS:000332939800019	23962693				2022-02-06	
J	Strong, J; Ray, K; Findley, PA; Torres, R; Pickett, L; Byrne, RJ				Strong, Jessica; Ray, Kathleen; Findley, Patricia A.; Torres, Rita; Pickett, Lisa; Byrne, Richard J.			Psychosocial Concerns of Veterans of Operation Enduring Freedom/Operation Iraqi Freedom	HEALTH & SOCIAL WORK			English	Article						mental health; psychosocial factors; social work; veterans	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; COMBAT VETERANS; US MILITARY; AFGHANISTAN; CARE; PAIN; ASSOCIATION; DEPLOYMENT; EMPLOYMENT	U.S. veterans present with complex medical and psychosocial concerns postdeployment. Identification of psychosocial concerns is necessary for appropriate and targeted social work interventions to improve delivery and receipt of health care through the U.S. Department of Veterans Affairs. The purpose of this article is to identify specific psychosocial concerns of veterans of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) presenting at the War Related Illness and Injury Study Center. A retrospective chart review of psychosocial concerns from all OIF/OEF veterans seen from June 2008 to June 2010 provided data for this mixed methods study. Veterans in the sample (N = 356) reported an average of 5.2 psychosocial concerns (SD = 2.32, range = 0 to 11). The most commonly reported concerns were pain (72 percent), sleep (62 percent), cognition (61 percent), vocational issues (53 percent), education (49 percent), finances (42 percent), relationships (37 percent), anger (30 percent), substance abuse (23 percent), and social support (20 percent), though these categories were not exclusive and many veterans endorsed more than one category. Multiple psychosocial concerns reported by veterans suggest the need for targeted social work intervention.	[Strong, Jessica] Univ N Carolina, Wilmington, NC 28403 USA; [Ray, Kathleen; Torres, Rita] US Dept Vet Affairs, War Related Illness & Injury Study Ctr, E Orange, NJ USA; [Findley, Patricia A.] Rutgers State Univ, Sch Social Work, New Brunswick, NJ 08903 USA; [Pickett, Lisa] US Dept Vet Affairs, Extended Care Serv, VA New Jersey Hlth Care Syst, Lyons, NJ USA; [Byrne, Richard J.] Family Intervent Serv, Sparta, NJ USA		Strong, J (corresponding author), Univ N Carolina, Wilmington, NC 28403 USA.	strongj@uncw.edu	Findley, Patricia/AAC-7539-2019; Strong, Jessica/Y-4393-2019; Ray, Kathleen/AAF-4386-2020	Findley, Patricia/0000-0001-6924-8248; 			ANDERSON KH, 1992, MED CARE, V30, P554, DOI 10.1097/00005650-199206000-00008; Bureau of Labor Statistics, 2009, EMPL SIT VET 2008; Burnett-Zeigler I, 2011, MIL MED, V176, P639, DOI 10.7205/MILMED-D-10-00450; Bush NE, 2013, SUICIDE LIFE-THREAT, V43, P262, DOI 10.1111/sltb.12012; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Daley JG, 2003, INT SOC WORK, V46, P437, DOI 10.1177/0020872803464002; Elbogen EB, 2012, MIL MED, V177, P669, DOI 10.7205/MILMED-D-11-00388; Evans S, 2005, EUR J PAIN, V9, P683, DOI 10.1016/j.ejpain.2005.01.002; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Hamilton AB, 2012, J SOC WORK PRACT ADD, V12, P52, DOI 10.1080/1533256X.2012.647584; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hoerster KD, 2012, PSYCHIAT SERV, V63, P380, DOI 10.1176/appi.ps.201100187; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Leger D, 2002, SLEEP, V25, P625; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; National Association of Social Workers, 2012, NASW STAND SOC WORK; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Savoca Elizabeth, 2000, J Ment Health Policy Econ, V3, P199, DOI 10.1002/mhp.102; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schell T.L., 2011, NEEDS ASSESSMENT NEW; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Tanskanen A, 2001, SLEEP, V24, P844; Thurston RC, 2007, PSYCHOSOM MED, V69, P748, DOI 10.1097/PSY.0b013e31815772a3; U.S. Department of Veterans Affairs, 2012, SOC WORK DEP VET AFF; U.S. Department of Veterans Affairs, 2012, WAR REL ILLN INJ STU; US Department of Housing and Urban Development US Department of Veterans Affairs, 2010, VET HOM SUPPL REP 20	32	10	10	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0360-7283	1545-6854		HEALTH SOC WORK	Health Soc. Work	FEB	2014	39	1			SI		17	24		10.1093/hsw/hlu002			8	Social Work	Social Science Citation Index (SSCI)	Social Work	AC7XC	WOS:000332745700003	24693600				2022-02-06	
J	Xu, HS; Ma, C; Cao, L; Wang, JJ; Fan, XX				Xu, H. -S.; Ma, C.; Cao, L.; Wang, J. -J.; Fan, X. -X.			Study of co-transplantation of SPIO labeled bone marrow stromal stem cells and Schwann cells for treating traumatic brain injury in rats and in vivo tracing of magnetically labeled cells by MRI	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Superparamagnetic iron oxide; Bone marrow stromal stem cells; Schwann cells; Traumatic brain injury	TRACKING; NEURONS	AIM: The aims of this study are to investigate the effects of co-transplantation Bone Marrow Stromal Stem Cells (BMSCs) and Schwann Cells (SCs) in treating rat traumatic brain injury (TBI), the migration of BMSCs in the brain, and whether co-transplantation treatment is superior to single transplantation. MATERIALS AND METHODS: Superparamagnetic iron oxide (SPIO) labeled BMSCs and SCs were transplanted and co-transplanted into the rats with TBI. The neurological functions of the rats were evaluated by the NSS (Neurological Severity Score) at day 3, 7, 14, and 30. Moreover, 7.0T MRI (Magnetic Resonance Imaging) scan was conducted in order to observe the migration of the labeled BMSCs. RESULTS: MRI scan showed that when SPIO labeled BMSCs were injected into the brain, T2WI (weighted image) showed low signals and these low signals migrated toward the lesion. The speed of migration was faster in the co-transplantation group than in the single transplantation group. NSS results showed that the prognosis was better in the co-transplantation group than in the single transplantation group at day 14 after injection. CONCLUSIONS: The co-transplantation of BMSCs and SCs showed faster cell migration and better prognosis in rat TBI.	[Xu, H. -S.; Ma, C.; Cao, L.; Wang, J. -J.; Fan, X. -X.] Cent Hosp Xuzhou, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China		Xu, HS (corresponding author), Cent Hosp Xuzhou, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China.	xhs51@126.com					Ben-Hur T, 2007, MAGN RESON MED, V57, P164, DOI 10.1002/mrm.21116; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Huang WD, 2005, NEUROSCI LETT, V389, P46, DOI 10.1016/j.neulet.2005.07.014; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057; Pinzon A, 2001, J NEUROSCI RES, V64, P533, DOI 10.1002/jnr.1105; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reddy AM, 2010, J KOREAN MED SCI, V25, P211, DOI 10.3346/jkms.2010.25.2.211; Rueger MA, 2008, NEUROSCI LETT, V434, P253, DOI 10.1016/j.neulet.2008.01.073; Sun R, 2005, INVEST RADIOL, V40, P504, DOI 10.1097/01.rli.0000162925.26703.3a; Trubiani O, 2005, INT J IMMUNOPATH PH, V18, P213, DOI 10.1177/039463200501800204; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	18	10	10	1	2	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	FEB	2014	18	4					520	525					6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AP3IA	WOS:000341967600012	24610619				2022-02-06	
J	Xu, T; Fan, XJ; Tan, YY; Yue, Y; Chen, WJ; Gu, XX				Xu, Ting; Fan, Xinjuan; Tan, Yuanyuan; Yue, Ying; Chen, Weijie; Gu, Xingxing			Expression of PHB2 in Rat Brain Cortex Following Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; Prohibitin2; neuron; astrocyte; proliferation; apoptosis	PROHIBITIN; ROLES; APOPTOSIS; PROTEIN; FAMILY; NEUROPATHOLOGY; PROLIFERATION; NEUROBIOLOGY; NUCLEUS; HAX-1	Prohibitin2 (PHB2) is a ubiquitous, evolutionarily strongly conserved protein. It is one of the components of the prohibitin complex, which comprises two highly homologous subunits, PHB1 and PHB2. PHB2 is present in various cellular compartments including the nucleus and mitochondria. Recent studies have identified PHB2 as a multifunctional protein that controls cell proliferation, apoptosis, cristae morphogenesis and the functional integrity of mitochondria. However its distribution and function in the central nervous system (CNS) are not well understood. In this study, we examined PHB2 expression and cellular localization in rats after acute traumatic brain injury (TBI). Western Blot analysis showed PHB2 level was significantly enhanced at five days after injury compared to control, and then declined during the following days. The protein expression of PHB2 was further analyzed by immunohistochemistry. In comparison to contralateral cerebral cortex, we observed a highly significant accumulation of PHB2 at the ipsilateral brain. Immunofluorescence double-labeling showed that PHB2 was co-expressed with NeuN, GFAP. Besides, PHB2 also colocalized with activated caspase-3 and PCNA. To further investigate the function of PHB2, primary cultured astrocytes and the neuronal cell line PC12 were employed to establish a proliferation model and an apoptosis model, respectively, to simulate the cell activity after TBI to a certain degree. Knocking down PHB2 by siRNA partly increased the apoptosis level of PC12 stimulated by H2O2. While the PHB2 was interrupted by siRNA, the proliferation level of primary cultured astrocytes was inhibited notably than that in the control group. Together with our data, we hypothesized that PHB2 might play an important role in CNS pathophysiology after TBI.	[Xu, Ting] Nanjing Med Univ, Huaian Peoples Hosp 1, Ctr Lab, Huaian 223300, Peoples R China; [Xu, Ting; Tan, Yuanyuan; Yue, Ying; Chen, Weijie; Gu, Xingxing] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Fan, Xinjuan] Nantong Univ, Affiliated Hosp, Nantong 226001, Peoples R China		Gu, XX (corresponding author), Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China.	xuting-1988@163.com; m18262712560@163.com; yuanyuan.easy@163.com; yueying1500628@163.com; guxingxing@hotmail.com; guxingxing@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31071228]; Natural Nature Science Foundation of Jiangsu Colleges and Universities [09KJB320011]	This work was supported by the National Natural Science Foundation of China (No.31071228) Natural Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011).	Artal-Sanz M, 2010, AGING-US, V2, P1004, DOI 10.18632/aging.100246; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Basmadjian C, 2013, FUTURE MED CHEM, V5, P2185, DOI 10.4155/fmc.13.177; Bernstein HG, 2012, NEUROMOL MED, V14, P270, DOI 10.1007/s12017-012-8185-y; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cheng G, 2013, MED HYPOTHESES, V80, P115, DOI 10.1016/j.mehy.2012.11.004; Chowdhury I, 2013, APOPTOSIS, V18, P1513, DOI 10.1007/s10495-013-0901-z; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee MY, 1999, NEUROSCI LETT, V265, P107, DOI 10.1016/S0304-3940(99)00219-0; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Marta A. S., 2009, TRENDS ENDOCRIN MET, V20, P394; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McIntosh TK, 1996, LAB INVEST, V74, P315; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ribeiro N, 2012, BIOORGAN MED CHEM, V20, P1857, DOI 10.1016/j.bmc.2011.10.048; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Shangxun L., 2011, J FORENSIC MED, V27, P286; Smalla KH, 2008, MOL PSYCHIATR, V13, P878, DOI 10.1038/mp.2008.60; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; Suzuki Y, 1997, J IMMUNOL, V158, P2736; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; Takata H, 2007, CURR BIOL, V17, P1356, DOI 10.1016/j.cub.2007.07.009; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Z Xu, 2001, SCI CHINA LIFE SCI, V54, P121; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	47	10	10	1	11	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB	2014	15	2					3299	3318		10.3390/ijms15023299			20	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AG9YP	WOS:000335776400098	24566151	Green Published, Green Submitted, gold			2022-02-06	
J	Yasuno, F; Matsuoka, K; Soichiro, KA; Kiuchi, K; Kosaka, J; Okada, K; Tanaka, S; Shinkai, T; Toshiaki, TC; Kishimoto, T				Yasuno, Fumihiko; Matsuoka, Kiwamu; Kitamura, Soichiro; Kiuchi, Kuniaki; Kosaka, Jun; Okada, Koji; Tanaka, Syohei; Shinkai, Takayuki; Taoka, Toshiaki; Kishimoto, Toshifumi			Decision-making deficit of a patient with axonal damage after traumatic brain injury	BRAIN AND COGNITION			English	Article						Traumatic Brain Injury (TBI); Decision-maiking process; Somatic-marker hypothesis; Diffusion tensor imaging (DTI); Voxel-based morphometry (VBM)	SOMATIC MARKER HYPOTHESIS; PREFRONTAL CORTEX; LOBE; PERFORMANCE	Patients with traumatic brain injury (TBI) were reported to have difficulty making advantageous decisions, but the underlying deficits of the network of brain areas involved in this process were not directly examined. We report a patient with TBI who demonstrated problematic behavior in situations of risk and complexity after cerebral injury from a traffic accident. The Iowa gambling task (IGT) was used to reveal his deficits in the decision-making process. To examine underlying deficits of the network of brain areas, we examined T1-weighted structural MRI, diffusion tensor imaging (DTI) and Tc-ECD SPECT in this patient. The patient showed abnormality in IGT. DTI-MRI results showed a significant decrease in fractional anisotropy (FA) in the fasciculus between the brain stem and cortical regions via the thalamus. He showed significant decrease in gray matter volumes in the bilateral insular cortex, hypothalamus, and posterior cingulate cortex, possibly reflecting Wallerian degeneration secondary to the fasciculus abnormalities. SPECT showed significant blood flow decrease in the broad cortical areas including the ventromedial prefrontal cortex (VM). Our study showed that the patient had dysfunctional decision-making process. Microstructural abnormality in the fasciculus, likely from the traffic accident, caused reduced afferent feedback to the brain, resulting in less efficient decision-making. Our findings support the somatic-marker hypothesis (SMH), where somatic feedback to the brain influences the decision-making process. (C) 2013 Elsevier Inc. All rights reserved.	[Yasuno, Fumihiko; Matsuoka, Kiwamu; Kitamura, Soichiro; Kiuchi, Kuniaki; Kosaka, Jun; Okada, Koji; Tanaka, Syohei; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Kashihara, Nara 6348522, Japan; [Shinkai, Takayuki] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara 6348522, Japan; [Taoka, Toshiaki] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348522, Japan		Yasuno, F (corresponding author), Nara Med Univ, Dept Psychiat, 840 Shijocho, Kashihara, Nara 6348522, Japan.	ejm86rp@yahoo.co.jp	Taoka, Toshiaki/A-1637-2016	Taoka, Toshiaki/0000-0001-9227-0240; Kiuchi, Kuniaki/0000-0003-3305-5270			Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A., 1998, Society for Neuroscience Abstracts, V24, P1176; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Damasio A, 2013, CEREB CORTEX, V23, P833, DOI 10.1093/cercor/bhs077; DAMASIO AR, 1994, DESCARTESERROR; Dimitrov M, 1999, NEUROCASE, V5, P345, DOI 10.1093/neucas/5.4.345; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Immordino-Yang MH, 2009, P NATL ACAD SCI USA, V106, P8021, DOI 10.1073/pnas.0810363106; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Maia TV, 2005, TRENDS COGN SCI, V9, P162, DOI 10.1016/j.tics.2005.02.006; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Mizumura Sunao, 2006, Radiat Med, V24, P545, DOI 10.1007/s11604-006-0056-8; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Raven JC., 1958, GUIDE STANDARD PROGR; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Spreen O, 1991, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006	34	10	10	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	FEB	2014	84	1					63	68		10.1016/j.bandc.2013.11.005			6	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	295AM	WOS:000330089000006	24316983				2022-02-06	
J	Monsalve, BC; Laxe, S; Guitart, MB; Vilarrasa, AB; Quemada, JI				Castano Monsalve, B.; Laxe, Sara; Bernabeu Guitart, M.; Bulbena Vilarrasa, Antoni; Ignacio Quemada, Jose			Behavioral scales used in severe and moderate traumatic brain injury	NEUROREHABILITATION			English	Article						Brain injury; neurobehavioral; emotional; scales; instruments; measure; assessment; disability; neurorehabilitation; outcome	NEUROBEHAVIORAL RATING-SCALE; APATHY EVALUATION SCALE; OVERT AGGRESSION SCALE; HEAD-INJURY; NEUROPSYCHIATRIC SYMPTOMS; PSYCHIATRIC-DISORDERS; MULTIPLE-SCLEROSIS; AXIS-I; INVENTORY; VALIDITY	Neurobehavioral disorders are common consequences of traumatic brain injury (TBI) that should be objectively assessed in this population. The use of scales allows us to unify terms both in clinical practice and investigative work; it also constitutes a useful guide in clinical interviews and makes it possible to see outcome changes in patients with or without intervention. The aim of this study is to review the most frequently neurobehavioral scales used to measure the non-cognitive disorders of conduct in TBI patients. METHOD: A systematic and descriptive literature review was done in Medline, without time limit, which focused on scales applied to behavioral disorders in moderate and severe TBI patients. RESULTS: Ninety articles were selected for the final review and thirty-seven different scales were identified. Seven of these instruments represent sixty-five percent of all behavioral scales applied in the studies collected and were selected for the present review. There are scales that are more general and include a wide range of neurobehavioral symptoms, like the Neurobehavioral Rating Scale and the Neuropsychiatric Inventory. On the opposite, there are questionnaires that focus on specific symptoms like aggressiveness, agitation and apathy such as the Agitated Behavior Scale or the Apathy Evaluation Scale. The forms for caregiver or staff were the most prevalent in our review. The most representative behavioral scales applied to moderate and severe TBI patients were analyzed using clinical useful, covered domains, item descriptions, administration procedures and psychometric properties.	[Castano Monsalve, B.; Laxe, Sara; Bernabeu Guitart, M.] Autonomous Univ Barcelona, Univ Inst, Rehabil Hosp, Brain Injury Unit,Guttmann Inst, Badalona, Spain; [Ignacio Quemada, Jose] Hosp Aita Menni, Brain Injury Unit, Bilbao, Spain		Monsalve, BC (corresponding author), Autonomous Univ Barcelona, Univ Inst, Rehabil Hosp, Brain Injury Unit,Guttmann Inst, Badalona, Spain.	bcastano@guttmann.com	Bulbena, Antonio/AAG-5411-2019	Bulbena, Antonio/0000-0003-2404-2478			Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Cattelani R, 2008, EUR J PHYS REHAB MED, V44, P245; Coetzer B. R., 2003, BRAIN INJURY G UNPUB; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Cummings JL, 2006, AM J GERIAT PSYCHIAT, V14, P605, DOI 10.1097/01.JGP.0000221293.91312.d3; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Diaz-Olavarrieta C, 1999, J NEUROPSYCH CLIN N, V11, P51, DOI 10.1176/jnp.11.1.51; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Figved N, 2005, ACTA PSYCHIAT SCAND, V112, P463, DOI 10.1111/j.1600-0447.2005.00624.x; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kulisevsky J, 2001, MOVEMENT DISORD, V16, P1098, DOI 10.1002/mds.1225; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Litvan I, 1998, J NEUROL NEUROSUR PS, V65, P717, DOI 10.1136/jnnp.65.5.717; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Manes F, 1999, J NERV MENT DIS, V187, P707, DOI 10.1097/00005053-199912000-00001; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Robin Tate, COMPENDIUM TESTS SCA; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Wilson B., 2001, J NEUROL NEUROSUR PS, V71, P566, DOI [10.1136/jnnp.71.4.566c, DOI 10.1136/JNNP.71.4.566C]; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	42	10	10	0	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	1					67	76		10.3233/NRE-141103			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP0PN	WOS:000341764700009	24990011				2022-02-06	
J	Dougan, BK; Horswill, MS; Geffen, GM				Dougan, Brooke K.; Horswill, Mark S.; Geffen, Gina M.			Do Injury Characteristics Predict the Severity of Acute Neuropsychological Deficits Following Sports-Related Concussion? A Meta-analysis	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article							RETURN		[Dougan, Brooke K.; Horswill, Mark S.; Geffen, Gina M.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia		Dougan, BK (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia.	brooke.dougan@uqconnect.edu.au	Horswill, Mark/J-9029-2019	Horswill, Mark/0000-0002-0286-6292	Australian Postgraduate AwardAustralian Government	This research was supported by an Australian Postgraduate Award and forms part of the doctoral thesis of the first author, submitted to the University of Queensland in December 2012. This research received no specific grant from any other funding agency, commercial or not-for-profit sectors. We confirm that the information in this manuscript and the manuscript itself has never been published either electronically or in print and that none of the authors has any financial or other conflict of interest affecting this manuscript. We acknowledge the help of John Guimelli in checking the data for accuracy.	Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cantu R. C., 2006, FDN SPORT RELATED BR; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Dougan B. K., J INT NEUROPSYCHOLOG, DOI 10. 1017/S1355617712001464; Guskiewicz KM, 2001, ATHLET THER TODAY, V6, P18, DOI 10.1123/att.6.1.18; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; JENNETT B, 1975, LANCET, V1, P480; Kelly JP, 1997, NEUROLOGY, V48, P581; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280	22	10	10	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2014	20	1					81	87		10.1017/S1355617713001288			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	AC2VC	WOS:000332373400010	24331116				2022-02-06	
J	Dougherty, ET; Turner, JC; Vogel, F				Dougherty, Edward T.; Turner, James C.; Vogel, Frank			Multiscale Coupling of Transcranial Direct Current Stimulation to Neuron Electrodynamics: Modeling the Influence of the Transcranial Electric Field on Neuronal Depolarization	COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE			English	Article							BRAIN-STIMULATION	Transcranial direct current stimulation (tDCS) continues to demonstrate success as a medical intervention for neurodegenerative diseases, psychological conditions, and traumatic brain injury recovery. One aspect of tDCS still not fully comprehended is the influence of the tDCS electric field on neural functionality. To address this issue, we present a mathematical, multiscale model that couples tDCS administration to neuron electrodynamics. We demonstrate the model's validity and medical applicability with computational simulations using an idealized two-dimensional domain and then an MRI-derived, three-dimensional human head geometry possessing inhomogeneous and anisotropic tissue conductivities. We exemplify the capabilities of these simulations with real-world tDCS electrode configurations and treatment parameters and compare the model's predictions to those attained from medical research studies. The model is implemented using efficient numerical strategies and solution techniques to allow the use of fine computational grids needed by the medical community.	[Dougherty, Edward T.; Turner, James C.] Virginia Polytech Inst & State Univ, Genet Bioinformat & Computat Biol Program, Blacksburg, VA 24061 USA; [Turner, James C.] Virginia Polytech Inst & State Univ, Dept Math, Blacksburg, VA 24061 USA; [Vogel, Frank] InuTech GmbH, D-90429 Nurnberg, Germany		Dougherty, ET (corresponding author), Virginia Polytech Inst & State Univ, Genet Bioinformat & Computat Biol Program, Blacksburg, VA 24061 USA.	edougherty@vt.edu			Virginia Tech's Open Access Subvention Fund	The authors would like to acknowledge the financial support received from Virginia Tech's Open Access Subvention Fund and the entire inuTech team for their assistance with Diffpack.	Agudelo-Toro A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026019; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2011, NEUROPSYCHOL REHABIL, V21, P703, DOI 10.1080/09602011.2011.617943; Brocker David T, 2013, Handb Clin Neurol, V116, P3, DOI 10.1016/B978-0-444-53497-2.00001-2; Bruaset A. M, 1997, P 15 IMACS WORLD C S, P553; Datta A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036018; Datta A, 2011, BRAIN STIMUL, V4, P169, DOI 10.1016/j.brs.2010.11.001; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fregni F, 2006, DEPRESS ANXIETY, V23, P482, DOI 10.1002/da.20201; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Gasca F, 2011, I IEEE EMBS C NEUR E, P36; GESELOWITZ DB, 1983, ANN BIOMED ENG, V11, P191, DOI 10.1007/BF02363286; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Hess CW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00565; Hesse S, 2011, NEUROREHAB NEURAL RE, V25, P838, DOI 10.1177/1545968311413906; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Kang Eun Kyoung, 2011, Exp Transl Stroke Med, V3, P4, DOI 10.1186/2040-7378-3-4; Kessler SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076112; KOCH C, 1998, METHODS NEURONAL MOD; Langtangen H.P., 2003, COMPUTATIONAL PARTIA, Vsecond; Malmivuo J, 1995, BIOELECTROMAGNETISM; Mandonnet E, 2011, ACTA NEUROCHIR, V153, P2351, DOI 10.1007/s00701-011-1151-x; Mardal KA, 2003, LECT NOTES COMPUTATI, P199; MATLAB, 2013, VERS 8 2 0 701 R2013; McIntyre Cameron C, 2013, Handb Clin Neurol, V116, P55, DOI 10.1016/B978-0-444-53497-2.00005-X; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; Sadleir R.J., 2010, INT J BIOELECTROMAGN, V12, P2; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Siegel A., 2006, ESSENTIAL NEUROSCIEN; Southern JA, 2009, IEEE T BIO-MED ENG, V56, P2404, DOI 10.1109/TBME.2009.2022548; STETSON DS, 1992, MUSCLE NERVE, V15, P1095, DOI 10.1002/mus.880151007; Suli E., 2003, INTRO NUMERICAL ANAL; Sundnes J., 2006, COMPUTING ELECT ACTI; Sutton AC, 2013, J NEUROPHYSIOL, V109, P363, DOI 10.1152/jn.00311.2012; Szmurlo Robert, 2007, EUROCON 2007. International Conference on "Computer as a Tool", P2343, DOI 10.1109/EURCON.2007.4400409; Szmurlo R., 2006, P 12 BIENN IEEE C EL; Szmurlo R, 2009, COMPEL, V28, P211, DOI 10.1108/03321640910919002; VANDERVORST HA, 2003, CAMBRIDGE MONOGRAPHS; Weiss D, 2011, J NEUROL, V258, P1183, DOI 10.1007/s00415-011-5906-3; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Ying WJ, 2007, IEEE T BIO-MED ENG, V54, P611, DOI 10.1109/TBME.2006.889172	49	10	10	1	7	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1748-670X	1748-6718		COMPUT MATH METHOD M	Comput. Math. Method Med.		2014	2014								360179	10.1155/2014/360179			14	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	AT5ZO	WOS:000345018700001	25404950	gold, Green Published, Green Submitted			2022-02-06	
J	Dudley, M; Wilson, D; Barker-Collo, S				Dudley, Margaret; Wilson, Denise; Barker-Collo, Suzanne			Cultural invisibility: Maori people with traumatic brain injury and their experiences of neuropsychological assessments	NEW ZEALAND JOURNAL OF PSYCHOLOGY			English	Article						Maori; Indigenous health services; neuropsychology; assessment; culture; traumatic brain injury	NEW-ZEALAND; AFRICAN-AMERICAN; TEST-PERFORMANCE; HEALTH; ACCULTURATION; TESTS; DISPARITIES; EDUCATION; EQUITY; ISSUES	Objectives: To explore aspects of Maori culture and cultural appropriateness of the neuropsychological assessment process. Participants: 16 Maori who had undergone a neuropsychological assessment following a traumatic brain injury. Research design: A qualitative study using semi-structured interviews that were thematically analysed. Results: The four themes were: positive experiences, cultural invisibility, having little or no choice, and preferred ways of doing things. Conclusions: Neuropsychological assessments are driven by the dominant Euro-Western culture, which renders the cultural identity and practices of Maori invisible. Implications: Cultural factors are known to impact neuropsychological functioning, which may have significant clinical implications for culturally and linguistically diverse clinical populations. More culturally friendly processes for neuropsychological assessments would promote motivation to achieve better performance.	[Dudley, Margaret; Wilson, Denise] Auckland Univ Technol, Taupua Waiora Ctr Maori Hlth Res, Private Bag 92006, Auckland 1142, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Auckland, New Zealand		Dudley, M (corresponding author), Auckland Univ Technol, Taupua Waiora Ctr Maori Hlth Res, Private Bag 92006, Auckland 1142, New Zealand.	mdudley@aut.ac.nz	Wilson, Denise/ABG-4979-2020	Wilson, Denise/0000-0001-9942-3561			Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; Anderson JM, 2009, ADV NURS SCI, V32, P282, DOI 10.1097/ANS.0b013e3181bd6955; Ansari D, 2012, TRENDS COGN SCI, V16, P93, DOI 10.1016/j.tics.2011.11.016; ARDILA A, 1995, J CLIN EXP NEUROPSYC, V17, P143, DOI 10.1080/13803399508406589; Ardilla A, 2007, INT HDB CROSS CULTUR, P1; Baltes P. B., 2001, EUROPEAN REV, V9, P59, DOI DOI 10.1017/S1062798701000060; Bellon-Harn M. L., 2008, COMMUNICATION DISORD, V29, P141, DOI [10.1177/1525740108315879, DOI 10.1177/1525740108315879]; Bird ME, 2002, AM J PUBLIC HEALTH, V92, P1391, DOI 10.2105/AJPH.92.9.1391; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Braun V., 2013, SUCCESSFUL QUALITATI; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Diana RA, 2006, PSYCHON B REV, V13, P1, DOI 10.3758/BF03193807; Durie M., 1998, WHAIORA MAORI HLTH D, V2nd; Fallow B., 2013, NZ HERALD; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ferraro FR, 2005, ALZ DIS ASSOC DIS, V19, P53, DOI 10.1097/01.wad.0000165754.85135.1d; Flick U, 2002, QUALITATIVE RES PSYC; Gergen KJ, 2010, THEOR PSYCHOL, V20, P795, DOI 10.1177/0959354310370906; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V81, P403, DOI 10.2466/pms.1995.81.2.403; Haitana T, 2010, NEW ZEAL J PSYCHOL, V39, P24; Jacobs DM, 1997, J CLIN EXP NEUROPSYC, V19, P331, DOI 10.1080/01688639708403862; Kelly Ursula A, 2009, ANS Adv Nurs Sci, V32, pE42, DOI 10.1097/ANS.0b013e3181a3b3fc; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; King RK, 2008, MILBANK Q, V86, P241, DOI 10.1111/j.1468-0009.2008.00521.x; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; LOEWENSTEIN DA, 1994, J CLIN EXP NEUROPSYC, V16, P623, DOI 10.1080/01688639408402673; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Ministry of Health, 2010, TAT KAH MAOR HLTH CH; New Zealand Psychological Society, 2002, COD ETH PSYCH WORK A; Ogden J. A., 2003, BRAIN IMPAIR, V4, P122, DOI [10.1375/brim.4.2.122.27026, DOI 10.1375/BRIM.4.2.122.27026]; Ogden J. A., 1997, PRACTICE ISSUES CLIN, P293; Ogden JA, 1997, NEW ZEAL J PSYCHOL, V26, P2; Pauly BM, 2009, ADV NURS SCI, V32, P118, DOI 10.1097/ANS.0b013e3181a3afaf; Pedraza O, 2008, NEUROPSYCHOL REV, V18, P184, DOI 10.1007/s11065-008-9067-9; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; Reid P., 2007, HAUORA MAORI HLTH ST, VIV; Ring I, 2003, BMJ-BRIT MED J, V327, P404, DOI 10.1136/bmj.327.7412.404; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Shepherd I, 1999, J INT NEUROPSYCH SOC, V5, P83, DOI 10.1017/S1355617799511119; Smith L.T., 2012, DECOLONIZING METHODO; Sohlberg M., 2001, COGNITIVE REHABILITA; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; Walker AJ, 2009, AUST PSYCHOL, V44, P216, DOI 10.1080/00050060902833469; Walters KL, 2011, DU BOIS REV, V8, P179, DOI 10.1017/S1742058X1100018X; Werkmeister-Rozas Lisa, 2009, Care Manag J, V10, P2; Wexler L., 2009, J HIST CHILDHOOD YOU, V2, P267, DOI DOI 10.1353/HCY.0.0055; Wong TM, 2000, CRIT ISS NE, P3	52	10	10	0	1	NEW ZEALAND PSYCHOL SOC	WELLINGTON	BUSINESS MANAGER PO BOX 4092, WELLINGTON, NEW ZEALAND	0112-109X	1179-7924		NEW ZEAL J PSYCHOL	N. Z. J. Psychol.		2014	43	3					14	21					8	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	V13TK	WOS:000214435500002					2022-02-06	
J	Eichstaedt, KE; Clifton, WE; Vale, FL; Benbadis, SR; Bozorg, AM; Rodgers-Neame, NT; Schoenberg, MR				Eichstaedt, Katie E.; Clifton, William E.; Vale, Fernando L.; Benbadis, Selim R.; Bozorg, Ali M.; Rodgers-Neame, Nancy T.; Schoenberg, Mike R.			Sensitivity of Green's Word Memory Test Genuine Memory Impairment Profile to Temporal Pathology: A Study in Patients With Temporal Lobe Epilepsy	CLINICAL NEUROPSYCHOLOGIST			English	Article						Word Memory Test; Epilepsy; Sensitivity; Performance validity test; Malingering	SYMPTOM VALIDITY TEST; PSYCHOGENIC NONEPILEPTIC SEIZURES; TRAUMATIC BRAIN-INJURY; TEST-PERFORMANCE; COGNITIVE IMPAIRMENT; EXTERNAL INCENTIVES; DEMENTIA PROFILE; HIGH SPECIFICITY; EXAGGERATION; SURGERY	Performance validity tests (PVTs) such as Green's Word Memory Test (WMT) are designed to have face validity as memory tests while individuals with neurologically based memory deficits can score adequately provided there is sufficient task engagement. Some patients with severe memory loss have performed poorly on the WMT, raising questions about false positive errors. This study compared performances of 43 patients with left, right, or bilateral temporal lobe epilepsy on the WMT to a test known to be sensitive to temporal lobe pathology, the Rey Auditory Verbal Learning Test (RAVLT). The right TLE group outperformed the left on the WMT free recall (FR) scores and RAVLT short-delay and long-delay trials (Trials 6 and 7) (p < .05); no other between-group differences occurred (p .10). Ten participants (20.4%) performed below the cut-off score on at least one WMT effort subtest, but eight (80%) exhibited the genuine memory impairment profile (GMIP). Logistic regression found no WMT subtest contributed to predicting side of seizure with RAVLT scores in the model. Data suggest WMT primary effort subtests are generally insensitive to known temporal lobe pathology, and using the GMIP is valuable to identify individuals with severe memory loss who score below criterion on WMT primary effort subtests.	[Eichstaedt, Katie E.] Argosy Univ, Florida Sch Profess Psychol, Tampa, FL USA; [Clifton, William E.; Vale, Fernando L.; Schoenberg, Mike R.] Univ S Florida, Morsani Coll Med, Dept Neurosurg, Tampa, FL USA; [Benbadis, Selim R.; Bozorg, Ali M.; Schoenberg, Mike R.] Univ S Florida, Morsani Coll Med, Dept Neurol, Tampa, FL USA; [Rodgers-Neame, Nancy T.] Florida Comprehens Epilepsy & Seizure Disorders C, Tampa, FL USA; [Schoenberg, Mike R.] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL USA		Schoenberg, MR (corresponding author), Univ S Florida, Coll Med, Neuropsychol Div, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA.	mschoenb@health.usf.edu	Clifton, William/AAA-6109-2019; Schoenberg, Mike R/J-9018-2012	Clifton, William/0000-0003-3533-8776; Schoenberg, Mike/0000-0003-1355-3651; Rodgers-Neame, Nancy/0000-0003-1406-3726			Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Allen MD, 2011, PSYCHOL INJ LAW, V4, P140, DOI 10.1007/s12207-011-9105-4; Benbadis SR, 2009, NEUROLOGY, V73, P843, DOI 10.1212/WNL.0b013e3181b78425; Boone K, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P551, DOI 10.1007/978-0-387-76978-3_18; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Buchtel HA, 2002, EPILEPSIA, V43, P1056, DOI 10.1046/j.1528-1157.2002.00902.x; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2014, APPL NEUROPSYCH-ADUL, V21, P155, DOI 10.1080/09084282.2012.755533; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; CONNOR C, 2004, ANN M AUSTR PSYCH SO; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2005, MANUAL WORD MEMORY T; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P., 1996, WORD MEMORY TEST USE; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoppe C, 2007, EPILEPSIA, V48, P26, DOI 10.1111/j.1528-1167.2007.01397.x; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Lee G. P., 2010, OXFORD WORKSHOP SERI; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; Loring DW, 2008, J INT NEUROPSYCH SOC, V14, P394, DOI 10.1017/S1355617708080582; Loring DW, 2011, CLIN NEUROPSYCHOL, V25, P799, DOI 10.1080/13854046.2011.583279; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rey A., 1941, ARCH PSYCHOL, V28, P21; Rienstra A, 2013, ARCH CLIN NEUROPSYCH, V28, P463, DOI 10.1093/arclin/act026; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Rohling ML, 2000, ARCH CLIN NEUROPSYCH, V15, P843, DOI 10.1016/S0887-6177(00)80349-2; Rudzinski Leslie A, 2013, Continuum (Minneap Minn), V19, P682, DOI 10.1212/01.CON.0000431382.06438.cd; Schmidt M., 1996, REY AUDITORY VERBAL; Schoenberg MR, 2013, CLIN NEUROPSYCHOL, V27, P599; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; SHORES EA, 2004, ASS FOR NEUR C I CHI; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroup E, 2003, NEUROLOGY, V60, P1266, DOI 10.1212/01.WNL.0000058765.33878.0D; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trenerry M R, 1995, Neuroimaging Clin N Am, V5, P721; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Williamson DJ, 2012, CLIN NEUROPSYCHOL, V26, P588, DOI 10.1080/13854046.2012.670266; Williamson DJ, 2004, EPILEPSIA, V45, P179; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C, P346	52	10	10	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2014	28	6					941	953		10.1080/13854046.2014.942374			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AP4MR	WOS:000342051600004	25084023				2022-02-06	
J	Ford, JH; Wise, M; Krahn, D; Oliver, KA; Hall, C; Sayer, N				Ford, James H., II; Wise, Meg; Krahn, Dean; Oliver, Karen Anderson; Hall, Carmen; Sayer, Nina			Family Care Map: Sustaining family-centered care in Polytrauma Rehabilitation Centers	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						affective commitment to change; barriers; Family Care Map; family-centered care; information; participation; polytrauma; program implementation; strategies; sustainability; traumatic brain injury; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; QUALITY IMPROVEMENT; HEALTH; SUSTAINABILITY; VETERANS; FRAMEWORK; SYSTEM; PAIN; IMPLEMENTATION	The study assessed sustainability of the Family Care Map, a family-centered approach to providing care for Veterans with polytrauma-related injuries, in four Department of Veterans Affairs Polytrauma Rehabilitation Centers. We applied a mixed-methods approach. Staff surveys used standardized measures of sustainability, commitment to change, information, and participation during implementation. Qualitative inquiry assessed Family Care Map implementation and facilitators and barriers to sustainability. Staff sustainability perceptions had a significant positive correlation with affective commitment to change, participation, and information received about the change process. Family Care Map integration into standard practices and use of its concepts with patients and families related to staff perceptions about sustainability. The degree of use and integration of the Family Care Map in traumatic brain injury/polytrauma care varied among the Polytrauma Rehabilitation Centers. Some successful sustainability strategies included integration into daily workflow and organizational culture. Examples of sustainability barriers included staff awareness and use and outdated information. Some practices, such as measuring and documenting the use of the Family Care Map in treatment plans, may not routinely occur. The focus on family-centered care will require further evaluation of organization-, staff-, and innovation-level attributes that influence sustainability of changes designed to improve family-centered care.	[Ford, James H., II] Univ Wisconsin, Ctr Hlth Syst Res & Anal, Madison, WI 53726 USA; [Wise, Meg] Univ Wisconsin, Sonderegger Res Ctr, Madison, WI 53726 USA; [Krahn, Dean; Oliver, Karen Anderson] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Krahn, Dean] Univ Wisconsin, Dept Psychiat, Madison, WI 53726 USA; [Hall, Carmen] Metropolitan State Univ, St Paul, MN USA; [Sayer, Nina] Vet Affairs Med Ctr, Minneapolis Dept, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Sayer, Nina] Vet Affairs Med Ctr, Minneapolis Dept, Polytrauma & Blast Related Injuries Qual Enhancem, Minneapolis, MN USA		Ford, JH (corresponding author), Univ Wisconsin, Ctr Hlth Syst Res & Anal, 610 Walnut St, Madison, WI 53726 USA.	jhfordii@wisc.edu	Sayer, Nina/E-3249-2016; Ford, James/C-7417-2014	Ford, James/0000-0003-3045-2414	VA Polytrauma and Blast-Related Injuries (PT/BRI) Quality Enhancement and Research Initiative (QUERI) Locally Initiated Project [QLP 56-002]; National Institute of Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [5 R01 DA020832]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA020832, R21DA036700] Funding Source: NIH RePORTER	Funding/Support: This material was based on work supported by the VA Polytrauma and Blast-Related Injuries (PT/BRI) Quality Enhancement and Research Initiative (QUERI) Locally Initiated Project (grant QLP 56-002). Dr. Ford's work was also supported in part by the National Institute of Drug Abuse (grant 5 R01 DA020832).	Aarons GA, 2011, ADM POLICY MENT HLTH, V38, P4, DOI 10.1007/s10488-010-0327-7; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benedict SM, 2010, GENERATIONS, V34, P106; Bjorner JB, 2014, QUAL LIFE RES, V23, P217, DOI 10.1007/s11136-013-0451-4; Bray P, 2009, JT COMM J QUAL PATIE, V35, P502, DOI 10.1016/S1553-7250(09)35069-2; Carlhed R, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000737; Chambers DA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-117; Chin MH, 2008, J AMBUL CARE MANAG, V31, P319, DOI 10.1097/01.JAC.0000336551.67922.2f; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dobscha SK, 2008, EVIDENCE BASED SYNTH; Doyle C, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-127; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Fine TH, 2013, J AFFECT DISORDERS, V150, P1001, DOI 10.1016/j.jad.2013.05.029; Ford James H 2nd, 2012, Qual Manag Health Care, V21, P240; Ford James H 2nd, 2011, Qual Manag Health Care, V20, P263, DOI 10.1097/QMH.0b013e3182314b20; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Grau J., 1994, J APPL COMMUNICATION, V22, P59, DOI [10.1080/00909889409365387, DOI 10.1080/00909889409365387]; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hall C, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1125-3; Herscovitch L, 2002, J APPL PSYCHOL, V87, P474, DOI 10.1037/0021-9010.87.3.474; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maher L, 2004, SUSTAINABILITY; Ovretveit J, 2013, HEALTH POLICY, V109, P175, DOI 10.1016/j.healthpol.2012.11.005; Parand A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001731; Parand A, 2012, INT J QUAL HEALTH C, V24, P380, DOI 10.1093/intqhc/mzs030; Parker LE, 2007, QUAL HEALTH RES, V17, P1268, DOI 10.1177/1049732307307447; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Scheirer MA, 2013, AM J PUBLIC HEALTH, V103, pE73, DOI 10.2105/AJPH.2012.300976; Scheirer MA, 2011, AM J PUBLIC HEALTH, V101, P2059, DOI 10.2105/AJPH.2011.300193; Schell SF, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-15; Schneider KL, 2012, J HEALTH CARE POOR U, V23, P174, DOI 10.1353/hpu.2012.0142; Strauss AL, 1987, QUALITATIVE ANAL SOC, DOI DOI 10.1017/CBO9780511557842; Wanberg CR, 2000, J APPL PSYCHOL, V85, P132, DOI 10.1037/0021-9010.85.1.132; [No title captured]; [No title captured]	40	10	10	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	8					1311	1324		10.1682/JRRD.2014.03.0066			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CA2ZZ	WOS:000348776400013	25671632	Green Accepted, Bronze			2022-02-06	
J	Guaraldi, P; Sancisi, E; La Morgia, C; Calandra-Buonaura, G; Carelli, V; Cameli, O; Battistini, A; Cortelli, P; Piperno, R				Guaraldi, Pietro; Sancisi, Elisa; La Morgia, Chiara; Calandra-Buonaura, Giovanna; Carelli, Valerio; Cameli, Olivia; Battistini, Alberto; Cortelli, Pietro; Piperno, Roberto			Nocturnal melatonin regulation in post-traumatic vegetative state: A possible role for melatonin supplementation?	CHRONOBIOLOGY INTERNATIONAL			English	Article						Circadian rhythms; disorders of consciousness; melatonin regulation; melatonin suppression; severe traumatic brain injury	GANGLION-CELLS; SLEEP; SUPPRESSION; SECRETION; INJURY; HUMANS; LIGHT	Circadian rhythms were recently proposed as a measure of physiological state and prognosis in disorders of consciousness (DOC). So far, melatonin regulation was never assessed in vegetative state (VS). Aim of our research was to investigate the nocturnal melatonin levels and light-induced melatonin suppression in a cohort of VS patients. We assessed six consecutive patients (four men, age 33.3 +/- 9.3 years) with post-traumatic VS and nine age-matched healthy volunteers (five men, age 34.3 +/- 8.9 years) on two consecutive nights: one baseline and one light exposure night. During baseline, night subjects were in bed in a dim (<5 lux) room from 10 pm to 8 am. Blood samples were collected hourly 00:30-3:30 am (00:30 = MLT1; 1:30 = MLT2; 2:30 = MLT3; and 3:30 = MLT4). Identical setting was used for melatonin suppression test night, except for the exposure to monochromatic (470 nm) light from 1:30 to 3:30 am. Plasma melatonin levels were evaluated by radioimmunoassay. Magnitude of melatonin suppression was assessed by melatonin suppression score (caMSS) and suppression rate. We searched for group differences in melatonin levels, differences between repeated samples melatonin concentrations during baseline night and light exposure night, and light-induced suppression of melatonin secretion. During baseline night, controls showed an increase of melatonin (MLT4 vs MLT1, p = 0.037), while no significant changes were observed in VS melatonin levels (p = 0.172). Baseline night MLT4 was significantly lower in VS vs controls (p = 0.036). During light-exposure night, controls displayed a significant suppression of melatonin (MLT3 and MLT4 vs MLT2, p = 0.016 and 0.002, respectively), while VS patients displayed no significant changes. The magnitude of light-induced suppression of melatonin levels was statistically different between groups considering control adjusted caMSS (p = 0.000), suppression rate (p = 0.002) and absolute percentage difference (p = 0.012). These results demonstrate for the first time that VS patients present an alteration in night melatonin secretion and reduced light-induced melatonin suppression. These findings confirm previous studies demonstrating a disruption of the circadian system in DOC and suggest a possible benefit from melatonin supplementation in VS.	[Guaraldi, Pietro; La Morgia, Chiara; Calandra-Buonaura, Giovanna; Carelli, Valerio; Cortelli, Pietro] IRCCS Ist Sci Neurol Bologna, Bologna, Italy; [Guaraldi, Pietro; La Morgia, Chiara; Calandra-Buonaura, Giovanna; Carelli, Valerio; Cortelli, Pietro] Univ Bologna, Dipartimento Sci Biomed Neuromotorie, Alma Mater Studiorum, Bologna, Italy; [Guaraldi, Pietro] City Modena Local Hlth Trust, Modena, Italy; [Sancisi, Elisa] Osped Delta, Unita Operat Neurofisiol, Lagosanto, FE, Italy; [Cameli, Olivia; Battistini, Alberto; Piperno, Roberto] Osped Maggiore Bologna, Unita Operat Med Riabilitat, Bologna, Italy; [Cameli, Olivia; Battistini, Alberto; Piperno, Roberto] Ctr Riabilitat Casa dei Risvegli Luca De Nigris, Bologna, Italy		Guaraldi, P (corresponding author), Alma Mater Studiorum Univ Bologna, IRCCS Ist Sci Neurol Bologna, Dipartimento Sci Biomed & Neuromotorie, Osped Bellaria, C-O Padigl G,Via Altura 3, I-40139 Bologna, Italy.	pietro.guaraldi@unibo.it	Cortelli, Pietro/K-6063-2016; Piperno, Roberto/AAC-3000-2021; Guaraldi, Pietro/K-4558-2018; Buonaura, Giovanna Calandra/K-5281-2016; La Morgia, Chiara/H-6765-2012	Piperno, Roberto/0000-0002-2251-9191; Buonaura, Giovanna Calandra/0000-0002-9447-3532; Guaraldi, Pietro/0000-0003-0597-603X; Cortelli, Pietro/0000-0002-3633-8818; LA MORGIA, Chiara/0000-0002-4639-8929; CARELLI, VALERIO/0000-0003-4923-6404	Edison Pharmaceuticals; Sigma-Tau; Centro Studi e Ricerca iGuzzini (Recanati, Italy)	V. C. was involved in clinical trials on Leber's Hereditary Optic Neuropathy patients sponsored by Edison Pharmaceuticals and Sigma-Tau and has consulting activity with Edison Pharmaceuticals and Boehringer Ingelheim, P. C. has received honoraria for speaking engagements or consulting activities with Allergan Italia, Boehringer Ingelheim Italia, Chelsea Therapeutics, GlaxoSmithKline S.p.A, Lundbeck Italy, Merck Sharp & Dohme (Italia), Teva, UCB Pharma S.p.A, Chiesi Farmaceutici, AbbVie srl. All authors have no competing interests to disclose.; This research was supported by the Centro Studi e Ricerca iGuzzini (Recanati, Italy).	Arendt J, 2005, J BIOL RHYTHM, V20, P291, DOI 10.1177/0748730405277492; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bekinschtein TA, 2009, BRAIN INJURY, V23, P915, DOI 10.1080/02699050903283197; Bekinschtein T, 2009, PROG BRAIN RES, V177, P171, DOI 10.1016/S0079-6123(09)17712-9; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155; Moskala Marek, 2004, Neurol Neurochir Pol, V38, P401; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3	16	10	11	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.		2014	31	5					741	745		10.3109/07420528.2014.901972			5	Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Physiology	AI6HE	WOS:000336971900015	24679225				2022-02-06	
J	Karr, JE; Garcia-Barrera, MA; Areshenkoff, CN				Karr, Justin E.; Garcia-Barrera, Mauricio A.; Areshenkoff, Corson N.			Executive functions and intraindividual variability following concussion	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Concussion; Mild traumatic brain injury; Executive function; Intraindividual variability	TRAUMATIC BRAIN-INJURY; SELF-REPORTED CONCUSSIONS; REACTION-TIME; NEUROPSYCHOLOGICAL PERFORMANCE; SPORTS; HISTORY; IMPAIRMENT; ATTENTION; ADULTS; AGE	The long-term outcomes of executive functions and intraindividual variability (IIV; i.e., trial-to-trial or across-task variability in cognitive performance) following concussion are unclear due to inconsistent and limited research findings, respectively. Objective: Responding to these gaps in scientific understanding, the current study aimed to assess the utility of both executive functions and IIV at predicting concussion history. Method: Altogether 138 self-identified athletes (M-age = 19.9 +/- 1.91 years, 60.8% female, 19.6% with one concussion, 18.1% with two or more concussions) completed three executive-related cognitive tasks (i.e., n-back, go/no-go, global-local). Ordinal logistic regression analyses examined the joint effect of person-mean and IIV as predictors of concussion status. Results: Only mean response time for the global-local task predicted the number of past concussions, while no IIV variables reached unique significance. Conclusions: IIV research on concussion remains limited; however, the preliminary results do not indicate any additional value of IIV indices above mean performances at predicting past concussion. For executive functions, shifting appears most sensitive at detecting concussion group differences, with past researchers identifying post concussion impairment in attentional processing.	[Karr, Justin E.; Garcia-Barrera, Mauricio A.; Areshenkoff, Corson N.] Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada		Karr, JE (corresponding author), Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8W 3P5, Canada.	jkarr@uvic.ca	Garcia-Barrera, Mauricio A/H-3850-2016; Garcia-Barrera, Mauricio A./AAO-9757-2021	Garcia-Barrera, Mauricio A/0000-0002-4302-4964; Garcia-Barrera, Mauricio A./0000-0002-4302-4964	American Psychological Foundation/Council of Graduate Departments of Psychology Peter and Malina James & Dr. Louis P. James Legacy Graduate Student Research Scholarship; University of Victoria Internal Research Grant	This research was supported financially by the American Psychological Foundation/Council of Graduate Departments of Psychology Peter and Malina James & Dr. Louis P. James Legacy Graduate Student Research Scholarship. It was also supported by a University of Victoria Internal Research Grant. The funding sources had no other role than financial support.	Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Barth J. T., 2010, MILITARY NEUROPSYCHO, P29; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Burton CL, 2002, CLIN NEUROPSYCHOL, V16, P264, DOI 10.1076/clin.16.3.264.13854; Christensen H, 1999, AGING NEUROPSYCHOL C, V6, P214, DOI 10.1076/anec.6.3.214.779; Cohen J., 2013, STAT POWER ANAL BEHA; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Crawford JR, 2006, COGN NEUROPSYCHOL, V23, P877, DOI 10.1080/02643290500538372; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Devilly G. J., 2004, EFFECT SIZE GENERATO; Donders F. C, 1969, ATTENTION PERFORMANC, V11; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dykiert D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045759; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hill B. D., 2011, BRAIN INJURIES NEW R, P159; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hultsch D. F., 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; JENSEN AR, 1992, PERS INDIV DIFFER, V13, P869, DOI 10.1016/0191-8869(92)90004-9; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kaplan, 1999, NEUROPSYCHOLOGICAL D, P163; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kelly JP, 1997, NEUROLOGY, V48, P581; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; MUTHEN L. K., 2011, MPLUS VERSION 6 12 C; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nemes S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-56; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6626; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Testa R, 2012, ARCH CLIN NEUROPSYCH, V27, P213, DOI 10.1093/arclin/acr112; Walhovd KB, 2007, NEUROPSYCHOLOGIA, V45, P2277, DOI 10.1016/j.neuropsychologia.2007.02.022; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044	78	10	10	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2014	36	1					15	31		10.1080/13803395.2013.863833			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AI4KT	WOS:000336834800002	24283964				2022-02-06	
J	Lee, YSC; Ashman, T; Shang, A; Suzuki, W				Lee, Yuen Shan Christine; Ashman, Teresa; Shang, Andrea; Suzuki, Wendy			Brief report: Effects of exercise and self-affirmation intervention after traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; physical exercise; cognition; mood	COGNITIVE FUNCTION; PHYSICAL-ACTIVITY; AEROBIC EXERCISE; NEGATIVE AFFECT; VALIDITY; PROGRAM; ADULTS; POWER; PANAS	BACKGROUND: Physical exercise has been proven to be an effective method for improving cognition and mood, but little is known about its benefits among individuals with traumatic brain injury. OBJECTIVE: This pilot study investigated the feasibility of a combined exercise and self-affirmation intervention (IntenSati) for enhancing cognition and mood in individuals with TBI. It was hypothesized that this intervention would improve individuals' cognition and mood following the completion of the program. METHOD: This intervention was held at an outpatient rehabilitation department in an urban medical center. A wait-list control design was conducted. Twenty-one adult participants-at least 12-months post-TBI-enrolled in the study. Twelve of them completed the study. Assessment was conducted at three time-points throughout the study using neuropsychological and self-report measures to evaluate participants' cognition and mood. Following initial evaluation, participants were assigned into either the immediate intervention group or the waitlist control group. During the intervention, participants attended the program twice a week over the course of 8 weeks. Debriefing was conducted following the completion of the program. RESULTS: Both independent t tests and paired t tests were utilized. Results indicated that the intervention group experienced less depressive symptoms following the completion of the IntenSati program compared to the waitlist control group. Participants also reported having less depressive symptoms, experienced more positive affect, and had a higher quality of life following the completion of the program. Moderate-to-large effect sizes were found on decrease in negative affect. However, results associated with cognitive benefits were mixed. The participants tolerated the program well and reported satisfaction with the program. CONCLUSIONS: Results from this study indicated that the IntenSati exercise program is a feasible and beneficial intervention for individuals with TBI as supported by the positive impact on their mood and quality of life.	[Lee, Yuen Shan Christine] NYU, Langone Med Ctr, New York, NY 10012 USA; [Ashman, Teresa] Shepherd Ctr, Atlanta, GA USA; [Shang, Andrea; Suzuki, Wendy] NYU, Ctr Neural Sci, New York, NY 10003 USA		Lee, YSC (corresponding author), NYU, Langone Med Ctr, New York, NY 10012 USA.	yuenshan.lee@nyumc.org					Agency for Healthcare Research and Quality, 2011, TRAUM BRAIN INJ DEPR, P25; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Andrews F. M., 1976, SOCIAL INDICATORS WE; Arenth PM, 2006, BRAIN INJURY, V20, P253, DOI 10.1080/02699050500487662; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Crewswell J. D., 2013, PLOS ONE, V8; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Golden CJ., 2002, STROOP COLOR WORD TE; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Legault L, 2012, PSYCHOL SCI, V23, P1455, DOI 10.1177/0956797612448483; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; McQueen A, 2006, SELF IDENTITY, V5, P289, DOI 10.1080/15298860600805325; Mossberg K, 2012, BRAIN INJURY, V26, P561; Peden AR, 2000, J NURS SCHOLARSHIP, V32, P145, DOI 10.1111/j.1547-5069.2000.00145.x; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Reitan R, 1988, HALSTEAD REITAN NEUR; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Steinberg M, 2009, INT J GERIATR PSYCH, V24, P680, DOI 10.1002/gps.2175; Targ EF, 2002, GEN HOSP PSYCHIAT, V24, P238, DOI 10.1016/S0163-8343(02)00191-3; Upadhyay D., 2007, WORLD APPL SCI J, V2, P687; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D., 2008, WECHSLER ADULT INTEL; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wood JV, 2009, PSYCHOL SCI, V20, P860, DOI 10.1111/j.1467-9280.2009.02370.x; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	39	10	11	0	29	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	1					57	65		10.3233/NRE-141100			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP0PN	WOS:000341764700008	24990010				2022-02-06	
J	Leonard, AV; Manavis, J; Blumbergs, PC; Vink, R				Leonard, A. V.; Manavis, J.; Blumbergs, P. C.; Vink, R.			Changes in substance P and NK1 receptor immunohistochemistry following human spinal cord injury	SPINAL CORD			English	Article						human spinal cord injury; substance P; NK1 receptor; claudin-5; neurogenic inflammation	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL DEFICITS; EDEMA; LOCALIZATION; INFLAMMATION	Study design: An immunohistological assessment of substance P (SP), its NK1 receptor and claudin-5 in human spinal cord injury (SCI) tissue. Objective: To determine whether SP and NK1 receptor immunoreactivity are altered following human traumatic SCI. Setting: Australia. Summary of background data: SP has been implicated in the development of neurogenic inflammation and subsequent edema development following both traumatic brain injury and ischemic stroke. In these conditions, inhibition of its NK1 receptor has been shown to be neuroprotective as reflected in a reduction of edema and improved functional outcome. However, the role of SP following human SCI has not yet been assessed. Methods: Archived human SCI tissue was grouped according to survival times: control (no injury; n = 5); immediate (death within an hour of the incident; n = 6); 2-5 h (n = 3); 3 days (n = 5); 1 week (n = 3); and 3-4 weeks (n = 6). Sections were assessed for SP, its NK1 receptor and claudin-5 using immunohistochemical techniques. Results: Following SCI, dorsal horn SP immunoreactivity demonstrated a profound decrease compared with control tissue, indicating the loss of SP with SCI. A marked increase in perivascular NK1 staining was demonstrated after SCI compared with control levels. No obvious change in claudin-5 immunoreactivity was present immediately following injury, however, by 1 week post-SCI, decreased levels were noted. Conclusion: This study demonstrates that severe acute traumatic human SCI results in decreased SP and an immediate increase in NK1 receptor immunoreactivity, suggesting that there is a neurogenic inflammatory component following human SCI.	[Leonard, A. V.; Blumbergs, P. C.; Vink, R.] Univ Adelaide, Sch Med Sci, Adelaide, SA 5005, Australia; [Manavis, J.; Blumbergs, P. C.] Hanson Inst Ctr Neurol Dis SA Pathol, Adelaide, SA, Australia		Leonard, AV (corresponding author), Univ Adelaide, Sch Med Sci, Med Sch South, Level 4,Frome Rd, Adelaide, SA 5005, Australia.	anna.leonard@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	Neil Sachse Foundation	We acknowledge the financial support of the Neil Sachse Foundation.	Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Campos MM, 2000, NEUROPEPTIDES, V34, P314, DOI 10.1054/npep.2000.0823; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; KOYANAGI I, 1989, PARAPLEGIA, V27, P190, DOI 10.1038/sc.1989.28; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; MAENO H, 1993, MOL BRAIN RES, V18, P43, DOI 10.1016/0169-328X(93)90172-L; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Olsson Y, 1996, NEUROPATH APPL NEURO, V22, P518, DOI 10.1111/j.1365-2990.1996.tb01129.x; PEARSON J, 1982, NATURE, V295, P61, DOI 10.1038/295061a0; PRZEWLOCKI R, 1983, BRAIN RES, V280, P95, DOI 10.1016/0006-8993(83)91177-0; Sharma HS, 2011, J NEURAL TRANSM, V118, P155, DOI 10.1007/s00702-010-0514-4; TATOR CH, 1993, SURG NEUROL, V40, P207, DOI 10.1016/0090-3019(93)90069-D; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066	20	10	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2014	52	1					17	23		10.1038/sc.2013.136			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	283CB	WOS:000329221100005	24216617	Bronze			2022-02-06	
J	Lozic, I; Bartlett, CA; Shaw, JA; Iyer, KS; Dunlop, SA; Kilburn, MR; Fitzgerald, M				Lozic, Ivan; Bartlett, Carole A.; Shaw, Jeremy A.; Iyer, K. Swaminathan; Dunlop, Sarah A.; Kilburn, Matt R.; Fitzgerald, Melinda			Changes in subtypes of Ca microdomains following partial injury to the central nervous system	METALLOMICS			English	Article							CORAL GALAXEA-FASCICULARIS; RAT OPTIC-NERVE; CALCIUM MICRODOMAINS; IN-VIVO; SECONDARY DEGENERATION; OXIDATIVE STRESS; SPINAL-CORD; MASS-SPECTROMETRY; CELL-DEATH; ASTROCYTES	Rapid changes in Ca2+ concentration and location in response to injury play key roles in a range of biological systems. However, quantitative analysis of changes in size and distribution of Ca2+ microdomains in specific cell types in whole tissue samples has been limited by analytical resolution and reliance on indirect Ca2+ indicator systems. Here, we combine the unique advantages of nanoscale secondary ion mass spectrometry (NanoSIMS) with immunohistochemistry to directly quantify changes in number, size and intensity of Ca microdomains specific to axonal or glial regions vulnerable to spreading damage following neurotrauma. Furthermore, using NanoSIMS allows separate quantification of Ca microdomains according to their co-localization with areas enriched in P. We rapidly excise and cryopreserve optic nerve segments from adult rat at time points ranging from 5 minutes to 3 months after injury, allowing assessment of Ca microdomains dynamics with minimal disruption due to tissue processing. We demonstrate significantly more non-P co-localized Ca microdomains in glial than axonal regions in normal optic nerve. The density of Ca microdomains not co-localized with areas enriched in P rapidly, selectively and significantly decreases after injury; densities of Ca microdomains co-localized with P enriched areas are unchanged. An efflux of Ca2+ from microdomains not co-localized with P may contribute to the structural and functional deficits observed in nerve vulnerable to spreading damage following neurotrauma. NanoSIMS analyses of Ca microdomains allow quantitative and novel insights into Ca dynamics, applicable to a range of normal, as well as diseased or injured mammalian systems.	[Lozic, Ivan; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, BioNano, Crawley, WA 6009, Australia; [Lozic, Ivan; Bartlett, Carole A.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol M317, Crawley, WA 6009, Australia; [Shaw, Jeremy A.; Kilburn, Matt R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol M317, 35 Stirling Hwy, Crawley, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Dunlop, Sarah A/G-9357-2013; Kilburn, Matthew R/C-4515-2011; Shaw, Jeremy A/B-4156-2011; Fitzgerald, Melinda/C-4235-2011; Iyer, Swaminathan/A-1648-2010	Kilburn, Matthew R/0000-0002-1858-8485; Shaw, Jeremy A/0000-0002-5140-457X; Fitzgerald, Melinda/0000-0002-4823-8179; Lozic, Ivan/0000-0001-7441-743X; Dunlop, Sarah/0000-0002-1306-3962	Neurotrauma Research Program (Western Australia); NHMRCNational Health and Medical Research Council of Australia [APP1028681]; NHMRC, AustraliaNational Health and Medical Research Council of Australia [APP1002347]; University, State and Commonwealth Governments; NIH/NIBIB National Resource for Imaging Mass Spectrometry, NIH/NIBIB [5P41 EB001974-10]	This work was supported by the Neurotrauma Research Program (Western Australia) and NH&MRC (Grant ID: APP1028681). Prof. Dunlop is a Principal Research Fellow of the NH&MRC, Australia (Grant ID: APP1002347). We thank Associate Professor Nathan J. Pavlos, The University of Western Australia, for kindly providing us with a sample of VDAC2 antibody; Mr Guy Ben-Ary of Cell Central, The University of Western Australia, for assistance with fluorescent microscopy; Mr John Murphy, The University of Western Australia, for assistance with confocal microscopy and Associate Professor Jenny Rodger for critical review of the manuscript. The authors acknowledge the facilities, scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments. This work was made possible in part by the OpenMIMS software whose development is funded by the NIH/NIBIB National Resource for Imaging Mass Spectrometry, NIH/NIBIB 5P41 EB001974-10.	Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663; Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Budd SL, 1996, J NEUROCHEM, V67, P2282; Camello-Almaraz MC, 2006, J CELL PHYSIOL, V206, P487, DOI 10.1002/jcp.20498; Clode PL, 2003, BIOL BULL-US, V204, P138, DOI 10.2307/1543549; Clode PL, 2003, PROTOPLASMA, V220, P153, DOI 10.1007/s00709-002-0046-3; Davidson SM, 2006, CELL CALCIUM, V40, P561, DOI 10.1016/j.ceca.2006.08.017; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; GELDERD JB, 1990, ACTA NEUROBIOL EXP, V50, P601; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Goldberg JA, 2012, NAT NEUROSCI, V15, P1414, DOI 10.1038/nn.3209; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Holmstrom KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2364; Honmou Osamu, 1995, P480; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Koch JC, 2011, NAT PROTOC, V6, P1887, DOI 10.1038/nprot.2011.403; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kuga N, 2011, J NEUROSCI, V31, P2607, DOI 10.1523/JNEUROSCI.5319-10.2011; Lau KH, 2010, J MICROSC-OXFORD, V240, P21, DOI [10.1111/j.1365-2818.20.10.03380.x, 10.1111/j.1365-2818.2010.03380.x]; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Liu BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016985; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; MORIYA T, 1994, J NEUROTRAUM, V11, P255, DOI 10.1089/neu.1994.11.255; Myoga MH, 2011, J NEUROSCI, V31, P5235, DOI 10.1523/JNEUROSCI.5252-10.2011; Oheim M, 2006, CELL CALCIUM, V40, P423, DOI 10.1016/j.ceca.2006.08.007; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Peteranderl R, 2004, J AM SOC MASS SPECTR, V15, P478, DOI 10.1016/j.jasms.2003.11.019; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Song W, 2012, J NEUROCHEM, V123, P325, DOI 10.1111/j.1471-4159.2012.07914.x; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Wang JB, 2012, AM J PATHOL, V181, P746, DOI 10.1016/j.ajpath.2012.05.019; Wedlock LE, 2011, METALLOMICS, V3, P917, DOI 10.1039/c1mt00053e; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1	52	10	10	0	8	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1756-5901	1756-591X		METALLOMICS	Metallomics		2014	6	3					455	464		10.1039/c3mt00336a			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD9DU	WOS:000333565800007	24425149	Green Submitted			2022-02-06	
S	Maroon, JC; Mathyssek, C; Bost, J		Niranjan, A; Lunsford, LD		Maroon, Joseph C.; Mathyssek, Christina; Bost, Jeffrey			Cerebral Concussion: A Historical Perspective	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORTS-RELATED CONCUSSION; BRAIN-INJURY; RATS	No topic in sports has gathered more attention and publicity than the diagnosis, management, and long-term effects of cerebral concussion. The relevant history of concussion starts in 1905 when President Theodore Roosevelt drew attention to the football 'death harvest'. Soon after, rules started to change to reduce the amount and severity of head injuries in football. Up until 1980, the primary focus regarding concussions was to diagnose a potentially fatal intracranial hemorrhage. While aware of long-term consequences of concussions, the perception at the time was that virtually all concussions would 'clear' with time and rest. Concussion management guidelines gave way to objective neuropsychological testing in the early 1990s with the development of the ImPACT TM (Immediate Post-Concussion Assessment and Cognitive Testing) neurocognitive test. Led by organized football, in 1994 the National Football League (NFL) formed the Mild Traumatic Brain Injury Committee which began to investigate the cause of concussions, evaluate equipment (particularly helmets), and recommend methods for prevention. In 2005, the first case of chronic traumatic encephalopathy was described in a deceased football player, raising concerns about the long-term consequences of head injuries and concussions. Major advancements in contact sports and the military are underway to reduce the incidence of concussions and subconcussive blows to the head. (C) 2014 S. Karger AG, Basel	[Maroon, Joseph C.; Mathyssek, Christina; Bost, Jeffrey] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA 15213 USA		Bost, J (corresponding author), Univ Pittsburgh, Med Ctr, Presbyterian Univ Hosp, Dept Neurosurg, Suite 5C,200 Lothrop St, Pittsburgh, PA 15213 USA.	bostj@upmc.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bennett MH, 2012, COCHRANE DB SYST REV, V12, P1; Blaylock Russell L, 2012, Surg Neurol Int, V3, P19, DOI 10.4103/2152-7806.92935; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hogyes E, 2003, NEUROSCIENCE, V119, P999, DOI 10.1016/S0306-4522(03)00198-2; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell M, 2009, PHYS MED REH CLIN N, V20, P39, DOI 10.1016/j.pmr.2008.10.003; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12; Maroon JC, 2012, PHYSICIAN SPORTSMED, V40, P73, DOI 10.3810/psm.2012.11.1990; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Petraglia Anthony L, 2011, Surg Neurol Int, V2, P146, DOI 10.4103/2152-7806.85987	19	10	11	0	11	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						1	13		10.1159/000358746	10.1159/isbn.978-3-318-02649-8		13	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000002	24923388				2022-02-06	
J	Peng, KA; Ahmed, S; Yang, I; Gopen, Q				Peng, Kevin A.; Ahmed, Sameer; Yang, Isaac; Gopen, Quinton			Temporal Bone Fracture Causing Superior Semicircular Canal Dehiscence	CASE REPORTS IN OTOLARYNGOLOGY			English	Article							MANIFESTATIONS	Importance. Superior semicircular canal dehiscence (SCD) is a third window lesion of the inner ear causing symptoms of vertigo, autophony, tinnitus, and hearing loss. A "two-hit" hypothesis has traditionally been proposed, whereby thinly developed bone overlying the superior canal is disrupted by a sudden change in intracranial pressure. Although the symptoms of SCD may be precipitated by head injury, no previous reports have described a temporal bone fracture directly causing SCD. Observations. Two patients sustained temporal bone fractures after closed head trauma, and developed unilateral otologic symptoms consistent with SCD. In each instance, computed tomography imaging revealed fractures extending through the bony roof of the superior semicircular canal. Conclusions and Relevance. Temporal bone fractures, which are largely treated nonoperatively, have not previously been reported to cause SCD. As it is a potentially treatable entity, SCD resulting from temporal bone fracture must be recognized as a possibility and diagnosed promptly if present.	[Peng, Kevin A.; Ahmed, Sameer; Gopen, Quinton] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, 10833 Conte Ave,CHS 62-132, Los Angeles, CA 90095 USA; [Yang, Isaac] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Peng, KA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, 10833 Conte Ave,CHS 62-132, Los Angeles, CA 90095 USA.	kap@ucla.edu	Yang, Isaac/AAT-5897-2020	Yang, Isaac/0000-0002-5176-5615; Peng, Kevin/0000-0002-9166-0869			Carey JP, 2000, ARCH OTOLARYNGOL, V126, P137, DOI 10.1001/archotol.126.2.137; Chi FL, 2010, OTOL NEUROTOL, V31, P2, DOI 10.1097/MAO.0b013e3181bc35ce; Lee GS, 2011, LARYNGOSCOPE, V121, P2256, DOI 10.1002/lary.22134; Mikulec AA, 2004, OTOL NEUROTOL, V25, P121, DOI 10.1097/00129492-200403000-00007; Minor LB, 2005, LARYNGOSCOPE, V115, P1717, DOI 10.1097/01.mlg.0000178324.55729.b7; Minor LB, 2000, AM J OTOL, V21, P9; Minor LB, 2003, OTOL NEUROTOL, V24, P270, DOI 10.1097/00129492-200303000-00023; Minor LB, 1998, ARCH OTOLARYNGOL, V124, P249, DOI 10.1001/archotol.124.3.249; Nadgir RN, 2011, AM J NEURORADIOL, V32, P947, DOI 10.3174/ajnr.A2437; Rosowski JJ, 2004, OTOL NEUROTOL, V25, P323, DOI 10.1097/00129492-200405000-00021; Watters KF, 2006, OTOL NEUROTOL, V27, P756, DOI 10.1097/01.mao.0000227894.27291.9f; Williamson RA, 2003, OTOLARYNG HEAD NECK, V129, P481, DOI 10.1016/S0194-5998(03)01391-3	12	10	10	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-6765	2090-6773		CASE REP OTOLARYNGOL	Case Rep. Otolaryngol.		2014	2014								817291	10.1155/2014/817291			4	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	V25DY	WOS:000215206500075	25295207	gold, Green Published, Green Submitted			2022-02-06	
J	Sbordone, RJ				Sbordone, Robert J.			The Hazards of Strict Reliance on Neuropsychological Tests	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						ecological validity; executive functions; frontal lobes; neurobehavioral symptoms; neuropsychological testing; traumatic brain damage	FRONTAL-SUBCORTICAL CIRCUITS; ECOLOGICAL VALIDITY; COGNITIVE DEFICITS; EVERYDAY; LOBES	The overwhelming majority of neuropsychologists rely on standardized neuropsychological tests when they evaluate patients who have frontal-lobe damage as a result of a moderate or severe traumatic brain injury. Unfortunately, these tests were never designed to assess the neurobehavioral symptoms of these patients and are poor at doing this. Neuropsychologists typically spend relatively little time with brain-damaged patients because they often rely on questionnaires that are completed by the patient rather than take a comprehensive face-to-face clinical history and assistants who administer neuropsychological tests. The ecological validity of the neuropsychological tests that are administered to these patients is frequently ignored. As a consequence, neuropsychologists often base their predictions about whether these patients can work, return to school, or function independently in the community on the patient's quantitative test scores that were never designed for this purpose and have little ecological validity. Although patients with frontal-lobe damage may not show any cognitive deficits when they are administered standardized neuropsychological tests in an office setting, particularly when the anterior and ventral areas of their frontal lobes are damaged, they frequently exhibit cognitive difficulties, neurobehavioral symptoms, and executive dysfunction in unstructured real-world settings. Because standardized neuropsychological tests are generally poor at assessing these problems and symptoms, neuropsychologists may not be aware that a patient has these symptoms if they rely solely on their neuropsychological test results-particularly if they have never observed these patients function in real-world settings or interviewed the significant others of these patients.			Sbordone, RJ (corresponding author), 23046 Ave Carlota,Suite 600, Laguna Hills, CA 92651 USA.	bobneurpsy@aol.com					ALBERT ML, 1974, J NEUROL NEUROSUR PS, V37, P121, DOI 10.1136/jnnp.37.2.121; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Askin-Edgar S., 2004, ESSENTIALS NEUROPSYC, P421; Barch D. M., 2003, NEUROPSYCHIATRY, P426; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benson D.F., 1986, FRONTAL LOBES; Benson DF, 1994, NEUROLOGY THINKING; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P279, DOI 10.1016/0887-6177(88)90020-0; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cripe L. I., 1996, ECOLOGICAL VALIDITY, P129; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Damasio A. R., 1985, CLIN NEUROPSYCHOLOGY, P409; Delis DC., 2001, DELIS KAPLAN EXECUTI; FLOWERS KA, 1985, J NEUROL NEUROSUR PS, V48, P517, DOI 10.1136/jnnp.48.6.517; Gioia  G., 2000, BRIEF RATING INVENTO; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grace J, 2001, FRONTAL SYSTEM BEHAV; GRAFMAN J, 1990, ARCH NEUROL-CHICAGO, V47, P553, DOI 10.1001/archneur.1990.00530050077015; Isquith P.K., 2005, BEHAV RATING INVENTO; Jankovic J., 2003, NEUROPSYCHIATRY, P934; KAUFER DI, 1997, BEHAV NEUROLOGY NEUR, P499; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak M. D., 1997, BEHAV NEUROLOGY NEUR, P43; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Long, 1996, ECOLOGICAL VALIDITY, P15; MAHER ER, 1985, J NEUROL NEUROSUR PS, V48, P1234, DOI 10.1136/jnnp.48.12.1234; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; OSHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; Sbordone R. J., 1997, NEUROPSYCHOLOGY HDB, V1, P365; Sbordone R. J., 2007, NEUROPSYCHOLOGY PSYC; Sbordone R. J, 2000, NEUROPSYCHOLOGICAL A, P437; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sbordone RJ, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P471; Sbordone RJ, 2000, CRIT ISS NE, P335; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; Silver J. M., 2004, ESSENTIALS NEUROPSYC, P241; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; ZANGWILL OL, 1966, INT J NEUROL, V5, P395; [No title captured]	48	10	10	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2014	21	2					98	107		10.1080/09084282.2012.762630			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AM9VL	WOS:000340229000004	24826503				2022-02-06	
S	Sheese, ALN; Hammeke, TA		Niranjan, A; Lunsford, LD		Sheese, Amelia L. Nelson; Hammeke, Thomas A.			Rehabilitation from Postconcussion Syndrome: Nonpharmacological Treatment	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MISERABLE MINORITY; SYMPTOMS	Following mild traumatic brain injury (mTBI), one or more symptoms commonly occur that are known as the postconcussion syndrome (PCS). While PCS typically resolves within a few weeks of injury for most concussed patients, some patients have a more prolonged or otherwise adverse recovery course. There is relatively little systematic research on the treatment of PCS. This report offers strategies for nonpharmacological treatment of PCS during the acute, subacute, and chronic stages of recovery following mTBI. The treatment strategies are supported by clinical consensus and the limited evidence-based research wherever possible. Core treatment strategies emphasize (1) education about mTBI, PCS, and the natural recovery course, (2) reassurance of a good outcome, (3) reduction in activity level and refrain from hazardous behaviors during the acute phase, (4) gradual return to lifestyle activities as symptoms permit, (5) careful monitoring and early intervention for adverse emotional responses, (6) symptom-specific treatment when needed, and (7) ready access to providers during acute and subacute recovery periods. (C) 2014 S. Karger AG, Basel	[Sheese, Amelia L. Nelson] Univ Nebraska Med Ctr, Omaha, NE USA; [Hammeke, Thomas A.] Clement J Zablocki Vet Adm Med Ctr, Milwaukee, WI USA; [Hammeke, Thomas A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA		Hammeke, TA (corresponding author), Zablocki VA Med Ctr, Acute Mental Hlth, Bldg 111,5000 West Natl Ave, Milwaukee, WI 53295 USA.	thammeke@mcw.edu					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM PSYCH ASS, 2000, AM PSYCH ASS DIAGN S; Beck AT., 1979, COGNITIVE THERAPY DE; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Defense and Veterans Brain Injury Center, 2013, TBI SYMPT MAN HLTH S; Faul M, 2010, TRAUMATIC BRAIN INJU; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P434; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2012, PTSD MILD TRAUMATIC; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; [Veterans Affairs Department of Defense], 2009, CLIN PRACT GUID MAN; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	22	10	10	0	0	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						149	160		10.1159/000358775	10.1159/isbn.978-3-318-02649-8		12	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000014	24923400				2022-02-06	
J	Webb, NE; Little, B; Loupee-Wilson, S; Power, EM				Webb, Nadia E.; Little, Brittany; Loupee-Wilson, Stephanie; Power, Elizabeth M.			Traumatic brain injury and neuro-endocrine disruption: Medical and psychosocial rehabilitation	NEUROREHABILITATION			English	Article						HPA axis; psychoneuroimmunology; TBI; endocrine; social isolation; anterior pituitary; hypopituitarism; brain injury; PTSD; neuroendocrine injury; neurorehabilitation	GROWTH-HORMONE DEFICIENCY; PITUITARY DYSFUNCTION; SOCIAL REGULATION; PHYSICAL HEALTH; GENE-EXPRESSION; SUBARACHNOID HEMORRHAGE; SIGNALING PATHWAYS; NERVOUS-SYSTEM; OVARIAN-CANCER; HEAD TRAUMA	INTRODUCTION: Traumatic Brain Injury (TBI) initiates a cascade of neuromodulatory damage that blurs the distinctions between physical and psychological medicine. Monitoring endocrine function through labs is not part of the medical care algorithm for treatment of TBI, but the clinical symptoms are easily misidentified as they include: depression, fatigue, poor concentration, irritability and a decline in overall cognitive functioning. The reciprocal flow of change between neuroendocrine health and psychosocial health is well established within the field of neuroscience, social psychology, endocrinology and behavioral neurology, but has not translated into patient care. OBJECTIVES: This paper outlines common neuroendocrine disruptions secondary to TBI and their clinical implications for treating mental health professionals. CONCLUSION: Wider adoption of the consensus guidelines on the detection and monitoring of endocrine abnormalities post-TBI may diminish the severity of functional impairment and improve quality of life.	[Webb, Nadia E.; Little, Brittany; Loupee-Wilson, Stephanie; Power, Elizabeth M.] Chicago Sch Profess Psychol, Chicago, IL 60654 USA		Webb, NE (corresponding author), Chicago Sch Profess Psychol, Sch Psychol Dept, 325 North Wells 525, Chicago, IL 60654 USA.	drnadiawebb@gmail.com					Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; ANDERSEN SM, 1995, J PERS SOC PSYCHOL, V69, P41, DOI 10.1037/0022-3514.69.1.41; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; [Anonymous], 2010, TRAUMATIC BRAIN INJU; Antoni MH, 2012, BIOL PSYCHIAT, V71, P366, DOI 10.1016/j.biopsych.2011.10.007; Aravich P., 2004, COMMUNICATION; Auble BA, 2014, J NEUROTRAUM, V31, P321, DOI 10.1089/neu.2013.2916; Barr CS, 2004, BIOL PSYCHIAT, V55, P733, DOI 10.1016/j.biopsych.2003.12.008; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bevenga S., 2000, J CLIN ENDOCRINOLOGY, V85, P1352; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Boyce WT, 2012, P NATL ACAD SCI USA, V109, P17143, DOI 10.1073/pnas.1121264109; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; Chen E, 2011, MOL PSYCHIATR, V16, P729, DOI 10.1038/mp.2010.53; Cohan CL, 2002, J FAM PSYCHOL, V16, P14, DOI 10.1037//0893-3200.16.1.14; Cole S. W., 2006, SOCIAL THREAT PERSON; Cole SW, 2008, BRAIN BEHAV IMMUN, V22, P1049, DOI 10.1016/j.bbi.2008.02.006; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Cole SW, 2010, PSYCHONEUROENDOCRINO, V35, P955, DOI 10.1016/j.psyneuen.2010.06.008; Cole SW, 2009, CURR DIR PSYCHOL SCI, V18, P132, DOI 10.1111/j.1467-8721.2009.01623.x; Cole SW, 2009, PSYCHOSOM MED, V71, P591, DOI 10.1097/PSY.0b013e3181aa95a9; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Cole SW, 2003, BIOL PSYCHIAT, V54, P1444, DOI 10.1016/S0006-3223(02)01888-7; Cole SW, 1996, HEALTH PSYCHOL, V15, P243, DOI 10.1037/0278-6133.15.4.243; DANIEL PM, 1959, LANCET, V2, P927; Dupuis C, 2010, INTENS CARE MED, V36, P1906, DOI 10.1007/s00134-010-2012-4; EDWARDS OM, 1986, MEDICINE, V65, P281; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Fernandez-Rodriguez E., 2011, FRONTIERS ENDOCRINOL, V2; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; GNEHM H E, 1979, Helvetica Paediatrica Acta, V34, P529; GRIFFIN JM, 1976, J TRAUMA, V16, P979, DOI 10.1097/00005373-197612000-00007; GUZMAN AL, 1992, ACTA PAEDIATR, V81, P698, DOI 10.1111/j.1651-2227.1992.tb12337.x; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kumari M, 2005, NEUROLOGY, V65, P1597, DOI 10.1212/01.wnl.0000184521.80820.e4; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lewis KE, 2006, PHILOS T R SOC B, V361, P45, DOI 10.1098/rstb.2005.1778; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lorenzo M., 2006, PITUITARY, V8, P233; LUSTMAN PJ, 1983, PSYCHOSOMATICS, V24, P70, DOI 10.1016/S0033-3182(83)73261-5; Lutgendorf SK, 2012, J CLIN ONCOL, V30, P2885, DOI 10.1200/JCO.2011.39.4411; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; LYNCH S, 1994, J ROY SOC MED, V87, P445; Maguire EA, 1997, PHILOS T R SOC B, V352, P1475, DOI 10.1098/rstb.1997.0134; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Masters C. L., 2012, PEDIAT ANN, V41; Miller GE, 1997, ANN BEHAV MED, V19, P139, DOI 10.1007/BF02883331; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Miller GE, 2009, PSYCHOSOM MED, V71, P57, DOI 10.1097/PSY.0b013e318190d7de; Mills NT, 2013, J CHILD PSYCHOL PSYC, V54, P816, DOI 10.1111/jcpp.12080; Murphy MLM, 2013, CLIN PSYCHOL SCI, V1, P30, DOI 10.1177/2167702612455743; Needelman H, 2008, J CHILD NEUROL, V23, P421, DOI 10.1177/0883073807309232; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; O'Donovan A, 2013, NEUROSCI BIOBEHAV R, V37, P96, DOI 10.1016/j.neubiorev.2012.10.013; O'Donovan A, 2011, DIS MARKERS, V30, P123, DOI [10.1155/2011/560572, 10.3233/DMA-2011-0768]; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; Piazza JR, 2013, ANN BEHAV MED, V45, P110, DOI 10.1007/s12160-012-9423-0; Platt SR, 1999, J AM ANIM HOSP ASSOC, V35, P117, DOI 10.5326/15473317-35-2-117; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Porter R. J., 1946, J NEUROL NEUROSUR PS, V11, P528; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Sapolsky RM, 1997, ARCH GEN PSYCHIAT, V54, P1137; Sapolsky RM, 2004, ANNU REV ANTHROPOL, V33, P393, DOI 10.1146/annurev.anthro.33.070203.144000; Schmahmann J. D., 2004, J NEUROPSYCHIATRY CL, V16, P267; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Smith JR, 2004, J SMALL ANIM PRACT, V45, P405, DOI 10.1111/j.1748-5827.2004.tb00256.x; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Sonino N, 2004, EUR J ENDOCRINOL, V151, P61, DOI 10.1530/eje.0.1510061; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Urban PP, 2004, MUSCLE NERVE, V29, P663, DOI 10.1002/mus.20011; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Wachter T, 2009, J TRAUMA DISSOCIATIO, V10, P261, DOI 10.1080/15299730902956770; Webb N., 1998, THESIS RUTGERS U; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7; YAMANAKA C, 1993, EUR J PEDIATR, V152, P99, DOI 10.1007/BF02072482; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	116	10	10	0	17	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	4					625	636		10.3233/NRE-141074			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AK5CY	WOS:000338443100004	24820169				2022-02-06	
J	Yang, TT; He, GL; Zhang, X; Chang, L; Zhang, HD; Ripple, MG; Fowler, DR; Li, L				Yang, Tiantong; He, Guanglong; Zhang, Xiang; Chang, Lin; Zhang, Haidong; Ripple, Mary G.; Fowler, David R.; Li, Ling			Preliminary Study on Diffuse Axonal Injury by Fourier Transform Infrared Spectroscopy Histopathology Imaging	JOURNAL OF FORENSIC SCIENCES			English	Article; Proceedings Paper	64th Annual Scientific Meeting of American-Academy-of-Forensic-Sciences (AAFS)	FEB 20-25, 2012	Atlanta, GA	Amer Acad Forens Sci		forensic science; forensic pathology; diffuse axonal injury; traumatic brain injury; Fourier transform infrared spectroscopy; animal study	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; BETA-APP; METASTASES; SYSTEM; DAMAGE; MODEL; RATS	The objective of this study was to evaluate the application of Fourier transform infrared (FTIR) spectroscopy for detecting diffuse axonal injury (DAI) in a mouse model. Brain tissues from DAI mouse model were prepared with H&E, silver, and beta-amyloid precursor protein (beta-APP) immunohistochemistry stains and were also studied with FTIR. The infrared spectrum images showed high absorption of amide II in the subcortical white matter of the experimental mouse brain, while there was no obvious expression of amide II in the control mouse brain. The areas with high absorption of amide II were in the same distribution as the DAI region confirmed by the silver and b-APP studies. The result suggests that high absorption of amide II correlates with axonal injury. The use of FTIR imaging allows the biochemical changes associated with DAI pathologies to be detected in the tissues, thus providing an important adjunct method to the current conventional pathological diagnostic techniques.	[Yang, Tiantong; Chang, Lin; Zhang, Haidong; Fowler, David R.; Li, Ling] China Univ Polit Sci & Law, Key Lab Evidence Sci, Minist Educ, Beijing 100088, Peoples R China; [He, Guanglong] Minist Publ Secur, Inst Forens Sci, Beijing 100038, Peoples R China; [Zhang, Xiang; Ripple, Mary G.; Fowler, David R.; Li, Ling] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhang, Xiang; Ripple, Mary G.; Fowler, David R.; Li, Ling] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA		Li, L (corresponding author), China Univ Polit Sci & Law, Key Lab Evidence Sci, 25 West Tucheng Rd, Beijing 100088, Peoples R China.	Ling001@aol.com					Bird B, 2011, TECHNOL CANCER RES T, V10, P135, DOI 10.7785/tcrt.2012.500188; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gallyas F, 2006, ACTA NEUROPATHOL, V111, P229, DOI 10.1007/s00401-006-0034-3; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Hsu THS, 2011, UROL RES, V39, P165, DOI 10.1007/s00240-010-0316-z; Isabelle M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3386061; Johnson MW, 2011, J FORENSIC SCI, V56, P1198, DOI 10.1111/j.1556-4029.2011.01814.x; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Krafft C, 2007, ANAL BIOANAL CHEM, V389, P1133, DOI 10.1007/s00216-007-1453-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wood BR, 2004, GYNECOL ONCOL, V93, P59, DOI 10.1016/j.ygyno.2003.12.028; Yang TAT, 2011, FORENSIC SCI INT, V207, pE34, DOI 10.1016/j.forsciint.2010.12.005	29	10	14	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	JAN	2014	59	1					231	235		10.1111/1556-4029.12290			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Legal Medicine	AJ4HP	WOS:000337635400029	24147828				2022-02-06	
J	Musteata, M; Nicolescu, A; Solcan, G; Deleanu, C				Musteata, Mihai; Nicolescu, Alina; Solcan, Gheorghe; Deleanu, Calin			The H-1 NMR Profile of Healthy Dog Cerebrospinal Fluid	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-RESOLUTION H-1-NMR; TRAUMATIC BRAIN-INJURY; MASS-SPECTROMETRY; METABOLITE CONCENTRATIONS; SUBARACHNOID HEMORRHAGE; PYRUVATE CONCENTRATIONS; PORTOSYSTEMIC SHUNTS; HUMAN PLASMA; AMINO-ACIDS	The availability of data for reference values in cerebrospinal fluid for healthy humans is limited due to obvious practical and ethical issues. The variability of reported values for metabolites in human cerebrospinal fluid is quite large. Dogs present great similarities with humans, including in cases of central nervous system pathologies. The paper presents the first study on healthy dog cerebrospinal fluid metabolomic profile using H-1 NMR spectroscopy. A number of 13 metabolites have been identified and quantified from cerebrospinal fluid collected from a group of 10 mix breed healthy dogs. The biological variability as resulting from the relative standard deviation of the physiological concentrations of the identified metabolites had a mean of 18.20% (range between 9.3% and 44.8%). The reported concentrations for metabolites may be used as normal reference values. The homogeneity of the obtained results and the low biologic variability show that the 1H NMR analysis of the dog's cerebrospinal fluid is reliable in designing and interpreting clinical and therapeutic trials in dogs with central nervous system pathologies.	[Musteata, Mihai; Solcan, Gheorghe] Univ Agr Sci & Vet Med Iasi, Fac Vet Med, Clin Dept, Iasi, Romania; [Nicolescu, Alina; Deleanu, Calin] Roumanian Acad, Inst Macromol Chem, Grp Biospect, Iasi, Romania; [Nicolescu, Alina; Deleanu, Calin] Roumanian Acad, Ctr Organ Chem, Grp Biospect, Bucharest, Romania		Deleanu, C (corresponding author), Roumanian Acad, Inst Macromol Chem, Grp Biospect, Iasi, Romania.	calin.deleanu@yahoo.com	Deleanu, Calin/G-7446-2011; Nicolescu, Alina/M-8562-2017; Musteata, Mihai/B-7144-2011	Deleanu, Calin/0000-0001-8206-5227; Nicolescu, Alina/0000-0001-7022-8893; Musteata, Mihai/0000-0002-8371-9170	Romanian National Authority for Scientific Research, (CNCS-UEFISCDI)Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI) [PD 628/2010, PN-II-ID-PCCE-2011-2-0045]	The research was supported by the Romanian National Authority for Scientific Research, (CNCS-UEFISCDI), through grants PD 628/2010 and PN-II-ID-PCCE-2011-2-0045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly J, 1997, ACTA NEUROL SCAND, V95, P9, DOI 10.1111/j.1600-0404.1997.tb00060.x; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bechter K, 2011, NEUROL PSYCHIAT BR, V17, P51, DOI 10.1016/j.npbr.2011.06.003; Benoist JF, 2003, CLIN CHEM, V49, P487, DOI 10.1373/49.3.487; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Butterworth J, 1997, METAB BRAIN DIS, V12, P299, DOI 10.1023/A:1022378209979; Ciurtin C, 2007, REV CHIM-BUCHAREST, V58, P51; COMMODARI F, 1991, NMR BIOMED, V4, P192, DOI 10.1002/nbm.1940040407; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; Dawidowicz AL, 2003, BIOMED CHROMATOGR, V17, P447, DOI 10.1002/bmc.269; Dekker LJ, 2005, MOL CELL PROTEOMICS, V4, P1341, DOI 10.1074/mcp.M500081-MCP200; Di Terlizzi R, 2006, VET J, V172, P422, DOI 10.1016/j.tvjl.2005.07.021; Dunne VG, 2005, NMR BIOMED, V18, P24, DOI 10.1002/nbm.918; Ellenberger C, 2004, AM J VET RES, V65, P1108, DOI 10.2460/ajvr.2004.65.1108; Frank R, 2003, NAT REV DRUG DISCOV, V2, P566, DOI 10.1038/nrd1130; Gomez-Mancilla B, 2005, NeuroRx, V2, P683, DOI 10.1602/neurorx.2.4.683; Holmes Elaine, 2006, NeuroRx, V3, P358, DOI 10.1016/j.nurx.2006.05.004; Holt DE, 2002, AM J VET RES, V63, P1167, DOI 10.2460/ajvr.2002.63.1167; Hong L, 2011, J PHARMACEUT BIOMED, V54, P1101, DOI 10.1016/j.jpba.2010.11.031; Hutchesson A, 1997, CLIN CHEM, V43, P158; Iwabuchi T, 1973, STROKE, V4, P207, DOI 10.1161/01.STR.4.2.207; Jukarainen NM, 2008, METABOLOMICS, V4, P150, DOI 10.1007/s11306-008-0106-6; KOSCHOREK F, 1993, NEUROSURG REV, V16, P307, DOI 10.1007/BF00383842; Kosicek M, 2010, ANAL BIOANAL CHEM, V398, P2929, DOI 10.1007/s00216-010-4273-8; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Levine J, 2000, BIOL PSYCHIAT, V47, P586, DOI 10.1016/S0006-3223(99)00284-X; Levine J, 2000, J NEURAL TRANSM, V107, P843, DOI 10.1007/s007020070064; Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009; Lindon JC, 2003, ANAL CHEM, V75, p384A, DOI 10.1021/ac031386+; Lutz NW, 1998, FEBS LETT, V425, P345, DOI 10.1016/S0014-5793(98)00262-2; Maillet S, 1998, BRAIN RES PROTOC, V3, P123, DOI 10.1016/S1385-299X(98)00033-6; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; MELLERUP ET, 1981, ACTA PSYCHIAT SCAND, V63, P57, DOI 10.1111/j.1600-0447.1981.tb00650.x; Mishur RJ, 2012, MASS SPECTROM REV, V31, P70, DOI 10.1002/mas.20338; Nagashima H, 2010, EUR SPINE J, V19, P1363, DOI 10.1007/s00586-010-1453-3; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicolescu A, 2012, REV ROUM CHIM, V57, P653; Nicolescu A, 2011, REV CHIM-BUCHAREST, V62, P1150; Oliver SG, 1997, MICROBIOL-UK, V143, P1483, DOI 10.1099/00221287-143-5-1483; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Pugliese M, 2005, PROG NEURO-PSYCHOPH, V29, P603, DOI 10.1016/j.pnpbp.2005.01.017; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Satoh H, 2007, BRAIN RES, V1133, P200, DOI 10.1016/j.brainres.2006.11.039; Silverstone PH, 2005, BIPOLAR DISORD, V7, P1, DOI 10.1111/j.1399-5618.2004.00174.x; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; SMITH AR, 1978, ANN SURG, V187, P343, DOI 10.1097/00000658-197803000-00024; Stefan LI, 2010, REV ROUM CHIM, V55, P1033; Stoop MP, 2010, MOL CELL PROTEOMICS, V9, P2063, DOI 10.1074/mcp.M900877-MCP200; Subramanian A, 2005, NMR BIOMED, V18, P213, DOI 10.1002/nbm.944; SUGI T, 1975, STROKE, V6, P715, DOI 10.1161/01.STR.6.6.715; TALLAKSEN CME, 1992, AM J CLIN NUTR, V56, P559, DOI 10.1093/ajcn/56.3.559; Tarnaris Andrew, 2006, Cerebrospinal Fluid Res, V3, P11, DOI 10.1186/1743-8454-3-11; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; WEVERS RA, 1995, CLIN CHEM, V41, P744; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Witsberger TH, 2012, JAVMA-J AM VET MED A, V240, P555, DOI 10.2460/javma.240.5.555; Wolowicka L, 1975, Resuscitation, V4, P33, DOI 10.1016/0300-9572(75)90062-3; Wuolikainen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017947; Zwingmann C, 2005, NEUROCHEM INT, V47, P19, DOI 10.1016/j.neuint.2005.04.003	62	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e81192	10.1371/journal.pone.0081192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	WOS:000328882000003	24376499	Green Published, gold, Green Submitted			2022-02-06	
J	Deng, SX; Zhu, HC; Wang, KL; Cao, TW				Deng, Shuixiang; Zhu, Hechen; Wang, Kunlun; Cao, Tongwa			Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: an observation study	BMC ANESTHESIOLOGY			English	Article						Procalcitonin; Systemic inflammatory response syndrome (SIRS); Sepsis; Mortality; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; C-REACTIVE PROTEIN; SERUM PROCALCITONIN; MULTIPLE TRAUMA; PLASMA-LEVELS; INFECTIONS	Background: Procalcitonin (PCT) is a reliable biomarker of sepsis and infection. The level of PCT associated with sepsis and infection in patients with traumatic brain injury is currently unknown. The purpose of this study was to investigate the value of PCT and C-reactive protein (CRP) as diagnostic markers of sepsis and to evaluate the prognostic value of these markers related to the severity of injury, sepsis and mortality. Methods: 105 adult patients with neurotrauma were enrolled in this study from June 2011 to February 2013. PCT and CRP were measured at admission and 2, 3, 5 and 7 days after admission. The sepsis criteria established by American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference were used to identify patients. Injury Severity Score (ISS) and Glasgow Coma Score (GCS) were used to assess the severity of the injury. All these patients were monitored for 28 days. Results: At admission, the median level of PCT was consistent with the severity of brain injury as follows: mild 0.08 ng/ml (0.05 - 0.13), moderate 0.25 ng/ml (0.11 - 0.55) and severe 0.31 ng/ml (0.17 - 0.79), but the range of CRP levels varied greatly within the given severity of brain injury. Seventy-one (67.6%) patients developed sepsis. The initial levels of PCT at admission were statistically higher in patients with sepsis, compared with patients with systemic inflammatory response syndrome (SIRS), but there were no differences in the initial concentration of CRP between sepsis and SIRS. After adjusting for these parameters, multivariate logistic regression analysis revealed that PCT was an independent risk factor for septic complications (p < 0.05). The areas under the ROCs at admission for the prediction of mortality were 0.76 (p < 0.05) and 0.733 for PCT and CRP, respectively. Conclusions: Increased levels of PCT during the course of the ICU stay could be an important indicator for the early diagnosis of sepsis after neurotrauma. In addition, high serum levels of PCT in patients with neurotrauma at admission indicate an increased risk of septic complications, and the daily measurement of PCT assists in guiding antibiotic therapy in neurotrauma patients.	[Deng, Shuixiang; Zhu, Hechen; Cao, Tongwa] Fudan Univ, Huashan Hosp, Div Intens Care Unit, Shanghai 200433, Peoples R China; [Wang, Kunlun] Fudan Univ, Jinshan Hosp, Dept Emergency, Shanghai 200433, Peoples R China		Cao, TW (corresponding author), Fudan Univ, Huashan Hosp, Div Intens Care Unit, 12 Wulumuqi Rd Middle, Shanghai 200433, Peoples R China.	caotongwa@sohu.com					Balci C, 2009, J INT MED RES, V37, P1709, DOI 10.1177/147323000903700606; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Civil ID, 1985, J TRAUMA, V1988, P87; de Wolf HK, 2009, CLIN CHEM, V55, P1043, DOI 10.1373/clinchem.2008.117655; Didebulidze K, 2007, Georgian Med News, P22; Georgopoulou AP, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.07.012; Haasper C, 2010, TECHNOL HEALTH CARE, V18, P89, DOI 10.3233/THC-2010-0571; Heyland DK, 2011, CRIT CARE MED, V39, P1792, DOI 10.1097/CCM.0b013e31821201a5; Irwin AD, 2011, ARCH DIS CHILDHOOD-E, V96, P228, DOI 10.1136/archdischild-2011-300178; Karlsson S, 2010, CRIT CARE, V14, DOI 10.1186/cc9327; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; LEVY MM, 2003, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Maier M, 2009, J TRAUMA, V66, P243, DOI 10.1097/TA.0b013e31817c966f; Marc E, 2002, ARCH PEDIATRIE, V9, P358, DOI 10.1016/S0929-693X(01)00793-X; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; O'Connor E, 2004, ANAESTH INTENS CARE, V32, P465, DOI 10.1177/0310057X0403200402; Reinhart K, 2011, CRIT CARE CLIN, V27, P253, DOI 10.1016/j.ccc.2011.01.002; Riedel S, 2011, AM J CLIN PATHOL, V135, P182, DOI 10.1309/AJCP1MFYINQLECV2; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sauerland S, 2003, J NEUROTRAUM, V20, P953, DOI 10.1089/089771503770195803; Schneider HG, 2007, PATHOLOGY, V39, P383, DOI 10.1080/00313020701444564; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Seligman R, 2006, CRIT CARE, V10, DOI 10.1186/cc5036; Sudhir U, 2011, INDIAN J CRIT CARE M, V15, P1, DOI 10.4103/0972-5229.78214; TEASDALE G, 1974, LANCET, V2, P81; Wanner GA, 2000, CRIT CARE MED, V28, P950, DOI 10.1097/00003246-200004000-00007	33	10	11	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	DEC 15	2013	13								48	10.1186/1471-2253-13-48			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	AC0LE	WOS:000332185000001	24330775	Green Published, gold			2022-02-06	
J	Zhu, H; Zhao, ZL; Zhou, Y; Chen, X; Li, Y; Liu, X; Lu, HJ; Zhang, YJ; Zhang, JN				Zhu, Hui; Zhao, Zilong; Zhou, Yuan; Chen, Xin; Li, Ying; Liu, Xiao; Lu, Hujie; Zhang, Yanjun; Zhang, Jianning			High-dose glucocorticoid aggravates TBI-associated corticosteroid insufficiency by inducing hypothalamic neuronal apoptosis	BRAIN RESEARCH			English	Article						Traumatic brain injury; Hypothalamic neuronal apoptosis; CIRCI; Glucocorticoid; HPICM	TRAUMATIC BRAIN-INJURY; HYPOTHALAMOPITUITARY DYSFUNCTION; ADRENAL INSUFFICIENCY; PITUITARY-GLAND; CELL-DEATH; SEPSIS; RAT; METHYLPREDNISOLONE; SURVIVAL; OUTCOMES	Emerging experimental and clinical data suggest that severe illness, such as traumatic brain injury (TBI), can induce critical illness-related corticosteroid insufficiency (CIRCI). However, underlying mechanisms of this TBI-associated CIRCI remain poorly understood. We hypothesized that dexamethasone (Dxm), a synthetic glucocorticoid, which was widely used to treat TBI, induces hypothalamic neuronal apoptosis to aggravate CIRCI. To test this hypothesis, we have evaluated the dose effect of DXM (1 or 10 mg/kg) on the development of acute CIRCI in rats with fluid percussion injury-induced TBI and on cultured rat hypothalamic neurons in vitro (Dxm, 10(-5)-10(-8) mol/L). Corticosterone Increase Index was recorded as the marker for CIRCI. In addition, MTT and TUNEL assays were used to measure the viability and apoptosis of hypothalamic neurons in primary culture. Moreover, high-resolution hopping probe ion conductance microscopy (HPICM) was used to monitor the DXM-induced morphological changes in neurons. The incidence of acute CIRCI was significantly higher in the high-dose DXM group on post-injury day 7. Cellular viability was significantly decreased from 12 h to 24 h after the treatment with a high-dose of DXM. A significantly increase in TUNEL positive cells were detected in cultured cells treated with a high-dose of DXM after 18 h. Neurites of hypothalamic neuron were dramatically thinner and the numbers of dendritic headings increased in neurons treated with the high dose of DXM for 12 h. In conclusion, high-dose DXM induced hypothalamic neurons to undergo apoptosis in vivo and in vitro, which may aggravate TBI-associated CIRCI. (C) 2013 Elsevier B.V. All rights reserved.	[Zhu, Hui; Zhao, Zilong; Zhou, Yuan; Chen, Xin; Li, Ying; Zhang, Yanjun; Zhang, Jianning] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Zhu, Hui; Zhao, Zilong; Zhou, Yuan; Chen, Xin; Li, Ying; Zhang, Yanjun; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Zhu, Hui; Zhao, Zilong; Zhou, Yuan; Chen, Xin; Li, Ying; Zhang, Yanjun; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Zhu, Hui; Zhao, Zilong; Zhou, Yuan; Chen, Xin; Li, Ying; Zhang, Yanjun; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Liu, Xiao; Lu, Hujie; Zhang, Yanjun] China Natl Acad Nanotechnol & Engn, Tianjin 300457, Peoples R China		Zhang, YJ (corresponding author), Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	clarencezhu@163.com; zilongzhaotianjin@hotmail.com; zy963000@126.com; liying11_@hotmail.com; liuxiao1220@163.com; noticee@live.cn; yanjun_zhang@hotmail.com; jianningzhang@hotmail.com	zhang, yanjun/S-5114-2019; Zhao, Zilong/AAZ-2196-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81370029, 81271361]; International Science & Technology Cooperation Program of China [2011DFG33430]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [13JCYBJC21900, 12JCYBJC31500]; "211 Project" Graduate Innovation Grant of Tianjin Medical University	This work was supported by grants from the National Natural Science Foundation of China (no. 81330029; no. 81370029; no. 81271361), the International Science & Technology Cooperation Program of China (no. 2011DFG33430), Tianjin Natural Science Foundation (no. 13JCYBJC21900; 12JCYBJC31500), and "211 Project" Graduate Innovation Grant of Tianjin Medical University.	Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Annane D, 2004, BMJ-BRIT MED J, V329, P480, DOI 10.1136/bmj.38181.482222.55; Annetta MG, 2009, CURR DRUG TARGETS, V10, P887, DOI 10.2174/138945009789108792; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Chen XW, 2013, J MEMBRANE BIOL, V246, P7, DOI 10.1007/s00232-012-9495-6; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Edwards P, 2005, LANCET, V365, P1957; Emir M, 2005, TOHOKU J EXP MED, V207, P119, DOI 10.1620/tjem.207.119; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fombonne J, 2004, MOL BIOL CELL, V15, P4938, DOI 10.1091/mbc.E04-07-0601; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Kashiwamura Y, 2011, NEUROCHEM RES, V36, P849, DOI 10.1007/s11064-011-0413-6; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Koishi AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051089; Kozler P, 2012, NEUROENDOCRINOL LETT, V33, P782; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Mark PE, 2007, CURR OPIN CRIT CARE, V13, P363, DOI 10.1097/MCC.0b013e32818a6d74; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Minneci PC, 2004, ANN INTERN MED, V141, P47, DOI 10.7326/0003-4819-141-1-200407060-00014; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Moreno G, 2011, ENDOCRINE, V39, P83, DOI 10.1007/s12020-010-9415-4; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Obrietan K, 2002, J NEUROPHYSIOL, V88, P1005, DOI 10.1152/jn.2002.88.2.1005; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051469; Patel AJ, 1998, J NEUROSCI, V18, P3117; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Sun DL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/985457; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; Vutskits L, 2006, TOXICOL SCI, V91, P540, DOI 10.1093/toxsci/kfj180; Walker ML, 2011, AM SURGEON, V77, P579; Zhang XM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/924327; Zhao YD, 2001, WORLD J SURG, V25, P1202	46	10	10	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 6	2013	1541						69	80		10.1016/j.brainres.2013.10.002			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	266GZ	WOS:000328013400008	24103812				2022-02-06	
J	Barker-Collo, S; Theadom, A; Ameratunga, S; Jones, K; Jones, A; Starkey, N; Feigin, VL				Barker-Collo, Suzanne; Theadom, Alice; Ameratunga, Shanthi; Jones, Kelly; Jones, Amy; Starkey, Nicola; Feigin, Valery L.		BIONIC Res Grp	Prevalence and Predictors of Post-traumatic Stress Disorder in Adults One Year Following Traumatic Brain Injury: A Population-based Study	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; post-traumatic stress disorder	MENTAL-HEALTH; SEQUELAE; GENDER; PSEUDOMEMORIES; OUTCOMES	Objective: Experiencing a traumatic brain injury (TBI) may increase the risk of post-traumatic stress disorder (PTSD); however, this has not been examined in a population-based context. This study examined prevalence and predictors (demographic and injury related) of PTSD 1 year after TBI in a population-based sample. Method: A population-based TBI incidence and outcomes study was conducted in Hamilton and Waikato Districts of New Zealand over 12 months (February 2011-March 2012) with follow-up at 1 year. The relationship of baseline demographic and TBI characteristics to PTSD (Post-traumatic Diagnostic Scale; PDS) was examined in 431 adults (> 15 years old) 1 year post-TBI. Results: On average, participants reported three PTSD symptoms, with heightened arousal being the most commonly reported. Nearly 18% of participants met criteria for PTSD. These participants were significantly more likely to report pre-TBI history of depression/anxiety, and to have drugs implicated in the injury. Regression indicated that female gender, increased loss of consciousness (LOC) and intentional injury predicted PTSD severity (R-2 = .109, F[6, 294] = 6.007, p < .001) and number of symptoms (R-2 = .098, F[3, 297] = 4.562, p < .001). Conclusion: PTSD occurred as a long-term sequela in 18% of participants after TBI, with increased PTSD severity and greater number of symptoms associated with female gender, longer LOC and intentional injury. These findings have implications for identification and targeting of assessment and intervention resources towards those at greatest risk of PTSD following TBI.	[Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Fac Sci, Auckland, New Zealand; [Theadom, Alice; Jones, Kelly; Jones, Amy; Feigin, Valery L.] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Fac Arts & Social Sci, Sch Psychol, Hamilton, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Dept Psychol, Tamaki Campus,Private Bag 92019, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz	Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019; Starkey, Nicola/AAJ-3795-2020; Jones, Kelly/G-4127-2015	Starkey, Nicola/0000-0002-4370-8186; Jones, Kelly/0000-0001-5692-653X; Theadom, Alice/0000-0003-0351-6216; Ameratunga, Shanthi/0000-0001-8042-2251; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand	This study was funded by the Health Research Council of New Zealand.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Bryant RA, 1998, APPL COGNITIVE PSYCH, V12, P81, DOI 10.1002/(SICI)1099-0720(199802)12:1<81::AID-ACP507>3.0.CO;2-8; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Ditlevsen DN, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-26; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Hefford M, 2005, HEALTH POLICY, V72, P9, DOI 10.1016/j.healthpol.2004.06.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; McCarthy S, 2008, OCCUP MED-OXFORD, V58, P379, DOI 10.1093/occmed/kqn062; Michaels AJ, 1999, J TRAUMA, V47, P867, DOI 10.1097/00005373-199911000-00009; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Punamaki RL, 2005, AM J PSYCHIAT, V162, P545, DOI 10.1176/appi.ajp.162.3.545; Rao S, 2009, CURR PSYCHIAT REP, V11, P429, DOI 10.1007/s11920-009-0065-2; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rosner R, 2003, J CLIN PSYCHOL, V59, P41, DOI 10.1002/jclp.10116; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneider JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047339; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; ULLMAN SE, 1995, J TRAUMA STRESS, V8, P179, DOI 10.1002/jts.2490080114; World Health Organization, 2004, ICD 10 INT STAT CLAS	31	10	10	0	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2013	14	3					425	435		10.1017/BrImp.2013.27			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	300MD	WOS:000330467100005					2022-02-06	
J	Bellone, S; Einaudi, S; Caputo, M; Prodam, F; Busti, A; Belcastro, S; Parlamento, S; Zavattaro, M; Verna, F; Bondone, C; Tessaris, D; Gasco, V; Bona, G; Aimaretti, G				Bellone, S.; Einaudi, S.; Caputo, M.; Prodam, F.; Busti, A.; Belcastro, S.; Parlamento, S.; Zavattaro, M.; Verna, F.; Bondone, C.; Tessaris, D.; Gasco, V.; Bona, G.; Aimaretti, G.			Measurement of height velocity is an useful marker for monitoring pituitary function in patients who had traumatic brain injury	PITUITARY			English	Article						Traumatic brain injury; Hypopituitarism; GH deficiency; Reduced height velocity	HEAD TRAUMA; ENDOCRINE-SOCIETY; CHILDREN; HYPOPITUITARISM; CHILDHOOD; DYSFUNCTION; PUBERTY; ADOLESCENTS; DEFICIENCY; WEIGHT	To assess the incidence of abnormal neuroendocrine function post-traumatic brain injuriy (TBI) in a large group of paediatric patients and its correlations with clinical parameters (Glasgow coma scale-GCS, Glasgow outcome scale-GOS, TC marshall scale, height velocity). We evaluated 70 patients [58 M, 12 F; age at the time of TBI (mean +/- A SEM) 8.12 +/- A 4.23 years] previously hospitalized for TBI at the "Regina Margherita" Hospital, in Turin and "Maggiore della CaritA Hospital" in Novara, Italy, between 1998 and 2008. All patients included underwent: auxological, clinical, hormonal and biochemical assessments at recall (after at least 1 year from TBI to T0); auxological visit after 6 months (T6) and hormonal assessments at 12 months (T12) in patients with height velocity (HV) below the 25th centile. At T0, 4 cases of hypothalamus-pituitary dysfunction had been diagnosed; At T6 20/70 patients had an HV < 25th centile, but no one had HV < the 3rd centile limit. At T12, among the 20 patients with HV < 25th centile, in 13 patients the HV was below the 25th centile and GHRH + Arginine test has been performed. Four subjects demonstrated an impaired GH peak and were classified as GH deficiency (GHD). Of these 4 subjects, 3 subjects showed isolated GHD, while one patient showed multiple hypopituitarism presenting also secondary hypocortisolism and hypothyroidism. The GCS at admission and GOS do not correlate with the onset of hypopituitarism. A simple measurement of the height velocity at least 1 year after the TBI, is enough to recognize patients with a pituitary impairment related to GH deficiency. We suggest to follow-up paediatric population who had TBI with auxological evaluations every 6 months, limiting hormonal evaluation in patients with a reduction of height velocity below the 25th centile limit.	[Bellone, S.; Prodam, F.; Parlamento, S.; Bona, G.] Univ Novara, Dept Hlth Sci, I-28100 Novara, Italy; [Einaudi, S.] OIRM S Anna, Turin, Italy; [Caputo, M.; Prodam, F.; Busti, A.; Belcastro, S.; Zavattaro, M.; Aimaretti, G.] Univ Novara, Dept Translat Med, I-28100 Novara, Italy; [Verna, F.; Bondone, C.; Tessaris, D.] OIRM S Anna, Dept Emergency, Turin, Italy; [Gasco, V.] Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Turin, Italy		Aimaretti, G (corresponding author), Univ Novara, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy.	gianluca.aimaretti@med.unipmn.it	Bondone, Claudia/AAI-7088-2021; Caputo, Marina/AAC-6707-2022; Bellone, Simonetta/K-2196-2016	Bondone, Claudia/0000-0003-4120-2533; Prodam, Flavia/0000-0001-9660-5335	Pfizer (Rome, Italy)	The work presented in this paper was partially supported by a grant from Pfizer (Rome, Italy).	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Baldelli Roberto, 2005, Pituitary, V8, P255, DOI 10.1007/s11102-006-6050-4; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BROOK C, 1995, CLIN PAEDIAT ENDOCRI; COLE TJ, 1986, ANN HUM BIOL, V13, P433, DOI 10.1080/03014468600008621; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Einaudi S, 2007, CURR OPIN PEDIATR, V19, P465, DOI 10.1097/MOP.0b013e3281ab6eeb; Erturk E, 1998, J CLIN ENDOCR METAB, V83, P2350, DOI 10.1210/jc.83.7.2350; Geffner Mitchell E, 2002, Cancer Control, V9, P212; Ghigo E, 1996, J CLIN ENDOCR METAB, V81, P3323, DOI 10.1210/jc.81.9.3323; Goldman M, 1997, PEDIATR NEUROL, V17, P339, DOI 10.1016/S0887-8994(97)00168-9; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Larsen PR, 2008, WILLIAMS TXB ENDOCRI; Mehta A, 1993, J CLIN ENDOCR METAB, V77, P1313; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; PYLE SI, 1971, AM J PHYS ANTHROPOL, V35, P331, DOI 10.1002/ajpa.1330350306; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, J PEDIATR ENDOCR MET, V3, P206; Seoane LM, 2006, J ENDOCRINOL INVEST, V29, DOI 10.1007/BF03344190; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; van Aken M O, 2005, Pituitary, V8, P183; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005	34	10	10	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	DEC	2013	16	4					499	506		10.1007/s11102-012-0446-0			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	250XZ	WOS:000326891400010	23179963				2022-02-06	
J	Boeck, CR; Carbonera, LS; Milioli, ME; Constantino, LC; Garcez, ML; Rezin, GT; Scaini, G; Streck, EL				Boeck, Carina R.; Carbonera, Leatrice S.; Milioli, Monia E.; Constantino, Leandra C.; Garcez, Michelle L.; Rezin, Gislaine T.; Scaini, Giselli; Streck, Emilio L.			Mitochondrial respiratory chain and creatine kinase activities following trauma brain injury in brain of mice preconditioned with N-methyl-D-aspartate	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						NMDA preconditioning; Neuroprotection; Trauma brain injury; Mitochondrial respiratory chain; Creatine kinase	OXYGEN-GLUCOSE DEPRIVATION; CEREBELLAR GRANULE CELLS; CLOSED-HEAD INJURY; HUMAN SKELETAL-MUSCLE; OXIDATIVE STRESS; QUINOLINIC ACID; GLUTAMATE EXCITOTOXICITY; INDUCED NEUROPROTECTION; RECEPTOR EXPRESSION; ISCHEMIC TOLERANCE	Traumatic brain injury (TBI) induces glutamatergic excitotoxicity through N-methyl-d-aspartate (NMDA) receptors, affecting the integrity of the mitochondrial membrane. Studies have pointed to mitochondria as the master organelle in the preconditioning-triggered endogenous neuroprotective response. The present study is aimed at understanding energy metabolism in the brains of mice after preconditioning with NMDA and TBI. For this purpose, male albino CF-1 mice were pre-treated with NMDA (75 mg/kg) and subjected to brain trauma. Mitochondrial respiratory chain and creatine kinase activities were assessed at 6 or 24 h after trauma. The mice preconditioned and subjected to TBI exhibited augmented activities of complexes II and IV in the cerebral cortex and/or cerebellum. Creatine kinase activity was also augmented in the cerebral cortex after 24 h. We suggest that even though NMDA preconditioning and TBI have similar effects on enzyme activities, each manage their response via opposite mechanisms because the protective effects of preconditioning are unambiguous. In conclusion, NMDA preconditioning induces protection via an increase of enzymes in the mitochondria.	[Boeck, Carina R.; Carbonera, Leatrice S.; Milioli, Monia E.; Constantino, Leandra C.; Garcez, Michelle L.] Univ Extremo Sul Catarinense UNESC, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude PPGCS, Lab Biol Celular & Mol,INCT TM, BR-88806000 Criciuma, SC, Brazil; [Rezin, Gislaine T.; Scaini, Giselli; Streck, Emilio L.] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Fisiopatol Expt,INCT TM, Criciuma, SC, Brazil		Boeck, CR (corresponding author), Univ Extremo Sul Catarinense UNESC, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude PPGCS, Lab Biol Celular & Mol,INCT TM, BR-88806000 Criciuma, SC, Brazil.	cariboeck@hotmail.com	Scaini, Giselli/G-1378-2014; Constantino, Leandra/AAF-2838-2021; Constantino, Leandra/H-8505-2018; Scaini, Giselli/AAX-4437-2020; Garcez, Michelle L/I-7564-2018; Garcez, Michelle/AAZ-1261-2021; Boeck, Carina Rodrigues/E-9472-2011; Scaini, Giselli/AAX-4436-2020; Streck, Emilio/J-7558-2013	Scaini, Giselli/0000-0002-9880-0887; Constantino, Leandra/0000-0003-0523-4351; Scaini, Giselli/0000-0002-9880-0887; Garcez, Michelle L/0000-0003-4333-5241; Garcez, Michelle/0000-0003-4333-5241; Boeck, Carina Rodrigues/0000-0002-6828-5634; Rezin, Gislaine/0000-0002-1352-0369; Streck, Emilio/0000-0002-2859-4678	Brazilian National Council Research (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [478249/20063]; UNESC	This work was supported by funds from the Brazilian National Council Research (CNPq Grants, no 478249/20063 to CRB) and UNESC.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.biochem.54.1.831; Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Boeck CR, 2004, EPILEPSIA, V45, P745, DOI 10.1111/j.0013-9580.2004.65203.x; Brucklacher RM, 2002, DEV NEUROSCI-BASEL, V24, P411, DOI 10.1159/000069051; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Correia SC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00138; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; DAMSCHRODERWILLIAMS P, 1995, J NEUROCHEM, V65, P1069; Dave KR, 2001, J CEREBR BLOOD F MET, V21, P1401, DOI 10.1097/00004647-200112000-00004; Ferguson AL, 2008, EUR J NEUROSCI, V28, P2084, DOI 10.1111/j.1460-9568.2008.06490.x; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fujimoto S, 2004, NEUROSCI RES, V50, P179, DOI 10.1016/j.neures.2004.06.013; Gaspar T, 2008, J NEUROCHEM, V105, P1115, DOI 10.1111/j.1471-4159.2007.05210.x; Gaspar T, 2009, BRAIN RES, V1285, P196, DOI 10.1016/j.brainres.2009.06.008; Grabb MC, 1999, J NEUROSCI, V19, P1657; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; HUGHES BP, 1962, CLIN CHIM ACTA, V7, P597, DOI 10.1016/0009-8981(62)90137-7; Jonas W, 2001, NEUROREPORT, V12, P335, DOI 10.1097/00001756-200102120-00031; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lin CH, 2008, EUR J PHARMACOL, V589, P85, DOI 10.1016/j.ejphar.2008.05.047; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Miro O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Ogita K, 2003, J NEUROCHEM, V85, P1336, DOI 10.1046/j.1471-4159.2003.01778.x; Pagliaro P, 2001, LIFE SCI, V69, P1, DOI 10.1016/S0024-3205(01)01113-4; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Ravati A, 2000, BRAIN RES, V866, P23, DOI 10.1016/S0006-8993(00)02210-1; Ravati A, 2001, J NEUROCHEM, V78, P909, DOI 10.1046/j.1471-4159.2001.00463.x; Rejdak R, 2001, POL J PHARMACOL, V53, P73; SASAHIRA M, 1995, NEUROSCI LETT, V185, P95, DOI 10.1016/0304-3940(94)11233-9; Schild L, 2003, J BIOL CHEM, V278, P25454, DOI 10.1074/jbc.M302743200; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Sei Y, 1998, NEUROSCI LETT, V241, P180, DOI 10.1016/S0304-3940(97)00980-4; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tauskela JS, 2003, AM J PHYSIOL-CELL PH, V285, pC899, DOI 10.1152/ajpcell.00110.2003; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; TOMIMOTO H, 1993, ACTA NEUROPATHOL, V86, P447; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Vandresen S, 2007, BRAIN RES, V1184, P38, DOI 10.1016/j.brainres.2007.09.091; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; WILLIS C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004168.PUB2; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang HX, 2003, NEUROL RES, V25, P471	72	10	10	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	DEC	2013	384	1-2					129	137		10.1007/s11010-013-1790-8			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	242SY	WOS:000326263500014	24013757				2022-02-06	
J	Chuang, CH; Hsu, YC; Wang, CC; Hu, CY; Kuo, JR				Chuang, Chih Hsiang; Hsu, Yao Chin; Wang, Che Chuan; Hu, ChoYa; Kuo, Jinn Rung			Cerebral blood flow and apoptosis-associated factor with electroacupuncture in a traumatic brain injury rat model	ACUPUNCTURE IN MEDICINE			English	Article						NEUROSURGERY; TRAUMA MANAGEMENT	ISCHEMIA; ACUPUNCTURE; EXPRESSION; IMPAIRMENT; ACTIVATION; PROTEIN	Objective Electroacupuncture (EA) has been widely used for treatment of stroke, but there is little information on the effect of EA on the neuroprotective function in traumatic brain injury (TBI). The aim of the present study was to investigate the protective effects and mechanisms of EA treatment in a TBI rat model. Methods Male Sprague-Dawley rats were randomly divided into four groups: sham operation, TBI control, TBI+EA treated for 30min or TBI+EA treated for 60min. The animals were treated with EA immediately after TBI. The EA was applied at acupuncture points GV20, GV26, LI4 and KI1 with a dense-dispersed wave, frequencies of 0.2 and 1Hz, and amplitude of 1mA for 30 or 60min. Regional blood flow, cell infarction volume, extent of neuronal apoptosis, expression of cell apoptosis-associated factor transforming growth-interacting factor (TGIF) were studied, and functional outcome was assessed by running speed test. All tests except regional blood flow were performed 72h after TBI onset. Results Immediately after TBI, compared with the TBI control groups, the regional blood flow was significantly increased by EA treatment for 60min. Compared with the TBI controls 72h after TBI, the TBI-induced run speed impairment, infarction volume, neuronal apoptosis and apoptosis-associated TGIF expression were significantly improved by EA treatment. Conclusions The treatment of TBI in the acute stage with EA for 60min could increase the regional blood flow and attenuate the levels of TGIF in the injured cortex, might lead to a decrease in neuronal apoptosis and cell infarction volume, and might represent one mechanism by which functional recovery may occur.	[Chuang, Chih Hsiang; Hsu, Yao Chin] Chi Mei Med Ctr, Dept Chinese Med, Tainan 710, Taiwan; [Wang, Che Chuan; Hu, ChoYa; Kuo, Jinn Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan 710, Taiwan; [Kuo, Jinn Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan 710, Taiwan.	kuojinnrung@gmail.com			Chi-Mei Medical Center [CMFHR10108]	This work was supported by Chi-Mei Medical Center, grant number CMFHR10108.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Bai Hui-Mei, 2008, Zhongguo Zhen Jiu, V28, P98; Barnes P., 2004, 343 CDC; Beare JE, 2009, J NEUROTRAUM, V26, P2045, DOI 10.1089/neu.2009.0914; Cakmak YO, 2009, ACUPUNCT MED, V27, P183, DOI 10.1136/aim.2009.001420; Chen AZ, 2012, INT J MOL MED, V30, P791, DOI 10.3892/ijmm.2012.1074; Chen Xiao-Yu, 2008, Zhen Ci Yan Jiu, V33, P107; Dai Wei, 2010, Zhen Ci Yan Jiu, V35, P330; Demange C, 2009, MOL CELL, V36, P1073, DOI 10.1016/j.molcel.2009.12.009; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Feng XD, 2013, MOL MED REP, V7, P1516, DOI 10.3892/mmr.2013.1392; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Gao HM, 2006, ACUPUNCTURE ELECTRO, V31, P259, DOI 10.3727/036012906815844247; Guo JC, 2010, ACUPUNCTURE THERAPY FOR NEUROLOGICAL DISEASES: A NEUROBIOLOGICAL VIEW, P226, DOI 10.1007/978-3-642-10857-0_9; Hsieh CL, 2006, AM J CHINESE MED, V34, P351, DOI 10.1142/S0192415X06003886; Kim J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077972, 10.1371/journal.pone.0060505, 10.1371/journal.pone.0062068]; Kim MW, 2012, ACUPUNCT MED, V30, P222, DOI 10.1136/acupmed-2011-010126; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lee GJ, 2010, NEUROL RES, V32, pS79, DOI 10.1179/016164109X12537002794200; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Ma Jing-Xi, 2007, Zhongguo Zhen Jiu, V27, P129; Marion DW, 2006, NEUROSURGERY, V58, P655; Mayer DJ, 2000, ANNU REV MED, V51, P49, DOI 10.1146/annurev.med.51.1.49; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Sun Ning, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P112; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang Q, 2012, J NEUROINFLAMM, V26, P9; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu Sheng-Bing, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P639; Yang R, 1999, ACUPUNCTURE ELECTRO, V24, P161, DOI 10.3727/036012999816356327; Zhang Hong-Xing, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P769, DOI 10.3736/jcim20090812; Zhou F, 2011, J APPL PHYSIOL, V111, P1877, DOI 10.1152/japplphysiol.00313.2011; Zhu JM, 2010, ACUPUNCTURE THERAPY FOR NEUROLOGICAL DISEASES: A NEUROBIOLOGICAL VIEW, P81, DOI 10.1007/978-3-642-10857-0_3	41	10	12	0	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0964-5284	1759-9873		ACUPUNCT MED	Acupunct. Med.	DEC	2013	31	4					395	403		10.1136/acupmed-2013-010406			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	266BI	WOS:000327996900008	24055977				2022-02-06	
J	Jelcic, N; della Puppa, A; Mottaran, R; Cecchin, D; Manara, R; Dam, M; Cagnin, A				Jelcic, Nela; della Puppa, Alessandro; Mottaran, Ruggero; Cecchin, Diego; Manara, Renzo; Dam, Mauro; Cagnin, Annachiara			Case series evidence for improvement of executive functions after late cranioplasty	BRAIN INJURY			English	Article						Craniectomy; cranioplasty; executive functions; volume transmission	VOLUME TRANSMISSION; BLOOD-FLOW	Objective: Craniectomy, used to relieve refractory intracranial pressure in traumatic brain injury (TBI), may cause cognitive deficits which could be improved by skull breach repair. This paper studied whether late cranioplasty improves a specific pattern of cognitive functions. Design: A case series of five TBI patients with craniectomy undergoing late cranioplasty (median interval time: 14 months, range: 12-36). Methods: Longitudinal neuropsychological and brain MRI assessments 1 week before cranioplasty and 3 months later. Results: After cranioplasty, mean score of the verbal fluency test improved compared to pre-cranioplasty (p = 0.02). Similarly, significant improvements after cranioplasty were observed in other tests scores exploring executive functions, such as working memory (p = 0.03) and speed of attention (p = 0.04), independently from the size and site of cranioplasty. Conclusions: The cognitive improvement induced by cranioplasty, even when performed after a long interval from craniectomy, may be due to the restoration of physiological cerebrospinal fluid circulation which, in turn, allows an efficient brain volume transmission signal circulation. The restoration of this essential way of signal communication seems to affect large-scale neuronal networks responsible for the executive functions.	[Jelcic, Nela; della Puppa, Alessandro; Manara, Renzo; Dam, Mauro; Cagnin, Annachiara] IRCCS San Camillo Hosp Fdn, Venice, Italy; [della Puppa, Alessandro; Mottaran, Ruggero] Padova Hosp, Neurosurg Unit, Padua, Italy; [Cecchin, Diego] Univ Padua, Dept Med DIMED, I-35128 Padua, Italy; [Manara, Renzo] Univ Salerno, I-84100 Salerno, Italy; [Cagnin, Annachiara] Univ Padua, Dept Neurosci SNPSRR, I-35128 Padua, Italy		Cagnin, A (corresponding author), Univ Padua, Dept Neurosci SNPSRR, Via Giustiniani 5, I-35128 Padua, Italy.	annachiara.cagnin@unipd.it	Cecchin, Diego/V-5771-2019	Cecchin, Diego/0000-0001-7956-1924; Della Puppa, Alessandro/0000-0001-8058-092X; Manara, Renzo/0000-0002-5130-3971	Department of Neuroscience: Sciences NPSRR	The authors report no conflicts of interest. This work was supported by the Department of Neuroscience: Sciences NPSRR.	Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; Agnati LF, 2007, J NEURAL TRANSM, V114, P3, DOI 10.1007/s00702-006-0563-x; Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Duinkerke Anja, 2004, Cogn Behav Neurol, V17, P179, DOI 10.1097/01.wnn.0000124916.16017.6a; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Jelcic N, 2013, ACTA NEUROCHIR, V155, P1597, DOI 10.1007/s00701-012-1519-6; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Spinnler H, 1987, ITAL J NEUROL SCI, V6, P5; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	13	10	13	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1723	1726		10.3109/02699052.2013.844857			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400032	24111680				2022-02-06	
J	Seddighi, AS; Motiei-Langroudi, R; Sadeghian, H; Moudi, M; Zali, A; Asheghi, E; Alereza-Amiri, R; Seddighi, A				Seddighi, Amir Saied; Motiei-Langroudi, Rouzbeh; Sadeghian, Homa; Moudi, Mohsen; Zali, Alireza; Asheghi, Ebrahim; Alereza-Amiri, Reza; Seddighi, Afsoun			Factors predicting early deterioration in mild brain trauma: A prospective study	BRAIN INJURY			English	Article						Brain injury; computed tomography; deterioration; mild; trauma	COMPUTED-TOMOGRAPHY; HEAD TRAUMA; INJURY; NEUROTRAUMA; PROGRESSION; RISK	Primary objective: To evaluate risk factors for clinical deterioration in mild traumatic brain injury. Research design: Prospective cross-sectional. Methods and procedures: This study evaluated 203 patients with mild traumatic brain injury. A brain computed tomography scan was performed in all patients and they were observed for 6-48 hours. Main outcomes and results: Among these patients, 2.5% had cerebral contusions and the most common sites for contusions were frontal lobes; 94% of patients had no hematoma in the initial scan, while 3% had subgaleal haematoma, 1.5% had subdural haematoma, 1% showed subarachnoid haemorrhage, 0.5% intracerebral haemorrhage and 0.5% epidural haemorrhage. GCS was 15 in 96.6% and 13-14 in 3.4%. GCS deteriorated in three (1.5%). Presence of coagulopathy, anticoagulant drug use, GCS of 13-14 and increased age predicted further deterioration. Among CT findings, those with midline shift, cerebral contusion and diffuse cerebral oedema deteriorated more. Among different haematoma types, only SDH predicted a worse outcome. Conclusions: Although deterioration rarely occurs in patients with mild brain injury, those with coagulopathy, anticoagulant drug use, GCS of 13-14, increased age, midline shift, cerebral contusions, diffuse cerebral oedema and SDH were more prone to deterioration.	[Seddighi, Amir Saied; Motiei-Langroudi, Rouzbeh; Zali, Alireza; Asheghi, Ebrahim; Alereza-Amiri, Reza; Seddighi, Afsoun] Shahid Beheshti Univ Med Sci, Dept Neurosurg, Shohada Tajrish Hosp, Tehran, Iran; [Seddighi, Amir Saied; Zali, Alireza; Seddighi, Afsoun] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Shohada Tajrish Hosp, Tehran, Iran; [Sadeghian, Homa] Shefa Neurosci Res Ctr, Tehran, Iran; [Moudi, Mohsen] Qazvin Azad Univ, Fac Ind & Mech Engn, Qazvin, Iran; [Seddighi, Afsoun] Qazvin Univ Med Sci, Shahid Rajaee Hosp, Dept Neurosurg, Qazvin, Iran		Seddighi, A (corresponding author), Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Shohada Tajrish Hosp, Tehran, Iran.	afsounseddighi@gmail.com	Zali, Alireza/AAM-7702-2021; Zali, Alireza/AAN-5503-2021	Zali, Alireza/0000-0002-2298-2290			Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hayashi T, 2007, AM J EMERG MED, V25, P989, DOI 10.1016/j.ajem.2007.02.041; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Pardini J, 2011, YOUMANS NEUROLOGICAL, P3380; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; Tan JE, 2004, ANN ACAD MED SINGAP, V33, P489; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	13	10	13	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1666	1670		10.3109/02699052.2013.830333			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400023	24087934				2022-02-06	
J	Alfasi, AM; Shulyakov, AV; Del Bigio, MR				Alfasi, Abdulghader M.; Shulyakov, Alexander V.; Del Bigio, Marc R.			Intracranial biomechanics following cortical contusion in live rats Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; contusion; viscoelasticity; edema; magnetic resonance imaging; animal model; rat	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE ELASTOGRAPHY; ANIMAL-MODELS; HEAD-INJURY; TIME-COURSE; TISSUE; EDEMA; IMPACT; PRESSURE; BEHAVIOR	Object. The goal of this study was to examine the mechanical properties of living rat intracranial contents and corresponding brain structural alterations following parietal cerebral cortex contusion. Methods. After being anesthetized, young adult rats were subjected to parietal craniotomy followed by cortical contusion using a calibrated weight-drop method. Magnetic resonance imaging was used to visualize the contusion. At the site of contusion, instrumented force-controlled indentation was performed 2 hours to 21 days later on the intact dural surface. The force-deformation (stress-strain) relationship was used to calculate elastic (indentation modulus) and strain changes over time, and constant hold or cyclic stress was used to evaluate viscoelastic deformation. These measurements were followed by histological studies. Results. At contusion sites, the indentation modulus was significantly decreased at 1-3 days and tended to be above control values at 21 days. Multicycle indentation showed that the brain tended to accumulate more strain (an indicator of viscosity) by 1 day after the contusion. Imaging and histological studies showed local edema and hemorrhage at 6 hours to 3 days and accumulation of reactive astrocytes, which began at 3 days and was pronounced by 21 days. Conclusions. The viscoelastic properties of living rat brain change following contusion. Initially, edema and tissue necrosis occur, and the brain becomes less elastic and less viscous. Later, along with undergoing reactive astroglial changes, the brain tends to become stiffer than normal. These quantitative data, which are related to the physical changes in the brain following trauma and which reflect subjective impressions upon palpation, will be useful for understanding emerging diagnostic tools such as magnetic resonance elastography.	[Alfasi, Abdulghader M.] Univ Manitoba, Dept Human Anat, Winnipeg, MB, Canada; [Alfasi, Abdulghader M.] Univ Manitoba, Dept Cell Sci, Winnipeg, MB, Canada; [Del Bigio, Marc R.] Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada; [Shulyakov, Alexander V.; Del Bigio, Marc R.] Manitoba Inst Child Hlth, Winnipeg, MB, Canada		Del Bigio, MR (corresponding author), Dept Pathol, Room 401 Brodie Ctr,727 McDermot Ave, Winnipeg, MB R3E 3P5, Canada.	marc.delbigio@med.umanitoba.ca		Del Bigio, Marc/0000-0001-8366-0394	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Educational Program of the Government of Libya	This work was made possible by a grant from the Canada Foundation for Innovation. The Educational Program of the Government of Libya funded Dr. Alfasi. Dr. Del Bigio holds the Canada Research Chair in Developmental Neuropathology.	Aoyagi N, 1982, No To Shinkei, V34, P509; Aoyagi N, 1980, No To Shinkei, V32, P47; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dogangil G, 2010, P I MECH ENG H, V224, P653, DOI 10.1243/09544119JEIM591; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fung Y. C., 1993, BIOMECHANICS MECH PR; Glaser KJ, 2012, J MAGN RESON IMAGING, V36, P757, DOI 10.1002/jmri.23597; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; HOLMIN S, 1995, NEUROSCI LETT, V194, P97, DOI 10.1016/0304-3940(95)11737-H; Kuroiwa T, 1997, ACT NEUR S, V70, P87; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; SCHETTIN.A, 1972, J NEUROSURG, V37, P170, DOI 10.3171/jns.1972.37.2.0170; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Shulyakov AV, 2008, J NEUROSURG, V109, P670, DOI 10.3171/JNS/2008/109/10/0670; Shulyakov AV, 2012, NEUROSURGERY, V71, P1032, DOI 10.1227/NEU.0b013e3182690a0c; Shulyakov AV, 2011, J MECH BEHAV BIOMED, V4, P484, DOI 10.1016/j.jmbbm.2010.12.012; Shulyakov AV, 2009, BIOMECH MODEL MECHAN, V8, P415, DOI 10.1007/s10237-008-0147-9; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takada Daikei, 2012, Surg Neurol Int, V3, P11, DOI 10.4103/2152-7806.92182; WALSH EK, 1976, AM J PHYSIOL, V230, P1058, DOI 10.1152/ajplegacy.1976.230.4.1058; WALSH EK, 1977, AM J PHYSIOL, V232, pR27, DOI 10.1152/ajpregu.1977.232.1.R27; Weaver JB, 2012, PHYS MED BIOL, V57, P7275, DOI 10.1088/0031-9155/57/22/7275; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto Y, 2004, NEUROL RES, V26, P622, DOI 10.1179/016164104225016326	34	10	10	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2013	119	5					1255	1262		10.3171/2013.7.JNS121973			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	238OB	WOS:000325956200032	24032707				2022-02-06	
J	Bardoni, A; Galbiati, S; Recla, M; Pastore, V; Formica, F; Strazzer, S				Bardoni, Alessandra; Galbiati, Susanna; Recla, Monica; Pastore, Valentina; Formica, Francesca; Strazzer, Sandra			Evolution of the cognitive profile in school-aged patients with severe TBI during the first 2 years of neurorehabilitation	BRAIN INJURY			English	Article						Brain injury; children; rehabilitation	TRAUMATIC BRAIN-INJURY; CHILDHOOD HEAD-INJURY; WECHSLER INTELLIGENCE SCALE; OUTCOME 30 MONTHS; CHILDREN; RECOVERY; PERFORMANCE; SEQUELAE; DEFICITS; INFANTS	Objective: Persistent post-injury cognitive, academic and behavioural deficits have been documented in children who sustained severe TBI during the school-age years. The major aim of this study was to examine and follow-up for 2 years the cognitive profile of a sample of post-injured patients (aged 6-16.11), in order to verify to what extent they recovered their intellectual functions after rehabilitation. Method: Twenty-six patients who received a specific neuropsychological treatment and three cognitive evaluations with WISC-III were selected from a pool of 77. Results: This group of patients showed a mild cognitive deficit at baseline, which improved over the 2 years to a borderline level. Despite the improvement in intellectual quotients and single sub-test scores achieved through rehabilitation, different recovery times were seen according to the function under study. The most common deficits are in processing speed, inferential and lexical-semantic skills. Conclusions: Detailed analysis of the WISC-III sub-tests allows for an accurate description of single cognitive functions after TBI. This allows one to make differential diagnoses between functional profiles and plan individualized rehabilitation treatments. Post-injured school-aged patients should receive rehabilitation for a period of at least 2 years, which is the time necessary for an at-least partial reorganization of basic cognitive functions.	[Bardoni, Alessandra; Galbiati, Susanna; Recla, Monica; Pastore, Valentina; Formica, Francesca; Strazzer, Sandra] IRCCS Eugenio Medea, I-23842 Bosisio Parini, LC, Italy		Bardoni, A (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, LC, Italy.	alessandra.bardoni@bp.lnf.it	Pastore, Valentina/AAH-6831-2019; formica, francesca/AAA-6043-2020; BARDONI, ALESSANDRA/AAH-7233-2019; Strazzer, Sandra/AAH-5712-2019; Galbiati, Susanna/AAH-6883-2019; Recla, Monica/ABG-1905-2020	Pastore, Valentina/0000-0002-3170-3070; BARDONI, ALESSANDRA/0000-0001-8404-3857; Strazzer, Sandra/0000-0001-8414-6565; Galbiati, Susanna/0000-0001-7209-4251; Recla, Monica/0000-0002-3001-8872; formica, francesca/0000-0002-4423-8200			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; ASHCRAFT MH, 1992, BRAIN COGNITION, V19, P208, DOI 10.1016/0278-2626(92)90046-O; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Flannery J, 1995, J Nurs Meas, V3, P43; Giza CC, 2006, INDIAN J NEUROTRAUM, V3, P19; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; ROVET JF, 1992, J PEDIATR PSYCHOL, V17, P187, DOI 10.1093/jpepsy/17.2.187; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schoenberg MR, 2008, PSYCHOL ASSESSMENT, V20, P377, DOI 10.1037/a0014010; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TAYLOR HG, 1993, J CLIN CHILD PSYCHOL, V22, P196, DOI 10.1207/s15374424jccp2202_6; TAYLOR HG, 2002, NEUROPSYCHOLOGY, V16, P5; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1974, WECHSLER INTELLIGENC; Weiss L. G., 2008, USING COGNITIVE PROF; [No title captured]	49	10	10	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1395	1401		10.3109/02699052.2013.823652			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500009	24102265				2022-02-06	
J	Lamberty, GJ; Nelson, NW; Yamada, T				Lamberty, Greg J.; Nelson, Nathaniel W.; Yamada, Torrii			Effects and Outcomes in Civilian and Military Traumatic Brain Injury: Similarities, Differences, and Forensic Implications	BEHAVIORAL SCIENCES & THE LAW			English	Article							GOOD-OLD-DAYS; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; SPORT-RELATED CONCUSSION; BLAST-RELATED CONCUSSION; MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; VETERANS	Traumatic brain injury (TBI) is a prominent public health problem in both civilian and military settings. This article discusses similarities and differences in the assessment and treatment of TBI and the attendant forensic implications. Acute care and management of moderate/severe TBI tend to be similar across environments, as is the recognition of disability status in affected individuals. By contrast, an increased focus on mild TBI in recent years has resulted in a reliance on self-report and screening measures to validate the occurrence of events leading to injury. This has complicated assessment, treatment and subsequent medicolegal proceedings. The neuropsychological literature has provided significant guidance on these difficult issues, although the complexity of disability adjudication for active duty members of the military and veterans continues to pose challenges for clinicians in evaluative and treatment contexts. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Lamberty, Greg J.] Minneapolis VA Hlth Care Syst, Phys Med & Rehabil Serv TBI 4K, Minneapolis, MN 55417 USA; [Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, Minneapolis, MN USA; [Yamada, Torrii] Minneapolis VA Hlth Care Syst, Mental Hlth Serv, Minneapolis, MN USA		Lamberty, GJ (corresponding author), Minneapolis VA Hlth Care Syst, Phys Med & Rehabil Serv TBI 4K, 1 Vet Dr, Minneapolis, MN 55417 USA.	gregory.lamberty@va.gov					Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Barth J T, 2000, Dent Clin North Am, V44, P67; Barth JT, 2001, J ATHL TRAINING, V36, P253; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bratton S., 2007, J NEUROTRAUMA, V24; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bush S. S., 2013, MILD TRAUMATIC BRAIN, P381; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1996, NEUROTRAUMA, P779; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Department of Defense and Department of Veterans Affairs (DoD/DVA), 2008, TRAUM BRAIN INJ TASK; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; DIKMEN S, 2009, NEUROPSYCHOLOGICAL A, P597; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; DVBIC, 2012, DOD WORLDW NUMB TBI; Engber D., 2013, DID CONCUSSIONS MAKE; Eskridge S. L., 2012, DISS ABSTR INT B, V72, P3929; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Faul M, 2010, TRAUMATIC BRAIN INJU; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fortier C.B., 2013, J HEAD TRAUMA REHABI; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gubata ME, 2013, J HEAD TRAUMA REHABI; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Knuth T., 2005, GUIDELINES FIELD MAN; Lamberty G. J., 2013, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0b013e31829a64d1; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nelson N. W., 2012, NEUROPSYCHOLOGICAL P, P101; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; O'Neil ME, 2012, COMPLICATIONS MILD T; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Peeples L., 2013, HUFFINGTON POST; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Roth R., 2013, INT J PHYS MED REHAB; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Silver JM, 2012, AM J PSYCHIAT, V169, P1230, DOI 10.1176/appi.ajp.2012.12091230; Spencer RJ, 2012, NEUROPSYCHOLOGICAL P, P77; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TEASDALE G, 1974, LANCET, V2, P81; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	106	10	10	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		814	832		10.1002/bsl.2091			19	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400010	24105940				2022-02-06	
J	Moein, P; Fard, SA; Asnaashari, A; Baratian, H; Barekatain, M; Tavakoli, N; Moein, H				Moein, Payam; Fard, Salman Abbasi; Asnaashari, Ali; Baratian, Hajar; Barekatain, Majid; Tavakoli, Naser; Moein, Houshang			The effect of Boswellia Serrata on neurorecovery following diffuse axonal injury	BRAIN INJURY			English	Article						Boswellia Serrata; cognition; diffuse axonal injury; neuroprotection; outcome assessment	TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; INCENSOLE ACETATE; TNF-ALPHA; CELL ACTIVATION; HEAD-INJURY; KAPPA-B; DAMAGE; INHIBITION	Objectives: This pilot trial was conducted to establish whether Boswellia Serrata (BS), a traditional herbal medicine, could improve the outcome of patients who have diffuse axonal injury (DAI). Methods: In total, 38 patients with pure DAI were enrolled in this 12-week, double-blind, randomized, cross-over study. The patients were randomly assigned to receive either placebo (group A, n = 20) or BS capsules (group B, n = 18) for 6 weeks and then switched to the other intervention for another 6 weeks. The disability rating scale (DRS) was used to assess the outcome at 2-, 6- and 12-weeks post-trauma. Results: A non-significant trend for improvement of DRS total scores was observed after the use of BS. Regarding the DRS sub-scores, however, there was significant improvement in 'cognitive ability to self-care' during the second 6 weeks in group A on BS compared to an insignificant spontaneous recovery in group B during the same period on placebo. Moreover, both groups experienced a close-to-significant increase in the cognitive function-related items of the DRS during the periods they were on BS. The reported adverse events were all of mild quality and had similar frequency between the groups. Conclusion: These results suggest that BS resin does not significantly affect general outcome, but may enhance the cognitive outcome of patients with DAI.	[Moein, Payam; Baratian, Hajar] Isfahan Univ Med Sci, Noor Hosp, Behav Sci Res Ctr, Esfahan, Iran; [Fard, Salman Abbasi] Isfahan Univ Med Sci, St Al Zahra Hosp, Dept Neurosurg, Esfahan, Iran; [Asnaashari, Ali] Isfahan Univ Med Sci, Kashani Hosp, Dept Neurosurg, Esfahan, Iran; [Barekatain, Majid] Isfahan Univ Med Sci, Noor Hosp, Dept Psychiat, Esfahan, Iran; [Tavakoli, Naser] Isfahan Univ Med Sci, Dept Pharmacol, Esfahan, Iran; [Moein, Houshang] Al Zahra Hosp, Dept Neurosurg, Esfahan, Iran		Moein, H (corresponding author), Al Zahra Hosp, Dept Neurosurg, POB 81746-75731,Sofeh Blvd, Esfahan, Iran.	h_moin@med.mui.ac.ir	Tavakoli, Naser/W-1982-2017; Barekatain, Majid/L-4579-2017	Tavakoli, Naser/0000-0003-0654-7675; Barekatain, Majid/0000-0003-4001-6261	Isfahan University of Medical Sciences, Medical School, Isfahan, Iran- Research [288262]	The authors report no conflicts of interest. Funding institution: Isfahan University of Medical Sciences, Medical School, Isfahan, Iran- Research #288262. (Iranian Registry of Clinical Trials; ID: IRCT138804082093N1)	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ammon H P T, 2002, Wien Med Wochenschr, V152, P373, DOI 10.1046/j.1563-258X.2002.02056.x; Ammon HPT, 2010, PHYTOMEDICINE, V17, P862, DOI 10.1016/j.phymed.2010.03.003; [Anonymous], 2008, ALTERN MED REV, V13, P165; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Ernst E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2813; Galasso JM, 2000, NEUROREPORT, V11, P231, DOI 10.1097/00001756-200002070-00002; Graham DI., 1996, NEUROTRAUMA, P43; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kita T, 2000, INT J LEGAL MED, V113, P221, DOI 10.1007/s004149900095; Kokkiripati PK, 2011, J ETHNOPHARMACOL, V137, P893, DOI 10.1016/j.jep.2011.07.004; Kruger P, 2008, DRUG METAB DISPOS, V36, P1135, DOI 10.1124/dmd.107.018424; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Moussaieff A, 2007, MOL PHARMACOL, V72, P1657, DOI 10.1124/mol.107.038810; Moussaieff A, 2012, BRAIN RES, V1443, P89, DOI 10.1016/j.brainres.2012.01.001; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Povlishock JT., 1996, NEUROTRAUMA, P1325; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reising K, 2005, ANAL CHEM, V77, P6640, DOI 10.1021/ac0506478; Sharma S, 2004, PHYTOMEDICINE, V11, P255, DOI 10.1078/0944-7113-00290; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Siemoneit U, 2008, BIOCHEM PHARMACOL, V75, P503, DOI 10.1016/j.bcp.2007.09.010; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weber CC, 2006, PLANTA MED, V72, P507, DOI 10.1055/s-2006-931536; Whyte J, 1993, REHABILITATION MED P, P825; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	44	10	10	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1454	1460		10.3109/02699052.2013.825009			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500018	24088189				2022-02-06	
J	Rivest, JB; Jemel, B; Bertone, A; McKerral, M; Mottron, L				Rivest, Jessica B.; Jemel, Boutheina; Bertone, Armando; McKerral, Michelle; Mottron, Laurent			Luminance- and Texture-Defined Information Processing in School-Aged Children with Autism	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MOTION PERCEPTION; 2ND-ORDER MOTION; SELECTIVE IMPAIRMENT; CONTRAST MODULATIONS; VISUAL-PERCEPTION; 1ST-ORDER MOTION; INDIVIDUALS; SEGREGATION; MECHANISMS	According to the complexity-specific hypothesis, the efficacy with which individuals with autism spectrum disorder (ASD) process visual information varies according to the extensiveness of the neural network required to process stimuli. Specifically, adults with ASD are less sensitive to texture-defined (or second-order) information, which necessitates the implication of several cortical visual areas. Conversely, the sensitivity to simple, luminance-defined (or first-order) information, which mainly relies on primary visual cortex (V1) activity, has been found to be either superior (static material) or intact (dynamic material) in ASD. It is currently unknown if these autistic perceptual alterations are present in childhood. In the present study, behavioural (threshold) and electrophysiological measures were obtained for static luminance-and texture-defined gratings presented to school-aged children with ASD and compared to those of typically developing children. Our behavioural and electrophysiological (P140) results indicate that luminance processing is likely unremarkable in autistic children. With respect to texture processing, there was no significant threshold difference between groups. However, unlike typical children, autistic children did not show reliable enhancements of brain activity (N230 and P340) in response to texture-defined gratings relative to luminance-defined gratings. This suggests reduced efficiency of neuro-integrative mechanisms operating at a perceptual level in autism. These results are in line with the idea that visual atypicalities mediated by intermediate-scale neural networks emerge before or during the school-age period in autism.	[Rivest, Jessica B.; Bertone, Armando; Mottron, Laurent] Univ Montreal, Ctr Excellence Pervas Dev Disorders CETEDUM, Montreal, PQ, Canada; [Rivest, Jessica B.; McKerral, Michelle] Univ Montreal, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Rivest, Jessica B.; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Jemel, Boutheina] Univ Montreal, Riviere des Prairies Hosp, Res Lab Neurosci & Cognit Electrophysiol, Montreal, PQ, Canada		Mottron, L (corresponding author), Univ Montreal, Ctr Excellence Pervas Dev Disorders CETEDUM, Montreal, PQ, Canada.	Laurent.mottron@gmail.com		Jemel, Boutheina/0000-0003-3125-5914; Mottron, Laurent/0000-0001-5668-5422	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [200703MOP-171795-BSB-CFCA-4239]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [327504-2006 RGPIN]; NSCERC; Autism Research Training (ART) program in Canada	This work was supported by a grant to LM from the Canadian Institutes of Health Research (CIHR) (grant number 200703MOP-171795-BSB-CFCA-4239), by a grant to MM from the Natural Sciences and Engineering Research Council of Canada (NSERC) (grant number 327504-2006 RGPIN), as well as scholarships to JBR from NSCERC and the Autism Research Training (ART) program in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcand C, 2007, EXP BRAIN RES, V180, P263, DOI 10.1007/s00221-007-0854-y; Armstrong V, 2009, VISION RES, V49, P2774, DOI 10.1016/j.visres.2009.08.016; Ashida H, 2007, J NEUROPHYSIOL, V97, P1319, DOI 10.1152/jn.00723.2006; Baker CL, 2001, PROG BRAIN RES, V134, P171; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bertone A, 2006, J AUTISM DEV DISORD, V36, P55, DOI 10.1007/s10803-005-0042-5; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Bertone A, 2003, J COGNITIVE NEUROSCI, V15, P218, DOI 10.1162/089892903321208150; Bertone A, 2008, NEUROREPORT, V19, P225, DOI 10.1097/WNR.0b013e3282f48401; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Calvert J, 2005, VISION RES, V45, P2218, DOI 10.1016/j.visres.2005.02.012; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Davis RAO, 2006, J AUTISM DEV DISORD, V36, P199, DOI 10.1007/s10803-005-0055-0; Del Viva MM, 2006, VISION RES, V46, P1242, DOI 10.1016/j.visres.2005.10.018; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Dumoulin SO, 2003, CEREB CORTEX, V13, P1375, DOI 10.1093/cercor/bhg085; Dunn LM., 1981, PEABODY PICTURE VOCA; Ellemberg D, 2003, VISION RES, V43, P651, DOI 10.1016/S0042-6989(03)00006-3; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greenaway R, 2013, NEUROPSYCHOLOGIA, V51, P592, DOI 10.1016/j.neuropsychologia.2013.01.005; Habak C, 2000, VISION RES, V40, P943, DOI 10.1016/S0042-6989(99)00235-7; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hillyard, 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P507; Jarrold C, 2005, DEVELOPMENTAL SCI, V8, P344, DOI 10.1111/j.1467-7687.2005.00422.x; Jemel B, 2010, J VISION, V10, DOI 10.1167/10.6.13; Jolij J, 2007, NEUROREPORT, V18, P39, DOI 10.1097/01.wnr.0000236863.46952.a6; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kaldy Z, 2011, DEVELOPMENTAL SCI, V14, P980, DOI 10.1111/j.1467-7687.2011.01053.x; Kayser J., 2009, CURRENT SOURCE DENSI; Keita L, 2011, BIOL PSYCHIAT, V70, P806, DOI 10.1016/j.biopsych.2011.07.031; Kemner C, 2007, NEUROPSYCHOLOGIA, V45, P1293, DOI 10.1016/j.neuropsychologia.2006.09.016; Kogan CS, 2004, NEUROLOGY, V63, P1634, DOI 10.1212/01.WNL.0000142987.44035.3B; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Landy M. S., 2004, VISUAL NEUROSCIENCES, V2, P1106; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Lewis TL, 2007, J VISION, V7, DOI 10.1167/7.4.9; Liu YN, 2011, NEUROPSYCHOLOGIA, V49, P2105, DOI 10.1016/j.neuropsychologia.2011.04.005; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; Milne E, 2009, BIOL PSYCHIAT, V65, P22, DOI 10.1016/j.biopsych.2008.07.017; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2013, NEUROSCI BIOBEHAV R, V37, P209, DOI 10.1016/j.neubiorev.2012.11.016; Nunez P.L, 1981, ELECT FIELDS BRAIN N; O'Riordan M, 2001, Q J EXP PSYCHOL-A, V54, P961, DOI 10.1080/02724980042000543; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Raven J., 1998, RAVEN MANUAL SECTION; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; Spencer JV, 2006, PERCEPTION, V35, P1047, DOI 10.1068/p5328; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Tsermentseli S, 2008, J AUTISM DEV DISORD, V38, P1201, DOI 10.1007/s10803-007-0500-3; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Vaina LM, 1998, VISUAL NEUROSCI, V15, P333, DOI 10.1017/S0952523898152082; Vandenbroucke MWG, 2008, J AUTISM DEV DISORD, V38, P941, DOI 10.1007/s10803-007-0467-0; Vandenbroucke MWG, 2008, BRAIN, V131, P1013, DOI 10.1093/brain/awm321; Wang LX, 2007, COGN NEUROPSYCHOL, V24, P550, DOI 10.1080/13546800701417096; ZHOU YX, 1994, J NEUROPHYSIOL, V72, P2134, DOI 10.1152/jn.1994.72.5.2134	73	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78978	10.1371/journal.pone.0078978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	WOS:000326152300087	24205355	Green Published, Green Submitted, gold			2022-02-06	
J	Barrett, RD; McLellan, TL; McKinlay, A				Barrett, Robert D.; McLellan, Tracey L.; McKinlay, Audrey			Self versus Family Ratings of the Frontal Systems Behaviour Scale and Measured Executive Functions: Adult Outcomes following Childhood Traumatic Brain Injury	PLOS ONE			English	Article							WORKING-MEMORY; SHORT-TERM; AWARENESS; RELIABILITY; CONCORDANCE; DEFICITS; PREVALENCE; AGREEMENT; CHILDREN; VALIDITY	Traumatic brain injury (TBI) frequently occurs during childhood and adolescence with long-term neuropsychological and behavioral effects. Greater personal awareness of injury is associated with better outcomes. However, personal awareness is often assessed using ratings obtained from family members or significant others. Surprisingly, the accuracy of family-ratings compared with self-ratings has not been well studied in the TBI population. Thus, the purpose of this study was to examine self versus family-ratings of frontal dysfunction and secondly, the association between self/family reported frontal dysfunction and measured executive function outcomes. A total of 60 participants, approximately 10 years post-TBI, comprised 3 groups including; moderate/severe TBI (N=26; mean age 22.9, SD=3.0), mild TBI (N=20; mean age, 21.7, SD=2.7), and control (N=14: mean age, 21.6, SD=3.7). Neuropsychological testing was used to obtain domain scores for executive function and working memory/attention for each participant, and nominated family members and participants with TBI were asked to complete the Frontal Systems Behaviour Scale (FrSBe), consisting of three sub-scales; apathy, disinhibition, and executive dysfunction. Using the FrSBe there was no significant difference between the groups in executive function score, but the moderate/severe and mild groups had significantly lower working memory/attention scores compared with the control group (p<0.05). Repeated measures analysis of variance showed higher self-ratings on all sub-scales compared with family in each group (p<0.05). Scores on executive function and working memory/attention domains correlated with self, but not family reported executive dysfunction. Self-rated executive dysfunction explained 36% of the variance in executive function (p<0.001). While agreement between self-rated and family-rated total FrSBe scores was significant in all groups (p<0.001), our results showed that self-ratings were of higher predictive utility for executive functioning compared with family ratings. Further, at 10 years post-TBI, patients show greater awareness of deficits compared with family who rate consistently closer to the normal functioning range.	[Barrett, Robert D.; McLellan, Tracey L.; McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia		McKinlay, A (corresponding author), Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand.	Audrey.mckinlay@monash.edu		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council; Accident Compensation Corporation of New Zealand	Dr. McKinlay was supported by a post-doctoral fellowship from the Health Research Council and the Accident Compensation Corporation of New Zealand (www.hrc.govt.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.acc.co.nz	Amminger GP, 2002, SCHIZOPHR RES, V54, P223, DOI 10.1016/S0920-9964(01)00278-X; Cabaret J, 2009, VET PARASITOL, V164, P21, DOI 10.1016/j.vetpar.2009.04.018; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Jonge JM, 2005, BEHAV COGN PSYCHOTH, V33, P285, DOI 10.1017/S1352465804001948; Delis DC., 2001, DELIS KAPLAN EXECUTI; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Kixmiller JS, 2000, J CLIN EXP NEUROPSYC, V22, P198, DOI 10.1076/1380-3395(200004)22:2;1-1;FT198; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Loeber R., 1989, DEV PSYCHOPATHOL, V1, P317, DOI DOI 10.1017/S095457940000050X; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; MUGNAI L, 1989, MYCOL RES, V92, P199, DOI 10.1016/S0953-7562(89)80012-7; Nelson H.E., 1982, NATL ADULT READING T; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHERER M, 1996, J INT NEUROPSYCH SOC, V2, P17; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wechsler D., 2011, WECHSLER ABBREVIATED; Werheid K, 2002, ARCH CLIN NEUROPSYCH, V17, P547, DOI 10.1016/S0887-6177(01)00134-2; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	43	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76916	10.1371/journal.pone.0076916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	WOS:000325552200083	24116182	gold, Green Published			2022-02-06	
J	Duan, HB; Hao, CY; Fan, YM; Wang, HQ; Liu, YT; Hao, JH; Xu, CP; Liu, XD; Zhang, HP				Duan, Hubin; Hao, Chunyan; Fan, Yimin; Wang, Hongqin; Liu, Yueting; Hao, Jiehe; Xu, Cuiping; Liu, Xiaodong; Zhang, Huaping			The role of neuropeptide Y and aquaporin 4 in the pathogenesis of intestinal dysfunction caused by traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Neuropeptide Y; Aquaporin 4; Pathogenesis; Intestinal dysfunction; Brain injury	WATER CHANNELS; NERVE-FIBERS; RAT; PEPTIDE; NEURONS; EXPRESSION	Background: Although the exact incidence is unknown, traumatic brain injury (TBI) can lead to intestinal dysfunction. It has important influence on the early nutrition and prognosis of TBI patients. Experiments were designed to study the roles of neuropeptide Y (NPY) and aquaporin 4 (AQP4) in the pathogenesis of intestinal dysfunction caused by TBI and to find some new solutions for the treatment of intestinal dysfunction after TBI. Methods: Forty adult male Wistar rats were randomly divided into control, mild trauma, moderate trauma, and severe trauma groups. TBI was induced by Feeney's impact method. Control animals were sham operated but not subjected to the impact test. All rats were killed 24 h after surgery. Blood samples were obtained from the abdominal aorta for enzyme-linked immunosorbent assay measurement of NPY concentrations. Jejunum segments 15 cm distal to the Treitz ligament were taken for analysis of NPY and AQP4 expression by polymerase chain reaction, Western blot, and immunohistochemistry. Pathologic changes in intestinal cell structure and ultrastructure were studied by light microscopy and transmission electron microscopy. Results: The specimens from different groups showed different degrees of structural changes, ranging from swelling and degeneration of villous epithelial cells to extensive denudation and collapse of the villi. The more severe the trauma, the more serious the degree of intestinal mucosal injury. Intestinal smooth muscle also showed varying degrees of edema and structural disorder. Electron microscopy showed that intestinal mitochondria had varying degrees of swelling and the structure of mitochondrial crista was disordered and even fractured. Plasma concentrations of NPY and jejunal gene and protein expressions of NPY and AQP4 increased significantly following TBI (P < 0.05), with greater increases at higher levels of injury. Moreover, there were positive correlations between NPY and AQP4 (P < 0.05). Conclusions: Increasing grades of TBI caused increasing degrees of intestinal ischemia and edema, and thus caused increasingly severe intestinal dysfunction. AQP4 and NPY may be involved in the pathogenesis of intestinal dysfunction after TBI. Increased NPY levels may be responsible for intestinal ischemia and hypoxia, and AQP4 may play an important role in intestinal edema. Increased NPY levels may be one of the main causes for the increase in AQP4 after TBI. (C) 2013 Elsevier Inc. All rights reserved.	[Duan, Hubin; Fan, Yimin; Wang, Hongqin; Liu, Yueting; Hao, Jiehe; Liu, Xiaodong] Shanxi Med Univ, Clin Med Coll 1, Dept Neurosurg, Taiyuan 030001, Shanxi Province, Peoples R China; [Hao, Chunyan] Shanxi Med Univ, Clin Med Coll 1, Dept Geriatr, Taiyuan 030001, Shanxi Province, Peoples R China; [Xu, Cuiping] Shanxi Med Univ, Clin Med Coll 1, Dept Gastroenterol, Taiyuan 030001, Shanxi Province, Peoples R China; [Zhang, Huaping] Shanxi Med Univ, Cent Lab, Taiyuan 030001, Shanxi Province, Peoples R China		Fan, YM (corresponding author), Shanxi Med Univ, Clin Med Coll 1, Dept Neurosurg, Taiyuan 030001, Shanxi Province, Peoples R China.	fanyimin2012@126.com			National Natural Science Foundation Youth Fund [30600637]; Shanxi Province Basic Research Program Youth Science and Technology Research Fund [2010021034-4]; Shanxi Scholarship Council of China [2011-096]; Technology Innovation Fund of Shanxi Medical University [01201010]	This study was supported by the National Natural Science Foundation Youth Fund (Fund No. 30600637), the Shanxi Province Basic Research Program Youth Science and Technology Research Fund (Fund No. 2010021034-4), the Shanxi Scholarship Council of China (No. 2011-096), and the Technology Innovation Fund of Shanxi Medical University (No. 01201010).	ADRIAN TE, 1983, NATURE, V306, P584, DOI 10.1038/306584a0; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; EDVINSSON L, 1984, BRIT J PHARMACOL, V83, P519, DOI 10.1111/j.1476-5381.1984.tb16516.x; EKBLAD E, 1987, NEUROSCIENCE, V20, P169, DOI 10.1016/0306-4522(87)90010-8; EKBLAD E, 1984, REGUL PEPTIDES, V8, P225, DOI 10.1016/0167-0115(84)90064-8; EKBLAD E, 1984, REGUL PEPTIDES, V10, P47, DOI 10.1016/0167-0115(84)90052-1; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Jin WM, 2012, J HUAZHONG U SCI-MED, V32, P59, DOI 10.1007/s11596-012-0010-1; KNEPPER MA, 1994, P NATL ACAD SCI USA, V91, P6255, DOI 10.1073/pnas.91.14.6255; Koyama Y, 1999, AM J PHYSIOL-CELL PH, V276, pC621, DOI 10.1152/ajpcell.1999.276.3.C621; Lehmann GL, 2004, CURR NEUROVASC RES, V1, P293, DOI 10.2174/1567202043362081; LUNDBERG JM, 1983, NEUROSCI LETT, V42, P167, DOI 10.1016/0304-3940(83)90401-9; Schebesch KM, 2011, ACTA NEUROCHIR, V153, P1663, DOI 10.1007/s00701-011-1056-8; SUNDLER F, 1983, CELL TISSUE RES, V230, P487, DOI 10.1007/BF00216194; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; WAHLESTEDT C, 1986, REGUL PEPTIDES, V13, P307, DOI 10.1016/0167-0115(86)90048-0	19	10	13	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	OCT	2013	184	2					1006	1012		10.1016/j.jss.2013.03.096			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	215XE	WOS:000324243500049	23622727				2022-02-06	
J	Jones, CF; Lee, JHT; Burstyn, U; Okon, EB; Kwon, BK; Cripton, PA				Jones, Claire F.; Lee, Jae H. T.; Burstyn, Uri; Okon, Elena B.; Kwon, Brian K.; Cripton, Peter A.			Cerebrospinal Fluid Pressures Resulting From Experimental Traumatic Spinal Cord Injuries in a Pig Model	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							ADULT-RAT BRAIN; LASTING IMPULSE NOISE; IN-VITRO MODEL; INTRACRANIAL-PRESSURE; AXONAL INJURY; BLAST OVERPRESSURE; SHOCK-WAVES; SWINE MODEL; EX-VIVO; EXPOSURE	Despite considerable effort over the last four decades, research has failed to translate into consistently effective treatment options for spinal cord injury (SCI). This is partly attributed to differences between the injury response of humans and rodent models. Some of this difference could be because the cerebrospinal fluid (CSF) layer of the human spine is relatively large, while that of the rodents is extremely thin. We sought to characterize the fluid impulse induced in the CSF by experimental SCIs of moderate and high human-like severity, and to compare this with previous studies in which fluid impulse has been associated with neural tissue injury. We used a new in vivo pig model (n = 6 per injury group, mean age 124.5 days, 20.9 kg) incorporating four miniature pressure transducers that were implanted in pairs in the subarachnoid space, cranial, and caudal to the injury at 30 mm and 100 mm. Tissue sparing was assessed with Eriochrome Cyanine and Neutral Red staining. The median peak pressures near the injury were 522.5 and 868.8 mmHg (range 96.7-1430.0) and far from the injury were 7.6 and 36.3 mmHg (range 3.8-83.7), for the moderate and high injury severities, respectively. Pressure impulse (mmHg.ms), apparent wave speed, and apparent attenuation factor were also evaluated. The data indicates that the fluid pressure wave may be sufficient to affect the severity and extent of primary tissue damage close to the injury site. However, the CSF pressure was close to normal physiologic values at 100 mm from the injury. The high injury severity animals had less tissue sparing than the moderate injury severity animals; this difference was statistically significant only within 1.6 mm of the epicenter. These results indicate that future research seeking to elucidate the mechanical origins of primary tissue damage in SCI should consider the effects of CSF. This pig model provides advantages for basic and preclinical SCI research due to its similarities to human scale, including the existence of a human-like CSF fluid layer.	[Jones, Claire F.; Cripton, Peter A.] Univ British Columbia, Orthopaed & Injury Biomech Grp, Dept Mech Engn, Vancouver, BC V5Z 1M9, Canada; [Jones, Claire F.; Cripton, Peter A.] Univ British Columbia, Orthopaed & Injury Biomech Grp, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Jones, Claire F.; Lee, Jae H. T.; Burstyn, Uri; Okon, Elena B.; Kwon, Brian K.; Cripton, Peter A.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC V5Z 1M9, Canada; [Kwon, Brian K.] Univ British Columbia, CNOSP, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada		Jones, CF (corresponding author), Univ British Columbia, Orthopaed & Injury Biomech Grp, Dept Mech Engn, Vancouver, BC V5Z 1M9, Canada.	claire.jones@alumni.ubc.ca; jaelee@icord.org; burstyn@icord.org; okon@icord.org; brian.kwon@vch.ca; cripton@mech.ubc.ca	Cripton, Peter Alec/AAC-8268-2020; Jones, Claire/C-4942-2012	Cripton, Peter Alec/0000-0002-5067-0833; Jones, Claire/0000-0002-0995-1182; Okon, Elena/0000-0001-8568-5771	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	The technical assistance of B. Chua, T. Godbey, G. Gray, R. Hildebrandt, K. Jones, R. Newell, A. Stammers, and S. Tigchelaar is gratefully acknowledged. A. Yung, A. Laing, and T. Oxland kindly provided MR images of the rat spinal cord. The authors received funding from the Canadian Institutes of Health Research (PAC/BKK) and the Natural Sciences and Engineering Research Council of Canada (PAC). Implants and surgical instrumentation for the injury device were provided by Medtronic Inc. (Minneapolis, MN).	AKESON J, 1993, ACTA ANAESTH SCAND, V37, P211, DOI 10.1111/j.1399-6576.1993.tb03703.x; Albin MS, 1975, NEUR ABSTR, V1, P697; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bouguet J. Y., 2004, CAMERA CALIBRATION T; Bozeman WP, 2005, J TRAUMA, V58, P278, DOI 10.1097/01.TA.0000152536.71932.85; BUNEGIN L, 1987, CRIT CARE CLIN, V3, P453; Carlson GD, 2003, SPINE, V28, P119, DOI 10.1097/00007632-200301150-00005; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Cornish R, 2000, SPINE, V25, P1227, DOI 10.1097/00007632-200005150-00005; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; DOHRMANN GJ, 1976, SURG FORUM, V27, P466; Eidlitz-Markus T, 2005, PEDIATR ANESTH, V15, P1078, DOI 10.1111/j.1460-9592.2005.01675.x; GELLAD F, 1983, AM J NEURORADIOL, V4, P614; GREENFIELD JC, 1984, STROKE, V15, P76, DOI 10.1161/01.STR.15.1.76; Grum D F, 1991, J Cardiothorac Vasc Anesth, V5, P331, DOI 10.1016/1053-0770(91)90155-M; Hall RM, 2006, J NEUROSURG-SPINE, V5, P243, DOI 10.3171/spi.2006.5.3.243; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; HUNG T-K, 1975, Surgical Neurology, V4, P271; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jones CF, 2008, SPINE, V33, pE580, DOI 10.1097/BRS.0b013e31817ecc57; Jones CF, 2012, J NEUROSURG-SPINE, V16, P624, DOI 10.3171/2012.3.SPINE11970; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Klarica M, 2006, CROAT MED J, V47, P233; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Krave U, 2005, EUR J NEUROSCI, V21, P2876, DOI 10.1111/j.1460-9568.2005.04115.x; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MOLT JT, 1979, J NEUROSURG, V50, P784, DOI 10.3171/jns.1979.50.6.0784; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; PANJABI MM, 1995, J SPINAL DISORD, V8, P39; Persson C, 2009, J NEUROSURG-SPINE, V10, P315, DOI 10.3171/2009.1.SPINE08286; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; PFENNINGER E, 1985, ACTA NEUROCHIR, V78, P113, DOI 10.1007/BF01808689; Pintar F. A., 1995, 5 S INJ PREV BIOM DE, P161; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; RINDER L, 1969, ACTA PHYSIOL SCAND, V76, P352, DOI 10.1111/j.1748-1716.1969.tb04478.x; ROALD OK, 1989, ACTA ANAESTH SCAND, V33, P210, DOI 10.1111/j.1399-6576.1989.tb02892.x; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Walter B, 1999, EXP TOXICOL PATHOL, V51, P124, DOI 10.1016/S0940-2993(99)80085-2; WENNERSTRAND J, 1978, J BIOMECH, V11, P315, DOI 10.1016/0021-9290(78)90065-9; Whiteley W, 2006, NEUROLOGY, V67, P1690, DOI 10.1212/01.wnl.0000242704.60275.e9; WILLIAMS B, 1981, ACTA NEUROCHIR, V58, P167, DOI 10.1007/BF01407124; YASUDA N, 1990, ANESTH ANALG, V71, P340; Yoganandan N., 1995, 39 ANN P ASS ADV AUT; Zaaroor M, 2006, MINIM INVAS NEUROSUR, V49, P220, DOI 10.1055/s-2006-948000	61	10	11	0	11	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT	2013	135	10							101005	10.1115/1.4025100			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	240IB	WOS:000326087600005	23897000				2022-02-06	
J	Altman, IM; Swick, S; Malec, JF				Altman, Irwin M.; Swick, Shannon; Malec, James F.			Effectiveness of Home- and Community-Based Rehabilitation in a Large Cohort of Patients Disabled by Cerebrovascular Accident: Evidence of a Dose-Response Relationship	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Cerebrovascular accident; Rehabilitation; Stroke	TRAUMATIC BRAIN-INJURY; PORTLAND ADAPTABILITY INVENTORY; OF-THE-LITERATURE; COGNITIVE REHABILITATION; TRIALS	Objectives: To (1) assess the effectiveness of home- and community-based rehabilitation (HCBR) in a large cohort of individuals with disabilities secondary to cerebrovascular accident (CVA); and (2) evaluate the responsiveness to treatment of the Mayo-Portland Adaptability Inventory (MPAI-4) to changes resulting from HCBR in this patient group. Design: Retrospective analysis of program evaluation data for treatment completers and noncompleters. Setting: HCBR conducted in 7 geographically distinct U.S. cities. Participants: Individuals with CVA (n=738) who completed the prescribed course of rehabilitation (completed course of treatment [CCT]) compared with 150 individuals who were precipitously discharged (PD) before program completion. Intervention: HCBR delivered by certified professional staff on an individualized basis. Main Outcome Measures: Mayo-Portland Adaptability Inventory (MPAI-4) completed by professional consensus on admission and at discharge. Results: With the use of analysis of covariance, MPAI-4 total scores at discharge for CCT participants were compared with those of PD participants, with admission MPAI-4, age, length of stay, and time since event as covariates. CCT participants showed greater improvement than PD participants (F=99.48, P<.001) with a moderate effect size (partial eta(2) = .10). Group differences and effect sizes were similar for the 3 index scores: Ability (F=75.96, P<.001; partial eta(2)=.08, Adjustment (F=99.67, P<.001; partial eta(2)=.10), and Participation (F=69.15, P<.001; partial eta(2)=.07). Conclusions: Individuals in the CCT group who received the entire planned course of HCBR showed greater improvement on all MPAI-4 indexes than those in the PD group who were discharged before completing the prescribed program. This dose-response relationship provides evidence of a causal relationship between treatment and outcome. (C) 2013 by the American Congress of Rehabilitation Medicine	[Altman, Irwin M.] Rehab Without Walls, Phoenix, AZ USA; [Swick, Shannon] Rehab Without Walls, Marshall, MI USA; [Malec, James F.] Indiana Univ Sch Med, PM&R, Indianapolis, IN 46254 USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA		Malec, JF (corresponding author), Indiana Univ Sch Med, PM&R, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com			National Institute for Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [3R42NS059133-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R42NS059133] Funding Source: NIH RePORTER	Supported by an STTR grant (grant no. 3R42NS059133-02) from the National Institute for Neurological Diseases and Stroke.	Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF., MANUAL MAYO PORTLAND; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2	13	10	10	0	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2013	94	9					1837	1841		10.1016/j.apmr.2013.02.014			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	214QZ	WOS:000324151900021	23462581				2022-02-06	
J	Rushby, JA; McDonald, S; Randall, R; de Sousa, A; Trimmer, E; Fisher, A				Rushby, Jacqueline Ann; McDonald, Skye; Randall, Rebekah; de Sousa, Arielle; Trimmer, Emily; Fisher, Alana			Impaired emotional contagion following severe traumatic brain injury	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Emotional empathy; Emotion contagion; Traumatic brain injury; Electromyography	ANXIETY STRESS SCALES; FACIAL REACTIONS; RESPONSES; EMPATHY; EXPRESSIONS; MIMICRY; STATES; RECOGNITION; DEPRESSION; BEHAVIOR	Empathy deficits are widely-documented in-individuals after severe traumatic brain injury (TBI). This study examined the relationship between empathy deficits and psychophysiological responsivity in adults with TBI to determine if impaired responsivity is ameliorated through repeated emotional stimulus presentations. Nineteen TBI participants (13 males; 41 years) and 25 control participants (14 males; 31 years) viewed five repetitions of six 2-min film clip segments containing pleasant, unpleasant, and neutral content. Facial muscle responses (zygomaticus and corrugator), tonic heart rate (HR) and skin conductance level (SCL) were recorded. Mean responses for each viewing period were compared to a pre-experiment 2-min resting baseline period. Self-reported emotional empathy was also assessed. TBI participants demonstrated identical EMG response patterns to controls, i.e. an initial large facial response to both pleasant and unpleasant films, followed by habituation over repetitions for pleasant films, and sustained response to unpleasant films. Additionally, an increase in both arousal and HR deceleration to stimulus repetitions was found, which was larger for TBI participants. Compared to controls, TBI participants self-reported lower emotional empathy, and had lower resting arousal, and these measures were positively correlated. Results are consistent with TBI producing impairments in emotional empathy and responsivity. While some normalisation of physiological arousal appeared with repeated stimulus presentations, this came at the cost of greater attentional effort. (C) 2013 Elsevier B.V. All rights reserved.	[Rushby, Jacqueline Ann; McDonald, Skye; Randall, Rebekah; de Sousa, Arielle; Trimmer, Emily; Fisher, Alana] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		Rushby, JA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	j.rushby@unsw.edu.au; s.mcdonald@unsw.edu.au; rebekahr@student.unimelb.edu.au; aydesous@bigpond.net.au; e.trimmer@unsw.edu.au; alana.fisher@unsw.edu.au	McDonald, Skye/G-4118-2014; Rushby, Jacqueline/D-1820-2010; Fisher, Alana/T-1869-2019	McDonald, Skye/0000-0003-0723-6094; Rushby, Jacqueline/0000-0002-5018-638X; Fisher, Alana/0000-0002-6027-659X	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1013796]	JAR is supported by an Australian National Health and Medical Research Council (NHMRC) Postdoctoral Fellowship (Clinical Training; APP1013796). The authors wish to thank all who participated in the study, including the people with traumatic brain injuries, their families and community controls who gave willingly their time.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Birkin J., 1992, MERRY CHRISTMAS MR B; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bruggemann JM, 2002, PERS INDIV DIFFER, V32, P1029, DOI 10.1016/S0191-8869(01)00108-8; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Devlin D. (, 1980, MY BODYGUARD MOTION; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1017/S0048577200990759; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Elliot A., 1994, EMOTION CONTAGION; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GERRARDSHESSE A, 1994, BRIT J PSYCHOL, V85, P55, DOI 10.1111/j.2044-8295.1994.tb02508.x; Gomez P, 2005, BIOL PSYCHOL, V68, P223, DOI 10.1016/j.biopsycho.2004.06.003; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; HUBERT W, 1991, INT J PSYCHOPHYSIOL, V11, P131, DOI 10.1016/0167-8760(91)90005-I; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kemp D., 2008, EXTREME ALASKA DENAL; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; LACEY BC, 1978, AM PSYCHOL, V33, P99, DOI 10.1037/0003-066X.33.2.99; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McDonald S, 1999, J HEAD TRAUMA REHAB, V16, P612; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; McHugo G. J., 1982, MOTIV EMOTION, V6, P365, DOI DOI 10.1007/BF00998191; Mehrabian A., 2000, MANUAL BALANCED EMOT; MERCKELBACH H, 1989, BEHAV RES THER, V27, P289, DOI 10.1016/0005-7967(89)90048-X; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Porges S W, 1976, Adv Child Dev Behav, V11, P35, DOI 10.1016/S0065-2407(08)60094-4; Reiner R., 1989, HARRY MET SALLY MOTI; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Spencer N., 1987, CRY FREEDOM MOTION P; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Trumbull R., 1967, PSYCHOL STRESS ISSUE, P14; Vrana SR, 2004, BIOL PSYCHOL, V66, P63, DOI 10.1016/j.biopsycho.2003.07.004; WechslerD, 2001, WECHSLER TEST ADULT; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326	59	10	10	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	SEP	2013	89	3			SI		466	474		10.1016/j.ijpsycho.2013.06.013			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	245AV	WOS:000326432200023	23792215				2022-02-06	
J	Asgari, S; Vespa, P; Hu, X				Asgari, Shadnaz; Vespa, Paul; Hu, Xiao			Is There Any Association Between Cerebral Vasoconstriction/Vasodilatation and Microdialysis Lactate to Pyruvate Ratio Increase?	NEUROCRITICAL CARE			English	Article						Hemodynamic signal; Microdialysis; Lactate/Pyruvate ratio; Cerebral vasodilatation; Cerebral vasoconstriction; Metabolic crisis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; BLOOD-FLOW; LACTATE/PYRUVATE RATIO; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; ISCHEMIA; WAVE	Although abnormally high Lactate/Pyruvate ratio (LPR) could indicate cerebral ischemia for brain injury patients, there is a debate on what is primary factor responsible for LPR increase. A data analysis experiment is taken to test whether any association between cerebral vasodilatation/vasoconstriction and LPR increase exists. We studied 4,316 microdialysis data samples collected in an average interval of 1.3 h from 30 severe traumatic brain injury (TBI) patients. The LPR increase episodes were automatically identified using a moving time-window of 5 samples. A novel pulse morphological template matching (PMTM) algorithm was applied to the intracranial pressure (ICP) data of the corresponding patients to assess the occurrence of cerebral vasodilatation and vasoconstriction during the identified LPR increase episodes. Several analyses were performed to evaluate the association between cerebral vasoconstriction/vasodilatation and LPR increase. Results revealed that although more than half of the LPR increase episodes are not associated with any detected cerebral vasoconstriction/vasodilatation, when a vaso-change happens in association of LPR increase, it is more likely that this vaso-change is in the form of vasoconstriction rather than vasodilatation. Also for few subjects with dominant number of vasoconstriction episodes, a causality relationship between vasoconstriction and LPR increase were observed (vasoconstriction precedes LPR increase). Using continuous intracranial pressure monitoring and our pulse morphological template matching (PMTM) algorithm could be potentially helpful in teasing out whether culprit cerebral vascular changes precede metabolic crisis for traumatic brain injury patients and hence guiding the management of this condition.	[Asgari, Shadnaz] Calif State Univ Long Beach, Dept Comp Engn & Comp Sci, Long Beach, CA 90840 USA; [Vespa, Paul; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neurocrit Care Program, Los Angeles, CA 90095 USA; [Hu, Xiao] Univ Calif Los Angeles, Biomed Engn Grad Program, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90095 USA		Hu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neural Syst & Dynam Lab, 18-265 Semel,10833 Le Conte Ave,Box 703919, Los Angeles, CA 90095 USA.	xhu@mednet.ucla.edu			UC Brain Injury Research Center (BIRC);  [NS066008];  [NS076738]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066008, R01NS076738] Funding Source: NIH RePORTER	The present work is partially supported by NS066008, NS076738, and UC Brain Injury Research Center (BIRC).	Asgari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050795; Asgari S, 2011, PHYSIOL MEAS, V32, P1639, DOI 10.1088/0967-3334/32/10/011; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; Bjerring PN, 2010, J HEPATOL, V53, P1054, DOI 10.1016/j.jhep.2010.05.032; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; LAITINEN L, 1968, ACTA NEUROL SCAND, V44, P168, DOI 10.1111/j.1600-0404.1968.tb05563.x; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Maurer MH, 2007, J CEREBR BLOOD F MET, V27, P1675, DOI 10.1038/sj.jcbfm.9600466; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Westermaier T, 2011, NEUROSURGERY, V68, P223, DOI 10.1227/NEU.0b013e3181fe23c1	27	10	10	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2013	19	1					56	64		10.1007/s12028-013-9821-6			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	187SP	WOS:000322140000009	23733172				2022-02-06	
J	Fairbanks, JM; Brown, TM; Cassedy, A; Taylor, HG; Yeates, KO; Wade, SL				Fairbanks, Joy M.; Brown, Tanya M.; Cassedy, Amy; Taylor, H. Gerry; Yeates, Keith O.; Wade, Shari L.			Maternal Warm Responsiveness and Negativity Following Traumatic Brain Injury in Young Children	REHABILITATION PSYCHOLOGY			English	Article						mother-child interactions; traumatic brain injury; early childhood; direct observation; longitudinal study	BEHAVIOR PROBLEMS; EXTERNALIZING BEHAVIOR; PARENTING PRACTICES; CUMULATIVE RISK; EARLY-CHILDHOOD; EXECUTIVE DYSFUNCTION; FAMILY ADAPTATION; CONTEXTUAL RISK; HEAD-INJURY; OUTCOMES	Purpose/Objective: To understand how traumatic brain injury (TBI) affects maternal warm responsiveness and negativity over the first 12 months following injury. Method/Design: We used a concurrent cohort research design to examine dyadic interactions in young children with a TBI (n = 78) and a comparison group of young children with orthopedic injuries (OI; n = 112) and their families during the initial weeks following injury (i.e., baseline) and at two follow-up periods (approximately 6 and 12 months later). Trained raters coded videotaped interactions during a free play and structured teaching task for maternal warm responsiveness and negativity. Results: Mothers in the complicated mild/moderate TBI group, but not those in the severe TBI group, exhibited significantly lower levels of maternal warm responsiveness than mothers in the OI group. However, these differences were observed only at baseline during free play and only at baseline and 6 months postinjury during the structured teaching task, suggesting diminishing adverse effects of complicated mild/moderate TBI on parenting over time postinjury. Analysis failed to reveal group differences in maternal negativity at any of the assessments. Across groups, lower socioeconomic status (SES) was associated with lower levels of warm responsiveness and higher levels of negativity. Conclusions/Implications: These findings, though preliminary, indicate possible alterations in mother child interactions in the months following a TBI.	[Fairbanks, Joy M.; Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Yeates, Keith O.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Yeates, Keith O.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02HD044099] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR008084, M01 RR 08084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02 HD044099, R01 HD42729, R01 HD042729, K02HD44099] Funding Source: Medline		Ackerman BP, 2004, DEV PSYCHOL, V40, P204, DOI 10.1037/0012-1649.40.2.204; Ackerman BP, 2003, CHILD DEV, V74, P694, DOI 10.1111/1467-8624.00563; Ackerman BP, 1999, CHILD DEV, V70, P1415, DOI 10.1111/1467-8624.00103; Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT, DOI 10.1037/t28248-000; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Appleyard K, 2005, J CHILD PSYCHOL PSYC, V46, P235, DOI 10.1111/j.1469-7610.2004.00351.x; Bagner DM, 2003, J CLIN CHILD ADOLESC, V32, P599, DOI 10.1207/S15374424JCCP3204_13; BAKEMAN R, 1980, CHILD DEV, V51, P437, DOI 10.2307/1129277; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; BARKLEY RA, 1985, J ABNORM CHILD PSYCH, V13, P631, DOI 10.1007/BF00923146; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bendikas EA, 2011, REHABIL PSYCHOL, V56, P374, DOI 10.1037/a0025634; Bornstein MH, 2008, DEV PSYCHOL, V44, P867, DOI 10.1037/0012-1649.44.3.867; Bradley RH, 2001, CHILD DEV, V72, P1868, DOI 10.1111/1467-8624.t01-1-00383; Bradley RH, 2007, DEV PSYCHOL, V43, P1390, DOI 10.1037/0012-1649.43.6.1390; Cohen ML, 2012, J PEDIATR PSYCHOL, V37, P251, DOI 10.1093/jpepsy/jsr086; Deater-Deckard K, 1998, DEV PSYCHOPATHOL, V10, P469, DOI 10.1017/S0954579498001709; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gardner F, 2000, Clin Child Fam Psychol Rev, V3, P185, DOI 10.1023/A:1009503409699; Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539; Glascoe FP, 2010, PEDIATRICS, V125, P313, DOI 10.1542/peds.2008-3129; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Healey DM, 2010, J CHILD PSYCHOL PSYC, V51, P1058, DOI 10.1111/j.1469-7610.2010.02220.x; Hoeve M, 2009, J ABNORM CHILD PSYCH, V37, P749, DOI 10.1007/s10802-009-9310-8; Jennings KD, 2008, INT J BEHAV DEV, V32, P108, DOI 10.1177/0165025407087209; Jones DJ, 2008, J FAM PSYCHOL, V22, P181, DOI 10.1037/0893-3200.22.2.181; Josie KL, 2008, J HEAD TRAUMA REHAB, V23, P357, DOI 10.1097/01.HTR.0000341431.29133.a8; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kochanska G, 2003, DEV PSYCHOL, V39, P949, DOI 10.1037/0012-1649.39.6.949; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Landry SH, 1997, DEV PSYCHOL, V33, P1040, DOI 10.1037/0012-1649.33.6.1040; Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Landry SH, 2001, DEV PSYCHOL, V37, P387, DOI 10.1037//0012-1649.37.3.387; Landry SH, 2012, DEV PSYCHOL, V48, P969, DOI 10.1037/a0026400; McFarlane E, 2010, ACAD PEDIATR, V10, P330, DOI 10.1016/j.acap.2010.06.011; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Raver CC, 2007, CHILD DEV, V78, P96, DOI 10.1111/j.1467-8624.2007.00987.x; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Sambuco M, 2008, BRAIN INJURY, V22, P7, DOI 10.1080/02699050701822022; Shanley JR, 2011, CHILD FAM BEHAV THER, V33, P248, DOI 10.1080/07317107.2011.596009; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Stormshak EA, 2000, J CLIN CHILD PSYCHOL, V29, P17, DOI 10.1207/S15374424jccp2901_3; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tomblin JB, 2007, LANG LEARN DEV, V3, P269, DOI 10.1080/15475440701377477; Trentacosta CJ, 2008, J CHILD PSYCHOL PSYC, V49, P1211, DOI 10.1111/j.1469-7610.2008.01941.x; von Suchodoletz A, 2011, SOC DEV, V20, P486, DOI 10.1111/j.1467-9507.2010.00588.x; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wahler RG, 1997, J CLIN CHILD PSYCHOL, V26, P433, DOI 10.1207/s15374424jccp2604_12; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Zhou Q, 2002, CHILD DEV, V73, P893, DOI 10.1111/1467-8624.00446	65	10	11	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2013	58	3					223	232		10.1037/a0033119			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	204ZB	WOS:000323408700001	23978080	Green Accepted			2022-02-06	
J	Keightley, M; Reed, N; Green, S; Taha, T				Keightley, M.; Reed, N.; Green, S.; Taha, T.			Age and Competition Level on Injuries in Female Ice Hockey	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						injury; female; ice hockey; sprain/strain; concussion	DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; RATES; SPORT	. The objective of this study was to describe the number, types and locations of known injuries occurring across different age categories and levels of competition in female ice hockey within the Ontario Women's Hockey Association from 2004/05 to 2007/08. We further examined under which aforementioned factors and combination of factors an unusually high or low number of injuries was recorded. Secondary analysis of anonymized injury data was conducted. The most common known injury type was strain/sprain, followed by concussion while the most frequent injury location was head/face/mouth. Analysis of deviance indicated that a significantly higher than expected number of sprain/strain, concussion and laceration injuries were recorded compared to all other injury types. In addition, there were a higher number of injuries recorded at the AA level compared to all other levels of competition. Finally, the age categories of Peewee, Midget and Intermediate within the AA level of competition, as well as Senior/Adult within the Houseleague level of competition also recorded a significantly higher number of injuries compared to other combinations of descriptive factors. Further research with female youth is needed to better understand the high number of injuries, including concussions, reported overall.	[Keightley, M.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Reed, N.; Green, S.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Taha, T.] Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON M5G 1V7, Canada		Keightley, M (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	michelle.keightley@utoronto.ca			Ontario Women's Hockey Association	The authors would like to thank the Ontario Women's Hockey Association for their collaboration and support of the research study.	Agel J, 2007, J ATHL TRAINING, V42, P202; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Crawley M. J, 2007, R BOOK, P449; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P211; Dryden D M, 2000, J Sci Med Sport, V3, P140, DOI 10.1016/S1440-2440(00)80076-6; Dryden DM, 2000, MED SCI SPORT EXER, V32, P1378, DOI 10.1097/00005768-200008000-00004; Eaton DK, 2006, J SCHOOL HEALTH, V76, P353, DOI 10.1111/j.1746-1561.2006.00127.x; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Falconer T, 1994, WOMENS HOCKEY SPEED; Harriss DJ, 2011, INT J SPORTS MED, V32, P819, DOI 10.1055/s-0031-1287829; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Ice hockey Canada, 2011, ANN REPORT; Malina R.M., 1991, GROWTH MATURATION PH; Molsa J, 2003, AM J SPORT MED, V31, P751; Ontario Women's Hockey Association, EX REP 2008 2009; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; USA Ice hockey, MEMB STAT; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	24	10	10	0	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2013	34	8					756	759		10.1055/s-0032-1327574			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AK2YN	WOS:000338286600014	23516144				2022-02-06	
J	Kelly, A; Ponsford, J; Couchman, G				Kelly, Amber; Ponsford, Jennie; Couchman, Grace			Impact of a family-focused intervention on self-concept after acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Self-concept; Family; Intervention; Brain injury	ESTEEM; SCHIZOPHRENIA; DEPRESSION	The present study examined the impact of a family inclusive intervention on the multidimensional self-concept of individuals with traumatic brain injury (TBI). Forty one individuals with TBI and a matched control group completed the Tennessee Self-Concept Scale: Second Edition (TSCS: 2), the Rosenberg Self-Esteem Scale (RSE), the Family Assessment Device (FAD), and the Hospital Anxiety and Depression Scale (HADS) on two occasions: at immediate contact (pre-group, T1) and post-group (3 months after initial contact, T2). Controls did not attend the intervention. Total scores for the measures, as well as scores on subdomains of self-concept, taken pre- and post-intervention for the TBI sample and at the same time for matched controls were compared between groups using Multivariate Analysis of Variance (MANOVA); followed by a series of repeated measures analyses of variance (ANOVA) to determine whether significant changes occurred. Contrary to the main aim, the use of a family-focused intervention did not result in self-concept improvement, either globally or across self-concept domains. Nor did mood or family functioning improve for the TBI sample. Measures remained stable across time for the controls.	[Kelly, Amber; Ponsford, Jennie; Couchman, Grace] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Ponsford, Jennie] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu					Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Baumeister Roy F, 1998, HDB SOCIAL PSYCHOL, V1, P680, DOI DOI 10.1002/PITS.20162; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bradley GM, 2006, PSYCHIAT SERV, V57, P521, DOI 10.1176/appi.ps.57.4.521; BRINKMANN JR, 1979, PHYS THER, V59, P859, DOI 10.1093/ptj/59.7.859; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; DELUGACH RR, 1992, PSYCHOL SCHOOLS, V29, P213, DOI 10.1002/1520-6807(199207)29:3<213::AID-PITS2310290303>3.0.CO;2-E; Dyck DG, 2000, PSYCHIAT SERV, V51, P513, DOI 10.1176/appi.ps.51.4.513; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fines L., 1994, J COGNITIVE REHABILI, P10; FITTS WH, 1996, TENNESSEE SELF CONCE, V2; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Harter S., 1998, HDB CHILD PSYCHOL; Hay I, 2000, BRIT J GUID COUNS, V28, P101, DOI 10.1080/030698800109646; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; Marsh HW, 1990, EDUC PSYCHOL REV, V2, P77, DOI 10.1007/BF01322177; McFarlane WR, 2003, J MARITAL FAM THER, V29, P223, DOI 10.1111/j.1752-0606.2003.tb01202.x; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; Rosenberg M., 1995, SOC ADOLESCENT SELF; Sander A., 2002, BRAIN INJURY, V16, P8; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Snaith R. P., 1983, HADS HOSP ANXIETY DE; Swann W. B., 1996, SELF TRAPS ELUSIVE Q; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	42	10	10	0	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 1	2013	23	4					563	579		10.1080/09602011.2013.795903			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	187WG	WOS:000322151600005	23656483				2022-02-06	
J	Smith, MD; Bell, DR				Smith, Mason D.; Bell, David R.			Negative Effects on Postural Control After Anterior Cruciate Ligament Reconstruction as Measured by the Balance Error Scoring System	JOURNAL OF SPORT REHABILITATION			English	Article						postural sway; BESS; static balance; knee injury	STABILITY; INJURY; CONCUSSION; DEFICITS; PLAYERS; RETURN; INSUFFICIENCY; INDIVIDUALS; RELIABILITY; RUPTURE	Context: Anterior cruciate ligament (ACL) reconstruction is the standard of care for individuals with ACL rupture. Balance deficits have been observed in patients with ACL reconstruction (ACLR) using advanced posturography, which is the current gold standard. It is unclear if postural-control deficits exist when assessed by the Balance Error Scoring System (BESS), which is a clinical assessment of balance. Objective: The purpose of this study is to determine if postural-control deficits are present in individuals with ACLR as measured by the BESS. Participants: Thirty participants were included in this study. Fifteen had a history of unilateral ACLR and were compared with 15 matched controls. Interventions: The BESS consists of 3 stances (double-limb, single-limb, and tandem) on 2 surfaces (firm and foam). Participants begin in each stance with hands on their hips and eyes closed while trying to stand as still as possible for 20 s. Main Outcome Measures: Each participant performed 3 trials of each stance (18 total), and errors were assessed during each trial and summed to create a total score. Results: We observed a significant group x stance interaction (P = .004) and a significant main effect for stance (P < .001). Post hoc analysis revealed that the ACLR group had worse balance on the single-leg foam stance than did controls. Finally, the reconstructed group had more errors when total BESS score was examined (P = .02). Conclusions: Balance deficits exist in individuals with ACLR as measured by the BESS. Total BESS score was different between groups. The only condition that differed between groups was the single-leg stance on the unstable foam surface.	[Smith, Mason D.; Bell, David R.] Univ Wisconsin Madison, Dept Kinesiol, Madison, WI USA		Smith, MD (corresponding author), Univ Wisconsin Madison, Dept Kinesiol, Madison, WI USA.				University of Wisconsin Sports Medicine Classic Grant	This research project was supported by the University of Wisconsin Sports Medicine Classic Grant.	Alonso AC, 2009, CLINICS, V64, P163, DOI 10.1590/S1807-59322009000300003; Ardern CL, 2011, BRIT J SPORT MED, V45, P596, DOI 10.1136/bjsm.2010.076364; Arendt EA, 1999, J ATHL TRAINING, V34, P86; BEARD DJ, 1993, J BONE JOINT SURG BR, V75, P311, DOI 10.1302/0301-620X.75B2.8444956; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bonfim TR, 2003, ARCH PHYS MED REHAB, V84, P1217, DOI 10.1016/S0003-9993(03)00147-3; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Cerulli G, 2001, J ORTHOP SPORT PHYS, V31, P655, DOI 10.2519/jospt.2001.31.11.655; Clark Richard C, 2010, N Am J Sports Phys Ther, V5, P122; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Dunn WR, 2010, AM J SPORT MED, V38, P2040, DOI 10.1177/0363546510370280; Fibiger Wojciech, 2011, Ortop Traumatol Rehabil, V13, P583; FRIDEN T, 1990, ACTA ORTHOP SCAND, V61, P131, DOI 10.3109/17453679009006504; GAUFFIN H, 1990, INT J SPORTS MED, V11, P73, DOI 10.1055/s-2007-1024766; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Howells BE, 2011, KNEE SURG SPORT TR A, V19, P1168, DOI 10.1007/s00167-011-1444-x; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; JOHANSSON H, 1991, CLIN ORTHOP RELAT R, P161; JOHANSSON H, 1991, CRIT REV BIOMED ENG, V18, P341; Lam MH, 2011, AM J SPORT MED, V39, P1032, DOI 10.1177/0363546510394430; Lysholm M, 1998, SCAND J MED SCI SPOR, V8, P432; Marshall S, 2007, UNDERSTANDING PREVEN, P5; Marx RG, 2003, ARTHROSCOPY, V19, P762, DOI 10.1016/S0749-8063(03)00398-0; Mattacola CG, 2002, J ATHL TRAINING, V37, P262; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Paterno MV, 2012, CLIN J SPORT MED, V22, P116, DOI 10.1097/JSM.0b013e318246ef9e; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Salmon LJ, 2006, AM J SPORT MED, V34, P721, DOI 10.1177/0363546505282626; Shiraishi M, 1996, CLIN J SPORT MED, V6, P32, DOI 10.1097/00042752-199601000-00008; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	36	10	10	0	13	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2013	22	3					224	228		10.1123/jsr.22.3.224			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	190UA	WOS:000322365100009	23628880				2022-02-06	
J	Clark, DJ; Kolias, AG; Corteen, EA; Ingham, SC; Piercy, J; Crick, SJ; Menon, DK; Hutchinson, PJ				Clark, D. J.; Kolias, A. G.; Corteen, E. A.; Ingham, S. C.; Piercy, J.; Crick, S. J.; Menon, D. K.; Hutchinson, P. J.		RESCUE-ASDH Collaborative Grp	Community consultation in emergency neurotrauma research: results from a pre-protocol survey	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Clinical trials; Consent; Medical ethics; Decompressive craniectomy	ACUTE SUBDURAL HEMATOMAS; INFORMED-CONSENT; DECOMPRESSIVE CRANIECTOMY; TRIALS; GUIDELINES; EXPERIENCE; WAIVER; TIME	Background Uncertainty remains as to the role of decompressive craniectomy (DC) for primary evacuation of an acute subdural haematoma (ASDH). In 2011, a collaborative group of neurosurgeons, neuro-intensive care physicians and trial methodologists was formed in the UK with the aim of answering the following question: "What is the clinical-and cost-effectiveness of DC, in comparison to simple craniotomy for adult patients undergoing primary evacuation of an ASDH?" The proposed RESCUE-ASDH trial (Randomised Evaluation of Surgery with Craniectomy for patients Undergoing Evacuation of Acute Subdural Haematoma) is a multi-centre, pragmatic, parallel group randomised trial of DC versus simple craniotomy for adult head-injured patients with an ASDH. Clinical trials in the emergency setting face the problem that potential participants may be incapacitated and their next of kin initially unavailable. As a result, consent and enrolment of participants can often be difficult. Method In the current study, we aimed to assess public opinion regarding participation in the RESCUE-ASDH trial and acceptability of surrogate consent by conducting a pre-protocol community consultation survey. Results One hundred and seventy-one subjects completed the survey. Eighty-four percent of participants responded positively when asked if they would participate in the proposed trial. Ninety-six percent and 91 % answered positively when asked if they found surrogate consent by their next of kin and an independent doctor acceptable, respectively. None of the characteristics of the study population were found to affect the decision to participate or the acceptability of surrogate consent by the next of kin. Being religious showed a trend towards higher acceptability of surrogate consent by a doctor. Conversely, an education to degree level and above showed a trend towards reduced acceptability of surrogate consent by a doctor. Conclusions Our community consultation survey shows that the proposed trial is acceptable to the public. In addition, the results suggest high levels of acceptability of surrogate consent by next of kin or independent doctor amongst our community.	[Clark, D. J.; Kolias, A. G.; Corteen, E. A.; Ingham, S. C.; Hutchinson, P. J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Clark, D. J.; Kolias, A. G.; Corteen, E. A.; Ingham, S. C.; Menon, D. K.; Hutchinson, P. J.] Univ Cambridge, Cambridge, England; [Piercy, J.] Sci Made Simple East, Norwich, Norfolk, England; [Crick, S. J.] NHS Cambridgeshire, NIHR Res Design Serv East England, Cambridge, England; [Menon, D. K.] Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 0QQ, England; [Kolias, A. G.] Addenbrookes Hosp, Div Neurosurg, Cambridge CB2 0QQ, England		Kolias, AG (corresponding author), Addenbrookes Hosp, Div Neurosurg, Box 167,Level 3,A Block, Cambridge CB2 0QQ, England.	angeloskolias@gmail.com	Viani, Rafael/V-1196-2018	Piercy, James/0000-0003-4891-7259; Kolias, Angelos/0000-0003-3992-0587; Corteen, Elizabeth/0000-0002-3069-9655	INsPIRE Public Involvement in Research Group for Cambridgeshire; NIHR Research Design Service for the East of England; RESCUE-ASDH Collaborative Group; British Neurosurgical Trainee Research Collaborative; UK Neurosurgical Research Network; Royal College of Surgeons of England Research Fellowship; Freemasons and the Rosetrees Trust; NIHR Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); INsPIRE Public Involvement in Research Group for Bedfordshire; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2011-14-003, NF-SI-0512-10090] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI	We wish to acknowledge the support of the INsPIRE Public Involvement in Research Group for Cambridgeshire and Bedfordshire, the NIHR Research Design Service for the East of England, the RESCUE-ASDH Collaborative Group, the British Neurosurgical Trainee Research Collaborative and the UK Neurosurgical Research Network. A.G.K. is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), an NIHR Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. D.K.M. is an NIHR Senior Investigator. P.J.H. is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the NIHR Cambridge Biomedical Research Centre. P.J.H. has been appointed as the Surgical Specialty Lead for Neurosurgery, Royal College of Surgeons of England Clinical Research Initiative.	Agard A, 2001, HEART, V86, P632, DOI 10.1136/heart.86.6.632; Ali K, 2006, STROKE, V37, P865, DOI 10.1161/01.STR.0000204053.36966.80; Baren JM, 1999, ACAD EMERG MED, V6, P1210, DOI 10.1111/j.1553-2712.1999.tb00135.x; Biros MH, 2009, RESUSCITATION, V80, P1382, DOI 10.1016/j.resuscitation.2009.08.019; Contant C, 2006, CRIT CARE MED, V34, P2049, DOI 10.1097/01.CCM.0000227649.72651.F1; Del Giudice A, 2009, ACAD EMERG MED, V16, P309, DOI 10.1111/j.1553-2712.2009.00367.x; Dix ES, 2004, J INVEST MED, V52, P113, DOI 10.1136/jim-52-02-20; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Kompanje EJO, 2007, SCI ENG ETHICS, V13, P371, DOI 10.1007/s11948-007-9027-4; Kremers MS, 1999, ANN EMERG MED, V33, P224, DOI 10.1016/S0196-0644(99)70399-9; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Liddell K, 2006, RESUSCITATION, V69, P9, DOI 10.1016/j.resuscitation.2005.12.004; Marion DW, 2006, NEUROSURGERY, V58, P655; NHS National Research Ethics Service, 2011, NRES GUID INF SHEETS; Raymond TT, 2010, PEDIATRICS, V125, pE866, DOI 10.1542/peds.2009-2427; Roberts I, 2004, EMERG MED J, V21, P703, DOI 10.1136/emj.2002.004788; Roberts I, 2011, LANCET, V377, P1071, DOI 10.1016/S0140-6736(11)60317-6; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; Roupie E, 2000, INTENS CARE MED, V26, P52, DOI 10.1007/s001340050011; Santora TA, 1998, J TRAUMA, V45, P907, DOI 10.1097/00005373-199811000-00012; US Department of Health and Human Services Code of Federal Regulation, 1996, FED REGISTER, V61, P51497	21	10	10	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2013	155	7					1329	1334		10.1007/s00701-013-1748-3			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	186SH	WOS:000322064500027	23674229				2022-02-06	
J	Jellinger, KA				Jellinger, Kurt A.			Neuropathology of prolonged unresponsive wakefulness syndrome after blunt head injury: Review of 100 post-mortem cases	BRAIN INJURY			English	Article						Apallic syndrome; blunt traumatic brain injury; brainstem lesions; minimal conscious state; neuropathology; Unresponsive wakefulness; vegetative state	MINIMALLY CONSCIOUS STATE; PERMANENT-VEGETATIVE-STATE; DEFAULT NETWORK; BRAIN; DISORDERS; CONNECTIVITY; SPECTROSCOPY; INSIGHTS; COMA	Objectives: Recently, 'unresponsive wakefulness syndrome' (UWS) was coined for challenging conditions previously termed vegetative state or apallic syndrome. Materials and methods: In a post-mortem series of 630 patients who sustained a blunt traumatic brain injury, 100 (59 men and 41 women, aged 5-86 years; 77% traffic accidents, 23% falls and others) showed various disorders of consciousness which were compared with neuropathology with focus on brainstem lesions. Results: In the total autopsy series (n = 630), the incidence of cortical contusions, diffuse axonal injury (DAI) and intracranial haemorrhages was 41, 55 and 73%, respectively, of diencephalic, hypothalamic and hippocampal lesions 62% each, brainstem lesions 92%. Clinical prognosis was related to the location and extent of brainstem damage. Lesions in central parts of the rostral brainstem, frequently associated with extensive DAI, allowed no recovery from coma or UWS (n = 67), which occurred only with damage to the dorso-lateral brainstem tegmentum or pontine basis (n = 33). Only two of 11 patients with minimally conscious state (MCS), in addition to haemorrhages (n = 4), contusions (n = 10) and DAI (n = 7), showed small lesions in dorsolateral pontine tegmentum or diffuse pontine gliosis. Conclusions: These and other data confirm the importance of the pattern and extent of brainstem damage for the prognosis of UWS, only small peripheral lesions in pontine tegmentum allowing progressive remission.	[Jellinger, Kurt A.] Med Univ Vienna, Inst Clin Neurobiol, Vienna, Austria		Jellinger, KA (corresponding author), Inst Clin Neurobiol, Kenyongasse 18, A-1070 Vienna, Austria.	kurt.jellinger@univie.ac.at			Society for the Support of Research in Experimental Neurology, Vienna, Austria	The author thanks Mr. E. Mitter-Ferstl, PhD, for secretarial and graphical work. The study was supported by the Society for the Support of Research in Experimental Neurology, Vienna, Austria.	Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Brezova V, 2012, BRAIN INJURY, V26, P652; Bruno MA, 2011, PROG BRAIN RES, V193, P323, DOI 10.1016/B978-0-444-53839-0.00021-1; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bruno MA, 2011, CURR OPIN CRIT CARE, V17, P146, DOI 10.1097/MCC.0b013e328343476d; Cevolani D, 2012, BRAIN INJURY, V26, P431; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2010, CURR OPIN NEUROL, V23, P656, DOI 10.1097/WCO.0b013e32833fd4e7; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Gerstenbrand P, 1967, TRAUMATISCHE APALLIS; Giacino JT, 2005, PROG BRAIN RES, V150, P381, DOI 10.1016/S0079-6123(05)50027-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; HEISS WD, 1972, Z NEUROL, V203, P197, DOI 10.1007/BF00316111; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; Jellinger K, 1977, MONOGRAPHIEN GESAMTG, P88; Jellinger KA, 2008, CLIN NEUROPATHOL, V27, P365; Jellinger KA, 2010, BRAIN DEATH VEGETATI; Jellinger KA, 1976, IDEGGYOGY SZLE, V29, P51; Jellinger KA, 1983, ADV NEUROTRAUMATOLOG, P58; Jellinger K, 2012, BRAIN INJURY, V26, P382; Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Kim YW, 2010, CHINESE MED J-PEKING, V123, P2853, DOI 10.3760/cma.j.issn.0366-6999.2010.20.020; Kretschmer E, 1940, Z GESAMTE NEUROL PSY, V169, P576, DOI 10.1007/BF02871384; Laureys S, 2008, NAT CLIN PRACT NEURO, V4, P544, DOI 10.1038/ncpneuro0887; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Laureys S, 2009, PROG BRAIN RES, V177, pXIII, DOI 10.1016/S0079-6123(09)17736-1; Luchetti M, 2010, J MED ETHICS, V36, P333, DOI 10.1136/jme.2009.034835; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moratti S, 2010, CAMB Q HEALTHC ETHIC, V19, P372, DOI 10.1017/S0963180110000150; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Owen AM, 2009, PROG BRAIN RES, V177, P399, DOI 10.1016/S0079-6123(09)17728-2; Posner JB, 2007, PLUM POSNERS DIAGNOS, P400; Prisco L, 2012, BRAIN INJURY, V26, P635; Rodriguez Moreno D, 2010, NEUROLOGY, V75, P1871; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Thonnard M, 2011, M S-MED SCI, V27, P77, DOI 10.1051/medsci/201127177; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; von Wild K, 2012, J Med Life, V5, P3; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Zhou JS, 2011, CONSCIOUS COGN, V20, P257, DOI 10.1016/j.concog.2010.08.003; [No title captured]	61	10	11	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					917	923		10.3109/02699052.2013.793395			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200020	23758492				2022-02-06	
J	Kleindienst, A; Grunbeck, F; Buslei, R; Emtmann, I; Buchfelder, M				Kleindienst, Andrea; Gruenbeck, Felicitas; Buslei, Rolf; Emtmann, Irene; Buchfelder, Michael			Intraperitoneal treatment with S100B enhances hippocampal neurogenesis in juvenile mice and after experimental brain injury	ACTA NEUROCHIRURGICA			English	Article						S100B; Traumatic brain injury; Hippocampus; Neurogenesis; Neuronal differentiation; Neuroregeneration	MARROW STROMAL CELLS; ADULT HIPPOCAMPUS; CEREBROSPINAL-FLUID; COGNITIVE RECOVERY; PROGENITOR CELLS; S-100 PROTEIN; RAT-BRAIN; PROLIFERATION; NEURONS; EXPRESSION	Background Neurogenesis is documented in adult mammals including humans, is promoted by neurotrophic factors, and constitutes an innate repair mechanism following brain injury. The glial neurotrophic protein S100B is released following various types of brain injuries, enhances hippocampal neurogenesis and improves cognitive function following brain injury in rats when applied intrathecally. The present study was designed to elucidate whether the beneficial effect of S100B on injury-induced neurogenesis can be confirmed in mice when applied intraperitoneally (i.p.), and whether this effect is dose-dependent. Methods Male juvenile mice were subjected to a unilateral parietal cryolesion or sham injury, and treated with S100B at 20nM, 200nM or vehicle i.p. once daily. Hippocampal progenitor cell proliferation was quantified following labelling with bromo-deoxyuridine (BrdU, 50 mg/KG i.p.) in the germinative area of the dentate gyrus, the subgranular zone (SGZ), on day 4 as well as on cell survival and migration to the granular cell layer (GCL) on day 28. Progenitor cell differentiation was assessed following colabelling with the glial marker GFAP and the neuronal marker NeuN. Results S100B enhanced significantly the early progenitor cell proliferation in the SGZ as well as cell survival and migration to the GCL, and promoted neuronal differentiation. While these effects were predominately dose-dependent, 200nM S100B failed to enhance the proliferation in the SGZ on day 4 post-injury. Conclusion We conclude that S100B participates in hippocampal neurogenesis after injury at lower nanomolar concentrations. Therefore S100B may serve as a potential adjunct treatment to promote neuroregeneration following brain damage.	[Kleindienst, Andrea; Gruenbeck, Felicitas; Buslei, Rolf; Emtmann, Irene; Buchfelder, Michael] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany; [Kleindienst, Andrea; Gruenbeck, Felicitas; Buslei, Rolf; Emtmann, Irene; Buchfelder, Michael] Univ Erlangen Nurnberg, Dept Neuropathol, D-91054 Erlangen, Germany		Kleindienst, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Schwabachanlage 6, D-91054 Erlangen, Germany.	andrea.kleindienst@uk-erlangen.de	Kleindienst, Andrea/F-1674-2014	Kleindienst, Andrea/0000-0003-4758-0324	Grant of the Section Neurosurgical Research; German Society of Neurosurgery (DGNC); Fond for Science and Education, Friedrich-Alexander-University Erlangen-Nurnberg Medical School (ELAN)	These studies were supported in part by a Grant of the Section Neurosurgical Research, German Society of Neurosurgery (DGNC) and the Fond for Science and Education, Friedrich-Alexander-University Erlangen-Nurnberg Medical School (ELAN) to AK. None of the authors nor the academic institution or employer has any financial or ownership interest directly related to the topic of this manuscript.	Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; BAKER RN, 1971, J NEUROPATH EXP NEUR, V30, P668, DOI 10.1097/00005072-197110000-00010; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Brewton LS, 2001, BRAIN RES, V912, P9, DOI 10.1016/S0006-8993(01)02519-7; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fazeli M S, 1990, Adv Exp Med Biol, V268, P369; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Green AJE, 1997, J IMMUNOL METHODS, V205, P35, DOI 10.1016/S0022-1759(97)00050-1; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Hu JR, 1997, J NEUROCHEM, V69, P2294; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iwasaki Y, 1997, J NEUROL SCI, V151, P7, DOI 10.1016/S0022-510X(97)00073-7; Kawai T, 2004, J CEREBR BLOOD F MET, V24, P548, DOI 10.1097/00004647-200405000-00009; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; KLEIN JR, 1989, CANCER IMMUNOL IMMUN, V29, P133; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Landar A, 1996, CELL CALCIUM, V20, P279, DOI 10.1016/S0143-4160(96)90033-0; Li YK, 1998, J NEUROCHEM, V71, P1421; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nishi M, 1997, NEUROSCI LETT, V229, P212, DOI 10.1016/S0304-3940(97)00443-6; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; ODowd BS, 1997, NEUROBIOL LEARN MEM, V67, P197, DOI 10.1006/nlme.1997.3766; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; RICKMANN M, 1995, BRAIN RES, V688, P8, DOI 10.1016/0006-8993(95)00495-C; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Sargin D, 2009, GLIA, V57, P693, DOI 10.1002/glia.20797; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Siren AL, 2000, NEUROCHEM RES, V25, P957, DOI 10.1023/A:1007552408463; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Souza TME, 2000, PHYSIOL BEHAV, V71, P29, DOI 10.1016/S0031-9384(00)00299-7; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; WHITAKERAZMITIA PM, 1990, BRAIN RES, V528, P155, DOI 10.1016/0006-8993(90)90210-3; Wilder PT, 1998, PROTEIN SCI, V7, P794, DOI 10.1002/pro.5560070330; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; ZIMMER DB, 1986, J BIOL CHEM, V261, P1424	63	10	10	0	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2013	155	7					1351	1360		10.1007/s00701-013-1720-2			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	186SH	WOS:000322064500032	23649988				2022-02-06	
J	Phelan, HA				Phelan, Herb A.			Venous Thromboembolism after Traumatic Brain Injury	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						traumatic brain injury; venous thromboembolism; prophylaxis; anticoagulation	VENA-CAVA FILTERS; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; SEVERITY SCORE GREATER-THAN-2; SEVERE HEAD-INJURY; FOLLOW-UP; INTRACRANIAL HEMORRHAGE; ENOXAPARIN PROPHYLAXIS; PULMONARY-EMBOLISM; PRACTICE PATTERNS	No standard exists for venous thromboembolism (VTE) prophylaxis after traumatic brain injury (TBI). Caregivers agree that there is an early time point after injury in which the chances of spontaneous injury progression are high and the risks of prophylactic anticoagulation are excessive, and that these injuries eventually stabilize to the point that anticoagulation may be safely started. Translating this consensus into an application that can inform bedside decision making has not occurred. National groups have promulgated guidelines in the United States suggesting that anticoagulants be used when the risk of renewed intracranial hemorrhage has ceased with no guidance beyond this vague recommendation. This is largely due to the relative paucity of literature about pharmacologic prophylaxis, which has in turn been due to fears of propagation of intracranial hemorrhage. Although interest in this field has increased of late, many studies are limited by the simple dichotomization of TBI patients as having the presence or absence of intracranial blood. Although methodologically easier, this approach does not account for the heterogeneity of TBI and, consequently, the spectrum of time to stabilization. To address this, our group has created an algorithm which stratifies patients by risk for spontaneous progression and tailors a unique VTE prophylaxis regimen to each arm.	Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burns Trauma Crit Care, Dallas, TX 75390 USA		Phelan, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burns Trauma Crit Care, 5323 Harry Hines Blvd,E5-508A, Dallas, TX 75390 USA.	herb.phelan@utsouthwestern.edu					ABDELFATTAH KR, 2012, NEUR CAR SOC OCT 5 D; Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Antevil JL, 2006, J TRAUMA, V60, P35, DOI 10.1097/01.ta.0000197607.23019.ab; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; BRAKENRIDGE SC, 2012, ANN M AM ASS SURG TR; Cherry RA, 2008, J TRAUMA, V65, P544, DOI 10.1097/TA.0b013e31817f980f; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Constantini S, 2001, J NEUROSURG, V94, P918, DOI 10.3171/jns.2001.94.6.0918; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Depew AJ, 2008, AM SURGEON, V74, P906; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Duszak R, 2011, J AM COLL RADIOL, V8, P483, DOI 10.1016/j.jacr.2010.12.021; FERRIS EJ, 1993, RADIOLOGY, V188, P851, DOI 10.1148/radiology.188.3.8351361; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Greenfield L J, 1995, Cardiovasc Surg, V3, P199, DOI 10.1016/0967-2109(95)90895-C; GREENFIELD LJ, 1991, J VASC SURG, V14, P253; Hamilton MG, 2011, NEUROSURGERY, V68, P571, DOI 10.1227/NEU.0b013e3182093145; HARTERT H, 1948, KLIN WOCHENSCHR, V16, P257; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Karmy-Jones R, 2007, J TRAUMA, V62, P17, DOI 10.1097/TA.0b013e31802dd72a; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; McMurtry AL, 1999, J AM COLL SURGEONS, V189, P314, DOI 10.1016/S1072-7515(99)00137-4; MESSMER JM, 1985, RADIOLOGY, V156, P613, DOI 10.1148/radiology.156.3.4023218; MEWISSEN MW, 1989, RADIOLOGY, V173, P155, DOI 10.1148/radiology.173.1.2675181; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Moore PS, 2010, J VASC SURG, V52, P118, DOI 10.1016/j.jvs.2009.09.067; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; PAIS SO, 1988, J VASC SURG, V8, P460; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Phelan HA, 2009, J TRAUMA, V67, P485, DOI 10.1097/TA.0b013e3181ad67c1; Rajasekhar A, 2011, J THROMB THROMBOLYS, V32, P40, DOI 10.1007/s11239-010-0544-7; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; ROWELL S, 2012, ANN M AM ASS SURG TR; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Shackford SR, 2007, J TRAUMA, V63, P764, DOI 10.1097/01.ta.0000240444.14664.5f; Shackford SR, 2007, J TRAUMA, V62, P24; SIMON M, 1989, RADIOLOGY, V172, P99, DOI 10.1148/radiology.172.1.2662259; Stein PD, 2004, ARCH INTERN MED, V164, P1541, DOI 10.1001/archinte.164.14.1541; Velmahos GC, 2000, J TRAUMA, V49, P132, DOI 10.1097/00005373-200007000-00020; Wahl WL, 2011, J TRAUMA, V71, P399	57	10	11	4	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	JUL	2013	39	5					541	548		10.1055/s-0033-1343356			8	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	163WB	WOS:000320367100010	23629824				2022-02-06	
J	Liu, Y; Wang, L; Long, ZY; Wu, YM; Wan, Q; Jiang, JX; Wang, ZG				Liu, Yuan; Wang, Li; Long, Zai-yun; Wu, Ya-min; Wan, Qi; Jiang, Jian-xin; Wang, Zheng-guo			Inhibiting PTEN Protects Hippocampal Neurons against Stretch Injury by Decreasing Membrane Translocation of AMPA Receptor GluR2 Subunit	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; IN-VITRO; SYNAPTIC-TRANSMISSION; GLUTAMATE; PLASTICITY; MECHANISMS; ISCHEMIA; SUSCEPTIBILITY; PERMEABILITY; INCREASES	The AMPA type of glutamate receptors (AMPARs)-mediated excitotoxicity is involved in the secondary neuronal death following traumatic brain injury (TBI). But the underlying cellular and molecular mechanisms remain unclear. In this study, the role of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in GluR2-lacking AMPARs mediated neuronal death was investigated through an in vitro stretch injury model of neurons. It was indicated that both the mRNA and protein levels of PTEN were increased in cultured hippocampal neurons after stretch injury, which was associated with the decreasing expression of GluR2 subunits on the surface of neuronal membrane. Inhibition of PTEN activity by its inhibitor can promote the survival of neurons through preventing reduction of GluR2 on membrane. Moreover, the effect of inhibiting GluR2-lacking AMPARs was similar to PTEN suppression-mediated neuroprotective effect in stretch injury-induced neuronal death. Further evidence identified that the total GluR2 protein of neurons was not changed in all groups. So inhibition of PTEN or blockage of GluR2-lacking AMPARs may attenuate the death of hippocampal neurons post injury through decreasing the translocation of GluR2 subunit on the membrane effectively.	[Liu, Yuan; Wang, Li; Long, Zai-yun; Wu, Ya-min; Jiang, Jian-xin; Wang, Zheng-guo] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Res Inst Surg, Chongqing, Peoples R China; [Wan, Qi] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA		Wang, ZG (corresponding author), Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Res Inst Surg, Chongqing, Peoples R China.	zhengguowang1212@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30728026]; Science funds of Chongqing [csct2012jjA10131]; funds of State Key Laboratory [SKLKF201109]	This work was supported by a grant from the National Natural Science Foundation of China (#30728026), Science funds of Chongqing (csct2012jjA10131) and funds of State Key Laboratory (SKLKF201109). The National Natural Science Foundation of China (#30728026) had role in study design, data collection; Science funds of Chongqing (csct2012jjA10131) had role in data analysis; Funds of State Key Laboratory (SKLKF201109) had role in preparation of the manuscript.	Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Alessandri B, 1998, PROG BRAIN RES, V116, P303, DOI 10.1016/S0079-6123(08)60445-8; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Krassioukov AV, 2002, BRAIN RES PROTOC, V10, P60, DOI 10.1016/S1385-299X(02)00180-0; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65431	10.1371/journal.pone.0065431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	WOS:000321397800006	23799014	gold, Green Published, Green Submitted			2022-02-06	
J	Graves, JM; Sears, JM; Vavilala, MS; Rivara, FP				Graves, Janessa M.; Sears, Jeanne M.; Vavilala, Monica S.; Rivara, Frederick P.			The burden of traumatic brain injury among adolescent and young adult workers in Washington State	JOURNAL OF SAFETY RESEARCH			English	Article						Head injuries; Youth; Occupational injuries; Costs of work-related TBI; Workers' compensation data	LONG-TERM DISABILITY; UNITED-STATES; EPIDEMIOLOGY; SURVEILLANCE; REGISTRY; RISK; MODELS; COSTS; CARE	Objective: This study describes injury characteristics and costs of work-related traumatic brain injury (WRTBI) among 16-24 year olds in Washington State between 1998 and 2008. Methods: WRTBIs were identified in the Washington Trauma Registry (WTR) and linked to workers' compensation (WC) claims data. Medical and time-loss compensation costs were compared between workers with isolated TB! and TBI with other trauma. Results: Of 273 WRTBI cases identified, most (61.5%) were TBI with other trauma. One-third of WRTBI did not link to a WC claim. Medical costs averaged $88,307 (median $16,426) for isolated TBI cases, compared to $73,669 (median $41,167) for TBI with other trauma. Conclusions: Results highlight the financial impact of WRTBI among young workers. Multiple data sources provided a more comprehensive picture than a single data source alone. This linked-data approach holds great potential for future traumatic occupational injury research. Impact on Industry: TBI among young workers not only involves long-term health and psychological impacts, but is costly as well. (C) 2013 National Safety Council and Elsevier Ltd. All rights reserved.	[Graves, Janessa M.] Univ Washington, HIPRC, Dept Pediat, Sch Med, Seattle, WA 98104 USA; [Sears, Jeanne M.] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, HIPRC, Dept Anesthesiol, Sch Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, HIPRC, Dept Pain Med & Pediat, Sch Med, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, HIPRC, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Sch Med, Seattle, WA 98104 USA		Graves, JM (corresponding author), Univ Washington, HIPRC, Dept Pediat, Sch Med, UW Box 359960, Seattle, WA 98104 USA.	janessa@uw.edu; jeannes@uw.edu; vavilala@uw.edu; fpr@uw.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822-01A2] Funding Source: Medline; NIOSH CDC HHS [R03 OH009883] Funding Source: Medline		Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blough DK, 1999, J HEALTH ECON, V18, P153, DOI 10.1016/S0167-6296(98)00032-0; Campbell Kevin M, 2008, Health Informatics J, V14, P5, DOI 10.1177/1460458208088855; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Faul M, 2010, TRAUMATIC BRAIN INJU; Forst LS, 1999, J OCCUP ENVIRON MED, V41, P514, DOI 10.1097/00043764-199906000-00019; Friedman LS, 2007, J OCCUP ENVIRON MED, V49, P401, DOI 10.1097/JOM.0b013e31803b9527; Guice KS, 2007, J TRAUMA, V62, P424, DOI 10.1097/01.ta.0000200862.93527.1c; Husberg BJ, 1998, AM J IND MED, V34, P493, DOI 10.1002/(SICI)1097-0274(199811)34:5&lt;493::AID-AJIM10&gt;3.0.CO;2-X; Jackson, 2001, INJ PREV S1, V7, pI21; Kim H, 2006, NEUROREHABILITATION, V21, P269; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lowry SJ, 2010, AM J IND MED, V53, P126, DOI 10.1002/ajim.20741; Mann NC, 2006, ACAD EMERG MED, V13, P946, DOI 10.1197/j.aem.2006.04.019; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Marr A., 2004, CENTRAL NERVOUS SYST; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; Reville RT, 2001, AM J IND MED, V40, P452, DOI 10.1002/ajim.1115; Runyan CW, 2000, ANNU REV PUBL HEALTH, V21, P247, DOI 10.1146/annurev.publhealth.21.1.247; Sears JM, 2012, J OCCUP ENVIRON MED, V54, P356, DOI 10.1097/JOM.0b013e3182444fe7; Sears JM, 2011, J OCCUP ENVIRON MED, V53, P1243, DOI 10.1097/JOM.0b013e31822cff63; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; State of Washington, 2009, RCW TITL 51; Stout N., 1998, TRAUMATIC OCCUPATION; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Wei Chia, 2012, Minn Med, V95, P55; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	35	10	10	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375			J SAFETY RES	J. Saf. Res.	JUN	2013	45						133	139		10.1016/j.jsr.2012.11.001			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	164SK	WOS:000320429600016	23708485	Green Accepted			2022-02-06	
J	Sasaki, K; Anderson, E; Shankland, SJ; Nicosia, RF				Sasaki, Kotaro; Anderson, Eric; Shankland, Stuart J.; Nicosia, Roberto F.			Diffuse Proliferative Glomerulonephritis Associated With Cetuximab, an Epidermal Growth Factor Receptor Inhibitor	AMERICAN JOURNAL OF KIDNEY DISEASES			English	Article						Immunoglobulin A (IgA); diffuse proliferative glomerulonephritis; cetuximab	IGA NEPHROPATHY; DISEASE	Cetuximab is an epidermal growth factor receptor inhibitor used for advanced squamous cell carcinoma of the head and neck. We report an unusual case of diffuse proliferative and crescentic glomerulonephritis in a 67-year-old man in close temporal association with cetuximab treatment for recurrent oral squamous cell carcinoma. The patient presented with acute renal failure and nephrotic-range proteinuria. Kidney biopsy showed diffuse proliferative and focally crescentic glomerulonephritis associated with immunoglobulin A (IgA)-dominant immune-complex deposition within glomerular capillary walls and mesangium. The patient showed dramatic improvement in kidney function after discontinuation of cetuximab therapy and a short course of cyclophosphamide and steroid. The clinical outcome of this case suggests that cetuximab therapy may trigger or exacerbate IgA-mediated glomerular injury and warrants close monitoring of kidney function in patients treated with this epidermal growth factor receptor inhibitor. (c) 2013 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.	[Sasaki, Kotaro; Nicosia, Roberto F.] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [Anderson, Eric; Shankland, Stuart J.] Univ Washington, Med Ctr, Dept Nephrol, Seattle, WA 98195 USA; [Nicosia, Roberto F.] VA Puget Sound Hlth Care Syst, Pathol Serv, Seattle, WA USA; [Nicosia, Roberto F.] VA Puget Sound Hlth Care Syst, Lab Med Serv, Seattle, WA USA		Sasaki, K (corresponding author), Univ Washington, Med Ctr, 1959 NE Pacific,Box 356100, Seattle, WA 98195 USA.	ksasaki@uw.edu					[Anonymous], 2012, ERB PACK INS; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Flamant M, 2012, NEPHROL DIAL TRANSPL, V27, P1297, DOI 10.1093/ndt/gfs030; GOODYER PR, 1988, AM J PHYSIOL, V255, pF1191, DOI 10.1152/ajprenal.1988.255.6.F1191; Masutani K, 2008, CLIN EXP NEPHROL, V12, P398, DOI 10.1007/s10157-008-0066-1; Moon C, 2010, EXP BIOL MED, V235, P907, DOI 10.1258/ebm.2009.009181; Nasr SH, 2011, NEPHRON CLIN PRACT, V119, pC18, DOI 10.1159/000324180; Petrelli F, 2012, ANN ONCOL, V23, P1672, DOI 10.1093/annonc/mdr592	9	10	12	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0272-6386	1523-6838		AM J KIDNEY DIS	Am. J. Kidney Dis.	JUN	2013	61	6					988	991		10.1053/j.ajkd.2013.01.008			4	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	145FC	WOS:000318999200021	23474009				2022-02-06	
J	Henrich-Noack, P; Voigt, N; Prilloff, S; Fedorov, A; Sabel, BA				Henrich-Noack, Petra; Voigt, Nadine; Prilloff, Sylvia; Fedorov, Anton; Sabel, Bernhard A.			Transcorneal electrical stimulation alters morphology and survival of retinal ganglion cells after optic nerve damage	NEUROSCIENCE LETTERS			English	Article						Neurotrauma; Neuroprotection; Non-invasive alternating current stimulation; In vivo imaging; Retinal ganglion cells; Vision restoration	ALTERNATING-CURRENT STIMULATION; CONFOCAL NEUROIMAGING ICON; VISION; PROMOTES; RESTORATION; SPEED; CRUSH; DEATH; LIFE; CNS	Traumatic optic nerve injury leads to retrograde death of retinal ganglion cells (RGCs), but transcorneal electrical stimulation (TES) can increase the cell survival rate. To understand the mechanisms and to further define the TES-induced effects we monitored in living animals RGC morphology and survival after optic nerve crush (ONC) in real time by using in vivo confocal neuroimaging (ICON) of the retina. ONC was performed in rats and ICON was performed before crush and on post-lesion days 3, 7 and 15 which allowed us to repeatedly record RGC number and size. TES or sham-stimulation were performed immediately after the crush and on post-injury day 11. Three days after ONC we detected a higher percentage of surviving RGCs in the TES group as compared to sham-treated controls. However, the difference was below significance level on day 7 and disappeared completely by day 15. The death rate was more variable amongst the TES-treated rats than in the control group. Morphological analysis revealed that average cell size changed significantly in the control group but not in stimulated animals and the morphological alterations of surviving neurons were smaller in TES-treated compared to control cells. In conclusion, TES delays post-traumatic cell death significantly. Moreover, we found "responder animals" which also benefited in the long-term from the treatment. Our in vivo cellular imaging results provide evidence that TES reduces ONC-associated neuronal swelling and shrinkage especially in RGCs which survived long-term. Further studies are now needed to determine the differences of responders vs. non-responders. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Henrich-Noack, Petra; Voigt, Nadine; Prilloff, Sylvia; Fedorov, Anton; Sabel, Bernhard A.] Otto von Guericke Univ, Inst Med Psychol, D-39120 Magdeburg, Germany; [Henrich-Noack, Petra] ZEBIK, D-39120 Magdeburg, Germany		Henrich-Noack, P (corresponding author), Otto von Guericke Univ, Inst Med Psychol, Leipziger Str 44, D-39120 Magdeburg, Germany.	Petra.Henrich-Noack@med.ovgu.de	Sabel, Bernhard A./E-6579-2013	Sabel, Bernhard/0000-0002-4472-5543; Henrich-Noack, Petra/0000-0002-3093-6227			Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Brushart TM, 2002, J NEUROSCI, V22, P6631; Chrysikou EG, 2011, RESTOR NEUROL NEUROS, V29, P375, DOI 10.3233/RNN-2011-0610; Fedorov A, 2011, BRAIN STIMUL, V4, P189, DOI 10.1016/j.brs.2011.07.007; Fedorov Anton, 2010, Restor Neurol Neurosci, V28, P825, DOI 10.3233/RNN-2010-0580; Fujikado T, 2006, JPN J OPHTHALMOL, V50, P266, DOI 10.1007/s10384-005-0304-y; Gall C, 2011, BRAIN STIMUL, V4, P175, DOI 10.1016/j.brs.2011.07.003; Gall C, 2010, NEUROREHABILITATION, V27, P335, DOI 10.3233/NRE-2010-0617; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Inomata K, 2007, GRAEF ARCH CLIN EXP, V245, P1773, DOI 10.1007/s00417-007-0610-9; Miyake K, 2007, INVEST OPHTH VIS SCI, V48, P2356, DOI 10.1167/iovs.06-1329; Morimoto T, 2005, INVEST OPHTH VIS SCI, V46, P2147, DOI 10.1167/iovs.04-1339; Morimoto T, 2002, NEUROREPORT, V13, P227, DOI 10.1097/00001756-200202110-00011; Morimoto T, 2007, INVEST OPHTH VIS SCI, V48, P4725, DOI 10.1167/iovs.06-1404; Morimoto T, 2010, EXP EYE RES, V90, P285, DOI 10.1016/j.exer.2009.11.002; Ni YQ, 2009, EXP NEUROL, V219, P439, DOI 10.1016/j.expneurol.2009.06.016; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Prilloff S, 2010, EUR J NEUROSCI, V31, P521, DOI 10.1111/j.1460-9568.2010.07078.x; Rousseau V, 1999, NEUROREPORT, V10, P3387, DOI 10.1097/00001756-199911080-00024; Sabel BA, 1997, NAT MED, V3, P244, DOI 10.1038/nm0297-244; Sabel BA, 2011, RESTOR NEUROL NEUROS, V29, P493, DOI 10.3233/RNN-2011-0624; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; SAUTTER J, 1991, BRAIN RES, V565, P23, DOI 10.1016/0006-8993(91)91732-G; Schatz A, 2011, INVEST OPHTH VIS SCI, V52, P4485, DOI 10.1167/iovs.10-6932	24	10	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 24	2013	543						1	6		10.1016/j.neulet.2013.03.013			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154BH	WOS:000319646000001					2022-02-06	
J	Cook, LG; Hanten, G; Orsten, KD; Chapman, SB; Li, XQ; Wilde, EA; Schnelle, KP; Levin, HS				Cook, Lori G.; Hanten, Gerri; Orsten, Kimberley D.; Chapman, Sandra B.; Li, Xiaoqi; Wilde, Elisabeth A.; Schnelle, Kathleen P.; Levin, Harvey S.			Effects of Moderate to Severe Traumatic Brain Injury on Anticipating Consequences of Actions in Adolescents: A Preliminary Study	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI; Adolescence; Virtual reality; Social; Decision making; Brain structure	VIRTUAL ENVIRONMENT TECHNOLOGY; EXECUTIVE FUNCTIONS; DECISION-MAKING; CORTICAL THICKNESS; SOCIAL OUTCOMES; RISK-TAKING; CHILDHOOD; REALITY; SKILLS; MRI	For this pilot study, we compared performance of 15 adolescents with moderate-severe traumatic brain injury (TBI) to that of 13 typically developing (TD) adolescents in predicting social actions and consequences for avatars in a virtual microworld environment faced with dilemmas involving legal or moral infractions. Performance was analyzed in relation to cortical thickness in brain regions implicated in social cognition. Groups did not differ in number of actions predicted nor in reasons cited for predictions when presented only the conflict situation. After viewing the entire scenario, including the choice made by the avatar, TD and TBI adolescents provided similar numbers of short-term consequences. However, TD adolescents provided significantly more long-term consequences (p = .010). Additionally, for the Overall qualitative score, TD adolescents' responses were more likely to reflect the long-term impact of the decision made (p = .053). Groups differed in relation of the Overall measure to thickness of right medial prefrontal cortex/frontal pole and precuneus, with stronger relations for the TD group (p <.01). For long-term consequences, the relations to the posterior cingulate, superior medial frontal, and precentral regions, and to a lesser extent, the middle temporal region, were stronger for the TBI group (p <.01).	[Cook, Lori G.; Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75235 USA; [Cook, Lori G.; Chapman, Sandra B.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75235 USA; [Hanten, Gerri; Li, Xiaoqi; Wilde, Elisabeth A.; Schnelle, Kathleen P.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hanten, Gerri; Orsten, Kimberley D.] Rice Univ, Dept Psychol, Houston, TX 77251 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA		Cook, LG (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 W Mockingbird Lane, Dallas, TX 75235 USA.	lori.cook@utdallas.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2R01 NS 21889-16]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Grant 2R01 NS 21889-16. The authors report no conflicts of interest.	Anderson V., 1999, PEDIAT REHAB, V3, P137; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Biocca F, 2003, PRESENCE-VIRTUAL AUG, V12, P456, DOI 10.1162/105474603322761270; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Cohen J., 2013, STAT POWER ANAL BEHA; Cook L. G., 2011, SIG 2 PERSPECTIVES N, V21, P33, DOI DOI 10.1044/NNSLD21.1.33; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dorfel D., 2009, EUROPEAN J NEUROSCIE, V30, P1947; Freeman D, 2008, BRIT J PSYCHIAT, V192, P258, DOI 10.1192/bjp.bp.107.044677; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 2006, MOL CELL ENDOCRINOL, V254, P154, DOI 10.1016/j.mce.2006.04.016; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2006, NEUROCASE, V12, P247, DOI 10.1080/13554790600910490; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Heeter C., 1992, PRESENCE TELEOPERATO, V1, P262, DOI [10.1162/pres.1992.1.2.262, DOI 10.1162/PRES.1992.1.2.262]; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; Krawczyk DC, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00062; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mitchell P, 2007, J AUTISM DEV DISORD, V37, P589, DOI 10.1007/s10803-006-0189-8; Moore K, 2002, CYBERPSYCHOL BEHAV, V5, P197, DOI 10.1089/109493102760147178; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Parsons S, 2004, J AUTISM DEV DISORD, V34, P449, DOI 10.1023/B:JADD.0000037421.98517.8d; Parsons S, 2002, J INTELL DISABIL RES, V46, P430, DOI 10.1046/j.1365-2788.2002.00425.x; Parsons S, 2006, COMPUT EDUC, V47, P186, DOI 10.1016/j.compedu.2004.10.003; Riva G, 2007, CYBERPSYCHOL BEHAV, V10, P45, DOI 10.1089/cpb.2006.9993; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Semel E., 1995, CLIN EVALUATION LANG, VThird; Sohlberg MM, 1998, APHASIOLOGY, V12, P1047, DOI 10.1080/02687039808249469; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; Wechsler D., 2011, WECHSLER ABBREVIATED; Weiderholt J.L., 2001, GRAY ORAL READING TE, V4th; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; YEATES KO, 1991, MERRILL PALMER QUART, V37, P369; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	59	10	10	0	23	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2013	19	5					508	517		10.1017/S1355617712001452			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	136OB	WOS:000318370100003	23312035				2022-02-06	
J	Esbjornsson, E; Skoglund, T; Mitsis, MK; Hofgren, C; Larsson, J; Sunnerhagen, KS				Esbjornsson, Eva; Skoglund, Thomas; Mitsis, Marios-Konstantinos; Hofgren, Caisa; Larsson, Jerry; Sunnerhagen, Katharina S.			Cognitive impact of traumatic axonal injury (TAI) and return to work	BRAIN INJURY			English	Article						Traumatic brain injury; traumatic axonal injury; cognition; employment; follow-up	BRAIN-INJURY; MAGNETIC-RESONANCE; HEAD-INJURY; INFORMATION; POPULATION; IMPAIRMENT; SEQUELAE; DEFICITS; SPEED; COMA	Objective: Axonal injury (AI) after traumatic brain injury (TBI) is often overlooked as an explanation for cognitive complaints when no damage is detected by computed tomography. The purpose was to assess cognition during the 12 months following a TBI and suspected traumatic axonal injury (TAI). Methods: The sample included 17 patients younger than 65 years old, however one died. In the acute phase and at 6 and 12 months, cognition, reaction time, psychomotor performance and finger tapping speed were assessed. Working memory and work status were added at 12 months. Acute MRI findings were recorded. Results: After 1 year, all patients still showed cognitive dysfunction. A recovery had been noted at 6 months, but a cognitive decline was indicated for the majority at 12 months. The sick-listed patients had TAI located in the corpus callosum and the brainstem. They were cognitively more impaired and in more areas than the four patients who had returned to work. Conclusion: Cognitive screening can identify the long-term impact of TAI identified by conventional MRI, used as a routine clinical technique. For rehabilitation and for insurance-related matters, these injuries must be taken seriously, as a deterioration over time might occur. Further research is needed.	[Esbjornsson, Eva; Skoglund, Thomas; Hofgren, Caisa; Larsson, Jerry; Sunnerhagen, Katharina S.] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Mitsis, Marios-Konstantinos] Sahlgrens Univ Hosp, Dept Radiol, S-41345 Gothenburg, Sweden		Esbjornsson, E (corresponding author), Sahlgrens Univ Hosp, Dubbsgatan 14,3rd Floor, S-41345 Gothenburg, Sweden.	eva.esbjornsson@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400	Health and Medical Care Committee of Vastra Gotaland	The study was supported in part by a grant from the Health and Medical Care Committee of Vastra Gotaland. No commercial interest is present among any of the authors.	Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2006, ACTA NEUROCHIR WIEN, V148, P93; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Fred O., 1994, REAKTIONSTIDSMATNING; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Johnson VE, 2012, EXPT NEUROLOGY; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Park SJ, 2009, J KOREAN NEUROSURG S, V46, P205, DOI 10.3340/jkns.2009.46.3.205; Prigatano GP, 2008, BNI SCREEN HIGHER CE; Reitan R, 1985, HALSTEAD REITAN NEUR; Rosenstein LD., 1995, ADM SCORING MANUAL B; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Senzaki Akira, 2007, Seishin Shinkeigaku Zasshi, V109, P199; Skandsen T, 2011, J NEUROTRAUM, V133, P556; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vik Anne, 2006, Tidsskr Nor Laegeforen, V126, P2940; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730	31	10	10	0	13	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2013	27	5					521	528		10.3109/02699052.2012.743179			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	124UK	WOS:000317493000002	23472977				2022-02-06	
J	Konczalla, J; Mrosek, J; Wanderer, S; Schuss, P; Guresir, E; Seifert, V; Vatter, H; Platz, J				Konczalla, Juergen; Mrosek, Jan; Wanderer, Stefan; Schuss, Patrick; Gueresir, Erdem; Seifert, Volker; Vatter, Hartmut; Platz, Johannes			Functional Effects of Levosimendan in Rat Basilar Arteries In Vitro	CURRENT NEUROVASCULAR RESEARCH			English	Article						ET(A) receptor; ET(B) receptor; ET-1; endothelin; levosimendan; prostaglandin	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL VASOSPASM; ENDOTHELIN-B RECEPTORS; TUMOR-NECROSIS-FACTOR; CEREBROSPINAL-FLUID; HEART-FAILURE; MODEL; METABOLISM; EXPRESSION; MANAGEMENT	Levosimendan is a novel calcium sensitizer that is an established treatment for congestive heart failure. In coronary vessels, levosimendan has a vasorelaxant, endothelium-independent effect and an antagonistic effect on endothelin-1 (ET-1). There is also some data for a neuroprotective effect in a traumatic brain injury model, and levosimendan can prevent the reduction of the luminal area of the basilar artery. We considered that patients who suffer heart attack after subarachnoid hemorrhage (SAH) might respond well to levosimendan, which might also be useful to induce hypertension in patients with cerebral vasospasm. However, the functional effects of levosimendan in the cerebrovasculature are unknown. Here, we investigated the functional role of levosimendan on rat basilar artery by assessing vasocontractile reactivity in response to ET-1, sarafotoxin S6c, acetylcholine, sodium nitroprusside, cGMP, and prostaglandin F2 alpha (PGF). Contrary to observations in coronary vessels, levosimendan did not affect the ET-1 system in cerebral arteries; neither ET(A)-receptor-induced contraction nor ET(B)-receptor-dependent relaxation were changed. For the nitric oxide (NO) pathway, only a slight increase was detected. Rather, levosimendan caused significant and dose-dependent relaxation after PGF precontraction. To our knowledge, this is the first report that describes levosimendan-induced functional changes of cerebrovascular contractility and relaxation. Under physiological conditions, levosimendan did not influence ET(A)/ET(B)-receptor signaling or the NO pathway. Interestingly, levosimendan seemed to affect the prostaglandin system and dose-dependently reversed PGF-induced contraction. We did not detect a vasospastic potential for levosimedan in cerebral arteries, suggesting that it would be safe for use in SAH patients.	[Konczalla, Juergen; Mrosek, Jan; Wanderer, Stefan; Schuss, Patrick; Gueresir, Erdem; Seifert, Volker; Vatter, Hartmut; Platz, Johannes] Goethe Univ Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany		Konczalla, J (corresponding author), Goethe Univ Frankfurt, Dept Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	J.Konczalla@med.uni-frankfurt.de	Guresir, Erdem/AAL-4484-2020; Guresir, Erdem/AAV-7224-2021; Schuss, Patrick/ABC-6469-2020; Konczalla, Juergen/AAJ-8528-2021	Guresir, Erdem/0000-0001-8319-0847; Schuss, Patrick/0000-0002-5806-2576; Konczalla, Juergen/0000-0001-9771-7806			Archan S, 2008, CURR OPIN ANESTHESIO, V21, P78, DOI 10.1097/ACO.0b013e3282f357a5; Asaeda M, 2005, NEUROSCI LETT, V373, P222, DOI 10.1016/j.neulet.2004.10.008; BARNARD JW, 1992, J APPL PHYSIOL, V72, P2469, DOI 10.1152/jappl.1992.72.6.2469; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Busani S, 2010, J TRAUMA, V68, pE108, DOI 10.1097/TA.0b013e31817c4284; Buyuklu M, 2012, ARQ BRAS CARDIOL, V99, P659; Cengiz SL, 2010, BRAIN INJURY, V24, P877, DOI 10.3109/02699051003789260; Figgitt DP, 2001, DRUGS, V61, P613, DOI 10.2165/00003495-200161050-00006; Gruhn N, 1998, J CARDIOVASC PHARM, V31, P741, DOI 10.1097/00005344-199805000-00013; Hansen-Schwartz J, 2004, ACTA NEUROL SCAND, V109, P33, DOI 10.1034/j.1600-0404.2003.00170.x; Jadhav VD, 2008, CEREBROVASC DIS, V25, P362, DOI 10.1159/000118383; Jensen H, 2011, SCAND CARDIOVASC J, V45, P307, DOI 10.3109/14017431.2011.583356; KITAZONO T, 1995, J PHARMACOL EXP THER, V273, P1; Komotar RJ, 2007, J NEUROL SCI, V261, P134, DOI 10.1016/j.jns.2007.04.046; Konczalla J, 2006, EXP BIOL MED, V231, P1064; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; LANZINO G, 1994, J NEUROSURG ANESTH, V6, P156; Larysz-Brysz M, 2012, CURR NEUROVASC RES, V9, P159, DOI 10.2174/156720212801619045; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; Montes FR, 2006, ANESTH ANALG, V103, P1094, DOI 10.1213/01.ane.0000244326.38206.a0; Nilsson T, 1997, NEUROSURGERY, V40, P346, DOI 10.1097/00006123-199702000-00023; Paczkowska E, 2013, J NEUROL SCI; Raabe A, 2005, ZBL NEUROCHIR, V66, P79, DOI 10.1055/s-2005-836479; Roehl AB, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-81; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; SCHILLING L, 1995, J CEREBR BLOOD F MET, V15, P699, DOI 10.1038/jcbfm.1995.86; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; SEIFERT V, 1987, SURG NEUROL, V27, P243, DOI 10.1016/0090-3019(87)90037-1; Trikas A, 2006, EUR J HEART FAIL, V8, P804, DOI 10.1016/j.ejheart.2006.03.003; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66; Vatter H, 2007, J NEUROSURG, V107, P121, DOI 10.3171/JNS-07/07/0121; Vatter H, 2011, ACTA NEUROCHIR SUPPL, V110, P177, DOI 10.1007/978-3-7091-0353-1_31	32	10	10	0	10	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	MAY	2013	10	2					126	133		10.2174/1567202611310020005			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	123NM	WOS:000317396900005	23469954				2022-02-06	
J	Molcanyi, M; Bosche, B; Kraitsy, K; Patz, S; Zivcak, J; Riess, P; El Majdoub, F; Hescheler, J; Goldbrunner, R; Schafer, U				Molcanyi, Marek; Bosche, Bert; Kraitsy, Klaus; Patz, Silke; Zivcak, Jozef; Riess, Peter; El Majdoub, Faycal; Hescheler, Juergen; Goldbrunner, Roland; Schaefer, Ute			Pitfalls and fallacies interfering with correct identification of embryonic stem cells implanted into the brain after experimental traumatic injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Embryonic stem cell; Cell transplantation; GFP; Traumatic brain injury; Macrophage; Phagocytosis; In vivo trafficking; Autofluorescence	REGENERATE INFARCTED MYOCARDIUM; SUPERPARAMAGNETIC IRON-OXIDE; MAGNETIC-RESONANCE TRACKING; GREEN FLUORESCENT PROTEIN; IN-VIVO; CEREBROCORTICAL NECROSIS; RAT-BRAIN; INFLAMMATORY RESPONSE; EXPERIMENTAL STROKE; SPINAL-CORD	Cell-therapy was proposed to be a promising tool in case of death or impairment of specific cell types. Correct identification of implanted cells became crucial when evaluating the success of transplantation therapy. Various methods of cell labeling have been employed in previously published studies. The use of intrinsic signaling of green fluorescent protein (GFP) has led to a well known controversy in the field of cardiovascular research. We encountered similar methodological pitfalls after transplantation of GFP-transfected embryonic stem cells into rat brains following traumatic brain injury (TBI). As the identification of implanted graft by intrinsic autofluorescence failed, anti-GFP labeling coupled to fluorescent and conventional antibodies was needed to visualize the implanted cells. Furthermore, different cell types with strong intrinsic autofluorescence were found at the sites of injury and transplantation, thus mimicking the implanted stem cells. GFP-positive stem cells were correctly localized, using advanced histological techniques. The activation of microglia/macrophages, accompanying the transplantation post TBI, was shown to be a significant source of artefacts, interfering with correct identification of implanted stem cells. Dependent on the strategy of stem cell tracking, the phagocytosis of implanted cells as observed in this study, might also impede the interpretation of results. Critical appraisal of previously published data as well as a review of different histological techniques provide tools for a more accurate identification of transplanted stem cells. (C) 2013 Elsevier B.V. All rights reserved.	[Molcanyi, Marek; Goldbrunner, Roland] Univ Cologne, Clin Neurosurg, D-50937 Cologne, Germany; [Bosche, Bert] Univ Essen Gesamthsch, Neurol Clin, D-45147 Essen, Germany; [Kraitsy, Klaus; Patz, Silke; Schaefer, Ute] Med Univ Graz, Res Unit Expt Neurotraumatol, A-8036 Graz, Austria; [Zivcak, Jozef] Tech Univ Kosice, Kosice 04200, Slovakia; [Riess, Peter] HELIOS Klinikum Siegburg, Clin Trauma & Orthopaed Surg, D-53721 Siegburg, Germany; [El Majdoub, Faycal] Univ Cologne, Clin Stereotaxy & Funct Neurosurg, D-50937 Cologne, Germany; [Hescheler, Juergen] Univ Cologne, Inst Neurophsysiol, D-50931 Cologne, Germany		Schafer, U (corresponding author), Med Univ Graz, Res Unit Expt Neurotraumatol, Auenbruggerpl 22, A-8036 Graz, Austria.	ute.schaefer@medunigraz.at	Bosche, Bert/AAB-7150-2020; Zivcak, Jozef/AAD-6090-2019	Zivcak, Jozef/0000-0003-4316-5107; Bosche, Bert/0000-0002-5313-3195	Stem Cell Network North Rhine Westphalia, Germany	This study was supported by theStem Cell Network North Rhine Westphalia, Germany. We would like to thank Prof. K. -A. Hossmann, emeritus director of Max Planck Institute for Neurological Research in Cologne for his kind help, scientific expertise and constructive comments, leading to the birth of this publication. The authors would like to recognize Michael Diedenhofen for his professional assistance in editing the confocal microscopy data. We are grateful to Pavol Gomolcak, Prof. Michael Brockmann, Pavol Kocan, Frantisek Gmiter, Marian Benicky, Prof. Ivan Jurkovic, Prof. Andrej Boor and Ladislav Sokol for sharing their methodological expertise in advanced histological procedures. Formatting was kindly done by Daniel Cieszkowski.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Arnhold S, 2000, J NEUROSURG, V93, P1026, DOI 10.3171/jns.2000.93.6.1026; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; BEISKER W, 1987, CYTOMETRY, V8, P235, DOI 10.1002/cyto.990080218; Bentz K, 2007, J NEUROSCI RES, V85, P1057, DOI 10.1002/jnr.21219; Bentz K, 2006, CELL PHYSIOL BIOCHEM, V18, P275, DOI 10.1159/000097674; Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Bulte JWM, 2002, J CEREBR BLOOD F MET, V22, P899, DOI 10.1097/00004647-200208000-00001; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Cao Qi-lin, 2002, Methods Mol Biol, V198, P307; Chen KA, 2006, EXP NEUROL, V198, P129, DOI 10.1016/j.expneurol.2005.11.016; COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396; Del Conte G, 1907, ZIEGLERS BEITRAGE, V42, P193; DEYL Z, 1980, BIOCHIM BIOPHYS ACTA, V625, P248, DOI 10.1016/0005-2795(80)90288-3; EDWIN EE, 1981, J NEUROCHEM, V37, P1054, DOI 10.1111/j.1471-4159.1981.tb04497.x; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Erdo Franciska, 2004, Orvosi Hetilap, V145, P1307; HAWRYLAK N, 1993, EXP NEUROL, V121, P181, DOI 10.1006/exnr.1993.1085; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; HORINO R, 1994, J VET MED SCI, V56, P481, DOI 10.1292/jvms.56.481; JACKMAN R, 1983, VET REC, V112, P548, DOI 10.1136/vr.112.23.548; Jander S, 2007, STROKE, V38, P642, DOI 10.1161/01.STR.0000250048.42916.ad; Jessberger S, 2007, STEM CELLS, V25, P871, DOI 10.1634/stemcells.2006-0620; Lee IH, 2004, EXP NEUROL, V187, P509, DOI 10.1016/j.expneurol.2004.02.007; Lepore AC, 2006, EXP NEUROL, V201, P49, DOI 10.1016/j.expneurol.2006.03.032; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; LITTLE PB, 1978, VET REC, V103, P76, DOI 10.1136/vr.103.4.76; MARKSON LM, 1982, VET REC, V111, P338, DOI 10.1136/vr.111.15.338; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Molcanyi M, 2009, CELL PHYSIOL BIOCHEM, V24, P87, DOI 10.1159/000227816; Mosiman VL, 1997, CYTOMETRY, V30, P151; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437, DOI 10.1177/002215540205000315; Nighoghossian N, 2007, STROKE, V38, P303, DOI 10.1161/01.STR.0000254548.30258.f2; OEHMICHEN M, 1986, FORENSIC SCI INT, V30, P281, DOI 10.1016/0379-0738(86)90136-2; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Pearson H, 2004, NAT MED, V10, P445, DOI 10.1038/nm0504-445; Prasad ML, 1999, AM J SURG PATHOL, V23, P176, DOI 10.1097/00000478-199902000-00006; Rausch M, 2001, MAGNET RESON MED, V46, P1018, DOI 10.1002/mrm.1290; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211; Saleh A, 2004, NMR BIOMED, V17, P163, DOI 10.1002/nbm.881; Schipper HM, 2002, DEV NEUROSCI-BASEL, V24, P169, DOI 10.1159/000065692; Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003788; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Schroeter M, 2004, MAGNET RESON MED, V52, P403, DOI 10.1002/mrm.20142; Shibahara T, 1999, AUST VET J, V77, P329, DOI 10.1111/j.1751-0813.1999.tb10275.x; Sortwell CE, 2003, FRONT BIOSCI, V8, pS522, DOI 10.2741/1096; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Weber R, 2005, MAGN RESON MED, V54, P59, DOI 10.1002/mrm.20532; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; Wurmser AE, 2002, NATURE, V416, P485, DOI 10.1038/416485a; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang PB, 2009, NEUROPATHOLOGY, V29, P410, DOI 10.1111/j.1440-1789.2008.00993.x	73	10	10	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	APR 30	2013	215	1					60	70		10.1016/j.jneumeth.2013.02.012			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	142WK	WOS:000318828100007	23454685				2022-02-06	
J	Chen, DX; Zhu, AD; Zhang, ZB				Chen, Dexing; Zhu, Andong; Zhang, Zhibo			Total Laparoscopic Roux-en-Y Cholangiojejunostomy for the Treatment of Biliary Disease	JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS			English	Article						Laparoscopy; Roux-en-Y cholangiojejunostomy; Common bile duct stone; Bile duct injury; Congenital choledochal cyst; Hepatic portal cholangiocarcinoma; Cancer of pancreatic head; Periampullary cancer	BILE-DUCT INJURY; MANAGEMENT; BYPASS	Background and Objectives: Roux-en-Y cholangiojejunostomy (RCJS) has been widely used in biliary bypass surgeries, but in most reported literature, an assisted mini-incision was needed, and studies reporting total laparoscopic Roux-en-Y cholangiojejunostomy (TLRCJS) are rare. The goal of this study was to investigate how to treat hepatic portal bile duct diseases and perform jejunojejunostomy and cholangiojejunostomy totally laparoscopically. We evaluated the feasibility of TLRCJS in treating biliary tract diseases. Methods: TLRCJS were performed in 103 patients from January 2000 to August 2011. There were 28 cases of recurrent choledocholithiasis combined with stricture of the common bile duct (CBD) after several stone extractions, 3 patients with iatrogenic bile duct injury, 24 patients with choledochal cyst, 36 patients with hepatic portal cholangiocarcinoma, and 12 patients with cancer of the pancreatic head and periampullary cancer. All surgeries were performed through 5 trocars. First, laparoscopic surgery on the CBD was performed according to the original disease. The CBD was opened and stones were extracted in choledocholithiasis patients. In iatrogenic injury patients, strictured CBD was resected and repaired. Dilated CBD or choledochal cyst with tumor was transected. In patients with malignant jaundice, the CBD was opened longitudinally. At the same time, the bile duct was prepared for cholangiojejunostomy. Second, the positions of the laparoscope and surgeons were altered. The jejunal mesentery and jejunum were transected, and side-to-side jejunojejunostomy (JJS) was performed. The laparoscope and surgeon positions were exchanged again; the Roux-en-Y biliary limb was lifted close to the residual bile duct; and side-to-side or end-to-side choledochojejunostomy (CJS) was performed. Finally, an abdominal drainage tube was placed. Results: All the surgeries were performed successfully. The diameter of the residual bile duct ranged from 0.4 to 3.2 cm (average, 0.9 cm). Three patients had postoperative bile leakage and were treated from 1 week to approximately 1 month with abdominal drainage. Postoperative intraperitoneal hemorrhage and stress ulcer of the stomach occurred in 2 patients with biliary tract injury combined with obstructive jaundice. One with intraperitoneal hemorrhage was cured by another laparoscopic surgery. The other patient was cured after 2 days of abdominal drainage, antacids, and hemostatic drug therapy. The follow-up duration of 95 patients was 4 to 93 months (average, 48.3 months). The follow-up rate was 92.2% (95/103). Patients with cancer died of metastasis or cachexia during 14-month follow-up with no postoperative complication. Reflux cholangitis occurred in 3 patients 2, 3, and 5 years after the operation, respectively. No anastomotic stricture or other complication was found in other patients during the follow-up. Conclusions: TLRCJS is the best and first choice for patients with biliary tract diseases that need biliary-jejunal anastomosis. But it is essential that the surgeon has proficiency in laparoscopic surgeries.	[Chen, Dexing; Zhu, Andong; Zhang, Zhibo] Qianwei Hosp Jilin Prov, Changchun 130012, Jilin Province, Peoples R China		Chen, DX (corresponding author), Qianwei Hosp Jilin Prov, 1445 Qianjin St, Changchun 130012, Jilin Province, Peoples R China.	jlchendexing@163.com					Chen DX, 2008, MINIMALLY INVASIVE S, P201; Connor S, 2006, BRIT J SURG, V93, P158, DOI 10.1002/bjs.5266; CUSCHIERI A, 1994, ENDOSCOPY, V26, P134, DOI 10.1055/s-2007-1008940; Date RS, 2005, PANCREATOLOGY, V5, P325, DOI 10.1159/000086533; Han HS, 2004, SURG LAPARO ENDO PER, V14, P80, DOI 10.1097/00129689-200404000-00006; Jia Jun, 2004, Zhonghua Wai Ke Za Zhi, V42, P1056; Lau WY, 2010, ANZ J SURG, V80, P75, DOI 10.1111/j.1445-2197.2009.05205.x; Long L, 2004, J PEDIATR SURG, V39, P1663, DOI 10.1016/j.jpedsurg.2004.07.012; Mann CD, 2009, ANZ J SURG, V79, P471, DOI 10.1111/j.1445-2197.2008.04798.x; Schob OM, 1997, AM J SURG, V173, P312, DOI 10.1016/S0002-9610(96)00397-2; Schob OM, 1996, SURG LAPAROSC ENDOSC, V6, P341, DOI 10.1097/00019509-199610000-00002; SHIMI S, 1992, BRIT J SURG, V79, P317, DOI 10.1002/bjs.1800790411; Tang CN, 2007, HEPATO-GASTROENTEROL, V54, P503; Tang ST, 2011, SURG ENDOSC, V25, P416, DOI 10.1007/s00464-010-1183-y; Tian Y, 2010, J GASTROINTEST SURG, V14; Toumi Z, 2011, SURG ENDOSC, V25, P2105, DOI 10.1007/s00464-010-1544-6; Urushihara N, 2011, J LAPAROENDOSC ADV S, V21, P361, DOI 10.1089/lap.2010.0373; Xu H, 1996, CHINESE J SURG, V34, P128; Xu XD, 2011, AM SURGEON, V77, P1584; Yuquan T, 2005, CHINESE J PRACT SURG, V14, P564	20	10	17	0	8	SOC LAPAROENDOSCOPIC SURGEONS	MIAMI	7330 SW 62 PL, STE 410, MIAMI, FL 33143-4825 USA	1086-8089			JSLS-J SOC LAPAROEND	JSLS-J. Soc. Laparoendosc. Surg.	APR-JUN	2013	17	2					178	187		10.4293/108680813X13654754535232			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	200CV	WOS:000323045800003	23815976	hybrid, Green Published, Green Submitted			2022-02-06	
J	Horner, MD; Mintzer, JE; Turner, TH; Edmiston, KR; Brawman-Mintzer, O				Horner, Michael David; Mintzer, Jacobo E.; Turner, Travis H.; Edmiston, Keith R.; Brawman-Mintzer, Olga			Attentional functioning in patients with posttraumatic stress disorder: a preliminary study	CNS SPECTRUMS			English	Article						PTSD; neuropsychology; attention; cognition	COMBAT VETERANS; MEMORY FUNCTION; PTSD; SYMPTOMS; DEFICITS	Objective. To compare patients with posttraumatic stress disorder (PTSD) to patients without psychiatric or cognitive disorders on neuropsychological measures of attention. Methods. The sample included 19 patients with PTSD and 22 participants with no cognitive or psychiatric diagnosis. All had been referred for clinical neuropsychological evaluation at a VA Medical Center. None were diagnosed with dementia, delirium, or current substance dependence except nicotine or caffeine, and none had a history of stroke or of traumatic brain injury with loss of consciousness. Patients were excluded if they failed to exert adequate effort on testing. Results. PTSD patients performed significantly more poorly than patients without psychiatric diagnoses on Digit Span. Conclusion. PTSD patients were impaired relative to participants without psychiatric diagnoses on a measure of focused attention. Several factors, including the small sample size, suggest that the results should be considered preliminary.	[Horner, Michael David; Mintzer, Jacobo E.; Turner, Travis H.; Brawman-Mintzer, Olga] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA; [Horner, Michael David; Mintzer, Jacobo E.; Turner, Travis H.; Brawman-Mintzer, Olga] Med Univ S Carolina, Charleston, SC 29425 USA; [Edmiston, Keith R.] Coll Charleston, Charleston, SC 29401 USA		Horner, MD (corresponding author), Ralph H Johnson VA Med Ctr, Mental Hlth Serv 116, 109 Bee St, Charleston, SC 29401 USA.	hornermd@musc.edu	Kilic, Cengiz/I-9145-2013		Department of Veterans AffairsUS Department of Veterans Affairs; PfizerPfizer; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); GenentechRoche HoldingGenentech; University of San Diego; Novartis, Inc.; JanssenJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; Wyeth, Inc.Wyeth; Lilly Research Labs; Eli Lilly CompanyEli Lilly; CSP [545]; Elan Pharmaceuticals; BioPharma Connex; TakedaTakeda Pharmaceutical Company Ltd; Shire; NovartisNovartis	This study was supported in part by the Department of Veterans Affairs.; Jacobo Mintzer has the following disclosures: Pfizer: research support (grant); NIH/NIA: research support (grant); Genentech: research support (grant); University of San Diego: research support (grant); Novartis, Inc.: research support (grant); Janssen: research support (grant); Wyeth, Inc.: research support (grant); Lilly Research Labs: research support (grant); Eli Lilly & Company: research support (grant); CSP #545: research support (grant); Elan Pharmaceuticals: research support (grant); BioPharma Connex: founder and chair (salary); NeuroQuest: consultant. Olga Brawman-Mintzer has the following disclosures: Takeda: research support (grant); Shire: research support (grant); Novartis: research support (grant). The remaining authors have nothing to disclose.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Eren-Kocak E, 2009, ACTA PSYCHIAT SCAND, V119, P35, DOI 10.1111/j.1600-0447.2008.01281.x; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Green P., 2003, WORD MEMORY TEST MAN; Hart J, 2008, J NEUROPSYCH CLIN N, V20, P309, DOI 10.1176/appi.neuropsych.20.3.309; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Kanagaratnam P, 2007, J ANXIETY DISORD, V21, P510, DOI 10.1016/j.janxdis.2006.06.008; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Reitan R, 1985, HALSTEAD REITAN NEUR; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wechsler D., 1997, WECHSLER MEMORY SCAL; Woodward SH, 2009, J INT NEUROPSYCH SOC, V15, P830, DOI 10.1017/S1355617709990476; Yaffe K, 2009, ALZH ASS INT C ALZH	30	10	10	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1092-8529	2165-6509		CNS SPECTRUMS	CNS Spectr.	APR	2013	18	2					90	94		10.1017/S1092852912000909			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	119WO	WOS:000317130200006	23298713				2022-02-06	
J	Kosty, JA; Stein, SC				Kosty, Jennifer A.; Stein, Sherman C.			Measuring outcome after severe TBI	NEUROLOGICAL RESEARCH			English	Article						TBI; Outcome; GOS; SF-36; Comparative effectiveness research	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; DISABILITY RATING-SCALE; SICKNESS IMPACT PROFILE; SPINAL-CORD-INJURY; LONG-TERM OUTCOMES; SEVERE HEAD-INJURY; 1ST 5 YEARS; COMMUNITY INTEGRATION; FUNCTIONAL ASSESSMENT	Objectives: To review current scales for measuring outcome following traumatic brain injury (TBI) and discuss changes in the types and use of these scales for the purposes of facilitating comparative effectiveness research. Methods: Functional, psychosocial/neurocognitive, and quality of life (QOL) scales used for assessing outcome following TBI are presented, along with the limitations of each. Core common data element scales are noted, and parametric, preference-based scales for performing comparative effectiveness research are discussed. Results: Many of the common outcome scales used in TBI research, including the Glasgow outcome scale (GOS), are functional measures. The emotional, cognitive, and psychosocial aspects of recovery are increasingly recognised, and metrics assessing these domains are becoming more common. Quality of life scales, which can be either directly used or translated into parametric preference-based indices for comparative effectiveness research are important for assessing patient-oriented outcomes, and in the upcoming years may yield information that improves medical decision-making, and ultimately outcomes following TBI. Discussion: Traumatic brain injury disrupts normal physical, cognitive, emotional, and social processes. Despite the dominance of functional scales like the GOS in the neurosurgical and neurocritical care literature, the use of other outcome modalities, including emotional, cognitive, psychosocial, and health-related QOL domains will be essential to improve patient care in the future.	[Kosty, Jennifer A.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45221 USA; [Stein, Sherman C.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Stein, SC (corresponding author), Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.	sherman.stein@uphs.upenn.edu					Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Choi SC, 1998, J NEUROTRAUM, V15, P771, DOI 10.1089/neu.1998.15.771; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Department CHR, 1999, CRAIG HAND ASS REP T; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dolan P, 1995, SOCIAL TARIFF EUROQO; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Finkelstein E., 2006, INCIDENCE EC BURDEN; Franks P, 2004, MED DECIS MAKING, V24, P247, DOI 10.1177/0272989X04265477; Fryback DG., 2010, WORKSH ADV SOC SCI T; GILSON BS, 1975, AM J PUBLIC HEALTH, V65, P1304, DOI 10.2105/AJPH.65.12.1304; Glick H.A., 2007, EC EVALUATION CLIN T; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hagen C., 1972, LEVELS COGNITIVE FUN; Hal KM, 1997, J REHABILITATION OUT, V1, P63; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hill MR, 2010, SPINAL CORD, V48, P438, DOI 10.1038/sc.2009.164; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Huybrechts KF, 2007, CURR MED RES OPIN, V23, P1627, DOI 10.1185/030079907X210444; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kinsella G, 1989, Int Disabil Stud, V11, P9; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kosty J, 2012, J NEUROTRAUM, V29, P1322, DOI 10.1089/neu.2011.2222; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Lu J, 2005, ACT NEUR S, V95, P281; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MAHONEY F I, 1965, Md State Med J, V14, P61; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; Mellick D., 2000, ANN M AM PUBL HLTH A; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nichol MB, 2001, MED DECIS MAKING, V21, P105, DOI 10.1177/02729890122062352; Nichols J, 2001, DEVELOPMENT, V128, P2333; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; TEMKIN N, 1988, J CLIN EPIDEMIOL, V41, P47, DOI 10.1016/0895-4356(88)90008-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Wechsler D. W., 1997, ADULT INTELLIGENCE S, VIII; Wechsler D. W., 2008, ADULT INTELLIGENCE S, VIV; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	102	10	11	1	28	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					277	284		10.1179/1743132813Y.0000000168			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	104QW	WOS:000316010700008	23485055				2022-02-06	
J	Lindgren, C; Dahlqvist, P; Lindvall, P; Nilsson, L; Koskinen, LO; Naredi, S				Lindgren, C.; Dahlqvist, P.; Lindvall, P.; Nilsson, L.; Koskinen, L. -O.; Naredi, S.			Cortisol levels are influenced by sedation in the acute phase after subarachnoid haemorrhage	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; ADRENAL-FUNCTION; SEPTIC SHOCK; CORTICOSTEROID INSUFFICIENCY; CRITICAL ILLNESS; SEPSIS; DYSFUNCTION; DEFICIENCY; MANAGEMENT	Background Subarachnoid haemorrhage (SAH) is a life-threatening condition that may be aggravated by acute pituitary damage and cortisol insufficiency. Robust diagnostic criteria for critical illness-related corticosteroid insufficiency (CIRCI) are lacking. The aim of this study was to assess the frequency of CIRCI in the acute phase (0240h) after SAH and to evaluate associations between cortisol levels and clinical parameters (sedation, circulatory failure, gender, age, severity of disease, treatment). CIRCI was defined as a single morning serum cortisol (mSC)<200nmol/L. The lower limit for calculated free cortisol (cFC) was set at <22nmol/L, and for saliva cortisol at <7.7nmol/L. Methods Fifty patients were included. Serum/saliva cortisol and corticosteroid-binding globulin were obtained every second morning. A logistic regression model was used for multivariate analysis comparing cortisol levels with clinical parameters. Results Of the patients, 21/50 (42%) had an mSC<200nmol/L and 30/50 (60%) had a cFC<22nmol/L. In patients with continuous intravenous sedation, the odds ratio for a mSC to be <200nmol/L was 18 times higher (95% confidence interval 4.285.0, P<0.001), and the odds ratio for a cFC to be <22nmol/L was 2.4 times higher (95% confidence interval 1.24.7, P<0.05) compared with patients with no continuous intravenous sedation. Conclusions Continuous intravenous sedation was significantly associated with cortisol values under defined limits (mSC<200, cFC<22nmol/L). The possibility that sedating drugs per se may influence cortisol levels should be taken into consideration before CIRCI is diagnosed.	[Lindgren, C.; Naredi, S.] Umea Univ, Inst Surg & Perioperat Sci, Dept Anaesthesiol & Intens Care Med, SE-90187 Umea, Sweden; [Dahlqvist, P.] Umea Univ, Inst Publ Hlth & Clin Med, Dept Med, SE-90187 Umea, Sweden; [Lindvall, P.; Koskinen, L. -O.] Umea Univ, Inst Pharmacol & Clin Neurosci, Dept Neurosurg, SE-90187 Umea, Sweden; [Nilsson, L.] Umea Univ, Umea Sch Business & Econ, Dept Stat, SE-90187 Umea, Sweden		Lindgren, C (corresponding author), Umea Univ, Inst Surg & Perioperat Sci, Dept Anaesthesiol & Intens Care Med, SE-90187 Umea, Sweden.	cecilia.lindgren@anestesi.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020; Lindvall, Peter/AAK-1225-2020	Lindvall, Peter/0000-0002-9552-2957; Koskinen, Lars-Owe/0000-0003-3528-8502; Nilsson, Lena Maria/0000-0002-2354-7258; Naredi, Silvana/0000-0002-4409-6089; Lindgren, Cecilia/0000-0002-4903-9374	Swedish Society of Medicine; Faculty of Medicine at Umea University; Stroke Foundation of Northern Sweden	The Swedish Society of Medicine, the Faculty of Medicine at Umea University and The Stroke Foundation of Northern Sweden supported this study financially.	Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; Arafah BM, 2007, J CLIN ENDOCR METAB, V92, P2965, DOI 10.1210/jc.2007-0181; Beishuizen Albertus, 2004, Curr Opin Crit Care, V10, P461, DOI 10.1097/01.ccx.0000142748.40422.c8; Bendel S, 2008, ANESTH ANALG, V106, P1813, DOI 10.1213/ane.0b013e318172fdba; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; Britt RC, 2006, ARCH SURG-CHICAGO, V141, P145, DOI 10.1001/archsurg.141.2.145; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Colameco S, 2009, J AM OSTEOPATH ASSOC, V109, P20; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Cuthbertson BH, 2009, INTENS CARE MED, V35, P1868, DOI 10.1007/s00134-009-1603-4; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FRAGEN RJ, 1987, ANESTHESIOLOGY, V66, P839, DOI 10.1097/00000542-198706000-00026; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kwon YS, 2010, INTENS CARE MED, V36, P1845, DOI 10.1007/s00134-010-1971-9; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Mistraletti G, 2005, CURR OPIN CRIT CARE, V11, P312, DOI 10.1097/01.ccx.0000166397.50517.1f; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Parker CR, 2000, J CLIN ENDOCR METAB, V85, P48, DOI 10.1210/jc.85.1.48; Poll EM, 2010, J NEUROTRAUM, V27, P189, DOI 10.1089/neu.2009.1014; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; SHAPIRO JM, 1986, ANESTHESIOLOGY, V64, P394, DOI 10.1097/00000542-198603000-00022; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Venkataraman S, 2007, REV ENDOCR METAB DIS, V8, P365, DOI 10.1007/s11154-007-9058-9; Venkatesh B, 2011, BEST PRACT RES CL EN, V25, P719, DOI 10.1016/j.beem.2011.04.007; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weant KA, 2008, NEUROSURGERY, V63, P645, DOI 10.1227/01.NEU.0000325728.50939.15; Wilkinson CW, 2001, J CLIN ENDOCR METAB, V86, P545, DOI 10.1210/jc.86.2.545; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638	39	10	10	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	APR	2013	57	4					452	460		10.1111/aas.12014			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	106JG	WOS:000316138800006	23167448				2022-02-06	
J	Crowe, SF; Crowe, LM				Crowe, Simon F.; Crowe, Louise M.			Does the presence of posttraumatic anosmia mean that you will be disinhibited?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Anosmia; Executive; Prefrontal cortex; Disinhibition; Symptom validity	VERBAL FLUENCY; OLFACTORY DYSFUNCTION; NORMATIVE DATA; PERFORMANCE; INJURY; TRAIL; TIME; FAS	Dispute has surrounded the issue of whether the relationship between anosmia and executive dysfunction in traumatic brain injury (TBI) may be artefactual due to poor ascertainment. Three groups matched for age, gender, education, Full Scale IQ, and the Wechsler Working Memory Index and showing adequate symptom validity were compared: 30 anosmic TBIs (TBI-A) matched for posttraumatic amnesia (PTA) and working memory functioning with 36 nonanosmic TBIs (TBI-NA) and 51 controls. The groups performed the FAS test, the Animal Fluency test, the Stroop Neurological Screening Test (SNST), the Wisconsin Card Sorting Test64 (WCST64) and the Trail Making Test (TMT-B) as well as tests of emotional functioning and return to work outcome. After adjusting for the covariates (i.e., gender; Wechsler Test of Adult Reading, WTAR; and years of education), a significant effect was found for items successfully completed on the SNST, the FAS task, the Animal Fluency task, and the WCST64 categories completed. After adjusting for the covariates, a significant difference was found for number of errors on the SNST and for the number and type of errors on TMT-B. The two groups did not differ in terms of their affective functioning (i.e., Beck Depression Inventory or Beck Anxiety Inventory), or in terms of their outcome with regard to return to work. The findings support the notion that the TBI-A group demonstrated considerably weaker performance on executive tasks than did the nonanosmic TBIs. These patients were not, however, more prone to an error-prone pattern of performance, and, if anything, their executive deficit was more likely attributable to a reduced productivity of response.	[Crowe, Simon F.] La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia; [Crowe, Louise M.] Univ Melbourne, Dept Psychol, Sch Behav Sci, Parkville, Vic 3052, Australia		Crowe, SF (corresponding author), La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia.	s.crowe@latrobe.edu.au		Crowe, Louise/0000-0003-4619-9708; Crowe, Simon/0000-0002-4407-8542			Army Individual Test Battery, 1944, MAN DIR SCOR; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Beck AT, 1993, BECK ANXIETY INVENTO; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Correia S, 2001, ARCH CLIN NEUROPSYCH, V16, P477, DOI 10.1016/S0887-6177(00)00059-7; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; COURVILLE CB, 1945, PATHOLOGY CENTRAL NE; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; CROWE SF, 1996, PSYCHIAT PSYCHOL LAW, V3, P39, DOI DOI 10.1080/13218719609524873; Cummings J, 1985, CLIN NEUROPSYCHIATRY; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Greiffenstein MF, 2003, J CLIN EXP NEUROPSYC, V25, P152, DOI 10.1076/jcen.25.1.152.13633; Greiffenstein MF, 2002, J CLIN EXP NEUROPSYC, V24, P705, DOI 10.1076/jcen.24.5.705.1011; Hurks PPM, 2012, CLIN NEUROPSYCHOL, V26, P1019, DOI 10.1080/13854046.2012.708361; Jennett B, 1981, MANAGEMENT HEAD INJU; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Kongs S. K., 2000, WCST 64 WISCONSIN CA; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lichter DC, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P260; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Trennery M. R., 1988, STROOP NEUROLOGICAL; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Varney NR, 2002, J CLIN EXP NEUROPSYC, V24, P852, DOI 10.1076/jcen.24.6.852.8398; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wise JB, 2006, ANN OTO RHINOL LARYN, V115, P124, DOI 10.1177/000348940611500208; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	51	10	10	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 1	2013	35	3					298	308		10.1080/13803395.2013.771616			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	104IM	WOS:000315985900007	23432111				2022-02-06	
J	Falk, AC				Falk, Ann-Charlotte			A nurse-led paediatric head injury follow-up service	SCANDINAVIAN JOURNAL OF CARING SCIENCES			English	Article						children; head injury; postconcussion complaints; follow-up service	TRAUMATIC BRAIN-INJURY; CONCUSSION SYMPTOMS QUESTIONNAIRE; POSTCONCUSSION SYNDROME; EARLY INTERVENTION; CHILDREN; MILD; RELIABILITY; MANAGEMENT; HEALTH; IMPACT	Scand J Caring Sci; 2013; 27; 5156 A nurse-led paediatric head injury follow-up service Aim: The aim of this study was to describe a nurse-led follow-up service, duration of children's late head injury symptoms and parent/child informational needs. Background: Traumatic brain injury (TBI) is an important cause of morbidity and mortality in children. In Sweden; 7200 children and adolescents are hospitalized every year because of head trauma, and 90% of all head traumas are considered a mild head injury. Although the head injury may be mild, 515% of children report sequelae (headache, dizziness, fatigue or memory problems), and the need for a follow-up service has been proposed several times. Methods/Design: An empirical descriptive study of a nurse-led follow-up service to improve the quality of care among children with mild-to-moderate head injuries. The data were collected in the period 20032005 at a Swedish University Hospital. Findings: In total, 149 children (mean age: 9.3years) received the follow-up service. In 92% of cases, one follow-up visit was performed. Eight per cent needed several visits to ensure symptom resolution. Ninety-one per cent of all children described late symptoms [headache (75%) and tiredness (74%)] at the follow-up visits. The mean symptom duration was 5weeks. However, 18% of the children reported long-lasting symptoms for 8weeks, and 16 children (10%) reported long-lasting symptoms beyond 3months postinjury. Conclusion: An early follow-up service with the aim of meeting the family's needs and reducing any negative impact after a childhood head injury could minimize long-lasting complications for both parents and children.	Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Woman & Child Hlth, Neuropediat Res Unit, SE-17176 Stockholm, Sweden		Falk, AC (corresponding author), Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Woman & Child Hlth, Neuropediat Res Unit, Q2 07, SE-17176 Stockholm, Sweden.	ann-charlotte.falk@karolinska.se	Falk, Ann-Charlotte/ABA-1730-2020	Falk, Ann-Charlotte/0000-0003-2246-7894			Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; CASEY R, 1986, PEDIATRICS, V78, P497; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Falk AC, 2008, PATIENT EDUC COUNS, V70, P251, DOI 10.1016/j.pec.2007.10.001; Falk AC, 2006, ACTA PAEDIATR, V95, P1533, DOI 10.1080/08035250600731957; Ferraro-McDuffie A R, 1992, Gastroenterol Nurs, V14, P204, DOI 10.1097/00001610-199202000-00010; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P165; Mackintosh C, 1997, J ADV NURS, V4, P2530; Maneesriwongul W, 2007, J ADV NURS, V58, P386; McCarthy L., 2003, AAPS PHARMSCITECH, V4, P1; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Mittenberg W, 2010, J CLIN EXP NEUROPSYC, V8, P29; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; SBU, 2000, S B F M U HJARSK OV; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Wong FKY, 2008, J CLIN NURS, V17, P901, DOI 10.1111/j.1365-2702.2006.01827.x; World Health Organization, 1992, INT CLASS DIS REL HL	29	10	10	0	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0283-9318			SCAND J CARING SCI	Scand. J. Caring Sci.	MAR	2013	27	1					51	56		10.1111/j.1471-6712.2012.00999.x			6	Nursing	Social Science Citation Index (SSCI)	Nursing	088FT	WOS:000314819900008	22571726				2022-02-06	
J	Goral, M; Conner, PS				Goral, Mira; Conner, Peggy S.			Language Disorders in Multilingual and Multicultural Populations	ANNUAL REVIEW OF APPLIED LINGUISTICS			English	Article							SPANISH-SPEAKING CHILDREN; TRAUMATIC BRAIN-INJURY; MORPHOLOGICAL AWARENESS; BILINGUAL-CHILDREN; DEVELOPMENTAL DYSLEXIA; SIMPLE VIEW; READING-COMPREHENSION; ALZHEIMERS-DISEASE; PHONOLOGICAL AWARENESS; LITERACY ACHIEVEMENT	We review the characteristics of developmental language disorders (primary language impairment, reading disorders, autism, Down syndrome) and acquired language disorders (aphasia, dementia, traumatic brain injury) among multilingual and multicultural individuals. We highlight the unique assessment and treatment considerations pertinent to this population, including, for example, concerns of language choice and availability of measures and of normative data in multiple languages. A summary of relevant, recent research studies is provided for each of the language disorders selected.	[Goral, Mira; Conner, Peggy S.] Lehman Coll, Bronx, NY 10468 USA; [Goral, Mira; Conner, Peggy S.] CUNY, Grad Ctr, New York, NY USA; [Goral, Mira] Boston Univ, Sch Med, Aphasia Res Ctr, Boston, MA 02215 USA		Goral, M (corresponding author), Lehman Coll, Bronx, NY 10468 USA.	mira.goral@lehman.cuny.edu; psconner@gmail.com			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [SC1DC009792] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [SC1 DC009792] Funding Source: Medline		Abu-Rabia S., 2012, OPEN J MODERN LINGUI, V2, P131, DOI [10.4236/ojml.2012.2401, DOI 10.4236/OJML.2012.2401]; Abutalebi J, 2008, LANG COGNITIVE PROC, V23, P557, DOI 10.1080/01690960801920602; Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Abutalebi J, 2009, BRAIN LANG, V109, P141, DOI 10.1016/j.bandl.2009.03.003; Albert M.L., 1978, BILINGUAL BRAIN NEUR; Almor A, 1999, BRAIN LANG, V67, P202, DOI 10.1006/brln.1999.2055; Alt M, 2012, J COMMUN DISORD, V45, P84, DOI 10.1016/j.jcomdis.2011.12.003; Amberber AM, 2012, J NEUROLINGUIST, V25, P588, DOI 10.1016/j.jneuroling.2011.10.002; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson R., 2009, HISPANIC CHILD LANGU, P29, DOI [10.1075/lald.50.03and, DOI 10.1075/LALD.50.03AND]; Ansaldo AI, 2008, J NEUROLINGUIST, V21, P539, DOI 10.1016/j.jneuroling.2008.02.001; Apel K, 2011, J SPEECH LANG HEAR R, V54, P1312, DOI 10.1044/1092-4388(2011/10-0115); Aronoff JM, 2006, NEUROPSYCHOLOGIA, V44, P21, DOI 10.1016/j.neuropsychologia.2005.04.014; Balaguer RDD, 2004, BRAIN LANG, V91, P212, DOI 10.1016/j.bandl.2004.02.007; Battle D. E., 1998, COMMUNICATION DISORD, P213; BATTLE DE, 2002, COMMUNICATION DISORD; Bayles K., 2007, COGNITIVE COMMUNICAT; Bedore LM, 2012, BILING-LANG COGN, V15, P616, DOI 10.1017/S1366728912000090; Bedore LM, 2005, APPL PSYCHOLINGUIST, V26, P195, DOI 10.1017/S0142716405050149; Bedore LM, 2001, J SPEECH LANG HEAR R, V44, P905, DOI 10.1044/1092-4388(2001/072); Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E., 2016, INT J BILINGUAL, V9, P103, DOI [DOI 10.1177/13670069050090010701, 10.1177/13670069050090010701]; Bialystok E, 2007, NEUROPSYCHOLOGIA, V45, P459, DOI 10.1016/j.neuropsychologia.2006.10.009; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Bialystok E, 2008, J NEUROLINGUIST, V21, P522, DOI 10.1016/j.jneuroling.2007.07.001; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Bird EKR, 2005, AM J SPEECH-LANG PAT, V14, P187, DOI 10.1044/1058-0360(2005/019); Bird EKR, 2012, INT J LANG COMM DIS, V47, P52, DOI 10.1111/j.1460-6984.2011.00071.x; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Caesar L. G., 2005, HILLTOP REV, V1, P7; Caesar LG, 2007, LANG SPEECH HEAR SER, V38, P190, DOI 10.1044/0161-1461(2007/020); Carlisle JF, 2010, READ RES QUART, V45, P464, DOI 10.1598/RRQ.45.4.5; Casas R, 2008, J CLIN EXP NEUROPSYC, V30, P956, DOI 10.1080/13803390801945046; Catts HW, 2005, J SPEECH LANG HEAR R, V48, P1378, DOI 10.1044/1092-4388(2005/096); Catts HW, 2002, J SPEECH LANG HEAR R, V45, P1142, DOI 10.1044/1092-4388(2002/093); Catts HW, 2003, J LEARN DISABIL-US, V36, P151, DOI 10.1177/002221940303600208; Cenoz J, 2003, MULTILINGUAL LEXICON, P1, DOI 10.1007/b101932; Chapman R S, 2001, Downs Syndr Res Pract, V7, P1, DOI 10.3104/reviews.108; Chapman Robin S, 2006, Downs Syndr Res Pract, V10, P61, DOI 10.3104/reports.306; Chilosi AM, 2008, BRAIN LANG, V106, P211, DOI 10.1016/j.bandl.2007.12.010; Chiu MM, 2012, J LEARN DISABIL-US, V45, P391, DOI 10.1177/0022219411431241; Chung KKH, 2010, J LEARN DISABIL-US, V43, P195, DOI 10.1177/0022219409345018; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Costa A., 2005, HDB BILINGUALISM PSY, P308, DOI DOI 10.1016/J.JML.2004.02.002; Croft S, 2011, INT J LANG COMM DIS, V46, P48, DOI 10.3109/13682822.2010.484845; Dodd B, 2001, J INTELL DISABIL RES, V45, P308, DOI 10.1046/j.1365-2788.2001.00327.x; Duncan LG, 2010, READING AND DYSLEXIA IN DIFFERENT ORTHOGRAPHIES, P43; Dunn LM., 2007, PEABODY PICTURE VOCA, VIV; DURGUNOGLU AY, 1993, J EDUC PSYCHOL, V85, P453, DOI 10.1037/0022-0663.85.3.453; Ebert K.D., J SPEECH LA IN PRESS; Edgin JO, 2011, J INTELL DISABIL RES, V55, P351, DOI 10.1111/j.1365-2788.2010.01362.x; Edmonds LA, 2006, J SPEECH LANG HEAR R, V49, P729, DOI 10.1044/1092-4388(2006/053); Eng N, 2002, TOP LANG DISORD, V22, P5, DOI 10.1097/00011363-200211000-00005; Fabbro F, 2001, BRAIN LANG, V79, P201, DOI 10.1006/brln.2001.2480; Faroqi-Shah Y, 2010, J NEUROLINGUIST, V23, P319, DOI 10.1016/j.jneuroling.2010.01.002; Feltmate K, 2008, CAN J SPEECH-LANG PA, V32, P6; Fredman M., 2006, FOLIA PHONIATR LOGO, V58, P458; Friedland D, 1999, APHASIOLOGY, V13, P427, DOI 10.1080/026870399402163; Frymark T., 2010, EFFECTIVENESS INTERV; Gerber S, 2012, LANG SPEECH HEAR SER, V43, P235, DOI 10.1044/0161-1461(2011/10-0047); Gerenser J, 2009, HDB CHILD LANGUAGE D, P67; Gollan TH, 2010, NEUROPSYCHOLOGIA, V48, P1356, DOI 10.1016/j.neuropsychologia.2009.12.038; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Goodwin AP, 2010, ANN DYSLEXIA, V60, P183, DOI 10.1007/s11881-010-0041-x; Goral M., 2012, HDB NEUROPSYCHOLOGY, P720; Goral M., 2012, ASPECTS MULTILINGUAL, P106; Goral M, 2006, BRAIN LANG, V98, P235, DOI 10.1016/j.bandl.2006.05.004; Goral M, 2012, J NEUROLINGUIST, V25, P538, DOI 10.1016/j.jneuroling.2011.06.001; Goral M, 2010, APHASIOLOGY, V24, P170, DOI 10.1080/02687030902958308; Gough P.B., 1986, REM SPEC EDUC, V7, P6, DOI [DOI 10.1177/074193258600700104, 10.1177/074193258600700104]; Goulandris N., 2003, DYSLEXIA DIFFERENT L; Grigorenko EL, 2003, J CHILD PSYCHOL PSYC, V44, P1079, DOI 10.1111/1469-7610.00193; Gustafson S, 2013, SCAND J EDUC RES, V57, P292, DOI 10.1080/00313831.2012.656279; Gutierrez-Clellen V, 2012, AM J SPEECH-LANG PAT, V21, P64, DOI 10.1044/1058-0360(2011/10-0090); Hadzibeganovic T, 2010, CORTEX, V46, P1312, DOI 10.1016/j.cortex.2010.06.011; Hambly C, 2012, J AUTISM DEV DISORD, V42, P1342, DOI 10.1007/s10803-011-1365-z; Hamilton HE, 2008, ANNU REV APPL LINGUI, V28, P91, DOI 10.1017/S0267190508080069; Hasson N, 2013, CHILD LANG TEACH THE, V29, P57, DOI 10.1177/0265659012459526; Hayiou-Thomas ME, 2004, J SPEECH LANG HEAR R, V47, P1347, DOI 10.1044/1092-4388(2004/101); Hernandez M, 2007, J NEUROLINGUIST, V20, P285, DOI 10.1016/j.jneuroling.2006.10.002; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hogan T., 2003, READING PSYCHOL, V24, P223, DOI [10.1080/02702710390227314, DOI 10.1080/02702710390227314]; HOOVER WA, 1990, READ WRIT, V2, P127, DOI 10.1007/BF00401799; Huber W, 1984, Adv Neurol, V42, P291; Ibrahim R, 2007, J PSYCHOLINGUIST RES, V36, P297, DOI 10.1007/s10936-006-9046-3; Ibrahim R, 2008, PSYCHOL RES BEHAV MA, V1, P11; Iluz-Cohen P, 2012, BILING-LANG COGN, V15, P58, DOI 10.1017/S1366728911000538; Indefrey P, 2006, APPL PSYCHOLINGUIST, V27, P66, DOI 10.1017/S0142716406280032; Jacobson PF, 2012, BILING-LANG COGN, V15, P22, DOI 10.1017/S1366728911000484; Jegatheesan B, 2011, BILING RES J, V34, P185, DOI 10.1080/15235882.2011.597824; Johnston TC, 2006, READ WRIT, V19, P339, DOI 10.1007/s11145-005-4644-2; Joshi RM, 2012, J LEARN DISABIL-US, V45, P480, DOI 10.1177/0022219411432690; Joshi RM, 2012, J LEARN DISABIL-US, V45, P387, DOI 10.1177/0022219411431240; Joshi RM, 2010, DYSLEXIA, V16, P99, DOI 10.1002/dys.402; Kambanaros M, 2012, BEHAV NEUROL, V25, P215, DOI [10.1155/2012/767405, 10.3233/BEN-2012-119006]; Kan PF, 2012, BILING-LANG COGN, V15, P452, DOI 10.1017/S1366728911000356; Kapantzoglou M, 2012, LANG SPEECH HEAR SER, V43, P81, DOI 10.1044/0161-1461(2011/10-0095); Kave G, 2004, J SPEECH LANG HEAR R, V47, P835, DOI 10.1044/1092-4388(2004/062); Kave G, 2008, PSYCHOL AGING, V23, P70, DOI 10.1037/0882-7974.23.1.70; Kave G, 2007, J NEUROLINGUIST, V20, P161, DOI 10.1016/j.jneuroling.2006.06.003; Kay J, 1992, PALPA PSYCHOLINGUIST; Kay-Raining Bird E., 2009, LANGUAGE LEARNING ED, V16, P90; Kempler D, 2008, ANNU REV APPL LINGUI, V28, P73, DOI 10.1017/S0267190508080045; Kennedy B, 2003, BRAIN LANG, V84, P204, DOI 10.1016/S0093-934X(02)00512-6; Kertesz A., 1982, W APHASIA BATTERY; Kieffer MJ, 2008, READ WRIT, V21, P783, DOI 10.1007/s11145-007-9092-8; Kirby J.R., 2008, LITERACY, V42, P75, DOI [10.1111/j.1741-4369.2008.00487.x, DOI 10.1111/J.1741-4369.2008.00487.X]; Kleim JA, 2011, J COMMUN DISORD, V44, P521, DOI 10.1016/j.jcomdis.2011.04.006; Knoph MIK, 2011, CLIN LINGUIST PHONET, V25, P530, DOI 10.3109/02699206.2011.563900; Kohnert K, 2004, BRAIN LANG, V91, P294, DOI 10.1016/j.bandl.2004.04.001; Kohnert K., 2012, ASPECTS MULTILINGUAL, P89; Kohnert K., 2008, LANGUAGE DISORDERS B; Kohnert K, 2010, J COMMUN DISORD, V43, P456, DOI 10.1016/j.jcomdis.2010.02.002; Kremer-Sadlik T., 2005, ISB4 P 4 INT S BIL A; Kroll JF, 2006, BILING-LANG COGN, V9, P119, DOI 10.1017/S1366728906002483; Laganaro M, 2001, FOLIA PHONIATR LOGO, V53, P135, DOI 10.1159/000052668; Lam K, 2012, READ WRIT, V25, P1847, DOI 10.1007/s11145-011-9329-4; Landerl K, 2013, J CHILD PSYCHOL PSYC, V54, P686, DOI 10.1111/jcpp.12029; Lanza E, 2007, INT J BILINGUAL, V11, P275, DOI 10.1177/13670069070110030201; Leonard, 1998, CHILDREN SPECIFIC LA; LEONARD L, 2009, HDB CHILD LAN GUAGE, P00308; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); Lindgren SA, 2011, CLIN LINGUIST PHONET, V25, P753, DOI 10.3109/02699206.2011.562594; Lindgren SA, 2011, DYSLEXIA, V17, P184, DOI 10.1002/dys.422; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Mahfoudhi A, 2010, J LEARN DISABIL-US, V43, P500, DOI 10.1177/0022219409355478; Manly JJ, 2005, J GERIATR PSYCH NEUR, V18, P213, DOI 10.1177/0891988705281868; Marian V, 2003, BRAIN LANG, V86, P70, DOI 10.1016/S0093-934X(02)00535-7; Marshall J, 2005, COGN NEUROPSYCHOL, V22, P719, DOI 10.1080/02643290442000266; McBride-Chang C, 2012, J LEARN DISABIL-US, V45, P503, DOI 10.1177/0022219411400748; McBride-Chang C, 2011, J CHILD PSYCHOL PSYC, V52, P204, DOI 10.1111/j.1469-7610.2010.02299.x; McMurtray Aaron, 2009, Hawaii Med J, V68, P223; Meguro K, 2003, INT PSYCHOGERIATR, V15, P9, DOI 10.1017/S104161020300872X; Meinzer M, 2007, NEUROPSYCHOLOGIA, V45, P1247, DOI 10.1016/j.neuropsychologia.2006.10.003; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Mendez M. F., 2003, DEMENTIA CLIN APPROA; Mendez MF, 2004, J NEUROPSYCH CLIN N, V16, P381, DOI 10.1176/appi.neuropsych.16.3.381; Mendez MF, 1999, J NEUROPSYCH CLIN N, V11, P411, DOI 10.1176/jnp.11.3.411; Mesulam M, 2009, BRAIN, V132, P2553, DOI 10.1093/brain/awp138; Miertsch B, 2009, J NEUROLINGUIST, V22, P135, DOI 10.1016/j.jneuroling.2008.07.003; Mindt MR, 2008, NEUROPSYCHOL REV, V18, P255, DOI 10.1007/s11065-008-9069-7; Nation K, 2008, SCI READING HDB, P248; Nijakowska J., 2011, ASPECTS CULTURE 2 LA, P95; Ober BA, 2002, J CLIN EXP NEUROPSYC, V24, P883, DOI 10.1076/jcen.24.7.883.8384; Obler L. K., 2012, ASPECTS MULTILINGUAL, P3; Obler L. K., 1990, DISCOURSE ABILITY BR, P224; Ohashi JK, 2012, RES AUTISM SPECT DIS, V6, P890, DOI 10.1016/j.rasd.2011.12.002; Oren R, 2005, J NEUROLINGUIST, V18, P127, DOI 10.1016/j.jneuroling.2004.11.003; Orgassa A, 2008, SECOND LANG RES, V24, P333, DOI 10.1177/0267658308090184; Ouellette G, 2010, READ WRIT, V23, P189, DOI 10.1007/s11145-008-9159-1; PARADIS J, 2001, LANGUAGE ACQUISITION, V0009; Paradis J., 2011, DUAL LANGUAGE DEV DI, P234; Paradis J, 2013, J SPEECH LANG HEAR R, V56, P971, DOI 10.1044/1092-4388(2012/12-0050); Paradis J, 2010, J COMMUN DISORD, V43, P474, DOI 10.1016/j.jcomdis.2010.01.002; Paradis J, 2010, APPL PSYCHOLINGUIST, V31, P345, DOI 10.1017/S0142716409990531; Paradis J, 2010, APPL PSYCHOLINGUIST, V31, P227, DOI 10.1017/S0142716409990373; Paradis M., 1983, READINGS APHASIA BIL; Paradis M., 2004, NEUROLINGUISTIC THEO; Paradis M., 1987, ASSESSMENT BILINGUAL; Pasquarella A, 2011, J RES READ, V34, P23, DOI 10.1111/j.1467-9817.2010.01484.x; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Paulesu E, 2010, READING AND DYSLEXIA IN DIFFERENT ORTHOGRAPHIES, P249; Pena, 2008, INT J BILING EDUC BI, V11, P1, DOI [10.2167/beb392.0, DOI 10.2167/BEB392.0]; Pena E. D., 2009, HDB CHILD LANGUAGE D, P281; PENA ED, BILINGUAL ENGL UNPUB; Petersen JM, 2012, J AUTISM DEV DISORD, V42, P1499, DOI 10.1007/s10803-011-1366-y; Petersen RC, 2001, ALZHEIMER'S DISEASE, P141, DOI 10.1002/0470846453.ch14; Pham G, 2011, LANG SPEECH HEAR SER, V42, P408, DOI 10.1044/0161-1461(2011/10-0073); Raut P, 2011, ANN ACAD MED SINGAP, V40, P493; Restrepo MA, 2013, J SPEECH LANG HEAR R, V56, P748, DOI [10.1044/1092-4388(2012/11-0173), 10.1044/1092-4388(2012/11-0173)x]; Rezaie R., 2012, READING WRITING MATH, V6, P25; Rice ML, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-27; Rice ML, 2000, J SPEECH LANG HEAR R, V43, P1126, DOI 10.1044/jslhr.4305.1126; Rice ML, 2004, DEVELOPMENTAL LANGUAGE DISORDERS: FROM PHENOTYPES TO ETIOLOGIES, P207; Rogers TT, 2006, NEUROPSYCHOLOGY, V20, P319, DOI 10.1037/0894-4105.20.3.319; Salvatierra JL, 2011, INT J BILINGUAL, V15, P26, DOI 10.1177/1367006910371021; Schiff R, 2011, ANN DYSLEXIA, V61, P44, DOI 10.1007/s11881-010-0046-5; Schwartz R. G., 2009, HDB CHILD LANGUAGE D, P3; Semel E., 2004, CLIN EVALUATION LANG; Shaywitz S., 2003, OVERCOMING DYSLEXIA; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Swanson TJ, 2005, LANG SPEECH HEAR SER, V36, P336, DOI 10.1044/0161-1461(2005/033); Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; Thordardottir E, 2008, J SPEECH LANG HEAR R, V51, P922, DOI 10.1044/1092-4388(2008/068); Thordardottir E, 2010, J COMMUN DISORD, V43, P523, DOI 10.1016/j.jcomdis.2010.06.001; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tong XL, 2011, J EDUC PSYCHOL, V103, P523, DOI 10.1037/a0023495; Tropper B., 2009, THESIS CITY U NEW YO; Tunmer WE, 2012, J LEARN DISABIL-US, V45, P453, DOI 10.1177/0022219411432685; Tyrrell J, 2001, INT J GERIATR PSYCH, V16, P1168, DOI 10.1002/gps.502; van der Lely HKJ, 2005, TRENDS COGN SCI, V9, P53, DOI 10.1016/j.tics.2004.12.002; Vaughn S, 2006, J LEARN DISABIL-US, V39, P56, DOI 10.1177/00222194060390010601; Vellutino FR, 2007, SCI STUD READ, V11, P3, DOI 10.1207/s1532799xssr1101_2; Verhoeven L, 2012, INT J LANG COMM DIS, V47, P176, DOI 10.1111/j.1460-6984.2011.00092.x; Verhoeven L, 2011, RES DEV DISABIL, V32, P1798, DOI 10.1016/j.ridd.2011.03.010; Vicari S, 2000, CORTEX, V36, P31, DOI 10.1016/S0010-9452(08)70834-7; Wang M, 2009, CONTEMP EDUC PSYCHOL, V34, P132, DOI 10.1016/j.cedpsych.2008.12.002; Welland RJ, 2002, J SPEECH LANG HEAR R, V45, P1175, DOI 10.1044/1092-4388(2002/095); White CDL, 2011, INT J LANG COMM DIS, V46, P613, DOI 10.1111/j.1460-6984.2011.00049.x; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; Windsor J, 2008, APPL PSYCHOLINGUIST, V29, P237, DOI 10.1017/S0142716407080113; Wolf M., 2004, READ WRIT, V17, P739, DOI [DOI 10.1007/S11145-004-2655-Z, 10.1007/s11145-004-2655-z]; Woll B, 2012, BILING-LANG COGN, V15, P75, DOI 10.1017/S1366728911000459; Wu S., 2009, LANGUAGE DISORDERS S, P112, DOI [10.21832/9781847691170-009, DOI 10.21832/9781847691170-009]; Wydell T. N, 2012, DYSLEXIA COMPREHENSI, P1, DOI 10.5772/1181; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, 2006, DEVELOPMENTAL SCI, V9, P429, DOI 10.1111/j.1467-7687.2006.00509.x; Zoccolotti P, 1999, APPL PSYCHOLINGUIST, V20, P191, DOI 10.1017/S0142716499002027; [No title captured]; [No title captured]; [No title captured]	214	10	10	5	73	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0267-1905	1471-6356		ANNU REV APPL LINGUI	Annu. Rev. Appl. Linguist.	MAR	2013	33						128	161		10.1017/S026719051300010X			34	Linguistics; Language & Linguistics	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Linguistics	259GV	WOS:000327516300006	26257455	Green Accepted			2022-02-06	
J	McGregor, AJ; Greenberg, M; Safdar, B; Seigel, T; Hendrickson, R; Poznanski, S; Davenport, M; Miner, J; Choo, EK				McGregor, Alyson J.; Greenberg, Marna; Safdar, Basmah; Seigel, Todd; Hendrickson, Robert; Poznanski, Stacey; Davenport, Moira; Miner, James; Choo, Esther K.			Focusing a Gender Lens on Emergency Medicine Research: 2012 Update	ACADEMIC EMERGENCY MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACUTE ISCHEMIC-STROKE; SEX-BASED DIFFERENCES; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ELECTROCARDIOGRAPHIC QT-INTERVAL; TISSUE-PLASMINOGEN ACTIVATOR; TRAUMATIC BRAIN-INJURY; FEMALE ATHLETE TRIAD; VISUAL ANALOG SCALE; QUALITY-OF-LIFE	The influence of sex and gender on patient care is just being recognized in emergency medicine (EM). Providers are realizing the need to improve outcomes for both men and women by incorporating sex- and gender-specific science into clinical practice, while EM researchers are now beginning to study novel sex- and gender-specific perspectives in the areas of acute care research. This article serves as an update on the sex differences in a variety of acute clinical care topics within the field of EM and showcases opportunities for improving patient care outcomes and expanding research to advance the science of gender-specific emergency care. ACADEMIC EMERGENCY MEDICINE 2013; 20:313-320 (C) 2013 by the Society for Academic Emergency Medicine	[McGregor, Alyson J.; Seigel, Todd; Choo, Esther K.] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Greenberg, Marna] Lehigh Valley Hosp & Hlth Network, Dept Emergency Med, Bethlehem, PA USA; [Safdar, Basmah] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Hendrickson, Robert] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Poznanski, Stacey] Wright State Univ, Sch Med, Dept Emergency Med, Dayton, OH USA; [Davenport, Moira] Drexel Univ, Coll Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Miner, James] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA		McGregor, AJ (corresponding author), Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA.	amcgregor@lifespan.org	Miner, James/AAI-4801-2020	Choo, Esther/0000-0001-8847-5745	Division of Women's Health in Emergency Care at the Department of Emergency Medicine at Alpert Medical School of Brown University	Funding was provided by the Division of Women's Health in Emergency Care at the Department of Emergency Medicine at Alpert Medical School of Brown University.	ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Arfken CL, 2001, J SUBST ABUSE TREAT, V20, P53, DOI 10.1016/S0740-5472(00)00155-0; Bernstein SL, 2009, ACAD EMERG MED, V16, P1054, DOI 10.1111/j.1553-2712.2009.00564.x; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Beynnon BD, 2008, J ATHL TRAINING, V43, P541, DOI 10.4085/1062-6050-43.5.530; Bijur PE, 2008, CLIN J PAIN, V24, P192, DOI 10.1097/AJP.0b013e31815d3619; Brady KT, 1999, PSYCHIAT CLIN N AM, V22, P241, DOI 10.1016/S0193-953X(05)70074-5; Brandes JL, 2006, JAMA-J AM MED ASSOC, V295, P1824, DOI 10.1001/jama.295.15.1824; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Camp Pat G, 2007, Proc Am Thorac Soc, V4, P686, DOI 10.1513/pats.200706-081SD; CARTER R, 1994, CHEST, V106, P1730, DOI 10.1378/chest.106.6.1730; Celli BR, 2000, CHEST, V117, P15; Centers for Disease Control and Prevention, INJ PREV CONTR MOT V; Cepeda MS, 2003, CLIN PHARMACOL THER, V74, P102, DOI 10.1016/S0009-9236(03)00152-8; Chang G, 2002, J SUBST ABUSE TREAT, V23, P1, DOI 10.1016/S0740-5472(02)00234-9; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; Chapman KR, 2004, CLIN CHEST MED, V25, P331, DOI 10.1016/j.ccm.2004.01.003; Charbit B, 2009, AM J CARDIOL, V103, P887, DOI 10.1016/j.amjcard.2008.11.041; Cohen SBZ, 2007, AM J RESP CRIT CARE, V176, P113, DOI 10.1164/rccm.20011-1655PP; Columbia University, PARTN GEND SPEC MED; D'Onofrio G, 2002, ACAD EMERG MED, V9, P627, DOI 10.1197/aemj.9.6.627; Daly C, 2006, CIRCULATION, V113, P490, DOI 10.1161/CIRCULATIONAHA.105.561647; de Visser RO, 2012, PSYCHOL HEALTH, V27, P618, DOI 10.1080/08870446.2011.617444; Deimel JF, 2012, CLIN SPORT MED, V31, P247, DOI 10.1016/j.csm.2011.09.007; Drici MD, 1996, CIRCULATION, V94, P1471, DOI 10.1161/01.CIR.94.6.1471; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fitch K, 2011, CURR MED RES OPIN, V27, P1425, DOI 10.1185/03007995.2011.583230; Forster A, 2009, STROKE, V40, P2428, DOI 10.1161/STROKEAHA.109.548750; Fosnocht DE, 2005, EMERG MED CLIN N AM, V23, P297, DOI 10.1016/j.emc.2004.12.003; Fosnocht DE, 2005, AM J EMERG MED, V23, P55, DOI 10.1016/j.ajem.2004.09.024; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Gargano JW, 2007, STROKE, V38, P2541, DOI 10.1161/STROKEAHA.107.485482; Gargano JW, 2009, STROKE, V40, P1114, DOI 10.1161/STROKEAHA.108.543116; Giralt D, 2012, ACTA NEUROL SCAND, V125, P83, DOI 10.1111/j.1600-0404.2011.01514.x; Greenfield SF, 2011, AM J DRUG ALCOHOL AB, V37, P301, DOI 10.3109/00952990.2011.596875; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Heck KE, 2008, J SAFETY RES, V39, P437, DOI 10.1016/j.jsr.2008.03.003; Hedlund Jim., INT C DISTR DRIV SUM; Hill MD, 2006, STROKE, V37, P2322, DOI 10.1161/01.STR.0000237060.21472.47; Hoch AZ, 2009, CLIN J SPORT MED, V19, P421, DOI 10.1097/JSM.0b013e3181b8c136; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Institute of Medicine, 2010, WOM HLTH RES PROGR P; Kaestner R, 2010, EVALUATION REV, V34, P52, DOI 10.1177/0193841X09353539; Katati MJ, 2007, CEREBROVASC DIS, V24, P66, DOI 10.1159/000103118; Kelly AM, 1998, ACAD EMERG MED, V5, P1086, DOI 10.1111/j.1553-2712.1998.tb02667.x; Kent DM, 2005, STROKE, V36, P62, DOI 10.1161/01.STR.0000150515.15576.29; Keyes KM, 2008, DRUG ALCOHOL DEPEN, V93, P21, DOI 10.1016/j.drugalcdep.2007.08.017; Kongable GL, 1996, J NEUROSURG, V84, P43, DOI 10.3171/jns.1996.84.1.0043; Lankhorst NE, 2012, J ORTHOP SPORT PHYS, V42, P81, DOI 10.2519/jospt.2012.3803; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Lichtman JH, 2010, CIRC-CARDIOVASC QUAL, V3, P684, DOI 10.1161/CIRCOUTCOMES.109.928713; Lipton RB, 2005, HEADACHE, V45, pS3, DOI 10.1111/j.1526-4610.2005.4501001.x; Lisabeth LD, 2009, STROKE, V40, P2031, DOI 10.1161/STROKEAHA.109.546812; Liu XK, 2003, CARDIOVASC RES, V57, P28, DOI 10.1016/S0008-6363(02)00673-9; Liu XK, 1998, J PHARMACOL EXP THER, V285, P672; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; McGregor AJ, 2012, ACAD EMERG MED, V19, P861, DOI 10.1111/j.1553-2712.2012.01389.x; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60; National Highway Traffic Safety Administration, DISTR DRIV; National Hospital Ambulatory Medical Care Survey (NHAMCS), 2008, NAT EM DEP SUMM TABL, P1; National Institute on Alcohol Abuse and Alcoholism, MOD BING DRINK; National Institute on Alcohol use and Alcoholism, ALC AL AR WOM MOR VU; Niska Richard, 2010, Natl Health Stat Report, P1; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Nolen-Hoeksema S, 2006, J GEN PSYCHOL, V133, P357, DOI 10.3200/GENP.133.4.357-374; Prescott E, 1997, EUR RESPIR J, V10, P822; Radeos MS, 2009, AM J EMERG MED, V27, P191, DOI 10.1016/j.ajem.2008.01.011; RAFTERY KA, 1995, ANN EMERG MED, V26, P414, DOI 10.1016/S0196-0644(95)70107-9; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Reeves M, 2009, STROKE, V40, P1743, DOI 10.1161/STROKEAHA.108.543181; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Reinhardt S, 2008, ALCOHOL ALCOHOLISM, V43, P334, DOI 10.1093/alcalc/agn004; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Rhodes N, 2011, ACCIDENT ANAL PREV, V43, P923, DOI 10.1016/j.aap.2010.11.015; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roudsari BS, 2005, INJURY, V36, P1316, DOI 10.1016/j.injury.2005.05.024; Sacco S, 2012, J HEADACHE PAIN, V13, P177, DOI 10.1007/s10194-012-0424-y; SANCHEZCRAIG M, 1989, BRIT J ADDICT, V84, P395; Savitz SI, 2005, STROKE, V36, P1447, DOI 10.1161/01.STR.0000170647.42126.a8; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Siddiq F, 2012, NEUROSURGERY, V71, P670, DOI 10.1227/NEU.0b013e318261749b; Soldin OP, 2009, CLIN PHARMACOKINET, V48, P143, DOI 10.2165/00003088-200948030-00001; Steingrimsson S, 2012, ADDICTION, V107, P1957, DOI 10.1111/j.1360-0443.2012.03954.x; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Todd KH, 2007, J PAIN, V8, P460, DOI 10.1016/j.jpain.2006.12.005; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; Vlak MHM, 2012, J NEUROL, V259, P1298, DOI 10.1007/s00415-011-6341-1; Ward DS, 2002, ANESTHESIOLOGY, V97, P1401, DOI 10.1097/00000542-200212000-00011; Wilson FA, 2010, AM J PUBLIC HEALTH, V100, P2213, DOI 10.2105/AJPH.2009.187179; Zhang YY, 2011, AM J EPIDEMIOL, V174, P403, DOI 10.1093/aje/kwr172	94	10	11	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAR	2013	20	3					313	320		10.1111/acem.12085			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	112VZ	WOS:000316623600015	23517266	Bronze			2022-02-06	
J	Sporer, KA; Solares, M; Durant, EJ; Wang, W; Wu, AHB; Rodriguez, RM				Sporer, Karl A.; Solares, Mariel; Durant, Edward J.; Wang, Wilbur; Wu, Alan H. B.; Rodriguez, Robert M.			Accuracy of the initial diagnosis among patients with an acutely altered mental status	EMERGENCY MEDICINE JOURNAL			English	Article							EMERGENCY-DEPARTMENT PATIENTS	Objectives The objectives of this prospective observational study were to: (1) determine the accuracy of physician diagnosis in patients with an acutely altered mental status (AMS) within the first 20 min of emergency department (ED) presentation; and (2) access if physician confidence in early diagnosis correlates with accuracy of diagnosis. Methods A prospective observational convenience study was conducted of 112 adult patients who presented to an urban county ED with AMS (Glasgow Coma Scale (GCS) score <= 14) between August 2008 and July 2009. Within the first 20 min of patient presentation to the ED, treating physicians were asked to record their best diagnostic guess of the cause of the patient's AMS and their confidence in this diagnosis. Serial hourly GCS was performed and the results of all diagnostic testing were recorded. Blinded investigators determined the final consensus diagnostic cause of the patient's AMS. Results The final consensus diagnoses for AMS aetiologies were as follows: isolated alcohol intoxication 31%, other (psychotic episodes, underlying dementia) 21%, combination alcohol/other drug intoxications 18%, isolated other drug intoxications 10%, other metabolic derangements 6%, cerebrovascular accident/transient ischaemic attack 4%, seizures/post-ictal states 4%, traumatic brain injuries 3%, isolated opiate intoxications 2%, isolated benzodiazepine intoxication 1% and septic episode 1%. The emergency physician's initial diagnosis of the AMS patient correlated with the accuracy of the final diagnosis (r(2)=0.807). The quintiles of confidence of diagnosis were: 0-20% degree of confidence had a 33% diagnostic accuracy, 21-40% had 25% accuracy, 41-60% had 43% accuracy, 61-80% had 52% accuracy and those with 81-100% confidence of initial diagnosis had 78% accuracy. Of the 106 patients with an initial diagnosis, 52 (51%) had a head CT performed, with eight (8%) having an acute abnormality. Discussion Early diagnoses of AMS patients are moderately accurate. Few early misdiagnoses of AMS patients were clinically relevant. Physicians' greater degree of confidence in their diagnosis correlated with greater accuracy.	[Sporer, Karl A.; Rodriguez, Robert M.] Univ Calif San Francisco, Sch Med, Dept Emergency Med, San Francisco, CA USA; [Solares, Mariel] Alameda Cty Med Ctr, Dept Emergency Med, Oakland, CA USA; [Durant, Edward J.; Wang, Wilbur] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Wu, Alan H. B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA		Sporer, KA (corresponding author), 1000 San Leandro Blvd,Suite 200, San Leandro, CA 94577 USA.	karl.sporer@emergency.ucsf.edu	Durant, Edward/M-6886-2019		UCSF; Howard Hughes Medical InstituteHoward Hughes Medical Institute	EJD and WW received support from a UCSF Dean's Summer Fellowship Award. MS received financial support from the Howard Hughes Medical Institute Research Fellowship.	[Anonymous], 1999, ANN EMERG MED, V33, P251; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Forsberg S, 2009, EMERG MED J, V26, P100, DOI 10.1136/emj.2007.054536; Hustey FM, 2003, ANN EMERG MED, V41, P678, DOI 10.1067/mem.2003.152; Kanich W, 2002, AM J EMERG MED, V20, P613, DOI 10.1053/ajem.2002.35464; Kekec Z, 2008, INT J NEUROSCI, V118, P609, DOI 10.1080/00207450701849133; Leong LB, 2008, INT J EMERG MED, V1, P179, DOI 10.1007/s12245-008-0049-8; Wilber ST, 2006, EMERG MED CLIN N AM, V24, P299, DOI 10.1016/j.emc.2006.01.011	8	10	10	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	MAR	2013	30	3					243	246		10.1136/emermed-2011-200452			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	089PI	WOS:000314922100029	22362650	Green Submitted			2022-02-06	
J	Tedmon, L; Barnes, JS; Nguyen, HP; Schug, KA				Tedmon, Lauren; Barnes, Jeremy S.; Nguyen, Hien P.; Schug, Kevin A.			Differentiating Isobaric Steroid Hormone Metabolites Using Multi-Stage Tandem Mass Spectrometry	JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY			English	Article						Steroid hormone; Sulfate metabolite; Electrospray ionization; Ion trap-time-of-flight mass spectrometry; Estrogen	STRUCTURAL-CHARACTERIZATION; FRAGMENTATION PATHWAYS; ESTROGENS; MECHANISMS; CONFORMATIONS; STABILITY; SPECTRA; ESTRONE; BINDING; ASSAY	Steroid hormones and their metabolites are currently undergoing clinical trials as potential therapeutics for traumatic brain injury (TBI). To support this work, it is necessary to develop improved procedures for differentiating isobaric species in this compound class. Equilin sulfate (E-S), estrone sulfate (E1-S), 17 alpha-dihydroequilin sulfate (ADHE-S), and 17 beta-dihydroequilin sulfate (BDHE-S) are primary constituents in hormone replacement therapies, such as Premarin, which are among pharmaceuticals being investigated for TBI treatment. The latter three compounds are isomers and can be difficult to differentiate in trace analytical determinations. In this work, a systematic study of the fragmentation of ADHE-S, BDHE-S, E1-S, and E-S under different stages of higher order tandem mass spectrometry (MSn) and variation of collision energy, allowed optimization of conditions for distinguishing the isomeric structures. For epimeric variants (e.g., ADHE-S versus BDHE-S; alpha- versus beta-stereoisomerization in the C-17 position), differentiation was achieved at MS4 and fragmentation was demonstrated through MS5. Computational analysis was performed to further explore differences in the fragmentation pathways due to changes in stereochemistry.	[Tedmon, Lauren; Barnes, Jeremy S.; Nguyen, Hien P.; Schug, Kevin A.] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA		Schug, KA (corresponding author), Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.	kschug@uta.edu	Schug, Kevin A/D-6471-2018		Eli LillyEli Lilly; Company ACACC	The authors acknowledge support from Eli Lilly and Company ACACC as an award to K. A. S. for discretionary research. Appreciation is also given to Shimadzu Scientific Instruments, Inc. for their support of instrumentation through the Shimadzu Equipment Grants for Research Program.	Adamski J, 2001, MOL CELL ENDOCRINOL, V171, P1, DOI 10.1016/S0303-7207(00)00383-X; Barnes JS, 2011, INT J MASS SPECTROM, V308, P71, DOI 10.1016/j.ijms.2011.07.026; Colorado A, 1996, J AM SOC MASS SPECTR, V7, P1116, DOI 10.1016/S1044-0305(96)00077-3; Croley TR, 2000, RAPID COMMUN MASS SP, V14, P1087; Dass C., 2007, FUNDAMENTALS CONT MA, P119, DOI [10.1002/9780470118498.ch4, DOI 10.1002/9780470118498.CH4]; DJERASSI C, 1962, J AM CHEM SOC, V84, P4544, DOI 10.1021/ja00882a034; FRIEDLAND SS, 1959, ANAL CHEM, V31, P169, DOI 10.1021/ac60146a002; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Ivanov J, 1998, QUANT STRUCT-ACT REL, V17, P437, DOI 10.1002/(SICI)1521-3838(199810)17:05<437::AID-QSAR437>3.3.CO;2-B; Kasper PT, 2012, RAPID COMMUN MASS SP, V26, P2275, DOI 10.1002/rcm.6340; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind Tobias, 2010, Bioanal Rev, V2, P23, DOI 10.1007/s12566-010-0015-9; Kushnir MM, 2008, AM J CLIN PATHOL, V129, P530, DOI 10.1309/LC03BHQ5XJPJYEKG; Lehane M, 2004, J CHROMATOGR A, V1024, P63, DOI 10.1016/j.chroma.2003.10.045; Lewars EG, 2007, RAPID COMMUN MASS SP, V21, P1669, DOI 10.1002/rcm.3002; Lugar CW, 2003, BIOORG MED CHEM LETT, V13, P4281, DOI 10.1016/j.bmcl.2003.09.060; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Montoya G, 2009, RAPID COMMUN MASS SP, V23, P3361, DOI 10.1002/rcm.4253; Nelson RE, 2004, CLIN CHEM, V50, P373, DOI 10.1373/clinchem.2003.025478; Nguyen H.P., 2010, THESIS U TEXAS ARLIN; Nguyen HP, 2011, J PHARMACEUT BIOMED, V55, P1218, DOI 10.1016/j.jpba.2011.03.003; Onose G., 2011, ROMANIAN NEUROSURG, VXVIII, P11; PALOMINO E, 1994, J STEROID BIOCHEM, V50, P75, DOI 10.1016/0960-0760(94)90174-0; Piccinelli AL, 2009, J AM SOC MASS SPECTR, V20, P1688, DOI 10.1016/j.jasms.2009.05.004; Rannulu NS, 2012, J AM SOC MASS SPECTR, V23, P1558, DOI 10.1007/s13361-012-0422-y; Rasche F, 2011, ANAL CHEM, V83, P1243, DOI 10.1021/ac101825k; Schug KA, 2008, J AM SOC MASS SPECTR, V19, P1629, DOI 10.1016/j.jasms.2008.07.010; SHARKEY AG, 1956, ANAL CHEM, V28, P934, DOI 10.1021/ac60114a003; Sheldon MT, 2009, J AM SOC MASS SPECTR, V20, P370, DOI 10.1016/j.jasms.2008.10.017; Singh M, 2006, EXP BIOL MED, V231, P514; TOKES L, 1968, J AM CHEM SOC, V90, P5465, DOI 10.1021/ja01022a025; Wan KX, 2000, J AM SOC MASS SPECTR, V11, P450, DOI 10.1016/S1044-0305(00)00095-7; Wei S, 2007, ANAL BIOANAL CHEM, V389, P423, DOI 10.1007/s00216-007-1358-0; WEXLER S, 1960, J CHEM PHYS, V32, P417, DOI 10.1063/1.1730710; WIESE TE, 1994, J STEROID BIOCHEM, V50, P61, DOI 10.1016/0960-0760(94)90173-2; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Xu L, 2008, ANAL BIOCHEM, V375, P105, DOI 10.1016/j.ab.2007.11.028; ZDERIC JA, 1963, STEROIDS, V1, P233, DOI 10.1016/S0039-128X(63)80109-9; Zhao LQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-24	39	10	11	0	24	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1044-0305	1879-1123		J AM SOC MASS SPECTR	J. Am. Soc. Mass Spectrom.	MAR	2013	24	3					399	409		10.1007/s13361-012-0542-4			11	Biochemical Research Methods; Chemistry, Analytical; Chemistry, Physical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	098AP	WOS:000315515700012	23345032				2022-02-06	
J	White, LC; McKinnon, BJ; Hughes, CA				White, Lauren C.; McKinnon, Brian J.; Hughes, C. Anthony			Etiologies of pediatric craniofacial injuries: A comparison of injuries involving all-terrain vehicles and golf carts	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						All-terrain vehicles; Golf carts; Craniofacial trauma; Temporal bone fractures; Children	TRAUMA; CHILDREN; HEAD; STATE	Objective: To determine incidence and etiologies of craniofacial injuries in the pediatric population through comparison of injuries caused by all-terrain vehicles and golf cart trauma. Study design: Case series with chart review. Setting: Level 1 trauma center. Subjects and methods: Retrospective review of pediatric traumas at a tertiary academic medical center from 2003 to 2012 identified 196 patients whose injuries resulted from accidents involving either all-terrain vehicles or golf carts. Data was collected and variables such as age, gender, driver vs. passenger, location of accident, Glasgow coma scale, Injury severity scale, Abbreviated injury scale, and presence or absence of helmet use were examined. Results: 196 pediatric patients were identified: 68 patients had injuries resulting from golf cart accidents, and 128 patients from ATV accidents. 66.4% of ATV-related traumas were male, compared to 52.9% of golf cart-related traumas. Ages of injured patients were similar between the two modalities with average age of ATV traumas 10.8 (+/- 4.0) years and golf cart traumas 10.0 (+/- 4.6) years. Caucasians were most commonly involved in both ATV (79.7%) and golf cart traumas (85.3%). 58.6% of all ATV related trauma and 69.1% of all golf cart trauma resulted in craniofacial injuries. The most common craniofacial injury was a closed head injury with brief loss of consciousness, occurring in 46.1% of the ATV traumas and 54.4% of the golf cart traumas. Temporal bone fractures were the second most common type of craniofacial injury, occurring in 5.5% of ATV accidents and 7.4% of the golf cart traumas. Length of hospital stay and, cases requiring surgery and severity scores were similar between both populations. Intensive care admissions and injury severity scores approached but not reach statistical significance (0.096 and 0.083, respectively). The only statistically significant differences between the two modalities were helmet use (P = 0.00018%) and days requiring ventilator assistance (P = 0.025). Conclusions: ATVs and golf carts are often exempt from the safety features and regulations required of motor vehicles, and ATV and golf cart accidents represent a significant portion of pediatric traumas. This study found that ATV and golf cart accidents contribute significantly to craniofacial trauma requiring hospitalization, with resultant morbidity and mortality. Further investigation of these injuries and their prevention in the pediatric population is needed before efforts to promote effective safety regulations for such vehicles in the future can be addressed. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[White, Lauren C.; McKinnon, Brian J.; Hughes, C. Anthony] Georgia Hlth Sci Univ, Dept Otolaryngol, Augusta, GA 30912 USA		White, LC (corresponding author), Georgia Hlth Sci Univ, Dept Otolaryngol, 1120 15th St,BP-4109, Augusta, GA 30912 USA.	LWhite1@georgiahealth.edu	liu, ting/AAA-1112-2022; McKinnon, Brian John/J-7902-2019	McKinnon, Brian John/0000-0002-2257-4721			American Academy of Orthopaedic Surgeons, POS STAT ALL TERR VE; Blecker N, 2012, PEDIATR EMERG CARE, V28, P443, DOI 10.1097/PEC.0b013e3182531d20; Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; Fountas KN, 2006, CHILD NERV SYST, V22, P1282, DOI 10.1007/s00381-006-0077-8; FRIEDMAN R, 1988, LARYNGOSCOPE, V98, P1251; Helmkamp JC, 2001, AM J PUBLIC HEALTH, V91, P1792, DOI 10.2105/AJPH.91.11.1792; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; McGwin G, 2008, J TRAUMA, V64, P1562, DOI 10.1097/TA.0b013e3181238d39; Miller B.L., 2011, HEAD NECK SURG, V144, P833; Passaro K T, 1996, Inj Prev, V2, P124, DOI 10.1136/ip.2.2.124; Phrampus ED, 2005, CLIN PEDIATR EMERG M, V6, P57, DOI 10.1016/j.cpem.2005.02.001; Prigozen JM, 2006, J ORAL MAXIL SURG, V64, P1333, DOI 10.1016/j.joms.2006.05.014; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Seluga KJ, 2005, ACCIDENT ANAL PREV, V37, P801, DOI 10.1016/j.aap.2005.03.022; Seluga KJ, 2009, ACCIDENT ANAL PREV, V41, P839, DOI 10.1016/j.aap.2009.04.017; Touma BJ, 1999, OTOLARYNG HEAD NECK, V121, P736, DOI 10.1053/hn.1999.v121.a98198; Unni P, 2012, J TRAUMA ACUTE CARE, V73, pS277, DOI 10.1097/TA0b013e31826b00d7; Vitale MA, 2011, PEDIATR EMERG CARE, V27, P11, DOI 10.1097/PEC.0b013e3182037c9a; Wang BS, 2007, OTOLARYNG HEAD NECK, V137, P201, DOI 10.1016/j.otohns.2007.01.033; Warda L, 1998, Inj Prev, V4, P44; Watson DS, 2008, AM J PREV MED, V35, P55, DOI 10.1016/j.amepre.2008.03.029	22	10	10	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	MAR	2013	77	3					414	417		10.1016/j.ijporl.2012.11.043			4	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	095XF	WOS:000315367600023	23299042				2022-02-06	
J	Hossienzadeh, F; Babri, S; Alipour, MR; Ebrahimi, H; Mohaddes, G				Hossienzadeh, Fezzeh; Babri, Shirin; Alipour, Mohammad Reza; Ebrahimi, Hadi; Mohaddes, Gisou			Effect of ghrelin on brain edema induced by acute and chronic systemic hypoxia	NEUROSCIENCE LETTERS			English	Article						Hypoxia; Brain edema; Ghrelin; Rat	TUMOR-NECROSIS-FACTOR; INDUCED VASCULAR LEAKAGE; FOCAL CEREBRAL-ISCHEMIA; HIGH-ALTITUDE; BARRIER PERMEABILITY; ENDOTHELIAL-CELL; HEAD-INJURY; RATS; EXPRESSION; CYTOKINES	Hypoxia is an important pathogenic factor for the induction of vascular leakage and brain edema formation. Recent studies suggest a role for TNF-alpha in the induction of brain edema. Ghrelin attenuates the synthesis of TNF-alpha following subarachnoid hemorrhage and traumatic brain injury (TBI). Therefore, we examined the effects of ghrelin on the brain edema, serum TNF-alpha levels and body weight in a systemic hypoxia model. Adult male Wistar rats were divided into acute and chronic controls, acute or chronic hypoxia and ghrelin-treated (80 mu g/kg/ip/daily) acute or chronic hypoxia groups. Systemic hypoxia was induced in rats by a normobaric hypoxic chamber (O-2 11%) for two days (acute) or ten days (chronic). Effect of ghrelin on brain edema and serum TNF-alpha levels was assessed by dry wet and ELISA method, respectively. The results showed that acute (P < 0.001) and chronic (P < 0.05) hypoxia caused an increase of brain water content. Administration of ghrelin only in the acute hypoxia group significantly (P < 0.001) reduced brain water content. Acute hypoxia caused an increase of serum TNF-alpha level (P < 0.001) and ghrelin significantly (P < 0.001) reduced it. TNF-alpha level in chronic hypoxia did not change significantly. Both acute and chronic hypoxia decreased body weight significantly (P < 0.001) and administration of ghrelin only could prevent further weight loss in chronic hypoxia group (P < 0.001). Our findings show that administration of ghrelin may be useful in reducing brain edema induced by acute systemic hypoxia and at least part of the anti-edematous effects of ghrelin is due to decrease of serum TNF-alpha levels. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Hossienzadeh, Fezzeh; Babri, Shirin; Ebrahimi, Hadi; Mohaddes, Gisou] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Alipour, Mohammad Reza] Tabriz Univ Med Sci, TB & Lung Res Ctr, Tabriz, Iran		Mohaddes, G (corresponding author), Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran.	gmohades@yahoo.com	Mohaddes, Gisou/L-7581-2017; Alipour, Mohammad Reza/H-2112-2012; babri, shirin/L-8819-2017; Hossienzadeh, Fezzeh/AAD-8320-2020	Mohaddes, Gisou/0000-0002-3732-1663; Alipour, Mohammad Reza/0000-0002-6484-4267; babri, shirin/0000-0002-0256-3152; 	Neuroscience Research Centre of Tabriz University of Medical Sciences [7-60-89]	This study was part of a Ph.D. thesis supported by the Neuroscience Research Centre of Tabriz University of Medical Sciences, grant number 7-60-89.	Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Dong Z, 2003, AM J PATHOL, V163, P663, DOI 10.1016/S0002-9440(10)63693-0; El Eter E, 2007, J GASTROEN HEPATOL, V22, P1791, DOI 10.1111/j.1440-1746.2006.04696.x; Ersahin M, 2010, J NEUROTRAUM, V27, P1143, DOI 10.1089/neu.2009.1210; Ferrini F, 2009, CURR NEUROPHARMACOL, V7, P37, DOI 10.2174/157015909787602779; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hackett PH, 1999, ADV EXP MED BIOL, V474, P23; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Iseri SO, 2005, J ENDOCRINOL, V187, P399, DOI 10.1677/joe.1.06432; Kalpana S, 2008, TOXICOL APPL PHARM, V231, P354, DOI 10.1016/j.taap.2008.05.008; Kimura H, 2003, BRAIN RES, V990, P148, DOI 10.1016/S0006-8993(03)03450-4; Kishimoto I, 2012, J CARDIOL, V59, P8, DOI 10.1016/j.jjcc.2011.11.002; Lee J, 2010, J ENDOCRINOL, V205, P262, DOI 10.1677/JOE-10-0040; Liu YJ, 2006, CHINESE J PHYSIOL, V49, P244; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Rao KVR, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-66; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schwenke DO, 2008, ENDOCRINOLOGY, V149, P237, DOI 10.1210/en.2007-0833; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; SHREENIWAS R, 1992, J CLIN INVEST, V90, P2333, DOI 10.1172/JCI116122; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Toshinai K, 2003, ENDOCRINOLOGY, V144, P1506, DOI 10.1210/en.2002-220788; Tsao N, 2001, J MED MICROBIOL, V50, P812, DOI 10.1099/0022-1317-50-9-812; Tschop M, 1998, LANCET, V352, P1119, DOI 10.1016/S0140-6736(05)79760-9; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, ADV EXP MED BIOL, V502, P237; Vakili A, 2007, BRAIN RES, V1170, P97, DOI 10.1016/j.brainres.2007.07.016; Waseern T, 2008, SURGERY, V143, P334, DOI 10.1016/j.surg.2007.09.039; WEN H, 2004, ANN DISASTER MED, V2, pS53; Wu RQ, 2009, CRIT CARE MED, V37, P2421, DOI 10.1097/CCM.0b013e3181a557a2; Wu RQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002026; Yang GY, 1999, MOL BRAIN RES, V69, P135, DOI 10.1016/S0169-328X(99)00007-8; Yin XF, 2009, ACTA BIOCH BIOPH SIN, V41, P188, DOI 10.1093/abbs/gmp001; Zhang XJ, 2006, NEUROL INDIA, V54, P402; Zwirska-Korczala K, 2007, J PHYSIOL PHARMACOL, V58, P53	46	10	11	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 8	2013	534						47	51		10.1016/j.neulet.2012.11.062			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160AL	WOS:000320088300009	23295905				2022-02-06	
J	Park, YH; Lee, YM; Kim, DS; Park, J; Suk, K; Kim, JK; Han, HS				Park, Youn Hee; Lee, Young Mi; Kim, Dong Sun; Park, Jaechan; Suk, Kyoungho; Kim, Jong Kun; Han, Hyung Soo			Hypothermia enhances induction of protective protein metallothionein under ischemia	JOURNAL OF NEUROINFLAMMATION			English	Article						Hypothermia; Ischemia; STAT3; MRE; Methylation; Gene expression	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; MEDIATES CARDIOPROTECTION; POSTISCHEMIC HYPOTHERMIA; TRANSCRIPTIONAL ACTIVITY; DIFFERENTIAL REGULATION; DNA METHYLTRANSFERASES; SIGNAL TRANSDUCER	Background: Hypothermic protection against ischemic stroke has been reported by many studies. Hypothermia is supposed to mitigate the effects of deleterious genes and proteins and promote the activity of protective genes and proteins in the ischemic brain. Metallothionein (MT)-1/2 is thought to be a crucial factor for metal homeostasis, immune function, and apoptosis. This protein was found to exert protective effects in models of brain injury as well. In the present study, we investigated the effect of hypothermia on MT expression and the underlying mechanisms. Methods: Cultured bEnd.3 brain endothelial cells were exposed to oxygen glucose deprivation and reperfusion (OGD+R). Reverse transcription PCR and western blot analyses were performed to measure the expression of MT, transcription factors, and methylation regulating factors. Transcription factor binding assays were also performed. Methylation profiles of the promoter area were obtained with pyrosequencing. Results: Hypothermia protected bEnd. 3 cells from OGD+R. When the cells were exposed to OGD+R, MT expression was induced. Hypothermia augmented MT levels. While OGD+R-induced MT expression was mainly associated with metal regulatory transcription factor 1 (MTF-1), MT expression promoted by hypothermia was primarily mediated by the signal transducer and activator of transcription 3 (STAT3). Significantly increased STAT3 phosphorylation at Ser727 was observed with hypothermia, and JSI-124, a STAT-3 inhibitor, suppressed MT expression. The DNA demethylating drug 5-aza-2'-deoxycytidine (5-Aza) enhanced MT expression. Some of the CpG sites in the promoter MT=> it should be "the CpG sites in the MT promoter" showed different methylation profiles and some methylation regulating factors had different expressional profiles in the presence of OGD+R and hypothermia. Conclusions: We demonstrated that hypothermia is a potent inducer of MT gene transcription in brain endothelial cells, and enhanced MT expression might contribute to protection against ischemia. MT gene expression is induced by hypothermia mainly through the STAT3 pathway. DNA methylation may contribute to MT gene regulation under ischemic or hypothermic conditions.	[Park, Youn Hee; Lee, Young Mi; Han, Hyung Soo] Kyungpook Natl Univ, Sch Med, Dept Physiol, Taegu 700422, South Korea; [Kim, Dong Sun; Park, Jaechan; Suk, Kyoungho; Kim, Jong Kun] Kyungpook Natl Univ, Sch Med, Taegu 700422, South Korea		Kim, JK (corresponding author), Kyungpook Natl Univ, Sch Med, 101 Dongin 2 Ga, Taegu 700422, South Korea.	kim7155@knu.ac.kr; hshan@knu.ac.kr		Park, Jaechan/0000-0001-7572-3260	BioMedical Research Institute grant; Kyungpook National University Hospital; Korea Healthcare Technology RD Project; Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A100870]; Industrial Strategic Technology Development Program [10035197]; Ministry of Knowledge Economy (MKE, Korea)Ministry of Knowledge Economy, Republic of Korea	This work was supported by a BioMedical Research Institute grant, Kyungpook National University Hospital (2009), Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100870), and Industrial Strategic Technology Development Program (10035197) funded by the Ministry of Knowledge Economy (MKE, Korea).	An W, 2006, ACTA PHARMACOL SIN, V27, P1431, DOI 10.1111/j.1745-7254.2006.00419.x; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; Blaskovich MA, 2003, CANCER RES, V63, P1270; Campagne MV, 2000, J NEUROSCI, V20, P5200, DOI 10.1523/JNEUROSCI.20-14-05200.2000; Colbourne F, 2000, J CEREBR BLOOD F MET, V20, P1702, DOI 10.1097/00004647-200012000-00009; Dalton TP, 1997, MOL CELL BIOL, V17, P2781, DOI 10.1128/MCB.17.5.2781; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Desrivieres S, 2006, J MAMMARY GLAND BIOL, V11, P75, DOI 10.1007/s10911-006-9014-4; Ghoshal K, 2000, J BIOL CHEM, V275, P539, DOI 10.1074/jbc.275.1.539; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Henrique R, 2005, CANCER EPIDEM BIOMAR, V14, P1274, DOI 10.1158/1055-9965.EPI-04-0659; Jacob ST, 2002, ENVIRON HEALTH PERSP, V110, P827, DOI 10.1289/ehp.02110s5827; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kelly EJ, 1997, P NATL ACAD SCI USA, V94, P10045, DOI 10.1073/pnas.94.19.10045; Kim EH, 2004, MOL CELLS, V18, P326; Kim JH, 2012, J NEUROCHEM, V121, P751, DOI 10.1111/j.1471-4159.2012.07725.x; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; LaRochelle O, 2001, BIOCHEM J, V353, P591, DOI 10.1042/0264-6021:3530591; Lee DK, 1999, BIOCHEM J, V337, P59, DOI 10.1042/0264-6021:3370059; Leung YKJ, 2010, EXP NEUROL, V221, P98, DOI 10.1016/j.expneurol.2009.10.006; Li HC, 2003, ACTA PHARMACOL SIN, V24, P1131; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Lin KA, 2005, J CELL PHYSIOL, V205, P428, DOI 10.1002/jcp.20417; Majumder S, 1999, ONCOGENE, V18, P6287, DOI 10.1038/sj.onc.1203004; Majumder S, 2006, J CELL BIOCHEM, V97, P1300, DOI 10.1002/jcb.20738; Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200; Miyazawa T, 2003, NEUROL RES, V25, P457, DOI 10.1179/016164103101201850; Murphy BJ, 1996, CANCER RES, V59, P1315; Ohta H, 2007, NEUROSCI RES, V57, P424, DOI 10.1016/j.neures.2006.12.002; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Penkowa M, 2004, J NEUROSCI RES, V77, P35, DOI 10.1002/jnr.20154; Penkowa M, 2006, J NEUROSCI RES, V84, P1452, DOI 10.1002/jnr.21043; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Radtke F, 1996, BIOL CHEM H-S, V377, P47, DOI 10.1515/bchm3.1996.377.1.47; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; Stankovic RK, 2007, INT J BIOCHEM CELL B, V39, P484, DOI 10.1016/j.biocel.2006.09.010; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Suzuki S, 2001, EXP NEUROL, V170, P63, DOI 10.1006/exnr.2001.7701; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Wakida K, 2007, NEUROSCIENCE, V148, P105, DOI 10.1016/j.neuroscience.2007.04.063; Wen TC, 2001, NEUROSCI LETT, V303, P153, DOI 10.1016/S0304-3940(01)01711-6; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003; Zhao H, 2004, STROKE, V35, P572, DOI 10.1161/01.STR.0000110787.42083.58	49	10	12	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	FEB 4	2013	10								21	10.1186/1742-2094-10-21			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	112SI	WOS:000316613200001	23374901	gold, Green Published			2022-02-06	
J	Jiang, HH; Kokiko-Cochran, ON; Li, K; Balog, B; Lin, CY; Damaser, MS; Lin, V; Cheng, JLYA; Lee, YS				Jiang, Hai-Hong; Kokiko-Cochran, Olga N.; Li, Kevin; Balog, Brian; Lin, Ching-Yi; Damaser, Margot S.; Lin, Vernon; Cheng, Julian Yaoan; Lee, Yu-Shang			Bladder dysfunction changes from underactive to overactive after experimental traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Bladder; Electromyogram; Rat; Traumatic brain injury; Urethra; Urodynamics	EXTERNAL URETHRAL SPHINCTER; URINARY-INCONTINENCE; MICTURITION REFLEX; URETHANE	Although bladder dysfunction is common after traumatic brain injury (TBI), few studies have investigated resultant bladder changes and the detailed relationship between TBI and bladder dysfunction. The goal of this study was to characterize the effects of TBI on bladder function in an animal model. Fluid-percussion injury was used to create an animal model with moderate TBI. Female Sprague-Dawley rats underwent TBI, sham TBI or were not manipulated (naive). All rats underwent filling cystometry while bladder pressure and external urethral sphincter electromyograms were simultaneously recorded 1 day, 1 week, 2 weeks, and 1 month after injury. One day after injury, 70% of the animals in the TBI group and 29% of the animals in the sham TBI group showed no bursting activity during urination. Compared to naive rats, bladder function was mainly altered 1 day and 1 week after sham TB!, suggesting the craniotomy procedure affected bladder function mostly in a temporary manner. Compared to either naive or sham TBI, bladder weight was significantly increased 1 month after TBI and collagen in the bladder wall was increased. Bladder function in the TBI group went from atonic 1 day post-TBI to overactive 1 month post-TBI, suggesting that TBI significantly affected bladder function. (C) 2012 Elsevier Inc. All rights reserved.	[Jiang, Hai-Hong; Balog, Brian; Damaser, Margot S.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Jiang, Hai-Hong; Damaser, Margot S.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA; [Kokiko-Cochran, Olga N.; Li, Kevin; Lin, Ching-Yi; Lee, Yu-Shang] Cleveland Clin, Dept Neurosci, Cleveland, OH 44195 USA; [Lin, Vernon; Lee, Yu-Shang] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44195 USA; [Damaser, Margot S.] Louis Stokes Cleveland VA Med Ctr, Adv Platform Technol Ctr, Cleveland, OH USA; [Cheng, Julian Yaoan] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA		Lee, YS (corresponding author), Cleveland Clin, Dept Neurosci, 9500 Euclid Ave,NE63, Cleveland, OH 44195 USA.	leey2@ccf.org	Jiang, Hai-Hong/G-5833-2015	Balog, Brian/0000-0002-3548-9315; Lin, Vernon/0000-0002-8078-0275	Cleveland Clinic; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 069765]; Rehabilitation Research and Development Service of the Department of Veterans AffairsUS Department of Veterans Affairs; American Urological Association Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069765] Funding Source: NIH RePORTER	This work was supported in part by the Cleveland Clinic, NIH/NINDS R01 NS 069765 (Y.S. Lee), and the Rehabilitation Research and Development Service of the Department of Veterans Affairs (M.S.D.). H.-H. Jiang was supported by the American Urological Association Foundation.	Bharat R, 2005, J COMP NEUROL, V493, P27, DOI 10.1002/cne.20753; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chang HY, 2008, AM J PHYSIOL-RENAL, V295, pF1248, DOI 10.1152/ajprenal.90259.2008; Chernev Ivan, 2009, Cases J, V2, P9120, DOI 10.1186/1757-1626-2-9120; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Dasgupta R, 2005, J UROLOGY, V174, P2268, DOI 10.1097/01.ju.0000181806.59363.d1; de Groat WC, 1998, EUR UROL, V34, P2, DOI 10.1159/000052265; de Groat WC, 1998, BEHAV BRAIN RES, V92, P127, DOI 10.1016/S0166-4328(97)00185-X; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Drake MJ, 2010, NEUROUROL URODYNAM, V29, P119, DOI 10.1002/nau.20841; Fowler CJ, 2010, NEUROUROL URODYNAM, V29, P49, DOI 10.1002/nau.20740; GABELLA G, 1990, CELL TISSUE RES, V262, P67, DOI 10.1007/BF00327747; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Giannantoni A, 2011, ARCH PHYS MED REHAB, V92, P1134, DOI 10.1016/j.apmr.2011.02.013; Griffiths D, 2008, NEUROUROL URODYNAM, V27, P466, DOI 10.1002/nau.20549; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Klassen BT, 2011, NEUROLOGY, V77, P1119, DOI 10.1212/WNL.0b013e31822f02f5; KRUSE MN, 1990, BRAIN RES, V532, P182, DOI 10.1016/0006-8993(90)91758-9; MAGGI CA, 1990, J AUTONOM NERV SYST, V30, P247, DOI 10.1016/0165-1838(90)90256-I; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Moiyadi AV, 2007, NEUROREHABILITATION, V22, P93; Moskalenko Yu. E., 2008, Human Physiology, V34, P299, DOI 10.1134/S0362119708030055; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sasaki M, 2002, J COMP NEUROL, V449, P355, DOI 10.1002/cne.10290; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Steward JE, 2010, WORLD J UROL, V28, P365, DOI 10.1007/s00345-009-0463-4; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198	31	10	10	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2013	240						57	63		10.1016/j.expneurol.2012.11.012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	081OZ	WOS:000314332800006	23178579	Green Accepted			2022-02-06	
J	Yu, B; Ma, HY; Kong, L; Shi, YX; Liu, YH				Yu, Bo; Ma, Haiying; Kong, Li; Shi, Yuxiu; Liu, Yunhui			Enhanced connexin 43 expression following neural stem cell transplantation in a rat model of traumatic brain injury	ARCHIVES OF MEDICAL SCIENCE			English	Article						neural stem cell; traumatic brain injury; transplantation; connexin43	GAP-JUNCTIONS; DIFFERENTIATION; ASTROCYTES; PENUMBRA; THERAPY; NEURONS	Introduction: Reestablishment of functional networks after traumatic brain injury (TBI) has been proffered as one of the goals of neural stem cell (NSC) transplantation therapeutics. Gap junctions provide essential means for direct cellular communication by transferring small molecules and ions, which may provide insights into the interplay between grafted NSCs and host cells. Material and methods: Thirty-six adult male Wister rats were used in this study. The controlled cortical impact (CCI) model of brain injury has been performed. Seventy-two hours after CCI injury, animals were randomly assigned to two groups: PBS- and NSC- transplanted group. NSCs-transplanted group received delivery of the NSCs suspension to the cortex below the injury cavity in the ipsilateral hemisphere. At 1, 2, and 4 weeks post-transplantation, we investigated the expression patterns of gap junction-associated connexin 43 (Cx43) in the transplant site and the border of CCI by immunohistochemistry, Western blot and RT-PCR. Results: Our findings showed that Cx43 staining was significantly greater in the transplant site and the border of CCI in the NSCs-transplanted rats compared to the control rats at different time points (p < 0.01 at 1 week, p < 0.05 at 2 and 4 weeks). Significantly higher gene and protein expression of Cx43 was found in NSCs-transplanted rats compared to the control rats in the period of 4 weeks post-transplantation (p < 0.01), and remained at a higher level until 2 weeks with or without NSC transplantation. Conclusions: It is proposed that gap junction-associated Cx43 might participate in NSCs' beneficial effects via gap-junctional coupling by which grafted NSCs integrate into host neural tissue following transplantation after TBI.	[Yu, Bo; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang 110004, Peoples R China; [Ma, Haiying; Kong, Li; Shi, Yuxiu] China Med Univ, Inst Pathol & Pathophysiol, Dept Histol & Embryol, Shenyang 110004, Peoples R China; [Ma, Haiying; Kong, Li] Dalian Med Univ, Dept Histol & Embryol, Dalian, Peoples R China		Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, 36 Sanhao St, Shenyang 110004, Peoples R China.	yuxiushi@163.com; yunhuiliuln@163.com					Benninger Y, 2000, BRAIN PATHOL, V10, P330; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Carvey PM, 2001, EXP NEUROL, V171, P98, DOI 10.1006/exnr.2001.7735; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Dang XT, 2003, MOL CELL BIOCHEM, V242, P35, DOI 10.1023/A:1021152709313; Farahani R, 2005, GLIA, V50, P351, DOI 10.1002/glia.20213; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hayashi A, 2008, EXP NEUROL, V212, P324, DOI 10.1016/j.expneurol.2008.04.018; Jaderstad J, 2011, EXP CELL RES, V317, P70, DOI 10.1016/j.yexcr.2010.07.011; Jaderstad J, 2010, P NATL ACAD SCI USA, V107, P5184, DOI 10.1073/pnas.0915134107; Jaderstad LM, 2010, REGEN MED, V5, P901, DOI [10.2217/rme.10.80, 10.2217/RME.10.80]; Lee IH, 2005, J COMP NEUROL, V489, P1, DOI 10.1002/cne.20567; Li JX, 2006, J NEUROSCI, V26, P7839, DOI 10.1523/JNEUROSCI.1624-06.2006; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Ma XH, 2010, CRYOBIOLOGY, V60, P184, DOI 10.1016/j.cryobiol.2009.10.013; Ma Y, 2010, ARCH MED SCI, V6, P843, DOI 10.5114/aoms.2010.19289; Moon Y, 2010, NEUROREPORT, V21, P1135, DOI 10.1097/WNR.0b013e32834051c7; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Paciaroni M, 2009, EUR NEUROL, V61, P321, DOI 10.1159/000210544; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Uyanikgil Y, 2009, ARCH MED SCI, V5, P296; Velazquez JLP, 2003, NEUROSCIENTIST, V9, P5, DOI 10.1177/1073858402239586; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yu B, 2011, INT J MOL MED, V28, P739, DOI 10.3892/ijmm.2011.734	27	10	11	0	7	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.	FEB	2013	9	1					132	138		10.5114/aoms.2012.31438			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102FJ	WOS:000315829900021	23515364	Green Published, gold, Green Submitted			2022-02-06	
J	Adams, RS; Larson, MJ; Corrigan, JD; Ritter, GA; Williams, TV				Adams, Rachel Sayko; Larson, Mary Jo; Corrigan, John D.; Ritter, Grant A.; Williams, Thomas V.			Traumatic Brain Injury Among US Active Duty Military Personnel and Negative Drinking-Related Consequences	SUBSTANCE USE & MISUSE			English	Article						traumatic brain injury; deployment; combat; military personnel; negative drinking-related consequences; alcohol drinking; alcohol-related disorders; posttraumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE; BINGE DRINKING; ALCOHOL-USE; AFGHANISTAN; HEALTH; IRAQ; SYMPTOMS; VETERANS; DEPLOYMENTS	This study used the 2008 Department of Defense Survey of Health Related Behaviors among Active Duty Military Personnel to determine whether traumatic brain injury (TBI) is associated with past year drinking-related consequences. The study sample included currently drinking personnel who had a combat deployment in the past year and were home for >= 6 months (N = 3,350). Negative binomial regression models were used to assess the incidence rate ratios of consequences, by TBI-level. Experiencing a TBI with a loss of consciousness for more than 20 minutes was significantly associated with consequences independent of demographics, combat exposure, posttraumatic stress disorder, and binge drinking. The study's limitations are noted.	[Adams, Rachel Sayko; Larson, Mary Jo; Ritter, Grant A.] Brandeis Univ, Inst Behav Hlth, Heller Sch Social Policy & Management, Waltham, MA 02454 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Williams, Thomas V.] US Dept Def, TRICARE Management Act, Falls Church, VA USA		Adams, RS (corresponding author), Brandeis Univ, Inst Behav Hlth, Heller Sch Social Policy & Management, Waltham, MA 02454 USA.	radams@brandeis.edu	Adams, Rachel/AAH-4653-2020		Ruth L. Kirschstein National Research Service from National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) [F31 AA021030]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32 AA007567]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007567, F31AA021030] Funding Source: NIH RePORTER	Dr. Adams conducted this research with pre-doctoral fellowship dissertation support from a Ruth L. Kirschstein National Research Service Award from the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) (F31 AA021030) and an institutional training grant from NIAAA (T32 AA007567).	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Armed Forces Health Surveillance Center, 2011, MSMR, V18, P9; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bray RM., 2009, DEP DEFENSE; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brown JM, 2007, 2006 UNIT LEVEL INFL; BURNAM MA, 1988, MED CARE, V26, P775, DOI 10.1097/00005650-198808000-00004; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Defense and Veterans Brain Injury Center, 2010, DEP DEF COD GUID TRA; Department of Defense, 2009, DEP DEF NUMB TRAUM B; Department of Defense, 2012, 649011 DODI DEP DEF; Deployment Health Clinical Center, 2011, TRAUMATIC BRAIN INJU; DOD Deployment Health Clinical Center, 2010, ENH POSTD HLTH ASS P; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Harwood HJ, 2009, MIL MED, V174, P728, DOI 10.7205/MILMED-D-03-9008; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hilbe, 2011, NEGATIVE BINOMIAL RE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Institute of Medicine, 2012, SUBST US DIS US ARM; Institute of Medicine, 2012, TREATM POSTTR STRESS; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keith T., 2011, HLTH CARE COSTS NEW; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McDonald Mark, 2012, INT HERALD TRIBUNE; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2005, NIH PUBLICATION, V05-3769; Ong AL, 2008, MIL MED, V173, P871, DOI 10.7205/MILMED.173.9.871; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; ROST K, 1993, MED CARE, V31, P189, DOI 10.1097/00005650-199303000-00001; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shen YC, 2012, AM J PUBLIC HEALTH, V102, pS80, DOI 10.2105/AJPH.2011.300425; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; StataCorp, 2011, STAT STAT SOFTW REL; Statistical Consulting Group, 2012, STAT ANN OUTP NEG BI; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Thurman DJ., 1995, GUIDELINES SURVEILLA; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	65	10	10	1	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2013	48	10					821	836		10.3109/10826084.2013.797995			16	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	186ES	WOS:000322025400004	23869456	Green Accepted			2022-02-06	
J	Fuller, DA; Mani, US; Keenan, MAE				Fuller, David A.; Mani, Usha S.; Keenan, Mary Ann E.			Heterotopic ossification of the shoulder in patients with traumatic brain injury	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Shoulder; heterotopic ossification; traumatic brain injury; surgical ressection; range of motion; activities of daily living	RESECTION	Background: We retrospectively reviewed 10 consecutive patients (11 shoulders) with traumatic brain injury who underwent surgical resection of heterotopic ossification (HO) of the shoulder. Our primary research goal was to determine the change in range of motion (ROM) at the shoulder after resection of heterotopic ossification in patients with traumatic brain injury. Secondary research goals were to determine simple functional outcome gains related to activities of daily living and to determine complications in this patient cohort. Methods and materials: Data were collected retrospectively and included measured ROM of the shoulder and observed ability to perform daily activities. The average age of the patients was 33 years (range, 20 - 45). Results: Sagittal plane motion (flexion/extension) increased by 85.0 degrees, coronal plane motion (adduction/abduction) increased by 59.1 degrees, and axial plane motion (internal/external rotation) increased by 66.8 degrees (P < .001). Nine patients increased independence with improved functional status (7 patients able to perform all 3 activities of feeding, grooming, and toiletry) (P < .001). Conclusion: Surgical resection of heterotopic ossification of the shoulder is an effective procedure to increase joint mobility and improve function.	[Fuller, David A.] Univ Med & Dent New Jersey, Cooper Univ, Camden, NJ USA; [Mani, Usha S.] Methodist Dallas Med Ctr, Dallas, TX 75203 USA; [Keenan, Mary Ann E.] Univ Penn, Philadelphia, PA 19104 USA		Mani, US (corresponding author), Methodist Dallas Med Ctr, 1441 N Beckley Ave, Dallas, TX 75203 USA.	ushamani288@aol.com	Keenan, Mary Ann/ABB-1551-2020				Botte MJ, 1997, ORTHOPEDICS, V20, P335; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOPAEDICS, V263, P13; Gennarelli T A, 1988, Brain Inj, V2, P175, DOI 10.3109/02699058809150942; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Kjaersgaard-Andersen P, 1989, J Arthroplasty, V4, P99; Kolessar DJ, 1996, J HEAD TRAUMA REHAB, V11, P78, DOI 10.1097/00001199-199608000-00010; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003	12	10	11	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JAN	2013	22	1					52	56		10.1016/j.jse.2012.01.028			5	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	068CY	WOS:000313343300012	22652064				2022-02-06	
J	Fulop, T; Lacombe, G; Cunnane, S; Le Page, A; Dupuis, G; Frost, EH; Bourgade-Navarro, K; Goldeck, D; Larbi, A; Pawelec, G				Fulop, Tamas; Lacombe, Guy; Cunnane, Stephen; Le Page, Aurelie; Dupuis, Gilles; Frost, Eric H.; Bourgade-Navarro, Karine; Goldeck, David; Larbi, Anis; Pawelec, Graham			Elusive Alzheimer's Disease: Can Immune Signatures Help Our Understanding of This Challenging Disease? Part 1: Clinical and Historical Background	DISCOVERY MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; VASCULAR RISK-FACTORS; NECROSIS-FACTOR-ALPHA; BETA-PROTEIN; NATIONAL INSTITUTE; DEMENTIA; HYPOTHESIS; CELLS	Alzheimer's disease (AD) is the most common form of dementia. Its most important pathological hallmarks are profound neuronal loss, presence of intracellular neurofibrillary tangles, and extracellular deposition of beta-amyloid protein (A beta) as beta-amyloid plaques. These latter aggregations result in neuronal degeneration in brain regions important not only for memory, but also for other cognitive functions. One of the most important risk factors for AD is age and with the increase of life-expectancy AD has thus become the most common form of dementia. It is now formally recognized by several new diagnostic criteria that AD is not a homogeneous disease. The current "Holy Grail" is to be able to diagnose variants of AD before they manifest clinically and before irreparable brain damage is done. To achieve this goal, robust and reliable biomarkers that reflect the pathogenesis of AD have to be implemented. This is of paramount importance because such biomarkers may provide clues to pathways that can be targeted for interventions aimed at disease prevention or improvement. Although much attention has focused on A beta as a major component of AD, A beta may be a less attractive target since an increasing amount of data has raised concerns about its causative role in AD. This review will be in two parts, this first part will deal with the current clinical knowledge and the questions raised by the A beta cascade hypothesis in the pathogenesis of AD and the second part will aim to synthesize our current knowledge and to discuss new data that suggest how immune alterations may contribute to the development of AD and may therefore provide beneficial targets in novel approaches for the treatment of AD. [Discovery Medicine 15(80):23-32, January 2013]	[Fulop, Tamas; Lacombe, Guy; Cunnane, Stephen; Le Page, Aurelie; Bourgade-Navarro, Karine] Univ Sherbrooke, Res Ctr Aging, Sherbrooke, PQ J1H 4C4, Canada; [Dupuis, Gilles] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Biochem, Grad Programme Immunol, Sherbrooke, PQ J1H 5N4, Canada; [Frost, Eric H.] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1H 5N4, Canada; [Goldeck, David; Pawelec, Graham] Univ Tubingen, Med Res Ctr, Tubingen, Germany; [Larbi, Anis] ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore, Singapore		Fulop, T (corresponding author), Univ Sherbrooke, Res Ctr Aging, Sherbrooke, PQ J1H 4C4, Canada.	tamas.fulop@usherbrooke.ca	Larbi, Anis/ABE-5868-2020; Pawelec, Graham/H-2713-2019	Pawelec, Graham/0000-0002-3600-0163; Frost, Eric/0000-0001-8958-4388; Bourgade, Karine/0000-0002-2802-2469	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [106634, 106701]; Universite de Sherbrooke; Research Center on Aging; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7 259679]; German Research FoundationGerman Research Foundation (DFG) [DFG-PA 361/14-1]; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 0315890F]	This work is partly supported by grants from the Canadian Institutes of Health Research (CIHR) (No. 106634 and No. 106701), the Universite de Sherbrooke, and the Research Center on Aging, as well as by the European Commission (FP7 259679 "IDEAL"), the German Research Foundation (DFG-PA 361/14-1), and the German Federal Ministry of Education and Research (BMBF 0315890F, "Gerontoshield").	Akiyama H, 1996, NEUROSCI LETT, V219, P115, DOI 10.1016/S0304-3940(96)13197-9; Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Alzheimer A., 1907, ALLG ZEITSCHR PSYCHI, V64, P146; Angata T, 2012, ANN NY ACAD SCI, V1253, P159, DOI 10.1111/j.1749-6632.2012.06469.x; Baars MAE, 2009, DEMENT GERIATR COGN, V27, P173, DOI 10.1159/000200465; Ball MJ, 2012, ALZHEIMERS DEMENT; Blasko I, 2007, J PSYCHIATR RES, V41, P694, DOI 10.1016/j.jpsychires.2006.02.001; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; Buchhave P, 2009, NEUROSCI LETT, V450, P56, DOI 10.1016/j.neulet.2008.10.091; Budson AE, 2012, NEUROLOGIST, V18, P356, DOI 10.1097/NRL.0b013e31826a998d; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Carter CJ, 2008, NEUROCHEM INT, V52, P920, DOI 10.1016/j.neuint.2007.11.003; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Castellani RJ, 2009, J ALZHEIMERS DIS, V18, P447, DOI 10.3233/JAD-2009-1151; Clark IA, 2011, J ALZHEIMERS DIS, V27, P691, DOI 10.3233/JAD-2011-110887; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; de la Monte SM, 2012, DRUGS, V72, P49, DOI 10.2165/11597760-000000000-00000; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Derouesne C, 2008, PSYCHOL NEUROPSYCHIA, V6, P115, DOI 10.1684/pnv.2008.0122; Devanand DP, 2008, BIOL PSYCHIAT, V64, P871, DOI 10.1016/j.biopsych.2008.06.020; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1, DOI DOI 10.1001/ARCHNEUR0L.2012.1282.[; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Eckert GP, 2010, CURR PROTEIN PEPT SC, V11, P319, DOI 10.2174/138920310791330668; Eckert GP, 2003, PHARMACOPSYCHIATRY, V36, pS136; Eikelenboom P, 2011, CURR ALZHEIMER RES, V8, P142, DOI 10.2174/156720511795256080; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fulop T, 2007, CLIN INTERV AGING, V2, P33, DOI 10.2147/ciia.2007.2.1.33; Fulop T, 2013, DISCOV MED, V15, P33; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Gorelick PB, 2012, J AM SOC HYPERTENS, V6, P309, DOI 10.1016/j.jash.2012.08.004; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grandy John K, 2012, JAAPA, V25, P50; Griffin W Sue T, 2011, F1000 Med Rep, V3, P24, DOI 10.3410/M3-24; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Grossberg GT, 2003, J GERONTOL A-BIOL, V58, P331; HACHINSKI VC, 1974, LANCET, V2, P207; HAGA S, 1989, ACTA NEUROPATHOL, V77, P569, DOI 10.1007/BF00687883; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris JR, 2010, SUBCELL BIOCHEM, V51, P47, DOI 10.1007/978-90-481-8622-8_2; Heister D, 2011, NEUROLOGY, V77, P1619, DOI 10.1212/WNL.0b013e3182343314; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Holmes C, 2009, CNS DRUGS, V23, P993, DOI 10.2165/11310910-000000000-00000; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; Karas G, 2008, AM J NEURORADIOL, V29, P944, DOI 10.3174/ajnr.A0949; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lang PO, 2010, EUR GERIATR MED, V1, P112, DOI 10.1016/j.eurger.2010.01.010; Larbi A, 2006, CELL SIGNAL, V18, P1017, DOI 10.1016/j.cellsig.2005.08.016; Laurin D, 2009, NEUROBIOL AGING, V30, P1724, DOI 10.1016/j.neurobiolaging.2008.01.008; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lukiw WJ, 2010, NEUROREPORT, V21, P922, DOI 10.1097/WNR.0b013e32833da51a; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; Maarouf CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027291; Magaki S, 2008, J PSYCHIATR RES, V42, P240, DOI 10.1016/j.jpsychires.2007.01.004; Maksimovich IV, 2012, HEALTH, V4, P735; Marx Florentine, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P205; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McNeal MC, 2001, J GERONTOL A-BIOL, V56, pB294, DOI 10.1093/gerona/56.7.B294; Meguro K, 2012, J NEUROL SCI, V322, P157, DOI 10.1016/j.jns.2012.07.048; Miklossy J, 2003, NEUROL RES, V25, P605, DOI 10.1179/016164103101202048; Moroney JT, 1997, NEUROLOGY, V49, P1096, DOI 10.1212/WNL.49.4.1096; Naylor MD, 2012, ALZHEIMERS DEMENT, V8, P445, DOI 10.1016/j.jalz.2012.08.001; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Okonkwo OC, 2008, NEUROLOGY, V71, P1474, DOI 10.1212/01.wnl.0000334301.32358.48; Orehek AJ, 2012, MED HYPOTHESES, V78, P562, DOI 10.1016/j.mehy.2012.01.020; Pawelec G, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-15; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qiu CX, 2012, J ALZHEIMERS DIS, V32, P721, DOI 10.3233/JAD-2012-120922; Reiman EM, 2011, J CLIN PSYCHIAT, V72, P1190, DOI [10.4088/JCP.10087tx2c, 10.4088/JCP.10087colc, 10.4088/JCP.10087co1c]; Reis HJ, 2010, NEURODEGENER DIS, V7, P272, DOI 10.1159/000309659; Richard E, 2012, J ALZHEIMERS DIS, V31, pS203, DOI 10.3233/JAD-2012-112216; Ritchie K, 1996, BRIT J PSYCHIAT, V168, P470, DOI 10.1192/bjp.168.4.470; Robinson SR, 2002, NEUROBIOL AGING, V23, P1051, DOI 10.1016/S0197-4580(01)00342-6; Rocha NP, 2012, MOL CELL NEUROSCI, V49, P77, DOI 10.1016/j.mcn.2011.09.005; Sardi F, 2011, AUTOIMMUN REV, V11, P149, DOI 10.1016/j.autrev.2011.09.005; Schuitemaker A, 2009, NEUROBIOL AGING, V30, P1885, DOI 10.1016/j.neurobiolaging.2008.01.014; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Skaper SD, 2012, INT REV NEUROBIOL, V102, P277, DOI 10.1016/B978-0-12-386986-9.00011-9; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Sojkova J, 2011, ARCH NEUROL-CHICAGO, V68, P644, DOI 10.1001/archneurol.2011.77; Solito E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00014; Solomon A, 2013, ADV ALZH DIS, V3, P465, DOI [10.3233/978-1-61499-154-0-465, 10.3233/JAD-2012-129021]; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Strandberg TE, 2004, ARCH GERONTOL GERIAT, P419; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski Elisabeth, 2002, Current Drug Targets - Inflammation and Allergy, V1, P193, DOI 10.2174/1568010023344670; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Visser PJ, 2012, ALZHEIMERS DEMENT, V8, P560, DOI 10.1016/j.jalz.2011.10.008; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Warren JD, 2012, NAT REV NEUROL, V8, P451, DOI 10.1038/nrneurol.2012.135; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Zhang C, 2012, DISCOV MED, V14, P189	111	10	10	0	3	DISCOVERY MEDICINE	TIMONIUM	10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA	1539-6509	1944-7930		DISCOV MED	Discov. Med.	JAN	2013	15	80					23	32					10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	094YA	WOS:000315300200003	23375011				2022-02-06	
J	Li, MF; Liu, XL; Yue, HY; Xiong, WM; Gu, JF; Xu, M				Li, Mingfeng; Liu, Xinlong; Yue, Haiyan; Xiong, Weiming; Gu, Jianfeng; Xu, Mao			Transplantation of N-Acetyl Aspartyl-Glutamate Synthetase-Activated Neural Stem Cells after Experimental Traumatic Brain Injury Significantly Improves Neurological Recovery	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						NAAGS; Neural stem cells; Traumatic brain injury; Neurological recovery	AMINO-ACID RELEASE; NAALADASE INHIBITION; DIABETIC-NEUROPATHY; CEREBRAL-ISCHEMIA; ACETYLASPARTYLGLUTAMATE; DIFFERENTIATE; SURVIVAL; MIGRATE; NEUROTRANSMITTER; HIPPOCAMPUS	Background/Aims: Neural stem cells (NSCs) hold considerable potential as a therapeutic tool for repair of the damaged nervous system. In the current study, we examined whether transplanted N-acetyl aspartyl-glutamate synthetase (NAAGS)-activated NSCs (NAAGS/NSCs) further improve neurological recovery following traumatic brain injury (TBI) in Sprague-Dawley rats. Methods: Animals received TBI and stereotactic injection of NSCs, NAAGS/NSCs or phosphate buffered saline without cells (control) into the injured cortex. NAAGS protein expression was detected through western blot analysis. Dialysate NAAG levels were analyzed with radioimmunoassay. Cell apoptosis was detected via TUNEL staining. The expression levels of specific pro-inflammatory cytokines were detected with enzyme-linked immunosorbent assay. Results: Groups with transplanted NSCs and NAAGS/NSCs displayed significant recovery of the motor behavior, compared to the control group. At 14 and 21 days post-transplantation, the motor behavior in NAAGS/NSC group was significantly improved than that in NSC group (p < 0.05). Additionally, transplanted NAAGS/NSCs inhibited cell apoptosis and the expression levels of specific pro-inflammatory cytokines, including interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha. Conclusion: Our results collectively demonstrate that NAAGS/NSCs provide a more powerful autoplastic therapy for the injured nervous system. Copyright (C) 2013 S. Karger AG, Basel	[Li, Mingfeng; Liu, Xinlong; Yue, Haiyan; Xiong, Weiming; Gu, Jianfeng; Xu, Mao] 455 Hosp PLA, Shanghai 200052, Peoples R China		Li, MF (corresponding author), 455 Hosp PLA, Dept Digest Tumor, 338 West Huaihai Rd, Shanghai 200052, Peoples R China.	mflee@vip.163.com			Scientific Research Funds of Ministry of Health of Nanjing Military Region [10MA027]	This work was supported by the grants from Scientific Research Funds of Ministry of Health of Nanjing Military Region (10MA027).	Becker I, 2010, J BIOL CHEM, V285, P29156, DOI 10.1074/jbc.M110.111765; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Clarkson ED, 1999, LIFE SCI, V65, P2427, DOI 10.1016/S0024-3205(99)00254-4; Conti L, 2006, BRAIN PATHOL, V16, P143, DOI 10.1111/j.1750-3639.2006.00009.x; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Koura SS, 1998, ACT NEUR S, V71, P244; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Ma XH, 2010, CRYOBIOLOGY, V60, P184, DOI 10.1016/j.cryobiol.2009.10.013; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; SOARES H, 1991, Journal of Neural Transplantation and Plasticity, V2, P207; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Van Hemelrijck A, 2005, J NEUROCHEM, V95, P1287, DOI 10.1111/j.1471-4159.2005.03450.x; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Wroblewska B, 1997, J NEUROCHEM, V69, P174; WROBLEWSKA B, 1993, J NEUROCHEM, V61, P943, DOI 10.1111/j.1471-4159.1993.tb03606.x; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang PB, 2009, NEUROPATHOLOGY, V29, P410, DOI 10.1111/j.1440-1789.2008.00993.x; Zhang W, 2006, J NEUROL SCI, V247, P217, DOI 10.1016/j.jns.2006.05.052; Zhang W, 2002, J NEUROL SCI, V194, P21, DOI 10.1016/S0022-510X(01)00670-0; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	45	10	11	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2013	32	6					1776	1789		10.1159/000356611			14	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	297YX	WOS:000330292100020	24356585	gold			2022-02-06	
J	McMillan, TM				McMillan, T. M.			Outcome of rehabilitation for neurobehavioural disorders	NEUROREHABILITATION			English	Article						Neurorehabilitation; neurobehavioural; holistic rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; OF-THE-LITERATURE; SELF-AWARENESS; COGNITIVE REHABILITATION; HEAD-INJURY; NEUROPSYCHOLOGICAL REHABILITATION; FOLLOW-UP; DEFICITS; MANAGEMENT	BACKGROUND: The evidence base on neurobehavioural disorders and their rehabilitation has been growing for four decades. Over that time understanding of the need for effective interventions for a range of handicaps in personal, interpersonal and employment spheres has developed. There is a continuing need to demonstrate whether interventions, are effective and cost-sensitive. Moreover, in pursuing effectiveness, clinicians need to be able to predict which individuals are likely to benefit from a programme and here, clinical experience needs to be informed by research evidence. OBJECTIVE: To review the outcome of rehabilitation for neurobehavioural disorders. METHODS: This review initially considers the background to neurobehavioural rehabilitation and discusses methodological issues. It reviews the evidence for neurobehavioural interventions for severe head injury with emphasis on holistic models of care, behavioural treatments, interventions in non-specialist settings and for emotion perception and self-awareness. RESULTS: In general, there is a need for further high quality studies with longer follow-ups and evidence for generalisation in the community. However, there is a growing consensus that intensive holistic rehabilitation programmes can improve community reintegration and self-efficacy. For behaviour disturbance the evidence base largely comprises studies with weaker (single group or single case) designs. Overall studies here provide limited evidence in support of behavioural approaches for externalised behaviour such as aggression. Further RCT or group comparison studies are needed. In terms of negative behaviours such as apathy, there are few studies on head injury and conclusions cannot be made with confidence. Self awareness is a key issue associated with good outcome in general and research to date supports use of interventions that focus in on-task behaviour and education. The correct perception of emotions in others is a precursor to successful social interaction, and here there is very little evidence although early studies are encouraging. CONCLUSION: There is mounting evidence to support the effectiveness of non-pharmacological interventions for neurobehavioural disorders. Successful outcomes are often associated with intensive and prolonged interventions involving multidisciplinary working.	Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk					Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Benton A. L., 2000, EXPLORING HIST NEURO; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bowen A, 2001, BRAIN INJURY, V15, P29, DOI 10.1080/02699050150209101; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Code C, 1996, CLASSIC CASES NEUROP; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cusick CP, 2003, BRAIN INJURY, V17, P931, DOI 10.1080/0269905031000110391; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Disler P. B., 2005, COCHRANE DB SYST REV, P3; Doig E, 2010, DISABIL REHABIL, V32, P2061, DOI 10.3109/09638281003797356; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; GOLDSTEIN K, 1959, J INDIV PSYCHOL, V15, P5; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; JOHNSTON S, 1991, J NEUROL NEUROSUR PS, V54, P272, DOI 10.1136/jnnp.54.3.272; Kaptchuk TJ, 2001, J CLIN EPIDEMIOL, V54, P541, DOI 10.1016/S0895-4356(00)00347-4; Lane-Brown A., 2009, INTERVENTIONS APATHY; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mateer CA, 2009, J INT NEUROPSYCH SOC, V15, P623, DOI 10.1017/S1355617709090924; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; McMillan TM, 1999, NEUROPSYCHOL REHABIL, V9, P129, DOI 10.1080/713755599; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Morgan J., 2011, CASEBOOK CLIN NEUROP; O'Neill M, 2012, NEUROPSYCHOL REHABIL, V22, P836, DOI 10.1080/09602011.2012.691886; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T., 2008, NEUROPSYCHOLOGICAL R, V18; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Ponsford J., 2013, NEUROREHABILITATION; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 2003, ARCH CLIN NEUROPSYCH, V18, P811, DOI 10.1016/S0887-6177(02)00205-6; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1989, NEUROPSYCHOLOGICAL R; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Roberts CB, 2006, BRAIN INJURY, V20, P485, DOI 10.1080/02699050600664665; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Saarni SI, 2004, J MED ETHICS, V30, P171, DOI 10.1136/jme.2003.003145; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Scargle J., 2000, J SCI EXPLORATION, V14, P91; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith MJ, 2006, J HEAD TRAUMA REHAB, V21, P76, DOI 10.1097/00001199-200601000-00008; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Whyte J, 2002, ARCH PHYS MED REHAB, V83, P1320, DOI 10.1053/apmr.2002.34807; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood R. L. L., 1981, APPL CONDITIONING TH; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	79	10	10	0	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	4					791	801		10.3233/NRE-130903			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	184QF	WOS:000321907100010	23867405				2022-02-06	
J	McMurtray, AM; Saito, EK; Diaz, N; Mehta, B; Nakamoto, B				McMurtray, Aaron M.; Saito, Erin K.; Diaz, Natalie; Mehta, Bijal; Nakamoto, Beau			GREATER FREQUENCY OF DEPRESSION ASSOCIATED WITH CHRONIC PRIMARY HEADACHES THAN CHRONIC POST-TRAUMATIC HEADACHES	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						chronic pain; depression; headache	TRAUMATIC BRAIN-INJURY; CHRONIC MIGRAINE; COMORBIDITY; DISORDERS; ANXIETY; PREVALENCE; ALCOHOL; LIFE; PAIN	Objective: To compare the prevalence of co-morbid depression between patients with chronic primary headache syndromes and chronic post-traumatic headaches. Method: A prospective cross-sectional analysis of all patients presenting sequentially to a community-based general neurology clinic during a 2-year period for evaluation of chronic headache pain was conducted. Headache diagnosis was determined according to the International Headache Society's Headache Classification criteria. Depression was determined through a combination of scores on the clinician administered Hamilton Rating Scale for Depression and patients' self-report. An additional group of patients who suffered traumatic brain injuries (TBI) but did not develop post-traumatic headaches was included for comparison. Results: A total of 83 patients were included in the study: 45 with chronic primary headaches (24 with chronic migraine headaches, 21 with chronic tension headaches), 24 with chronic post-traumatic headaches, and 14 with TBI but no headaches. Depression occurred less frequently among those with chronic post-traumatic headaches (33.3%) compared to those with chronic migraine (66.7%) and chronic tension (52.4%) headaches (Chi-Square = 7.68; df = 3; p = 0.053), and did not significantly differ from TBI patients without headaches. A multivariate logistic regression model using depression as the outcome variable and including headache diagnosis, gender, ethnicity, and alcohol and illicit substance use was statistically significant (Chi-Square = 27.201; df = 10; p < 0.01) and identified primary headache (migraine and tension) diagnoses (Score = 7.349; df = 1; p = 0.04) and female gender (Score = 15.281; df = 1; p < 0.01) as significant predictor variables. The overall model accurately predicted presence of co-morbid depression in 74.7% of the cases. Conclusions: Co-morbid depression occurs less frequently among patients with chronic post-traumatic headaches and TBI without headaches than among those with chronic primary headaches.	[McMurtray, Aaron M.; Saito, Erin K.; Diaz, Natalie; Mehta, Bijal] Univ Calif Los Angeles, Torrance, CA USA; [McMurtray, Aaron M.; Saito, Erin K.; Diaz, Natalie; Mehta, Bijal] Harbor UCLA Med Ctr, Neurol Dept Bld N 25, Torrance, CA 90509 USA; [Nakamoto, Beau] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Nakamoto, Beau] Straub Clin & Hosp, Honolulu, HI USA		McMurtray, AM (corresponding author), Harbor UCLA Med Ctr, Neurol Dept Bld N 25, 1000 West Carson St, Torrance, CA 90509 USA.	amcmurtray@mednet.ucla.edu	McMurtray, Aaron/AAE-5492-2021		NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54 RR026136] Funding Source: Medline; NIMHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54 MD007584] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54RR026136] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007584] Funding Source: NIH RePORTER		Aamodt AH, 2006, EUR J NEUROL, V13, P1233, DOI 10.1111/j.1468-1331.2006.01492.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chen YC, 2012, J HEADACHE PAIN, V13, P311, DOI 10.1007/s10194-012-0447-4; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hedlund J. L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; IBM Corp, IBM SPSS STAT WIND V; Juang KD, 2000, HEADACHE, V40, P818, DOI 10.1046/j.1526-4610.2000.00148.x; McWilliams LA, 2004, PAIN, V111, P77, DOI 10.1016/j.pain.2004.06.002; Molarius A, 2008, HEADACHE, V48, P1426, DOI 10.1111/j.1526-4610.2008.01178.x; Mongini F, 2006, J PSYCHOSOM RES, V61, P447, DOI 10.1016/j.jpsychores.2006.03.005; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Penacoba-Puente C, 2008, EUR J PAIN, V12, P886, DOI 10.1016/j.ejpain.2007.12.016; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Teixeira AL, 2012, J HEADACHE PAIN, V13, P551, DOI 10.1007/s10194-012-0480-3; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Yucel B, 2002, HEADACHE, V42, P194, DOI 10.1046/j.1526-4610.2002.02051.x	19	10	10	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2174	1541-3527		INT J PSYCHIAT MED	Int. J. Psychiatr. Med.		2013	45	3					227	236		10.2190/PM.45.3.b			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	207AN	WOS:000323568700002	24066406	Green Accepted			2022-02-06	
J	Sultan, E; Najafizadeh, L; Gandjbakhche, AH; Pourrezaei, K; Daryoush, A				Sultan, Ebraheem; Najafizadeh, Laleh; Gandjbakhche, Amir H.; Pourrezaei, Kambiz; Daryoush, Afshin			Accurate optical parameter extraction procedure for broadband near-infrared spectroscopy of brain matter	JOURNAL OF BIOMEDICAL OPTICS			English	Article						functional near-infrared; traumatic brain injury; finite element method; diffusion equation; COMSOL; optical transmitter; optical receiver; tri-wavelength; continuous wave; time domain; frequency domain; photon density wave; vertical cavity surface emitting laser; insertion loss; insertion phase	NONINVASIVE DETERMINATION; PHOTON MIGRATION; FREQUENCY-DOMAIN; DIFFUSE-REFLECTANCE; SCATTERING MEDIA; MODEL; PROPAGATION; LIGHT	Modeling behavior of broadband (30 to 1000 MHz) frequency modulated near-infrared (NIR) photons through a phantom is the basis for accurate extraction of optical absorption and scattering parameters of biological turbid media. Photon dynamics in a phantom are predicted using both analytical and numerical simulation and are related to the measured insertion loss (IL) and insertion phase (IP) for a given geometry based on phantom optical parameters. Accuracy of the extracted optical parameters using finite element method (FEM) simulation is compared to baseline analytical calculations from the diffusion equation (DE) for homogenous brain phantoms. NIR spectroscopy is performed using custom-designed, broadband, free-space optical transmitter (Tx) and receiver (Rx) modules that are developed for photon migration at wavelengths of 680, 780, and 820 nm. Differential detection between two optical Rx locations separated by 0.3 cm is employed to eliminate systemic artifacts associated with interfaces of the optical Tx and Rx with the phantoms. Optical parameter extraction is achieved for four solid phantom samples using the least-square-error method in MATLAB (for DE) and COMSOL (for FEM) simulation by fitting data to measured results over broadband and narrowband frequency modulation. Confidence in numerical modeling of the photonic behavior using FEM has been established here by comparing the transmission mode's experimental results with the predictions made by DE and FEM for known commercial solid brain phantoms. (c) The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.18.1.017008]	[Sultan, Ebraheem; Daryoush, Afshin] Drexel Univ, Dept ECE, Philadelphia, PA 19104 USA; [Pourrezaei, Kambiz] Drexel Univ, Sch Biomed Engn & Hlth Syst, Philadelphia, PA 19104 USA; [Najafizadeh, Laleh; Gandjbakhche, Amir H.] NIH, Bethesda, MD 20892 USA		Sultan, E (corresponding author), Drexel Univ, Dept ECE, Philadelphia, PA 19104 USA.	medxe@medxe.com			Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense; Intramural Research Program (IRP) of Eunice Shriver National Institute of Child Health and Human Development (NICHD) of the National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD008882, ZIAHD000261] Funding Source: NIH RePORTER	This research is partly supported by the Center for Neuroscience and Regenerative Medicine (CNRM), and the Intramural Research Program (IRP) of Eunice Shriver National Institute of Child Health and Human Development (NICHD) of the National Institute of Health. We are grateful to Professor Jessica Rammella-Roman, at the Catholic University of America, for her support in providing the phantoms.	Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Bevilacqua F, 2000, APPL OPTICS, V39, P6498, DOI 10.1364/AO.39.006498; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; Choi J, 2004, J BIOMED OPT, V9, P221, DOI 10.1117/1.1628242; Contini D, 1997, APPL OPTICS, V36, P4587, DOI 10.1364/AO.36.004587; Di Ninni P, 2010, OPT EXPRESS, V18, P26854, DOI 10.1364/OE.18.026854; Duderstadt J.J., 1979, TRANSPORT THEORY; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Fishkin JB, 1996, PHYS REV E, V53, P2307, DOI 10.1103/PhysRevE.53.2307; FLOCK ST, 1989, IEEE T BIO-MED ENG, V36, P1169, DOI 10.1109/10.42107; Grosenick D, 2003, APPL OPTICS, V42, P3170, DOI 10.1364/AO.42.003170; Guan KW, 2011, OPT LASER TECHNOL, V43, P425, DOI 10.1016/j.optlastec.2009.12.007; Hebden JC, 2001, APPL OPTICS, V40, P3278, DOI 10.1364/AO.40.003278; Heino J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031908; Izzetoglu K, 2004, INT J HUM-COMPUT INT, V17, P211, DOI 10.1207/s15327590ijhc1702_6; Kienle A, 1998, APPL OPTICS, V37, P779, DOI 10.1364/AO.37.000779; Manseta K., 2010, IEEE TOP M MICR PHOT, P354; Manseta K., 2011, MICR S MTT 2011 IEEE, P1; Patterson M. S., 1991, 1991 IEEE MTT-S International Microwave Symposium Digest (91CH2870-4), P905, DOI 10.1109/MWSYM.1991.147155; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; PERELMAN LT, 1995, PHYS REV E, V51, P6134, DOI 10.1103/PhysRevE.51.6134; Pham TH, 2000, REV SCI INSTRUM, V71, P2500, DOI 10.1063/1.1150665; Sassaroli A, 2011, OPT LETT, V36, P2095, DOI 10.1364/OL.36.002095; Sassaroli A, 2011, PROC SPIE, V7896, DOI 10.1117/12.876943; SCHWEIGER M, 1995, MED PHYS, V22, P1779, DOI 10.1118/1.597634; Sultan E, 2011, PROC SPIE, V7902, DOI 10.1117/12.875618; Zhao J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891345; Zhou J, 2001, P ANN INT IEEE EMBS, V23, P3203, DOI 10.1109/IEMBS.2001.1019504; Zhu CG, 2011, OPT EXPRESS, V19, P17799, DOI 10.1364/OE.19.017799	29	10	10	2	17	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	JAN	2013	18	1							017008	10.1117/1.JBO.18.1.017008			8	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	092XT	WOS:000315157000029	23322361	Green Published, hybrid			2022-02-06	
J	Veeravagu, A; Joseph, R; Jiang, BW; Lober, RM; Ludwig, C; Torres, R; Singh, H				Veeravagu, Anand; Joseph, Richard; Jiang, Bowen; Lober, Robert M.; Ludwig, Cassie; Torres, Roland; Singh, Harminder			Traumatic epistaxis: Skull base defects, intracranial complications and neurosurgical considerations	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Epistaxis; Foley catheter; Intracranial; Nasogastric tube; Skull base fracture		INTRODUCTION: Endonasal procedures may be necessary during management of craniofacial trauma. When a skull base fracture is present, these procedures carry a high risk of violating the cranial vault and causing brain injury or central nervous system infection. PRESENTATION OF CASE: A 52-year-old bicyclist was hit by an automobile at high speed. He sustained extensive maxillofacial fractures, including frontal and sphenoid sinus fractures (Fig. 1). He presented to the emergency room with brisk nasopharyngeal hemorrhage, and was intubated for airway protection. He underwent emergent stabilization of his nasal epistaxis by placement of a Foley catheter in his left nare and tamponade with the Foley balloon. A six-vessel angiogram showed no evidence of arterial dissection or laceration. Imaging revealed inadvertent insertion of the Foley catheter and deployment of the balloon in the frontal lobe (Fig. 2). The balloon was subsequently deflated and the Foley catheter removed. The patient underwent bifrontal craniotomy for dural repair of CSF leak. He also had placement of a ventriculoperitoneal shunt for development of post-traumatic hydrocephalus. Although the hospital course was a prolonged one, he did make a good neurological recovery. DISCUSSION: The authors review the literature involving violation of the intracranial compartment with medical devices in the settings of craniofacial trauma. CONCLUSION: Caution should be exercised while performing any endonasal procedure in the settings of trauma where disruption of the anterior cranial base is possible. (C) 2013 Surgical Associates Ltd. Published by Elsevier Ltd.	[Veeravagu, Anand; Joseph, Richard; Jiang, Bowen; Lober, Robert M.; Ludwig, Cassie; Torres, Roland; Singh, Harminder] Stanford Hosp & Clin, Dept Neurosurg, 300 Pasteur Dr,R200-MC 5826, Stanford, CA 94305 USA		Singh, H (corresponding author), Stanford Hosp & Clin, Dept Neurosurg, 300 Pasteur Dr,R200-MC 5826, Stanford, CA 94305 USA.	harman@stanford.edu		Ludwig, Cassie A/0000-0002-9586-3735			ADLER JS, 1992, CAN MED ASSOC J, V147, P668; Allen F, 2011, ANESTH ANALG, V112, P198, DOI 10.1213/ANE.0b013e3181fca689; Arslantas A, 2001, CHILD NERV SYST, V17, P112, DOI 10.1007/s003810000385; Baskaya MK, 1999, SURG NEUROL, V52, P426, DOI 10.1016/S0090-3019(99)00077-4; BOROVICH B, 1981, NEUROSURGERY, V8, P245, DOI 10.1227/00006123-198102000-00019; BOUZARTH WF, 1978, J TRAUMA, V18, P818, DOI 10.1097/00005373-197812000-00008; Castiglione AG, 1998, AM J FOREN MED PATH, V19, P329, DOI 10.1097/00000433-199812000-00007; Chandra R, 2010, NEUROL INDIA, V58, P804, DOI 10.4103/0028-3886.72192; CORNETT MA, 1993, AM J EMERG MED, V11, P94, DOI 10.1016/0735-6757(93)90073-K; Dees G, 1989, Emerg Med Clin North Am, V7, P177; Ferreras J, 2000, ORAL SURG ORAL MED O, V90, P564, DOI 10.1067/moe.2000.110032; FLETCHER SA, 1987, J TRAUMA, V27, P948, DOI 10.1097/00005373-198708000-00017; Freij RM, 1997, J ACCID EMERG MED, V14, P45; FREMSTAD JD, 1978, J TRAUMA, V18, P820, DOI 10.1097/00005373-197812000-00009; GALLOWAY DC, 1979, SOUTHERN MED J, V72, P240, DOI 10.1097/00007611-197902000-00035; Genu PR, 2004, J ORAL MAXIL SURG, V62, P1435, DOI 10.1016/j.joms.2004.07.005; GLASSER SA, 1990, AM J NEURORADIOL, V11, P1170; GREGORY JA, 1978, J TRAUMA, V18, P823, DOI 10.1097/00005373-197812000-00010; GUERRA B, 1979, SURG NEUROL, V12, P135; GUSTAVSSON S, 1978, ACTA CHIR SCAND, V144, P55; HANDE A, 1991, British Journal of Neurosurgery, V5, P205, DOI 10.3109/02688699108998469; Hanna AS, 2012, AM J OTOLARYNG, V33, P178, DOI 10.1016/j.amjoto.2011.04.001; Holland NJ, 2001, INT J CLIN PRACT, V55, P14; HORELLOU MF, 1978, ANAESTHESIA, V33, P73, DOI 10.1111/j.1365-2044.1978.tb08301.x; Huang HM, 2011, J CRANIOFAC SURG, V22, P748, DOI 10.1097/SCS.0b013e31820854ea; KATZ MI, 1994, AM J ROENTGENOL, V163, P222, DOI 10.2214/ajr.163.1.8010228; KOCH KJ, 1989, AM J NEURORADIOL, V10, P443; KRAULAND W, 1983, HNO, V31, P247; Marlow Troy J., 1997, Journal of Emergency Medicine, V15, P187, DOI 10.1016/S0736-4679(96)00356-3; Metheny NA, 2002, AM J NURS, V102, P25, DOI 10.1097/00000446-200208000-00033; Monem S A, 2000, Auris Nasus Larynx, V27, P357; MOUSTOUKAS N, 1983, SOUTHERN MED J, V76, P816, DOI 10.1097/00007611-198306000-00038; Muzumdar D, 2008, CHILD NERV SYST, V24, P609, DOI 10.1007/s00381-007-0554-8; Nathoo N, 1999, BRIT J NEUROSURG, V13, P409; Pandey A K, 2004, J Assoc Physicians India, V52, P322; Pawar SJ, 2003, J CLIN NEUROSCI, V10, P248, DOI 10.1016/S0967-5868(02)00330-2; PORRAS LF, 1993, NEUROSURGERY, V33, P310; Rahimi-Movaghar V, 2005, ACTA NEUROCHIR, V147, P573, DOI 10.1007/s00701-004-0463-5; Roka YB, 2010, NEUROL INDIA, V58, P802, DOI 10.4103/0028-3886.72191; Sacks A D, 1993, Ear Nose Throat J, V72, P800; SEEBACHER J, 1975, ANESTHESIOLOGY, V42, P100, DOI 10.1097/00000542-197501000-00016; VANDENANKER JN, 1992, PEDIATR RADIOL, V22, P545, DOI 10.1007/BF02013011; Woo HJ, 2008, OTOLARYNG HEAD NECK, V138, P115, DOI 10.1016/j.otohns.2007.10.003; WYLER AR, 1977, J NEUROSURG, V47, P297, DOI 10.3171/jns.1977.47.2.0297; YOUNG RF, 1979, J TRAUMA, V19, P789, DOI 10.1097/00005373-197910000-00014	45	10	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2013	4	8					656	661		10.1016/j.ijscr.2013.04.033			6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	V5E1K	WOS:000219525100004	23792475	gold, Green Published			2022-02-06	
J	Bay, E; Covassin, T				Bay, Esther; Covassin, Tracey			Chronic Stress, Somatic and Depressive Symptoms Following Mild to Moderate Traumatic Brain Injury	ARCHIVES OF PSYCHIATRIC NURSING			English	Article							MAJOR DEPRESSION; HEAD-INJURY; IMPACT; OUTCOMES; NEUROENDOCRINE; SENSITIVITY; COMPLAINTS; DISORDERS; VALIDITY; FATIGUE	Despite advances in research on symptoms, stress, and depression after traumatic brain injury, there has been limited focus on the collective relationships between neurocognitive performance, chronic stress, and somatic and depressive symptoms. Guided by our adaptation of the allostatic load theory, we examined relationships between chronic stress, somatic and depressive symptoms, and cognitive performance using the Immediate Postconcussion Assessment and Cognitive Testing cognitive battery. Only somatic symptoms and chronic stress explained variation in depressive symptoms (R-2 = .71, P < .0001), not neurocognitive performance, preinjury, or injury-specific variables. Our findings suggest that increased chronic stress and somatic symptoms can contribute significantly to depressive symptoms after mild to moderate traumatic brain injury. (C) 2012 Elsevier Inc. All rights reserved.	[Bay, Esther] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; Michigan State Univ, E Lansing, MI 48824 USA		Bay, E (corresponding author), Univ Michigan, Sch Nursing, 400 N Ingalls Bldg,Suite 2160, Ann Arbor, MI 48109 USA.	ejbbwb@charter.net; pdq@med.umich.edu			Office of the Vice President of Research	This study was funded by the Office of the Vice President of Research to Dr. Bay at Michigan State University.	Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E., 2005, J NEUROSCIENCE NURSI, V36, P55; Bay E., 2009, WESTERN J NURS RES, P1; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; [Centers for Disease Control and Prevention U.S. Department of Health and Human Services], 2010, TRAUM BRAIN INJ FACT; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee BK, 2007, ARCH GEN PSYCHIAT, V64, P810, DOI 10.1001/archpsyc.64.7.810; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lupien SJ, 2005, PSYCHONEUROENDOCRINO, V30, P225, DOI 10.1016/j.psyneuen.2004.08.003; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; McEwen B., 2002, END STRESS WE KNOW I; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McMillan T., 2011, J NEUROL NEUROSUR PS, P1; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nash WP, 2010, ARCH PHYS MED REHAB, V91, P1673, DOI 10.1016/j.apmr.2010.06.035; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Radley JJ, 2008, J COMP NEUROL, V507, P1141, DOI 10.1002/cne.21588; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rockhill C., 2012, J NEUROTRAUM, V29, P1; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Substance Abuse and Mental Health Disorders, 2011, STRESS STRESS MAN; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yehuda Rachel, 2004, Psychoneuroendocrinology, V29, P1212, DOI 10.1016/j.psyneuen.2004.01.006	57	10	10	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9417	1532-8228		ARCH PSYCHIAT NURS	Arch. Psychiatr. Nurs.	DEC	2012	26	6					477	486		10.1016/j.apnu.2012.06.002			10	Nursing; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Psychiatry	047CD	WOS:000311814400006	23164404				2022-02-06	
J	Hua, R; Mao, SS; Zhang, YM; Chen, FX; Zhou, ZH; Liu, JQ				Hua, Rong; Mao, Shan-shan; Zhang, Yong-mei; Chen, Fu-xing; Zhou, Zhong-hai; Liu, Jun-quan			Effects of pituitary adenylate cyclase activating polypeptide on CD4(+)/CD8(+) T cell levels after traumatic brain injury in a rat model	WORLD JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Pituitary adenylate cyclase activating polypeptide; CD4(+) T lymphocyte; CD8(+) T lymphocyte; Rat; Spleen; Blood; Flow cytometry		BACKGROUND: The effect of pituitary adenylate cyclase activating polypeptide (PACAP) during traumatic brain injury (TBI) and whether it can modulate secondary injury has not been reported previously. The present study evaluated the potential protective effects of ventricular infusion of PACAP in a rat model of TBI. METHODS: Male Sprague Dawley rats were randomly divided into 3 treatment groups (n=6, each): sham- operated, vehicle (normal saline)+ TBI, and PACAP+ TBI. Normal saline or PACAP (1 mu g/ 5 mu L) was administered intracerebroventricularly 20 minutes before TBI. Right parietal cortical contusion was produced via a weight- dropping method. Brains were extracted 24 hours after trauma. Histological changes in brains were examined by HE staining. The numbers of CD4(+) and CD8(+) T cells in blood and the spleen were detected via fl ow cytometry. RESULTS: In injured brain regions, edema, hemorrhage, inflammatory cell infiltration, and swollen and degenerated neurons were observed under a light microscope, and the neurons were disorderly arrayed in the hippocampi. Compared to the sham group, average CD4(+) CD8(-) lymphocyte counts in blood and the spleen were significantly decreased in rats that received TBI+ vehicle, and CD4(-) CD8(+) were increased. In rats administered PACAP prior to TBI, damage was attenuated as evidenced by significantly increased CD4(+), and decreased CD8(+), T lymphocytes in blood and the spleen. CONCLUSION: Pretreatment with PACAP may protect against TBI by infl uencing periphery T cellular immune function.	[Hua, Rong; Mao, Shan-shan; Zhang, Yong-mei; Chen, Fu-xing; Zhou, Zhong-hai; Liu, Jun-quan] 97th Hosp PLA, Dept Emergency Med, Xuzhou 221000, Peoples R China		Hua, R (corresponding author), 97th Hosp PLA, Dept Emergency Med, Xuzhou 221000, Peoples R China.	ilovezq@sohu.com					Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Delgado M, 2001, J NEUROIMMUNOL, V112, P78, DOI 10.1016/S0165-5728(00)00414-8; Delgado M, 2008, BRAIN BEHAV IMMUN, V22, P1146, DOI 10.1016/j.bbi.2008.06.001; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ganea D, 2003, CELL MOL BIOL, V49, P127; Ganea D, 2003, CURR PHARM DESIGN, V9, P997, DOI 10.2174/1381612033455116; Hobbs TR, 2010, COMPARATIVE MED, V60, P233; Kato H, 2004, MULT SCLER J, V10, P651, DOI 10.1191/1352458504ms1096oa; Kovesdi E, 2008, NEUROTOX RES, V13, P71, DOI 10.1007/BF03033558; Liu Si-lan, 2005, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V21, P127; Lv B, 2009, SHOCK, V31, P185, DOI 10.1097/SHK.0b013e31817d423a; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Paxinos G, 1986, RAT BRAIN STEREOTAXI, pF23; Sanchez A, 2008, NEUROSCI LETT, V448, P52, DOI 10.1016/j.neulet.2008.10.021; Schibler A, 2012, CRIT CARE RESUSC, V14, P20; Siveen KS, 2012, J IMMUNOTOXICOL, V9, P25, DOI 10.3109/1547691X.2011.609191; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yong VW, 2009, NEURON, V64, P55, DOI 10.1016/j.neuron.2009.09.035	20	10	10	0	1	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	SECOND AFFILIATED HOSPITAL, 88 JIEFANG RD, HANGZHOU, 310009, PEOPLES R CHINA	1920-8642			WORLD J EMERG MED	World J. Emerg. Med.	DEC	2012	3	4					294	298		10.5847/wjem.j.issn.1920-8642.2012.04.010			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V4X5Y	WOS:000219354900010	25215080	Green Published, Bronze			2022-02-06	
J	Jacobson, BH				Jacobson, Bert H.			ANTHROPOMETRIC CROSS-SECTIONAL COMPARISONS OF COLLEGE FOOTBALL PLAYERS AND POTENTIAL HEALTH IMPLICATIONS	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						characteristics; body size; morphology; obesity; size; risk	METABOLIC SYNDROME; HEAD IMPACTS; PERFORMANCE-CHARACTERISTICS; AMERICAN FOOTBALL; LEAGUE LINEMEN; CONCUSSION; ASSOCIATION; OVERWEIGHT; SIZE; RISK	Jacobson, BH. Anthropometric cross-sectional comparisons of college football players and potential health implications. J Strength Cond Res 26(12): 3358-3364, 2012-Current college football players appear to be larger in stature than those of the past, but few comparisons exist that have quantified such data over the span of over half a century. The purpose of this study was to compare anthropometric changes in college football players over a period of 7 decades and to address the health implications associated with extreme size. Offensive and defensive positions were targeted based on line play (offensive linemen [OLs] and defensive linemen [DLs]) or speed positions (wide receivers [WRs] and cornerbacks [DBs]), and data on height and weight were collected from official rosters provided by the participating National Collegiate Athletic Association Division I universities. The results indicated that OL significantly (p < 0.001) increased 50.8% in body weight (88.5 vs. 133.5 kg) and 5.4% in height, DLs significantly increased 50.9% in weight (87.2 vs. 131.6 kg) and 6.7% in height, WRs increased 7.7% in weight (79.3 vs. 85.5 kg) and 1.9% in height, and cornerbacks increased 10.1% in weight (78 vs. 86.7 kg) and 2.3% in height since 1950. There were no significant differences in weight by offensive line position (center, guard, and tackle) and no significant differences among class status. The extraordinary size of linemen begins in high school and is sustained through college and the pros. Without efforts in detraining, such extreme sizes may warrant concerns regarding injury, heat stress, obesity, and general health status.	Oklahoma State Univ, Harrison Hlth & Human Performance Lab, Sch Appl Hlth & Educ Psychol, Stillwater, OK 74078 USA		Jacobson, BH (corresponding author), Oklahoma State Univ, Harrison Hlth & Human Performance Lab, Sch Appl Hlth & Educ Psychol, Stillwater, OK 74078 USA.	bert.jacobson@okstate.edu					[Anonymous], FOOTB RECR TEAM RANK; ARONSON V, 1986, Physician and Sportsmedicine, V14, P199, DOI 10.1080/00913847.1986.11709081; BERG K, 1990, RES Q EXERCISE SPORT, V61, P395, DOI 10.1080/02701367.1990.10607504; Bliss S., 1986, BUCKEYE FOOTBALL FIT; Borchers JR, 2009, MED SCI SPORT EXER, V41, P2105, DOI 10.1249/MSS.0b013e3181abdfec; Buell JL, 2008, J ATHL TRAINING, V43, P608, DOI 10.4085/1062-6050-43.6.608; Coris EE, 2009, SOUTH MED J, V102, P569, DOI 10.1097/SMJ.0b013e3181a4f389; Croft LB, 2008, AM J CARDIOL, V102, P343, DOI 10.1016/j.amjcard.2008.03.065; Food and Beverage, 2008, FOOD BEV SPORTS NUTR; Godek SF, 2008, J ATHL TRAINING, V43, P184, DOI 10.4085/1062-6050-43.2.184; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Health Check Systems, HEIGHT WEIGHT CHARTS; Helzberg JH, 2010, AM J CARDIOL, V106, P664, DOI 10.1016/j.amjcard.2010.04.022; Huang TTK, 2004, DIABETES CARE, V27, P3000, DOI 10.2337/diacare.27.12.3000; Hunter GR, 1985, J STRENGTH COND RES, V6, P26; Jacobson B, 1981, CONDITIONING FOOTBAL; Jacobson BH, 2003, PERCEPT MOTOR SKILL, V96, P931, DOI 10.2466/PMS.96.3.931-932; JUDGE LW, 2010, J STRENGTH COND RES, V32, P28, DOI DOI 10.1519/SSC.0B013E3181DF8963; Kaiser GE, 2008, J STRENGTH COND RES, V22, P243, DOI 10.1519/JSC.0b013e31815f5d97; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Kraemer WJ, 2000, EXERCISE SPORT SCI, P800; Lohman T.G., 1997, ACSMS HLTH FIT J, V1, P30; Mathews EM, 2008, J AM COLL HEALTH, V57, P33, DOI 10.3200/JACH.57.1.33-38; McArdle W., 2007, EXERCISE PHYSL ENERG; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Noel MB, 2003, J STRENGTH COND RES, V17, P228; Riley DP, 1978, STRENGTH TRAINING FO; Secora CA, 2004, J STRENGTH COND RES, V18, P286; SHORT SH, 1993, NEW YORK STATE J MED, V93, P112; Stodden DF, 2010, J STRENGTH COND RES, V24, P2300, DOI 10.1519/JSC.0b013e3181dc4255; *WHO, 1996, OB PREV MAN GLOB EP; Wilkerson GB, 2010, J ATHL TRAINING, V45, P67, DOI 10.4085/1062-6050-45.1.67; Yamamoto Joelle B, 2008, Res Sports Med, V16, P111, DOI 10.1080/15438620802103320	35	10	10	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1064-8011			J STRENGTH COND RES	J. Strength Cond. Res.	DEC	2012	26	12					3358	3364		10.1519/JSC.0b013e31824b5e6c			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	048FG	WOS:000311895100024	22290523				2022-02-06	
J	Kurczek, J; Duff, MC				Kurczek, Jake; Duff, Melissa C.			Intact discourse cohesion and coherence following bilateral ventromedial prefrontal cortex	BRAIN AND LANGUAGE			English	Article						Cohesion; Coherence; Referential processing; Ventromedial prefrontal cortex; Discourse	CLOSED-HEAD-INJURY; FRONTAL-LOBE; REFERENTIAL COHESION; LOGICAL COHERENCE; COGNITIVE THEORY; WORKING-MEMORY; DAMAGE; ADULTS; COMMUNICATION; DYSFUNCTION	Discourse cohesion and coherence give communication its continuity providing the grammatical and lexical links that hold an utterance or text together and give it meaning. Researchers often link cohesion and coherence deficits to the frontal lobes by drawing attention to frontal lobe dysfunction in populations where discourse cohesion and coherence deficits are reported and through attribution of these deficits to underlying cognitive impairments putatively associated with the frontal lobes. We examined the distinct contribution of a region of the frontal lobes, the ventromedial prefrontal cortex (vmPFC), to discourse cohesion and coherence across a range of discourse tasks. We found that bilateral vmPFC damage does not impair cohesion and coherence in spoken discourse. This study provides insights into the contribution of the major anatomical subdivisions of the frontal lobes to language use and furthers our understanding of the neural and cognitive underpinnings of discourse cohesion and coherence. (C) 2012 Elsevier Inc. All rights reserved.	[Duff, Melissa C.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Kurczek, Jake; Duff, Melissa C.] Univ Iowa, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA; [Duff, Melissa C.] Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA		Duff, MC (corresponding author), Univ Iowa, Dept Commun Sci & Disorders, 250 Hawkins Dr, Iowa City, IA 52242 USA.	melissa-duff@uiowa.edu	Kurczek, Jake/I-8619-2016	Kurczek, Jake/0000-0002-5965-2498	ASHFoundation; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS19632]; NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [RO1 DC011755]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011755] Funding Source: NIH RePORTER	We thank M. Miller for assistance in data coding and analysis, Joel Bruss preparing Fig. 1 and the Duff Communication and Memory Laboratory for helpful comments on earlier versions of this manuscript. Support from ASHFoundation, NINDS P50 NS19632, and NIDCD RO1 DC011755.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Almor A, 1999, BRAIN LANG, V67, P202, DOI 10.1006/brln.1999.2055; ARBUCKLE TY, 1993, J GERONTOL, V48, pP225, DOI 10.1093/geronj/48.5.P225; Barense MD, 2007, NEUROPSYCHOLOGIA, V45, P2963, DOI 10.1016/j.neuropsychologia.2007.05.023; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Bourgeois M. S., 2009, DEMENTIA DIAGNOSIS M; CAPPELLA JN, 1981, PSYCHOL BULL, V89, P101, DOI 10.1037/0033-2909.89.1.101; Chalmers K, 2005, NEUROPATH APPL NEURO, V31, P623, DOI 10.1111/j.1365-2990.2005.00678.x; Coelho C, 2003, APHASIOLOGY, V17, P173, DOI 10.1080/729255216; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cohen, 2001, CONDITIONING CONSCIO; Coupland N., 2010, CONTEXTS ACCOMMODATI, DOI [10.1017/cbo9780511663673.001, DOI 10.1017/CBO9780511663673.001, DOI 10.1017/CBO9780511663673]; Croft KE, 2010, NEUROPSYCHOLOGIA, V48, P1789, DOI 10.1016/j.neuropsychologia.2010.03.001; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Davis GA, 1997, BRAIN LANG, V56, P183; Dijkstra K, 2004, J NEUROLINGUIST, V17, P263, DOI 10.1016/S0911-6044(03)00048-4; Docherty NM, 1996, ARCH GEN PSYCHIAT, V53, P358; Duff MC, 2008, BRAIN LANG, V106, P41, DOI 10.1016/j.bandl.2007.10.004; Duff MC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00069; Frattali C., 2005, LANGUAGE DISCOURSE D; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Gupta R, 2012, NEUROPSYCHOLOGIA, V50, P145, DOI 10.1016/j.neuropsychologia.2011.11.012; Gupta R, 2011, NEUROPSYCHOLOGY, V25, P137, DOI 10.1037/a0021123; Halliday M. K., 1976, COHESION ENGLISH; Hanlon FM, 2011, NEUROIMAGE, V58, P1158, DOI 10.1016/j.neuroimage.2011.06.091; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hengst JA, 2007, TOP LANG DISORD, V27, P37, DOI 10.1097/00011363-200701000-00005; Hunt K., 1970, MONOGRAPHS SOC RES C, V35; Koenigs M, 2008, SOC COGN AFFECT NEUR, V3, P1, DOI 10.1093/scan/nsm032; Kurczek J, 2011, APHASIOLOGY, V25, P700, DOI 10.1080/02687038.2010.537345; Le K., 2009, CLIN APH C KEYST CO; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Liles BZ, 1998, ANAL DISCOURSE COMMU, P65; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Murray Laura L., 2001, Seminars in Speech and Language, V22, P127; Ogden J. A., 1991, MEMORY MECH TRIBUTE, P195; Ripich DN, 2000, INT J LANG COMM DIS, V35, P49; Rochester Sherry, 1979, CRAZY TALK STUDY DIS; Rogalski Y, 2008, APHASIOLOGY, V22, P763, DOI 10.1080/02687030701803796; Rogalski Y, 2010, J COMMUN DISORD, V43, P212, DOI 10.1016/j.jcomdis.2010.02.001; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Sirigu A, 1998, CORTEX, V34, P771, DOI 10.1016/S0010-9452(08)70780-9; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	56	10	10	2	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	DEC	2012	123	3					222	227		10.1016/j.bandl.2012.09.003			6	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	050JE	WOS:000312048800009	23102898	Green Accepted			2022-02-06	
J	Lammert, A; Bode, H; Hammes, HP; Birck, R; Fatar, M; Zohsel, K; Schmieder, K; Schubert, GA; Thome, C; Seiz, M				Lammert, Alexander; Bode, Hinrich; Hammes, Hans-Peter; Birck, Rainer; Fatar, Marc; Zohsel, Katrin; Schmieder, Kirsten; Schubert, Gerrit Alexander; Thome, Claudius; Seiz, Marcel			Aneurysmal subarachnoid hemorrhage (aSAH) results in low prevalence of neuro-endocrine dysfunction and NOT deficiency	PITUITARY			English	Article						Aneurysmal subarachnoid hemorrhage; Neuro-endocrine dysfunction; Neuropsychological deficits; Glasgow outcome scale	TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY FUNCTION; GROWTH-FACTOR-I; PROSPECTIVE COHORT; FOLLOW-UP; HIGH-RISK; HYPOPITUITARISM; COILING; HEALTH	Neuro-endocrine deficiencies have been argued to be common sequelae after aneurysmal subarachnoid hemorrhage (aSAH). As this, however, does not resemble our clinical experience, we studied the incidence of neuro-endocrine and neuropsychological deficits after aSAH. Twenty-six patients (20 females) were prospectively screened for neuro-endocrine and neuropsychological deficits 3, 6 and 12 months after aSAH. GH, IGF-1, prolactin, LH, FSH, estradiol, testosterone, ACTH as well as cortisol during ACTH-stimulation were assessed. Neuropsychological analysis covered verbal comprehension, short term and working memory, visuospatial construction, figural memory, psychomotor speed, attention, and concentration. During the study period 5 individuals demonstrated neuro-endocrine dysfunction. Hypogonadotrophic hypogonadism resolved spontaneously in 2 patients and central hypothyroidism in one of these patients during the study. After 12 months three patients presented low IGF-1 levels. 73.9% of our cohort was affected by neuropsychological deficits during follow-up. At 3, 6 and 12 months the prevalences were 56.5, 52.6 and 42.1%, respectively. Interestingly, all patients with neuro-endocrine dysfunction presented impaired clinical outcome with a GOS 4 at some time point of the study (GOS 4 vs. 5, 45.5% vs. 0, P = 0.007). We found a low prevalence of neuro-endocrine and a high prevalence of neuropsychological deficits in patients 3, 6 and 12 months after aSAH without significant interrelation. Spontaneous recovery of neuro-endocrine alterations most likely presents an adaption to or dysfunction after severe illness. This hypothesis is strengthened by the fact that only patients with inferior clinical outcome after aSAH as assessed by GOS demonstrated neuro-endocrine dysfunction.	[Seiz, Marcel] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria; [Lammert, Alexander; Bode, Hinrich; Hammes, Hans-Peter; Birck, Rainer] Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany; [Fatar, Marc; Zohsel, Katrin] Univ Med Ctr Mannheim, Dept Neurol, Mannheim, Germany; [Schmieder, Kirsten] Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany; [Schubert, Gerrit Alexander; Thome, Claudius; Seiz, Marcel] Univ Innsbruck Hosp, Dept Neurosurg, A-6020 Innsbruck, Austria		Seiz, M (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria.	marcel.seiz-rosenhagen@i-med.ac.at	Schubert, Gerrit Alexander/Q-9192-2017; Hammes, Hans-Peter/S-3719-2019; Fatar, Marc/E-6892-2015	Schubert, Gerrit Alexander/0000-0001-9135-6042; 			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; Bendel S, 2010, CRIT CARE, V14, DOI 10.1186/cc8988; Berry E, 1997, BRIT J NEUROSURG, V11, P378; Bidlingmaier M, 2009, HORM RES, V71, P30, DOI 10.1159/000178034; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sievers C, 2010, CLIN ENDOCRINOL, V73, P89, DOI 10.1111/j.1365-2265.2009.03773.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436; Vanhorebeek I, 2006, NAT CLIN PRACT ENDOC, V2, P20, DOI 10.1038/ncpendmet0071	24	10	10	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	DEC	2012	15	4					505	512		10.1007/s11102-011-0357-5			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	034UM	WOS:000310898400007	22038031				2022-02-06	
J	Xu, F; Yu, ZY; Ding, L; Zheng, SY				Xu, Feng; Yu, Zheng-Yuan; Ding, Li; Zheng, Shi-Ying			Experimental studies of erythropoietin protection following traumatic brain injury in rats	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						erythropoietin; traumatic brain injury; apoptosis; monocyte chemotactic protein-1; CD68(+) cells	ENHANCES NEUROLOGICAL RECOVERY; CEREBRAL-ISCHEMIA; NEURONAL APOPTOSIS; NERVOUS-SYSTEM; MESSENGER-RNA; MODULATION; MODEL; MICE; NEUROPROTECTION; ACTIVATION	This study aimed to explore the effect of erythropoietin (EPO) on brain tissue after traumatic brain injury in rats. Animals were divided into sham, control and EPO groups. The model was constructed using the improved Feeney's free falling weight traumatic brain injury model. The brain water content and the number of the apoptotic monocyte chemotactic protein-1(+) (MCP-1(+)) and CD68(+) cells were monitored at 12, 48 and 120 h post-trauma. The water content was lower in the EPO group at each time point compared to the control group. The number of apoptotic MCP-1(+) and CD68(+) cells surrounding the traumatic brain injury lesion was less in the EPO group compared to these values in the control group. In conclusion, following traumatic brain injury, EPO significantly decreased the number of apoptotic cells, the expression of MCP-1(+), the infiltration of CD68(+) cells as well as.brain edema to protect the brain.	[Zheng, Shi-Ying] Soochow Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China; [Xu, Feng; Yu, Zheng-Yuan; Ding, Li] Soochow Univ, Affiliated Hosp 1, Dept Emergency Surg, Suzhou 215006, Jiangsu, Peoples R China		Zheng, SY (corresponding author), Soochow Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China.	dingli@163.com; syzheng88@163.com					Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Boran BO, 2005, RESTOR NEUROL NEUROS, V23, P341; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chong ZZ, 2004, ANTIOXID REDOX SIGN, V6, P277, DOI 10.1089/152308604322899341; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Eid Tore, 2002, Clin Breast Cancer, V3 Suppl 3, pS109, DOI 10.3816/CBC.2002.s.021; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Kalialis Louise Vennegaard, 2003, Ugeskr Laeger, V165, P2477; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; TAN CC, 1992, AM J PHYSIOL, V263, pF474, DOI 10.1152/ajprenal.1992.263.3.F474; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	27	10	14	0	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981			EXP THER MED	Exp. Ther. Med.	DEC	2012	4	6					977	982		10.3892/etm.2012.723			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	036HD	WOS:000311016100005	23226759	Green Submitted, gold, Green Published			2022-02-06	
J	Lippert-Gruner, M				Lippert-Gruener, Marcela			Botulinum toxin in the treatment of post-traumatic headache - case study	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						botulinum toxin; post-traumatic headache; traumatic brain injury	TENSION-TYPE HEADACHE; EPISODIC MIGRAINE HEADACHES; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; CONTROLLED PHASE; PARALLEL-GROUP; A INJECTION; ONABOTULINUMTOXINA; MULTICENTER	Pharmacotherapy of acute post-traumatic tension headaches consists of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs). Treatment of chronic tension-type headaches consists mainly of tricyclic antidepressants; local injection of botulinum toxin is one of the comparatively newer therapeutic options. No data on the treatment of post-traumatic headaches with botulinum toxin exist. A 62-year-old woman with a history of major traumatic brain injury five years previously developed chronic tension-type headaches of an oppressive nature. The results of treatment with oral medication were not satisfactory. The patient was treated with local injections of 22 IU Botox (R) into the frontalis muscle and corrugator supercilii muscle. After only five days, the headaches had improved and after ten days the patient was free of symptoms even when under stress. Sufficiently large-scale clinical studies are now required to better evaluate the effects of botulinum toxin on post-traumatic headaches.	[Lippert-Gruener, Marcela] Ambulantes Neurol Rehabil Zentrum, Dept Neurol Rehabil, Bonn, Germany; [Lippert-Gruener, Marcela] Univ Cologne, Fac Med, Cologne, Germany; [Lippert-Gruener, Marcela] 1LF Charles Univ, Dept Rehabil Med, Prague, Czech Republic		Lippert-Gruner, M (corresponding author), ANR Bonn, Graurheindorfer Str 149 A, D-53117 Bonn, Germany.						Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Aurora SK, 2007, HEADACHE, V47, P486, DOI 10.1111/j.1526-4610.2006.00624.x; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Chan VW, 2009, J NEUROSCI NURS, V41, P235, DOI 10.1097/JNN.0b013e3181aaa98f; de Ru JA, 2009, J LARYNGOL OTOL, V123, P412, DOI 10.1017/S0022215108003198; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Dowson AJ, 2008, DRUGS R&D, V9, P147, DOI 10.2165/00126839-200809030-00002; Elkind AH, 2006, J PAIN, V7, P688, DOI 10.1016/j.jpain.2006.03.002; Evers Stefan, 2007, Neuropsychiatr Dis Treat, V3, P761; Freitag FG, 2008, HEADACHE, V48, P201, DOI 10.1111/i.1526-4610.2007.00963.x; Hamdy SM, 2009, J HEADACHE PAIN, V10, P27, DOI 10.1007/s10194-008-0082-2; Jost WH, 2003, FORTSCHR NEUROL PSYC, V71, P296; Keidel M, 1997, NERVENARZT, V68, P769, DOI 10.1007/s001150050193; Keidel M, 2007, NERVENHEILKUNDE, V26, P156; Keidel M., 2001, MANUELLE MED, V39, P259; Magalhaes E, 2010, CLIN NEUROL NEUROSUR, V112, P463, DOI 10.1016/j.clineuro.2010.02.004; Mathew NT, 2005, HEADACHE, V45, P293, DOI 10.1111/j.1526-4610.2005.05066.x; Mitchell MP, 2008, J MANAGE CARE PHARM, V14, P442, DOI 10.18553/jmcp.2008.14.5.442; Pfaffenrath V, 2008, MMW Fortschr Med, V150, P46; Relja M, 2007, CEPHALALGIA, V27, P492, DOI 10.1111/j.1468-2982.2007.01315.x; Saper JR, 2007, PAIN MED, V8, P478, DOI 10.1111/j.1526-4637.2006.00168.x; Shuhendler AJ, 2009, PHARMACOTHERAPY, V29, P784, DOI 10.1592/phco.29.7.784; Silberstein S, 2000, HEADACHE, V40, P445, DOI 10.1046/j.1526-4610.2000.00066.x; Silberstein SD, 2006, CEPHALALGIA, V26, P790, DOI 10.1111/j.1468-2982.2006.01114.x; Silberstein SD, 2005, MAYO CLIN PROC, V80, P1126, DOI 10.4065/80.9.1126; Wacker H.R., 2000, REV THER, V57, P53	27	10	10	0	5	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	WENEDOW ST 9-1, POZNAN, 61-614, POLAND	0028-3843			NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.	NOV-DEC	2012	46	6					591	594		10.5114/ninp.2012.32109			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	064PH	WOS:000313087400010	23319227	Green Submitted			2022-02-06	
J	Ajina, S; Kennard, C				Ajina, S.; Kennard, C.			Rehabilitation of damage to the visual brain	REVUE NEUROLOGIQUE			English	Article						Homonymous hemianopia; Rehabilitation; Eye movements; Neuroplasticity; Stroke	HOMONYMOUS HEMIANOPIA; FIELD DEFECTS; RESIDUAL VISION; RECOVERY; STROKE; DEFICITS; THERAPY; SCOTOMA; REPRESENTATION; SENSITIVITY	Homonymous visual field loss is a common consequence of stroke and traumatic brain injury. It is associated with an adverse functional prognosis and has implications on day-today activities such as driving, reading, and safe navigation. Early recovery is expected in around half of cases, and may be associated with a return in V1 activity. In stable disease, recovery is unlikely beyond 3 and certainly 6 months. Rehabilitative approaches generally target three main areas, encompassing a range of techniques with variable success: visual aids aim to expand or relocate the affected visual field; eye movement training builds upon compensatory strategies to improve explorative saccades; visual field restitution aims to improve visual processing within the damaged field itself. All these approaches seem to offer modest improvements with repeated practice, with none clearly superior to the rest. However, a number of areas are demonstrating particular promise currently, including simple web-based training initiatives, and work on neuroimaging and learning. The research interest in this area is encouraging, and it is to be hoped that future trials can better untangle and control for the number of complicated confounds, so that we will be in a much better position to evaluate and select the most appropriate therapy for patients. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Ajina, S.] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; [Ajina, S.; Kennard, C.] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England		Ajina, S (corresponding author), Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Headley Way, Oxford OX3 9DU, England.	sara.ajina@ndcn.ox.ac.uk		Ajina, Sara/0000-0002-9685-5315	Wellcome TrustWellcome TrustEuropean Commission [WT096001/Z/11/Z]; NIHR Oxford Biomedical Research CentreNational Institute for Health Research (NIHR)	SA is supported by the Wellcome Trust (WT096001/Z/11/Z) and CK by the NIHR Oxford Biomedical Research Centre.	Bao M, 2010, J NEUROSCI, V30, P15080, DOI 10.1523/JNEUROSCI.5703-09.2010; Barbur JL, 1998, VISION RES, V38, P3447, DOI 10.1016/S0042-6989(98)00147-3; BARBUR JL, 1988, BRAIN, V111, P63, DOI 10.1093/brain/111.1.63; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; Bowers AR, 2008, ARCH OPHTHALMOL-CHIC, V126, P657, DOI 10.1001/archopht.126.5.657; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; Celebisoy M, 2011, J NEUROL NEUROSUR PS, V82, P695, DOI 10.1136/jnnp.2010.214387; Cohen J M, 1993, J Am Optom Assoc, V64, P60; Das A, 2010, NEUROSCIENTIST, V16, P374, DOI 10.1177/1073858409356112; Dilks DD, 2007, J NEUROSCI, V27, P9585, DOI 10.1523/JNEUROSCI.2650-07.2007; FEINBERG TE, 1978, BRAIN RES, V152, P422, DOI 10.1016/0006-8993(78)90276-7; FENDRICH R, 1992, SCIENCE, V258, P1489, DOI 10.1126/science.1439839; FUJINO T, 1986, NEURO-OPHTHALMOLOGY, V6, P17, DOI 10.3109/01658108608997320; Gilhotra JS, 2002, STROKE, V33, P2417, DOI 10.1161/01.STR.0000037647.10414.d2; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; GRAY CS, 1989, AGE AGEING, V18, P419, DOI 10.1093/ageing/18.6.419; Haerer AF, 1973, STROKE, V4, P163, DOI 10.1161/01.STR.4.2.163; Hankey GJ, 1999, ARCH NEUROL-CHICAGO, V56, P748, DOI 10.1001/archneur.56.6.748; Hardiess G, 2010, VISION RES, V50, P1158, DOI 10.1016/j.visres.2010.04.004; Henriksson L, 2007, J NEUROL NEUROSUR PS, V78, P74, DOI 10.1136/jnnp.2006.099374; Horton JC, 2005, BRIT J OPHTHALMOL, V89, P792, DOI 10.1136/bjo.2005.072967; Huxlin KR, 2009, J NEUROSCI, V29, P3981, DOI 10.1523/JNEUROSCI.4882-08.2009; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; Jacquin-Courtois S, 2013, CORTEX, V49, P994, DOI 10.1016/j.cortex.2012.03.025; KARNI A, 1995, NATURE, V377, P155; Kasten E, 1998, NAT MED, V4, P1083, DOI 10.1038/2079; Kasten E, 1997, SPATIAL VISION, V10, P499, DOI 10.1163/156856897X00456; KASTEN E, 1995, RESTOR NEUROL NEUROS, V8, P113, DOI 10.3233/RNN-1995-8302; Lane AR, 2010, BRAIN, V133, P1717, DOI 10.1093/brain/awq088; Leh SE, 2006, BRAIN, V129, P1822, DOI 10.1093/brain/awl111; Martin T, 2007, VISION RES, V47, P3434, DOI 10.1016/j.visres.2007.09.021; MEIENBERG O, 1981, ANN NEUROL, V9, P537, DOI 10.1002/ana.410090605; Nelles G, 2001, NEUROSCI LETT, V306, P189, DOI 10.1016/S0304-3940(01)01907-3; Nelles G, 2010, J NEUROL, V257, P1832, DOI 10.1007/s00415-010-5617-1; Nelles G, 2009, J NEUROL, V256, P726, DOI 10.1007/s00415-009-5005-x; Ong YH, 2012, J NEUROL, V259, P2611, DOI 10.1007/s00415-012-6549-8; Pambakian ALM, 2000, J NEUROL NEUROSUR PS, V69, P751, DOI 10.1136/jnnp.69.6.751; Pambakian ALM, 2004, J NEUROL NEUROSUR PS, V75, P1443, DOI 10.1136/jnnp.2003.025957; Peli E, 2000, OPTOMETRY VISION SCI, V77, P453, DOI 10.1097/00006324-200009000-00006; Plant GT, 2005, BRIT J OPHTHALMOL, V89, P2, DOI 10.1136/bjo.2004.053173; Polonara Gabriele, 2011, International Ophthalmology, V31, P129, DOI 10.1007/s10792-011-9420-5; Raemaekers M, 2011, J NEUROPHYSIOL, V105, P872, DOI 10.1152/jn.00308.2010; Raninen A, 2007, J NEUROL NEUROSUR PS, V78, P66, DOI 10.1136/jnnp.2006.099366; Raposo N, 2011, NEUROREHAB NEURAL RE, V25, P703, DOI 10.1177/1545968311407520; Reinhard J, 2005, BRIT J OPHTHALMOL, V89, P30, DOI 10.1136/bjo.2003.040543; Romano JG, 2008, J NEUROL SCI, V273, P70, DOI 10.1016/j.jns.2008.06.026; Roth T, 2009, NEUROLOGY, V72, P324, DOI 10.1212/01.wnl.0000341276.65721.f2; Sabel BA, 2005, J NEURO-OPHTHALMOL, V25, P143, DOI 10.1097/01.WNO.0000165107.24108.49; Sahraie A, 1997, P NATL ACAD SCI USA, V94, P9406, DOI 10.1073/pnas.94.17.9406; Sahraie A, 2008, NEUROPSYCHOLOGIA, V46, P879, DOI 10.1016/j.neuropsychologia.2007.11.008; Sahraie A, 2006, P NATL ACAD SCI USA, V103, P14971, DOI 10.1073/pnas.0607073103; Sahraie A, 2010, EXP BRAIN RES, V206, P25, DOI 10.1007/s00221-010-2395-z; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; Schmid MC, 2010, NATURE, V466, P373, DOI 10.1038/nature09179; Schreiber A, 2006, NEUROLOGY, V67, P143, DOI 10.1212/01.wnl.0000223338.26040.fb; Schuett S, 2008, NEUROPSYCHOLOGIA, V46, P2445, DOI 10.1016/j.neuropsychologia.2008.04.016; Schuett S, 2012, BRAIN, V135, P912, DOI 10.1093/brain/awr356; SMITH JL, 1962, AM J OPHTHALMOL, V54, P616, DOI 10.1016/0002-9394(62)92192-X; Spitzyna GA, 2007, NEUROLOGY, V68, P1922, DOI 10.1212/01.wnl.0000264002.30134.2a; Stoerig P, 1998, NEUROREPORT, V9, P21, DOI 10.1097/00001756-199801050-00005; Stoerig P, 2008, RESTOR NEUROL NEUROS, V26, P291; Striemer CL, 2009, P NATL ACAD SCI USA, V106, P15996, DOI 10.1073/pnas.0905549106; TIEL K, 1991, NEURO-OPHTHALMOLOGY, V11, P33, DOI 10.3109/01658109109009640; Trauzettel-Klosinski S, 2011, DTSCH ARZTEBL INT, V108, P871, DOI 10.3238/arztebl.2011.0871; TROBE JD, 1973, ARCH OPHTHALMOL-CHIC, V89, P377, DOI 10.1001/archopht.1973.01000040379005; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Weiskrantz L, 2003, PROG BRAIN RES, V144, P229, DOI 10.1016/S0079-6123(03)14401-6; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 1987, BRAIN, V110, P77, DOI 10.1093/brain/110.1.77; Zhang X, 2006, NEUROLOGY, V66, P906, DOI 10.1212/01.wnl.0000203913.12088.93; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22; ZIHL J, 1980, BEHAV BRAIN RES, V1, P287; ZIHL J, 1985, BRAIN, V108, P335, DOI 10.1093/brain/108.2.335; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; Zihl J, 1982, Hum Neurobiol, V1, P5	75	10	12	0	32	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787	2213-0004		REV NEUROL-FRANCE	Rev. Neurol.	OCT	2012	168	10					754	761		10.1016/j.neurol.2012.07.015			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	050MM	WOS:000312057400013	22981268	Green Accepted			2022-02-06	
J	Khani, GMK; Baig, A; Humail, M; Memon, M; Quarashi, MA				Khani, Ghulam Mustafa Kaim; Baig, Akhtar; Humail, Mujahid; Memon, Manzoor; Quarashi, M. A.			Musculoskeletal Injuries Among Victims of the Battagram, Pakistan Earthquake in October 2005	PREHOSPITAL AND DISASTER MEDICINE			English	Article						disaster planning; earthquake; musculoskeletal injuries	MARMARA EARTHQUAKE; PEDIATRIC TRAUMA; BAM; CHILDREN	Objective: This study was conducted to assess the type, pattern, and severity of musculoskeletal injuries, as well as the type of simple orthopedic surgical procedures, that can be performed at the site of a disaster. Methods: This was a cross-sectional study conducted in Battagram, located in the North West Frontier Province of Pakistan after the October 2005 earthquake. Researchers arrived in the affected area during the second week after the earthquake, and remained there for one week. During this period, patients were received from distant areas of the district. These patients were admitted to a tent hospital because the district headquarters hospital was completely damaged. Those requiring orthopedic surgical intervention or closed manipulation and plaster of paris casts were included in the study. Results: Of 110 patients, 61 were female and 49 were male, and 140 bones were involved. In this series, 92 fractures were closed, while 48 were open. A total of 67.3% of the patients were,40 years of age. The tibia was involved in 32.1% of cases and the femur 16.4%. No cases of compartment syndrome were found. Wound debridement was performed in 35 cases. An external fixator was applied to 10 cases of open tibia fractures. Four humerus fractures and a fracture to the radius and ulna were fixed with the Rashnail method. One open femur fracture was repaired with external fixation. Pre-and post-operative antibiotics were administered in all cases. Thirty patients sustained injuries in addition to orthopedic trauma: 13 vertebral injuries, eight head injuries, six fractured ribs, three blunt injuries to the abdomen, and 10 significant soft tissues injuries without bony involvement. Conclusions: After the earthquake in Battagram, young persons, especially females, were prone to orthopedic injuries, mainly involving the extremities. A comprehensive disaster plan would have helped to manage these emergencies, and further experience is needed for on-site surgical interventions.	[Khani, Ghulam Mustafa Kaim] Dow Univ Hlth Sci, Orthopaed Unit 1, Karachi, Pakistan; Civil Hosp Karachi, Karachi, Pakistan		Khani, GMK (corresponding author), Dow Univ Hlth Sci, Orthopaed Unit 1, Karachi, Pakistan.	drkk58@hotmail.com					Ata-ur-Rehman Saleem, 2006, PAK J SURG, V22, P119; Donmez O, 2001, PEDIATR INT, V43, P678, DOI 10.1046/j.1442-200X.2001.01469.x; Emami MJ, 2005, PREHOSP DISASTER MED, V20, P327, DOI 10.1017/S1049023X0000279X; Hanley M B, 1990, J Emerg Nurs, V16, p36A; *INT FED RED CROSS, 1996, WORLD DIS REP 1996; Iskit SH, 2001, J PEDIATR SURG, V36, P368, DOI 10.1053/jpsu.2001.20719; Naghi TM, 2005, INJURY, V36, P27, DOI 10.1016/j.injury.2004.06.021; Peek-Asa C, 1998, INT J EPIDEMIOL, V27, P459, DOI 10.1093/ije/27.3.459; Peek-Asa C, 2003, INJ PREV, V9, P62, DOI 10.1136/ip.9.1.62; Ramirez M, 2005, EPIDEMIOL REV, V27, P47, DOI 10.1093/epirev/mxi005; Roy Nobhojit, 2002, Prehosp Disaster Med, V17, P186; Sabzehchian M, 2006, PREHOSP DISASTER MED, V21, P336, DOI 10.1017/S1049023X00003976; Sarisozen B, 2003, J PEDIATR ORTHOP B, V12, P288, DOI 10.1097/01.bpb.0000049581.53117.65	13	10	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	OCT	2012	27	5					489	491		10.1017/S1049023X12001161			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	VG1AI	WOS:000445129400017	22985734				2022-02-06	
J	Kokkalis, ZT; Mavrogenis, AF; Ballas, EG; Papagelopoulos, PJ; Zoubos, AB				Kokkalis, Zinon T.; Mavrogenis, Andreas F.; Ballas, Efstathios G.; Papagelopoulos, Panayiotis J.; Zoubos, Aristides B.			Bilateral Neglected Posterior Fracture-Dislocation of the Shoulders	ORTHOPEDICS			English	Article							MCLAUGHLIN PROCEDURE; RECONSTRUCTION; OSTEOTOMY; DEFECTS	Posterior dislocation of the shoulder is an uncommon injury. Diagnosis is difficult and often missed. Once diagnosed, management must be individualized depending on the amount of the defect of the humeral head and the time from injury. This article presents a case of a 40-year-old man with a 4-month history of bilateral locked posterior fracture-dislocation of the shoulders after a grand mal seizure. Imaging showed loss of the glenohumeral joint lines congruency, reverse Hill-Sachs lesions, and articular defects of 35% and 40% of the humeral heads. A modified McLaughlin technique was performed in both shoulders in a single stage. Through the standard deltopectoral approach, the lesser tuberosity was osteotomized with the subscapularis and capsule attached and elevated to expose the humeral head and glenoid. The shape of the humeral head was restored by packing the defect with morselized bone allograft. Before packing the allograft into the defect, 2 absorbable suture anchors were inserted at the bottom of the defect; the lesser tuberosity was transferred into the defect, and fixed with 2 transosseous horizontal mattress sutures. Stable fixation was evaluated intraoperatively, and the wound was closed in layers. Postoperatively, both shoulders were immobilized with external rotation braces for 6 weeks, followed by passive, active-assisted, and progressively active range of shoulder motion and rotator cuff strengthening exercises for the next 6 weeks. At 12 weeks postoperatively, full range of motion was accomplished, and full activity was allowed. At 22-month follow-up, the patient was satisfied with his level of function; both shoulder joints were painless and stable without apprehension or recurrence of instability. Radiographs showed congruent joints and complete incorporation of the allograft into the defect with restoration of the shape of the humeral head.	[Kokkalis, Zinon T.; Mavrogenis, Andreas F.; Ballas, Efstathios G.; Papagelopoulos, Panayiotis J.; Zoubos, Aristides B.] Univ Athens, Sch Med, Dept Orthopaed 1, Attikon Univ Hosp, Athens 15562, Greece		Kokkalis, ZT (corresponding author), Univ Athens, Sch Med, Dept Orthopaed 1, Attikon Univ Hosp, 41 Ventouri St, Athens 15562, Greece.	kokkaliszinon@yahoo.com	Papagelopoulos, Panayiotis/AAR-9492-2020	Papagelopoulos, Panayiotis/0000-0003-2211-5709			Aparicio G, 2000, J Orthop Sci, V5, P37, DOI 10.1007/s007760050006; Bock P, 2007, ARCH ORTHOP TRAUM SU, V127, P543, DOI 10.1007/s00402-007-0359-y; BROWN RJ, 1984, INJURY, V15, P267, DOI 10.1016/0020-1383(84)90012-3; Charalambous CP, 2009, ARCH ORTHOP TRAUM SU, V129, P753, DOI 10.1007/s00402-008-0721-8; Checchia SL, 1998, J SHOULDER ELB SURG, V7, P53, DOI 10.1016/S1058-2746(98)90183-5; Cheng SL, 1997, J SHOULDER ELB SURG, V6, P11, DOI 10.1016/S1058-2746(97)90065-3; Cicak N, 2004, J BONE JOINT SURG BR, V86B, P324, DOI 10.1302/0301-620X.86B3.14985; Dubousset J, 1967, Rev Chir Orthop Reparatrice Appar Mot, V53, P65; FINKELSTEIN JA, 1995, J ORTHOP TRAUMA, V9, P190; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P376, DOI 10.2106/00004623-199603000-00008; Gerber C, 1991, CAHIERS ENSEIGNEMENT, V40, P223; Hatzis N, 2001, Tex Med, V97, P62; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; Hottya GA, 1998, AM J ROENTGENOL, V171, P763, DOI 10.2214/ajr.171.3.9725313; Jones TP, 2003, ORTHOPEDICS, V26, P682; KELLY JP, 1954, J BONE JOINT SURG BR, V36, P70, DOI 10.1302/0301-620X.36B1.70; KEPPLER P, 1994, J ORTHOP TRAUMA, V8, P286, DOI 10.1097/00005131-199408000-00003; Loebenberg MI, 2000, ORTHOP CLIN N AM, V31, P23, DOI 10.1016/S0030-5898(05)70125-5; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; PAGE AE, 1995, J ORTHOP TRAUMA, V9, P526, DOI 10.1097/00005131-199509060-00012; PORTEOUS MJL, 1990, J BONE JOINT SURG BR, V72, P468, DOI 10.1302/0301-620X.72B3.2341450; Wallace W A, 1983, Radiography, V49, P229	22	10	10	0	5	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447			ORTHOPEDICS	Orthopedics	OCT	2012	35	10					E1537	E1541		10.3928/01477447-20120919-26			5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	020MN	WOS:000309814600015	23027494				2022-02-06	
J	Lee, TW; Yu, YWY; Hong, CJ; Tsai, SJ; Wu, HC; Chen, TJ				Lee, Tien-Wen; Yu, Younger W. -Y.; Hong, Chen-Jee; Tsai, Shih-Jen; Wu, Hung-Chi; Chen, Tai-Jui			The Influence of Apolipoprotein E Epsilon4 Polymorphism on qEEG Profiles in Healthy Young Females: A Resting EEG Study	BRAIN TOPOGRAPHY			English	Article						Electroencephalography (EEG); Power spectrum; Mutual information; Apolipoprotein E (ApoE); Genetic polymorphism	MILD COGNITIVE IMPAIRMENT; VISUAL-SPATIAL ATTENTION; TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; E ALLELE EPSILON-4; ALZHEIMERS-DISEASE; ALPHA RHYTHMS; E GENE; FUNCTIONAL CONNECTIVITY; APOE-EPSILON-4 ALLELE	The epsilon4 allele of the Apolipoprotein E (ApoE) gene has been linked to various neurological conditions and the aging process in the elderly. However, evidence has suggested that the influence of ApoE epsilon4 may commence in early life. This study examined the modulatory effects of ApoE epsilon4 on regional neural activity as well as inter-regional neural interactions in a young population aged 19-21. Blood samples and resting state eyes-closed EEG signals were collected from 265 healthy females, and stratified into two groups: epsilon4 carriers and non-carriers. The values of the log-transformed mean power of 18 electrodes and the mutual information of 20 channel pairs across delta, theta, alpha and beta frequencies were analyzed. Our connectivity analysis was based on information theory, which combined Morlet wavelet transform and mutual information calculation. Between-group statistics were performed by independent t-test. We notice a consistent trend across the brain, in which ApoE epsilon4 carriers possess lower regional power at the alpha band. The epsilon4 allele is also associated with lower regional power at the theta frequency in the left frontal and posterior brain regions. Functional connectivity analyses reveal a right-lateralized network that differentiates epsilon4 carriers and non-carriers, with lower connectivity strengths for the former. Our tonic EEG analyses complement those of previous reports in that the ApoE epsilon4 allele has a negative impact on regional neural synchronization and inter-regional neural interaction.	[Chen, Tai-Jui] E DA Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lee, Tien-Wen] Chang Gung Mem Hosp, Dept Psychiat, Tao Yuan, Taiwan; [Lee, Tien-Wen] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Yu, Younger W. -Y.] Yus Psychiat Clin, Kaohsiung, Taiwan; [Hong, Chen-Jee; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hong, Chen-Jee; Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Hung-Chi] Kai Suan Psychiat Hosp, Kaohsiung, Taiwan; [Chen, Tai-Jui] I Shou Univ, Dept Occupat Therapy, Kaohsiung, Taiwan		Chen, TJ (corresponding author), E DA Hosp, Dept Psychiat, 1 E Da Rd, Kaohsiung, Taiwan.	tjchen71@kimo.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X	Department of Health, Taiwan, ROC [DOH94-NNB-1035]; Kai-Suan Psychiatric Hospital, Kaohsiung [KS92-015]	This work was supported by grant DOH94-NNB-1035 from the Department of Health, Taiwan, ROC and grant KS92-015 from the Kai-Suan Psychiatric Hospital, Kaohsiung. We are grateful to Mr. Ascencio who helped prepare this manuscript. We are also grateful to the technical support provided by Professor YT Wu (the correspondent author of TFCMI method).	Alexander DM, 2007, BIOL PSYCHOL, V75, P229, DOI 10.1016/j.biopsycho.2007.03.001; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Babiloni C, 2006, ANN NEUROL, V59, P323, DOI 10.1002/ana.20724; Bartres-Faz D, 2001, J AM GERIATR SOC, V49, P985, DOI 10.1046/j.1532-5415.2001.49191.x; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Bondi MW, 1995, NEUROLOGY, V45, P2203, DOI 10.1212/WNL.45.12.2203; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Brignani D, 2007, BRAIN RES, V1136, P122, DOI 10.1016/j.brainres.2006.12.018; Buckholtz JW, 2007, MOL PSYCHIATR, V12, P893, DOI 10.1038/sj.mp.4002008; Cacabelos Ramon, 2008, V448, P213, DOI 10.1007/978-1-59745-205-2_10; Caccamo A, 2009, CURR ALZHEIMER RES, V6, P112, DOI 10.2174/156720509787602915; Caldu X, 2007, NEUROIMAGE, V37, P1437, DOI 10.1016/j.neuroimage.2007.06.021; Chen CC, 2008, HUM BRAIN MAPP, V29, P265, DOI 10.1002/hbm.20386; COBEN LA, 1990, ELECTROEN CLIN NEURO, V75, P148, DOI 10.1016/0013-4694(90)90168-J; Danos P, 2001, NEUROPSYCHOBIOLOGY, V43, P265, DOI 10.1159/000054901; daSilva FHL, 1997, INT J PSYCHOPHYSIOL, V26, P237; Del Bo R, 2003, J NEUROL, V250, P688, DOI 10.1007/s00415-003-1057-5; Donix M, 2010, NEUROIMAGE, V53, P37, DOI 10.1016/j.neuroimage.2010.06.009; Draca S, 2010, REV NEUROSCIENCE, V21, P421; Duffy F.H., 1989, CLIN ELECTROENCEPHAL; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; Filippini N, 2009, J MAGN RESON IMAGING, V29, P1021, DOI 10.1002/jmri.21757; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fisher A, 1998, J NEUROCHEM, V70, P1991; Forstl H, 2008, DEUT MED WOCHENSCHR, V133, P431, DOI 10.1055/s-2008-1046730; Forstl H, 1996, NERVENARZT, V67, P730, DOI 10.1007/s001150050047; Godin O, 2009, STROKE, V40, P3186, DOI 10.1161/STROKEAHA.109.555839; Greenwood PM, 2000, P NATL ACAD SCI USA, V97, P11661, DOI 10.1073/pnas.97.21.11661; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Hermens DF, 2005, PEDIATR NEUROL, V32, P248, DOI 10.1016/j.pediatrneurol.2004.11.009; Hoptman MJ, 1998, NEUROPSYCHOLOGIA, V36, P1343, DOI 10.1016/S0028-3932(98)00023-2; Hyman BT, 1996, ANN NEUROL, V40, P55, DOI 10.1002/ana.410400111; Jelic V, 1997, J NEUROL NEUROSUR PS, V63, P59, DOI 10.1136/jnnp.63.1.59; Jelic V, 2009, CLIN EEG NEUROSCI, V40, P129, DOI 10.1177/155005940904000211; Jeong J, 2001, CLIN NEUROPHYSIOL, V112, P827, DOI 10.1016/S1388-2457(01)00513-2; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P47, DOI 10.1016/S0167-8760(96)00054-2; Kokubo Y, 2000, STROKE, V31, P1299, DOI 10.1161/01.STR.31.6.1299; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lehtovirta M, 1996, J NEUROL NEUROSUR PS, V60, P644, DOI 10.1136/jnnp.60.6.644; Lehtovirta M, 2000, DEMENT GERIATR COGN, V11, P29, DOI 10.1159/000017210; Li Jin, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P50; Liu YW, 2002, J CEREBR BLOOD F MET, V22, P1336, DOI 10.1097/01.WCB.0000033200.58646.B3; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; McIntosh AM, 2007, BIOL PSYCHIAT, V61, P1127, DOI 10.1016/j.biopsych.2006.05.020; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; Mulert C, 2007, J AFFECT DISORDERS, V98, P215, DOI 10.1016/j.jad.2006.07.021; Neuper C, 2005, CLIN NEUROPHYSIOL, V116, P1681, DOI 10.1016/j.clinph.2005.03.013; Niedermeyer E, 1997, INT J PSYCHOPHYSIOL, V26, P31, DOI 10.1016/S0167-8760(97)00754-X; NIEDERMEYER E, 1990, CLIN ELECTROENCEPHAL, V21, P210, DOI 10.1177/155005949002100410; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; Pennanen C, 2006, DEMENT GERIATR COGN, V22, P60, DOI 10.1159/000093263; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Plassman BL, 1997, NEUROLOGY, V48, P985, DOI 10.1212/WNL.48.4.985; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Raz N, 2009, NEUROPSYCHOLOGY, V23, P105, DOI 10.1037/a0013487; REED T, 1994, ARCH NEUROL-CHICAGO, V51, P1189, DOI 10.1001/archneur.1994.00540240033012; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Riekkinen P, 1997, PSYCHOPHARMACOLOGY, V129, P285, DOI 10.1007/s002130050192; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rodriguez-Valdes R, 2008, REV NEUROLOGIA, V46, P267, DOI 10.33588/rn.4605.2007520; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Schultz MR, 2008, NEUROLOGY, V70, P1771, DOI 10.1212/01.wnl.0000286941.74372.cc; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Shi J, 2008, NEUROLOGY, V70, P185, DOI 10.1212/01.wnl.0000264004.62612.44; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Stomrud E, 2010, NEUROBIOL AGING, V31, P215, DOI 10.1016/j.neurobiolaging.2008.03.025; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teipel SJ, 2010, NEUROIMAGE, V49, P2021, DOI 10.1016/j.neuroimage.2009.10.067; Thomann PA, 2008, DEMENT GERIATR COGN, V26, P300, DOI 10.1159/000161054; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Tu JL, 2009, BIOCHEM BIOPH RES CO, V384, P466, DOI 10.1016/j.bbrc.2009.04.153; Vertes RP, 1997, NEUROSCIENCE, V81, P893; VOGEL SA, 1990, J LEARN DISABIL-US, V23, P44, DOI 10.1177/002221949002300111; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Yaffe K, 1997, ARCH NEUROL-CHICAGO, V54, P1110, DOI 10.1001/archneur.1997.00550210044011; Zitzmann M, 2001, EXP CLIN ENDOCR DIAB, V109, P302, DOI 10.1055/s-2001-16351	90	10	10	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0896-0267	1573-6792		BRAIN TOPOGR	Brain Topogr.	OCT	2012	25	4					431	442		10.1007/s10548-012-0229-y			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	000XX	WOS:000308425200008	22562716				2022-02-06	
